Citrus Sinensis ID: 004954
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 722 | 2.2.26 [Sep-21-2011] | |||||||
| Q9P6P3 | 534 | Serine/threonine-protein | yes | no | 0.422 | 0.571 | 0.388 | 5e-55 | |
| Q9V3D5 | 722 | Dual specificity tyrosine | yes | no | 0.436 | 0.436 | 0.389 | 1e-54 | |
| Q09690 | 1087 | Dual specificity protein | no | no | 0.436 | 0.289 | 0.379 | 2e-54 | |
| Q54BC9 | 915 | Probable serine/threonine | yes | no | 0.418 | 0.330 | 0.387 | 4e-54 | |
| Q8BI55 | 632 | Dual specificity tyrosine | yes | no | 0.427 | 0.488 | 0.384 | 8e-54 | |
| Q09815 | 836 | Serine/threonine-protein | no | no | 0.434 | 0.375 | 0.365 | 3e-53 | |
| Q9NR20 | 520 | Dual specificity tyrosine | yes | no | 0.426 | 0.592 | 0.382 | 2e-52 | |
| A8WJR8 | 815 | Dual specificity tyrosine | N/A | no | 0.448 | 0.397 | 0.36 | 2e-51 | |
| P83102 | 828 | Putative dual specificity | no | no | 0.421 | 0.367 | 0.380 | 6e-51 | |
| Q9XTF3 | 817 | Dual specificity tyrosine | yes | no | 0.448 | 0.396 | 0.357 | 2e-50 |
| >sp|Q9P6P3|PPK15_SCHPO Serine/threonine-protein kinase ppk15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk15 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 216 bits (550), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 134/345 (38%), Positives = 188/345 (54%), Gaps = 40/345 (11%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L T +Y + + LG F +V + QDL T V +K+IKN F++Q + E+ +L+L
Sbjct: 121 LLGTDEGRKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILEL 180
Query: 467 VN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+N K DP D+ H++RLYD F H HL +V ELL NLYE K NQ G L ++
Sbjct: 181 LNNKYDPEDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRG----LHLSLVRS 236
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q L L IIHCDLKPENIL++ +K+ID GS+C + + Y+QSR
Sbjct: 237 FATQLLSCTSLLKQARIIHCDLKPENILLQDLSSPIVKVIDFGSACHERQTVYTYIQSRF 296
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
YR+PEVI+GL Y+ ID+WSLGCILAEL+ G LFP ++ L RI+ MLG ML
Sbjct: 297 YRSPEVILGLHYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLCRIVDMLGNPPTWMLE 356
Query: 646 QGQEIYKYFT-------KEYDLYYI------NEETNQ----------LEYII-------- 674
G+ KY+ K Y+L I N +T Q L+ I+
Sbjct: 357 MGKNSKKYYNSGFVNGRKTYELKSIEQFSIENNKTEQPGKQYFGEKTLDAIVLNYPRRKT 416
Query: 675 -PEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718
P+ + EH + FIDF++ LE+NP +R T +A +HP++
Sbjct: 417 TPKLTPEEHEERLC---FIDFIKQFLELNPLKRWTPDQAKNHPFI 458
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9V3D5|DYRK2_DROME Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Drosophila melanogaster GN=smi35A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 125/321 (38%), Positives = 180/321 (56%), Gaps = 6/321 (1%)
Query: 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
++N + II + IA RY + E +G +F +V +A D T V +KII+N K F +Q++
Sbjct: 181 DDNGNYKIIEHDHIAFRYEILEVIGKGSFGQVIRALDHKTNTHVAIKIIRNKKRFLNQAV 240
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
E+ +L + + D H+++ + DY Y +HL I EL+ NLYE K N +G F
Sbjct: 241 VELNILDELREKDADGSHNVIHMLDYTYFRKHLCITFELMSLNLYELIKKNNYNG----F 296
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
++ ++ ++ L L+ IIHCDLKPENIL+K IK+ID GSSC+ +
Sbjct: 297 SMSLIRRFCNSIVKCLRLLYKENIIHCDLKPENILLKQRGSSSIKVIDFGSSCYVDRKIY 356
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
Y+QSR YR+PEVI+GL Y ID+WSLGCILAEL+TG LFP + V LA I+ +LG
Sbjct: 357 TYIQSRFYRSPEVILGLQYGTAIDMWSLGCILAELYTGFPLFPGENEVEQLACIMEVLG- 415
Query: 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 698
+ ++L+ + F D T + P SL H L D +FIDF++
Sbjct: 416 LPPKVLISVARRRRLFFDSRDAPRCITNTKGRKR-SPGSKSLAHILHCQDRYFIDFLQRC 474
Query: 699 LEINPQRRPTAREALDHPWLQ 719
LE +P R T EA H +LQ
Sbjct: 475 LEWDPAERMTPDEAAHHEFLQ 495
|
In vitro; can phosphorylate exogenous substrates on Ser and Thr residues. May have a physiological role in development being involved in cellular growth and differentiation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q09690|POM1_SCHPO Dual specificity protein kinase pom1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pom1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 123/324 (37%), Positives = 186/324 (57%), Gaps = 9/324 (2%)
Query: 397 GFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD 455
GF+ E D ++L IA RY V ++LG +F +V + D TG V LKII+N K F
Sbjct: 679 GFDDERGDYKVVLGDHIAYRYEVVDFLGKGSFGQVLRCIDYETGKLVALKIIRNKKRFHM 738
Query: 456 QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 515
Q+L E K+L+ + + DP DE+ +++ D+FY +HL + ELL NLYE K N G
Sbjct: 739 QALVETKILQKIREWDPLDEYCMVQYTDHFYFRDHLCVATELLGKNLYELIKSNGFKG-- 796
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
+ ++ ITRQ ++ L L+ +IHCDLKPENIL+ + ++K+ID GSSCF+ +
Sbjct: 797 --LPIVVIKSITRQLIQCLTLLNEKHVIHCDLKPENILLCHPFKSQVKVIDFGSSCFEGE 854
Query: 576 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
+ Y+QSR YR+PEVI+G+ Y ID+WSLGCI+AE++TG LFP + LA I+ +
Sbjct: 855 CVYTYIQSRFYRSPEVILGMGYGTPIDVWSLGCIIAEMYTGFPLFPGENEQEQLACIMEI 914
Query: 636 LGPIDLEMLMQGQEIYKYF-TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 694
GP D ++ + +F + +++ + P SL LQ D F+ F
Sbjct: 915 FGPPDHSLIDKCSRKKVFFDSSGKPRPFVSSKGVSRR---PFSKSLHQVLQCKDVSFLSF 971
Query: 695 VRTLLEINPQRRPTAREALDHPWL 718
+ L+ +P R T ++A H +L
Sbjct: 972 ISDCLKWDPDERMTPQQAAQHDFL 995
|
Involved in localization of polarized growth and cytokinesis. May interact with both the actin and microtubule cytoskeleton. Requires tea1 for localization to the cell ends but not to the cell center. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q54BC9|DYRK2_DICDI Probable serine/threonine-protein kinase dyrk2 OS=Dictyostelium discoideum GN=dyrk2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 119/307 (38%), Positives = 170/307 (55%), Gaps = 5/307 (1%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
IA R+ + LG +F +V + D TG V LKI++N K F +Q+L EIK+L+ + ND
Sbjct: 601 IAYRFEIVSILGQGSFCQVVKGYDYKTGEMVALKILRNQKRFHNQALTEIKILEYLKTND 660
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
P I+ L +YFY HL + ELL NLY+F K N G + L ++ Q L
Sbjct: 661 PNSTASIVHLNNYFYFRNHLILTFELLSMNLYDFLKVNHFQG----YNLNLVRRFGAQIL 716
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
+L +L IIH DLKPENIL+KS + IK+ID GSSCF+ + + Y+QSR YR+PEV
Sbjct: 717 TSLRFLSKRNIIHADLKPENILLKSPTKSGIKLIDFGSSCFENEQIFTYIQSRFYRSPEV 776
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651
I+G YD+ ID+WSLGCIL E++TG LFP LA I+ +LG ++
Sbjct: 777 ILGTKYDKSIDIWSLGCILVEIFTGVPLFPGSDEPEQLACIMEVLGAPPKSVIDNSTRKD 836
Query: 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711
+F + + T Y I + S + ++ D F +F+ L+ P +R TA +
Sbjct: 837 IFFEDDGTPKPVKNSTTGELYTIGTK-SFKDSIRSGDEDFDNFILDCLKWEPSQRITAEQ 895
Query: 712 ALDHPWL 718
L H W+
Sbjct: 896 GLKHDWI 902
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus GN=Dyrk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (540), Expect = 8e-54, Method: Compositional matrix adjust.
Identities = 121/315 (38%), Positives = 172/315 (54%), Gaps = 6/315 (1%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L+ IA RY V E +G +F +V + D V LKII+N K F Q+L E+K+L+
Sbjct: 210 VLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHHQALVELKILEA 269
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ + D + H+++ + D+FY HL I ELL NLYE K N G F L ++
Sbjct: 270 LRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYELMKNNSFHG----FNLSIVRRF 325
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
T L+ L L+ IIHCDLKPENI++ + +K+ID GSSC++ + Y+QSR Y
Sbjct: 326 TFSILKCLHMLYVEKIIHCDLKPENIVLYQRGQVTVKVIDFGSSCYEHQKVYTYIQSRFY 385
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
R+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP + V LA I+ +LG
Sbjct: 386 RSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACIMEVLGLPPAHFTQT 445
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+F + IN Y P+ L ++ D+ F+DF+R L P R
Sbjct: 446 ASRRQVFFDSKGLPKNINNNRGGKRY--PDSKDLTMVVKTYDSSFLDFLRRCLVWEPSLR 503
Query: 707 PTAREALDHPWLQHP 721
T +AL H W+ P
Sbjct: 504 MTPEQALKHAWIHEP 518
|
Possible non-essential role in spermiogenesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q09815|PPK5_SCHPO Serine/threonine-protein kinase ppk5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (535), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 117/320 (36%), Positives = 178/320 (55%), Gaps = 6/320 (1%)
Query: 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
++N D I + RY + + +G +F +V + D G V +K+IKN + F Q+L
Sbjct: 501 DDNGDYKAIQGDHLLYRYEIIDTVGKGSFGQVLKCIDHKRGQVVAIKVIKNRQKFHGQTL 560
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
E+ +LK + + DPAD+++++R +F HL IV ELL +NL++ + N G
Sbjct: 561 VEVGILKRLCEADPADKNNVIRYLSHFDFRGHLCIVTELLGSNLFDVIRENNYKG----L 616
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
L ++ Q L+AL L IIHCDLKPEN+L+ + IK+ID GSSCF + +
Sbjct: 617 PLIVVKSFALQGLQALRLLQGQNIIHCDLKPENLLLSHPLKARIKLIDFGSSCFYNEKVY 676
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
Y+QSR YRAPE+I+GL Y ++ID+WS GCILAEL+TG LFP L I+ +LGP
Sbjct: 677 TYLQSRFYRAPEIILGLEYGKEIDIWSFGCILAELFTGVPLFPGGNETEQLGYIMEVLGP 736
Query: 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 698
+ ++ YF E + I + N+L ++P + L A F+DF+
Sbjct: 737 PPMALIRNSTRSKAYFDSEGKPHPITDSHNRL--LVPSTRTFSQLLNTKQASFLDFLSKC 794
Query: 699 LEINPQRRPTAREALDHPWL 718
L+ +P+ R T AL H ++
Sbjct: 795 LKWDPKDRITVDSALQHEFI 814
|
Has a role in meiosis. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 207 bits (528), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 120/314 (38%), Positives = 170/314 (54%), Gaps = 6/314 (1%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L+ IA RY V E +G +F +V + D V LKII+N K F Q+L E+K+L+
Sbjct: 95 VLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHQQALMELKILEA 154
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ K D + ++++ + D+FY H I ELL NLYE K N G F+L ++
Sbjct: 155 LRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQG----FSLSIVRRF 210
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC++ + Y+QSR Y
Sbjct: 211 TLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCYEHQKVYTYIQSRFY 270
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
R+PEVI+G PYD ID+WSLGCI AEL+TG LFP + V LA I+ +LG +
Sbjct: 271 RSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACIMEVLGLPPAGFIQT 330
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+F + I + Y P+ L L+ D F+DF+R L P R
Sbjct: 331 ASRRQTFFDSKGFPKNITNNRGKKRY--PDSKDLTMVLKTYDTSFLDFLRRCLVWEPSLR 388
Query: 707 PTAREALDHPWLQH 720
T +AL H W+
Sbjct: 389 MTPDQALKHAWIHQ 402
|
Possible non-essential role in spermiogenesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|A8WJR8|MBK2_CAEBR Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 OS=Caenorhabditis briggsae GN=mbk-2 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 126/350 (36%), Positives = 183/350 (52%), Gaps = 26/350 (7%)
Query: 389 IIHRKNRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII 447
+I N G++ EN ++++ IA RY V + +G +F +V +A D V LK++
Sbjct: 432 VIGGANNGGYDDENGSYQLVVHDHIAYRYEVLKVIGKGSFGQVIKAFDHKYQQYVALKLV 491
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQK 507
+N+K F Q+ +EI++L + + D H+I+ + DYF H I ELL NLYE K
Sbjct: 492 RNEKRFHRQADEEIRILDHLRRQDSDGTHNIIHMLDYFNFRNHKCITFELLSINLYELIK 551
Query: 508 FNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567
N+ G F+L ++ L L+ L +IHCDLKPEN+L+K R IK+ID
Sbjct: 552 RNKFQG----FSLMLVRKFAYSMLLCLDLLQKNRLIHCDLKPENVLLKQQGRSGIKVIDF 607
Query: 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP----ND 623
GSSCF + Y+QSR YRAPEVI+G Y ID+WSLGCILAEL TG L P ND
Sbjct: 608 GSSCFDDQRIYTYIQSRFYRAPEVILGTKYGMPIDMWSLGCILAELLTGYPLLPGEDEND 667
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYII--------- 674
+ +I+ ++GM P LE + + +K Y Y ++
Sbjct: 668 QLALII-ELLGMPPPKSLETAKRARTFIT--SKGYPRYCTATSMPDGSVVLAGARSKRGK 724
Query: 675 ----PEESSLEHHLQ-FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
PE S L+ D F+DF++ L+ +P+ R T +AL H WL+
Sbjct: 725 MRGPPESRSWSTALKNMGDELFVDFLKRCLDWDPETRMTPAQALKHKWLR 774
|
Required for oocyte-to-zygote transition in which it phosphorylates oocyte proteins, including mei-1, oma-1, oma-2, mex-5, and mex-6, modifying their activity and/or stability following meiosis. Functions in both spindle positioning and in the posterior localization of cytoplasmic determinants, including pie-1, pos-1, and pgl-1, in early embryos. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P83102|DYRK3_DROME Putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog OS=Drosophila melanogaster GN=Dyrk3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 202 bits (515), Expect = 6e-51, Method: Compositional matrix adjust.
Identities = 123/323 (38%), Positives = 180/323 (55%), Gaps = 19/323 (5%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+A RY + + +G +F +V +A D T V LKI++N+K F Q+ +EI++L + ++D
Sbjct: 272 VAYRYEMLKIIGKGSFGQVIKAYDHKTHEHVALKIVRNEKRFHRQAQEEIRILHHLRRHD 331
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ +I+ ++DYF H I ELL NLYE K N G F+L ++ L
Sbjct: 332 KYNTMNIIHMFDYFTFRNHTCITFELLSINLYELIKKNGFKG----FSLQLVRKFAHSLL 387
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
+ L+ L+ IIHCD+KPEN+L+K R IK+ID GSSCF+ + Y+QSR YRAPEV
Sbjct: 388 QCLDALYKNDIIHCDMKPENVLLKQQGRSGIKVIDFGSSCFENQRIYTYIQSRFYRAPEV 447
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651
I+G Y + ID+WSLGCILAEL +G LFP + LA II +LG + +L +
Sbjct: 448 ILGGKYGRAIDMWSLGCILAELLSGHALFPGENESDQLACIIEVLGMPNKNILASSKRSK 507
Query: 652 KYFT-KEYDLY-YINEETNQLEYII------------PEESSLEHHLQ-FSDAFFIDFVR 696
+F+ K Y Y + ++ + +I P SL L D F++F+R
Sbjct: 508 SFFSPKGYPRYCTVRTMSDGMVVLIGGQSRRGKQRGPPCSKSLSKALDGCKDPLFLNFIR 567
Query: 697 TLLEINPQRRPTAREALDHPWLQ 719
LE + +R T EAL HPWL+
Sbjct: 568 GCLEWDADKRLTPSEALKHPWLR 590
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9XTF3|MBK2_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 OS=Caenorhabditis elegans GN=mbk-2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 125/350 (35%), Positives = 182/350 (52%), Gaps = 26/350 (7%)
Query: 389 IIHRKNRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII 447
+I N G++ EN ++++ IA RY V + +G +F +V +A D V LK++
Sbjct: 433 VIGGANNGGYDDENGSYQLVVHDHIAYRYEVLKVIGKGSFGQVIKAFDHKYQQYVALKLV 492
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQK 507
+N+K F Q+ +EI++L + + D H+I+ + DYF H I ELL NLYE K
Sbjct: 493 RNEKRFHRQADEEIRILDHLRRQDSDGTHNIIHMLDYFNFRNHKCITFELLSINLYELIK 552
Query: 508 FNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567
N+ G F+L ++ L L+ L +IHCDLKPEN+L+K R IK+ID
Sbjct: 553 RNKFQG----FSLMLVRKFAYSMLLCLDLLQKNRLIHCDLKPENVLLKQQGRSGIKVIDF 608
Query: 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP----ND 623
GSSCF + Y+QSR YRAPEVI+G Y ID+WSLGCILAEL TG L P ND
Sbjct: 609 GSSCFDDQRIYTYIQSRFYRAPEVILGTKYGMPIDMWSLGCILAELLTGYPLLPGEDEND 668
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYII--------- 674
+ +I+ ++GM P LE + + +K Y Y ++
Sbjct: 669 QLALII-ELLGMPPPKSLETAKRARTFIT--SKGYPRYCTATSMPDGSVVLAGARSKRGK 725
Query: 675 ----PEESSLEHHLQ-FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
P S L+ D F+DF++ L+ +P+ R T +AL H WL+
Sbjct: 726 MRGPPASRSWSTALKNMGDELFVDFLKRCLDWDPETRMTPAQALKHKWLR 775
|
Required for oocyte-to-zygote transition in which it phosphorylates oocyte proteins, including mei-1, oma-1, oma-2, mex-5, and mex-6, modifying their activity and/or stability following meiosis. Functions in both spindle positioning and in the posterior localization of cytoplasmic determinants, including pie-1, pos-1, and pgl-1, in early embryos. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 722 | ||||||
| 224101151 | 725 | predicted protein [Populus trichocarpa] | 0.939 | 0.935 | 0.626 | 0.0 | |
| 297736602 | 728 | unnamed protein product [Vitis vinifera] | 0.977 | 0.969 | 0.639 | 0.0 | |
| 356551440 | 710 | PREDICTED: dual specificity tyrosine-pho | 0.961 | 0.977 | 0.597 | 0.0 | |
| 255585370 | 609 | ATP binding protein, putative [Ricinus c | 0.529 | 0.627 | 0.825 | 0.0 | |
| 359486399 | 596 | PREDICTED: probable serine/threonine-pro | 0.519 | 0.629 | 0.813 | 0.0 | |
| 224109312 | 591 | predicted protein [Populus trichocarpa] | 0.481 | 0.588 | 0.842 | 1e-179 | |
| 356501164 | 593 | PREDICTED: probable serine/threonine-pro | 0.502 | 0.612 | 0.816 | 1e-177 | |
| 449441300 | 575 | PREDICTED: dual specificity protein kina | 0.472 | 0.593 | 0.812 | 1e-174 | |
| 226506060 | 725 | ATP binding protein [Zea mays] gi|195616 | 0.929 | 0.925 | 0.479 | 1e-171 | |
| 357125722 | 715 | PREDICTED: dual specificity protein kina | 0.918 | 0.927 | 0.478 | 1e-171 |
| >gi|224101151|ref|XP_002312161.1| predicted protein [Populus trichocarpa] gi|222851981|gb|EEE89528.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2308), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/749 (62%), Positives = 551/749 (73%), Gaps = 71/749 (9%)
Query: 8 DVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQTEVD 67
DVE V++FLRKNG ++AE ALKEDM+E+ +LGSFD+EKFLF VLPPV++PAS+R +V+
Sbjct: 14 DVEAVLDFLRKNGLRDAELALKEDMIERSNELGSFDFEKFLF-VLPPVRVPASVRPLDVE 72
Query: 68 EGGADRSSRSSSASSSDDDEFVSLASSTS--DLCSSEFTNPYGLRSTSHGNSEASSESLS 125
EGG SS+ S DDEFVSL SSTS ++ SSEF+NPYGL STS NSE SS+ LS
Sbjct: 73 EGGGAVERLRSSSGSPSDDEFVSLGSSTSASEVYSSEFSNPYGLHSTSQANSETSSDRLS 132
Query: 126 QFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFENP 182
QF TARDY D+QND YW+DEK+EG+FM+P + G D+FGCPSEDKF+MTSE + FEN
Sbjct: 133 QFGTARDYPDFDMQNDSYWYDEKEEGHFMSPCFNGPDYFGCPSEDKFVMTSETGKQFENS 192
Query: 183 LAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYR-FEKTNQPEAGGIKEKL 241
L +YD+SEG ++ + DYLDK CL+++ +N+ E +Y+ F+K NQ E G I
Sbjct: 193 LGLYDKSEG-ETQGNIDYLDKQCLYNVTSVNNKNEAQSMNYHHDFDKKNQLE-GDID--- 247
Query: 242 KDCAAYGCSEPLCKCCAGEGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGTE 301
+D ++ ++ + G+I+ D Y SSK DL D Q VG+S TD D P
Sbjct: 248 RDGSSAHNAKFFTETGGIYGRISVDCIYTSSKGPDLGDFQLK-VGESPTDYDTVP----- 301
Query: 302 KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRD-GEVNGALHEGKA 360
+H + + ID+ + D G VNG HE A
Sbjct: 302 -------------------------VHMENKNANYYENGIDDFEVGDGGGVNGEAHELAA 336
Query: 361 DAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNR------------------------- 395
V +LLM+ N E+E E+F+LR+IHRKNR
Sbjct: 337 AIGGEDVNANELLMYYNQEDEYEVFNLRVIHRKNRSCGHGIDPADSTLFSWRSDACAMQV 396
Query: 396 --TGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF 453
TGFEENKDLPI+LNTVIAGRYYVTEYLGSAAFSKV QA DLHTG+DVCLKIIKNDKDF
Sbjct: 397 KWTGFEENKDLPIVLNTVIAGRYYVTEYLGSAAFSKVIQAHDLHTGIDVCLKIIKNDKDF 456
Query: 454 FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESG 513
FDQSLDEIKLLK+VNK DPADE HILRLYDYFYH EHLFIVCELL+ANLYEFQKFNQESG
Sbjct: 457 FDQSLDEIKLLKIVNKLDPADERHILRLYDYFYHQEHLFIVCELLKANLYEFQKFNQESG 516
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
GEAYFTL RLQVITRQCLEALEYLH LGIIHCDLKPEN+LIKSY++CEIK+IDLGSSCF+
Sbjct: 517 GEAYFTLSRLQVITRQCLEALEYLHDLGIIHCDLKPENVLIKSYRKCEIKVIDLGSSCFK 576
Query: 574 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+DNLCLYVQSRSYRAPEVI+GLPYDQKIDLWSLGCILAEL +GEVLFPNDAVVMIL R+I
Sbjct: 577 SDNLCLYVQSRSYRAPEVILGLPYDQKIDLWSLGCILAELCSGEVLFPNDAVVMILTRMI 636
Query: 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFID 693
GMLGP+D EML GQE +KYFT+EYDLY++NEETNQ+EY+IPEESSLEHHLQ SD FID
Sbjct: 637 GMLGPLDPEMLETGQETHKYFTEEYDLYHLNEETNQVEYLIPEESSLEHHLQVSDVGFID 696
Query: 694 FVRTLLEINPQRRPTAREALDHPWLQHPY 722
FVR LLE+NP RRPTAREAL+HPWL H Y
Sbjct: 697 FVRDLLELNPLRRPTAREALEHPWLSHSY 725
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736602|emb|CBI25473.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/730 (63%), Positives = 556/730 (76%), Gaps = 24/730 (3%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPV---KIPAS 60
++ SDV+ V+EFLRK G E+ESAL++D+ E+ + SFD+E F+FP++PP +IPAS
Sbjct: 1 MAVSDVDAVLEFLRKYGLSESESALRQDVSER-GGVASFDFESFVFPMVPPPPPVRIPAS 59
Query: 61 LRQTEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEAS 120
R+ E G D SS S D+FVSL SS +D SSEFTNPYG+ S + NS AS
Sbjct: 60 SRRMEEAVGDTDSSSVCS-------DDFVSLGSSATDAYSSEFTNPYGVHSATQANSTAS 112
Query: 121 SESLSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADR 177
S+SL +F TARDY D+QND YW+DEKD+ YF T +GGS+ FGCPSEDKF+MT E D+
Sbjct: 113 SDSLCEFGTARDYSDFDMQNDLYWYDEKDDDYFNTSCFGGSESFGCPSEDKFVMTLEKDK 172
Query: 178 LFENPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGI 237
E+ L + +SEG + +T+YL+KPC+F++ ++ ++ VTDYY + QP+ G
Sbjct: 173 QSESQLTLIHKSEGYPTLPTTNYLEKPCVFNLTSMDGVNDIPVTDYYHLGEHFQPD-GAR 231
Query: 238 KEKLKDCAAYGCSEPLCKCCAG----EGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCD 293
+ + CA Y CS PLCKCCAG G DY ++ E DL Q VVG TDCD
Sbjct: 232 EGDHESCAVYSCSVPLCKCCAGAEGFRGGDPVDYSQMNFAETDLDGSQLKVVGKIPTDCD 291
Query: 294 LAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNG 353
A KS YS KR S+ D I FK +SDLH + E + DGEV G
Sbjct: 292 SASEYKINKSFDYSI-KRSSANDLIGEFKSTSDLHIENTEPN---GNYGYEVGDDGEVAG 347
Query: 354 ALHEGKADAEEHGVATPD-LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVI 412
+E +A+ ++ AT D LLM++N E+E E+F+LRIIHRKNRTGFEENKDLPI+LNTV+
Sbjct: 348 ECYEPEANVDDQEGATADELLMYENQEDEYEVFNLRIIHRKNRTGFEENKDLPIVLNTVL 407
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK+DP
Sbjct: 408 AGRYYITEYLGSAAFSKVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKYVNKHDP 467
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
ADE HILRLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YFTL RLQVITRQCLE
Sbjct: 468 ADERHILRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGETYFTLKRLQVITRQCLE 527
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
ALEYLH LGIIHCDLKPENILIKSY+RC+IK+IDLGSSCF+TDNL LYVQSRSYRAPEVI
Sbjct: 528 ALEYLHDLGIIHCDLKPENILIKSYRRCDIKVIDLGSSCFRTDNLSLYVQSRSYRAPEVI 587
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652
+GLPYDQ+ID+WSLGCILAEL +GEVLFPND +V +L R+IGMLGPIDLEML++GQE YK
Sbjct: 588 LGLPYDQRIDIWSLGCILAELCSGEVLFPNDELVTLLVRMIGMLGPIDLEMLVRGQETYK 647
Query: 653 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712
YFTKEYDLY+INEETN++EY+IPEESSLE HLQ SD F++F+R LLEINPQRRPTA+EA
Sbjct: 648 YFTKEYDLYHINEETNEMEYLIPEESSLEDHLQISDVGFLNFLRDLLEINPQRRPTAKEA 707
Query: 713 LDHPWLQHPY 722
LDHPWL H Y
Sbjct: 708 LDHPWLSHSY 717
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551440|ref|XP_003544083.1| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2048), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/730 (59%), Positives = 520/730 (71%), Gaps = 36/730 (4%)
Query: 6 SSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQTE 65
S+ VE V+EFLRKNG EAESAL++D++E DLG+FDYEKF FP++PP +
Sbjct: 4 SNGVEAVLEFLRKNGLSEAESALRQDIIEN-NDLGNFDYEKFFFPMVPPPPPVRVRSFSR 62
Query: 66 VDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSH--GNSEASSES 123
+ E AD + S S DEFVS+ S TS + SSEF NPYG+RS+S +S +SSE
Sbjct: 63 LSELSAD-----GNCSKSSSDEFVSIGSPTSRVSSSEFINPYGIRSSSQTQNDSASSSER 117
Query: 124 LSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
LSQF TARDY ++QN+ YW++EKD+ YFMTPS+ G DFF C SEDKF+MT+E + +
Sbjct: 118 LSQFGTARDYHDFEMQNEPYWYNEKDDDYFMTPSFEGPDFFACQSEDKFVMTAETENQHD 177
Query: 181 NPL-AVYDQSEGL-HSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIK 238
N L VY+ E L + ++DK CL++ + D +Y + N E
Sbjct: 178 NSLDLVYNSEEFLLKGNGNGGFMDKACLYNHSSVRDGNATYSKEYCHVDNNNLFEGELEG 237
Query: 239 EKLKDCAAYGCSEPLCKCCAGEGKINND---YGYLSSKEADLIDLQHNVVGDSSTDCDLA 295
+ K A C P CK G G + D +GY + KE I L+ + + +L
Sbjct: 238 KAEKHTVACSCEVPFCKSSPG-GSCSLDPTNFGYPNLKE---IHLKFGDINSFDSTSELT 293
Query: 296 PHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGAL 355
+ + + SSK + G DL K +KDL P +D RDG G L
Sbjct: 294 VNQSFDYYTKNDSSKE---------YNGPYDLTIKVNQKDL-PNGLDTYKARDG---GEL 340
Query: 356 HEGKADAE---EHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVI 412
E D E + T D L+ EEE E+F LRIIHRKNRTGFEENK+LPI+LNTV+
Sbjct: 341 AEECQDPEITADGEDTTDDELLKYTQEEEYEVFDLRIIHRKNRTGFEENKELPIVLNTVL 400
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AGRYYVTEYLGSAAFS+V QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLKLVNK+DP
Sbjct: 401 AGRYYVTEYLGSAAFSRVVQAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKLLKLVNKHDP 460
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
AD HH LRLYDYFYH EHLFIV ELL+ANLYEFQKF QESGGE YFTL RLQ+ITRQCLE
Sbjct: 461 ADLHHFLRLYDYFYHQEHLFIVTELLQANLYEFQKFKQESGGEEYFTLNRLQLITRQCLE 520
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
AL+YLHSLGI+HCDLKPENILIKSY+RCEIK+IDLGSSCFQTDNLCLYVQSRSYRAPEV+
Sbjct: 521 ALQYLHSLGIVHCDLKPENILIKSYRRCEIKVIDLGSSCFQTDNLCLYVQSRSYRAPEVM 580
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652
+GL YD+KID+WSLGCILAEL +GEVLFPNDAVVMILAR+IGM G ID+EML++GQE +K
Sbjct: 581 LGLQYDEKIDIWSLGCILAELCSGEVLFPNDAVVMILARMIGMFGSIDMEMLVKGQETHK 640
Query: 653 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712
YFTKEYD+YY+NEET+QLEYIIPEESSLE HLQ +D FIDFVR LL INP+RRPTAR+A
Sbjct: 641 YFTKEYDIYYVNEETDQLEYIIPEESSLEQHLQVTDTTFIDFVRYLLSINPKRRPTARQA 700
Query: 713 LDHPWLQHPY 722
L HPWL + Y
Sbjct: 701 LRHPWLSYVY 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585370|ref|XP_002533381.1| ATP binding protein, putative [Ricinus communis] gi|223526774|gb|EEF28999.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/384 (82%), Positives = 344/384 (89%), Gaps = 2/384 (0%)
Query: 341 IDNSDTRDGEVNGALHEGKADAEEHG--VATPDLLMFDNLEEECEIFHLRIIHRKNRTGF 398
+ +S + GE N E +A EE V T DLLM D E+E E+F LRIIHRKNRTGF
Sbjct: 221 MKSSKDKIGEANEEADELRATEEEEDGEVNTNDLLMLDAQEDEYEVFDLRIIHRKNRTGF 280
Query: 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
EENKDLPI+LNTVIAGRYYVTEYLGSAAFSKV QA DL+TG+DVCLKIIKNDKDFFDQSL
Sbjct: 281 EENKDLPIVLNTVIAGRYYVTEYLGSAAFSKVVQAHDLYTGIDVCLKIIKNDKDFFDQSL 340
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
DEIKLLKLVNK+DPADE HI+RLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YF
Sbjct: 341 DEIKLLKLVNKHDPADERHIIRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGEPYF 400
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
TL RLQVITRQCLEALEYLH LGIIHCDLKPENILIKSY+RCEIK+IDLGSSCFQ+DNLC
Sbjct: 401 TLSRLQVITRQCLEALEYLHHLGIIHCDLKPENILIKSYRRCEIKVIDLGSSCFQSDNLC 460
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
LYVQSRSYRAPEVI+GLPYDQKIDLWSLGCILAEL +GEVLFPNDAVVMILAR+IGMLGP
Sbjct: 461 LYVQSRSYRAPEVILGLPYDQKIDLWSLGCILAELCSGEVLFPNDAVVMILARVIGMLGP 520
Query: 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 698
IDLEML++GQE +KYFT EYDLYY+NEE NQ+EYIIPEESSLEHHLQ SD FIDFV++L
Sbjct: 521 IDLEMLVRGQETHKYFTTEYDLYYVNEEKNQIEYIIPEESSLEHHLQTSDVEFIDFVKSL 580
Query: 699 LEINPQRRPTAREALDHPWLQHPY 722
LE+NP RRPTAREAL+HPWL + Y
Sbjct: 581 LEVNPVRRPTAREALEHPWLLYSY 604
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486399|ref|XP_002272072.2| PREDICTED: probable serine/threonine-protein kinase dyrk2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1670), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 306/376 (81%), Positives = 342/376 (90%), Gaps = 1/376 (0%)
Query: 348 DGEVNGALHEGKADAEEHGVATPD-LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPI 406
DGEV G +E +A+ ++ AT D LLM++N E+E E+F+LRIIHRKNRTGFEENKDLPI
Sbjct: 210 DGEVAGECYEPEANVDDQEGATADELLMYENQEDEYEVFNLRIIHRKNRTGFEENKDLPI 269
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+LNTV+AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK
Sbjct: 270 VLNTVLAGRYYITEYLGSAAFSKVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKY 329
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
VNK+DPADE HILRLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YFTL RLQVI
Sbjct: 330 VNKHDPADERHILRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGETYFTLKRLQVI 389
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
TRQCLEALEYLH LGIIHCDLKPENILIKSY+RC+IK+IDLGSSCF+TDNL LYVQSRSY
Sbjct: 390 TRQCLEALEYLHDLGIIHCDLKPENILIKSYRRCDIKVIDLGSSCFRTDNLSLYVQSRSY 449
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
RAPEVI+GLPYDQ+ID+WSLGCILAEL +GEVLFPND +V +L R+IGMLGPIDLEML++
Sbjct: 450 RAPEVILGLPYDQRIDIWSLGCILAELCSGEVLFPNDELVTLLVRMIGMLGPIDLEMLVR 509
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
GQE YKYFTKEYDLY+INEETN++EY+IPEESSLE HLQ SD F++F+R LLEINPQRR
Sbjct: 510 GQETYKYFTKEYDLYHINEETNEMEYLIPEESSLEDHLQISDVGFLNFLRDLLEINPQRR 569
Query: 707 PTAREALDHPWLQHPY 722
PTA+EALDHPWL H Y
Sbjct: 570 PTAKEALDHPWLSHSY 585
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224109312|ref|XP_002315156.1| predicted protein [Populus trichocarpa] gi|222864196|gb|EEF01327.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1636), Expect = e-179, Method: Compositional matrix adjust.
Identities = 300/356 (84%), Positives = 329/356 (92%)
Query: 367 VATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAA 426
V +LLM+ N E+E E+F+LR+IHRKNRTGFEENKDLPI+LNTVIAGRYYVTEYLGSAA
Sbjct: 236 VNAAELLMYYNQEDEYEVFNLRVIHRKNRTGFEENKDLPIVLNTVIAGRYYVTEYLGSAA 295
Query: 427 FSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486
FSKV QA DLHTG+DVCLKIIKNDKDFFDQSLDEIKLLK+VNK+DPADE HILRLYDYFY
Sbjct: 296 FSKVIQAHDLHTGIDVCLKIIKNDKDFFDQSLDEIKLLKIVNKHDPADERHILRLYDYFY 355
Query: 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCD 546
H EHLFIVCELL+ANLYEFQKF+QES G+AYFTL RLQVITRQCLEALEYLH LGIIHCD
Sbjct: 356 HQEHLFIVCELLKANLYEFQKFSQESDGKAYFTLSRLQVITRQCLEALEYLHHLGIIHCD 415
Query: 547 LKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSL 606
LKPENILIKSY+RCEIK+IDLGSSCF++DNLCLYVQSRSYRAPEVI+GLPYDQKIDLWSL
Sbjct: 416 LKPENILIKSYRRCEIKVIDLGSSCFKSDNLCLYVQSRSYRAPEVILGLPYDQKIDLWSL 475
Query: 607 GCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEE 666
GCILAEL +GEVLFPNDAVVMILAR+IGMLGPI EML+ GQE +KYFT+EYDLYY NEE
Sbjct: 476 GCILAELCSGEVLFPNDAVVMILARMIGMLGPIHSEMLVMGQETHKYFTEEYDLYYSNEE 535
Query: 667 TNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
TNQ+EY+IPEESSLEHHLQ SD FIDF+R LLE+NP RR TA+EAL+HPWL H Y
Sbjct: 536 TNQIEYLIPEESSLEHHLQISDVGFIDFMRNLLELNPLRRLTAKEALEHPWLSHSY 591
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501164|ref|XP_003519398.1| PREDICTED: probable serine/threonine-protein kinase dyrk2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1617), Expect = e-177, Method: Compositional matrix adjust.
Identities = 299/366 (81%), Positives = 331/366 (90%), Gaps = 3/366 (0%)
Query: 357 EGKADAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRY 416
E AD E+ T D L+ EEE E+F LRIIHRKNRTGFEENK+LPI+LNTV+AGRY
Sbjct: 231 EITADGED---TTDDELLKYTQEEEYEVFDLRIIHRKNRTGFEENKELPIVLNTVLAGRY 287
Query: 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476
YVTEYLGSAAFS+V QA DL TG+D CLKIIKNDKDFFDQSLDEIKLLKLVNK+DPAD+H
Sbjct: 288 YVTEYLGSAAFSRVVQAHDLQTGIDFCLKIIKNDKDFFDQSLDEIKLLKLVNKHDPADKH 347
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
HILRLYDYFYH EHLFIV ELLRANLYEFQKFNQESGGEAYFTL RLQ+ITRQCLEAL+Y
Sbjct: 348 HILRLYDYFYHQEHLFIVTELLRANLYEFQKFNQESGGEAYFTLNRLQLITRQCLEALQY 407
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLP 596
LHSLGI+HCDLKPENILIKSY+RCEIK+IDLGSSCFQTDNLCLYVQSRSYRAPEV++GL
Sbjct: 408 LHSLGIVHCDLKPENILIKSYRRCEIKVIDLGSSCFQTDNLCLYVQSRSYRAPEVMLGLQ 467
Query: 597 YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK 656
YD+KIDLWSLGCILAEL +GEVLFPNDAVVMILAR+IGMLG ID+EML++GQE +KYFTK
Sbjct: 468 YDEKIDLWSLGCILAELCSGEVLFPNDAVVMILARMIGMLGSIDMEMLVKGQETHKYFTK 527
Query: 657 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716
EYD+YY+NEET+QLEYIIPEESSLE HLQ +D FIDFVR LL INP+RRP+AR+AL HP
Sbjct: 528 EYDIYYVNEETDQLEYIIPEESSLEQHLQVTDTMFIDFVRYLLSINPKRRPSARQALRHP 587
Query: 717 WLQHPY 722
WL + Y
Sbjct: 588 WLSYVY 593
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441300|ref|XP_004138420.1| PREDICTED: dual specificity protein kinase pom1-like [Cucumis sativus] gi|449533074|ref|XP_004173502.1| PREDICTED: dual specificity protein kinase pom1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1590), Expect = e-174, Method: Compositional matrix adjust.
Identities = 290/357 (81%), Positives = 326/357 (91%)
Query: 366 GVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSA 425
A +L M+ ++E E+F LRIIHRKNRTGFEE+KDLPI+LNTV+AGRYYVTEYLGSA
Sbjct: 218 AAADDELPMYYTNDDEFEVFDLRIIHRKNRTGFEESKDLPIVLNTVLAGRYYVTEYLGSA 277
Query: 426 AFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485
AFS+V +A DLH GVDVCLKIIKNDK+FFDQSLDEIKLLKLVNK+DPAD+ HILRLYDYF
Sbjct: 278 AFSRVVRAHDLHMGVDVCLKIIKNDKEFFDQSLDEIKLLKLVNKHDPADQCHILRLYDYF 337
Query: 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHC 545
YH EHLFIVCELLRANLYEFQKFNQESGG+AYFT RLQVITRQCLEALE+LH LGIIHC
Sbjct: 338 YHQEHLFIVCELLRANLYEFQKFNQESGGDAYFTFRRLQVITRQCLEALEFLHHLGIIHC 397
Query: 546 DLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWS 605
DLKPENILIKSY+RCEIK+IDLGSSCFQ+DNLCLYVQSRSYRAPEV++GLPY+ KIDLWS
Sbjct: 398 DLKPENILIKSYKRCEIKVIDLGSSCFQSDNLCLYVQSRSYRAPEVMLGLPYNPKIDLWS 457
Query: 606 LGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
LGCILAELW+GEVLFPN+AVVMILAR+IG+ GPIDLEML++GQE +KYFTKEYDL+YINE
Sbjct: 458 LGCILAELWSGEVLFPNNAVVMILARMIGLFGPIDLEMLLKGQETHKYFTKEYDLFYINE 517
Query: 666 ETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
ET+Q+E+IIPEESSLE HLQ D FIDF+ +LLEINP+RRPTA+EAL HPWL Y
Sbjct: 518 ETDQMEFIIPEESSLEDHLQVFDLGFIDFLTSLLEINPERRPTAKEALAHPWLSQSY 574
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|226506060|ref|NP_001148168.1| ATP binding protein [Zea mays] gi|195616354|gb|ACG30007.1| ATP binding protein [Zea mays] gi|414879861|tpg|DAA56992.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1572), Expect = e-171, Method: Compositional matrix adjust.
Identities = 371/773 (47%), Positives = 459/773 (59%), Gaps = 102/773 (13%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL +GF A SAL++D++E+ G ++ L P LPP+++PAS
Sbjct: 1 MAAPGLDKVMAFLTDHGFAGAASALRDDVLERTA-AGDESHDAALDPHLPPLRMPASAGG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDE------FVSLASSTSDLCSSEFTNPYGLRSTSHGNS 117
G + + AS FVSL S+ S L NPYGL S H S
Sbjct: 60 AGAGAGAGAGAGTPTPASPGSSSGSASSSAFVSLRSTPSGL-----LNPYGLWSPRHSQS 114
Query: 118 EASSESLSQFDTARDYDLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADR 177
+ASS + +F TAR YD + F+ ++D Y D
Sbjct: 115 DASSSEM-EFGTARQYDTTDLFF---QEDWLY-------------------------DDH 145
Query: 178 LFENPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGI 237
LF + L D + D D I ++G +R E GG
Sbjct: 146 LFPSKLDDEDDEGKEEDKFVLDAHDGSEQVEI------GKLGAGHNHRHEHI-----GG- 193
Query: 238 KEKLKDCA-AYGCSEPLCKCCAGEGKINN-DYGYLSSKEA----DLIDLQHNVVGDSSTD 291
++ + CA Y CS PLC CC G K + D SS ++D Q ++ D + D
Sbjct: 194 -DRCEGCAEVYICSSPLCGCCGGGLKNDGLDVARSSSSTVYGRYKIMDDQTEILDDCAQD 252
Query: 292 -------------CDLAPHPG----------TEKS----SSYSSSKRGSSIDWIEG--FK 322
C + PG EK SS+ + + D+ E
Sbjct: 253 AFQLKQSRDIMFECGMTRDPGRGYDDSGLSVVEKELQILSSFDTVVNHGTYDFTENGELN 312
Query: 323 GSSDLHFKGAEKDLMP-----------AEIDNSD--TRDGEVNGALHEGKADAEEHGVAT 369
GS D + K + P ++D +D G +N + A E T
Sbjct: 313 GSCDKNLKSSIHKEYPKGHRIQPFPESGDLDEADEFRHVGSLNTDVQHSTALKAEEDAET 372
Query: 370 PDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSK 429
L + E E+F LRIIHRKNRTGFEENKD PI+LN+V+AGRYY+TEYLGSAAFSK
Sbjct: 373 NIDLALSDFHREYEVFELRIIHRKNRTGFEENKDFPIVLNSVVAGRYYITEYLGSAAFSK 432
Query: 430 VFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489
V QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK DP DEHH+LRLYDYFYH E
Sbjct: 433 VVQAHDLRTGMDVCLKIIKNDKDFFDQSLDEIKLLKFVNKYDPLDEHHVLRLYDYFYHQE 492
Query: 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549
HLFIV ELLRANLYEFQK+NQESGGE YFTL R+QVI RQCLEAL YLH L IIHCDLKP
Sbjct: 493 HLFIVTELLRANLYEFQKYNQESGGEVYFTLPRIQVIARQCLEALVYLHRLRIIHCDLKP 552
Query: 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCI 609
ENILIKSY RCEIK+IDLGSSCF TDNLCLYVQSRSYRAPEVI+GLPYDQ+ID+WSLGCI
Sbjct: 553 ENILIKSYSRCEIKVIDLGSSCFLTDNLCLYVQSRSYRAPEVILGLPYDQRIDIWSLGCI 612
Query: 610 LAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQ 669
L+EL+TGEVLFPN+ V ++LA++IG+ GPID+EML GQE KYFT +YDL+ NEET+Q
Sbjct: 613 LSELYTGEVLFPNEPVSVMLAQMIGITGPIDMEMLELGQETQKYFTDDYDLFTENEETDQ 672
Query: 670 LEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
LEY+IPE+SSL H+Q D+ F+DF+ LL+INP++RPTA EAL HPWL Y
Sbjct: 673 LEYLIPEKSSLRQHIQCPDSEFVDFLSYLLQINPRKRPTADEALQHPWLSFSY 725
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357125722|ref|XP_003564539.1| PREDICTED: dual specificity protein kinase YAK1-like isoform 2 [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1569), Expect = e-171, Method: Compositional matrix adjust.
Identities = 369/771 (47%), Positives = 457/771 (59%), Gaps = 108/771 (14%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL ++GF SAL++D++++ D G D L P LPP+++PAS
Sbjct: 1 MAAPGLDEVMAFLTEHGFASTASALRDDVLDRSAD-GESDSTATLGPQLPPLRLPASASG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEASSES 123
+ + S+S+S S A + S NPYG+ S H S+ SS
Sbjct: 60 GAGGGVALEAPASPGSSSNSA----SSSAFVSMSSSPSGLLNPYGVWSPPHSQSDGSSSE 115
Query: 124 LSQFDTARDYDLQNDFY---WHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
+ +F TAR YD + F+ W + D + P G D EDKF+
Sbjct: 116 M-EFGTARQYDTTDLFFQEGWLYD-DHLFHSKPDDDGRD----KEEDKFVHGGSG----- 164
Query: 181 NPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEK 240
++E L ++ +DD+ R E G E
Sbjct: 165 -------RTEML----------------VLNADDDR--------RHEHAGNNSCEGCAE- 192
Query: 241 LKDCAAYGCSEPLCKCCAGEGK---------------------INNDYGYLSSKEADLID 279
Y CS PLC CC GE K +++ L DL
Sbjct: 193 -----VYTCSSPLCGCCGGELKNEEGLQVVSNSSSVVYGRYKVMDDQTEILDECGLDLFQ 247
Query: 280 LQHNVVGDSSTDCDLAPHPGT-----EKSSSYSSSKRGSSIDWI---------------E 319
L+ +V DS +CDL PG E + + SS D
Sbjct: 248 LKQSV--DSVLECDLPRDPGQGDEHLELNVVEKELQMLSSFDRFIPHVTDNIKLHDSTEN 305
Query: 320 GFKGSSDLHFKGAEKDLMPAEIDNSDTRD-------GEVNGALHEGKA-DAEEHGVATPD 371
+ SSD + L P ++ D D G +N + A AE+ + +
Sbjct: 306 NLESSSDKEYLKESYSLHPFP-ESGDPDDPYEFGDIGPLNTGVKSSTALIAEKEDMESNI 364
Query: 372 LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVF 431
L N + E E+F LRI+HRKNRTGFEENKD PI+LN+VIAGRYYVTEYLGSAAFSKV
Sbjct: 365 DLALSNFQREYEVFELRIVHRKNRTGFEENKDFPIVLNSVIAGRYYVTEYLGSAAFSKVV 424
Query: 432 QAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491
QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK DP+DEHH+LRLYDYFYH EHL
Sbjct: 425 QAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKLLKFVNKYDPSDEHHVLRLYDYFYHQEHL 484
Query: 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551
FIV ELLRANLYEFQK+NQE GGE YFTL R+QVI RQCLEAL YLH L I+HCDLKPEN
Sbjct: 485 FIVTELLRANLYEFQKYNQEFGGEVYFTLPRIQVIARQCLEALVYLHHLRIVHCDLKPEN 544
Query: 552 ILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILA 611
ILIKSY+RCEIK+IDLGSSCF TDNLCLYVQSRSYRAPEVI+GLPYDQ+ID+WSLGCILA
Sbjct: 545 ILIKSYRRCEIKVIDLGSSCFLTDNLCLYVQSRSYRAPEVILGLPYDQRIDIWSLGCILA 604
Query: 612 ELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLE 671
EL TGEVLFPN+ + M+LAR+IG++GPID+EML GQE +KYFT +YDL+ NEET+QLE
Sbjct: 605 ELCTGEVLFPNEPLPMMLARMIGIIGPIDMEMLALGQEAHKYFTDDYDLFTKNEETDQLE 664
Query: 672 YIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
Y+IPE+SSL HLQ DA F+DF+ LL+INP++RPTA EAL H WL Y
Sbjct: 665 YLIPEKSSLRRHLQCHDAEFVDFLSYLLQINPRKRPTASEALKHHWLSSEY 715
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 722 | ||||||
| TAIR|locus:2047741 | 570 | AT2G40120 [Arabidopsis thalian | 0.493 | 0.624 | 0.794 | 1.5e-190 | |
| TAIR|locus:2206840 | 1169 | AT1G73460 [Arabidopsis thalian | 0.548 | 0.338 | 0.639 | 1.8e-147 | |
| TAIR|locus:2206855 | 1152 | AT1G73450 [Arabidopsis thalian | 0.544 | 0.341 | 0.641 | 6.3e-146 | |
| TAIR|locus:2089774 | 1138 | AT3G17750 [Arabidopsis thalian | 0.476 | 0.302 | 0.709 | 1.4e-142 | |
| POMBASE|SPAC823.03 | 534 | ppk15 "serine/threonine protei | 0.421 | 0.569 | 0.395 | 1.1e-56 | |
| RGD|1306800 | 633 | Dyrk4 "dual-specificity tyrosi | 0.452 | 0.516 | 0.374 | 2.3e-56 | |
| UNIPROTKB|D4A0W8 | 597 | Dyrk4 "Protein Dyrk4" [Rattus | 0.452 | 0.547 | 0.374 | 2.3e-56 | |
| MGI|MGI:1330292 | 632 | Dyrk4 "dual-specificity tyrosi | 0.452 | 0.517 | 0.380 | 4.8e-56 | |
| ASPGD|ASPL0000065013 | 885 | AN7104 [Emericella nidulans (t | 0.430 | 0.351 | 0.391 | 9.8e-56 | |
| UNIPROTKB|F5H6L9 | 545 | DYRK4 "Dual-specificity tyrosi | 0.441 | 0.585 | 0.374 | 1.6e-55 |
| TAIR|locus:2047741 AT2G40120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1522 (540.8 bits), Expect = 1.5e-190, Sum P(2) = 1.5e-190
Identities = 283/356 (79%), Positives = 320/356 (89%)
Query: 363 EEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYL 422
++ V ++ + +E+E E+F+LRIIH KNRTGFEENKDLPI++NTVI GRYY+TEY+
Sbjct: 208 DQLNVTDEEVDVVHEVEDEYEVFNLRIIHWKNRTGFEENKDLPIVINTVIGGRYYITEYI 267
Query: 423 GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482
GSAAFSKV QAQDLH GVDVCLKIIKNDKDFFDQSLDEIKLLK VNK+DPADEHHILRLY
Sbjct: 268 GSAAFSKVVQAQDLHNGVDVCLKIIKNDKDFFDQSLDEIKLLKHVNKHDPADEHHILRLY 327
Query: 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGI 542
DYFYH EHLFIVCELLRANLYEFQKFNQESGGE YF L RLQVITRQCL+AL +LH LGI
Sbjct: 328 DYFYHQEHLFIVCELLRANLYEFQKFNQESGGEPYFNLSRLQVITRQCLDALVFLHGLGI 387
Query: 543 IHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKID 602
IHCDLKPENILIKSY+RC +KIIDLGSSCF++DNLCLYVQSRSYRAPEVI+GLPYD+KID
Sbjct: 388 IHCDLKPENILIKSYKRCAVKIIDLGSSCFRSDNLCLYVQSRSYRAPEVILGLPYDEKID 447
Query: 603 LWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYY 662
LWSLGCILAEL +GEVLFPN+AV MILARI+ +LGPI+ EML +GQE +KYFTKEYDLY+
Sbjct: 448 LWSLGCILAELCSGEVLFPNEAVAMILARIVAVLGPIETEMLEKGQETHKYFTKEYDLYH 507
Query: 663 INEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718
+NEE+N++EYII EESSLE LQ SD F+DFVRTLL+INP RRPTA EAL+HPWL
Sbjct: 508 LNEESNEIEYIITEESSLEEQLQVSDELFLDFVRTLLDINPLRRPTALEALNHPWL 563
|
|
| TAIR|locus:2206840 AT1G73460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1341 (477.1 bits), Expect = 1.8e-147, Sum P(4) = 1.8e-147
Identities = 255/399 (63%), Positives = 312/399 (78%)
Query: 324 SSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 383
SS ++ E+ E D +D+ + E + A D EE + EEE E
Sbjct: 769 SSLSNYACEERKHADKEDDRNDSSEIEDDNAT---ALDDEEAVAVQEQVRQIKAQEEEFE 825
Query: 384 IFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVC 443
F L+I+HRKNRTGFEE K+ ++LN+VIAGRY+VTEYLGSAAFSK QA DL TG+DVC
Sbjct: 826 TFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGMDVC 885
Query: 444 LKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLY 503
+KIIKN+KDFFDQSLDEIKLLK VNK+DPAD++H+LRLYDYFY+ EHL IVCELL+ANLY
Sbjct: 886 IKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKANLY 945
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
EF KFN+ESGGE YFT+ RLQ IT QCLE+L++LH LG+IHCDLKPENIL+KSY RCEIK
Sbjct: 946 EFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRCEIK 1005
Query: 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG VLF ND
Sbjct: 1006 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNVLFQND 1065
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 683
+ +LAR++G++G D EML +G++ +KYFTK LY N+E+N+LEY+IP+ +SL H
Sbjct: 1066 SPASLLARVMGIVGSFDNEMLTKGRDSHKYFTKNRMLYERNQESNRLEYLIPKRTSLRHR 1125
Query: 684 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
L D F DFV LLEINP++RP+A EAL HPWL +PY
Sbjct: 1126 LPMGDQGFTDFVAHLLEINPKKRPSAAEALKHPWLSYPY 1164
|
|
| TAIR|locus:2206855 AT1G73450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 6.3e-146, Sum P(3) = 6.3e-146
Identities = 256/399 (64%), Positives = 311/399 (77%)
Query: 324 SSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 383
SS ++ E+ E D+S+ DG H D EE + EEE E
Sbjct: 755 SSLSNYARGERKHAEKENDSSEREDG------HATALDDEEAVAVQEQVRQIKAQEEEFE 808
Query: 384 IFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVC 443
F L+I+HRKNRTGFEE K+ ++LN+VIAGRY+VTEYLGSAAFSK QA DL TG+DVC
Sbjct: 809 TFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGMDVC 868
Query: 444 LKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLY 503
+KIIKN+KDFFDQSLDEIKLLK VNK+DPAD++H+LRLYDYFY+ EHL IVCELL+ANLY
Sbjct: 869 IKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKANLY 928
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
EF KFN+ESGGE YFT+ RLQ IT QCLE+L++LH LG+IHCDLKPENIL+KSY RCEIK
Sbjct: 929 EFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRCEIK 988
Query: 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG VLF ND
Sbjct: 989 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNVLFQND 1048
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 683
+ +LAR++G++G D EML +G++ +KYFTK LY N+E+N+LEY+IP+ +SL H
Sbjct: 1049 SPASLLARVMGIVGSFDNEMLTKGRDSHKYFTKNRMLYERNQESNRLEYLIPKRTSLRHR 1108
Query: 684 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
L D F DFV LLEINP++RP+A EAL HPWL +PY
Sbjct: 1109 LPMGDQGFTDFVAHLLEINPKKRPSAAEALKHPWLSYPY 1147
|
|
| TAIR|locus:2089774 AT3G17750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1334 (474.7 bits), Expect = 1.4e-142, Sum P(2) = 1.4e-142
Identities = 244/344 (70%), Positives = 296/344 (86%)
Query: 379 EEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT 438
E++ E F+L+I+HRKNRTGFEE+K+ ++LN+VIAGRY+VTE+LGSAAFSK QA DLHT
Sbjct: 790 EQDFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEHLGSAAFSKAIQAHDLHT 849
Query: 439 GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498
G+DVC+KIIKN+KDFFDQSLDEIKLLK VN++DPAD++H+LRLYDYFY EHL IVCELL
Sbjct: 850 GIDVCVKIIKNNKDFFDQSLDEIKLLKYVNQHDPADKYHLLRLYDYFYFREHLLIVCELL 909
Query: 499 RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
+ANLYEFQKFN+ESGGE YFT+ RLQ IT QCLEAL +LH LG+IHCDLKPENILIKSY
Sbjct: 910 KANLYEFQKFNRESGGEVYFTMPRLQSITIQCLEALNFLHGLGLIHCDLKPENILIKSYS 969
Query: 559 RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
RCEIK+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG V
Sbjct: 970 RCEIKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAELCTGNV 1029
Query: 619 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 678
LF ND+ +LAR+IG++G ID EML +G++ KYFTK + LY N+E+N LEY+IP++S
Sbjct: 1030 LFQNDSPATLLARVIGIIGSIDQEMLAKGRDTCKYFTKNHLLYERNQESNNLEYLIPKKS 1089
Query: 679 SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
SL L D FIDFV LL+++P++RP+A EAL HPWL +PY
Sbjct: 1090 SLRRRLPMGDQGFIDFVAYLLQVDPKKRPSAFEALKHPWLTYPY 1133
|
|
| POMBASE|SPAC823.03 ppk15 "serine/threonine protein kinase Ppk15 (predicted)" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 1.1e-56, Sum P(2) = 1.1e-56
Identities = 128/324 (39%), Positives = 186/324 (57%)
Query: 397 GFEE-NKDLPIILNTVIA---GR-YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK 451
GF+ N D + +N ++ GR Y + + LG F +V + QDL T V +K+IKN
Sbjct: 106 GFDNVNHDYVLYVNDLLGTDEGRKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKP 165
Query: 452 DFFDQSLDEIKLLKLVN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQ 510
F++Q + E+ +L+L+N K DP D+ H++RLYD F H HL +V ELL NLYE K NQ
Sbjct: 166 AFYNQCVMEVSILELLNNKYDPEDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQ 225
Query: 511 ESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
G L ++ Q L L IIHCDLKPENIL++ +K+ID GS+
Sbjct: 226 FRG----LHLSLVRSFATQLLSCTSLLKQARIIHCDLKPENILLQDLSSPIVKVIDFGSA 281
Query: 571 CFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630
C + + Y+QSR YR+PEVI+GL Y+ ID+WSLGCILAEL+ G LFP ++ L
Sbjct: 282 CHERQTVYTYIQSRFYRSPEVILGLHYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLC 341
Query: 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYIN-EETNQLEYIIPEESSLEHHL--QFS 687
RI+ MLG ML G+ KY Y+ ++N +T +L+ I E+ S+E++ Q
Sbjct: 342 RIVDMLGNPPTWMLEMGKNSKKY----YNSGFVNGRKTYELKSI--EQFSIENNKTEQPG 395
Query: 688 DAFFIDFVRTLLEIN-PQRRPTAR 710
+F + + +N P+R+ T +
Sbjct: 396 KQYFGEKTLDAIVLNYPRRKTTPK 419
|
|
| RGD|1306800 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 2.3e-56, Sum P(2) = 2.3e-56
Identities = 127/339 (37%), Positives = 191/339 (56%)
Query: 387 LRIIHRK-NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F++ + +L+ IA RY V + +G +F +V + D V L
Sbjct: 189 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 248
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 249 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 308
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
K N G F+L ++ T L+ L+ L+ IIHCDLKPENI++ + +K+
Sbjct: 309 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 364
Query: 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624
ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP +
Sbjct: 365 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGEN 424
Query: 625 VVMILARIIGMLG--PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682
V LA I+ +LG P L ++I+ + +K N N+ E P L
Sbjct: 425 EVEQLACIMEVLGLPPTHLIQTATRRQIF-FDSKGLPKNITN---NRGEKRYPNSKDLPM 480
Query: 683 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721
++ D+ F+DF+R L P R T +AL H W+ P
Sbjct: 481 VVKTYDSSFLDFLRRCLVWEPSLRMTPDQALKHAWIHEP 519
|
|
| UNIPROTKB|D4A0W8 Dyrk4 "Protein Dyrk4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 2.3e-56, Sum P(2) = 2.3e-56
Identities = 127/339 (37%), Positives = 191/339 (56%)
Query: 387 LRIIHRK-NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F++ + +L+ IA RY V + +G +F +V + D V L
Sbjct: 153 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 212
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 213 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 272
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
K N G F+L ++ T L+ L+ L+ IIHCDLKPENI++ + +K+
Sbjct: 273 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 328
Query: 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624
ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP +
Sbjct: 329 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGEN 388
Query: 625 VVMILARIIGMLG--PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682
V LA I+ +LG P L ++I+ + +K N N+ E P L
Sbjct: 389 EVEQLACIMEVLGLPPTHLIQTATRRQIF-FDSKGLPKNITN---NRGEKRYPNSKDLPM 444
Query: 683 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721
++ D+ F+DF+R L P R T +AL H W+ P
Sbjct: 445 VVKTYDSSFLDFLRRCLVWEPSLRMTPDQALKHAWIHEP 483
|
|
| MGI|MGI:1330292 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 546 (197.3 bits), Expect = 4.8e-56, Sum P(2) = 4.8e-56
Identities = 129/339 (38%), Positives = 186/339 (54%)
Query: 387 LRIIHRK-NRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F+ E+ +L+ IA RY V E +G +F +V + D V L
Sbjct: 188 LNVVPEKFSKTSFDDEHGSYMKVLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNELVAL 247
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 248 KIIRNKKRFHHQALVELKILEALRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYE 307
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI-- 562
K N G F L ++ T L+ L L+ IIHCDLKPENI++ YQR ++
Sbjct: 308 LMKNNSFHG----FNLSIVRRFTFSILKCLHMLYVEKIIHCDLKPENIVL--YQRGQVTV 361
Query: 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
K+ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP
Sbjct: 362 KVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPG 421
Query: 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682
+ V LA I+ +LG +F + IN Y P+ L
Sbjct: 422 ENEVEQLACIMEVLGLPPAHFTQTASRRQVFFDSKGLPKNINNNRGGKRY--PDSKDLTM 479
Query: 683 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721
++ D+ F+DF+R L P R T +AL H W+ P
Sbjct: 480 VVKTYDSSFLDFLRRCLVWEPSLRMTPEQALKHAWIHEP 518
|
|
| ASPGD|ASPL0000065013 AN7104 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 9.8e-56, Sum P(2) = 9.8e-56
Identities = 130/332 (39%), Positives = 192/332 (57%)
Query: 393 KNRTGFE-ENKDLPIILNTVI----AG---RYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
KN G++ E+ D + +N ++ AG RY + + LG F +V + Q+L T V +
Sbjct: 311 KN-DGYDNEDSDYILYVNDILGSEEAGHKNRYLILDVLGQGTFGQVVKCQNLKTQEVVAV 369
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKN-DPADEHHILRLYDYFYHLEHLFIVCELLRANLY 503
K+IKN +F+QS+ E+ +L L+N D D+HH+LRL D F H +HL +V ELL NLY
Sbjct: 370 KVIKNKTAYFNQSMMEVSVLDLLNSRYDKNDDHHLLRLKDTFIHRQHLCLVFELLSVNLY 429
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
E K NQ G TL R V +Q L AL L+ +IHCDLKPENIL+K+ + IK
Sbjct: 430 ELIKQNQFRGLST--TLVR--VFAQQLLNALSLLNKAHLIHCDLKPENILLKNLESPIIK 485
Query: 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ID GS+C + + Y+QSR YR+PEV++GLPY ID+WSLGCI+ EL+ G LFP
Sbjct: 486 VIDFGSACDERQTVYTYIQSRFYRSPEVLLGLPYSSAIDMWSLGCIVVELFLGLPLFPGS 545
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 683
+ + RI+ MLG ML G++ ++F K D + ++ +L+ + E+ S EH+
Sbjct: 546 SEYNQVCRIVEMLGLPPTWMLEMGKQSGEFFEKTQDEF--GRKSYRLKSL--EQYSREHN 601
Query: 684 L--QFSDAFF-IDFVRTLLEINPQRRPTAREA 712
Q S +F + ++ P R ++A
Sbjct: 602 TKEQPSKKYFQASTLEEIIRSYPMPRKNMKQA 633
|
|
| UNIPROTKB|F5H6L9 DYRK4 "Dual-specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 1.6e-55, Sum P(2) = 1.6e-55
Identities = 122/326 (37%), Positives = 177/326 (54%)
Query: 394 NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD 452
++T F++ + +L+ IA RY V E +G +F +V + D V LKII+N K
Sbjct: 196 SKTSFDDEHGFYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKR 255
Query: 453 FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQES 512
F Q+L E+K+L+ + K D + ++++ + D+FY H I ELL NLYE K N
Sbjct: 256 FHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQ 315
Query: 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
G F+L ++ T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC+
Sbjct: 316 G----FSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 371
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
+ + Y+QSR YR+PEVI+G PYD ID+WSLGCI AEL+TG LFP + V LA I
Sbjct: 372 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACI 431
Query: 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692
+ +LG + +F + I + Y P+ L L+ D F+
Sbjct: 432 MEVLGLPPAGFIQTASRRQTFFDSKGFPKNITNNRGKKRY--PDSKDLTMVLKTYDTSFL 489
Query: 693 DFVRTLLEINPQRRPTAREALDHPWL 718
DF+R L P R T +AL H W+
Sbjct: 490 DFLRRCLVWEPSLRMTPDQALKHAWI 515
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pg.C_LG_VIII0583 | hypothetical protein (726 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 722 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-56 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-51 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-50 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-49 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-46 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-44 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-41 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-40 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-39 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-38 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-38 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-38 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-35 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-35 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-35 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-35 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-35 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-35 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-33 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-31 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-30 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-29 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-28 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-28 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-28 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-28 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-27 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-27 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-25 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-23 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-23 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.001 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.001 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.001 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 6e-68
Identities = 99/309 (32%), Positives = 141/309 (45%), Gaps = 61/309 (19%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPA 473
Y + E LG +F KV+ A+D TG V +K+IK K ++ L EIK+LK +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK----- 55
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+RLYD F + L++V E +L++ K + + RQ L
Sbjct: 56 --HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQIL 107
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAP 589
ALEYLHS GI+H DLKPENIL+ +K+ D G + L +V + Y AP
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDE--DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
EV++G Y + +D+WSLG IL EL TG+ FP D ++ L + IG
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-------------- 211
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
P+ S D +R LL +P++R TA
Sbjct: 212 -------------------------PKPPFPPPEWDISPE-AKDLIRKLLVKDPEKRLTA 245
Query: 710 REALDHPWL 718
EAL HP+
Sbjct: 246 EEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 7e-56
Identities = 93/306 (30%), Positives = 136/306 (44%), Gaps = 61/306 (19%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
LGS +F V++A+ TG V +KI+K + EI++L+ ++ H +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-------HPN 59
Query: 478 ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL D F +HL++V E +L+++ + + I Q L LEY
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEY 113
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVII 593
LHS GIIH DLKPENIL+ + +KI D G + + L +V + Y APEV++
Sbjct: 114 LHSNGIIHRDLKPENILLD--ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 594 -GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652
G Y K+D+WSLG IL EL TG+ F + ++ L I +LGP
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGP-------------- 217
Query: 653 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712
E EE D ++ L +P +RPTA E
Sbjct: 218 ----------PLEFDEPKWSSGSEE-------------AKDLIKKCLNKDPSKRPTAEEI 254
Query: 713 LDHPWL 718
L HPW
Sbjct: 255 LQHPWF 260
|
Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 6e-51
Identities = 94/315 (29%), Positives = 142/315 (45%), Gaps = 45/315 (14%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDP 472
Y E LG + V++A+D TG V LK I+ D + +L EI LLK +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---- 56
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I++L D + L++V E +L ++ + ++ I Q L
Sbjct: 57 ---HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP-----LSPNLIKSIMYQLL 108
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQ------TDNLCLYVQSR 584
L Y HS I+H DLKP+NILI +K+ D G + F T V +
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARAFGIPLRTYTHE----VVTL 162
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643
YRAPE+++G Y +D+WS+GCI AE+ TG+ LFP D+ + L +I +LG E
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703
G + + + LE L D ID + +L+ NP
Sbjct: 223 WP-GVTKLPDYKPTFPKF--------------PPKDLEKVLPRLDPEGIDLLSKMLQYNP 267
Query: 704 QRRPTAREALDHPWL 718
+R +A+EAL HP+
Sbjct: 268 AKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-50
Identities = 96/314 (30%), Positives = 148/314 (47%), Gaps = 42/314 (13%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVN-KND 471
Y +G + V++A+D TG V +K IK + +L EIKLLK +N N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I++L D F H L++V E + +LY+ K Q ++ Q L
Sbjct: 60 ------IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-----LPESLIKSYLYQLL 108
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-CFQTDNLCL--YVQSRSYRA 588
+ L + HS GI+H DLKPEN+LI +K+ D G + F + YV +R YRA
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLIN--TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PIDLEMLMQ 646
PE+++G Y +D+WS+GCI AEL + LFP + + L +I LG P
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD------- 219
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF--IDFVRTLLEINPQ 704
E++ FT Y + P+++ + F +A +D + +L +P
Sbjct: 220 -PEVWPKFTSLARNYKFS---------FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 705 RRPTAREALDHPWL 718
+R TA +AL HP+
Sbjct: 270 KRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 5e-49
Identities = 108/330 (32%), Positives = 151/330 (45%), Gaps = 60/330 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + + +GS A+ V A D TG V +K I N FD +D EIKLL+ +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHLR 57
Query: 469 KNDPADEH-HILRLYDYFYH-----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
H +I+ L D ++IV EL+ +L++ K Q T
Sbjct: 58 -------HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP------LTDDH 104
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDN 576
+Q Q L L+YLHS +IH DLKP NIL+ S C++KI D G +
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICDFGLARGVDPDEDEKGF 162
Query: 577 LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIG 634
L YV +R YRAPE+++ Y + ID+WS+GCI AEL T + LFP D + L I+
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVE 221
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINE----ETNQLEYIIPEESSLEHHLQFSDAF 690
+LG E L K+ T E Y+ L + P S
Sbjct: 222 VLGTPSEEDL-------KFITSEKARNYLKSLPKKPKKPLSKLFPGASPE---------- 264
Query: 691 FIDFVRTLLEINPQRRPTAREALDHPWLQH 720
ID + +L +P++R TA EAL HP+L
Sbjct: 265 AIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 91/315 (28%), Positives = 158/315 (50%), Gaps = 44/315 (13%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--SLDEIKLLKLVNKNDPA 473
Y V + LG F V+ A++ TG V +K +K +++ +L E+K L+ +N++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++L + F + L+ V E + NLY+ K + F+ ++ I Q L+
Sbjct: 59 ---NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGK----PFSESVIRSIIYQILQG 111
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYR 587
L ++H G H DLKPEN+L+ + +KI D G S TD YV +R YR
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD----YVSTRWYR 165
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIGMLGPIDLEMLM 645
APE+++ Y +D+W+LGCI+AEL+T LFP + + + +I +LG +
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY-KICSVLGTPTKQDWP 224
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINP 703
+G ++ ++L + P+ +SL + + ID ++ +L +P
Sbjct: 225 EGYKL----------------ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDP 268
Query: 704 QRRPTAREALDHPWL 718
++RPTA +AL HP+
Sbjct: 269 KKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 5e-45
Identities = 95/317 (29%), Positives = 149/317 (47%), Gaps = 45/317 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKN 470
RY + +G A VF+A+D TG V LK + +Q+L EIK L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQAC--- 56
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+H ++++L D F H +V E + ++L E + + +++ R
Sbjct: 57 ----QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERP-----LPEAQVKSYMRM 107
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY---VQSRS 585
L+ + Y+H+ GI+H DLKP N+LI + +KI D G + F + LY V +R
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLARLFSEEEPRLYSHQVATRW 165
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
YRAPE++ G YD +DLW++GCI AEL G LFP + + LA + LG
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG------- 218
Query: 645 MQGQEIYKYFTKEYD---LYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
+E + T D + + + LE I P+ S +D ++ LL
Sbjct: 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEA----------LDLLKGLLVY 268
Query: 702 NPQRRPTAREALDHPWL 718
+P +R +A EAL HP+
Sbjct: 269 DPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-44
Identities = 76/199 (38%), Positives = 104/199 (52%), Gaps = 19/199 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F V+ A+D TG V +KIIK + ++ L EI++LK +N +I+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH------PNIV 54
Query: 480 RLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY F HL++V E +L + K N+ + + I Q LE LEYLH
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLH 109
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGL 595
S GIIH DLKPENIL+ S +K+ D G S L V + +Y APEV++G
Sbjct: 110 SNGIIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 596 P-YDQKIDLWSLGCILAEL 613
Y +K D+WSLG IL EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 89/316 (28%), Positives = 146/316 (46%), Gaps = 39/316 (12%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKN 470
+Y V +G A+ V + ++ TG V +K K +D+D +L E+K+L+ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL--- 57
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H +I+ L + F L++V E + L E + + ++ Q
Sbjct: 58 ----RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA-----VRSYIWQ 108
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLCLYVQSRS 585
L+A+ Y HS IIH D+KPENIL+ +K+ D G L YV +R
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPLTDYVATRW 166
Query: 586 YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
YRAPE+++G Y + +D+W++GCI+AEL GE LFP D+ + L I LGP+
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYI-IPEESSLEH-HLQFSDAFFIDFVRTLLEIN 702
+L+ N + + + SLE + + +DF++ L ++
Sbjct: 227 --------------ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD 272
Query: 703 PQRRPTAREALDHPWL 718
P+ R T E L HP+
Sbjct: 273 PKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 58/302 (19%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478
E +G F +V++A+ TG +V +K+IK K+ ++ ++EI++LK +I
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNI 59
Query: 479 LRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++ Y + + L+IV E +L + K ++ T ++ + ++ L+ LEYL
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-----LTESQIAYVCKELLKGLEYL 114
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGL 595
HS GIIH D+K NIL+ S E+K+ID G S +D V + + APEVI G
Sbjct: 115 HSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 596 PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 655
PYD K D+WSLG EL G+ + P +
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSEL--------------PPMKALFKIATN------ 212
Query: 656 KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715
PE+ S E F DF++ L+ NP++RPTA + L H
Sbjct: 213 ------------GPPGLRNPEKWSDE---------FKDFLKKCLQKNPEKRPTAEQLLKH 251
Query: 716 PW 717
P+
Sbjct: 252 PF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 106/327 (32%), Positives = 162/327 (49%), Gaps = 64/327 (19%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLDEIKLLKLVNK 469
RY +GS A+ +V A D TG V +K K + F ++ E++LLK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHM-- 71
Query: 470 NDPADEHHILRLYDYFYHLEHL------FIVCELLRANLY---EFQKFNQESGGEAYFTL 520
D +++ L D F L ++V L+ A+L + QK + +
Sbjct: 72 ----DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD--------- 118
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+Q + Q L L+Y+HS GIIH DLKP NI + CE+KI+D G + D + Y
Sbjct: 119 -HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARHTDDEMTGY 175
Query: 581 VQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
V +R YRAPE+++ + Y+Q +D+WS+GCI+AEL TG+ LFP + L RI+ ++G
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ--FSDAF------F 691
D E L+Q I+ E+ + YI SL + F + F
Sbjct: 236 DEE-LLQK---------------ISSESAR-NYI----QSLPQMPKKDFKEVFSGANPLA 274
Query: 692 IDFVRTLLEINPQRRPTAREALDHPWL 718
ID + +L ++P +R TA EAL HP+L
Sbjct: 275 IDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 89/323 (27%), Positives = 148/323 (45%), Gaps = 58/323 (17%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKNDP 472
Y +G + +V++A++ TG V LK I+ N+K+ F ++ EIKLL+ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLY---EFQKFNQESG----GEAYFTLGRLQ 524
H +I+RL + IV + ++Y E+ + +G E FT +++
Sbjct: 57 ---HPNIVRLKE---------IVTSKGKGSIYMVFEYMDHDL-TGLLDSPEVKFTESQIK 103
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+Q LE L+YLHS GI+H D+K NILI + +K+ D G + T +R
Sbjct: 104 CYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLARPYTKRNSADYTNR 161
Query: 585 S----YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
YR PE+++G Y ++D+WS+GCILAEL+ G+ +F + L +I + G
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 640 DLE-----MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 694
E + E K K Y + E D +D
Sbjct: 222 TDENWPGVSKLPWFENLK-PKKPY-----------------KRRLREFFKHLIDPSALDL 263
Query: 695 VRTLLEINPQRRPTAREALDHPW 717
+ LL ++P++R +A +AL H +
Sbjct: 264 LDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--SLDEIKLLKLVNKNDPA 473
Y + +G FS+V +AQ TG +K +K +Q +L EI+ L+ ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----- 55
Query: 474 DEHHILRLYDYFYHLEH--LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ILRL + + + L +V EL+ NLYE K G + R++ Q L
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--FQTDNLCLYVQSRSYRAP 589
++L+++H GI H D+KPENILIK +K+ D GS + Y+ +R YRAP
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD---ILKLADFGSCRGIYSKPPYTEYISTRWYRAP 167
Query: 590 EVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
E ++ G Y K+D+W++GC+ E+ + LFP + +A+I +LG D E+L
Sbjct: 168 ECLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL--- 223
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFIDFVRTLLEINPQR 705
K F K + + Y P + + L L + A +D ++ LL +P
Sbjct: 224 ----KKFRK----------SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDE 269
Query: 706 RPTAREALDHPW 717
R TA++AL HP+
Sbjct: 270 RITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 93/316 (29%), Positives = 131/316 (41%), Gaps = 78/316 (24%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLK--IIKNDKDFFDQSLD-EIKLLK-LVNKNDPADE 475
E LG +F V+ A D TG + +K + D + ++L+ EI++L L + N
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN----- 60
Query: 476 HHILRLYDYFYHLE--HLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I+R Y E L I E L + L +F K E ++ TR
Sbjct: 61 --IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EP---------VIRKYTR 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q LE L YLHS GI+H D+K NIL+ S +K+ D G + + ++ + S R
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFGCA-KRLGDIETGEGTGSVRG 165
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
APEVI G Y + D+WSLGC + E+ TG+ + M
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA------------- 212
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
LY I E IPE S E DF+R L +
Sbjct: 213 -----------------LYKIGSSGEPPE--IPEHLSEE---------AKDFLRKCLRRD 244
Query: 703 PQRRPTAREALDHPWL 718
P++RPTA E L HP+L
Sbjct: 245 PKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 104/335 (31%), Positives = 160/335 (47%), Gaps = 60/335 (17%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLK 465
+ RY + +GS A V A D TG +V +K K + F + + E+ L+K
Sbjct: 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMK 70
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
LVN KN I+ L + F + +++V EL+ ANL Q + E
Sbjct: 71 LVNHKN-------IIGLLNVFTPQKSLEEFQDVYLVMELMDANLC--QVIQMDLDHE--- 118
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCF 572
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G +S
Sbjct: 119 ---RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFM 173
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
T YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + +I
Sbjct: 174 MTP----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229
Query: 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEY---------IIPEESSLEHH 683
I LG E + + Q + Y+ Y + P +S +
Sbjct: 230 IEQLGTPSDEFMSRLQPTVR--------NYVENRPKYAGYSFEELFPDVLFPPDSESHNK 281
Query: 684 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718
L+ S A D + +L I+P++R + +AL HP++
Sbjct: 282 LKASQAR--DLLSKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 89/316 (28%), Positives = 148/316 (46%), Gaps = 42/316 (13%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQS-LDEIKLLKLVNKNDP 472
Y +G A+ V++A+DL+TG V LK ++ ++ S L EI LLK +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE---- 56
Query: 473 ADEH-HILRLYD--YFYHLEH---LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ EH +I+RL D + + L +V E + +L + + G ++ +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE----TIKDL 112
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQS 583
RQ L +++LHS I+H DLKP+NIL+ S + +KI D G + F+ L V +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEM-ALTSVVVT 169
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PIDLE 642
YRAPEV++ Y +D+WS+GCI AEL+ LF + L +I ++G P + E
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
+ + + + + + +PE D ++ +L N
Sbjct: 230 W---PRNV--SLPRS---SFPSYTPRSFKSFVPEICEEGL----------DLLKKMLTFN 271
Query: 703 PQRRPTAREALDHPWL 718
P +R +A EAL HP+
Sbjct: 272 PHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 101/329 (30%), Positives = 150/329 (45%), Gaps = 51/329 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQ-SLDEIKLLKLVNK 469
+ RY Y+G A+ V A TGV V +K I + F Q +L EIK+L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEA-YFTLGRLQVITR 528
+ I+R + ++IV EL+ +LY+ K S YF
Sbjct: 63 ENIIGILDIIRPPSFES-FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-------- 113
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDN---LCLYVQ 582
Q L L+Y+HS ++H DLKP N+L+ + C++KI D G + + D+ L YV
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 583 SRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+R YRAPE+++ Y + ID+WS+GCILAE+ + LFP + L I+G+LG
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH--LQFSDAF------FID 693
E DL I YI SL + ++ F +D
Sbjct: 232 E----------------DLNCIISL-RARNYIK----SLPFKPKVPWNKLFPNADPKALD 270
Query: 694 FVRTLLEINPQRRPTAREALDHPWLQHPY 722
+ +L NP +R T EAL HP+L+ Y
Sbjct: 271 LLDKMLTFNPHKRITVEEALAHPYLE-QY 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 100/342 (29%), Positives = 155/342 (45%), Gaps = 81/342 (23%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I +Y + + LG A+ V++A D T V LK I D F + D EI L+
Sbjct: 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF---DAFRNATDAQRTFREIMFLQ 61
Query: 466 LVNKNDPADEHHILRLYD----------Y--FYHLE---HLFIVCELLRAN-LYEFQKFN 509
+ + +I++L + Y F ++E H I RAN L + K
Sbjct: 62 ELGDHP-----NIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHK-- 109
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG- 568
+ I Q L+AL+Y+HS +IH DLKP NIL+ S C +K+ D G
Sbjct: 110 --------------RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGL 153
Query: 569 SSCFQTDNLCL-------YVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF 620
+ YV +R YRAPE+++G Y + +D+WS+GCIL E+ G+ LF
Sbjct: 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
Query: 621 PNDAVVMILARIIGMLGPI---DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 677
P + + L +II ++GP D+E ++ L+ ++P+
Sbjct: 214 PGTSTLNQLEKIIEVIGPPSAEDIES-IKSPFAATMLDSLPSRPRKP-----LDELLPKA 267
Query: 678 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
S DA +D ++ LL NP +R TA EAL+HP++
Sbjct: 268 S--------DDA--LDLLKKLLVFNPNKRLTAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 91/327 (27%), Positives = 149/327 (45%), Gaps = 56/327 (17%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD------QSLDEIKLLKLVN 468
RY E +GS A+ V A D +G V +K I + FD ++L E+K+L+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVPTLAKRTLRELKILRHFK 62
Query: 469 KNDPADEHHILRLYDYFY----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
++ I+ + D + +++V +L+ ++L+ +Q T ++
Sbjct: 63 HDN------IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP------LTEEHIR 110
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------SSCFQTDNL 577
Q L L+Y+HS +IH DLKP N+L+ + CE++I D G S +
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVN--EDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 578 CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
YV +R YRAPE+++ LP Y ID+WS+GCI AE+ LFP V L I+ +L
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228
Query: 637 GPIDLEML--MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF--FI 692
G E+L + + KY +P + + F A +
Sbjct: 229 GSPSEEVLNRIGSDRVRKYIQN-----------------LPRKQPVPWSKIFPKASPEAL 271
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
D + +L+ +P+ R T +AL HP+L
Sbjct: 272 DLLSQMLQFDPEERITVEQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 107/325 (32%), Positives = 157/325 (48%), Gaps = 40/325 (12%)
Query: 407 ILNTV--IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEI 461
I TV I RY + +G AF V A+D TG +V +K I ++ E+
Sbjct: 1 IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYREL 60
Query: 462 KLLK-LVNKNDPADEHHILRLYDYFYH-LEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
KLLK L ++N I+ L D F LE ++ V ELL +L+ + E F
Sbjct: 61 KLLKHLRHEN-------IISLSDIFISPLEDIYFVTELLGTDLH---RLLTSRPLEKQF- 109
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
+Q Q L L+Y+HS G++H DLKP NILI + C++KI D G + Q +
Sbjct: 110 ---IQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN--ENCDLKICDFGLARIQDPQMTG 164
Query: 580 YVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG- 637
YV +R YRAPE+++ YD ++D+WS GCI AE+ G+ LFP V + I +LG
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
P D ++ E L ++ + E + +D ID +
Sbjct: 225 PPD--------DVINTICSENTLRFVQSLPKR------EPVPFSEKFKNADPSAIDLLEK 270
Query: 698 LLEINPQRRPTAREALDHPWLQHPY 722
+L +PQ+R +A EAL HP+L PY
Sbjct: 271 MLVFDPQKRISAAEALAHPYLA-PY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 102/320 (31%), Positives = 150/320 (46%), Gaps = 53/320 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-----NDKDFFDQS-LDEIKLLKLVN 468
RY + LG ++ V++A+D TG V +K IK KD + + L EIKLL+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D F H ++ +V E + +L + K T ++
Sbjct: 61 -------HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDK-----SIVLTPADIKSYM 108
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQ--SR 584
L LEYLHS I+H DLKP N+LI S +K+ D G + F + N + Q +R
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PI--- 639
YRAPE++ G Y +D+WS+GCI AEL P D+ + L +I LG P
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 640 --DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
+ L E +K F L+ I P S DA +D ++
Sbjct: 227 WPGVTSLPDYVE-FKPFPP-----------TPLKQIFPAAS--------DDA--LDLLQR 264
Query: 698 LLEINPQRRPTAREALDHPW 717
LL +NP +R TAR+AL+HP+
Sbjct: 265 LLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 100/325 (30%), Positives = 153/325 (47%), Gaps = 51/325 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + E +G ++ V A D HTG V +K I D F+ D EIKLL+L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN---DVFEHVSDATRILREIKLLRLLR 57
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
D + HI+ L + +++V EL+ ++L++ K N + E + Q
Sbjct: 58 HPDIVEIKHIM-LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH------QFFLY 110
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------SSCFQTDNLC 578
Q L AL+Y+H+ + H DLKP+NIL + C++KI D G ++ F TD
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTD--- 165
Query: 579 LYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
YV +R YRAPE+ Y ID+WS+GCI AE+ TG+ LFP VV L I +L
Sbjct: 166 -YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224
Query: 637 GPIDLEML--MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 694
G E + ++ ++ +Y + + P +D +
Sbjct: 225 GTPSPETISRVRNEKARRYL-------------SSMRKKQP--VPFSQKFPNADPLALRL 269
Query: 695 VRTLLEINPQRRPTAREALDHPWLQ 719
+ LL +P+ RPTA EAL P+ +
Sbjct: 270 LERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 105/319 (32%), Positives = 162/319 (50%), Gaps = 37/319 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D G++V +K K + F +Q+ E+ LLK VN
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 470 NDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
+ I+ L + F + +++V EL+ ANL Q + E E R+
Sbjct: 80 KN------IISLLNVFTPQKSLEEFQDVYLVMELMDANL--CQVIHMELDHE------RM 125
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YV 581
+ Q L +++LHS GIIH DLKP NI++KS C +KI+D G + N + YV
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTACTNFMMTPYV 183
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+R YRAPEVI+G+ Y + +D+WS+GCI+ EL G V+F + ++I LG
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
Query: 642 EMLMQGQEIYKYFTKEYDLYY-INEETNQLEYIIPEESSLEH-HLQFSDAFFIDFVRTLL 699
E + + Q + + + Y I+ E ++I P ES E L+ S A D + +L
Sbjct: 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSES--ERDKLKTSQAR--DLLSKML 299
Query: 700 EINPQRRPTAREALDHPWL 718
I+P +R + EAL HP++
Sbjct: 300 VIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 79/321 (24%), Positives = 126/321 (39%), Gaps = 58/321 (18%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPA 473
+ LG +F +V+ A+D V LK++ + ++ L EI++L +N
Sbjct: 4 ILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLN----- 55
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++LYD+F L++V E + + ++ G + + I Q L A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGG--SLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---------LCLYVQSR 584
LEYLHS GIIH D+KPENIL+ +K+ID G + D V +
Sbjct: 114 LEYLHSKGIIHRDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 585 SYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
Y APEV++GL D+WSLG L EL TG F +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT------------ 220
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
+ K + + + +I + D ++ LL
Sbjct: 221 ------SQTLKIILELPTPSLASPLSPSNPELISKA-------------ASDLLKKLLAK 261
Query: 702 NPQRRPTAREALDHPWLQHPY 722
+P+ R ++ L H L H
Sbjct: 262 DPKNRLSSSSDLSHDLLAHLK 282
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 82/313 (26%), Positives = 134/313 (42%), Gaps = 68/313 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPAD 474
Y E +G A +V++A D TG +V +K ++ K + ++EI ++K + N
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPN---- 76
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ YD + + L++V E + L + N ++ + R+ L+
Sbjct: 77 ---IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQG 128
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------Y 586
LEYLHS +IH D+K +NIL+ +K+ D G F L R+ +
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFG---FAA-QLTKEKSKRNSVVGTPYW 182
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
APEVI Y K+D+WSLG I+ EM +
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLG--------------------IMCI----------EM-AE 211
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
G+ Y L+ I T + IP L++ ++S F DF+ L +P++R
Sbjct: 212 GEPPYLREPPLRALFLI---TTKG---IPP---LKNPEKWSPE-FKDFLNKCLVKDPEKR 261
Query: 707 PTAREALDHPWLQ 719
P+A E L HP+L+
Sbjct: 262 PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 92/314 (29%), Positives = 149/314 (47%), Gaps = 52/314 (16%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLK-LVNKNDPADEH 476
E LG ++ V++ ++ TG V LK I D + S + EI L+K L ++N
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN------ 59
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL+D + L +V E + +L ++ + G ++ T Q L+ + +
Sbjct: 60 -IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAF 115
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRSYRA 588
H ++H DLKP+N+LI +R E+K+ D G + F + + L+ YRA
Sbjct: 116 CHENRVLHRDLKPQNLLIN--KRGELKLADFGLARAFGIPVNTFSNEVVTLW-----YRA 168
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFP----NDAVVMILARIIGMLGPIDLEM 643
P+V++G Y ID+WS+GCI+AE+ TG LFP D ++ I RI+G P +
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF-RIMGT--PTESTW 225
Query: 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703
Q EY + L+ + P +D ID + LL++NP
Sbjct: 226 PGISQ------LPEYKPTFPRYPPQDLQQLFPH----------ADPLGIDLLHRLLQLNP 269
Query: 704 QRRPTAREALDHPW 717
+ R +A +AL HPW
Sbjct: 270 ELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 98/321 (30%), Positives = 154/321 (47%), Gaps = 43/321 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT--GVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNK 469
RY + + LG A+ V A++ T V +K I N K ++L E+KLL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 470 NDPADEHHILRLYD----YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+ +I LYD + + L++ EL+ A+L++ + Q +A+F Q
Sbjct: 61 HK-----NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHF-----QS 109
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-------LC 578
Q L L+Y+HS ++H DLKP N+L+ + CE+KI D G + ++N +
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKICDFGLARGFSENPGENAGFMT 167
Query: 579 LYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ Y + ID+WS+GCILAEL + +F V L +I+ +LG
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
D E L I + Y N E I P + L +D +
Sbjct: 228 TPDEETL---SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLA----------LDLLEK 274
Query: 698 LLEINPQRRPTAREALDHPWL 718
LL +P +R + EAL+HP+L
Sbjct: 275 LLAFDPTKRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 82/311 (26%), Positives = 138/311 (44%), Gaps = 64/311 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+Y + + +G +F KV+ + G LK I ++K+ + +L+E+K+LK +N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLN-- 57
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ Y+ F L IV E +L + K Q+ G+ F ++
Sbjct: 58 -----HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGK-PFPEEQILDWFV 110
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCL-YVQSRS 585
Q AL+YLHS I+H D+KP+NI + S +K+ D G S T +L V +
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTVVGTPY 168
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
Y +PE+ PY+ K D+WSLGC+L EL T + F + ++ + +I+
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL------------ 216
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
+Y IP Q+S + V +LL+ +P+
Sbjct: 217 ---------KGQYPP-------------IPS--------QYSS-ELRNLVSSLLQKDPEE 245
Query: 706 RPTAREALDHP 716
RP+ + L P
Sbjct: 246 RPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 86/319 (26%), Positives = 155/319 (48%), Gaps = 45/319 (14%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDP 472
Y E +G + KV++A+D +TG V LK + +++ +L EI LL++++++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI- 61
Query: 473 ADEHHILRLYDYFYHLEH---------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
+I+RL D +EH L++V E L ++L +F N G +
Sbjct: 62 ----YIVRLLD----VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPA-KTI 112
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY--- 580
+ Q L+ + + H G++H DLKP+N+L+ + +KI DLG + + Y
Sbjct: 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL-LKIADLGLGRAFSIPVKSYTHE 171
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
+ + YRAPEV++G Y +D+WS+GCI AE+ + LFP D+ + L I +LG
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-- 229
Query: 640 DLEMLMQGQEIYKYFTKEYDLY-YINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 698
++++ +K D + + + L +P L +D ++ +
Sbjct: 230 -----TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVP---DLSPEG-------LDLLQKM 274
Query: 699 LEINPQRRPTAREALDHPW 717
L +P +R +A+ AL HP+
Sbjct: 275 LRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 88/310 (28%), Positives = 129/310 (41%), Gaps = 68/310 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG + V++ + TG LK I D++F Q L E+K L+ + +++
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS------CESPYVV 62
Query: 480 RLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+ Y FY + IV E L L + K E L I RQ L+ L
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP-----EPV-----LAYIARQILKGL 112
Query: 535 EYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCL-YVQSRSYRAPE 590
+YLH+ IIH D+KP N+LI S E+KI D G S T + C +V + +Y +PE
Sbjct: 113 DYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
I G Y D+WSLG L E G+ FP G +L
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK--FPFLPP--------GQPSFFEL--------- 211
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710
+ I + SL +FS F DF+ L+ +P++RP+A
Sbjct: 212 ---------MQAICDG---------PPPSLPAE-EFSPE-FRDFISACLQKDPKKRPSAA 251
Query: 711 EALDHPWLQH 720
E L HP+++
Sbjct: 252 ELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 96/321 (29%), Positives = 161/321 (50%), Gaps = 52/321 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-------DEIKLLKLV 467
RY +GS A+ V A D V +K K + F QSL E++LLK +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPF--QSLIHARRTYRELRLLKHM 71
Query: 468 NKNDPADEHHILRLYDYFY------HLEHLFIVCELLRA---NLYEFQKFNQESGGEAYF 518
+++ L D F + +++V L+ A N+ + QK + E
Sbjct: 72 K------HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDE------- 118
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+Q + Q L L+Y+HS GIIH DLKP N+ + + CE++I+D G + D +
Sbjct: 119 ---HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN--EDCELRILDFGLARQADDEMT 173
Query: 579 LYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ + Y+Q +D+WS+GCI+AEL G+ LFP + + L RI+ ++G
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
E+L + + E+ YI L + +P++ L+ + ++ ID +
Sbjct: 234 TPSPEVLKK-------ISSEHARKYI----QSLPH-MPQQ-DLKKIFRGANPLAIDLLEK 280
Query: 698 LLEINPQRRPTAREALDHPWL 718
+L ++ +R +A EAL HP+
Sbjct: 281 MLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 90/302 (29%), Positives = 147/302 (48%), Gaps = 44/302 (14%)
Query: 430 VFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYF 485
V++A+D TG V LK +K +K+ F SL EI LLKL + N I+ + +
Sbjct: 21 VYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN-------IVTVKEVV 73
Query: 486 Y--HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGII 543
+L+ +++V E + +L + ++ F ++ + Q L + +LH I+
Sbjct: 74 VGSNLDKIYMVMEYVEHDLKSLMETMKQP-----FLQSEVKCLMLQLLSGVAHLHDNWIL 128
Query: 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ---SRSYRAPEVIIGLP-YDQ 599
H DLK N+L+ + R +KI D G + L Y Q + YRAPE+++G Y
Sbjct: 129 HRDLKTSNLLLNN--RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 600 KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PIDLEMLMQGQEIYKYFTKEY 658
ID+WS+GCI AEL T + LFP + + L +I +LG P + +I+ F++
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE--------KIWPGFSE-- 236
Query: 659 DLYYINEETNQLEYIIPEESSLEHH---LQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715
L ++T + + L L SD F D + LL +P +R +A +AL H
Sbjct: 237 -LPGAKKKT----FTKYPYNQLRKKFPALSLSDNGF-DLLNRLLTYDPAKRISAEDALKH 290
Query: 716 PW 717
P+
Sbjct: 291 PY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 91/331 (27%), Positives = 153/331 (46%), Gaps = 64/331 (19%)
Query: 418 VTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNK 469
VTE+ +G + V++A+D +G V LK ++ N++D SL EI LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-- 63
Query: 470 NDPADEHH--ILRLYDYFY--HLEHLFIV---CELLRANLYEFQKFNQESGGEAYFTLGR 522
H I+ L + HL+ +F+V CE A+L + F+ +
Sbjct: 64 ------RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP--------TPFSESQ 109
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
++ + Q L L+YLH IIH DLK N+L+ + +KI D G L +
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT--DKGCLKIADFG----LARTYGLPAK 163
Query: 583 SRS-------YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
+ YRAPE+++G Y ID+W++GCILAEL + L P + + L II
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFI 692
+LG + I+ F+ DL + ++ +P++ ++L+H + +
Sbjct: 224 LLG-------TPNESIWPGFS---DLPLVG------KFTLPKQPYNNLKHKFPWLSEAGL 267
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ-HPY 722
+ LL +P++R TA EAL+ + + P
Sbjct: 268 RLLNFLLMYDPKKRATAEEALESSYFKEKPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 91/316 (28%), Positives = 149/316 (47%), Gaps = 42/316 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-----FDQSLDEIKLLKLVNK 469
RY +GS A+ V A D TG+ V +K K + F ++ E++LLK +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 75
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ + +++V L+ A+L K + T +Q + Q
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQ 128
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
L L+Y+HS IIH DLKP N+ + + CE+KI+D G + D + YV +R YRAP
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARHTDDEMTGYVATRWYRAP 186
Query: 590 EVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
E+++ + Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G G
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-------TPGA 239
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF------IDFVRTLLEIN 702
E+ K + E YI T +P+ + F++ F +D + +L ++
Sbjct: 240 ELLKKISSESARNYIQSLTQ-----MPK-------MNFANVFIGANPLAVDLLEKMLVLD 287
Query: 703 PQRRPTAREALDHPWL 718
+R TA +AL H +
Sbjct: 288 SDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 89/317 (28%), Positives = 149/317 (47%), Gaps = 42/317 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
RY + +GS A+ V A D TG V +K + + F ++ E++LLK + +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 472 PADEHHILRLYDYFYHLEHL------FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
++ L D F L ++V + +L + K E E R+Q
Sbjct: 76 ------VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSED-----RIQF 122
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
+ Q L+ L+Y+H+ GIIH DLKP N+ + + CE+KI+D G + + YV +R
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQTDSEMTGYVVTRW 180
Query: 586 YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG--PIDLE 642
YRAPEVI+ + Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G +
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
+Q ++ Y K ++P + L ++ + +L ++
Sbjct: 241 QKLQSEDAKNYVKKLPRF-----RKKDFRSLLPNANPLA----------VNVLEKMLVLD 285
Query: 703 PQRRPTAREALDHPWLQ 719
+ R TA EAL HP+ +
Sbjct: 286 AESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 82/319 (25%), Positives = 125/319 (39%), Gaps = 89/319 (27%)
Query: 426 AFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
A+ +VF A+ TG +K+IK K+ DQ L E +L ++++L
Sbjct: 5 AYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP------YVVKL 58
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-----QVITRQCLEA 533
Y F ++L++V E L GG+ L G L ++ + + A
Sbjct: 59 YYSFQGKKNLYLVMEYLP-------------GGDLASLLENVGSLDEDVARIYIAEIVLA 105
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------- 585
LEYLHS GIIH DLKP+NILI S +K+ D G S + +
Sbjct: 106 LEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
Y APEVI+G + + +D WSLGCIL E G F + I I+
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL--------- 214
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
+ + E +++ ID + LL +
Sbjct: 215 ------------NGKIEWPEDVEVSDEA---------------------IDLISKLLVPD 241
Query: 703 PQRRPTAR---EALDHPWL 718
P++R A+ E +HP+
Sbjct: 242 PEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 95/318 (29%), Positives = 145/318 (45%), Gaps = 55/318 (17%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
+G A+ V A++ T V +K I N FD +D EIKLL+ ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 476 HHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ + F ++IV EL+ +L++ + +Q + Q Q L
Sbjct: 70 KDIMPPPHREAF---NDVYIVYELMDTDLHQIIRSSQT------LSDDHCQYFLYQLLRG 120
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPE 590
L+Y+HS ++H DLKP N+L+ + C++KI D G ++ + D + YV +R YRAPE
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 591 VIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
+++ Y ID+WS+GCI AEL + LFP V L I +LG
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS--------- 229
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEH--HLQFSDAF------FIDFVRTLLEI 701
E DL +I E YI SL + F+ F ID + +L
Sbjct: 230 -------EEDLGFIRNE-KARRYI----RSLPYTPRQSFARLFPHANPLAIDLLEKMLVF 277
Query: 702 NPQRRPTAREALDHPWLQ 719
+P +R T EAL HP+L
Sbjct: 278 DPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 86/319 (26%), Positives = 131/319 (41%), Gaps = 82/319 (25%)
Query: 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
+G F KV+ A +L TG + +K I+ ND + DE+K+L+L+ H
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-------HP 59
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR------LQVITRQC 530
++++ Y H E ++I F ++ E GR ++V T Q
Sbjct: 60 NLVKYYGVEVHREKVYI-----------FMEYCSGGTLEELLEHGRILDEHVIRVYTLQL 108
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ-------S 583
LE L YLHS GI+H D+KP NI + IK+ D G + +N + +
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 584 RSYRAPEVIIGLPYDQK---IDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPI 639
+Y APEVI G D+WSLGC++ E+ TG+ + D I+ + P
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP- 225
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699
IP+ LQ S DF+ L
Sbjct: 226 ---------------------------------PIPD------SLQLSPE-GKDFLDRCL 245
Query: 700 EINPQRRPTAREALDHPWL 718
E +P++RPTA E L HP++
Sbjct: 246 ESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 81/316 (25%), Positives = 126/316 (39%), Gaps = 87/316 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV + TG +K++K + + +L E +L +N H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--------H 52
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
I++L+ F E L++V E GGE F+ R +
Sbjct: 53 PFIVKLHYAFQTEEKLYLVLEYA-------------PGGELFSHLSKEGRFSEERARFYA 99
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--FQTDNLCL-YVQSR 584
+ + ALEYLHSLGII+ DLKPENIL+ IK+ D G + + + +
Sbjct: 100 AEIVLALEYLHSLGIIYRDLKPENILLD--ADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
Y APEV++G Y + +D WSLG +L E+ TG+ F + I +I+
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL----------- 206
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
+ L + PE S E D + LL+ +P
Sbjct: 207 ----------------------KDPLRF--PEFLSPE---------ARDLISGLLQKDPT 233
Query: 705 RRPTAREALD---HPW 717
+R + A + HP+
Sbjct: 234 KRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 88/317 (27%), Positives = 150/317 (47%), Gaps = 43/317 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
RY + +GS A+ V A D TG V +K + + F ++ E+ LLK +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--- 72
Query: 472 PADEHHILRLYDYF------YHLEHLFIVCELLRANLYEFQ--KFNQESGGEAYFTLGRL 523
+++ L D F + ++V ++ +L + +++ ++
Sbjct: 73 ---HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED----------KV 119
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
Q + Q L L+Y+HS GIIH DLKP N+ + + CE+KI+D G + + YV +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN--EDCELKILDFGLARHADAEMTGYVVT 177
Query: 584 RSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
R YRAPEVI+ + Y+Q +D+WS+GCI+AE+ TG+ LF + L +I+ + G E
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
+ Q++ K Y + P+ S +D + +LE++
Sbjct: 238 FV---QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQA----------VDLLEKMLELD 284
Query: 703 PQRRPTAREALDHPWLQ 719
+R TA EAL+HP+
Sbjct: 285 VDKRLTATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 99/319 (31%), Positives = 152/319 (47%), Gaps = 52/319 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLK-LVN 468
+Y E +G + VF+A++ T V LK ++ D D D+ +L EI LLK L +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 58
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
KN I+RLYD + + L +V E +L +K+ G+ + ++
Sbjct: 59 KN-------IVRLYDVLHSDKKLTLVFEYCDQDL---KKYFDSCNGDIDPEI--VKSFMF 106
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLY 580
Q L+ L + HS ++H DLKP+N+LI + E+K+ D G + C+ + + L+
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGIPVRCYSAEVVTLW 164
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638
YR P+V+ G Y ID+WS GCI AEL G LFP + V L RI +LG
Sbjct: 165 -----YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219
Query: 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 698
E ++ Y K Y +Y T L ++P+ +S D ++ L
Sbjct: 220 PTEESWPGVSKLPDY--KPYPMY---PATTSLVNVVPKLNSTGR----------DLLQNL 264
Query: 699 LEINPQRRPTAREALDHPW 717
L NP +R +A EAL HP+
Sbjct: 265 LVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 99/314 (31%), Positives = 157/314 (50%), Gaps = 27/314 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D +V +K K + F +Q+ E+ L+K VN
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ + ++IV EL+ ANL Q E E R+ + Q
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL--CQVIQMELDHE------RMSYLLYQ 134
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYR 587
L +++LHS GIIH DLKP NI++KS C +KI+D G + + + YV +R YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
APEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + ++I LG E + +
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 648 QEIYKYFTKEYDLY--YINEETNQLEYIIPEESSLEHH-LQFSDAFFIDFVRTLLEINPQ 704
Q + + + Y Y E+ + + P +S EH+ L+ S A D + +L I+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFP-DVLFPADS--EHNKLKASQAR--DLLSKMLVIDAS 307
Query: 705 RRPTAREALDHPWL 718
+R + EAL HP++
Sbjct: 308 KRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 95/313 (30%), Positives = 156/313 (49%), Gaps = 25/313 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D +V +K K + F +Q+ E+ L+K VN
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ + +++V EL+ ANL Q E E R+ + Q
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANL--CQVIQMELDHE------RMSYLLYQ 127
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYR 587
L +++LHS GIIH DLKP NI++KS C +KI+D G + + + YV +R YR
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
APEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG E + +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 648 QEIYKYFTKEYDLYY-INEETNQLEYIIPEESSLEHH-LQFSDAFFIDFVRTLLEINPQR 705
Q + + + Y + + + P +S EH+ L+ S A D + +L I+P +
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADS--EHNKLKASQAR--DLLSKMLVIDPAK 301
Query: 706 RPTAREALDHPWL 718
R + EAL HP++
Sbjct: 302 RISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 86/344 (25%), Positives = 139/344 (40%), Gaps = 81/344 (23%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK--IIKNDKDFFD-QSLDEIKLLKLVN-K 469
Y + LG F +V++A+ + TG V LK ++ N+KD F +L EIK+LK +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 470 N---------DPADEHHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
N + D+ R +Y +++H +L + L E
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-----DL--SGLLENPSVK--------L 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------- 568
T +++ Q LE + YLH I+H D+K NILI + + +KI D G
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QGILKIADFGLARPYDGPPP 170
Query: 569 ----SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPND 623
T V +R YR PE+++G Y +D+W +GC+ AE++T +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ-- 228
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIP-------- 675
G D++ Q I+K EET +P
Sbjct: 229 -------------GKSDID---QLHLIFKL------CGTPTEETWPGWRSLPGCEGVHSF 266
Query: 676 --EESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717
+LE +D + LL ++P +R TA +AL+HP+
Sbjct: 267 TNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 85/316 (26%), Positives = 137/316 (43%), Gaps = 49/316 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD------QSLDEIKLLKLVNKNDPADE 475
+G AF V+ D G V LK + N F + E+K+L ++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 476 HHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
IL+ D F E +++V EL++++L++ Q + ++V Q L
Sbjct: 65 LDILQPPHIDPF---EEIYVVTELMQSDLHKIIVSPQP------LSSDHVKVFLYQILRG 115
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRS 585
L+YLHS GI+H D+KP N+L+ S C +KI D G S T V ++
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNS--NCVLKICDFGLARVEEPDESKHMTQE----VVTQY 169
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE-M 643
YRAPE+++G Y +D+WS+GCI AEL +LF + + L I +LG LE M
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229
Query: 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703
+ + + + P L + + + +L +P
Sbjct: 230 RSACEGARAHIL-------------RGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDP 276
Query: 704 QRRPTAREALDHPWLQ 719
+R +A +AL HP+L
Sbjct: 277 DKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLKLVNKNDPAD 474
E +G + V++A+D TG V LK I+ + + D+ ++ EI LLK +N P
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELN--HP-- 58
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+RL D + L++V E L +L K +S ++ Q L+ +
Sbjct: 59 --NIVRLLDVVHSENKLYLVFEFLDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY---VQSRSYRAPE 590
Y HS ++H DLKP+N+LI +K+ D G + F + Y V + YRAPE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 169
Query: 591 VIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
+++G Y +D+WS+GCI AE+ LFP D+ + L RI LG D E + G
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD-EDVWPGVT 228
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
+Y + L ++P +L+ +D + +L +P +R +A
Sbjct: 229 SL----PDYKPTFPKWARQDLSKVVP---NLDED-------GLDLLSKMLVYDPAKRISA 274
Query: 710 REALDHPWL 718
+ AL HP+
Sbjct: 275 KAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 87/342 (25%), Positives = 149/342 (43%), Gaps = 64/342 (18%)
Query: 412 IAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---------DKDFFDQ----- 456
I+ RY +LG + KV +A D TG V +K +K D+
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 457 -SLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 515
+L E+K++ + +I+ L D + + + +V +++ ++L + +++
Sbjct: 66 TTLRELKIMNEIK------HENIMGLVDVYVEGDFINLVMDIMASDLKKV--VDRK---- 113
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQT 574
T +++ I Q L L LH +H DL P NI I S C KI D G + +
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC--KIADFGLARRYGY 171
Query: 575 DNLC------LYVQSRS----------YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
+Q R YRAPE+++G Y +D+WS+GCI AEL TG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
Query: 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 677
LFP + + L RI +LG + + Q +++ Y E+ +
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYT----------------EFTPRKP 275
Query: 678 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
L+ + ID +++LL++NP R +A+EAL H + +
Sbjct: 276 KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 85/339 (25%), Positives = 126/339 (37%), Gaps = 102/339 (30%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA------ 473
+ +G +FS V A++ T + +KI LD+ +L+K K
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKI-----------LDKRQLIKE-KKVKYVKIEKEV 54
Query: 474 ---DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H I++LY F E+L+ V E A E ++ ++ G +
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEY--APNGELLQYIRKYGS---LDEKCTRFYAA 109
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---------- 578
+ L ALEYLHS GIIH DLKPENIL+ IKI D G++ N
Sbjct: 110 EILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 579 -----LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF--PND 623
+ R Y +PE++ P + DLW+LGCI+ ++ TG+ F N+
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 683
+ Q+I +LEY P
Sbjct: 228 YLTF--------------------QKI-----------------LKLEYSFPP------- 243
Query: 684 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
DA D + LL ++PQ R E D HP+
Sbjct: 244 NFPPDA--KDLIEKLLVLDPQDRLGVNEGYD-ELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 89/303 (29%), Positives = 130/303 (42%), Gaps = 55/303 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG+ V + TG + +K I+ + + Q L E+ +L N P +I+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH--KCNSP----YIV 62
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
Y FY+ + I E + +L + K Q E LG+ I L+ L YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE--RILGK---IAVAVLKGLTYLH 117
Query: 539 S-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQSRSYRAPEVIIGLP 596
IIH D+KP NIL+ S R +IK+ D G S ++L +V + SY APE I G
Sbjct: 118 EKHKIIHRDVKPSNILVNS--RGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGND 175
Query: 597 YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK 656
Y K D+WSLG L EL TG +P + G +L
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPEN--------DPPDGIFEL--------------- 212
Query: 657 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716
L+YI+ E +FS F DFV L +P+ RP+ +E L+HP
Sbjct: 213 -------------LQYIVNEPPPRLPSGKFS-PDFQDFVNLCLIKDPRERPSYKELLEHP 258
Query: 717 WLQ 719
+++
Sbjct: 259 FIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 83/311 (26%), Positives = 153/311 (49%), Gaps = 36/311 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKND 471
++ V +G A+ V + + T V +K K+ +++ + +L E+K+L+ + + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I+ L + F L++V E + N+ E + +G +++ Q +
Sbjct: 62 ------IVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPP----EKVRSYIYQLI 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD----NLCLYVQSRSYR 587
+A+ + H I+H D+KPEN+LI +K+ D G + ++ N YV +R YR
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
+PE+++G PY + +D+WS+GCIL EL G+ LFP ++ + L I +LGP+ E +
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM--- 225
Query: 648 QEIYKYFTKEYDLYYINEETNQLEY-IIPEESSLE-HHLQFSDAFFIDFVRTLLEINPQR 705
L+Y N + L + + SLE +L +D ++ LL++NP
Sbjct: 226 -----------KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTD 274
Query: 706 RPTAREALDHP 716
R + L+HP
Sbjct: 275 RYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 82/315 (26%), Positives = 123/315 (39%), Gaps = 72/315 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
Y + + +G AF V++ +L TG V +K I K ++ + EI LLK +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--- 57
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+I++ + L+I+ E LR + +F F ES Y
Sbjct: 58 ---HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYV-------- 105
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQS 583
Q L+ L YLH G+IH D+K NIL +K+ D G + D V +
Sbjct: 106 -YQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDASVVGT 162
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643
+ APEVI D+WSLGC + EL TG + + L P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD-------------LNP----- 204
Query: 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703
M L+ I ++ +PE S E DF+ + +P
Sbjct: 205 -MAA------------LFRIVQDD---HPPLPEGISPE---------LKDFLMQCFQKDP 239
Query: 704 QRRPTAREALDHPWL 718
RPTA++ L HPW+
Sbjct: 240 NLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-25
Identities = 90/342 (26%), Positives = 150/342 (43%), Gaps = 46/342 (13%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
V R+ + LG F KV +A D +KI++N + + EI+ ++ V +
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA 185
Query: 471 DPADEHHILRLYDYFYHLE-HLFIVCELLRANLYEF----QKFNQESGGEAYFTLGRLQV 525
DPAD ++++ YF + H+ IV L ++ F+ + F G
Sbjct: 186 DPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTG---- 241
Query: 526 ITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQR--------------CEIKIIDLGSS 570
AL+Y H+ L ++H DLKPENIL+++ C ++I DLG
Sbjct: 242 ------VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295
Query: 571 CFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF---PNDAVVM 627
C + + V +R YR+PEV++GL + D+WS+GCI+ EL+TG++L+ N +
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355
Query: 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 687
++ + +G L P + +E + L + L I E
Sbjct: 356 LMEKTLGRL-PSEWAGRCGTEEARLLYNSAGQLRPCT-DPKHLARIARARPVRE---VIR 410
Query: 688 DAFFIDFVRTLLEINPQRRPTAREALDHPWL--------QHP 721
D D + LL + Q+R AR+ HP++ QHP
Sbjct: 411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHP 452
|
Length = 467 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 82/309 (26%), Positives = 131/309 (42%), Gaps = 67/309 (21%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+ E LG ++ V++A TG V +K++ ++D + EI +LK D +
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII-KEISILK------QCDSPY 59
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I++ Y ++ L+IV E A + + K ++ E + I Q L+ LEY
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE-----EIAAILYQTLKGLEY 114
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII 593
LHS IH D+K NIL+ + + K+ D G S TD + + + + APEVI
Sbjct: 115 LHSNKKIHRDIKAGNILLN--EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 594 GLPYDQKIDLWSLGCILAELWTGEV----LFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
+ Y+ K D+WSLG E+ G+ + P A+ MI
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------------------- 211
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
N+ L PE+ S E F DFV+ L +P+ RP+A
Sbjct: 212 -------------PNKPPPTLS--DPEKWSPE---------FNDFVKKCLVKDPEERPSA 247
Query: 710 REALDHPWL 718
+ L HP++
Sbjct: 248 IQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 38/307 (12%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEH 476
E +G + V++A++ TG V LK I+ D + ++ EI LLK +N +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN----- 60
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I++L D + L++V E L +L +F + SG L ++ Q L+ L +
Sbjct: 61 -IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG----IPLPLIKSYLFQLLQGLAF 115
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEVII 593
HS ++H DLKP+N+LI + IK+ D G + + Y V + YRAPE+++
Sbjct: 116 CHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 594 GLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652
G Y +D+WSLGCI AE+ T LFP D+ + L RI LG D + ++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-------EVVWP 226
Query: 653 YFT--KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710
T +Y + ++P D D + +L +P +R +A+
Sbjct: 227 GVTSLPDYKPSFPKWARQDFSKVVPP----------LDEDGRDLLSQMLHYDPNKRISAK 276
Query: 711 EALDHPW 717
AL HP+
Sbjct: 277 AALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 31/202 (15%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILI-KSYQRCEIKIIDLGSSCFQT---DNLCLYV 581
I Q L+A+ + H IH D+KPENILI K Q IK+ D G + T D+ YV
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYV 161
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+R YRAPE+++G Y +D+W++GC+ AEL TG+ L+P + V L I LG
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG--- 218
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQL--EYIIPEESSLEH-HLQFSDAFF--IDFV 695
+++ + Q+I+ TNQ IPE + E +F + + F+
Sbjct: 219 -DLIPRHQQIF--------------STNQFFKGLSIPEPETREPLESKFPNISSPALSFL 263
Query: 696 RTLLEINPQRRPTAREALDHPW 717
+ L+++P R + E L+HP+
Sbjct: 264 KGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 64/308 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG AF KV++A++ TG K+I K++++ D + EI++L + +I+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILA------TCNHPYIV 72
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+L FY L+I+ E + + G T ++QVI RQ LEAL+YLHS
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHS 128
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII--- 593
+ IIH DLK N+L+ +IK+ D G S L ++ + + APEV++
Sbjct: 129 MKIIHRDLKAGNVLLT--LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 594 --GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651
PYD K D+WSLG L E+ ++ P+ + + R++ + + L Q
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM--AQIEPPHHELNPM--RVLLKIAKSEPPTLSQ----- 237
Query: 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711
P + S+E F DF++T L+ +P+ RP+A +
Sbjct: 238 -----------------------PSKWSME---------FRDFLKTALDKHPETRPSAAQ 265
Query: 712 ALDHPWLQ 719
L+HP++
Sbjct: 266 LLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 87/322 (27%), Positives = 148/322 (45%), Gaps = 57/322 (17%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
+Y +G ++ V + + TG V +K ++DK ++ EI++LK +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL---- 57
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H ++ L + F + L++V E + L + +K+ +G R++
Sbjct: 58 ----RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNG----LDESRVRKYLF 107
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-------QTDNLCLYV 581
Q L +E+ HS IIH D+KPENIL+ Q +K+ D G + TD YV
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVS--QSGVVKLCDFGFARTLAAPGEVYTD----YV 161
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+R YRAPE+++G Y + +D+W++GC++ E+ TGE LFP D+ + L II LG
Sbjct: 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG--- 218
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI-----IPEESSLEHHLQFSDAFFIDFV 695
++ + QEI+ + N L + E LE +D
Sbjct: 219 -NLIPRHQEIF--------------QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLA 263
Query: 696 RTLLEINPQRRPTAREALDHPW 717
+ L I+P RP++ + L H +
Sbjct: 264 KQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 91/338 (26%), Positives = 151/338 (44%), Gaps = 70/338 (20%)
Query: 421 YLGSAAFSKVFQA--QDLHTGVDVCLKIIKNDKDFFD---QS-LDEIKLLK-LVNKNDPA 473
+G + +V++A ++ G + +K K DK+ + QS EI LL+ L ++N
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN--- 63
Query: 474 DEHHILRLYDYFYHLEH----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
++ L + F LEH ++++ + +L++ KF++++ ++ + Q
Sbjct: 64 ----VVSLVEVF--LEHADKSVYLLFDYAEHDLWQIIKFHRQAKR-VSIPPSMVKSLLWQ 116
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLG-SSCFQTDNLCLY-----V 581
L + YLHS ++H DLKP NIL+ +R +KI DLG + F L V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP-----NDAVVMI----LAR 631
+ YRAPE+++G Y + ID+W++GCI AEL T E +F L R
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 632 IIGMLGPIDLEM------------LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS 679
I +LG + LM+ + Y + + E +
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWM--------EKHKKPD-- 286
Query: 680 LEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717
S F D +R LLE +P +R TA EAL+HP+
Sbjct: 287 -------SQGF--DLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 85/319 (26%), Positives = 148/319 (46%), Gaps = 47/319 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+Y E +G + V++A+D T + LK I+ D+ ++ EI LLK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLK------ 56
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ H I+RL D + + L++V E L +L K + +S + ++ Q
Sbjct: 57 --EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDL----KKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYV 581
L + Y HS ++H DLKP+N+LI + +K+ D G + F + + L+
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFTHEVVTLW- 168
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
YRAPE+++G Y +D+WS+GCI AE+ + LFP D+ + L +I +LG +
Sbjct: 169 ----YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
E + +Y + L ++P +LE +D + +L
Sbjct: 225 EETWPGVTSL-----PDYKSAFPKWPPKDLATVVP---TLEPA-------GVDLLSKMLR 269
Query: 701 INPQRRPTAREALDHPWLQ 719
++P +R TAR AL+H + +
Sbjct: 270 LDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 81/331 (24%), Positives = 136/331 (41%), Gaps = 52/331 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK-IIKNDKDFFDQSLDEIKLLKLVNKN 470
+ RY LG + VF A D V +K I+ D +L EIK+++ +
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL--- 59
Query: 471 DPADEHHILRLYDYF--------------YHLEHLFIVCELLRANLYEFQKFNQESGGEA 516
D +I+++Y+ L ++IV E + +L Q E
Sbjct: 60 ---DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANV--LEQGPLSEE 114
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---- 572
+ L Q L L+Y+HS ++H DLKP N+ I + +KI D G +
Sbjct: 115 HARL-----FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV-LKIGDFGLARIVDPH 168
Query: 573 --QTDNLCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
L + ++ YR+P +++ P Y + ID+W+ GCI AE+ TG+ LF +
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227
Query: 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 688
+ I+ + + E + + F + E L ++P +
Sbjct: 228 MQLILESVPVVREEDRNELLNVIPSFVRNDG----GEPRRPLRDLLPG---VNPEA---- 276
Query: 689 AFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
+DF+ +L NP R TA EAL HP++
Sbjct: 277 ---LDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 83/307 (27%), Positives = 147/307 (47%), Gaps = 35/307 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLK-LVNKNDPADE 475
E +G + V++ ++ TG V +K I+ ++ ++ EI LLK L + N
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN----- 60
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+ L D L+++ E L +L +K+ Y ++ Q L+ +
Sbjct: 61 --IVCLQDVLMQESRLYLIFEFLSMDL---KKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEVI 592
+ HS ++H DLKP+N+LI + + IK+ D G + + +Y V + YRAPEV+
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 593 IGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651
+G P Y +D+WS+G I AE+ T + LF D+ + L RI +LG ++++
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPT-------EDVW 226
Query: 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711
T D Y N ++ SL ++ D +D + +L +P +R +A++
Sbjct: 227 PGVTSLPD--YKNTFPKW------KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278
Query: 712 ALDHPWL 718
AL+HP+
Sbjct: 279 ALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-23
Identities = 92/340 (27%), Positives = 155/340 (45%), Gaps = 39/340 (11%)
Query: 391 HRKNRTGFEEN-KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN 449
H N E+ K + +N Y + +G+ +F V++A + T V +K +
Sbjct: 42 HNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 450 DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY------HLEHLF--IVCELLRAN 501
D + ++ L +K L +N I+ L DY+Y + +++F +V E +
Sbjct: 102 DPQYKNRELLIMKNLNHIN---------IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 502 LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561
++++ K + L +L + Q AL Y+HS I H DLKP+N+LI
Sbjct: 153 VHKYMKHYARNNHALPLFLVKL--YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT- 209
Query: 562 IKIIDLGSS--CFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
+K+ D GS+ Y+ SR YRAPE+++G Y IDLWSLGCI+AE+ G
Sbjct: 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
Query: 619 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 678
+F + V L RII +LG + L + Y D+ + + + L+ + P+ +
Sbjct: 270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA------DIKFPDVKPKDLKKVFPKGT 323
Query: 679 SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718
+ I+F+ L+ P +R EAL P+
Sbjct: 324 PDDA---------INFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-----LVNK 469
+ + E +G +F +V++A D T V +K+I +++ DEI+ ++ L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQC 56
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLR----ANLYEFQKFNQESGGEAYFTLGRLQV 525
P +I + Y F L+I+ E +L + K ++ +
Sbjct: 57 RSP----YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY----------IAF 102
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQ 582
I R+ L LEYLH G IH D+K NIL+ ++K+ D G S T + +V
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTSTMSKRNTFVG 160
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + APEVI YD+K D+WSLG EL GE
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 9e-23
Identities = 82/322 (25%), Positives = 149/322 (46%), Gaps = 38/322 (11%)
Query: 414 GRYYVTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLK 465
G+ V ++ +G + +V++A+D TG V LK ++ N+K+ F ++ EIK+L+
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 466 LVNKNDPADEHHIL----RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+N + + I+ D+ ++V E + +L ESG +F+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL----ESG-LVHFSED 116
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY 580
++ +Q LE L Y H +H D+K NIL+ + + +IK+ D G + + ++ Y
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN--KGQIKLADFGLARLYNSEESRPY 174
Query: 581 ---VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
V + YR PE+++G Y ID+WS GCIL EL+T + +F + + L I +
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234
Query: 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696
G + ++ + T + Y + +I +D +
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPA--------------LDLLD 280
Query: 697 TLLEINPQRRPTAREALDHPWL 718
+L ++P +R TA EAL+ PWL
Sbjct: 281 HMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 79/326 (24%), Positives = 142/326 (43%), Gaps = 60/326 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y +G A+ V++A+D H+G V LK ++ + L ++ + L+ + + D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQESGGEAYFT--------LG 521
+I+RL D VC R + F+ +Q+ Y
Sbjct: 61 HPNIVRLMD----------VCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAE 108
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
++ + RQ L L++LH+ I+H DLKPENIL+ S ++K+ D G + + + L
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLADFGLARIYSCQMALTP 166
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-- 637
V + YRAPEV++ Y +D+WS+GCI AE++ + LF ++ L +I ++G
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226
Query: 638 -----PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692
P D+ + + ++ ++PE +
Sbjct: 227 PEDDWPRDVTLPRGA--------------FSPRGPRPVQSVVPE----------IEESGA 262
Query: 693 DFVRTLLEINPQRRPTAREALDHPWL 718
+ +L NP +R +A AL HP+
Sbjct: 263 QLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 74/319 (23%), Positives = 128/319 (40%), Gaps = 81/319 (25%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK------NDKDFFDQSL-DEIKLLKLVNKNDP 472
+ LG+ AFS +QA+D+ TG + +K + ++++ ++L EI+L+ +N
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN---- 61
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQESGGEAYFTLGRLQVIT 527
HI+R+ H + E + L ++ F +E+ Y T
Sbjct: 62 --HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAF-KEAVIINY---------T 109
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-------LY 580
Q L L YLH IIH D+K N+LI S + ++I D G++
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGMLG 637
+ + ++ APEV+ G Y + D+WS+GC++ E+ T + + + + ++ +I
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
IPE L L+ D
Sbjct: 229 APS---------------------------------IPE--HLSPGLR-------DVTLR 246
Query: 698 LLEINPQRRPTAREALDHP 716
LE+ P+ RP +RE L HP
Sbjct: 247 CLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 84/312 (26%), Positives = 138/312 (44%), Gaps = 38/312 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFD-QSLDEIKLLKLVNKNDPADEHHI 478
+G F +VF+A+ T V LK + +N+K+ F +L EIK+L+L+ + + I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 479 LR----LYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
R Y+ + +L F CE A L + FTL ++ + + L
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--------FTLSEIKKVMKMLLNG 131
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLCLY---VQSRSY 586
L Y+H I+H D+K NILI + +K+ D G S + Y V + Y
Sbjct: 132 LYYIHRNKILHRDMKAANILIT--KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
R PE+++G Y ID+W GCI+AE+WT + + L I + G I
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT----- 244
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
E++ K +L+ E + + E L+ + D +D + LL ++P +
Sbjct: 245 --PEVWPGVDK-LELFKKMELPQGQKRKVKER--LKPY--VKDPHALDLIDKLLVLDPAK 297
Query: 706 RPTAREALDHPW 717
R A AL+H +
Sbjct: 298 RIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ V + LG ++ V++ + L LK + + K+ D +++EI++L VN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIRILASVN-- 57
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITR- 528
+I+ + F L IV E +L + ++ L Q I R
Sbjct: 58 ----HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-----KLIPEQEIWRI 108
Query: 529 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ--SR 584
Q L L+ LH I+H DLK NIL+ +KI DLG S N+ Q +
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILL--VANDLVKIGDLGISKVLKKNM-AKTQIGTP 165
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
Y APEV G PY K D+WSLGC+L E+ T F
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 86/320 (26%), Positives = 134/320 (41%), Gaps = 88/320 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG AF KV++AQ TG+ KII+ ++ + + EI +L +I+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS------ECKHPNIVG 66
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG---------EAYFTLGRLQVITRQCL 531
LY+ +++ L+I+ E GG E T +++ + RQ L
Sbjct: 67 LYEAYFYENKLWILIEFC-------------DGGALDSIMLELERGLTEPQIRYVCRQML 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------ 585
EAL +LHS +IH DLK NIL+ ++K+ D G S L Q R
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLT--LDGDVKLADFGVSAKNKSTL----QKRDTFIGTP 167
Query: 586 -YRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
+ APEV+ PYD K D+WSLG L EL E P+ + + R++
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHELNPM--RVL------ 217
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699
L+ + E +L+ ++S +F DF+++ L
Sbjct: 218 ------------------------------LKILKSEPPTLDQPSKWSSSFN-DFLKSCL 246
Query: 700 EINPQRRPTAREALDHPWLQ 719
+P RPTA E L HP++
Sbjct: 247 VKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 80/325 (24%), Positives = 131/325 (40%), Gaps = 90/325 (27%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + + +GS + V++A+D+ TG V +K+IK D F+ EI +LK +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN-- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCE------------LLRANLYEFQKFNQESGGEAYFTLG 521
I+ + + + L+IV E + R L E Q AY
Sbjct: 62 ----IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI--------AY---- 105
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC--- 578
+ R+ L+ L YLH G IH D+K NIL+ ++K+ D G S T +
Sbjct: 106 ----VCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVSAQLTATIAKRK 159
Query: 579 LYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
++ + + APEV YD K D+W+LG EL E+ P
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL--AELQPPM------------- 204
Query: 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ----FSDAFF 691
+DL+ + + ++I + + L+ +S F
Sbjct: 205 ----------------------FDLHPM-----RALFLISKSNFPPPKLKDKEKWSPVF- 236
Query: 692 IDFVRTLLEINPQRRPTAREALDHP 716
DF++ L +P++RPTA + L HP
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 88/327 (26%), Positives = 129/327 (39%), Gaps = 91/327 (27%)
Query: 420 EYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKND----KDFFDQSLDEIKLLKLVN 468
E +G + +V+ A ++ TG V++ I KD EI+ LK
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK--- 63
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIV----CELLRANLYEFQKF-NQESGGEAYFTLGRL 523
L+HL IV E L F ++ S G T GR
Sbjct: 64 ------------------DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF 105
Query: 524 Q-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ T Q LE L YLHS GI+H DLK +N+L+ + C KI D G S ++D++
Sbjct: 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC--KISDFGIS-KKSDDIY 162
Query: 579 LYVQSRSYR------APEVI--IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630
Q+ S + APEVI Y K+D+WSLGC++ E++ G + ++ +
Sbjct: 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---- 218
Query: 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 690
++K K IP + S + S
Sbjct: 219 -----------------AAMFKLGNKRS------------APPIPPDVS----MNLSPV- 244
Query: 691 FIDFVRTLLEINPQRRPTAREALDHPW 717
+DF+ INP RPTARE L HP+
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 79/317 (24%), Positives = 121/317 (38%), Gaps = 70/317 (22%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPA 473
Y + E +G A + V+ A L V +K I +K D+ E++ + N
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN----- 57
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++ Y F + L++V L +L + K + GG + + ++ L
Sbjct: 58 --HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA---TVLKEVL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------ 585
+ LEYLHS G IH D+K NIL+ +KI D G S D + R
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 586 -YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV----LFPNDAVVMILARIIGMLGPI 639
+ APEV+ + YD K D+WS G EL TG P +++ L P
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-----DPP 225
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699
LE YK ++K F + L
Sbjct: 226 SLET----GADYKKYSKS---------------------------------FRKMISLCL 248
Query: 700 EINPQRRPTAREALDHP 716
+ +P +RPTA E L H
Sbjct: 249 QKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 55/236 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + +G LKI+ K + L+E ++L+ + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--------H 60
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL----GRL-----QVI 526
++ LY F +L++V E + GGE F+ GR +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYV-------------PGGE-LFSHLRKSGRFPEPVARFY 106
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q + ALEYLHSL I++ DLKPEN+L+ S IKI D G V+ R+
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFG--------FAKRVKGRTY 156
Query: 586 -------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
Y APE+I+ Y + +D W+LG ++ E+ G F +D + I +I+
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDE-IKLLKLVNKNDPADEHHILR 480
LG F +V + LK +K + E I K + + + I++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-IVETGQQEHIFSEKEILEE--CNHPFIVK 57
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-----QVITRQCLE 532
LY F ++++++ E GGE + L G + +
Sbjct: 58 LYRTFKDKKYIYMLMEYCL-------------GGELWTILRDRGLFDEYTARFYIACVVL 104
Query: 533 ALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS----- 585
A EYLH+ GII+ DLKPEN+L+ S Y +K++D G + ++S
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFA--------KKLKSGQKTWTF 152
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGP 638
Y APE+I+ YD +D WSLG +L EL TG F D + I I+ G
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212
Query: 639 ID 640
++
Sbjct: 213 LE 214
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 83/315 (26%), Positives = 127/315 (40%), Gaps = 83/315 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLD-EIKLLKLVNKNDPADE 475
LG AF +V+ D+ TG ++ +K + D D + +L+ EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE----- 64
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG------EAYFTLGR--LQVIT 527
R+ Y+ C L F ++ GG +AY L + T
Sbjct: 65 ----RIVQYYG--------CLRDDETLSIFMEYM--PGGSVKDQLKAYGALTETVTRKYT 110
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYV 581
RQ LE +EYLHS I+H D+K NIL S +K+ D G+S C +
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+ + +PEVI G Y +K D+WS+GC + E+ T + P A +
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK---PPWA---------------EF 210
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
E + I+K T+ +P S DA +F+R
Sbjct: 211 EAM---AAIFKIATQP------------TNPQLPSHVS-------PDA--RNFLRRTFVE 246
Query: 702 NPQRRPTAREALDHP 716
N ++RP+A E L H
Sbjct: 247 NAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG AF KV++AQ+ TGV K+I ++ + + EI +L D +I++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILA------SCDHPNIVK 66
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
L D FY+ +L+I+ E + E T +++V+ +Q LEAL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII---- 593
IIH DLK NIL +IK+ D G S T + ++ + + APEV++
Sbjct: 123 KIIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 594 -GLPYDQKIDLWSLGCILAEL 613
PYD K D+WSLG L E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 82/318 (25%), Positives = 141/318 (44%), Gaps = 45/318 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y +G A+ KVF+A+DL G V LK ++ L I+ + ++ +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQ------ESGGEAYFTLGR 522
+ +++RL+D VC + R + F+ +Q + E
Sbjct: 62 EHPNVVRLFD----------VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 111
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCL 579
++ + Q L L++LHS ++H DLKP+NIL+ S +IK+ D G + FQ L
Sbjct: 112 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQM-ALTS 168
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
V + YRAPEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699
E + + + + ++ +E + + L L L
Sbjct: 229 GEEDWPRDVALPRQ-------AFHSKSAQPIEKFVTDIDELGKDLLLK----------CL 271
Query: 700 EINPQRRPTAREALDHPW 717
NP +R +A AL HP+
Sbjct: 272 TFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 60/191 (31%), Positives = 90/191 (47%), Gaps = 35/191 (18%)
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAP 589
L+ L YLHS IIH D+KP NIL+ + ++K+ D G S ++L + + Y AP
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP 172
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
E I G PY D+WSLG L E+ FP + LGPI+L
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG--------EPPLGPIELLS------ 218
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
Y +N +L + + +++S+ F DF++ LE +P RRPT
Sbjct: 219 -----------YIVNMPNPEL------KDEPGNGIKWSEE-FKDFIKQCLEKDPTRRPTP 260
Query: 710 REALDHPWLQH 720
+ L+HPW++
Sbjct: 261 WDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 49/224 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
Y E +G A+ V++ + + TG V LKII D D S E+ LL + ++ P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 474 DEHHILRLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+ I + Y + L+I+ E L++A E Y +
Sbjct: 63 N---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA----------EKY-----IS 104
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
VI R+ L AL+Y+H +G+IH D+K NIL+ + +K+ D G + L Q+
Sbjct: 105 VIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVA-------ALLNQNS 155
Query: 585 SYR----------APEVII-GLPYDQKIDLWSLGCILAELWTGE 617
S R APEVI G YD K D+WSLG + E+ TG
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 420 EYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
+ LG AF +V++ + V+V +K +K D L E ++++ ++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD----- 59
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++L E L+IV E + +L + + N+ +L L Q
Sbjct: 60 --HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIA 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS----YR 587
+EYL S IH DL N L+ +KI D G S D Y + R R
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYD--DDYYRKRGGKLPIR 168
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 28/227 (12%)
Query: 420 EYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
+ LG AF +V++ V+V +K +K D L E ++++ ++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD----- 59
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I++L E L IV E + +L ++ + N+ +L L Q
Sbjct: 60 --HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIA 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS---YR- 587
+EYL S IH DL N L+ +KI D G S D+ Y R
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRW 170
Query: 588 -APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 83/309 (26%), Positives = 137/309 (44%), Gaps = 33/309 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG ++ VF+ + T V LK I+ +++ ++ E+ LLK + +
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN-- 64
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ L+D + L +V E L ++L +++ G ++ +++ Q L
Sbjct: 65 ----IVTLHDIIHTERCLTLVFEYLDSDL---KQYLDNCGN--LMSMHNVKIFMFQLLRG 115
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPE 590
L Y H I+H DLKP+N+LI ++ E+K+ D G + T V + YR P+
Sbjct: 116 LSYCHKRKILHRDLKPQNLLIN--EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173
Query: 591 VIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
V++G Y ID+W +GCIL E+ TG +FP V L I +LG +E
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG-------TPTEE 226
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
+ T NEE + L +H D ID + +LL + R +A
Sbjct: 227 TWPGITS-------NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279
Query: 710 REALDHPWL 718
AL H +
Sbjct: 280 EAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 82/312 (26%), Positives = 139/312 (44%), Gaps = 37/312 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG ++ V++ + T V LK I+ +++ ++ E+ LLK
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK-------- 59
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
D H I+ L+D + + L +V E L +L +++ + G + +++ Q L
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDL---KQYLDDCGN--SINMHNVKLFLFQLL 114
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRA 588
L Y H ++H DLKP+N+LI +R E+K+ D G + T V + YR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
P++++G Y +ID+W +GCI E+ TG LFP V L I +LG
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-------TPT 225
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
+E + NEE Y L +H D+ + + LL+ ++R
Sbjct: 226 EETWPGILS-------NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278
Query: 708 TAREALDHPWLQ 719
+A EA+ HP+
Sbjct: 279 SAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 79/320 (24%), Positives = 130/320 (40%), Gaps = 81/320 (25%)
Query: 415 RYYVTEY--LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKND 471
R Y+ + +G + V A D TG V +K + K + L +E+ +++
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMR------ 71
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEA--YFTLGRLQ--- 524
D H I+ +Y + + L++V E L GG T R+
Sbjct: 72 --DYQHPNIVEMYSSYLVGDELWVVMEFL-------------EGGALTDIVTHTRMNEEQ 116
Query: 525 --VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---- 578
+ L+AL +LH+ G+IH D+K ++IL+ S R +K+ D G C Q
Sbjct: 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFG-FCAQVSKEVPRRK 173
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
V + + APEVI LPY ++D+WSLG ++ E+ GE + N+ + + RI L P
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP 233
Query: 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 698
L++ + S F+ +
Sbjct: 234 ----------------------------------------KLKNLHKVS-PRLRSFLDRM 252
Query: 699 LEINPQRRPTAREALDHPWL 718
L +P +R TA E L+HP+L
Sbjct: 253 LVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNK 469
G + + + +G FS V++A L G V LK ++ D L EI LLK
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK---- 57
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
D ++++ F L IV EL A +L K ++ + +
Sbjct: 58 --QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR----LIPERTIWKY 111
Query: 529 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQS 583
Q ALE++HS I+H D+KP N+ I + +K+ DLG F +T V +
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 426 AFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKN--DPADEHHILRLY 482
AF V+ A+ TG +K++ K+D + +++ +K + ++ +LY
Sbjct: 8 AFGSVYLAKKRSTGDYFAIKVLKKSDMI----AKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ--------CLEAL 534
F ++L++V E L +GG+ + L + + +
Sbjct: 64 YSFQSKDYLYLVMEYL-------------NGGDCASLIKTLGGLPEDWAKQYIAEVVLGV 110
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG 594
E LH GIIH D+KPEN+LI Q +K+ D G S +N +V + Y APE I+G
Sbjct: 111 EDLHQRGIIHRDIKPENLLID--QTGHLKLTDFGLSRNGLENK-KFVGTPDYLAPETILG 167
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLF----PNDAVVMILARIIG 634
+ D+ D WSLGC++ E G F P+ IL+R I
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN 211
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 75/316 (23%), Positives = 126/316 (39%), Gaps = 72/316 (22%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS----LDEIKLLKLVNKND 471
+ + +G AF KV Q T +K + K S L+E ++L+ +N
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVI 526
++ L+ F E++++V +L LR +L + KF++E +++
Sbjct: 61 -----FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE----------QVKFW 105
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSR 584
+ + ALEYLHS GIIH D+KP+NIL+ ++ + I D + T + +
Sbjct: 106 ICEIVLALEYLHSKGIIHRDIKPDNILLD--EQGHVHITDFNIATKVTPDTLTTSTSGTP 163
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
Y APEV+ Y +D WSLG E G+ + + +
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---------------- 207
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
D +ET + Y P S E ID + LLE +PQ
Sbjct: 208 --------------DQIRAKQETADVLY--PATWSTE---------AIDAINKLLERDPQ 242
Query: 705 RR--PTAREALDHPWL 718
+R ++ +HP+
Sbjct: 243 KRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 7e-17
Identities = 62/257 (24%), Positives = 98/257 (38%), Gaps = 57/257 (22%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG AF +V++ T V +K +K ++F L+E ++K +
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKL---- 58
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+I+RL E L+IV E + +L +F + + E TL L + Q
Sbjct: 59 --SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-----LTLKDLLQMALQI 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY---- 586
+ +EYL S +H DL N L+ KI D G L + Y
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVV--KISDFG--------LSRDIYEDDYYRKR 161
Query: 587 ---------RAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG-- 634
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY 221
Query: 635 -----MLGPIDLEMLMQ 646
P +L LM
Sbjct: 222 RLPRPENCPDELYELML 238
|
Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 80/315 (25%), Positives = 125/315 (39%), Gaps = 78/315 (24%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLK---IIKNDKDFFD---QSLDEIKLL-KLVNKNDP 472
E LGS +F V++ +L G +K + + + + Q EI LL KL + N
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN-- 63
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLR----ANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I++ ++L+I EL+ A L +K+ F +++ TR
Sbjct: 64 -----IVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGS-------FPEPVIRLYTR 109
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSY 586
Q L LEYLH +H D+K NIL+ + +K+ D G + + + S +
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADFGMAKQVVEFSFAKSFKGSPYW 167
Query: 587 RAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI--IGMLGPIDLEM 643
APEVI Y D+WSLGC + E+ TG+ + V + +I L P
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP----- 222
Query: 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703
IP+ S E DF+ L+ +P
Sbjct: 223 ------------------------------IPDHLSDEAK---------DFILKCLQRDP 243
Query: 704 QRRPTAREALDHPWL 718
RPTA E L+HP++
Sbjct: 244 SLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 65/201 (32%), Positives = 87/201 (43%), Gaps = 56/201 (27%)
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
RQ L+ L YLH+ GIIH D+K NIL+ + + IKI D G S N L ++ R
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIKISDFGISKKLEANS-LSTKTNGAR 169
Query: 588 ----------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
APEV+ Y +K D+WSLGC++ E+ TG+ FP+
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD--------------- 214
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
Q Q I+K + E IP S E IDF+
Sbjct: 215 ------CTQLQAIFKIGE------NASPE-------IPSNISSEA---------IDFLEK 246
Query: 698 LLEINPQRRPTAREALDHPWL 718
EI+ +RPTA E L HP+L
Sbjct: 247 TFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 520 LGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
LG+ I+ L L YL I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 101 LGK---ISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMA 155
Query: 579 -LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIGML 636
+V +RSY +PE + G Y + D+WSLG L E+ G P DA + M
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMF 210
Query: 637 GPID--LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 694
G E + + + I E L+YI+ E FSD F DF
Sbjct: 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFE---LLDYIVNEPPPKLPSGAFSDE-FQDF 266
Query: 695 VRTLLEINPQRRPTAREALDHPWLQ 719
V L+ NP+ R +E HP+++
Sbjct: 267 VDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 81/318 (25%), Positives = 137/318 (43%), Gaps = 77/318 (24%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y E +G A V+ A D+ TG +V +K + + + ++EI +++ NK+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR-ENKHP-- 76
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQVI 526
+I+ D + + L++V E L +GG E G++ +
Sbjct: 77 ---NIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIAAV 120
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQ 582
R+CL+ALE+LHS +IH D+K +NIL+ +K+ D G C Q V
Sbjct: 121 CRECLQALEFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVG 177
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
+ + APEV+ Y K+D+WSLG + E+ GE P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE---PP-------------------- 214
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLE-HHLQFSDAFFIDFVRTLLEI 701
Y+NE + Y+I + E + + A F DF+ LE+
Sbjct: 215 -------------------YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 255
Query: 702 NPQRRPTAREALDHPWLQ 719
+ ++R +A+E L HP+L+
Sbjct: 256 DVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 55/302 (18%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHH 477
E LG V++A L T + +K+I D + Q + E+++L D +
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILY------KCDSPY 60
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ Y F+ + I E + + + E LGR+ V ++ L YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH------VLGRIAVAV---VKGLTYL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVIIGLP 596
SL I+H D+KP N+L+ + R ++K+ D G S +++ YV + +Y APE I G
Sbjct: 112 WSLKILHRDVKPSNMLVNT--RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ 169
Query: 597 YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK 656
Y D+WSLG EL G +P + + G L P+ L
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQ------IQKNQGSLMPLQL--------------- 208
Query: 657 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716
L+ I+ E+ + QFS+ F+ F+ + P+ RP +DHP
Sbjct: 209 -------------LQCIVDEDPPVLPVGQFSEK-FVHFITQCMRKQPKERPAPENLMDHP 254
Query: 717 WL 718
++
Sbjct: 255 FI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 81/312 (25%), Positives = 141/312 (45%), Gaps = 37/312 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y E LG ++ VF+ + T V LK I+ +++ ++ E+ LLK
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLK-------- 59
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
D H I+ L+D + + L +V E L +L +++ + G ++ +++ Q L
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDL---KQYMDDCG--NIMSMHNVKIFLYQIL 114
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRA 588
L Y H ++H DLKP+N+LI +R E+K+ D G + T V + YR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
P+V++G Y +ID+W +GCI E+ +G LFP V L I +LG
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG-------TPT 225
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
+E + + N+E + + L +H D I+ + L+ ++R
Sbjct: 226 EETWPGISS-------NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI 278
Query: 708 TAREALDHPWLQ 719
+A EA+ H + +
Sbjct: 279 SAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 6e-16
Identities = 80/321 (24%), Positives = 141/321 (43%), Gaps = 48/321 (14%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKN 470
A Y E LG +++ V++ + G V LK+I+ ++ ++ E LLK +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ I+ L+D + E L +V E + +L ++ ++ GG +++ Q
Sbjct: 64 N------IVLLHDIIHTKETLTLVFEYVHTDLCQY--MDKHPGG---LHPENVKLFLFQL 112
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQ 582
L L Y+H I+H DLKP+N+LI E+K+ D G S + + + L+
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLW-- 168
Query: 583 SRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPID 640
YR P+V++G Y +D+W +GCI E+ G FP + L RI +LG +
Sbjct: 169 ---YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225
Query: 641 LEMLMQGQEIYKYFTKEYDLYY---INEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
+ + + + + LY + + N+L Y+ E D
Sbjct: 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAE---------------DLASK 270
Query: 698 LLEINPQRRPTAREALDHPWL 718
LL+ P+ R +A+ AL H +
Sbjct: 271 LLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 82/311 (26%), Positives = 131/311 (42%), Gaps = 63/311 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-SLDEIKLLK-LVNKNDP 472
+Y E +G A VF A D+ TG +V +K I K + ++EI ++K L N N
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN-- 77
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
I+ D F + LF+V E L + E ++ + R+CL+
Sbjct: 78 -----IVNFLDSFLVGDELFVVMEYLAGGSL------TDVVTETCMDEAQIAAVCRECLQ 126
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRA 588
ALE+LH+ +IH D+K +N+L+ +K+ D G C Q V + + A
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMA 183
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEV+ Y K+D+WSLG + E+ GE + N+ + L
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------------------- 224
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
Y+ E PE+ S F DF+ LE++ ++R +
Sbjct: 225 -------------YLIATNGTPELQNPEKLS---------PIFRDFLNRCLEMDVEKRGS 262
Query: 709 AREALDHPWLQ 719
A+E L HP+L+
Sbjct: 263 AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 79/310 (25%), Positives = 130/310 (41%), Gaps = 61/310 (19%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y E +G A V+ A D+ TG +V +K + + + + L+ NKN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP--- 76
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ D + + L++V E L + E G++ + R+CL+AL
Sbjct: 77 --NIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRAPE 590
++LHS +IH D+K +NIL+ +K+ D G C Q V + + APE
Sbjct: 129 DFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
V+ Y K+D+WSLG + E+ GE P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGE---PP---------------------------- 214
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLE-HHLQFSDAFFIDFVRTLLEINPQRRPTA 709
Y+NE + Y+I + E + + A F DF+ LE++ RR +A
Sbjct: 215 -----------YLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSA 263
Query: 710 REALDHPWLQ 719
+E L HP+L+
Sbjct: 264 KELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 76/257 (29%), Positives = 109/257 (42%), Gaps = 66/257 (25%)
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I++ Y YF +FI EL+ L + K Q G LG++ V ++AL Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ--GPIPEDILGKMTVAI---VKALHY 129
Query: 537 L---HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRA 588
L H G+IH D+KP NIL+ + +K+ D G S D+ ++RS Y A
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDA--SGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMA 182
Query: 589 PEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
PE I YD + D+WSLG L EL TG+ + N + E+L
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--------------EFEVL 228
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES-SLEHHLQFSDAFFIDFVRTLLEINP 703
TK I+ EE SL + FS F FV L +
Sbjct: 229 ----------TK----------------ILQEEPPSLPPNEGFS-PDFCSFVDLCLTKDH 261
Query: 704 QRRPTAREALDHPWLQH 720
++RP RE L HP+++
Sbjct: 262 RKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KVF A+ T +K +K D D ++ E ++L L A EH
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL------AWEHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L LY F E+LF V E L ++ Q ++ F L R + + L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-------FDLPRATFYAAEIICGL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEV 591
++LHS GI++ DLK +NIL+ IKI D G + C + + Y APE+
Sbjct: 110 QFLHSKGIVYRDLKLDNILLD--TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLF 620
++G Y+ +D WS G +L E+ G+ F
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKII----------KNDKD-FFDQSLDEIKL 463
Y V E+LGS AF V++ + + G + + LK I K ++D + E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 464 LK--LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTL 520
+K L + N I+R Y F + L+IV +L+ A L E +E FT
Sbjct: 62 IKEQLRHPN-------IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR--FTE 112
Query: 521 GRLQVITRQCLEALEYLH-SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
R+ I Q + AL YLH I+H DL P NI++ + I L L
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
V + Y PE++ PY +K D+W+ GCIL ++ T + F
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 70/254 (27%), Positives = 102/254 (40%), Gaps = 61/254 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-----LVNKNDPADEH 476
+G AF +V+ +D TG +K+++ D + ++I ++ L + + P
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRK-SDMIKR--NQIAHVRAERDILADADSP---- 61
Query: 477 HILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I++LY F EHL++V E L L F +E A F I L
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE---TARF------YIAELVL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------------CFQTDNL 577
AL+ +H LG IH D+KP+NILI + IK+ D G
Sbjct: 113 -ALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 578 CLYVQSR------------------SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619
V R Y APEV+ G PY + D WSLG IL E+ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 620 FPNDAVVMILARII 633
F +D + +II
Sbjct: 230 FYSDTLQETYNKII 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
+ LG AF +V++ +V +K +K D ++ L E +++K +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------ 54
Query: 475 EH-HILRLYDYFYHLEHLFIVCELL-RANLYEF---QKFNQESGGEAYFTLGRLQVITRQ 529
H +++RL E L++V E + +L ++ + S ++ +L L Q
Sbjct: 55 -HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL S +H DL N L+ KI D G L V Y
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVV--KISDFG--------LSRDVYDDDYYRK 163
Query: 588 -----------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE + + K D+WS G +L E++T G +P
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 74/310 (23%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +V++ D T V +KII +++ DEI+ + + + D +I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL--GRLQ-----VITRQCL 531
R Y + L+I+ E L GG A L G L+ I R+ L
Sbjct: 65 TRYYGSYLKGTKLWIIMEYL-------------GGGSALDLLKPGPLEETYIATILREIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
+ L+YLHS IH D+K N+L+ ++ ++K+ D G + TD +V + + A
Sbjct: 112 KGLDYLHSERKIHRDIKAANVLLS--EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEVI YD K D+WSLG EL GE PN
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEP--PNS------------------------- 202
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
DL+ + ++ ++IP+ S Q+S F +FV L +P+ RPT
Sbjct: 203 ----------DLHPM-----RVLFLIPKNSPPTLEGQYSKP-FKEFVEACLNKDPRFRPT 246
Query: 709 AREALDHPWL 718
A+E L H ++
Sbjct: 247 AKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK------LVNKNDPADE 475
+G + +VF A+ TG V LK +K K L+E++ + K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLL-FKLNEVRHVLTERDILTTTKSE---- 61
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESG----GEAYFTLGRLQVITRQCL 531
+++L F E+L++ E + +F+ G A F + +
Sbjct: 62 -WLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEM-------F 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
EA++ LH LG IH DLKPEN LI IK+ D G S V S Y APEV
Sbjct: 112 EAVDALHELGYIHRDLKPENFLID--ASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEV 169
Query: 592 IIGLPYDQKIDLWSLGCILAELWTG 616
+ G YD +D WSLGC+L E G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 52/234 (22%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
G + + E +G + KV++A+ TG V +KI+ +D ++ +E +L+
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR-----KY 59
Query: 473 ADEHHILRLYDYFYHLEH------LFIVCELLRA----NLYEFQKFNQESGGE---AYFT 519
++ +I Y F L++V EL +L + + + E AY
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-- 117
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
I R+ L L YLH +IH D+K +NIL+ E+K++D G +
Sbjct: 118 ------ILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLVDFG--------VSA 161
Query: 580 YVQSRSYR-----------APEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
+ S R APEVI YD + D+WSLG EL G+
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 22/243 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
+Y +G AF V + V +K I + KD + +E ++LKL++ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I+ Y+ F + L IV E ++ Q+ L Q L
Sbjct: 61 ------IIEYYENFLEDKALMIVMEYAPGGTLA--EYIQKRCNSLLDEDTILHFFV-QIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAP 589
AL ++H+ I+H DLK +NIL+ ++ +KI D G S + Y V + Y +P
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPI------DLE 642
E+ G PY+QK D+W+LGC+L EL + + F + ++ +I+ G PI DL
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230
Query: 643 MLM 645
L+
Sbjct: 231 QLI 233
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y V +G +F + Q +++ +K I+ K + + L P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP-- 58
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ + F HL+IV E QK + G + + LQ + CL +
Sbjct: 59 --NIVAFKESFEADGHLYIVMEYCDGGDL-MQKIKLQRG-KLFPEDTILQWFVQMCL-GV 113
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL---CLYVQSRSYRAPEV 591
+++H ++H D+K +NI + Q ++K+ D GS+ T C YV + Y PE+
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLT--QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 592 IIGLPYDQKIDLWSLGCILAELWT 615
+PY+ K D+WSLGCIL EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 81/316 (25%), Positives = 139/316 (43%), Gaps = 38/316 (12%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLK-LVNK 469
A Y E LG +++ V++ G V LK+I K ++ ++ E LLK L +
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
N I+ L+D + E L V E + +L ++ Q GG + + ++ Q
Sbjct: 64 N-------IVLLHDIIHTKETLTFVFEYMHTDLAQY--MIQHPGGLHPYNV---RLFMFQ 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSY 586
L L Y+H I+H DLKP+N+LI E+K+ D G + + V + Y
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYSSEVVTLWY 169
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPIDLEML 644
R P+V++G Y +D+W GCI E+ G+ FP + V L +I +LG
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG------- 222
Query: 645 MQGQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
+ ++ + +K Y + Q ++ + S + D +L +
Sbjct: 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAE-------DLASQMLMMF 275
Query: 703 PQRRPTAREALDHPWL 718
P+ R +A++AL HP+
Sbjct: 276 PKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 82/314 (26%), Positives = 139/314 (44%), Gaps = 48/314 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLK-LVNKNDPAD 474
+ LG +++ V++ + TG V LK I+ + + F ++ E LLK L + N
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKHAN---- 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
I+ L+D + + L +V E L +L Q + GG ++ +++ Q L L
Sbjct: 65 ---IVTLHDIIHTKKTLTLVFEYLDTDLK--QYMDDCGGG---LSMHNVRLFLFQLLRGL 116
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRSY 586
Y H ++H DLKP+N+LI +R E+K+ D G S + + + L+ Y
Sbjct: 117 AYCHQRRVLHRDLKPQNLLIS--ERGELKLADFGLARAKSVPSKTYSNEVVTLW-----Y 169
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIGMLGPIDLEML 644
R P+V++G Y +D+W +GCI E+ TG LFP + V L +I +LG E
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
++ + Y L P + H + L+ P+
Sbjct: 230 PGVSSNPEFKPYSFPFY----PPRPLINHAPRLDRIPHG--------EELALKFLQYEPK 277
Query: 705 RRPTAREALDHPWL 718
+R +A EA+ HP+
Sbjct: 278 KRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 415 RYYVTEYL--GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
R Y+ ++ G + V A + HTG V +K + D Q E+ ++V D
Sbjct: 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRD- 75
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVI 526
HH ++ +Y+ + + L++V E L ++ + N+E ++ +
Sbjct: 76 --YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIATV 123
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LYVQ 582
L AL YLH+ G+IH D+K ++IL+ S R IK+ D G C Q V
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGF-CAQVSKEVPKRKSLVG 180
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
+ + APEVI LPY ++D+WSLG ++ E+ GE + N+ + + RI L P
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KV A+ G +K +K D D ++ E ++L L +N P H
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN-PFLTH- 60
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
LY F EHLF V E L F Q+ G F L R + + L++L
Sbjct: 61 ---LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKG---RFDLYRATFYAAEIVCGLQFL 112
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIG 594
HS GII+ DLK +N+++ IKI D G + F + + + Y APE++ G
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLFPND 623
L Y +D WS G +L E+ G+ F D
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 59/309 (19%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y E +G A V+ A D+ TG +V ++ + + + + L+ NKN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 77
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ D + + L++V E L + E G++ + R+CL+AL
Sbjct: 78 --NIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQAL 129
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRAPE 590
E+LHS +IH D+K +NIL+ +K+ D G C Q V + + APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
V+ Y K+D+WSLG + E+ GE + N+ + L
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--------------------- 225
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710
Y+ E PE+ S A F DF+ L+++ ++R +A+
Sbjct: 226 -----------YLIATNGTPELQNPEKLS---------AIFRDFLNRCLDMDVEKRGSAK 265
Query: 711 EALDHPWLQ 719
E L H +L+
Sbjct: 266 ELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K++K D D + ++ E ++L L K H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------HP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L +L+ F + LF V E + ++ Q+ + A F + + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL-------GL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRA 588
++LH GII+ DLK +N+L+ S IKI D G + + V + + Y A
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
PE++ PY +D W+LG +L E+ G+ F D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F KV Q + T LK I+ + +L E +L VN P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CP----F 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+ L F E L++V + + Q+ E F L R + T + L ALE
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-------EGRFDLSRARFYTAELLCALE 107
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYRAP 589
LH +I+ DLKPENIL+ YQ I + D G +T+ C + Y AP
Sbjct: 108 NLHKFNVIYRDLKPENILL-DYQG-HIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAP 162
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTG 616
E+++G Y + +D W+LG +L E+ TG
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C K+ K + +L+E K+L+ V+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ L F + L +V L+ ++ +N GE F R Q + LE+L
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGL 595
H I++ DLKPEN+L+ + +I DLG + + + Y APEV+ G
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNV--RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 596 PYDQKIDLWSLGCILAELWTGEVLF 620
YD +D ++LGC L E+ G F
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 84/318 (26%), Positives = 125/318 (39%), Gaps = 86/318 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLK-LVNKNDPADEHHIL 479
LG + V+ A+DL T V + +K I + Q L +EI L L ++N I+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN-------IV 68
Query: 480 RLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ I E LLR+ K+ E + T+Q
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRS------KWGPLKDNEQ-----TIIFYTKQI 117
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYVQ 582
LE L+YLH I+H D+K +N+L+ +Y +KI D G+S C +T +
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINPCTET-----FTG 171
Query: 583 SRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+ Y APEVI P Y D+WSLGC + E+ TG+ F LG
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE-------------LGEPQ 218
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
M G ++ I+ E IPE S E +F+ E
Sbjct: 219 AAMFKVG------------MFKIHPE-------IPESLSAEAK---------NFILRCFE 250
Query: 701 INPQRRPTAREALDHPWL 718
+P +R +A + L P+L
Sbjct: 251 PDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLG-SSCFQTD-----NLCLY 580
Q L+ + YLH+ ++H DLKP NIL+ + +R +KI D+G + F + +L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF---------PNDAVVMILA 630
V + YRAPE+++G Y + ID+W++GCI AEL T E +F N L
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235
Query: 631 RIIGMLG-PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQL-EYIIPEESSLEHHLQFSD 688
RI ++G P D + +++ +Y T + D + L +Y +E H D
Sbjct: 236 RIFSVMGFPADKDW-EDIRKMPEYPTLQKDFRRTTYANSSLIKY-------MEKHKVKPD 287
Query: 689 AFFIDFVRTLLEINPQRRPTAREALDHPWL 718
+ ++ LL ++P +R T+ +AL P+
Sbjct: 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/242 (26%), Positives = 118/242 (48%), Gaps = 36/242 (14%)
Query: 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQ 558
++ +F + ++ + G ++ + Q L+ + YLH+ ++H DLKP NIL+ + +
Sbjct: 88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 147
Query: 559 RCEIKIIDLG-SSCFQTD-----NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILA 611
R +KI D+G + F + +L V + YRAPE+++G Y + ID+W++GCI A
Sbjct: 148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207
Query: 612 ELWTGEVLF---------PNDAVVMILARIIGMLG-PI-----DLEMLMQGQEIYKYFTK 656
EL T E +F N L RI ++G P D++ + + + K F +
Sbjct: 208 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR 267
Query: 657 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716
Y N + ++Y +E H D+ ++ LL ++P +R T+ +A+ P
Sbjct: 268 N---TYTN--CSLIKY-------MEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315
Query: 717 WL 718
+
Sbjct: 316 YF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D ++ E ++L L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL-----PGKPPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y Q+ + A F + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAI-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVI 592
+LHS GII+ DLK +N+++ + IKI D G + F + + Y APE+I
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLF 620
PY + +D W+ G +L E+ G+ F
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 64/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K +K D D + ++ E ++L L A EH
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL------AWEHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
L L+ F EHLF V E L F Q SG F R + + + L++
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSG---RFDEARARFYAAEIICGLQF 111
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ------TDNLCLYVQSRSYRAPE 590
LH GII+ DLK +N+L+ IKI D G C + Y APE
Sbjct: 112 LHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFC---GTPDYIAPE 166
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
++ G Y++ +D WS G +L E+ G+ F
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 64/204 (31%), Positives = 88/204 (43%), Gaps = 50/204 (24%)
Query: 523 LQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
L I ++ALEYLHS L +IH D+KP N+LI + ++K+ D G S + D++ +
Sbjct: 105 LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTI 162
Query: 582 Q--SRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
+ Y APE I YD K D+WSLG + EL TG FP D+
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDS----------- 209
Query: 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 695
+ L Q + E + QL P E FS F DFV
Sbjct: 210 -WKTPFQQLKQ---------------VVEEPSPQL----PAEK-------FS-PEFQDFV 241
Query: 696 RTLLEINPQRRPTAREALDHPWLQ 719
L+ N + RP E L HP+ +
Sbjct: 242 NKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
A+ +H I++L+ F L+++ + LR F + S E FT ++ +
Sbjct: 53 AEVNHPFIVKLHYAFQTEGKLYLILDFLRGG----DLFTRLSK-EVMFTEEDVKFYLAEL 107
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSR 584
AL++LHSLGII+ DLKPENIL+ + IK+ D G S D+ C V+
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-- 163
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP----NDAVVMILARIIGM 635
Y APEV+ + Q D WS G ++ E+ TG + F + + MIL +GM
Sbjct: 164 -YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +VF+ D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL-------GRLQVITRQCL 531
+ Y + L+I+ E L GG A L ++ I R+ L
Sbjct: 65 TKYYGSYLKDTKLWIIMEYL-------------GGGSALDLLEPGPLDETQIATILREIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
+ L+YLHS IH D+K N+L+ + E+K+ D G + TD +V + + A
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEVI YD K D+WSLG EL GE
Sbjct: 170 PEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA- 473
RY + + LG +F V+ +D + LK++K + + E+ + V N A
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLK------EIPVGELNPNETVQANQEAQ 54
Query: 474 -----DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
D I++ + F + I+ E + + + G+ TL QV
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK---TLSENQVCEW 111
Query: 529 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQS 583
Q L + Y+H I+H DLK +NI +K+ +KI D G S D + +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLLMGSCDLATTFTGT 168
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y +PE + YD K D+WSLGCIL E+ F + ++ RI+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 24/234 (10%)
Query: 416 YYVTEYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
+ + +G +F VF+ D + + K ++ ++++DE ++L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL----- 56
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQV--ITRQ 529
D +I+R Y+ F L IV E +L++ K + L QV Q
Sbjct: 57 -DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR------PLPEDQVWRFFIQ 109
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSY 586
L L +LHS I+H D+K N+ + +Y +KI DLG + +DN V + Y
Sbjct: 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPI 639
+PE+ PY++K D+W+LG +L E TG+ F N+ +IL I G+ P+
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 67/226 (29%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
E LG+ +F +V A+ TG +K +K EI +K V H+
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR---------EILKMKQVQ--------HVA 66
Query: 480 RLYDYFYHLEHLFIV---CELLRAN-LYEFQKFNQESGGEAYFTL---GRL--QVITRQC 530
+ L H FIV C N +Y +F GGE + L GR V
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEF--VVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 531 LE---ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
E A EYLHS II+ DLKPEN+L+ + +K+ D G + D + Y
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLD--NKGHVKVTDFGFAKKVPDRTFTLCGTPEYL 182
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
APEVI + + +D W++G +L E G F +D I +I+
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228
|
Length = 329 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 23/107 (21%)
Query: 520 LGRLQV--ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 577
LG QV + RQ L A++Y+H GIIH D+K EN+L+ + +I + D G++CF
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARG-- 312
Query: 578 CLYVQSRS------------YRAPEVIIGLPYDQKIDLWSLGCILAE 612
S S APEV+ G PY +D+WS G ++ E
Sbjct: 313 -----SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 70/268 (26%), Positives = 107/268 (39%), Gaps = 59/268 (22%)
Query: 455 DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG 513
+L+EI +L L+ + I+ Y++F L I E LY K ++ G
Sbjct: 44 RDALNEIVILSLLQHPN------IIAYYNHFMDDNTLLIEMEYANGGTLY--DKIVRQKG 95
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
F + Q + A+ Y+H GI+H D+K NI + + IK+ D G S
Sbjct: 96 --QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT--KAGLIKLGDFGISKIL 151
Query: 574 TDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630
+ V + Y +PE+ G+ Y+ K D+W+LGC+L EL T L
Sbjct: 152 GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-------------LK 198
Query: 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 690
R P++L + K Y + S E
Sbjct: 199 RTFDATNPLNL--------VVKIVQGNYT-------------PVVSVYSSE--------- 228
Query: 691 FIDFVRTLLEINPQRRPTAREALDHPWL 718
I V +LL+ +P++RPTA E LD P L
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 79/313 (25%), Positives = 133/313 (42%), Gaps = 80/313 (25%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +VF+ D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 479 LRLYDYFYHLEHLFIVCE---------LLRANLY-EFQKFNQESGGEAYFTLGRLQVITR 528
+ Y + L+I+ E LLRA + EFQ + + +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ----------------IATMLK 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L+ L+YLHS IH D+K N+L+ ++ ++K+ D G + TD +V +
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLS--EQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
+ APEVI YD K D+WSLG EL GE PN
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEP--PNS---------------------- 202
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
D++ + ++ ++IP+ + +FS F +F+ L +P
Sbjct: 203 -------------DMHPM-----RVLFLIPKNNPPTLTGEFSKP-FKEFIDACLNKDPSF 243
Query: 706 RPTAREALDHPWL 718
RPTA+E L H ++
Sbjct: 244 RPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 28/228 (12%)
Query: 415 RYYVTEY--LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
R + Y +G + V A++ H+G V +K++ D Q E+ ++V D
Sbjct: 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRD- 74
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVITR 528
+++ +Y + E L+++ E L+ ++ + N+E ++ +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----------QIATVCE 124
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LYVQSR 584
L+AL YLHS G+IH D+K ++IL+ R +K+ D G C Q V +
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGF-CAQISKDVPKRKSLVGTP 181
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
+ APEVI PY ++D+WSLG ++ E+ GE + +D+ V + R+
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 56/202 (27%), Positives = 83/202 (41%), Gaps = 54/202 (26%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
I L+ L YLHS IH D+K NIL+ + +K+ D GS+ +V +
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLT--EPGTVKLADFGSASL-VSPANSFVGTPY 176
Query: 586 YRAPEVIIGL---PYDQKIDLWSLG--CI-LAELWTGEVLFPNDAVVMILARIIGMLGPI 639
+ APEVI+ + YD K+D+WSLG CI LAE LF +A+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE--RKPPLFNMNAMSA------------ 222
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699
LY+I + N + + S F +FV + L
Sbjct: 223 --------------------LYHIAQ--NDSPTLSSNDWSDY---------FRNFVDSCL 251
Query: 700 EINPQRRPTAREALDHPWLQHP 721
+ PQ RP++ E L H ++
Sbjct: 252 QKIPQDRPSSEELLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q +TG + C K+ K K +L E ++L+ VN
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN------SPF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ L F HL +V L+ ++ +N GE + R+ + Q + +L
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
HS+ I++ D+KPEN+L+ C + + L + + Y APE++ PY
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 598 DQKIDLWSLGCILAELWTGEVLFPN 622
+D +++GC + E+ G F +
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL-KLVNKN 470
Y V E +G +F V + + G + K I +K+ Q + E+ +L +L + N
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPN 60
Query: 471 DPADEHHILRLYDYFYHLEH--LFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRL 523
I+R YD + L+IV E L + + +K + Y +
Sbjct: 61 -------IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------YIEEEFI 107
Query: 524 QVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEI------KIIDLGSSCF 572
I Q L AL H+ ++H DLKP NI + + ++ KI+ SS
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+T YV + Y +PE + + YD+K D+WSLGC++ EL
Sbjct: 168 KT-----YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 78/311 (25%), Positives = 120/311 (38%), Gaps = 69/311 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
+GS A V++ TG LK+I ++ Q EI++L+ VN P ++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH--PN----VV 135
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+ +D F H + ++ E + E E L + RQ L + YLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE---------QFLADVARQILSGIAYLHR 186
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLC-LYVQSRSYRAPEVI---- 592
I+H D+KP N+LI S + +KI D G S QT + C V + +Y +PE I
Sbjct: 187 RHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 593 -IGLPYDQKI-DLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
G YD D+WSLG + E + G F +G G D LM
Sbjct: 245 NHGA-YDGYAGDIWSLGVSILEFYLGRFPFG-----------VGRQG--DWASLMCA--- 287
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710
+ P E+ +F F+ L+ P +R +A
Sbjct: 288 -------------------ICMSQPPEAPATASREFR-----HFISCCLQREPAKRWSAM 323
Query: 711 EALDHPWLQHP 721
+ L HP++
Sbjct: 324 QLLQHPFILRA 334
|
Length = 353 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 512 SGGEAYFTLG--------RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE +F L R + + AL YLHS+ I++ DLKPENIL+ S + +
Sbjct: 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVV 136
Query: 564 IIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G Q+D + + Y APEVI PYD +D W LG +L E+ G
Sbjct: 137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 42/119 (35%), Positives = 62/119 (52%), Gaps = 16/119 (13%)
Query: 512 SGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE +FT ++V + + AL++LH LGII+ D+K ENIL+ S +
Sbjct: 88 NGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVV 145
Query: 564 IIDLG-SSCFQTDNL---CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 616
+ D G S F + + + Y APEVI G +D+ +D WSLG + EL TG
Sbjct: 146 LTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
LG AF +V+ D+ TG ++ K ++ D + + S + EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 476 HHILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAY--FTLGRLQVITRQCLE 532
+ LR E L I E + + Q +AY T + TRQ LE
Sbjct: 70 YGCLR-----DRAEKTLTIFMEYMPGGSVKDQL-------KAYGALTESVTRKYTRQILE 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYVQSRSY 586
+ YLHS I+H D+K NIL S +K+ D G+S C + + +
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+PEVI G Y +K D+WSLGC + E+ T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 40/199 (20%)
Query: 526 ITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQS 583
I +E L YL++ I+H D+KP NIL+ S R +IK+ D G S +++ +V +
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGVSGELINSIADTFVGT 165
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF--PNDAVVMILARIIGMLGPIDL 641
+Y +PE I G Y K D+WSLG + EL G+ F N G P+ +
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD-------GQDDPMGI 218
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
L+Q + E +L P E DFV L
Sbjct: 219 LDLLQ--------------QIVQEPPPRL----PSSDFPED--------LRDFVDACLLK 252
Query: 702 NPQRRPTAREALD-HPWLQ 719
+P RPT ++ P++Q
Sbjct: 253 DPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 42/122 (34%), Positives = 57/122 (46%), Gaps = 26/122 (21%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--------------------- 571
ALEYLH+ GI+H DLKP+N+LI S IK+ D G S
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631
F +C + Y APEVI+ Y + +D W++G IL E G V F D + +
Sbjct: 171 FLDKQVC---GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 632 II 633
+I
Sbjct: 228 VI 229
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 77/309 (24%), Positives = 126/309 (40%), Gaps = 63/309 (20%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPAD 474
Y + + +GS + V++A++LHTG +KIIK + D F EI ++K
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVK------ECK 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV--ITRQCLE 532
+I+ + + E L+I E Q +G L LQ+ + R+ L+
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGG--SLQDIYHVTG-----PLSELQIAYVCRETLQ 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAP 589
L YLHS G +H D+K NIL+ ++K+ D G + T + ++ + + AP
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
Query: 590 EVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
EV Y+Q D+W++G EL E+ P + L P+ LM
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL--AELQPP-----------MFDLHPMRALFLMS 222
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+ L+ ++S F +FV+ L NP++R
Sbjct: 223 KSNF-------------------------QPPKLKDKTKWSSTFH-NFVKISLTKNPKKR 256
Query: 707 PTAREALDH 715
PTA L H
Sbjct: 257 PTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 50/219 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD---EHHI 478
LG + KVFQ + + TG D K F + L + +++ N+ D A E +I
Sbjct: 4 LGKGGYGKVFQVRKV-TGAD-------TGKIFAMKVLKKATIVR--NQKDTAHTKAERNI 53
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGRLQVITR--- 528
L ++H FIV +L+ Y FQ SGGE + L R +
Sbjct: 54 LE------AVKHPFIV-DLI----YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA 102
Query: 529 -----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQ---TDNL 577
+ ALE+LH GII+ DLKPENIL+ + +K+ D G S + T
Sbjct: 103 CFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTF 160
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
C ++ Y APE+++ + + +D WSLG ++ ++ TG
Sbjct: 161 CGTIE---YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ +G +K++K D D + ++ E ++L L A H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL------ARNHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L +LY F + LF V E + ++ QK + F R + + AL
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-------FDEARARFYAAEITSAL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEV 591
+LH GII+ DLK +N+L+ C K+ D G N + + Y APE+
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHC--KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLF 620
+ + Y +D W++G +L E+ G F
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 39/214 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK-LVNKNDPAD 474
LG AF +V+ D TG ++ +K ++ D + + S + EI+LLK L+++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE----- 64
Query: 475 EHHILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTLGR--LQVIT 527
R+ Y+ L L I E + + Q ++Y L + T
Sbjct: 65 -----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-------KSYGALTENVTRKYT 112
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYV 581
RQ LE + YLHS I+H D+K NIL S +K+ D G+S C +
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + +PEVI G Y +K D+WS+GC + E+ T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 77/316 (24%), Positives = 123/316 (38%), Gaps = 70/316 (22%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADE 475
V + LG + V++ TGV + +K I+ D+ F+Q + E+ +L A
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILH------KAVS 58
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+I+ Y F+ +++ E + A K L+ IT ++ L+
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAG--SLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 536 YL-HSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYRA 588
+L IIH D+KP N+L+ ++K+ D G +S +T+ C +SY A
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGVSGNLVASLAKTNIGC-----QSYMA 169
Query: 589 PEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
PE I Y + D+WSLG + E+ G +P + I A+ L
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---------LS 220
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
++ G +P S DA DFV L
Sbjct: 221 AIVDGDPPT----------------------LPSGYS-------DDA--QDFVAKCLNKI 249
Query: 703 PQRRPTAREALDHPWL 718
P RRPT + L+HPWL
Sbjct: 250 PNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 42/115 (36%), Positives = 58/115 (50%), Gaps = 13/115 (11%)
Query: 513 GGEAYFTLGR----LQVITR----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
GGE +F L R + R + AL YLHSL II+ DLKPENIL+ S + + +
Sbjct: 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVL 137
Query: 565 IDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
D G + + + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 138 TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + + +G FS+V++A L GV V LK ++ D + EI LLK +N +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQ---ESGGEAYFTLGRL 523
+++ Y F L IV EL A + F+K + E YF
Sbjct: 64 ------VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV---- 113
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLY 580
Q ALE++HS ++H D+KP N+ I + +K+ DLG F +T
Sbjct: 114 -----QLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSL 166
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 74/302 (24%), Positives = 128/302 (42%), Gaps = 65/302 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F V+ A+D+ T V +K + K + + + E+K L+ + + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE--- 89
Query: 478 ILRLYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
Y Y EH ++V E + + + +++ E + IT L+ L Y
Sbjct: 90 ----YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAITHGALQGLAY 140
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL- 595
LHS +IH D+K NIL+ + ++K+ D GS+ + +V + + APEVI+ +
Sbjct: 141 LHSHNMIHRDIKAGNILLT--EPGQVKLADFGSASIASPANS-FVGTPYWMAPEVILAMD 197
Query: 596 --PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653
YD K+D+WSLG EL
Sbjct: 198 EGQYDGKVDVWSLGITCIEL---------------------------------------- 217
Query: 654 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713
++ L+ +N + L +I ES ++SD +F +FV + L+ PQ RPT+ E L
Sbjct: 218 AERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSD-YFRNFVDSCLQKIPQDRPTSEELL 275
Query: 714 DH 715
H
Sbjct: 276 KH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 43/214 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-QSLDEIKLLKLVNKNDPADEHHILR 480
+G +F KV A+ K+D F+ + L + +LK +N E ++L
Sbjct: 3 IGKGSFGKVLLAKR------------KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL- 49
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGRLQVITR----- 528
+L+H F+V L Y FQ + +GGE +F L R +
Sbjct: 50 ----LKNLKHPFLVG--LH---YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF 100
Query: 529 ---QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQ 582
+ A+ YLHSL II+ DLKPENIL+ S + + + D G + +
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTSTFCG 158
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K++K D D D ++ E ++L L K+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP-----F 57
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ L+ F + LF V E + +++ Q+ + F R + + AL
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-------FDEPRSRFYAAEVTLALM 110
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-------TDNLCLYVQSRSYRA 588
+LH G+I+ DLK +NIL+ + C K+ D G C + T C + Y A
Sbjct: 111 FLHRHGVIYRDLKLDNILLDAEGHC--KLADFGM-CKEGILNGVTTTTFC---GTPDYIA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
PE++ L Y +D W+LG ++ E+ G+ F D
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
ALEYLHS I++ DLKPENIL+ IK+ D G + D + Y APEVI
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI 170
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+++ +D W+LG ++ E+ G F +D I +I+
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-EIKLLKLVNKNDPADEHHILR 480
LGS F +V++ + V V +KI+K+D Q E++ LK + H++
Sbjct: 14 LGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLR------HKHLIS 66
Query: 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
L+ E ++I+ EL+ +L F + S + L + Q E + YL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLR----SPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRAPEVIIG 594
IH DL NIL+ C K+ D G + +++ Y+ S + APE
Sbjct: 123 QNSIHRDLAARNILVGEDLVC--KVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASH 178
Query: 595 LPYDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L E++T G+V +P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
LG AF +V+ D TG ++ +K + D D + S + EI+LLK + +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR--LQVITRQCLEA 533
+ LR + + L I E + + Q +AY L + TRQ L+
Sbjct: 70 YGCLRDPEE----KKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQILQG 118
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYVQSRSYR 587
+ YLHS I+H D+K NIL S +K+ D G+S C + + +
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWT 615
+PEVI G Y +K D+WS+ C + E+ T
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 33/268 (12%)
Query: 461 IKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL 520
I+ + L N N P+ ++R+ D +V ++LY + + S +
Sbjct: 106 IEAMLLQNVNHPS----VIRMKDTLVSGAITCMVLPHYSSDLYTY--LTKRSRP---LPI 156
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +I +Q LE L YLH+ IIH D+K ENI I ++ I DLG++ F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPVVAPAFL 214
Query: 581 --VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAE-------LWTGEVLFPNDAVV---MI 628
+ APEV+ Y+ K D+WS G +L E ++ P + V
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274
Query: 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 688
L +II L + E + + + Y E Y P + + D
Sbjct: 275 LLKIISTLK-VHPEEFPRDPG--SRLVRGFIEYASLERQPYTRY--PCFQRVNLPI---D 326
Query: 689 AFFIDFVRTLLEINPQRRPTAREALDHP 716
F+ V +L + RP+A E L++P
Sbjct: 327 GEFL--VHKMLTFDAAMRPSAEEILNYP 352
|
Length = 357 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 70/258 (27%)
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVIT 527
D H ++ +Y+ + + L++V E L ++ + N+E ++ +
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIAAVC 122
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
L+AL LH+ G+IH D+K ++IL+ R +K+ D G C Q V R
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGF-CAQVSK---EVPRRKSL 176
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+ APE+I LPY ++D+WSLG ++ E+ GE + N+ + + I L P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-- 234
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
+ L + P F+ LL
Sbjct: 235 -------------------------KLKNLHKVSP--------------SLKGFLDRLLV 255
Query: 701 INPQRRPTAREALDHPWL 718
+P +R TA E L HP+L
Sbjct: 256 RDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D + ++ E ++L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL-----SGKPPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y+ Q+ + A F + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAP 589
+LHS GII+ DLK +N+++ S IKI D G +N+ V +++ Y AP
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC---KENMWDGVTTKTFCGTPDYIAP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
E+I PY + +D W+ G +L E+ G+ F
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 15/109 (13%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
I R L A++YLH IIH D+K ENI I ++ + D G++CF D ++
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN--HPGDVCLGDFGAACFPVD----INANKY 240
Query: 586 Y--------RAPEVIIGLPYDQKIDLWSLGCILAELWTGE-VLFPNDAV 625
Y APE++ PY +D+WS G +L E+ T LF D +
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGL 289
|
Length = 391 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 13/116 (11%)
Query: 512 SGGEAYFTLGR----LQVITR----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE ++ L R L+ R + AL YLHSL I++ DLKPENIL+ S + I
Sbjct: 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIV 136
Query: 564 IIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G + + + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 137 LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
LG++ + + L L H I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 105 LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621
+V +RSY +PE + G Y + D+WS+G L EL G P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + + +G FS+V++A L V LK ++ D + EI LLK +N +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR-- 528
+++ D F L IV EL A +L + K YF + + R
Sbjct: 64 ------VIKYLDSFIEDNELNIVLELADAGDLSQMIK---------YFKKQKRLIPERTV 108
Query: 529 -----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLY 580
Q A+E++HS ++H D+KP N+ I + +K+ DLG F +T
Sbjct: 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSL 166
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D + ++ E ++L L +K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK-----PPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y Q+ + +A F + V L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT--DNLCL--YVQSRSYRAPEV 591
+LH GII+ DLK +N+++ S IKI D G C + D + + + Y APE+
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLF 620
I PY + +D W+ G +L E+ G+ F
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 52/201 (25%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQS 583
T+Q L+ + YLH+ ++H D+K N+++ IK+ID G + + +
Sbjct: 108 TKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 584 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+S APEVI Y +K D+WS+GC + E+ TG+ + + R+ M
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS------MDRLAAM-- 217
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
+YI ++P L FS A IDFV +
Sbjct: 218 -----------------------FYIGAHRG----LMP---RLPDS--FSAA-AIDFVTS 244
Query: 698 LLEINPQRRPTAREALDHPWL 718
L + RP+A + L H +L
Sbjct: 245 CLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 32/187 (17%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLY 503
KIIK K+F + E + +L+ N + ++LY L+ ++ + ++ +L+
Sbjct: 47 KIIKA-KNF---NAIEPMVHQLMKDNP-----NFIKLYYSVTTLKGHVLIMDYIKDGDLF 97
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+ K + ++ I RQ +EAL LH IIH D+K EN+L + I
Sbjct: 98 DLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA-KDRIY 150
Query: 564 IIDLGSSCFQTDNLCLYVQSRS-------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G LC + + S Y +PE I G YD D W++G + EL TG
Sbjct: 151 LCDYG--------LCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
Query: 617 EVLFPND 623
+ F D
Sbjct: 203 KHPFKED 209
|
Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI++ + KD ++ E ++L+ H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-------NTRHP 55
Query: 478 ILRLYDY-FYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
L Y F + L V E AN GGE +F L R +V T
Sbjct: 56 FLTALKYAFQTHDRLCFVMEY--AN-----------GGELFFHLSRERVFTEERARFYGA 102
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ--TDNLCL--YVQSR 584
+ + ALEYLHS +++ D+K EN+++ + IKI D G C + +D + + +
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFG-LCKEGISDGATMKTFCGTP 159
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ H
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-------HP 55
Query: 478 ILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
L Y + L V E +GGE +F L R +V +
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYGA 102
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQ 582
+ + AL YLHS +++ DLK EN+++ + IKI D G S C
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFC---G 157
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
+ Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 17/241 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
RY + + +G +F K++ A+ +K I K + K + L+ K +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
I+ + F LFIV E ++ N++ G F+ ++ Q L
Sbjct: 61 ---IVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRG--VLFSEDQILSWFVQISLGL 114
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEV 591
+++H I+H D+K +NI + K+ D G + D++ L V + Y +PE+
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVA-KLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPI------DLEML 644
PY+ K D+WSLGC+L EL T + F + + ++ +I G PI DL L
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL 233
Query: 645 M 645
+
Sbjct: 234 I 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ +G +KI+K + KD +L E ++LK N P
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK--NTRHP----F 56
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR--------Q 529
+ L F + L V E + +GGE +F L R +V + +
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYV-------------NGGELFFHLSRERVFSEDRTRFYGAE 103
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSY 586
+ AL+YLHS I++ DLK EN+++ + IKI D G + + + Y
Sbjct: 104 IVSALDYLHSGKIVYRDLKLENLMLD--KDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ +D ++ EI +LK +
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS---- 70
Query: 473 ADEHH--ILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
HH I Y F H + L++V E A + + G A +
Sbjct: 71 ---HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAG--SVTDLVKNTKGNA-LKEDWIA 124
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LY 580
I R+ L L +LH+ +IH D+K +N+L+ + E+K++D G S Q D +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSA-QLDRTVGRRNTF 181
Query: 581 VQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTG 616
+ + + APEVI YD + D+WSLG E+ G
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C ++ K + +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN------SQF 61
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++ L + + L +V ++ +F +N + G F R + L LE L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FEEERALFYAAEILCGLEDL 118
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
H ++ DLKPENIL+ Y I + L + +++ V + Y APEV+ Y
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 598 DQKIDLWSLGCILAELWTGEVLF 620
D W LGC++ E+ G+ F
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 39/236 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V+ T V +K +K + + F L E +++K + +
Sbjct: 14 LGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAF----LQEAQIMKKLRHD------K 62
Query: 478 ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++LY E ++IV E + +L +F K SG L +L + Q E + Y
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK----SGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR---SYRAPEVI 592
L S IH DL NIL+ C KI D G + + D ++ + APE
Sbjct: 119 LESRNYIHRDLAARNILVGENLVC--KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 593 IGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
+ K D+WS G +L E+ T G V +P GM LE + +G
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYP------------GMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 72/311 (23%), Positives = 130/311 (41%), Gaps = 63/311 (20%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPAD 474
+ + + +GS + V++A++++TG +K+IK + + F EI ++K
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK------DCK 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV--ITRQCLE 532
+I+ + + + L+I E Q +G L Q+ ++R+ L+
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGG--SLQDIYHVTG-----PLSESQIAYVSRETLQ 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAP 589
L YLHS G +H D+K NIL+ +K+ D G S T + ++ + + AP
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 590 EVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
EV Y+Q D+W++G EL E+ P + L P+ LM
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL--AELQPP-----------MFDLHPMRALFLMT 222
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+ L+ +++S++F FV+ L NP++R
Sbjct: 223 KSNF-------------------------QPPKLKDKMKWSNSFH-HFVKMALTKNPKKR 256
Query: 707 PTAREALDHPW 717
PTA + L HP+
Sbjct: 257 PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 51/153 (33%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF---TLGRLQVITRQCLEAL 534
I++ Y + +I EL+ +L +F K+ E ++ LG++ V T ++AL
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILGKIAVAT---VKAL 120
Query: 535 EYL-HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS--RSYRAPEV 591
YL L IIH D+KP NIL+ + IK+ D G S D++ + R Y APE
Sbjct: 121 NYLKEELKIIHRDVKPSNILLD--RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 178
Query: 592 I---IGLPYDQKIDLWSLGCILAELWTGEVLFP 621
I YD + D+WSLG L E+ TG+ +P
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 38/103 (36%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
LG++ + + L L H I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 105 LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621
+V +RSY +PE + G Y + D+WS+G L E+ G P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 74/307 (24%), Positives = 124/307 (40%), Gaps = 67/307 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLL-KLVNKNDPADEH 476
+G +F V+ A+D+ V +K + K + + + E++ L KL + N
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 477 HILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
LR + + +E+ L +LL + Q+ + +T L+ L
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-------------EIAAVTHGALQGLA 129
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL 595
YLHS +IH D+K NIL+ + +K+ D GS+ +V + + APEVI+ +
Sbjct: 130 YLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASIMAPANX-FVGTPYWMAPEVILAM 186
Query: 596 ---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652
YD K+D+WSLG EL E P
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL--AERKPP------------------------------- 213
Query: 653 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712
L+ +N + L +I ES +S+ +F +FV + L+ PQ RPT+
Sbjct: 214 -------LFNMN-AMSALYHIAQNESPALQSGHWSE-YFRNFVDSCLQKIPQDRPTSEVL 264
Query: 713 LDHPWLQ 719
L H ++
Sbjct: 265 LKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 39/116 (33%), Positives = 55/116 (47%), Gaps = 4/116 (3%)
Query: 507 KFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566
KF+ + G F R + LE LH I++ DLKPENIL+ Y I+I D
Sbjct: 88 KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISD 145
Query: 567 LGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
LG + + + V + Y APEV+ Y D W LGC++ E+ G+ F
Sbjct: 146 LGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 45/146 (30%), Positives = 70/146 (47%), Gaps = 24/146 (16%)
Query: 492 FIVCELLRANLYEFQKFNQES-------GGEAYFTLGRLQVITRQCLE--------ALEY 536
FIVC Y F ++ S GG+ ++ L + V + + LE+
Sbjct: 58 FIVCMS-----YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRAPEVII-G 594
+H+ +++ DLKP NIL+ + ++I DLG +C F V + Y APEV+ G
Sbjct: 113 MHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLF 620
+ YD D +SLGC+L +L G F
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 48/213 (22%)
Query: 464 LKLVNKNDPADEH------------------HILRLYDYFYHLEH-LFIVCEL-----LR 499
+KL+ + P +EH +I+ L D LF V E LR
Sbjct: 8 IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLR 67
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-KSYQ 558
L G GRL + Q L+AL H+ GI+H DLKP+NI++ ++
Sbjct: 68 EVL-------AADGALPAGETGRLML---QVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 559 RCEIKIID-----LGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGC 608
R K++D L D L + + +Y APE + G P DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 609 ILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
I E TG+ + +V IL + L P+D+
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQ---QLSPVDV 207
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ D ++ EI +LK +
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS---- 60
Query: 473 ADEHH--ILRLYDYFYHL------EHLFIVCELLRA----NLYEFQKFNQESGGEAYFTL 520
HH I Y F + L++V E A +L + K N TL
Sbjct: 61 ---HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---------TL 108
Query: 521 GR--LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ I R+ L L +LH +IH D+K +N+L+ + E+K++D G S Q D
Sbjct: 109 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSA-QLDRTV 165
Query: 579 ----LYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTG 616
++ + + APEVI YD K DLWSLG E+ G
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKI----IKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476
LG F +V Q TG + C K+ IK K +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-SMALNEKQILEKVN------SR 60
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++ L + + L +V L+ +F ++ GEA F GR + LE
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLED 117
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIG 594
LH I++ DLKPENIL+ + I+I DLG + + + V + Y APEV+
Sbjct: 118 LHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLF 620
Y D W+LGC+L E+ G+ F
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 44/219 (20%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIK----NDKDFFDQSLDEIKLL-KLVNKND 471
LGS F V H G +DV +K+I+ ++ DF + E K++ KL + N
Sbjct: 12 LGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPN- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+++LY +FIV E + L + + + G + L + + C
Sbjct: 61 ------LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL----LDMCSDVC 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--- 587
EA+EYL S G IH DL N L+ +K+ D G + + D+ Y S+ +
Sbjct: 111 -EAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARYVLDDQ--YTSSQGTKFPV 165
Query: 588 ---APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
PEV + K D+WS G ++ E+++ G++ +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 22/130 (16%)
Query: 512 SGGEAY--------FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE + F +Q+ + + + ALE+LH LGII+ D+K ENIL+ S +
Sbjct: 88 NGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVV 145
Query: 564 IIDLG-SSCFQTD------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELW 614
+ D G S F D + C ++ Y AP+++ G +D+ +D WS+G ++ EL
Sbjct: 146 LTDFGLSKEFHEDEVERAYSFCGTIE---YMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
Query: 615 TGEVLFPNDA 624
TG F D
Sbjct: 203 TGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 36/112 (32%), Positives = 50/112 (44%), Gaps = 12/112 (10%)
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYR 587
A+ +H +G +H D+KPEN+LI IK+ D GS+ T N L V + Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 588 APEVIIGL------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
APEV+ + Y + D WSLG I E+ G F I+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 74/280 (26%), Positives = 99/280 (35%), Gaps = 96/280 (34%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG +VF + TG LK++ DK + + + +K V E IL
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVL--DK----KEMIKRNKVKRV-----LTEQEILAT 57
Query: 482 YDYFYHLEHLFIVCELLRANLY-EFQK-----FNQE--SGGEAYFTLGRLQVITRQCLE- 532
D H F+ LY FQ + GGE + L Q +CL
Sbjct: 58 LD------HPFLP------TLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSE 102
Query: 533 ------------ALEYLHSLGIIHCDLKPENILIK------------SYQ-----RCEIK 563
ALEYLH LGI++ DLKPENIL+ S Q K
Sbjct: 103 EVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 564 IIDLGSSCFQTDNLCLYV-------QSRS------YRAPEVIIGLPYDQKIDLWSLGCIL 610
+ GS +++ +S S Y APEVI G + +D W+LG +L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222
Query: 611 AELWTG-------------------EVLFPNDAVVMILAR 631
E+ G EV FP V AR
Sbjct: 223 YEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSAR 262
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476
E +G F V Q + +TG V +K IK D + F +++ + KL +KN
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEET---AVMTKLHHKN------ 60
Query: 477 HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
++RL H L+IV EL+ + NL F + + G A ++ +L + E +E
Sbjct: 61 -LVRLLGVILH-NGLYIVMELMSKGNLVNFLR----TRGRALVSVIQLLQFSLDVAEGME 114
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT---DNLCLYVQSRSYRAPEVI 592
YL S ++H DL NIL+ + K+ D G + + DN L V+ + APE +
Sbjct: 115 YLESKKLVHRDLAARNILVS--EDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEAL 169
Query: 593 IGLPYDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L E+++ G +P
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 50/194 (25%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRS 585
Q AL+YLH I+H DLK +N+ + IK+ DLG + Q D + +
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPY 167
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPIDLEML 644
Y +PE+ PY+ K D+W+LGC + E+ T + F + ++ RII G L P+
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM----- 222
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
K+Y PE + + T+L P+
Sbjct: 223 ----------PKDYS---------------PE--------------LGELIATMLSKRPE 243
Query: 705 RRPTAREALDHPWL 718
+RP+ + L P++
Sbjct: 244 KRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL-R 480
+G +++KV + T +K+IK + D+ +D ++ K V + A H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFET--ASNHPFLVG 60
Query: 481 LYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
L+ F LF V E + ++ Q+ + A F + + AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL-------ALNFLH 113
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT----DNLCLYVQSRSYRAPEVIIG 594
GII+ DLK +N+L+ + IK+ D G C + D + + +Y APE++ G
Sbjct: 114 ERGIIYRDLKLDNVLLDA--EGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLF 620
Y +D W+LG ++ E+ G F
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F V+ A + HT V +K + K + + + E+K L+ + + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE--- 85
Query: 478 ILRLYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
Y Y EH ++V E + + + +++ E + IT L+ L Y
Sbjct: 86 ----YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAITHGALQGLAY 136
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL- 595
LHS +IH D+K NIL+ + ++K+ D GS+ + +V + + APEVI+ +
Sbjct: 137 LHSHNMIHRDIKAGNILLT--EPGQVKLADFGSASKSSPANS-FVGTPYWMAPEVILAMD 193
Query: 596 --PYDQKIDLWSLGCILAEL 613
YD K+D+WSLG EL
Sbjct: 194 EGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV A+ TG +K +K +D + + E ++ + N E H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS-----ERH 61
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQVITR 528
++ L+ F +H+ V E +GG F+ R
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYA-------------AGGDLMMHIHTDVFSEPRAVFYAA 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L+YLH I++ DLK +N+L+ + +KI D G LC + R+
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFG--------LCKEGMGFGDRT 158
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ APEV+ Y + +D W LG ++ E+ GE FP D
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ----SLDEIKLLKLVNKNDPADEHH 477
+G F +V+ + TG +K + + Q +L+E +L LV+ D
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP---F 58
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE----- 532
I+ + F+ + L + +L+ +GG+ ++ L + V + + +
Sbjct: 59 IVCMTYAFHTPDKLCFILDLM-------------NGGDLHYHLSQHGVFSEKEMRFYATE 105
Query: 533 ---ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRA 588
LE++H+ +++ DLKP NIL+ + ++I DLG +C F V + Y A
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMA 163
Query: 589 PEVI-IGLPYDQKIDLWSLGCILAELWTGEVLF 620
PEV+ G YD D +SLGC+L +L G F
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G +++KV + T +K++K + D+ +D ++ K V + ++ ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ-ASNHPFLVGL 61
Query: 482 YDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+ F LF V E + ++ Q+ + A F + + AL YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------ALNYLHE 114
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLP 596
GII+ DLK +N+L+ S IK+ D G D + + +Y APE++ G
Sbjct: 115 RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 597 YDQKIDLWSLGCILAELWTGEVLF 620
Y +D W+LG ++ E+ G F
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 42/125 (33%), Positives = 65/125 (52%), Gaps = 21/125 (16%)
Query: 512 SGGEA--------YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
SGGE F+ ++ + + + ALE+LH LGI++ D+K ENIL+ S +
Sbjct: 88 SGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVV 145
Query: 564 IIDLG-SSCF------QTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT 615
+ D G S F +T + C ++ Y APE+I G + + +D WSLG ++ EL T
Sbjct: 146 LTDFGLSKEFLSEEKERTYSFCGTIE---YMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
Query: 616 GEVLF 620
G F
Sbjct: 203 GASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 24/48 (50%), Positives = 32/48 (66%), Gaps = 1/48 (2%)
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+Q I RQ L AL+ LHS GI+H D+KP+NI+ KIIDLG++
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 12/116 (10%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-----V 581
T + + AL+ +HS+G+IH D+KP+N+L+ + +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFG-TCMKMDETGMVRCDTAV 204
Query: 582 QSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 40/141 (28%), Positives = 73/141 (51%), Gaps = 16/141 (11%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-----V 581
T + + AL+ +HS+G IH D+KP+N+L+ +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFG-TCMKMDANGMVRCDTAV 204
Query: 582 QSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII---- 633
+ Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264
Query: 634 GMLGPIDLEMLMQGQEIYKYF 654
+ P D+E+ Q +++ F
Sbjct: 265 SLTFPDDIEISKQAKDLICAF 285
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL----CL- 579
I R+ LEAL YLH GIIH D+K ENI + + + D G++C + C
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYG 246
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+ + +PE++ PY K D+WS G +L E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+ E +G + KVF+ + G +KI+ D ++ E +LK + +D +
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKAL-----SDHPN 76
Query: 478 ILRLYDYFYHLE-----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+++ Y +Y + L++V EL ++ + K + G + + I + L
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEAL 134
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
L++LH IH D+K NIL+ + +K++D G S T V + + A
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 589 PEVI-----IGLPYDQKIDLWSLGCILAELWTGE 617
PEVI + YD + D+WSLG EL G+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 51/224 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ N P
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ--NSRHP----- 55
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQ-------ESGGEAYFTLGRLQVITR-- 528
L A Y FQ ++ +GGE +F L R +V +
Sbjct: 56 -------------------FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 96
Query: 529 ------QCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLC 578
+ + AL+YLHS +++ DLK EN+++ + IKI D G +
Sbjct: 97 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 154
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
+ + Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 49/225 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD------- 474
LG AF KVF A+ C ++ D+ L +K LK +++ D
Sbjct: 13 LGEGAFGKVFLAE--------CHNLLPEQ----DKMLVAVKALKEASESARQDFQREAEL 60
Query: 475 -----EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAY------------ 517
HI+R Y L +V E +R + +F + G +A
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG--DLNRFLRSHGPDAKILAGGEDVAPGQ 118
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
TLG++ I Q + YL SL +H DL N L+ Q +KI D G S + TD
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG--QGLVVKIGDFGMSRDIYSTD 176
Query: 576 NLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
V R+ + PE I+ + + D+WS G +L E++T
Sbjct: 177 Y--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLL-KLVNKNDPADEHHI 478
+G F V + G V +K +K+D L E ++ L + N +
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPN-------L 62
Query: 479 LRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++L L+IV E + + +L ++ + S G A TL + E +EYL
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLR----SRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIG 594
+H DL N+L+ + K+ D G + D+ L V+ + APE +
Sbjct: 119 EEKNFVHRDLAARNVLVS--EDLVAKVSDFGLAKEASQGQDSGKLPVK---WTAPEALRE 173
Query: 595 LPYDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L E+++ G V +P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ + V +K +K L+E L+K + + ++RL
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD------KLVRL 66
Query: 482 YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
Y E ++I+ E + + +L +F K + GG+ L +L + Q E + Y+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLK--SDEGGK--VLLPKLIDFSAQIAEGMAYIERK 122
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLP 596
IH DL+ N+L+ C KI D G + DN + + APE I
Sbjct: 123 NYIHRDLRAANVLVSESLMC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 597 YDQKIDLWSLGCILAELWT-GEVLFP---NDAVVMILAR 631
+ K D+WS G +L E+ T G++ +P N V+ L R
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 79/261 (30%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPA 473
++ + +G AF +V Q TG +K + + F L +K + L + P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV----ITR- 528
++ LY F ++L+++ E L GG+ L + +TR
Sbjct: 62 ---WVVSLYYSFQDAQYLYLIMEFL-------------PGGDLMTMLIKYDTFSEDVTRF 105
Query: 529 ---QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-------------- 571
+C+ A+E +H LG IH D+KP+NILI + IK+ D G S
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILID--RGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 572 FQ---------------TDNLCLYVQSRS---------------------YRAPEVIIGL 595
Q D++ L + S+ Y APE+ +
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 596 PYDQKIDLWSLGCILAELWTG 616
Y Q+ D WSLG I+ E G
Sbjct: 224 GYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 42/214 (19%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-------FQTDNLC 578
I + L AL+Y+HS G IH +K +IL+ + + + L S Q
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 579 LYVQSRS---YRAPEV----IIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILA 630
S + +PEV + G Y++K D++S+G EL G V F + A M+L
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221
Query: 631 RIIG-MLGPID-----LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL 684
++ G + +D L Q N+ P +
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSS----------NEHPNNRDSVDHPYTRT----- 266
Query: 685 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718
FS+ F FV L+ +P+ RP+A + L+H +
Sbjct: 267 -FSEHFH-QFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
+ + E +G + KV++ + G +KI+ D ++ E +L+ + N P
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL-PNHP 79
Query: 473 ADEHHILRLYDYFYHLEH-----LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
++++ Y FY + L++V EL ++ E K G + I
Sbjct: 80 ----NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYI 133
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQS 583
L L++LH+ IIH D+K NIL+ + +K++D G S T V +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 584 RSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
+ APEVI YD + D+WSLG EL G+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 23/151 (15%)
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE---- 532
+++ L+ Y + +F+V + GG+ + + + I +C++
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQ-------------HAEGGKLWSHISKFLNIPEECVKRWAA 92
Query: 533 ----ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
AL+ LH GI+ DL P NIL+ R I++ D+ Y A
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLD--DRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619
PEV + D WSLG IL EL TG+ L
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 422 LGSAAFSKVFQAQDL-------HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
LG F +V A+ L V V +K++K+D KD D + E++++K++ K+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 81
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGR-------- 522
+I+ L L+++ E + NL E+ + + G E + + R
Sbjct: 82 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 523 --LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
L T Q +EYL S IH DL N+L+ + +KI D G + +N+ Y
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVMKIADFGLA-RDVNNIDYY 193
Query: 581 VQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + R APE + Y + D+WS G ++ E++T
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G +++KV + +K++K + D+ +D ++ K V + ++ ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF-LVGL 61
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+ F LF+V E + F Q E + ++ C+ AL +LH G
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEI----CI-ALNFLHERG 116
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYD 598
II+ DLK +N+L+ IK+ D G D + + +Y APE++ G Y
Sbjct: 117 IIYRDLKLDNVLLD--ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 599 QKIDLWSLGCILAELWTGEVLF 620
+D W+LG ++ E+ G F
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPA 473
LG F KV +A V +K++K + + D L E LLK VN
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDL-LSEFNLLKQVN----- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKF---------NQESG-----G 514
H+++LY L ++ E LR+ L E +K N+ S
Sbjct: 62 -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E T+G L Q ++YL + ++H DL N+L+ ++ +I L ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 575 DNLCLYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
D+ + R + A E + Y + D+WS G +L E+ T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C K+ K + ++ ++ E ++L V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH------SRF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFN--QESGGEAYFTLGRLQVITRQCLEALE 535
I+ L F L +V ++ + +N +E+ G F R T Q + LE
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLE 111
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVI 592
+LH II+ DLKPEN+L+ + ++I DLG + D Y + + APE++
Sbjct: 112 HLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 593 IGLPYDQKIDLWSLGCILAEL 613
G YD +D ++LG L E+
Sbjct: 170 QGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK---IIKNDKDFFDQSLDEIKLLKLVNKND 471
+Y + +G +F K + G +K I K ++S E+ +L N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS--NMKH 58
Query: 472 PADEHHILRLYDYFYHLEHLFIV---CELLRANLYEFQKFNQESGGEAYFTLGR-LQVIT 527
P +I++ + F +L+IV CE +LY +K N + G F + L
Sbjct: 59 P----NIVQYQESFEENGNLYIVMDYCE--GGDLY--KKINAQRG--VLFPEDQILDWFV 108
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-----SSCFQTDNLCLYVQ 582
+ CL AL+++H I+H D+K +NI + + IK+ D G +S + C +
Sbjct: 109 QICL-ALKHVHDRKILHRDIKSQNIFLT--KDGTIKLGDFGIARVLNSTVELARTC--IG 163
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ Y +PE+ PY+ K D+W+LGC+L E+ T
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 531 LEALEYLHSLGIIHCDLKPENILIK-------SYQRCEIKIIDLGSSCFQTDNLCLY-VQ 582
L+AL+Y+H +G +H +K +ILI S R + +I+ G + Y V+
Sbjct: 111 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK 170
Query: 583 SRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPI 639
+ +PEV+ YD K D++S+G EL G V F + A M+L ++ G + +
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 230
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYII--PEESSLEHHLQFSDAFFIDFVRT 697
+ +E+ ++ + E T E SS ++ FS F FV
Sbjct: 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFH-HFVEQ 289
Query: 698 LLEINPQRRPTAREALDHPWLQH 720
L+ NP RP+A L+H + +
Sbjct: 290 CLQRNPDARPSASTLLNHSFFKQ 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 17/185 (9%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
K +K Q +EI L +N + ILR Y + + +LY
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY------DFDLYS 251
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
F +++ + L + + I +Q L A+EY+H +IH D+K ENI + C+ KI
Sbjct: 252 FM-YDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN----CDGKI 306
Query: 565 I--DLGSSC-FQTDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+ D G++ F+ + +V + + +PE++ G Y + D+WS G IL ++ + +
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
Query: 619 LFPND 623
D
Sbjct: 367 CPIGD 371
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 49/199 (24%), Positives = 76/199 (38%), Gaps = 63/199 (31%)
Query: 473 ADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
AD +++LY F ++L+ V + + + L F ++ L R +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED--------LARFYIAE 109
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------------------- 568
C A+E +H +G IH D+KP+NILI + IK+ D G
Sbjct: 110 LTC--AIESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 569 ---------------SSC---------FQTDNLCL---YVQSRSYRAPEVIIGLPYDQKI 601
C + CL V + +Y APEV++ Y Q
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 602 DLWSLGCILAELWTGEVLF 620
D WS+G IL E+ G+ F
Sbjct: 226 DWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-07
Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 50/242 (20%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
Y V + +G+ F +VF + T C K I + ++ +L+ VN
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKH 71
Query: 476 HHILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV-----ITR 528
+I+R D F + + L+I+ E A + + Q+ Y G+++ ITR
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAG--DLSRNIQK----CYKMFGKIEEHAIVDITR 125
Query: 529 QCLEALEYLHSLG-------IIHCDLKPENILIKS---------------YQRCEIKIID 566
Q L AL Y H+L ++H DLKP+NI + + R KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 567 LGSSCFQTDNLCLYVQSRS------YRAPEVII--GLPYDQKIDLWSLGCILAELWTGEV 618
G S N+ + + S Y +PE+++ YD K D+W+LGCI+ EL +G+
Sbjct: 186 FGLS----KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 619 LF 620
F
Sbjct: 242 PF 243
|
Length = 1021 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 23/207 (11%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476
+ LG +F V + + V +K +K+DK +D+ LK D
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--LSDIMDD--FLKEAAIMHSLDHE 56
Query: 477 HILRLYDYFYHLEH-LFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++RLY L H L +V EL +L + + + +F + L Q +
Sbjct: 57 NLIRLYGVV--LTHPLMMVTELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGM 110
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------A 588
YL S IH DL NIL+ S ++KI D G N YV + A
Sbjct: 111 RYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT 615
PE + + D+W G L E++T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 14/117 (11%)
Query: 512 SGGEAY--------FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
SGGE + F+ R + + + ALE+LH I++ DLKPENIL+ + I
Sbjct: 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIA 136
Query: 564 IIDLG-SSCFQTDNLC--LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
+ D G S TDN + + Y APEV++ Y + +D WSLG ++ E+ G
Sbjct: 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 422 LGSAAFSKVFQAQ-DLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG+ F +V+ A + HT V V K +K + L E ++K +H L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAV--KTMKPGSMSVEAFLAEANVMK-------TLQHDKLV 64
Query: 481 LYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
E ++I+ E + + +L +F K + G + L +L + Q E + ++
Sbjct: 65 KLHAVVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQ--PLPKLIDFSAQIAEGMAFIEQ 120
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGL 595
IH DL+ NIL+ + C KI D G + DN + + APE I
Sbjct: 121 RNYIHRDLRAANILVSASLVC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 596 PYDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L E+ T G + +P
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYP 205
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 12/139 (8%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++IV E + + +L +F K G Y L +L + Q + + Y+ + IH DL
Sbjct: 73 EPIYIVTEFMGKGSLLDFLK----EGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C KI D G + DN Q + APE + + K D+
Sbjct: 129 RAANILVGDNLVC--KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 604 WSLGCILAELWT-GEVLFP 621
WS G +L EL T G V +P
Sbjct: 187 WSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 420 EYLGSAAFSKVF----QAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
E +G F +VF +A + V C + + D + L E ++LK + +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPN---- 54
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+RL + ++IV EL++ +F F + G + L + +E
Sbjct: 55 --IVRLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEG--PRLKVKELIQMVENAAAGME 108
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-------A 588
YL S IH DL N L+ ++ +KI D G S + D + Y + + A
Sbjct: 109 YLESKHCIHRDLAARNCLVT--EKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
PE + Y + D+WS G +L E ++ G V + N
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE-LLRANLY 503
KIIK + D E K+L +N + LY F +L++V E ++ +
Sbjct: 68 KIIKQKQ--VDHVFSERKILNYIN------HPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 504 EFQKFNQESGGE-AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562
F + N+ + F ++ +I EYL SL I++ DLKPEN+L+ + I
Sbjct: 120 TFLRRNKRFPNDVGCFYAAQIVLI-------FEYLQSLNIVYRDLKPENLLLD--KDGFI 170
Query: 563 KIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619
K+ D G + +T LC + Y APE+++ + + + D W+LG + E+ G
Sbjct: 171 KMTDFGFAKVVDTRTYTLC---GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
Query: 620 FPNDAVVMILARII 633
F + ++I +I+
Sbjct: 228 FYANEPLLIYQKIL 241
|
Length = 340 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 71/255 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG AF +V A + T +K ++ + +K + + AD +++L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE--ADNEWVVKL 66
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE--------A 533
Y F ++L+ V + + GG+ L R++V A
Sbjct: 67 YYSFQDKDNLYFVMDYI-------------PGGDMMSLLIRMEVFPEVLARFYIAELTLA 113
Query: 534 LEYLHSLGIIHCDLKPENILI-----------------------KSYQ------------ 558
+E +H +G IH D+KP+NILI K YQ
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 559 ----------RCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWS 605
RC ++ L + CL V + +Y APEV++ Y Q D WS
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 606 LGCILAELWTGEVLF 620
+G IL E+ G+ F
Sbjct: 234 VGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 422 LGSAAFSKVFQAQDLHTG----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADE 475
LGS AF V++ + G + V +K+++ + + LDE ++ V D
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV------DH 68
Query: 476 HHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVIT--RQCLE 532
H++RL + ++ +L+ L ++ + +++ +G ++ Q +
Sbjct: 69 PHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-------NIGSQYLLNWCVQIAK 120
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR----- 587
+ YL ++H DL N+L+K+ Q +KI D G + L V + Y
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKL------LDVDEKEYHAEGGK 172
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E I+ Y K D+WS G + EL T
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYVQSRSYRAPEV 591
LE L I++ DLKPENIL+ R I+I DLG + + + + V + Y APEV
Sbjct: 115 LEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV 172
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLF 620
I Y D W LGC++ E+ G+ F
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 60/257 (23%), Positives = 96/257 (37%), Gaps = 75/257 (29%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG AF +V A+ + T +K ++ + +K + + AD ++RL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE--ADNEWVVRL 66
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE--------A 533
Y F ++L+ V + + GG+ L R+ + A
Sbjct: 67 YYSFQDKDNLYFVMDYI-------------PGGDMMSLLIRMGIFPEDLARFYIAELTCA 113
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------------------------- 568
+E +H +G IH D+KP+NILI + IK+ D G
Sbjct: 114 VESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 569 ---------SSCFQTDNL-------------CL---YVQSRSYRAPEVIIGLPYDQKIDL 603
++C D L CL V + +Y APEV++ Y Q D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 604 WSLGCILAELWTGEVLF 620
WS+G IL E+ G+ F
Sbjct: 232 WSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 56/238 (23%), Positives = 106/238 (44%), Gaps = 36/238 (15%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-------KNDKDFFDQSLDEIKLLK 465
A Y V + +G AF +V + T +K++ ++D FF + D +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-- 99
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
A+ +++L+ F +L++V E + +L A F
Sbjct: 100 -------ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF------ 146
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---- 580
T + + AL+ +HS+G IH D+KP+N+L+ + +K+ D G +C + + +
Sbjct: 147 -YTAEVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFG-TCMKMNKEGMVRCDT 202
Query: 581 -VQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
V + Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 23/103 (22%)
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQSRS---- 585
+EY+HS G++H DLKP+NIL+ + E+ I+D G++ F + D L + V R+
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 586 -------------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
Y APE ++G+P + D+++LG IL ++ T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ + V +K +K + L+E +++K + ++D +++L
Sbjct: 14 LGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHD-----KLVQL 66
Query: 482 YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
Y E ++IV E + + +L +F K G L L + Q + Y+ +
Sbjct: 67 YAVVSE-EPIYIVTEYMSKGSLLDFLK----DGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLP 596
IH DL+ NIL+ C KI D G + DN Q + APE +
Sbjct: 122 NYIHRDLRSANILVGDGLVC--KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 597 YDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L EL T G V +P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR---- 584
Q + AL+ +HS ++H DLK NI + IK+ D G S +D++ L V S
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 585 -SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
Y APE+ Y +K D+WSLG IL EL T
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 422 LGSAAFSKVFQAQ----DLHTGVDVC----LKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
LG AF +V +A+ D LK +KD D + E++++K++ K+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK-- 76
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYF----------TLGR 522
+I+ L L++V E NL +F + + G A T
Sbjct: 77 ---NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L Q +E+L S IH DL N+L+ + +KI D G + + + Y +
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVT--EDHVMKIADFGLA--RDIHHIDYYR 189
Query: 583 SRS-------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + APE + Y + D+WS G +L E++T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 29/91 (31%), Positives = 37/91 (40%), Gaps = 12/91 (13%)
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
QCL AL LH L + L+K GS F+T +
Sbjct: 24 LQCLGALRELHRQAKSGNILLTWDGLLKLD----------GSVAFKTPEQSR--PDPYFM 71
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
APEVI G Y +K D++SLG L E E+
Sbjct: 72 APEVIQGQSYTEKADIYSLGITLYEALDYEL 102
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 52/200 (26%), Positives = 79/200 (39%), Gaps = 64/200 (32%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
Q L A+ ++HS +IH D+K NIL+ C ++ LG F +Y + S
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILL-----CSNGLVKLGDFGFSK----MYAATVSDDV 201
Query: 586 ---------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
Y APE+ PY +K D++SLG +L EL T + P D
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT--LKRPFDGE----------- 248
Query: 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696
++E +M K YD +P S E + V
Sbjct: 249 ---NMEEVMH-----KTLAGRYD-------------PLPPSISPE---------MQEIVT 278
Query: 697 TLLEINPQRRPTAREALDHP 716
LL +P+RRP++ + L+ P
Sbjct: 279 ALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 30/129 (23%), Positives = 53/129 (41%), Gaps = 43/129 (33%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY------- 580
+ + A++ +H LG IH D+KP+N+L+ + + IK+ D G + + + +
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 581 ---------------------------------VQSRSYRAPEVIIGLPYDQKIDLWSLG 607
V + Y APEV + Y+++ D WSLG
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 608 CILAELWTG 616
I+ E+ G
Sbjct: 227 VIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LGS F V + + + V +KI+KND + D +L + +LL+ N D +I+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKD-ELLREANVMQQLDNPYIV 59
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
R+ E +V EL A L KF Q++ + T + + Q ++YL
Sbjct: 60 RMIG-ICEAESWMLVMEL--AELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEE 113
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------YRAPEVI 592
+H DL N+L+ + +I L + +N Y ++++ + APE +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPVKWYAPECM 170
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ K D+WS G ++ E ++
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V++ +T V +K +K + KDF L E +++K + H
Sbjct: 14 LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDF----LAEAQIMKKL--------RH 60
Query: 478 --ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++LY E ++IV EL++ +L E+ Q G A L +L + Q +
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRA-LKLPQLIDMAAQVASGM 116
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR---SYRAPE 590
YL + IH DL N+L+ C K+ D G + + D ++ + APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNIC--KVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
+ + K D+WS G +L E+ T G + +P GM L+ + QG
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYP------------GMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 422 LGSAAFSKVFQAQDL-------HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
LG F +V A+ + + V V +K++K+D KD D + E++++K++ K+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL-VSEMEMMKMIGKHK 78
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYF----------TL 520
+I+ L L+++ E + NL E+ + + G + F T
Sbjct: 79 -----NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
L Q +EYL S IH DL N+L+ + +KI D G + N+ Y
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVMKIADFGLA-RDVHNIDYY 190
Query: 581 VQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 633
++ + R APE + Y + D+WS G +L E++T G +P V +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL----- 245
Query: 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEE 666
++L +G + K ++LY I E
Sbjct: 246 -------FKLLKEGHRMDKPANCTHELYMIMRE 271
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 22/182 (12%)
Query: 441 DVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499
DV +K+IK D+ ++E K ++KL ++ +++LY ++IV E +
Sbjct: 30 DVAIKMIKEGSMSEDEFIEEAKVMMKLSHEK-------LVQLYGVCTKQRPIYIVTEYMS 82
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559
N F +L + + E + YL S IH DL N L+ Q
Sbjct: 83 NGCL----LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD-QG 137
Query: 560 CEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPEVIIGLPYDQKIDLWSLGCILAEL 613
C +K+ D G S + D+ Y S + PEV++ + K D+W+ G ++ E+
Sbjct: 138 C-VKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
Query: 614 WT 615
++
Sbjct: 195 YS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS---LDEIKLLKLVNKNDPADEH 476
E +G F V++ L +V +K ++ D L E ++LK + P
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRST-LPPDLKRKFLQEAEILK--QYDHP---- 52
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA--- 533
+I++L + ++IV EL+ F ++ T+ +L + L+A
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGG--SLLTFLRKKKNR--LTVKKL---LQMSLDAAAG 105
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------ 587
+EYL S IH DL N L+ + +KI D G S + + +Y S +
Sbjct: 106 MEYLESKNCIHRDLAARNCLVG--ENNVLKISDFGMS--REEEGGIYTVSDGLKQIPIKW 161
Query: 588 -APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE + Y + D+WS G +L E ++ G+ +P
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 12/139 (8%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++IV E + + +L +F K E G Y L +L + Q + Y+ + +H DL
Sbjct: 73 EPIYIVTEYMSKGSLLDFLK--GEMG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C K+ D G + DN Q + APE + + K D+
Sbjct: 129 RAANILVGENLVC--KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 604 WSLGCILAELWT-GEVLFP 621
WS G +L EL T G V +P
Sbjct: 187 WSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 13/149 (8%)
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
H+I+RL + I+ E + K+ ++ GE F+ +L + R ++
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENG--ALDKYLRDHDGE--FSSYQLVGMLRGIAAGMK 121
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-----YRAP 589
YL + +H DL NIL+ S C K+ D G S + D Y S + AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLEC--KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GE 617
E I + D+WS G ++ E+ + GE
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVD---------VCLKIIKN---DKDFFDQSLDEIKLLKLVNK 469
LG F +V +A+ G+D V +K++K+ DKD D + E++L+KL+ K
Sbjct: 20 LGEGCFGQVVRAEAY--GIDKSRPDQTVTVAVKMLKDNATDKDLADL-ISEMELMKLIGK 76
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGR------ 522
+ +I+ L L+++ E + NL EF + + G + F + +
Sbjct: 77 HK-----NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 523 ----LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
L Q +EYL S IH DL N+L+ +I L D
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 579 LYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
R + APE + Y + D+WS G ++ E++T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 20/48 (41%), Positives = 32/48 (66%), Gaps = 2/48 (4%)
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
++ + RQ L L LH +GI+H D+KPEN+L+ ++KIID G++
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 474 DEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
D +I+RL + I+ E + +L +F + N + FT+G+L + R
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-----DGKFTVGQLVGMLRGIAS 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------Y 586
++YL + +H DL NIL+ S C K+ D G S D+ Y ++ +
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVC--KVSDFGLSRRLEDSEATY-TTKGGKIPIRW 174
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617
APE I + D+WS G ++ E+ + GE
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVD---------VCLKIIKND---KDFFDQSLDEIKLLKLVNK 469
LG F +V A+ + G+D V +K++K+D KD D + E++++K++ K
Sbjct: 26 LGEGCFGQVVMAEAI--GLDKEKPNRVTKVAVKMLKSDATEKDLSDL-ISEMEMMKMIGK 82
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQK----------FNQESGGEAYF 518
+ +I+ L L+++ E + NL E+ + +N E
Sbjct: 83 HK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ L Q +EYL S IH DL N+L+ +I L D
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 579 LYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
R + APE + Y + D+WS G +L E++T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG AF KVF A+ +L D L +K KD D + + + N HI+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN--LQHEHIV 70
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF----------TLGRLQVITRQ 529
+ Y + L +V E ++ + KF + G +A T ++ I +Q
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSR--- 584
+ YL S +H DL N L+ + +KI D G S + TD + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVG--ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ PE I+ + + D+WSLG +L E++T
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADE 475
LG F KV +TG V +K + + + +S EI++L+ + D
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL------DH 65
Query: 476 HHILRL--YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
+I++ L ++ E L +L ++ + +++ L RL + + Q +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN-----LKRLLLFSSQICK 120
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-QTDNLCLYVQSRS-----Y 586
++YL S IH DL NIL++S +KI D G + D YV+ +
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + D+WS G L EL+T
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 23/128 (17%)
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------S 585
E +EYL IH DL N L+ S +K+ D G + + D+ Y S
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVK 166
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644
+ PEV Y K D+WS G ++ E++T G++ F + + +EM+
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------------VEMI 214
Query: 645 MQGQEIYK 652
+G +Y+
Sbjct: 215 SRGFRLYR 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++I+ E + +L +F K G + T+ +L + Q E + ++ IH DL
Sbjct: 73 EPIYIITEYMENGSLVDFLK--TPEGIK--LTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C KI D G + DN + + APE I + K D+
Sbjct: 129 RAANILVSETLCC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 604 WSLGCILAELWT-GEVLFP---NDAVVMILARIIGMLGP 638
WS G +L E+ T G + +P N V+ L R M P
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP 225
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 32/111 (28%), Positives = 58/111 (52%), Gaps = 13/111 (11%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ--TDNLC---LYVQSRSYR 587
A++ +H LG +H D+KP+N+L+ + I++ D G SC + D + V + Y
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLD--KNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYI 170
Query: 588 APEVIIGLP-----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 13/111 (11%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-----TDNLCLYVQSRSYR 587
A++ +H L +H D+KP+NIL+ I++ D G SC + T + V + Y
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMD--MNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYI 170
Query: 588 APEVIIGLP-----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 67/243 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPADEHHIL 479
+G AF +V Q TG +KI++ + + I+ + LV AD ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE----ADSLWVV 64
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE------- 532
+++ F +L+++ E L GG+ L + +T + +
Sbjct: 65 KMFYSFQDKLNLYLIMEFL-------------PGGDMMTLLMKKDTLTEEETQFYIAETV 111
Query: 533 -ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------------------SS 570
A++ +H LG IH D+KP+N+L+ S + +K+ D G S
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 571 CFQTDNLCLYVQSRSYR-----------------APEVIIGLPYDQKIDLWSLGCILAEL 613
F N+ ++ +++ APEV + Y++ D WSLG I+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 614 WTG 616
G
Sbjct: 230 LIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 21/38 (55%), Positives = 26/38 (68%), Gaps = 2/38 (5%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
AL+YLH GIIH DLKP+N+LI + IK+ D G S
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID--LGSSCFQTDNLCLY-VQSRS 585
Q + YLH G+IH D+ N +I + +KI D L F D CL ++R
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 586 YR--APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ A E ++ Y D+WS G +L EL T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-----TDNLCLYVQSRSYR 587
A+ +H L +H D+KP+N+L+ I++ D G SC + T + V + Y
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLD--MNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYI 170
Query: 588 APEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 43/220 (19%)
Query: 422 LGSAAFSKVFQ--AQDL---HTGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKNDPAD 474
LG +F V++ A+ + V +K + + + + L+E ++K N
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC----- 68
Query: 475 EHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
HH++RL + +V EL L++ L + + + G TL + + +
Sbjct: 69 -HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR 587
+ + YL + +H DL N ++ KI D G + ++TD Y YR
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTV--KIGDFGMTRDIYETD----Y-----YR 176
Query: 588 ------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + K D+WS G +L E+ T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 8/105 (7%)
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQ 573
+ FT+ +L + R ++YL +G +H DL NIL+ S C K+ D G S +
Sbjct: 100 DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC--KVSDFGLSRVLE 157
Query: 574 TDNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAEL 613
D Y + APE I + D+WS G ++ E+
Sbjct: 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDKDF--------FDQS---LDEIK----- 462
E LG AF K+++ G+D L IK KD F Q + E+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 463 -LLKLVNKNDPADEHHILRLYDYFYHLE-HLFIVCELLRANLYEFQKFNQESGG-EAYFT 519
LL +V + P + L++Y + H F++ +R+ + + E G ++
Sbjct: 71 CLLGVVTQEQP-----VCMLFEYLNQGDLHEFLI---MRSPHSDVGCSSDEDGTVKSSLD 122
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
G I Q +EYL S +H DL NILI ++ +KI DLG S
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG--EQLHVKISDLGLSREIYSADYY 180
Query: 580 YVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
VQ +S + PE I+ + D+WS G +L E+++
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 55/237 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPADEHHIL 479
+G AF +V Q TG +KI++ + + I+ + LV AD ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE----ADGAWVV 64
Query: 480 RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
+++ F +L+++ E L + K + S F + + + A++ +
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-------ETVLAIDAI 117
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------------------SSCFQTDN 576
H LG IH D+KP+N+L+ + + +K+ D G S F N
Sbjct: 118 HQLGFIHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 577 L---------------CLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y V + Y APEV + Y++ D WSLG I+ E+ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 31/155 (20%), Positives = 57/155 (36%), Gaps = 26/155 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
L ++V+ D LKI + + D+ E+ +L+L+ + + ++
Sbjct: 6 LKGGLTNRVYLLGT--KDEDYVLKINPSREKGADR-EREVAILQLLARKGL----PVPKV 58
Query: 482 YDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
+++ E + L E + +E I Q E L LH L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEEKED-------------IAEQLAELLAKLHQL 105
Query: 541 ---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
+ H DL P NIL+ + + IID + +
Sbjct: 106 PLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 2/43 (4%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
I + L LEY+H GI H D+KPENI++ R IID G
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG--YIIDYG 171
|
Length = 294 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 13/95 (13%)
Query: 530 CL---EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
CL E + YL S +IH DL N L+ Q +K+ D G + F D+ Y S
Sbjct: 106 CLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQ--YTSSTGT 161
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ +PEV Y K D+WS G ++ E+++
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 32/110 (29%), Positives = 48/110 (43%), Gaps = 13/110 (11%)
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSC 571
+ TL L + Q +E+L S IH DL NIL+ +KI D G
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDI 223
Query: 572 FQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + YV+ R APE I Y + D+WS G +L E+++
Sbjct: 224 YKDPD---YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 52/225 (23%), Positives = 80/225 (35%), Gaps = 49/225 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA-------- 473
LG AF KVF + C + + D+ L +K LK ND
Sbjct: 13 LGEGAFGKVFLGE--------CYHLEPEN----DKELVAVKTLKETASNDARKDFEREAE 60
Query: 474 -----DEHHILRLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFT 519
+I++ Y + +V E LR++ + T
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNL 577
L +L I Q + YL S +H DL N L+ +KI D G S + TD
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY--DLVVKIGDFGMSRDVYTTD-- 176
Query: 578 CLYVQSRSYR-------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y + + PE I+ + + D+WS G +L E++T
Sbjct: 177 --YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 18/121 (14%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLY-VQ 582
I Q +EYL S +H DL N L+ + +KI D G S + D Y VQ
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSAD---YYRVQ 183
Query: 583 SRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL----FPNDAVV-MILARI 632
S+S + PE I+ + + D+WS G +L E+++ + F N V+ MI +R
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
Query: 633 I 633
+
Sbjct: 244 L 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 47/229 (20%)
Query: 414 GRYYVTEYLGSAAFS-KVFQAQDLHTGVD-VCLKIIKND------KDFFDQSLDEIKLLK 465
G ++ E G FS K F D V +K+++ D +DF L E+K+L
Sbjct: 19 GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF----LKEVKILS 74
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
++ DP +I RL L ++ E + + +F Q+ E +
Sbjct: 75 RLS--DP----NIARLLGVCTVDPPLCMIMEYM--ENGDLNQFLQKHVAETSGLACNSKS 126
Query: 526 ITRQCL--------EALEYLHSLGIIHCDLKPENILI-KSYQRCEIKIIDLGSSCFQTDN 576
++ L + YL SL +H DL N L+ K+Y IKI D G S N
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGMS----RN 179
Query: 577 L--CLYVQSRSYRAP--------EVIIGLPYDQKIDLWSLGCILAELWT 615
L Y + + RAP E ++ + K D+W+ G L E+ T
Sbjct: 180 LYSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 491 LFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549
L+IV E + + +L ++ + S G + L + EA+EYL + +H DL
Sbjct: 75 LYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 550 ENILIKSYQRCEIKIIDLG-----SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLW 604
N+L+ K+ D G SS T L + + APE + + K D+W
Sbjct: 131 RNVLVSEDNVA--KVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSDVW 183
Query: 605 SLGCILAELWT-GEVLFPNDAVVMILARI 632
S G +L E+++ G V +P + ++ R+
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPRV 212
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 28/215 (13%)
Query: 421 YLGSAAFSKVFQAQDLHTGVD------VCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+LGS AF +V++ V +K ++ K DQ ++ + LK + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQ--EKKEFLKEAHLMSNFN 57
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
+I++L E +I+ EL+ L + E G TL L I +
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 533 ALEYLHSLGIIHCDLKPENILI--KSYQRCEI-KIIDLG--SSCFQTDNLCLYVQSRSYR 587
YL + IH DL N L+ K Y + KI D G +++D Y +
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD----YYRKEGEG 173
Query: 588 -------APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE ++ + + D+WS G ++ E+ T
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 8/100 (8%)
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
+L + Q + +EYL S +H DL NIL++S R +KI D G + + Y
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYK 166
Query: 582 QSRS------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE + + D+WS G +L EL+T
Sbjct: 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 13/121 (10%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-- 585
Q + ++YL S +H DL N+L++S + +KI D G + +TD V+
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
+ APE +I + D+WS G L EL T D+ + + M+GP +
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKMIGPTHGQ 229
Query: 643 M 643
M
Sbjct: 230 M 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 25/203 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH--IL 479
LG + +V++ + V +K +K D ++ L E ++K + H ++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK--------EIKHPNLV 65
Query: 480 RLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+L +I+ E + NL ++ + A L + Q A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL----YMATQISSAMEYLE 121
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYRAPEVI 592
IH DL N L+ +K+ D G S T + Y + APE +
Sbjct: 122 KKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESL 177
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ K D+W+ G +L E+ T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 722 | |||
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| cd08677 | 118 | C2A_Synaptotagmin-13 C2 domain. Synaptotagmin is a | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| cd08692 | 135 | C2B_Tac2-N C2 domain second repeat found in Tac2-N | 99.83 | |
| cd08407 | 138 | C2B_Synaptotagmin-13 C2 domain second repeat prese | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd08406 | 136 | C2B_Synaptotagmin-12 C2 domain second repeat prese | 99.8 | |
| cd08680 | 124 | C2_Kibra C2 domain found in Human protein Kibra. K | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| cd04028 | 146 | C2B_RIM1alpha C2 domain second repeat contained in | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| cd08392 | 128 | C2A_SLP-3 C2 domain first repeat present in Synapt | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| cd08381 | 122 | C2B_PI3K_class_II C2 domain second repeat present | 99.75 | |
| cd08685 | 119 | C2_RGS-like C2 domain of the Regulator Of G-Protei | 99.74 | |
| cd08393 | 125 | C2A_SLP-1_2 C2 domain first repeat present in Syna | 99.73 | |
| cd08408 | 138 | C2B_Synaptotagmin-14_16 C2 domain second repeat pr | 99.73 | |
| cd04029 | 125 | C2A_SLP-4_5 C2 domain first repeat present in Syna | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd08395 | 120 | C2C_Munc13 C2 domain third repeat in Munc13 (mamma | 99.68 | |
| cd08409 | 137 | C2B_Synaptotagmin-15 C2 domain second repeat prese | 99.67 | |
| cd08410 | 135 | C2B_Synaptotagmin-17 C2 domain second repeat prese | 99.65 | |
| cd08384 | 133 | C2B_Rabphilin_Doc2 C2 domain second repeat present | 99.64 | |
| cd08404 | 136 | C2B_Synaptotagmin-4 C2 domain second repeat presen | 99.64 | |
| KOG1028 | 421 | consensus Ca2+-dependent phospholipid-binding prot | 99.63 | |
| cd04020 | 162 | C2B_SLP_1-2-3-4 C2 domain second repeat present in | 99.62 | |
| cd08403 | 134 | C2B_Synaptotagmin-3-5-6-9-10 C2 domain second repe | 99.61 | |
| cd08402 | 136 | C2B_Synaptotagmin-1 C2 domain second repeat presen | 99.61 | |
| cd08388 | 128 | C2A_Synaptotagmin-4-11 C2A domain first repeat pre | 99.61 | |
| cd08521 | 123 | C2A_SLP C2 domain first repeat present in Synaptot | 99.6 | |
| cd08387 | 124 | C2A_Synaptotagmin-8 C2A domain first repeat presen | 99.6 | |
| cd08389 | 124 | C2A_Synaptotagmin-14_16 C2A domain first repeat pr | 99.6 | |
| cd04010 | 148 | C2B_RasA3 C2 domain second repeat present in RAS p | 99.59 | |
| cd04030 | 127 | C2C_KIAA1228 C2 domain third repeat present in unc | 99.59 | |
| cd04031 | 125 | C2A_RIM1alpha C2 domain first repeat contained in | 99.59 | |
| cd08405 | 136 | C2B_Synaptotagmin-7 C2 domain second repeat presen | 99.59 | |
| cd08385 | 124 | C2A_Synaptotagmin-1-5-6-9-10 C2A domain first repe | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| KOG1028 | 421 | consensus Ca2+-dependent phospholipid-binding prot | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.57 | |
| cd04041 | 111 | C2A_fungal C2 domain first repeat; fungal group. C | 99.55 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| cd08386 | 125 | C2A_Synaptotagmin-7 C2A domain first repeat presen | 99.53 | |
| cd04009 | 133 | C2B_Munc13-like C2 domain second repeat in Munc13 | 99.52 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| cd04039 | 108 | C2_PSD C2 domain present in Phosphatidylserine dec | 99.52 | |
| cd08682 | 126 | C2_Rab11-FIP_classI C2 domain found in Rab11-famil | 99.51 | |
| cd08688 | 110 | C2_KIAA0528-like C2 domain found in the Human KIAA | 99.51 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.51 | |
| cd08401 | 121 | C2A_RasA2_RasA3 C2 domain first repeat present in | 99.5 | |
| cd04032 | 127 | C2_Perforin C2 domain of Perforin. Perforin contai | 99.48 | |
| cd08390 | 123 | C2A_Synaptotagmin-15-17 C2A domain first repeat pr | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.47 | |
| cd08376 | 116 | C2B_MCTP_PRT C2 domain second repeat found in Mult | 99.46 | |
| cd04036 | 119 | C2_cPLA2 C2 domain present in cytosolic PhosphoLip | 99.45 | |
| cd04018 | 151 | C2C_Ferlin C2 domain third repeat in Ferlin. Ferli | 99.44 | |
| cd04025 | 123 | C2B_RasA1_RasA4 C2 domain second repeat present in | 99.44 | |
| cd00276 | 134 | C2B_Synaptotagmin C2 domain second repeat present | 99.43 | |
| cd04016 | 121 | C2_Tollip C2 domain present in Toll-interacting pr | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| cd04022 | 127 | C2A_MCTP_PRT_plant C2 domain first repeat found in | 99.42 | |
| cd08690 | 155 | C2_Freud-1 C2 domain found in 5' repressor element | 99.42 | |
| cd08686 | 118 | C2_ABR C2 domain in the Active BCR (Breakpoint clu | 99.42 | |
| cd04035 | 123 | C2A_Rabphilin_Doc2 C2 domain first repeat present | 99.42 | |
| cd04026 | 131 | C2_PKC_alpha_gamma C2 domain in Protein Kinase C ( | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.42 | |
| cd04042 | 121 | C2A_MCTP_PRT C2 domain first repeat found in Multi | 99.41 | |
| cd08379 | 126 | C2D_MCTP_PRT_plant C2 domain fourth repeat found i | 99.4 | |
| cd04019 | 150 | C2C_MCTP_PRT_plant C2 domain third repeat found in | 99.4 | |
| cd04033 | 133 | C2_NEDD4_NEDD4L C2 domain present in the Human neu | 99.4 | |
| KOG1030 | 168 | consensus Predicted Ca2+-dependent phospholipid-bi | 99.39 | |
| cd08676 | 153 | C2A_Munc13-like C2 domain first repeat in Munc13 ( | 99.38 | |
| cd08374 | 133 | C2F_Ferlin C2 domain sixth repeat in Ferlin. Ferli | 99.38 | |
| cd08375 | 136 | C2_Intersectin C2 domain present in Intersectin. A | 99.38 | |
| cd04043 | 126 | C2_Munc13_fungal C2 domain in Munc13 (mammalian un | 99.37 | |
| cd04037 | 124 | C2E_Ferlin C2 domain fifth repeat in Ferlin. Ferli | 99.36 | |
| cd04024 | 128 | C2A_Synaptotagmin-like C2 domain first repeat pres | 99.35 | |
| cd04017 | 135 | C2D_Ferlin C2 domain fourth repeat in Ferlin. Ferl | 99.35 | |
| cd08681 | 118 | C2_fungal_Inn1p-like C2 domain found in fungal Ing | 99.34 | |
| cd04054 | 121 | C2A_Rasal1_RasA4 C2 domain first repeat present in | 99.34 | |
| cd04011 | 111 | C2B_Ferlin C2 domain second repeat in Ferlin. Ferl | 99.34 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-71 Score=577.79 Aligned_cols=425 Identities=22% Similarity=0.294 Sum_probs=346.9
Q ss_pred CCCccccccccCCCCCcccccceeeccccCCCccCCccccccccccccCCCCCccccCCCCccccceeEEEEeec-CCcc
Q 004954 201 LDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEKLKDCAAYGCSEPLCKCCAGEGKINNDYGYLSSKEA-DLID 279 (722)
Q Consensus 201 ~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~l~v~l~e~-~L~~ 279 (722)
++++|+.||||+||.++|+++ |++...++. ..+.|+|.|+|| ||.|
T Consensus 148 VH~rCv~nVPslCG~DhtE~R-------------Grl~l~~~~--------------------~~~~l~v~i~ea~NLiP 194 (683)
T KOG0696|consen 148 VHHRCVENVPSLCGTDHTERR-------------GRLYLEAHI--------------------KRDVLTVTIKEAKNLIP 194 (683)
T ss_pred HHHHHhhcCCcccCCcchhhc-------------ceEEEEEEe--------------------cCceEEEEehhhccccc
Confidence 458999999999999665555 555544444 558999999999 9999
Q ss_pred ccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCCCCCCccccccccCc
Q 004954 280 LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGK 359 (722)
Q Consensus 280 ~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~~~~~d~iG~v~~~~ 359 (722)
||.||+||||||+.|+||.+.+.|+||+++|+||||+|||+|+|+ +...+.+++|.++||||||.++|||+|.+++++
T Consensus 195 MDpNGlSDPYvk~kliPD~~~~sKqKTkTik~~LNP~wNEtftf~--Lkp~DkdrRlsiEvWDWDrTsRNDFMGslSFgi 272 (683)
T KOG0696|consen 195 MDPNGLSDPYVKLKLIPDPKNESKQKTKTIKATLNPVWNETFTFK--LKPSDKDRRLSIEVWDWDRTSRNDFMGSLSFGI 272 (683)
T ss_pred cCCCCCCCcceeEEeccCCcchhhhhhhhhhhhcCccccceeEEe--cccccccceeEEEEecccccccccccceecccH
Confidence 999999999999999999999999999999999999999999999 999999999999999999999999999999999
Q ss_pred cccccccCCCcchhhhhhhHhHhhhheeee--------------eeccccCCccCCC-----------Ccce-eeCceec
Q 004954 360 ADAEEHGVATPDLLMFDNLEEECEIFHLRI--------------IHRKNRTGFEENK-----------DLPI-ILNTVIA 413 (722)
Q Consensus 360 ~~~~~e~~~~~~~l~f~~L~ee~~~~~lr~--------------i~~~~~~~~~~~~-----------~~pi-~~~~~l~ 413 (722)
.++.+++..+ |++.|.+++.++..-. .-++.+.+..+.+ .+.. ....+-.
T Consensus 273 sEl~K~p~~G----WyKlLsqeEGEyyNvp~~~~~~e~~~~lr~k~~~~~~~~~~s~p~~~~~~~~~~~~~~~~~d~i~~ 348 (683)
T KOG0696|consen 273 SELQKAPVDG----WYKLLSQEEGEYYNVPVPDEDSEDNEELRQKFERARIGPGSSKPEKKTMPTDSKFHNSSKRDRIKA 348 (683)
T ss_pred HHHhhcchhh----HHHHhhhhcCceeccCCCCchhhHHHHHHHHHhhcccCCCcCCCCCCCCCCcccCCCCCcccceee
Confidence 9999999999 7777777765542211 1111111110000 0000 0112335
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+|..+.+||+|+||+|.++..+.+.+.+|||+++++. +..+-.+.|.++|..... .|.++++..+|++.+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~k-----ppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-----PPFLVQLHSCFQTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCC-----CchHHHHHHHhhhhh
Confidence 67999999999999999999999999999999998753 233445567777665543 479999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.+|+||||+.|+-+-+....-. .+.+..+..++..|+-||-|||++|||+||||.+|||++. +|.|||+|||+
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~--eGHiKi~DFGm 496 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGM 496 (683)
T ss_pred heeeEEEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc--CCceEeeeccc
Confidence 9999999999875555443222 1788889999999999999999999999999999999996 89999999999
Q ss_pred cccc---cCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~---~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
++.. .....+++|||.|+|||++..++|+..+|+||+||+|||||.|++||.+.+..++++.|+..--..|
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP------ 570 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP------ 570 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc------
Confidence 8642 3345568999999999999999999999999999999999999999999999999998873221111
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
+..+.+.+++.+.+|...|.+|.. -.++-.||||+.
T Consensus 571 --------------------------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 571 --------------------------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred --------------------------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 122356789999999999999974 468889999975
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-55 Score=485.32 Aligned_cols=319 Identities=49% Similarity=0.763 Sum_probs=289.4
Q ss_pred CccCCCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCC
Q 004954 397 GFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476 (722)
Q Consensus 397 ~~~~~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hp 476 (722)
.+...+++.++.++.+..||.|+++||+|+||.|.+|.|..|++.||||++++.+....+...|+++|..|+.....+..
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~ 248 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY 248 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 45567788999999999999999999999999999999999999999999999999999999999999999976667778
Q ss_pred ceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 477 nIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
|||+++++|...+|+|||+|.+..+|+++++.++..+ +++..++.|+.||+.||.+||+.||||+||||+||||..
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~G----lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRG----LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD 324 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc
Confidence 9999999999999999999999999999999887765 999999999999999999999999999999999999998
Q ss_pred cCCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
.....|||+|||+|++.....+.+++++.|+|||+++|.+|+.++||||||||+.||++|.+.|++.+..+++..|++.+
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred CCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 77889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcHHHHhhhhhhhhhhcc-cccchhhhhcc----------------ccccccCC-ccchhhhhcc-cCcHHHHHHHHH
Q 004954 637 GPIDLEMLMQGQEIYKYFTK-EYDLYYINEET----------------NQLEYIIP-EESSLEHHLQ-FSDAFFIDFVRT 697 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----------------~~~~~~ip-~~~~l~~~~~-~~~~~l~dLL~~ 697 (722)
|.+|..++..+....+|++. .....+..... .......| ....+..... ..+..|.+||++
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 99999999999999999988 33322222211 12444455 5555555555 566789999999
Q ss_pred hcccCCCCCcCHHHHHhCCCCC
Q 004954 698 LLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 698 mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
||.+||.+|+|+.++|+||||.
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred HhccCchhcCCHHHHhcCcccc
Confidence 9999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=423.82 Aligned_cols=252 Identities=32% Similarity=0.546 Sum_probs=224.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~----~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
..+|...++||+|||++||.+++..+|+.||+|++.+ .....++..+|++|.+.|+ |||||+++++|++.
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~------HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK------HPNIVQFYHFFEDS 90 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC------CCcEEeeeeEeecC
Confidence 3789999999999999999999999999999999976 3455678889999999886 78999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+++|||+|+|. ++|..+++... .+++.+++.+++||+.||.|||+.+|+|||||..|+++++ +.+|||+||
T Consensus 91 ~nVYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~--~~~VKIgDF 162 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE--NMNVKIGDF 162 (592)
T ss_pred CceEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC--cCcEEeccc
Confidence 99999999997 56666655222 3999999999999999999999999999999999999996 889999999
Q ss_pred CCccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|+|.... ....+.||||.|.|||++.....+..+||||+||+||.||.|++||...+..+.+.+|.
T Consensus 163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik----------- 231 (592)
T KOG0575|consen 163 GLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK----------- 231 (592)
T ss_pred ceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-----------
Confidence 9998876 45667899999999999999999999999999999999999999999999999998885
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~~ 722 (722)
..+|.+|... +.+.++||++||+.||.+|||+++||.|+||++.|
T Consensus 232 ------------------------~~~Y~~P~~l---------s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 232 ------------------------LNEYSMPSHL---------SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred ------------------------hcCccccccc---------CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 2245566522 35578999999999999999999999999997664
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=413.24 Aligned_cols=259 Identities=31% Similarity=0.503 Sum_probs=212.3
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--------hhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--------FFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--------~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
..+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++... ......+|+++|++|+ ||+||++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~------HP~IV~~ 241 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS------HPNIVRI 241 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC------CCCEEEE
Confidence 3467789999999999999999999999999999999976431 2234578999999997 6899999
Q ss_pred EEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-CC
Q 004954 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QR 559 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~~ 559 (722)
+++|...+..||||||++| .|.+.+..+.. +.+...+.+++||+.||.|||++||+||||||+|||+..+ .+
T Consensus 242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 242 KDFFEVPDSSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eeeeecCCceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc
Confidence 9999999999999999985 68887765443 7788889999999999999999999999999999999864 46
Q ss_pred CeEEEEecCCcccccCC--ccccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCChHHH-HHHHHH
Q 004954 560 CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARII 633 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~---~s~ksDIWSLGviL~elltG~~PF~~~~~~e-~l~~i~ 633 (722)
+.+||+|||+|+..+.. ..+.||||.|.|||++.+.. +..++|||||||+||-+|+|.+||.+..... ...+|.
T Consensus 316 ~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~ 395 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL 395 (475)
T ss_pred eEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence 89999999999988543 56689999999999998765 3358899999999999999999997754433 444443
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
+..=.+- .+... ..+++.++||.+||..||++|||++|+|
T Consensus 396 ~G~y~f~---------------------------------p~~w~-------~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 396 KGRYAFG---------------------------------PLQWD-------RISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred cCccccc---------------------------------Chhhh-------hhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 2111100 00011 1235678999999999999999999999
Q ss_pred hCCCCCC
Q 004954 714 DHPWLQH 720 (722)
Q Consensus 714 ~HPwf~~ 720 (722)
+||||+.
T Consensus 436 ~hpW~~~ 442 (475)
T KOG0615|consen 436 NHPWFKD 442 (475)
T ss_pred cChhhhc
Confidence 9999974
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=418.51 Aligned_cols=283 Identities=32% Similarity=0.524 Sum_probs=242.3
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhh--HhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF--DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~--~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.+.+||+++++||.|+||.||+|+.+.+|..||||.+++.-... -.-++|++.|++++ .||||+++.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln-----~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----PHPNIIKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC-----CCCcchhhHHHhhcc
Confidence 34689999999999999999999999999999999987642222 23457888888886 378999999999998
Q ss_pred C-eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 E-HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~-~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+ ++++|||||..+|+++++.+. ..|++..++.|+.||++||+|+|++|+.||||||+||||.. ...|||+||
T Consensus 82 ~~~L~fVfE~Md~NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~--~~~iKiaDF 154 (538)
T KOG0661|consen 82 DRILYFVFEFMDCNLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG--NDVIKIADF 154 (538)
T ss_pred CceEeeeHHhhhhhHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc--cceeEeccc
Confidence 8 999999999999999998663 34999999999999999999999999999999999999995 778999999
Q ss_pred CCcccccC--CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQTD--NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|+|+.... +.+.++.|++|+|||+++. ..|+.++||||+|||++|+.+-++.|+|.+..+.+.+|...+|.+..+.|
T Consensus 155 GLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 155 GLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 99987654 4566899999999999875 45899999999999999999999999999999999999999999998888
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCC--ccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIP--EESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip--~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
..+.++..-.. ..+| ....+.+......+++.+||.+||.|||.+||||.|+|+|||||.+
T Consensus 235 ~eg~~La~~mn----------------f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 235 PEGYNLASAMN----------------FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hhHHHHHHHhc----------------cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 77654433221 1222 2234445555567889999999999999999999999999999865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=395.56 Aligned_cols=253 Identities=31% Similarity=0.471 Sum_probs=214.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEee--cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~--~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
...+.+.++.||+|+.|+||+++|+.+++.+|+|++. .+.....++.+|+++++..+ ||+||.+|++|....
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~------spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ------SPYIVGFYGAFYSNG 150 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC------CCCeeeEeEEEEeCC
Confidence 3456778889999999999999999999999999994 45566788999999999885 679999999999999
Q ss_pred -eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEe
Q 004954 490 -HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 490 -~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.|+||||.| +|..+++..+ .+++..+..|++++++||.|||+ .+||||||||+||||++ .|+|||+|
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs--kGeVKicD 222 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS--KGEVKICD 222 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc--CCCEEecc
Confidence 59999999986 5555554332 28999999999999999999995 89999999999999997 89999999
Q ss_pred cCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----hHHHHHHHHHhhcCCCc
Q 004954 567 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-----AVVMILARIIGMLGPID 640 (722)
Q Consensus 567 FGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~-----~~~e~l~~i~~~lg~~~ 640 (722)
||.+....+. ..+++||..|||||.+.+..|+.++||||||++++|+.+|+.||+.. ...+++..|+.. ++|
T Consensus 223 FGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~--ppP 300 (364)
T KOG0581|consen 223 FGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE--PPP 300 (364)
T ss_pred ccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC--CCC
Confidence 9999876554 46789999999999999999999999999999999999999999774 444555555411 111
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+|.. ..+++|++||..||++||.+|||+.|+|+|||+++
T Consensus 301 --------------------------------~lP~~--------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 301 --------------------------------RLPEG--------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred --------------------------------CCCcc--------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 11211 24578999999999999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=377.05 Aligned_cols=278 Identities=32% Similarity=0.501 Sum_probs=240.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.||..+++||+|.||.||+|+|..+|+.||||.++.... ......+|++.|++++ |+||+.++++|-+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~------h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK------HPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc------CcchhhhhhhccCCCc
Confidence 578899999999999999999999999999999986432 2456789999999997 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+.||+|||+.+|...++.... .++...+..++.++++||+|||++.|+||||||.|+||++ ++.+||+|||++
T Consensus 76 l~lVfEfm~tdLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~--~g~lKiADFGLA 148 (318)
T KOG0659|consen 76 LSLVFEFMPTDLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS--DGQLKIADFGLA 148 (318)
T ss_pred eEEEEEeccccHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC--CCcEEeecccch
Confidence 999999999999988875543 3999999999999999999999999999999999999997 999999999999
Q ss_pred ccccCCcc---ccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDNLC---LYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~~~---~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+....+.. ..+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|++.+.-+++..|.+.+|.+..+.|+.
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 98775433 34679999999999886 599999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...+.+|..-. ..| ...+...+.....+..|||.+||..||.+|+|+.|+|+||||+.
T Consensus 229 ~~~lpdY~~~~---------------~~P-~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 229 MTSLPDYVKIQ---------------QFP-KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccccccHHHHh---------------cCC-CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 87776664311 011 11222233344566799999999999999999999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=384.99 Aligned_cols=279 Identities=27% Similarity=0.441 Sum_probs=236.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|..+.++|+|+||.||+++++.||+.||||.+..+.+ .....++|+++|+.++ |+|+|.++.+|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk------H~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK------HENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc------cchHHHHHHHHHhcce
Confidence 578899999999999999999999999999999975432 3456789999999997 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+++|+|||..++++.+...... ++...+..+++|++.|+.|+|++++|||||||+||||+. .+.+||+|||+|
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G-----~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~--~gvvKLCDFGFA 148 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNG-----VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ--NGVVKLCDFGFA 148 (396)
T ss_pred eEEEeeecchHHHHHHHhccCC-----CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec--CCcEEeccchhh
Confidence 9999999999988888765543 889999999999999999999999999999999999995 899999999999
Q ss_pred ccccC---CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTD---NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+.... ..+.++.|++|+|||.+.| ..|+.++||||+||++.||++|++.|++.+..+++..|++.+|++.+....
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~- 227 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS- 227 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH-
Confidence 87763 3445788999999999998 789999999999999999999999999999999999999999987765321
Q ss_pred hhhhhhhhcccccchhhhhcccccccc-CCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYI-IPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+ | ..+....++... ++...+++..+......+.||+++||+.||.+|++-+|+|.||+|+
T Consensus 228 ---i---F-------~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 228 ---I---F-------SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ---H---h-------ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1 1 111111222222 2223455555555666789999999999999999999999999994
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=392.75 Aligned_cols=282 Identities=29% Similarity=0.474 Sum_probs=239.4
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
...-.+.|+.+++||+|+||.||+|++..+|+.||+|.++.+. ....-..+|+.||++|. ||||+++.+..
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~------HpNIikL~eiv 185 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD------HPNIIKLEEIV 185 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC------CCcccceeeEE
Confidence 3444677999999999999999999999999999999987643 34456779999999996 78999999999
Q ss_pred Eec--CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 486 YHL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 486 ~~~--~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
... ..+|+|+|||..+|..++.... ..|++.++..+++||+.||.|+|++||+|||||.+||||+. +|.+|
T Consensus 186 t~~~~~siYlVFeYMdhDL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn--~G~LK 258 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDHDLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDN--NGVLK 258 (560)
T ss_pred EecCCceEEEEEecccchhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcC--CCCEE
Confidence 877 6899999999999888776433 23999999999999999999999999999999999999995 89999
Q ss_pred EEecCCcccccCC----ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 564 IIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 564 L~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|+|||+|+++... .+..+-|.+|+|||.++|. .|+.++|+||.||||.||++|++.|++.+..+++..|.++.|.
T Consensus 259 iaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 259 IADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred eccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC
Confidence 9999999976543 4456779999999999986 5999999999999999999999999999999999999999999
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
+..+.|. ...+.. ........+....+.......++..++|+..||..||.+|.||.++|+|+||
T Consensus 339 P~e~~W~-~~kLP~--------------~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 339 PTEDYWP-VSKLPH--------------ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred CChhccc-cccCCc--------------ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 9988776 222211 0112222333445555566778889999999999999999999999999999
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=379.57 Aligned_cols=253 Identities=29% Similarity=0.464 Sum_probs=216.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
-.+.|+++++||+|+||+|++++.+.+++.+|+|++++.. ...+....|..||..++ ||+||+++..|++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~------hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK------HPFIVKLIYSFQT 96 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC------CCcEeeeEEeccc
Confidence 3578999999999999999999999999999999998643 34567788888888864 7899999999999
Q ss_pred cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 488 ~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
.+++|+|+||+.|+-+-.....+ ..|++..++.++..|+.||.|||++|||||||||+|||++. .|.++|+||
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~--~GHi~LtDF 169 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDE--QGHIKLTDF 169 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecC--CCcEEEecc
Confidence 99999999999875333333222 22999999999999999999999999999999999999996 899999999
Q ss_pred CCcccc---cCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~---~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|+++.. +....+++||+.|||||++.+.+|+..+|+||||+++|+|++|.+||.+.+...+..+|.+...+.+
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~---- 245 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP---- 245 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC----
Confidence 999743 3345568999999999999999999999999999999999999999999999888888864321111
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc----CHHHHHhCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP----TAREALDHPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp----Ta~ElL~HPwf~~ 720 (722)
+...+.+.++||+++|+.||++|. .+.++-+||||..
T Consensus 246 ---------------------------------------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 246 ---------------------------------------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ---------------------------------------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 112356789999999999999995 7999999999975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=377.10 Aligned_cols=280 Identities=34% Similarity=0.583 Sum_probs=236.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEee---cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~---~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~- 487 (722)
+..+|..++.||+|+||.|+.+.++.+|+.||||.+. .......+..+|+++|++++ |+||+.+++++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~------HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR------HENIIGLLDIFRPP 93 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc------CCCcceEEeecccc
Confidence 3566777899999999999999999999999999876 24455678889999999996 6799999999986
Q ss_pred ----cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 488 ----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 488 ----~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
-+.+|+|+|+|+.+|...++..+. ++...++.+++||+.||+|+|+.+|+||||||.|+|++. ++.+|
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~--~c~lK 165 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA--DCDLK 165 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc--CCCEE
Confidence 256999999999888888875543 889999999999999999999999999999999999996 89999
Q ss_pred EEecCCccccc-----CCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 564 IIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 564 L~DFGls~~~~-----~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|+|||+|+... ...+.++.|.+|+|||++.. ..|+.++||||+||||.||++|++.|++.+...++..|+..+|
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999998873 33466888999999999864 5799999999999999999999999999999999999999999
Q ss_pred CCcHHHHhhhh--hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 638 PIDLEMLMQGQ--EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.++.+.+.... ....|+... ...| ...++..++..++...+||.+||..||.+|+|++|+|+|
T Consensus 246 tP~~e~l~~i~s~~ar~yi~sl--------------p~~p-~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSL--------------PQIP-KQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhC--------------CCCC-CCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 99887765533 122222210 1111 233455566778889999999999999999999999999
Q ss_pred CCCCC
Q 004954 716 PWLQH 720 (722)
Q Consensus 716 Pwf~~ 720 (722)
|||..
T Consensus 311 PYl~~ 315 (359)
T KOG0660|consen 311 PYLAP 315 (359)
T ss_pred hhhhh
Confidence 99964
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=381.04 Aligned_cols=314 Identities=35% Similarity=0.608 Sum_probs=260.3
Q ss_pred CCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 401 ~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
.+.+-...++.+.+||.|..+||+|+||.|..+.|..++..||||+++.-....+..+-|+++|+++....+..---+++
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 34456788999999999999999999999999999999999999999987778888899999999998877666668899
Q ss_pred EEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc---
Q 004954 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--- 557 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~--- 557 (722)
+.++|...+|.|||+|.++-++.++++.+... +++...++.|++||+++++|||+.+++|-||||+|||+.+.
T Consensus 156 m~~wFdyrghiCivfellG~S~~dFlk~N~y~----~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELLGLSTFDFLKENNYI----PFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEeccChhHHHHhccCCcc----ccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 99999999999999999998999999876544 39999999999999999999999999999999999998531
Q ss_pred ---------------CCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004954 558 ---------------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (722)
Q Consensus 558 ---------------~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~ 622 (722)
....|+|+|||.|.+........+.|..|+|||++++.+|+.+.||||+||||+|+.||...|+.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 13469999999999988888888999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhc-cccccccCCccchhhhhcc---cCcHHHHHHHHHh
Q 004954 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEE-TNQLEYIIPEESSLEHHLQ---FSDAFFIDFVRTL 698 (722)
Q Consensus 623 ~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ip~~~~l~~~~~---~~~~~l~dLL~~m 698 (722)
.+..+.++.|...+||+|..|+.... ..+||... .....+.. .....+.......+..... .....|.|||++|
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 99999999999999999999987764 34444433 11111111 1111111111111111111 1124589999999
Q ss_pred cccCCCCCcCHHHHHhCCCCCC
Q 004954 699 LEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 699 L~~dP~kRpTa~ElL~HPwf~~ 720 (722)
|..||.+|+|+.|+|.||||..
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HccCccccccHHHHhcCHHhhc
Confidence 9999999999999999999975
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.41 Aligned_cols=285 Identities=26% Similarity=0.401 Sum_probs=236.1
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
+..-.+.|+.++.|++|+||.||+|+|+.+++.||+|.++.++. +.-..++|+.+|..++ |||||.+-.+.
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~------H~NIV~vkEVV 144 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR------HPNIVEVKEVV 144 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC------CCCeeeeEEEE
Confidence 34445789999999999999999999999999999999986542 2334678999998886 68999999887
Q ss_pred Ee--cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 486 YH--LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 486 ~~--~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
.. .+.+|||||||+.+|..++.... ..|...++..+..|++.||+|||.+.|+||||||+|+|++. .|.+|
T Consensus 145 vG~~~d~iy~VMe~~EhDLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~--~G~lK 217 (419)
T KOG0663|consen 145 VGSNMDKIYIVMEYVEHDLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSH--KGILK 217 (419)
T ss_pred eccccceeeeeHHHHHhhHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeecc--CCcEE
Confidence 74 46899999999999988887654 23999999999999999999999999999999999999995 89999
Q ss_pred EEecCCcccccCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|+|||+|+.++.+ .+..+-|.+|+|||.+++.+ |+.++|+||+|||+.||+++++.|++.+..+++.+|.+.+|.+
T Consensus 218 iaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP 297 (419)
T KOG0663|consen 218 IADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP 297 (419)
T ss_pred ecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence 9999999999887 45567799999999999865 9999999999999999999999999999999999999999998
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccC--cHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS--DAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~--~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
....|+.-.....+-.-+.. ......+...+... ++.-.+||+++|..||.+|.||.|+|+|+|
T Consensus 298 te~iwpg~~~lp~~k~~~f~--------------~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFS--------------EHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ccccCCCccccchhhccccC--------------CCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 88777664433221100000 00112222222222 256679999999999999999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|..
T Consensus 364 F~e 366 (419)
T KOG0663|consen 364 FRE 366 (419)
T ss_pred ccc
Confidence 975
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=396.57 Aligned_cols=299 Identities=29% Similarity=0.488 Sum_probs=235.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-CeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-EHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~-~~l 491 (722)
.++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+++.+...|++|++++++|... .+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 5889999999999999999999999999999999976544455667899999999988777888999999999865 589
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccC------------
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQ------------ 558 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~------------ 558 (722)
++|||+++++|++++.... .+++..++.|+.||+.||.|||+ .|||||||||+|||++..+
T Consensus 208 ~iv~~~~g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEeccCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 9999999888988876432 28899999999999999999998 5999999999999998532
Q ss_pred --CCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 559 --RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 559 --~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
.+.+||+|||.+..........++|+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+...+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 135999999998766655666789999999999999999999999999999999999999999988889999999999
Q ss_pred CCCcHHHHhhhh--hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 637 GPIDLEMLMQGQ--EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 637 g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
|.+|.++..... ....++......... .....+... .....+. ....++.+.+||.+||++||.+||||+|+|+
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~--~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPC-TDPKHLARI-ARARPVR--EVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhccccccc-CCHHHHHhh-hcccchh--hhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 999877654321 111121111100000 000000000 0000000 0112467889999999999999999999999
Q ss_pred CCCCCCC
Q 004954 715 HPWLQHP 721 (722)
Q Consensus 715 HPwf~~~ 721 (722)
||||++-
T Consensus 438 Hp~~~~~ 444 (467)
T PTZ00284 438 HPYVLKY 444 (467)
T ss_pred Ccccccc
Confidence 9999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=385.96 Aligned_cols=251 Identities=30% Similarity=0.487 Sum_probs=220.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
..+|.+.+.||.|+|++|++|+++.+++.||||++.+.- ...+-..+|..+|.+|. .||.|++||..|++.
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-----~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-----GHPGIVKLYFTFQDE 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-----CCCCeEEEEEEeecc
Confidence 367999999999999999999999999999999986532 22345667888999887 589999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
..+|+|+||++ |.|+++++.... |.+..++.++.||+.||+|||++|||||||||+|||++. ++.++|+||
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~--dmhikITDF 218 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDK--DGHIKITDF 218 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcC--CCcEEEeec
Confidence 99999999997 689999987643 999999999999999999999999999999999999996 999999999
Q ss_pred CCcccccCC----------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHH
Q 004954 568 GSSCFQTDN----------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631 (722)
Q Consensus 568 Gls~~~~~~----------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~ 631 (722)
|.|+..... .+.++||-.|.+||++.....+..+|||+||||||+|+.|.+||.+.+..-++++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk 298 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK 298 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 988653321 2458999999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 632 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
|+++ .+.+|+. .++.+.+||+++|..||.+|+|+++
T Consensus 299 I~~l-----------------------------------~y~fp~~---------fp~~a~dLv~KLLv~dp~~Rlt~~q 334 (604)
T KOG0592|consen 299 IQAL-----------------------------------DYEFPEG---------FPEDARDLIKKLLVRDPSDRLTSQQ 334 (604)
T ss_pred HHHh-----------------------------------cccCCCC---------CCHHHHHHHHHHHccCccccccHHH
Confidence 8743 3444443 2366889999999999999999999
Q ss_pred HHhCCCCCC
Q 004954 712 ALDHPWLQH 720 (722)
Q Consensus 712 lL~HPwf~~ 720 (722)
|-+||||..
T Consensus 335 Ik~HpFF~~ 343 (604)
T KOG0592|consen 335 IKAHPFFEG 343 (604)
T ss_pred HhhCccccc
Confidence 999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.78 Aligned_cols=250 Identities=26% Similarity=0.488 Sum_probs=222.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
-++|++++.||.|+||+|.+++++.+|..+|+|++.+.. ...+...+|.++|+.+. ||+++++++.|.+.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~------~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS------HPFLVKLYGTFKDN 116 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc------CceeEEEEEeeccC
Confidence 367999999999999999999999999999999998653 34566778888888875 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+.++|||||++| .|..+++..++ |++..++.++.||+.||+|||+++|++|||||+|||++. +|.+||+||
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~--~G~iKitDF 188 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ--NGHIKITDF 188 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc--CCcEEEEec
Confidence 999999999985 57777776544 999999999999999999999999999999999999996 899999999
Q ss_pred CCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 568 Gls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
|+|+.......+.||||.|+|||++..++|..++|+|||||++|||+.|.+||.+.++..++.+|...--
T Consensus 189 GFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v---------- 258 (355)
T KOG0616|consen 189 GFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV---------- 258 (355)
T ss_pred cceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc----------
Confidence 9999999988889999999999999999999999999999999999999999999999999988874322
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC-----cCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR-----PTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR-----pTa~ElL~HPwf~~ 720 (722)
.+|. ..+..+++||+++|+.|-.+| .-..++-.||||+.
T Consensus 259 -------------------------~fP~---------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 259 -------------------------KFPS---------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred -------------------------cCCc---------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 2222 234668999999999999999 35789999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=374.32 Aligned_cols=319 Identities=35% Similarity=0.604 Sum_probs=273.6
Q ss_pred cccCCccCCCCcceeeCceec-CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccC
Q 004954 393 KNRTGFEENKDLPIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471 (722)
Q Consensus 393 ~~~~~~~~~~~~pi~~~~~l~-~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~ 471 (722)
+....|..++++|+.+++++. +||-+.++||.|.|++||+|.|..+.+.||+|+.+......+..+.|+++|+.++...
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence 445677888999999999998 9999999999999999999999999999999999998888889999999999999876
Q ss_pred --CCCCCceeEEEEEEEec----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCcc
Q 004954 472 --PADEHHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIH 544 (722)
Q Consensus 472 --~~~hpnIv~l~~~f~~~----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvH 544 (722)
.....+||++++.|... .|+|||+|+++.+|+.+++.....+ +++..++.|++||+.||.|||. +||||
T Consensus 136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrG----lpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRG----LPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred CCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCC----CcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 44566999999999854 5999999999999999999876655 9999999999999999999995 69999
Q ss_pred ccCCCCceEEcc--------------------------------------------------------------------
Q 004954 545 CDLKPENILIKS-------------------------------------------------------------------- 556 (722)
Q Consensus 545 rDLKp~NILl~~-------------------------------------------------------------------- 556 (722)
-||||+|||+..
T Consensus 212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~ 291 (590)
T KOG1290|consen 212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL 291 (590)
T ss_pred cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence 999999999820
Q ss_pred ----------------------------------------------c---------------------------------
Q 004954 557 ----------------------------------------------Y--------------------------------- 557 (722)
Q Consensus 557 ----------------------------------------------~--------------------------------- 557 (722)
.
T Consensus 292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~ 371 (590)
T KOG1290|consen 292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP 371 (590)
T ss_pred ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence 0
Q ss_pred -----------------CCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004954 558 -----------------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620 (722)
Q Consensus 558 -----------------~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF 620 (722)
.+..+||+|||-|++.....+.-++|+.|+|||++.+.+|+..+||||++|++|||+||..+|
T Consensus 372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLF 451 (590)
T KOG1290|consen 372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLF 451 (590)
T ss_pred cccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceee
Confidence 011489999999999998888889999999999999999999999999999999999999999
Q ss_pred CC------ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccC---cHHH
Q 004954 621 PN------DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS---DAFF 691 (722)
Q Consensus 621 ~~------~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~---~~~l 691 (722)
.. ...++.++.|++++|.+|......+.....||++....-+..... .+ |-..-|...+... ...|
T Consensus 452 ePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK----~W-pL~~VL~eKY~~s~e~A~~f 526 (590)
T KOG1290|consen 452 EPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLK----PW-PLYEVLIEKYEWSEEDAQQF 526 (590)
T ss_pred cCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccC----CC-cHHHHHHHHhCCCHHHHHHH
Confidence 53 346789999999999999999999999999999887766544321 11 1111122222222 3468
Q ss_pred HHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 692 IDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 692 ~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+||.-||+.+|++||||.++|+||||..
T Consensus 527 sdFL~PmLef~PeKR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 527 SDFLSPMLEFDPEKRPTAAQCLKHPWLNP 555 (590)
T ss_pred HHHHHHHHhcCccccccHHHHhcCccccC
Confidence 99999999999999999999999999973
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.98 Aligned_cols=278 Identities=28% Similarity=0.406 Sum_probs=224.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.++||.|+||+||+|++..+++.||+|+++... .......+|+.+++.++ ||||+++++++...+..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK------HANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC------CCCEeeEEEEEcCCCeE
Confidence 57999999999999999999999999999999987532 22345678888888775 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~DfG~~~ 151 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE--KGELKLADFGLAR 151 (288)
T ss_pred EEEEeCCCcCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEECcCccee
Confidence 99999999988887764322 2788999999999999999999999999999999999986 7889999999986
Q ss_pred cccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred eccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 54322 223467899999999876 56899999999999999999999999999999999999999998888777654
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.....+..-..+. .....+.......+.++++||++||++||.+|||++|+|+||||
T Consensus 232 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYLFPQ--------------YRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccccCc--------------cCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 3222221100000 00011111222345778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=362.17 Aligned_cols=280 Identities=27% Similarity=0.490 Sum_probs=222.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++.+.||+|+||+||++++..+++.+|+|+++... .......+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK------QENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC------CccccchhhhEecCCE
Confidence 47999999999999999999999999999999987542 23345677888887775 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+.+++++.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~ 147 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH--NDVLKLCDFGFA 147 (287)
T ss_pred EEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEeeccCc
Confidence 99999999988777665322 23889999999999999999999999999999999999985 788999999998
Q ss_pred ccccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||++.+..+.+..+....++++.+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 765432 2235689999999999998999999999999999999999999999888888888888888888766543
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
......+.. . ...................+..+.+||++||+.||++|||++|+|+||||
T Consensus 228 ~~~~~~~~~-----~-------~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 228 FYSNPRFHG-----L-------RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhccchhcc-----c-------ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 211100000 0 00000000000111122345779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=377.05 Aligned_cols=255 Identities=32% Similarity=0.507 Sum_probs=218.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----h--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----K--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
...++|.+.+.||+|+||+|++|.+..+|+.||+|++.+. . .....+.+|+.+++.+++ ||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~-----HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRS-----HPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhcc-----CCCEeEEEEE
Confidence 4568999999999999999999999999999999987653 1 234556689999998873 6799999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+....++++||||+.| .|++.+.... .+.+..++.+++||+.|++|||++||+||||||+|||++.+. +.+|
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~K 161 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLK 161 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEE
Confidence 9999999999999985 8888887632 288999999999999999999999999999999999999732 8999
Q ss_pred EEecCCcccc---cCCccccccCCcccCchhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 564 IIDLGSSCFQ---TDNLCLYVQSRSYRAPEVIIGLP-YD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 564 L~DFGls~~~---~~~~~~~~gt~~y~APE~l~~~~-~s-~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|+|||++... .......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...++..|...
T Consensus 162 l~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--- 238 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--- 238 (370)
T ss_pred EeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC---
Confidence 9999999876 34567789999999999999988 86 7899999999999999999999997777777665421
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
...+|.... ++++++||++||..||.+|+|+.++++||||
T Consensus 239 --------------------------------~~~~p~~~~--------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 239 --------------------------------EFKIPSYLL--------SPEARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred --------------------------------CccCCCCcC--------CHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 222332210 4668899999999999999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 279 ~~ 280 (370)
T KOG0583|consen 279 QK 280 (370)
T ss_pred cc
Confidence 86
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=365.33 Aligned_cols=280 Identities=32% Similarity=0.510 Sum_probs=228.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC----
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---- 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~---- 489 (722)
-.|.-.+++|+|+||.||+|+...+++.||||.+-.++.. -.+|+++|+.+ +|||||++..+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l------~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKL------DHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhc------CCcCeeeEEEEEEecCCCch
Confidence 3588899999999999999999999999999998777643 34788999855 5889999999998542
Q ss_pred -eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 -HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 -~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+.+|||||+.+|..+++..-. ....++.-.++.+..||++||+|||+.||+||||||.|+||+. .++.+||+|||
T Consensus 95 ~~lnlVleymP~tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~-~tg~LKicDFG 171 (364)
T KOG0658|consen 95 VYLNLVLEYMPETLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP-DTGVLKICDFG 171 (364)
T ss_pred hHHHHHHHhchHHHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC-CCCeEEeccCC
Confidence 4678999999999999886422 1223888889999999999999999999999999999999997 67999999999
Q ss_pred CcccccC--CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~~--~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
+|+.... +...+.-|+.|+|||.+.|. .|+.++||||.||++.||+-|++.|++.+..+++..|++.+|.++.+.+.
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 9987543 34556779999999999986 59999999999999999999999999999999999999999999988776
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..+....-+ . ...+.......-.....++++.+|+.++|+.+|.+|.++.|+|.||||..
T Consensus 252 ~mn~~y~~~--------------~-~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 252 SMNPNYTEF--------------K-FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred hcCcccccc--------------c-CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 543221100 0 00000000000122345688999999999999999999999999999963
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=381.95 Aligned_cols=316 Identities=34% Similarity=0.593 Sum_probs=273.3
Q ss_pred CCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 401 ~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
.+++.+.+++++..||.|....|+|-||+|..|.|..-|..||||||.++......-+.|++||+.|+...+-+-.|+++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 35678899999999999999999999999999999999999999999998888888899999999999988778889999
Q ss_pred EEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC
Q 004954 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~ 560 (722)
++..|.+.+|+|||+|.+.-+|.++++...... .|.+..++.++.||.-||..|..+||+|.||||+||||+. ...
T Consensus 499 l~r~F~hknHLClVFE~LslNLRevLKKyG~nv---GL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE-~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNV---GLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE-SKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhhhchHHHHHHHhCccc---ceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc-Ccc
Confidence 999999999999999999999999998765543 3889999999999999999999999999999999999996 567
Q ss_pred eEEEEecCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 561 EIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
.+||||||.|.....+ .+.+.-+..|+|||+++|.+|+...|+||+||+||||.||+..|++.+...++.-++.+.|++
T Consensus 575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 8999999999887655 555677888999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccc-------cccccCCccchhhhhccc---C-------cHHHHHHHHHhcccC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETN-------QLEYIIPEESSLEHHLQF---S-------DAFFIDFVRTLLEIN 702 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ip~~~~l~~~~~~---~-------~~~l~dLL~~mL~~d 702 (722)
|..|+..++...+.|+.....++...... .+....|.. .+...+.. . -..|++||.+||..|
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtk-dl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTK-DLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcch-hHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 99999999999999888776655332211 111112211 11111110 1 136899999999999
Q ss_pred CCCCcCHHHHHhCCCCCCC
Q 004954 703 PQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 703 P~kRpTa~ElL~HPwf~~~ 721 (722)
|++|.|..++|+||||+.+
T Consensus 734 P~KRit~nqAL~HpFi~~k 752 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITEK 752 (752)
T ss_pred hhhcCCHHHHhcCCcccCC
Confidence 9999999999999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=363.97 Aligned_cols=283 Identities=25% Similarity=0.395 Sum_probs=218.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.++|++.+.||+|+||+||+|++..+++.||||+++... .......+|+.+++.++ ||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK------HANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC------CCCcCeEEEEEecCCe
Confidence 468999999999999999999999999999999987532 22235667888888774 7899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+.+++.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~ 150 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD--TGELKLADFGLA 150 (303)
T ss_pred EEEEEECCCcCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECCCCcc
Confidence 99999999999888876432 22888999999999999999999999999999999999985 788999999998
Q ss_pred ccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~-~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..+.+..+...++.+....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred eeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 654322 2335678999999998764 5889999999999999999999999874 4556677777777766655554
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.......+..... ....|......-........+.+||++||+.||++|||+.|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 231 GVHSLPHFKPERF------------TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred chhhccccccccc------------cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 4332211111000 00001000000000112356889999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=363.35 Aligned_cols=255 Identities=30% Similarity=0.486 Sum_probs=211.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+. +...+....|+++|+.++ |||||+++++.+..
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~------H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK------HPNIVRLLDCIEDD 81 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC------CcceeeEEEEEecC
Confidence 357899999999999999999999999999999988654 345567789999999997 78999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-CC---CeEE
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QR---CEIK 563 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~~---~~vk 563 (722)
+.+|+|||||. |+|.++++.... +++..++.++.||+.||++||+++||||||||.||||+.. .. ..+|
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 99999999998 567777765542 8999999999999999999999999999999999999863 22 5799
Q ss_pred EEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
|+|||+|+..... ..+.+|+|.|||||++..+.|+.|+|+||+|+|+|+|++|+.||...+..+++..+.+.-.
T Consensus 156 IADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~---- 231 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE---- 231 (429)
T ss_pred ecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc----
Confidence 9999999987654 5568999999999999999999999999999999999999999999998888875542211
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.+|..... ......+|+...|+.||..|.+..+-+.|+++.
T Consensus 232 -------------------------------~~~~~~~~------~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~ 272 (429)
T KOG0595|consen 232 -------------------------------IVPVLPAE------LSNPLRELLISLLQRNPKDRISFEDFFDHPFLA 272 (429)
T ss_pred -------------------------------ccCchhhh------ccCchhhhhhHHHhcCccccCchHHhhhhhhcc
Confidence 11110000 011244777778888888888888888887764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=385.07 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=220.8
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.+-.++|+++++||+|.||+|+++..+.+++.+|||+++++ ++..+..+.|.+|+...+ .||.+++++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-----~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-----RHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-----cCCeEeeccccc
Confidence 34457899999999999999999999999999999999975 355677888999998887 589999999999
Q ss_pred EecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 486 ~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
++.+++|+||||+.|+. ++...+ ...|++.+++.++..++.||+|||++||||||||.+|||++. +|.+||+
T Consensus 439 QT~~~l~fvmey~~Ggd--m~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~--eGh~kiA 510 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGD--LMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT--EGHVKIA 510 (694)
T ss_pred ccCCeEEEEEEecCCCc--EEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc--cCcEEec
Confidence 99999999999999875 222211 123999999999999999999999999999999999999996 8999999
Q ss_pred ecCCccc---ccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 566 DLGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 566 DFGls~~---~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|||+++. .++...++||||.|+|||++.+..|+.++|+|||||+|||||.|+.||++++.+++...|+..-
T Consensus 511 DFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~------ 584 (694)
T KOG0694|consen 511 DFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE------ 584 (694)
T ss_pred ccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------
Confidence 9999975 4556778999999999999999999999999999999999999999999999999998886211
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPW 717 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPw 717 (722)
...| ...+.+..++|+++|..||++|.- +.+|.+|||
T Consensus 585 -----------------------------~~yP---------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 585 -----------------------------VRYP---------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF 626 (694)
T ss_pred -----------------------------CCCC---------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence 1111 233467889999999999999985 688999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 627 Fr~ 629 (694)
T KOG0694|consen 627 FRS 629 (694)
T ss_pred ccc
Confidence 986
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.26 Aligned_cols=284 Identities=32% Similarity=0.488 Sum_probs=236.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC-
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~- 489 (722)
..|..+++||+|+||+||+|+++.+|+.||+|.++.+.. ......+|+-+++.|++.+ ||+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~-----~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHAN-----HIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCc-----ceEEEEeeeeeccc
Confidence 457777889999999999999999999999999986543 4456789999999998652 2999999999877
Q ss_pred -----eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 490 -----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 490 -----~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
.+++|+||+.-.|..++....... ..++...++.+++||+.||+|||+++|+||||||.||||++ .+.+||
T Consensus 86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~--~G~lKl 161 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS--SGVLKL 161 (323)
T ss_pred ccccceEEEEEEeecccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC--CCcEee
Confidence 799999999999999988765432 23777899999999999999999999999999999999997 899999
Q ss_pred EecCCcccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 565 IDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 565 ~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
+|||+|+-..-+ .+..+.|.+|+|||++.+. .|+..+||||+|||+.||+++++.|++.+..+++.+|...+|.+.
T Consensus 162 aDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred eccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 999999865532 3446789999999999987 699999999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+.|+......+|-.. + ...+....+....+..++...+++.+||+.+|.+|.||+.+|+||||+.
T Consensus 242 e~~Wp~v~~~~~~k~~----f----------~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAP----F----------PKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred ccCCCCcccccccccc----C----------cCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 8888775544433210 0 0011122233333344467889999999999999999999999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=372.03 Aligned_cols=254 Identities=29% Similarity=0.451 Sum_probs=210.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
-.++|.+++.||+|+||.||+|+.+.||..+|+|++++.. ........|..+|... +.|.||++|..|++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~------ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV------DSPWVVKLYYSFQD 212 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc------CCCcEEEEEEEecC
Confidence 3578999999999999999999999999999999998754 3344556677777663 35799999999999
Q ss_pred cCeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+++||||||++|+ +-.++.... .|++..++.++.+++.|+..||+.|+|||||||+|+||+. .|.+||+|
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~--~GHiKLSD 284 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA--KGHIKLSD 284 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC--CCCEeecc
Confidence 99999999999864 555554332 2999999999999999999999999999999999999996 99999999
Q ss_pred cCCcccccC-------------------------C-------------------------ccccccCCcccCchhhcCCC
Q 004954 567 LGSSCFQTD-------------------------N-------------------------LCLYVQSRSYRAPEVIIGLP 596 (722)
Q Consensus 567 FGls~~~~~-------------------------~-------------------------~~~~~gt~~y~APE~l~~~~ 596 (722)
||++.-... . ....+|||.|+|||++.+.+
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 998731000 0 01148999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCc
Q 004954 597 YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE 676 (722)
Q Consensus 597 ~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~ 676 (722)
|+...|+|||||||||||.|.+||.+.++.+...+|+. |.. ....|.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n------------wr~---------------------~l~fP~ 411 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN------------WRE---------------------TLKFPE 411 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH------------Hhh---------------------hccCCC
Confidence 99999999999999999999999999999999999872 110 112233
Q ss_pred cchhhhhcccCcHHHHHHHHHhcccCCCCCc---CHHHHHhCCCCCC
Q 004954 677 ESSLEHHLQFSDAFFIDFVRTLLEINPQRRP---TAREALDHPWLQH 720 (722)
Q Consensus 677 ~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp---Ta~ElL~HPwf~~ 720 (722)
...+ ..+..|||.+||. ||.+|. .++||-+||||+.
T Consensus 412 ~~~~-------s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 412 EVDL-------SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred cCcc-------cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 2222 2568899999999 999998 4999999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=380.08 Aligned_cols=249 Identities=31% Similarity=0.522 Sum_probs=219.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+-|++.+.||.|+.|.|-+|++..||+..|||++.+. ......+.+|+-||+.+. ||||+++|++++...
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~------HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE------HPNVLRLYDVWENKQ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc------CCCeeeeeeeeccCc
Confidence 5699999999999999999999999999999999765 234567889999999997 679999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++|+|.||+. |.|++++..... +++.++..+++||+.|+.|+|..+|+||||||+|+|++. +..|||+|||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~--~~nIKIADFG 157 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV--KNNIKIADFG 157 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc--ccCEeeeccc
Confidence 9999999997 578888875543 899999999999999999999999999999999999996 5669999999
Q ss_pred CcccccCC--ccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQTDN--LCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~~~--~~~~~gt~~y~APE~l~~~~~s-~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
+|...... ..+.||+|.|.|||++.|.+|. .++||||.|||||.||||++||.+++...++.++...
T Consensus 158 MAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G---------- 227 (786)
T KOG0588|consen 158 MASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG---------- 227 (786)
T ss_pred eeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC----------
Confidence 99765443 5568999999999999999986 7999999999999999999999999999998887522
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+.+|. +.+++.++||++||..||++|+|++||++|||++.
T Consensus 228 -------------------------~f~MPs---------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 228 -------------------------VFEMPS---------NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred -------------------------cccCCC---------cCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 223332 23467889999999999999999999999999975
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=357.86 Aligned_cols=279 Identities=28% Similarity=0.449 Sum_probs=219.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECC-CCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~-tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-- 487 (722)
.+|++.+.||+|+||+||+|++.. +++.+|+|+++... .......+|+.+++.+.. ..||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET---FEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcc---cCCCCcceEEEEEeccc
Confidence 479999999999999999999854 57889999987532 222345678888777753 468999999999863
Q ss_pred ---cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 488 ---LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 488 ---~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
...+++||||+.++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~--~~~~kl 151 (290)
T cd07862 78 TDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKL 151 (290)
T ss_pred CCCCCcEEEEEccCCCCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC--CCCEEE
Confidence 356899999999988888764332 23889999999999999999999999999999999999986 788999
Q ss_pred EecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+...
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 152 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred ccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999998765433 233568999999999999899999999999999999999999999998888888888877766555
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.+......... .+.. .+ ...+.......++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 232 ~~~~~~~~~~~---------------~~~~-~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQ---------------AFHS-KS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccch---------------hccC-CC-CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 44332111100 0000 00 011111222345778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=368.84 Aligned_cols=298 Identities=31% Similarity=0.513 Sum_probs=227.3
Q ss_pred CcceeeCc---eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCC
Q 004954 403 DLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476 (722)
Q Consensus 403 ~~pi~~~~---~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hp 476 (722)
.+++..++ .+.++|++.+.||+|+||.||++.+..+|+.||+|++... ........+|+.+++.++ ||
T Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ 80 (359)
T cd07876 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN------HK 80 (359)
T ss_pred cceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC------CC
Confidence 34444444 4568999999999999999999999999999999998643 233455667888777764 78
Q ss_pred ceeEEEEEEEecC------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 004954 477 HILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (722)
Q Consensus 477 nIv~l~~~f~~~~------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~ 550 (722)
||+++++++.... ..++||||+.+++...+.. .+++..+..++.||+.||.|||+.||+||||||+
T Consensus 81 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 152 (359)
T cd07876 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 152 (359)
T ss_pred CEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 9999999987543 5799999999988776532 1788899999999999999999999999999999
Q ss_pred ceEEcccCCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~ 628 (722)
|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 153 NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 153 NIVVKS--DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred HEEECC--CCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999986 789999999998754332 2335789999999999999999999999999999999999999999888888
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCcc--chhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~--~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
+..+...++.++.+.+.........+.......... ......+.. ..........+..+++||.+||+.||++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 231 WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGI----SFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCc----chhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 888888888877665544332222111111000000 000011100 00011122335678999999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 004954 707 PTAREALDHPWLQH 720 (722)
Q Consensus 707 pTa~ElL~HPwf~~ 720 (722)
||+.|+|+||||+.
T Consensus 307 ~t~~e~l~hp~~~~ 320 (359)
T cd07876 307 ISVDEALRHPYITV 320 (359)
T ss_pred CCHHHHhcCchhhh
Confidence 99999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.88 Aligned_cols=277 Identities=33% Similarity=0.565 Sum_probs=220.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (722)
+|++.++||+|+||.||+|++..+|+.||||++... .....++.+|+++++.++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR------HPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC------CCCEeeecceEeccCCC
Confidence 699999999999999999999999999999998642 223345678888888775 78999999988643
Q ss_pred --CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 489 --~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
..+++||||+.++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kL~D 146 (338)
T cd07859 75 EFKDIYVVFELMESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICD 146 (338)
T ss_pred CCceEEEEEecCCCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEcc
Confidence 3589999999988888776432 2889999999999999999999999999999999999986 78899999
Q ss_pred cCCcccccCC------ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 567 LGSSCFQTDN------LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 567 FGls~~~~~~------~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...+|.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9998754221 123578999999999876 57899999999999999999999999998888888888888888
Q ss_pred CcHHHHhhhhhh--hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 639 IDLEMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 639 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
++...+...... ..++. .+....+ ..+.......++.+.+||.+||+.||++|||++|+|+||
T Consensus 227 ~~~~~~~~i~~~~~~~~~~-------------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 227 PSPETISRVRNEKARRYLS-------------SMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred CCHHHHHHhhhhhHHHHHH-------------hhcccCC--CchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 777665443211 01100 0111111 112222334567789999999999999999999999999
Q ss_pred CCCC
Q 004954 717 WLQH 720 (722)
Q Consensus 717 wf~~ 720 (722)
||+.
T Consensus 292 ~f~~ 295 (338)
T cd07859 292 YFKG 295 (338)
T ss_pred hhhh
Confidence 9964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=378.40 Aligned_cols=282 Identities=29% Similarity=0.474 Sum_probs=220.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (722)
...+|++.++||+|+||+||+|.+..+++.||||++..... ...+|+.+++.++ ||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~------h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLN------HINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcC------CCCCcceeeeEeecccc
Confidence 35689999999999999999999999999999998865432 3346888888775 78999999987542
Q ss_pred -----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 489 -----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
..+++||||+++++.+++...... ...+++..++.++.||+.||+|||+.||+||||||+|||++. ..+.+|
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~-~~~~vk 211 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP-NTHTLK 211 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC-CCCcee
Confidence 257799999999988877643322 234899999999999999999999999999999999999985 345799
Q ss_pred EEecCCcccccC--CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.+++..+|.++
T Consensus 212 L~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 212 LCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred eeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999999976432 23345789999999998764 689999999999999999999999999988899999998888877
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+.+........ .-..+ ......+...+ +...+.++++||.+||++||.+|||+.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~--~~~~~----~~~~~~l~~~~---------p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 292 EDQLKEMNPNYA--DIKFP----DVKPKDLKKVF---------PKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHHhchhhh--cccCC----ccCchhHHHHh---------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 666543211100 00000 00000111111 1224567899999999999999999999999999963
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=357.30 Aligned_cols=280 Identities=27% Similarity=0.424 Sum_probs=226.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.++||+|+||+||+|++..+++.+|+|.++... .......+|+.+++.++ ||||+++++++...+..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIVHTDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC------CCCcceEEEEEeeCCeE
Confidence 67999999999999999999999999999999987542 22234667888888775 68999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.+++.+.+..... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++.
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~ 152 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECccccce
Confidence 99999999988887754322 2788999999999999999999999999999999999986 7889999999986
Q ss_pred cccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 54322 223467899999999875 45889999999999999999999999999999999999999998888777654
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....+........ ....+.......+.++++||++||+.||.+|||+.|+|+||||+.
T Consensus 233 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 233 SSNDEFKNYNFPKY--------------KPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred cchhhhhhhhcCcc--------------CCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 43322211111000 000111122334677899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=364.29 Aligned_cols=290 Identities=30% Similarity=0.513 Sum_probs=223.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.++|++.+.||+|+||.||++.+..+++.+|||++... ........+|+.+++.++ ||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~ 87 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------HKNIISLLNVFTP 87 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC------CCchhceeeeeec
Confidence 3568999999999999999999999999999999998653 223455667888887775 7899999999875
Q ss_pred c------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 488 L------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 488 ~------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
. ...++||||+.+++...+.. .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~--~~~ 157 (355)
T cd07874 88 QKSLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCT 157 (355)
T ss_pred cccccccceeEEEhhhhcccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC--CCC
Confidence 4 35799999999988776642 1788899999999999999999999999999999999986 788
Q ss_pred EEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 562 vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+
T Consensus 158 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred EEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999999765443 233578999999999999999999999999999999999999999988888888888888877
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccc--hhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~--~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
..+.+...+.....+......... .......+... .........+..+++||.+||+.||++|||+.|+|+|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAG----LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCcccc----ccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 666655444322211111110000 00000000000 000111223467899999999999999999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 314 ~~~ 316 (355)
T cd07874 314 INV 316 (355)
T ss_pred hhc
Confidence 974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=355.87 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=217.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.-.+.|++.+.||.|..++||+|+...+++.||||++..++ ...+.+.+|+..+..++ ||||++++..|...
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~------HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID------HPNIVTYHCSFVVD 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC------CCCcceEEEEEEec
Confidence 44578999999999999999999999999999999997653 23566777877777775 78999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
..+|+||.||. |+++++++..-..+ +.+..+..|++++++||.|||++|.||||||+.||||+. +|.|||+||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~G----l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~--dG~VkLadF 170 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDG----LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS--DGTVKLADF 170 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHcccc----ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC--CCcEEEcCc
Confidence 99999999997 68888888766554 999999999999999999999999999999999999996 999999999
Q ss_pred CCcccccCC-------ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 568 GSSCFQTDN-------LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 568 Gls~~~~~~-------~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|.+....+. ..+++|||.|||||++.. ..|+.|+||||||++..||.+|..||....+..++..-.. +.
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~ 248 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--ND 248 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CC
Confidence 976433221 145689999999999654 4699999999999999999999999998887776654433 22
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
+|... ..... ....+..+..|+.+|..||+.||++||||+++|+|+||
T Consensus 249 pp~~~-t~~~~-------------------------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 249 PPTLL-TSGLD-------------------------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred CCCcc-cccCC-------------------------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 22111 11000 00112233469999999999999999999999999999
Q ss_pred CCC
Q 004954 719 QHP 721 (722)
Q Consensus 719 ~~~ 721 (722)
++.
T Consensus 297 k~~ 299 (516)
T KOG0582|consen 297 KKA 299 (516)
T ss_pred hhc
Confidence 863
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.87 Aligned_cols=278 Identities=27% Similarity=0.428 Sum_probs=218.9
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (722)
+|++.+.||+|+||+||+|+++.+++.||+|+++... .......+|+.+++.++. ..||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA---FDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh---cCCCCeeeeeeeeccccCC
Confidence 5899999999999999999999999999999987532 122345678888888764 3589999999998742
Q ss_pred --CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 489 --~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
...++||||+.+++.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~kl~d 151 (288)
T cd07863 78 RETKVTLVFEHVDQDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLAD 151 (288)
T ss_pred CCceEEEEEcccccCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECc
Confidence 46899999999988887764322 23899999999999999999999999999999999999985 78899999
Q ss_pred cCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 567 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 567 FGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+.++....+.+....+
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 9998765433 23356789999999999989999999999999999999999999998888888888877776554443
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
........ ...... ....+.......+..+.+||.+||+.||++|||+.|+|.||||
T Consensus 232 ~~~~~~~~---------------~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPR---------------GAFSPR--GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccc---------------cccCCC--CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 32111000 000000 0011112222345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=356.84 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=209.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.++ ||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS------HPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC------CCcHhhhHhhhccCC
Confidence 47999999999999999999999999999999987532 23345667888887774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~--~~~~kl~Dfg 146 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFG 146 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEEecC
Confidence 99999999975 6777765432 2889999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 569 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
++...........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 147 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------ 214 (291)
T cd05612 147 FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK------------ 214 (291)
T ss_pred cchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 99877665556689999999999999999999999999999999999999998877666665553210
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
..+|. ..+..+++||++||+.||.+|++ ++++++||||+.
T Consensus 215 -----------------------~~~~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 215 -----------------------LEFPR---------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred -----------------------cCCCc---------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 01111 12456889999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=373.83 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=212.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
..|...++||+|+.|.||.|....+++.||||.+..... ..+-+++|+.+|+.++ |+|||++++.|...+.+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~------H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH------HPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc------chHHHHHHHHhcccceeE
Confidence 468888999999999999999999999999999876443 2356779999999886 679999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+|||||+| +|.+.+.... +++.++..|++.++.||+|||.+||+|||||.+|||++. ++.+||+|||++.
T Consensus 347 VVMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~--~g~vKltDFGFca 417 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM--DGSVKLTDFGFCA 417 (550)
T ss_pred EEEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc--CCcEEEeeeeeee
Confidence 99999986 5655555332 889999999999999999999999999999999999996 7889999999987
Q ss_pred cccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 572 FQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 572 ~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
+... ...+.+|||.|||||++....|+.++||||||++++||+.|++||-+.++..-+..|. ..|.++.
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-~ng~P~l------- 489 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPKL------- 489 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-hcCCCCc-------
Confidence 6543 3566899999999999999999999999999999999999999998766655444442 2222111
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
......+.+|++||.+||+.||.+|++|.|||+||||+.
T Consensus 490 ---------------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 490 ---------------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ---------------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 111234577999999999999999999999999999964
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=346.23 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=219.4
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+.+.|.+.+.||+|.|+.|+++.+..+|+.+|+|++... ....+++.+|++|-+.|+ ||||+++.+.+.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq------HP~IvrL~~ti~ 80 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDSIQ 80 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC------CCcEeehhhhhc
Confidence 35678899999999999999999999999999999998642 335577888999888886 789999999999
Q ss_pred ecCeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeEEE
Q 004954 487 HLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKI 564 (722)
Q Consensus 487 ~~~~l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~vkL 564 (722)
.....|||+|+|.|+ |..-+... ..+++..+..+++||++||.|+|.+||||||+||.|+|+-+.. ..-+||
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceee
Confidence 999999999999875 44444333 2388888999999999999999999999999999999997533 346999
Q ss_pred EecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
+|||++....+. ...++|||.|+|||++...+|+..+|||+.|||||-||.|.+||.+.+...++++|++..-..|..
T Consensus 155 ~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 155 ADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred cccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc
Confidence 999999887644 345789999999999999999999999999999999999999999999999999987543332221
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.| . ..+++.++||++||..||.+|+|+.|+|+|||+.+
T Consensus 235 ~w---------------------------------~-------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 235 EW---------------------------------D-------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred cc---------------------------------C-------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 11 1 12467899999999999999999999999999975
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=363.15 Aligned_cols=290 Identities=31% Similarity=0.516 Sum_probs=223.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++.+.||+|+||.||++.+..+++.||||++... ........+|+.+++.++ ||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------HKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC------CCCccccceeeccc
Confidence 468999999999999999999999999999999998753 223345667887777664 78999999988644
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
...++||||+.+++...+.. .++...+..++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 165 (364)
T cd07875 96 KSLEEFQDVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTL 165 (364)
T ss_pred ccccccCeEEEEEeCCCCCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC--CCcE
Confidence 35799999999988876642 1778899999999999999999999999999999999986 7889
Q ss_pred EEEecCCcccccCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 563 KIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 563 kL~DFGls~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+.
T Consensus 166 kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred EEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999999997654432 335789999999999999999999999999999999999999999998899999988888877
Q ss_pred HHHHhhhhhhhhhhcccccchhhhh-ccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINE-ETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.+.+..................... .........+.. .......+..+++||.+||+.||.+|||+.|+|+||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPAD---SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccc---ccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 6665554433222111111000000 000000000100 011112345689999999999999999999999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 323 ~ 323 (364)
T cd07875 323 V 323 (364)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=369.59 Aligned_cols=280 Identities=23% Similarity=0.324 Sum_probs=216.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
...+|++++.||+|+||.||++.+..+++.||+|.... ....+|+++++.++ ||||++++++|......
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAIN------HPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCC------CCCCCCEeEEEEECCee
Confidence 34679999999999999999999999999999997542 34678999998885 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++|||++.++|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.
T Consensus 159 ~lv~e~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~--~~~vkL~DFG~a~ 230 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH--PGDVCLGDFGAAC 230 (391)
T ss_pred EEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC--CCCEEEEeCCccc
Confidence 9999999988887775432 2789999999999999999999999999999999999985 7889999999986
Q ss_pred cccC----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------hHHHHHHHHHhhcCCCc
Q 004954 572 FQTD----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-------AVVMILARIIGMLGPID 640 (722)
Q Consensus 572 ~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~-------~~~e~l~~i~~~lg~~~ 640 (722)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||-.. .....+..++...|..|
T Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred ccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 5332 223357899999999999999999999999999999999999887432 23456677777777766
Q ss_pred HHHHhhhhh-hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 641 LEMLMQGQE-IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 641 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.+....... ....+.. .. ......|............+.++.+||.+||++||.+||||+|+|+||||+
T Consensus 311 ~~~~~~~~~~~~~~~~~------~~----~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 311 NEFPIDAQANLDEIYIG------LA----KKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred hhcCcchhHHHHHHHHH------HH----hccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 543221111 1110000 00 000001111111111122345789999999999999999999999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 381 ~ 381 (391)
T PHA03212 381 D 381 (391)
T ss_pred c
Confidence 6
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=361.10 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=211.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS------HPFIVNMMCSFQDE 90 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC------CCCCCcEEEEEEcC
Confidence 468999999999999999999999999999999997542 23345677888888774 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+..++||||+.+ +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kl~Df 162 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN--KGHVKVTDF 162 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC--CCCEEEeec
Confidence 999999999975 6766665332 2788999999999999999999999999999999999986 788999999
Q ss_pred CCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 568 Gls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
|++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 163 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~----------- 231 (329)
T PTZ00263 163 GFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR----------- 231 (329)
T ss_pred cCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 999877666666789999999999999999999999999999999999999998877665555543110
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
..+|. ..+..+.+||++||+.||.+|++ ++++++||||++
T Consensus 232 ------------------------~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 232 ------------------------LKFPN---------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ------------------------cCCCC---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 01111 12456889999999999999997 799999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=369.64 Aligned_cols=250 Identities=28% Similarity=0.484 Sum_probs=219.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|.+.+.||+|.||.||+|+.+.+.+.||||.+.+.. .....+.+|++|++.++ ||||+.++++|++..+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk------Hpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK------HPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC------CcchhhHHHhhcccce
Confidence 57889999999999999999999999999999986543 34566888999999886 6899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+++|+||+.|+|..++..... ++++.++.|+.+++.||.|||+.+|+|||+||.|||+.. .+.+|++|||+|
T Consensus 76 ~~vVte~a~g~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~--~~~~KlcdFg~A 147 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDGK------LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK--GGTLKLCDFGLA 147 (808)
T ss_pred EEEEehhhhhhHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC--CCceeechhhhh
Confidence 999999999999888876544 999999999999999999999999999999999999995 889999999999
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+..... .+...|||.|||||.+.+.+|+..+|+||||||+||+++|++||-..+..++...|..-..++|.
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~------ 221 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS------ 221 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc------
Confidence 876654 34468999999999999999999999999999999999999999988888877777532211111
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
..+..|++||..+|..||.+|.|..+++.|||.+..
T Consensus 222 --------------------------------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 222 --------------------------------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred --------------------------------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 234679999999999999999999999999998653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=363.78 Aligned_cols=279 Identities=28% Similarity=0.468 Sum_probs=221.4
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (722)
.|++.+.||+|+||+||++.+..+|+.||||++... .....++.+|+.+++.++ |+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK------HDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC------CCCcCCHhheecCCCcc
Confidence 378899999999999999999999999999998643 223356677888888775 689999999998776
Q ss_pred ---eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 490 ---HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 490 ---~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
+.++||||+.++|...+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~--~~~~kL~D 146 (372)
T cd07853 75 PFEEIYVVTELMQSDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--NCVLKICD 146 (372)
T ss_pred ccceEEEEeeccccCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC--CCCEEecc
Confidence 899999999988877765322 3889999999999999999999999999999999999996 78999999
Q ss_pred cCCcccccCC----ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
||++...... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.++.
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9998754322 2234678899999999874 4789999999999999999999999999999999999999998877
Q ss_pred HHHhhhhh-hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 642 EMLMQGQE-IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 642 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+.+..... ..+++... ....|....+.......++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 227 EAMRSACEGARAHILRG-------------PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHhhHHHHHHHHhC-------------CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 65544321 11111100 00011111111111233577899999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=362.12 Aligned_cols=260 Identities=33% Similarity=0.507 Sum_probs=224.0
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
...+..+|.+.+.||+|.||.||+++++.+|+.+|+|++.+... ......+|+.+|+.+.. ||||++++++
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~-----hpniv~l~~~ 104 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG-----HPNIVQLKDA 104 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC-----CCCEEEEEEE
Confidence 45567889999999999999999999999999999999976543 33578899999999974 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC--Ce
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--CE 561 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~--~~ 561 (722)
|.+...+++|||++.| .|.+.+... .+++..+..+++|++.|++|||+.||+||||||+|+|+..... +.
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCc
Confidence 9999999999999985 677777654 1999999999999999999999999999999999999986543 58
Q ss_pred EEEEecCCcccccC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 562 IKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 562 vkL~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
+|++|||++..... .....+||+.|+|||++.+.+|+..+||||+|+++|.|++|.+||.+.+......+|...-..+
T Consensus 178 ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF 257 (382)
T ss_pred EEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC
Confidence 99999999988776 4566899999999999999999999999999999999999999999988877777665332222
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+.++| ...+..+++||++||..||.+|+||.++|+|||++
T Consensus 258 ~~~~w----------------------------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 258 TSEPW----------------------------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred CCCCc----------------------------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 21111 11245688999999999999999999999999998
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 298 ~ 298 (382)
T KOG0032|consen 298 S 298 (382)
T ss_pred C
Confidence 5
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=357.32 Aligned_cols=279 Identities=32% Similarity=0.578 Sum_probs=222.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++++.||+|+||+||+|.+..+++.||||++.... .......+|+.+++.++ |+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK------HENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC------CCchhhhhhhhccc
Confidence 3578999999999999999999999999999999987532 22345667888888775 67999999988643
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
...+++|+++.++|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~--~~~~ 157 (343)
T cd07878 87 TSIENFNEVYLVTNLMGADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCEL 157 (343)
T ss_pred ccccccCcEEEEeecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC--CCCE
Confidence 457999999988887665421 2899999999999999999999999999999999999986 7889
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.
T Consensus 158 kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 158 RILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred EEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999877666666789999999999987 56889999999999999999999999998888888888887777766
Q ss_pred HHHhhhhhh--hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+.+...... ..+.. .+ ...+. ..+.......++.+.+||.+||+.||.+|||+.|+|+||||.
T Consensus 238 ~~~~~~~~~~~~~~~~-------------~~-~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 238 EVLKKISSEHARKYIQ-------------SL-PHMPQ-QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HHHHhcchhhHHHHhh-------------cc-ccccc-hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 554332110 00100 00 00111 112222233456788999999999999999999999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 303 ~ 303 (343)
T cd07878 303 Q 303 (343)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=356.89 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=210.8
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCC-cEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg-~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
.....++|++.+.||+|+||.||+|.+..++ ..||+|++.... .....+.+|+.+++.++ ||||+++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~Iv~~~~ 98 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN------HPFCVNLYG 98 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC------CCCCcceEE
Confidence 4455678999999999999999999876554 689999986532 23345667888888774 789999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
++...+..++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~i 170 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK--DGFI 170 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCE
Confidence 99999999999999975 6766665432 2889999999999999999999999999999999999985 7899
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 171 kL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~----- 245 (340)
T PTZ00426 171 KMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----- 245 (340)
T ss_pred EEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-----
Confidence 999999998766555667899999999999998899999999999999999999999988776665555432110
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPW 717 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPw 717 (722)
.+|. ..+..+.+||++||+.||.+|+ +++++++|||
T Consensus 246 ------------------------------~~p~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 246 ------------------------------YFPK---------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred ------------------------------CCCC---------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 1111 1235678999999999999995 8999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|++
T Consensus 287 f~~ 289 (340)
T PTZ00426 287 FGN 289 (340)
T ss_pred cCC
Confidence 975
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=353.98 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=210.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK------SEWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC------CCCCccEEEEEEcCC
Confidence 47999999999999999999999999999999997542 22345666777777664 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kL~Dfg 146 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA--SGHIKLTDFG 146 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEEEeCc
Confidence 99999999975 6766665322 2889999999999999999999999999999999999986 7889999999
Q ss_pred CcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 569 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
++...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+
T Consensus 147 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------- 217 (333)
T cd05600 147 LSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL--------- 217 (333)
T ss_pred CCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc---------
Confidence 99876665556789999999999999999999999999999999999999998887766665543210000
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
. .|... ......+..+.+||.+||..+|.+||++.++++||||..
T Consensus 218 ----------------------~--~~~~~---~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 218 ----------------------Q--RPVYD---DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred ----------------------c--CCCCC---ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 0 00000 000123467889999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.71 Aligned_cols=278 Identities=27% Similarity=0.419 Sum_probs=220.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.+.||.|+||.||++.+..+++.||+|.++... .......+|+.+++.++ ||||+++++++...+..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIIHTEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC------CCCcceEEEEEecCCeE
Confidence 67999999999999999999999999999999987532 22345667888888775 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.++|..++..... .+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~ 152 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (301)
T ss_pred EEEEeccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC--CCcEEECcCcchh
Confidence 99999999988887764322 2788999999999999999999999999999999999986 7889999999986
Q ss_pred cccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+...++.+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 54322 1224568899999998764 4788999999999999999999999998888888888888877666555432
Q ss_pred hhhhhhhcccccchhhhhccccccccCCc--cchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~--~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....+... ..|. ...+.......+..+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 233 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 233 LSNEEFKSY----------------NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred hcccccccc----------------ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 111111000 0010 00111122334567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.78 Aligned_cols=287 Identities=25% Similarity=0.398 Sum_probs=210.6
Q ss_pred EEEeccCCCCceEEEEEC--CCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--cCeEEEE
Q 004954 419 TEYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEHLFIV 494 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--~~~l~iV 494 (722)
.++||+|+||+||+|+++ .+++.+|+|.+..... .....+|+.+++.++ ||||+++++++.. ....++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELK------HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcC------CCCCcceeeeEecCCCcEEEEE
Confidence 357999999999999965 4678999999875432 245678999998885 7899999999864 4578999
Q ss_pred EEccccchHHHHhhhhccC---CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc--cCCCeEEEEecCC
Q 004954 495 CELLRANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGS 569 (722)
Q Consensus 495 mEy~~gsLl~~l~~~~~~~---~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~--~~~~~vkL~DFGl 569 (722)
|||+.+++.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|||+.. ...+.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9999999888776443211 1234889999999999999999999999999999999999953 2357899999999
Q ss_pred cccccCC------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH---------HHHHHHHH
Q 004954 570 SCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMILARII 633 (722)
Q Consensus 570 s~~~~~~------~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~---------~e~l~~i~ 633 (722)
+...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|++||..... ...+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 9765432 2235779999999999874 589999999999999999999999965332 35667777
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
..+|.+....+.....+......... . . .......+....++......+..+.+||++||++||.+|||++|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~---~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l 312 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKD-F--R---RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 312 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhh-h--h---ccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence 77887766655543322111000000 0 0 0000000000011111223356788999999999999999999999
Q ss_pred hCCCC
Q 004954 714 DHPWL 718 (722)
Q Consensus 714 ~HPwf 718 (722)
+||||
T Consensus 313 ~hp~f 317 (317)
T cd07868 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.31 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=210.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---------------hhhHhHHHHHHHHHHhcccCCCC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------------DFFDQSLDEIKLLKLVNKNDPAD 474 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---------------~~~~~~~~E~~il~~L~~~~~~~ 474 (722)
....++|++++.||+|.||.|-+|++..+++.||||++.+.. ...++..+|+.||+++.
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~------ 166 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH------ 166 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC------
Confidence 345688999999999999999999999999999999986532 12357888999999986
Q ss_pred CCceeEEEEEEEec--CeEEEEEEccccchHHHHhhhhccCCCcc-cCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 004954 475 EHHILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAY-FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (722)
Q Consensus 475 hpnIv~l~~~f~~~--~~l~iVmEy~~gsLl~~l~~~~~~~~~~~-ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~N 551 (722)
|||||+++.+..+. +.+|||+|||..+-.... ..... +++.+++.+++.++.||+|||.+|||||||||+|
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~------p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC------PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN 240 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccC------CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 67999999998765 689999999985432221 22223 8999999999999999999999999999999999
Q ss_pred eEEcccCCCeEEEEecCCcccccC--------CccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCC
Q 004954 552 ILIKSYQRCEIKIIDLGSSCFQTD--------NLCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVL 619 (722)
Q Consensus 552 ILl~~~~~~~vkL~DFGls~~~~~--------~~~~~~gt~~y~APE~l~~~~----~s~ksDIWSLGviL~elltG~~P 619 (722)
+||+. ++++||+|||.+..... .....+|||.|+|||.+.+.. .+.+.||||+||+||.|+.|+.|
T Consensus 241 LLl~~--~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 241 LLLSS--DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred eEEcC--CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 99996 79999999998875421 133468999999999998732 45789999999999999999999
Q ss_pred CCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhc
Q 004954 620 FPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699 (722)
Q Consensus 620 F~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL 699 (722)
|-++...++..+|+...- .+|... ...+.+++||.+||
T Consensus 319 F~~~~~~~l~~KIvn~pL-----------------------------------~fP~~p-------e~~e~~kDli~~lL 356 (576)
T KOG0585|consen 319 FFDDFELELFDKIVNDPL-----------------------------------EFPENP-------EINEDLKDLIKRLL 356 (576)
T ss_pred cccchHHHHHHHHhcCcc-----------------------------------cCCCcc-------cccHHHHHHHHHHh
Confidence 999999898888863211 122211 12356899999999
Q ss_pred ccCCCCCcCHHHHHhCCCCCCC
Q 004954 700 EINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 700 ~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
++||.+|+++.++-.|||....
T Consensus 357 ~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 357 EKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hcChhheeehhhheecceeccC
Confidence 9999999999999999998753
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=353.79 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=199.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||.||++++..+|+.||||+++... .......+|+.+++.++ ||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR------HPFLTALKYSFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC------CCCCCCEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999997532 22345566777777664 789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|.+.+.... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 75 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEeeCCCCcccc
Confidence 99985 5655554322 3889999999999999999999999999999999999986 7889999999986532
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------------- 211 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------------- 211 (323)
T ss_pred cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 22334678999999999999999999999999999999999999998776655554432110
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
..+| ...+..+.+||++||+.||++|| ++.++++||||+.
T Consensus 212 --------------------~~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 212 --------------------IRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred --------------------CCCC---------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 0111 12346688999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.11 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=203.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (722)
..+|...+.||+|+||+||++.+..+|...|||.+.... ...+.+.+|+++|..++ |||||++++......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~------~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN------HPNIVQYYGSSSSREND 89 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC------CCCEEeeCCccccccCe
Confidence 346888899999999999999999999999999887642 12456789999999996 679999999865555
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.++|.|||+. |+|.+++..... .+++..++.+++||++||+|||++|||||||||+|||++.. ++.+||+|||
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-~~~~KlaDFG 163 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-NGDVKLADFG 163 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-CCeEEeccCc
Confidence 6999999997 577777775543 29999999999999999999999999999999999999952 5799999999
Q ss_pred CcccccC------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCc
Q 004954 569 SSCFQTD------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPID 640 (722)
Q Consensus 569 ls~~~~~------~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~-~~~e~l~~i~~~lg~~~ 640 (722)
++..... ......||+.|||||++.+. ....++|||||||++.||+||++||... ...+.+..+.
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig------- 236 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG------- 236 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh-------
Confidence 8876552 23347899999999999953 3345999999999999999999999763 2222221111
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.......+|. ..+...++||++||+.||++||||+++|+|||++.
T Consensus 237 --------------------------~~~~~P~ip~---------~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 237 --------------------------REDSLPEIPD---------SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred --------------------------ccCCCCCCCc---------ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 0000112222 24567889999999999999999999999999965
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.05 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=204.4
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
|++++.||+|+||.||++.+..+|+.||||+++... .....+.+|.+++..++ ...||||+++++++...++.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~---~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc---ccCCCChhceeeEEEcCCEE
Confidence 789999999999999999999999999999997532 23345666777766654 34699999999999999999
Q ss_pred EEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.++ |...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~lv~E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~--~~~~kL~Dfg~~ 148 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFGLC 148 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCcEEeCcccCC
Confidence 9999999865 4433321 13899999999999999999999999999999999999996 789999999987
Q ss_pred cccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
.... ......+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~---------- 218 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV---------- 218 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 6432 223346789999999999999999999999999999999999999988776666555431100
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
..| ...+..+.+||++||+.||.+|| ++.++++||||++
T Consensus 219 -------------------------~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 219 -------------------------RYP---------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred -------------------------CCC---------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 111 11245688999999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.75 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=203.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||++++..+++.||||+++... .....+.+|+.+++.++ |++|+++++.+....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~------~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD------SLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC------CCCcceEEEEEecCC
Confidence 47999999999999999999999999999999997532 22345566777777664 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+++||||+.| +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~--~~~vkL~DFG 146 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFG 146 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCCEEEeecc
Confidence 99999999975 6666665322 3889999999999999999999999999999999999986 7889999999
Q ss_pred CcccccCC--------------------------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHH
Q 004954 569 SSCFQTDN--------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610 (722)
Q Consensus 569 ls~~~~~~--------------------------------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL 610 (722)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 98643211 1234789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHH
Q 004954 611 AELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 690 (722)
Q Consensus 611 ~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~ 690 (722)
|+|++|+.||.+.+..+.+.++...... ..+|... ..++.
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~p~~~-------~~s~~ 266 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKET---------------------------------LIFPPEV-------PISEK 266 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCc---------------------------------ccCCCcC-------CCCHH
Confidence 9999999999988777766665421110 1112111 12356
Q ss_pred HHHHHHHhcccCCC---CCcCHHHHHhCCCCCC
Q 004954 691 FIDFVRTLLEINPQ---RRPTAREALDHPWLQH 720 (722)
Q Consensus 691 l~dLL~~mL~~dP~---kRpTa~ElL~HPwf~~ 720 (722)
+++||.+|+. +|. .||+++|+++||||+.
T Consensus 267 ~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 267 AKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred HHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 8899999875 444 4689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=352.37 Aligned_cols=298 Identities=32% Similarity=0.540 Sum_probs=229.5
Q ss_pred CcceeeCc---eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCC
Q 004954 403 DLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476 (722)
Q Consensus 403 ~~pi~~~~---~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hp 476 (722)
.+|+..++ .+.++|++.+.||+|+||.||++.+..+|+.||||++... ........+|+.+++.++ |+
T Consensus 2 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ 75 (353)
T cd07850 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN------HK 75 (353)
T ss_pred ceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC------CC
Confidence 35566665 4578999999999999999999999999999999998642 223345667888887774 78
Q ss_pred ceeEEEEEEEec------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 004954 477 HILRLYDYFYHL------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (722)
Q Consensus 477 nIv~l~~~f~~~------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~ 550 (722)
||++++++|... .+.++||||+.+++.+.+... ++...+..++.||+.||+|||+.||+||||||+
T Consensus 76 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~ 147 (353)
T cd07850 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 147 (353)
T ss_pred CCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 999999998744 357999999999888776421 788899999999999999999999999999999
Q ss_pred ceEEcccCCCeEEEEecCCcccccCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~ 628 (722)
||+++. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 148 Nil~~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 225 (353)
T cd07850 148 NIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225 (353)
T ss_pred HEEECC--CCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999986 7789999999997655432 234578899999999999999999999999999999999999999888888
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccc---hhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES---SLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~---~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
...+...++.++.++..........+........ ...+....+... .........+..+++||.+||+.||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 226 WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYA----GYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCC----CcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 8899888898887765554332222111111000 000011111100 000111233566889999999999999
Q ss_pred CcCHHHHHhCCCCCC
Q 004954 706 RPTAREALDHPWLQH 720 (722)
Q Consensus 706 RpTa~ElL~HPwf~~ 720 (722)
|||+.|+|+||||+.
T Consensus 302 R~t~~eiL~~~~~~~ 316 (353)
T cd07850 302 RISVDDALQHPYINV 316 (353)
T ss_pred CcCHHHHhcChhHhh
Confidence 999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.44 Aligned_cols=276 Identities=31% Similarity=0.435 Sum_probs=219.4
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++.+.||+|+||.||+|++..+|+.+|+|.++... .......+|+.+++.++ |+||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC------CCCeeeHHHHhccCCce
Confidence 6899999999999999999999999999999987532 12245667888888775 67999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++|+||+.+++.+.+.... ..+++..++.++.||++||.|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 75 ~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~--~~~~~l~dfg~~~ 147 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK--NGELKLADFGLAR 147 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC--CCcEEECccchhh
Confidence 9999999998888765432 23899999999999999999999999999999999999996 7889999999987
Q ss_pred cccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCC-CCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~P-F~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|..| |.+.+..+.+..+...++..+...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 54432 2234568899999998775 478999999999999999998877 566777788888888888777665544
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
......+. .....+....+.......+..+.+||++||+.||.+|||++++|+||||
T Consensus 228 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 228 VSKLPDYK---------------PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hhhccccc---------------ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 33222110 0011111112222333456788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.24 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=201.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.|++.+.||+|+||+||++.+..+|+.||+|++.... .....+.+|+.+++.++ |++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~iv~~~~~~~~~~~ 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN------SRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC------CCcEEEEEEEEccCCe
Confidence 3789999999999999999999999999999986532 12234567888888775 6799999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+ +|...+.... ...+++..+..++.||+.||+|||+.||+||||||+|||++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~--~~~~kl~Dfg~ 148 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD--RGHIRISDLGL 148 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeCCC
Confidence 9999999986 4544443221 123889999999999999999999999999999999999985 77899999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~---------- 218 (285)
T cd05631 149 AVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK---------- 218 (285)
T ss_pred cEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----------
Confidence 8764332 2345789999999999999999999999999999999999999976543222211110000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
.....++ ...+..+.+||++||+.||.+||+ ++++++||||+.
T Consensus 219 ---------------------~~~~~~~---------~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 219 ---------------------EDQEEYS---------EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred ---------------------cccccCC---------ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 0000011 123467889999999999999997 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.12 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=204.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE-EEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD-YFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~---~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~-~f~~~ 488 (722)
...|+|+++||+|.||+||+++++.+|..+|.|.++- +....+....|+.+|+.|+ |||||++++ .|...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~------HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN------HPNIVQYYAHSFIED 91 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC------CchHHHHHHHhhhcc
Confidence 3569999999999999999999999999999998863 3455677889999999997 689999999 55555
Q ss_pred Ce-EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH--CC--CccccCCCCceEEcccCCCeE
Q 004954 489 EH-LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--LG--IIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ~~-l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs--~g--IvHrDLKp~NILl~~~~~~~v 562 (722)
.. ++||||||. |+|...++..+. ....+++..+|.++.|++.||..+|+ .. |+||||||.||+++. +|.+
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~--~gvv 167 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA--NGVV 167 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC--CCce
Confidence 44 899999998 566666665443 34569999999999999999999998 44 999999999999995 8999
Q ss_pred EEEecCCcccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 563 KIIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 563 kL~DFGls~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||+|||+++...... ...+|||.||+||++.+.+|+.++|||||||++|||+.-++||.+.+..++..+|...--+
T Consensus 168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~- 246 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP- 246 (375)
T ss_pred eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC-
Confidence 999999999877653 4589999999999999999999999999999999999999999999888887777532110
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa 709 (722)
.+|. ...+..+..||.-|+..||..||+.
T Consensus 247 ---------------------------------~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 247 ---------------------------------PLPD--------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ---------------------------------CCcH--------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 0110 0123568899999999999999985
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.36 Aligned_cols=278 Identities=27% Similarity=0.435 Sum_probs=219.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++.+.||+|++|.||+|++..+++.||+|+++... .......+|+.+++.+. ||||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ------HPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC------CCCEeeeEEEEeeCCeE
Confidence 4889999999999999999999999999999986532 22345677888888775 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.+++.+++..... ...+++..++.++.||+.||+|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~ 149 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLAR 149 (285)
T ss_pred EEEEecCCCCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC--CCcEEECccccee
Confidence 99999999888877754321 234899999999999999999999999999999999999986 7889999999986
Q ss_pred cccCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~~~~~---~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... ....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+...++.+....+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 150 AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 543322 223568889999998754 4788999999999999999999999988877777777777776665555443
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.....+...... . ....+.......+.++.+||++||+.||.+|||+.+|++||||
T Consensus 230 ~~~~~~~~~~~~-------------~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 230 TSLPDYKNTFPK-------------W--KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhhHHHHhhccc-------------c--CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 333222110000 0 0001111122346778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=345.93 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=204.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+|++++.||+|+||.||+|++..+++.||||+++... ........|.+++..+.+ |++|+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-----~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-----PPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCC-----CCceeeeEEEEEcCCE
Confidence 4899999999999999999999999999999997542 233456677777777653 3579999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+++||||+.+ +|...+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~ 147 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGM 147 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC--CCCEEEeecCc
Confidence 9999999975 5665554322 2788999999999999999999999999999999999986 78899999998
Q ss_pred ccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------- 218 (324)
T cd05587 148 CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------- 218 (324)
T ss_pred ceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 86422 223345789999999999999999999999999999999999999988777666655542111
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH-----HHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-----REALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa-----~ElL~HPwf~~ 720 (722)
.+|. ..+..+.+||++||+.||.+|+++ .++++||||+.
T Consensus 219 --------------------------~~~~---------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 219 --------------------------SYPK---------SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred --------------------------CCCC---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 1111 124568899999999999999976 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=353.51 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=205.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||++++..+|+.||||++.... .....+.+|+.+++.++ ||||++++++|...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------NPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCCcceEEEEEcCC
Confidence 47999999999999999999999999999999997542 23344567888888775 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++++||||+.+ +|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.++|+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg 146 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFG 146 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEeecc
Confidence 99999999975 5666665322 2899999999999999999999999999999999999986 7889999999
Q ss_pred CcccccCC-----------------------------------------ccccccCCcccCchhhcCCCCCchhhHHHHH
Q 004954 569 SSCFQTDN-----------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLG 607 (722)
Q Consensus 569 ls~~~~~~-----------------------------------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLG 607 (722)
++...... ....+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 87543211 0123689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccC
Q 004954 608 CILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 687 (722)
Q Consensus 608 viL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~ 687 (722)
|++|+|++|..||.+.+..+.+..+..... ...+|... ..
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~~~~~-------~~ 266 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKE---------------------------------TLQFPDEV-------PL 266 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------------------------ccCCCCCC-------CC
Confidence 999999999999988776665555431100 00111111 22
Q ss_pred cHHHHHHHHHhcccCCCCCcC---HHHHHhCCCCCC
Q 004954 688 DAFFIDFVRTLLEINPQRRPT---AREALDHPWLQH 720 (722)
Q Consensus 688 ~~~l~dLL~~mL~~dP~kRpT---a~ElL~HPwf~~ 720 (722)
++.+.+||++||. +|.+|++ +.++|+||||+.
T Consensus 267 s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 267 SPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 4668899999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=347.59 Aligned_cols=291 Identities=24% Similarity=0.284 Sum_probs=210.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
..++|++++.||+|+||.||++++..+|..+|+|++... ......+.+|+++++.++ ||||+++++++...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 76 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSDG 76 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC------CCCCCeEEEEEEECC
Confidence 357899999999999999999999999999999998754 233456778888888775 689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEec
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
.+++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.++|+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Df 148 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS--RGEIKLCDF 148 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC--CCcEEEccC
Confidence 99999999985 6666665322 288999999999999999999986 5999999999999986 788999999
Q ss_pred CCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 568 GSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 568 Gls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||......++...+..............
T Consensus 149 g~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred cccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 998755432 3345789999999999999999999999999999999999999987665554332211100000000000
Q ss_pred hhhhhh----hhcccc-cc---hhhhhccc-cccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 647 GQEIYK----YFTKEY-DL---YYINEETN-QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 647 ~~~~~~----~~~~~~-~~---~~~~~~~~-~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
...... ...... .. ........ ......|.. .....+.++++||++||++||++|||+.++|+|||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL-----PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCC-----CCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 000000 000000 00 00000000 000000100 01124567999999999999999999999999999
Q ss_pred CCCC
Q 004954 718 LQHP 721 (722)
Q Consensus 718 f~~~ 721 (722)
|+..
T Consensus 304 ~~~~ 307 (331)
T cd06649 304 IKRS 307 (331)
T ss_pred Hhhc
Confidence 9753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.47 Aligned_cols=252 Identities=29% Similarity=0.442 Sum_probs=207.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||+||+|++..+|+.||||+++... .....+..|+.++..++ |+||+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD------SPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC------CCCccchhhheecCC
Confidence 47999999999999999999999999999999997542 23345667777777775 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++++||||+.+ +|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~--~~~~kL~Dfg 146 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFG 146 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEeecCC
Confidence 99999999975 677766543 23889999999999999999999999999999999999986 7889999999
Q ss_pred CcccccCCc--------------------------------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC
Q 004954 569 SSCFQTDNL--------------------------------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616 (722)
Q Consensus 569 ls~~~~~~~--------------------------------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG 616 (722)
++....... ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 987544322 235689999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHH
Q 004954 617 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696 (722)
Q Consensus 617 ~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~ 696 (722)
+.||......+...++...... ..+|... ..++.+.+||.
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~p~~~-------~~~~~~~~li~ 266 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKES---------------------------------LRFPPDP-------PVSPEAIDLIC 266 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCc---------------------------------ccCCCCC-------CCCHHHHHHHH
Confidence 9999887766655555421100 0111111 13467899999
Q ss_pred HhcccCCCCCcC-HHHHHhCCCCCC
Q 004954 697 TLLEINPQRRPT-AREALDHPWLQH 720 (722)
Q Consensus 697 ~mL~~dP~kRpT-a~ElL~HPwf~~ 720 (722)
+||+ ||.+|++ +.++|+||||+.
T Consensus 267 ~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 267 RLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9998 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=331.07 Aligned_cols=253 Identities=30% Similarity=0.472 Sum_probs=211.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---------~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+.|.-.+.||+|..++|.++.++.+|+.+|+|++... ....+....|+.||+++. +||+|+++.++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-----GHP~II~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-----GHPYIIDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-----CCCcEEEeeee
Confidence 4577778899999999999999999999999998532 123455677899999986 68999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
|++...+++|+|.|+ |.|.+++...- .+++++.+.|++|+++|+.|||.++||||||||+|||++. +.++|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd--n~~i~ 163 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD--NMNIK 163 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc--ccceE
Confidence 999999999999997 78988886433 3999999999999999999999999999999999999995 88999
Q ss_pred EEecCCcccccCC--ccccccCCcccCchhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 004954 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~y~APE~l~~------~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~ 635 (722)
|+|||+++..... ....||||+|+|||.+.. ..|+..+|+|++|||||.|+.|.+||......-++..|+..
T Consensus 164 isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred EeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 9999999987654 556899999999999863 35899999999999999999999999877666666555532
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.=.+.. |+.... +...++||.+||+.||.+|.|++|+|.|
T Consensus 244 kyqF~s---------------------------------peWadi-------s~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 KYQFRS---------------------------------PEWADI-------SATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccccCC---------------------------------cchhhc-------cccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 211111 111111 2446799999999999999999999999
Q ss_pred CCCC
Q 004954 716 PWLQ 719 (722)
Q Consensus 716 Pwf~ 719 (722)
|||+
T Consensus 284 pff~ 287 (411)
T KOG0599|consen 284 PFFI 287 (411)
T ss_pred hHHH
Confidence 9994
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.53 Aligned_cols=241 Identities=30% Similarity=0.454 Sum_probs=198.2
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
||+|+||+||++++..+++.||+|+++.. ........+|+.+++.++ ||||+++++++...+..++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN------CPFIVPLKFSFQSPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCcEeceeeEEecCCeEEEEEcC
Confidence 79999999999999999999999998753 223345567777777664 78999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC-
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 575 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~- 575 (722)
+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 75 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~--~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 75 INGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY--QGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC--CCcEEEEECcccccCccC
Confidence 985 5666665322 2889999999999999999999999999999999999985 78899999999875322
Q ss_pred --CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 004954 576 --NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (722)
Q Consensus 576 --~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~ 653 (722)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~----------------- 209 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP----------------- 209 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-----------------
Confidence 2234578999999999999999999999999999999999999998876665554443110
Q ss_pred hcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc---CHHHHHhCCCCCC
Q 004954 654 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP---TAREALDHPWLQH 720 (722)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp---Ta~ElL~HPwf~~ 720 (722)
..+| ...++.+.+||.+||+.||.+|| ++.++|.||||+.
T Consensus 210 ------------------~~~~---------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 210 ------------------LRFP---------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred ------------------CCCC---------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 0111 12346688999999999999997 6899999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=354.11 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=201.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ |+||+++++++...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~l~~~~~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD------NEWVVKLYYSFQDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC------CCCeeeeEEEEecCCE
Confidence 6899999999999999999999999999999997532 23445677888887764 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+. ++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~--~~~~kL~DFGl 147 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL--DGHIKLTDFGL 147 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC--CCCEEEeeCcC
Confidence 9999999975 6666665322 2888999999999999999999999999999999999986 78899999998
Q ss_pred cccccC--------------------------------------------------CccccccCCcccCchhhcCCCCCc
Q 004954 570 SCFQTD--------------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQ 599 (722)
Q Consensus 570 s~~~~~--------------------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ 599 (722)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 642210 011347899999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccch
Q 004954 600 KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS 679 (722)
Q Consensus 600 ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~ 679 (722)
++|||||||++|+|++|..||...+..+....+..... ...+|..
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~~~~-- 272 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------------------------TLHIPPQ-- 272 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------------------------ccCCCCC--
Confidence 99999999999999999999987766555444431100 0011111
Q ss_pred hhhhcccCcHHHHHHHHHhccc--CCCCCcCHHHHHhCCCCCC
Q 004954 680 LEHHLQFSDAFFIDFVRTLLEI--NPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 680 l~~~~~~~~~~l~dLL~~mL~~--dP~kRpTa~ElL~HPwf~~ 720 (722)
...++++++||.+||.. +|..|+++.++++||||+.
T Consensus 273 -----~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 273 -----VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred -----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 11346788999996654 5556999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=354.24 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=202.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+|+++++||+|+||+||+|++..+++.+|+|++.... .....+.+|+.+++.++ |+||+++++.|...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~------h~~iv~~~~~~~~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD------NEWVVRLYYSFQDKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC------CCcCCeEEEEEEeCCE
Confidence 6999999999999999999999999999999987542 23445667888887764 6899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+++||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~--~g~~kL~DFGl 147 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFGL 147 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEEeECCC
Confidence 9999999975 5666664322 2888999999999999999999999999999999999986 78899999998
Q ss_pred cccccC--------------------------------------------------CccccccCCcccCchhhcCCCCCc
Q 004954 570 SCFQTD--------------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQ 599 (722)
Q Consensus 570 s~~~~~--------------------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ 599 (722)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 642110 011246899999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccch
Q 004954 600 KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS 679 (722)
Q Consensus 600 ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~ 679 (722)
++|||||||++|+|++|++||.+.+..+....+..... ...+|..
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~p~~-- 272 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------------------------SLHIPPQ-- 272 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------------------------CcCCCCc--
Confidence 99999999999999999999988766555544431100 0111111
Q ss_pred hhhhcccCcHHHHHHHHHhcccCCCCCcC---HHHHHhCCCCCC
Q 004954 680 LEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALDHPWLQH 720 (722)
Q Consensus 680 l~~~~~~~~~~l~dLL~~mL~~dP~kRpT---a~ElL~HPwf~~ 720 (722)
...++++.+||.+|+ .+|.+|++ +.++++||||+.
T Consensus 273 -----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 273 -----AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred -----ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 112466889999986 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.36 Aligned_cols=286 Identities=26% Similarity=0.413 Sum_probs=208.1
Q ss_pred EEEeccCCCCceEEEEECC--CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--cCeEEEE
Q 004954 419 TEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEHLFIV 494 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~--tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--~~~l~iV 494 (722)
..+||+|+||+||+|++.. ++..+|+|.+..... .....+|+.+++.++ ||||+++++++.. ...+++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELK------HPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCC------CCCeeeEEEEEeccCCCeEEEE
Confidence 3579999999999999653 668899999875432 245678888888875 6899999999864 4678999
Q ss_pred EEccccchHHHHhhhhcc---CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc--CCCeEEEEecCC
Q 004954 495 CELLRANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDLGS 569 (722)
Q Consensus 495 mEy~~gsLl~~l~~~~~~---~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~--~~~~vkL~DFGl 569 (722)
|||+.+++.+++...... .....+++..++.++.||+.||.|||+.||+||||||+|||+... .++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999988887643321 122348889999999999999999999999999999999999532 357899999999
Q ss_pred cccccCC------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH---------HHHHHHHH
Q 004954 570 SCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMILARII 633 (722)
Q Consensus 570 s~~~~~~------~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~---------~e~l~~i~ 633 (722)
+...... .....+|+.|+|||++.+. .++.++|||||||++|+|+||++||..... ...+.++.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9765432 1234678999999999774 578999999999999999999999965332 34556677
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCc-cchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE-ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
..+|.+..+.+........+......... .....+. ...........+..+.+||.+||+.||.+|||+.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~ 311 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRR-------TTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQA 311 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcc-------cccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHH
Confidence 77776666655443322221110000000 0000000 000111111234568899999999999999999999
Q ss_pred HhCCCC
Q 004954 713 LDHPWL 718 (722)
Q Consensus 713 L~HPwf 718 (722)
|+||||
T Consensus 312 l~hp~f 317 (317)
T cd07867 312 LQDPYF 317 (317)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.03 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=201.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|+++++||+|+||+||++++..+++.||||++.... .....+.+|+++++.+ .||||++++++|....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES------DSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC------CCCCcceEEEEEEcCC
Confidence 47999999999999999999999999999999987532 2334566777777765 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++++||||+.+ +|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~--~~~~kl~DfG 146 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR--GGHIKLSDFG 146 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEEeecc
Confidence 99999999974 6766665322 2889999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCC--------------------------------------------------ccccccCCcccCchhhcCCCCC
Q 004954 569 SSCFQTDN--------------------------------------------------LCLYVQSRSYRAPEVIIGLPYD 598 (722)
Q Consensus 569 ls~~~~~~--------------------------------------------------~~~~~gt~~y~APE~l~~~~~s 598 (722)
++...... ....+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 88532110 0024689999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccc
Q 004954 599 QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 678 (722)
Q Consensus 599 ~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~ 678 (722)
.++|||||||++|+|++|.+||.+.+..+.+..+...... ..+|..
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------------~~~p~~- 272 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------------------------LYFPDD- 272 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------------------------cCCCCC-
Confidence 9999999999999999999999887766665554321000 001111
Q ss_pred hhhhhcccCcHHHHHHHHHhcccCCCCC---cCHHHHHhCCCCCC
Q 004954 679 SLEHHLQFSDAFFIDFVRTLLEINPQRR---PTAREALDHPWLQH 720 (722)
Q Consensus 679 ~l~~~~~~~~~~l~dLL~~mL~~dP~kR---pTa~ElL~HPwf~~ 720 (722)
...+..+.+||.+||+ +|.+| +|+.|+++||||+.
T Consensus 273 ------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 273 ------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred ------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 0124568899999998 77765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=347.08 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=198.1
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||.||++++..+|+.||+|++.... .......+|+++++.++ ||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR------HPFLTSLKYSFQTKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCCcceEEEEEcCCEEEEEE
Confidence 36999999999999999999999999997542 23345566777776664 789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 Ey~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~--~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 75 EYVNGGELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (328)
T ss_pred eCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC--CCcEEEecCcCCccCC
Confidence 99986 555544322 13889999999999999999999999999999999999986 7889999999986532
Q ss_pred C---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------- 210 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------------- 210 (328)
T ss_pred CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC----------------
Confidence 2 223457899999999999999999999999999999999999999877655544433210
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQHP 721 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~~ 721 (722)
...+| ...+..+.+||++||+.||++|+ ++.++++||||...
T Consensus 211 -------------------~~~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 211 -------------------DIKFP---------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -------------------CccCC---------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00111 12346688999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=344.68 Aligned_cols=244 Identities=25% Similarity=0.431 Sum_probs=199.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||+||+|+++.+++.||||+++... ........|..++..+. .||||+++++++...+.+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-----CCCchhceeeEEEcCCEEEEEE
Confidence 36999999999999999999999999987542 22344556777666553 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|...+.... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~--~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGI 147 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeeCCCCeecC
Confidence 99985 5655554322 2889999999999999999999999999999999999986 7889999999986532
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+.....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-------------- 213 (320)
T cd05590 148 FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-------------- 213 (320)
T ss_pred cCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 223345789999999999999999999999999999999999999988877666655531100
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH------HHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA------REALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa------~ElL~HPwf~~ 720 (722)
.+|. ..+..+.+||++||+.||.+||++ +++++||||+.
T Consensus 214 ---------------------~~~~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 214 ---------------------VYPT---------WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred ---------------------CCCC---------CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 0111 124568899999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.40 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=203.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+|++.+.||+|+||+||+|++..+++.+|||++++... .......|..++..+. .|++|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-----KPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCeEeeEEEEEecCCE
Confidence 48899999999999999999999999999999976431 2233455666665553 36899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+++||||+.+ +|...+.... .+++..+..++.||+.||+|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kL~DfG~ 147 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC--CCcEEEccCCC
Confidence 9999999975 6665554322 2889999999999999999999999999999999999996 78899999999
Q ss_pred ccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+.....
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------- 218 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------- 218 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 86532 223345789999999999999999999999999999999999999998877766666542111
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
.+|. ..+..+.+||.+||+.||.+|++ ..++++||||+.
T Consensus 219 --------------------------~~p~---------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 219 --------------------------AYPK---------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred --------------------------CCCC---------cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 1111 12456889999999999999997 589999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.42 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=200.3
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
++||+|+||.||+|++..+++.||||+++... ........|.+++..+. .||||++++++|...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-----KHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCeEEEEE
Confidence 36999999999999999999999999997642 22344566777776653 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+++ +|...+.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~--~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA--EGHCKLADFGMCKEGI 147 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEeecccceecc
Confidence 99985 5655554322 2888999999999999999999999999999999999986 7889999999986532
Q ss_pred C---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--------------- 212 (321)
T cd05591 148 LNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--------------- 212 (321)
T ss_pred cCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 2 2334568999999999999999999999999999999999999999887776665553210
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-------CHHHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-------TAREALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-------Ta~ElL~HPwf~~ 720 (722)
...|. ..+..+.+||++||+.||++|+ ++.++++||||+.
T Consensus 213 --------------------~~~p~---------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 213 --------------------VLYPV---------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred --------------------CCCCC---------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 01111 1245688999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.22 Aligned_cols=243 Identities=25% Similarity=0.390 Sum_probs=198.2
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||.||++++..+|+.||+|+++... .......+|+++++.++ ||||+++++.|...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR------HPFLTALKYAFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC------CCCCcceeeEEecCCEEEEEE
Confidence 36999999999999999999999999997542 23344556777777664 789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 75 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC--CCCEEecccHHhcccc
Confidence 99986 5544443221 3889999999999999999999999999999999999985 7889999999876532
Q ss_pred C---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--------------- 211 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------------- 211 (323)
T ss_pred CCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 2 1233578999999999999999999999999999999999999998776655554442100
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
..+| ...++.+.+||++||+.||.+|+ ++.++++||||.+
T Consensus 212 --------------------~~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 212 --------------------IRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred --------------------CCCC---------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 0111 12346688999999999999998 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=353.31 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=202.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+|++++.||+|+||+||++++..+++.||||++.... .....+.+|+.+++.+. |+||+++++.|...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD------NEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC------CCCcceEEEEEEcCC
Confidence 36999999999999999999999999999999986532 22345667888888774 689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+++||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~ikL~DFG 146 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFG 146 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC--CCCEEEEeCC
Confidence 99999999975 6777765432 2788999999999999999999999999999999999986 7889999999
Q ss_pred CcccccC----------------------------------------------CccccccCCcccCchhhcCCCCCchhh
Q 004954 569 SSCFQTD----------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQKID 602 (722)
Q Consensus 569 ls~~~~~----------------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksD 602 (722)
++..... .....+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 8742110 011246899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhh
Q 004954 603 LWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682 (722)
Q Consensus 603 IWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~ 682 (722)
||||||++|+|++|+.||.+.+..+....+..... ...+|..
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~~~~----- 268 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWET---------------------------------TLHIPSQ----- 268 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------------------------cccCCCC-----
Confidence 99999999999999999988776555444321100 0011111
Q ss_pred hcccCcHHHHHHHHHhcccCCCCCc---CHHHHHhCCCCCC
Q 004954 683 HLQFSDAFFIDFVRTLLEINPQRRP---TAREALDHPWLQH 720 (722)
Q Consensus 683 ~~~~~~~~l~dLL~~mL~~dP~kRp---Ta~ElL~HPwf~~ 720 (722)
...+..+.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 269 --~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 269 --AKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred --CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 112456789999976 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.40 Aligned_cols=244 Identities=29% Similarity=0.431 Sum_probs=197.1
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
++||+|+||.||+|+++.+|+.||+|+++... ........|..++..+ .+||+|+++++++...+++++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-----WENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCCccCeeEEEEeCCEEEEEE
Confidence 46999999999999999999999999997642 2233455566665544 25789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc-
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 573 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~- 573 (722)
||+.+ +|...+... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.++|+|||++...
T Consensus 76 E~~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 76 EFLNGGDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR--DGHIKIADFGMCKENV 147 (316)
T ss_pred CCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEeCccCCCeecc
Confidence 99985 565555432 12889999999999999999999999999999999999986 778999999988642
Q ss_pred --cCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 574 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 574 --~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--------------- 212 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--------------- 212 (316)
T ss_pred cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------
Confidence 222344678999999999999999999999999999999999999998877665554442110
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH-HHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-REALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa-~ElL~HPwf~~ 720 (722)
..+| ...+..+.+||++||+.||++||++ +++++||||+.
T Consensus 213 --------------------~~~~---------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 213 --------------------PHYP---------RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred --------------------CCCC---------CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 0111 1134568899999999999999997 58889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.55 Aligned_cols=281 Identities=27% Similarity=0.413 Sum_probs=220.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~- 488 (722)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++.... ......+|+.+++.++ |+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR------HPNIVELKEVVVGKH 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC------CCCCcceEEEEecCC
Confidence 4689999999999999999999999999999999875322 1224557888888775 67999999998765
Q ss_pred -CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 -EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 -~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+..++||||+.++|.+++.... ..+++..++.++.||+.||+|||+.|++||||||+||+++. ++.+||+||
T Consensus 80 ~~~~~lv~e~~~~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~kL~df 152 (309)
T cd07845 80 LDSIFLVMEYCEQDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD--KGCLKIADF 152 (309)
T ss_pred CCeEEEEEecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECcc
Confidence 5689999999988888776432 23899999999999999999999999999999999999985 788999999
Q ss_pred CCcccccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
|++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 153 GLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred ceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 998765433 222345778999999876 4578999999999999999999999999999999999988888776655
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+.........- ...........+.......++.+.+||.+||++||++|||+.++|+||||+.
T Consensus 233 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 233 WPGFSDLPLVG--------------KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred chhhhcccccc--------------cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 44322111100 0000000001112222334577899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.32 Aligned_cols=252 Identities=35% Similarity=0.560 Sum_probs=203.0
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHh---HHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ---SLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~---~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
|++.+.||+|+||+||++++..+++.+|+|++......... ..+|+.+++.++ ||||+++++++......+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR------HPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT------BTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc------cccccccccccccccccc
Confidence 89999999999999999999999999999999876533322 345888888885 679999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+.+ +|.+++.... .+++..+..++.||+.||.+||+.||+|+||||+||+++. ++.++|+|||.+.
T Consensus 75 ~v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~--~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDE--NGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEEST--TSEEEESSGTTTE
T ss_pred ccccccccccccccccccc------cccccccccccccccccccccccccccccccccccccccc--ccccccccccccc
Confidence 99999997 7877777222 2899999999999999999999999999999999999995 8889999999986
Q ss_pred cc---cCCccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQ---TDNLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~---~~~~~~~~gt~~y~APE~l~-~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
.. ........+++.|+|||++. +..++.++||||||+++|+|++|..||...........+.+.........
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 222 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---- 222 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc----
Confidence 42 22334467899999999998 78899999999999999999999999988733333322221111000000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.. ........+.++|.+||+.||++|||+.++++||||
T Consensus 223 --------------------------~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 --------------------------SQ-------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------------------------TT-------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------------------------cc-------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00 000011568999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=330.19 Aligned_cols=278 Identities=31% Similarity=0.506 Sum_probs=222.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++.+.||.|++|.||+|.+..+|+.||+|++.... .....+.+|+.+++.++ |+||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ------HPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC------CCCCcceeeEEecCCee
Confidence 5899999999999999999999999999999987543 23456777888887775 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||.+.
T Consensus 75 ~~v~e~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~--~~~~~l~dfg~~~ 147 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLAR 147 (286)
T ss_pred EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC--CCcEEEeeeeecc
Confidence 9999999778887776433 23899999999999999999999999999999999999996 7889999999887
Q ss_pred cccCC----ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 572 FQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 572 ~~~~~----~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+......+..+...++.+....+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 65433 2335678899999998754 468999999999999999999999998888888888888888776665554
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
...+.++-.. .........+.......+..+.+||++||+.+|++|||++++|+||||.
T Consensus 228 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 228 LTSLPDYNKI--------------TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCcchhhcc--------------cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 3333222110 0000001112222233457899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.50 Aligned_cols=277 Identities=25% Similarity=0.282 Sum_probs=205.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
.+|++++.||+|+||.||+|++..+++.||+|+.... ....|+.+++.++ |+||+++++++......++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVN------HPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCC------CCCCcChhheEEeCCeeEE
Confidence 4799999999999999999999999999999986443 2346888888775 7899999999999999999
Q ss_pred EEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 494 VmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||++.++|++++.... ..+++..++.|+.||+.||.|||+.||+||||||+|||++. .+.+||+|||++...
T Consensus 135 v~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEecCcccccc
Confidence 99999999988876432 23889999999999999999999999999999999999986 778999999998754
Q ss_pred cCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCh---------HHHHHHHHHhhcCCCcH
Q 004954 574 TDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPNDA---------VVMILARIIGMLGPIDL 641 (722)
Q Consensus 574 ~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~P-F~~~~---------~~e~l~~i~~~lg~~~~ 641 (722)
... .....||+.|+|||++.+..++.++|||||||++|+|+++..| |.... ....+..++..++..+.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 322 2345789999999999999999999999999999999985444 43311 12333444444443332
Q ss_pred HHHh--hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLM--QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.... .......++... . ....|............+..+.+||.+||+.||.+||||.|||+||||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~-----------~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYA-----------S-LERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred hcCCCCccHHHHHHHhhc-----------c-cCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 2210 000001110000 0 0000000000000112345677899999999999999999999999998
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
+
T Consensus 356 ~ 356 (357)
T PHA03209 356 Q 356 (357)
T ss_pred c
Confidence 6
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=320.20 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=215.8
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
..-.++|.+.+.||+|-||.||+|+.+.++-.||+|++.+.. ......|-++.+.+.....+.||||+++|++|.+..
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 344578999999999999999999999999999999997653 122222333333343344456899999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+|+++||.. |.++..+..... ..+.+...+.+++|++.||.|+|.+++|||||||+|+|++. .+.+||+|||
T Consensus 96 riyLilEya~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~--~~~lkiAdfG 169 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS--AGELKIADFG 169 (281)
T ss_pred eeEEEEEecCCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC--CCCeeccCCC
Confidence 9999999996 677777763332 33889999999999999999999999999999999999997 8899999999
Q ss_pred Ccccc-cCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 569 SSCFQ-TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 569 ls~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
-+... .....+.|||..|.|||+..+..++..+|+|++|++.||++.|.+||...+..+.+.+|.+..
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~----------- 238 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD----------- 238 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-----------
Confidence 88766 444667899999999999999999999999999999999999999999988888888886432
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..+|. ..+....|||.+||..+|.+|.+..|++.|||+..
T Consensus 239 ------------------------~~~p~---------~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 239 ------------------------LKFPS---------TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ------------------------ccCCc---------ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 22231 12355789999999999999999999999999853
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=346.25 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=204.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||+||++++..+|+.||+|+++.... ....+.+|+.+++.+ .|+||+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS------NSPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceeeEEecCC
Confidence 479999999999999999999999999999999986432 334455666766655 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~--~~~~kL~Dfg 147 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR--TGHIKLADFG 147 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC--CCCEEeccCC
Confidence 99999999974 67776654321 3899999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCCc----cccccCCcccCchhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~------~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
++....... ....+|+.|+|||++. ...++.++|||||||++|+|++|+.||...+....+.++.....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~- 226 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR- 226 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-
Confidence 987654322 2246899999999987 45678999999999999999999999988766665555432100
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....|.. ...+..+.+||++||+ +|.+|||+.++++||||
T Consensus 227 --------------------------------~~~~~~~-------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 227 --------------------------------FLKFPED-------PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred --------------------------------ccCCCCC-------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 0001111 1234668899999998 99999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 267 ~~ 268 (330)
T cd05601 267 SK 268 (330)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.18 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=204.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++|++.+.||+|+||+||++++..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~------h~~iv~~~~~~~~~ 115 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN------SEWIVQLHYAFQDD 115 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC------CCCcceEEEEEecC
Confidence 468999999999999999999999999999999997532 22234556777777664 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
..+++||||+.+ +|.+++... .+++..+..++.||+.||+|||+.||+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~~kL~Df 186 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC--CCCEEEEec
Confidence 999999999975 566655421 2788899999999999999999999999999999999986 789999999
Q ss_pred CCcccccCC----ccccccCCcccCchhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 568 Gls~~~~~~----~~~~~gt~~y~APE~l~~~----~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-- 264 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-- 264 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--
Confidence 998765432 2345789999999998754 378899999999999999999999988776666555542110
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC--CcCHHHHHhCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k--RpTa~ElL~HPw 717 (722)
...+|.. ...+..+.+||++||+.+|.+ |+|++++++|||
T Consensus 265 -------------------------------~~~~~~~-------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 265 -------------------------------SLTFPDD-------IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred -------------------------------cCCCCCc-------CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 0111111 113467899999999999998 999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 307 ~~~ 309 (370)
T cd05596 307 FKN 309 (370)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.27 Aligned_cols=282 Identities=24% Similarity=0.343 Sum_probs=214.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEEC--CCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.++..+|++++.||+|+||.||++... .+++.||+|.+.... ...+|+++++.++ ||||+++++++..
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~------h~~iv~~~~~~~~ 157 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTIS------HRAIINLIHAYRW 157 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcC------CCCccceeeeEee
Confidence 445678999999999999999999753 456889999886543 3457889988875 6899999999999
Q ss_pred cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 488 ~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
....++|||++.+++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+||
T Consensus 158 ~~~~~lv~e~~~~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~--~~~~~l~Df 229 (392)
T PHA03207 158 KSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE--PENAVLGDF 229 (392)
T ss_pred CCEEEEEehhcCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEccC
Confidence 9999999999999888877422 23899999999999999999999999999999999999985 788999999
Q ss_pred CCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh---HHHHHHHHHhhcCCC
Q 004954 568 GSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGMLGPI 639 (722)
Q Consensus 568 Gls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~---~~e~l~~i~~~lg~~ 639 (722)
|++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ....+..+++.++..
T Consensus 230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~ 309 (392)
T PHA03207 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309 (392)
T ss_pred ccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence 9987544321 23578999999999999999999999999999999999999996543 345666677666655
Q ss_pred cHHHHhhhh-hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 640 DLEMLMQGQ-EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 640 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
+.+...... ...+.+.+... .....+.+|.. +. ....+..+.+||++||+.||++|||+.|+|.||||
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~--~~--~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 310 PLEFPQNGSTNLCKHFKQYAI-------VLRPPYTIPPV--IR--KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred ccccCCccchhHHHHHHhhcc-------cccCCccccch--hh--ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 443221100 00111100000 00000111110 00 11234678899999999999999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
++
T Consensus 379 ~~ 380 (392)
T PHA03207 379 TK 380 (392)
T ss_pred hc
Confidence 75
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.06 Aligned_cols=291 Identities=24% Similarity=0.312 Sum_probs=209.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
..++|++.++||+|+||.||++.+..+++.+|+|++.... .....+.+|+++++.++ |+||++++++|...+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 76 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSDG 76 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC------CCcccceeEEEEECC
Confidence 4578999999999999999999999999999999987542 33456778888888774 689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEec
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+.++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+. +|+|+||||+|||++. ++.+||+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~--~~~~kL~Df 148 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDF 148 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC--CCCEEEeeC
Confidence 99999999975 6777765432 278899999999999999999985 7999999999999985 778999999
Q ss_pred CCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc-CCCcHHHHh
Q 004954 568 GSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML-GPIDLEMLM 645 (722)
Q Consensus 568 Gls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l-g~~~~~~~~ 645 (722)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.... +........
T Consensus 149 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228 (333)
T ss_pred CcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence 998755332 234578999999999999889999999999999999999999998765544332221111 100000000
Q ss_pred -----hhhhhhhhhcccccch-hhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 646 -----QGQEIYKYFTKEYDLY-YINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 646 -----~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.......+.....+.. .............|.. .....+.++.+||.+||+.||++|||+.|+|+||||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-----PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccC-----CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 0000000000000000 0000000000000000 0112356799999999999999999999999999997
Q ss_pred CC
Q 004954 720 HP 721 (722)
Q Consensus 720 ~~ 721 (722)
..
T Consensus 304 ~~ 305 (333)
T cd06650 304 RS 305 (333)
T ss_pred cC
Confidence 64
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.43 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=196.3
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
++||+|+||+||+|++..+++.||||+++... ........|..++..+ ..||||+++++++......++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-----WEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc-----cCCCCccceeeEEEcCCEEEEEE
Confidence 36999999999999999999999999997643 2223344455555433 35899999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|...+.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK--DGHIKIADFGMCKENM 147 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC--CCCEEEccCcCCeECC
Confidence 99975 5655554322 2889999999999999999999999999999999999986 7889999999987532
Q ss_pred C---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+.....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------- 213 (316)
T cd05592 148 NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP-------------- 213 (316)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 2 23345789999999999999999999999999999999999999988776666555431110
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH-HHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-REALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa-~ElL~HPwf~~ 720 (722)
.+| ...+..+.+||.+||+.||.+||++ .++++||||+.
T Consensus 214 ---------------------~~~---------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 214 ---------------------HFP---------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred ---------------------CCC---------CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 011 1124567899999999999999986 58889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.42 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=199.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||+||++++..+++.||||++++.. ........|.++++.+. .||||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCEEEEEE
Confidence 36999999999999999999999999998642 23345567777777664 4889999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|...+.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGI 147 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC--CCcEEecccCCCeecC
Confidence 99986 5555444321 2899999999999999999999999999999999999986 7889999999886422
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
......++++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~---------------- 211 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED---------------- 211 (318)
T ss_pred cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----------------
Confidence 2223356899999999999999999999999999999999999999887765555443211
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH-----HHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-----REALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa-----~ElL~HPwf~~ 720 (722)
...+| ...+..+.+||++||+.||.+|||+ .++++||||+.
T Consensus 212 -------------------~~~~~---------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 212 -------------------EVRYP---------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred -------------------CCCCC---------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 00111 1124568899999999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=341.33 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=197.5
Q ss_pred cEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+|++++.||+|+||+||++++. .+++.||+|++.+.. ........|+.+++.++ .|++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-----QSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCcccEEEEEe
Confidence 4899999999999999999863 578999999987532 22345667888888775 3689999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+.+++||||+.+ +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~--~~~~kl~ 147 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVVLT 147 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC--CCCEEEe
Confidence 99999999999985 6666664322 2889999999999999999999999999999999999986 7889999
Q ss_pred ecCCcccccCC----ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH----HHHHHHHHhhc
Q 004954 566 DLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV----VMILARIIGML 636 (722)
Q Consensus 566 DFGls~~~~~~----~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~----~e~l~~i~~~l 636 (722)
|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..+...+..
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-- 225 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-- 225 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--
Confidence 99998754221 2235789999999999875 478899999999999999999999964321 111111110
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHH
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TARE 711 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~E 711 (722)
....+| ...+..+.+||.+||+.||++|| ++++
T Consensus 226 ---------------------------------~~~~~~---------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 263 (332)
T cd05614 226 ---------------------------------CDPPFP---------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263 (332)
T ss_pred ---------------------------------CCCCCC---------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 000111 12346688999999999999999 8999
Q ss_pred HHhCCCCCC
Q 004954 712 ALDHPWLQH 720 (722)
Q Consensus 712 lL~HPwf~~ 720 (722)
+++||||+.
T Consensus 264 ~l~h~~~~~ 272 (332)
T cd05614 264 IKEHPFFKG 272 (332)
T ss_pred HHcCCCcCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.02 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=196.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||+||++++..+|+.||+|+++... .......+|+++++.+ .||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~------~hp~i~~~~~~~~~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS------RHPFLTALKYSFQTHDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCCceEEEEEcCCEEEEEE
Confidence 36999999999999999999999999997642 2223445566666655 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
||+.+ +|...+... ..+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||++...
T Consensus 75 E~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~--~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 75 EYANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEG 146 (325)
T ss_pred eCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC--CCCEEEecCCCCeec
Confidence 99986 454444322 138899999999999999999997 79999999999999985 788999999998643
Q ss_pred cC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 574 TD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 574 ~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--------------- 211 (325)
T cd05594 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------- 211 (325)
T ss_pred CCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC---------------
Confidence 21 223457899999999999999999999999999999999999999877655544443210
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQHP 721 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~~ 721 (722)
...+| ...++.+.+||++||+.||++|+ ++.++|+||||+..
T Consensus 212 --------------------~~~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 212 --------------------EIRFP---------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred --------------------CCCCC---------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 00111 12346688999999999999997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=329.78 Aligned_cols=279 Identities=27% Similarity=0.424 Sum_probs=216.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.++|++.+.||+|++|.||++.++.+++.||||.+..... ......+|+.+++.++ |+||+++++++...+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK------HANIVTLHDIIHTKKT 77 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC------CcceeeEEEEEecCCe
Confidence 3689999999999999999999998999999999865322 2234567888888875 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+.++|.+++..... .+++..++.++.||++||.|||+.||+|+||||+||+++. ++.++|+|||++
T Consensus 78 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~ 150 (291)
T cd07844 78 LTLVFEYLDTDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE--RGELKLADFGLA 150 (291)
T ss_pred EEEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC--CCCEEECccccc
Confidence 999999999888877654321 3889999999999999999999999999999999999986 778999999988
Q ss_pred ccccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~-~~e~l~~i~~~lg~~~~~~~~ 645 (722)
...... .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.. ..+.+..+...++.+..+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 151 RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred cccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 654322 122346788999999876 458899999999999999999999997655 566777777777776666655
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccC--cHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS--DAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~--~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.......+........ ....+....... ...+.++|.+||+.+|.+|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKPYSFPFY--------------PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhcccccccccccc--------------CChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 4433222211111000 000011111111 2567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.41 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=203.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++|++.+.||+|+||.||++++..+++.+|+|++.+.. .....+.+|+.+++.++ ||||+++++++...
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~------hp~iv~~~~~~~~~ 115 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------SPWVVQLFCAFQDD 115 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC------CCCEeeEEEEEEcC
Confidence 478999999999999999999999999999999986532 12234556777776654 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
..+++||||+.+ +|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~--~~~~kL~DF 186 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK--HGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEEec
Confidence 999999999975 677766422 2788899999999999999999999999999999999985 788999999
Q ss_pred CCcccccCC----ccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 568 Gls~~~~~~----~~~~~gt~~y~APE~l~~~~----~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+.+++.....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~- 265 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS- 265 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc-
Confidence 998765432 23457899999999997643 788999999999999999999999887766666555421110
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC--CcCHHHHHhCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k--RpTa~ElL~HPw 717 (722)
..+|... ..+..+++||.+||+.++.+ |+|+.|+++|||
T Consensus 266 --------------------------------~~~p~~~-------~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 266 --------------------------------LNFPEDV-------EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred --------------------------------cCCCCcc-------cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 1111111 12356889999999866544 899999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 307 ~~~ 309 (370)
T cd05621 307 FKN 309 (370)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.66 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=203.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||++++..+++.||||+++... .....+.+|+.++..++ |++|+++++.+...+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD------GAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC------CCCEeeEEEEEEcCC
Confidence 46899999999999999999999999999999997532 23345566777776664 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++++||||+.| +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~--~~~vkL~DfG 146 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA--KGHVKLSDFG 146 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCEEEeecc
Confidence 99999999975 6766665332 2889999999999999999999999999999999999985 7899999999
Q ss_pred CcccccCC--------------------------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHH
Q 004954 569 SSCFQTDN--------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610 (722)
Q Consensus 569 ls~~~~~~--------------------------------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL 610 (722)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 87543210 1134689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHH
Q 004954 611 AELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 690 (722)
Q Consensus 611 ~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~ 690 (722)
|+|++|+.||.+.+....+.++..... ...+|... ..+..
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~p~~~-------~~s~~ 266 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKE---------------------------------TLVFPPEV-------PISEK 266 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCC---------------------------------ceecCCCC-------CCCHH
Confidence 999999999988777666655531100 01112111 12456
Q ss_pred HHHHHHHhcccCCCCCc---CHHHHHhCCCCCC
Q 004954 691 FIDFVRTLLEINPQRRP---TAREALDHPWLQH 720 (722)
Q Consensus 691 l~dLL~~mL~~dP~kRp---Ta~ElL~HPwf~~ 720 (722)
+++||.+|+. ||.+|+ ++.++++||||+.
T Consensus 267 ~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 267 AKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred HHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 8899999874 999998 5899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.01 Aligned_cols=244 Identities=28% Similarity=0.441 Sum_probs=197.1
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||+||+|++..+++.||||+++... ........|..++..+ ..||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCcCcceEEEEEeCCEEEEEE
Confidence 36999999999999999999999999997642 2233445566655543 35899999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|...+.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT--DGHIKIADFGMCKENM 147 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEccCCcceECC
Confidence 99975 6666655322 2888999999999999999999999999999999999986 7789999999986432
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------------- 212 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--------------- 212 (316)
T ss_pred CCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------
Confidence 22334578999999999999999999999999999999999999998876655554432100
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH-HHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR-EALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~-ElL~HPwf~~ 720 (722)
..+|. ..+..+.+||.+||+.||++||++. ++++||||+.
T Consensus 213 --------------------~~~~~---------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 213 --------------------PCYPR---------WLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred --------------------CCCCc---------cCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 00111 1235688999999999999999996 8999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=329.55 Aligned_cols=277 Identities=30% Similarity=0.454 Sum_probs=218.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++++.||.|++|.||+|++..+|+.+|||.+.... .....+.+|+++++.++ ||||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN------HPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC------CCCCcchhhhcccCCcE
Confidence 4899999999999999999999999999999886532 12245678888888875 68999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.+++..++..... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~--~~~~~l~dfg~~~ 148 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLAR 148 (284)
T ss_pred EEEeeccccCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEeeccchh
Confidence 99999998888777654322 23889999999999999999999999999999999999996 7889999999886
Q ss_pred cccCCc---cccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQTDNL---CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~~~~~---~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... ....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...+....+.++....+.++...+...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 543321 2234678899999987654 688999999999999999999999998888888888888887766655443
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.....+..... ... ...+.......++.+.+||.+||+.||++|||+.++|+||||
T Consensus 229 ~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 229 TSLPDYKPSFP-------------KWA--RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hHHHHHHhhcc-------------ccc--ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 33222111000 000 001111122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.03 Aligned_cols=279 Identities=26% Similarity=0.392 Sum_probs=215.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.+.||+|+||.||+|.+..+|+.+|+|++..... ......+|+.+++.+. |+||+++++++...+..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK------HANIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC------CCCEeEEEEEEecCCeE
Confidence 689999999999999999999999999999999865432 2234567888888774 67999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.+++++.+.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 79 ~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg~~~ 151 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY--LGELKLADFGLAR 151 (291)
T ss_pred EEEEecccCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC--CCcEEEecccccc
Confidence 9999999988887765332 12778889999999999999999999999999999999985 7889999999886
Q ss_pred cccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcHHHHhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~-~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
..... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||... ...+.+.++...++.+...++..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred ccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 54322 2234568899999998764 5788999999999999999999999764 34567777777777766666555
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccc-hhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEES-SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~-~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.....++....... ..+... ...... ..+..+.++|.+||+.||++|||+.|+|.||||
T Consensus 232 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKLPNYKPEWFLP------------CKPQQLRVVWKRL-SRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhcccccchhccc------------cCCcchhhhcccc-CCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 44333322110000 000000 000000 124678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.43 Aligned_cols=283 Identities=29% Similarity=0.460 Sum_probs=218.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... ....+.+|+.+++.+.+ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE-----SIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccC-----CCCccceeeeEeecCC
Confidence 479999999999999999999999999999998865422 23456788998888863 5799999999987765
Q ss_pred -----EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 491 -----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 491 -----l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
.++||||+.+++.+++...... ....+++..++.++.||+.||.|||+.||+||||+|+||+++. .++.++|+
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-~~~~~kl~ 153 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-QKGLLKIA 153 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-CCCeEEEe
Confidence 8999999999888887654322 1234899999999999999999999999999999999999985 36789999
Q ss_pred ecCCcccccCCc---cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 566 DLGSSCFQTDNL---CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 566 DFGls~~~~~~~---~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+....+.++...++.++.
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999987543321 22356788999999865 45789999999999999999999999988777777777776666555
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
..+........+... ....+ ..+.......+..+.+||.+||+.||.+|||+.|+|.||||+
T Consensus 234 ~~~~~~~~~~~~~~~--------------~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEF--------------PQWKP--QDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhc--------------Ccccc--hhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 444332222111100 00000 011111123456789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.68 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=213.4
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
-...|++++.||+|.-|+||+++...++..+|+|++.+.. ....+...|.+||..+ +||.++.+|..|+.
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l------DHPFlPTLYa~fet 148 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL------DHPFLPTLYASFET 148 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc------CCCccchhhheeec
Confidence 3467999999999999999999999999999999997643 3345566777888777 58899999999999
Q ss_pred cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 488 ~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
....|+|||||.|+-+..++..+ ....|++..++.++..++.||+|||-.|||+|||||+||||.. +|.|-|+||
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvre--dGHIMLsDF 223 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRE--DGHIMLSDF 223 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEec--CCcEEeeec
Confidence 99999999999876555555443 3455999999999999999999999999999999999999996 899999999
Q ss_pred CCccccc-----------------------------------CC------------------------ccccccCCcccC
Q 004954 568 GSSCFQT-----------------------------------DN------------------------LCLYVQSRSYRA 588 (722)
Q Consensus 568 Gls~~~~-----------------------------------~~------------------------~~~~~gt~~y~A 588 (722)
.++.... .. ...++||-.|.|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 9752100 00 011467888999
Q ss_pred chhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccc
Q 004954 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETN 668 (722)
Q Consensus 589 PE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (722)
||++.|...+.++|+|+|||++||||.|..||.+.+..+.+.+|+..--.
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~------------------------------ 353 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK------------------------------ 353 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc------------------------------
Confidence 99999999999999999999999999999999999999999998733221
Q ss_pred cccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC----HHHHHhCCCCCC
Q 004954 669 QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT----AREALDHPWLQH 720 (722)
Q Consensus 669 ~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT----a~ElL~HPwf~~ 720 (722)
+|... .....++|||+++|.+||++|.. |.||=+||||+.
T Consensus 354 -----Fp~~~-------~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 354 -----FPEEP-------EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred -----CCCCC-------cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 22221 12345889999999999999998 999999999975
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.04 Aligned_cols=279 Identities=27% Similarity=0.442 Sum_probs=213.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++.+.||+|++|.||++.+..+|+.||+|++.... .....+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK------HPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC------CCCEeeeeeEEeeCCE
Confidence 47999999999999999999999999999999886432 12344667888888775 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||++++++..+..... .+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||++
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~ 147 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK--QGQIKLCDFGFA 147 (286)
T ss_pred EEEEEeccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC--CCcEEECccccc
Confidence 999999999877766543221 2889999999999999999999999999999999999986 778999999998
Q ss_pred ccccCCc---cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDNL---CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~~---~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|++||.+....+.+..+....+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 7654432 23457888999999876 4578899999999999999999999998877777777666555443321111
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.. ...+.. .. ... .......+.......+..+.+||.+||+.+|++|||+.|+|.||||
T Consensus 228 ~~-~~~~~~--------~~---~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 228 FS-TNQFFK--------GL---SIP-EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cc-cccccc--------cc---cCC-CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 000000 00 000 0000011112222346778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=331.66 Aligned_cols=279 Identities=32% Similarity=0.460 Sum_probs=219.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhh------hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF------FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~------~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+|++.+.||.|++|.||+|.+..+++.||||.++..... ...+..|+.+++.++ |+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------HPNIIGLLDVFGHK 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC------CCCChhhhheeecC
Confidence 588999999999999999999999999999998764321 234456777777664 78999999999999
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 489 ~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
+.+++||||+.++|.+++.... ..+++..++.++.||++||.|||+.||+|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg 147 (298)
T cd07841 75 SNINLVFEFMETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFG 147 (298)
T ss_pred CEEEEEEcccCCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC--CCCEEEccce
Confidence 9999999999777877775432 13899999999999999999999999999999999999996 7889999999
Q ss_pred CcccccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 569 SSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 569 ls~~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++...++.+...++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred eeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 98765432 222356788999999865 45789999999999999999999999888777777777777776666555
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~~ 722 (722)
........+... ...............+..+.+||.+||++||++|||+.|+|+||||++.+
T Consensus 228 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 228 PGVTSLPDYVEF----------------KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred hhcccccccccc----------------cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 443322211110 00011111122233456789999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.96 Aligned_cols=257 Identities=29% Similarity=0.491 Sum_probs=223.9
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
.+..|++-|.+.+.||+|.|+.|-+|++..+|+.||||++.+.+ .....+..|++.|+.++ |||||++|.+
T Consensus 12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ------HpNiVRLYEV 85 (864)
T KOG4717|consen 12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ------HPNIVRLYEV 85 (864)
T ss_pred cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc------CcCeeeeeeh
Confidence 34567888999999999999999999999999999999997654 33456778888888886 6899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
......+|+|+|+-. |+|.+++...... +.+..+++++.||+.|+.|+|+..+|||||||+||.+-. .-|-||
T Consensus 86 iDTQTKlyLiLELGD~GDl~DyImKHe~G-----l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVK 159 (864)
T KOG4717|consen 86 IDTQTKLYLILELGDGGDLFDYIMKHEEG-----LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVK 159 (864)
T ss_pred hcccceEEEEEEecCCchHHHHHHhhhcc-----ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceE
Confidence 999999999999987 5899999876543 899999999999999999999999999999999998875 578999
Q ss_pred EEecCCccc--ccCCccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCF--QTDNLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~--~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++-. .+....+.||+..|.|||+++|..|+ .++||||||||||.|++|++||+..+..+.+..|+.+
T Consensus 160 LTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC----- 234 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC----- 234 (864)
T ss_pred eeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-----
Confidence 999999843 34567789999999999999999988 5899999999999999999999998888888887633
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.|.+|... +.+.++||..||..||.+|.+.+||..|+|+|.
T Consensus 235 ------------------------------KYtvPshv---------S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 235 ------------------------------KYTVPSHV---------SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred ------------------------------cccCchhh---------hHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 34444322 356889999999999999999999999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=336.56 Aligned_cols=253 Identities=31% Similarity=0.511 Sum_probs=218.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
-+..||.+.+.||+|.||+|-+|.+...|+.||||.+++++ ...-.+.+|++|+..|+ ||||+++|.+|+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN------HPhII~IyEVFE 123 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN------HPHIIQIYEVFE 123 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC------CCceeehhhhhc
Confidence 45679999999999999999999999999999999998753 33345678888888886 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+.+.|||||.. |.|++++..++. +++.+++.+++||+.|+.|+|+++++|||||.+|||++. ++.+||+
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~--N~NiKIA 195 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ--NNNIKIA 195 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC--CCCeeee
Confidence 9999999999997 679999987654 999999999999999999999999999999999999995 8899999
Q ss_pred ecCCcccccCC--ccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s-~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|||++-.+.+. ..++||+|-|.+||++.|.+|. ..+|.|||||+||.|+.|..||.+.+...+..+|...
T Consensus 196 DFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G------- 268 (668)
T KOG0611|consen 196 DFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG------- 268 (668)
T ss_pred ccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-------
Confidence 99999776554 5678999999999999999976 6899999999999999999999998887777766421
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~~ 722 (722)
.|.-|+. +....-||++||..||.+|.|+.++..|=|+.-.|
T Consensus 269 ----------------------------aYrEP~~----------PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 269 ----------------------------AYREPET----------PSDASGLIRWMLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred ----------------------------cccCCCC----------CchHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence 1222221 23356899999999999999999999999987554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.56 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=202.9
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+|++.+.||+|+||+||+|+++.+|+.||||+++... ........|..+++.+.+ |++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-----~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK-----PPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC-----CCchhheeeEEecCCE
Confidence 4788999999999999999999999999999997542 223345667777766643 5689999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+++||||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~--~~~ikL~Dfg~ 147 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEecccc
Confidence 9999999975 5655554322 2889999999999999999999999999999999999996 78899999999
Q ss_pred cccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------- 218 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------- 218 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 865322 22345689999999999999999999999999999999999999988776666655542110
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
..| ...+..+.+|+.+||+.+|.+|++ ..++++||||+.
T Consensus 219 --------------------------~~p---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 219 --------------------------SYP---------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred --------------------------CCC---------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 011 112356789999999999999997 589999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.36 Aligned_cols=273 Identities=33% Similarity=0.518 Sum_probs=214.1
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--CeE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EHL 491 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--~~l 491 (722)
|++.+.||+|+||.||++.+..+++.+|+|+++.... ......+|+.+++++. .|+||+++++++... +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS-----PHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC-----CCCCccceEEEEecCCCCcE
Confidence 6789999999999999999999999999999875321 1223345666666654 378999999999987 899
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.+++++.+.... ..+++..++.++.||+.||.|||+.|++||||+|+||+++. +.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~ 147 (282)
T cd07831 76 ALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCR 147 (282)
T ss_pred EEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEeccccc
Confidence 9999999999888776432 23899999999999999999999999999999999999994 889999999987
Q ss_pred cccCC--ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 572 FQTDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 572 ~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... .....+++.|+|||.+.. ..++.++|||||||++|+|++|..||++.+..+.+..+...++..+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 65332 223457889999998654 457889999999999999999999999988888888888888877765521110
Q ss_pred hhhhhhcccccchhhhhccccccccCCc--cchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~--~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
. . .......|. ...+.......+..+.+||.+||+.||++|||+.++|+||||
T Consensus 228 ---~----~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 228 ---K----S----------RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ---c----c----------ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0 0 000011111 111122223346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.22 Aligned_cols=248 Identities=31% Similarity=0.470 Sum_probs=208.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..|+.++.||+|.||.||+|.+..+++.||+|++..+ ......+..|+.+|..++. +||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~------~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS------PNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc------chHHhhhhheeecccH
Confidence 4588889999999999999999999999999999764 3445677788888888864 6999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+|+||||.| +++++++.... +.+..+..|+++++.||.|||..+.+|||||+.|||+.. .+.+||+|||.+
T Consensus 87 wiiMey~~gGsv~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~--~g~vkl~DfgVa 158 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNI------LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE--SGDVKLADFGVA 158 (467)
T ss_pred HHHHHHhcCcchhhhhccCCC------CccceeeeehHHHHHHhhhhhhcceecccccccceeEec--cCcEEEEeccee
Confidence 999999985 67777764432 477888899999999999999999999999999999997 689999999998
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
.+.... ..+++|||.|||||++.+..|+.++||||||++.+||++|.+||....+.-++
T Consensus 159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------------------ 220 (467)
T KOG0201|consen 159 GQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------------------ 220 (467)
T ss_pred eeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------------------
Confidence 776543 35689999999999999999999999999999999999999999765442111
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccc--hhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~--~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..||... .+.. ..++.|++||..||+.||+.||+|.+||+|+|++.
T Consensus 221 ------------------------flIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 221 ------------------------FLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ------------------------EeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 1222211 1111 33567999999999999999999999999999975
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=339.04 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=194.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||.||++++..+++.||+|+++... .....+..|..+++.+. .||||++++++|.....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCCCceEEEEEcCCEEEEEE
Confidence 36999999999999999999999999998632 22345667777777664 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc-
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 573 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~- 573 (722)
||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~--~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 76 EFVSGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGI 147 (329)
T ss_pred eCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEECcCccccccc
Confidence 99986 555554422 12899999999999999999999999999999999999986 788999999998642
Q ss_pred --cCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 574 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 574 --~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .....+.. .
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-------~~~~~~~~------~ 214 (329)
T cd05588 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-------DQNTEDYL------F 214 (329)
T ss_pred cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc-------cccchHHH------H
Confidence 22234467899999999999999999999999999999999999999532110000 00000000 0
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC------HHHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT------AREALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT------a~ElL~HPwf~~ 720 (722)
+.+ ......+|. ..+..+.+||++||+.||.+|+| +.++++||||..
T Consensus 215 ~~~-------------~~~~~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 215 QVI-------------LEKQIRIPR---------SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHH-------------HcCCCCCCC---------CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 000 000011121 23456889999999999999987 799999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=303.10 Aligned_cols=278 Identities=31% Similarity=0.447 Sum_probs=235.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|.-.++||+|.||+|+++++..+++.||+|.++.+.+ .....++|+-++++++| .|||+++++.-.+..+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkh------knivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH------KNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhh------cceeehhhhhccCcee
Confidence 46667899999999999999999999999999986532 34567899999999974 5899999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
-+|+|||...|..+...... .+..+.++.++.|+++||.|+|+.++.|||+||.|.||+. +|++||+|||+++
T Consensus 77 tlvfe~cdqdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~--ngelkladfglar 149 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR--NGELKLADFGLAR 149 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc--CCcEEecccchhh
Confidence 99999999888888775443 2888999999999999999999999999999999999996 8999999999998
Q ss_pred cccCCcc---ccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 572 FQTDNLC---LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 572 ~~~~~~~---~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
-.+-+.. ..+-|.+|++|.++.+.+ |+...|+||.|||+.|+.. |++.|++.+..+++.+|...+|.+..+.|+.
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 7766542 245689999999999865 8999999999999999987 9999999999999999999999999888877
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...+.+|.. ....|...++++..+.....-++|++++|.-+|.+|++|+++|+||+|..
T Consensus 230 ~t~lpdyk~---------------yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 230 MTKLPDYKP---------------YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cccCCCCcc---------------cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 655544321 12234444444444444455679999999999999999999999999975
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.83 Aligned_cols=254 Identities=24% Similarity=0.280 Sum_probs=202.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.|++.++||+|+||+||++.+..+++.||+|++..... ......+|+.+++.++ ||||+++++.+...++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN------SRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC------CCCEeeeeeeecCCCe
Confidence 48999999999999999999999999999999875321 1234567888888775 6799999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+++||||+.+ +|.+.+.... ...+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC--CCCEEEeeCCC
Confidence 9999999985 5554443221 123889999999999999999999999999999999999985 78899999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+...... .....+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+...+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--------- 219 (285)
T cd05605 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--------- 219 (285)
T ss_pred ceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh---------
Confidence 8765332 22357899999999999989999999999999999999999999876543333222211000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
....++ ...+..+.+||.+||+.||.+|| +++++++||||..
T Consensus 220 ----------------------~~~~~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 220 ----------------------DQEEYS---------EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ----------------------cccccC---------cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 000011 12345688999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=337.46 Aligned_cols=243 Identities=27% Similarity=0.422 Sum_probs=197.4
Q ss_pred EEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 420 EYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+.||+|+||.||++++. .+++.||+|+++... .......+|+.+++.++ ||||+++++.|...+..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK------HPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC------CCchhceeeEEecCCeE
Confidence 67999999999999863 578999999987532 22234567888887774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+.+.... .+.+..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA--QGHVKLTDFGLC 147 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEeeCcCC
Confidence 999999985 5666554322 2788889999999999999999999999999999999986 788999999998
Q ss_pred ccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~----------- 216 (323)
T cd05584 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK----------- 216 (323)
T ss_pred eecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 64322 2233578999999999999889999999999999999999999998877655555443110
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
..+| ...+..+.+||++||+.||++|| ++.++++||||+.
T Consensus 217 ------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 217 ------------------------LNLP---------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred ------------------------CCCC---------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 0111 11245688999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.37 Aligned_cols=281 Identities=26% Similarity=0.431 Sum_probs=215.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.++|++.++||+|+||.||+|++..+++.||||++..... ......+|+.+++.++ ||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC------CCCccceEEEEeccc
Confidence 4679999999999999999999999999999998864321 2234456788887775 689999999987653
Q ss_pred --------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 490 --------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 490 --------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
..++||||+.+++.+.+.... ..+++.+++.++.||+.||.|||+.|++|+||||+||+++. ++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~ 157 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEHDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK--DGI 157 (310)
T ss_pred ccccCCCceEEEEEcCCCcCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC--CCc
Confidence 459999999988877765322 23899999999999999999999999999999999999985 788
Q ss_pred EEEEecCCcccccCCc-------cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 562 IKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 562 vkL~DFGls~~~~~~~-------~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
+||+|||++....... ....++..|+|||.+.+. .++.++||||||+++|+|++|++||.+.+....+..+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999886543221 223567889999998764 37889999999999999999999999988888888888
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
...|.++.+.+........+-..... .......+ ..+ .....+..+.+||.+||..||.+|||++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~--~~l--~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELP--------QGQKRKVK--ERL--KPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCC--------CccchhhH--Hhc--ccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 88888887766554322211100000 00000000 000 1112345688999999999999999999999
Q ss_pred hCCCC
Q 004954 714 DHPWL 718 (722)
Q Consensus 714 ~HPwf 718 (722)
+||||
T Consensus 306 ~h~~f 310 (310)
T cd07865 306 NHDFF 310 (310)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.67 Aligned_cols=281 Identities=28% Similarity=0.451 Sum_probs=219.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++.+.||.|++|+||+|.++.+|+.||+|.+.... .....+.+|+++++.++ |+||+++++++....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ------HGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc------CCCEeeEEEEEecCCe
Confidence 57999999999999999999999999999999886532 22345667888888775 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+++++.+.+..... ..+++..++.++.||+.||+|||+++++|+||+|+||+++. .+..+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-~~~~~kl~dfg~~ 150 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLA 150 (294)
T ss_pred EEEEEecccccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-CCCEEEEcccccc
Confidence 999999999888877654322 22678889999999999999999999999999999999985 3567999999998
Q ss_pred ccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
...... .....+++.|+|||.+.+. .++.++|||||||++|+|++|++||...+..+.+.++....+.+....|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 654322 2234567899999998764 578999999999999999999999998877777777777777666555543
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
......+... .. ..+ ...+.......++.+.++|.+||+.+|++||++.++|+||||+.
T Consensus 231 ~~~~~~~~~~-------------~~-~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 231 VTSLPDYKSA-------------FP-KWP-PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred cccchhhhhh-------------cc-cCC-CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 3222222110 00 000 01111122334567899999999999999999999999999975
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.60 Aligned_cols=287 Identities=29% Similarity=0.497 Sum_probs=216.3
Q ss_pred cEEEEEEeccCCCCceEEEEECC--CCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~--tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+|++.++||+|+||.||+|.+.. +++.||+|++.... .......+|+.+++.++ ||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK------HENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC------CCCccceEEEEeCC
Confidence 58999999999999999999988 89999999987632 23355677888888775 68999999999988
Q ss_pred --CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc--CCCeEEE
Q 004954 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKI 564 (722)
Q Consensus 489 --~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~--~~~~vkL 564 (722)
..+++||||+++++.+++....... ...+++..++.++.||+.||.|||+.+|+||||||+||+++.+ .++.+||
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence 8899999999998888776443321 2348999999999999999999999999999999999999841 2678999
Q ss_pred EecCCcccccCCcc------ccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH---------HHH
Q 004954 565 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMI 628 (722)
Q Consensus 565 ~DFGls~~~~~~~~------~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~---------~e~ 628 (722)
+|||++........ ...+++.|+|||++.+. .++.++|||||||++|+|++|++||.+... ...
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 99999876543322 24568889999998764 578999999999999999999999976433 235
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhc---ccCcHHHHHHHHHhcccCCCC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL---QFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~---~~~~~~l~dLL~~mL~~dP~k 705 (722)
+..+...++.++...+........+.... .. ......+. ..+.... ...+..+.++|.+||+.||++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 303 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLM-------KD--FKTKTYPS-NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTK 303 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhh-------hh--ccCCCCCC-ccHHHHHHhccCCCHHHHHHHHHHhcCCccc
Confidence 56666777766655554333222211100 00 00001110 1111111 134567899999999999999
Q ss_pred CcCHHHHHhCCCC
Q 004954 706 RPTAREALDHPWL 718 (722)
Q Consensus 706 RpTa~ElL~HPwf 718 (722)
|||+.|+++||||
T Consensus 304 Rps~~eil~~~~f 316 (316)
T cd07842 304 RITAEEALEHPYF 316 (316)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.84 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=200.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||+||++++..+++.||+|++.+.. .....+.+|..+++.+ .|+||++++++|...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG------DRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCCCceEEEEecCC
Confidence 47999999999999999999999999999999997532 2233455667776655 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg 147 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK--NGHIRLADFG 147 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC--CCCEEEEECC
Confidence 99999999974 6777665322 12889999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCCc----cccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~~-----~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
++....... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~-- 225 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-- 225 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--
Confidence 986543321 22468999999999973 3577899999999999999999999988776666555431110
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC--CcCHHHHHhCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k--RpTa~ElL~HPw 717 (722)
...+|.. ....+..+++||++||..++.+ |+++.++++|||
T Consensus 226 -------------------------------~~~~~~~------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 226 -------------------------------HFQFPPD------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred -------------------------------cccCCCc------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0001110 1113467889999999764444 789999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|..
T Consensus 269 ~~~ 271 (331)
T cd05597 269 FEG 271 (331)
T ss_pred CCC
Confidence 964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=351.45 Aligned_cols=279 Identities=24% Similarity=0.298 Sum_probs=205.4
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
...+|.+.+.||+|+||.||++.+..+++.||||.... ....+|+++++.++ |+||+++++++...+..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~------HpnIv~l~~~~~~~~~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLS------HPAVLALLDVRVVGGLT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCC------CCCCCcEEEEEEECCEE
Confidence 45689999999999999999999999999999996432 34568999998885 68999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++|||++.++|+.++..... .+++..++.|+.||+.||.|||+.||+||||||+||||+. ++.+||+|||+++
T Consensus 236 ~lv~e~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~--~~~vkL~DFGla~ 308 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG--PEDICLGDFGAAC 308 (461)
T ss_pred EEEEEccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC--CCCEEEcccCCce
Confidence 99999999998888764322 3899999999999999999999999999999999999985 7789999999987
Q ss_pred cccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-C------hHHHHHHHHHhhcCCC
Q 004954 572 FQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-D------AVVMILARIIGMLGPI 639 (722)
Q Consensus 572 ~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~-~------~~~e~l~~i~~~lg~~ 639 (722)
...... ....||+.|+|||++.+..++.++|||||||+||||++|..|+-. . .....+.+++...+..
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 643321 234689999999999999999999999999999999998765422 1 1122233333222211
Q ss_pred cHHHHhh--hhhhhhhhcccccchhhhhccccccccCCc-cchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 640 DLEMLMQ--GQEIYKYFTKEYDLYYINEETNQLEYIIPE-ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 640 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
..+.... ......+.. .......+. ....+......+..+.+||.+||+.||.+|||+.|||+||
T Consensus 389 ~~~~~~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRH------------RAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred cccCCCCcchHHHHHHHh------------hhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 1000000 000000000 000000000 0000111122345688999999999999999999999999
Q ss_pred CCCC
Q 004954 717 WLQH 720 (722)
Q Consensus 717 wf~~ 720 (722)
||++
T Consensus 457 ~f~~ 460 (461)
T PHA03211 457 LFQS 460 (461)
T ss_pred ccCC
Confidence 9986
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.38 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=192.5
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||+||++++..+++.+|+|++++.. .......+|+.++..+. .||||+++++++...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-----CCCcCCceeeEEEeCCEEEEEE
Confidence 36999999999999999999999999997532 23344566777666553 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 E~~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~--~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 76 EYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGL 147 (329)
T ss_pred eCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCCEEEeeCCcccccc
Confidence 99986 454444322 23889999999999999999999999999999999999986 7889999999986432
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH--------HHHHHHHHhhcCCCcHHH
Q 004954 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--------VMILARIIGMLGPIDLEM 643 (722)
Q Consensus 575 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~--------~e~l~~i~~~lg~~~~~~ 643 (722)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+.+.+
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------- 217 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------- 217 (329)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH----------
Confidence 223346789999999999999999999999999999999999999953110 00000000
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC------HHHHHhCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT------AREALDHPW 717 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT------a~ElL~HPw 717 (722)
......+|. ..+..+.+||++||+.||.+||+ +.++++|||
T Consensus 218 ------------------------~~~~~~~p~---------~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05618 218 ------------------------LEKQIRIPR---------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 264 (329)
T ss_pred ------------------------hcCCCCCCC---------CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence 000111221 23466889999999999999998 589999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 265 f~~ 267 (329)
T cd05618 265 FRN 267 (329)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=326.22 Aligned_cols=293 Identities=29% Similarity=0.438 Sum_probs=232.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~----~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..|+++++||+|.||.||+|..+.++. .+|||.++..+ .......+|+.++++++ ||||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~------h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK------HPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc------CCcchhHHHHHh
Confidence 468999999999999999996554432 68999998653 23456789999999997 679999999998
Q ss_pred e-cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc--CCCeEE
Q 004954 487 H-LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIK 563 (722)
Q Consensus 487 ~-~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~--~~~~vk 563 (722)
. +..+++++||.+.+|+..++....... ..++...+..|+.||+.|+.|||++.|+||||||.||||..+ ..|.||
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 678999999999999999998877655 569999999999999999999999999999999999999752 248999
Q ss_pred EEecCCcccccCCccc------cccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCh---------HHH
Q 004954 564 IIDLGSSCFQTDNLCL------YVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDA---------VVM 627 (722)
Q Consensus 564 L~DFGls~~~~~~~~~------~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF~~~~---------~~e 627 (722)
|+|||+++....+... .+-|.+|+|||.++|.. |+.++|||++|||+.||+|-++.|.+.. ..+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999987776443 45689999999999865 8999999999999999999999996532 356
Q ss_pred HHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc
Q 004954 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707 (722)
Q Consensus 628 ~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp 707 (722)
.+.+|...+|.+..+.|+....+.+|...-.+.. . . .+..-....+-+..+..++...+||.+||+.||.+|.
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~---~--~--~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI 329 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFR---R--H--YYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI 329 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhH---H--h--hcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence 8899999999998888877666555422111000 0 0 0000000111122233445578999999999999999
Q ss_pred CHHHHHhCCCCCC
Q 004954 708 TAREALDHPWLQH 720 (722)
Q Consensus 708 Ta~ElL~HPwf~~ 720 (722)
|++++|+|+||..
T Consensus 330 ta~qAleh~yF~~ 342 (438)
T KOG0666|consen 330 TAEQALEHPYFTE 342 (438)
T ss_pred cHHHHhccccccc
Confidence 9999999999964
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=342.98 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=195.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..|+++++||+|+||+||++++..+++.||||++.... .....+.+|+++++.++ |+||+++++++...+.+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN------HPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC------CCCcceeeeEeccCCeE
Confidence 56788899999999999999999999999999986532 33456778888888774 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.++.+.. .....+..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 148 ~lv~e~~~~~~L~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~DfG~~~ 216 (353)
T PLN00034 148 QVLLEFMDGGSLEG---------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS--AKNVKIADFGVSR 216 (353)
T ss_pred EEEEecCCCCcccc---------cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEcccccce
Confidence 99999998754321 112567788899999999999999999999999999999986 7889999999987
Q ss_pred cccCC---ccccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~-----~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
..... .....||+.|+|||++.. ...+.++|||||||++|+|++|+.||......+....+....
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~------- 289 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC------- 289 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-------
Confidence 65432 234578999999998743 234568999999999999999999997432211111110000
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
....... ....+..+.+||.+||+.||++|||+.|+|+||||.+.
T Consensus 290 ------------------------~~~~~~~---------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 290 ------------------------MSQPPEA---------PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------------------------ccCCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0000000 11234678999999999999999999999999999764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.56 Aligned_cols=245 Identities=29% Similarity=0.412 Sum_probs=199.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcE-EEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~-vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
....+.+.||+|+||+||++.+. |+. ||||++.... .....+.+|+.+|.+++ |||||+++|++....
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~------HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLR------HPNIVQFYGACTSPP 112 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCC------CCCeeeEEEEEcCCC
Confidence 34556666999999999999874 555 9999997543 22457889999999875 789999999999887
Q ss_pred -eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC-CccccCCCCceEEcccCCC-eEEEE
Q 004954 490 -HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-IIHCDLKPENILIKSYQRC-EIKII 565 (722)
Q Consensus 490 -~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g-IvHrDLKp~NILl~~~~~~-~vkL~ 565 (722)
.++|||||+++ +|..++... ....+++..+..|+.||+.||.|||+++ ||||||||+||||+. +. ++||+
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~--~~~~~KI~ 186 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDL--KGKTLKIA 186 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcC--CCCEEEEC
Confidence 79999999985 566666543 1233999999999999999999999999 999999999999996 65 99999
Q ss_pred ecCCcccccC---CccccccCCcccCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 566 DLGSSCFQTD---NLCLYVQSRSYRAPEVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 566 DFGls~~~~~---~~~~~~gt~~y~APE~l~--~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|||+++.... ..+...||+.|||||++. ..+|+.++||||||+++|||+||+.||.+.........++..
T Consensus 187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~----- 261 (362)
T KOG0192|consen 187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG----- 261 (362)
T ss_pred CCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-----
Confidence 9999987664 333468999999999999 568999999999999999999999999998775555554421
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
..+..+|.. .++.+..||.+||..||.+||+..+++.
T Consensus 262 ----------------------------~~Rp~~p~~---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 262 ----------------------------GLRPPIPKE---------CPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------------------CCCCCCCcc---------CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 112222221 3467899999999999999999999874
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=336.59 Aligned_cols=243 Identities=25% Similarity=0.371 Sum_probs=193.9
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHH-HHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKL-LKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~i-l~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
+.||+|+||+||+|++..+|+.||||++..... .......|..+ ++. ..||||+++++.+...+..++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~------l~hp~iv~~~~~~~~~~~~~lv 74 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN------VKHPFLVGLHYSFQTADKLYFV 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhh------CCCCCCCCeeEEEEeCCEEEEE
Confidence 369999999999999999999999999875421 12223333332 222 3589999999999999999999
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~--~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 75 LDYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (323)
T ss_pred EcCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeccCCCccc
Confidence 999986 5555554322 3889999999999999999999999999999999999986 788999999998643
Q ss_pred cC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 574 TD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 574 ~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------------- 212 (323)
T cd05575 147 IEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-------------- 212 (323)
T ss_pred ccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 22 2234578999999999999999999999999999999999999998877666655543110
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH----HHHHhCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 720 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa----~ElL~HPwf~~ 720 (722)
..++ ...+..+.+||++||+.||.+||++ .++++||||..
T Consensus 213 ---------------------~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 213 ---------------------LRLK---------PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred ---------------------CCCC---------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 0001 1124568899999999999999998 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=326.74 Aligned_cols=278 Identities=28% Similarity=0.428 Sum_probs=220.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~-- 488 (722)
++|++.+.||.|+||.||+|.+..+++.+|+|.++.... ......+|+.+++.++ ||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ------HPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC------CCCEEEEEEEEEecCC
Confidence 579999999999999999999999999999999875432 2234567888887774 78999999999877
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 489 ~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
...++||||+.++|.+++..... .+++..++.++.||+.||+|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 79 ~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~--~~~~~l~d~g 151 (293)
T cd07843 79 DKIYMVMEYVEHDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN--RGILKICDFG 151 (293)
T ss_pred CcEEEEehhcCcCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCcEEEeecC
Confidence 89999999999888887764332 3899999999999999999999999999999999999996 7889999999
Q ss_pred CcccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 569 ls~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
++...... .....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||......+.+.++....+.+....+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 152 LAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred ceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 88765443 2234568889999998764 4688999999999999999999999998888888888888887776666
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhccc--CcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQF--SDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~--~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.....+......... .+....+....+. .+..+.+||++||+.||++|||+.|+|+||||
T Consensus 232 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 232 PGFSELPGAKKKTFT--------------KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHhhccchhcccccc--------------cccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 544332221110000 0000111111111 25678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.39 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=202.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..++|++.+.||+|+||.||+++++.+++.+|+|++.... .....+.+|..+++.+ .||||+++++.+..
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~~~~~~~ 114 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFYAFQD 114 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEc
Confidence 3478999999999999999999999999999999986422 2223455677777665 47899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
...+++||||+.+ +|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~--~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC--CCCEEEEe
Confidence 9999999999975 566665422 2788899999999999999999999999999999999986 78899999
Q ss_pred cCCcccccCC----ccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~y~APE~l~~~~----~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+.++......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 9998765432 22457899999999997643 788999999999999999999999988776666555421110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC--CcCHHHHHhCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHP 716 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k--RpTa~ElL~HP 716 (722)
+ .+|.. ...+..+++||.+||+.++.+ |+++.++++||
T Consensus 266 ~---------------------------------~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 L---------------------------------TFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred c---------------------------------cCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 11111 123466889999999854443 78999999999
Q ss_pred CCCC
Q 004954 717 WLQH 720 (722)
Q Consensus 717 wf~~ 720 (722)
||++
T Consensus 306 ~~~~ 309 (371)
T cd05622 306 FFKN 309 (371)
T ss_pred ccCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.25 Aligned_cols=276 Identities=30% Similarity=0.502 Sum_probs=217.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+|++.+.||.|++|.||+|++..+|+.||||+++... .......+|+.+++.++ |+||+++++.+...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK------HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc------CCCEeeeeeeEeeCCcEE
Confidence 5899999999999999999999999999999987543 22355667888888775 679999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
+||||+.+++.+++..... ...+++..+..++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||++..
T Consensus 75 lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~--~~~~~l~d~g~~~~ 149 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK--RGELKLADFGLARA 149 (284)
T ss_pred EEEecCCccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCcEEEeecchhhh
Confidence 9999999988887764332 234899999999999999999999999999999999999985 78899999999865
Q ss_pred ccCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 573 ~~~~~---~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... ....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++......+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 43321 224568889999998764 57889999999999999999999999888888777777666655555443332
Q ss_pred hhhhhhcccccchhhhhccccccccCCcc--chhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~--~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....+.. ..|.. ..........+..+.++|.+||+.||.+||++.++++||||
T Consensus 230 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 QLPEYKP-----------------TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCchhcc-----------------cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 2111110 01100 01111112235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.43 Aligned_cols=280 Identities=30% Similarity=0.454 Sum_probs=220.7
Q ss_pred eecCcEEEE-EEeccCCCCceEEEEECCCCcEEEEEEeecchhhh---------------HhHHHHHHHHHHhcccCCCC
Q 004954 411 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF---------------DQSLDEIKLLKLVNKNDPAD 474 (722)
Q Consensus 411 ~l~~rY~i~-~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~---------------~~~~~E~~il~~L~~~~~~~ 474 (722)
.+.+||.++ +.||+|+||+||+|.+..+++.||||+++...... ..+.+|+.+++.++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------ 78 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK------ 78 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC------
Confidence 456788754 67999999999999999999999999986532211 13567888887775
Q ss_pred CCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEE
Q 004954 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (722)
Q Consensus 475 hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl 554 (722)
|+||+++++++...+..++||||+.+++.+.+.... .+++..+..++.||+.||+|||+.||+|+||+|+||++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 689999999999999999999999998888775322 28899999999999999999999999999999999999
Q ss_pred cccCCCeEEEEecCCcccccC-----------------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhC
Q 004954 555 KSYQRCEIKIIDLGSSCFQTD-----------------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTG 616 (722)
Q Consensus 555 ~~~~~~~vkL~DFGls~~~~~-----------------~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG 616 (722)
+. ++.++|+|||.+..... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|
T Consensus 153 ~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 153 NS--KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred CC--CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 86 77899999998865441 11123457789999998764 468999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHH
Q 004954 617 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696 (722)
Q Consensus 617 ~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~ 696 (722)
.+||.+.+..+.+..+...++.++..+|........+.. .....+ ..........+..+.+||.
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~--~~~~~~~~~~~~~~~~li~ 294 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE--------------FTPRKP--KDLKTIFPNASDDAIDLLQ 294 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccc--------------cCcCCc--ccHHHhCcCCChHHHHHHH
Confidence 999999888888888888888777665544332211110 000001 1112222334567899999
Q ss_pred HhcccCCCCCcCHHHHHhCCCCCC
Q 004954 697 TLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 697 ~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+||+.+|++|||++|+|.||||+.
T Consensus 295 ~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 295 SLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHcCCCchhccCHHHHhcCcccCC
Confidence 999999999999999999999975
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.19 Aligned_cols=279 Identities=30% Similarity=0.484 Sum_probs=220.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+++++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR------HENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC------CCCeeehhheEEECCE
Confidence 4799999999999999999999999999999988653 233456778888888885 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||++++++..+..... .+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~--~~~~kl~d~g~~ 147 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE--SGVLKLCDFGFA 147 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEEeeecc
Confidence 999999999887776543321 2889999999999999999999999999999999999996 888999999998
Q ss_pred ccccCCc----cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~~----~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
....... ....++..|+|||++.+. .++.++||||||+++|+|++|++||.+....+.+..+...++..+..+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 7654332 235678889999999888 78999999999999999999999999887777777777777776665433
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhh-cccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH-LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~-~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.......+.. ..... .......... ....+..+.+||++||..+|++|||++++++||||
T Consensus 228 ~~~~~~~~~~------------~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 228 LFSSNPRFAG------------VAFPE-PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred hcccCccccc------------cccCC-CCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 2211100000 00000 0000111111 12236779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.15 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=193.8
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
||+|+||+||++.+..+++.+|+|++..... ....+..|+++++.++ |+||+++++++....+.++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH------SRFIVSLAYAFQTKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC------CCcEeeeeEEEcCCCeEEEEEeC
Confidence 7999999999999999999999999875321 2244567888888775 67999999999999999999999
Q ss_pred cccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+.++ |...+.... .....+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 75 ~~~g~L~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 75 MNGGDLRYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEeeCccceecCCC
Confidence 9864 544443211 12234899999999999999999999999999999999999985 778999999998654332
Q ss_pred ---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 004954 577 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (722)
Q Consensus 577 ---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~ 653 (722)
.....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------------- 214 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL---------------- 214 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc----------------
Confidence 2234689999999999999999999999999999999999999976432111111110000
Q ss_pred hcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 654 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
.....+| ...+..+.+||.+||+.||++|| |++++++||||+.
T Consensus 215 ---------------~~~~~~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 215 ---------------NDSVTYP---------DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred ---------------ccCCCCc---------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 0000011 12346688999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.33 Aligned_cols=280 Identities=33% Similarity=0.576 Sum_probs=217.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~- 488 (722)
++++|++.+.||+|+||.||+|.+..+|+.||+|++... ........+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK------HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC------CCCcCchhheeeccc
Confidence 457899999999999999999999999999999998642 233455677888888775 67999999887644
Q ss_pred ----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 489 ----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 489 ----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
.+.++||||+.+++...+... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~--~~~~kl 147 (336)
T cd07849 77 FESFNDVYIVQELMETDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKI 147 (336)
T ss_pred ccccceEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEE
Confidence 368999999998877666421 2889999999999999999999999999999999999986 788999
Q ss_pred EecCCcccccCCc------cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 565 ~DFGls~~~~~~~------~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
+|||++....... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...++
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~ 227 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999986543221 22467889999998765 4688999999999999999999999998888888888888888
Q ss_pred CCcHHHHhhhhhhh--hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 638 PIDLEMLMQGQEIY--KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.++.+.+....... .++. ... ......+.......+..+.+||.+||+.+|.+|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 228 TPSQEDLNCIISLRARNYIK-------------SLP--FKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCHHHHHHhhchhhhhHHh-------------hcC--cCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 76665543221100 0000 000 000011111122235678999999999999999999999999
Q ss_pred CCCCCC
Q 004954 716 PWLQHP 721 (722)
Q Consensus 716 Pwf~~~ 721 (722)
|||..-
T Consensus 293 p~~~~~ 298 (336)
T cd07849 293 PYLEQY 298 (336)
T ss_pred cccccc
Confidence 999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=351.60 Aligned_cols=256 Identities=24% Similarity=0.322 Sum_probs=205.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
...++|++.+.||+|+||+||++++..+|+.||||++.... .......+|+.++..+ .|+||++++..+..
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~------~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC------DFFSIVKCHEDFAK 102 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC------CCCcEEEeecceec
Confidence 34579999999999999999999999999999999986532 2334455666666554 47899999888764
Q ss_pred cC--------eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 488 LE--------HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 488 ~~--------~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
.+ .+++||||+. |+|.+.+..... ....+++..+..++.|++.||.|||+.+|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~-- 178 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS-- 178 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC--
Confidence 32 3789999998 577777654332 2234899999999999999999999999999999999999986
Q ss_pred CCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 788999999998754322 234578999999999999999999999999999999999999998877666554443
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
.... ..+| ...++.+.+||.+||+.||.+||++.++|
T Consensus 259 ~~~~----------------------------------~~~~---------~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 259 AGRY----------------------------------DPLP---------PSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred cCCC----------------------------------CCCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 1100 0011 12346789999999999999999999999
Q ss_pred hCCCCC
Q 004954 714 DHPWLQ 719 (722)
Q Consensus 714 ~HPwf~ 719 (722)
+|||++
T Consensus 296 ~~p~~~ 301 (496)
T PTZ00283 296 NMPICK 301 (496)
T ss_pred hCHHHH
Confidence 999975
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=336.62 Aligned_cols=243 Identities=29% Similarity=0.408 Sum_probs=198.3
Q ss_pred EEeccCCCCceEEEEE---CCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 420 EYLGSAAFSKVFQAQD---LHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d---~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
+.||+|+||.||++++ ..+|+.+|+|++..... ......+|+++++.++ ||||+++++++...+.+++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------HPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC------CCCcccEEEEEEcCCEEEE
Confidence 5799999999999986 35789999999976432 2234556777777664 7899999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kL~Dfg~~~~ 147 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTDFGLSKE 147 (318)
T ss_pred EEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC--CCcEEEeeccCCcc
Confidence 999997 4666665432 23889999999999999999999999999999999999985 78899999999876
Q ss_pred ccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 573 ~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 148 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~------------ 215 (318)
T cd05582 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL------------ 215 (318)
T ss_pred cCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 4333 2335789999999999998899999999999999999999999988776665555432110
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
.+| ...+..+.+||++||+.||++||+ +.++++||||+.
T Consensus 216 -----------------------~~p---------~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 216 -----------------------GMP---------QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred -----------------------CCC---------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 111 123456889999999999999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=323.74 Aligned_cols=249 Identities=28% Similarity=0.474 Sum_probs=208.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||.||++.+..+++.+|+|+++... ...+.+.+|+++++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR------HPFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCccceeeEEEcCC
Confidence 47999999999999999999999999999999987532 23455667888887774 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+. ++|.+.+.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.+||+|||
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~dfg 146 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS--DGYIKITDFG 146 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC--CCCEEEeeCC
Confidence 9999999995 67777765432 3889999999999999999999999999999999999986 7889999999
Q ss_pred CcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 569 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
++...........+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+....
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 214 (290)
T cd05580 147 FAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK------------ 214 (290)
T ss_pred CccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------
Confidence 99876666555678999999999998888999999999999999999999998776544444433110
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
..+|. ..+..+.++|++||+.||.+|+ +++|+++||||+.
T Consensus 215 -----------------------~~~~~---------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 215 -----------------------VRFPS---------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred -----------------------ccCCc---------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 01111 1246688999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=340.09 Aligned_cols=243 Identities=24% Similarity=0.363 Sum_probs=205.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
.+++++.||+|-||.||+|.+.. ...||+|.++......+.+.+|+++|+.|+ |++||++++++...+.++||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~------H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLR------HEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCc------ccCeEEEEEEEecCCceEEE
Confidence 35566789999999999999743 347999999887666678889999999997 56899999999998899999
Q ss_pred EEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
||||. |+|+++++... ...+...+++.++.|||+||+||+++++|||||..+||||+. +..+||+|||+|+..
T Consensus 280 tE~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~--~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE--DLVVKISDFGLARLI 353 (468)
T ss_pred EEecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc--CceEEEccccccccc
Confidence 99997 78999998622 234899999999999999999999999999999999999996 789999999999965
Q ss_pred cCCccc-c---ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 574 TDNLCL-Y---VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 574 ~~~~~~-~---~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
.+.... . .-+..|.|||.+....++.++|||||||+||||+| |+.||++.+..+.+..+.+...
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR----------- 422 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR----------- 422 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-----------
Confidence 544332 1 22566999999999999999999999999999999 9999999999998888753211
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
+| .+...++++.++|..||..+|++|||.+.+.
T Consensus 423 -------------------------lp-------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 423 -------------------------LP-------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -------------------------CC-------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 11 1234567789999999999999999988665
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=338.39 Aligned_cols=245 Identities=25% Similarity=0.370 Sum_probs=193.9
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
||+|+||+||+|++..+++.||+|++..... .......|..++..+.. ..||||+++++.+....+.++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~---~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL---DESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhcc---CCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999999999999999999865321 12233445555554431 2589999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC-
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 575 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~- 575 (722)
+.+ +|...+.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 78 MSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIALCDFGLSKANLTD 149 (330)
T ss_pred CCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEecCCcCcCCCCC
Confidence 975 5665554322 2889999999999999999999999999999999999986 77899999999865322
Q ss_pred --CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhh
Q 004954 576 --NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652 (722)
Q Consensus 576 --~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~ 652 (722)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------- 213 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK---------------- 213 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 22345789999999999765 48899999999999999999999998876665554443110
Q ss_pred hhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc----CHHHHHhCCCCCC
Q 004954 653 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP----TAREALDHPWLQH 720 (722)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp----Ta~ElL~HPwf~~ 720 (722)
..+|. ...+..+.+||++||+.||.+|| ++.++++||||..
T Consensus 214 -------------------~~~~~--------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 214 -------------------VRFPK--------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred -------------------CCCCC--------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 01111 01245688999999999999998 7999999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=352.75 Aligned_cols=291 Identities=22% Similarity=0.273 Sum_probs=205.7
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCC-CcEEEE------------------EEeecchhhhHhHHHHHHHHHHhcc
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCL------------------KIIKNDKDFFDQSLDEIKLLKLVNK 469 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~t-g~~vAv------------------Kil~~~~~~~~~~~~E~~il~~L~~ 469 (722)
++.+.++|++++.||+|+||+||++..+.. +...++ |.+.........+.+|+.+++.++
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~- 221 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN- 221 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-
Confidence 445668999999999999999999875432 222222 222222333455678888888875
Q ss_pred cCCCCCCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 470 ~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
|+||+++++++...+..++||+++.+++++++....... .....+..++.|+.||+.||.|||++||+||||||
T Consensus 222 -----HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 222 -----HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred -----CCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 789999999999999999999999988888765432211 11244677888999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCC--
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPN-- 622 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~P-F~~-- 622 (722)
+|||++. ++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|..+ |..
T Consensus 296 ~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~ 373 (501)
T PHA03210 296 ENIFLNC--DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373 (501)
T ss_pred HHEEECC--CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence 9999986 7889999999997654322 235789999999999999999999999999999999998764 432
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 623 ~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
......+.+++..++..+.+.......+.+++.... .......++ .+-.. ...+..+.++|.+||++|
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~--------~~~~~~~~~---~~~~~-~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAE--------IDHAGHSVP---PLIRN-LGLPADFEYPLVKMLTFD 441 (501)
T ss_pred CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhh--------cccCccchh---hHHHh-cCCChHHHHHHHHHhccC
Confidence 234455555555554333222111111222221100 000000011 01111 123456889999999999
Q ss_pred CCCCcCHHHHHhCCCCCC
Q 004954 703 PQRRPTAREALDHPWLQH 720 (722)
Q Consensus 703 P~kRpTa~ElL~HPwf~~ 720 (722)
|.+|||+.|+|+||||+.
T Consensus 442 P~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 442 WHLRPGAAELLALPLFSA 459 (501)
T ss_pred cccCcCHHHHhhChhhhc
Confidence 999999999999999975
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=332.13 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=199.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.++||+|+||+||+++++.+++.+|+|++.+.. .....+.+|..++..+ .|++|+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG------DNQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC------CCCCEeeEEEEEecCC
Confidence 47999999999999999999999999999999986532 1122344555555544 4789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++++||||+. |+|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~--~~~~kL~DfG 147 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLADFG 147 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEeecc
Confidence 9999999997 567777654221 2889999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCC----ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 569 SSCFQTDN----LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 569 ls~~~~~~----~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
++...... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-- 225 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-- 225 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc--
Confidence 98653221 12357899999999986 34578899999999999999999999988777666655542110
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC--CcCHHHHHhCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k--RpTa~ElL~HPw 717 (722)
...+|. .....+..+.+||++||..++.+ |+++.++++|||
T Consensus 226 -------------------------------~~~~p~------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 226 -------------------------------RFQFPA------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred -------------------------------cccCCC------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 001111 11123467889999999765554 689999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 269 f~~ 271 (332)
T cd05623 269 FTG 271 (332)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=321.07 Aligned_cols=276 Identities=29% Similarity=0.463 Sum_probs=218.2
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
|++.+.||.|++|.||+|.++.+|+.||+|++.... .....+.+|+.+++.++ |+||+++++++...+..+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC------CCCccCHhheeccCCeEE
Confidence 678899999999999999999999999999987543 22245677888888775 689999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
+||||++++|.+++..... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++..
T Consensus 75 iv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~--~~~~~l~df~~~~~ 148 (283)
T cd07835 75 LVFEFLDLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR--EGALKLADFGLARA 148 (283)
T ss_pred EEEeccCcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCcEEEeecccccc
Confidence 9999998888887764332 23889999999999999999999999999999999999996 78899999999865
Q ss_pred ccCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 573 ~~~~~---~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... ....+++.|+|||++.+. .++.++||||||+++|+|++|++||...+....+.++....+.+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 43221 223457889999988764 57889999999999999999999999888777777777777776666554443
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....+...-.. .. ...........+..+.++|.+||+.||.+|||+.|+++||||
T Consensus 229 ~~~~~~~~~~~------------~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 229 SLPDYKPTFPK------------WA---RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hchhhhhhccc------------cc---ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 33322110000 00 001111122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.52 Aligned_cols=243 Identities=27% Similarity=0.404 Sum_probs=193.2
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHH-HHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKL-LKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~i-l~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
+.||+|+||+||++++..+|+.+|+|++..... ....+..|..+ ++. ..||||+++++++...+..++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------~~hp~iv~~~~~~~~~~~~~lv 74 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN------VKHPFLVGLHYSFQTTEKLYFV 74 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHh------CCCCCCccEEEEEecCCEEEEE
Confidence 369999999999999999999999999975421 22233334332 222 3589999999999999999999
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+.+ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~--~~~~kL~DfG~~~~~ 146 (325)
T cd05604 75 LDFVNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (325)
T ss_pred EcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEeecCCcccC
Confidence 999986 455544322 23889999999999999999999999999999999999986 788999999998643
Q ss_pred c---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 574 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 574 ~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--------------- 211 (325)
T cd05604 147 IAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--------------- 211 (325)
T ss_pred CCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence 2 2233457899999999999999999999999999999999999999887766655444310
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH----HHHHhCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 720 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa----~ElL~HPwf~~ 720 (722)
...++ ...+..+.++|++||+.||.+||++ .++++||||+.
T Consensus 212 --------------------~~~~~---------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 212 --------------------PLVLR---------PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred --------------------CccCC---------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 00001 1123567899999999999999976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=331.21 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=194.2
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||+|+||+||++++..+++.+|+|+++... .....+.+|..++..+. .||+|+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-----CCCCEeeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999998642 23345667777777764 3789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|...+.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA--DGHIKLTDYGMCKEGL 147 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC--CCCEEEeccccceecc
Confidence 99975 5555544321 2899999999999999999999999999999999999986 7889999999986422
Q ss_pred ---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh------HHHHHHHHHhhcCCCcHHHHh
Q 004954 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA------VVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 575 ---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~------~~e~l~~i~~~lg~~~~~~~~ 645 (722)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+.+.+++.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 216 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL----------- 216 (327)
T ss_pred CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-----------
Confidence 22334678999999999999999999999999999999999999995321 1111111100
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC------HHHHHhCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT------AREALDHPWLQ 719 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT------a~ElL~HPwf~ 719 (722)
.....+| ...+..+.++|++||+.||.+|++ ..++++||||+
T Consensus 217 -----------------------~~~~~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~ 264 (327)
T cd05617 217 -----------------------EKPIRIP---------RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264 (327)
T ss_pred -----------------------hCCCCCC---------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence 0001111 123456889999999999999998 57999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 265 ~ 265 (327)
T cd05617 265 S 265 (327)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=319.83 Aligned_cols=276 Identities=29% Similarity=0.489 Sum_probs=218.7
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--Ce
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EH 490 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--~~ 490 (722)
|++.+.||+|++|.||+|.+..+++.+|+|++.... .....+.+|+.+++.+. |+||+++++++... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR------HPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc------CCCeeeheeeEecCCCCc
Confidence 678999999999999999999999999999998652 23345677888888875 67999999999988 89
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+++++.+++.... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~--~~~~~l~d~g~~ 147 (287)
T cd07840 75 IYMVFEYMDHDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLA 147 (287)
T ss_pred EEEEeccccccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC--CCCEEEccccce
Confidence 99999999988877775432 23899999999999999999999999999999999999996 788999999998
Q ss_pred ccccCCc----cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDNL----CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~~----~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....+..+....+.++...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 148 RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 7655432 23456788999998765 457899999999999999999999999988888888888777776665554
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhccc-CcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQF-SDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~-~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.......+ .......+....+...... .+..+.++|++||+.+|.+||++.++++||||
T Consensus 228 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 228 GVSKLPWF--------------ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhh--------------hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 33222100 0000001111112222222 26778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.90 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=200.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||+||+++++.+++.||+|++.+.. .....+.+|..++..+ .|++|+++++++...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG------DCQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEcCC
Confidence 47999999999999999999999999999999987532 1223345566666554 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
+.++||||+.| +|.+++..... .+++..+..++.|++.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfG 147 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM--NGHIRLADFG 147 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC--CCCEEEEecc
Confidence 99999999975 67766654221 2889999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCCc----cccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~~-----~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~- 226 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER- 226 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc-
Confidence 987654321 22468999999999876 45788999999999999999999999887766655554321100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC--CcCHHHHHhCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k--RpTa~ElL~HPw 717 (722)
..+|.. ....++.+++||.+||+.++++ |++++++++|||
T Consensus 227 --------------------------------~~~p~~------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 227 --------------------------------FQFPSH------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred --------------------------------ccCCCc------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 001110 1112466889999999876655 579999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 269 f~~ 271 (331)
T cd05624 269 FEG 271 (331)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=324.22 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=199.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.|++.+.||+|+||+||++.+..+++.+|+|.+.... .......+|+.+++.++ |++|+++++.+...++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN------SRFVVSLAYAYETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC------CCCeeeeeEEEecCCE
Confidence 3788999999999999999999999999999986532 12234567888887775 6799999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+ +|.+.+..... ..+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD--HGHIRISDLGL 148 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeccc
Confidence 9999999975 56555543221 23889999999999999999999999999999999999986 77899999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~----------- 217 (285)
T cd05630 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----------- 217 (285)
T ss_pred eeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-----------
Confidence 8654332 223578999999999999999999999999999999999999997642211110000000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
. ...... ....++.+.+||++||+.||++||| ++|+++||||+.
T Consensus 218 -------~-------------~~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 218 -------K-------------EVQEEY---------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred -------h-------------hhhhhc---------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 0 000000 1123466889999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=346.99 Aligned_cols=254 Identities=24% Similarity=0.290 Sum_probs=205.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCC-CcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~t-g~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+.+|+.+++.++ ||||+++++++...++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~------Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD------HFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCEeEEEEEEEECCE
Confidence 34599999999999999999998777 7889999775433 23345566888777664 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.+|||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~~kL~DFgl 215 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP--TGIIKLGDFGF 215 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC--CCcEEEEeCcC
Confidence 9999999975 66666543221 2234889999999999999999999999999999999999996 78899999999
Q ss_pred cccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+.....
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~------- 288 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY------- 288 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Confidence 9765433 2335689999999999999999999999999999999999999988776665555431100
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
..+| ...+..+.+||.+||+.||++||++.++|.|||++
T Consensus 289 ---------------------------~~~~---------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 289 ---------------------------DPFP---------CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred ---------------------------CCCC---------ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 0001 11235688999999999999999999999999985
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.46 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=199.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.++||+|+||.||++.+..+++.+|+|++..+ ......+.+|+.+++.+. ||||+++++.+...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD------SPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC------CCCeeeEEEEEEECCEE
Confidence 3688999999999999999999999999999998754 223345667888777664 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||++++.+.... .+++..+..++.|++.||.|||+.||+|+||||+|||++. ++.++|+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~--~~~~~l~dfg~~~ 143 (279)
T cd06619 75 SICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT--RGQVKLCDFGVST 143 (279)
T ss_pred EEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC--CCCEEEeeCCcce
Confidence 9999999976554331 1678889999999999999999999999999999999986 7889999999987
Q ss_pred cccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 572 FQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 572 ~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
..... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||.......... .+...
T Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--------~~~~~------- 208 (279)
T cd06619 144 QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MPLQL------- 208 (279)
T ss_pred ecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--------chHHH-------
Confidence 65433 334578999999999999899999999999999999999999996522111000 00000
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+.... ......+ ....++.+.+||.+||+.||.+||+++++++||||+.
T Consensus 209 ~~~~~~------------~~~~~~~--------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 209 LQCIVD------------EDPPVLP--------VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHhc------------cCCCCCC--------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 000000 0000000 0113467899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=321.01 Aligned_cols=279 Identities=27% Similarity=0.468 Sum_probs=212.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++.++||+|+||.||+|.+..+++.+|+|++..... ....+.+|+++++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR------HENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC------CcchhhHHHhcccCCe
Confidence 479999999999999999999998999999998764321 2345667888877775 6899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+.++++..+.... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~--~~~~~l~dfg~~ 147 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFA 147 (286)
T ss_pred EEEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCcEEEEeeeee
Confidence 99999999987666544322 12889999999999999999999999999999999999986 788999999998
Q ss_pred ccccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
...... .....++..|+|||++.+ ..++.++||||||+++|+|++|++||......+.+..+....+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 654332 223457889999999875 3478899999999999999999999998877777777776666544321110
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
... ...+. .......+............+..+.+||.+||+.+|.+||++.++|+||||
T Consensus 228 ~~~-~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 228 FQK-NPLFA------------GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hcc-chHhh------------ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 00000 000000111111222233456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.20 Aligned_cols=249 Identities=29% Similarity=0.387 Sum_probs=199.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+.|++.+.||+|++|.||++.+..+++.+|+|.+..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ------HERIVQYYGCLRD 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC------CCCeeeeEEEEcc
Confidence 468999999999999999999999999999999865321 2234566777777664 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+++||||+.+ +|.+.+.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~--~~~~~l~d 147 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS--AGNVKLGD 147 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEee
Confidence 9999999999975 6666665332 2788999999999999999999999999999999999985 78899999
Q ss_pred cCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 567 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 567 FGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||++....... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----- 222 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ----- 222 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-----
Confidence 99986543211 2245678899999999988999999999999999999999999765443333222100
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.....+| ...+..+.+||++||..+|.+|||+.++|+||||
T Consensus 223 ----------------------------~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 223 ----------------------------PTNPQLP---------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----------------------------CCCCCCC---------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0001111 1234668899999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=331.21 Aligned_cols=280 Identities=31% Similarity=0.537 Sum_probs=218.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+..+|++.+.||+|+||+||++++..+++.||||.+... ........+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni~~~~~~~~~~ 76 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD------HENVIAIKDIMPPP 76 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC------CCCccchHHheecc
Confidence 457899999999999999999999999999999988642 222345667888887774 67999999988754
Q ss_pred -----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 489 -----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
...++||||+.++|.+.+.... .+++..+..++.||+.||.|||+.+++|+||||+||+++. ++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~--~~~~k 148 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLK 148 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEE
Confidence 3589999999988887775332 2899999999999999999999999999999999999986 78899
Q ss_pred EEecCCcccccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|+|||++...... .....++..|+|||.+.. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+
T Consensus 149 L~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 149 ICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998765432 223467889999999875 468899999999999999999999999888888888888888877
Q ss_pred cHHHHhhhh--hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 640 DLEMLMQGQ--EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
+.+.+.... ...++.. .... .............+..+.+||++||+.+|++|||+.++|+|||
T Consensus 229 ~~~~~~~~~~~~~~~~~~-------------~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 229 SEEDLGFIRNEKARRYIR-------------SLPY--TPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred ChHHhhhcCchhhhHHHH-------------hcCc--ccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 665542110 0111100 0000 0001111122234567899999999999999999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 294 ~~~ 296 (337)
T cd07858 294 LAS 296 (337)
T ss_pred hhh
Confidence 965
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=330.69 Aligned_cols=277 Identities=36% Similarity=0.527 Sum_probs=223.3
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (722)
||++.+.||+|++|.||+|++..+++.+|||++... ......+.+|+.+++.++ |+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR------HENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC------CcchhhhhhhhcccCcc
Confidence 689999999999999999999989999999998753 233456778888888775 679999999998775
Q ss_pred ---eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 490 ---HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 490 ---~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+++||||+++++.+.+.... .+++..++.++.||+.||+|||+.||+|+||||+|||++. ++.++|+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~--~~~~~L~d 146 (330)
T cd07834 75 DFNDVYIVTELMETDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICD 146 (330)
T ss_pred cccceEEEecchhhhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcc
Confidence 799999999988777765322 3899999999999999999999999999999999999996 68999999
Q ss_pred cCCcccccCC------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 567 LGSSCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 567 FGls~~~~~~------~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||.+...... .....+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..+....+.+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9998765443 2234678899999999887 78999999999999999999999999999889999999888887
Q ss_pred cHHHHhhh--hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 640 DLEMLMQG--QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
+.+.+... .....+... ........+.......+..+.+||++||+++|.+|||+.++|+|||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 227 SEEDLKFITSEKARNYLKS---------------LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred ChhHhhhccccchhhHHhh---------------cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 76655421 111111110 0000111122222334677899999999999999999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|++
T Consensus 292 ~~~ 294 (330)
T cd07834 292 LAQ 294 (330)
T ss_pred HHh
Confidence 975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=329.38 Aligned_cols=284 Identities=23% Similarity=0.285 Sum_probs=198.4
Q ss_pred EEEEeccC--CCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 418 VTEYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 418 i~~~LG~G--~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
++++||+| +|++||++.+..+|+.||+|++.... .....+.+|+.+++.++ ||||+++++++...+..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN------HPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC------CCCeeeEEEEEEECCEEE
Confidence 56789999 68899999999999999999987542 23345666777777764 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+.+ ++.+++...... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.++++||+...
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~--~~~~~l~~~~~~~ 149 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNL 149 (327)
T ss_pred EEEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec--CCcEEEcccchhh
Confidence 99999985 676766543221 2889999999999999999999999999999999999986 7789999998643
Q ss_pred cccC----------CccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC-
Q 004954 572 FQTD----------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP- 638 (722)
Q Consensus 572 ~~~~----------~~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~- 638 (722)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||................-+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 2211 1112345677999999976 45889999999999999999999999876554433333211100
Q ss_pred ------CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCcc--chhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 639 ------IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 639 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~--~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
++.+.+.... ............ .......+.. ..........++.+.+||++||+.||++|||++
T Consensus 230 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 302 (327)
T cd08227 230 LLDTTTIPAEELTMKP------SRSGANSGLGES-TTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS 302 (327)
T ss_pred cccccchhhhhcccCC------cccCCcCCCCcc-cccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH
Confidence 0111100000 000000000000 0000000000 000011123456799999999999999999999
Q ss_pred HHHhCCCCCC
Q 004954 711 EALDHPWLQH 720 (722)
Q Consensus 711 ElL~HPwf~~ 720 (722)
|+|+||||+.
T Consensus 303 ell~~p~f~~ 312 (327)
T cd08227 303 TLLNHSFFKQ 312 (327)
T ss_pred HHhcChhhhh
Confidence 9999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.15 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=214.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec-chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~-~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+.|.|+.-||.|+||+||+|.++.++-..|-|++.. .......++.|+.||..+ +||+||++++.|+..+.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C------dHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC------DHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC------CChHHHHHHHHHhccCceE
Confidence 458888999999999999999999998889998854 445667888899998776 4889999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
|+.|||+|+..+.+...-. ..+++.+++.+++|++.||.|||+++|||||||..|||++- +|.|+|+|||.+..
T Consensus 106 iliEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl--dGdirLADFGVSAK 179 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL--DGDIRLADFGVSAK 179 (1187)
T ss_pred EEEeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe--cCcEeeeccccccc
Confidence 9999999887776654332 23999999999999999999999999999999999999996 89999999998754
Q ss_pred ccC---CccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 573 QTD---NLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 573 ~~~---~~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
... ....+.|||+|||||+.. ..+|++++||||||++|.||..+.+|....++.-++.+|.+--.| .
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP-T---- 254 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-T---- 254 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC-c----
Confidence 332 344589999999999864 678999999999999999999999999998888888777532111 0
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..-|. ..+..|.|||.+||..||..||++.++|+|||+++
T Consensus 255 ---------------------------LlqPS---------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 255 ---------------------------LLQPS---------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred ---------------------------ccCcc---------hhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 00111 12356899999999999999999999999999985
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.80 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=200.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec----
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~---- 488 (722)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.........+..|+.+++.+. .|+||+++++.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc-----CCCCeeeEeeEEeecCCCC
Confidence 46799999999999999999999999999999999776555567788888888774 378999999998753
Q ss_pred --CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 489 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 489 --~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
...++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.+|+|+||||+||+++. ++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~--~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC--CCCEEEc
Confidence 468999999985 6776665422 123889999999999999999999999999999999999996 7789999
Q ss_pred ecCCcccccCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|||++...... .....+++.|+|||++. +..++.++|||||||++|+|++|..||...........+..
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--- 230 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--- 230 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---
Confidence 99998754322 23356888999999986 34588899999999999999999999965433222211100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.......+ ...+..+.+||.+||..||.+|||+.++++|||
T Consensus 231 ------------------------------~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 231 ------------------------------NPAPRLKS---------KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred ------------------------------CCCCCCCC---------CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 00000000 012356889999999999999999999999999
Q ss_pred C
Q 004954 718 L 718 (722)
Q Consensus 718 f 718 (722)
|
T Consensus 272 ~ 272 (272)
T cd06637 272 I 272 (272)
T ss_pred C
Confidence 8
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=330.48 Aligned_cols=243 Identities=27% Similarity=0.395 Sum_probs=192.1
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHH-HHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~-il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
++||+|+||+||+|++..+++.||+|++..... ....+..|.. +++. ..||||+++++.+...+..++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------~~h~~iv~~~~~~~~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN------LKHPFLVGLHYSFQTAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHh------CCCCCccceeeEEEcCCEEEEE
Confidence 369999999999999999999999999875421 1222333333 2333 3588999999999999999999
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+.+ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 75 LDYVNGGELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (321)
T ss_pred EcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEccCCCCccC
Confidence 999986 454444322 23888999999999999999999999999999999999986 788999999998653
Q ss_pred cC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 574 TD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 574 ~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--------------- 211 (321)
T cd05603 147 VEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--------------- 211 (321)
T ss_pred CCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---------------
Confidence 22 223457899999999999999999999999999999999999999887765555444311
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH----HHHHhCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 720 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa----~ElL~HPwf~~ 720 (722)
...+| ...+..+.++|.+||+.||.+|+++ .++++||||+.
T Consensus 212 --------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 212 --------------------PLQLP---------GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred --------------------CCCCC---------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 00111 1123568899999999999999875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=331.09 Aligned_cols=243 Identities=24% Similarity=0.367 Sum_probs=192.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHH-HHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKL-LKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~i-l~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
+.||+|+||+||++++..+++.+|+|++..... .......|... ++. ..|+||+++++++...+.+++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------~~h~~Iv~~~~~~~~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN------VKHPFLVGLHFSFQTADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHh------CCCCCCCceeEEEEcCCeEEEE
Confidence 369999999999999999999999999975421 11222233222 222 3588999999999999999999
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+.+ +|...+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~--~~~~kl~DfG~a~~~ 146 (325)
T cd05602 75 LDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGLCKEN 146 (325)
T ss_pred EeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEEccCCCCccc
Confidence 999986 5655554321 2788899999999999999999999999999999999985 788999999998643
Q ss_pred cC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 574 TD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 574 ~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------------- 212 (325)
T cd05602 147 IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------------- 212 (325)
T ss_pred ccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 22 2334578999999999999999999999999999999999999998877666555543110
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH----HHHhCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR----EALDHPWLQH 720 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~----ElL~HPwf~~ 720 (722)
..++ ...+..+.+||++||+.||.+|+++. ++++|+||..
T Consensus 213 ---------------------~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 213 ---------------------LQLK---------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ---------------------cCCC---------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 0000 12245688999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.48 Aligned_cols=254 Identities=24% Similarity=0.302 Sum_probs=202.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.|++.+.||+|+||+||++.+..+++.+|+|++.... .......+|+.+++.++ |++|+++++.+...+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN------SQFVVNLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC------CcCceeEEEEEecCCE
Confidence 4788999999999999999999999999999986532 12234567888888775 6799999999999999
Q ss_pred EEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.++ |.+.+.... ...+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~--~~~~kl~Dfg~ 148 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEEeccCccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC--CCCEEEecCCc
Confidence 99999999864 544443221 123899999999999999999999999999999999999986 67899999998
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+...... .....+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.......
T Consensus 149 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-------- 220 (285)
T cd05632 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-------- 220 (285)
T ss_pred ceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--------
Confidence 8654322 233578999999999999899999999999999999999999998765443333322110000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
...++ ...+..+.+|+.+||+.||++||+ +.+++.||||+.
T Consensus 221 -----------------------~~~~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 221 -----------------------EEVYS---------AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred -----------------------ccccC---------ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 00011 122456889999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.72 Aligned_cols=280 Identities=31% Similarity=0.547 Sum_probs=216.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|.+.+.||+|+||.||+|++..+|+.||+|++... ......+.+|+.+++.++ |+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~ 86 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ------HENVIGLLDVFTSA 86 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC------CCCccchhheeccc
Confidence 357899999999999999999999999999999998653 222345667888877764 68999999998754
Q ss_pred C------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ~------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
. ..++||||+..++..... ..+++..+..++.|++.||+|||+.||+||||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~--~~~~ 156 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQTDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE--DCEL 156 (342)
T ss_pred ccCCCCceEEEEecccccCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCE
Confidence 3 569999999876554431 12889999999999999999999999999999999999996 7889
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
+|+|||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....+.+..
T Consensus 157 kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 157 KILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred EEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999998766554445577889999999876 45889999999999999999999999998877888888877776665
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..+......... .+.. . ....+ ...+.......+..+.+||++||+.||.+||++.++|.||||+.
T Consensus 237 ~~~~~~~~~~~~-------~~~~----~-~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 237 EFVQKLEDKAAK-------SYIK----S-LPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred HHHHHhcccchH-------HHHh----h-cCCcc-cchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 544332211100 0000 0 00001 11112222234567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.39 Aligned_cols=281 Identities=31% Similarity=0.541 Sum_probs=218.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++.+.||+|+||.||++.+..+|+.||||++... ......+.+|+.+++.++ |+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK------HENVIGLLDVFTPD 86 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC------CCCccceeeeecCC
Confidence 568899999999999999999999999999999998642 222345667888888775 67999999998765
Q ss_pred C------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ~------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
. ..++||||+++++..++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE--DCEL 157 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCE
Confidence 3 4689999997777666542 12889999999999999999999999999999999999985 7789
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
+|+|||++...........+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+.+..+..+.
T Consensus 158 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 158 KILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred EEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999999876655555677899999999876 45789999999999999999999999988777777777776666665
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+.......... ..+ ...+.... ...+.......+..+.++|.+||+.||++|||+.+++.||||+.
T Consensus 238 ~~~~~~~~~~~------~~~-----~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 238 EFVQKLQSEDA------KNY-----VKKLPRFR--KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred HHHHhhcchhH------HHH-----HHhccccC--cchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 54333211100 000 00000000 01111222344567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.66 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=201.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~---- 487 (722)
..++|++.+.||.|+||.||+|++..+++.+|+|++.........+..|+.+++++. .|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS-----HHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc-----CCCcEEEEeeehhccccc
Confidence 347899999999999999999999999999999999776555566778888888874 37899999999863
Q ss_pred --cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 488 --~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
....++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++. ++.++|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~--~~~~~l 162 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE--NAEVKL 162 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEE
Confidence 4678999999985 67666654321 23788889999999999999999999999999999999995 778999
Q ss_pred EecCCcccccCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 565 IDLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 565 ~DFGls~~~~~~---~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
+|||++...... .....+++.|+|||.+. +..++.++|+|||||++|+|++|..||...........+...
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~- 241 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN- 241 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC-
Confidence 999998654322 23356889999999986 346788999999999999999999999665432222111100
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
.+.. ......+..+.+||++||+.||.+|||+.|+|+||
T Consensus 242 -------------------------------------~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~ 280 (282)
T cd06636 242 -------------------------------------PPPK----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280 (282)
T ss_pred -------------------------------------CCCC----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence 0000 00112346799999999999999999999999999
Q ss_pred CC
Q 004954 717 WL 718 (722)
Q Consensus 717 wf 718 (722)
||
T Consensus 281 ~~ 282 (282)
T cd06636 281 FI 282 (282)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.40 Aligned_cols=279 Identities=34% Similarity=0.605 Sum_probs=221.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++.+.||+|++|.||+|++..+++.||+|++... ........+|+.+++.+. |+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD------HENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc------CCCHHHHHHHhhcc
Confidence 467899999999999999999999999999999998643 223345667888887774 67999999988766
Q ss_pred Ce------EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 EH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ~~------l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
.. .++|+||++++|.+++.. ..+++..++.++.||+.||+|||+.||+|+||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCEL 157 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCE
Confidence 54 899999998888777653 12899999999999999999999999999999999999996 7889
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
+|+|||++...........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......+..+....+.++.
T Consensus 158 kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 158 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred EEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 99999999876665556678899999999865 36789999999999999999999999998888888888887777666
Q ss_pred HHHhhhhhh--hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.++...... ..+.. ... ......+.......+..+.+||++||+.||.+|||+.+||+||||+
T Consensus 238 ~~~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 238 ELLQKISSESARNYIQ-------------SLP--QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred HHHhhccchhHHHHHH-------------hcc--ccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 554432210 00000 000 0000111111222357799999999999999999999999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
+
T Consensus 303 ~ 303 (343)
T cd07851 303 E 303 (343)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=310.09 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=203.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.|.+.+.||+|++|.||++.+..+++.+++|.+... ......+.+|+++++.++ ||||+++++++...+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD------SSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC------CCCeehheeeeccCCEE
Confidence 488999999999999999999999999999998643 334456677788777664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++..... ..++...++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~--~~~~~l~df~~~ 148 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA--YDNVKIGDLGVA 148 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC--CCCEEEcccccc
Confidence 999999974 77777664321 23889999999999999999999999999999999999996 788999999988
Q ss_pred ccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
....... ....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 217 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV----------- 217 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 7654332 22467889999999999889999999999999999999999998776554443332100
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
...++ ...+..+.++|++||+.+|++||++.++++|||+
T Consensus 218 -----------------------~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 -----------------------FPPVS---------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------------------CCCCc---------cccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00011 0234568999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.06 Aligned_cols=280 Identities=27% Similarity=0.414 Sum_probs=215.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
..++|++.++||.|+||.||+|++..+++.+|+|++..... ......+|+++++.++ |+||+++++.+...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 79 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK------HPNVVPLIDMAVER 79 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC------CCCccchhhheecc
Confidence 35899999999999999999999999999999998864321 1234567888888775 67999999987643
Q ss_pred --------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC
Q 004954 489 --------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 489 --------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~ 560 (722)
..+++||||+.+++...+.... ..+++..++.++.||++||.|||+.||+|+||||+||+++. ++
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~--~~ 152 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDHDLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QG 152 (311)
T ss_pred cccccccCceEEEEEecCCcCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CC
Confidence 3479999999988777665322 23899999999999999999999999999999999999996 78
Q ss_pred eEEEEecCCcccccCCc--------------cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH
Q 004954 561 EIKIIDLGSSCFQTDNL--------------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~~--------------~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~ 625 (722)
.++|+|||++....... ....+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 89999999886543221 123457889999998754 578999999999999999999999999888
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
...+..+....+.++...+..+......... ......+ ..+........+.+.+||++||+.||.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 298 (311)
T cd07866 233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGV------------HSFTNYP--RTLEERFGKLGPEGLDLLSKLLSLDPYK 298 (311)
T ss_pred HHHHHHHHHHhCCCChhhchhhhhccccccc------------ccCCCCC--ccHHHHcccCChhHHHHHHHHcccCccc
Confidence 8888888877776665555443222211100 0000001 1111222233467899999999999999
Q ss_pred CcCHHHHHhCCCC
Q 004954 706 RPTAREALDHPWL 718 (722)
Q Consensus 706 RpTa~ElL~HPwf 718 (722)
|||+.|+|.||||
T Consensus 299 R~t~~ell~~~~f 311 (311)
T cd07866 299 RLTASDALEHPYF 311 (311)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.17 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=216.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|.+++++|+|+||.+++++++..++.+++|.+.... ...+....|..++.+++ |||||.+++.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~------hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL------HPNIVEYKDSFEEDGQ 77 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc------CCCeeeeccchhcCCc
Confidence 67999999999999999999999999999999987543 33446778888888875 7899999999999988
Q ss_pred -EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 491 -LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 491 -l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++|||+|++| ++.+.++..+ ...++++.+..|+.||+.|+.|||+++|+|||||+.||+++. +..|+|.|||
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk--~~~VkLgDfG 151 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK--DKKVKLGDFG 151 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc--cCceeecchh
Confidence 9999999986 4555555444 234999999999999999999999999999999999999997 7778999999
Q ss_pred CcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
+|+..+.. ..+.+|||.|++||++.+.+|..++|||||||++|||++-+++|.+.+...+..+|......+
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P------ 225 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP------ 225 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC------
Confidence 99987655 456899999999999999999999999999999999999999999999988888887443111
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+| .....+++.||+.||+.+|..||+|.++|.+|.++
T Consensus 226 ----------------------------lp---------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 226 ----------------------------LP---------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ----------------------------CC---------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 11 12345688999999999999999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.82 Aligned_cols=280 Identities=30% Similarity=0.533 Sum_probs=218.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~- 487 (722)
+..+|.+.+.||+|+||.||++.++.+|+.||+|++.... .....+.+|+.+++.++ ||||++++++|..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~ 76 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK------HDNIIAIRDILRPP 76 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC------CCCccCHHHhcccc
Confidence 3478999999999999999999999999999999987532 23345667888888775 6899999998863
Q ss_pred ---cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 488 ---LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 488 ---~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
...+++||||+.++|..++.... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl 148 (334)
T cd07855 77 GADFKDVYVVMDLMESDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE--DCELRI 148 (334)
T ss_pred CCCCceEEEEEehhhhhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEe
Confidence 35789999999988777765322 2899999999999999999999999999999999999996 888999
Q ss_pred EecCCcccccCCc-------cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 565 IDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 565 ~DFGls~~~~~~~-------~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
+|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHh
Confidence 9999986543211 23467889999999866 458899999999999999999999999988888888888888
Q ss_pred CCCcHHHHhhhhh--hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 637 GPIDLEMLMQGQE--IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 637 g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
|.++.+.+..... ...++. .... .....+.......+..+.+||++||+.+|++|||+.++|.
T Consensus 229 g~~~~~~~~~~~~~~~~~~~~-------------~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 229 GSPSEEVLNRIGSDRVRKYIQ-------------NLPR--KQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred CCChhHhhhhhchhhHHHHHh-------------hccc--CCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 8777665432210 000000 0000 0001111122234677999999999999999999999999
Q ss_pred CCCCCC
Q 004954 715 HPWLQH 720 (722)
Q Consensus 715 HPwf~~ 720 (722)
||||+.
T Consensus 294 ~~~~~~ 299 (334)
T cd07855 294 HPFLAQ 299 (334)
T ss_pred Chhhhh
Confidence 999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.84 Aligned_cols=283 Identities=27% Similarity=0.456 Sum_probs=217.4
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
+....++|++.+.||+|+||.||+|.++.+|+.||+|+++... .......+|+.+++.++ ||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~------h~~i~~~~~~~ 75 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN------HRNIVNLKEIV 75 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC------CCCeeeeehee
Confidence 3456688999999999999999999999999999999987532 22234566778887774 68999999998
Q ss_pred EecC----------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEc
Q 004954 486 YHLE----------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (722)
Q Consensus 486 ~~~~----------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~ 555 (722)
.... .+++||||+++++...+.... ..+++..++.++.||+.||+|||+.||+|+||||+||+++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~ 150 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN 150 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCccHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 7654 799999999998877765431 2389999999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCcccccCCc----cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 004954 556 SYQRCEIKIIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (722)
Q Consensus 556 ~~~~~~vkL~DFGls~~~~~~~----~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~ 630 (722)
. ++.+||+|||++....... ....++..|+|||.+.+. .++.++|||||||++|+|++|++||...+..+.+.
T Consensus 151 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 151 N--KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred C--CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 5 7889999999987654322 123457789999988653 47889999999999999999999999888888888
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+....+..+...+........+...... ......+.......+..+.+||.+||+.||++|||+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 294 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPK--------------KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccc--------------cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 88777766655544332222111100000 0000011111222356789999999999999999999
Q ss_pred HHHhCCCC
Q 004954 711 EALDHPWL 718 (722)
Q Consensus 711 ElL~HPwf 718 (722)
++|.||||
T Consensus 295 ~il~~~~~ 302 (302)
T cd07864 295 EALNSPWL 302 (302)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.11 Aligned_cols=248 Identities=24% Similarity=0.301 Sum_probs=191.8
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
||+|+||+||+++++.+|+.+|+|.+..... .......|+.+++.++ ||||+++++.+....+.++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN------SPFIVNLAYAFESKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC------CCcEEEEEEEEecCCeEEEEEec
Confidence 7999999999999999999999999864321 1233455778877764 78999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+.| +|...+..... ..+++..+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 75 ~~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 75 MNGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD--QGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC--CCCEEEeeceeeeecCCC
Confidence 975 55555543221 22788899999999999999999999999999999999986 788999999998765432
Q ss_pred c--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 004954 577 L--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (722)
Q Consensus 577 ~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~ 654 (722)
. ....+++.|+|||++.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~------------------- 209 (277)
T cd05607 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR------------------- 209 (277)
T ss_pred ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH-------------------
Confidence 2 2346889999999999988999999999999999999999999754221111111000
Q ss_pred cccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH----HHHHhCCCCCC
Q 004954 655 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 720 (722)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa----~ElL~HPwf~~ 720 (722)
.....++. .....+..+++||++||+.||.+||++ ++++.||||+.
T Consensus 210 --------------~~~~~~~~------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 210 --------------TLEDEVKF------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred --------------hhcccccc------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 00000000 011234668999999999999999999 77889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=323.84 Aligned_cols=279 Identities=34% Similarity=0.563 Sum_probs=220.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~- 487 (722)
+.++|++.+.||.|+||.||++.+..+++.+|+|++... ......+..|+.+++.++ ||||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR------HENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC------CCCeeeEeeeEecC
Confidence 578899999999999999999999999999999987542 223355667888888775 7899999999876
Q ss_pred cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 488 ~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
....++||||++++|..++... .++...+..++.||++||+|||+.||+|+||+|+||+++. ++.++|+||
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~--~~~~~l~df 152 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE--NCDLKICDF 152 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC--CCCEEeCcc
Confidence 4678999999988877665421 2778888999999999999999999999999999999985 788999999
Q ss_pred CCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 568 GSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 568 Gls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
|.+...........+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...........+.+.+|.++.+....
T Consensus 153 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 153 GLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 998766554455567889999999866 5689999999999999999999999998888777788888888877665443
Q ss_pred hhhh--hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.... .+++. . +. ...........+..+..+.++|++||+.+|++|||+.++|.||||+.
T Consensus 233 ~~~~~~~~~~~---------~----~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 233 ICSENTLRFVQ---------S----LP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred ccchhhHHHHh---------h----cc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 2110 00000 0 00 00011111222334577999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.67 Aligned_cols=287 Identities=26% Similarity=0.320 Sum_probs=206.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.+.||+|+||.||++.+..++..+|+|.+... .....++.+|+++++.++ ||||+++++.+...+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN------SPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEeeCCEE
Confidence 4699999999999999999999999999999998754 223455777888888774 68999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+|||++. ++.++|+|||+
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 146 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGV 146 (308)
T ss_pred EEEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec--CCcEEEccCCC
Confidence 999999985 6666665432 28899999999999999999997 59999999999999985 77899999998
Q ss_pred cccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 570 s~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
+...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.......+......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 224 (308)
T cd06615 147 SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR-- 224 (308)
T ss_pred cccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc--
Confidence 8654332 3345788999999999888899999999999999999999999977654333222211110000000000
Q ss_pred hhhhhhcccccchhhhhccc-cccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETN-QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~-~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
.................... ......|. +. ....+..+.+||.+||..+|++|||+.++++||||++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPK---LP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCcc---Cc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000000000000000000 00000010 00 01135679999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.49 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=194.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
+-.++|++.++||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.+. .||||+++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~ 78 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG-----NHLNVVNLLG 78 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc-----cCcceeeEEe
Confidence 3357899999999999999999975 2456789999987532 23456778999988884 3789999999
Q ss_pred EEEec-CeEEEEEEccc-cchHHHHhhhhccC------------------------------------------------
Q 004954 484 YFYHL-EHLFIVCELLR-ANLYEFQKFNQESG------------------------------------------------ 513 (722)
Q Consensus 484 ~f~~~-~~l~iVmEy~~-gsLl~~l~~~~~~~------------------------------------------------ 513 (722)
++... ..+++||||+. |+|.+++.......
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 88764 46899999997 56777765432100
Q ss_pred --------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCCc-----ccc
Q 004954 514 --------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLY 580 (722)
Q Consensus 514 --------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~ 580 (722)
....+++..+..++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++....... ...
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC--CCcEEEeecccccccccCcchhcccCC
Confidence 0124788889999999999999999999999999999999985 7789999999987543221 123
Q ss_pred ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhccccc
Q 004954 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYD 659 (722)
Q Consensus 581 ~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~ 659 (722)
.+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+......
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~------------------------ 292 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD------------------------ 292 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc------------------------
Confidence 34678999999999999999999999999999997 99999875433222221100
Q ss_pred chhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 660 LYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 660 ~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
......| ...++.+.+||.+||+.||.+|||+.|+++
T Consensus 293 ---------~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 293 ---------GTRMRAP---------ENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ---------CCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000011 123466889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.92 Aligned_cols=279 Identities=26% Similarity=0.413 Sum_probs=210.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (722)
..+|++.+.||.|+||.||+|.+..+|+.||+|.+.... .......+|+.+++.++ ||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD------HDNIVKVYEVLGPSGSD 77 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC------CCcchhhHhhhcccccc
Confidence 579999999999999999999999999999999886543 33355677888888775 67999999776643
Q ss_pred -----------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc
Q 004954 489 -----------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (722)
Q Consensus 489 -----------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~ 557 (722)
...++||||++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~- 149 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT- 149 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-
Confidence 368999999998777666421 2889999999999999999999999999999999999975
Q ss_pred CCCeEEEEecCCcccccCC------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 004954 558 QRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~------~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~ 630 (722)
.+..++|+|||.+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 3567999999998754322 122356888999998754 568889999999999999999999998877776666
Q ss_pred HHHhhcCCCcHHHHhhhhh-hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH
Q 004954 631 RIIGMLGPIDLEMLMQGQE-IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa 709 (722)
.+.........+....... ...... ....+............+.++++||++||+.||.+|||+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 294 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVR---------------NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhh---------------hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence 6655444333222211100 000000 000011111222233456778999999999999999999
Q ss_pred HHHHhCCCCCC
Q 004954 710 REALDHPWLQH 720 (722)
Q Consensus 710 ~ElL~HPwf~~ 720 (722)
.++|+||||+.
T Consensus 295 ~ell~h~~~~~ 305 (342)
T cd07854 295 EEALMHPYMSC 305 (342)
T ss_pred HHHhCCCcccc
Confidence 99999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.19 Aligned_cols=255 Identities=31% Similarity=0.485 Sum_probs=201.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.+.|+++++||+|+||.||++++..+++.+++|++.... .....+.+|+.+++.++ |+||+++++.+......
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN------HPYIVKLLGAFYWDGKL 84 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCcEeeeEEEEEeCCeE
Confidence 467999999999999999999999999999999987543 33455667777777664 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.++.+..+..... ..+++..+..++.||+.||.|||+.|++||||||+||+++. ++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~dfg~~~ 158 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL--DGDIKLADFGVSA 158 (292)
T ss_pred EEEEecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC--CCCEEEccCccce
Confidence 99999998765443322211 12889999999999999999999999999999999999985 7889999999876
Q ss_pred cccCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
..... .....+++.|+|||.+. ...++.++|+|||||++|+|++|.+||...+....+.++.....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 233 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP----- 233 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-----
Confidence 53322 22346788999999985 345788999999999999999999999776554443333211000
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..+. ....+..+.+||++||+.||++||++.++|+||||+.
T Consensus 234 -----------------------------~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 234 -----------------------------TLSQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred -----------------------------cCCC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000 0112356889999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=325.99 Aligned_cols=279 Identities=31% Similarity=0.564 Sum_probs=217.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|.+.+.||+|+||.||++.+..+|+.||+|++.... .......+|+.+++.++ |+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC------CCcccceeeeeeec
Confidence 4588999999999999999999999999999999986532 22345667777777774 78999999988643
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
...++++++++++|.+.+... .+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 159 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC--CCCE
Confidence 347899999987877665421 2889999999999999999999999999999999999996 7789
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
+|+|||++...........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+....+..+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 160 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred EEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999998876655555678899999999876 46888999999999999999999999988777777788777776665
Q ss_pred HHHhhhhhhh--hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEIY--KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
..+....... .++. .+ ..+|. ..........+..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 240 ~~~~~~~~~~~~~~~~-------------~~-~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 240 ELLKKISSESARNYIQ-------------SL-TQMPK-MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred HHHhhcccHhHHHHHH-------------Hh-cccCC-cchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 5543321110 0000 00 00111 011111123456789999999999999999999999999998
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
+
T Consensus 305 ~ 305 (345)
T cd07877 305 Q 305 (345)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.99 Aligned_cols=274 Identities=33% Similarity=0.535 Sum_probs=219.0
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
|++.+.||+|++|.||++.+..+++.+++|.+..... ......+|+.+++.++ |+||+++++++......+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN------HPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc------CCCcchHHHhhccCCCEE
Confidence 5778899999999999999999999999999865432 3456677888888775 679999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
+||||+.+++...+.... ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~df~~~~~ 147 (283)
T cd05118 75 LVFEFMDTDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT--EGVLKLADFGLARS 147 (283)
T ss_pred EEEeccCCCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC--CCcEEEeeeeeeEe
Confidence 999999998888776533 23889999999999999999999999999999999999995 78899999998866
Q ss_pred ccCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 573 ~~~~~---~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||+..+..+.+..+...++.+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 54432 224567889999999876 78899999999999999999999999988888888887777766655554433
Q ss_pred hhhhhhcccccchhhhhccccccccCCc--cchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~--~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
........ .++. ...........+..+.+||.+||+.||.+||++.++|.||||
T Consensus 228 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 228 SLARNYKF----------------SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhh----------------hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 22111100 0000 001111122346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=313.60 Aligned_cols=277 Identities=30% Similarity=0.460 Sum_probs=214.1
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe--
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH-- 490 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~-- 490 (722)
|++.+.||+|+||.||++++..+++.+|+|+++.... ......+|+.+++.+.. ..|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES---FEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc---cCCCCcceEEEEEeeccCCC
Confidence 6889999999999999999988899999999874322 22345578888887763 358999999999998876
Q ss_pred ---EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 491 ---LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 491 ---l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
.+++|||+.+++.+++..... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+||
T Consensus 78 ~~~~~l~~e~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~--~~~~~l~df 151 (287)
T cd07838 78 ELKLTLVFEHVDQDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS--DGQVKIADF 151 (287)
T ss_pred CceeEEEehhcccCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc--CCCEEEecc
Confidence 999999999888887764332 13889999999999999999999999999999999999996 688999999
Q ss_pred CCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
|.+...... .....+++.|+|||++.+..++.++|+|||||++|+|++|.+||......+.+.++....+......+.
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 152 GLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred CcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 998765433 223457888999999999999999999999999999999999999988888888877655443322221
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....... .......+ ..........+..+.+||.+||+.||.+||++.++|+||||
T Consensus 232 ~~~~~~~---------------~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 232 RNVSLPR---------------SSFPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCcccch---------------hhcccccc--cchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 1100000 00000000 00011112234668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=307.98 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=199.3
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-Ce
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-EH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~-~~ 490 (722)
+|++++.||+|++|.||++.+..+++.+|+|.+.... ...+...+|+.+++.++ |+|++++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK------HPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC------CCCeeeeeeeecCCCCE
Confidence 5899999999999999999999999999999986532 23345666777777664 67999999988744 46
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+++||||+.+ ++.+.+.... ...+++.+++.++.|++.||.+||+.||+|+||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~--~~~~~l~df~~ 148 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR--TNIIKVGDLGI 148 (257)
T ss_pred EEEEecccCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec--CCcEEEecccc
Confidence 8999999975 6766665422 123889999999999999999999999999999999999985 78899999999
Q ss_pred cccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+...... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------- 219 (257)
T cd08223 149 ARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------- 219 (257)
T ss_pred eEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 8755332 2334678899999999999999999999999999999999999987655444333321100
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
...+ ...+..+.+||.+||+.||.+|||+.++|+||||
T Consensus 220 -------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -------------------------PPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------------------------CCCc---------cccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 1234568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=322.83 Aligned_cols=279 Identities=34% Similarity=0.552 Sum_probs=217.3
Q ss_pred cEEEEEEeccCCCCceEEEEECCC--CcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHT--GVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~t--g~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~- 488 (722)
+|++.+.||+|+||.||++.+..+ +..+|+|++... ........+|+.+++.++ .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-----GHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc-----CCCChheeeeeeeecc
Confidence 589999999999999999999888 899999998642 222345678888888874 378999999875433
Q ss_pred ---CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 489 ---EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 489 ---~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
...+++|+|+.++|...+.... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~--~~~~kl~ 147 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKIC 147 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC--CCCEEeC
Confidence 4688999999988887775322 3889999999999999999999999999999999999986 7789999
Q ss_pred ecCCcccccCC-------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 566 DLGSSCFQTDN-------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 566 DFGls~~~~~~-------~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|||++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..++..+|
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99998754321 123467899999998866 4689999999999999999999999999888899999999999
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.++.+.+......... .... .. ...+ ...+.......+..+.+||.+||+.||++|||+.+++.|||
T Consensus 228 ~~~~~~~~~~~~~~~~-------~~~~----~~-~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 228 TPDEETLSRIGSPKAQ-------NYIR----SL-PNIP-KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred CCCHHHHHhhhhhhHH-------HHHH----hc-cccC-CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 8777655443211100 0000 00 0000 01111112223567999999999999999999999999999
Q ss_pred CC
Q 004954 718 LQ 719 (722)
Q Consensus 718 f~ 719 (722)
|+
T Consensus 295 ~~ 296 (332)
T cd07857 295 LA 296 (332)
T ss_pred hh
Confidence 96
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.67 Aligned_cols=256 Identities=28% Similarity=0.395 Sum_probs=199.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.+.||+|+||.||++++..+|+.||+|+++... ....+...|+.++.+. ..||||+++++++......
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS-----VDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH-----cCCCCeeeeeEEEecCCcE
Confidence 46999999999999999999999999999999987542 2223444555543332 3588999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||++++|.+++...... ...+++..++.++.||+.||+|||++ +++||||||+||+++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~--~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR--NGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhcccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecccc
Confidence 999999999888877643322 23489999999999999999999997 9999999999999986 788999999998
Q ss_pred ccccCCc--cccccCCcccCchhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHHHhhcCCCcHHH
Q 004954 571 CFQTDNL--CLYVQSRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 571 ~~~~~~~--~~~~gt~~y~APE~l~~----~~~s~ksDIWSLGviL~elltG~~PF~~~~-~~e~l~~i~~~lg~~~~~~ 643 (722)
....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+.+..+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 223 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-------- 223 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--------
Confidence 7654322 22467889999999865 456889999999999999999999996421 11222111100
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
....+|. ...+..+.+||.+||..+|.+|||+.++++||||++
T Consensus 224 --------------------------~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 224 --------------------------PSPQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred --------------------------CCCCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 0000110 012466899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=357.11 Aligned_cols=261 Identities=26% Similarity=0.365 Sum_probs=204.5
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
++...++|++++.||+|+||+||++++..+++.+|+|++... ......+..|+.+++.++ ||||++++++|
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~------HPNIVrl~d~f 81 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK------HKNIVRYIDRF 81 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC------CCCcCeEEEEE
Confidence 456678999999999999999999999999999999998743 234456778899888885 68999999998
Q ss_pred Eec--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-------CCccccCCCCceEEc
Q 004954 486 YHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-------GIIHCDLKPENILIK 555 (722)
Q Consensus 486 ~~~--~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-------gIvHrDLKp~NILl~ 555 (722)
... ..++|||||+.+ +|.+++...... ...+++..++.|+.||+.||.|||+. +||||||||+||||+
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 654 579999999984 777777643221 12389999999999999999999985 499999999999996
Q ss_pred cc---------------CCCeEEEEecCCcccccCC--ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhC
Q 004954 556 SY---------------QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTG 616 (722)
Q Consensus 556 ~~---------------~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG 616 (722)
.. ....+||+|||++...... .....+|+.|+|||++.+ ..++.++||||||||||+|++|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 41 2345999999998765432 233578999999999865 4588999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHH
Q 004954 617 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696 (722)
Q Consensus 617 ~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~ 696 (722)
..||........+...+... ..+|. ...+..+.+||.
T Consensus 240 k~PF~~~~~~~qli~~lk~~-----------------------------------p~lpi--------~~~S~eL~dLI~ 276 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRG-----------------------------------PDLPI--------KGKSKELNILIK 276 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcC-----------------------------------CCCCc--------CCCCHHHHHHHH
Confidence 99997654332222211000 00000 112456889999
Q ss_pred HhcccCCCCCcCHHHHHhCCCCCC
Q 004954 697 TLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 697 ~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.||+.+|.+||++.|+|.||||+.
T Consensus 277 ~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 277 NLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHhcCChhHCcCHHHHhccHHHhh
Confidence 999999999999999999999964
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=321.02 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=204.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|++|+||++.+..+++.+|+|.+..... ....+..|+++++.+. |+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD------HPFLPTLYASFQTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC------CCCchhheeeeecCC
Confidence 479999999999999999999999999999999876432 3345667777777764 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++.... ...+++..++.++.|++.||+|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg 148 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE--SGHIMLSDFD 148 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC--CCCEEEeecc
Confidence 99999999975 6766654321 223899999999999999999999999999999999999996 7789999999
Q ss_pred CcccccCC--------------------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC
Q 004954 569 SSCFQTDN--------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616 (722)
Q Consensus 569 ls~~~~~~--------------------------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG 616 (722)
++...... .....|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 87543211 1123578889999999998899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHH
Q 004954 617 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696 (722)
Q Consensus 617 ~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~ 696 (722)
..||.+.+....+..+..... ..+.. ...+..+.++|+
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~-----------------------------------~~~~~-------~~~~~~~~~li~ 266 (316)
T cd05574 229 TTPFKGSNRDETFSNILKKEV-----------------------------------TFPGS-------PPVSSSARDLIR 266 (316)
T ss_pred CCCCCCCchHHHHHHHhcCCc-----------------------------------cCCCc-------cccCHHHHHHHH
Confidence 999987765554444321100 00110 013467899999
Q ss_pred HhcccCCCCCcC----HHHHHhCCCCCCC
Q 004954 697 TLLEINPQRRPT----AREALDHPWLQHP 721 (722)
Q Consensus 697 ~mL~~dP~kRpT----a~ElL~HPwf~~~ 721 (722)
+||+.||++||| ++|+|+||||+..
T Consensus 267 ~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 267 KLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.51 Aligned_cols=276 Identities=32% Similarity=0.529 Sum_probs=219.2
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
|++.+.||+|++|+||+|++..+++.+|||.+..... ......+|+..++.++ .|+||+++++++...+..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc-----CCCCchhHHHHhhcCCcEEE
Confidence 6789999999999999999988999999999865432 1223345666665553 27899999999999999999
Q ss_pred EEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 494 VmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
||||+.+++.+.+.... ...+++..+..++.|++.+|.|||++|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 v~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~--~~~~~l~d~~~~~~~ 149 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG--PEVVKIADFGLAREI 149 (283)
T ss_pred EEecCCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCCEEEeecccceec
Confidence 99999888888776543 123889999999999999999999999999999999999996 789999999998765
Q ss_pred cCC--ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 574 TDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 574 ~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
... .....++..|+|||++.. ..++.++|+||||+++|+|++|++||+.....+.+..+...++.++.+.+.....+
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 150 RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred cCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 432 233567889999998854 45789999999999999999999999999888888899888888887766554433
Q ss_pred hhhhcccccchhhhhccccccccCCcc--chhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~--~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
...... .++.. ..+.......+..+.+||++||+.+|++|||+.|++.||||
T Consensus 230 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKLGF----------------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hccccc----------------cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 322110 11110 01111222235679999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=311.15 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=203.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~--- 489 (722)
.++|++.+.||+|++|.||+|.+..+++.+++|++.......+.+.+|+.+++.+. .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS-----NHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc-----CCCChheEEEEEEecCCCC
Confidence 47899999999999999999999989999999999876665677888999998874 3789999999997654
Q ss_pred ---eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 490 ---HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 490 ---~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..++||||+.+ +|.+++..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~--~~~~~l~ 155 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLV 155 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc--CCeEEEC
Confidence 48999999986 66666554321 1223889999999999999999999999999999999999986 7889999
Q ss_pred ecCCcccccCC---ccccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~y~APE~l~~-----~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|||++...... .....+++.|+|||++.. ..++.++|||||||++|+|++|..||........+.++....
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~- 234 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP- 234 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC-
Confidence 99988654332 223467889999999854 346788999999999999999999997654443333322100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
. ..+.. ....+..+.+||.+||..||++|||+.++++|||
T Consensus 235 -~--------------------------------~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 235 -P--------------------------------PTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred -C--------------------------------CCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 0 00000 0112356889999999999999999999999999
Q ss_pred C
Q 004954 718 L 718 (722)
Q Consensus 718 f 718 (722)
+
T Consensus 275 ~ 275 (275)
T cd06608 275 I 275 (275)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.67 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=202.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (722)
..++|.+.+.||+|+||.||++.+..+++.+|+|++...........+|+.+++.+. .||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~-----~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEEecccc
Confidence 468899999999999999999999999999999998765444456677888887774 378999999998754
Q ss_pred --CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 489 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 489 --~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
...++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~--~~~~kl~ 170 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLV 170 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEe
Confidence 368999999975 666666532211 223889999999999999999999999999999999999986 7789999
Q ss_pred ecCCcccccCC---ccccccCCcccCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~y~APE~l~~~-----~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|||++...... .....++..|+|||++... .++.++|||||||++|+|++|+.||........+..+....
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~- 249 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP- 249 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC-
Confidence 99988754322 2234678899999998643 36789999999999999999999997765444333322100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.+ ....+ ......+.+||.+||+.+|++||++.|+|+|||
T Consensus 250 -~~------------------------------~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 250 -PP------------------------------TLLHP---------EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred -CC------------------------------CCCcc---------cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 00 00000 112346889999999999999999999999999
Q ss_pred CC
Q 004954 718 LQ 719 (722)
Q Consensus 718 f~ 719 (722)
|+
T Consensus 290 ~~ 291 (291)
T cd06639 290 IK 291 (291)
T ss_pred cC
Confidence 96
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.39 Aligned_cols=275 Identities=33% Similarity=0.515 Sum_probs=222.3
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
|++.+.||+|++|.||+|++..+++.+|+|++... .........|+.+++.++ |+||+++++++...+..+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK------HPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC------CCCHHHHHhhhhcCCceE
Confidence 67788999999999999999999999999998764 233455667888888775 689999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
+||||++++|.+++.... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~--~~~~~l~d~g~~~~ 147 (282)
T cd07829 75 LVFEYCDMDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARA 147 (282)
T ss_pred EEecCcCcCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC--CCCEEEecCCcccc
Confidence 999999998888877542 23899999999999999999999999999999999999996 78899999999876
Q ss_pred ccCCc---cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 573 ~~~~~---~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... .....+..|+|||.+.+. .++.++|+|||||++|+|++|.+||......+.+.++....+.++..++....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 54332 223457789999999876 78999999999999999999999999998888888998888888777766554
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
... ++....... + ...........+..+.++|++||+.||++||++.+++.||||
T Consensus 228 ~~~-~~~~~~~~~-------------~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 228 KLP-DYKPTFPKF-------------P-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccc-ccccccccc-------------C-ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 433 111111000 0 001111122235679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=309.19 Aligned_cols=250 Identities=29% Similarity=0.460 Sum_probs=203.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
++|++.+.||+|+||.||++.+..+++.+++|.+..... ...+.+|+++++.+ .|+||+++++.+....+.++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC------DSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC------CCCcEeeeeeeeecCCcEEE
Confidence 579999999999999999999988899999999976654 56788888888887 37899999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
++||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++..
T Consensus 76 ~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~--~~~~~l~dfg~~~~ 148 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE--EGQAKLADFGVSGQ 148 (256)
T ss_pred EEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC--CCcEEEcccccchh
Confidence 9999986 5666654322 23889999999999999999999999999999999999996 77899999999876
Q ss_pred ccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 573 QTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 573 ~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
..... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...........+...
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 214 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-------------- 214 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--------------
Confidence 54432 2345788999999999999999999999999999999999999765443322111100
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
...... .....+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 215 --------------------~~~~~~-------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 --------------------PPPTLS-------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --------------------CCCCCC-------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000000 011123568899999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.10 Aligned_cols=253 Identities=30% Similarity=0.441 Sum_probs=203.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
++|++++.||.|+||.||++.+..+++.+|+|++.... .....+.+|+.+++.++ |+||+++++.+......+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK------HPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC------CCceeEEEEEEecCCeEE
Confidence 57999999999999999999998899999999987543 33456778888888775 679999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~--~~~~~l~d~g~~~ 151 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL--DGDVKLADFGVSA 151 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC--CCCEEEccCccch
Confidence 99999986 5555544322 23899999999999999999999999999999999999985 7889999999876
Q ss_pred cccCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
..... .....+++.|+|||.+. ...++.++|+||||+++|+|++|+.||........+..+..... +
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--- 226 (280)
T cd06611 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP--P--- 226 (280)
T ss_pred hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC--C---
Confidence 54322 23356889999999985 34577899999999999999999999987655544433321100 0
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.... ....+..+.+||.+||+.+|.+||++.++|+||||.+
T Consensus 227 ---------------------------~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 227 ---------------------------TLDQ---------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred ---------------------------CcCC---------cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 0000 0122356889999999999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=316.81 Aligned_cols=252 Identities=28% Similarity=0.457 Sum_probs=202.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..+|++.+.||+|++|.||++.+..+++.+|+|.+.... .....+.+|+.+++.+. |+||+++++.+....+.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~------h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC------CCCEeeEEEEEEeCCEE
Confidence 468999999999999999999999999999999887543 23355667888777664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++... .++..++..++.|++.||+|||+.||+|+||||+||+++. ++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~--~~~~kl~dfg~~ 163 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (296)
T ss_pred EEeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC--CCCEEECccccc
Confidence 999999975 566655321 2788899999999999999999999999999999999985 778999999988
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........+..+... +.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~--------- 233 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT--------- 233 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC---------
Confidence 654322 22346788999999999888999999999999999999999999776543322221100 00
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..++ .....+..+.+||.+||..+|.+|||+.++++||||..
T Consensus 234 ------------------------~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 234 ------------------------PELQ-------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ------------------------CCCC-------CccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 0000 01122356889999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.37 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=200.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-----
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY----- 486 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~----- 486 (722)
..++|++.+.||+|+||.||++++..+++.+|+|++.........+.+|+.+++.+. .|+||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh-----cCCCeeeeeeeeeecccC
Confidence 467999999999999999999999999999999998765444456778888888885 3789999999884
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
.....++||||+++ +|.+++..... ....+++..++.++.|++.||.|||+.+|+||||||+||+++. ++.++|+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~kl~ 166 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLV 166 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC--CCCEEEc
Confidence 34578999999975 56665543221 1234888999999999999999999999999999999999996 6779999
Q ss_pred ecCCcccccCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|||++...... .....+++.|+|||++. +..++.++|||||||++|+|++|+.||........+..+....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~- 245 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP- 245 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-
Confidence 99998754432 22346889999999975 3457889999999999999999999997654333222111000
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
...... ....+..+.+||.+||+.||++|||+.|||+|||
T Consensus 246 -------------------------------~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 246 -------------------------------PPTLHQ---------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred -------------------------------CCcccC---------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 000000 0112356889999999999999999999999999
Q ss_pred C
Q 004954 718 L 718 (722)
Q Consensus 718 f 718 (722)
|
T Consensus 286 ~ 286 (286)
T cd06638 286 I 286 (286)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=319.01 Aligned_cols=252 Identities=30% Similarity=0.483 Sum_probs=200.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.+ .|+||+++++.+...++.
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC------CCCCEeeEEEEEecCCEE
Confidence 478999999999999999999999999999999987532 2334556777777765 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+|||++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~--~~~~~l~Dfg~~ 162 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (297)
T ss_pred EEeecccCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEECcCccc
Confidence 999999975 55555532 12788899999999999999999999999999999999985 788999999988
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....+..+.. .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~---------- 231 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG---------- 231 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CC----------
Confidence 654332 2234678899999999998899999999999999999999999976543221111100 00
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.|. ...+...+..+.+||.+||+.+|.+||++.++|+||||+.
T Consensus 232 --------------------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 232 --------------------------TPE----LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred --------------------------CCC----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 000 0001123466889999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.34 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=203.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++.+.||+|+||.||++++..+|+.+|+|.+... ......+.+|+.+++.++ |+||+++++++...++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK------HPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC------CCCeeeeEeeecCCCeE
Confidence 689999999999999999999999999999998643 233346677888877774 68999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+.+..... ..+++..++.++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~--~~~~~l~d~~~~ 148 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTIKLGDFGIA 148 (256)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEEeeccce
Confidence 999999975 67776653221 22788899999999999999999999999999999999986 778999999998
Q ss_pred ccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
....... ....+++.|+|||++.+..++.++|+|||||++|+|++|..||......+....+.... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~-------- 218 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--Y-------- 218 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--C--------
Confidence 7654332 22457888999999998889999999999999999999999998766655554443110 0
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
... ....+..+.++|.+||+.+|.+||++.++|+||||
T Consensus 219 ------------------------~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 ------------------------PPV---------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------------------CCC---------cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 000 11234668999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.68 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=203.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.+.||.|+||+||++.+..++..+|+|++.... ...+.+.+|+.+++.++ |+||+++++.+...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN------HPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC------CCCEEEEEEEEeeCCEE
Confidence 47999999999999999999998899999999986532 24466778888877664 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++|||++.+ .|.+++..... ...+++..++.++.||+.||+|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~--~~~~~l~df~~~ 149 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE--DGSVKIADFGVS 149 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEEcccchH
Confidence 999999975 56666654322 123889999999999999999999999999999999999996 678999999988
Q ss_pred ccccCCc-------cccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 571 CFQTDNL-------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 571 ~~~~~~~-------~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
....... ....++..|+|||++... .++.++|+|||||++|+|++|+.||...+....+.++..... +
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-- 225 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP--P-- 225 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC--C--
Confidence 6544322 224678899999998876 788999999999999999999999977655444433321100 0
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
..+.. ......++.+.+||.+||+.||++|||+.++|+||||
T Consensus 226 ------------------------------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 ------------------------------SLETG----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ------------------------------CcCCc----cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00000 0011234668899999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=314.49 Aligned_cols=252 Identities=32% Similarity=0.462 Sum_probs=200.0
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
|++.+.||+|+||.||++.+..++..+++|.+.... .....+.+|+++++.+. |+||+++++.+......++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD------HPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC------CCCeeeEEEEEeeCCEEEEE
Confidence 678899999999999999999999999999986532 33455677888877764 78999999999999999999
Q ss_pred EEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 495 CELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 495 mEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
|||+.++.+..+.... ...+++..+..++.|++.||.|||+.|++||||||+||+++. ++.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 81 IEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNT 154 (282)
T ss_pred EEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc--CCCEEEcccccccccc
Confidence 9999875544332221 123889999999999999999999999999999999999986 7789999999986543
Q ss_pred CC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 575 DN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 575 ~~---~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
.. .....+++.|+|||++. +..++.++|||||||++|+|++|++||...+.......+.....+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------- 226 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-------- 226 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--------
Confidence 32 22356789999999984 445788999999999999999999999876655544443211100
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.++ .....+..+.+||++||+.||.+|||+.++++||||+.
T Consensus 227 --------------------------~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 227 --------------------------TLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred --------------------------CCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 000 00112356889999999999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=313.47 Aligned_cols=260 Identities=29% Similarity=0.428 Sum_probs=206.2
Q ss_pred ecCcEEEEE-EeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--
Q 004954 412 IAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (722)
Q Consensus 412 l~~rY~i~~-~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~-- 488 (722)
+.++|+|.. +||-|-.|+|..+.++.||+++|+|++... .+..+|+++..... .|||||.++++|...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s-----~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMAS-----GHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhc-----CCCceEEeehhhhhhcc
Confidence 456777764 699999999999999999999999998654 45678888877765 589999999998743
Q ss_pred --CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEE
Q 004954 489 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKI 564 (722)
Q Consensus 489 --~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL 564 (722)
..+.||||.|+| .|+..+... +...+++.++..|++||+.|+.|||+.+|.||||||+|+|.+. ..+..+||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~----g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR----GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc----ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 578999999986 466655532 3455999999999999999999999999999999999999975 34678999
Q ss_pred EecCCccccc--CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 565 IDLGSSCFQT--DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 565 ~DFGls~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
+|||+|+... ....+.+.||.|.|||++-..+|+...|+|||||++|-||+|.+||..+.... ++..
T Consensus 206 tDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------ispg 274 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPG 274 (400)
T ss_pred cccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------CChh
Confidence 9999998766 33556788999999999999999999999999999999999999996543211 1111
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
|- . ......+.+|.... + ..+++.+++|+++|..+|++|.|+.+++.|||+.+
T Consensus 275 Mk------------------~--rI~~gqy~FP~pEW-s----~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 275 MK------------------R--RIRTGQYEFPEPEW-S----CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred HH------------------h--HhhccCccCCChhH-h----HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 10 0 11122333332110 0 12466889999999999999999999999999964
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.04 Aligned_cols=254 Identities=29% Similarity=0.427 Sum_probs=197.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEee---cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~---~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+..|+++++||+||.++||++... ..+.+|+|.+. .+....+-+.+|+.+|.+|+. |.+|+++|++-..++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg-----~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKG-----HDKIIQLYDYEVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcC-----CceEEEEeeeeccCc
Confidence 456999999999999999999854 34556666543 244556778999999999985 459999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.+||||||-+.+|-..+...... .+.-.++.+..||+.|+.++|+.||||.||||.|+|+. .|.+||+|||.
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGI 505 (677)
T ss_pred eEEEEeecccccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeech
Confidence 99999999888888887755432 33347889999999999999999999999999999998 79999999999
Q ss_pred cccccCCcc-----ccccCCcccCchhhcCC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 570 SCFQTDNLC-----LYVQSRSYRAPEVIIGL-----------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 570 s~~~~~~~~-----~~~gt~~y~APE~l~~~-----------~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
|.......+ ..+||+.||+||.+... +.++++||||||||||+|+.|+.||..-. ..++++.
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~ 583 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLH 583 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHH
Confidence 976554432 36899999999998633 26689999999999999999999995432 1222222
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
+...| ..+..+|.... .-+++++++.||.+||.+|||..+||
T Consensus 584 aI~~P------------------------------~~~Iefp~~~~--------~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 584 AITDP------------------------------NHEIEFPDIPE--------NDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred hhcCC------------------------------CccccccCCCC--------chHHHHHHHHHHhcCcccCCCcHHHh
Confidence 11110 01111222111 12288999999999999999999999
Q ss_pred hCCCCCC
Q 004954 714 DHPWLQH 720 (722)
Q Consensus 714 ~HPwf~~ 720 (722)
+|||++-
T Consensus 626 qhpFl~~ 632 (677)
T KOG0596|consen 626 QHPFLQI 632 (677)
T ss_pred cCccccc
Confidence 9999974
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.57 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=206.3
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++++.||.|+||.||.+++..+++.+++|.+... ......+.+|+.+++.++ |+||+++++++...+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ------HPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC------CCCeeEEEeEEecCCeE
Confidence 699999999999999999999999999999987643 333456778888888774 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+.+.... ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~--~~~~kl~d~~~~ 148 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK--AGLIKLGDFGIS 148 (256)
T ss_pred EEEEEecCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC--CCCEEECcCcce
Confidence 999999975 7777665432 123889999999999999999999999999999999999986 778999999998
Q ss_pred ccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+... ..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~------- 219 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT------- 219 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 7654432 3356889999999999888899999999999999999999999887666655554311 000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.. ....+..+.++|.+||..+|.+||++.++|+|||+
T Consensus 220 -------------------------~~---------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -------------------------PV---------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------------------------CC---------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 00 01224568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.09 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=202.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..+|++.+.||.|++|.||++.+..+++.||+|.+.... .....+.+|+.+++.++ |+||+++++.+......
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK------NPNIVNFLDSFLVGDEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC------CCceeeeeeeEecCceE
Confidence 357999999999999999999999999999999886532 23355667788777764 78999999999999999
Q ss_pred EEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.++ |..++.. ..+++.++..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~--~~~~kl~dfg~~ 162 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM--DGSVKLTDFGFC 162 (296)
T ss_pred EEEEEecCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccCccc
Confidence 9999999864 4444432 12889999999999999999999999999999999999985 788999999987
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....+..+... +. +
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~-~------- 233 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT-P------- 233 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC-c-------
Confidence 654332 22346788999999999888999999999999999999999999876554433222110 00 0
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+ ......+..+.+||++||..||.+|||+.++++||||+.
T Consensus 234 -------------------------~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 234 -------------------------EL-------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred -------------------------cc-------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 00 001123456889999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=312.03 Aligned_cols=251 Identities=29% Similarity=0.425 Sum_probs=205.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.+.||.|++|.||++++..+++.+|+|++.... .....+.+|+.+++.++ |+||+++++.+......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR------SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC------CCCeeeeeEEEEECCeE
Confidence 47899999999999999999999999999999987543 23345667888887775 68999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++|+||+.+ +|.+.+... .+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~ 145 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE--EGDVKLADFGVS 145 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999975 676666532 3889999999999999999999999999999999999996 788999999998
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------- 214 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN----------- 214 (274)
T ss_pred eeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-----------
Confidence 765533 234567888999999999889999999999999999999999997665443333222110
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
...++.. ..++.+.++|.+||..+|++|||++++++||||++.
T Consensus 215 -----------------------~~~~~~~--------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 215 -----------------------PPSLEGN--------KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------------------CCCCccc--------ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0000100 034568899999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.97 Aligned_cols=247 Identities=31% Similarity=0.455 Sum_probs=198.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+|.+.+.||.|++|.||+|.+..+++.+|+|.+..... ....+.+|+.+++.++ ||||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 74 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ------HENIVQYLGS 74 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC------CCCeeeEEEE
Confidence 57888999999999999999988999999998864321 1234566777777774 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+...+..++||||+++ +|.+++.... .+++..+..++.|++.||+|||+.|++||||+|+||+++. ++.++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~--~~~~~ 146 (267)
T cd06628 75 SLDADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIK 146 (267)
T ss_pred EEeCCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC--CCCEE
Confidence 9999999999999975 6666665322 2788899999999999999999999999999999999985 78899
Q ss_pred EEecCCcccccCC---------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 004954 564 IIDLGSSCFQTDN---------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (722)
Q Consensus 564 L~DFGls~~~~~~---------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~ 634 (722)
|+|||.+...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 9999988655421 1123578889999999988899999999999999999999999987544333322211
Q ss_pred hcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
. ....+| ...+..+.++|++||+.||.+||++.++++
T Consensus 227 ~----------------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 N----------------------------------ASPEIP---------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c----------------------------------CCCcCC---------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 000111 123466889999999999999999999999
Q ss_pred CCCC
Q 004954 715 HPWL 718 (722)
Q Consensus 715 HPwf 718 (722)
||||
T Consensus 264 ~~~~ 267 (267)
T cd06628 264 HPFL 267 (267)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.40 Aligned_cols=252 Identities=24% Similarity=0.412 Sum_probs=211.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
-|.|+++||+|+||.||+|.++.+|+.+|||.+..+.+ .+.+..|+.|++++.. +++|++|+.|.....++||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S------~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKS------KYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCC------chhhhhhhhhccCCceEee
Confidence 47788899999999999999999999999999987764 4678889999988864 6999999999999999999
Q ss_pred EEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
||||+ |+.-+.++.+... +++.++..+++..++||+|||...-||||||..|||++. +|..||+|||.+.++
T Consensus 107 MEYCGAGSiSDI~R~R~K~-----L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT--~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKP-----LSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT--DGIAKLADFGVAGQL 179 (502)
T ss_pred hhhcCCCcHHHHHHHhcCC-----ccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc--cchhhhhhccccchh
Confidence 99998 6777777765443 999999999999999999999999999999999999996 899999999999887
Q ss_pred cCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 574 TDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 574 ~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
.+. ..+..|||.|||||++..-.|..++||||||++..||..|++||.+-.+.-.+..| ...
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~------------ 244 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTK------------ 244 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCC------------
Confidence 765 45678999999999999999999999999999999999999999764332111111 000
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
.|+.. ..+...+.+|.|||+.||...|++|.||.++++|||++++
T Consensus 245 -----------------------PPPTF---~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 245 -----------------------PPPTF---KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred -----------------------CCCCC---CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 01100 0111223568999999999999999999999999999864
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.75 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=203.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... .....+.+|+.+++.++ ||||+++++.+...+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS------HPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC------CCchhheeeeEecCCEE
Confidence 5899999999999999999999999999999986532 23456677888888774 68999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++.... ...+++..+..++.|++.+|.|||++|++|+||+|+||+++. .+..++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK-HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEecCCCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEccCCCc
Confidence 999999975 6777765432 123789999999999999999999999999999999999975 3457899999998
Q ss_pred ccccCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 571 CFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 571 ~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~------------ 217 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT------------ 217 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC------------
Confidence 7655432 23567889999999998888999999999999999999999998766554443332100
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
...++ ...+..+.++|.+||+.+|.+|||+.|+|+||||
T Consensus 218 ----------------------~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 218 ----------------------FAPIS---------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------------------CCCCC---------CCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00011 1124568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.67 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=200.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++++.||+|+||.||++.+..+++.+|+|.++.. ......+.+|+.+++.++ |+||+++++.+...+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV------SPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC------CCcHHhhhhheecCCeE
Confidence 3689999999999999999999999999999988753 233456778888887764 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++||||+.+ +|..++.... ....+++..+..++.||+.||.|||+ .+|+|+||||+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 149 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGV 149 (286)
T ss_pred EEEEeecCCCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC--CCCEEEeecCC
Confidence 999999986 4555544321 12248999999999999999999997 59999999999999996 78899999999
Q ss_pred cccccCC-ccccccCCcccCchhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 570 s~~~~~~-~~~~~gt~~y~APE~l~~~~------~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
+...... .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--- 226 (286)
T cd06622 150 SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD--- 226 (286)
T ss_pred cccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC---
Confidence 8755332 23346788999999986543 5789999999999999999999997654433332222111000
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...+| ...+..+.+||.+||+.+|++||++.+++.||||..
T Consensus 227 ----------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 227 ----------------------------PPTLP---------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred ----------------------------CCCCC---------cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 00011 113466889999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=343.95 Aligned_cols=246 Identities=28% Similarity=0.451 Sum_probs=202.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEee-cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-ec--
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HL-- 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~-~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~-~~-- 488 (722)
..+++|.++|.+|||+.||+|++...|..+|+|.+- .+........+|+.+|+.|. .|+|||.+++... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-----gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS-----GHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc-----CCCceeeEeccccccccC
Confidence 468999999999999999999998888999999764 46667788999999999997 4789999999432 11
Q ss_pred ----CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCCCe
Q 004954 489 ----EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 489 ----~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~~~ 561 (722)
-+++|.||||. |+|.+++..+.... |++.++++|+.++++|+++||.+. |||||||-+||||.. ++.
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~----lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~--~g~ 184 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTR----LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA--DGN 184 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhcc----CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC--CCC
Confidence 35889999999 69999998654433 999999999999999999999998 999999999999996 889
Q ss_pred EEEEecCCcccccCCccc------------cccCCcccCchhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH
Q 004954 562 IKIIDLGSSCFQTDNLCL------------YVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (722)
Q Consensus 562 vkL~DFGls~~~~~~~~~------------~~gt~~y~APE~l---~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~ 626 (722)
+||||||.++........ ..-|+.|+|||++ .+.+++.|+|||+|||+||.|+....||......
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 999999998654333211 2348999999997 5788999999999999999999999999765322
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
.+ ....|.+|.-... ...|++||+.||+.||.+|
T Consensus 265 aI---------------------------------------lng~Y~~P~~p~y-------s~~l~~LI~~mL~~nP~~R 298 (738)
T KOG1989|consen 265 AI---------------------------------------LNGNYSFPPFPNY-------SDRLKDLIRTMLQPNPDER 298 (738)
T ss_pred eE---------------------------------------EeccccCCCCccH-------HHHHHHHHHHHhccCcccC
Confidence 11 1234556654333 3558999999999999999
Q ss_pred cCHHHHHhC
Q 004954 707 PTAREALDH 715 (722)
Q Consensus 707 pTa~ElL~H 715 (722)
|++.+++.+
T Consensus 299 PnI~Qv~~~ 307 (738)
T KOG1989|consen 299 PNIYQVLEE 307 (738)
T ss_pred CCHHHHHHH
Confidence 999999865
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.14 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=196.3
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+|++.+.||+|+||+||+|.+ .+++.+|+|.+.... .....+.+|+.+++.++ |+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~ 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK------HVNIVQYLGTCLD 73 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC------CCCEeeEeeEeec
Confidence 588899999999999999986 578999999886432 12344666777777664 6799999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..++||||+.+ +|.+++.... .+++..++.++.|++.||+|||+.+|+|+||+|+||+++. ++.++|+|
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l~d 145 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLID 145 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC--CCeEEecc
Confidence 9999999999976 5666654322 2788999999999999999999999999999999999985 78899999
Q ss_pred cCCcccccC---------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 567 LGSSCFQTD---------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 567 FGls~~~~~---------~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
||++..... ......++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG 225 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence 998765321 12234678899999999998899999999999999999999999976543332222211100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.. ..++ ...+..+.+||++||+.+|.+||++.++|+|||
T Consensus 226 ~~--------------------------------~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 226 LM--------------------------------PRLP---------DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred CC--------------------------------CCCC---------CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 00 0011 123467899999999999999999999999999
Q ss_pred C
Q 004954 718 L 718 (722)
Q Consensus 718 f 718 (722)
|
T Consensus 265 ~ 265 (265)
T cd06631 265 L 265 (265)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.70 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=196.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..+|++.+.||+|+||.||+|++..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++.+...+..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~------~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC------KHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc------CCCCeeeeeEEEEeCCEE
Confidence 467999999999999999999999999999999987532 2334566788877766 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+++ +|.+++.... .+++..+..++.|++.||.|||+.||+||||+|+||+++. ++.++|+|||++
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg~~ 153 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD--NGDVKLADFGVA 153 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEECcCccc
Confidence 999999985 5666654321 2889999999999999999999999999999999999985 778999999998
Q ss_pred ccccCC---ccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
...... .....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 224 (267)
T cd06646 154 AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS--------- 224 (267)
T ss_pred eeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC---------
Confidence 765432 22346788999999985 344778999999999999999999999654322211111000
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
....+. .. .....+..+.+||++||+.+|++|||++++|+|+|
T Consensus 225 --------------------------~~~~~~---~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 --------------------------NFQPPK---LK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --------------------------CCCCCC---Cc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 00 01123467899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=310.01 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=198.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+|++.+.||+|++|.||++.+..+++.+|+|++.... .....+.+|+++++.++ |+||+++++++..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN------HPHIIRMLGATCE 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC------CCceehhhceecc
Confidence 4788899999999999999999999999999987432 12356677888888775 6799999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.++.++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ....++|+|
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~-~~~~~~l~d 147 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS-TGQRLRIAD 147 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEcc
Confidence 9999999999986 5666554321 3889999999999999999999999999999999999975 234699999
Q ss_pred cCCcccccCCc-------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 567 LGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 567 FGls~~~~~~~-------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--- 224 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--- 224 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---
Confidence 99986654321 12457889999999998889999999999999999999999996543222111111000
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.......+| ...+..+.++|.+||+.+|.+|||+.++|+||||+
T Consensus 225 ---------------------------~~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 ---------------------------SATTAPSIP---------EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------------------ccCCCCCCc---------hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000000011 12346688999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=311.63 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=198.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.++|++.+.||+|+||.||+|++..+++.+|+|+++... .......+|+.+++.++ ||||+++++.+...+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~------h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK------HSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC------CCCeeeEEEEEEeCCEE
Confidence 357889999999999999999999999999999987643 22344566777777664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+++ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~~l~dfg~~ 153 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVS 153 (267)
T ss_pred EEEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECcceee
Confidence 999999985 6776665332 2889999999999999999999999999999999999985 778999999998
Q ss_pred ccccCC---ccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
...... .....+++.|+|||++. ...++.++|+|||||++|+|++|..||........+..+... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~------ 225 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--N------ 225 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--C------
Confidence 654432 23356889999999974 455888999999999999999999999654432222211100 0
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
...+.. . .....+..+.+||++||+.+|++|||++++++|||
T Consensus 226 ---------------------------~~~~~~---~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 226 ---------------------------FQPPKL---K-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ---------------------------CCCCcc---c-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000000 0 00112356889999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.98 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=205.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.....+|++.+.||+|+||+||++++..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~~~~~~ 84 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR------HPNTIEYKGCY 84 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC------CCCEEEEEEEE
Confidence 344567999999999999999999999999999999986432 22345667887777764 68999999999
Q ss_pred EecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 486 ~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
...+..++||||+.+++.+++..... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+
T Consensus 85 ~~~~~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~--~~~~kL~ 157 (307)
T cd06607 85 LREHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE--PGTVKLA 157 (307)
T ss_pred EeCCeEEEEHHhhCCCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC--CCCEEEe
Confidence 99999999999999988887754322 2889999999999999999999999999999999999986 7889999
Q ss_pred ecCCcccccCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 566 DLGSSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 566 DFGls~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|||++...... ....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 158 dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~----- 231 (307)
T cd06607 158 DFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS----- 231 (307)
T ss_pred ecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----
Confidence 99998655433 3456788999999974 35578899999999999999999999977654443333221000
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
...+. ...+..+.+||.+||+.+|.+||++.+++.||||+..
T Consensus 232 -----------------------------~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 -----------------------------PTLSS--------NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred -----------------------------CCCCc--------hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 00000 0123568899999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.52 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=201.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++ ||||+++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE------NPFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC------CCCeeeeEEEEecCC
Confidence 36899999999999999999999999999999987542 22345567777777654 689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
+.++||||+.| +|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~--~~~~~l~dfg 146 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS--MGHIKLTDFG 146 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC--CCCEEEeeCC
Confidence 99999999986 5666654322 2888999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCC------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 004954 569 SSCFQTDN------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (722)
Q Consensus 569 ls~~~~~~------------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~ 630 (722)
++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 87531110 011346778999999998889999999999999999999999998876666555
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC--
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-- 708 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-- 708 (722)
.+....... |.. ....+..+.+||++||+.||++||+
T Consensus 227 ~~~~~~~~~-----------------------------------~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 227 QVISDDIEW-----------------------------------PEG------DEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred HHHhcccCC-----------------------------------CCc------cccCCHHHHHHHHHHhccChhhccCcc
Confidence 443111000 000 0123456889999999999999997
Q ss_pred -HHHHHhCCCCCC
Q 004954 709 -AREALDHPWLQH 720 (722)
Q Consensus 709 -a~ElL~HPwf~~ 720 (722)
+.++|+||||..
T Consensus 266 ~~~~ll~~~~~~~ 278 (305)
T cd05609 266 GAFEVKQHRFFLG 278 (305)
T ss_pred CHHHHHhCccccC
Confidence 899999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.36 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=213.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+-.++|..+++||+|.||+|.+++.+.+++.+|||+++++ ++.....+.|-++|+..+ ||.+..+...|+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~------HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR------HPFLTSLKYSFQ 238 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc------CcHHHHhhhhhc
Confidence 3446789999999999999999999999999999999874 344455667778887765 789999999999
Q ss_pred ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 487 ~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
..+++|+||||.+|+-+-+.... ...+++.+.+.+...|+.||.|||+++||+||||.+|.|++. +|.|||+|
T Consensus 239 t~drlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDk--DGHIKitD 311 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDK--DGHIKITD 311 (516)
T ss_pred cCceEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheecc--CCceEeee
Confidence 99999999999987633332222 223999999999999999999999999999999999999996 99999999
Q ss_pred cCCccc---ccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 567 LGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 567 FGls~~---~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
||+.+. .+....++||||.|+|||++....|++++|+|.+||+||||++|++||.+.+...++.-|...
T Consensus 312 FGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------- 383 (516)
T KOG0690|consen 312 FGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------- 383 (516)
T ss_pred cccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--------
Confidence 999864 455667799999999999999999999999999999999999999999988777766665421
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWL 718 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf 718 (722)
+..+|. ..+++.+.||..+|..||.+|. .|.|+.+|+||
T Consensus 384 ---------------------------d~kFPr---------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF 427 (516)
T KOG0690|consen 384 ---------------------------DLKFPR---------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFF 427 (516)
T ss_pred ---------------------------hccCCc---------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence 111222 2346688999999999999996 49999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
..
T Consensus 428 ~~ 429 (516)
T KOG0690|consen 428 AS 429 (516)
T ss_pred cc
Confidence 75
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.04 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=213.4
Q ss_pred cCcEEEE--EEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVT--EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~--~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..-|+|. ++||+|-||+||-|++..+|+.||||++.+. .....++.+|+.||+.+. ||.||.+--.|++
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~------HPGiV~le~M~ET 634 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH------HPGIVNLECMFET 634 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC------CCCeeEEEEeecC
Confidence 3446665 6899999999999999999999999998653 344578889999999886 6799999999999
Q ss_pred cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC-CeEEEEe
Q 004954 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~-~~vkL~D 566 (722)
.+.+++|||-+.|+.++.+...... .+++...+.++.||+.||.|||.++|+|+||||+|||+.+..+ .++||+|
T Consensus 635 ~ervFVVMEKl~GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 635 PERVFVVMEKLHGDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred CceEEEEehhhcchHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecc
Confidence 9999999999999999988755433 3999999999999999999999999999999999999986433 4899999
Q ss_pred cCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCcHHH
Q 004954 567 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 567 FGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~-~~~~e~l~~i~~~lg~~~~~~ 643 (722)
||+|+..+.. ....+|||.|+|||++..+.|.+..|+||+|||+|--|+|.+||.. .+..+++++-.-+..+-|+.
T Consensus 711 FGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~- 789 (888)
T KOG4236|consen 711 FGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWS- 789 (888)
T ss_pred ccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchh-
Confidence 9999988765 3457999999999999999999999999999999999999999954 34444443322111111110
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..++...|||..+|+..=++|.|.+..|.|||+|.
T Consensus 790 ------------------------------------------eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 790 ------------------------------------------EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ------------------------------------------hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 12355789999999999999999999999999985
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=303.26 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=201.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--cC
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LE 489 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--~~ 489 (722)
+|++++.||.|+||.||++.+..+++.+|+|++... .....++..|+.+++.++ |+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK------HPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC------CCccceeeeeeecCCCC
Confidence 589999999999999999999999999999998643 233455667888877775 6799999998764 35
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH-----HCCCccccCCCCceEEcccCCCeEE
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-----SLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLH-----s~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
..+++|||+++ +|.+++..... ....+++..++.++.||+.||.||| +.+++|+||+|+||+++. ++.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~--~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec--CCCEE
Confidence 68999999975 67777654322 1234889999999999999999999 889999999999999995 78999
Q ss_pred EEecCCcccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++....... ....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---- 226 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK---- 226 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC----
Confidence 99999987654432 23467899999999998889999999999999999999999998766444333322100
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
...++ ...+..+.+||.+||+.+|.+|||+.++|+|||+
T Consensus 227 ------------------------------~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ------------------------------FRRIP---------YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------------------CCCCc---------cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00011 1224568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.35 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=201.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
++|++.+.||.|+||.||++.+..+++.+|+|++.... .....+.+|+.+++.++ ||||+++++.+.....++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR------HPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC------CCChhceEEEEEeCCEEE
Confidence 68999999999999999999999999999999987643 23456777888777764 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++|||+++ +|.+++.... ..+++..++.++.|++.||+|||+.||+|+||+|+||+++. ++.++|+|||++.
T Consensus 77 l~~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~ 149 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVSA 149 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC--CCCEEECccccch
Confidence 99999986 5555554321 23889999999999999999999999999999999999995 7789999999987
Q ss_pred cccCC---ccccccCCcccCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~---~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+.......+.... ++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~--~~----- 222 (262)
T cd06613 150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN--FP----- 222 (262)
T ss_pred hhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CC-----
Confidence 64432 2334678899999999877 78899999999999999999999998765444332221100 00
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.+. +. .....+..+.+||++||..+|..|||+.++|.|||
T Consensus 223 ----------------------------~~~---~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 223 ----------------------------PPK---LK-DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------------------------Ccc---cc-chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 000 00 00012356889999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.08 Aligned_cols=281 Identities=32% Similarity=0.532 Sum_probs=217.7
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+... ........+|+.+++.+. .|+||+++++++..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~ni~~~~~~~~~ 78 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNIVKLLNVIKA 78 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc-----CCCCccceeeeecc
Confidence 4568899999999999999999999989999999987542 223345667888888772 36899999999875
Q ss_pred c--CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 488 L--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 488 ~--~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
. ...++||||+.++|...+... .+.+..++.++.||+.||+|||+.||+|+||||+||+++. ++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~--~~~~kl~ 149 (337)
T cd07852 79 ENDKDIYLVFEYMETDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLA 149 (337)
T ss_pred CCCceEEEEecccccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEe
Confidence 4 468999999998887776532 2778889999999999999999999999999999999986 8899999
Q ss_pred ecCCcccccCC--------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 566 DLGSSCFQTDN--------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 566 DFGls~~~~~~--------~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
|||.+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|++||.+....+.+.++....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99988654321 223567889999998765 457889999999999999999999999988888888888777
Q ss_pred CCCcHHHHhhhhhhh--hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 637 GPIDLEMLMQGQEIY--KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 637 g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
+..+...+....... ..+.. .............+..+..+.+||.+||+.||++|||+.++|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDS---------------LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhh---------------cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 766655443322110 00000 0000011111222234677999999999999999999999999
Q ss_pred CCCCCC
Q 004954 715 HPWLQH 720 (722)
Q Consensus 715 HPwf~~ 720 (722)
||||+.
T Consensus 295 ~~~~~~ 300 (337)
T cd07852 295 HPYVAQ 300 (337)
T ss_pred Chhhhh
Confidence 999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.93 Aligned_cols=248 Identities=29% Similarity=0.401 Sum_probs=199.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+|+..+.||+|++|+||+|.+..+++.|++|.+.... .....+.+|+.+++.++ |+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ------HPNIVQYLGTEREE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC------CCCchheeeeEecC
Confidence 5788899999999999999998899999999886532 23456677887777664 67999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
...++||||+++ +|.+++.... .+++..+..++.||+.||+|||+.||+|+||+|+||+++. ++.+||+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~--~~~~kl~d~ 146 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADF 146 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccC
Confidence 999999999985 6666665321 2788999999999999999999999999999999999986 788999999
Q ss_pred CCcccccCC--ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|++...... .....+++.|+|||.+.... ++.++|+||||+++|+|++|+.||...........+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 218 (258)
T cd06632 147 GMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-------- 218 (258)
T ss_pred ccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--------
Confidence 988654433 23456788999999998766 8999999999999999999999997654333322221000
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....++ ...++.+.+||++||+.+|.+||++.++|+||||
T Consensus 219 -------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 -------------------------ELPPIP---------DHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -------------------------cCCCcC---------CCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 000011 1234678899999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=307.51 Aligned_cols=260 Identities=30% Similarity=0.435 Sum_probs=200.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--C
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--~ 489 (722)
++|.+.+.||.|++|.||++.+..+++.+|+|++.... ....++.+|+++++.++ ||||++++++|... .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK------SPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC------CCCeeeeeeEEEccCCC
Confidence 47999999999999999999999999999999987543 24456778888877764 78999999998754 4
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+++||||+++ +|.+++..... ....+++..+..++.||+.||+|||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~--~~~~~l~dfg 150 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFG 150 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec--CCeEEEeecc
Confidence 78999999975 66665543222 1233888999999999999999999999999999999999986 7789999999
Q ss_pred CcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH-----HHHHHHHHhhcCCCcHH
Q 004954 569 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-----VMILARIIGMLGPIDLE 642 (722)
Q Consensus 569 ls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~-----~e~l~~i~~~lg~~~~~ 642 (722)
++...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... .+....+... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~-- 224 (287)
T cd06621 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----P-- 224 (287)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----C--
Confidence 98654332 2234578889999999998999999999999999999999999975421 1111111100 0
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...+....+.. ...++.+.+||.+||+.+|++|||+.|+++||||++
T Consensus 225 ------------------------~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 225 ------------------------NPELKDEPGNG-------IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred ------------------------chhhccCCCCC-------CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 00000000000 012356889999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=311.68 Aligned_cols=259 Identities=20% Similarity=0.248 Sum_probs=195.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECC----------------CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLH----------------TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPA 473 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~----------------tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~ 473 (722)
..++|++.++||+|+||.||+|.+.. ++..||+|++... ......+.+|+.+++.++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----- 77 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK----- 77 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-----
Confidence 35789999999999999999997532 3457999998763 233456778888887774
Q ss_pred CCCceeEEEEEEEecCeEEEEEEcccc-chHHHHhhhhcc-------------CCCcccCHHHHHHHHHHHHHHHHHHHH
Q 004954 474 DEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES-------------GGEAYFTLGRLQVITRQCLEALEYLHS 539 (722)
Q Consensus 474 ~hpnIv~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~-------------~~~~~ls~~~i~~i~~qIl~aL~yLHs 539 (722)
||||+++++++...+..++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||+
T Consensus 78 -h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 78 -DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred -CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999974 677766543211 111237788899999999999999999
Q ss_pred CCCccccCCCCceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHH
Q 004954 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 614 (722)
Q Consensus 540 ~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ell 614 (722)
.||+||||||+|||++. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|+
T Consensus 157 ~~ivH~dlkp~Nill~~--~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 157 LNFVHRDLATRNCLVGE--NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CCccccCcchhheEEcC--CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999996 7889999999987543321 1233477899999999889999999999999999998
Q ss_pred h--CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHH
Q 004954 615 T--GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692 (722)
Q Consensus 615 t--G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~ 692 (722)
+ +..||...+..+.+..+...+... ........ +...+..+.
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~---------~~~~~~~~~ 278 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFFRDQ---------------------------GRQVYLFR---------PPPCPQGLY 278 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHhhhc---------------------------cccccccC---------CCCCCHHHH
Confidence 7 678887766555544332111000 00000000 112346689
Q ss_pred HHHHHhcccCCCCCcCHHHHHh
Q 004954 693 DFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 693 dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
+||.+||+.||.+|||+.++.+
T Consensus 279 ~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 279 ELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHHccCCchhCcCHHHHHH
Confidence 9999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.36 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=201.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|.+.+.||+|+||.||++.++.+|..+|+|.+.... ...+.+.+|+.+++.++ |+||+++++.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~------h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK------HPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC------CCChhhhhheeccCCeE
Confidence 5899999999999999999999999999999986532 23456677888888775 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++|+||+.+ +|.+.+..... ..+++..+..++.||+.||.|||+.+++|+||||+||+++. ....++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK-NGMVAKLGDFGIA 149 (257)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC-CCCeEEecccccc
Confidence 999999975 67666653221 23789999999999999999999999999999999999985 2345799999988
Q ss_pred ccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
....... ....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 217 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG------------ 217 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc------------
Confidence 7654432 2245788999999998888999999999999999999999999876554444332210
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
... .+ ....+..+.++|.+||+.+|++|||+.++++||||
T Consensus 218 ---------------------~~~-~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 218 ---------------------YFA-PI---------SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ---------------------cCC-CC---------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 000 00 01123568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.95 Aligned_cols=261 Identities=26% Similarity=0.369 Sum_probs=199.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|...+.||+|+||.||++.+..+++.+|+|.+.... .....+.+|+.++.++. +|+||+++++++......
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-----DCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-----CCCCEeeeeeEEecCCcE
Confidence 35667788999999999999999999999999987532 33455677777777664 378999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+++|||+..++.++....... ....+++..+..++.|++.||+|||+. +++||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~ 155 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR--NGNIKLCDFGIS 155 (288)
T ss_pred EEEEecccCCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc--CCcEEEeecchh
Confidence 999999987766654332111 113389999999999999999999975 9999999999999986 778999999998
Q ss_pred ccccCC--ccccccCCcccCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDN--LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~--~~~~~gt~~y~APE~l~~~---~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.... .....+.......+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~----- 228 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDP----- 228 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCC-----
Confidence 654332 2234678899999999876 68899999999999999999999997543 11111111100000
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..++.. .....+..+.+||++||+.||++|||+.++++||||+.
T Consensus 229 --------------------------~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 229 --------------------------PILSNS-----EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred --------------------------CcCCCc-----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 000000 00123567899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=305.71 Aligned_cols=246 Identities=17% Similarity=0.221 Sum_probs=193.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..+|++.+.||+|+||.||+|.++ ..+..||+|+++... .....+.+|+.+++.+ .||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF------DHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEec
Confidence 467999999999999999999764 456789999987643 2234556677777655 47899999999999
Q ss_pred cCeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.++.++||||++++ |.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++. ++.++|+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~--~~~~~l~d 150 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS--DLVCKISG 150 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC--CCcEEECC
Confidence 99999999999865 544554321 23889999999999999999999999999999999999985 78899999
Q ss_pred cCCcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 567 LGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 567 FGls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
||.+....... ....++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+..+.+..+.....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---- 226 (266)
T cd05064 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR---- 226 (266)
T ss_pred CcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----
Confidence 99875432221 11234578999999999999999999999999999875 9999988766655544421100
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...| ...+..+.+++.+||+.+|.+||+++++++
T Consensus 227 ------------------------------~~~~---------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 ------------------------------LPAP---------RNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------------------CCCC---------CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0011 123456889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.85 Aligned_cols=252 Identities=32% Similarity=0.440 Sum_probs=201.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.+.||+|++|.||++.++.+++.+|+|++.... ....++.+|+.+++.+. ||||+++++.+......
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN------SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC------CCchhhhheeeecCCEE
Confidence 36788899999999999999999999999999987653 33455677777777664 78999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 492 ~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~--~~~~~l~d~g~ 147 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS--RGQIKLCDFGV 147 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC--CCCEEEeeccc
Confidence 99999998 56777665432 238899999999999999999999 99999999999999996 77899999998
Q ss_pred cccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh-----HHHHHHHHHhhcCCCcHHH
Q 004954 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-----VVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 570 s~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~-----~~e~l~~i~~~lg~~~~~~ 643 (722)
+...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+.+..+...
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 219 (265)
T cd06605 148 SGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-------- 219 (265)
T ss_pred chhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC--------
Confidence 8654322 112567889999999999999999999999999999999999996542 11111111100
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....+.. ..+..+.+||.+||..||.+|||+.+++.||||+.
T Consensus 220 --------------------------~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 220 --------------------------PPPRLPSG--------KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred --------------------------CCCCCChh--------hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 00001100 03466899999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=304.47 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=195.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+|++.+.||+|+||.||++.+..++..+|+|++.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 75 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ------HERIVQYYGCLRD 75 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC------CCCeeeEEEEEEc
Confidence 36899999999999999999999999999999886431 22345667888887775 6799999999875
Q ss_pred c--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 488 ~--~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
. ..++++|||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|
T Consensus 76 ~~~~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~--~~~~~l 147 (266)
T cd06651 76 RAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (266)
T ss_pred CCCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEE
Confidence 3 678999999975 6766665322 2788899999999999999999999999999999999985 778999
Q ss_pred EecCCcccccCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 565 IDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 565 ~DFGls~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+|||++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+....
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-- 225 (266)
T cd06651 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-- 225 (266)
T ss_pred ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--
Confidence 999998654321 122457888999999999889999999999999999999999997654333322221000
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....+| ...++.+.+|| +||..+|++||+++|+++||||
T Consensus 226 -------------------------------~~~~~~---------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~ 264 (266)
T cd06651 226 -------------------------------TNPQLP---------SHISEHARDFL-GCIFVEARHRPSAEELLRHPFA 264 (266)
T ss_pred -------------------------------CCCCCc---------hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence 000011 12245677888 5777899999999999999999
Q ss_pred C
Q 004954 719 Q 719 (722)
Q Consensus 719 ~ 719 (722)
+
T Consensus 265 ~ 265 (266)
T cd06651 265 Q 265 (266)
T ss_pred c
Confidence 7
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=303.00 Aligned_cols=249 Identities=20% Similarity=0.299 Sum_probs=202.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
....|.+.+.||+|+||.||+|.+..+++.+|+|++..+......+.+|+.+++.+. |+||+++++++......
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREPPF 77 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCC------CCChhheEEEEcCCCCc
Confidence 345699999999999999999999999999999999876555567788888888874 67999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+.|++||||||+||+++. ++.+||+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~df~~~ 151 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLS 151 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCcEEeCCCccc
Confidence 99999997 467776653321 23888999999999999999999999999999999999985 788999999998
Q ss_pred ccccCCccc----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~~~~----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
......... ...++.|+|||.+.+..++.++|||||||++|+|++ |..||++....+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------- 222 (263)
T cd05052 152 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------- 222 (263)
T ss_pred cccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---------
Confidence 765443211 223567999999999999999999999999999998 999998876655544432110
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...+..+.+||.+||+.||++|||+.++++.
T Consensus 223 -------------------------~~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 223 -------------------------RMERP---------EGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred -------------------------CCCCC---------CCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 00011 1224668899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=302.88 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=192.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchhh----hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF----FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~----~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
+.||.|+||.||+|.+..+|+.||+|+++..... ......|..++.. ...|+||+++++++...+..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~-----~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI-----QGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhh-----cCCCCCeeeeeeeEEcCCeEEEEE
Confidence 5699999999999999999999999998754321 1122233322222 236899999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ +|.+++.... .+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++....
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGL 148 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEeecccceecc
Confidence 99975 6666654322 2889999999999999999999999999999999999986 7889999999887544
Q ss_pred CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 004954 575 DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (722)
Q Consensus 575 ~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~ 654 (722)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......
T Consensus 149 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 211 (260)
T cd05611 149 E-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN---------------- 211 (260)
T ss_pred c-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC----------------
Confidence 3 23346788999999999888899999999999999999999999877665554443211000
Q ss_pred cccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC---HHHHHhCCCCCC
Q 004954 655 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALDHPWLQH 720 (722)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT---a~ElL~HPwf~~ 720 (722)
.+.. .....+..+.++|.+||+.||++||+ ++|+|.||||++
T Consensus 212 -------------------~~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 212 -------------------WPEE-----VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred -------------------CCCc-----ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 0000 00123466889999999999999995 579999999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=308.52 Aligned_cols=237 Identities=20% Similarity=0.245 Sum_probs=192.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchhh----hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----cCeE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF----FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----LEHL 491 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~----~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~----~~~l 491 (722)
..||+|+++.||+|.. +|+.||||+++..... .+.+.+|+.++++++ ||||+++++++.. ...+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID------SNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC------CCCEEEEeeeEEecccCCCce
Confidence 4689999999999986 7899999998764322 355668899888875 6799999999987 3578
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++||||+.+ +|.+++.... .+++.....++.|++.||.|||+. +++||||||+|||++. ++.+||+|||+
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~--~~~~kl~dfg~ 169 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE--NYKLKIICHGL 169 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC--CCcEEEcccch
Confidence 999999986 5766665322 278889999999999999999984 9999999999999996 78899999999
Q ss_pred cccccCCccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+...........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..++...+......
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------- 240 (283)
T PHA02988 170 EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS--------- 240 (283)
T ss_pred HhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC---------
Confidence 9876655555678999999999976 67899999999999999999999999887766665554311100
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
..+| ...+..+.+||.+||+.||++|||+.|+++
T Consensus 241 ------------------------~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 241 ------------------------LKLP---------LDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ------------------------CCCC---------CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0011 113467899999999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.04 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=200.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+|++.+.||.|+||.||++.+..+++.+|+|++.... ...+.+.+|+++++.++ ||||+++++.+.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN------HPFLVNLWYSFQDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC------CCChHHHHHhhcCCCe
Confidence 5899999999999999999999999999999997532 33456677777777664 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+ +|...+... ..+++..+..++.||++||.|||++|++|+||+|+||+++. ++.++|+|||.
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~l~d~~~ 146 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE--QGHVHITDFNI 146 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC--CCCEEEeeccc
Confidence 9999999986 565555433 23889999999999999999999999999999999999986 78899999998
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH---HHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~---~e~l~~i~~~lg~~~~~~~ 644 (722)
+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ..+...+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 216 (258)
T cd05578 147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---------- 216 (258)
T ss_pred ccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----------
Confidence 8765443 2335678889999999988899999999999999999999999976553 111111100
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH--HHHHhCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA--REALDHPWL 718 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa--~ElL~HPwf 718 (722)
.....|. ..+..+.++|++||+.||.+||++ +|+++||||
T Consensus 217 -------------------------~~~~~~~---------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 -------------------------ADVLYPA---------TWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------------------------ccccCcc---------cCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0011111 123668899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.37 Aligned_cols=246 Identities=25% Similarity=0.417 Sum_probs=199.4
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+|++.+.||.|+||.||++++..+++.+|+|.++.. ....+...+|+.+++.++ |+||+++++.+...+.++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK------HPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC------CCCcceEEEEEEECCEEE
Confidence 589999999999999999999999999999998643 233456667878777664 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+++ ++.+++.... ...+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.++|+|||.+.
T Consensus 75 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~ 148 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ--NGKVKLGDFGSAR 148 (255)
T ss_pred EEEeeCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC--CCcEEEcccCcce
Confidence 99999975 6776665322 123789999999999999999999999999999999999986 7789999999987
Q ss_pred cccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 216 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS------------ 216 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC------------
Confidence 55432 223568889999999999889999999999999999999999998766555444332100
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...+| ...+..+.+||++||+.||++|||+.++|.-
T Consensus 217 ----------------------~~~~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 ----------------------YKPLP---------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------------------CCCCC---------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00011 1123558899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=302.74 Aligned_cols=243 Identities=28% Similarity=0.436 Sum_probs=197.0
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
||.|++|.||++++..+++.+|+|++.... .....+.+|+.+++.++ ||||+++++.+......++||||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN------HPFIVKLYRTFKDKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC------CCCEeeeeeeEEcCCccEEEEec
Confidence 799999999999999999999999987532 23455677777777664 78999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+.+ +|.+++.... .+++..+..++.||+.||+|||+.+++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~--~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 75 CLGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS--NGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC--CCCEEEeeCCcccccCcc
Confidence 974 6777665432 2888999999999999999999999999999999999986 788999999998765543
Q ss_pred --ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh--HHHHHHHHHhhcCCCcHHHHhhhhhhhh
Q 004954 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--VVMILARIIGMLGPIDLEMLMQGQEIYK 652 (722)
Q Consensus 577 --~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~--~~e~l~~i~~~lg~~~~~~~~~~~~~~~ 652 (722)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ....+..+....
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 210 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------- 210 (262)
T ss_pred cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC----------------
Confidence 233567889999999988889999999999999999999999997654 333333322100
Q ss_pred hhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 653 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
.....|. ..+..+.++|.+||+.+|++||+ +.|+++||||++
T Consensus 211 -----------------~~~~~~~---------~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 211 -----------------GKLEFPN---------YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred -----------------CCCCCCc---------ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 0001111 11467899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=301.06 Aligned_cols=250 Identities=32% Similarity=0.463 Sum_probs=204.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++.+.||+|++|.||++++..+++.+++|++.... .....+.+|+.++..++ |+||+++++++......
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE------SPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC------CCCeeeEEEEEccCCeE
Confidence 36899999999999999999999999999999987653 23466777888887775 68999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 492 ~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++||||+. ++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||+|+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~--~~~~~l~df~~ 146 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS--KGEVKIADFGI 146 (264)
T ss_pred EEEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC--CCCEEEccCcc
Confidence 99999998 5677776543 238999999999999999999999 99999999999999986 78899999998
Q ss_pred cccccCCcc---ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh---HHHHHHHHHhhcCCCcHHH
Q 004954 570 SCFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 570 s~~~~~~~~---~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~---~~e~l~~i~~~lg~~~~~~ 643 (722)
+........ ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------- 218 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-------- 218 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC--------
Confidence 876543222 3467889999999999889999999999999999999999997653 22222222100
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhccc-CcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQF-SDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~-~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..+. .... .+..+.++|.+||..+|++|||+.++|+||||+.
T Consensus 219 -----------------------------~~~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 219 -----------------------------PPPS------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred -----------------------------CCCC------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 0000 0011 3467899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=305.23 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=202.4
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
.|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.++. ..||||+++++++......+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~---~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ---SQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc---CCCCCeeeEeeeeeeCCEEE
Confidence 478889999999999999999999999999998653 3344567789999998875 35899999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+.+ +|.+++... .+++..++.++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN--TGNVKLCDFGVAA 149 (277)
T ss_pred EEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC--CCCEEEccCCcee
Confidence 99999976 565554321 3889999999999999999999999999999999999996 7889999999987
Q ss_pred cccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 65433 223467889999999865 45789999999999999999999999765432221111000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
....++. ...+..+.++|.+||+.||.+||++.++++||||++.
T Consensus 218 ----------------------~~~~~~~--------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 ----------------------KPPRLED--------NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred ----------------------CCCCCCc--------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 0000000 0124568899999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=307.16 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=189.4
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 004954 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmE 496 (722)
.||+|+||.||++.+..+++.+|+|++..... ......+|..+++.+.. ..|++|+.+++.+...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh---CCCCcEeEEEEEEecCCeEEEEEe
Confidence 38999999999999999999999998865321 12233445555555543 358999999999999999999999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC
Q 004954 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 497 y~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
|+.+ +|..++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~--~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 78 LMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (279)
T ss_pred cCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC--CCCEEEccCCcceeccc
Confidence 9986 4555544221 3899999999999999999999999999999999999985 77899999999865433
Q ss_pred C-ccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH--HHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 576 N-LCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM--ILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 576 ~-~~~~~gt~~y~APE~l~-~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e--~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
. .....+++.|+|||.+. +..++.++||||+||++|+|++|..||....... .+..+.
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------------ 211 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------------ 211 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh------------------
Confidence 2 23346899999999986 4568899999999999999999999996532111 111100
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
......+| ...+..+.++|++||+.||++|| |++|+++||||+.
T Consensus 212 ----------------~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 212 ----------------LTVNVELP---------DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred ----------------hcCCcCCc---------cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 00000111 11345688999999999999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=305.62 Aligned_cols=248 Identities=26% Similarity=0.348 Sum_probs=193.2
Q ss_pred CcEEEEEEe--ccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYL--GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~L--G~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|.+.+.+ |+|+||.||++.++.+++.+|+|++...... ..|..+...+. .|+||+++++.|...+..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~e~~~~~~~~-----~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----AIEPMVHQLMK-----DNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----hhhHHHHHHhh-----cCCCEEEEEEEEecCCee
Confidence 456666665 9999999999999999999999998754211 11233322222 489999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC-eEEEEecCC
Q 004954 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGS 569 (722)
Q Consensus 492 ~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~-~vkL~DFGl 569 (722)
++||||++ ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++. ++ .++|+|||+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~~l~dfg~ 156 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR--AKDRIYLCDYGL 156 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC--CCCeEEEecCcc
Confidence 99999997 57877776432 3899999999999999999999999999999999999986 45 899999999
Q ss_pred cccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHH-HHHHhhcCCCcHHHHhhhh
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMIL-ARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l-~~i~~~lg~~~~~~~~~~~ 648 (722)
+....... ...++..|+|||++.+..++.++|+||||+++|+|++|..||........- ..+...
T Consensus 157 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 222 (267)
T PHA03390 157 CKIIGTPS-CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR------------- 222 (267)
T ss_pred ceecCCCc-cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-------------
Confidence 87654332 346889999999999989999999999999999999999999754322210 110000
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-HHHHHhCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-AREALDHPWLQH 720 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-a~ElL~HPwf~~ 720 (722)
.....+ .....++.+.+||.+||+.+|.+||+ .+++|+||||++
T Consensus 223 ---------------------~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 223 ---------------------QQKKLP-------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ---------------------hcccCC-------cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 000000 01134567899999999999999996 599999999974
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.03 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=196.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-----------hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-----------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.++.... ..+.+.+|+.+++.++ |+||+++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~ 75 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD------HLNIVQYLG 75 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC------CCCcceEEE
Confidence 68899999999999999999988999999998864211 1223456666666664 789999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
++...+..++||||+.+ +|.+.+... ..++...+..++.||+.||.|||+.+++|+||+|+||+++. ++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~--~~~~ 147 (272)
T cd06629 76 FETTEEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA--DGIC 147 (272)
T ss_pred EeccCCceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC--CCeE
Confidence 99999999999999975 566665533 23888999999999999999999999999999999999985 7899
Q ss_pred EEEecCCcccccCC-----ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 004954 563 KIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 563 kL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~--~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~ 635 (722)
+|+|||++...... .....++..|+|||.+.... ++.++|+||||+++|++++|..||......+.+..+...
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc
Confidence 99999998654322 12245788999999987654 789999999999999999999999765443322221100
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.....++.. .....+..+.+||.+||..+|.+|||+.++|+|
T Consensus 228 ---------------------------------~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 ---------------------------------RSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------------------------------ccCCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000011110 011234678999999999999999999999999
Q ss_pred CCC
Q 004954 716 PWL 718 (722)
Q Consensus 716 Pwf 718 (722)
|||
T Consensus 270 ~~~ 272 (272)
T cd06629 270 PFI 272 (272)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=305.85 Aligned_cols=248 Identities=30% Similarity=0.482 Sum_probs=203.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|.+.+.||+|+||.||++++..+|+.+|+|++.... .....+.+|..+++.+. .|+||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-----GHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-----cCCCchhHHHHhcCCc
Confidence 47999999999999999999999999999999987532 22345667777777765 3789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+. ++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~--~~~~~l~df~ 147 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK--DMHIKITDFG 147 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEecCCc
Confidence 9999999995 67777776432 3899999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCCc-----------------------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH
Q 004954 569 SSCFQTDNL-----------------------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (722)
Q Consensus 569 ls~~~~~~~-----------------------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~ 625 (722)
++....... ....++..|+|||++.+..++.++|+||||++++++++|+.||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 886544322 123567889999999988899999999999999999999999987764
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
...+..+... ...+|. ..++.+.+||++||+.+|.+
T Consensus 228 ~~~~~~~~~~-----------------------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~ 263 (280)
T cd05581 228 YLTFQKILKL-----------------------------------EYSFPP---------NFPPDAKDLIEKLLVLDPQD 263 (280)
T ss_pred HHHHHHHHhc-----------------------------------CCCCCC---------ccCHHHHHHHHHHhcCCHhh
Confidence 4444333211 111111 12456889999999999999
Q ss_pred CcCH----HHHHhCCCC
Q 004954 706 RPTA----REALDHPWL 718 (722)
Q Consensus 706 RpTa----~ElL~HPwf 718 (722)
|||+ .++|+||||
T Consensus 264 R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 264 RLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCcccCHHHHhcCCCC
Confidence 9999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=305.82 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=199.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..|++++.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+. |+||+++++++......
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD------SPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEECCEE
Confidence 46888899999999999999999999999999987542 33455667777777664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+.+... .+++..+..++.|++.||+|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~--~~~~~l~dfg~~ 148 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC--CCCEEEcccccc
Confidence 999999976 666655421 2788899999999999999999999999999999999986 778999999998
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~----------- 217 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN----------- 217 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-----------
Confidence 654432 222457888999999998889999999999999999999999997655433322211000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...++ ...+..+.+||.+||+.+|++||++.++++||||..
T Consensus 218 -----------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 218 -----------------------PPTLT---------GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred -----------------------CCCCc---------hhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 00000 112355789999999999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=325.50 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=210.6
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~----~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
|.=++-||+|+||-||-|+|..+.+.||||.+.- .......++.|+++|+.++ |||++.+.++|......
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~------HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR------HPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc------CCCcccccceeeccchH
Confidence 4445569999999999999999999999998853 3445577889999999886 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
|+|||||-|+-.+++...... +.+.++..|..+.+.||+|||+.+.||||||..|||++. .+.|||+|||.+.
T Consensus 102 WLVMEYClGSAsDlleVhkKp-----lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse--~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE--PGLVKLADFGSAS 174 (948)
T ss_pred HHHHHHHhccHHHHHHHHhcc-----chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC--CCeeeeccccchh
Confidence 999999999877777765543 889999999999999999999999999999999999995 8999999999987
Q ss_pred cccCCccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 572 FQTDNLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 572 ~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
... +...++|||.|||||+++. +.|+-++||||||++..||...++|+-+.+....+..|...-.|.
T Consensus 175 i~~-PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--------- 244 (948)
T KOG0577|consen 175 IMA-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------- 244 (948)
T ss_pred hcC-chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC---------
Confidence 544 4566899999999999973 569999999999999999999999998877766666664221110
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
++ ....+..|++||..||+.-|..|||++++|.|+|....
T Consensus 245 -------------------------Lq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 245 -------------------------LQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -------------------------CC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 00 01123568999999999999999999999999998653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.63 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=195.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+|++.++||+|+||.||++.+..+|+.||||.+.... .....+.+|+.+++.+. ||||+++++++..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~ 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL------HERIVQYYGCLRD 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC------CCCeeeEEeEecc
Confidence 47999999999999999999999999999999886421 22345667888888774 7899999999876
Q ss_pred c--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 488 ~--~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
. ..+++||||+++ +|.+++.... .+++..+..++.|++.||.|||+.+|+|+||||+||+++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l 147 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS--VGNVKL 147 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC--CCCEEE
Confidence 4 568899999975 6766655322 2788889999999999999999999999999999999985 788999
Q ss_pred EecCCcccccC------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 565 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 565 ~DFGls~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+|||++..... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||..........++....
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 225 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-- 225 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC--
Confidence 99998865432 1223457889999999998889999999999999999999999997654333332221000
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....+| ...+..+.++|++||. +|++||+++++++|||+
T Consensus 226 -------------------------------~~~~~~---------~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 226 -------------------------------TNPVLP---------PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred -------------------------------CCCCCc---------hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 000011 1123457899999994 99999999999999998
Q ss_pred C
Q 004954 719 Q 719 (722)
Q Consensus 719 ~ 719 (722)
.
T Consensus 265 ~ 265 (265)
T cd06652 265 H 265 (265)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.81 Aligned_cols=251 Identities=29% Similarity=0.443 Sum_probs=206.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+++++.++ |+|++++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN------HPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC------CCChhheEEEEecCCEE
Confidence 5899999999999999999999899999999987542 34456777888887775 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+++ +|.+.+..... ....+++..+..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~--~~~~~l~d~~~~ 150 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS--NGLVKLGDFGIS 150 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC--CCcEEECCccce
Confidence 999999985 67776664431 1234899999999999999999999999999999999999995 788999999998
Q ss_pred ccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
....... ....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.......+...+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 220 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY---------- 220 (258)
T ss_pred eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----------
Confidence 7654432 234678899999999998899999999999999999999999987665544444321100
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
..+|. ..+..+.++|++||..+|++|||+.++|+||||
T Consensus 221 ------------------------~~~~~---------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 ------------------------PPIPS---------QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------------------------CCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00111 224568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.02 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=197.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
++|++.+.||+|+||.||++.++ .+..+|+|.+.........+.+|+.+++.++ ||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLS------HPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCC------CCCceeEEEEEccCCCEEE
Confidence 46899999999999999999864 4568999998765544567788999998885 6899999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+. ++|.+.+..... .+++..+..++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||.+..
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~d~g~~~~ 149 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC--CCeEEECCCCCccc
Confidence 999997 467666653221 2788999999999999999999999999999999999985 78899999998875
Q ss_pred ccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 573 ~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... ...++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~---------- 219 (256)
T cd05114 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR---------- 219 (256)
T ss_pred cCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------
Confidence 432211 1234567999999998899999999999999999999 9999988776666555432100
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...| ...+..+.+||.+||+.+|.+||++.++++
T Consensus 220 ------------------------~~~~---------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 ------------------------LYRP---------KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------------------------CCCC---------CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0001 112356889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.64 Aligned_cols=249 Identities=32% Similarity=0.501 Sum_probs=199.4
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
||++.+.||+|+||.||++.+..+++.+|+|+++.... ....+.+|+.+++.++ |+||+++++.+...+..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK------HPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC------CCChhheeeeEecCCEE
Confidence 69999999999999999999988999999999876543 4566778888888775 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++|+||+.+ +|.+.+... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~kl~d~g~~ 146 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCA 146 (264)
T ss_pred EEEEecCCCCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999985 566655432 12788899999999999999999999999999999999996 788999999998
Q ss_pred ccccCCcc-------ccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHHhhcCCC
Q 004954 571 CFQTDNLC-------LYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPI 639 (722)
Q Consensus 571 ~~~~~~~~-------~~~gt~~y~APE~l~~~~---~s~ksDIWSLGviL~elltG~~PF~~~~~-~e~l~~i~~~lg~~ 639 (722)
........ ...+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ......+.. +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~-- 222 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--G-- 222 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--C--
Confidence 76543221 245678999999998766 88999999999999999999999975422 222211110 0
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....+|.. ...+..+.+||++||+.+|.+|||+.+++.|||+
T Consensus 223 ------------------------------~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 223 ------------------------------HKPPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ------------------------------CCCCCCcc-------cccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00111111 1124568899999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=307.90 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=201.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.++|++++.||+|+||+||++.+..+|+.+|+|++... ......+.+|+++++.++ ||||+++++.+.....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR------SPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC------CCCcceEeeeEecCCE
Confidence 36789999999999999999999999999999988654 233456778888887764 6899999999999999
Q ss_pred EEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 491 LFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 491 l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.++||||++++ |.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~d~g 149 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFG 149 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC--CCcEEEccCC
Confidence 99999999864 54444332 138899999999999999999997 58999999999999985 7889999999
Q ss_pred CcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 569 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 569 ls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
++...... .....++..|+|||++.+..++.++|||||||++|+|++|+.||............ +.....
T Consensus 150 l~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~-------~~~~~~-- 220 (284)
T cd06620 150 VSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD-------PMGILD-- 220 (284)
T ss_pred cccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh-------hhHHHH--
Confidence 87654322 23356899999999998888999999999999999999999999765432110000 000000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
..+... ......++. ...+..+.+||.+||+.||.+|||+.|+++||||.+.
T Consensus 221 --~~~~~~------------~~~~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 221 --LLQQIV------------QEPPPRLPS--------SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred --HHHHHh------------hccCCCCCc--------hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000000 000000000 0123568899999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.24 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=199.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+.|.....||+|+||.||++.+..++..||||.+.... .....+.+|+.+++.++ |+||+++++.+...+..+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH------HENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC------CCcHHHHHHheecCCeEE
Confidence 45666678999999999999999999999999986533 23345667777777664 789999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
+||||+.++.+..+.... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++..
T Consensus 96 lv~e~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kL~dfg~~~~ 167 (292)
T cd06658 96 VVMEFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS--DGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEeCCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEccCcchhh
Confidence 999999875443333221 2788999999999999999999999999999999999986 67899999998865
Q ss_pred ccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 573 ~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
.... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+....+..+.....+
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 236 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP----------- 236 (292)
T ss_pred cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence 4322 22356789999999999888999999999999999999999999876654444333211100
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.++. ....+..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 237 -----------------------~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 237 -----------------------RVKD-------SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred -----------------------cccc-------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 0000 0112456889999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=311.41 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=197.7
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
|.....||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++.+...+..++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY------QHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC------CCCchhhhhhheeeCCeEEEE
Confidence 334457999999999999999999999999986432 2234556677766665 478999999999999999999
Q ss_pred EEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 495 CELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 495 mEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
|||+.++.+..+... ..+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++....
T Consensus 97 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~--~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 97 MEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQIS 168 (297)
T ss_pred EecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc--CCcEEEeechhHhhcc
Confidence 999986544333322 12889999999999999999999999999999999999985 7889999999886443
Q ss_pred CC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 575 DN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 575 ~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
.. .....+++.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.... .+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~----------- 235 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--PP----------- 235 (297)
T ss_pred cccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC--CC-----------
Confidence 22 223568899999999998889999999999999999999999997765544443332100 00
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
........+..+.++|++||+.+|.+||++.++++||||.+.
T Consensus 236 ----------------------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 236 ----------------------------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred ----------------------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 000011234568899999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.66 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=199.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~-----tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
+..++|++.+.||+|+||.||+|.++. .+..||+|.+..... ....+.+|+.+++.+. ||||+++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~ 76 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT------CHHVVRLLG 76 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC------CCCeeeEEE
Confidence 456799999999999999999997542 355899998865432 2234556666666664 689999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHhhhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~----~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
++...+..++||||+. ++|.+++...... .....++...+..++.||+.||.|||+++|+||||||+||+++.
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~-- 154 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH-- 154 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC--
Confidence 9999999999999997 5787777643221 11233567788999999999999999999999999999999996
Q ss_pred CCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i 632 (722)
++.++|+|||++....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+....+
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7889999999986543221 11234667999999998889999999999999999998 79999876665544433
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
... + ....+ ...++.+.++|.+||+.||++|||+.++
T Consensus 235 ~~~-~---------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l 271 (288)
T cd05061 235 MDG-G---------------------------------YLDQP---------DNCPERVTDLMRMCWQFNPKMRPTFLEI 271 (288)
T ss_pred HcC-C---------------------------------CCCCC---------CCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 210 0 00001 1123568999999999999999999999
Q ss_pred Hh------CCCCCC
Q 004954 713 LD------HPWLQH 720 (722)
Q Consensus 713 L~------HPwf~~ 720 (722)
++ ||||+.
T Consensus 272 l~~l~~~~~~~~~~ 285 (288)
T cd05061 272 VNLLKDDLHPSFPE 285 (288)
T ss_pred HHHHHhhcCCCCCC
Confidence 97 999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.90 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=196.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCC-----cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg-----~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
.-.++|++.+.||+|+||.||++++...| ..||+|+++... .....+.+|+.+++.+. .|+||+++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----~h~nIv~~~~ 109 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-----QHKNIVNLLG 109 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc-----cCCceeeEee
Confidence 34568999999999999999999864443 579999997532 33456778888888773 3789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHhhhhcc--------------------------------------------------
Q 004954 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQES-------------------------------------------------- 512 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~-------------------------------------------------- 512 (722)
++......++||||+. |+|.+++......
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999997 5777776532210
Q ss_pred --------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCCcc
Q 004954 513 --------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578 (722)
Q Consensus 513 --------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~ 578 (722)
.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~--~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD--GRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC--CCeEEEeeceeeeeccCCcc
Confidence 11124788899999999999999999999999999999999985 78899999999875433211
Q ss_pred -----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhh
Q 004954 579 -----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652 (722)
Q Consensus 579 -----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~ 652 (722)
...+++.|+|||++.+..++.++|||||||++|+|++ |+.||........+..+....
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~---------------- 331 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG---------------- 331 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc----------------
Confidence 1224567999999998899999999999999999997 999997654333222222100
Q ss_pred hhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 653 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.....| ...+..+.++|.+||+.||.+|||+.++++
T Consensus 332 -----------------~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 332 -----------------YQMSRP---------DFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -----------------cCccCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000011 112467899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.77 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=199.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (722)
.+||+|.+.||.|||+.||+++...+++.+|+|.+.... ......++|+...++++ ||||++++++....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~------s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN------SPNVLRLVDHQLREEKD 93 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC------CcchHHHHHHHHHhhcc
Confidence 579999999999999999999999999999999887544 56677888888888886 57999998876543
Q ss_pred --CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCCCeEE
Q 004954 489 --EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 489 --~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~~~vk 563 (722)
...||+++|.. |+|++.+......+. .+++.++..|+.+|++||++||+.. ++||||||.|||++. .+.++
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~--~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~--~~~~v 169 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGN--FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD--SGLPV 169 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC--CCceE
Confidence 34899999986 779999887765543 3999999999999999999999998 999999999999995 78999
Q ss_pred EEecCCcccccCCcc------------ccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 004954 564 IIDLGSSCFQTDNLC------------LYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (722)
Q Consensus 564 L~DFGls~~~~~~~~------------~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~ 628 (722)
|.|||++....-... ...-|..|+|||.+. +...+.++|||||||+||.||.|..||..
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~------ 243 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER------ 243 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH------
Confidence 999999865332211 123478899999985 44578899999999999999999999942
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
+...-|. .-... ....+.+|.... .++.+.+||+.||+.||.+||+
T Consensus 244 ---~~~~GgS----------------------laLAv--~n~q~s~P~~~~-------yse~l~~lik~mlqvdP~qRP~ 289 (302)
T KOG2345|consen 244 ---IYQQGGS----------------------LALAV--QNAQISIPNSSR-------YSEALHQLIKSMLQVDPNQRPT 289 (302)
T ss_pred ---HhhcCCe----------------------EEEee--eccccccCCCCC-------ccHHHHHHHHHHhcCCcccCCC
Confidence 1111110 00000 111233343332 4577999999999999999999
Q ss_pred HHHHHhC
Q 004954 709 AREALDH 715 (722)
Q Consensus 709 a~ElL~H 715 (722)
+.+++.+
T Consensus 290 i~~ll~~ 296 (302)
T KOG2345|consen 290 IPELLSK 296 (302)
T ss_pred HHHHHHH
Confidence 9999975
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.34 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=190.1
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 004954 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmE 496 (722)
.||+|+||.||++.+..+++.||+|++..... .......|..+++.++. ..||+|+++++.+...+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh---CCCCcEeeeeeeeecCCEEEEEEe
Confidence 38999999999999999999999999865321 11223455555555543 358999999999999999999999
Q ss_pred ccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC
Q 004954 497 LLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 497 y~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
|+.|+ |...+... ..+++..++.++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||++.....
T Consensus 78 ~~~g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~--~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 78 LMNGGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (278)
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC--CCCEEEccCcCccccCc
Confidence 99865 44444321 23899999999999999999999999999999999999986 77899999999865432
Q ss_pred -CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHH---HHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 576 -NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVV---MILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 576 -~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~---e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
......++..|+|||++.+. .++.++||||+||++|+|++|+.||...... .....+.
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 212 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------------- 212 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----------------
Confidence 22345789999999999754 6889999999999999999999999764211 1110000
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
.....+|. ..+..+.++|++||..+|.+|| ++.++++||||+.
T Consensus 213 ------------------~~~~~~~~---------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 213 ------------------TMAVELPD---------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred ------------------ccCCCCCC---------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 00011111 1246688999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.54 Aligned_cols=249 Identities=33% Similarity=0.524 Sum_probs=203.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
.|.+.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+.+++.++ |++|+++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC------CCCEeEEEEEEecCCeEEE
Confidence 47889999999999999999988999999999976543 4567778888888775 6799999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
++||+. ++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~~~~~~ 147 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQ 147 (253)
T ss_pred EEecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc--CCeEEEeecccccc
Confidence 999998 46666655332 23899999999999999999999999999999999999996 78899999999876
Q ss_pred ccCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 573 QTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 573 ~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 212 (253)
T cd05122 148 LSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--------------- 212 (253)
T ss_pred ccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---------------
Confidence 65543 4457788999999999888899999999999999999999999776433333222110
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.....+. ....+..+.++|.+||+.||++|||+.++|+|||
T Consensus 213 -------------------~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 213 -------------------GPPGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -------------------CCCCcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0000000 0112456889999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.13 Aligned_cols=249 Identities=29% Similarity=0.400 Sum_probs=199.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
-|++.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++.++ ||||+++++.+......+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD------SPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC------CCCEeEEEEEEEeCCeEE
Confidence 3778899999999999999999999999999976432 23345667777777664 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+.+ +|..++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAG 149 (277)
T ss_pred EEEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC--CCCEEEeecccce
Confidence 99999986 55555432 12789999999999999999999999999999999999985 7789999999886
Q ss_pred cccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~---------- 217 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--N---------- 217 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--C----------
Confidence 54332 12245788899999998888899999999999999999999999765443333222100 0
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
...+ ....+..+.++|.+||+.+|.+||++.++++||||.+.
T Consensus 218 ----------------------~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 218 ----------------------PPTL---------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ----------------------CCCC---------CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0000 01234668899999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.59 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=199.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCC-----cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg-----~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
++|++.+.||+|+||.||+|.+...+ ..+|+|.++... .....+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ------HPNIVCLLGVCT 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC------CcccceEEEEEc
Confidence 57899999999999999999876555 689999986532 23455677888887764 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEc
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~----------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~ 555 (722)
.....+++|||+. ++|.+++....... ....+++..++.++.||+.||.|||+.|++|+||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 9999999999997 47777776432211 113488899999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHH
Q 004954 556 SYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 629 (722)
Q Consensus 556 ~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l 629 (722)
. ++.++|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..++.
T Consensus 159 ~--~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 E--GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred C--CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 778999999998654222 122345788999999998899999999999999999998 99999887666555
Q ss_pred HHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH
Q 004954 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709 (722)
Q Consensus 630 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa 709 (722)
..+..... ... ....+..+.+|+.+||+.||.+||++
T Consensus 237 ~~i~~~~~----------------------------------~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~ 273 (283)
T cd05048 237 EMIRSRQL----------------------------------LPC---------PEDCPARVYALMIECWNEIPARRPRF 273 (283)
T ss_pred HHHHcCCc----------------------------------CCC---------cccCCHHHHHHHHHHccCChhhCcCH
Confidence 44321100 000 11234678999999999999999999
Q ss_pred HHHHhC
Q 004954 710 REALDH 715 (722)
Q Consensus 710 ~ElL~H 715 (722)
.+++++
T Consensus 274 ~~i~~~ 279 (283)
T cd05048 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=297.70 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=199.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
-.++|++.++||+|+||.||+|.+ ..+..+|+|.+.......+.+.+|+.+++.++ |+||+++++.+...+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ------HDKLVRLYAVVTKEEPI 76 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCC------CCCeeeEEEEEcCCCCc
Confidence 346899999999999999999986 45678999998765555567788888888775 67999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+.+++|+||||+||+++. ++.++|+|||++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~ 150 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE--SLMCKIADFGLA 150 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC--CCcEEECCCccc
Confidence 99999997 577777654321 23788899999999999999999999999999999999986 788999999998
Q ss_pred ccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 222 (261)
T cd05072 151 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-------- 222 (261)
T ss_pred eecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 76543221 1234567999999998889999999999999999998 9999987665555444321100
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.|. ....+..+.++|.+||..+|++|||++++++
T Consensus 223 ----------------------------~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 ----------------------------MPR-------MENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------------------CCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 0112356889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.16 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=196.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.++|++.+.||+|+||+||+|++ ..++..||||+++... .....+.+|+.+++.+. .||||+++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~-----~HpnIv~l~~~~ 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHINIVNLLGAC 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc-----CCcceeeeeeee
Confidence 46899999999999999999974 3467789999987532 23456778999988884 378999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHhhhhcc----------------------------------------------------
Q 004954 486 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 512 (722)
Q Consensus 486 ~~~~~l~iVmEy~~-gsLl~~l~~~~~~---------------------------------------------------- 512 (722)
...+..++||||+. |+|.+++......
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999997 5777776542210
Q ss_pred -----------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC
Q 004954 513 -----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 513 -----------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
.....+++..+..++.||+.||+|||+.||+||||||+|||++. +..+||+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~--~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH--GRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC--CCcEEEecCccceeccC
Confidence 01124788889999999999999999999999999999999985 77899999999876543
Q ss_pred Ccc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 576 NLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 576 ~~~-----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
... ...++..|+|||++.+..++.++|||||||++|+|++ |..||........+.+++.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~--------------- 331 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK--------------- 331 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH---------------
Confidence 221 1233567999999999999999999999999999998 8999976543322222110
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
. ......| ...+..+.+||.+||+.||++|||+.|+++.
T Consensus 332 ------~------------~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 ------E------------GYRMLSP---------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ------h------------CccCCCC---------CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 0000011 1224568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.79 Aligned_cols=255 Identities=19% Similarity=0.268 Sum_probs=197.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
++..++|++.+.||+|+||.||+|.+. .++..+|+|++.... .....+.+|+.+++.++ ||||++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~------~~~iv~~~ 75 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN------CHHVVRLL 75 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCeeeEE
Confidence 356788999999999999999999864 245789999886432 22344667777777664 78999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHhhhhccC----CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc
Q 004954 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~----~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~ 557 (722)
+++......++||||+.+ +|.+++....... ....+++..+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~- 154 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 154 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC-
Confidence 999999999999999975 6766665322110 1223677889999999999999999999999999999999996
Q ss_pred CCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHH
Q 004954 558 QRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 631 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~ 631 (722)
++.++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..
T Consensus 155 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (277)
T cd05062 155 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233 (277)
T ss_pred -CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 7889999999986543221 12244678999999999889999999999999999999 7999987766555443
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 632 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
+..... ..++ ...+..+.+||.+||+.||++|||+.|
T Consensus 234 ~~~~~~----------------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e 270 (277)
T cd05062 234 VMEGGL----------------------------------LDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLE 270 (277)
T ss_pred HHcCCc----------------------------------CCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 321100 0001 112356899999999999999999999
Q ss_pred HHhC
Q 004954 712 ALDH 715 (722)
Q Consensus 712 lL~H 715 (722)
++++
T Consensus 271 ~l~~ 274 (277)
T cd05062 271 IISS 274 (277)
T ss_pred HHHH
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.23 Aligned_cols=289 Identities=19% Similarity=0.239 Sum_probs=194.4
Q ss_pred EEeccC--CCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G--~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
..||+| +||+||++++..+|+.||+|++.... ...+.+.+|+.+++.+ .||||++++++|...+..++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF------RHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCcceEeeeEecCCceEEE
Confidence 346666 99999999999999999999987533 2234556666666655 478999999999999999999
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+.+ ++.+++..... ..+++..+..++.||+.||+|||+.||+||||||+|||++. ++.++++||+.+...
T Consensus 78 ~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~--~~~~~~~~~~~~~~~ 151 (328)
T cd08226 78 SPFMAYGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG--DGLVSLSGLSHLYSL 151 (328)
T ss_pred EecccCCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC--CCcEEEechHHHhhh
Confidence 999985 66666654322 12889999999999999999999999999999999999985 788999999854321
Q ss_pred cCC----------ccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 574 TDN----------LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 574 ~~~----------~~~~~gt~~y~APE~l~~~--~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
... .....++..|+|||++.+. .++.++|||||||++|+|++|..||........+..+.......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence 110 1112345679999999764 4789999999999999999999999887655555444432221111
Q ss_pred HHHhhhhhhhhhhcccccchh--h-hhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYY--I-NEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
..................... . ................-.......+..+.+||++||+.||++|||+.|+|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 110000000000000000000 0 0000000000000000000011234678999999999999999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
..
T Consensus 312 ~~ 313 (328)
T cd08226 312 KQ 313 (328)
T ss_pred HH
Confidence 64
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=292.77 Aligned_cols=248 Identities=32% Similarity=0.431 Sum_probs=202.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--C
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E 489 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--~ 489 (722)
+|++.+.||+|++|.||+|.+..+++.+++|++.... ...+.+.+|+.+++.++ |+||+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ------HPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC------CCCEeeEEEEEecCCCC
Confidence 5889999999999999999999899999999987654 34567778888888875 68999999999988 8
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+. ++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~--~~~~~l~d~~ 146 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFG 146 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEcccc
Confidence 9999999996 56766665332 3899999999999999999999999999999999999996 7889999999
Q ss_pred CcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHHHhhcCCCcHH
Q 004954 569 SSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLE 642 (722)
Q Consensus 569 ls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~-~~e~l~~i~~~lg~~~~~ 642 (722)
.+....... ....++..|+|||.+.+...+.++||||||+++|+|++|..||.... .......+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 218 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-------- 218 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--------
Confidence 987655442 33567889999999998889999999999999999999999997754 1111111100
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
......+|. ..+..+.+||.+||+.||.+||++.++|+||||
T Consensus 219 -------------------------~~~~~~~~~---------~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 -------------------------SGEPPEIPE---------HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------------------------cCCCcCCCc---------ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000011111 124678999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.81 Aligned_cols=247 Identities=27% Similarity=0.346 Sum_probs=193.3
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
||+|+||+||++.+..+|+.+|+|++.... .....+.+|+++++.++ ||||+++++.+...+..++||||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS------SRFIVSLAYAFETKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC------CCCEeeeeeEEecCCeEEEEEec
Confidence 699999999999999999999999986532 22334567888887775 68999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+++ +|.+.+..... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 75 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~--~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 75 MNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD--HGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEccCcchhhhccC
Confidence 985 66666553322 23899999999999999999999999999999999999986 778999999988654322
Q ss_pred --ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 004954 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (722)
Q Consensus 577 --~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~ 654 (722)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+....
T Consensus 149 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 210 (277)
T cd05577 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT------------------ 210 (277)
T ss_pred CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc------------------
Confidence 223456788999999998889999999999999999999999997643211111111000
Q ss_pred cccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 655 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
.......+ ...++.+.+||++||+.||.+|| ++.++++||||..
T Consensus 211 -------------~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 211 -------------LEMAVEYP---------DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred -------------ccccccCC---------ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 00000011 11246789999999999999999 9999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.46 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=201.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+.|...+.||+|+||+||+|++..+++.+++|++.... .....+.+|+.+++.++ |+|++++++++....
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 94 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK------HPNTIEYKGCYLKEH 94 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC------CCCCccEEEEEEeCC
Confidence 34777888999999999999999999999999986432 22345667777777764 689999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
..++||||+.+++.+++..... .+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~--~~~~kL~dfg~ 167 (313)
T cd06633 95 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGS 167 (313)
T ss_pred EEEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC--CCCEEEeecCC
Confidence 9999999999988887764321 2888999999999999999999999999999999999985 77899999998
Q ss_pred cccccCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+..... .....++..|+|||++. ...++.++|||||||++|+|++|..||...+....+..+....
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---------- 236 (313)
T cd06633 168 ASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---------- 236 (313)
T ss_pred CcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------
Confidence 865432 23456888999999984 3567889999999999999999999997765544443332100
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.|... ....+..+.+||.+||+.+|.+||++.++|.||||+.
T Consensus 237 ---------------------------~~~~~-----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 237 ---------------------------SPTLQ-----SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ---------------------------CCCCC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 00000 0012345889999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.87 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=200.3
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
+|...++||+|++|.||++.+..+++.+++|.+.... .....+.+|+.+++.+. |+||+++++++...++.++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~------h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC------CCChheEEEEEEcCCeEEE
Confidence 4566679999999999999999999999999886433 22345667777777764 7899999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
|+||+.+ +|.+.+.. . .++...+..++.||+.||+|||+.||+||||+|+||+++. ++.++|+|||.+..
T Consensus 94 v~e~~~~~~L~~~~~~-~------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~d~g~~~~ 164 (285)
T cd06648 94 VMEFLEGGALTDIVTH-T------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS--DGRVKLSDFGFCAQ 164 (285)
T ss_pred EEeccCCCCHHHHHHh-C------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC--CCcEEEcccccchh
Confidence 9999975 56555543 1 2788999999999999999999999999999999999986 78899999998764
Q ss_pred ccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 573 ~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
.... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+..+.....
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~------------ 232 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP------------ 232 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC------------
Confidence 3322 1224678899999999988899999999999999999999999977665544444321100
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..+. .....+..+.+||++||+.+|++|||+.++|+||||++
T Consensus 233 ----------------------~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 233 ----------------------PKLK-------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred ----------------------CCCc-------ccccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 0000 01113456899999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.75 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=199.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.++|.+.+.||+|+||.||+|.+. .+++.+|+|+++.... ....+.+|+++++.+. |+||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~ 77 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ------HENIVKFYGVC 77 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC------CCCchheeeEE
Confidence 356899999999999999999874 3468899999876432 3467788888888775 67999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhc--------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQE--------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~--------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
......++||||+.+ +|.+++..... ......+++..+..++.||+.||+|||++|++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 999999999999974 67777654321 122334888999999999999999999999999999999999986
Q ss_pred cCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 004954 557 YQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~ 630 (722)
++.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+...
T Consensus 158 --~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 158 --DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred --CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 789999999998653221 122345678999999999999999999999999999998 999997766555444
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+..... ...+ ...+..+.+||++||+.||.+|||+.
T Consensus 236 ~~~~~~~----------------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~ 272 (280)
T cd05049 236 CITQGRL----------------------------------LQRP---------RTCPSEVYDIMLGCWKRDPQQRINIK 272 (280)
T ss_pred HHHcCCc----------------------------------CCCC---------CCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 4321100 0001 12345688999999999999999999
Q ss_pred HHHh
Q 004954 711 EALD 714 (722)
Q Consensus 711 ElL~ 714 (722)
|+++
T Consensus 273 eil~ 276 (280)
T cd05049 273 DIHE 276 (280)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.53 Aligned_cols=255 Identities=28% Similarity=0.391 Sum_probs=198.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.+.|++.+.||+|+||.||+|.+..+++.+|||+++... ........|+.++..+. +|+||+++++++.....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc-----CCCchHhhheeeecCCe
Confidence 467999999999999999999999889999999987542 22234455555554432 58899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+.+..++..... .+++..+..++.|++.||+|||+ .||+||||+|+||+++. ++.++|+|||+
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~--~~~~kL~dfg~ 161 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA--SGNVKLCDFGI 161 (296)
T ss_pred EEEEeeccCcCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC--CCCEEECcccc
Confidence 999999998877776654322 38899999999999999999997 59999999999999985 78899999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHHhhcCCCcHH
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPIDLE 642 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~----~s~ksDIWSLGviL~elltG~~PF~~~~~-~e~l~~i~~~lg~~~~~ 642 (722)
+...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+.+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------ 235 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE------ 235 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC------
Confidence 8654332 22234678899999987654 78899999999999999999999976322 22222221100
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
....+.. ...+..+.+||.+||..||.+||++.++++||||+.
T Consensus 236 ----------------------------~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 236 ----------------------------PPSLPPN-------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ----------------------------CCCCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0000100 123466899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.32 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=198.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~-----tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.++|++.+.||+|++|.||+|.+.. ++..||+|.+.... .....+.+|+.+++.++ |+||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~ 78 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN------HQNIVRLIGVS 78 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEE
Confidence 4679999999999999999999877 78899999886432 22345677777777764 68999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHhhhhcc-CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeE
Q 004954 486 YHLEHLFIVCELLR-ANLYEFQKFNQES-GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 562 (722)
Q Consensus 486 ~~~~~l~iVmEy~~-gsLl~~l~~~~~~-~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~v 562 (722)
......++||||+. ++|.+++...... .....+++..+..++.||+.||+|||+.+++|+||||+||+++..+ ...+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 99999999999996 5777777654321 1123489999999999999999999999999999999999998533 3469
Q ss_pred EEEecCCcccccCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 004954 563 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 563 kL~DFGls~~~~~~~~-----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~l 636 (722)
||+|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876532211 1223567999999999899999999999999999997 999998876655443332100
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...+..+.++|.+||+.+|++|||+.++|+|
T Consensus 239 ----------------------------------~~~~~---------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 ----------------------------------RLDPP---------KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ----------------------------------cCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00001 1124568899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.11 Aligned_cols=248 Identities=30% Similarity=0.416 Sum_probs=197.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .|+||+++++.+......
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC------CCCccHhhhcccccCCce
Confidence 34667788999999999999999999999999987432 3334566777777766 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~--~~~~~l~dfg~~ 148 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEEccCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC--CCCEEEcccccc
Confidence 999999986 55555432 12788999999999999999999999999999999999985 788999999998
Q ss_pred ccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
....... ....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------ 216 (277)
T cd06642 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN------------ 216 (277)
T ss_pred ccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC------------
Confidence 6644322 2245788899999999988999999999999999999999999754433222111000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
....++ ...+..+.+||.+||+.+|.+|||+.++|+||||+
T Consensus 217 ----------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 217 ----------------------SPPTLE---------GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred ----------------------CCCCCC---------cccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 000000 11235688999999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=303.66 Aligned_cols=282 Identities=25% Similarity=0.462 Sum_probs=224.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec--c-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN--D-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~--~-~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~- 488 (722)
.+.|.-+.+||+|.||.||+|+.+.+|+.||+|++.. . ..+....++|+++|+.|+ |+|++.++..+...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk------Henv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc------chhHHHHHHHHhhcc
Confidence 4667788899999999999999999999999987543 2 233456788999999887 55777777666532
Q ss_pred -------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 489 -------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 489 -------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
..+|+||++|+.+|..++.... ..+++.++..++.++++||.|+|...|+|||+|++|+||+. ++.
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~--dgi 162 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK--DGI 162 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC--Cce
Confidence 3589999999998887775432 23999999999999999999999999999999999999995 899
Q ss_pred EEEEecCCcccccCC-------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 562 IKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 562 vkL~DFGls~~~~~~-------~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
+||+|||+++..... .+..+-|.+|++||.+.|. .|+.+.|||..|||+.||+|+.+.|++++....+..|.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 999999998643322 2234568999999999875 58999999999999999999999999999999999999
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCc--cchhh--hhcccCcHHHHHHHHHhcccCCCCCcCH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLE--HHLQFSDAFFIDFVRTLLEINPQRRPTA 709 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~--~~~l~--~~~~~~~~~l~dLL~~mL~~dP~kRpTa 709 (722)
.+.|.+..+.|+....+.-|..-+... +|. ...+. ..+...+.+..+||.+||..||.+|+++
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~eP-------------l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a 309 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEP-------------LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA 309 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCC-------------CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch
Confidence 999999999888765443332211000 111 01111 1133456778899999999999999999
Q ss_pred HHHHhCCCCCC
Q 004954 710 REALDHPWLQH 720 (722)
Q Consensus 710 ~ElL~HPwf~~ 720 (722)
+++|.|.||.+
T Consensus 310 d~alnh~~F~k 320 (376)
T KOG0669|consen 310 DQALNHDFFWK 320 (376)
T ss_pred Hhhhchhhhhc
Confidence 99999999953
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.09 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=201.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.++|.+.+.||+|+||.||++.+..+++.+|+|.+... ....+.+.+|+.+++.++ ||||+++++.+...+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK------HPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC------CCCeeehhheeeeCCcE
Confidence 47899999999999999999999889999999998643 223345667777776654 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++|+||+.+ +|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~--~~~~kL~dfg~~ 162 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (293)
T ss_pred EEEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC--CCCEEEccCcce
Confidence 999999975 666655421 2788899999999999999999999999999999999985 778999999987
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... .....+++.|+|||.+.+..++.++|+|||||++|++++|+.||...+....+..+.. +.
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~--------- 231 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NG--------- 231 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CC---------
Confidence 654332 2234678889999999888899999999999999999999999977544322211110 00
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
....+ .....+..+.+||++||+.+|++||++.+++.||||+..
T Consensus 232 -----------------------~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 232 -----------------------TPELQ-------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred -----------------------CCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 00000 011123568899999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=296.10 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=197.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||.||+|++..+++.||||.++.. ......+.+|+.+++.++ ||||+++++++...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN------HPNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC------CcceeeeeeeEEECC
Confidence 5799999999999999999999999999999987542 233345677888888775 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++|++|+||||+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~--~~~~~l~d~g 151 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC--CCCEEECccc
Confidence 99999999985 66666653322 1233788999999999999999999999999999999999986 7789999999
Q ss_pred CcccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH--HHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~--~e~l~~i~~~lg~~~~~~ 643 (722)
++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+. ..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~----- 225 (267)
T cd08228 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDY----- 225 (267)
T ss_pred cceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh-cCCC-----
Confidence 887654322 234678899999999988899999999999999999999999965422 22222211 0000
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
|... ....+..+.++|.+||+.+|++||++.++|+.
T Consensus 226 -------------------------------~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 226 -------------------------------PPLP-----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -------------------------------CCCC-----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0000 00123568899999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.56 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=208.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..+.|++.+.||+|++|.||++.+..+++.+++|++.........+.+|+.+++.++ |+||+++++.+......
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK------HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCC------CCCeeEEEEEEEECCEE
Confidence 456799999999999999999999889999999999865544566778888887775 67999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~--~~~~~l~d~~~~ 163 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFGFA 163 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC--CCCEEECccchh
Confidence 99999998 57877776543 23899999999999999999999999999999999999996 778999999987
Q ss_pred ccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... +..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-------- 234 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP-------- 234 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCC--------
Confidence 654332 12345678899999999888999999999999999999999999876555443332210 000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
..+. ....+..+.+||++||+.+|.+|||+.++|+||||++.
T Consensus 235 -------------------------~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 235 -------------------------PLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -------------------------CCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 0000 01124568899999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=297.22 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=191.0
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
...||+|+||.||+|++..+++.+|+|.+.... .....+.+|+.+++.++ |+||+++++++...+..++||||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK------HRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC------CCCeeeeeeeeccCCEEEEEEec
Confidence 357999999999999999999999999886543 33456778888888775 68999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+.+ +|.+.+...... ...+...+..++.||+.||+|||+.||+||||||+||+++. ..+.++|+|||.+......
T Consensus 87 ~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCeEEEecchhheecccC
Confidence 975 666666533211 11277888899999999999999999999999999999974 3568999999988654321
Q ss_pred ---ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCChHHH-HHHHHHhhcCCCcHHHHhhhhhh
Q 004954 577 ---LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 577 ---~~~~~gt~~y~APE~l~~~~--~s~ksDIWSLGviL~elltG~~PF~~~~~~e-~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....... ....+. .
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-~--------------- 226 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-M--------------- 226 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-h---------------
Confidence 22345788999999987643 7889999999999999999999996532111 100000 0
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
......+| ...++.+.+||++||+.+|.+|||+.|++.||||
T Consensus 227 -----------------~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 227 -----------------FKIHPEIP---------ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------------hccCCCCC---------cccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00000111 1234678999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=296.27 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=199.7
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+..++|++.+.||+|++|.||++.+. .++.||+|.++........+.+|+.+++.++ |+||+++++++...+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLR------HPKLIQLYAVCTLEEP 75 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCC------CCCccceeEEEecCCC
Confidence 34578999999999999999999964 4578999999866544566788888888875 6799999999999999
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+. ++|.+++.... ...+++..+..++.|++.||.+||+.||+|+||||+||+++. ++.++|+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~dfg~ 149 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE--NNICKVADFGL 149 (261)
T ss_pred eeeeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC--CCCEEECCcce
Confidence 999999995 67877775432 123889999999999999999999999999999999999996 77899999999
Q ss_pred cccccCCccc-cc---cCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDNLCL-YV---QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~~~~-~~---gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
+......... .. .+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+......+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 222 (261)
T cd05068 150 ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------- 222 (261)
T ss_pred EEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 8765433211 12 2357999999998899999999999999999999 9999988766555544431100
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...+ ...+..+.++|.+||+.+|.+||++.++++
T Consensus 223 ---------------------------~~~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 ---------------------------MPCP---------PGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------------------CCCC---------CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0000 112356889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.74 Aligned_cols=246 Identities=29% Similarity=0.443 Sum_probs=197.7
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeec-chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEccc
Q 004954 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg~~vAvKil~~-~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~ 499 (722)
+||+|.||+||-|+|..+...+|||-+.. +....+-...|+.+.+.|+| .|||+++|.+..++++-|.||-++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrH------kNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRH------KNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhh------HhHHHHhhccCCCCeEEEEeecCC
Confidence 69999999999999999999999998864 44455667788889888874 589999999999999999999998
Q ss_pred cc-hHHHHhhhhccCCCccc--CHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC-
Q 004954 500 AN-LYEFQKFNQESGGEAYF--TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 575 (722)
Q Consensus 500 gs-Ll~~l~~~~~~~~~~~l--s~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~- 575 (722)
|+ |-++++..-. ++ .+.++..+.+||++||.|||++.|||||||-+||||+. -.|.+||+|||-++....
T Consensus 656 GGSLSsLLrskWG-----PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWG-----PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred CCcHHHHHHhccC-----CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccC
Confidence 64 5555553322 24 78889999999999999999999999999999999986 368999999998876532
Q ss_pred --CccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 576 --NLCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 576 --~~~~~~gt~~y~APE~l~~~--~~s~ksDIWSLGviL~elltG~~PF~~~-~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
-..++.||..|||||++..+ .|+.++|||||||++.||.||++||... ++...+.++ ++
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-Gm--------------- 793 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GM--------------- 793 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cc---------------
Confidence 23457899999999999765 4889999999999999999999999543 222222111 00
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
-+....+|+. .+++.+.||.+|+.++|.+||+|.++|++||++.
T Consensus 794 -----------------yKvHP~iPee---------lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 794 -----------------YKVHPPIPEE---------LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred -----------------eecCCCCcHH---------HHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 0111222321 2356789999999999999999999999999985
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=295.91 Aligned_cols=245 Identities=20% Similarity=0.327 Sum_probs=195.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
++|++.+.||+|+||+||++.+.. +..+|+|.+.......+.+.+|+.+++.++ ||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLS------HEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCC------CCCeeeEEEEEccCCCcEE
Confidence 579999999999999999998643 456999988765444456778888887664 7899999999998899999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+.+ +|.+++..... .+++..++.++.||+.||+|||+.|++|+||||+||+++. ++.+||+|||.+..
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~d~g~~~~ 149 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD--QGCVKVSDFGLSRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCCEEECCCcccee
Confidence 9999975 57666653221 3889999999999999999999999999999999999985 77899999998865
Q ss_pred ccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 573 ~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 220 (256)
T cd05113 150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------- 220 (256)
T ss_pred cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------
Confidence 433221 1234567999999998889999999999999999998 99999876655554444321110
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+ ...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 221 -------------------------~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 -------------------------YRP---------HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -------------------------CCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 001 1124668999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.10 Aligned_cols=247 Identities=30% Similarity=0.448 Sum_probs=202.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++.+.||+|++|.||++++..+++.+++|.+.... ...+.+.+|++++..++ |+|++++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK------HPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC------CCCccEEEEEEEeCCEE
Confidence 5899999999999999999999999999999987654 34556777888877774 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++... ..+++..++.++.|++.||.+||+.||+|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~~~ 146 (254)
T cd06627 75 YIILEYAENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK--DGVVKLADFGVA 146 (254)
T ss_pred EEEEecCCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC--CCCEEEeccccc
Confidence 999999986 666665533 23889999999999999999999999999999999999996 788999999998
Q ss_pred ccccCCcc---ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~~~~---~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
........ ...++..|+|||.+.+..++.++||||||+++|+|++|..||...........+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------ 214 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD------------ 214 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc------------
Confidence 76554332 346788999999998888899999999999999999999999765433322222100
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
....++ ...+..+.++|.+||..+|++|||+.+++.||||
T Consensus 215 ----------------------~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 ----------------------DHPPLP---------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----------------------CCCCCC---------CCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 000011 1224678899999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=296.77 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=194.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..++|++.++||+|+||.||+|++..+ ..+|+|+++........+.+|+.+++.++ |+||+++++.+. ....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~-~~~~ 75 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVS-EEPI 75 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCC------CCCcceEEEEEC-CCCc
Confidence 457899999999999999999998655 46999999865444456778888888774 679999999874 4568
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.+++|+||||+||+++. ++.++|+|||.+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~--~~~~~L~dfg~~ 149 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLA 149 (262)
T ss_pred EEEEEcCCCCcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC--CCcEEeccCCce
Confidence 999999985 7777775322 123788999999999999999999999999999999999985 788999999998
Q ss_pred ccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
........ ...++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-------- 221 (262)
T cd05071 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------- 221 (262)
T ss_pred eeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC--------
Confidence 75543322 1234667999999998889999999999999999999 8999987765554444321100
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.+. ....+..+.+||.+||+.||++||++.++++
T Consensus 222 ----------------------------~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 ----------------------------MPC-------PPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ----------------------------CCC-------ccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 0112456889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=297.37 Aligned_cols=249 Identities=19% Similarity=0.271 Sum_probs=193.4
Q ss_pred EEEEEEeccCCCCceEEEEECC---CCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~---tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
|++.+.||+|+||.||+|.+.. ++..+|+|+++... .....+.+|+.+++.+. |+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD------HPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC------CCCeeeEEeeeccCC
Confidence 5788999999999999998754 34789999987542 23456677888777764 789999999887654
Q ss_pred e------EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 490 H------LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 490 ~------l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
. .++||||+.+ +|..++...........+++..++.++.|++.||.|||+.+++||||||+||+++. ++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE--DMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC--CCeE
Confidence 4 7999999985 66666544332222345899999999999999999999999999999999999985 7889
Q ss_pred EEEecCCcccccCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 004954 563 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 563 kL~DFGls~~~~~~~~-----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~l 636 (722)
||+|||++........ ....+..|+|||.+.+..++.++|||||||++|||++ |.+||.+....+.+..+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999875443221 1234667999999988889999999999999999999 999998776655544432110
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...+..+.++|.+||+.||.+|||+.|++++
T Consensus 233 ----------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 ----------------------------------RLKQP---------EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------------------CCCCC---------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011 1234568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=295.39 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=198.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++..++|+++++||+|+||.||+|.+ .+++.+|+|.+.........+.+|+.+++.++ |+||+++++++ ..+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~-~~~ 73 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ------HPRLVRLYAVV-TQE 73 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcC------CcCeeeEEEEE-ccC
Confidence 34567899999999999999999985 46788999999876655567888998888875 67999999986 456
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+. ++|.+.+.... ...++...+..++.|++.||+|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l~dfg 147 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE--TLCCKIADFG 147 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC--CCCEEEccCc
Confidence 7899999997 56777665332 223888999999999999999999999999999999999996 7889999999
Q ss_pred CcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
++....... ....++..|+|||++.+..++.++||||||+++|+|++ |++||.+.+..+....+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 221 (260)
T cd05067 148 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR------ 221 (260)
T ss_pred ceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC------
Confidence 987654221 12234678999999998889999999999999999999 9999987765555444321100
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...+ ...+..+.++|.+||..+|++|||++++++
T Consensus 222 ----------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 222 ----------------------------MPRP---------DNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ----------------------------CCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0001 112456899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=301.92 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=197.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCc--EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV--DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~--~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ......+.+|+.++.++. .||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-----HHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc-----CCCchhheEEEEccCC
Confidence 579999999999999999999877765 4688887642 233456777888888774 3789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~----------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
..++||||+. ++|.+++....... ....+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~-- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE-- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC--
Confidence 9999999997 57877776433211 1134889999999999999999999999999999999999985
Q ss_pred CCeEEEEecCCcccccCCccc--cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 004954 559 RCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~~~~--~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~ 635 (722)
++.+||+|||++......... ...+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 788999999998643322221 222456999999998889999999999999999997 99999877665544433211
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
. ...+| ...+..+.+||.+||+.+|.+|||++++++.
T Consensus 235 ~----------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 Y----------------------------------RMEKP---------RNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C----------------------------------CCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00011 1234668899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=295.78 Aligned_cols=245 Identities=21% Similarity=0.340 Sum_probs=196.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
.+|++.+.||+|+||.||++.+. ++..+|+|++.......+.+.+|+.+++.++ |+||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLS------HPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCC------CCCEEEEEEEEcCCCceEE
Confidence 46889999999999999999875 5678999998764444456778888888764 7899999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+++ +|.+++..... .+++..++.++.||+.||+|||+.|++||||||+||+++. ++.+||+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~dfg~~~~ 149 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARY 149 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC--CCcEEECCccccee
Confidence 9999975 67777654322 3889999999999999999999999999999999999996 78899999999876
Q ss_pred ccCCccc----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 573 QTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 573 ~~~~~~~----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
....... ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05059 150 VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY----------- 218 (256)
T ss_pred cccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 5432211 122357999999999899999999999999999999 899998766555444432110
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...+..+.+++.+||..+|++|||+.++++.
T Consensus 219 -----------------------~~~~~---------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 219 -----------------------RLYRP---------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -----------------------cCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00011 1234678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.67 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=196.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
||.+.+.||+|+||+||++.+..++..+++|+++... ....+...|..+++.++ ||||+++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD------HPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC------CCcHHHHHHHHhcC
Confidence 6899999999999999999998888878888775421 12234455666666654 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
...++||||+.+ +|.+.+...... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++.++|+||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~---~~~~~l~d~ 149 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK---NNLLKIGDF 149 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee---cCCEeeccc
Confidence 999999999985 565555432211 23489999999999999999999999999999999999997 456999999
Q ss_pred CCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|.+...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+... .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~------ 221 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--P------ 221 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--C------
Confidence 988655332 22345788999999998888899999999999999999999999776554444333210 0
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.+. .....+..+.++|.+||+.+|++||++.++++||||
T Consensus 222 -----------------------------~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 -----------------------------TPS------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----------------------------CCC------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 000 001223568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=296.23 Aligned_cols=244 Identities=32% Similarity=0.466 Sum_probs=197.6
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
||.|+||.||++++..+|+.+++|++.... .....+.+|+.+++.++ |+||+++++.+......++||||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ------SPYVVKLYYSFQGKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC------CcchhHHHHheecCcEEEEEEec
Confidence 689999999999999899999999987543 23455666777777664 78999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+.+ +|.+++.... .+++..++.++.||+.||+|||+.|++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~--~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 75 LPGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS--NGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC--CCCEEEEecccchhcccC
Confidence 975 6766665322 3899999999999999999999999999999999999996 788999999987654322
Q ss_pred -----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 577 -----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 577 -----------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
.....++..|+|||.+....++.++|+||||+++|+|++|..||......+....+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 217 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--------- 217 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------
Confidence 123457888999999998889999999999999999999999998776655554443100
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH---HHHHhCCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA---REALDHPWLQHP 721 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa---~ElL~HPwf~~~ 721 (722)
...|... ..+..+.+||++||+.+|.+|||+ .++|+||||++.
T Consensus 218 --------------------------~~~~~~~-------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 218 --------------------------IEWPEDV-------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred --------------------------cCCCccc-------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0001100 024668899999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.87 Aligned_cols=248 Identities=24% Similarity=0.317 Sum_probs=200.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+..++|++.+.||+|+||.||++.+. .++.+|||.+.........+.+|+.+++.++ |+||+++++++.....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR------HDKLVQLYAVCSEEEP 75 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCC------CCCEeeeeeeeecCCc
Confidence 45678999999999999999999975 5678999999876555567888888888775 6799999999998899
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+||+++. ++.++|+|||+
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~--~~~~~l~d~g~ 149 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE--NLVCKIADFGL 149 (261)
T ss_pred eEEEEeccCCCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC--CCCEEECcccc
Confidence 9999999975 6777765432 123889999999999999999999999999999999999996 78899999999
Q ss_pred cccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
+........ ....+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+....+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~------- 222 (261)
T cd05034 150 ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR------- 222 (261)
T ss_pred ceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 876543211 1223567999999999889999999999999999998 9999988766665555432110
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...+ ...+..+.++|.+||+.+|++||+++++++
T Consensus 223 ---------------------------~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 ---------------------------MPRP---------PNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------------------CCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0001 012356889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=292.44 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=202.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+|++.+.||+|++|.||++++..+++.+|+|.+.... .......+|+++++.++ |+||+++++++......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN------HPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC------CCCchhhhhhhccCCEE
Confidence 5899999999999999999999999999999987532 22345556777777664 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+++ +|..++..... ....+++..++.++.|++.||+|||+.|++|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~--~~~~kl~d~g~~ 150 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA--NDLVKIGDLGIS 150 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec--CCcEEEeeccch
Confidence 999999975 66666654322 1234889999999999999999999999999999999999996 778999999998
Q ss_pred ccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 571 CFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 571 ~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd08530 151 KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-------------- 216 (256)
T ss_pred hhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Confidence 765443 22245788999999999989999999999999999999999999876654443332210
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
..+.. ....+..++++|.+||+.+|.+|||+.++|+||++
T Consensus 217 -----------------------~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 -----------------------KYPPI------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----------------------CCCCC------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00000 00124568999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=295.10 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=196.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+..++|++.+.||+|+||.||++.+. .+..+|+|.+.......+.+.+|+.+++.++ |++|+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLR------HDKLVQLYAVVS-EEP 74 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcC------CCceEEEEeEEC-CCC
Confidence 45678999999999999999999865 5677999999875555567788998888875 679999999875 456
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+ +|.+++.... ...+++..++.++.|++.||+|||+.+|+|+||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~--~~~~~l~dfg~ 148 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD--GLVCKIADFGL 148 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC--CceEEeCCcee
Confidence 8999999975 6777665322 223889999999999999999999999999999999999985 78899999999
Q ss_pred cccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
+........ ...++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 220 (260)
T cd05070 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-------- 220 (260)
T ss_pred eeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 876543321 1234567999999988889999999999999999999 999998776555554432110
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....+ ...+..+.+||.+||+.+|++|||+.++++
T Consensus 221 --------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 --------------------------RMPCP---------QDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --------------------------CCCCC---------CcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00001 122456899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.27 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=201.3
Q ss_pred CcEEEE-EEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~-~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+-|++. +.||+|+|+.|-.+....+|..||||++.+.. ....+..+|++++...+ +|+||++++++|+++..+
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq-----gh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ-----GHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc-----CCccHHHHHHHhcccceE
Confidence 345554 47999999999999999999999999997643 34567889999998887 588999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEEEecCC
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL~DFGl 569 (722)
|+|||-|.| .|+.-+.... .|++.++.++++.|+.||.|||.+||.||||||+|||... +.-.-|||+||.+
T Consensus 152 YLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999986 5666555433 3999999999999999999999999999999999999864 2335699999987
Q ss_pred ccccc----------CCccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCh----------
Q 004954 570 SCFQT----------DNLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDA---------- 624 (722)
Q Consensus 570 s~~~~----------~~~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~---------- 624 (722)
+.... ....+.+|+..|||||++. ...|+.+.|+||||||+|-||.|.+||.+.=
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 64211 1233467788899999974 2358899999999999999999999996531
Q ss_pred -----HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhc
Q 004954 625 -----VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699 (722)
Q Consensus 625 -----~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL 699 (722)
...++..|. ...+.+|.... . ..+.+.++||+.+|
T Consensus 306 ~Cr~CQ~~LFesIQ-----------------------------------EGkYeFPdkdW--a---hIS~eakdlisnLl 345 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQ-----------------------------------EGKYEFPDKDW--A---HISSEAKDLISNLL 345 (463)
T ss_pred ccHHHHHHHHHHHh-----------------------------------ccCCcCChhhh--H---HhhHHHHHHHHHHH
Confidence 112222222 22333443211 1 11356789999999
Q ss_pred ccCCCCCcCHHHHHhCCCCCC
Q 004954 700 EINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 700 ~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..++..|.+|.++|+|||++.
T Consensus 346 vrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 346 VRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred hccHHhhhhhhhccCCccccc
Confidence 999999999999999999975
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=296.35 Aligned_cols=248 Identities=19% Similarity=0.258 Sum_probs=191.3
Q ss_pred EEEEEeccCCCCceEEEEECCCCc--EEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 004954 417 YVTEYLGSAAFSKVFQAQDLHTGV--DVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (722)
Q Consensus 417 ~i~~~LG~G~fG~Vy~a~d~~tg~--~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (722)
.+.++||+|+||.||+|++..++. .+|+|.++.. ......+.+|..+++.++ |+||+++++.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD------HPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEccCCcc
Confidence 467889999999999999877765 6899988653 333456677888887774 78999999986532
Q ss_pred ---CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 489 ---EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 489 ---~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
...++||||+. ++|.+++...........+++..+..++.||+.||+|||+++|+||||||+|||++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl 153 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE--NMNVCV 153 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC--CCCEEE
Confidence 35789999997 466666644332222344889999999999999999999999999999999999985 788999
Q ss_pred EecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 565 IDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 565 ~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+...-
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 231 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-- 231 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Confidence 9999987654321 12245678999999999899999999999999999999 899998766555443332100
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....+ ...+..+.++|.+||+.||.+|||+.+++++
T Consensus 232 --------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 232 --------------------------------RLKQP---------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------------------------------CCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000 1123568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.72 Aligned_cols=251 Identities=21% Similarity=0.287 Sum_probs=196.2
Q ss_pred CcEEEEEEeccCCCCceEEEEE----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..|++.+.||+|+||+||+|.+ ..+++.+|+|.++... .....+.+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH------HPNIVCLLGVVTQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC------CCCeeeEEEEEec
Confidence 5689999999999999999985 3456789999987432 22345677888888774 6899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEc
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQES-----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~-----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~ 555 (722)
....++||||+.+ +|.+++...... .....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 9999999999974 777776432210 0122378888999999999999999999999999999999999
Q ss_pred ccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHH
Q 004954 556 SYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 629 (722)
Q Consensus 556 ~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l 629 (722)
. +..+||+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....+.
T Consensus 159 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 E--QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred C--CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 6 778999999998654322 122344667999999998889999999999999999998 99999876655544
Q ss_pred HHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH
Q 004954 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709 (722)
Q Consensus 630 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa 709 (722)
..+.... . .+ .....++.+.++|.+||+.||.+||++
T Consensus 237 ~~~~~~~-~-----------------------------------~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (283)
T cd05090 237 EMVRKRQ-L-----------------------------------LP-------CSEDCPPRMYSLMTECWQEGPSRRPRF 273 (283)
T ss_pred HHHHcCC-c-----------------------------------CC-------CCCCCCHHHHHHHHHHcccCcccCcCH
Confidence 4432100 0 00 011234668899999999999999999
Q ss_pred HHHHhC
Q 004954 710 REALDH 715 (722)
Q Consensus 710 ~ElL~H 715 (722)
.+++++
T Consensus 274 ~~i~~~ 279 (283)
T cd05090 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.15 Aligned_cols=245 Identities=20% Similarity=0.344 Sum_probs=200.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
.+.|++.+.||.|+||.||++.+ .|+.+|+|.++.......++.+|+.+++.++ |+||+++++++......+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLR------HPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcC------CcceeeeEEEEcCCCCeE
Confidence 46789999999999999999986 4889999999876555567888888888775 679999999999999999
Q ss_pred EEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||++ ++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||.+.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~--~~~~~l~d~g~~~ 150 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE--DLVAKVSDFGLAK 150 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC--CCCEEEccccccc
Confidence 9999998 578777664321 23899999999999999999999999999999999999985 7889999999988
Q ss_pred cccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 572 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
...........+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05039 151 EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-------------- 216 (256)
T ss_pred ccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 76544444445667999999988889999999999999999997 999998766555443332100
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...++.+.++|++||..+|++|||+.++++
T Consensus 217 --------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 --------------------RMEAP---------EGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------------CCCCc---------cCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00001 122467889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.87 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=201.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
..|.+.+.||+|+||.||++++..+++.+|+|++.... .....+.+|+.+++.++ |+|++++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK------HPNSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC------CCCEEEEEEEEeeCC
Confidence 45788899999999999999999999999999986432 22345666777777664 679999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
..++||||+.|++.+.+..... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||+
T Consensus 99 ~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~--~~~~kl~dfg~ 171 (317)
T cd06635 99 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGS 171 (317)
T ss_pred eEEEEEeCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC--CCCEEEecCCC
Confidence 9999999999988877654322 2889999999999999999999999999999999999985 78899999998
Q ss_pred cccccCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+..... .....+++.|+|||.+. ...++.++|||||||++|+|++|..||...........+.....+.
T Consensus 172 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------- 243 (317)
T cd06635 172 ASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT------- 243 (317)
T ss_pred ccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC-------
Confidence 765443 23356888999999984 4567889999999999999999999997765444444432110000
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+ ....+..+.+||.+||+.+|.+||++.++++|||+..
T Consensus 244 ---------------------------~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 ---------------------------LQ--------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---------------------------CC--------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00 0112356889999999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=322.81 Aligned_cols=248 Identities=29% Similarity=0.419 Sum_probs=206.1
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+.. .+..+|+.++.... +||||+++.+++.+..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~-----~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR-----DHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc-----CCCcceeecceecCCcee
Confidence 4577999999999999999999999999999999997763 34556777777765 478999999999999999
Q ss_pred EEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
|+|||.+.|+ +++-+.... ....++..|+.+|+.|+.|||++|+|||||||+|||+. +..++++|+|||.+
T Consensus 392 ~~v~e~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFW 463 (612)
T ss_pred eeeehhccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechh
Confidence 9999999875 444444322 22377888999999999999999999999999999995 34889999999999
Q ss_pred ccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH-HHHHHHHhhcCCCcHHHHhhhhh
Q 004954 571 CFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 571 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~-e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
+.......+.+-|..|.|||++...+|+.++||||||++||+||+|+.||...... +++.+| +.++..
T Consensus 464 ~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s------- 532 (612)
T KOG0603|consen 464 SELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS------- 532 (612)
T ss_pred hhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc-------
Confidence 98887766667899999999999999999999999999999999999999765444 333332 111100
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC-CCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL-QHP 721 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf-~~~ 721 (722)
...+..+++||++||+.||.+|+++.+++.|||| +++
T Consensus 533 -----------------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 533 -----------------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHP 570 (612)
T ss_pred -----------------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCC
Confidence 2334678999999999999999999999999999 554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=299.90 Aligned_cols=288 Identities=32% Similarity=0.541 Sum_probs=234.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+..||.-++.+|.|+- .|..+.|.-.+++||+|.+... .....+..+|+.+++.++ |+||++++.+|.-
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~------~~nii~l~n~ftP 86 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN------HKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc------ccceeeeeeccCc
Confidence 34578999999999998 8999999999999999986432 233467788999999887 5699999999985
Q ss_pred c------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 488 L------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 488 ~------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
. ...|+|||+|..+|...+... +.-.++..|+.|++.|++|||+.||+||||||+||++.. ++.
T Consensus 87 ~~~l~~~~e~y~v~e~m~~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~--~~~ 156 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDANLCQVILME--------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS--DCT 156 (369)
T ss_pred cccHHHHHhHHHHHHhhhhHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc--hhh
Confidence 4 368999999999998887721 677889999999999999999999999999999999996 899
Q ss_pred EEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 562 vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
+||.|||++...... .+.++.|+.|+|||++.+..+...+||||+||++.||++|+..|++.+.-+...+++..+|.+
T Consensus 157 lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 157 LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred eeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 999999999765543 455788999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchh--hhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSL--EHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l--~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
+.....+.+.....+....+.+... .....+|...-. ....+.....+++|+.+||..||++|.+++++|+|||
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~----~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAI----SFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhcc----chhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 9998888777665544433332221 111122211000 0111222356789999999999999999999999999
Q ss_pred CC
Q 004954 718 LQ 719 (722)
Q Consensus 718 f~ 719 (722)
++
T Consensus 313 ~~ 314 (369)
T KOG0665|consen 313 IK 314 (369)
T ss_pred ee
Confidence 96
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=303.13 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=195.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcE--EEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~--vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||.||+|.+..++.. +|+|.++.. ......+.+|+.++.++. .|+||+++++++...+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~-----~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc-----CCCCcceEEEEECCCC
Confidence 5799999999999999999998877764 477766532 233456677888888874 3789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
..++||||+. ++|.+++...... .....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~-- 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC--
Confidence 9999999997 5777777644321 11234889999999999999999999999999999999999985
Q ss_pred CCeEEEEecCCcccccCCccc--cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 004954 559 RCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~~~~--~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~ 635 (722)
++.+||+|||++......... ...+..|+|||.+.+..++.++|||||||++|+|+| |..||...+..+....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 778999999998643222111 223567999999988889999999999999999998 99999776554443332100
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.....+ ...++.+.+||.+||+.+|++||++.++|++
T Consensus 240 ----------------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 ----------------------------------YRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ----------------------------------CcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000000 1124568899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=296.38 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=199.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..+|++.++||.|+||.||+|.+.. ++.+|+|++..... ....+.+|+.+++.++ |+||+++++++......
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR------HKHLISLFAVCSVGEPV 77 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC------CcchhheeeeEecCCCe
Confidence 4568999999999999999999877 89999999876543 3456777888877774 68999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++. ++.+||+|||.+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~--~~~~kl~d~g~~ 151 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE--DLVCKVADFGLA 151 (261)
T ss_pred EEEEeecccCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC--CceEEEccccch
Confidence 999999975 7777776432 123889999999999999999999999999999999999985 788999999998
Q ss_pred ccccCCcc---ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~~~---~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
........ ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR--------- 222 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---------
Confidence 76543321 2234567999999998899999999999999999998 8999988776555554431100
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...+ ...++.+.++|.+||+.||.+|||+.++++
T Consensus 223 -------------------------~~~~---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 -------------------------MPCP---------AKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------------------CCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000 122466889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.08 Aligned_cols=246 Identities=21% Similarity=0.276 Sum_probs=191.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcE----EEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~----vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+|++.+.||+|+||.||+|++..+++. ||+|+++... .....+.+|+.+++.+. ||||+++++++.
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~g~~~ 79 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGICL 79 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEc
Confidence 46799999999999999999998666654 8999986432 33456667777777664 789999999987
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
.. ..++|+||+. |+|.+++..... .++...++.++.||+.||+|||+.||+||||||+|||++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~--~~~~kl~ 151 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT--PQHVKIT 151 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC--CCcEEEc
Confidence 64 5678999987 577777764332 2788899999999999999999999999999999999985 7789999
Q ss_pred ecCCcccccCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~~~-----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||++........ ....+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....++...+...
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~---- 227 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---- 227 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC----
Confidence 9999976543221 1223567999999999999999999999999999998 99999876554433221100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...|. ....+..+.++|.+||..+|.+|||+.+++.+
T Consensus 228 --------------------------------~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 228 --------------------------------ERLPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred --------------------------------CCCCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 01123568899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=293.17 Aligned_cols=239 Identities=23% Similarity=0.357 Sum_probs=188.2
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
+.||+|+||.||+|++..+++.+|+|.+... ......+.+|+++++.+. ||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS------HPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEcCCCCeEEEEee
Confidence 3699999999999999999999999987643 333456778888888764 78999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+.+ +|.+++.... ..+++..++.++.|++.||+|||+.||+|+||||+||+++. ++.+||+|||++......
T Consensus 75 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 75 VQGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE--KNVLKISDFGMSREEEDG 147 (252)
T ss_pred ccCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC--CCcEEECccccCcccccc
Confidence 975 6666654322 23789999999999999999999999999999999999985 778999999998654332
Q ss_pred ccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 577 LCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 577 ~~~-----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
... ...+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-------------- 213 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-------------- 213 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------------
Confidence 111 122456999999998889999999999999999998 999997654443332221100
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....+ ...+..+.+||.+||+.+|++|||+.++++
T Consensus 214 --------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 214 --------------------RLPCP---------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred --------------------CCCCc---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011 112456889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.34 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=195.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..++|++.+.||+|++|.||++.+..+ ..+|+|++.........+.+|+.+++.+. |+|++++++++. .+..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLR------HDKLVPLYAVVS-EEPI 75 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCC------CCCeeeEEEEEc-CCCc
Confidence 357899999999999999999987654 46999998765555566778888888775 679999998875 4668
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||.+
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~--~~~~~l~dfg~~ 149 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD--NLVCKIADFGLA 149 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCeEEECCCccc
Confidence 999999985 7877776432 123788999999999999999999999999999999999986 788999999998
Q ss_pred ccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
........ ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------- 221 (260)
T cd05069 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-------- 221 (260)
T ss_pred eEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 76543221 1234667999999998889999999999999999999 9999987765554444321100
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...+ ...+..+.+||++||..||.+||+++++++
T Consensus 222 --------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 --------------------------MPCP---------QGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --------------------------CCCC---------cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0001 112466899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.22 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=199.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECC-------CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~-------tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
++..++|.+.+.||+|+||.||++++.. +...+|+|+++... .....+.+|+.+++.+. .|+||++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~ 88 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 88 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-----CCCCEee
Confidence 3445789999999999999999998643 23579999987542 23456777888888774 3789999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
+++++...+..++||||+. ++|.+++...... .....+++.+++.++.||+.||+|||+.|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 9999999999999999997 4788787654321 1223488899999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~ 623 (722)
+||+++. ++.++|+|||.+....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 169 ~Nill~~--~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 169 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HheEEcC--CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 9999985 7889999999986543211 11223468999999999889999999999999999998 89999876
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 624 ~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
+..+....+.... ....| ...+..+.+||.+||..+|
T Consensus 247 ~~~~~~~~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p 283 (307)
T cd05098 247 PVEELFKLLKEGH----------------------------------RMDKP---------SNCTNELYMMMRDCWHAVP 283 (307)
T ss_pred CHHHHHHHHHcCC----------------------------------CCCCC---------CcCCHHHHHHHHHHcccCh
Confidence 6555444332100 00011 1124568899999999999
Q ss_pred CCCcCHHHHHhC
Q 004954 704 QRRPTAREALDH 715 (722)
Q Consensus 704 ~kRpTa~ElL~H 715 (722)
.+|||+.+++++
T Consensus 284 ~~Rps~~evl~~ 295 (307)
T cd05098 284 SQRPTFKQLVED 295 (307)
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.33 Aligned_cols=234 Identities=29% Similarity=0.406 Sum_probs=192.5
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~ 498 (722)
++-||+|+.|.||+|+ ..++.||||.++..+ ..+++-|++| +||||+.+.++|.....+|||||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~elk------ETdIKHLRkL------kH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRELK------ETDIKHLRKL------KHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhhh------hhhHHHHHhc------cCcceeeEeeeecCCceeEEeeecc
Confidence 4559999999999998 467899999875432 2345555555 4789999999999999999999999
Q ss_pred c-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCCc
Q 004954 499 R-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 577 (722)
Q Consensus 499 ~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~ 577 (722)
. |-|+++++..+. ++...+..|..+|+.||.|||..+|||||||.-||||+. +..|||+|||-++...+..
T Consensus 195 a~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~--~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY--DDVVKISDFGTSKELSDKS 266 (904)
T ss_pred ccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec--cceEEeccccchHhhhhhh
Confidence 7 678888875543 888999999999999999999999999999999999996 7789999999998777664
Q ss_pred cc--cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhc
Q 004954 578 CL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 655 (722)
Q Consensus 578 ~~--~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~ 655 (722)
+. ++||..|||||++...+.+.|+|||||||+|||||||..||.+.+...++.-
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG------------------------ 322 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG------------------------ 322 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe------------------------
Confidence 43 7899999999999999999999999999999999999999987654332211
Q ss_pred ccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 656 KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
.....+....|. ..+.-|+=||+.||+.-|..||+..++|.|-
T Consensus 323 ---------VGsNsL~LpvPs---------tcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 323 ---------VGSNSLHLPVPS---------TCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ---------ccCCcccccCcc---------cCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 111222223332 2345688999999999999999999999993
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=301.67 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=196.9
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
..+||+|+||.||++.+..+++.+|||.+.... .....+.+|+.+++.++ |+||+++++.+...++.++||||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC------CcchhheeeEEEeCCEEEEEEec
Confidence 457999999999999999999999999886432 23345677888777764 67999999999999999999999
Q ss_pred cccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC-
Q 004954 498 LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN- 576 (722)
Q Consensus 498 ~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~- 576 (722)
+.++.+..+.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++. ++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~--~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 99 LEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEcccccceeccccc
Confidence 9875443333221 2788999999999999999999999999999999999986 678999999987654332
Q ss_pred --ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 004954 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (722)
Q Consensus 577 --~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~ 654 (722)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+....+.....
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----------------- 233 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----------------- 233 (292)
T ss_pred ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-----------------
Confidence 2234678899999999888899999999999999999999999987655444433221100
Q ss_pred cccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 655 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
..++ .....+..+.++|.+||+.+|.+||++.++|+||||.+.
T Consensus 234 -----------------~~~~-------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 234 -----------------PKLK-------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred -----------------cccC-------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 0000 011234568899999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.33 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=200.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+|.+.+.||+|+||.||+|+++.+++.+|+|.+... .....++.+|+++++.++ |+|++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC------CCCcccEEEEEEcCC
Confidence 4578888999999999999999999999999988642 222345667888887775 679999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
..++||||+.+++.+.+.... ..+++..+..++.|++.||.|||+.+++||||+|+||+++. ++.++|+|||+
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~ 161 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGS 161 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC--CCcEEECCccc
Confidence 999999999988877765332 22788999999999999999999999999999999999985 78899999999
Q ss_pred cccccCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||......+....+....
T Consensus 162 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---------- 230 (308)
T cd06634 162 ASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---------- 230 (308)
T ss_pred ceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC----------
Confidence 8765432 3356788999999985 3457889999999999999999999997654433333222100
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.|.. .....+..+.+||++||+.+|.+||++.++++|||+..
T Consensus 231 ---------------------------~~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 231 ---------------------------SPAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---------------------------CCCc-----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0000 00123456889999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=330.24 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=209.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
..+.+..+.||+|+||+||+|+-. ...+.||||.++...+ ...++.+|++++..++ |||||+++|++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~------H~nIVrLlGVC 558 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ------HPNIVRLLGVC 558 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc------CCCeEEEEEEE
Confidence 345677888999999999999852 2346799999986543 4678999999999986 68999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHhhhhccCC--------CcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGG--------EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 486 ~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~--------~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
..++.+++|+|||. |+|.++++....... ...++..+.+.|+.||+.||.||-++.+|||||..+|+||..
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 99999999999997 789999886654321 223888999999999999999999999999999999999996
Q ss_pred cCCCeEEEEecCCcccccCCcccc-----ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 004954 557 YQRCEIKIIDLGSSCFQTDNLCLY-----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~~~~~-----~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~ 630 (722)
+..|||+|||+++..-...... .-+.+|||||.|...+++.++||||+||+|||+++ |+.||.+.+.+++++
T Consensus 639 --~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 639 --NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred --ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 8899999999997644433322 23678999999999999999999999999999999 999999999999887
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.|.+. .+...+...+.++.+||..||+.+|++||+.+
T Consensus 717 ~i~~g-------------------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 717 CIRAG-------------------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred HHHcC-------------------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence 77521 11223345667899999999999999999999
Q ss_pred HHH
Q 004954 711 EAL 713 (722)
Q Consensus 711 ElL 713 (722)
||-
T Consensus 754 eI~ 756 (774)
T KOG1026|consen 754 EIH 756 (774)
T ss_pred HHH
Confidence 873
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.93 Aligned_cols=251 Identities=23% Similarity=0.284 Sum_probs=197.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+|.+.+.||+|+||+||++.+ ..++..+|+|.+.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 77 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ------HEHIVKFYGVCV 77 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEe
Confidence 35799999999999999999985 3355679999886533 33456778888888775 679999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhc-------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQE-------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~-------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
..+..++||||+. ++|.+++..... ......+++..++.++.||+.||+|||+.|++||||||+||+++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~-- 155 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-- 155 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc--
Confidence 9999999999997 467777653321 011224899999999999999999999999999999999999985
Q ss_pred CCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i 632 (722)
++.++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||......+.+..+
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7889999999987543221 12234678999999999889999999999999999998 99999877665555444
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
..... ...+ ...+..+.+||.+||+.||.+|||+.++
T Consensus 236 ~~~~~----------------------------------~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~v 272 (288)
T cd05093 236 TQGRV----------------------------------LQRP---------RTCPKEVYDLMLGCWQREPHMRLNIKEI 272 (288)
T ss_pred HcCCc----------------------------------CCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 31100 0000 1124568999999999999999999998
Q ss_pred Hh
Q 004954 713 LD 714 (722)
Q Consensus 713 L~ 714 (722)
+.
T Consensus 273 ~~ 274 (288)
T cd05093 273 HS 274 (288)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.66 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=199.2
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~t-----g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
+-.++|++.+.||+|+||.||++.+... ...+|+|++.... .....+.+|+.+++.+. .|+||+++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~~ 83 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLLG 83 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 3357899999999999999999987643 3789999987542 23345677888888773 3789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 004954 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~-gsLl~~l~~~~~----------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NI 552 (722)
++.....+++||||+. ++|..++..... ......+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 9999999999999997 467777653221 02233488999999999999999999999999999999999
Q ss_pred EEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHH
Q 004954 553 LIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVV 626 (722)
Q Consensus 553 Ll~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~ 626 (722)
+++. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 164 l~~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 164 LVTE--DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EEcC--CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9985 7899999999987644321 11234567999999998899999999999999999998 99999877655
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
+....+.... ....| ...+..+.+||.+||+.||.+|
T Consensus 242 ~~~~~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~R 278 (293)
T cd05053 242 ELFKLLKEGY----------------------------------RMEKP---------QNCTQELYHLMRDCWHEVPSQR 278 (293)
T ss_pred HHHHHHHcCC----------------------------------cCCCC---------CCCCHHHHHHHHHHcccCcccC
Confidence 5443332100 00011 1224568899999999999999
Q ss_pred cCHHHHHhC
Q 004954 707 PTAREALDH 715 (722)
Q Consensus 707 pTa~ElL~H 715 (722)
||+.|+|++
T Consensus 279 ps~~eil~~ 287 (293)
T cd05053 279 PTFKQLVED 287 (293)
T ss_pred cCHHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.72 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=197.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~t-----g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
+..++|++.+.||+|+||.||++.+... +..+|+|.+.... .....+.+|+.+++.+. |+||+++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~ 76 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN------CHHVVRLLG 76 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC------CCceeEEEE
Confidence 3457899999999999999999987643 4889999986543 22334566777776654 789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHhhhhccC----CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESG----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~----~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
++......++||||+. ++|.+++....... ....+++..+..++.||+.||.|||+.+++||||||+||+++.
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~-- 154 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE-- 154 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC--
Confidence 9999999999999997 57777765432211 1234788899999999999999999999999999999999996
Q ss_pred CCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i 632 (722)
++.+||+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 788999999998654322 122345778999999998889999999999999999998 99999877665554433
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
... . ....|. ..+..+.+||.+||+.+|++|||+.++
T Consensus 235 ~~~-~---------------------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~l 271 (277)
T cd05032 235 IDG-G---------------------------------HLDLPE---------NCPDKLLELMRMCWQYNPKMRPTFLEI 271 (277)
T ss_pred hcC-C---------------------------------CCCCCC---------CCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 200 0 001111 124668899999999999999999999
Q ss_pred HhC
Q 004954 713 LDH 715 (722)
Q Consensus 713 L~H 715 (722)
++.
T Consensus 272 ~~~ 274 (277)
T cd05032 272 VSS 274 (277)
T ss_pred HHH
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.47 Aligned_cols=264 Identities=20% Similarity=0.231 Sum_probs=188.5
Q ss_pred eeCceecCcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecchhhh-Hh-----HHHHHHHHHHhcccCCCCCCc
Q 004954 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKDFF-DQ-----SLDEIKLLKLVNKNDPADEHH 477 (722)
Q Consensus 407 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~~~~~-~~-----~~~E~~il~~L~~~~~~~hpn 477 (722)
.+.++..++|++.++||+|+||+||+|.+..+ +..+|+|+........ .. ...+......+.......|++
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34567778999999999999999999998777 6778888754332110 00 001111222222233457999
Q ss_pred eeEEEEEEEecC----eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceE
Q 004954 478 ILRLYDYFYHLE----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (722)
Q Consensus 478 Iv~l~~~f~~~~----~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NIL 553 (722)
|+++++++.... ..+++|+++..++.+.+.... ..++..++.++.|++.||+|||+.+|+||||||+|||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999999776543 457888988777766654322 1567788999999999999999999999999999999
Q ss_pred EcccCCCeEEEEecCCcccccC----------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004954 554 IKSYQRCEIKIIDLGSSCFQTD----------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623 (722)
Q Consensus 554 l~~~~~~~vkL~DFGls~~~~~----------~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~ 623 (722)
++. ++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 159 l~~--~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 159 VDG--NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EcC--CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 985 77899999999865421 112346899999999999999999999999999999999999999876
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 624 ~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
.....+...... +.+ +.+. .... .....+..+.++++.|++.+|
T Consensus 237 ~~~~~~~~~~~~------~~~-------~~~~-------------~~~~----------~~~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 237 GHNGNLIHAAKC------DFI-------KRLH-------------EGKI----------KIKNANKFIYDFIECVTKLSY 280 (294)
T ss_pred ccchHHHHHhHH------HHH-------HHhh-------------hhhh----------ccCCCCHHHHHHHHHHHhCCC
Confidence 322211111100 000 0000 0000 011234668999999999999
Q ss_pred CCCcCHHHHHh
Q 004954 704 QRRPTAREALD 714 (722)
Q Consensus 704 ~kRpTa~ElL~ 714 (722)
++||+..++++
T Consensus 281 ~~rp~~~~l~~ 291 (294)
T PHA02882 281 EEKPDYDALIK 291 (294)
T ss_pred CCCCCHHHHHH
Confidence 99999999975
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.54 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=197.2
Q ss_pred EEeccCCCCceEEEEECCC---CcEEEEEEeecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~~~~--~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
+.||+|+||.||++.+... +..+|+|+++..... ...+.+|+++++.++ |+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------HPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC------CCChheeeeeecCCCceEEE
Confidence 3699999999999998765 899999999865433 466777888887775 67999999999999999999
Q ss_pred EEccc-cchHHHHhhhhcc---CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 495 CELLR-ANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 495 mEy~~-gsLl~~l~~~~~~---~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
|||+. ++|.+++...... .....+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~--~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE--DLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC--CCcEEEcccccc
Confidence 99995 6777776654211 01233899999999999999999999999999999999999996 688999999998
Q ss_pred ccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 571 CFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 571 ~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
...... .....+++.|+|||.+....++.++||||||+++|+|++ |..||......+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------- 223 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------- 223 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence 765543 223456788999999998889999999999999999999 69999887665555444310
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.....| ...+..+.++|.+||+.+|++|||+.+++++
T Consensus 224 -------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -------------------------YRLPKP---------EYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------------------CCCCCC---------ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000011 1124678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=291.96 Aligned_cols=253 Identities=27% Similarity=0.381 Sum_probs=201.7
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
..+++..||+|..|.||+++.+.+|..+|||.+.... ....+++..+.++...+ +.|+||+++++|..+..++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~-----dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc-----CCCeeeeeeeEEeeCchHH
Confidence 3566778999999999999999999999999997643 33445555555554443 4689999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
|.||.|..-+..+++..+. ++++.-+-.+...+++||.||.++ ||+|||+||+|||++. .|.|||+|||.+.
T Consensus 168 IcMelMs~C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe--~GniKlCDFGIsG 240 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE--RGNIKLCDFGISG 240 (391)
T ss_pred HHHHHHHHHHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc--CCCEEeecccccc
Confidence 9999998665555554332 288888899999999999999865 7999999999999996 8999999999997
Q ss_pred cccCCc--cccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHHHhhcCCCcHHHHh
Q 004954 572 FQTDNL--CLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 572 ~~~~~~--~~~~gt~~y~APE~l~~---~~~s~ksDIWSLGviL~elltG~~PF~~~~-~~e~l~~i~~~lg~~~~~~~~ 645 (722)
+..+.. +...|.+.|||||.+.- ..|+.++||||||++++||.||+.||++.+ ..+.+..+....
T Consensus 241 rlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--------- 311 (391)
T KOG0983|consen 241 RLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--------- 311 (391)
T ss_pred eeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC---------
Confidence 766543 34678999999999864 358899999999999999999999998853 445555553210
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
| ..|..+ ...++.|++|+..||+.|+.+||.-.++|+|||+..
T Consensus 312 -----------------------------P--P~L~~~-~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 312 -----------------------------P--PLLPGH-MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred -----------------------------C--CCCCcc-cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 1 011111 114577999999999999999999999999999853
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=287.89 Aligned_cols=293 Identities=26% Similarity=0.435 Sum_probs=221.0
Q ss_pred CCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 402 KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 402 ~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
..+-+.++ ..++|+|.+++|+|-++.|+.|.+..++++++||+++.-+. .++.+|++||+.|. +||||+++
T Consensus 28 E~~~i~wg--~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~-----gg~NIi~L 98 (338)
T KOG0668|consen 28 ESLVIDWG--NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLR-----GGPNIIKL 98 (338)
T ss_pred hheeeecc--ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhcc-----CCCCeeeh
Confidence 33444454 34789999999999999999999999999999999986543 67899999999997 47899999
Q ss_pred EEEEEecC--eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC
Q 004954 482 YDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (722)
Q Consensus 482 ~~~f~~~~--~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~ 559 (722)
+++..+.. ...+|+||++..- +....+. ++.-.++.++.+++.||.|+|++||+|||+||.|++|+. ..
T Consensus 99 ~DiV~Dp~SktpaLiFE~v~n~D--fk~ly~t------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh-~~ 169 (338)
T KOG0668|consen 99 LDIVKDPESKTPSLIFEYVNNTD--FKQLYPT------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH-EL 169 (338)
T ss_pred hhhhcCccccCchhHhhhhcccc--HHHHhhh------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech-hh
Confidence 99988764 5789999997642 2222222 778889999999999999999999999999999999996 45
Q ss_pred CeEEEEecCCcccccCCc--cccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCChHHHHHHHHHhh
Q 004954 560 CEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGM 635 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~~--~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF-~~~~~~e~l~~i~~~ 635 (722)
-.++|+|||+|.++.... ...+.+..|.-||.+.. +.|+...|+|||||+|..|+..+-|| .+.+..+++-+|.+.
T Consensus 170 rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 170 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred ceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 689999999998876543 33567888999999875 45889999999999999999988776 788889999999999
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
+|.-.......--.+ .+++.............+..-++... + ....++..|||.++|..|.++|+||.|++.|
T Consensus 250 LGt~el~~Yl~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n---~--hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQI--DLDPQFEDILGRHSRKPWSRFINSEN---Q--HLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hChHHHHHHHHHHcc--CCChhHhhHhhccccccHHHhCCccc---c--ccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 885433222111000 01111111111111111221121110 1 1224778999999999999999999999999
Q ss_pred CCCC
Q 004954 716 PWLQ 719 (722)
Q Consensus 716 Pwf~ 719 (722)
|||.
T Consensus 323 pyF~ 326 (338)
T KOG0668|consen 323 PYFA 326 (338)
T ss_pred chHH
Confidence 9995
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=309.27 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=193.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
-.++|++.+.||+|+||.||+|.+. .+++.||+|+++... .....+..|+.+++.+. .|+||++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~-----~h~niv~~~~~ 79 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-----HHLNVVNLLGA 79 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc-----cCcchhheeee
Confidence 3468999999999999999999753 345789999987532 23355677888888774 37899999998
Q ss_pred EEec-CeEEEEEEcccc-chHHHHhhhhcc--------------------------------------------------
Q 004954 485 FYHL-EHLFIVCELLRA-NLYEFQKFNQES-------------------------------------------------- 512 (722)
Q Consensus 485 f~~~-~~l~iVmEy~~g-sLl~~l~~~~~~-------------------------------------------------- 512 (722)
+... ..+++||||+.+ +|.+++......
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 8754 578999999985 676666432210
Q ss_pred -----CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCCc-----ccccc
Q 004954 513 -----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQ 582 (722)
Q Consensus 513 -----~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~g 582 (722)
.....+++..+..++.||+.||+|||++||+||||||+|||++. ++.++|+|||++....... ....+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~--~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC--CCcEEEeccccchhcccCcchhhccCCCC
Confidence 00124788999999999999999999999999999999999995 7889999999987643221 12344
Q ss_pred CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccch
Q 004954 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLY 661 (722)
Q Consensus 583 t~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~ 661 (722)
+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+..
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-------------------------- 291 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-------------------------- 291 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc--------------------------
Confidence 678999999999999999999999999999998 99999764333222221100
Q ss_pred hhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 662 YINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 662 ~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
......| ....+.+.+++.+||+.+|++||++.|+++|
T Consensus 292 -------~~~~~~~---------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 -------GTRMRAP---------EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -------cCCCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000011 1223568899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.46 Aligned_cols=260 Identities=28% Similarity=0.395 Sum_probs=204.8
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHh--------HHHHHHHHHHhcccCCCCCCceeEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--------SLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~--------~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
..+.+||-++++||+|||+.||+|.|....++||+|+-..++.|.+. ..+|.+|.+. ++||.||++
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKe------LDHpRIVKl 532 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKE------LDHPRIVKL 532 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhc------cCcceeeee
Confidence 36789999999999999999999999999999999997766554332 3345555544 468899999
Q ss_pred EEEEEe-cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEccc-
Q 004954 482 YDYFYH-LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSY- 557 (722)
Q Consensus 482 ~~~f~~-~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~- 557 (722)
|++|.- .+.+|-|+|||+|+-+++....... +++.+++.|+.||+.||.||.+.. |||-||||.|||+...
T Consensus 533 YDyfslDtdsFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeccccceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 999985 4678999999999888877654433 899999999999999999999875 9999999999998643
Q ss_pred CCCeEEEEecCCcccccCCc----------cccccCCcccCchhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004954 558 QRCEIKIIDLGSSCFQTDNL----------CLYVQSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPND 623 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~~----------~~~~gt~~y~APE~l~~~----~~s~ksDIWSLGviL~elltG~~PF~~~ 623 (722)
.-|.|||+|||+++...+.. ....||.+|+|||++.-. +++.++||||+|||+|.++.|+.||..+
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 34689999999998765432 235789999999998633 4789999999999999999999999775
Q ss_pred hHH-HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 624 AVV-MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 624 ~~~-e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
... +++..- ......+-.+|..+ ..+.+.++||++||++.
T Consensus 688 qsQQdILqeN--------------------------------TIlkAtEVqFP~KP-------vVsseAkaFIRRCLaYR 728 (775)
T KOG1151|consen 688 QSQQDILQEN--------------------------------TILKATEVQFPPKP-------VVSSEAKAFIRRCLAYR 728 (775)
T ss_pred hhHHHHHhhh--------------------------------chhcceeccCCCCC-------ccCHHHHHHHHHHHHhh
Confidence 432 333220 00111122333332 23466889999999999
Q ss_pred CCCCcCHHHHHhCCCCC
Q 004954 703 PQRRPTAREALDHPWLQ 719 (722)
Q Consensus 703 P~kRpTa~ElL~HPwf~ 719 (722)
-+.|....++..||+|.
T Consensus 729 KeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 729 KEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhhhhhHHHHccCcccc
Confidence 99999999999999984
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.52 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=194.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-ecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~-~~~~l~ 492 (722)
.+|++.+.||+|+||.||++.. .|..+|+|.++.... .+.+.+|+.+++.++ |+|++++++++. .....+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~-~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-AQAFLAEASVMTQLR------HSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCch-HHHHHHHHHHHHhCC------CCCeeeEEEEEEcCCCceE
Confidence 5799999999999999999975 478899999876543 356778888888775 679999999765 456799
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+.+ +|.+++..... ..+++..+..++.||+.||+|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~ 150 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE--DNVAKVSDFGLTK 150 (256)
T ss_pred EEEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC--CCcEEecCCccce
Confidence 99999974 77777664322 23788999999999999999999999999999999999985 7889999999987
Q ss_pred cccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 572 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
...........+..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05082 151 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------- 216 (256)
T ss_pred eccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 65444444455678999999998889999999999999999998 999998765555443332100
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....+ ...+..+.++|.+||+.+|++|||+.++++
T Consensus 217 --------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 --------------------KMDAP---------DGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --------------------CCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00000 123467889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=295.03 Aligned_cols=249 Identities=27% Similarity=0.381 Sum_probs=196.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||.||++++..+++.+|||.+... ......+.+|+.+++.+. |+||+++++++...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN------HPNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc------CCchhhhhheeEeCC
Confidence 4688999999999999999999999999999987642 223356677888887774 689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++|++|+||||+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg 151 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEECcch
Confidence 99999999985 67766654322 2234889999999999999999999999999999999999985 7789999999
Q ss_pred CcccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH--HHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV--MILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~--e~l~~i~~~lg~~~~~~ 643 (722)
++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 223 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-------- 223 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--------
Confidence 886654322 2346788999999999988999999999999999999999999654321 111111100
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
..+... ....++.+.+||.+||+.||++|||+.+|++
T Consensus 224 -----------------------------~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 224 -----------------------------DYPPLP-----SDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------------------CCCCCC-----cccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000000 0123467899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=290.63 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=196.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~------~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+|++.+.||+|+||.||++++..+++.+|+|++... ......+.+|+.+++.++ |+||+++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~~ 75 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR------HDRIVQYYGCLRD 75 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC------CCCcceEEEEEEc
Confidence 4799999999999999999999999999999987532 123346667888888775 6799999999876
Q ss_pred c--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 488 ~--~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
. ..+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l 147 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEE
Confidence 4 468899999975 6666665321 2788899999999999999999999999999999999985 778999
Q ss_pred EecCCcccccC------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 565 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 565 ~DFGls~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+|||++..... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||..........++.. .
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~ 224 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---Q 224 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---C
Confidence 99999865432 11234678899999999998899999999999999999999999976544433322210 0
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
. ....+| ...+..+.++|++||+ +|.+|||+.++|.|||.
T Consensus 225 ~------------------------------~~~~~p---------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 225 P------------------------------TKPMLP---------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred C------------------------------CCCCCC---------cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0 001111 1234668999999999 57999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.91 Aligned_cols=252 Identities=29% Similarity=0.498 Sum_probs=212.1
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
-.+.|.++++||+|.|++|.++++..++..||||++.+.. .......+|+++++.|+ |||||+++.+....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~------HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN------HPNIVKLFSVIETE 127 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC------Ccceeeeeeeeeec
Confidence 3577999999999999999999999999999999997643 33445778888888886 78999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
..+|+||||+. |.+.+++..+.. ..+..+..++.|++.|++|||+++|+|||||++|||++. +..+||+||
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~--~mnikIaDf 199 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE--NMNIKIADF 199 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc--ccceeeecc
Confidence 99999999996 578888876654 566889999999999999999999999999999999995 788999999
Q ss_pred CCcccccC--CccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~~--~~~~~~gt~~y~APE~l~~~~~s-~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|++.++.. ...+.+|++.|.|||++.+..|. .++|+||+|+++|.|+.|.+||.+.+..++-.+.+.
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------- 269 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------- 269 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------
Confidence 99987654 35668999999999999998865 789999999999999999999988765444333321
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
..+.||. ....+..+||+++|..+|.+|++.+++..|.|+...
T Consensus 270 -------------------------gk~rIp~---------~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 270 -------------------------GKYRIPF---------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred -------------------------eeecccc---------eeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 1122222 123456799999999999999999999999998653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=289.70 Aligned_cols=239 Identities=32% Similarity=0.503 Sum_probs=197.4
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
||.|+||.||++.+..+++.+|+|++..... ....+..|+.+++.++ |+||+++++.+......++||||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN------HPFIVKLHYAFQTEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC------CCcHHHHHHHeecCCeeEEEEec
Confidence 6999999999999988999999999876432 3456777888888775 68999999999999999999999
Q ss_pred cc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~--~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 75 APGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC--CCcEEEeecCcceecccC
Confidence 95 67777766432 2889999999999999999999999999999999999986 778999999998765442
Q ss_pred ---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 004954 577 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (722)
Q Consensus 577 ---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~ 653 (722)
.....++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+...
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 208 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD------------------ 208 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC------------------
Confidence 33456788999999999888899999999999999999999999776654444443210
Q ss_pred hcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH---HHHHhCCCC
Q 004954 654 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA---REALDHPWL 718 (722)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa---~ElL~HPwf 718 (722)
...+|. ..+..+.++|++||..||++|||+ .++++||||
T Consensus 209 -----------------~~~~~~---------~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 209 -----------------PLRFPE---------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----------------CCCCCC---------CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 001111 114568899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.40 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=195.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.++|++.+.||+|+||+||+|.+..+ ...+|||+++... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD------HPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC------CCCcceEeEEEec
Confidence 35799999999999999999998644 4579999987542 23345667888877774 6899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..++||||+.+ +|.+++..... .+++..++.++.|++.||+|||+.+|+|+||||+||+++. ++.++|+|
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~--~~~~~l~d 149 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSD 149 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCCEEECc
Confidence 9999999999975 67666654321 3889999999999999999999999999999999999986 78899999
Q ss_pred cCCcccccCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 567 LGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 567 FGls~~~~~~~~-----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||++........ ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--- 226 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR--- 226 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---
Confidence 999876642111 1233567999999998899999999999999999998 9999977655554444321100
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.|. ....+..+.+|+.+||+.+|++||++.+++++
T Consensus 227 ---------------------------------~~~-------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 227 ---------------------------------LPP-------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ---------------------------------CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 01224568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.73 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=196.5
Q ss_pred cEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
.|++.+.||.|+||.||++++. .+|+.||+|+++... .......+|+++++.+.+ |++|+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhccc-----CCChhceeeEee
Confidence 4889999999999999999874 478999999987532 223456678888888753 689999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
.....++||||+.+ +|.+.+.... .+++..+..++.|++.||.|||+.|++||||+|+|||++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~ 147 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLT 147 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC--CCCEEEe
Confidence 99999999999985 6766665332 2788999999999999999999999999999999999986 7889999
Q ss_pred ecCCcccccCC----ccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~----~~~~~gt~~y~APE~l~~~--~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||++...... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+....
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--- 224 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--- 224 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh---
Confidence 99988654332 1234578899999998753 46789999999999999999999996432111111111000
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~ 714 (722)
. ......| ...+..+.+||++||+.||.+|| ++.+++.
T Consensus 225 ---------------~-------------~~~~~~~---------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 ---------------L-------------KSEPPYP---------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------------h-------------ccCCCCC---------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 0000011 12346688999999999999997 8999999
Q ss_pred CCCCCC
Q 004954 715 HPWLQH 720 (722)
Q Consensus 715 HPwf~~ 720 (722)
||||+.
T Consensus 268 ~~~~~~ 273 (290)
T cd05613 268 HPFFQK 273 (290)
T ss_pred Cccccc
Confidence 999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.02 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=203.2
Q ss_pred eeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 406 i~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
...+++..+...+...||+|.||+||+|++.. .||||+++.+ ....+.+.+|+.+++.-+ |.||+-+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR------H~NIlLFM 454 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR------HENILLFM 454 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc------hhhheeee
Confidence 35566777888999999999999999999754 5999999753 456778889999999887 45899999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
|++..... .||+-+|+| +|+..++..... |.+.+++.|++||++||.|||.++|||||||..||++.. ++.
T Consensus 455 G~~~~p~~-AIiTqwCeGsSLY~hlHv~etk-----fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~--~~k 526 (678)
T KOG0193|consen 455 GACMNPPL-AIITQWCEGSSLYTHLHVQETK-----FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE--DLK 526 (678)
T ss_pred hhhcCCce-eeeehhccCchhhhhccchhhh-----hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc--CCc
Confidence 99988777 999999998 677777654432 899999999999999999999999999999999999995 699
Q ss_pred EEEEecCCcccccC-----CccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 562 IKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 562 vkL~DFGls~~~~~-----~~~~~~gt~~y~APE~l~~---~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
|||+|||++..... ......+...|||||++.. .+|+.++||||||+++|||++|.+||.......++..+-
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG 606 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG 606 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec
Confidence 99999999854332 2333456778999999973 579999999999999999999999999766655553332
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
...+ .|. +.......+.++++|+..||..++++||...+||
T Consensus 607 rG~l------------------------------------~pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il 647 (678)
T KOG0193|consen 607 RGYL------------------------------------MPD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLL 647 (678)
T ss_pred cccc------------------------------------Ccc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHH
Confidence 1111 111 1111223345799999999999999999999888
Q ss_pred h
Q 004954 714 D 714 (722)
Q Consensus 714 ~ 714 (722)
.
T Consensus 648 ~ 648 (678)
T KOG0193|consen 648 S 648 (678)
T ss_pred H
Confidence 6
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=287.60 Aligned_cols=245 Identities=20% Similarity=0.340 Sum_probs=196.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
.+|++.+.||+|+||.||++.+. .++.+|+|++.........+.+|+++++.+. ||+|+++++++......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLS------HPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCC------CCCeeeEEEEEccCCceEE
Confidence 47899999999999999999875 4778999998765544567788999888874 6799999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+.+ +|.+++.... ..+++..++.++.|++.||++||+.+++|+||||+||+++. ++.++|+|||.+..
T Consensus 77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~~ 149 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE--NQVVKVSDFGMTRF 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC--CCeEEECCCcceee
Confidence 9999986 5555554322 13788999999999999999999999999999999999985 77899999998865
Q ss_pred ccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 573 ~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05112 150 VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----------- 218 (256)
T ss_pred cccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-----------
Confidence 433221 1234568999999998889999999999999999998 999998766555544432110
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 219 -----------------------~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 -----------------------RLYKP---------RLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----------------------CCCCC---------CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00011 1123568899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=295.74 Aligned_cols=258 Identities=21% Similarity=0.248 Sum_probs=197.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCC----------------cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG----------------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPAD 474 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg----------------~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~ 474 (722)
.++|++.+.||+|+||.||++.+...+ ..+|+|.+.... .....+.+|+++++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~------ 77 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS------ 77 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC------
Confidence 468999999999999999999876544 568999987543 34456778888888875
Q ss_pred CCceeEEEEEEEecCeEEEEEEcccc-chHHHHhhhhcc-----CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 004954 475 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES-----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (722)
Q Consensus 475 hpnIv~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~-----~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLK 548 (722)
||||+++++++...+..++||||+.+ +|.+++...... .....+++..++.++.|++.||+|||+.||+|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 67999999999999999999999975 676666543211 111248999999999999999999999999999999
Q ss_pred CCceEEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 004954 549 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFP 621 (722)
Q Consensus 549 p~NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt--G~~PF~ 621 (722)
|+||+++. ++.++|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK--NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC--CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999996 688999999998654322 122345678999999998889999999999999999998 788887
Q ss_pred CChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhccc
Q 004954 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701 (722)
Q Consensus 622 ~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~ 701 (722)
..+..+.+..+........ .....+ .....+.++.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~-------~~~~~~~~l~~li~~cl~~ 279 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDG-----------------------------RQIYLP-------RPPNCPKDIYELMLECWRR 279 (296)
T ss_pred CcChHHHHHHHHhcccccc-----------------------------ccccCC-------CccCCCHHHHHHHHHHhcc
Confidence 7665555544432110000 000000 0112346789999999999
Q ss_pred CCCCCcCHHHHHh
Q 004954 702 NPQRRPTAREALD 714 (722)
Q Consensus 702 dP~kRpTa~ElL~ 714 (722)
||.+|||+.|+++
T Consensus 280 ~p~~Rpt~~el~~ 292 (296)
T cd05051 280 DEEDRPTFREIHL 292 (296)
T ss_pred ChhcCCCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.52 Aligned_cols=250 Identities=27% Similarity=0.479 Sum_probs=208.8
Q ss_pred CcE-EEEEEeccCCCCceEEEEECCCCcEEEEEEee-----cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-----NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY-~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~-----~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+|| +...+||+|+|-+||+|.|..+|..||.-.++ +.....+++..|+.+|+.|+ |+||+++|+.+.+
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~------H~NIirfy~SW~d 112 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK------HPNIIRFYDSWVD 112 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC------CCceeeeeeheec
Confidence 444 34567999999999999999999999864433 23445578899999999886 6799999999997
Q ss_pred cCe--EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCCCeE
Q 004954 488 LEH--LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 488 ~~~--l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~~~v 562 (722)
... +.+|+|.+. |+|..+.+..+. +..+.++.|++||++||.|||++. |||||||-+||+|+. ..|.|
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~V 185 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGEV 185 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCce
Confidence 754 889999996 788888876654 788899999999999999999985 999999999999995 68999
Q ss_pred EEEecCCcccccCCcc-ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCc
Q 004954 563 KIIDLGSSCFQTDNLC-LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPID 640 (722)
Q Consensus 563 kL~DFGls~~~~~~~~-~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~-~~~~e~l~~i~~~lg~~~ 640 (722)
||+|+|+|........ ..+|||.|||||++. ..|...+||||||++|+||+|+..||.. .++.+++.+++..+-|
T Consensus 186 KIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP-- 262 (632)
T KOG0584|consen 186 KIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP-- 262 (632)
T ss_pred eecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH--
Confidence 9999999988776544 468999999999998 6799999999999999999999999964 5666777776532211
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
. ...+..+++.++||.+||.. .+.|+|+.|||.||||+.
T Consensus 263 -~---------------------------------------sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 263 -A---------------------------------------ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -H---------------------------------------HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1 11234468899999999999 999999999999999974
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=288.23 Aligned_cols=249 Identities=28% Similarity=0.372 Sum_probs=196.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||.||+|.+..+|+.+|+|.++.. ......+.+|+++++.++ |++|+++++.+...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~------~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD------HPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC------CCCeeeeeeeeecCC
Confidence 5899999999999999999999989999999988642 223456778888888775 679999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|..++..... ....+++..++.++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~--~~~~~l~d~~ 151 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC--CCcEEEeccc
Confidence 99999999985 67766654322 1234889999999999999999999999999999999999986 7789999999
Q ss_pred CcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH--HHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~--~e~l~~i~~~lg~~~~~~ 643 (722)
++...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... .+....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 222 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--------- 222 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc---------
Confidence 98654432 2234678899999999998899999999999999999999999965421 111111110
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
......|. ...+..+.++|.+||..+|++|||+.++++
T Consensus 223 -------------------------~~~~~~~~--------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 223 -------------------------CDYPPLPA--------DHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -------------------------CCCCCCCh--------hhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00000110 122456889999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=338.78 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=209.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
-.++|.|+++||+|+||.|.+++++.+++.||+|++.+- ......+..|..+|..-. .+-|+++..+|++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n------s~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN------SEWIVQLHYAFQD 146 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC------cHHHHHHHHHhcC
Confidence 357899999999999999999999999999999999762 223345566666776554 3589999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
..++|+|||||.| +|+.++.... .+++..++.++..|+-||.-||+.|+|||||||+||||+. .|.|||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~--~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK--SGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc--cCcEeecc
Confidence 9999999999975 6777776443 2999999999999999999999999999999999999996 89999999
Q ss_pred cCCcccccCC----ccccccCCcccCchhhc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 567 LGSSCFQTDN----LCLYVQSRSYRAPEVII----G-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~y~APE~l~----~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
||.+...... ....+|||.|.+||++. + +.|+...|+||+||++|||+.|..||..++..+.+.+|+..-.
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE 298 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence 9987655422 33468999999999986 3 4689999999999999999999999999999999999873210
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC---HHHHHh
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALD 714 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT---a~ElL~ 714 (722)
...+|.... .+++.++||.+++. +|+.|.. ++++-.
T Consensus 299 ---------------------------------~l~FP~~~~-------VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 299 ---------------------------------SLSFPDETD-------VSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ---------------------------------hcCCCcccc-------cCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 111221111 34678899998775 7888988 999999
Q ss_pred CCCCCC
Q 004954 715 HPWLQH 720 (722)
Q Consensus 715 HPwf~~ 720 (722)
||||..
T Consensus 338 HpFF~g 343 (1317)
T KOG0612|consen 338 HPFFEG 343 (1317)
T ss_pred CccccC
Confidence 999975
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.89 Aligned_cols=273 Identities=23% Similarity=0.292 Sum_probs=189.3
Q ss_pred CCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc-c
Q 004954 426 AFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-N 501 (722)
Q Consensus 426 ~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g-s 501 (722)
+++.||++++..+++.||||+++.. ......+.+|+.+++.++ |+||+++++++...+..+++|||+.+ +
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ------HPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC------CcchhhhhheeecCCeEEEEEeccCCCC
Confidence 5566777777789999999998754 334466778888888774 68999999999999999999999985 5
Q ss_pred hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC-----
Q 004954 502 LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----- 576 (722)
Q Consensus 502 Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~----- 576 (722)
+.+++...... .+++..+..++.|++.||+|||+.+|+||||||+||+++. ++.++|+|||.+......
T Consensus 86 l~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~--~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG--DGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec--CCceEEecCccceeecccccccc
Confidence 66665533221 2888999999999999999999999999999999999985 788999999987543211
Q ss_pred -----ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 577 -----LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 577 -----~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
.....++..|+|||++.. ..++.++|+||+||++|+|++|..||........+.+.. .+..+.. +....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~-~~~~~- 235 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV--RGTVPCL-LDKST- 235 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCccc-cccCc-
Confidence 122356778999999876 358889999999999999999999998765443332211 1111100 00000
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.... ..... .......................+..+.+||++||++||++|||+.++|+||||+.
T Consensus 236 ~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 236 YPLY---EDSMS---QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred hhhh---cCCcC---cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0000 00000 00000000000000000011122356889999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=292.50 Aligned_cols=246 Identities=22% Similarity=0.273 Sum_probs=190.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~----~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+|+++++||+|+||+||+|++..+++ .||+|+++... .....+.+|..+++.+ .|+||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV------GSPYVCRLLGICL 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc------CCCCCceEEEEEc
Confidence 4689999999999999999999877776 48999986532 2334556677766655 4789999999987
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
. ...+++|||++ |+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++. ++.+||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~--~~~~kL~ 151 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS--PNHVKIT 151 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC--CCcEEEC
Confidence 5 45778999997 57777765432 23889999999999999999999999999999999999985 6789999
Q ss_pred ecCCcccccCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~~~~-----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||++......... ..+++.|+|||.+.+..++.++|||||||++|||++ |..||.......+...+....
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--- 228 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE--- 228 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---
Confidence 99998765432221 233567999999999899999999999999999998 999997765444333221100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....+ ...+..+.++|.+||+.||++||++.+++..
T Consensus 229 -------------------------------~~~~~---------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 229 -------------------------------RLPQP---------PICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred -------------------------------cCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 1123568899999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=330.38 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=194.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.++||+|+||.||+|++..+|+.||||+++.. .....++.+|+++++.++ ||||+++++++...+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~------HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI------HPGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC------CcCcCeEEEEEeeCC
Confidence 6899999999999999999999999999999998753 223456778888887775 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhcc-----CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQES-----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~-----~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
..++||||++| +|.+++...... .....++...+..++.||+.||+|||+.||+||||||+|||++. ++.++
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~--dg~vK 153 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL--FGEVV 153 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC--CCCEE
Confidence 99999999985 666666432110 11123567788899999999999999999999999999999986 78899
Q ss_pred EEecCCcccccCC---------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004954 564 IIDLGSSCFQTDN---------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (722)
Q Consensus 564 L~DFGls~~~~~~---------------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~ 622 (722)
|+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999998654110 1124689999999999999999999999999999999999999976
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 623 ~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
........... .. .+ ....| ....++.+.+++.+||+.|
T Consensus 234 ~~~~ki~~~~~--i~-~P------------------------------~~~~p--------~~~iP~~L~~LI~rcL~~D 272 (932)
T PRK13184 234 KKGRKISYRDV--IL-SP------------------------------IEVAP--------YREIPPFLSQIAMKALAVD 272 (932)
T ss_pred cchhhhhhhhh--cc-Ch------------------------------hhccc--------cccCCHHHHHHHHHHccCC
Confidence 43322211100 00 00 00000 0123456889999999999
Q ss_pred CCCCcCHHHHHh
Q 004954 703 PQRRPTAREALD 714 (722)
Q Consensus 703 P~kRpTa~ElL~ 714 (722)
|++|++..+.|.
T Consensus 273 P~kR~ss~eeLl 284 (932)
T PRK13184 273 PAERYSSVQELK 284 (932)
T ss_pred hhhCcCHHHHHH
Confidence 999987666553
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=297.61 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=197.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECC-------CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~-------tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
-.++|.+.++||+|+||.||++++.. ....+|+|+++... .....+.+|+.+++.+. .||||++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 84 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-----KHKNIINLL 84 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-----CCCCeeeEE
Confidence 35789999999999999999998632 34579999987532 33456677888887774 378999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~----------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~N 551 (722)
+++......++||||+. ++|.+++..... ......+++..+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 99999999999999997 467777754321 1122348889999999999999999999999999999999
Q ss_pred eEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChH
Q 004954 552 ILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAV 625 (722)
Q Consensus 552 ILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~ 625 (722)
||++. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 165 ill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTE--DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcC--CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99985 7789999999987543321 11223467999999999889999999999999999999 8999988766
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
.+....+.... ....+ ...+..+.+||.+||..||.+
T Consensus 243 ~~~~~~~~~~~----------------------------------~~~~~---------~~~~~~l~~li~~cl~~~p~~ 279 (314)
T cd05099 243 EELFKLLREGH----------------------------------RMDKP---------SNCTHELYMLMRECWHAVPTQ 279 (314)
T ss_pred HHHHHHHHcCC----------------------------------CCCCC---------CCCCHHHHHHHHHHcCCCccc
Confidence 65554432100 00001 112356889999999999999
Q ss_pred CcCHHHHHh
Q 004954 706 RPTAREALD 714 (722)
Q Consensus 706 RpTa~ElL~ 714 (722)
|||+.++++
T Consensus 280 Rps~~~ll~ 288 (314)
T cd05099 280 RPTFKQLVE 288 (314)
T ss_pred CcCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.88 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=196.6
Q ss_pred eecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
...++|.+.+.||+|+||.||++.+ ..++..+|+|+++... .....+.+|+.+++++. .|+||+++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~ 106 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-----NHENIVNLLG 106 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc-----CCCCcceEEE
Confidence 4457899999999999999999975 3356689999987542 33456778899888873 3789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
.+...+..++||||+. ++|.+++..... ..+++.++..++.||+.||+|||+++|+|+||||+|||++. ++.+
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~ 180 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH--GKIV 180 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC--CCeE
Confidence 9999999999999997 567776653221 23889999999999999999999999999999999999985 7789
Q ss_pred EEEecCCcccccCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 004954 563 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 563 kL~DFGls~~~~~~~~-----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~l 636 (722)
+|+|||++........ ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+.+.++...
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~- 259 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE- 259 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-
Confidence 9999999875433221 1234678999999999899999999999999999998 99999775543333222100
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
......+ ...+..+.+||.+||..+|++|||+.|+++
T Consensus 260 --------------------------------~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 --------------------------------GYRMAQP---------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------------------------CCcCCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000000 112456899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=301.62 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=199.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCC-------CcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT-------GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~t-------g~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
++...+|++.+.||+|+||.||++++... +..+|+|+++.. ......+.+|+.+++.+. .|+||++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~ 82 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-----KHKNIIN 82 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc-----CCCCeee
Confidence 34456899999999999999999986432 246899988753 233456778888888874 3689999
Q ss_pred EEEEEEecCeEEEEEEcccc-chHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
+++++...+.+++||||+.+ +|.+++...... .....++...+..++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 99999999999999999975 777777643211 1233478889999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~ 623 (722)
+|||++. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 163 ~Nill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 163 RNVLVTE--DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ceEEEcC--CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999985 7889999999987544321 11223467999999999999999999999999999998 89999887
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 624 ~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
+..+....+.... ....+ ...+..+.+||.+||+.+|
T Consensus 241 ~~~~~~~~~~~~~----------------------------------~~~~~---------~~~~~~l~~li~~cl~~~p 277 (334)
T cd05100 241 PVEELFKLLKEGH----------------------------------RMDKP---------ANCTHELYMIMRECWHAVP 277 (334)
T ss_pred CHHHHHHHHHcCC----------------------------------CCCCC---------CCCCHHHHHHHHHHcccCh
Confidence 6655544432100 00011 1123568899999999999
Q ss_pred CCCcCHHHHHhC
Q 004954 704 QRRPTAREALDH 715 (722)
Q Consensus 704 ~kRpTa~ElL~H 715 (722)
.+|||+.|+|++
T Consensus 278 ~~Rps~~ell~~ 289 (334)
T cd05100 278 SQRPTFKQLVED 289 (334)
T ss_pred hhCcCHHHHHHH
Confidence 999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.56 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=208.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.+.|+.-++||+||||.||-++...||+-+|+|.+.+. +......++|..||.+++. +.||.+-.+|++.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s------~FiVslaYAfeTk 257 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS------PFIVSLAYAFETK 257 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc------CcEEEEeeeecCC
Confidence 45688889999999999999999999999999987432 2234567889999999975 4899999999999
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 489 ~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
+.+|+||..|+|+-+.+...+... ..|++.+++.++.+|+.||++||..+||+|||||+|||++. .|.|+|+|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd--~GhvRISDLG 332 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD--HGHVRISDLG 332 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc--CCCeEeeccc
Confidence 999999999998877766655432 34999999999999999999999999999999999999995 8999999999
Q ss_pred CcccccC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH----HHHHHHHhhcCCCcHH
Q 004954 569 SSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV----MILARIIGMLGPIDLE 642 (722)
Q Consensus 569 ls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~----e~l~~i~~~lg~~~~~ 642 (722)
+|..... +....+||.+|||||++.+..|+...|+|||||++|||+.|+.||...... ++-.++.
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--------- 403 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--------- 403 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh---------
Confidence 9976544 345569999999999999999999999999999999999999999542111 1111111
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPW 717 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPw 717 (722)
......| ...++++++|.+.+|+.||.+|. .++++-+|||
T Consensus 404 --------------------------~~~~ey~---------~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf 448 (591)
T KOG0986|consen 404 --------------------------EDPEEYS---------DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF 448 (591)
T ss_pred --------------------------cchhhcc---------cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence 0111111 22347789999999999999997 5889999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 449 Fk~ 451 (591)
T KOG0986|consen 449 FKD 451 (591)
T ss_pred ccc
Confidence 975
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=289.44 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=197.2
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++..++|++.+.||+|+||.||++.+. .+..+|+|.+.......+.+.+|+.+++.++ |+||+++++.+.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~-~ 73 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ------HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcC------CCCcceEEEEEcC-C
Confidence 456789999999999999999999854 5567999998876555567788988888775 6799999999887 7
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++. .+.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~ 147 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFG 147 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCCc
Confidence 8899999997 57877775432 223788889999999999999999999999999999999985 7899999999
Q ss_pred CcccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
.+........ ...++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------- 220 (260)
T cd05073 148 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------- 220 (260)
T ss_pred ceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------
Confidence 8865443211 1234567999999998889999999999999999999 999998766554443332100
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
..+. ....+..+.+++.+||+.+|++||++.++++
T Consensus 221 -----------------------------~~~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 -----------------------------RMPR-------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----------------------------CCCC-------cccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0000 0122456889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.43 Aligned_cols=243 Identities=28% Similarity=0.422 Sum_probs=190.4
Q ss_pred EEEEEeccCCCCceEEEEEC----CCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 417 YVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 417 ~i~~~LG~G~fG~Vy~a~d~----~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.+.+.||.|.||.||+|.+. ..+..|+||+++.. ....+.+.+|+++++.++ ||||+++++++...+.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~g~~~~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR------HPNIVKLYGFCIENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS------BTTBE-EEEEEESSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc------cccccccccccccccc
Confidence 56789999999999999986 45788999999653 233577888888888774 6799999999998888
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+. |+|.+++.... ...+++..++.|+.||+.||.|||+.+++|++|+++||+++. ++.+||+|||+
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~--~~~~Kl~~f~~ 149 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS--NGQVKLSDFGL 149 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET--TTEEEEESTTT
T ss_pred ccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccccccccc--ccccccccccc
Confidence 999999997 67888887651 122899999999999999999999999999999999999996 78999999999
Q ss_pred cccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 570 SCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 570 s~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
+....... ........|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~------- 222 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ------- 222 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 87663221 12345678999999998889999999999999999999 789998877766665553110
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...++ ...+..+.++|..||..||.+|||+.++++
T Consensus 223 ---------------------------~~~~~---------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 ---------------------------RLPIP---------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------------------ETTSB---------TTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------------------cceec---------cchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00011 123466889999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.65 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=194.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~t-----g~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
.+|++.+.||.|+||.||+|.+..+ ++.||||+++.... ....+.+|..++..+ .||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~ 78 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL------QHPNIVCLLGVVT 78 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEc
Confidence 4578889999999999999987543 57899999875432 234455666666655 4789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEc
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~----------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~ 555 (722)
.....++++||+.+ +|.+++..... ......+++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 99999999999974 56666542211 01123478888999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHH
Q 004954 556 SYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 629 (722)
Q Consensus 556 ~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l 629 (722)
. ++.+||+|||++....... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+
T Consensus 159 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 D--KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred C--CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 7789999999876543221 12344678999999988889999999999999999998 89999887666655
Q ss_pred HHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH
Q 004954 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709 (722)
Q Consensus 630 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa 709 (722)
..+..... ...+ ...+..+.+|+.+||+.+|.+||++
T Consensus 237 ~~i~~~~~----------------------------------~~~~---------~~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 237 EMIRNRQV----------------------------------LPCP---------DDCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred HHHHcCCc----------------------------------CCCC---------CCCCHHHHHHHHHHhCCCcccCCCH
Confidence 55431100 0001 1234668899999999999999999
Q ss_pred HHHHhC
Q 004954 710 REALDH 715 (722)
Q Consensus 710 ~ElL~H 715 (722)
+++++.
T Consensus 274 ~~i~~~ 279 (283)
T cd05091 274 KDIHSR 279 (283)
T ss_pred HHHHHH
Confidence 999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.96 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=200.6
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEEC-------CCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~-------~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
.+..++|.+.+.||+|+||.||++++. ..+..+|+|.+... ......+.+|+.+++.+. .||||++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~ 85 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIIN 85 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc-----cCCCchh
Confidence 355678999999999999999999752 23457999998653 233456778888888774 3789999
Q ss_pred EEEEEEecCeEEEEEEcccc-chHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~----------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
+++++......++||||+.+ +|.+++....... ....+++..+..++.||+.||.|||+.||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 99999999999999999975 7777776432211 123478888999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~ 623 (722)
+||+++. ++.+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 166 ~Nili~~--~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTE--NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcC--CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999985 7889999999987654321 11234577999999998889999999999999999998 89999877
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 624 ~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
+..++...+.... ....+ ...+..+.+||.+||+.+|
T Consensus 244 ~~~~~~~~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~cl~~~p 280 (304)
T cd05101 244 PVEELFKLLKEGH----------------------------------RMDKP---------ANCTNELYMMMRDCWHAIP 280 (304)
T ss_pred CHHHHHHHHHcCC----------------------------------cCCCC---------CCCCHHHHHHHHHHcccCh
Confidence 6665554432100 00001 1234668899999999999
Q ss_pred CCCcCHHHHHhC
Q 004954 704 QRRPTAREALDH 715 (722)
Q Consensus 704 ~kRpTa~ElL~H 715 (722)
.+|||+.|+|+.
T Consensus 281 ~~Rps~~e~l~~ 292 (304)
T cd05101 281 SHRPTFKQLVED 292 (304)
T ss_pred hhCCCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=293.61 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=193.4
Q ss_pred cEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~-----tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... ....++.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN------HPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC------CCCEeeEEEEEec
Confidence 47889999999999999998743 23568999887543 23456777888887774 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhcc------------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQES------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~------------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLK 548 (722)
.+..++||||+. ++|.+++...... .....+++..++.++.|++.||.|||+.+|+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 999999999998 5676666532211 112348889999999999999999999999999999
Q ss_pred CCceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 004954 549 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622 (722)
Q Consensus 549 p~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~ 622 (722)
|+|||++. ++.+||+|||++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE--GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC--CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999985 7789999999986543221 12234678999999998889999999999999999998 9999987
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 623 ~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
.....+...+... .....| ...+..+.+||.+||+.+
T Consensus 233 ~~~~~~~~~~~~~----------------------------------~~~~~~---------~~~~~~~~~~i~~cl~~~ 269 (290)
T cd05045 233 IAPERLFNLLKTG----------------------------------YRMERP---------ENCSEEMYNLMLTCWKQE 269 (290)
T ss_pred CCHHHHHHHHhCC----------------------------------CCCCCC---------CCCCHHHHHHHHHHccCC
Confidence 6655444332110 000011 123456889999999999
Q ss_pred CCCCcCHHHHHh
Q 004954 703 PQRRPTAREALD 714 (722)
Q Consensus 703 P~kRpTa~ElL~ 714 (722)
|.+||++.++++
T Consensus 270 P~~Rp~~~~i~~ 281 (290)
T cd05045 270 PDKRPTFADISK 281 (290)
T ss_pred cccCCCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=288.45 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=193.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~---~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.++|+..+.||+|+||.||+|.+..++. .+|+|.++.. ......+..|+++++.+. |+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS------HHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC------CCCeeEEEEEEcc
Confidence 4678999999999999999999876654 7999988654 223455667777776664 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~--~~~~kl~d 150 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS--NLECKVSD 150 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC--CCcEEECC
Confidence 9999999999986 5555554321 23889999999999999999999999999999999999985 78899999
Q ss_pred cCCcccccCCccc------cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 567 LGSSCFQTDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 567 FGls~~~~~~~~~------~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||++......... ...++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~-- 228 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-- 228 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC--
Confidence 9998655332111 122456999999998889999999999999999998 9999977665555444431100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.|. ....+..+.+|+.+||+.+|.+||++.++++
T Consensus 229 ----------------------------------~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 229 ----------------------------------LPA-------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ----------------------------------CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 0012356889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=293.85 Aligned_cols=251 Identities=20% Similarity=0.243 Sum_probs=196.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.++|++.+.||+|+||.||++.+. .++..+|+|++.... .....+.+|+.+++.+. ||||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~------h~~iv~~~~~~ 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------HPNIVKLLGVC 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC------CCchheEEEEE
Confidence 367999999999999999999874 367899999987542 23455777888888774 78999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhcc----------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQES----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~~----------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLK 548 (722)
......++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||+.+++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 999999999999984 777777643211 112237888899999999999999999999999999
Q ss_pred CCceEEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 004954 549 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622 (722)
Q Consensus 549 p~NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~ 622 (722)
|+||+++. ++.++|+|||++...... ......++.|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus 158 p~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE--NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC--CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999985 788999999988653322 112234667999999998899999999999999999998 8889977
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 623 ~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
....+....+.... . ...| ...+..+.+||.+||+.+
T Consensus 236 ~~~~~~~~~~~~~~---------------------------------~-~~~~---------~~~~~~l~~li~~~l~~~ 272 (288)
T cd05050 236 MAHEEVIYYVRDGN---------------------------------V-LSCP---------DNCPLELYNLMRLCWSKL 272 (288)
T ss_pred CCHHHHHHHHhcCC---------------------------------C-CCCC---------CCCCHHHHHHHHHHcccC
Confidence 66555444332100 0 0001 112456889999999999
Q ss_pred CCCCcCHHHHHh
Q 004954 703 PQRRPTAREALD 714 (722)
Q Consensus 703 P~kRpTa~ElL~ 714 (722)
|.+|||+.|+++
T Consensus 273 p~~Rpt~~el~~ 284 (288)
T cd05050 273 PSDRPSFASINR 284 (288)
T ss_pred cccCCCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=309.57 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=194.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~t-----g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.++|++.++||+|+||.||+|.+... +..||||+++... .....+.+|+.+++.+. .||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-----~HpnIv~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-----PHLNIVNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCCCeeeEEEEE
Confidence 46899999999999999999987433 3579999997532 23456778999888885 378999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHhhhhcc----------------------------------------------------
Q 004954 486 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 512 (722)
Q Consensus 486 ~~~~~l~iVmEy~~-gsLl~~l~~~~~~---------------------------------------------------- 512 (722)
.....++|||||+. |+|.+++......
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999997 5677766543210
Q ss_pred --------------------------------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEE
Q 004954 513 --------------------------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (722)
Q Consensus 513 --------------------------------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl 554 (722)
.....+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 001237788889999999999999999999999999999999
Q ss_pred cccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHH
Q 004954 555 KSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMI 628 (722)
Q Consensus 555 ~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~ 628 (722)
+. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 271 ~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 271 AQ--GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred eC--CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 86 7789999999987543221 12345678999999999899999999999999999997 9999976533222
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
+...+.. ......+ ...+..+.+||.+||+.||++|||
T Consensus 349 ~~~~~~~---------------------------------~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 349 FYNKIKS---------------------------------GYRMAKP---------DHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred HHHHHhc---------------------------------CCCCCCC---------ccCCHHHHHHHHHHCccCHhHCcC
Confidence 2111100 0000001 123456889999999999999999
Q ss_pred HHHHHh
Q 004954 709 AREALD 714 (722)
Q Consensus 709 a~ElL~ 714 (722)
+.++.+
T Consensus 387 ~~~l~~ 392 (400)
T cd05105 387 FLHLSD 392 (400)
T ss_pred HHHHHH
Confidence 999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=289.19 Aligned_cols=246 Identities=21% Similarity=0.282 Sum_probs=194.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~---~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..+|++.+.||+|+||.||+|+++.++. .+|+|.++... .....+.+|+.+++.++ ||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD------HPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEec
Confidence 3689999999999999999999865443 79999886532 23346677777777664 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..++||||+++ +|.+++.... ..+++.++..++.|++.||+|||+.|++||||||+|||++. ++.++|+|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~--~~~~~l~d 149 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS--NLVCKVSD 149 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC--CCeEEeCC
Confidence 9999999999975 5666665322 23788999999999999999999999999999999999985 78899999
Q ss_pred cCCcccccCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 567 LGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 567 FGls~~~~~~~~------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||++........ ....+..|+|||.+.+..++.++|+|||||++|++++ |..||......+....+.....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-- 227 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-- 227 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--
Confidence 999876543221 1122457999999998889999999999999999887 9999987665555444331100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.|. ....++.+.+++.+||+.+|.+||++.++++
T Consensus 228 ----------------------------------~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 ----------------------------------LPA-------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ----------------------------------CCC-------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 010 0112456889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=287.52 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=194.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
++|++.+.||+|+||.||++. .+++.+|+|+++.... ...+.+|+.+++.++ ||||+++++++... ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~-~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT-AQAFLEETAVMTKLH------HKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch-HHHHHHHHHHHHhCC------CCCcCeEEEEEcCC-CcEE
Confidence 579999999999999999986 5788999999876432 356778888887775 67999999998654 5799
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+. ++|.+++..... ..+++..++.++.|++.||.|||+.|++||||||+||+++. ++.++|+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~--~~~~kl~Dfg~~~~ 149 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE--DGVAKVSDFGLARV 149 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCcEEECCCcccee
Confidence 999997 477777764322 23788999999999999999999999999999999999985 78899999999876
Q ss_pred ccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 573 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
..........+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+....
T Consensus 150 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 214 (254)
T cd05083 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------------- 214 (254)
T ss_pred ccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------------
Confidence 5443333445678999999998889999999999999999998 999998776555443332100
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....+ ...+..+.+||++||+.+|.+||+++++++.
T Consensus 215 -------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 215 -------------------RMEPP---------EGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred -------------------CCCCC---------CcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 1224668899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=293.11 Aligned_cols=250 Identities=23% Similarity=0.282 Sum_probs=195.4
Q ss_pred CcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+|.+.+.||+|+||.||++++. .++..+++|.+..... ....+.+|+.+++.++ |+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ------HEHIVKFYGVCGD 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC------CCCcceEEEEEcc
Confidence 56899999999999999999853 3456789998865432 2345667777777664 6899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
.+..++||||+. ++|.+++...... .....+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999997 5777776543210 11234889999999999999999999999999999999999996
Q ss_pred cCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 004954 557 YQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~ 630 (722)
++.++|+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+...
T Consensus 159 --~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 --NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred --CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 7889999999986543321 22345778999999999999999999999999999999 999997766555443
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+..... +. .....+..+.+||.+||+.+|.+|||+.
T Consensus 237 ~~~~~~~-------------------------------------~~------~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 273 (291)
T cd05094 237 CITQGRV-------------------------------------LE------RPRVCPKEVYDIMLGCWQREPQQRLNIK 273 (291)
T ss_pred HHhCCCC-------------------------------------CC------CCccCCHHHHHHHHHHcccChhhCcCHH
Confidence 3321000 00 0011245688999999999999999999
Q ss_pred HHHh
Q 004954 711 EALD 714 (722)
Q Consensus 711 ElL~ 714 (722)
++++
T Consensus 274 ~v~~ 277 (291)
T cd05094 274 EIYK 277 (291)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=290.03 Aligned_cols=246 Identities=21% Similarity=0.300 Sum_probs=193.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~---~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.|++.+.||+|+||.||+|.+..+++ .||||++... ......+..|+.+++.+. ||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD------HPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CcCcceEEEEECCC
Confidence 568999999999999999999877665 5999998753 333456777888887764 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
...++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~--~~~~kl~df 150 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDF 150 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC--CCcEEECCC
Confidence 999999999986 5655554322 23889999999999999999999999999999999999985 778999999
Q ss_pred CCcccccCCccc-----cc---cCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 568 GSSCFQTDNLCL-----YV---QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 568 Gls~~~~~~~~~-----~~---gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|++......... .. .+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~- 229 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR- 229 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 988654332111 11 1346999999999899999999999999999986 9999987665554444321100
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.|.. ...+..+.+++.+||+.+|.+||++.++++.
T Consensus 230 -----------------------------------~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 230 -----------------------------------LPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred -----------------------------------CCCc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1123568899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=326.70 Aligned_cols=144 Identities=27% Similarity=0.431 Sum_probs=123.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|+++++||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.++ |+||+++++++....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~------hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK------SPFIVHLYYSLQSAN 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC------CCCcCeEEEEEEECC
Confidence 68999999999999999999999999999999997532 22355667777777664 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
+++|||||+. ++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+||||+. ++.+||+|||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~--~g~vkL~DFG 149 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFG 149 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC--CCCEEEEeCC
Confidence 9999999996 46777665332 2788899999999999999999999999999999999985 7889999999
Q ss_pred Ccc
Q 004954 569 SSC 571 (722)
Q Consensus 569 ls~ 571 (722)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=287.50 Aligned_cols=237 Identities=22% Similarity=0.271 Sum_probs=185.8
Q ss_pred EeccCCCCceEEEEE--CCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 004954 421 YLGSAAFSKVFQAQD--LHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d--~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVm 495 (722)
.||+|+||.||+|.+ +.++..+|+|+++... ...+.+.+|+.+++.+. |+||+++++++. .+..++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD------NPYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC------CCCcceEEEEEc-CCCcEEEE
Confidence 589999999999964 5678899999986542 23455677777777764 789999999875 45678999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc
Q 004954 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 496 Ey~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
||+.+ .|.+++.... .+++..+..++.||+.||+|||++||+||||||.||+++. ++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~--~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 75 ELAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT--QHYAKISDFGLSKALG 146 (257)
T ss_pred ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC--CCeEEECCCccccccC
Confidence 99985 5766664322 2889999999999999999999999999999999999996 7789999999987654
Q ss_pred CCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 575 DNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 575 ~~~~------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
.... ...+++.|+|||.+....++.++|||||||++|+|++ |..||......+....+....
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~----------- 215 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE----------- 215 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-----------
Confidence 3321 1233578999999988889999999999999999998 999998776655544432100
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...++.+.+||++||+.||++||++.+|.+.
T Consensus 216 -----------------------~~~~~---------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~ 251 (257)
T cd05116 216 -----------------------RMECP---------QRCPPEMYDLMKLCWTYGVDERPGFAVVELR 251 (257)
T ss_pred -----------------------CCCCC---------CCCCHHHHHHHHHHhccCchhCcCHHHHHHH
Confidence 00111 1234678999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=295.43 Aligned_cols=258 Identities=21% Similarity=0.264 Sum_probs=194.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCC--------------cEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG--------------VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEH 476 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg--------------~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hp 476 (722)
.++|++.+.||+|+||.||++++..++ ..||+|+++.. ......+.+|+++++.++ |+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~------h~ 77 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK------NP 77 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CC
Confidence 368999999999999999999875432 35899998753 233456778888888775 67
Q ss_pred ceeEEEEEEEecCeEEEEEEcccc-chHHHHhhhhcc------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 477 nIv~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
||+++++++......++||||+.+ +|.+++...... .....+++..+..++.|++.||+|||+.|++|+||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999999999999999999999985 676666432210 0112367888999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPN 622 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt--G~~PF~~ 622 (722)
+||+++. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 158 ~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGN--HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcC--CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999985 7789999999986543221 11234678999999998889999999999999999988 7788887
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 623 ~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
.+..+.+..+........ ...... .....+..+.+||++||+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~---------~~~~~~~~l~~li~~~l~~~ 279 (295)
T cd05097 236 LSDEQVIENTGEFFRNQG---------------------------RQIYLS---------QTPLCPSPVFKLMMRCWSRD 279 (295)
T ss_pred cChHHHHHHHHHhhhhcc---------------------------ccccCC---------CCCCCCHHHHHHHHHHcCCC
Confidence 666555544332110000 000000 01123467899999999999
Q ss_pred CCCCcCHHHHHh
Q 004954 703 PQRRPTAREALD 714 (722)
Q Consensus 703 P~kRpTa~ElL~ 714 (722)
|.+|||+.++++
T Consensus 280 p~~RPs~~~i~~ 291 (295)
T cd05097 280 IKDRPTFNKIHH 291 (295)
T ss_pred chhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.10 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=193.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
-.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.++..+.+ ||||++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~niv~~~~~ 79 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLGA 79 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccC-----CccHhhhcce
Confidence 357899999999999999999984 3567899999997532 334567789999988853 6899999998
Q ss_pred EEec-CeEEEEEEcccc-chHHHHhhhhcc--------------------------------------------------
Q 004954 485 FYHL-EHLFIVCELLRA-NLYEFQKFNQES-------------------------------------------------- 512 (722)
Q Consensus 485 f~~~-~~l~iVmEy~~g-sLl~~l~~~~~~-------------------------------------------------- 512 (722)
+... ...++||||+.+ +|.+++......
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 8654 568999999974 677766532110
Q ss_pred -----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCCc----
Q 004954 513 -----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL---- 577 (722)
Q Consensus 513 -----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~---- 577 (722)
.....+++..+..++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC--CCcEEEEecccccccccCcchhh
Confidence 00123678888999999999999999999999999999999985 7789999999987543221
Q ss_pred -cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhc
Q 004954 578 -CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 655 (722)
Q Consensus 578 -~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~ 655 (722)
....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........+...+.
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------------------- 296 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------------------- 296 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh---------------------
Confidence 11234567999999999899999999999999999997 9999976433221111110
Q ss_pred ccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 656 KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.......| ...++.+.+++.+||+.||.+|||+.++++|
T Consensus 297 ------------~~~~~~~~---------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 297 ------------EGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------------ccCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000111 1134568899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=291.76 Aligned_cols=254 Identities=28% Similarity=0.395 Sum_probs=194.4
Q ss_pred cEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+|++.+.||+|++|.||++++. .+++.+|||+++... .....+.+|+.+++.+.+ |++|+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~-----~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR-----CPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccC-----Ccchhhhheeee
Confidence 4889999999999999999864 467899999987532 223456678888887753 689999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
.....++||||+.+ +|.+.+.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~--~~~~~l~ 147 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVVLT 147 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEE
Confidence 99999999999985 6666654321 2888999999999999999999999999999999999986 7789999
Q ss_pred ecCCcccccCCc----cccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~~----~~~~gt~~y~APE~l~~~~--~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||++....... ....+++.|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----- 222 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----- 222 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----
Confidence 999886543221 2245788999999987765 78899999999999999999999964321111111100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC---HHHHHhCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALDHP 716 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT---a~ElL~HP 716 (722)
... ......| ...+..+.+||.+||+.||++||| +.++|+||
T Consensus 223 -------------~~~-------------~~~~~~~---------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 223 -------------RIL-------------KSKPPFP---------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -------------HHH-------------ccCCCCC---------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 000 0000011 113456889999999999999998 57789999
Q ss_pred CCCCC
Q 004954 717 WLQHP 721 (722)
Q Consensus 717 wf~~~ 721 (722)
||+..
T Consensus 268 ~~~~~ 272 (288)
T cd05583 268 FFQGI 272 (288)
T ss_pred ccccC
Confidence 99763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=293.10 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=194.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC----------------CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLH----------------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPAD 474 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~----------------tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~ 474 (722)
.++|++.+.||+|+||.||++.+.. ++..+|+|+++... .....+.+|+.+++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~------ 77 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK------ 77 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC------
Confidence 4689999999999999999986432 34579999987542 33456778888888775
Q ss_pred CCceeEEEEEEEecCeEEEEEEccc-cchHHHHhhhhccC-----CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 004954 475 EHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (722)
Q Consensus 475 hpnIv~l~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~-----~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLK 548 (722)
|+||+++++++...+..++||||+. ++|.+++....... ....+++..+..++.||+.||+|||+.|++|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 6799999999999999999999997 47777765433211 11347788999999999999999999999999999
Q ss_pred CCceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 004954 549 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFP 621 (722)
Q Consensus 549 p~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt--G~~PF~ 621 (722)
|+|||++. ++.++|+|||++....... .....++.|+|||+..+..++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 158 TRNCLVGK--NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred hheEEEcC--CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999985 7889999999987543221 11233567999999988889999999999999999998 789997
Q ss_pred CChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhccc
Q 004954 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701 (722)
Q Consensus 622 ~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~ 701 (722)
..+..+....... ++.... . ...+|. +...+..+.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~------------------~~~~~~---------~--~~~~~~-------~~~~~~~~~~li~~cl~~ 279 (296)
T cd05095 236 QLSDEQVIENTGE------------------FFRDQG---------R--QVYLPK-------PALCPDSLYKLMLSCWRR 279 (296)
T ss_pred ccChHHHHHHHHH------------------HHhhcc---------c--cccCCC-------CCCCCHHHHHHHHHHcCC
Confidence 7655544432210 000000 0 000010 011235688999999999
Q ss_pred CCCCCcCHHHHHh
Q 004954 702 NPQRRPTAREALD 714 (722)
Q Consensus 702 dP~kRpTa~ElL~ 714 (722)
||.+||++.++++
T Consensus 280 ~p~~Rp~~~~i~~ 292 (296)
T cd05095 280 NAKERPSFQEIHA 292 (296)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.16 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=196.4
Q ss_pred EEEEEEeccCCCCceEEEEECCCC----cEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg----~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+++.+.||.|+||.||++++...+ ..+|+|+++.... ....+..|+.+++.+. |+||+++++.+...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD------HPNIVKLLGVCTEEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC------CCchheEEEEEcCCC
Confidence 357788999999999999988766 8999999976543 4567778888888774 679999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..+++|||+.+ +|.+.+...... .+++..+..++.||+.||++||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~--~~~~~l~dfg 148 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFG 148 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc--CCeEEEcccC
Confidence 99999999975 676666543321 1789999999999999999999999999999999999996 7789999999
Q ss_pred CcccccCCccc----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~~~----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
++......... ..+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~------- 221 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY------- 221 (258)
T ss_pred CceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------
Confidence 98765433111 225688999999988889999999999999999998 899998766655554442110
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....+ ...+..+.+++.+||..||++|||+.++++
T Consensus 222 ---------------------------~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 222 ---------------------------RLPKP---------ENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------------------CCCCC---------CcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 00011 113466889999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=285.98 Aligned_cols=237 Identities=24% Similarity=0.287 Sum_probs=186.3
Q ss_pred EEeccCCCCceEEEEECCCC---cEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg---~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
++||+|+||.||+|.+..++ ..+|+|.+..... ....+.+|+.+++.+ +|+||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL------DHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc------CCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999876554 7899999876543 445677788887766 4789999999875 4568999
Q ss_pred EEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+. ++|.+++.... .+++..+..++.|++.||+|||..+++|+||||+|||++. ++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~--~~~~kl~df~~~~~~ 145 (257)
T cd05060 74 MELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN--RHQAKISDFGMSRAL 145 (257)
T ss_pred EEeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC--CCcEEecccccccee
Confidence 99997 47777776433 3889999999999999999999999999999999999986 788999999998765
Q ss_pred cCCccc------cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 574 TDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 574 ~~~~~~------~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
...... ..++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~---------- 215 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE---------- 215 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----------
Confidence 433221 112357999999998899999999999999999998 999997765544443332100
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...+..+.++|.+||..+|.+||++.++++
T Consensus 216 ------------------------~~~~~---------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 216 ------------------------RLPRP---------EECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------------------------cCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00011 112356889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.22 Aligned_cols=245 Identities=22% Similarity=0.288 Sum_probs=190.2
Q ss_pred EeccCCCCceEEEEECCCCc--EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 004954 421 YLGSAAFSKVFQAQDLHTGV--DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg~--~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmE 496 (722)
.||+|+||.||+|++..++. .+++|.++.. ......+.+|+.++.++. .||||+++++++...+..++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-----cCCCeeeEEEEEecCCCceEEEE
Confidence 58999999999999888776 4688887642 334456778888888885 37899999999999999999999
Q ss_pred ccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 497 LLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 497 y~~-gsLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
|+. ++|.+++...... .....+++..++.++.|++.||+|||+.|++|+||||+||+++. ++.+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~--~~~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC--CCeEEEC
Confidence 997 5788777644321 11234789999999999999999999999999999999999985 7889999
Q ss_pred ecCCcccccCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 566 DLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 566 DFGls~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|||++....... .....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------- 227 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------- 227 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-------
Confidence 999985332211 11223567999999988889999999999999999997 99999776554444332100
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.....+ ...+..+.+|+.+||..||.+|||+.+++..
T Consensus 228 ---------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 228 ---------------------------YRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred ---------------------------CCCCCC---------CcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 000001 1123568899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.90 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=195.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~-~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+|++.++||+|+||.||+++. ..++..+|+|.+... ......+.+|+++++.++ |+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ------HQHIVRFYGVCT 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC------CCCCceEEEEEe
Confidence 35788999999999999999974 335678999987643 333456777888887764 679999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhc---------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQE---------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~---------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
..+..++||||+. ++|.+++..... ......+++..++.++.||+.||+|||+.|++|+||||+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 9999999999997 467777654321 011124788999999999999999999999999999999999985
Q ss_pred cCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 004954 557 YQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~ 630 (722)
++.++|+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+.+.
T Consensus 158 --~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 158 --GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred --CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 7889999999986543221 12234678999999999999999999999999999998 999997765554443
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+.... ....+ ...++.+.+||.+||+.||.+||++.
T Consensus 236 ~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~cl~~~P~~Rp~~~ 272 (280)
T cd05092 236 CITQGR----------------------------------ELERP---------RTCPPEVYAIMQGCWQREPQQRMVIK 272 (280)
T ss_pred HHHcCc----------------------------------cCCCC---------CCCCHHHHHHHHHHccCChhhCCCHH
Confidence 332110 00001 12245688999999999999999999
Q ss_pred HHHh
Q 004954 711 EALD 714 (722)
Q Consensus 711 ElL~ 714 (722)
++++
T Consensus 273 ~l~~ 276 (280)
T cd05092 273 DIHS 276 (280)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=289.55 Aligned_cols=245 Identities=21% Similarity=0.238 Sum_probs=185.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~----~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
.++|++.+.||+|+||+||+|.+..+++ .+++|.+.... .....+..|+.++.. ..||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~------l~h~~iv~~~~~~~ 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS------LDHAYIVRLLGICP 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhc------CCCCCcceEEEEEC
Confidence 3578999999999999999999887776 46777764322 122333344444433 45899999999875
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
....++|+||+. |+|.+++..... .+++..+..++.||+.||+|||+.+++||||||+|||++. ++.+||+
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~--~~~~kl~ 151 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS--DSIVQIA 151 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEEc
Confidence 456788999997 678777764322 3889999999999999999999999999999999999985 7889999
Q ss_pred ecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---- 227 (279)
T cd05111 152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG---- 227 (279)
T ss_pred CCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC----
Confidence 999987543221 12345678999999998899999999999999999998 99999876544332221100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.....+ ...+..+.+++.+||..||.+|||+.|+++
T Consensus 228 ------------------------------~~~~~~---------~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 228 ------------------------------ERLAQP---------QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------------------CcCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000001 112356789999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=283.43 Aligned_cols=240 Identities=25% Similarity=0.324 Sum_probs=190.3
Q ss_pred EEeccCCCCceEEEEECC-CC--cEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLH-TG--VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~-tg--~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
+.||+|++|.||+|.+.. .+ ..+|||.+..... ....+.+|+.+++.++ |+||+++++.+.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD------HENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC------CCCccceeEEEcC-CeEEEE
Confidence 368999999999999855 33 3689999876543 3456677888777774 6899999999988 899999
Q ss_pred EEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+. ++|.+.+..... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++. ++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~--~~~~kl~dfg~~~~~ 147 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRAL 147 (257)
T ss_pred EEecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec--CCEEEeccccccccc
Confidence 99996 577777664331 23889999999999999999999999999999999999996 689999999998765
Q ss_pred cCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 574 TDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 574 ~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
.... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 218 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE--------- 218 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 4321 12345678999999998899999999999999999998 9999987766665544431000
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....+ ...+..+.++|.+||+.+|++|||+.++++
T Consensus 219 ------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 ------------------------RLERP---------EACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------------------cCCCC---------ccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00001 112356889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=287.55 Aligned_cols=228 Identities=24% Similarity=0.294 Sum_probs=181.1
Q ss_pred CCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc-chH
Q 004954 425 AAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLY 503 (722)
Q Consensus 425 G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g-sLl 503 (722)
|.+|+||++++..+++.+|+|.++..... .+|...+.. ..||||+++++++...+..++||||+.+ +|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~----~~~~~~~~~------~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY----SRERLTIIP------HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh----hhHHHHHHh------cCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 88999999999999999999999765321 222222221 2478999999999999999999999985 676
Q ss_pred HHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCCccccccC
Q 004954 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583 (722)
Q Consensus 504 ~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt 583 (722)
+.+.... .+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||.+...........++
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~ 145 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD--RGHIQLTYFSRWSEVEDSCDGEAVE 145 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEecccchhccccccccCCcC
Confidence 7665432 2889999999999999999999999999999999999996 7789999999876665554455667
Q ss_pred CcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhh
Q 004954 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYI 663 (722)
Q Consensus 584 ~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (722)
..|+|||.+.+..++.++|+||+|+++|+|++|..||...... +.
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~------------------------------ 190 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN------------------------------ 190 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc------------------------------
Confidence 8899999998888999999999999999999999887432100 00
Q ss_pred hhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH-----HHHHhCCCC
Q 004954 664 NEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-----REALDHPWL 718 (722)
Q Consensus 664 ~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa-----~ElL~HPwf 718 (722)
......+| ...++.+.+||++||+.||++||++ +++++||||
T Consensus 191 ----~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 ----THTTLNIP---------EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ----cccccCCc---------ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00000111 1234668899999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.68 Aligned_cols=197 Identities=22% Similarity=0.349 Sum_probs=167.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhh-hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC-eE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-HL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~-~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~-~l 491 (722)
++|.-...||+|+||.||+|.. .+|+.||||.+...... ..++.+|+.++.+++ |||||+++|+|...+ +.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~------H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR------HPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC------CcCcccEEEEEecCCceE
Confidence 5677778899999999999984 55689999988765543 456889999998886 679999999999998 59
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC---CccccCCCCceEEcccCCCeEEEEec
Q 004954 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG---IIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 492 ~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g---IvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
++|+|||. |+|.+.+...... .++|..+..|+.++++||+|||+.. ||||||||+|||++. +.+.||+||
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~--~~~aKlsDF 221 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE--DFNAKLSDF 221 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC--CCCEEccCc
Confidence 99999997 5777766543321 5899999999999999999999854 999999999999996 899999999
Q ss_pred CCcccccC-Cccc--c-ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004954 568 GSSCFQTD-NLCL--Y-VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623 (722)
Q Consensus 568 Gls~~~~~-~~~~--~-~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~ 623 (722)
|+|+.... .... . .||.+|+|||.+.....+.++||||||++|.||+||+.|....
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99976654 3222 2 7999999999999888999999999999999999999887643
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.92 Aligned_cols=258 Identities=22% Similarity=0.257 Sum_probs=189.1
Q ss_pred cCcE-EEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRY-YVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY-~i~~~LG~G~fG~Vy~a~----d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.+|| ++++.||+|+||+||++. ...+++.||+|+++.... ....+.+|+.+++.++ ||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~ 75 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY------HENIVKYKGCC 75 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC------CCCEeeEEEEE
Confidence 3566 999999999999998864 345788999999876432 3456677888888774 78999999988
Q ss_pred Eec--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 486 YHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 486 ~~~--~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
... ..+++||||+.+ +|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~ 146 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN--DRLV 146 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC--CCcE
Confidence 754 468999999985 565655422 2899999999999999999999999999999999999986 7789
Q ss_pred EEEecCCcccccCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH-hh
Q 004954 563 KIIDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GM 635 (722)
Q Consensus 563 kL~DFGls~~~~~~~~------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~-~~ 635 (722)
+|+|||++........ ...++..|+|||.+.+..++.++||||||+++|+|++|..||....... ..+. ..
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~ 224 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPK 224 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhccc
Confidence 9999999876543221 1234567999999998889999999999999999999999986543211 1111 00
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.+......+. +.. ..... .+ .....+..+.+++.+||+.+|++|||++++++
T Consensus 225 ~~~~~~~~~~------~~~------------~~~~~--~~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 225 QGQMTVVRLI------ELL------------ERGMR--LP-------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ccccchhhhh------hhh------------hcCCC--CC-------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000000 000 00000 00 01223467999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=285.36 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=193.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
-..+|.+.++||+|+||.||+|.+... ...+|||...... ...+.+.+|+.+++.+. ||||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~ 77 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD------HPHIVKLIGVIT 77 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC------CCchhceeEEEc
Confidence 346799999999999999999987543 4568999887543 34456777888887774 689999999886
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
. ...++||||+. ++|.+++..... .+++..++.++.||+.||.|||+.|++|+||||+||+++. .+.++|+
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~ 149 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS--PDCVKLG 149 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec--CCCeEEc
Confidence 5 56789999997 467777654321 2889999999999999999999999999999999999996 7789999
Q ss_pred ecCCcccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 566 DLGSSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 566 DFGls~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|||++........ ...+++.|+|||.+....++.++||||||+++|+|++ |..||......+.+..+....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---- 225 (270)
T cd05056 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE---- 225 (270)
T ss_pred cCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----
Confidence 9999875443311 1223467999999988889999999999999999986 999998776655544432100
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...+..+.++|.+||..+|.+|||+.+++..
T Consensus 226 ------------------------------~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 226 ------------------------------RLPMP---------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ------------------------------cCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011 1224568999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=304.32 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=197.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
-.++|.+.++||+|+||.||+|++. .+++.||+|+++... .....+.+|++++..+. .||||++++++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----~H~niv~~~~~ 109 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG-----PHLNIVNLLGA 109 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC-----CCCCeEEEEEE
Confidence 3467889999999999999999853 355789999997542 22345778888888774 27899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhcc---------------------------------------------------
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQES--------------------------------------------------- 512 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~--------------------------------------------------- 512 (722)
+....+.++||||+. |+|.+++......
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999997 5788777643210
Q ss_pred -----------------------------------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 004954 513 -----------------------------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (722)
Q Consensus 513 -----------------------------------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~N 551 (722)
.....+++..++.++.||+.||.|||+.+|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 011246778889999999999999999999999999999
Q ss_pred eEEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChH
Q 004954 552 ILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAV 625 (722)
Q Consensus 552 ILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~ 625 (722)
||++. .+.+||+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 270 iLl~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 270 VLICE--GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEEeC--CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99985 778999999998754321 112345788999999998889999999999999999998 8999976544
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
.+.+...+.. ......| ...+..+.+||.+||..+|.+
T Consensus 348 ~~~~~~~~~~---------------------------------~~~~~~p---------~~~~~~l~~li~~cl~~~P~~ 385 (401)
T cd05107 348 NEQFYNAIKR---------------------------------GYRMAKP---------AHASDEIYEIMQKCWEEKFEI 385 (401)
T ss_pred hHHHHHHHHc---------------------------------CCCCCCC---------CCCCHHHHHHHHHHcCCChhH
Confidence 4333222100 0000011 112467899999999999999
Q ss_pred CcCHHHHHhC
Q 004954 706 RPTAREALDH 715 (722)
Q Consensus 706 RpTa~ElL~H 715 (722)
||++++||+.
T Consensus 386 RPs~~ell~~ 395 (401)
T cd05107 386 RPDFSQLVHL 395 (401)
T ss_pred CcCHHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=282.50 Aligned_cols=238 Identities=24% Similarity=0.362 Sum_probs=188.0
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
++||+|+||.||++.+.. ++.||+|++..... ....+.+|+++++.+. |+||+++++++......++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD------HPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCeEEEEEEEecCCCeEEEEEc
Confidence 369999999999999877 99999998875432 3456677888777664 78999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+.+ +|.+++.... ..++...+..++.|++.||.|||+++++||||+|+||+++. ++.++|+|||.+......
T Consensus 74 ~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~--~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 74 VPGGSLLTFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC--CCcEEEeeccccccccCC
Confidence 975 5666664322 13788999999999999999999999999999999999985 788999999998755422
Q ss_pred cc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 004954 577 LC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (722)
Q Consensus 577 ~~-----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~ 650 (722)
.. ....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+....
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-------------- 212 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-------------- 212 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------------
Confidence 11 1223556999999998889999999999999999999 899997765544333322100
Q ss_pred hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...+..+.++|.+||+.+|.+|||+.|+|+
T Consensus 213 --------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 213 --------------------RMPAP---------QLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------------------CCCCC---------ccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00001 112456889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=286.01 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=196.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~-----tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
.+|++++.||+|+||+||+|+.+. ..+.+++|.+..... ....+.+|+++++.++ |+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS------HKNVVRLLGLCR 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC------CcceeeeEEEEC
Confidence 679999999999999999999653 356799998865432 3466788999988885 679999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccC---CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~---~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
.....++||||+. ++|.+++....... ....+++..+..++.||+.||+|||+.+|+||||||+||+++. ++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~ 156 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS--QREV 156 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC--CCcE
Confidence 9899999999998 57777765433111 1124899999999999999999999999999999999999986 7889
Q ss_pred EEEecCCcccccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 004954 563 KIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 563 kL~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg 637 (722)
+|+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........+..+...
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999987643321 122345677999999988888999999999999999999 88999765544443332200
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
......+ ...+..+.++|.+||+.+|.+|||+.+++.+
T Consensus 235 -------------------------------~~~~~~~---------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 -------------------------------KLELPVP---------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------------CcCCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0000000 1234568999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=285.11 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=193.6
Q ss_pred cEEEEEEeccCCCCceEEEEECC-CCcEEEEEEeecch-----------hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK-----------DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~-tg~~vAvKil~~~~-----------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
.|++.+.||+|+||.||++++.. +++.+|+|.+.... ....+...|+.++... ..|+||++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ-----LRHPNIVRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc-----CCCCCeeeEE
Confidence 47889999999999999999877 78899999875321 1122344455544432 3588999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCC
Q 004954 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~ 560 (722)
+++...++.++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~--~~ 151 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE--DD 151 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC--CC
Confidence 999999999999999975 676665432211 1238899999999999999999996 78999999999999986 78
Q ss_pred eEEEEecCCcccccCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 561 EIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|++||...........+......
T Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 89999999987654432 3356788999999999888999999999999999999999999776555444333211000
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+ ....+..+.+||++||+.||++||++.|+..+
T Consensus 232 ----------------------------------~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 232 ----------------------------------PLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ----------------------------------cCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 000 01124668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.31 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=188.8
Q ss_pred EeccCCCCceEEEEECCCC------cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 421 YLGSAAFSKVFQAQDLHTG------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg------~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
.||+|+||.||+++++... +.+|+|.+.... .....+.+|+.+++.++ ||||+++++++......+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN------HPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC------CCCeeeEeeeecCCCCeE
Confidence 5899999999999976544 789999876543 33456667777777664 789999999999999999
Q ss_pred EEEEccc-cchHHHHhhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC---CCeEEEEec
Q 004954 493 IVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ---RCEIKIIDL 567 (722)
Q Consensus 493 iVmEy~~-gsLl~~l~~~~~~~-~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~---~~~vkL~DF 567 (722)
+||||+. ++|.+++....... ....+++.++..++.||+.||+|||+.+++|+||||+||+++.+. ...++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999997 57777775432221 234478899999999999999999999999999999999998622 127999999
Q ss_pred CCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 568 GSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 568 Gls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
|++....... .....+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~------ 229 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG------ 229 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC------
Confidence 9986543221 12244678999999999899999999999999999998 99999876555444333100
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.....+ ...+..+.+||.+||+.+|.+||+++++++
T Consensus 230 ----------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 ----------------------------GRLQKP---------ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------------------------CccCCc---------ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000001 112356889999999999999999999985
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=285.17 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=193.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~----~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+|++.+.||+|+||.||+|.++.+|. .+|+|.+.... .....+.+|+.+++.+. |+||+++++++.
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 79 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD------HPHVVRLLGICL 79 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEe
Confidence 4689999999999999999999876665 58999887653 23355667888887764 789999999988
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
. ...++||||+. ++|.+.+..... .+++..+..++.||+.||+|||+.||+|+||||+||+++. ++.+||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~--~~~~kL~ 151 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT--PQHVKIT 151 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC--CCeEEEC
Confidence 7 78999999997 567776653322 2889999999999999999999999999999999999985 7789999
Q ss_pred ecCCcccccCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~~~~-----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||.+......... ..++..|+|||.+....++.++|+|||||++|++++ |+.||......++...+.....
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-- 229 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-- 229 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC--
Confidence 99998765432211 122567999999988889999999999999999998 9999988766555444321100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...| ...+..+.++|.+||..||.+|||+.++++
T Consensus 230 --------------------------------~~~~---------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 --------------------------------LPQP---------PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred --------------------------------CCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0001 112356789999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=282.60 Aligned_cols=238 Identities=20% Similarity=0.263 Sum_probs=184.9
Q ss_pred EeccCCCCceEEEEEC--CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 004954 421 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmE 496 (722)
.||+|+||.||+|.+. ..+..+|+|++.... ...+.+.+|+.+++.++ |+||+++++++. ....++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~------h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD------NPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC------CCCeEEEEEEEc-CCCeEEEEE
Confidence 3899999999999764 445679999987543 23455778888888874 689999999875 457899999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC
Q 004954 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 497 y~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
|+++ +|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||++. ++.+||+|||++.....
T Consensus 75 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 75 MASGGPLNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGA 147 (257)
T ss_pred eCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC--CCcEEeccCCccccccC
Confidence 9975 5665554322 23899999999999999999999999999999999999985 77899999999875433
Q ss_pred Ccc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 576 NLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 576 ~~~------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
... ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------ 215 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK------------ 215 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------------
Confidence 211 1123567999999998889999999999999999996 999998766555443332110
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...++++.++|.+||+.+|++||++.++++.
T Consensus 216 ----------------------~~~~~---------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 216 ----------------------RLDCP---------AECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred ----------------------CCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011 1234678899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=285.23 Aligned_cols=252 Identities=19% Similarity=0.246 Sum_probs=195.1
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECC----CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLH----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~----tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
-.++|++.+.||+|+||.||+|.+.. ++..|++|++... ......+.+|..+++.+. |+||+++++++
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~ 77 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS------HQNILPILHVC 77 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEE
Confidence 35789999999999999999999865 3688999988754 233455667777777664 78999999987
Q ss_pred Ee-cCeEEEEEEccc-cchHHHHhhhhcc--CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 486 YH-LEHLFIVCELLR-ANLYEFQKFNQES--GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 486 ~~-~~~l~iVmEy~~-gsLl~~l~~~~~~--~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
.. ....+++++|+. ++|.+++...... .....+++..++.++.||+.||+|||+.+++|+||||+||+++. ++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~--~~~ 155 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE--ELQ 155 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC--CCc
Confidence 65 467899999997 5677766543221 11234899999999999999999999999999999999999985 788
Q ss_pred EEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 004954 562 IKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 562 vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~ 635 (722)
+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|++++ |+.||...+..++...+...
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999999987543221 11234667999999999899999999999999999999 99999876655443332210
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
. .++. ....++.+.++|.+||+.||++|||+.++++
T Consensus 236 ~------------------------------------~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 Y------------------------------------RLAQ-------PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred C------------------------------------CCCC-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0000 0112356889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=284.54 Aligned_cols=240 Identities=19% Similarity=0.244 Sum_probs=177.8
Q ss_pred EEeccCCCCceEEEEECC------------CCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLH------------TGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~------------tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+.||+|+||.||+|+... ....+++|++..... ....+.+|+.+++.++ ||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~------hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS------HKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC------CCCEeeEEEEEe
Confidence 368999999999998532 233588898765432 2234555666666664 789999999999
Q ss_pred ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC-----Ce
Q 004954 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-----CE 561 (722)
Q Consensus 487 ~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~-----~~ 561 (722)
.....++||||+.++.++.+..... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.... ..
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 9999999999998765554433221 23889999999999999999999999999999999999975221 23
Q ss_pred EEEEecCCcccccCCccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 562 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELW-TGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 562 vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDIWSLGviL~ell-tG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+... +.
T Consensus 151 ~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~------ 222 (262)
T cd05077 151 IKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FY------ 222 (262)
T ss_pred eEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HH------
Confidence 899999998654322 2345788899999987 467899999999999999998 5899887654322211 00
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.. ... .. ......+.+||.+||+.||.+||++.++|++
T Consensus 223 ---------------~~------------~~~--~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 223 ---------------EG------------QCM--LV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---------------hc------------Ccc--CC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 000 00 0113568899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=283.44 Aligned_cols=247 Identities=20% Similarity=0.253 Sum_probs=181.5
Q ss_pred EeccCCCCceEEEEEC--CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 004954 421 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmE 496 (722)
.||+|+||.||+|... .....+|+|.+.... .....+.+|+.+++.+ .|+||+++++.+......++|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL------NHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC------CCCCcceEEEEECCCCceEEEEE
Confidence 5899999999999643 244578888775432 2234556777777665 47899999999999999999999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC
Q 004954 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 497 y~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
|+.+ +|.+++...... .....++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA--DLSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC--CCcEEEecccccccccc
Confidence 9985 677776544321 1223567788899999999999999999999999999999996 78899999999864322
Q ss_pred C-----ccccccCCcccCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 576 N-----LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 576 ~-----~~~~~gt~~y~APE~l~~-------~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
. .....+++.|+|||++.. ..++.++|||||||++|+|++ |..||......+.+..+......
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~---- 228 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI---- 228 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc----
Confidence 1 122345677999999753 356789999999999999999 89999877655554443321100
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.++.. ......+..+.+++..|+ .||++|||+++|++-
T Consensus 229 ------------------------------~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 229 ------------------------------KLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred ------------------------------cCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 00000 001123456778999888 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=306.30 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=205.6
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCC----cEEEEEEeec----chhhhHhHHHHHHHHHHhcccCCCCCCcee
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg----~~vAvKil~~----~~~~~~~~~~E~~il~~L~~~~~~~hpnIv 479 (722)
.+.+...+..+.++||+|+||.||+|..+..+ ..||+|..+. .......+++|.++++.++ |||||
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~------H~NVV 224 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN------HPNVV 224 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC------CCCEE
Confidence 34555667777799999999999999875542 2389999874 3456677889999999875 78999
Q ss_pred EEEEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 480 ~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
++||+......++||||+|.| +|.++++.... .++..+...++.+.+.||+|||++++|||||-.+|+|++.
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~-- 297 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK-- 297 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC--
Confidence 999999999999999999985 78888886654 2899999999999999999999999999999999999995
Q ss_pred CCeEEEEecCCcccccCCc--c-ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHh
Q 004954 559 RCEIKIIDLGSSCFQTDNL--C-LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG 634 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~~--~-~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~ 634 (722)
+..+||+|||+++....-. . ...-+..|+|||.+....++.++|||||||++||+++ |..||++....++...|..
T Consensus 298 ~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred CCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 6778999999987654111 1 1134678999999999999999999999999999999 8889999998888877742
Q ss_pred hcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
..- +..+|. ..+..+..++.+|+..+|++|||+.++.+
T Consensus 378 ~~~---------------------------------r~~~~~---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 378 NGY---------------------------------RMPIPS---------KTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred cCc---------------------------------cCCCCC---------CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 111 111111 23466889999999999999999998864
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=281.66 Aligned_cols=237 Identities=22% Similarity=0.280 Sum_probs=181.2
Q ss_pred EEeccCCCCceEEEEECCCC----------cEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 420 EYLGSAAFSKVFQAQDLHTG----------VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg----------~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+.||+|+||.||+|.+..++ ..+++|++.........+.+|+.+++.+. ||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS------HKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCC------CcchhheeeEEec-C
Confidence 36999999999999987776 45888887665443456667777777664 7899999999988 7
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC-----eEE
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-----EIK 563 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~-----~vk 563 (722)
..++||||+.+ +|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++..... .+|
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 78999999985 55555553321 38899999999999999999999999999999999999863211 799
Q ss_pred EEecCCcccccCCccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. .
T Consensus 149 l~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~----- 221 (259)
T cd05037 149 LSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-D----- 221 (259)
T ss_pred eCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-c-----
Confidence 999999876544 2234567789999999876 78999999999999999999 588886543222111100 0
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....+. .....+.+||.+||..+|.+|||+.++++
T Consensus 222 ------------------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 ------------------------------QHRLPM---------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------------------------CCCCCC---------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000 00156889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=336.33 Aligned_cols=251 Identities=31% Similarity=0.436 Sum_probs=204.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.-||+-..+||.|.||.||.|.+..+|+..|+|-++.. ....+.+.+|.+++..++ |||+|++|++-.+.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln------HpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN------HPNLVRYYGVEVHR 1306 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc------CccccccCceeecH
Confidence 456888899999999999999999999999999977542 344567778888998886 68999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+..+|.||||.+ +|.+++..... ..+...+.+..|++.||+|||+.|||||||||.||+++. +|.+|++||
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~--~g~iK~~DF 1378 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF--NGLIKYGDF 1378 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec--CCcEEeecc
Confidence 999999999975 66666654432 667778889999999999999999999999999999996 789999999
Q ss_pred CCcccccCCc-------cccccCCcccCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHHHhhc
Q 004954 568 GSSCFQTDNL-------CLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGML 636 (722)
Q Consensus 568 Gls~~~~~~~-------~~~~gt~~y~APE~l~~~---~~s~ksDIWSLGviL~elltG~~PF~~~~-~~e~l~~i~~~l 636 (722)
|.|....... ....||+.|||||++.+. +-..+.|||||||++.||+||+.||...+ ...++.++...
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g- 1457 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG- 1457 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-
Confidence 9987654432 346899999999999764 46679999999999999999999997643 33444443211
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
-...+|+. .+.+-++||.+||+.||++|+++.|+|+|-
T Consensus 1458 ---------------------------------h~Pq~P~~---------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1458 ---------------------------------HKPQIPER---------LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ---------------------------------CCCCCchh---------hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 11123332 235567999999999999999999999998
Q ss_pred CCC
Q 004954 717 WLQ 719 (722)
Q Consensus 717 wf~ 719 (722)
|-+
T Consensus 1496 f~~ 1498 (1509)
T KOG4645|consen 1496 FGK 1498 (1509)
T ss_pred ccc
Confidence 754
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=277.84 Aligned_cols=239 Identities=24% Similarity=0.345 Sum_probs=187.0
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
++||+|+||.||++.. .++..+|+|++.... .....+.+|+.+++.+ .||||+++++.+...+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY------DHPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC------CCCCcCeEEEEEecCCccEEEEEC
Confidence 3699999999999985 468899999987543 2233566777777766 478999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC
Q 004954 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (722)
Q Consensus 498 ~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 576 (722)
+.+ +|.+++.... ..+.+..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++......
T Consensus 74 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 74 VPGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC--CCeEEECCCccceecccc
Confidence 975 5666554322 12788999999999999999999999999999999999985 788999999998654332
Q ss_pred cc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 004954 577 LC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (722)
Q Consensus 577 ~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~ 651 (722)
.. ....++.|+|||++.+..++.++||||||+++|+|++ |..||...........+....
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--------------- 211 (250)
T cd05085 147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--------------- 211 (250)
T ss_pred ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 21 1233567999999998889999999999999999998 999998765544443332100
Q ss_pred hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 652 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....+ ...+..+.+|+.+||..+|++||++.++++.
T Consensus 212 -------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 -------------------RMSCP---------QKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -------------------CCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00001 1124568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=283.88 Aligned_cols=262 Identities=21% Similarity=0.279 Sum_probs=189.7
Q ss_pred CcEEEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~----d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.+|++++.||+|+||.||++. +..+++.||+|.+.... .....+.+|+++++.++ ||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ------HDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCCeeEEEEEEccC
Confidence 579999999999999999997 45678999999987543 33456678888888774 78999999987543
Q ss_pred --CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 489 --EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 489 --~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+||+++. ++.++|+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~--~~~~~l~ 150 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIG 150 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC--CCeEEEC
Confidence 46899999997 57777765332 12889999999999999999999999999999999999986 7789999
Q ss_pred ecCCcccccCCccc------cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~~~~------~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||++......... ..++..|+|||++.+..++.++|||||||++|+|++|..|+..... .....+ +..
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~----~~~ 225 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMM----GND 225 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhc----ccc
Confidence 99998765432211 1234459999999988899999999999999999999887654321 111111 110
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..... ....+.+... .. ...+. ....+..+.+||.+||+.+|++|||+.++++.
T Consensus 226 ~~~~~-~~~~~~~~~~------------~~--~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 226 KQGQM-IVYHLIELLK------------NN--GRLPA-------PPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred ccccc-chHHHHHHHh------------cC--CcCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00000 0000000000 00 00110 11234678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=284.99 Aligned_cols=239 Identities=20% Similarity=0.239 Sum_probs=176.6
Q ss_pred EeccCCCCceEEEEECCC------------------------CcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCC
Q 004954 421 YLGSAAFSKVFQAQDLHT------------------------GVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADE 475 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~t------------------------g~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~h 475 (722)
.||+|+||.||+|....+ ...|++|++..... ....+.+|..+++.+ .|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l------~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV------SH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC------CC
Confidence 599999999999974322 24588898865432 223445555555554 47
Q ss_pred CceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEc
Q 004954 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (722)
Q Consensus 476 pnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~ 555 (722)
|||+++++++......++||||+.++.++.+.... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 89999999999999999999999875444433221 12378899999999999999999999999999999999997
Q ss_pred ccC-----CCeEEEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCChHHHH
Q 004954 556 SYQ-----RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELW-TGEVLFPNDAVVMI 628 (722)
Q Consensus 556 ~~~-----~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~ell-tG~~PF~~~~~~e~ 628 (722)
... ...++|+|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||......+.
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 522 235899999987544322 22356788999999875 56889999999999999995 69999976544332
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
...+.. ...+|. .....+.++|.+||+.+|++|||
T Consensus 231 ~~~~~~------------------------------------~~~~~~---------~~~~~~~~li~~cl~~~p~~Rps 265 (274)
T cd05076 231 ERFYEK------------------------------------KHRLPE---------PSCKELATLISQCLTYEPTQRPS 265 (274)
T ss_pred HHHHHh------------------------------------ccCCCC---------CCChHHHHHHHHHcccChhhCcC
Confidence 211100 000111 11245889999999999999999
Q ss_pred HHHHHhC
Q 004954 709 AREALDH 715 (722)
Q Consensus 709 a~ElL~H 715 (722)
+.++|++
T Consensus 266 ~~~il~~ 272 (274)
T cd05076 266 FRTILRD 272 (274)
T ss_pred HHHHHHh
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=286.08 Aligned_cols=239 Identities=19% Similarity=0.301 Sum_probs=180.2
Q ss_pred EEeccCCCCceEEEEECCCCc-------EEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGV-------DVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~-------~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+.||+|+||.||+|.+...+. .+|+|.+.... ...+.+..|..+++.+ .||||+++++++......
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~------~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL------SHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC------CCCChhheeeEEEeCCCc
Confidence 369999999999999865544 38888876433 2334566677777665 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC------CeEEE
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR------CEIKI 564 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~------~~vkL 564 (722)
++||||+.+ +|..++..... .+++..+..++.||+.||+|||+.||+||||||+||+++.+.. ..++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEe
Confidence 999999986 56666554322 3788899999999999999999999999999999999986322 24899
Q ss_pred EecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 565 ~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
+|||.+..... .....+++.|+|||++.+ ..++.++|||||||++|+|++| .+||............. .
T Consensus 150 ~d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~------- 220 (258)
T cd05078 150 SDPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-D------- 220 (258)
T ss_pred cccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-c-------
Confidence 99998865443 223567889999999986 4578999999999999999998 56665443322111100 0
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...+|. .....+.+||.+||+.||++|||++++++.
T Consensus 221 ----------------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ----------------------------RHQLPA---------PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------------------------cccCCC---------CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 001111 112458899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=281.02 Aligned_cols=246 Identities=20% Similarity=0.218 Sum_probs=181.9
Q ss_pred EeccCCCCceEEEEEC--CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 004954 421 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmE 496 (722)
.||+|+||.||+|.+. .++..+|+|.++... .....+.+|+.+++.++ ||||+++++.+......++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ------HSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC------CCCEeeEEEEEcCCCCcEEEEE
Confidence 5899999999999854 456789999887543 22345667787777774 7899999999999999999999
Q ss_pred ccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC
Q 004954 497 LLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 497 y~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
|+. ++|.+++...... .....++..++.++.|++.||+|||+.+++|+||||+||+++. ++.++|+|||.+.....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~--~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA--DLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEECCccccccccC
Confidence 998 4676766543321 1223667788899999999999999999999999999999986 78899999999865432
Q ss_pred Cc-----cccccCCcccCchhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 576 NL-----CLYVQSRSYRAPEVIIGL-------PYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 576 ~~-----~~~~gt~~y~APE~l~~~-------~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
.. ....+++.|+|||++.+. .++.++||||||+++|+|++ |+.||......+.....+...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------ 226 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ------ 226 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc------
Confidence 21 123467789999998642 35789999999999999996 999997765444332221000
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
......|.. ....+..+.++|++|+ .+|.+|||++||+.
T Consensus 227 --------------------------~~~~~~~~~------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 227 --------------------------QLKLPKPRL------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------------------cCCCCCCcc------CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000000100 0112355889999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=281.90 Aligned_cols=249 Identities=19% Similarity=0.255 Sum_probs=189.2
Q ss_pred EEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
|++.+.||+|+||.||+|.+. .+++.+|||++... ....+++.+|+++++.++ ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD------HPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC------CCCcceEEEEEccCC
Confidence 677889999999999999864 46789999998753 233455677887777664 789999999887542
Q ss_pred ------eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 490 ------HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 490 ------~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
..+++++|+.+ ++..++...........+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~--~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE--NMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC--CCCE
Confidence 24788999974 55555543222222234788999999999999999999999999999999999985 7889
Q ss_pred EEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 004954 563 KIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 563 kL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~l 636 (722)
||+|||++....... ....+++.|++||.+.+..++.++|||||||++|+|++ |++||......+....+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987653221 12234577999999998889999999999999999999 899998766554443332100
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.. ..+ ...+..+.+++.+||+.+|++|||+.+++++
T Consensus 233 --------------------------------~~--~~~---------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 233 --------------------------------RL--KQP---------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------------------cC--CCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 000 0123568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=287.30 Aligned_cols=260 Identities=22% Similarity=0.270 Sum_probs=190.3
Q ss_pred cEEEEEEeccCCCCceEEEEE----CCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 415 RYYVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d----~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
-|++++.||+|+||.||+++. ..+++.||+|.++.. ......+.+|+.+++.+. ||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY------HENIVKYKGICTED 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC------CCCeeeeeeEEecC
Confidence 478999999999999999974 467889999998744 233456778888888774 78999999998875
Q ss_pred --CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 489 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 489 --~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
...++||||+.+ +|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++. ++.++|+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~--~~~~~l~ 151 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES--EHQVKIG 151 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC--CCCEEEC
Confidence 578999999975 5666654321 13789999999999999999999999999999999999985 7789999
Q ss_pred ecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||++....... ....++..|+|||++.+..++.++|||||||++|+|++++.|+.... . .+.+..++.
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~--~---~~~~~~~~~ 226 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM--T---LFLKMIGPT 226 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc--c---hhhhhcccc
Confidence 999987544321 12345667999999998889999999999999999999887654321 1 111222222
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+..... ..+.. .......++ ...+..+.+||.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~--~~~~~------------~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 227 HGQMTVTR--LVRVL------------EEGKRLPRP---------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cccccHHH--HHHHH------------HcCccCCCC---------CCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11110000 00000 000000011 1234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=279.13 Aligned_cols=240 Identities=20% Similarity=0.285 Sum_probs=179.8
Q ss_pred EEeccCCCCceEEEEECC---CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-ecCeEEE
Q 004954 420 EYLGSAAFSKVFQAQDLH---TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLFI 493 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~---tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~-~~~~l~i 493 (722)
+.||+|+||.||+|.+.. .+..+|+|.+... ......+.+|+.+++.+ +||||+++++++. ..+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF------SHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC------CCCCcceEEEEeecCCCCcEE
Confidence 368999999999998643 3467999987542 22334556676666655 4789999999776 4556889
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+. ++|.+++..... .+++..+..++.|++.||.|||+.+++||||||+|||++. ++.+||+|||++..
T Consensus 75 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~--~~~~kl~dfg~~~~ 147 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE--SFTVKVADFGLARD 147 (262)
T ss_pred EEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCcccccc
Confidence 999997 467776653221 1567778889999999999999999999999999999986 77899999999865
Q ss_pred ccCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 573 QTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 573 ~~~~-------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
.... .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-------- 219 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-------- 219 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--------
Confidence 4321 112345678999999998899999999999999999999 577787655444333221100
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....+ ...+..+.+++.+||+.+|++||++.++++.
T Consensus 220 --------------------------~~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 220 --------------------------RLLQP---------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred --------------------------CCCCC---------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00001 1123568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=286.57 Aligned_cols=246 Identities=20% Similarity=0.248 Sum_probs=188.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~----~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+|++.+.||+|+||.||++.+..+|+ .+|+|++..... ....+.+|+.+++.+. ||||+++++.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~------h~niv~~~~~~~ 79 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD------HPHLVRLLGVCL 79 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCcccEEEEEc
Confidence 4678999999999999999999877776 568888765432 2234566777766654 789999999987
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
.. ..++|+||+. |++.+++..... .+++..+..++.||+.||.|||++||+|+||||+||+++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~--~~~~kL~ 151 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS--PNHVKIT 151 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC--CCceEEc
Confidence 54 4678999997 567777654321 2788899999999999999999999999999999999985 6789999
Q ss_pred ecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---- 227 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG---- 227 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC----
Confidence 999987644321 12234678999999999999999999999999999997 99999775443332221100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...+. ....+..+.++|.+||..+|++||++.++++.
T Consensus 228 --------------------------------~~~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 228 --------------------------------ERLPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred --------------------------------CCCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 01123568899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=312.17 Aligned_cols=274 Identities=21% Similarity=0.244 Sum_probs=175.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCC----CcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE----
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHT----GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY---- 484 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~t----g~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~---- 484 (722)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .|..+..++++.. +.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e~l~~~~---~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNERVRRAC---PNSCADFVYGFLEP 201 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHHHHHhhc---hhhHHHHHHhhhcc
Confidence 46899999999999999999999888 99999998764321 1222222222110 1111111111
Q ss_pred --EEecCeEEEEEEcccc-chHHHHhhhhcc--------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 004954 485 --FYHLEHLFIVCELLRA-NLYEFQKFNQES--------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547 (722)
Q Consensus 485 --f~~~~~l~iVmEy~~g-sLl~~l~~~~~~--------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDL 547 (722)
.......++||||+.+ +|.+++...... ..........+..++.||+.||.|||+.+|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2345679999999975 566666532110 00011223456789999999999999999999999
Q ss_pred CCCceEEcccCCCeEEEEecCCcccccCC----ccccccCCcccCchhhcCC----------------------CCCchh
Q 004954 548 KPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL----------------------PYDQKI 601 (722)
Q Consensus 548 Kp~NILl~~~~~~~vkL~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~----------------------~~s~ks 601 (722)
||+|||++. .++.+||+|||++...... .....+++.|+|||.+... .+..++
T Consensus 282 KP~NILl~~-~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSE-GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeC-CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999984 3578999999999754322 2346789999999976432 233456
Q ss_pred hHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhh
Q 004954 602 DLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLE 681 (722)
Q Consensus 602 DIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~ 681 (722)
|||||||+||||+++..|+.. ....+.++....+. +...|.. ..... ..+......
T Consensus 361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~-~~~~~~~------~~~~~---------------~~~~~~~~~ 416 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDY-DLVAWRK------LVEPR---------------ASPDLRRGF 416 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCC-cHHHHHH------hhccc---------------cchhhhhhh
Confidence 999999999999997766432 22333333322221 1111100 00000 000000000
Q ss_pred hhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 682 HHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 682 ~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...........+||.+||+.||++|||+.++|+||||+.
T Consensus 417 ~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 417 EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCC
Confidence 001112345679999999999999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=321.72 Aligned_cols=253 Identities=29% Similarity=0.408 Sum_probs=189.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-- 487 (722)
-...|..++.||+||||.||+++++-+|+.||||.+... .....++.+|+++|.+|+ |||||++|..+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn------HpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN------HPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC------CcceeeeehhhhccC
Confidence 345688899999999999999999999999999998765 445667888999999887 5788888766410
Q ss_pred --------------------------------------------------------------------------------
Q 004954 488 -------------------------------------------------------------------------------- 487 (722)
Q Consensus 488 -------------------------------------------------------------------------------- 487 (722)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred -----------------------------c--------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHH
Q 004954 488 -----------------------------L--------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530 (722)
Q Consensus 488 -----------------------------~--------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qI 530 (722)
. ..+||-||||+..++..+....... -.....|+++++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI 706 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence 0 1368999999876655554332210 1367899999999
Q ss_pred HHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccccc--------------------C-CccccccCCcccCc
Q 004954 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT--------------------D-NLCLYVQSRSYRAP 589 (722)
Q Consensus 531 l~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~--------------------~-~~~~~~gt~~y~AP 589 (722)
++||+|+|++|||||||||.||++++ ++.|||+|||++.... . ..+..+||--|+||
T Consensus 707 lEGLaYIH~~giIHRDLKP~NIFLd~--~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 707 LEGLAYIHDQGIIHRDLKPRNIFLDS--RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHHhCceeeccCCcceeEEcC--CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 99999999999999999999999996 8889999999986511 0 12346889999999
Q ss_pred hhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhh
Q 004954 590 EVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665 (722)
Q Consensus 590 E~l~~~~---~s~ksDIWSLGviL~elltG~~PF~~~-~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (722)
|++.+.. |+.|+||||||+||+||+. ||... ....++..+. -|.+|.+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~----------------------- 836 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEP----------------------- 836 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCC-----------------------
Confidence 9997655 9999999999999999984 57543 2222333322 1111111
Q ss_pred ccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 666 ETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 666 ~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
...... .-+.-..+|++||+.||.+||||.|+|++.||.
T Consensus 837 ----------~~f~~~-----~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 ----------ADFFDP-----EHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ----------cccccc-----cchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 000000 012235899999999999999999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=285.03 Aligned_cols=272 Identities=29% Similarity=0.484 Sum_probs=213.0
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-----CeE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-----EHL 491 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~---~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~-----~~l 491 (722)
+-||.|+||.||.+.|..+|+.||+|.+.+ +-....+..+|+++|...+ |.|++..++..+.. ..+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk------HdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR------HDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc------cccHHHHHHhcCCCCchHHHHH
Confidence 359999999999999999999999998764 2233467778888888886 45788877776643 357
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
|+|+|.|..+|...+... ..++...+..+++||++||+|||+.+|.||||||.|.|+++ ++.+||+|||+++
T Consensus 133 YV~TELmQSDLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS--NCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS--NCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHhhhhheeccC------CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc--CceEEeccccccc
Confidence 888998887766655433 33888899999999999999999999999999999999997 9999999999998
Q ss_pred cccCC----ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 572 FQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 572 ~~~~~----~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
..... .+..+-|-.|+|||++.|. .|+.++||||+|||+.|++-.+..|+..++-+.+..|..++|.+..+.+..
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 75533 2334568899999999986 499999999999999999999999999999999999999999998887654
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcc-----cCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ-----FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~-----~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.-+=.+. ... ...+...+++..+. ....+...++.+||..||.+|.+..+++.|+++..
T Consensus 285 ACEGAk~-------H~L--------R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 285 ACEGAKN-------HVL--------RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhhhHH-------Hhh--------ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 3221110 000 00111111111111 12245779999999999999999999999999854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=317.14 Aligned_cols=251 Identities=20% Similarity=0.323 Sum_probs=202.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCC-----cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg-----~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
..+.+..+.||+|+||.||.|.-.... ..||||.++... .....+++|..+|..+ +|||||+++|++
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f------~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF------DHPNIVSLIGVC 764 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC------CCcceeeEEEee
Confidence 456788889999999999999864332 348999987653 3345566676666666 588999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHhhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 486 YHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 486 ~~~~~l~iVmEy~~-gsLl~~l~~~~~~~-~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
......+|++|||. |+|+.+++...... ....++..++..++.||++|+.||+++++|||||..+|+|++. ...+|
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~--~r~VK 842 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE--RRVVK 842 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc--cCcEE
Confidence 99999999999997 58999998763321 2345999999999999999999999999999999999999997 68999
Q ss_pred EEecCCcccccCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 004954 564 IIDLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 564 L~DFGls~~~~~~~~~-----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg 637 (722)
|+|||+|+...+.... ..-+..|||||.+....++.|+|||||||++||++| |..||++.+..+++......
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-- 920 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-- 920 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC--
Confidence 9999999843322221 133567999999999999999999999999999999 99999999888887654421
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.+...| ...+..+.++|..||+.+|++||+...+++
T Consensus 921 --------------------------------gRL~~P---------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 --------------------------------GRLDPP---------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --------------------------------CccCCC---------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 111112 234456779999999999999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-34 Score=283.75 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=206.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+.-.++.+-+..||.|+||+|++..++.+|+..|||.++... ..+.+++.|.....+-. ..|+||++||....
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-----~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-----NCPNIVKFYGALFS 134 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-----CCcHHHHHhhhhhc
Confidence 344455666778999999999999999999999999997643 33455666666554443 36899999999999
Q ss_pred cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..||.||.|.-++..+.+.-...+ ...+++.-+-.|....+.||.||.. .+||||||||+|||++. .|.|||+|
T Consensus 135 EGdcWiCMELMd~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr--~G~vKLCD 211 (361)
T KOG1006|consen 135 EGDCWICMELMDISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR--HGDVKLCD 211 (361)
T ss_pred CCceeeeHHHHhhhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec--CCCEeeec
Confidence 99999999999988776665433222 1238899999999999999999985 58999999999999996 89999999
Q ss_pred cCCcccccCCc--cccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcH
Q 004954 567 LGSSCFQTDNL--CLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDL 641 (722)
Q Consensus 567 FGls~~~~~~~--~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF~~~-~~~e~l~~i~~~lg~~~~ 641 (722)
||.+.++.+.. +.-.|...|||||.+.. ..|+-++|+||||++|||+.||+.||..- +..+++.+++. |.+|.
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~ 289 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPI 289 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCe
Confidence 99987766543 33578899999999963 45899999999999999999999999874 44555555542 22211
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
..........+..|+.||.-||.+|-+.||.-.+++++||++
T Consensus 290 ------------------------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr 331 (361)
T KOG1006|consen 290 ------------------------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR 331 (361)
T ss_pred ------------------------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence 000111112345689999999999999999999999999985
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=281.55 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=192.9
Q ss_pred CcEEEEEEeccCCCCceEEEEEC----CCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~----~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..|++.+.||+|+||.||++... .+++.+|+|+++.... ....+.+|+++++.+. |+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~------~~~i~~~~~~~~~ 77 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD------HENIVKYKGVCEK 77 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC------CCChheEEeeeec
Confidence 46888999999999999999854 3488999999986544 3567778888887774 6799999999887
Q ss_pred --cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 488 --LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 488 --~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
....++||||+. ++|.+++..... .+++..+..++.||+.||+|||+.|++|+||||+||+++. ++.++|
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l 150 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES--EDLVKI 150 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEE
Confidence 568999999997 477777754332 3889999999999999999999999999999999999986 788999
Q ss_pred EecCCcccccCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 565 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 565 ~DFGls~~~~~~~~------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+|||.+........ ...++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....++
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~ 225 (284)
T cd05038 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGI 225 (284)
T ss_pred cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccc
Confidence 99999876553211 1233556999999998899999999999999999999999986532211 111111
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...... ...+..... ... ..+. ....+..+.+|+.+||+.+|.+|||+.|+++
T Consensus 226 ~~~~~~--~~~~~~~~~------------~~~--~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 226 AQGQMI--VTRLLELLK------------EGE--RLPR-------PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cccccc--HHHHHHHHH------------cCC--cCCC-------CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 110000 000000000 000 0000 0122467899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=281.15 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=207.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+-.++|.++.+||+|+|++|.+++.+.+.+.+|+|++++. ....+-...|..+..... .||.+|-+..+|+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as-----n~pflvglhscfq 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NNPFLVGLHSCFQ 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-----CCCeEEehhhhhc
Confidence 3347899999999999999999999999999999998763 333444556666766654 4789999999999
Q ss_pred ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 487 ~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
+...+++|.||++|+-+-+....++. ++++.++.+...|+-||.|||+.|||+||||.+|||++. .+.+||+|
T Consensus 322 tesrlffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvllda--eghikltd 394 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTD 394 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEcc--CCceeecc
Confidence 99999999999998755554444433 999999999999999999999999999999999999996 89999999
Q ss_pred cCCccc---ccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC-------CChHHHHHHHHHhhc
Q 004954 567 LGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP-------NDAVVMILARIIGML 636 (722)
Q Consensus 567 FGls~~---~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~-------~~~~~e~l~~i~~~l 636 (722)
+|+.+. .++...+++|||.|.|||++.+..|+..+|+|+|||+|+||+.|+.||. ..+.++++.+++-
T Consensus 395 ygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-- 472 (593)
T KOG0695|consen 395 YGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-- 472 (593)
T ss_pred cchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--
Confidence 999864 3445677999999999999999999999999999999999999999993 2344555555430
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc------CHH
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP------TAR 710 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp------Ta~ 710 (722)
.-...||...+. -...+|+..|..||.+|. ...
T Consensus 473 --------------------------------ekqiriprslsv---------kas~vlkgflnkdp~erlgc~~~~g~~ 511 (593)
T KOG0695|consen 473 --------------------------------EKQIRIPRSLSV---------KASHVLKGFLNKDPKERLGCRPQTGFS 511 (593)
T ss_pred --------------------------------hhcccccceeeh---------hhHHHHHHhhcCCcHHhcCCCcccchh
Confidence 011223332222 244788999999999996 378
Q ss_pred HHHhCCCCCC
Q 004954 711 EALDHPWLQH 720 (722)
Q Consensus 711 ElL~HPwf~~ 720 (722)
++-.||||+.
T Consensus 512 dik~h~ffr~ 521 (593)
T KOG0695|consen 512 DIKSHAFFRS 521 (593)
T ss_pred hhhcchhhhh
Confidence 9999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=306.04 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=212.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-----
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----- 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~----- 487 (722)
.+-|.|.+.||.|.+|.||+++++.+++..|+||...+.+..+.+..|.+||+.+. .|||++.+|++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~-----~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYS-----HHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhcc-----CCCCcceEEEEEEEecCCC
Confidence 46799999999999999999999999999999999988777778888888998886 48999999999984
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
++.+|+|||||+| +..++++... ...+.+..+..|++.++.||.+||.+.++|||||-.|||++. ++.|||+|
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~--e~~VKLvD 166 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE--NAEVKLVD 166 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec--cCcEEEee
Confidence 3689999999984 6777776544 223889999999999999999999999999999999999996 89999999
Q ss_pred cCCcccccCC---ccccccCCcccCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 567 LGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 567 FGls~~~~~~---~~~~~gt~~y~APE~l~~~-----~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
||.+.+.... ..+.+|||.|||||++... .|+..+|+||||++..||..|.+|+-+..+.-.+..|. .+
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RN 243 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RN 243 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CC
Confidence 9998876543 4567999999999998643 37789999999999999999999997765544333321 11
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
+|+. ..++......|.+||..||..|-.+||+..++|+|||+
T Consensus 244 PPPk--------------------------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 244 PPPK--------------------------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred CCcc--------------------------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 1111 01122234568899999999999999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 286 ~e 287 (953)
T KOG0587|consen 286 TE 287 (953)
T ss_pred cc
Confidence 74
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-33 Score=300.49 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=213.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~----~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
-.+.+++..||-||||.|-++..+.....+|+|++++ +....+.+..|.+||..++. |.||++|..|.+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s------~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRS------DFIVRLYRTFRDS 492 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCc------hHHHHHHHHhccc
Confidence 3567788899999999999998766655689999875 34556778889999988873 6999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
..+|++||-|- |.+...++..+ .|....++.++.++++|+.|||.+|||+|||||+|.|++. +|-+||.||
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~--~Gy~KLVDF 564 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN--RGYLKLVDF 564 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc--CCceEEeeh
Confidence 99999999985 56666666443 2888999999999999999999999999999999999996 899999999
Q ss_pred CCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
|+|+..... .-+++|||.|.|||+++++..+.++|.||||+++||||+|.+||.+.++...+..|.+.+..+.
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~----- 639 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE----- 639 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-----
Confidence 999887654 3458999999999999999999999999999999999999999999999988888875433211
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
+|. .......+||+++...+|.+|.- +.++-+|-||..
T Consensus 640 ----------------------------~Pr---------~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 640 ----------------------------FPR---------RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ----------------------------ccc---------ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 111 11233669999999999999986 899999999963
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-31 Score=275.45 Aligned_cols=245 Identities=17% Similarity=0.190 Sum_probs=178.9
Q ss_pred EeccCCCCceEEEEECCC--CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 004954 421 YLGSAAFSKVFQAQDLHT--GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~t--g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmE 496 (722)
.||+|+||+||+++.... ...+++|.+.... .....+.+|..+++.+ .||||+++++.+......++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL------QHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc------CCcchhheEEEecCCCccEEEEe
Confidence 599999999999975332 3356677665432 2334566677666655 47899999999999999999999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC
Q 004954 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 497 y~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
|+.+ +|.+++...... ...+++..++.++.||+.||+|||+.+++||||||+|||++. ++.++|+|||++.....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~--~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS--DLTVKVGDYGIGPSRYK 151 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC--CccEEecccccccccCc
Confidence 9984 677776543221 223677788899999999999999999999999999999985 78899999998754221
Q ss_pred -----CccccccCCcccCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 576 -----NLCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 576 -----~~~~~~gt~~y~APE~l~~-------~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
......+++.|+|||++.. ..++.++|||||||++|+|++ |..||......+.+..+......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~---- 227 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV---- 227 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc----
Confidence 1123467889999999753 245789999999999999997 67899776665555443211000
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
......+ ....++.+.++|..|| .+|.+||++.++++
T Consensus 228 -------------------------~~~~~~~---------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 -------------------------KLFKPQL---------ELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------------------------ccCCCcc---------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000000 1113456889999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.22 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=210.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
..+..+.++||-|-||.||.|.|+.-.-.||||.++.+......++.|..+|+.++ |||+|+++++|.....+|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeik------HpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhc------CccHHHHhhhhccCCCeE
Confidence 34566778999999999999999999999999999999888899999999999997 679999999999999999
Q ss_pred EEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
||+|||. |+|+++++.+.... ++.-.++.|+.||..||.||..+++|||||..+|+||.. +..|||+|||+++
T Consensus 340 IiTEfM~yGNLLdYLRecnr~e----v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgE--nhiVKvADFGLsR 413 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSE----VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHIVKVADFGLSR 413 (1157)
T ss_pred EEEecccCccHHHHHHHhchhh----cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccc--cceEEeeccchhh
Confidence 9999997 89999999876654 777788899999999999999999999999999999996 8889999999999
Q ss_pred cccCCccc-ccc---CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 572 FQTDNLCL-YVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 572 ~~~~~~~~-~~g---t~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+......+ ..| +..|.|||.+....++.++|||+|||+||||.| |-.||++-+...++..+.+.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg----------- 482 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG----------- 482 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-----------
Confidence 87654332 233 567999999999999999999999999999998 99999998776665444311
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
.+..- ++..++...+||+.||+|+|+.||+..|+-
T Consensus 483 -----------------------yRM~~---------PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 483 -----------------------YRMDG---------PEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred -----------------------ccccC---------CCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 11111 233456688999999999999999988874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=304.64 Aligned_cols=206 Identities=27% Similarity=0.351 Sum_probs=174.0
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
+...-..-|...+.||+||||.||+++++.+|+.||||.++.. ....+...+|+++|++|+ |+|||+++++-
T Consensus 7 l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn------h~NIVk~f~ie 80 (732)
T KOG4250|consen 7 LTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN------HPNIVKLFDIE 80 (732)
T ss_pred cccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC------chhhhhhcccC
Confidence 3333446688889999999999999999999999999999863 345678899999999997 57999999986
Q ss_pred Eec------CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 486 YHL------EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 486 ~~~------~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
... ....+|||||.| +|...+.. +.....+++.+++.++..++.||.|||++||+||||||.||++-...
T Consensus 81 e~~~~~~~~~~~vlvmEyC~gGsL~~~L~~---PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge 157 (732)
T KOG4250|consen 81 ETKFLGLVTRLPVLVMEYCSGGSLRKVLNS---PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE 157 (732)
T ss_pred CccccCcccccceEEEeecCCCcHHHHhcC---cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Confidence 544 467899999985 56655543 23344599999999999999999999999999999999999986544
Q ss_pred CC--eEEEEecCCcccccCC--ccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004954 559 RC--EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (722)
Q Consensus 559 ~~--~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~-~~~~s~ksDIWSLGviL~elltG~~PF~~ 622 (722)
++ ..||+|||.|+-..+. ....+||+.|.+||++. .+.|+..+|.|||||++|++.||.+||-.
T Consensus 158 dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 158 DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 33 5799999999877654 55689999999999999 48899999999999999999999999954
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=286.94 Aligned_cols=293 Identities=26% Similarity=0.402 Sum_probs=214.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECC---CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~---tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.+.|+++++||.|.|++||++.+.. ..+.||+|.+..... ..++.+|+++|..+... .||+++.+++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~-----~ni~~~~~~~rn 106 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGS-----DNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccc-----hhhhcchhhhcc
Confidence 345679999999999999999999877 788999998865432 35789999999999754 599999999999
Q ss_pred cCeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+...+||||++.. ..++... ++...++.+++.++.||+++|.+|||||||||.|+|.+. ..+.-.|+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~-~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR-RTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc-ccCCceEEe
Confidence 99999999999864 3333331 778899999999999999999999999999999999986 567788999
Q ss_pred cCCcccc-----------------cC----------------C--------------ccccccCCcccCchhhcCCC-CC
Q 004954 567 LGSSCFQ-----------------TD----------------N--------------LCLYVQSRSYRAPEVIIGLP-YD 598 (722)
Q Consensus 567 FGls~~~-----------------~~----------------~--------------~~~~~gt~~y~APE~l~~~~-~s 598 (722)
||++... .. + .....||++|+|||++...+ .+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9987510 00 0 00147899999999987654 77
Q ss_pred chhhHHHHHHHHHHHHhCCCCC-CCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhcccccccc----
Q 004954 599 QKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI---- 673 (722)
Q Consensus 599 ~ksDIWSLGviL~elltG~~PF-~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 673 (722)
.++||||.|||+.-+++++.|| ...+..+.+.+|+-.+|.....-.+......-.+.+.. ..........++..
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn-~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSN-IPTIPELRVNFETLHIES 335 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecccc-ccccHHHHhchhccChhh
Confidence 8999999999999999999998 44555667777777777655443332211100111000 00000000000000
Q ss_pred -CCcc---chhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 674 -IPEE---SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 674 -ip~~---~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+.. ...+......+..+.+||.+||..||.+|.||+++|+||||..
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0000 1112223344567899999999999999999999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=290.93 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=196.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
..-|..++.||-|+||+|.++....|...||+|.+++.. ........|..||.+.. .+-||+||..|+++
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD------n~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD------NEWVVRLYYSFQDK 701 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC------CcceEEEEEEeccC
Confidence 345889999999999999999988999999999987643 22334455666776654 45899999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+.+|+||+|+.| ++-.++..... |.+..++.++..+..|+++.|+.|+|||||||+||||+. +|.|||+||
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmgI------FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr--dGHIKLTDF 773 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMGI------FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDF 773 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc--CCceeeeec
Confidence 999999999986 55555554332 889999999999999999999999999999999999996 999999999
Q ss_pred CCccc---------ccCC------------------------------------ccccccCCcccCchhhcCCCCCchhh
Q 004954 568 GSSCF---------QTDN------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKID 602 (722)
Q Consensus 568 Gls~~---------~~~~------------------------------------~~~~~gt~~y~APE~l~~~~~s~ksD 602 (722)
|++.- +... ....+||+.|+|||++....|+...|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 98621 0000 01148899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhh
Q 004954 603 LWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682 (722)
Q Consensus 603 IWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~ 682 (722)
+||.|||||||+.|++||..+.+.+...+++ +|+. ...+|....
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~tq~kv~------------nw~~---------------------~l~~~~~~~--- 897 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGETQYKVI------------NWRN---------------------FLHIPYQGN--- 897 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcceeeee------------ehhh---------------------ccccccccc---
Confidence 9999999999999999998765544333322 1111 111222222
Q ss_pred hcccCcHHHHHHHHHhcccCCCCCc---CHHHHHhCCCCCC
Q 004954 683 HLQFSDAFFIDFVRTLLEINPQRRP---TAREALDHPWLQH 720 (722)
Q Consensus 683 ~~~~~~~~l~dLL~~mL~~dP~kRp---Ta~ElL~HPwf~~ 720 (722)
.+.+..+||.++ ...++.|. -+++|-.||||+.
T Consensus 898 ----ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 898 ----LSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred ----cCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccc
Confidence 245677888875 45777886 4788999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=261.53 Aligned_cols=238 Identities=39% Similarity=0.618 Sum_probs=192.2
Q ss_pred CCCceEEEEECCCCcEEEEEEeecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc-ch
Q 004954 426 AFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NL 502 (722)
Q Consensus 426 ~fG~Vy~a~d~~tg~~vAvKil~~~~~~--~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g-sL 502 (722)
+||.||++++..+|+.+|+|++...... .+.+.+|++.++.+ .|+||+++++.+......++||||+.+ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL------KHPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC------CCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 5899999999889999999998764332 46777888888877 367999999999999999999999987 77
Q ss_pred HHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC--cccc
Q 004954 503 YEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLY 580 (722)
Q Consensus 503 l~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~--~~~~ 580 (722)
.+++..... ++...++.++.+++.+|.+||+.+++|+||+|+||+++. ++.++|+|||.+...... ....
T Consensus 75 ~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 75 FDLLKKRGR------LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE--DGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred HHHHHhccC------CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC--CCcEEEccccceeeeccccccccc
Confidence 776654321 788999999999999999999999999999999999996 688999999998776553 3445
Q ss_pred ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhccccc
Q 004954 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYD 659 (722)
Q Consensus 581 ~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~-~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~ 659 (722)
.++..|+|||.+.+..++.++||||||+++++|++|..||.. .........+........
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------- 207 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP------------------- 207 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------
Confidence 678899999999988889999999999999999999999977 333333322211100000
Q ss_pred chhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 660 LYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 660 ~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
+.. ...+..+.+++.+||..+|++||++.++++||||
T Consensus 208 ---------------~~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 208 ---------------PPE-------WKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---------------ccc-------ccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 000 0023568899999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=297.89 Aligned_cols=247 Identities=21% Similarity=0.280 Sum_probs=207.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~---~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
....+|.++||.|-||.|++|+.+..|+ .||||.++... .....++.|..||- +.+||||++|.++...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG------QFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG------QFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc------cCCCCcEEEEEEEEec
Confidence 4568899999999999999999877764 59999998743 34455666666654 4578999999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
...+.||+|||+ |+|..+++.+.. .|+..++.-|++.|+.||+||-+.++|||||..+||||++ +..+|++|
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs--nLvCKVsD 774 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS--NLVCKVSD 774 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc--ceEEEecc
Confidence 999999999997 677777775542 2899999999999999999999999999999999999997 88999999
Q ss_pred cCCcccccCCccc---ccc---CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 567 LGSSCFQTDNLCL---YVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 567 FGls~~~~~~~~~---~~g---t~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||+++...+.... ..| +.+|.|||.+...+++.++||||+|++|||.|+ |+.||.+.+..+.+..|....+-+
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP 854 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP 854 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence 9999987654421 111 467999999999999999999999999999887 999999999999999887544432
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
|+ .-.+..|.+|+..||++|-.+||+..+|+.+
T Consensus 855 pP-------------------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 855 PP-------------------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CC-------------------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 21 1235678999999999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=286.85 Aligned_cols=241 Identities=23% Similarity=0.337 Sum_probs=194.6
Q ss_pred EEEEEEeccCCCCceEEEEECC----CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLH----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~----tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
....++||.|-||.||+|.... ..--||||+.+.+ .+..+.++.|.-+++.+ +||||++++|++.. .
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf------dHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF------DHPHIIKLIGVCVE-Q 463 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC------CCcchhheeeeeec-c
Confidence 3445679999999999997532 2345899999874 34467788888888777 58899999999864 6
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..+||||.+. |.|..++..+... ++...+..++.||+.||+|||+.++|||||..+||||.+ .--|||+|||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS--p~CVKLaDFG 536 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS--PQCVKLADFG 536 (974)
T ss_pred ceeEEEecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC--cceeeecccc
Confidence 7899999998 7788888866554 889999999999999999999999999999999999997 5569999999
Q ss_pred CcccccCCcccc----ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNLCLY----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~~~~----~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
+++...+..... .-+..|||||.+....++.++|||.|||++|||+. |..||.+....+++..|...
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-------- 608 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-------- 608 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC--------
Confidence 999887764432 22556999999999999999999999999999987 99999887665555443211
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
-+. ..+.+.++.+..|+.+||.++|.+||+..++.
T Consensus 609 --------------------------eRl---------P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 609 --------------------------ERL---------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred --------------------------CCC---------CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 011 12235667889999999999999999987764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=292.35 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=204.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCC-C--cEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHT-G--VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~t-g--~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
++.++.++||+|.||.|++|.|... | ..||||+++.+.. ..+.+++|..+|.+|+ |+|++++|++..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~------H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ------HPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc------CcceeEEeeeecc-
Confidence 4677788999999999999998643 3 4589999987543 4678889999888886 7899999999887
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
..+.+|||++. |+|++-++... ...|....+..++.||+.||.||.++++|||||..+|+|+-+ ...|||+||
T Consensus 183 qp~mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas--prtVKI~DF 256 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS--PRTVKICDF 256 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc--cceeeeecc
Confidence 78889999998 68888877622 223888999999999999999999999999999999999986 778999999
Q ss_pred CCcccccCCcccccc------CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 568 GSSCFQTDNLCLYVQ------SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 568 Gls~~~~~~~~~~~g------t~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+.+-+......++- ...|+|||.+....++.++|+|++||++|||+| |+-||.+.....++.+|-+.
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~----- 331 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG----- 331 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-----
Confidence 999877766544332 345999999999999999999999999999999 89999999988888776310
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
+.+ .+++..++.+.+++..||..+|.+|||...|.+.-
T Consensus 332 -------------------------------erL-------pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 -------------------------------ERL-------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -------------------------------ccC-------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 011 12334567899999999999999999999886543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=288.61 Aligned_cols=276 Identities=19% Similarity=0.288 Sum_probs=184.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC----------------CCCcEEEEEEeecchhh---------------hHhHHHHH
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL----------------HTGVDVCLKIIKNDKDF---------------FDQSLDEI 461 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~----------------~tg~~vAvKil~~~~~~---------------~~~~~~E~ 461 (722)
.++|.+.++||+|+||+||+|.+. ..++.||||.++..... .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 468999999999999999999752 34567999998653211 11223466
Q ss_pred HHHHHhcccCCCCCCceeEEEEEEEe--------cCeEEEEEEcccc-chHHHHhhhhcc------------------CC
Q 004954 462 KLLKLVNKNDPADEHHILRLYDYFYH--------LEHLFIVCELLRA-NLYEFQKFNQES------------------GG 514 (722)
Q Consensus 462 ~il~~L~~~~~~~hpnIv~l~~~f~~--------~~~l~iVmEy~~g-sLl~~l~~~~~~------------------~~ 514 (722)
.++.++++.+ ..+.++++++++|.. .+..++||||+.+ +|.+++...... ..
T Consensus 224 ~~l~~l~~~~-l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIKRNP-IAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhhccc-chhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 6666666542 344566788887753 3568999999974 676666532110 01
Q ss_pred CcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCCc--c--ccccCCcccCch
Q 004954 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--C--LYVQSRSYRAPE 590 (722)
Q Consensus 515 ~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~--~--~~~gt~~y~APE 590 (722)
...+.+..++.++.|++.+|.|||+.+|+||||||+|||++. ++.+||+|||++....... . ....++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC--CCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 122567788899999999999999999999999999999986 6789999999986543221 1 123478999999
Q ss_pred hhcCCC--------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 591 VIIGLP--------------------YD--QKIDLWSLGCILAELWTGEV-LFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 591 ~l~~~~--------------------~s--~ksDIWSLGviL~elltG~~-PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
.+.... ++ .+.||||+||++|+|++|.. ||.+........+. ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----------~~~- 448 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----------YDN- 448 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----------ccc-
Confidence 986432 11 24799999999999999875 77542211100000 000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC---CCCcCHHHHHhCCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP---QRRPTAREALDHPWLQHPY 722 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP---~kRpTa~ElL~HPwf~~~~ 722 (722)
....| .. .....+.++. ....++...+||.+||..+| .+|+|++|+|+||||...|
T Consensus 449 -~~~~~----------r~-~~~~~~~~~~-------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~~ 507 (507)
T PLN03224 449 -DLNRW----------RM-YKGQKYDFSL-------LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPEF 507 (507)
T ss_pred -hHHHH----------Hh-hcccCCCccc-------ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCCC
Confidence 00000 00 0000111110 11234678899999999766 7899999999999998654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=300.38 Aligned_cols=245 Identities=30% Similarity=0.417 Sum_probs=189.8
Q ss_pred EEeccCCCCc-eEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 004954 420 EYLGSAAFSK-VFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (722)
Q Consensus 420 ~~LG~G~fG~-Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~ 498 (722)
+++|.|+.|+ ||+|. ..|+.||||.+-.+ ..+...+|+..|+.-. .|||||++|+.-++...+||+.|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e--~~~~A~rEi~lL~eSD-----~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLEE--FFDFAQREIQLLQESD-----EHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhhH--hHHHHHHHHHHHHhcc-----CCCceEEEEeeccCCceEEEEehHh
Confidence 3589999876 67887 57899999987543 3356778999888775 5899999999999999999999999
Q ss_pred ccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc---cCCCeEEEEecCCcccccC
Q 004954 499 RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 499 ~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~---~~~~~vkL~DFGls~~~~~ 575 (722)
..+|.+++....... .....-..+.+..|++.||++||+.+||||||||.||||.. .....++|+|||+++....
T Consensus 586 ~~sL~dlie~~~~d~--~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDV--EMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhhHHHHHhccccch--hhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999999998741110 00111456788999999999999999999999999999986 3457899999999987554
Q ss_pred C------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 576 N------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 576 ~------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
. .....||-+|+|||++.......++||+||||++|+.++| .+||...-.. -.+|.. |
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~--~----------- 728 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILT--G----------- 728 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhc--C-----------
Confidence 3 2345789999999999998888999999999999999995 9999764221 122210 0
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.+. +. .++ ...+.+..+||.+||..+|..||+|.++|.||+|
T Consensus 729 --------~~~----------L~-------~L~---~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 729 --------NYT----------LV-------HLE---PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred --------ccc----------ee-------eec---cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 000 00 000 0111257899999999999999999999999998
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=282.57 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=204.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
-..+..+.++||+|-||.|.+++- ..+..||+|+++.+. .....+.+|+++|.+|+ ||||++++++|..++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk------hPNIveLvGVC~~De 608 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLK------HPNIVELLGVCVQDD 608 (807)
T ss_pred chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccC------CCCeeEEEeeeecCC
Confidence 346788999999999999999984 446999999998643 34467889999998885 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+++|||||+ |.|.+++..+.... +.......|+.||+.||+||.+.++|||||.++|||++. +.++||+|||
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~--e~~iKiadfg 682 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDG--EFTIKIADFG 682 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecC--cccEEecCcc
Confidence 9999999997 67878777654332 344556679999999999999999999999999999995 8999999999
Q ss_pred CcccccCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 569 SSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 569 ls~~~~~~~~~-----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt--G~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
+++.+-..... .+-+.+|||+|.+.-.+++.++|+|++|+++||+++ .+.||.....+++..+.-.++...+.
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR 762 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence 99854443332 234788999999999999999999999999999876 78999887777766665433321110
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
+ .....+...+..+.+||.+||..|-++||+.+++..|
T Consensus 763 ---------------------------~---------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 763 ---------------------------Q---------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred ---------------------------c---------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 0 1111233445668899999999999999999998543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=264.45 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=197.2
Q ss_pred CCCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCcee
Q 004954 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (722)
Q Consensus 400 ~~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv 479 (722)
++..+|+.....++.+.++.+.||+|.||.||+|.+ -|+.||||++....+ +.+.+|.+|.+.+- +.|+||+
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE--~SWfrEtEIYqTvm----LRHENIL 268 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDE--RSWFRETEIYQTVM----LRHENIL 268 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccch--hhhhhHHHHHHHHH----hccchhh
Confidence 456788888999999999999999999999999986 588999999976544 56788888888764 3489999
Q ss_pred EEEEEEEec----CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-----C---CCcccc
Q 004954 480 RLYDYFYHL----EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-----L---GIIHCD 546 (722)
Q Consensus 480 ~l~~~f~~~----~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-----~---gIvHrD 546 (722)
.+++.-... ..+++|++|.+ |+|.+++...- ++......++..++.||++||. + .|.|||
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 999986544 36999999997 89999987532 8899999999999999999994 2 499999
Q ss_pred CCCCceEEcccCCCeEEEEecCCcccccC-------CccccccCCcccCchhhcCCC-----CC-chhhHHHHHHHHHHH
Q 004954 547 LKPENILIKSYQRCEIKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGLP-----YD-QKIDLWSLGCILAEL 613 (722)
Q Consensus 547 LKp~NILl~~~~~~~vkL~DFGls~~~~~-------~~~~~~gt~~y~APE~l~~~~-----~s-~ksDIWSLGviL~el 613 (722)
||..||||.+ ++.+.|+|+|+|-.... .....+||.+|||||++...- -+ ..+||||||.++||+
T Consensus 342 lKSKNILVKk--n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 342 LKSKNILVKK--NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred cccccEEEcc--CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 9999999996 88999999999854332 345579999999999986532 12 358999999999999
Q ss_pred HhC----------CCCCCCC----hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccch
Q 004954 614 WTG----------EVLFPND----AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS 679 (722)
Q Consensus 614 ltG----------~~PF~~~----~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~ 679 (722)
... ++||.+. ...+.+.+++ . ..+++..+|..+.
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV---------------------C-----------v~~~RP~ipnrW~ 467 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV---------------------C-----------VQKLRPNIPNRWK 467 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce---------------------e-----------ecccCCCCCcccc
Confidence 752 6677432 1122222221 0 1223333343222
Q ss_pred hhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 680 LEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 680 l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
-.... ..+..+|+.||..||.-|.||--+
T Consensus 468 s~~~l----~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 468 SDPAL----RVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCHHH----HHHHHHHHHhhcCCchhhhHHHHH
Confidence 11111 246789999999999999987443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=242.74 Aligned_cols=213 Identities=25% Similarity=0.383 Sum_probs=175.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+....+..||+|++|.|-+.++..+|+..|+|.++..- ....+.++|+.+..+ ..++|.+|++|+.+.....+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r-----~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMR-----TVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhcc-----CCCCCeEEEeehhhhccccE
Confidence 34445567999999999999999999999999987543 233444455554433 34679999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+|.||.|.-+|..+.+.--..+ ..+++.-+-+|+..++.||.|||++ .+||||+||+||||+. +|++||+|||.+
T Consensus 121 wIcME~M~tSldkfy~~v~~~g--~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~--~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKG--GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY--DGQVKICDFGIS 196 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcC--CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc--CCcEEEcccccc
Confidence 9999999988877766544333 3389999999999999999999975 8999999999999996 999999999999
Q ss_pred ccccCCccc--cccCCcccCchhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhh
Q 004954 571 CFQTDNLCL--YVQSRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGM 635 (722)
Q Consensus 571 ~~~~~~~~~--~~gt~~y~APE~l~~----~~~s~ksDIWSLGviL~elltG~~PF~~-~~~~e~l~~i~~~ 635 (722)
..+.+.... -.|...|+|||.+.. ..|+-++||||||+++.||.+++.||+. .++.+++.+++..
T Consensus 197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 887766433 467888999999853 4689999999999999999999999976 5677888887744
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=302.41 Aligned_cols=186 Identities=21% Similarity=0.302 Sum_probs=152.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
..|+..+.||+|+||.||+|++..+++.||||.+..... ....|+++++.+ .||||+++++++...+..++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l------~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL------QHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC------CCCCcceEEEEEEcCCCCEE
Confidence 456777899999999999999999999999999865432 123445555555 58999999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH---HCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH---SLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLH---s~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
||||++ |+|.++++. +++..+..|+.|++.||+||| +.+|+||||||+||+++. +...++. ||.
T Consensus 761 v~Ey~~~g~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~--~~~~~~~-~~~ 828 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG--KDEPHLR-LSL 828 (968)
T ss_pred EEeCCCCCcHHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC--CCceEEE-ecc
Confidence 999997 467666641 788899999999999999999 669999999999999986 4445544 555
Q ss_pred cccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~ 621 (722)
+...... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 829 ~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 829 PGLLCTD-TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ccccccC-CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 4332211 22367899999999999999999999999999999999999994
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=267.35 Aligned_cols=261 Identities=22% Similarity=0.250 Sum_probs=191.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC----
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---- 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~---- 489 (722)
...+++++||+|+||.||+|+ -+++.||||++..... +.+.+|..|..... ..|+||++++++-....
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~----m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQEK--QSFQNEKNIYSLPG----MKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHHHH--HHHHhHHHHHhccC----ccchhHHHhhchhccCCcccc
Confidence 456778899999999999997 4669999999976543 56778888887764 46999999999877555
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH---------CCCccccCCCCceEEcccCC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS---------LGIIHCDLKPENILIKSYQR 559 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs---------~gIvHrDLKp~NILl~~~~~ 559 (722)
.++||++|.+ |+|.++++.+- +++....+|+..|++||+|||+ ..|+|||||..||||.. +
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~--D 352 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN--D 352 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc--C
Confidence 7899999996 89999998654 8999999999999999999995 35999999999999996 8
Q ss_pred CeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCC-CC-----chhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 004954 560 CEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLP-YD-----QKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~-~s-----~ksDIWSLGviL~elltG~~PF~~~~~~e~ 628 (722)
++..|+|||+|..+... ....+||.+|||||++.+.- .. .+.||||+|.+||||++....+....+.++
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 99999999999765432 22368999999999997643 11 368999999999999997665532222222
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
.......+|.-|.-. ++...+ -..+.+..+|..+. .+ ..-..+++.+..||+.||+-|.|
T Consensus 433 qlpfe~evG~hPt~e-----~mq~~V-----------V~kK~RP~~p~~W~--~h--~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLE-----EMQELV-----------VRKKQRPKIPDAWR--KH--AGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred cCchhHHhcCCCCHH-----HHHHHH-----------HhhccCCCChhhhh--cC--ccHHHHHHHHHHHcCCchhhhhh
Confidence 222233334333211 111111 11223333333221 11 12356899999999999999999
Q ss_pred HHH
Q 004954 709 ARE 711 (722)
Q Consensus 709 a~E 711 (722)
|.=
T Consensus 493 A~C 495 (534)
T KOG3653|consen 493 AGC 495 (534)
T ss_pred hHH
Confidence 753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=271.46 Aligned_cols=198 Identities=29% Similarity=0.516 Sum_probs=174.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHh---------HHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ---------SLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~---------~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
..|..++.||.|+||.|++|.++.+...|+||.+.+++-..+. .-.|+.||..|+.+ .|+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~---sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH---SHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc---Cccchhhhhhe
Confidence 3499999999999999999999999999999999876543333 33599999999865 59999999999
Q ss_pred EEecCeEEEEEEcccc--chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 485 FYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g--sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
|++++..||+||-.+. +|.+++..... +++.++..|++|++.|+++||+.||||||||-+||+++. +|-+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~--~g~~ 709 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS--NGFV 709 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhccccccccCceecccccccEEEec--CCeE
Confidence 9999999999998863 67777776543 899999999999999999999999999999999999996 8999
Q ss_pred EEEecCCcccc-cCCccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 004954 563 KIIDLGSSCFQ-TDNLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPN 622 (722)
Q Consensus 563 kL~DFGls~~~-~~~~~~~~gt~~y~APE~l~~~~~s-~ksDIWSLGviL~elltG~~PF~~ 622 (722)
||+|||.+... ..+...++||..|.|||++.|.+|- ..-|||+||++||.++..+.||.+
T Consensus 710 klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999998765 4456678999999999999998864 678999999999999999999854
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=277.69 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=200.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEEC----C---CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDL----H---TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~----~---tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
+..++..+.+.||+|+||.|++|.-. . ....||||.++... .....+..|+++++.+. .|+||+.+
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g-----~H~niv~l 367 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG-----KHPNIVNL 367 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc-----CCcchhhh
Confidence 33445567779999999999999732 1 14679999987543 44677889999999986 48899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHhhhh---------ccCCC-cccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 004954 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQ---------ESGGE-AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~---------~~~~~-~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~ 550 (722)
++++...+.+++|+||+. |+|+.+++..+ ..... ..++...+..++.||+.|++||++..+|||||..+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999997 78999998777 11111 23899999999999999999999999999999999
Q ss_pred ceEEcccCCCeEEEEecCCcccccCCcccc-c-----cCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQTDNLCLY-V-----QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~~~~~~~-~-----gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~ 623 (722)
|||++. +..+||+|||+++......... . -+..|||||.+....++.++||||+|++||||+| |..||++.
T Consensus 448 NVLi~~--~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 448 NVLITK--NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hEEecC--CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999996 7899999999998544432221 1 2345999999999999999999999999999999 99999884
Q ss_pred h-HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 624 A-VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 624 ~-~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
. ..+++..+.. +.+...| .....++.++++.||+.+
T Consensus 526 ~~~~~l~~~l~~----------------------------------G~r~~~P---------~~c~~eiY~iM~~CW~~~ 562 (609)
T KOG0200|consen 526 PPTEELLEFLKE----------------------------------GNRMEQP---------EHCSDEIYDLMKSCWNAD 562 (609)
T ss_pred CcHHHHHHHHhc----------------------------------CCCCCCC---------CCCCHHHHHHHHHHhCCC
Confidence 4 3344332211 0011111 223567889999999999
Q ss_pred CCCCcCHHHHHh
Q 004954 703 PQRRPTAREALD 714 (722)
Q Consensus 703 P~kRpTa~ElL~ 714 (722)
|++||+..++.+
T Consensus 563 p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 563 PEDRPTFSECVE 574 (609)
T ss_pred cccCCCHHHHHH
Confidence 999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-28 Score=270.15 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=202.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.++|..+..+|+|.||.||+++|+.+++..|+|+++.... ...-+..|+-+++..+ ||||+.+++.+...+.+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~------h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR------HPNIVAYFGSYLRRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC------CcChHHHHhhhhhhcCc
Confidence 3679999999999999999999999999999999987542 3445566777776664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+|+||||+| +|.+....- .++++.++..+.+..+++|+|||++|-+|||||-.|||++. .+.+||+|||.+
T Consensus 88 wicMEycgggslQdiy~~T------gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd--~gDvklaDfgvs 159 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTD--EGDVKLADFGVS 159 (829)
T ss_pred EEEEEecCCCcccceeeec------ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecc--cCceeecccCch
Confidence 999999986 555543322 23889999999999999999999999999999999999996 888999999998
Q ss_pred ccccCC---ccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
...+.. ...+.|||.|||||+.. ...|....|||++|+...|+-.-++|--...+...+..+.+-.-.
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q------ 233 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ------ 233 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC------
Confidence 776543 34578999999999963 456889999999999999998877776544443333333211100
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.|.. .......+.|.+|++.+|..+|.+|||++.+|+|||.+.
T Consensus 234 -----------------------------pp~l----kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 234 -----------------------------PPTL----KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -----------------------------CCcc----cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 0100 001112356899999999999999999999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=223.66 Aligned_cols=208 Identities=42% Similarity=0.683 Sum_probs=178.9
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEccc
Q 004954 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (722)
Q Consensus 422 LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~ 499 (722)
||.|.+|.||++.+..+++.+++|++..... ....+.+|+.+++.+.+ ++|+++++++......+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~------~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH------PNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC------CCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999999988899999999987654 24678888888888864 699999999999999999999999
Q ss_pred -cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC--
Q 004954 500 -ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-- 576 (722)
Q Consensus 500 -gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~-- 576 (722)
++|.+++.... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++.. ...++|+|||.+......
T Consensus 75 ~~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~-~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 75 GGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC-CCcEEEecCCceEEccCCcc
Confidence 57777665432 238899999999999999999999999999999999999841 578999999998766554
Q ss_pred -ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 004954 577 -LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (722)
Q Consensus 577 -~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~ 654 (722)
.....+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------- 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------- 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence 3345678889999999887 788999999999999999
Q ss_pred cccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 655 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
..+.++|.+||+.||.+||++.++++|+
T Consensus 188 ----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1256899999999999999999999986
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=266.82 Aligned_cols=242 Identities=22% Similarity=0.264 Sum_probs=191.3
Q ss_pred EEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~----~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+..++||+|+||+||+|.+...|+ +||||++..... ....+++|.-+|..| +|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl------dHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL------DHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC------CCchHHHHhhhcccch
Confidence 4456789999999999999866554 688888865432 234555555555544 6899999999998766
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
+-||++|++ |.|+++++..+.. +-.+..+.|..||++||.|||+++++||||-.+||||.+ ...+||.|||
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks--P~hvkitdfg 843 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS--PNHVKITDFG 843 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC--CCeEEEEecc
Confidence 889999998 6899999876543 778899999999999999999999999999999999996 7789999999
Q ss_pred CcccccCCcccc-----ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 569 SSCFQTDNLCLY-----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 569 ls~~~~~~~~~~-----~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
+++........+ .-.+.|+|-|.+...+|+.++||||+||++||+|| |..|+.+.+..++-.-+...
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g------- 916 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG------- 916 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-------
Confidence 998766543322 22566999999999999999999999999999999 99999888766654333210
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.+..- ++..+.++.-+|.+||..|+..||+++++..
T Consensus 917 ---------------------------eRLsq---------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 ---------------------------ERLSQ---------PPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ---------------------------ccCCC---------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 00011 1223455678899999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-28 Score=244.81 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=197.1
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE-EEecCe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY-FYHLEH 490 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~-f~~~~~ 490 (722)
+.+.|.|.+.||+|.||.+-+++++.+++.+++|.++........+.+|..---.|. .|.||+.-|++ |++.+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls-----~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLS-----PHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeec-----cchhhhHHHHHHhhcCce
Confidence 467899999999999999999999999999999999877666667777765444443 47799987765 677888
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
..++|||++ |+|.+.+... .+-+.....++.|++.||.|||++++||||||.+||||-..+...|||+|||.
T Consensus 97 YvF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 999999998 6666655432 27788899999999999999999999999999999999766677999999999
Q ss_pred cccccCCccccccCCcccCchhhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVIIGLP-----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~~~~-----~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
++..+........+..|.+||.+...+ ....+|||.||+++|.+|||++||+.....+ .+.-.|
T Consensus 170 t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-----------~~Y~~~ 238 (378)
T KOG1345|consen 170 TRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-----------KPYWEW 238 (378)
T ss_pred ccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-----------chHHHH
Confidence 987776665566678899999876432 4567999999999999999999997432211 111111
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC---cCHHHHHhCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR---PTAREALDHPWL 718 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR---pTa~ElL~HPwf 718 (722)
..|+.. ....++..+...++.+..+.++-|..+|.+| .++...-...|.
T Consensus 239 ~~w~~r-------------------------k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 239 EQWLKR-------------------------KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHhcc-------------------------cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 111110 0112333344456778899999999999999 666665555553
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=222.53 Aligned_cols=205 Identities=37% Similarity=0.565 Sum_probs=172.0
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
|.+.+.||.|++|.||++.+..+++.+|+|.+..... ....+.+|+..++.++ |+|++++++.+......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~------~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK------HPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC------CCChhhheeeeecCCceEE
Confidence 5678899999999999999988899999999976543 3566777888888773 6799999999999899999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
++|++.+ +|.+.+...... +++..+..++.+++.+|.+||+.+++|+||+|.||+++. +..++|+|||.+..
T Consensus 75 v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~--~~~~~l~d~g~~~~ 147 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM--DGLVKLADFGLARF 147 (225)
T ss_pred EEeccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeeCceeeE
Confidence 9999987 777766543211 678899999999999999999999999999999999996 58899999999877
Q ss_pred ccCCc----cccccCCcccCchhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHH
Q 004954 573 QTDNL----CLYVQSRSYRAPEVI-IGLPYDQKIDLWSLGCILAELWTGEVLFPN--DAVVMILARII 633 (722)
Q Consensus 573 ~~~~~----~~~~gt~~y~APE~l-~~~~~s~ksDIWSLGviL~elltG~~PF~~--~~~~e~l~~i~ 633 (722)
..... ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+...+...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 65543 445678889999999 667788899999999999999999999977 44445555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=279.84 Aligned_cols=194 Identities=19% Similarity=0.215 Sum_probs=143.7
Q ss_pred ceeEEEEEE-------EecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 477 HILRLYDYF-------YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 477 nIv~l~~~f-------~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
||.+++++| .....++++||++.++|.+++... ...+++.+++.+++||+.||.|||++||+||||||
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 677777776 233567889999999999888632 12389999999999999999999999999999999
Q ss_pred CceEEcc-----------------cCCCeEEEEecCCcccccCC-------------------ccccccCCcccCchhhc
Q 004954 550 ENILIKS-----------------YQRCEIKIIDLGSSCFQTDN-------------------LCLYVQSRSYRAPEVII 593 (722)
Q Consensus 550 ~NILl~~-----------------~~~~~vkL~DFGls~~~~~~-------------------~~~~~gt~~y~APE~l~ 593 (722)
+||||+. +.++.+||+|||+++..... ....++|+.|+|||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999963 23456778888877532110 01135788999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhcccccccc
Q 004954 594 GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI 673 (722)
Q Consensus 594 ~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (722)
+..++.++|||||||+||||++|.+|+.... ..+..+....
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~------------------------------------- 229 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV------------------------------------- 229 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-------------------------------------
Confidence 9999999999999999999999988864321 1111111000
Q ss_pred CCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 674 IPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 674 ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.|... . ...+...+++.+||+.||.+||++.|+|+||||..
T Consensus 230 ~~~~~-~-----~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 230 LPPQI-L-----LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cChhh-h-----hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 00000 0 00123568899999999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=227.62 Aligned_cols=226 Identities=22% Similarity=0.318 Sum_probs=197.3
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+++-.|+|.++||+|+||.++.|++..++++||||.-.... ...++..|.+..+.|... ++|+.+|.+....-+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~-----~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGT-----EGIPQVYYFGQEGKY 98 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCC-----CCCCceeeeccccch
Confidence 56778999999999999999999999999999999865433 347888999999999854 699999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc---CCCeEEEEec
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKIIDL 567 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~---~~~~vkL~DF 567 (722)
-.+|||+++.+|.+++..+.+. |+.+++..++.||+.-++++|++.+|+|||||+|+||... +...|.|+||
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~-----FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRR-----FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCc-----ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 9999999999999999998765 9999999999999999999999999999999999999752 2347999999
Q ss_pred CCcccccCCcc----------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---ChHHHHHHHHHh
Q 004954 568 GSSCFQTDNLC----------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN---DAVVMILARIIG 634 (722)
Q Consensus 568 Gls~~~~~~~~----------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~---~~~~e~l~~i~~ 634 (722)
|+|+.+.++.+ ...||.+||+-...+|...|++.|+-|||.+++..|-|.+||++ .+..+-+++|-.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 99998776643 25789999999999999999999999999999999999999977 456667777766
Q ss_pred hcCCCcHHHHhhh
Q 004954 635 MLGPIDLEMLMQG 647 (722)
Q Consensus 635 ~lg~~~~~~~~~~ 647 (722)
.....|.+.+..+
T Consensus 254 ~Kr~T~i~~Lc~g 266 (449)
T KOG1165|consen 254 TKRSTPIEVLCEG 266 (449)
T ss_pred ccccCCHHHHHhc
Confidence 6667777666543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=215.36 Aligned_cols=226 Identities=21% Similarity=0.345 Sum_probs=191.3
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++.++|+++++||+|+||.+|+|....+|..||||+-.... ...+...|.++.+.|+.. ..|+++..++....+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g-----~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGG-----VGIPHIRHYGTEKDY 85 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccC-----CCCchhhhhcccccc
Confidence 45789999999999999999999999999999999876544 346788899999999875 478888888889999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC-CeEEEEecCC
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~-~~vkL~DFGl 569 (722)
-.+||+.++.+|.+++..+... ++..+++.++-||+.-++|+|..++|||||||+|+|+.-+.. ..+.|+|||+
T Consensus 86 nvlVMdLLGPsLEdLfnfC~R~-----ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 86 NVLVMDLLGPSLEDLFNFCSRR-----FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ceeeeeccCccHHHHHHHHhhh-----hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 9999999999999999888765 999999999999999999999999999999999999864333 3699999999
Q ss_pred cccccCCc----------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHHHhhc
Q 004954 570 SCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARIIGML 636 (722)
Q Consensus 570 s~~~~~~~----------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~---~~~e~l~~i~~~l 636 (722)
|+.+.+.. ....||..|.+--...+...++..|+-|+|.+|..+.-|.+||++. +..+-+++|.+..
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 97655432 2357899999999999989999999999999999999999999874 3444556666666
Q ss_pred CCCcHHHHhhh
Q 004954 637 GPIDLEMLMQG 647 (722)
Q Consensus 637 g~~~~~~~~~~ 647 (722)
-..+.+.+..+
T Consensus 241 ~s~~ie~LC~G 251 (341)
T KOG1163|consen 241 MSTPIEVLCKG 251 (341)
T ss_pred cCCCHHHHhCC
Confidence 66666655543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=222.48 Aligned_cols=252 Identities=19% Similarity=0.227 Sum_probs=191.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCC-----cEEEEEEeecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg-----~~vAvKil~~~~~~--~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
-..|++..-++-+|.||.||.|.+.... +.|-+|.++..... ...++.|-.++. ...|||++.+.++
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly------~~sH~nll~V~~V 355 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLY------GASHPNLLSVLGV 355 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHh------cCcCCCccceeEE
Confidence 3567888889999999999999765432 34556666544322 222333333333 2348999999999
Q ss_pred EEec-CeEEEEEEccc-cchHHHHhhhhccCC--CcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC
Q 004954 485 FYHL-EHLFIVCELLR-ANLYEFQKFNQESGG--EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 485 f~~~-~~l~iVmEy~~-gsLl~~l~~~~~~~~--~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~ 560 (722)
.... ...++++.+++ |+|..++..++.... ...++..++..++.|++.|++|||+.|+||.||..+|++|+. ..
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd--~L 433 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD--QL 433 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh--he
Confidence 8754 56788899997 789988886654333 234667778889999999999999999999999999999995 78
Q ss_pred eEEEEecCCcccccCCcccccc-----CCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHh
Q 004954 561 EIKIIDLGSSCFQTDNLCLYVQ-----SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG 634 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~~~~~~g-----t~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~ 634 (722)
++||+|=.+++..-.......| +..||+||.+....|+.++|+|||||+||||+| |+.||..-++.++..-+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 9999999998765544333333 567999999999999999999999999999999 9999988777666544421
Q ss_pred hcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
. + +. ..+.+.+.++..++.-||...|++||+.+|++.
T Consensus 514 G----------------------y------------Rl---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 G----------------------Y------------RL---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred c----------------------c------------ee---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1 0 00 112345677889999999999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-23 Score=222.75 Aligned_cols=204 Identities=28% Similarity=0.343 Sum_probs=170.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCC-cEEEEEEeecchhh-hHhHHHHHHHHHHhcccCCCCCCceeEEEEEE-EecCeE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYF-YHLEHL 491 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg-~~vAvKil~~~~~~-~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f-~~~~~l 491 (722)
+|++.++||+|+||.||++.+..++ ..+|+|+....... ...+..|..++..+.. ...-++++++++.+ .....-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~--~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK--KNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh--hcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999987774 68999988764322 2267789999999985 11235899999999 477889
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-C--CeEEEEecC
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-R--CEIKIIDLG 568 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~--~~vkL~DFG 568 (722)
+|||+.++.+|.++..... ...++..++..|+.|++.+|.+||+.|++||||||+|+++.... . ..+.|+|||
T Consensus 97 ~iVM~l~G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEeccCccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999999999999876544 23499999999999999999999999999999999999998532 1 579999999
Q ss_pred Ccc--ccc-C---------C-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh
Q 004954 569 SSC--FQT-D---------N-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (722)
Q Consensus 569 ls~--~~~-~---------~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~ 624 (722)
+++ ... . . .....||..|+++.+..+...+++.|+||++.++.+++.|..||.+..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 998 311 1 1 123559999999999999999999999999999999999999997654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=210.00 Aligned_cols=168 Identities=28% Similarity=0.332 Sum_probs=124.0
Q ss_pred cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCCccc
Q 004954 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579 (722)
Q Consensus 500 gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~ 579 (722)
|+|.+++..... .+++..++.|+.||+.||.|||+.+ ||+|||++. ++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~--~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW--DGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC--ccceee--ccceEeecccc--
Confidence 467777764322 3899999999999999999999999 999999985 778888 99987665433
Q ss_pred cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccc
Q 004954 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEY 658 (722)
Q Consensus 580 ~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~-~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~ 658 (722)
..+|+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..+.....+...
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------------- 126 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP----------------- 126 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-----------------
Confidence 2689999999999999999999999999999999999999965432 2222222211100000
Q ss_pred cchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 659 DLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 659 ~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
...+...... ....+.+||++||..||.+|||+.|+++|+|+.
T Consensus 127 -------------~~~~~~~~~~-----~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 -------------RDRSNLESVS-----AARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred -------------cccccHHHHH-----hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0000000000 002588999999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=242.95 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=188.0
Q ss_pred CcE-EEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY-~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
..| .-..++|.|++|.|+.+........++.|..... ........ ...+..++-......|+|++..+..+.....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~-~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKY-NYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHH-hhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 345 3456799999999998887766666666654311 11111111 1125555555566788999888777776666
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
..-+|||+++.|..++.... .++..++..++.|++.|++|||+.||.|||||++|+++.. .+.+||+|||.+
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~--~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE--NGILKIIDFGAA 467 (601)
T ss_pred chhhhhcccHHHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec--CCceEEeecCcc
Confidence 55669999987777776441 2788899999999999999999999999999999999996 779999999987
Q ss_pred ccccC-------CccccccCCcccCchhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCChHHHHHH-HHHhhcCCCcH
Q 004954 571 CFQTD-------NLCLYVQSRSYRAPEVIIGLPYDQ-KIDLWSLGCILAELWTGEVLFPNDAVVMILA-RIIGMLGPIDL 641 (722)
Q Consensus 571 ~~~~~-------~~~~~~gt~~y~APE~l~~~~~s~-ksDIWSLGviL~elltG~~PF~~~~~~e~l~-~i~~~lg~~~~ 641 (722)
....- .....+|+..|+|||++.+..|.. .+||||.|+++..|.+|+.||.-....+... .+.
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-------- 539 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-------- 539 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------
Confidence 54321 123468899999999999999884 7899999999999999999996543222110 000
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
. ..+...... ........+...+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 540 ---------------~---------~~~~~~~~~----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 540 ---------------Y---------SDQRNIFEG----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ---------------c---------ccccccccC----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 0 000000000 011111223557799999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-20 Score=196.28 Aligned_cols=257 Identities=32% Similarity=0.489 Sum_probs=193.4
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
|.+.+.||.|+|+.||++.+. ..+++|.+..... ....+.+|..++..+.+. ++|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~-----~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP-----PNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCC-----cceeeEEEEEecCCEE
Confidence 788999999999999999986 7889999875432 345677888888877643 2799999999877888
Q ss_pred EEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC-eEEEEecCC
Q 004954 492 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGS 569 (722)
Q Consensus 492 ~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~-~vkL~DFGl 569 (722)
+++++++.+. +.+++...... ..+.......++.|++.+|.|+|+.+++|||+||+||+++. .. .++++|||.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~--~~~~~~l~dfg~ 148 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGL 148 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC--CCCeEEEeccCc
Confidence 9999999864 44333322211 24889999999999999999999999999999999999996 44 799999999
Q ss_pred cccccCC---------ccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCChH----HHHHHHHH
Q 004954 570 SCFQTDN---------LCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAV----VMILARII 633 (722)
Q Consensus 570 s~~~~~~---------~~~~~gt~~y~APE~l~~---~~~s~ksDIWSLGviL~elltG~~PF~~~~~----~e~l~~i~ 633 (722)
+...... .....++..|++||.+.+ ..++...|+||+|++++++++|..||..... ......+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 8754432 245688999999999988 5788999999999999999999999876653 23332222
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
....+ ........... ......+.+++.+++..+|..|.++.+..
T Consensus 229 ~~~~~------------------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 229 ELPTP------------------------------SLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred hcCCc------------------------------ccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 11111 00000000000 11124578999999999999999999998
Q ss_pred hCCCCCC
Q 004954 714 DHPWLQH 720 (722)
Q Consensus 714 ~HPwf~~ 720 (722)
.++|...
T Consensus 274 ~~~~~~~ 280 (384)
T COG0515 274 SHDLLAH 280 (384)
T ss_pred hchHhhC
Confidence 8876543
|
|
| >cd08677 C2A_Synaptotagmin-13 C2 domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=183.33 Aligned_cols=93 Identities=14% Similarity=0.051 Sum_probs=83.5
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
+.+.|+|+|++| ||+ + .|.+|||||++|+|+.+ ++|+||+++|+|+||+|||+|.|. ++.+++ +++|.++||
T Consensus 12 ~~~~L~V~vikA~~L~-~--~g~sDPYVKv~L~~~~k-~~k~kT~v~rktlnPvfnE~f~F~--v~~~~l~~~tL~~~V~ 85 (118)
T cd08677 12 QKAELHVNILEAENIS-V--DAGCECYISGCVSVSEG-QKEAQTALKKLALHTQWEEELVFP--LPEEESLDGTLTLTLR 85 (118)
T ss_pred cCCEEEEEEEEecCCC-C--CCCCCeEEEEEEcCCcC-ccEEEcceecCCCCCccccEEEEe--CCHHHhCCcEEEEEEE
Confidence 568999999999 999 3 47799999999998766 357799999999999999999999 998888 666999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|++++|++||++.++..+.
T Consensus 86 d~Drfs~~d~IG~v~l~l~~~ 106 (118)
T cd08677 86 CCDRFSRHSTLGELRLKLADV 106 (118)
T ss_pred eCCCCCCCceEEEEEEccccc
Confidence 999999999999999988664
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 13, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 12, does not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domain |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=208.59 Aligned_cols=166 Identities=20% Similarity=0.180 Sum_probs=126.7
Q ss_pred ceeeCceecCcEEEEEEeccCCCCceEEEEECC-CCcEEEEEEeecc------hhhhHhHHHHHHHHHHhcccCCCCCCc
Q 004954 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHH 477 (722)
Q Consensus 405 pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~-tg~~vAvKil~~~------~~~~~~~~~E~~il~~L~~~~~~~hpn 477 (722)
|-.....+.++|.+.+.||+|+||+||+|++.. +++.+|||++... ......+.+|+++|+.++ |+|
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~------h~~ 82 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR------GIG 82 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc------CCC
Confidence 334456778999999999999999999999876 6788899986532 223456789999999996 456
Q ss_pred ee-EEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccC-CCCceEEc
Q 004954 478 IL-RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL-KPENILIK 555 (722)
Q Consensus 478 Iv-~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDL-Kp~NILl~ 555 (722)
++ ++++. +..++||||+.|..+.... . .. ...++.|+++||.|||+.||+|||| ||+|||++
T Consensus 83 iv~~l~~~----~~~~LVmE~~~G~~L~~~~---~------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~ 146 (365)
T PRK09188 83 VVPQLLAT----GKDGLVRGWTEGVPLHLAR---P------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG 146 (365)
T ss_pred CCcEEEEc----CCcEEEEEccCCCCHHHhC---c------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc
Confidence 66 45542 5689999999876554221 0 11 1467889999999999999999999 99999997
Q ss_pred ccCCCeEEEEecCCcccccCCc-----------cccccCCcccCchhhcC
Q 004954 556 SYQRCEIKIIDLGSSCFQTDNL-----------CLYVQSRSYRAPEVIIG 594 (722)
Q Consensus 556 ~~~~~~vkL~DFGls~~~~~~~-----------~~~~gt~~y~APE~l~~ 594 (722)
. ++.+||+|||+++...... +...+++.|+|||.+..
T Consensus 147 ~--~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 147 P--DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred C--CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 5 6789999999987544332 23466788999999853
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-20 Score=192.17 Aligned_cols=206 Identities=22% Similarity=0.328 Sum_probs=131.7
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhccc-CC---CCCCceeEEEEEEEe
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKN-DP---ADEHHILRLYDYFYH 487 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~-~~---~~hpnIv~l~~~f~~ 487 (722)
....+.||.|+++.||.++|..||+.+|+|++..... ..+++.+|.-....+... ++ ..|-.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4566789999999999999999999999999864322 223333333222221110 00 001123333333221
Q ss_pred ---------c--------CeEEEEEEccccchHHHHhhhhccCC-CcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 488 ---------L--------EHLFIVCELLRANLYEFQKFNQESGG-EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 488 ---------~--------~~l~iVmEy~~gsLl~~l~~~~~~~~-~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
. -..+++|+-+.++|.+++........ ...+.......+..|+++.+++||..|++|+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 1 13478899999998888764332221 22244444566779999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCccccccCCcccCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG--------LPYDQKIDLWSLGCILAELWTGEVLFP 621 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDIWSLGviL~elltG~~PF~ 621 (722)
+|++++. +|.++|+||+.....+........+..|.|||.... ..++.+.|.|+||+++|.|++|+.||.
T Consensus 174 ~nfll~~--~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLDQ--DGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE-T--TS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEcC--CCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 9999996 899999999987666554433455678999998743 247889999999999999999999996
Q ss_pred CC
Q 004954 622 ND 623 (722)
Q Consensus 622 ~~ 623 (722)
..
T Consensus 252 ~~ 253 (288)
T PF14531_consen 252 LS 253 (288)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
|
| >cd08692 C2B_Tac2-N C2 domain second repeat found in Tac2-N (Tandem C2 protein in Nucleus) | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=181.56 Aligned_cols=107 Identities=12% Similarity=0.021 Sum_probs=96.9
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCC-CcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGS-SIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tl-nP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
++++|+|+|++| ||++|+..+..|||||+.|++++++.+|+||+++|+|+ ||+|||+|.|+ ++.+..+.+|.++||
T Consensus 12 ~~~rLtV~VikarnL~~~~~~~~~dpYVKV~L~~~~k~~~KkKT~v~k~t~~~P~fNEsF~Fd--v~~~~~~v~l~v~v~ 89 (135)
T cd08692 12 VNSRIQLQILEAQNLPSSSTPLTLSFFVKVGMFSTGGLLYKKKTRLVKSSNGQVKWGETMIFP--VTQQEHGIQFLIKLY 89 (135)
T ss_pred cCCeEEEEEEEccCCCcccCCCCCCcEEEEEEEECCCcceeecCccEECCCCCceecceEEEe--CCchhheeEEEEEEE
Confidence 678899999999 99999888888999999999999999999999999996 59999999999 887766766999999
Q ss_pred ccCCCCCCccccccccCccccccccCCCcch
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHGVATPDL 372 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~~~~~~~ 372 (722)
|+|++++|++||.+.+|..+..+++...|.+
T Consensus 90 d~~~~~~n~~IG~v~lG~~~~~~~~~~hW~~ 120 (135)
T cd08692 90 SRSSVRRKHFLGQVWISSDSSSSEAVEQWKD 120 (135)
T ss_pred eCCCCcCCceEEEEEECCccCCchhhhhHHH
Confidence 9999999999999999988777777777666
|
Tac2-N contains two C2 domains and a short C-terminus including a WHXL motif, which are key in stabilizing transport vesicles to the plasma membrane by binding to a plasma membrane. However unlike the usual carboxyl-terminal-type (C-type) tandem C2 proteins, it lacks a transmembrane domain, a Slp-homology domain, and a Munc13-1-interacting domain. Homology search analysis indicate that no known protein motifs are located in its N-terminus, making Tac2-N a novel class of Ca2+-independent, C-type tandem C2 proteins. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polypho |
| >cd08407 C2B_Synaptotagmin-13 C2 domain second repeat present in Synaptotagmin 13 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-21 Score=181.31 Aligned_cols=106 Identities=12% Similarity=-0.022 Sum_probs=92.6
Q ss_pred ccceeEEEEeec-CCccccCC--CCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHN--VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPA 339 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~--g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~ 339 (722)
++++|+|+|++| ||.++|.+ +.+|||||++|++++++.+|+||+++++++||+|||+|.|. ++.+.+ +.+|.++
T Consensus 13 ~~~~L~V~V~karnL~~~d~~~~~~~DpYVKv~l~~~~~k~~kkkT~v~k~t~nPvfNE~f~F~--v~~~~L~~~~L~~~ 90 (138)
T cd08407 13 AANRLLVVVIKAKNLHSDQLKLLLGIDVSVKVTLKHQNAKLKKKQTKRAKHKINPVWNEMIMFE--LPSELLAASSVELE 90 (138)
T ss_pred CCCeEEEEEEEecCCCccccCCCCCCCeEEEEEEEcCCcccceeccceeeCCCCCccccEEEEE--CCHHHhCccEEEEE
Confidence 567899999999 99999954 55899999999999888899999999999999999999999 998888 5569999
Q ss_pred ccccCCCCCCccccccccCccccccccCCCcch
Q 004954 340 EIDNSDTRDGEVNGALHEGKADAEEHGVATPDL 372 (722)
Q Consensus 340 V~D~D~~~~~d~iG~v~~~~~~~~~e~~~~~~~ 372 (722)
|||+|++++++++|++.++... .++....|.+
T Consensus 91 V~d~d~~~~~d~iG~v~lg~~~-~g~~~~hW~~ 122 (138)
T cd08407 91 VLNQDSPGQSLPLGRCSLGLHT-SGTERQHWEE 122 (138)
T ss_pred EEeCCCCcCcceeceEEecCcC-CCcHHHHHHH
Confidence 9999999999999999999864 4444445443
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 13, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 12, does not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recy |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-21 Score=213.40 Aligned_cols=236 Identities=27% Similarity=0.350 Sum_probs=183.8
Q ss_pred EeccCCCCceEEEEE---CCCCcEEEEEEeecchhh---hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 421 YLGSAAFSKVFQAQD---LHTGVDVCLKIIKNDKDF---FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d---~~tg~~vAvKil~~~~~~---~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
++|.|.||.|+++.- ...|+-+|+|++++.... ......|..++..++ .||.++++...|+....++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~-----~~~f~v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH-----NTPFLVKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc-----CCCceeeeeeeeccccchhHh
Confidence 379999999998852 345677899988753211 113445666666665 368999999999999999999
Q ss_pred EEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
+++..|+ +..-+.. ...+.+.....+...++-++.++|+.+|+|||+|++||+++. +|.+++.|||+++..
T Consensus 76 ld~~rgg~lft~l~~------~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~--~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSK------EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL--EGHIKLTDFGLSKEA 147 (612)
T ss_pred hhhcccchhhhcccc------CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc--cCccccCCchhhhHh
Confidence 9999874 3332221 223777788888889999999999999999999999999996 899999999999765
Q ss_pred cCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 004954 574 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (722)
Q Consensus 574 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~ 653 (722)
-..... +||..|||||++. ....++|.||+|+++++|+||..||.. ++..+|.+.--.+|.+
T Consensus 148 v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~----------- 209 (612)
T KOG0603|consen 148 VKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE----------- 209 (612)
T ss_pred Hhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh-----------
Confidence 444333 8999999999998 567899999999999999999999987 4555554322222222
Q ss_pred hcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 654 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
...++.+++..|+..+|.+|.- +.|+++|+||+.
T Consensus 210 ---------------------------------l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 210 ---------------------------------LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred ---------------------------------hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 2355779999999999999975 589999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-20 Score=214.72 Aligned_cols=219 Identities=29% Similarity=0.383 Sum_probs=162.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
...+|..++.|-.|+||.||+++|+.+.+++|+|+=+++- |++ ||+.+- +..
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----------ilR-----------nilt~a------~np 132 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----------ILR-----------NILTFA------GNP 132 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccch-----------hhh-----------cccccc------CCc
Confidence 3467999999999999999999999999999996533221 111 121111 112
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+.| |+-..+++.... ++... +.+++|||+.||+|||+||+|.+|+. -|.+|++|||+++
T Consensus 133 fvv-----gDc~tllk~~g~------lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~--mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 133 FVV-----GDCATLLKNIGP------LPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITS--MGHIKLTDFGLSK 191 (1205)
T ss_pred cee-----chhhhhcccCCC------Ccchh--------hHHhHhhccCCeecCCCCCCcceeee--cccccccchhhhh
Confidence 222 333333332111 33222 66999999999999999999999997 8899999999875
Q ss_pred cccCC------------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 572 FQTDN------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 572 ~~~~~------------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
..... ....+|||.|+|||++..+.|+..+|+|++|+|+|+.+-|+.||-++.+++++..++
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 31111 123589999999999999999999999999999999999999999999999998887
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc---CHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP---TAR 710 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp---Ta~ 710 (722)
......|.+ -....++.+++|.++|+.+|..|. .+-
T Consensus 272 sd~i~wpE~-----------------------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 272 SDDIEWPEE-----------------------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhhcccccc-----------------------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 432221111 011246688999999999999995 577
Q ss_pred HHHhCCCCCC
Q 004954 711 EALDHPWLQH 720 (722)
Q Consensus 711 ElL~HPwf~~ 720 (722)
+|-+|+||+.
T Consensus 311 evk~h~ff~~ 320 (1205)
T KOG0606|consen 311 EVKQHGFFQL 320 (1205)
T ss_pred hhhhccceee
Confidence 8889999974
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=187.22 Aligned_cols=177 Identities=15% Similarity=0.197 Sum_probs=131.4
Q ss_pred cceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHh------HHHHHHHHHHhcccCCC
Q 004954 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQ------SLDEIKLLKLVNKNDPA 473 (722)
Q Consensus 404 ~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~------~~~E~~il~~L~~~~~~ 473 (722)
+..+..+.+.++|+++++||.|+||.||++.+ ++..+|||++..... .... +.+|++.+.++.
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~----- 93 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR----- 93 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-----
Confidence 45567788899999999999999999999765 477899999974321 1112 467777888886
Q ss_pred CCCceeEEEEEEEec--------CeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 004954 474 DEHHILRLYDYFYHL--------EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIH 544 (722)
Q Consensus 474 ~hpnIv~l~~~f~~~--------~~l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvH 544 (722)
|++|..+.+++... ...+|||||++|. |.+... +++ ....+++.+|..||+.|++|
T Consensus 94 -~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~gi~H 158 (232)
T PRK10359 94 -SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQHGMVS 158 (232)
T ss_pred -HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHcCCcc
Confidence 45788777776643 3589999999984 544311 332 24569999999999999999
Q ss_pred ccCCCCceEEcccCCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHH
Q 004954 545 CDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 614 (722)
Q Consensus 545 rDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ell 614 (722)
||+||+||++++ ++ ++|+|||........... ...++...+..++|+|+||+++..+.
T Consensus 159 ~Dikp~Nili~~--~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 159 GDPHKGNFIVSK--NG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCChHHEEEeC--CC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999986 55 999999987554322111 11344555778999999999987665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=216.01 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=172.9
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
.|...+.||++.|=+|.+|++ ..|. |+||++.+... ..+.+.++++-++.. ...+||.+.+.-+-......|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~----l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFA----LMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHH----hhcCCcccchHHHHHhhHHHH
Confidence 678888999999999999986 4555 99999865432 223333333333311 124689998887777777889
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||-+|+..+|++.+..+. .+.+-+.+.|+.||+.||.-+|..||+|||||.+||||++ -.-+.|+||..-+.
T Consensus 98 lvRqyvkhnLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS--WNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 98 LVRQYVKHNLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS--WNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHhhhhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee--echhhhhcccccCC
Confidence 999999999998776543 3778888999999999999999999999999999999997 55688999985432
Q ss_pred ---ccCCcc---ccccC----CcccCchhhcCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 004954 573 ---QTDNLC---LYVQS----RSYRAPEVIIGL----------P-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (722)
Q Consensus 573 ---~~~~~~---~~~gt----~~y~APE~l~~~----------~-~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~ 630 (722)
..+++. .+..| ..|.|||.+... + .+.+.||||+||++.||++ |++||.-.+...+-.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~ 249 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS 249 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc
Confidence 122221 12222 349999998531 1 5678999999999999988 899995322111100
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
. +..+. .++...| .+..+++||..|++.||++|.+|+
T Consensus 250 ~-----~~~~~--------------------------e~~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAe 286 (1431)
T KOG1240|consen 250 G-----NADDP--------------------------EQLLEKI------------EDVSLRNLILSMIQRDPSKRLSAE 286 (1431)
T ss_pred c-----CccCH--------------------------HHHHHhC------------cCccHHHHHHHHHccCchhccCHH
Confidence 0 00000 0111111 234578999999999999999999
Q ss_pred HHHhC
Q 004954 711 EALDH 715 (722)
Q Consensus 711 ElL~H 715 (722)
+.|+-
T Consensus 287 dyL~~ 291 (1431)
T KOG1240|consen 287 DYLQK 291 (1431)
T ss_pred HHHHh
Confidence 99974
|
|
| >cd08406 C2B_Synaptotagmin-12 C2 domain second repeat present in Synaptotagmin 12 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-20 Score=176.81 Aligned_cols=104 Identities=12% Similarity=0.004 Sum_probs=92.3
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..++|+|.|++| ||+++|.+|.+|||||++|+|++++.+|+||+++|+|+||+|||+|.|. ++.+.+ +.+|.++||
T Consensus 13 ~~~~L~V~Vi~A~nL~~~~~~g~~DpyVkv~l~~~~~~~~k~kT~v~k~t~nP~~nE~f~F~--v~~~~l~~~~l~~~V~ 90 (136)
T cd08406 13 TAERLTVVVVKARNLVWDNGKTTADPFVKVYLLQDGRKISKKKTSVKRDDTNPIFNEAMIFS--VPAIVLQDLSLRVTVA 90 (136)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCeEEEEEEEeCCccccccCCccccCCCCCeeceeEEEE--CCHHHhCCcEEEEEEE
Confidence 457899999999 9999999999999999999999888889999999999999999999999 888777 566999999
Q ss_pred ccCCCCCCccccccccCccccccccCCCc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHGVATP 370 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~~~~~ 370 (722)
|+|++++++++|.+.++... .+++...|
T Consensus 91 ~~d~~~~~~~iG~v~lg~~~-~g~~~~hW 118 (136)
T cd08406 91 ESTEDGKTPNVGHVIIGPAA-SGMGLSHW 118 (136)
T ss_pred eCCCCCCCCeeEEEEECCCC-CChhHHHH
Confidence 99999999999999998764 33444443
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 12, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 13, do not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycl |
| >cd08680 C2_Kibra C2 domain found in Human protein Kibra | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-20 Score=170.43 Aligned_cols=98 Identities=14% Similarity=0.054 Sum_probs=89.6
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCc-ccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE-KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~-~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
..++|+|+|++| ||+++|.+|.+|||||++|+|++++. +++||+++++++||+|||+|.|. ++.+++ +++|.++|
T Consensus 12 ~~~~L~V~V~~arnL~~~~~~~~~dpyVKv~Llp~~~~~~~~~kT~v~~~t~nPvfnE~F~f~--v~~~~L~~~~L~~~V 89 (124)
T cd08680 12 GDSSLVISVEQLRNLSALSIPENSKVYVRVALLPCSSSTSCLFRTKALEDQDKPVFNEVFRVP--ISSTKLYQKTLQVDV 89 (124)
T ss_pred CCCEEEEEEeEecCCcccccCCCCCeEEEEEEccCCCCCCceEEcCccCCCCCCccccEEEEE--CCHHHhhcCEEEEEE
Confidence 457899999999 99999999999999999999998763 68999999999999999999999 888888 67799999
Q ss_pred cccCCCCCCccccccccCccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
||++++++++++|+++++..+.+
T Consensus 90 ~~~~~~~~~~~lG~~~i~L~~~~ 112 (124)
T cd08680 90 CSVGPDQQEECLGGAQISLADFE 112 (124)
T ss_pred EeCCCCCceeEEEEEEEEhhhcc
Confidence 99999999999999999876553
|
Kibra is thought to be a regulator of the Salvador (Sav)/Warts (Wts)/Hippo (Hpo) (SWH) signaling network, which limits tissue growth by inhibiting cell proliferation and promoting apoptosis. The core of the pathway consists of a MST and LATS family kinase cascade that ultimately phosphorylates and inactivates the YAP/Yorkie (Yki) transcription coactivator. The FERM domain proteins Merlin (Mer) and Expanded (Ex) are part of the upstream regulation controlling pathway mechanism. Kibra colocalizes and associates with Mer and Ex and is thought to transduce an extracellular signal via the SWH network. The apical scaffold machinery that contains Hpo, Wts, and Ex recruits Yki to the apical membrane facilitating its inhibitory phosphorlyation by Wts. Since Kibra associates with Ex and is apically located it is hypothesized that KIBRA is part of the scaffold, helps in the Hpo/Wts complex, and helps recruit Yki for inactivation that prom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-20 Score=184.56 Aligned_cols=242 Identities=19% Similarity=0.254 Sum_probs=183.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
....++.+|.....|..|+|++. |..++.|+++... .....+..|.-.|+. ..||||+.+++.+....+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lri------fshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRI------FSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceee------ecCCchhhhhhhccCCCC
Confidence 34556677999999999999974 4567778876432 222344444444444 458999999999999999
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCCCeEEEEec
Q 004954 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 491 l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+.++..||+ |+|+.++... ........++.+++..|+.|++|||+.. |.---|....|+|+.+-+..+..+|-
T Consensus 262 lv~isq~mp~gslynvlhe~----t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQ----TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhcC----ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 999999998 7888887743 3345788899999999999999999985 55557889999999744445555554
Q ss_pred CCcccccCCccccccCCcccCchhhcCCCCC---chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYD---QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~~~~~~~~gt~~y~APE~l~~~~~s---~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
-++.+.. .....|.|++||.+..++.+ .+.|+|||++++||+.|.+.||...++.+.-.+|.
T Consensus 338 kfsfqe~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia----------- 402 (448)
T KOG0195|consen 338 KFSFQEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----------- 402 (448)
T ss_pred eeeeecc----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----------
Confidence 4443322 23458999999999887644 57999999999999999999999988877766653
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
.+.++..||+.. +..+..|+.-|+..||.+||..+.++
T Consensus 403 ----------------------leglrv~ippgi---------s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 ----------------------LEGLRVHIPPGI---------SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------------hccccccCCCCc---------cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 234455566543 35688999999999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.2e-19 Score=176.50 Aligned_cols=139 Identities=17% Similarity=0.214 Sum_probs=103.3
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhh---------------------------hHhHHHHHHHHHHhcccC
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------------------FDQSLDEIKLLKLVNKND 471 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~---------------------------~~~~~~E~~il~~L~~~~ 471 (722)
...||+|+||.||+|.+. +|+.||||+++..... ......|.+++..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 8999999999754210 012234888999987542
Q ss_pred CCCCCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHH-HHCCCccccCCCC
Q 004954 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL-HSLGIIHCDLKPE 550 (722)
Q Consensus 472 ~~~hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yL-Hs~gIvHrDLKp~ 550 (722)
. .+|+++. ... .+|||||++|+.+....... ..+++..+..++.|++.+|.+| |+.||+||||||+
T Consensus 81 v-~~p~~~~------~~~-~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~ 147 (190)
T cd05147 81 I-PCPEPIL------LKS-HVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCRLVHADLSEY 147 (190)
T ss_pred C-CCCcEEE------ecC-CEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 1 2344321 122 37999999976433222111 2388899999999999999999 7999999999999
Q ss_pred ceEEcccCCCeEEEEecCCccccc
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQT 574 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~ 574 (722)
|||++ ++.++|+|||++....
T Consensus 148 NIli~---~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 148 NLLYH---DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HEEEE---CCcEEEEEccccccCC
Confidence 99998 4679999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=204.55 Aligned_cols=202 Identities=20% Similarity=0.305 Sum_probs=163.2
Q ss_pred ceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 405 pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
|.....+-+..|.|.+.||+|+||+||+|.+.. |+.||+|+-+....+ .+.--.+++.+|+- ..-+-|..+..+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~q~~~RLk~---~~~~~~~~~~~a 762 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICLQVMERLKP---QMLPSIMHISSA 762 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehHHHHHhhch---hhhcchHHHHHH
Confidence 444445667889999999999999999999766 999999998776543 34444556666651 112457777777
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-----cC
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-----YQ 558 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-----~~ 558 (722)
+...+..++|+||.+ |+|++++. ....+++..+..++.||+..+..||..+|||+||||+|+||.. .+
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N------~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLIN------TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HccCCcceeeeeccccccHHHhhc------cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 778888999999998 78999887 2334889999999999999999999999999999999999964 23
Q ss_pred CCeEEEEecCCcccc---cC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 004954 559 RCEIKIIDLGSSCFQ---TD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618 (722)
Q Consensus 559 ~~~vkL~DFGls~~~---~~--~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~ 618 (722)
...++|||||.+... .+ .....++|-.+-.+|+..|++|++++|.|.|+.+++-||.|+.
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 456999999988532 22 2344678889999999999999999999999999999999974
|
|
| >cd04028 C2B_RIM1alpha C2 domain second repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.6e-19 Score=168.46 Aligned_cols=96 Identities=9% Similarity=-0.034 Sum_probs=86.5
Q ss_pred ccceeEEEEeec-CCcccc-CCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d-~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
..+.|+|+|++| ||.++| .+|.+|||||++|+|++++..|+||+++|+|+||+|||+|.|. +. ..+++|.++||
T Consensus 27 ~~~~L~V~Vi~ArnL~~~~~~~g~sDPYVKv~Llp~~~~~~k~KT~v~kktlnPvfNE~F~f~--v~--l~~~~L~v~V~ 102 (146)
T cd04028 27 KKGQLEVEVIRARGLVQKPGSKVLPAPYVKVYLLEGKKCIAKKKTKIARKTLDPLYQQQLVFD--VS--PTGKTLQVIVW 102 (146)
T ss_pred CCCEEEEEEEEeeCCCcccCCCCCcCCeEEEEEECCCccccceeceecCCCCCCccCCeEEEE--Ec--CCCCEEEEEEE
Confidence 457899999999 999985 6889999999999999998889999999999999999999999 66 34677999999
Q ss_pred -ccCCCCCCccccccccCccccc
Q 004954 342 -DNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 342 -D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|++++++++++|++.+.....+
T Consensus 103 ~d~~~~~~~~~iG~~~i~L~~l~ 125 (146)
T cd04028 103 GDYGRMDKKVFMGVAQILLDDLD 125 (146)
T ss_pred eCCCCCCCCceEEEEEEEccccc
Confidence 7999999999999999877664
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=181.41 Aligned_cols=189 Identities=24% Similarity=0.342 Sum_probs=136.8
Q ss_pred CCCCceeEEEEEEEec---------------------------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHH
Q 004954 473 ADEHHILRLYDYFYHL---------------------------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525 (722)
Q Consensus 473 ~~hpnIv~l~~~f~~~---------------------------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~ 525 (722)
..|||||++..+|.+. ..+|+||.....+|..++..+. .+......
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-------CchHHHHH
Confidence 4799999999998642 2589999999999998887543 56677888
Q ss_pred HHHHHHHHHHHHHHCCCccccCCCCceEEcccCC--CeEEEEecCCccccc---------CCccccccCCcccCchhhcC
Q 004954 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--CEIKIIDLGSSCFQT---------DNLCLYVQSRSYRAPEVIIG 594 (722)
Q Consensus 526 i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~--~~vkL~DFGls~~~~---------~~~~~~~gt~~y~APE~l~~ 594 (722)
|+.|+++|+.|||++||.|||+|.+||||.-+++ ..+.|+|||.+--.. ......-|.-.-||||+...
T Consensus 346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999999999999999999865433 478999999752111 11112345566899999875
Q ss_pred CC------CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccc
Q 004954 595 LP------YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETN 668 (722)
Q Consensus 595 ~~------~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (722)
.+ --.++|.|+.|.+.||++....||.......+ . ...|
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------------~---~r~Y--------------- 470 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------------D---TRTY--------------- 470 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----------------c---hhhh---------------
Confidence 43 12479999999999999999999965211000 0 0000
Q ss_pred cccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 669 QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 669 ~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+ ..++..+...++.+++|+..+|+.||+||+++.
T Consensus 471 -qe------~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 471 -QE------SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred -hh------hhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 00 111112223457789999999999999999854
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.9e-18 Score=167.96 Aligned_cols=140 Identities=18% Similarity=0.211 Sum_probs=102.7
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhh---------------------------hHhHHHHHHHHHHhcccC
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------------------FDQSLDEIKLLKLVNKND 471 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~---------------------------~~~~~~E~~il~~L~~~~ 471 (722)
.+.||+|++|.||+|.+. +|+.||||+++..... ......|...+.++.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA- 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 567999999999999986 8999999998764210 11124677788887654
Q ss_pred CCCCCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCC
Q 004954 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPE 550 (722)
Q Consensus 472 ~~~hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~ 550 (722)
+|.....+... ..++||||++|..+....... ..++...+..++.|++.+|.+||+ .||+||||||+
T Consensus 80 -----~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~ 147 (190)
T cd05145 80 -----GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY 147 (190)
T ss_pred -----CCCCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence 33222222112 248999999876222111111 126788899999999999999999 99999999999
Q ss_pred ceEEcccCCCeEEEEecCCcccccC
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
|||++ ++.++|+|||++.....
T Consensus 148 NIll~---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE---CCCEEEEEcccceecCC
Confidence 99998 57899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd08392 C2A_SLP-3 C2 domain first repeat present in Synaptotagmin-like protein 3 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-19 Score=164.82 Aligned_cols=99 Identities=11% Similarity=-0.012 Sum_probs=90.1
Q ss_pred ccceeEEEEeec-CCccccCC-CCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~-g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
..+.|+|.|++| ||+++|.+ |.+|||||++|+|++++..|+||+++++++||+|||+|.|. ++.+.+ +++|.++|
T Consensus 13 ~~~~L~V~V~~a~nL~~~d~~~g~~dpYVkv~llp~~~~~~k~kT~v~~~t~nPvfNE~F~f~--v~~~~l~~~~L~v~V 90 (128)
T cd08392 13 RTSCLEITIKACRNLAYGDEKKKKCHPYVKVCLLPDKSHNSKRKTAVKKGTVNPVFNETLKYV--VEADLLSSRQLQVSV 90 (128)
T ss_pred CCCEEEEEEEecCCCCccCCCCCCCCeEEEEEEEeCCcccceeecccccCCCCCccceEEEEE--cCHHHhCCcEEEEEE
Confidence 457999999999 99999986 99999999999999988889999999999999999999999 887777 56799999
Q ss_pred cccCCCCCCccccccccCcccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
||++++++++++|++.++..+.+-
T Consensus 91 ~~~~~~~~~~~lG~~~i~L~~~~~ 114 (128)
T cd08392 91 WHSRTLKRRVFLGEVLIPLADWDF 114 (128)
T ss_pred EeCCCCcCcceEEEEEEEcCCccc
Confidence 999999999999999998766644
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. SHD of Slp (except for the Slp4-SHD) function as a specific Rab27A/B-binding domain. In addition to Slp, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. Little is known about the expression or localization of Slp3. The C2A domain of Slp3 is Ca2+ dependent. It has been demonstrated that Slp3 promotes dense-core vesicle exocytosis. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-17 Score=165.64 Aligned_cols=182 Identities=17% Similarity=0.124 Sum_probs=137.4
Q ss_pred EEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhH-----hHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 417 ~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~-----~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.+...|++|+||+|+++.. .+.+++.+.+.....+.. .+.+|+++|++|.+ +++|++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~-----~~~vP~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG-----LPRTPRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC-----CCCCCEEEEE----cCE
Confidence 4567899999999998864 778888887776554333 57789999999975 3578888875 457
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccC-CCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL-KPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDL-Kp~NILl~~~~~~~vkL~DFGls 570 (722)
+++|||+.|..+.... ... ...++.|++.+|.++|+.||+|||| ||+|||++. ++.++|+|||++
T Consensus 74 ~lvmeyI~G~~L~~~~-----------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~--~g~i~LIDFG~A 139 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP-----------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE--DGSPAVIDFQLA 139 (218)
T ss_pred EEEEeeecCccHHhhh-----------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC--CCCEEEEECCCc
Confidence 9999999886543211 011 1347789999999999999999999 799999985 678999999999
Q ss_pred ccccCCcc----------------ccccCCcccCchhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 004954 571 CFQTDNLC----------------LYVQSRSYRAPEVIIGL-PYD-QKIDLWSLGCILAELWTGEVLFPND 623 (722)
Q Consensus 571 ~~~~~~~~----------------~~~gt~~y~APE~l~~~-~~s-~ksDIWSLGviL~elltG~~PF~~~ 623 (722)
........ ....++.|+.|+...-. ..+ ...++++.|+.+|.++|+..|+.++
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 75443321 02357788888875432 234 5678999999999999999887543
|
|
| >cd08381 C2B_PI3K_class_II C2 domain second repeat present in class II phosphatidylinositol 3-kinases (PI3Ks) | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-18 Score=162.33 Aligned_cols=97 Identities=12% Similarity=0.054 Sum_probs=87.8
Q ss_pred cceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeeccccc-ccCcc-ccccccccc
Q 004954 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDL-HFKGA-EKDLMPAEI 341 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v-~~~~~-~~~L~~~V~ 341 (722)
.+.|+|.|++| ||+++| +|.+|||||++|+|+.++..++||+++++++||+|||+|.|. + +.+.+ +.+|.++||
T Consensus 12 ~~~L~V~Vi~A~~L~~~~-~~~~DpyVkv~l~~~~~~~~~~kT~v~~~~~nP~wnE~F~f~--~~~~~~l~~~~L~~~V~ 88 (122)
T cd08381 12 NGTLFVMVMHAKNLPLLD-GSDPDPYVKTYLLPDPQKTTKRKTKVVRKTRNPTFNEMLVYD--GLPVEDLQQRVLQVSVW 88 (122)
T ss_pred CCEEEEEEEEeeCCCCCC-CCCCCCEEEEEEeeCCccCCceeCCccCCCCCCCcccEEEEe--cCChHHhCCCEEEEEEE
Confidence 57899999999 999999 999999999999999888889999999999999999999999 5 55555 566999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|++++++++|++.++..+...
T Consensus 89 d~d~~~~~~~lG~~~i~l~~l~~ 111 (122)
T cd08381 89 SHDSLVENEFLGGVCIPLKKLDL 111 (122)
T ss_pred eCCCCcCCcEEEEEEEecccccc
Confidence 99999999999999998876654
|
There are 3 classes of PI3Ks based on structure, regulation, and specificity. All classes contain a N-terminal C2 domain, a PIK domain, and a kinase catalytic domain. Unlike class I and class III, class II PI3Ks have additionally a PX domain and a C-terminal C2 domain containing a nuclear localization signal both of which bind phospholipids though in a slightly different fashion. PI3Ks (AKA phosphatidylinositol (PtdIns) 3-kinases) regulate cell processes such as cell growth, differentiation, proliferation, and motility. PI3Ks work on phosphorylation of phosphatidylinositol, phosphatidylinositide (4)P (PtdIns (4)P),2 or PtdIns(4,5)P2. Specifically they phosphorylate the D3 hydroxyl group of phosphoinositol lipids on the inositol ring. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permut |
| >cd08685 C2_RGS-like C2 domain of the Regulator Of G-Protein Signaling (RGS) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-18 Score=160.24 Aligned_cols=97 Identities=15% Similarity=0.094 Sum_probs=88.3
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
..++|+|.|++| ||.++| +|.+|||||++|+|++++..++||+++++|+||+|||+|.|. ++.+..++.|.++|||
T Consensus 10 ~~~~L~V~Vi~ar~L~~~~-~g~~dpYVkv~l~p~~~~~~~~kT~v~~~t~~P~~nE~F~f~--v~~~~~~~~l~v~V~~ 86 (119)
T cd08685 10 QNRKLTLHVLEAKGLRSTN-SGTCNSYVKISLSPDKEVRFRQKTSTVPDSANPLFHETFSFD--VNERDYQKRLLVTVWN 86 (119)
T ss_pred cCCEEEEEEEEEECCCCCC-CCCCCeeEEEEEEeCCCCcceEeCccccCCCCCccccEEEEE--cChHHhCCEEEEEEEC
Confidence 457899999999 999999 899999999999999888889999999999999999999999 8777776678999999
Q ss_pred cCCCCC-CccccccccCccccc
Q 004954 343 NSDTRD-GEVNGALHEGKADAE 363 (722)
Q Consensus 343 ~D~~~~-~d~iG~v~~~~~~~~ 363 (722)
.+...+ ++++|+++++..+..
T Consensus 87 ~~~~~~~~~~lG~~~i~l~~~~ 108 (119)
T cd08685 87 KLSKSRDSGLLGCMSFGVKSIV 108 (119)
T ss_pred CCCCcCCCEEEEEEEecHHHhc
Confidence 999874 799999999987775
|
This CD contains members of the regulator of G-protein signaling (RGS) family. RGS is a GTPase activating protein which inhibits G-protein mediated signal transduction. The protein is largely cytosolic, but G-protein activation leads to translocation of this protein to the plasma membrane. A nuclear form of this protein has also been described, but its sequence has not been identified. There are multiple alternatively spliced transcript variants in this family with some members having additional domains (ex. PDZ and RGS) downstream of the C2 domain. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind pho |
| >cd08393 C2A_SLP-1_2 C2 domain first repeat present in Synaptotagmin-like proteins 1 and 2 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-18 Score=160.98 Aligned_cols=99 Identities=10% Similarity=-0.006 Sum_probs=89.3
Q ss_pred ccceeEEEEeec-CCccccCC-CCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~-g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
....|+|.|++| ||+++|.+ |.+|||||++|+|+++...++||+++++|+||+|||+|.|. ++.+.+ +++|.++|
T Consensus 13 ~~~~L~V~vi~a~~L~~~d~~~g~~dpyVkv~l~p~~~~~~~~kT~v~~~t~nP~~nE~f~f~--v~~~~l~~~~L~~~V 90 (125)
T cd08393 13 KLRELHVHVIQCQDLAAADPKKQRSDPYVKTYLLPDKSNRGKRKTSVKKKTLNPVFNETLRYK--VEREELPTRVLNLSV 90 (125)
T ss_pred CCCEEEEEEEEeCCCCCcCCCCCCCCcEEEEEEEcCCCccccccCccCcCCCCCccCceEEEE--CCHHHhCCCEEEEEE
Confidence 456899999999 99999986 89999999999999887788999999999999999999999 887666 56699999
Q ss_pred cccCCCCCCccccccccCcccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
||+|++++++++|++.+...+.+-
T Consensus 91 ~d~~~~~~~~~iG~~~i~L~~~~~ 114 (125)
T cd08393 91 WHRDSLGRNSFLGEVEVDLGSWDW 114 (125)
T ss_pred EeCCCCCCCcEeEEEEEecCcccc
Confidence 999999999999999998766543
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike Slp3 and Slp4/granuphilin which are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety |
| >cd08408 C2B_Synaptotagmin-14_16 C2 domain second repeat present in Synaptotagmins 14 and 16 | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.9e-19 Score=165.92 Aligned_cols=105 Identities=15% Similarity=0.079 Sum_probs=91.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCC-CcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~-~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
..++|+|+|++| ||+++|.+|..|||||++|+|+.+ +..|+||+++++++||+|||+|.|. ++.+++ +++|.++|
T Consensus 13 ~~~~L~V~VikarnL~~~~~~~~~dpyVkv~llp~~~~~~~~~kT~v~~~t~nPvfnEtF~f~--i~~~~l~~~~L~~~V 90 (138)
T cd08408 13 LTGRLSVEVIKGSNFKNLAMNKAPDTYVKLTLLNSDGQEISKSKTSIRRGQPDPEFKETFVFQ--VALFQLSEVTLMFSV 90 (138)
T ss_pred CCCeEEEEEEEecCCCccccCCCCCeeEEEEEEeCCCcceeeccceeecCCCCCcEeeeEEEE--CCHHHhCccEEEEEE
Confidence 568999999999 999999999999999999999754 4468899999999999999999999 888777 56699999
Q ss_pred cccCCCCCCccccccccCccccccccCCCc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEEHGVATP 370 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~e~~~~~ 370 (722)
||++++++++++|++.++......+....|
T Consensus 91 ~~~~~~~~~~~iG~v~l~~~~~~~~~~~hW 120 (138)
T cd08408 91 YNKRKMKRKEMIGWFSLGLNSSGEEEEEHW 120 (138)
T ss_pred EECCCCCCCcEEEEEEECCcCCCchHHHHH
Confidence 999999999999999998765544444443
|
Synaptotagmin 14 and 16 are membrane-trafficking proteins in specific tissues outside the brain. Both of these contain C-terminal tandem C2 repeats, but only Synaptotagmin 14 has an N-terminal transmembrane domain and a putative fatty-acylation site. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium and this is indeed the case here. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicle |
| >cd04029 C2A_SLP-4_5 C2 domain first repeat present in Synaptotagmin-like proteins 4 and 5 | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.2e-18 Score=156.99 Aligned_cols=99 Identities=11% Similarity=0.017 Sum_probs=88.8
Q ss_pred ccceeEEEEeec-CCccccC-CCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~-~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
..+.|+|.|++| ||.++|. +|.+|||||++++|++.+..++||+++++++||+|||+|.|. ++.+.+ ++.|.++|
T Consensus 13 ~~~~L~V~Vi~a~~L~~~~~~~~~~DpyVkv~l~p~~~~~~~~kT~v~~~t~nP~wnE~f~f~--i~~~~l~~~~L~~~V 90 (125)
T cd04029 13 KTQSLNVHVKECRNLAYGDEAKKRSNPYVKTYLLPDKSRQSKRKTSIKRNTTNPVYNETLKYS--ISHSQLETRTLQLSV 90 (125)
T ss_pred CCCeEEEEEEEecCCCccCCCCCCCCcEEEEEEEcCCccccceEeeeeeCCCCCcccceEEEE--CCHHHhCCCEEEEEE
Confidence 567899999999 9999986 589999999999999887788999999999999999999999 887766 55699999
Q ss_pred cccCCCCCCccccccccCcccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
||+|.+++++++|++.++..+..-
T Consensus 91 ~d~~~~~~~~~lG~~~i~l~~~~~ 114 (125)
T cd04029 91 WHYDRFGRNTFLGEVEIPLDSWNF 114 (125)
T ss_pred EECCCCCCCcEEEEEEEeCCcccc
Confidence 999999999999999998766544
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. SHD of Slp (except for the Slp4-SHD) function as a specific Rab27A/B-binding domain. In addition to Slp, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp4/granuphilin promotes dense-core vesicle exocytosis. The C2A domain of Slp4 is Ca2+ dependent. Slp5 mRNA has been shown to be restricted to human placenta and liver suggesting a role in Rab27A-dependent membrane trafficking in specific tissues. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2 |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=162.17 Aligned_cols=139 Identities=21% Similarity=0.234 Sum_probs=106.7
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---e-EEE
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---H-LFI 493 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~---~-l~i 493 (722)
.+.||+|+||.||. +..++.. +||++... ....+...+|+++++.+.+. ..+||||+++++++.+.. . ..+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~-~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRR-LIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhcc-CCCCcccceeeEEEEeCCCCeEEEEE
Confidence 35799999999996 6667666 79988754 22446789999999999763 467999999999999873 4 347
Q ss_pred EEEccc---cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHH-HHHHHCCCccccCCCCceEEccc--CCCeEEEEec
Q 004954 494 VCELLR---ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL-EYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDL 567 (722)
Q Consensus 494 VmEy~~---gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL-~yLHs~gIvHrDLKp~NILl~~~--~~~~vkL~DF 567 (722)
||||.+ ++|.+++.... +++. ..++.|++.++ +|||+.+|+||||||+|||++.. ....++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 899954 57888775321 4444 35677888777 89999999999999999999853 2347999995
Q ss_pred CCc
Q 004954 568 GSS 570 (722)
Q Consensus 568 Gls 570 (722)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=165.13 Aligned_cols=144 Identities=16% Similarity=0.158 Sum_probs=108.9
Q ss_pred EEEEEEeccCCCCceEEEE-ECCCCcEEEEEEeecchh-------------------------hhHhHHHHHHHHHHhcc
Q 004954 416 YYVTEYLGSAAFSKVFQAQ-DLHTGVDVCLKIIKNDKD-------------------------FFDQSLDEIKLLKLVNK 469 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~-d~~tg~~vAvKil~~~~~-------------------------~~~~~~~E~~il~~L~~ 469 (722)
|.+.+.||+|++|.||+|. +..+|+.||||+++.... ......+|..+++.+..
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7889999999999999999 678999999999875321 01124578999999974
Q ss_pred cCCCCCCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC-CccccCC
Q 004954 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-IIHCDLK 548 (722)
Q Consensus 470 ~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g-IvHrDLK 548 (722)
. ...++++++. ...++||||++|..+....... ..+....+..++.||+.+|.+||+.| |+|||||
T Consensus 110 ~----~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 110 A----GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred c----CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 2 2234455543 2348999999985433222111 12556677899999999999999999 9999999
Q ss_pred CCceEEcccCCCeEEEEecCCcccccC
Q 004954 549 PENILIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 549 p~NILl~~~~~~~vkL~DFGls~~~~~ 575 (722)
|+||+++ ++.++|+|||.+.....
T Consensus 177 p~NIli~---~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH---DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE---CCCEEEEEChhhhccCC
Confidence 9999998 56899999999875444
|
|
| >cd08395 C2C_Munc13 C2 domain third repeat in Munc13 (mammalian uncoordinated) proteins | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-17 Score=151.71 Aligned_cols=97 Identities=16% Similarity=0.045 Sum_probs=81.2
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecC--CCCCcccceeeecccCCCcceeeeeecccccccC-cc-ccccccccc
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAP--HPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFK-GA-EKDLMPAEI 341 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~--d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~-~~-~~~L~~~V~ 341 (722)
+|+|+|.+| ||+++| .|.+|||||++|.- ...+.+|++|+++++|+||+|||+|.|. ++.+ .. ...|.+.||
T Consensus 1 kL~V~Vi~A~~L~~~d-~g~~DPYVkV~l~g~~~~~k~~k~kTkv~~~tlnPvwNE~f~F~--v~~~~~~~~~~L~~~V~ 77 (120)
T cd08395 1 KVTVKVVAANDLKWQT-TGMFRPFVEVNLIGPHLSDKKRKFATKSKNNNWSPKYNETFQFI--LGNEDDPESYELHICVK 77 (120)
T ss_pred CEEEEEEECcCCCccc-CCCCCCEEEEEEecCCCcccccEeeeEEecCCCCCccCcEEEEE--eeCcCCCceeEEEEEEE
Confidence 589999999 999999 49999999999962 2333457889999999999999999999 7754 34 455999999
Q ss_pred ccCCCCCCccccccccCcccccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~ 366 (722)
|+|.++++++||.+.++.......+
T Consensus 78 D~d~~~~dd~IG~~~l~l~~~~~~~ 102 (120)
T cd08395 78 DYCFARDDRLVGVTVLQLRDIAQAG 102 (120)
T ss_pred EecccCCCCEEEEEEEEHHHCcCCC
Confidence 9998888999999999877666544
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, synaptobrevi |
| >cd08409 C2B_Synaptotagmin-15 C2 domain second repeat present in Synaptotagmin 15 | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-17 Score=156.99 Aligned_cols=106 Identities=13% Similarity=0.067 Sum_probs=90.8
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~-~~L~~~V~ 341 (722)
..++|+|.|++| ||+++| .|.+|||||+.|.|++++.+++||+++++++||+|||+|.|. ++.+.++ .+|.++||
T Consensus 13 ~~~~L~V~V~~a~nL~~~~-~~~~d~yVkv~l~~~~~~~~~~kT~v~~~~~nP~fnE~F~f~--i~~~~l~~~~L~~~V~ 89 (137)
T cd08409 13 TLNRLTVVVLRARGLRQLD-HAHTSVYVKVSLMIHNKVVKTKKTEVVDGAASPSFNESFSFK--VTSRQLDTASLSLSVM 89 (137)
T ss_pred CCCeEEEEEEEecCCCccc-CCCCCeEEEEEEEECCEEeeeeecccEeCCCCCcccceEEEE--CCHHHhCccEEEEEEE
Confidence 457899999999 999999 888999999999998777778899999999999999999999 8888774 66999999
Q ss_pred ccCCCCCCccccccccCccc-cccccCCCcch
Q 004954 342 DNSDTRDGEVNGALHEGKAD-AEEHGVATPDL 372 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~-~~~e~~~~~~~ 372 (722)
|.+.+++++++|++.++... ..++....|..
T Consensus 90 ~~~~~~~~~~lG~v~ig~~~~~~~~~~~hW~~ 121 (137)
T cd08409 90 QSGGVRKSKLLGRVVLGPFMYARGKELEHWND 121 (137)
T ss_pred eCCCCCCcceEEEEEECCcccCCChHHHHHHH
Confidence 99999999999999998543 23344455444
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. It is thought to be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues and is Ca2+ independent. Human synaptotagmin 15 has 2 alternatively spliced forms that encode proteins with different C-termini. The larger, SYT15a, contains a N-terminal TM region, a putative fatty-acylation site, and 2 tandem C terminal C2 domains. The smaller, SYT15b, lacks the C-terminal portion of the second C2 domain. Unlike most other synaptotagmins it is nearly absent in the brain and rather is found in the heart, lungs, skeletal muscle, and testis. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 id |
| >cd08410 C2B_Synaptotagmin-17 C2 domain second repeat present in Synaptotagmin 17 | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-17 Score=154.11 Aligned_cols=99 Identities=11% Similarity=0.020 Sum_probs=87.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
+.+.|+|.|++| +|+++|.+|.+|||||+.+.++.+...++||+++++|+||+|||+|.|. ++.+.. +..|.++||
T Consensus 12 ~~~~L~V~vi~a~~L~~~d~~g~~DPyV~v~l~~~~~~~~~~kT~v~~~t~nP~wnE~F~f~--i~~~~l~~~~l~~~V~ 89 (135)
T cd08410 12 SAGRLNVDIIRAKQLLQTDMSQGSDPFVKIQLVHGLKLIKTKKTSCMRGTIDPFYNESFSFK--VPQEELENVSLVFTVY 89 (135)
T ss_pred CCCeEEEEEEEecCCCcccCCCCCCeEEEEEEEcCCcccceEcCccccCCCCCccceeEEEe--CCHHHhCCCEEEEEEE
Confidence 557899999999 9999999999999999999887776678899999999999999999999 877766 445999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|..++++++|++.++......
T Consensus 90 d~d~~~~~~~iG~~~l~~~~~~~ 112 (135)
T cd08410 90 GHNVKSSNDFIGRIVIGQYSSGP 112 (135)
T ss_pred eCCCCCCCcEEEEEEEcCccCCc
Confidence 99999999999999877644444
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 17 is located in the brain, kidney, and prostate and is thought to be a peripheral membrane protein. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta- |
| >cd08384 C2B_Rabphilin_Doc2 C2 domain second repeat present in Rabphilin and Double C2 domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-16 Score=150.98 Aligned_cols=96 Identities=16% Similarity=0.147 Sum_probs=87.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|..|.+|||||+.+.++..+..++||+++++|+||+|||+|.|. ++...+ ++.|.++||
T Consensus 11 ~~~~L~V~Vi~a~~L~~~d~~~~~DpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--~~~~~l~~~~l~~~V~ 88 (133)
T cd08384 11 QRRGLIVGIIRCVNLAAMDANGYSDPFVKLYLKPDAGKKSKHKTQVKKKTLNPEFNEEFFYD--IKHSDLAKKTLEITVW 88 (133)
T ss_pred CCCEEEEEEEEEcCCCCcCCCCCCCcEEEEEEEcCCCccCCceeeeEeccCCCCcccEEEEE--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999998777778999999999999999999999 776655 566999999
Q ss_pred ccCCCCCCccccccccCccc
Q 004954 342 DNSDTRDGEVNGALHEGKAD 361 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~ 361 (722)
|+|.+++++++|++.++...
T Consensus 89 d~d~~~~~~~lG~~~i~l~~ 108 (133)
T cd08384 89 DKDIGKSNDYIGGLQLGINA 108 (133)
T ss_pred eCCCCCCccEEEEEEEecCC
Confidence 99999999999999998754
|
Rabphilin is found neurons and in neuroendrocrine cells, while Doc2 is found not only in the brain but in tissues, including mast cells, chromaffin cells, and osteoblasts. Rabphilin and Doc2s share highly homologous tandem C2 domains, although their N-terminal structures are completely different: rabphilin contains an N-terminal Rab-binding domain (RBD),7 whereas Doc2 contains an N-terminal Munc13-1-interacting domain (MID). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domai |
| >cd08404 C2B_Synaptotagmin-4 C2 domain second repeat present in Synaptotagmin 4 | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.7e-17 Score=151.88 Aligned_cols=103 Identities=14% Similarity=0.043 Sum_probs=89.6
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|++| ||+++|.+|.+|||||+++.+++++..++||+++++|+||+|||+|.|. ++.... +..|.++||
T Consensus 13 ~~~~L~V~vi~a~~L~~~d~~g~~Dpyv~v~l~~~~~~~~~~kT~v~k~t~nP~w~e~F~f~--v~~~~~~~~~l~~~v~ 90 (136)
T cd08404 13 TTNRLTVVVLKARHLPKMDVSGLADPYVKVNLYYGKKRISKKKTHVKKCTLNPVFNESFVFD--IPSEELEDISVEFLVL 90 (136)
T ss_pred CCCeEEEEEEEeeCCCccccCCCCCeEEEEEEEcCCceeeeEcCccccCCCCCccCceEEEE--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999998776678999999999999999999999 876666 455999999
Q ss_pred ccCCCCCCccccccccCccccccccCCC
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHGVAT 369 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~~~~ 369 (722)
|+|++++++++|++.++... .+++...
T Consensus 91 d~d~~~~~~~iG~~~~~~~~-~~~~~~~ 117 (136)
T cd08404 91 DSDRVTKNEVIGRLVLGPKA-SGSGGHH 117 (136)
T ss_pred ECCCCCCCccEEEEEECCcC-CCchHHH
Confidence 99999999999999998876 3444333
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 4, a member of class 4 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmin-11, has an Asp to Ser substitution in its C2A domain. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling s |
| >KOG1028 consensus Ca2+-dependent phospholipid-binding protein Synaptotagmin, required for synaptic vesicle and secretory granule exocytosis [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-16 Score=176.22 Aligned_cols=97 Identities=11% Similarity=0.055 Sum_probs=87.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|++| +|+++|..|.+|||||++|+||+ +.|.||+++|+|+||+|||+|.|. |+.+++ .++|.++||
T Consensus 165 ~~~~L~V~V~qa~~Lp~~d~~g~sdpyVK~~llPdk--~~k~kT~v~r~tlnP~fnEtf~f~--v~~~~l~~~~L~l~V~ 240 (421)
T KOG1028|consen 165 ELNLLTVRVIQAHDLPAKDRGGTSDPYVKVYLLPDK--KGKFKTRVHRKTLNPVFNETFRFE--VPYEELSNRVLHLSVY 240 (421)
T ss_pred cCCEEEEEEEEecCCCcccCCCCCCCeeEEEEcCCC--CCcceeeeeecCcCCccccceEee--cCHHHhccCEEEEEEE
Confidence 567899999999 99999988899999999999998 469999999999999999999999 787766 778999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|+|++++++|++.+....++.
T Consensus 241 ~~drfsr~~~iGev~~~l~~~~~ 263 (421)
T KOG1028|consen 241 DFDRFSRHDFIGEVILPLGEVDL 263 (421)
T ss_pred ecCCcccccEEEEEEecCccccc
Confidence 99999999999999887443333
|
|
| >cd04020 C2B_SLP_1-2-3-4 C2 domain second repeat present in Synaptotagmin-like proteins 1-4 | Back alignment and domain information |
|---|
Probab=99.62 E-value=4e-16 Score=152.11 Aligned_cols=118 Identities=18% Similarity=0.192 Sum_probs=97.3
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
+.+.|+|.|.+| ||+++|..|.+|||||++++++..+..++||+++++|+||.|||+|.|.. ++.+.+ +..|.++||
T Consensus 25 ~~g~L~V~Vi~A~nL~~~d~~g~~DPYVkv~l~~~~~~~~~~kT~vi~~t~nP~WnE~f~f~~-~~~~~l~~~~L~i~V~ 103 (162)
T cd04020 25 STGELHVWVKEAKNLPALKSGGTSDSFVKCYLLPDKSKKSKQKTPVVKKSVNPVWNHTFVYDG-VSPEDLSQACLELTVW 103 (162)
T ss_pred CCceEEEEEEeeeCCCCCCCCCCCCCEEEEEEEcCCCCCcceeCCccCCCCCCCCCCEEEEec-CCHHHhCCCEEEEEEE
Confidence 568899999999 99999999999999999999988777899999999999999999999983 333343 556999999
Q ss_pred ccCCCCCCccccccccCccccccccCCCcchhhhhhhHhHhhhh
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIF 385 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~~~~~~~l~f~~L~ee~~~~ 385 (722)
|+|.+++++++|++.++..+....+. ...|++...+|..++
T Consensus 104 d~d~~~~d~~lG~v~i~l~~~~~~~~---~~~w~~~~~~~~~~w 144 (162)
T cd04020 104 DHDKLSSNDFLGGVRLGLGTGKSYGQ---AVDWMDSTGEEILLW 144 (162)
T ss_pred eCCCCCCCceEEEEEEeCCccccCCC---ccccccCChHHHHHH
Confidence 99999999999999998877655432 233665555555444
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike the case in Slp3 and Slp4/granuphilin in which their C2A domains are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp3 and Slp4/granuphilin promote dense-core vesicle exocytosis. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involvin |
| >cd08403 C2B_Synaptotagmin-3-5-6-9-10 C2 domain second repeat present in Synaptotagmins 3, 5, 6, 9, and 10 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-16 Score=148.42 Aligned_cols=95 Identities=16% Similarity=0.091 Sum_probs=85.8
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~-~~L~~~V~ 341 (722)
..+.|+|.|.+| +|+++|..|.+|||||++|.+++++..++||+++++++||.|||+|.|. ++.+..+ ..|.++||
T Consensus 12 ~~~~L~V~v~~A~~L~~~d~~g~~dpyvkv~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--i~~~~~~~~~l~~~v~ 89 (134)
T cd08403 12 TAGRLTLTIIKARNLKAMDITGFSDPYVKVSLMCEGRRLKKKKTSVKKNTLNPTYNEALVFD--VPPENVDNVSLIIAVV 89 (134)
T ss_pred CCCEEEEEEEEeeCCCccccCCCCCceEEEEEEeCCcccceecCCcccCCCCCcccceEEEE--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999988776678899999999999999999998 7776664 45999999
Q ss_pred ccCCCCCCccccccccCcc
Q 004954 342 DNSDTRDGEVNGALHEGKA 360 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~ 360 (722)
|++++++++++|++.++..
T Consensus 90 d~~~~~~~~~IG~~~l~~~ 108 (134)
T cd08403 90 DYDRVGHNELIGVCRVGPN 108 (134)
T ss_pred ECCCCCCCceeEEEEECCC
Confidence 9999999999999999865
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 3, a member of class 3 synaptotagmins, is located in the brain and localized to the active zone and plasma membrane. It functions as a Ca2+ sensor for fast exocytosis. It, along with synaptotagmins 5,6, and 10, has disulfide bonds at its N-terminus. Synaptotagmin 9, a class 5 synaptotagmins, is located in the brain and localized to the synaptic vesicles. It is thought to be a Ca2+-sensor for dense-core vesicle exocytosis. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind |
| >cd08402 C2B_Synaptotagmin-1 C2 domain second repeat present in Synaptotagmin 1 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-16 Score=148.82 Aligned_cols=103 Identities=15% Similarity=0.103 Sum_probs=89.1
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~-~~L~~~V~ 341 (722)
+.+.|+|.|.+| +|+++|.+|.+||||++++.+++++..+++|+++++++||+|||+|.|. ++.+.++ ..|.++||
T Consensus 13 ~~~~l~V~Vi~a~~L~~~d~~g~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--i~~~~l~~~~l~~~v~ 90 (136)
T cd08402 13 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKRTLNPYYNESFSFE--VPFEQIQKVHLIVTVL 90 (136)
T ss_pred CCCeEEEEEEEeeCCCcccCCCCCCCeEEEEEEECCcccceeeccceeCCCCCcccceEEEE--CCHHHhCCCEEEEEEE
Confidence 567899999999 9999999999999999999987776678899999999999999999999 7766664 45999999
Q ss_pred ccCCCCCCccccccccCccccccccCCC
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHGVAT 369 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~~~~ 369 (722)
|++++++++++|.+.++.... ++....
T Consensus 91 d~~~~~~~~~iG~~~i~~~~~-~~~~~~ 117 (136)
T cd08402 91 DYDRIGKNDPIGKVVLGCNAT-GAELRH 117 (136)
T ss_pred eCCCCCCCceeEEEEECCccC-ChHHHH
Confidence 999999999999999988653 333344
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 1, a member of the class 1 synaptotagmins, is located in the brain and endocranium and localized to the synaptic vesicles and secretory granules. It functions as a Ca2+ sensor for fast exocytosis. It, like synaptotagmin-2, has an N-glycosylated N-terminus. Synaptotagmin 4, a member of class 4 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmin-11, has an Asp to Ser substitution in its C2A domain. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: |
| >cd08388 C2A_Synaptotagmin-4-11 C2A domain first repeat present in Synaptotagmins 4 and 11 | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.5e-16 Score=144.80 Aligned_cols=98 Identities=14% Similarity=0.097 Sum_probs=83.9
Q ss_pred ccceeEEEEeec-CCccccCC-CCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~-g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
....|+|.|.+| ||+++|.. |.+||||++.|+|+++ +++||+++++|+||+|||+|.|.. ++.+.. +..|.++|
T Consensus 14 ~~~~L~V~Vi~a~~L~~~~~~~~~~DpyV~v~l~~~~~--~~~kT~v~~~t~nP~wnE~F~f~~-~~~~~~~~~~L~~~V 90 (128)
T cd08388 14 EKKALLVNIIECRDLPAMDEQSGTSDPYVKLQLLPEKE--HKVKTRVLRKTRNPVYDETFTFYG-IPYNQLQDLSLHFAV 90 (128)
T ss_pred CCCEEEEEEEEeECCCCCCCCCCCcCCEEEEEEeCCcC--ceeeccEEcCCCCCceeeEEEEcc-cCHHHhCCCEEEEEE
Confidence 457899999999 99999987 9999999999998754 467899999999999999999931 665555 55699999
Q ss_pred cccCCCCCCccccccccCcccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
||+|++++++++|++.+...+.+-
T Consensus 91 ~d~d~~~~d~~lG~~~i~L~~l~~ 114 (128)
T cd08388 91 LSFDRYSRDDVIGEVVCPLAGADL 114 (128)
T ss_pred EEcCCCCCCceeEEEEEeccccCC
Confidence 999999999999999988765533
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmins 4 and 11, class 4 synaptotagmins, are located in the brain. Their functions are unknown. They are distinguished from the other synaptotagmins by having and Asp to Ser substitution in their C2A domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence |
| >cd08521 C2A_SLP C2 domain first repeat present in Synaptotagmin-like proteins | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.3e-16 Score=142.86 Aligned_cols=98 Identities=11% Similarity=0.033 Sum_probs=88.0
Q ss_pred ccceeEEEEeec-CCcccc-CCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d-~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
..+.|+|.|.+| ||+++| ..|.+|||||++++|++....++||+++++++||+|||+|.|. ++...+ .+.|.+.|
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~--i~~~~l~~~~l~i~v 89 (123)
T cd08521 12 KTGSLEVHIKECRNLAYADEKKKRSNPYVKVYLLPDKSKQSKRKTSVKKNTTNPVFNETLKYH--ISKSQLETRTLQLSV 89 (123)
T ss_pred CCCEEEEEEEEecCCCCcCCCCCCCCcEEEEEEecCCCcCceeeccccCCCCCCcccceEEEe--CCHHHhCCCEEEEEE
Confidence 567899999999 999999 8899999999999998876678999999999999999999999 887666 55699999
Q ss_pred cccCCCCCCccccccccCccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
||++.+++++++|++.++..+..
T Consensus 90 ~d~~~~~~~~~iG~~~i~l~~l~ 112 (123)
T cd08521 90 WHHDRFGRNTFLGEVEIPLDSWD 112 (123)
T ss_pred EeCCCCcCCceeeEEEEeccccc
Confidence 99999999999999999876663
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike the case in Slp3 and Slp4/granuphilin in which their C2A domains are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp3 and Slp4/granuphilin promote dense-core vesicle exocytosis. Slp5 mRNA has been shown to be restricted to human placenta and liver suggesting a role in Rab27A-dependent membrane trafficking in specific tissues. C2 domains fold into |
| >cd08387 C2A_Synaptotagmin-8 C2A domain first repeat present in Synaptotagmin 8 | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-16 Score=143.68 Aligned_cols=97 Identities=13% Similarity=0.071 Sum_probs=86.5
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|.+|.+||||++++.|++. .++||+++++++||+|||+|.|. ++...+ +..|.++||
T Consensus 14 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~--~~~kT~v~~~t~~P~wne~f~f~--v~~~~l~~~~l~i~V~ 89 (124)
T cd08387 14 DMGILNVKLIQARNLQPRDFSGTADPYCKVRLLPDRS--NTKQSKIHKKTLNPEFDESFVFE--VPPQELPKRTLEVLLY 89 (124)
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCCeEEEEEecCCC--CcEeCceEcCCCCCCcccEEEEe--CCHHHhCCCEEEEEEE
Confidence 456899999999 999999999999999999988765 36789999999999999999998 887666 556999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|++.+++++++|.+.++..+...
T Consensus 90 d~~~~~~~~~iG~~~i~l~~~~~ 112 (124)
T cd08387 90 DFDQFSRDECIGVVELPLAEVDL 112 (124)
T ss_pred ECCCCCCCceeEEEEEecccccC
Confidence 99999999999999998877764
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involv |
| >cd08389 C2A_Synaptotagmin-14_16 C2A domain first repeat present in Synaptotagmins 14 and 16 | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.9e-16 Score=143.41 Aligned_cols=98 Identities=10% Similarity=-0.026 Sum_probs=85.6
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|+|++| ||+++|.+|.+|||||+.++|+++ .++||+++++ +||+|||+|.|.. ++.+.+ +++|.+.||
T Consensus 14 ~~~~L~V~Vi~a~nL~~~~~~~~~d~yVk~~llp~~~--~~~kTkv~~~-~nP~fnE~F~f~~-i~~~~l~~~~L~~~V~ 89 (124)
T cd08389 14 SARKLTVTVIRAQDIPTKDRGGASSWQVHLVLLPSKK--QRAKTKVQRG-PNPVFNETFTFSR-VEPEELNNMALRFRLY 89 (124)
T ss_pred CCCEEEEEEEEecCCCchhcCCCCCcEEEEEEccCCc--ceeecccccC-CCCcccCEEEECC-CCHHHhccCEEEEEEE
Confidence 457899999999 999999999999999999999865 4788998887 9999999999973 555555 677999999
Q ss_pred ccCCCCCCccccccccCccccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEH 365 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e 365 (722)
|++++++++++|++.++......+
T Consensus 90 ~~~~~~~~~~lG~~~i~L~~l~~~ 113 (124)
T cd08389 90 GVERMRKERLIGEKVVPLSQLNLE 113 (124)
T ss_pred ECCCcccCceEEEEEEeccccCCC
Confidence 999999999999999988766443
|
Synaptotagmin 14 and 16 are membrane-trafficking proteins in specific tissues outside the brain. Both of these contain C-terminal tandem C2 repeats, but only Synaptotagmin 14 has an N-terminal transmembrane domain and a putative fatty-acylation site. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium and this is indeed the case here. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicle |
| >cd04010 C2B_RasA3 C2 domain second repeat present in RAS p21 protein activator 3 (RasA3) | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-15 Score=146.55 Aligned_cols=97 Identities=13% Similarity=0.009 Sum_probs=82.9
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccc-----------cccCcc-c
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSD-----------LHFKGA-E 333 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~-----------v~~~~~-~ 333 (722)
+|+|.|.+| ||.+ .+|.+||||++++.+++++..+++|+++++|+||+|||+|.|... ++.+.. .
T Consensus 1 kL~V~Vi~ArnL~~--~~g~sDPYV~V~l~~~~~k~~~~kT~v~~~t~nP~wNE~F~F~v~~~~~~~~~~~~~~~~~~~~ 78 (148)
T cd04010 1 KLSVRVIECSDLAL--KNGTCDPYASVTLIYSNKKQDTKRTKVKKKTNNPQFDEAFYFDVTIDSSPEKKQFEMPEEDAEK 78 (148)
T ss_pred CEEEEEEeCcCCCC--CCCCCCceEEEEEeCCcccCcccCCccEeCCCCCccceEEEEEEecccccccccccCCcccccE
Confidence 589999999 9998 789999999999999877777899999999999999999999921 133444 3
Q ss_pred ccccccccccCCCCCCccccccccCccccccc
Q 004954 334 KDLMPAEIDNSDTRDGEVNGALHEGKADAEEH 365 (722)
Q Consensus 334 ~~L~~~V~D~D~~~~~d~iG~v~~~~~~~~~e 365 (722)
..|.+.|||.+.+++++++|++.+....+...
T Consensus 79 ~~L~i~V~d~~~~~~ddfLG~v~i~l~~l~~~ 110 (148)
T cd04010 79 LELRVDLWHASMGGGDVFLGEVRIPLRGLDLQ 110 (148)
T ss_pred EEEEEEEEcCCCCCCCceeEEEEEeccccccc
Confidence 55999999999999999999999987766554
|
RasA3 are members of GTPase activating protein 1 (GAP1), a Ras-specific GAP, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. RasA3 contains an N-terminal C2 domain, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain |
| >cd04030 C2C_KIAA1228 C2 domain third repeat present in uncharacterized human KIAA1228-like proteins | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-15 Score=142.61 Aligned_cols=99 Identities=13% Similarity=0.101 Sum_probs=88.3
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|++| ||+++|.+|.+|||||++++++++...++||+++++++||+|||+|.|. ++...+ +..|.++||
T Consensus 14 ~~~~L~V~vi~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~~~nP~wne~f~f~--i~~~~l~~~~l~i~v~ 91 (127)
T cd04030 14 QRQKLIVTVHKCRNLPPCDSSDIPDPYVRLYLLPDKSKSTRRKTSVKKDNLNPVFDETFEFP--VSLEELKRRTLDVAVK 91 (127)
T ss_pred CCCEEEEEEEEEECCCCccCCCCCCceEEEEEEcCCCCCceEecccccCCCCCEECeEEEEe--cCHHHhcCCEEEEEEE
Confidence 457899999999 9999999999999999999998877788999999999999999999999 877666 456999999
Q ss_pred ccCCC--CCCccccccccCcccccc
Q 004954 342 DNSDT--RDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~--~~~d~iG~v~~~~~~~~~ 364 (722)
|.+.+ ++++++|.+.++..+...
T Consensus 92 ~~~~~~~~~~~~iG~~~i~l~~l~~ 116 (127)
T cd04030 92 NSKSFLSREKKLLGQVLIDLSDLDL 116 (127)
T ss_pred ECCcccCCCCceEEEEEEecccccc
Confidence 99986 679999999998877644
|
KIAA proteins are uncharacterized human proteins. They were compiled by the Kazusa mammalian cDNA project which identified more than 2000 human genes. They are identified by 4 digit codes that precede the KIAA designation. Many KIAA genes are still functionally uncharacterized including KIAA1228. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1 |
| >cd04031 C2A_RIM1alpha C2 domain first repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-15 Score=141.37 Aligned_cols=98 Identities=16% Similarity=0.173 Sum_probs=85.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|++| ||+++|.+|.+||||++++.++.....++||+++++|+||+|||+|.|.. ++.+.. +..|.++||
T Consensus 14 ~~~~L~V~vi~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~l~~~~l~~~V~ 92 (125)
T cd04031 14 VTSQLIVTVLQARDLPPRDDGSLRNPYVKVYLLPDRSEKSKRRTKTVKKTLNPEWNQTFEYSN-VRRETLKERTLEVTVW 92 (125)
T ss_pred CCCEEEEEEEEecCCCCcCCCCCCCCEEEEEEccCCCccccccccccCCCCCCccccEEEEcc-cCHHHhCCCEEEEEEE
Confidence 457899999999 99999999999999999999987766788999999999999999999982 233334 556999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|++.+++++++|.+.++..+.
T Consensus 93 d~~~~~~~~~iG~~~i~l~~~ 113 (125)
T cd04031 93 DYDRDGENDFLGEVVIDLADA 113 (125)
T ss_pred eCCCCCCCcEeeEEEEecccc
Confidence 999999999999999987663
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >cd08405 C2B_Synaptotagmin-7 C2 domain second repeat present in Synaptotagmin 7 | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.7e-16 Score=146.58 Aligned_cols=97 Identities=14% Similarity=0.091 Sum_probs=86.7
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|.+|.+|||||+++.+..++..++||+++++++||+|||+|.|. ++.+.. +..|.++||
T Consensus 13 ~~~~L~v~vi~a~~L~~~~~~g~~dpyV~v~l~~~~~~~~~~kT~v~~~t~~P~wne~F~f~--i~~~~~~~~~l~~~v~ 90 (136)
T cd08405 13 TANRITVNIIKARNLKAMDINGTSDPYVKVWLMYKDKRVEKKKTVIKKRTLNPVFNESFIFN--IPLERLRETTLIITVM 90 (136)
T ss_pred CCCeEEEEEEEeeCCCccccCCCCCceEEEEEEeCCCccccccCcceeCCCCCcccceEEEe--CCHHHhCCCEEEEEEE
Confidence 446799999999 9999999999999999999987666668899999999999999999999 777666 456999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|++.+++++++|++.++..+.
T Consensus 91 d~~~~~~~~~lG~~~i~~~~~ 111 (136)
T cd08405 91 DKDRLSRNDLIGKIYLGWKSG 111 (136)
T ss_pred ECCCCCCCcEeEEEEECCccC
Confidence 999999999999999987654
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 7, a member of class 2 synaptotagmins, is located in presynaptic plasma membranes in neurons, dense-core vesicles in endocrine cells, and lysosomes in fibroblasts. It has been shown to play a role in regulation of Ca2+-dependent lysosomal exocytosis in fibroblasts and may also function as a vesicular Ca2+-sensor. It is distinguished from the other synaptotagmins by having over 12 splice forms. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic ves |
| >cd08385 C2A_Synaptotagmin-1-5-6-9-10 C2A domain first repeat present in Synaptotagmins 1, 5, 6, 9, and 10 | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-15 Score=141.89 Aligned_cols=97 Identities=13% Similarity=0.089 Sum_probs=85.9
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|.+|.+||||++++.|+++ ++++|+++++++||+|||+|.|. ++...+ +..|.++||
T Consensus 14 ~~~~L~V~v~~a~~L~~~d~~~~~dpyv~v~l~~~~~--~~~kT~v~~~t~nP~wne~f~f~--i~~~~l~~~~l~~~V~ 89 (124)
T cd08385 14 QSNQLTVGIIQAADLPAMDMGGTSDPYVKVYLLPDKK--KKFETKVHRKTLNPVFNETFTFK--VPYSELGNKTLVFSVY 89 (124)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCCEEEEEEEcCCC--CceecccCcCCCCCceeeeEEEe--CCHHHhCCCEEEEEEE
Confidence 457899999999 999999999999999999998765 37899999999999999999999 776555 456999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|++++++++|++.+...+...
T Consensus 90 d~d~~~~~~~lG~~~i~l~~~~~ 112 (124)
T cd08385 90 DFDRFSKHDLIGEVRVPLLTVDL 112 (124)
T ss_pred eCCCCCCCceeEEEEEecCcccC
Confidence 99999999999999998876644
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 1, a member of class 1 synaptotagmins, is located in the brain and endocranium and localized to the synaptic vesicles and secretory granules. It functions as a Ca2+ sensor for fast exocytosis as do synaptotagmins 5, 6, and 10. It is distinguished from the other synaptotagmins by having an N-glycosylated N-terminus. Synaptotagmins 5, 6, and 10, members of class 3 synaptotagmins, are located primarily in the brain and localized to the active zone and plasma membrane. They is distinguished from the other synaptotagmins by having disulfide bonds at its N-terminus. Synaptotagmin 6 also regulates the acrosome reaction, a unique Ca2+-regulated exocytosis, in sperm. Synaptotagmin 9, a class 5 synaptotagmins, is located in the brain and |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.8e-14 Score=145.57 Aligned_cols=132 Identities=21% Similarity=0.301 Sum_probs=102.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh---------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+.||+|++|.||+|.+ .|..+++|+...... ......+|..++..+.+ ++|+....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~------~~i~~p~~~~~~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK------AGVNVPAVYFVDPEN 73 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH------CCCCCCeEEEEeCCC
Confidence 5799999999999986 778899998653211 12346678888888864 355555555666778
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||++| +|.+.+.. ... .+..++.+++.+|.+||+.|++|+|++|.|||++ .+.++|+|||.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~---------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---~~~~~liDf~~ 140 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINS---------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---GGKIYLIDFGL 140 (211)
T ss_pred CEEEEEEeCCcCHHHHHHh---------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---CCCEEEEECCc
Confidence 8999999987 55555432 112 7788999999999999999999999999999998 57799999999
Q ss_pred ccc
Q 004954 570 SCF 572 (722)
Q Consensus 570 s~~ 572 (722)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.4e-16 Score=168.27 Aligned_cols=177 Identities=33% Similarity=0.441 Sum_probs=129.3
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
.+++|.|++|.- +|.+.+..... ... .++...+.++.|++.|+.| +|.+|+|+||.||.... ++++||.||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~--~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~--d~q~kIgDF 400 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEE--RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD--DDQLKIGDF 400 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccc--cchhHHHHHHHhhccchhh---ccchhhhcccccccccc--chhhhhhhh
Confidence 468999999984 66666653332 222 6777889999999999999 99999999999999985 778999999
Q ss_pred CCcccccCCc---------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 004954 568 GSSCFQTDNL---------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 568 Gls~~~~~~~---------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg 637 (722)
|+........ +..+||..||+||.+.+..|+.++||||||+||+|++. =..+|. ....+...
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~~d~-- 472 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RIATLTDI-- 472 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HHHhhhhh--
Confidence 9876544332 34688999999999999999999999999999999997 122221 11111000
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
. ...+|+... ...+.-.+||.+||...|.+||++.+.--|+|
T Consensus 473 -------r-------------------------~g~ip~~~~------~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~ 514 (516)
T KOG1033|consen 473 -------R-------------------------DGIIPPEFL------QDYPEEYTLLQQLLSPSPEERPSAIEVALHEF 514 (516)
T ss_pred -------h-------------------------cCCCChHHh------hcCcHHHHHHHHhcCCCcccCchHHHHhhhhh
Confidence 0 001111100 11122348999999999999999999999998
Q ss_pred CC
Q 004954 718 LQ 719 (722)
Q Consensus 718 f~ 719 (722)
++
T Consensus 515 ~~ 516 (516)
T KOG1033|consen 515 LQ 516 (516)
T ss_pred cC
Confidence 75
|
|
| >KOG1028 consensus Ca2+-dependent phospholipid-binding protein Synaptotagmin, required for synaptic vesicle and secretory granule exocytosis [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6e-16 Score=172.08 Aligned_cols=96 Identities=13% Similarity=0.018 Sum_probs=90.7
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccc-cccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKD-LMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~-L~~~V~ 341 (722)
.+++|+|+|++| ||++||.+|.+|||||++++++.++.+|+||.++|+++||+|||+|.|. ++.+.++++ |.++||
T Consensus 296 ~~g~ltv~v~kar~L~~~~~~~~~d~~Vk~~l~~~~~~~~kkkT~~~~~~~npv~nesf~F~--vp~~~l~~~~l~l~V~ 373 (421)
T KOG1028|consen 296 TAGRLTVVVIKARNLKSMDVGGLSDPYVKVTLLDGDKRLSKKKTSVKKKTLNPVFNETFVFD--VPPEQLAEVSLELTVW 373 (421)
T ss_pred CCCeEEEEEEEecCCCcccCCCCCCccEEEEEecCCceeeeeeeecccCCCCCcccccEEEe--CCHHHhheeEEEEEEE
Confidence 678999999999 9999999999999999999999999999999999999999999999998 999998665 999999
Q ss_pred ccCCCCCCccccccccCccc
Q 004954 342 DNSDTRDGEVNGALHEGKAD 361 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~ 361 (722)
|+|++++++++|.+.++...
T Consensus 374 d~d~~~~~~~iG~~~lG~~~ 393 (421)
T KOG1028|consen 374 DHDTLGSNDLIGRCILGSDS 393 (421)
T ss_pred EcccccccceeeEEEecCCC
Confidence 99999999999999888654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=144.65 Aligned_cols=138 Identities=22% Similarity=0.216 Sum_probs=102.7
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhh-----------------------hHhHHHHHHHHHHhcccCC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-----------------------FDQSLDEIKLLKLVNKNDP 472 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~-----------------------~~~~~~E~~il~~L~~~~~ 472 (722)
|.+.+.||+|+||.||++.+ .+|+.+|||+++..... ......|..++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~- 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG- 94 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC-
Confidence 78889999999999999986 48999999987653210 112456777777776532
Q ss_pred CCCCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 004954 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (722)
Q Consensus 473 ~~hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NI 552 (722)
..++..++. ...++||||+.|..+..+.. ......++.+++.++.++|+.||+|+||||+||
T Consensus 95 ---i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni 156 (198)
T cd05144 95 ---FPVPKPIDW----NRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI 156 (198)
T ss_pred ---CCCCceeec----CCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence 134444442 44589999998754432211 134567889999999999999999999999999
Q ss_pred EEcccCCCeEEEEecCCcccccC
Q 004954 553 LIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 553 Ll~~~~~~~vkL~DFGls~~~~~ 575 (722)
+++. ++.++|+|||.+.....
T Consensus 157 ll~~--~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDD--DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcC--CCcEEEEECCccccCCC
Confidence 9985 78999999999855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd04041 C2A_fungal C2 domain first repeat; fungal group | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.1e-15 Score=135.15 Aligned_cols=95 Identities=13% Similarity=0.017 Sum_probs=81.4
Q ss_pred ceeEEEEeec-CCccccCC-CCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc--ccccccccc
Q 004954 266 DYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA--EKDLMPAEI 341 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~-g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~--~~~L~~~V~ 341 (722)
+.|+|.|.+| ||+++|.. |.+||||++++.++++ .+++|+++++|+||+|||+|.|. +...+. +..|.++||
T Consensus 1 G~L~V~v~~a~~L~~~d~~~~~~Dpyv~v~~~~~~~--~~~kT~v~~~t~nP~Wne~f~f~--~~~~~~~~~~~l~~~V~ 76 (111)
T cd04041 1 GVLVVTIHRATDLPKADFGTGSSDPYVTASFAKFGK--PLYSTRIIRKDLNPVWEETWFVL--VTPDEVKAGERLSCRLW 76 (111)
T ss_pred CEEEEEEEEeeCCCcccCCCCCCCccEEEEEccCCC--ccEeeeeECCCCCCccceeEEEE--eCchhccCCCEEEEEEE
Confidence 3689999999 99999998 9999999999987653 46789999999999999999998 544332 456999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|++++++++|.+.+...+..+
T Consensus 77 d~d~~~~dd~lG~~~i~l~~l~~ 99 (111)
T cd04041 77 DSDRFTADDRLGRVEIDLKELIE 99 (111)
T ss_pred eCCCCCCCCcceEEEEEHHHHhc
Confidence 99999999999999998766653
|
C2 domains were first identified in Protein Kinase C (PKC). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/aczonin and intersectin which only have a single C2 domain. C2 domains with a calcium binding region have negatively charged residues, primarily aspartates, that serve as ligan |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.3e-14 Score=140.36 Aligned_cols=128 Identities=20% Similarity=0.266 Sum_probs=96.0
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.||+|+||.||++. ..|..+++|+..... ....+..+|.++++.+.+.. -+++.++ +......
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~----i~~p~~~--~~~~~~~ 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG----VNTPVVY--DVDPDNK 72 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC----CCCCEEE--EEECCCC
Confidence 38999999999998 467889999865321 01245667999999887542 1233343 3455667
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||++| ++.+.+.... . .++.|++.+|.+||+.|++|+|++|.||+++ ++.++|+|||++
T Consensus 73 ~lv~e~~~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~---~~~~~liDfg~a 136 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR---DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEEECCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE---CCcEEEEECCCC
Confidence 899999986 4544432110 0 7899999999999999999999999999998 678999999998
Q ss_pred cc
Q 004954 571 CF 572 (722)
Q Consensus 571 ~~ 572 (722)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 65
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-14 Score=139.75 Aligned_cols=139 Identities=22% Similarity=0.286 Sum_probs=96.7
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhhh---HhH----------------------HHHHHHHHHhcccCCC
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF---DQS----------------------LDEIKLLKLVNKNDPA 473 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~---~~~----------------------~~E~~il~~L~~~~~~ 473 (722)
.+.||+|+||+||+|.+. +|+.||||+++...... ... ..|...+..+....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-- 78 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG-- 78 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC--
Confidence 467999999999999976 89999999987542111 111 24455555554321
Q ss_pred CCCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCce
Q 004954 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENI 552 (722)
Q Consensus 474 ~hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NI 552 (722)
-.+++++++ ...++||||++++........... . ...++.++.+++.++.++|. .||+|+||||+||
T Consensus 79 --~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 79 --VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNI 146 (187)
T ss_pred --CCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhE
Confidence 234455543 346899999987321111100000 1 15678899999999999999 9999999999999
Q ss_pred EEcccCCCeEEEEecCCcccccC
Q 004954 553 LIKSYQRCEIKIIDLGSSCFQTD 575 (722)
Q Consensus 553 Ll~~~~~~~vkL~DFGls~~~~~ 575 (722)
+++ ++.++|+|||.+.....
T Consensus 147 li~---~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD---DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE---CCcEEEEECcccccccC
Confidence 998 67899999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd08386 C2A_Synaptotagmin-7 C2A domain first repeat present in Synaptotagmin 7 | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.8e-15 Score=135.83 Aligned_cols=98 Identities=12% Similarity=0.097 Sum_probs=84.3
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++++++++.. +.+|+++++++||+|||+|.|.. ++.+.+ ++.|.++||
T Consensus 14 ~~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~--~~kT~v~~~t~~P~Wne~f~f~~-~~~~~l~~~~l~~~v~ 90 (125)
T cd08386 14 QESTLTLKILKAVELPAKDFSGTSDPFVKIYLLPDKKH--KLETKVKRKNLNPHWNETFLFEG-FPYEKLQQRVLYLQVL 90 (125)
T ss_pred CCCEEEEEEEEecCCCCccCCCCCCceEEEEECCCCCc--ceeeeeecCCCCCccceeEEEcc-cCHHHhCCCEEEEEEE
Confidence 346899999999 9999999999999999999987553 67999999999999999999973 344444 566999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|++++++++|++.+...+...
T Consensus 91 d~d~~~~~~~iG~~~i~l~~l~~ 113 (125)
T cd08386 91 DYDRFSRNDPIGEVSLPLNKVDL 113 (125)
T ss_pred eCCCCcCCcEeeEEEEecccccC
Confidence 99999999999999998876654
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 7, a member of class 2 synaptotagmins, is located in presynaptic plasma membranes in neurons, dense-core vesicles in endocrine cells, and lysosomes in fibroblasts. It has been shown to play a role in regulation of Ca2+-dependent lysosomal exocytosis in fibroblasts and may also function as a vesicular Ca2+-sensor. It is distinguished from the other synaptotagmins by having over 12 splice forms. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic ves |
| >cd04009 C2B_Munc13-like C2 domain second repeat in Munc13 (mammalian uncoordinated)-like proteins | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-14 Score=137.62 Aligned_cols=99 Identities=14% Similarity=0.045 Sum_probs=85.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCC--CcccceeeecccCCCcceeeeeecccccccCc---cccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG--TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG---AEKDLM 337 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~--~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~---~~~~L~ 337 (722)
....|+|.|.+| +|+++|.+|.+||||++++.++.+ ...++||+++++|+||+|||+|.|. +.... .+..|.
T Consensus 14 ~~~~L~V~Vi~A~~L~~~~~~g~~dPyv~v~l~~~~~~~~~~~~kT~v~~~t~nP~wnE~f~f~--i~~~~~~~~~~~l~ 91 (133)
T cd04009 14 SEQSLRVEILNARNLLPLDSNGSSDPFVKVELLPRHLFPDVPTPKTQVKKKTLFPLFDESFEFN--VPPEQCSVEGALLL 91 (133)
T ss_pred CCCEEEEEEEEeeCCCCcCCCCCCCCEEEEEEECCCcCccccccccccCcCCCCCccCCEEEEE--echhhcccCCCEEE
Confidence 346899999999 999999999999999999998764 3568899999999999999999999 65432 245699
Q ss_pred ccccccCCCCCCccccccccCcccccc
Q 004954 338 PAEIDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 338 ~~V~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
++|||++++++++++|++.+...+..+
T Consensus 92 ~~V~d~d~~~~d~~iG~~~i~l~~l~~ 118 (133)
T cd04009 92 FTVKDYDLLGSNDFEGEAFLPLNDIPG 118 (133)
T ss_pred EEEEecCCCCCCcEeEEEEEeHHHCCc
Confidence 999999999999999999998765553
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, s |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.7e-14 Score=157.41 Aligned_cols=197 Identities=21% Similarity=0.250 Sum_probs=145.1
Q ss_pred CCCCceeEEEEEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCC-ccccCCCC
Q 004954 473 ADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGI-IHCDLKPE 550 (722)
Q Consensus 473 ~~hpnIv~l~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gI-vHrDLKp~ 550 (722)
..|.|+.++++.+......++|.+||. |+|.+.+..... .+.......+++.|+.||+|||..-| .|+.+++.
T Consensus 4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~-----~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI-----KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc-----CccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 468899999999999999999999997 788888775322 26677778899999999999998765 99999999
Q ss_pred ceEEcccCCCeEEEEecCCcccccCCcc-----ccccCCcccCchhhcCCC-------CCchhhHHHHHHHHHHHHhCCC
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLP-------YDQKIDLWSLGCILAELWTGEV 618 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~~~~~-----~~~gt~~y~APE~l~~~~-------~s~ksDIWSLGviL~elltG~~ 618 (722)
|++++. ...+||+|||+......... ......-|.|||.+.+.. .+.+.||||+|++++||++...
T Consensus 79 nClvd~--~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 79 NCLVDS--RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cceeee--eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999996 89999999999876643111 111234499999997642 3567999999999999999999
Q ss_pred CCCCCh----HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHH
Q 004954 619 LFPNDA----VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 694 (722)
Q Consensus 619 PF~~~~----~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dL 694 (722)
||.... +.+++..+.+ .+. ....|...... ...+++..+
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-~~~--------------------------------~~~rP~i~~~~----e~~~~l~~l 199 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-GGS--------------------------------NPFRPSIELLN----ELPPELLLL 199 (484)
T ss_pred ccccccccCChHHHHHHHHh-cCC--------------------------------CCcCcchhhhh----hcchHHHHH
Confidence 996522 2233333221 000 00111111110 122468899
Q ss_pred HHHhcccCCCCCcCHHHHH
Q 004954 695 VRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 695 L~~mL~~dP~kRpTa~ElL 713 (722)
++.||..+|.+||+++++-
T Consensus 200 ~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 200 VARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HHHhcccChhhCccHHHHH
Confidence 9999999999999998874
|
|
| >cd04039 C2_PSD C2 domain present in Phosphatidylserine decarboxylase (PSD) | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-14 Score=132.12 Aligned_cols=92 Identities=10% Similarity=-0.044 Sum_probs=77.1
Q ss_pred ceeEEEEeec-CCccccCC----CCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccc
Q 004954 266 DYGYLSSKEA-DLIDLQHN----VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~----g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V 340 (722)
+.|.|.|++| ||+++|.. +.+||||++.+- .+++||+++++++||+|||.|.|. +.....+..|.+.|
T Consensus 1 g~l~v~v~~A~~L~~~~~~~~~~~~~DPYv~v~~~-----~~~~kT~v~~~t~nPvWne~f~f~--v~~~~~~~~L~~~V 73 (108)
T cd04039 1 GVVFMEIKSITDLPPLKNMTRTGFDMDPFVIISFG-----RRVFRTSWRRHTLNPVFNERLAFE--VYPHEKNFDIQFKV 73 (108)
T ss_pred CEEEEEEEeeeCCCCccccCCCCCccCceEEEEEC-----CEeEeeeeecCCCCCcccceEEEE--EeCccCCCEEEEEE
Confidence 3588999999 99999842 357999999982 246789999999999999999998 66544556699999
Q ss_pred cccCCCCCCccccccccCcccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
||+|++++++++|.+.+...+...
T Consensus 74 ~D~d~~~~dd~IG~~~l~L~~l~~ 97 (108)
T cd04039 74 LDKDKFSFNDYVATGSLSVQELLN 97 (108)
T ss_pred EECCCCCCCcceEEEEEEHHHHHh
Confidence 999999999999999998766544
|
PSD is involved in the biosynthesis of aminophospholipid by converting phosphatidylserine (PtdSer) to phosphatidylethanolamine (PtdEtn). There is a single C2 domain present and it is thought to confer PtdSer binding motif that is common to PKC and synaptotagmin. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM |
| >cd08682 C2_Rab11-FIP_classI C2 domain found in Rab11-family interacting proteins (FIP) class I | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.4e-15 Score=136.38 Aligned_cols=89 Identities=15% Similarity=0.047 Sum_probs=77.0
Q ss_pred eEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeeccccccc---Ccc-cccccccccc
Q 004954 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHF---KGA-EKDLMPAEID 342 (722)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~---~~~-~~~L~~~V~D 342 (722)
++|.|.+| ||.++|.+|.+||||++.+. ..++||+++++|+||+|||+|.|. ++. +.. ...|.++|||
T Consensus 1 ~~V~V~~A~~L~~~d~~g~~dpYv~v~l~-----~~~~kT~v~~~t~nP~Wne~f~F~--v~~~~~~~~~~~~l~~~v~d 73 (126)
T cd08682 1 VQVTVLQARGLLCKGKSGTNDAYVIIQLG-----KEKYSTSVKEKTTSPVWKEECSFE--LPGLLSGNGNRATLQLTVMH 73 (126)
T ss_pred CEEEEEECcCCcCCCCCcCCCceEEEEEC-----CeeeeeeeecCCCCCEeCceEEEE--ecCcccCCCcCCEEEEEEEE
Confidence 47999999 99999999999999999994 246789999999999999999998 665 223 4569999999
Q ss_pred cCCCCCCccccccccCccccc
Q 004954 343 NSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~~~~~ 363 (722)
++++++++++|.+.+...+..
T Consensus 74 ~~~~~~d~~iG~~~i~l~~l~ 94 (126)
T cd08682 74 RNLLGLDKFLGQVSIPLNDLD 94 (126)
T ss_pred ccccCCCceeEEEEEEHHHhh
Confidence 999999999999988876654
|
Rab GTPases recruit various effector proteins to organelles and vesicles. Rab11-family interacting proteins (FIPs) are involved in mediating the role of Rab11. FIPs can be divided into three classes: class I FIPs (Rip11a, Rip11b, RCP, and FIP2) which contain a C2 domain after N-terminus of the protein, class II FIPs (FIP3 and FIP4) which contain two EF-hands and a proline rich region, and class III FIPs (FIP1) which exhibits no homology to known protein domains. All FIP proteins contain a highly conserved, 20-amino acid motif at the C-terminus of the protein, known as Rab11/25 binding domain (RBD). Class I FIPs are thought to bind to endocytic membranes via their C2 domain, which interacts directly with phospholipids. Class II FIPs do not have any membrane binding domains leaving much to speculate about the mechanism involving FIP3 and FIP4 interactions with endocytic membranes. The member |
| >cd08688 C2_KIAA0528-like C2 domain found in the Human KIAA0528 cDNA clone | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=132.81 Aligned_cols=90 Identities=12% Similarity=0.080 Sum_probs=79.8
Q ss_pred eEEEEeec-CCccccC-CCCCCcceEEEecCCCCCcccceeeecccCCCcce-eeeeecccccccCcc-ccccccccccc
Q 004954 268 GYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDW-IEGFKGSSDLHFKGA-EKDLMPAEIDN 343 (722)
Q Consensus 268 l~v~l~e~-~L~~~d~-~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~-nE~f~f~~~v~~~~~-~~~L~~~V~D~ 343 (722)
|+|.|.+| ||++||. +|.+||||++++.. .++||+++++++||.| ||+|.|. ++...+ +..|.++|||+
T Consensus 1 l~V~v~~a~~L~~~d~~~~~~Dpyv~v~~~~-----~~~kT~v~~~~~nP~W~ne~f~f~--i~~~~l~~~~l~i~V~d~ 73 (110)
T cd08688 1 LKVRVVAARDLPVMDRSSDLTDAFVEVKFGS-----TTYKTDVVKKSLNPVWNSEWFRFE--VDDEELQDEPLQIRVMDH 73 (110)
T ss_pred CEEEEEEEECCCccccCCCCCCceEEEEECC-----eeEecceecCCCCCcccCcEEEEE--cChHHcCCCeEEEEEEeC
Confidence 67999999 9999994 78999999999953 5788999999999999 9999999 776655 45699999999
Q ss_pred CCCCCCccccccccCcccccc
Q 004954 344 SDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 344 D~~~~~d~iG~v~~~~~~~~~ 364 (722)
+.+++++++|++.+...+...
T Consensus 74 d~~~~~~~iG~~~~~l~~l~~ 94 (110)
T cd08688 74 DTYSANDAIGKVYIDLNPLLL 94 (110)
T ss_pred CCCCCCCceEEEEEeHHHhcc
Confidence 999999999999998877665
|
The members of this CD are named after the Human KIAA0528 cDNA clone. All members here contain a single C2 repeat. No other information on this protein is currently known. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/a |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=159.87 Aligned_cols=135 Identities=21% Similarity=0.248 Sum_probs=101.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----h-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----K-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
...|...+.||+|+||+||++.+.. ..+++|+.... . ....+..+|.++++.+++ ++++..+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~------~~i~~p~~ 403 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR------AGVPTPVI 403 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc------cCCCeeEE
Confidence 3445678899999999999998643 34444432211 1 122456788888888864 56777666
Q ss_pred EEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
++......++||||++| +|.+++. ....++.|++.+|.+||+.|++||||||+|||++ ++.+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~---~~~~ 466 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR---DDRL 466 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE---CCcE
Confidence 66677778999999986 4544443 3457899999999999999999999999999994 6789
Q ss_pred EEEecCCccc
Q 004954 563 KIIDLGSSCF 572 (722)
Q Consensus 563 kL~DFGls~~ 572 (722)
+|+|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999865
|
|
| >cd08401 C2A_RasA2_RasA3 C2 domain first repeat present in RasA2 and RasA3 | Back alignment and domain information |
|---|
Probab=99.50 E-value=2e-14 Score=133.38 Aligned_cols=89 Identities=18% Similarity=0.066 Sum_probs=75.6
Q ss_pred eEEEEeec-CCcccc-CCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCC
Q 004954 268 GYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (722)
Q Consensus 268 l~v~l~e~-~L~~~d-~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~ 345 (722)
|+|.|.+| ||++++ .+|.+||||++++. .+++.||+++++|+||+|||+|.|. ++.. .+.|.+.|||+++
T Consensus 2 l~v~v~~a~~L~~~~~~~g~sDpYv~v~l~----~~~~~kT~v~~kt~~P~WnE~F~f~--v~~~--~~~l~~~v~d~~~ 73 (121)
T cd08401 2 LKIKIGEAKNLPPRSGPNKMRDCYCTVNLD----QEEVFRTKTVEKSLCPFFGEDFYFE--IPRT--FRHLSFYIYDRDV 73 (121)
T ss_pred eEEEEEEccCCCCCCCCCCCcCcEEEEEEC----CccEEEeeEEECCCCCccCCeEEEE--cCCC--CCEEEEEEEECCC
Confidence 67999999 999985 57899999999992 2246789999999999999999999 7643 3569999999999
Q ss_pred CCCCccccccccCcccccc
Q 004954 346 TRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 346 ~~~~d~iG~v~~~~~~~~~ 364 (722)
+++++++|.+.+...+...
T Consensus 74 ~~~~~~iG~~~i~l~~l~~ 92 (121)
T cd08401 74 LRRDSVIGKVAIKKEDLHK 92 (121)
T ss_pred CCCCceEEEEEEEHHHccC
Confidence 9999999999887665543
|
RasA2 and RasA3 are GAP1s (GTPase activating protein 1s ), Ras-specific GAP members, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. RasA2 and RasA3 are both inositol 1,3,4,5-tetrakisphosphate-binding proteins and contain an N-terminal C2 domain, a Ras-GAP domain, a pleckstrin-homology (PH) domain which localizes it to the plasma membrane, and Bruton's Tyrosine Kinase (BTK) a zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular p |
| >cd04032 C2_Perforin C2 domain of Perforin | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.4e-14 Score=131.35 Aligned_cols=91 Identities=10% Similarity=-0.050 Sum_probs=75.5
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
....|+|.|.+| +|+ +|..|.+|||||+++. .+++||+++++++||+|||+|.|. .........|.++|||
T Consensus 26 ~~~~L~V~V~~A~~L~-~d~~g~~DPYVkV~~~-----~~~~kT~vi~~t~nPvWNE~F~f~--~~~~~~~~~L~v~V~D 97 (127)
T cd04032 26 GLATLTVTVLRATGLW-GDYFTSTDGYVKVFFG-----GQEKRTEVIWNNNNPRWNATFDFG--SVELSPGGKLRFEVWD 97 (127)
T ss_pred CcEEEEEEEEECCCCC-cCcCCCCCeEEEEEEC-----CccccCceecCCCCCcCCCEEEEe--cccCCCCCEEEEEEEe
Confidence 446899999999 997 5888999999999983 127899999999999999999997 3222234559999999
Q ss_pred cCCCCCCccccccccCcccc
Q 004954 343 NSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~~~~ 362 (722)
+|.+++++++|.+.++...+
T Consensus 98 ~d~~s~dd~IG~~~i~l~~~ 117 (127)
T cd04032 98 RDNGWDDDLLGTCSVVPEAG 117 (127)
T ss_pred CCCCCCCCeeEEEEEEecCC
Confidence 99999999999998876533
|
Perforin contains a single copy of a C2 domain in its C-terminus and plays a role in lymphocyte-mediated cytotoxicity. Mutations in perforin leads to familial hemophagocytic lymphohistiocytosis type 2. The function of perforin is calcium dependent and the C2 domain is thought to confer this binding to target cell membranes. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few |
| >cd08390 C2A_Synaptotagmin-15-17 C2A domain first repeat present in Synaptotagmins 15 and 17 | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-14 Score=131.57 Aligned_cols=98 Identities=15% Similarity=0.054 Sum_probs=85.4
Q ss_pred ccceeEEEEeec-CCcccc-CCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d-~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
..+.|+|.|.+| ||+++| .+|.+||||++++.|+.+. +++|+++++++||+|||+|.|. ++.... .+.|.+.|
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~~dpyV~v~l~~~~~~--~~~T~v~~~~~~P~wne~f~f~--i~~~~l~~~~l~i~v 87 (123)
T cd08390 12 EEEQLTVSLIKARNLPPRTKDVAHCDPFVKVCLLPDERR--SLQSKVKRKTQNPNFDETFVFQ--VSFKELQRRTLRLSV 87 (123)
T ss_pred CCCEEEEEEEEecCCCCccCCCCCCCcEEEEEEeeCCCC--ceEeeeEcCCCCCccceEEEEE--cCHHHhcccEEEEEE
Confidence 457899999999 999999 7889999999999987653 5789999999999999999999 877666 45699999
Q ss_pred cccCCCCCCccccccccCccccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~e 365 (722)
||++..++++++|.+.++..+....
T Consensus 88 ~d~~~~~~~~~iG~~~i~L~~l~~~ 112 (123)
T cd08390 88 YDVDRFSRHCIIGHVLFPLKDLDLV 112 (123)
T ss_pred EECCcCCCCcEEEEEEEeccceecC
Confidence 9999999999999999887665553
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. It is thought to be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues and is Ca2+ independent. Human synaptotagmin 15 has 2 alternatively spliced forms that encode proteins with different C-termini. The larger, SYT15a, contains a N-terminal TM region, a putative fatty-acylation site, and 2 tandem C terminal C2 domains. The smaller, SYT15b, lacks the C-terminal portion of the second C2 domain. Unlike most other synaptotagmins it is nearly absent in the brain and rather is found in the heart, lungs, skeletal muscle, and testis. Synaptotagmin 17 is located in the brain, kidney, and prostate and is thought to be a peripheral membrane protein. Previously all synaptotagmins were thought to be calcium sensors in the regulat |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.3e-13 Score=125.83 Aligned_cols=134 Identities=20% Similarity=0.229 Sum_probs=108.6
Q ss_pred EEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 004954 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (722)
Q Consensus 418 i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy 497 (722)
+.+.||.|.++.||++.+. +..+++|+...... ...+..|..+++.+++. ..++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~----~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-GADREREVAILQLLARK----GLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHc----CCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999964 37899999876543 45688899999999864 24688888888877889999999
Q ss_pred cccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC---CCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 498 LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 498 ~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~---gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
+.+..+..+ +......++.+++.+|+.||.. +++|+|++|.||+++. .+.++++|||.+..
T Consensus 75 ~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~--~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD--GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC--CcEEEEEecccccC
Confidence 986533211 3456677899999999999985 6999999999999985 68899999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd08376 C2B_MCTP_PRT C2 domain second repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP) | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.9e-14 Score=129.40 Aligned_cols=89 Identities=15% Similarity=0.133 Sum_probs=76.9
Q ss_pred eEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCCC
Q 004954 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (722)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~~ 346 (722)
++|.|.+| ||+++|.+|.+||||++++. ..+.||+++++|+||.|||+|.|. +... .+..|.++|||++.+
T Consensus 2 ~~V~v~~a~~L~~~~~~~~~dPyv~v~~~-----~~~~kT~v~~~t~nP~Wne~f~f~--~~~~-~~~~l~v~v~d~~~~ 73 (116)
T cd08376 2 VTIVLVEGKNLPPMDDNGLSDPYVKFRLG-----NEKYKSKVCSKTLNPQWLEQFDLH--LFDD-QSQILEIEVWDKDTG 73 (116)
T ss_pred EEEEEEEEECCCCCCCCCCCCcEEEEEEC-----CEeEecccccCCCCCceeEEEEEE--ecCC-CCCEEEEEEEECCCC
Confidence 68999999 99999999999999999983 246889999999999999999998 5543 245699999999999
Q ss_pred CCCccccccccCcccccc
Q 004954 347 RDGEVNGALHEGKADAEE 364 (722)
Q Consensus 347 ~~~d~iG~v~~~~~~~~~ 364 (722)
++++++|.+.++..+...
T Consensus 74 ~~~~~iG~~~~~l~~l~~ 91 (116)
T cd08376 74 KKDEFIGRCEIDLSALPR 91 (116)
T ss_pred CCCCeEEEEEEeHHHCCC
Confidence 999999999988765443
|
MCTPs are involved in Ca2+ signaling at the membrane. MCTP is composed of a variable N-terminal sequence, three C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular protei |
| >cd04036 C2_cPLA2 C2 domain present in cytosolic PhosphoLipase A2 (cPLA2) | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.8e-14 Score=129.65 Aligned_cols=91 Identities=11% Similarity=0.036 Sum_probs=77.6
Q ss_pred eEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCCC
Q 004954 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (722)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~~ 346 (722)
|+|.|.+| ||++.|..|.+||||++.+...+ ..+++|+++++++||+|||+|.|. +... ....|.++|||+|.+
T Consensus 2 L~V~vi~a~~L~~~~~~~~~Dpyv~v~~~~~~--~~~~kT~vv~~t~nP~Wne~f~f~--i~~~-~~~~l~v~v~d~d~~ 76 (119)
T cd04036 2 LTVRVLRATNITKGDLLSTPDCYVELWLPTAS--DEKKRTKTIKNSINPVWNETFEFR--IQSQ-VKNVLELTVMDEDYV 76 (119)
T ss_pred eEEEEEEeeCCCccCCCCCCCcEEEEEEcCCC--CccCccceecCCCCCccceEEEEE--eCcc-cCCEEEEEEEECCCC
Confidence 78999999 99999999999999999996543 347889999999999999999998 6654 344599999999999
Q ss_pred CCCccccccccCcccccc
Q 004954 347 RDGEVNGALHEGKADAEE 364 (722)
Q Consensus 347 ~~~d~iG~v~~~~~~~~~ 364 (722)
+++++|++.+.......
T Consensus 77 -~~~~iG~~~~~l~~l~~ 93 (119)
T cd04036 77 -MDDHLGTVLFDVSKLKL 93 (119)
T ss_pred -CCcccEEEEEEHHHCCC
Confidence 99999999887765443
|
A single copy of the C2 domain is present in cPLA2 which releases arachidonic acid from membranes initiating the biosynthesis of potent inflammatory mediators such as prostaglandins, leukotrienes, and platelet-activating factor. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants o |
| >cd04018 C2C_Ferlin C2 domain third repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.7e-14 Score=134.53 Aligned_cols=94 Identities=15% Similarity=0.106 Sum_probs=79.2
Q ss_pred eeEEEEeec-CCccccCCC--------------CCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCc
Q 004954 267 YGYLSSKEA-DLIDLQHNV--------------VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG 331 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g--------------~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~ 331 (722)
.|+|+|.+| +|++||..+ .+||||++.+.. ++.||+++++++||+|||+|.|. +....
T Consensus 1 ~~~V~V~~A~dLp~~d~~~~~~~~~~~~~~~~~~~DPYV~V~~~g-----~~~kT~v~~~t~nPvWNE~f~f~--v~~p~ 73 (151)
T cd04018 1 RFIFKIYRAEDLPQMDSGIMANVKKAFLGEKKELVDPYVEVSFAG-----QKVKTSVKKNSYNPEWNEQIVFP--EMFPP 73 (151)
T ss_pred CeEEEEEEeCCCCccChhhhccceeccccCCCCCcCcEEEEEECC-----EeeecceEcCCCCCCcceEEEEE--eeCCC
Confidence 478999999 999999665 689999999853 35689999999999999999998 55444
Q ss_pred ccccccccccccCCCCCCccccccccCccccccccC
Q 004954 332 AEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGV 367 (722)
Q Consensus 332 ~~~~L~~~V~D~D~~~~~d~iG~v~~~~~~~~~e~~ 367 (722)
.+..|.++|||+|.+++++++|.+.+....+..++.
T Consensus 74 ~~~~l~~~v~D~d~~~~dd~iG~~~l~l~~l~~~~~ 109 (151)
T cd04018 74 LCERIKIQIRDWDRVGNDDVIGTHFIDLSKISNSGD 109 (151)
T ss_pred cCCEEEEEEEECCCCCCCCEEEEEEEeHHHhccCCc
Confidence 556799999999999999999999998776655554
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04025 C2B_RasA1_RasA4 C2 domain second repeat present in RasA1 and RasA4 | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-13 Score=128.78 Aligned_cols=90 Identities=17% Similarity=0.043 Sum_probs=77.7
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCC
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~ 345 (722)
+|+|.|.+| +|.++|.+|.+||||++++. ..+.+|+++++|+||.|||+|.|. +.... ...|.++|||++.
T Consensus 1 ~L~v~vi~a~~L~~~d~~~~~DPyv~v~~~-----~~~~kT~v~~~t~nP~Wne~f~f~--~~~~~-~~~l~~~v~d~~~ 72 (123)
T cd04025 1 RLRCHVLEARDLAPKDRNGTSDPFVRVFYN-----GQTLETSVVKKSCYPRWNEVFEFE--LMEGA-DSPLSVEVWDWDL 72 (123)
T ss_pred CEEEEEEEeeCCCCCCCCCCcCceEEEEEC-----CEEEeceeecCCCCCccCcEEEEE--cCCCC-CCEEEEEEEECCC
Confidence 589999999 99999999999999999983 245789999999999999999998 65533 4559999999999
Q ss_pred CCCCccccccccCcccccc
Q 004954 346 TRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 346 ~~~~d~iG~v~~~~~~~~~ 364 (722)
+++++++|.+.++..+...
T Consensus 73 ~~~~~~iG~~~~~l~~l~~ 91 (123)
T cd04025 73 VSKNDFLGKVVFSIQTLQQ 91 (123)
T ss_pred CCCCcEeEEEEEEHHHccc
Confidence 9999999999998766543
|
RasA1 and RasA4 are GAP1s (GTPase activating protein 1s ), Ras-specific GAP members, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. Both proteins contain two C2 domains, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such a |
| >cd00276 C2B_Synaptotagmin C2 domain second repeat present in Synaptotagmin | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.8e-14 Score=131.45 Aligned_cols=103 Identities=16% Similarity=0.081 Sum_probs=89.6
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
+.+.|+|.|.+| ||+++|.+|..||||++.+.++.....+++|++++++.||.|||+|.|. ++...+ +..|.++||
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~~T~~~~~~~~P~wne~f~f~--i~~~~l~~~~l~~~v~ 89 (134)
T cd00276 12 TAERLTVVVLKARNLPPSDGKGLSDPYVKVSLLQGGKKLKKKKTSVKKGTLNPVFNEAFSFD--VPAEQLEEVSLVITVV 89 (134)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCcEEEEEEEcCCeEeeeecCcceecCCCCeeeeeEEEE--CCHHHhCCcEEEEEEE
Confidence 457899999999 9999999999999999999998766678899999999999999999999 777665 456999999
Q ss_pred ccCCCCCCccccccccCccccccccCCC
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHGVAT 369 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~~~~ 369 (722)
|.+.+++++++|.+.++..+ .+.+...
T Consensus 90 d~~~~~~~~~lG~~~i~l~~-~~~~~~~ 116 (134)
T cd00276 90 DKDSVGRNEVIGQVVLGPDS-GGEELEH 116 (134)
T ss_pred ecCCCCCCceeEEEEECCCC-CCcHHHH
Confidence 99999999999999999877 4444443
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. There are several classes of Synaptotagmins. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distin |
| >cd04016 C2_Tollip C2 domain present in Toll-interacting protein (Tollip) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.5e-13 Score=127.30 Aligned_cols=85 Identities=8% Similarity=-0.044 Sum_probs=72.2
Q ss_pred ceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeeccc-CCCcceeeeeecccccccCccccccccccccc
Q 004954 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKR-GSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~-tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (722)
+.|+|.|++| +|+.++ .|.+||||++.+- .++.+|+++++ ++||+|||+|.|. +... ...|.++|||.
T Consensus 2 g~L~v~v~~Ak~l~~~~-~g~sDPYv~i~lg-----~~~~kT~v~~~~~~nP~WNe~F~f~--v~~~--~~~l~~~V~d~ 71 (121)
T cd04016 2 GRLSITVVQAKLVKNYG-LTRMDPYCRIRVG-----HAVYETPTAYNGAKNPRWNKTIQCT--LPEG--VDSIYIEIFDE 71 (121)
T ss_pred cEEEEEEEEccCCCcCC-CCCCCceEEEEEC-----CEEEEeEEccCCCCCCccCeEEEEE--ecCC--CcEEEEEEEeC
Confidence 5789999999 888887 6899999999992 24678988665 8999999999998 6543 24599999999
Q ss_pred CCCCCCccccccccCcc
Q 004954 344 SDTRDGEVNGALHEGKA 360 (722)
Q Consensus 344 D~~~~~d~iG~v~~~~~ 360 (722)
|.+++++++|++.+...
T Consensus 72 d~~~~dd~iG~~~i~l~ 88 (121)
T cd04016 72 RAFTMDERIAWTHITIP 88 (121)
T ss_pred CCCcCCceEEEEEEECc
Confidence 99999999999887764
|
Tollip is a part of the Interleukin-1 receptor (IL-1R) signaling pathway. Tollip is proposed to link serine/threonine kinase IRAK to IL-1Rs as well as inhibiting phosphorylation of IRAK. There is a single C2 domain present in Tollip. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice varian |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-14 Score=168.15 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=183.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC-CCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL-HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~-~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
...|.+.+.||+|+|+.|-+.... .+...+|+|.+... .........|..+-+.+.. |+|++++++.....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~-----h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSK-----HSNTVHMIEPSSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccc-----cccccccCCccCCC
Confidence 356888889999999999999863 33445666655433 2223333345554444432 88999999999999
Q ss_pred CeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCceEEcccCCC-eEEEE
Q 004954 489 EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-SLGIIHCDLKPENILIKSYQRC-EIKII 565 (722)
Q Consensus 489 ~~l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLH-s~gIvHrDLKp~NILl~~~~~~-~vkL~ 565 (722)
+..+++++|..|+ +.+.+.. ......+......++.|+..+|.|+| ..++.|+||||+|.+++. .+ .++++
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~----~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~--s~~~l~~~ 167 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISH----PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE--SGSALKIA 167 (601)
T ss_pred cccccccCccccccccccccc----CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc--CCCcccCC
Confidence 9999999997653 4333311 11113667788899999999999999 999999999999999996 55 89999
Q ss_pred ecCCcccccC-C-----cccccc-CCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 566 DLGSSCFQTD-N-----LCLYVQ-SRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 566 DFGls~~~~~-~-----~~~~~g-t~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|||+|..... . ....+| ++.|+|||...+. -.....|+||.|+++..+++|..||.........
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------- 239 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------- 239 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------
Confidence 9999976554 2 223578 9999999999885 4567899999999999999999999654321100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
...|.. .. ....+ .. .........+++.++|..+|..|.+.+++-.+||
T Consensus 240 ------------~~~~~~--------~~--~~~~~--~~-------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 240 ------------YSSWKS--------NK--GRFTQ--LP-------WNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred ------------ceeecc--------cc--ccccc--Cc-------cccCChhhhhcccccccCCchhcccccccccccc
Confidence 000000 00 00000 00 0112234679999999999999999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
+..
T Consensus 289 ~~~ 291 (601)
T KOG0590|consen 289 LSS 291 (601)
T ss_pred ccc
Confidence 975
|
|
| >cd04022 C2A_MCTP_PRT_plant C2 domain first repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-13 Score=129.16 Aligned_cols=90 Identities=9% Similarity=0.011 Sum_probs=77.6
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeeccccccc-Ccc-ccccccccccc
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHF-KGA-EKDLMPAEIDN 343 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~-~~~-~~~L~~~V~D~ 343 (722)
+|+|.|++| ||.++|.+|.+||||++++.. .+++|+++++++||+|||+|.|. +.. ... +..|.++|||.
T Consensus 1 ~L~V~vi~A~~L~~~d~~g~~dpyv~v~~~~-----~~~rT~v~~~t~nP~Wne~f~f~--~~~~~~~~~~~l~~~V~d~ 73 (127)
T cd04022 1 KLVVEVVDAQDLMPKDGQGSSSAYVELDFDG-----QKKRTRTKPKDLNPVWNEKLVFN--VSDPSRLSNLVLEVYVYND 73 (127)
T ss_pred CeEEEEEEeeCCCCCCCCCCcCcEEEEEECC-----EEecceeEcCCCCCccceEEEEE--ccCHHHccCCeEEEEEeeC
Confidence 589999999 999999999999999999864 36789999999999999999999 553 222 45699999999
Q ss_pred CCCC-CCccccccccCccccc
Q 004954 344 SDTR-DGEVNGALHEGKADAE 363 (722)
Q Consensus 344 D~~~-~~d~iG~v~~~~~~~~ 363 (722)
+++. +++++|++.++..+..
T Consensus 74 ~~~~~~d~~lG~v~i~l~~l~ 94 (127)
T cd04022 74 RRSGRRRSFLGRVRISGTSFV 94 (127)
T ss_pred CCCcCCCCeeeEEEEcHHHcC
Confidence 9997 7999999999876655
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates |
| >cd08690 C2_Freud-1 C2 domain found in 5' repressor element under dual repression binding protein-1 (Freud-1) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=131.94 Aligned_cols=94 Identities=15% Similarity=0.033 Sum_probs=75.5
Q ss_pred EEEEeec---CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCc------c-cccccc
Q 004954 269 YLSSKEA---DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG------A-EKDLMP 338 (722)
Q Consensus 269 ~v~l~e~---~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~------~-~~~L~~ 338 (722)
.|+|+.| +|++.+.+|.+|||||++|+....+.++.||+++|+|+||+|||+|.|. ++... . ++.|.+
T Consensus 5 el~i~~~~~~~l~~~~~~~~~DpYVk~~l~~p~~~~~k~KT~v~k~TlnPvfNE~f~f~--I~~~~~~~~R~l~~~~L~~ 82 (155)
T cd08690 5 ELTIVRCIGIPLPSGWNPKDLDTYVKFEFPYPNEEPQSGKTSTIKDTNSPEYNESFKLN--INRKHRSFQRVFKRHGLKF 82 (155)
T ss_pred EEEEEEeeccccCCCcCCCCCCeEEEEEEecCCCCCceeecCcccCCCCCcccceEEEE--eccccchhhhhccCCcEEE
Confidence 4445555 5899999999999999998543556789999999999999999999999 76552 3 455999
Q ss_pred cccccCCCC-CCccccccccCcccccc
Q 004954 339 AEIDNSDTR-DGEVNGALHEGKADAEE 364 (722)
Q Consensus 339 ~V~D~D~~~-~~d~iG~v~~~~~~~~~ 364 (722)
+|||++.+. +++++|++.+.......
T Consensus 83 ~V~d~~~f~~~D~~iG~~~i~L~~l~~ 109 (155)
T cd08690 83 EVYHKGGFLRSDKLLGTAQVKLEPLET 109 (155)
T ss_pred EEEeCCCcccCCCeeEEEEEEcccccc
Confidence 999999975 69999999886654433
|
Freud-1 is a novel calcium-regulated repressor that negatively regulates basal 5-HT1A receptor expression in neurons. It may also play a role in the altered regulation of 5-HT1A receptors associated with anxiety or major depression. Freud-1 contains two DM-14 basic repeats, a helix-loop-helix DNA binding domain, and a C2 domain. The Freud-1 C2 domain is thought to be calcium insensitive and it lacks several acidic residues that mediate calcium binding of the PKC C2 domain. In addition, it contains a poly-basic insert that is not present in calcium-dependent C2 domains and may function as a nuclear localization signal. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules tha |
| >cd08686 C2_ABR C2 domain in the Active BCR (Breakpoint cluster region) Related protein | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-13 Score=125.58 Aligned_cols=80 Identities=10% Similarity=0.058 Sum_probs=68.4
Q ss_pred eEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccccc---
Q 004954 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN--- 343 (722)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~--- 343 (722)
|+|+|++| ||+ |.+||||++.+.+.++...+.||+++++|+||+|||+|.|. ++ ..++|.+.|||+
T Consensus 1 L~V~V~~A~~L~-----~~sDPYV~l~v~~~~~~~~~~KTk~i~~TlnPvWnE~F~i~--l~---~s~~L~~~v~d~~~~ 70 (118)
T cd08686 1 LNVIVHSAQGFK-----QSANLYCTLEVDSFGYFVKKAKTRVCRDTTEPNWNEEFEIE--LE---GSQTLRILCYEKCYS 70 (118)
T ss_pred CEEEEEeCCCCC-----CCCCCEEEEEEcCccccceeeeeeeecCCCCCccceEEEEE--eC---CCCEEEEEEEEcccc
Confidence 67999999 995 67999999999998765678999999999999999999998 65 244799999998
Q ss_pred ----CCCCCCcccccccc
Q 004954 344 ----SDTRDGEVNGALHE 357 (722)
Q Consensus 344 ----D~~~~~d~iG~v~~ 357 (722)
|.++.++.+|...+
T Consensus 71 ~~~~d~~~~d~~~G~g~i 88 (118)
T cd08686 71 KVKLDGEGTDAIMGKGQI 88 (118)
T ss_pred cccccccCcccEEEEEEE
Confidence 57778899976544
|
The ABR protein is similar to the breakpoint cluster region protein. It has homology to guanine nucleotide exchange proteins and GTPase-activating proteins (GAPs). ABR is expressed primarily in the brain, but also includes non-neuronal tissues such as the heart. It has been associated with human diseases such as Miller-Dieker syndrome in which mental retardation and malformations of the heart are present. ABR contains a RhoGEF domain and a PH-like domain upstream of its C2 domain and a RhoGAP domain downstream of this domain. A few members also contain a Bcr-Abl oncoprotein oligomerization domain at the very N-terminal end. Splice variants of ABR have been identified. ABR is found in a wide variety of organisms including chimpanzee, dog, mouse, rat, fruit fly, and mosquito. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arr |
| >cd04035 C2A_Rabphilin_Doc2 C2 domain first repeat present in Rabphilin and Double C2 domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-13 Score=126.95 Aligned_cols=100 Identities=12% Similarity=0.075 Sum_probs=84.5
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
.+.+|+|.|.+| +|+++|..|.+|||||+++.++.....+++|+++++++||+|||+|.|.. ++.... +..|.++||
T Consensus 13 ~~~~L~V~v~~a~~L~~~~~~~~~dpyv~v~~~~~~~~~~~~rT~v~~~~~~P~Wne~f~f~~-~~~~~~~~~~l~~~v~ 91 (123)
T cd04035 13 ANSALHCTIIRAKGLKAMDANGLSDPYVKLNLLPGASKATKLRTKTVHKTRNPEFNETLTYYG-ITEEDIQRKTLRLLVL 91 (123)
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCceEEEEEecCCCCCCceeeeeecCCCCCCccceEEEcC-CCHHHhCCCEEEEEEE
Confidence 457899999999 99999999999999999999887666789999999999999999999963 333333 456999999
Q ss_pred ccCCCCCCccccccccCccccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEH 365 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e 365 (722)
|++.+ +++++|.+.++..+...+
T Consensus 92 d~~~~-~~~~iG~~~i~l~~l~~~ 114 (123)
T cd04035 92 DEDRF-GNDFLGETRIPLKKLKPN 114 (123)
T ss_pred EcCCc-CCeeEEEEEEEcccCCCC
Confidence 99999 899999999887655443
|
Rabphilin is found neurons and in neuroendrocrine cells, while Doc2 is found not only in the brain but in tissues, including mast cells, chromaffin cells, and osteoblasts. Rabphilin and Doc2s share highly homologous tandem C2 domains, although their N-terminal structures are completely different: rabphilin contains an N-terminal Rab-binding domain (RBD),7 whereas Doc2 contains an N-terminal Munc13-1-interacting domain (MID). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain |
| >cd04026 C2_PKC_alpha_gamma C2 domain in Protein Kinase C (PKC) alpha and gamma | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=128.73 Aligned_cols=115 Identities=21% Similarity=0.241 Sum_probs=94.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
....|+|.|.+| ||++.|..|..||||++.+.+++....+++|+++++++||.|||+|.|. +.....+..|.++|||
T Consensus 11 ~~~~l~v~i~~a~nL~~~~~~~~~dpyv~v~~~~~~~~~~~~rT~v~~~~~~P~wne~f~~~--~~~~~~~~~l~v~v~d 88 (131)
T cd04026 11 KDNKLTVEVREAKNLIPMDPNGLSDPYVKLKLIPDPKNETKQKTKTIKKTLNPVWNETFTFD--LKPADKDRRLSIEVWD 88 (131)
T ss_pred CCCEEEEEEEEeeCCCCcCCCCCCCCcEEEEEEcCCCCCceecceeecCCCCCCccceEEEe--CCchhcCCEEEEEEEE
Confidence 347899999999 9999999999999999999887766678899999999999999999999 6655455669999999
Q ss_pred cCCCCCCccccccccCccccccccCCCcchhhhhhhHhHhhh
Q 004954 343 NSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEI 384 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~~~~~~e~~~~~~~l~f~~L~ee~~~ 384 (722)
++.+++++++|.+.++..+........ |+....+....
T Consensus 89 ~~~~~~~~~iG~~~~~l~~l~~~~~~~----w~~L~~~~~~~ 126 (131)
T cd04026 89 WDRTTRNDFMGSLSFGVSELIKMPVDG----WYKLLNQEEGE 126 (131)
T ss_pred CCCCCCcceeEEEEEeHHHhCcCccCc----eEECcCccccc
Confidence 999999999999999877666543333 55555544433
|
A single C2 domain is found in PKC alpha and gamma. The PKC family of serine/threonine kinases regulates apoptosis, proliferation, migration, motility, chemo-resistance, and differentiation. There are 3 groups: group 1(alpha, betaI, beta II, gamma) which require phospholipids and calcium, group 2 (delta, epsilon, theta, eta) which do not require calcium for activation, and group 3 (xi, iota/lambda) which are atypical and can be activated in the absence of diacylglycerol and calcium. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transd |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.1e-12 Score=132.73 Aligned_cols=133 Identities=17% Similarity=0.192 Sum_probs=96.9
Q ss_pred Eec-cCCCCceEEEEECCCCcEEEEEEeecch--------------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 421 YLG-SAAFSKVFQAQDLHTGVDVCLKIIKNDK--------------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 421 ~LG-~G~fG~Vy~a~d~~tg~~vAvKil~~~~--------------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.|| .||.|+||.+.. .+..++||.+.... ....+..+|+.++..+.+.. ..+++.+++.
T Consensus 38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~g----i~vP~pl~~~ 111 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAG----LPVPRPIAAR 111 (239)
T ss_pred eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCC----CCCceeEeee
Confidence 577 889999999975 47889999875311 12245678999999997642 2346666664
Q ss_pred EecC----eEEEEEEcccc--chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC
Q 004954 486 YHLE----HLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (722)
Q Consensus 486 ~~~~----~l~iVmEy~~g--sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~ 559 (722)
.... ..++|||+++| +|.+++... .++.. .+.||+.+|.+||+.||+|+||||.|||++. +
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~--~ 178 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP--D 178 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC--C
Confidence 4322 23699999986 455554321 14433 3578999999999999999999999999986 5
Q ss_pred CeEEEEecCCccc
Q 004954 560 CEIKIIDLGSSCF 572 (722)
Q Consensus 560 ~~vkL~DFGls~~ 572 (722)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 6899999998865
|
|
| >cd04042 C2A_MCTP_PRT C2 domain first repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-13 Score=126.57 Aligned_cols=89 Identities=12% Similarity=0.063 Sum_probs=76.5
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCC
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~ 345 (722)
.|+|.|++| ||+++|.+|.+||||++.+.. ...++|+++++|+||+|||+|.|. +.. ....|.++|||+|.
T Consensus 1 ~L~v~v~~a~~L~~~d~~g~~Dpyv~v~~~~----~~~~kT~~~~~t~nP~Wne~f~f~--v~~--~~~~l~~~v~D~d~ 72 (121)
T cd04042 1 QLDIHLKEGRNLAARDRGGTSDPYVKFKYGG----KTVYKSKTIYKNLNPVWDEKFTLP--IED--VTQPLYIKVFDYDR 72 (121)
T ss_pred CeEEEEEEeeCCCCcCCCCCCCCeEEEEECC----EEEEEeeeccCCCCCccceeEEEE--ecC--CCCeEEEEEEeCCC
Confidence 378999999 999999999999999999842 246788889999999999999998 542 34569999999999
Q ss_pred CCCCccccccccCccccc
Q 004954 346 TRDGEVNGALHEGKADAE 363 (722)
Q Consensus 346 ~~~~d~iG~v~~~~~~~~ 363 (722)
+++++++|.+.+...+..
T Consensus 73 ~~~~~~iG~~~~~l~~l~ 90 (121)
T cd04042 73 GLTDDFMGSAFVDLSTLE 90 (121)
T ss_pred CCCCcceEEEEEEHHHcC
Confidence 999999999998776544
|
MCTPs are involved in Ca2+ signaling at the membrane. MCTP is composed of a variable N-terminal sequence, three C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular protein |
| >cd08379 C2D_MCTP_PRT_plant C2 domain fourth repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-13 Score=127.32 Aligned_cols=87 Identities=15% Similarity=0.039 Sum_probs=73.6
Q ss_pred eEEEEeec-C---CccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccccc
Q 004954 268 GYLSSKEA-D---LIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (722)
Q Consensus 268 l~v~l~e~-~---L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (722)
|+|.|.+| | |.++|..|.+||||++.+- .++.+|+++++++||+|||+|.|. +.. ....|.++|||+
T Consensus 2 L~v~v~~A~~~~~l~~~d~~g~sDPYv~i~~g-----~~~~rTk~~~~~~nP~WnE~f~f~--v~~--~~~~l~v~V~d~ 72 (126)
T cd08379 2 LEVGILGAQGLDVLRAKDGRGSTDAYCVAKYG-----PKWVRTRTVEDSSNPRWNEQYTWP--VYD--PCTVLTVGVFDN 72 (126)
T ss_pred eEEEEEEeECCccccccccCCCCCeeEEEEEC-----CEEeEcCcccCCCCCcceeEEEEE--ecC--CCCEEEEEEEEC
Confidence 78999999 9 9999999999999999983 236789999999999999999998 542 223699999999
Q ss_pred CCCC------CCccccccccCccccc
Q 004954 344 SDTR------DGEVNGALHEGKADAE 363 (722)
Q Consensus 344 D~~~------~~d~iG~v~~~~~~~~ 363 (722)
+.++ +++++|++.+......
T Consensus 73 d~~~~~~~~~~dd~lG~~~i~l~~l~ 98 (126)
T cd08379 73 SQSHWKEAVQPDVLIGKVRIRLSTLE 98 (126)
T ss_pred CCccccccCCCCceEEEEEEEHHHcc
Confidence 9884 7999999988755443
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphate |
| >cd04019 C2C_MCTP_PRT_plant C2 domain third repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-13 Score=131.25 Aligned_cols=90 Identities=20% Similarity=0.146 Sum_probs=76.4
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeeccc-CCCcceeeeeecccccccCcccccccccccccC
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKR-GSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~-tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D 344 (722)
+|+|.|.+| ||+++|.+|.+||||++.+.. .+.||+++++ |+||+|||+|.|. ++.. ....|.+.|||++
T Consensus 1 ~L~V~Vi~A~~L~~~d~~g~sDPYV~v~l~~-----~~~kTk~~~~~t~nP~WNE~F~f~--v~~~-~~~~l~v~V~d~~ 72 (150)
T cd04019 1 YLRVTVIEAQDLVPSDKNRVPEVFVKAQLGN-----QVLRTRPSQTRNGNPSWNEELMFV--AAEP-FEDHLILSVEDRV 72 (150)
T ss_pred CEEEEEEEeECCCCCCCCCCCCeEEEEEECC-----EEeeeEeccCCCCCCcccCcEEEE--ecCc-cCCeEEEEEEEec
Confidence 689999999 999999999999999999963 4667877655 7999999999998 6532 2345899999999
Q ss_pred CCCCCccccccccCcccccc
Q 004954 345 DTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 345 ~~~~~d~iG~v~~~~~~~~~ 364 (722)
..++++++|.+.++..+...
T Consensus 73 ~~~~dd~lG~v~i~L~~l~~ 92 (150)
T cd04019 73 GPNKDEPLGRAVIPLNDIER 92 (150)
T ss_pred CCCCCCeEEEEEEEHHHCcc
Confidence 99999999999998876644
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates |
| >cd04033 C2_NEDD4_NEDD4L C2 domain present in the Human neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) and NEDD4-like (NEDD4L/NEDD42) | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.2e-13 Score=127.02 Aligned_cols=95 Identities=15% Similarity=0.098 Sum_probs=80.3
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCC--CCcccceeeecccCCCcceeeeeecccccccCccccccccccccc
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHP--GTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~--~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (722)
.|+|.|.+| ||+++|..|.+||||++.+...+ +...+.+|+++++|+||.|||+|.|. ++.. +..|.++|||+
T Consensus 1 ~L~v~Vi~a~~L~~~d~~~~~Dpyv~v~~~~~~~~~~~~~~kT~v~~~t~nP~Wne~f~f~--~~~~--~~~l~~~v~d~ 76 (133)
T cd04033 1 ILRVKVLAGIDLAKKDIFGASDPYVKISLYDPDGNGEIDSVQTKTIKKTLNPKWNEEFFFR--VNPR--EHRLLFEVFDE 76 (133)
T ss_pred CEEEEEEEeECCCcccCCCCcCcEEEEEEECCCCCCcccceeeeEEcCCCCCcEeeEEEEE--EcCC--CCEEEEEEEEC
Confidence 378999999 99999999999999999998652 23346789999999999999999998 6543 34589999999
Q ss_pred CCCCCCccccccccCccccccc
Q 004954 344 SDTRDGEVNGALHEGKADAEEH 365 (722)
Q Consensus 344 D~~~~~d~iG~v~~~~~~~~~e 365 (722)
+.+++++++|.+.+...+....
T Consensus 77 ~~~~~~~~iG~~~i~l~~l~~~ 98 (133)
T cd04033 77 NRLTRDDFLGQVEVPLNNLPTE 98 (133)
T ss_pred CCCCCCCeeEEEEEEHHHCCCc
Confidence 9999999999999887665544
|
Nedd4 and Nedd4-2 are two of the nine members of the Human Nedd4 family. All vertebrates appear to have both Nedd4 and Nedd4-2 genes. They are thought to participate in the regulation of epithelial Na+ channel (ENaC) activity. They also have identical specificity for ubiquitin conjugating enzymes (E2). Nedd4 and Nedd4-2 are composed of a C2 domain, 2-4 WW domains, and a ubiquitin ligase Hect domain. Their WW domains can bind PPxY (PY) or LPSY motifs, and in vitro studies suggest that WW3 and WW4 of both proteins bind PY motifs in the key substrates, with WW3 generally exhibiting higher affinity. Most Nedd4 family members, especially Nedd4-2, also have multiple splice variants, which might play different roles in regulating their substrates. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >KOG1030 consensus Predicted Ca2+-dependent phospholipid-binding protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.1e-13 Score=127.97 Aligned_cols=86 Identities=12% Similarity=0.051 Sum_probs=75.6
Q ss_pred cceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccccc
Q 004954 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (722)
.+-|+|.|+.+ ||...|+.|.|||||-+.+- ..|.||++.++++||+|||.|+|. + .+....|.++|||+
T Consensus 5 vGLL~v~v~~g~~L~~rD~~~sSDPyVVl~lg-----~q~lkT~~v~~n~NPeWNe~ltf~--v--~d~~~~lkv~VyD~ 75 (168)
T KOG1030|consen 5 VGLLRVRVKRGKNLAIRDFLGSSDPYVVLELG-----NQKLKTRVVYKNLNPEWNEELTFT--V--KDPNTPLKVTVYDK 75 (168)
T ss_pred ceEEEEEEEeecCeeeeccccCCCCeEEEEEC-----CeeeeeeeecCCCCCcccceEEEE--e--cCCCceEEEEEEeC
Confidence 36789999999 99999999999999999995 458889999999999999999987 3 44456699999999
Q ss_pred CCCCCCccccccccCc
Q 004954 344 SDTRDGEVNGALHEGK 359 (722)
Q Consensus 344 D~~~~~d~iG~v~~~~ 359 (722)
|.++..|++|+..+..
T Consensus 76 D~fs~dD~mG~A~I~l 91 (168)
T KOG1030|consen 76 DTFSSDDFMGEATIPL 91 (168)
T ss_pred CCCCcccccceeeecc
Confidence 9999999999986643
|
|
| >cd08676 C2A_Munc13-like C2 domain first repeat in Munc13 (mammalian uncoordinated)-like proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.6e-13 Score=129.75 Aligned_cols=99 Identities=14% Similarity=0.087 Sum_probs=80.4
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCc------------------------ccceeeecccCCCccee
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE------------------------KSSSYSSSKRGSSIDWI 318 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~------------------------~k~kt~~~k~tlnP~~n 318 (722)
+...|+|.|.+| ||.++|.+|.+||||++.+.+..++. ..++|.++++|+||.||
T Consensus 26 ~~~~L~V~vi~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kT~v~~~tlnP~Wn 105 (153)
T cd08676 26 PIFVLKVTVIEAKGLLAKDVNGFSDPYCMLGIVPASRERNSEKSKKRKSHRKKAVLKDTVPAKSIKVTEVKPQTLNPVWN 105 (153)
T ss_pred CeEEEEEEEEeccCCcccCCCCCCCceEEEEEcccccccccccccccccccccccccccccccccEecceecCCCCCccc
Confidence 457899999999 99999999999999999998753321 23678889999999999
Q ss_pred eeeecccccccCcccccccccccccCCCCCCccccccccCccccccccCCC
Q 004954 319 EGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVAT 369 (722)
Q Consensus 319 E~f~f~~~v~~~~~~~~L~~~V~D~D~~~~~d~iG~v~~~~~~~~~e~~~~ 369 (722)
|+|.|. +... .+..|.++|||++ ++++|++.+...++...+...
T Consensus 106 E~F~f~--v~~~-~~~~L~i~V~D~d----d~~IG~v~i~l~~l~~~~~d~ 149 (153)
T cd08676 106 ETFRFE--VEDV-SNDQLHLDIWDHD----DDFLGCVNIPLKDLPSCGLDS 149 (153)
T ss_pred cEEEEE--eccC-CCCEEEEEEEecC----CCeEEEEEEEHHHhCCCCCCC
Confidence 999998 5432 2455999999998 899999999887776444443
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, sy |
| >cd08374 C2F_Ferlin C2 domain sixth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.5e-13 Score=126.27 Aligned_cols=90 Identities=13% Similarity=0.006 Sum_probs=76.8
Q ss_pred eEEEEeec-CCc--cccCCCC--CCcceEEEecCCCCCcccceeeecccCCC--cceeeeeeccccccc-----------
Q 004954 268 GYLSSKEA-DLI--DLQHNVV--GDSSTDCDLAPHPGTEKSSSYSSSKRGSS--IDWIEGFKGSSDLHF----------- 329 (722)
Q Consensus 268 l~v~l~e~-~L~--~~d~~g~--sDpyvk~~l~~d~~~~~k~kt~~~k~tln--P~~nE~f~f~~~v~~----------- 329 (722)
|||+|-+| |++ .++.+|. ||||||++|.+. ...|+||.||.+++| |.||+.|.|. ++.
T Consensus 2 LRViIw~~~~v~~~~~~~~g~~~sD~yVK~~L~~~--~~~kqkTDVHyrslnG~~~FNwRfvF~--~~~~~~~~~~~~~~ 77 (133)
T cd08374 2 LRVIVWNTRDVLNDDTNITGEKMSDIYVKGWLDGL--EEDKQKTDVHYRSLDGEGNFNWRFVFP--FDYLPAEKKIVVIK 77 (133)
T ss_pred EEEEEEECcCCcccccccCCccccCeEEEEEEccC--cccccccceEEecCCCCcEEeEEEEEe--eecCCccceeEEEe
Confidence 79999999 955 4556885 999999999997 456999999999999 9999999998 555
Q ss_pred ----------Ccc-cccccccccccCCCCCCccccccccCccc
Q 004954 330 ----------KGA-EKDLMPAEIDNSDTRDGEVNGALHEGKAD 361 (722)
Q Consensus 330 ----------~~~-~~~L~~~V~D~D~~~~~d~iG~v~~~~~~ 361 (722)
+.+ ..+|.++|||.|++++++++|++.++...
T Consensus 78 ~~~~~~~~~~e~~~~~~L~lqvwD~D~~s~dd~iG~~~l~l~~ 120 (133)
T cd08374 78 KEHFWSLDETEYKIPPKLTLQVWDNDKFSPDDFLGSLELDLSI 120 (133)
T ss_pred eccccccCcceEecCcEEEEEEEECcccCCCCcceEEEEEhhh
Confidence 445 45599999999999999999999887653
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd08375 C2_Intersectin C2 domain present in Intersectin | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.7e-13 Score=126.78 Aligned_cols=93 Identities=12% Similarity=0.017 Sum_probs=79.6
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
..+.|+|.|++| +|+++|..|.+||||++.+. ..+++|+++++|+||.|||+|.|. +... ....|.++|||
T Consensus 13 ~~G~L~V~Vi~A~~L~~~d~~g~~DPYv~v~~~-----~~~~kT~vi~~t~nP~Wne~f~f~--v~~~-~~~~l~i~V~D 84 (136)
T cd08375 13 GIGRLMVVIVEGRDLKPCNSNGKSDPYCEVSMG-----SQEHKTKVVSDTLNPKWNSSMQFF--VKDL-EQDVLCITVFD 84 (136)
T ss_pred CcEEEEEEEEEeeCCCCCCCCCCcCcEEEEEEC-----CEeeeccccCCCCCCccCceEEEE--ecCc-cCCEEEEEEEE
Confidence 557899999999 99999999999999999983 346889999999999999999998 6432 23459999999
Q ss_pred cCCCCCCccccccccCcccccc
Q 004954 343 NSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
+|.+++++++|.+.+...+...
T Consensus 85 ~d~~~~d~~lG~~~i~l~~l~~ 106 (136)
T cd08375 85 RDFFSPDDFLGRTEIRVADILK 106 (136)
T ss_pred CCCCCCCCeeEEEEEEHHHhcc
Confidence 9999999999999887765554
|
A single instance of the C2 domain is located C terminally in the intersectin protein. Intersectin functions as a scaffolding protein, providing a link between the actin cytoskeleton and the components of endocytosis and plays a role in signal transduction. In addition to C2, intersectin contains several additional domains including: Eps15 homology domains, SH3 domains, a RhoGEF domain, and a PH domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking pro |
| >cd04043 C2_Munc13_fungal C2 domain in Munc13 (mammalian uncoordinated) proteins; fungal group | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.6e-13 Score=124.73 Aligned_cols=91 Identities=11% Similarity=-0.040 Sum_probs=77.3
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCC
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~ 345 (722)
.++|.|.+| ||+++|.+|.+||||++++...+ ..+.||+++++++||.|||+|.|. ++.. ....|.++|||++.
T Consensus 2 ~~~V~v~~a~~L~~~~~~~~~Dpyv~v~~~~~~--~~~~kT~~~~~t~~P~Wne~f~f~--i~~~-~~~~L~i~v~d~d~ 76 (126)
T cd04043 2 LFTIRIVRAENLKADSSNGLSDPYVTLVDTNGK--RRIAKTRTIYDTLNPRWDEEFELE--VPAG-EPLWISATVWDRSF 76 (126)
T ss_pred EEEEEEEEeECCCCCCCCCCCCceEEEEECCCC--eeeecccEecCCCCCcccceEEEE--cCCC-CCCEEEEEEEECCC
Confidence 588999999 99999999999999999875432 346789899999999999999999 6654 34559999999999
Q ss_pred CCCCccccccccCcccc
Q 004954 346 TRDGEVNGALHEGKADA 362 (722)
Q Consensus 346 ~~~~d~iG~v~~~~~~~ 362 (722)
+++++++|++.+.....
T Consensus 77 ~~~~~~iG~~~i~l~~~ 93 (126)
T cd04043 77 VGKHDLCGRASLKLDPK 93 (126)
T ss_pred CCCCceEEEEEEecCHH
Confidence 99999999998876543
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, synap |
| >cd04037 C2E_Ferlin C2 domain fifth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.3e-13 Score=123.43 Aligned_cols=87 Identities=11% Similarity=-0.031 Sum_probs=73.1
Q ss_pred eEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCCC
Q 004954 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (722)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~~ 346 (722)
++|.|.+| +|+++|..|.+||||++.+...+ .+.||.++++|+||+|||+|.|. +.... ...|.++|||+|.+
T Consensus 2 lrV~Vi~a~~L~~~d~~g~~DPYv~v~~~~~~---~~~kT~~v~~t~nP~Wne~f~f~--~~~~~-~~~L~~~V~d~d~~ 75 (124)
T cd04037 2 VRVYVVRARNLQPKDPNGKSDPYLKIKLGKKK---INDRDNYIPNTLNPVFGKMFELE--ATLPG-NSILKISVMDYDLL 75 (124)
T ss_pred EEEEEEECcCCCCCCCCCCCCcEEEEEECCee---ccceeeEEECCCCCccceEEEEE--ecCCC-CCEEEEEEEECCCC
Confidence 78999999 99999999999999999995432 34677778899999999999998 43221 34599999999999
Q ss_pred CCCccccccccCcc
Q 004954 347 RDGEVNGALHEGKA 360 (722)
Q Consensus 347 ~~~d~iG~v~~~~~ 360 (722)
++++++|++.+...
T Consensus 76 ~~dd~iG~~~i~l~ 89 (124)
T cd04037 76 GSDDLIGETVIDLE 89 (124)
T ss_pred CCCceeEEEEEeec
Confidence 99999999988664
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04024 C2A_Synaptotagmin-like C2 domain first repeat present in Synaptotagmin-like proteins | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.1e-13 Score=123.60 Aligned_cols=90 Identities=10% Similarity=-0.027 Sum_probs=77.3
Q ss_pred ceeEEEEeec-CCccccC--CCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 266 DYGYLSSKEA-DLIDLQH--NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~--~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
+.|+|.|.+| ||+++|. .|.+||||++++- ..+.+|+++++|+||.|||+|.|. +.. .....|.++|||
T Consensus 1 g~l~v~v~~a~~L~~~~~~~~~~~dPyv~v~~~-----~~~~kT~~~~~t~~P~Wne~f~~~--~~~-~~~~~l~i~v~d 72 (128)
T cd04024 1 GVLRVHVVEAKDLAAKDRSGKGKSDPYAILSVG-----AQRFKTQTIPNTLNPKWNYWCEFP--IFS-AQNQLLKLILWD 72 (128)
T ss_pred CEEEEEEEEeeCCCcccCCCCCCcCCeEEEEEC-----CEEEecceecCCcCCccCCcEEEE--ecC-CCCCEEEEEEEE
Confidence 3588999999 9999999 8999999999983 246789999999999999999998 654 234569999999
Q ss_pred cCCCCCCccccccccCccccc
Q 004954 343 NSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~~~~~ 363 (722)
++.+++++++|.+.+...+..
T Consensus 73 ~~~~~~~~~lG~~~i~l~~~~ 93 (128)
T cd04024 73 KDRFAGKDYLGEFDIALEEVF 93 (128)
T ss_pred CCCCCCCCcceEEEEEHHHhh
Confidence 999999999999999876654
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permu |
| >cd04017 C2D_Ferlin C2 domain fourth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-12 Score=124.15 Aligned_cols=86 Identities=14% Similarity=0.038 Sum_probs=71.7
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccc-cc--cCcc---ccccccc
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSD-LH--FKGA---EKDLMPA 339 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~-v~--~~~~---~~~L~~~ 339 (722)
+|+|.|.+| +|+++|.+|.+|||||+.+. ..++||+++++|+||+|||+|.|... +. .+.. ...|.++
T Consensus 2 ~l~v~V~~a~~L~~~d~~g~~dpyv~v~~~-----~~~~kT~v~~~t~nP~Wne~~~f~~~~~~~~~~~~~~~~~~l~v~ 76 (135)
T cd04017 2 QLRAYIYQARDLLAADKSGLSDPFARVSFL-----NQSQETEVIKETLSPTWDQTLIFDEVELYGSPEEIAQNPPLVVVE 76 (135)
T ss_pred EEEEEEEEeecCcCCCCCCCCCCEEEEEEC-----CeeeEeeeEcCCCCCccCcEEEEeeeeccCChHHhhcCCCEEEEE
Confidence 588999999 99999999999999999985 24678999999999999999999721 11 1111 2348899
Q ss_pred ccccCCCCCCcccccccc
Q 004954 340 EIDNSDTRDGEVNGALHE 357 (722)
Q Consensus 340 V~D~D~~~~~d~iG~v~~ 357 (722)
|||+|.+++++++|++..
T Consensus 77 V~d~d~~~~d~~iG~~~i 94 (135)
T cd04017 77 LFDQDSVGKDEFLGRSVA 94 (135)
T ss_pred EEeCcCCCCCccceEEEe
Confidence 999999999999999975
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangeme |
| >cd08681 C2_fungal_Inn1p-like C2 domain found in fungal Ingression 1 (Inn1) proteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.2e-13 Score=121.30 Aligned_cols=90 Identities=12% Similarity=0.089 Sum_probs=74.5
Q ss_pred ceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeec-ccCCCcceeeeeecccccccCccccccccccccc
Q 004954 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~-k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (722)
+.|+|.|.+| ||+++|..|.+||||++.+.. .+++|+++ +.++||+|||+|.|. ++.. ....|.++|||+
T Consensus 1 g~L~V~v~~A~~L~~~~~~~~~dpyv~v~~~~-----~~~kT~~~~~~~~nP~Wne~f~f~--v~~~-~~~~l~i~v~d~ 72 (118)
T cd08681 1 GTLVVVVLKARNLPNKRKLDKQDPYCVLRIGG-----VTKKTKTDFRGGQHPEWDEELRFE--ITED-KKPILKVAVFDD 72 (118)
T ss_pred CEEEEEEEEccCCCCCCcCCCCCceEEEEECC-----CccccccccCCCCCCccCceEEEE--ecCC-CCCEEEEEEEeC
Confidence 4689999999 999999999999999999854 35567665 568999999999998 7654 334599999999
Q ss_pred CCCCCCccccccccCcccccc
Q 004954 344 SDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 344 D~~~~~d~iG~v~~~~~~~~~ 364 (722)
+..+ ++++|++.++..+...
T Consensus 73 ~~~~-~~~iG~~~~~l~~~~~ 92 (118)
T cd08681 73 DKRK-PDLIGDTEVDLSPALK 92 (118)
T ss_pred CCCC-CcceEEEEEecHHHhh
Confidence 9887 8999999988765533
|
Saccharomyces cerevisiae Inn1 associates with the contractile actomyosin ring at the end of mitosis and is needed for cytokinesis. The C2 domain of Inn1, located at the N-terminus, is required for ingression of the plasma membrane. The C-terminus is relatively unstructured and contains eight PXXP motifs that are thought to mediate interaction of Inn1 with other proteins with SH3 domains in the cytokinesis proteins Hof1 (an F-BAR protein) and Cyk3 (whose overexpression can restore primary septum formation in Inn1Delta cells) as well as recruiting Inn1 to the bud-neck by binding to Cyk3. Inn1 and Cyk3 appear to cooperate in activating chitin synthase Chs2 for primary septum formation, which allows coordination of actomyosin ring contraction with ingression of the cleavage furrow. It is thought that the C2 domain of Inn1 helps to preserve the link between the actomyosin ring and the plasma membrane, contr |
| >cd04054 C2A_Rasal1_RasA4 C2 domain first repeat present in RasA1 and RasA4 | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.7e-13 Score=122.01 Aligned_cols=87 Identities=13% Similarity=0.024 Sum_probs=74.2
Q ss_pred eEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCCC
Q 004954 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (722)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~~ 346 (722)
|+|.|.+| +|+++|.+|.+||||++.+- + ....||+++++|+||+|||.|.|. ++.. .+.|.+.|||++.+
T Consensus 2 l~v~vi~a~~L~~~d~~g~~DPYv~v~~~--~--~~~~kT~v~~~t~nP~Wne~f~~~--~~~~--~~~l~v~v~d~~~~ 73 (121)
T cd04054 2 LYIRIVEGKNLPAKDITGSSDPYCIVKVD--N--EVIIRTATVWKTLNPFWGEEYTVH--LPPG--FHTVSFYVLDEDTL 73 (121)
T ss_pred EEEEEEEeeCCcCCCCCCCCCceEEEEEC--C--EeeeeeeeEcCCCCCcccceEEEe--eCCC--CCEEEEEEEECCCC
Confidence 78999999 99999999999999999983 2 234689899999999999999998 5432 35699999999999
Q ss_pred CCCccccccccCcccc
Q 004954 347 RDGEVNGALHEGKADA 362 (722)
Q Consensus 347 ~~~d~iG~v~~~~~~~ 362 (722)
++++++|.+.++....
T Consensus 74 ~~d~~iG~~~~~~~~~ 89 (121)
T cd04054 74 SRDDVIGKVSLTREVI 89 (121)
T ss_pred CCCCEEEEEEEcHHHh
Confidence 9999999998875443
|
Rasal1 and RasA4 are both members of GAP1 (GTPase activating protein 1). Rasal1 responds to repetitive Ca2+ signals by associating with the plasma membrane and deactivating Ras. RasA4 suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. Both of these proteins contains two C2 domains, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. |
| >cd04011 C2B_Ferlin C2 domain second repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.34 E-value=1e-12 Score=119.89 Aligned_cols=90 Identities=13% Similarity=0.017 Sum_probs=74.8
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccccccC
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEIDNS 344 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~D~D 344 (722)
.++|.|.+| ||. +|..||||++.+.. +++||+++++++||.|||+|.|....+...+ +..|.++|||++
T Consensus 5 ~l~V~v~~a~~L~----~~~~dpyv~v~~~~-----~~~kT~~~~~t~nP~wne~f~f~~~~~~~~l~~~~l~i~V~d~~ 75 (111)
T cd04011 5 QVRVRVIEARQLV----GGNIDPVVKVEVGG-----QKKYTSVKKGTNCPFYNEYFFFNFHESPDELFDKIIKISVYDSR 75 (111)
T ss_pred EEEEEEEEcccCC----CCCCCCEEEEEECC-----EeeeeeEEeccCCCccccEEEEecCCCHHHHhcCeEEEEEEcCc
Confidence 678999999 998 78999999999972 3568999999999999999999833344333 455999999999
Q ss_pred CCCCCccccccccCccccccc
Q 004954 345 DTRDGEVNGALHEGKADAEEH 365 (722)
Q Consensus 345 ~~~~~d~iG~v~~~~~~~~~e 365 (722)
.+++++++|++.+........
T Consensus 76 ~~~~~~~iG~~~i~l~~v~~~ 96 (111)
T cd04011 76 SLRSDTLIGSFKLDVGTVYDQ 96 (111)
T ss_pred ccccCCccEEEEECCccccCC
Confidence 999999999999987665443
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangeme |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 722 | ||||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-48 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-48 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-48 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-43 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-42 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-42 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-39 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-39 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-39 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-38 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-35 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-34 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-34 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-34 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-32 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-32 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-32 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-30 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-29 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-28 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-28 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-27 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-27 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-27 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-27 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-27 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-27 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-27 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-27 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-27 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-27 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-27 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-27 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-27 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-27 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-27 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-27 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-27 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-27 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-27 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-27 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-27 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-27 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-27 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-27 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-27 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-27 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-27 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-27 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-27 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-27 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-27 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-27 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-27 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-27 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-27 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-27 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-27 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-27 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-27 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-26 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-26 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-26 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-26 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-26 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-26 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-26 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-26 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-26 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-26 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-26 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-26 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-26 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-26 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-26 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-26 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-26 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-26 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-26 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-26 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-26 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-26 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-26 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-26 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-26 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-26 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-25 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-25 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-25 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-25 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-25 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-25 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-25 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-25 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-25 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-25 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-25 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-25 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-25 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-25 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-25 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-25 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-25 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-25 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-25 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-25 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-25 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-25 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-25 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-25 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-25 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-25 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-25 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-25 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-25 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-25 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-25 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-25 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-25 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-24 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-24 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-24 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-24 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-24 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-24 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-24 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-24 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-24 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-24 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-24 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-24 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-24 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-24 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-24 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-24 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-24 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-24 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-24 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-23 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-23 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-23 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-23 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-23 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-23 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-23 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-23 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-23 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-22 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-22 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-22 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-22 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-22 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-22 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-22 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-22 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-22 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-22 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-22 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-22 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-22 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-22 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-21 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-20 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-20 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-19 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-18 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-16 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-16 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-16 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-16 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-16 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-16 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-16 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-16 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-16 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-16 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-16 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-16 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-16 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-15 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 9e-15 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-15 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-14 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-14 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-04 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 5e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-04 |
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 722 | |||
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-139 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-138 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-135 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-130 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-128 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-123 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-74 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-54 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-53 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-52 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-52 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-52 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-52 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-52 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-51 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-51 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-50 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-50 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-50 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-50 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-49 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-49 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-49 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-49 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-47 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-47 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-47 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-47 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 7e-46 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-46 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-46 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-45 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-45 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-44 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-44 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-44 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-44 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-44 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-44 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-43 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-43 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-43 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-43 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-43 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-42 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-42 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-42 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-42 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-42 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-42 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 7e-42 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-42 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-42 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-41 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-41 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-41 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-41 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-41 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-41 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-41 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-41 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-40 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-40 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-40 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-40 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-40 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-40 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-40 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-40 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-40 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 7e-40 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 9e-40 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-40 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-39 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-39 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-39 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-39 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-38 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-38 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-38 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-38 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-38 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-37 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-37 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-37 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-36 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-07 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-36 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-36 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-35 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-35 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-35 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-35 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-35 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 5e-35 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-35 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-34 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-34 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-06 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 7e-34 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-06 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-34 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-33 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-07 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-33 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-06 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-33 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-33 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-33 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-33 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-33 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-07 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-33 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-33 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-06 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-33 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-33 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-32 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-32 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-06 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-32 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-07 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 9e-32 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-31 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-06 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-31 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 8e-07 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-31 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-07 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-31 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-06 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 7e-31 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-06 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-31 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-06 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-30 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 7e-07 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-30 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 9e-07 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-30 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-30 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-07 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-29 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-06 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-29 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-28 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-27 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-04 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-26 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-26 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-25 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 9e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-04 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-24 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-24 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-24 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-23 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-22 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-22 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-21 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-21 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-21 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-20 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-20 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-20 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-19 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-19 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-19 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-19 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-18 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-18 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-18 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-18 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-18 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-18 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 6e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-18 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 7e-18 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 9e-18 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-17 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-16 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-16 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-16 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 8e-15 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-14 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-14 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-14 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-14 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-14 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-14 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-14 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-13 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-13 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-13 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-13 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-13 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-13 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-13 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-13 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 9e-13 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 9e-13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-12 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-11 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-11 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-11 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-10 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 6e-10 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 9e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-09 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-09 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 5e-09 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-08 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-08 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-08 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-08 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-07 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-07 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-07 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-04 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-06 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-06 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 6e-06 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-05 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-04 |
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 415 bits (1069), Expect = e-139
Identities = 116/343 (33%), Positives = 178/343 (51%), Gaps = 20/343 (5%)
Query: 393 KNRTGF-EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK 451
N G+ ++ + + +A RY V + +G +F +V +A D V LK+++N+K
Sbjct: 75 PNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK 134
Query: 452 DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQE 511
F Q+ +EI++L+ + K D + +++ + + F H+ + ELL NLYE K N+
Sbjct: 135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF 194
Query: 512 SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571
G F+L ++ L+ L+ LH IIHCDLKPENIL+K R IK+ID GSSC
Sbjct: 195 QG----FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631
++ + Y+QSR YRAPEVI+G Y ID+WSLGCILAEL TG L P + LA
Sbjct: 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYI-NEETNQLEYIIPEESSLEHHLQF---- 686
+I +LG ++L + + + + Y + ++ S L+
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
Query: 687 ----------SDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
D F+DF++ LE +P R T +AL HPWL+
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 410 bits (1056), Expect = e-138
Identities = 119/362 (32%), Positives = 181/362 (50%), Gaps = 31/362 (8%)
Query: 385 FHLRIIHRKNRTGF-----EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG 439
F H+K R + ++N D + RY + +G +F +V +A D
Sbjct: 20 FQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ 79
Query: 440 VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499
V +KIIKN K F +Q+ E++LL+L+NK+D +++I+ L +F HL +V E+L
Sbjct: 80 EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--LGIIHCDLKPENILIKSY 557
NLY+ + G +L + +Q AL +L + L IIHCDLKPENIL+ +
Sbjct: 140 YNLYDLLRNTNFRG----VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195
Query: 558 QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+R IKI+D GSSC + Y+QSR YR+PEV++G+PYD ID+WSLGCIL E+ TGE
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
Query: 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYY--INEETNQLEYIIP 675
LF V + +I+ +LG +L Q + K+F K D + + + EY P
Sbjct: 256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315
Query: 676 EESSLEHHLQFSDAF------------------FIDFVRTLLEINPQRRPTAREALDHPW 717
L + L F D + +L+ +P+ R AL H +
Sbjct: 316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375
Query: 718 LQ 719
+
Sbjct: 376 FK 377
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-135
Identities = 95/364 (26%), Positives = 164/364 (45%), Gaps = 35/364 (9%)
Query: 386 HLRIIHRKNRTGF-----EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV 440
H H R +E ++ + V +G F +V Q +
Sbjct: 2 HHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK 61
Query: 441 DVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA 500
+K+++N K + + E +LK + +D + ++I++ + F + +H+ ++ E L
Sbjct: 62 YYAVKVVRNIKKYTRSAKIEADILKKIQNDDI-NNNNIVKYHGKFMYYDHMCLIFEPLGP 120
Query: 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---- 556
+LYE N +G F + +++ + L+AL YL + + H DLKPENIL+
Sbjct: 121 SLYEIITRNNYNG----FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176
Query: 557 -------------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
+ IK+ID G + F++D + +R YRAPEVI+ L +
Sbjct: 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW 236
Query: 598 DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ--EIYKYFT 655
D D+WS GC+LAEL+TG +LF + LA + ++ PI ML + KY
Sbjct: 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVN 296
Query: 656 KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715
K+ E + + I + L + F DF+ ++L+I+P RP+ E L H
Sbjct: 297 KDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356
Query: 716 PWLQ 719
+L+
Sbjct: 357 KFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-130
Identities = 102/339 (30%), Positives = 170/339 (50%), Gaps = 28/339 (8%)
Query: 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSLD 459
+ L V++ RY + + LG AF KV + D G V +KI+KN + + +
Sbjct: 1 SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 460 EIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
EI++L+ +N DP +++ ++F H H+ IV ELL + Y+F K N F
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP----FR 116
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCEI 562
L ++ + Q +++ +LHS + H DLKPENIL ++ +I
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
K++D GS+ + ++ V +R YRAPEVI+ L + Q D+WS+GCIL E + G +FP
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682
LA + +LGP+ M+ + ++ KYF + + +E ++ Y+ L+
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRK-RKYFHHDRLDW--DEHSSAGRYVSRACKPLKE 293
Query: 683 HLQFSDAF---FIDFVRTLLEINPQRRPTAREALDHPWL 718
+ D D ++ +LE +P +R T REAL HP+
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-128
Identities = 102/343 (29%), Positives = 155/343 (45%), Gaps = 26/343 (7%)
Query: 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSL 458
+ L + + RY + LG F KV + D G V LKII+N + + +
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR 64
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
EI +LK + + D ++ + + D+F H+ I ELL N +EF K N +
Sbjct: 65 LEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP----Y 120
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCE 561
L ++ + Q AL +LH + H DLKPENIL KS +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 562 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621
I++ D GS+ F ++ V +R YR PEVI+ L + Q D+WS+GCIL E + G LF
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240
Query: 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQL--EYIIPEESS 679
L + +LGPI M+ + ++ KYF K ++ N + E P +S
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRK-QKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299
Query: 680 LEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
+ D +R +LE +P +R T EAL HP+
Sbjct: 300 MLQDSLE-HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 372 bits (958), Expect = e-123
Identities = 107/330 (32%), Positives = 172/330 (52%), Gaps = 28/330 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
RY + LG FS V+ A+D+ V +KI++ DK + + + DEIKLL+ VN D
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 472 PADE-----HHILRLYDYFYH----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
E +HIL+L D+F H H+ +V E+L NL K + G L
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG----IPLIY 132
Query: 523 LQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCE----IKIIDLGSSCFQTDNL 577
++ I++Q L L+Y+H GIIH D+KPEN+L++ E IKI DLG++C+ ++
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI------LAR 631
+Q+R YR+PEV++G P+ D+WS C++ EL TG+ LF D +A+
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQ-LEYIIPEESSLEHHLQFSDAF 690
II +LG + +L G+ +F L I++ LE ++ E+
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD---EAKE 309
Query: 691 FIDFVRTLLEINPQRRPTAREALDHPWLQH 720
DF+ +L+++P++R A ++HPWL+
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 2e-74
Identities = 107/378 (28%), Positives = 179/378 (47%), Gaps = 72/378 (19%)
Query: 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 463
+ + + GRY+V LG FS V+ + D+ V +K++K+ + + + +LDEI+L
Sbjct: 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRL 86
Query: 464 LKLVNKNDPADE--HHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAY 517
LK V +DP D +++L D F H+ +V E+L +L ++ + G
Sbjct: 87 LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG---- 142
Query: 518 FTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILI---------------------- 554
L ++ I +Q L+ L+YLH+ IIH D+KPENIL+
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 555 -------------------------KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
K+ ++ ++KI DLG++C+ + +Q+R YR+
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFP------NDAVVMILARIIGMLGPIDLEM 643
EV+IG Y+ D+WS C+ EL TG+ LF +A II +LG + ++
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD---AFFIDFVRTLLE 700
++ G+ ++FTK+ DL +I + L ++S A F DF+ +LE
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKP-----WGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377
Query: 701 INPQRRPTAREALDHPWL 718
+ P++R TA E L HPWL
Sbjct: 378 LIPEKRATAAECLRHPWL 395
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 4e-54
Identities = 84/316 (26%), Positives = 140/316 (44%), Gaps = 40/316 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y T+ +G+ +F V+QA+ +G V +K + DK F E+++++ ++
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLD------ 105
Query: 475 EH-HILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+RL +FY +L +V + + +Y + + + +++
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYM 162
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRS 585
Q +L Y+HS GI H D+KP+N+L+ +K+ D GS + + Y+ SR
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
YRAPE+I G Y ID+WS GC+LAEL G+ +FP D+ V L II +LG E
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE-- 279
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEY-IIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703
+ +N + ++ I + + I LLE P
Sbjct: 280 --------------QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 704 QRRPTAREALDHPWLQ 719
R T EA H +
Sbjct: 326 TARLTPLEACAHSFFD 341
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-53
Identities = 94/324 (29%), Positives = 151/324 (46%), Gaps = 45/324 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + +GS A V A D +V +K + F E+ L+K VN
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN 82
Query: 469 -KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEF--QKFNQESGGEAYFT 519
KN I+ L + F + ++IV EL+ ANL + + + E
Sbjct: 83 HKN-------IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-------- 127
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSCFQTDNL 577
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G + + +
Sbjct: 128 --RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMM 183
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + ++I LG
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFV 695
E + + Q + + + Y E + P+ + H + + D +
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKY----AGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299
Query: 696 RTLLEINPQRRPTAREALDHPWLQ 719
+L I+ +R + EAL HP++
Sbjct: 300 SKMLVIDASKRISVDEALQHPYIN 323
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-52
Identities = 89/322 (27%), Positives = 148/322 (45%), Gaps = 41/322 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + +GS A V A D +V +K + F E+ L+K VN
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN 119
Query: 469 -KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
KN I+ L + F + +++V EL+ ANL + +
Sbjct: 120 HKN-------IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--------MELDHE 164
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G + + +
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTP 222
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIP--EESSLEHHLQFSDAFFIDFVRT 697
E + + Q + + + Y + P + H + + D +
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKY----AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338
Query: 698 LLEINPQRRPTAREALDHPWLQ 719
+L I+P +R + +AL HP++
Sbjct: 339 MLVIDPAKRISVDDALQHPYIN 360
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-52
Identities = 89/322 (27%), Positives = 145/322 (45%), Gaps = 46/322 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ RY +GS A+ V A D TG+ V +K + F + E++LLK
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLK 83
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
+ +N ++ L D F +++V L+ A+L K +
Sbjct: 84 HMKHEN-------VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------L 129
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
T +Q + Q L L+Y+HS IIH DLKP N+ + CE+KI+D G + D +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTADEMT 187
Query: 579 LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
E+L ++I + Y + + L +D +
Sbjct: 248 TPGAELL---KKISSESARNYIQSLTQMPKMNFANVFIGANPLA----------VDLLEK 294
Query: 698 LLEINPQRRPTAREALDHPWLQ 719
+L ++ +R TA +AL H +
Sbjct: 295 MLVLDSDKRITAAQALAHAYFA 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-52
Identities = 85/324 (26%), Positives = 146/324 (45%), Gaps = 51/324 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y ++GS A+ V A D +G V +K + F + E+ LLK
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLK 78
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEF--QKFNQESGGEA 516
+ +N ++ L D F + ++V ++ +L + KF++E
Sbjct: 79 HMQHEN-------VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE----- 126
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576
++Q + Q L+ L+Y+HS G++H DLKP N+ + CE+KI+D G +
Sbjct: 127 -----KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCELKILDFGLARHADAE 179
Query: 577 LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
+ YV +R YRAPEVI+ Y+Q +D+WS+GCI+AE+ TG+ LF + L +I+ +
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 695
G E + + + YI L + D +
Sbjct: 240 TGVPGTEFV-------QKLNDKAAKSYI----QSLPQT--PRKDFTQLFPRASPQAADLL 286
Query: 696 RTLLEINPQRRPTAREALDHPWLQ 719
+LE++ +R TA +AL HP+ +
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFE 310
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 85/318 (26%), Positives = 136/318 (42%), Gaps = 37/318 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
R+ V G F V ++ TG+ V +K + D F ++ L ++ L ++
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL------- 76
Query: 475 EHH--ILRLYDYFYHLEH-------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
HH I++L YFY L L +V E + L+ + ++V
Sbjct: 77 -HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA--PPPILIKV 133
Query: 526 ITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYV 581
Q + ++ LH S+ + H D+KP N+L+ + +K+ D GS ++ Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
SR YRAPE+I G Y +D+WS+GCI AE+ GE +F D L I+ +LG
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
E+L + + + DLY IP + H D + LL+
Sbjct: 253 REVLRKLNPSH----TDVDLYNSKG--------IPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 701 INPQRRPTAREALDHPWL 718
P+ R EAL HP+
Sbjct: 301 YLPEERMKPYEALCHPYF 318
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-52
Identities = 77/342 (22%), Positives = 135/342 (39%), Gaps = 50/342 (14%)
Query: 394 NRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK-IIKNDKD 452
N GF+ + RY + LG VF A D V +K I+ D
Sbjct: 3 NIHGFD------------LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ 50
Query: 453 FFDQSLDEIKLLKLVN-KN-------DPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
+L EIK+++ ++ N + L ++IV E + +L
Sbjct: 51 SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN 110
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
+ ++ Q L L+Y+HS ++H DLKP N+ I + + +KI
Sbjct: 111 VLEQGP-------LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-EDLVLKI 162
Query: 565 IDLG------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
D G +L + ++ YR+P +++ Y + ID+W+ GCI AE+ TG+
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
Query: 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 677
LF + + I+ + + E + + + + + E L ++P
Sbjct: 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRN----DMTEPHKPLTQLLPGI 278
Query: 678 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
S +DF+ +L +P R TA EAL HP++
Sbjct: 279 SREA----------VDFLEQILTFSPMDRLTAEEALSHPYMS 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 90/322 (27%), Positives = 143/322 (44%), Gaps = 46/322 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y + +GS A+ V A D TG V +K + F L E++LLK
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLK 79
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
+ +N ++ L D F ++V + +L + K +
Sbjct: 80 HMRHEN-------VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------L 125
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
R+Q + Q L+ L Y+H+ GIIH DLKP N+ + CE+KI+D G + +
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQADSEMT 183
Query: 579 LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPEVI+ Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
E + Q + K Y E I+ S L ++ +
Sbjct: 244 TPPAEFV---QRLQSDEAKNYMKGLPELEKKDFASILTNASPLA----------VNLLEK 290
Query: 698 LLEINPQRRPTAREALDHPWLQ 719
+L ++ ++R TA EAL HP+ +
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFE 312
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-51
Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 35/313 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKND 471
+Y +G ++ VF+ ++ TG V +K +D +L EI++LK +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--- 60
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +++ L + F L +V E + Q ++ IT Q
Sbjct: 61 ----HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-----VPEHLVKSITWQT 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYR 587
L+A+ + H IH D+KPENILI IK+ D G +D V +R YR
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
+PE+++G Y +D+W++GC+ AEL +G L+P + V L I LG + Q
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI-PRHQQ 228
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+YF+ + E LE + ++ L ++P R
Sbjct: 229 VFSTNQYFSG----------VKIPDPEDME--PLELKFPNISYPALGLLKGCLHMDPTER 276
Query: 707 PTAREALDHPWLQ 719
T + L HP+ +
Sbjct: 277 LTCEQLLHHPYFE 289
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-50
Identities = 81/329 (24%), Positives = 135/329 (41%), Gaps = 48/329 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF------FDQSLD------ 459
+ Y V ++ S ++ V D G+ V +K + N S
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 460 EIKLLKLVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESG 513
EI+LL + N IL L D F + L++V EL+R +L + +
Sbjct: 79 EIRLLNHFHHPN-------ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV- 130
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSC 571
+ +Q L L LH G++H DL P NIL+ +I I D
Sbjct: 131 ----ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD--NNDITICDFNLARED 184
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630
N YV R YRAPE+++ + + +D+WS GC++AE++ + LF L
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 690
+I+ ++G +E + F+ Y+ N L + + + +D
Sbjct: 245 KIVEVVGTPKIEDV-------VMFSSPSARDYLR---NSLSNV--PARAWTAVVPTADPV 292
Query: 691 FIDFVRTLLEINPQRRPTAREALDHPWLQ 719
+D + +LE NPQRR + +AL HP+ +
Sbjct: 293 ALDLIAKMLEFNPQRRISTEQALRHPYFE 321
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-50
Identities = 86/316 (27%), Positives = 143/316 (45%), Gaps = 41/316 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + +G+ +F VFQA+ + + +V +K + DK F E++++++V
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRF---KNRELQIMRIVK------ 90
Query: 475 EH-HILRLYDYFYHLEH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +++ L +FY L +V E + +Y + + + +++
Sbjct: 91 -HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT--MPMLLIKLYM 147
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRS 585
Q L +L Y+HS+GI H D+KP+N+L+ +K+ID GS + Y+ SR
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
YRAPE+I G Y ID+WS GC++AEL G+ LFP ++ + L II +LG E
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE-- 264
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS-DAFFIDFVRTLLEINP 703
+ +N + ++ + ID + LLE P
Sbjct: 265 --------------QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310
Query: 704 QRRPTAREALDHPWLQ 719
R TA EAL HP+
Sbjct: 311 SARLTAIEALCHPFFD 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 82/312 (26%), Positives = 141/312 (45%), Gaps = 31/312 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + LG +S+VF+A ++ V +KI+K K + EIK+L+ + + P
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENL-RGGP-- 91
Query: 475 EHHILRLYDYFY---HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+ L D + + + + + T ++ + L
Sbjct: 92 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEIL 140
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAP 589
+AL+Y HS+GI+H D+KP N++I + ++++ID G + F V SR ++ P
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 590 EVIIGLP-YDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
E+++ YD +D+WSLGC+LA + E F L RI +LG DL +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
I ++ + E + E+ HL +A +DF+ LL + Q R
Sbjct: 260 YNIEL--DPRFNDILGRHSRKRWERFVHSEN---QHLVSPEA--LDFLDKLLRYDHQSRL 312
Query: 708 TAREALDHPWLQ 719
TAREA++HP+
Sbjct: 313 TAREAMEHPYFY 324
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-50
Identities = 89/327 (27%), Positives = 141/327 (43%), Gaps = 52/327 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ RY Y+G A+ V A D V V +K I F+ EIK+L
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILL 80
Query: 466 LVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N I+ + D ++ ++IV +L+ +LY+ K +
Sbjct: 81 RFRHEN-------IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------LS 126
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQ 573
+ Q L L+Y+HS ++H DLKP N+L+ + C++KI D G
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDH 184
Query: 574 TDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
T L YV +R YRAPE+++ Y + ID+WS+GCILAE+ + +FP + L I
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692
+G+LG E L I + Y L ++ + P S +
Sbjct: 245 LGILGSPSQEDL---NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA----------L 291
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
D + +L NP +R +AL HP+L+
Sbjct: 292 DLLDKMLTFNPHKRIEVEQALAHPYLE 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 94/339 (27%), Positives = 149/339 (43%), Gaps = 68/339 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I+ + + LG A+ V A TG V +K I+ FD+ L EIK+LK
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILK 64
Query: 466 LVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N I+ +++ + ++I+ EL++ +L+ +
Sbjct: 65 HFKHEN-------IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-------LS 110
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
+Q Q L A++ LH +IH DLKP N+LI S C++K+ D G
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESAAD 168
Query: 569 --SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAV 625
Q + +V +R YRAPEV++ Y + +D+WS GCILAEL+ +FP
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 626 VMILARIIGMLG-PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI----IPEESSL 680
L I G++G P + DL I + EYI + + L
Sbjct: 229 RHQLLLIFGIIGTP----------------HSDNDLRCIESPRAR-EYIKSLPMYPAAPL 271
Query: 681 EHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
E + ID ++ +L +P +R TA+EAL+HP+LQ
Sbjct: 272 EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-49
Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 84/334 (25%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKL 466
+V Y + + +GS SKVFQ + + +K + + D D +EI L
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNK 82
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTLGR 522
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 83 LQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW----------E 128
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYV 581
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVK 185
Query: 582 QSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDAVV 626
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 627 M-ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 685
+ L II I+ P+ +
Sbjct: 246 ISKLHAIIDPNHEIE---------------------------------FPDIPEKD---- 268
Query: 686 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
D ++ L+ +P++R + E L HP++Q
Sbjct: 269 -----LQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-49
Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 37/314 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKND 471
+Y +G ++ V + ++ TG V +K D ++ EIKLLK +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--- 82
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +++ L + + ++V E + + + + +Q Q
Sbjct: 83 ----HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQI 133
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYR 587
+ + + HS IIH D+KPENIL+ +K+ D G + + V +R YR
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
APE+++G Y + +D+W++GC++ E++ GE LFP D+ + L I+ LG +
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI------ 245
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEY-IIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
+ F K N + I E LE ID + L I+P +
Sbjct: 246 -PRHQELFNK-------NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK 297
Query: 706 RPTAREALDHPWLQ 719
RP E L H + Q
Sbjct: 298 RPFCAELLHHDFFQ 311
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-49
Identities = 82/351 (23%), Positives = 146/351 (41%), Gaps = 72/351 (20%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ +Y + + LG+ +F V + D+ +G LK + D + E+ ++K+++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLD-- 58
Query: 471 DPADEH-HILRLYDYFYHLEH--------------------------------------L 491
H +I++L DYFY L
Sbjct: 59 -----HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551
++ E + L++ K SG + + + Q A+ ++HSLGI H D+KP+N
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRS--IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 552 ILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGC 608
+L+ S + +K+ D GS ++ Y+ SR YRAPE+++G Y IDLWS+GC
Sbjct: 172 LLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 609 ILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETN 668
+ EL G+ LF + + L RII ++G E + +N
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKE----------------QMIRMNPHYT 274
Query: 669 QLEYIIPEESSLEHHL-QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718
++ + + L + + + ID + +L P R EA+ HP+
Sbjct: 275 EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-47
Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 84/334 (25%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKL 466
+V Y + + +GS SKVFQ + + +K + + D D +EI L
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTLGR 522
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 64 LQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW----------E 109
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYV 581
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVK 166
Query: 582 QSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDAVV 626
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 627 M-ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 685
+ L II I+ P+ +
Sbjct: 227 ISKLHAIIDPNHEIE---------------------------------FPDIPEKD---- 249
Query: 686 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
D ++ L+ +P++R + E L HP++Q
Sbjct: 250 -----LQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-47
Identities = 42/335 (12%), Positives = 87/335 (25%), Gaps = 65/335 (19%)
Query: 414 GRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVN 468
R E L S VF +D+ D LK+ +N + ++ + +
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 469 KNDPADEHHILRLYDYF--------------------YHLEHLFIVCELLRANLYEFQK- 507
P + RL Y + + ++ +L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 508 FNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567
+ + L ++T Q + L S G++H P+N+ I + + D+
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM--PDGRLMLGDV 238
Query: 568 GSSCFQTDNLCLYVQSRSYRAPEVI--IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625
+ +Y E + + ++ W LG + +W + F
Sbjct: 239 SALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 685
+ + L + +
Sbjct: 299 GIKGSWKRPSLRVPG----------------------------------TDSLAFGSCTP 324
Query: 686 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
D + L + +RR EA++ P
Sbjct: 325 LPDF-VKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 4e-47
Identities = 74/336 (22%), Positives = 126/336 (37%), Gaps = 88/336 (26%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLL 464
+V Y + + +GS SKVFQ + +K + + + D +EI L
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV--NLEEADNQTLDSYRNEIAYL 108
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTL 520
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 109 NKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--------- 155
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCL 579
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 156 -ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSV 211
Query: 580 YVQSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDA 624
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
Query: 625 VVM-ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 683
+ L II I+ P+ +
Sbjct: 272 NQISKLHAIIDPNHEIE---------------------------------FPDIPEKD-- 296
Query: 684 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
D ++ L+ +P++R + E L HP++Q
Sbjct: 297 -------LQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-47
Identities = 58/332 (17%), Positives = 109/332 (32%), Gaps = 51/332 (15%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLV 467
+ + +++ LG A + VF+ + TG +K+ N D + E ++LK +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 468 NKNDPADEH-HILRLYDYF--YHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 519
N H +I++L+ H ++ E L L E E
Sbjct: 65 N-------HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--- 114
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQTDNL 577
++ R + + +L GI+H ++KP NI+ + + K+ D G++ D+
Sbjct: 115 ----LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 578 CLYVQ--SRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627
+ Y P++ Y +DLWS+G TG + F
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF------- 223
Query: 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 687
GP + +M K + +P SL LQ
Sbjct: 224 -----RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ-- 276
Query: 688 DAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
+ +LE + ++ +
Sbjct: 277 -VLLTPVLANILEADQEKCWGFDQFFAETSDI 307
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-46
Identities = 88/347 (25%), Positives = 153/347 (44%), Gaps = 59/347 (17%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ +Y + + LG A+ V+++ D TG V +K I + F S D EI +L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILT 63
Query: 466 LVNKNDPADEHHILRLYDYFY--HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
++ ++ +I+ L + + +++V + + +L+ + N
Sbjct: 64 ELSGHE-----NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI-------LEPVHK 111
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------------- 568
Q + Q ++ ++YLHS G++H D+KP NIL+ + C +K+ D G
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 569 ---------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
+ L YV +R YRAPE+++G Y + ID+WSLGCIL E+ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 619 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEY--DLYYINEETNQLEYIIPE 676
+FP + + L RIIG++ E + + I F K L E + I
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDV---ESIQSPFAKTMIESLKEKVEIRQSNKRDIFT 286
Query: 677 ESSLEHHLQFSDAFF----IDFVRTLLEINPQRRPTAREALDHPWLQ 719
+ A +D + LL+ NP +R +A +AL HP++
Sbjct: 287 KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-46
Identities = 68/335 (20%), Positives = 115/335 (34%), Gaps = 74/335 (22%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ + LG + V Q G V +K + DF D +L EIKLL
Sbjct: 13 LKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTES---- 65
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQ 529
D+H +++R Y L+I EL NL + + N + RQ
Sbjct: 66 --DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS-----------YQRCEIKIIDLGSSCFQTDNLC 578
+ +LHSL IIH DLKP+NIL+ + + I I D G
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 579 LYVQSRS-------YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTGEVLFPNDA 624
+ + + +RAPE++ + ID++S+GC+ + + D
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD- 242
Query: 625 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL 684
+ + L ++++ + E
Sbjct: 243 ---------------------KYSRESNIIRGIFSL-------DEMKCLHDRSLIAE--- 271
Query: 685 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
D + +++ +P +RPTA + L HP
Sbjct: 272 ------ATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-46
Identities = 69/337 (20%), Positives = 124/337 (36%), Gaps = 73/337 (21%)
Query: 400 ENKDLPIILNTVIAG--RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS 457
E D + VI G + + LG A + + + DV +K I + F +
Sbjct: 8 EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LPECFSFA 64
Query: 458 LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEF--QKFNQESGG 514
E++LL+ DEH +++R + + +I EL A L E+ QK G
Sbjct: 65 DREVQLLRES------DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL 118
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSSC 571
E + +Q L +LHSL I+H DLKP NILI + + + I D G
Sbjct: 119 EP-------ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 572 FQTDNLCLYVQ------SRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPN 622
+ + + + APE++ +D++S GC+ + +
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682
++ ++G L+ + PE+
Sbjct: 232 KSLQRQANILLG--------------------------------ACSLDCLHPEKH---- 255
Query: 683 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
D + + ++ ++PQ+RP+A+ L HP+
Sbjct: 256 ----EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 68/331 (20%), Positives = 123/331 (37%), Gaps = 75/331 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG FS V + LH G LK I +++ +++ E + +L N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN----- 84
Query: 474 DEH-HILRLYDYFYHLE----HLFIVCEL-LRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +ILRL Y +++ R L+ + ++ G + T ++ +
Sbjct: 85 --HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLL 140
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR--- 584
LE +H+ G H DLKP NIL+ + ++DLGS ++ Q+
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILL--GDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 585 ---------SYRAPEVIIGLPY---DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
SYRAPE+ + D++ D+WSLGC+L + GE +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------------ 246
Query: 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692
+ ++ + + + + S+ + S A
Sbjct: 247 ----------------------------DMVFQKGDSVALAVQNQLSIPQSPRHSSA-LW 277
Query: 693 DFVRTLLEINPQRRPTAREALDHPW-LQHPY 722
+ +++ ++P +RP L LQ P
Sbjct: 278 QLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 88/314 (28%), Positives = 149/314 (47%), Gaps = 30/314 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDP 472
++ E LG+ ++ V++ + TGV V LK +K D + ++ EI L+K +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK---- 61
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+RLYD + L +V E + +L ++ L ++ Q L
Sbjct: 62 ---HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRA 588
+ L + H I+H DLKP+N+LI R ++K+ D G + + + V + YRA
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
P+V++G Y ID+WS GCILAE+ TG+ LFP L I ++G +
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN------- 229
Query: 648 QEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
+ ++ TK +Y+ L ++ + + D +DF+ LL++NP
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK-----EPLDGNLMDFLHGLLQLNPDM 284
Query: 706 RPTAREALDHPWLQ 719
R +A++AL HPW
Sbjct: 285 RLSAKQALHHPWFA 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 68/334 (20%), Positives = 118/334 (35%), Gaps = 82/334 (24%)
Query: 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDE 460
++++ RY +LG F+K F+ D T KI+ ++ E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 461 IKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
I + + + H H++ + +F + +F+V EL
Sbjct: 66 ISIHRSLA-------HQHVVGFHGFFEDNDFVFVVLELC-------------RRRSLLEL 105
Query: 520 L---GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SS 570
L RQ + +YLH +IH DLK N+ + E+KI D G ++
Sbjct: 106 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLAT 163
Query: 571 CFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
+ D V + +Y APEV+ + ++D+WS+GCI+ L G+ F +
Sbjct: 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
Query: 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 688
RI + EY IP+ +
Sbjct: 224 YLRI-----------------------------------KKNEYSIPKHIN-------PV 241
Query: 689 AFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
A ++ +L+ +P RPT E L+ + Y
Sbjct: 242 A--ASLIQKMLQTDPTARPTINELLNDEFFTSGY 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 77/351 (21%), Positives = 123/351 (35%), Gaps = 97/351 (27%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
+ A + LG AF +V +A++ +K I++ ++ L E+ LL +N
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 469 KNDPADEH-HILRLYDYFYHLEH-------------LFIVCEL-----LRANLYEFQKFN 509
H +++R Y + + LFI E L ++
Sbjct: 61 -------HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
Q + RQ LEAL Y+HS GIIH DLKP NI I +KI D G
Sbjct: 114 QRD---------EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE--SRNVKIGDFGL 162
Query: 570 SCFQTDNLCLYVQSRS-----------------YRAPEVIIGLP-YDQKIDLWSLGCILA 611
+ +L + Y A EV+ G Y++KID++SLG I
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222
Query: 612 ELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLE 671
E+ V IL ++ + + F ++D +
Sbjct: 223 EMIYP--FSTGMERVNILKKL---------------RSVSIEFPPDFDDNKMKV------ 259
Query: 672 YIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
+R L++ +P +RP AR L+ WL +
Sbjct: 260 -------------------EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-44
Identities = 68/334 (20%), Positives = 119/334 (35%), Gaps = 82/334 (24%)
Query: 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDE 460
++++ RY +LG F+K F+ D T KI+ ++ E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 461 IKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
I + + + H H++ + +F + +F+V EL
Sbjct: 92 ISIHRSLA-------HQHVVGFHGFFEDNDFVFVVLELC-------------RRRSLLEL 131
Query: 520 L---GRL-----QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SS 570
L + RQ + +YLH +IH DLK N+ + E+KI D G ++
Sbjct: 132 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLAT 189
Query: 571 CFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
+ D V + +Y APEV+ + ++D+WS+GCI+ L G+ F +
Sbjct: 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249
Query: 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 688
RI + EY IP+ +
Sbjct: 250 YLRI-----------------------------------KKNEYSIPKHIN-------PV 267
Query: 689 AFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
A ++ +L+ +P RPT E L+ + Y
Sbjct: 268 A--ASLIQKMLQTDPTARPTINELLNDEFFTSGY 299
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 65/314 (20%), Positives = 105/314 (33%), Gaps = 67/314 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ LG ++ +VF+ + G +K KD + L E+ + V ++
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQ 529
+RL + L++ EL +L + + + ++ R
Sbjct: 117 P-----CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA------SLPEAQVWGYLRD 165
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ--SRSYR 587
L AL +LHS G++H D+KP NI + R K+ D G VQ Y
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
APE++ G Y D++SLG + E+ L + L QG
Sbjct: 224 APELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------------GWQQLRQG 267
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
L S E + +LE +P+ R
Sbjct: 268 ---------------------YLPPEFTAGLSSE---------LRSVLVMMLEPDPKLRA 297
Query: 708 TAREALDHPWLQHP 721
TA L P L+ P
Sbjct: 298 TAEALLALPVLRQP 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 75/319 (23%), Positives = 135/319 (42%), Gaps = 41/319 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ----SLDEIKLLKLVN 468
RY +G A+ V++A+D H+G V LK ++ N ++ E+ LL+ +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 469 KNDPADEH-HILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
+ H +++RL D + +V E + +L + +
Sbjct: 70 AFE----HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL----DKAPPPGLPAET 121
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--Y 580
++ + RQ L L++LH+ I+H DLKPENIL+ S +K+ D G + + + L
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFGLARIYSYQMALTPV 179
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
V + YRAPEV++ Y +D+WS+GCI AE++ + LF ++ L +I ++G
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
E + ++ + + + +L
Sbjct: 240 -EDDWPRDVSLPRGA----------------FPPRGPRPVQSVVPEMEESGAQLLLEMLT 282
Query: 701 INPQRRPTAREALDHPWLQ 719
NP +R +A AL H +L
Sbjct: 283 FNPHKRISAFRALQHSYLH 301
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 35/310 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDP 472
Y + LG ++ V++ + T V LK I+ + + ++ E+ LLK +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK---- 58
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+ L+D + + L +V E L +L ++ + +++ Q L
Sbjct: 59 ---HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRA 588
L Y H ++H DLKP+N+LI R E+K+ D G + ++ Y V + YR
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
P++++G Y +ID+W +GCI E+ TG LFP V L I +LG
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT------- 221
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
+E + NEE Y +L H D+ D + LL+ + R
Sbjct: 222 EETWPGILS-------NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274
Query: 708 TAREALDHPW 717
+A +A+ HP+
Sbjct: 275 SAEDAMKHPF 284
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 71/318 (22%), Positives = 142/318 (44%), Gaps = 42/318 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ-SLDEIKLLKLVNKND 471
RY LG + +V++A D T V +K I+ ++++ ++ E+ LLK +
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ--- 91
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+ L +H L ++ E +L ++ N + ++ ++ Q
Sbjct: 92 ----HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD------VSMRVIKSFLYQL 141
Query: 531 LEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLY---VQSR 584
+ + + HS +H DLKP+N+L+ + + +KI D G + + + + +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643
YR PE+++G Y +D+WS+ CI AE+ LFP D+ + L +I +LG D
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD--- 258
Query: 644 LMQGQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
+ T ++ + L+ ++ + +D + +LE+
Sbjct: 259 ----DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLD-------DEG--LDLLTAMLEM 305
Query: 702 NPQRRPTAREALDHPWLQ 719
+P +R +A+ AL+HP+
Sbjct: 306 DPVKRISAKNALEHPYFS 323
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-43
Identities = 87/323 (26%), Positives = 135/323 (41%), Gaps = 75/323 (23%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ RY LG +F +V +D TG + +K+I K + L E++LLK +
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
D +I++LY++F + ++V E+ +GGE F+
Sbjct: 84 ------DHPNIMKLYEFFEDKGYFYLVGEVY-------------TGGELFDEIISRKRFS 124
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCF--QTDN 576
I RQ L + Y+H I+H DLKPEN+L++S + I+IID G S +
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
+ + + Y APEV+ G YD+K D+WS G IL L +G F IL ++
Sbjct: 185 MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EK 241
Query: 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696
G E + K + E + D +R
Sbjct: 242 GKYTFE--------LPQWKK-----------------VSESA-------------KDLIR 263
Query: 697 TLLEINPQRRPTAREALDHPWLQ 719
+L P R +AR+ALDH W+Q
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQ 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-43
Identities = 84/323 (26%), Positives = 137/323 (42%), Gaps = 76/323 (23%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVN 468
++ Y + LGS A+ +V +D T V+ +KII + L+E+ +LKL++
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I++LYD+F + ++V E GGE F
Sbjct: 95 -------HPNIMKLYDFFEDKRNYYLVMECY-------------KGGELFDEIIHRMKFN 134
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCF--QTDN 576
VI +Q L + YLH I+H DLKPEN+L++S + IKI+D G S
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
+ + + Y APEV+ YD+K D+WS+G IL L G F IL ++
Sbjct: 195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EK 251
Query: 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696
G + + + E + D ++
Sbjct: 252 GKYTFD--------SPEWKN-----------------VSEGA-------------KDLIK 273
Query: 697 TLLEINPQRRPTAREALDHPWLQ 719
+L+ + QRR +A++AL+HPW++
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIK 296
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 9e-43
Identities = 46/343 (13%), Positives = 94/343 (27%), Gaps = 88/343 (25%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK--------LLKL 466
LG +A D TG + + + ++ ++K L +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRAN---------LYEFQKFNQESGGEAY 517
N+ + +D + ++ L LY + N ++ GE
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 518 FTLGRLQ---------VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ +T Q + L LH G++H L+P +I++ R + +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ--RGGVFLTGFE 251
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVII-----------GLPYDQKIDLWSLGCILAELWTGE 617
+ + SR + PE+ D W+LG ++ +W +
Sbjct: 252 HLV-RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 677
+ DA + I F + IP+
Sbjct: 311 LPITKDAALGGSEWI---------------------FRSCKN--------------IPQP 335
Query: 678 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
+ L + R +A++ P +
Sbjct: 336 VR-------------ALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-42
Identities = 82/375 (21%), Positives = 139/375 (37%), Gaps = 99/375 (26%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y + +G ++ V+ A D +T +V +K + F+ +D EI +L
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILN 80
Query: 466 LVNKNDPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+ +I+RLYD + L+IV E+ ++L + K + T
Sbjct: 81 RLK-------SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI------FLT 127
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
++ I L ++H GIIH DLKP N L+ C +K+ D G
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ--DCSVKVCDFGLARTINSEKDT 185
Query: 569 --------------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAEL 613
+ L +V +R YRAPE+I+ Y + ID+WS GCI AE
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE- 244
Query: 614 WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEE-TNQLEY 672
++ + P + L G + + +QL
Sbjct: 245 -------------LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNI 291
Query: 673 II-----PEESSLEH-----------------HLQFSDAF------FIDFVRTLLEINPQ 704
I P E L++ + + I+ + ++L+ NP
Sbjct: 292 IFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN 351
Query: 705 RRPTAREALDHPWLQ 719
+R T +ALDHP+L+
Sbjct: 352 KRITIDQALDHPYLK 366
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 77/323 (23%), Positives = 123/323 (38%), Gaps = 86/323 (26%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ + LG F V+ A++ + + LK++ + Q E+++ +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-- 523
H +ILRLY YF+ ++++ E G Y L +
Sbjct: 68 ------HPNILRLYGYFHDATRVYLILEYA-------------PLGTVYRELQKLSKFDE 108
Query: 524 ---QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 576
+ AL Y HS +IH D+KPEN+L+ S E+KI D G S +
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTD 166
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
LC + Y PE+I G +D+K+DLWSLG + E G+ F + RI
Sbjct: 167 LC---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--- 220
Query: 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696
++E+ P+ + A D +
Sbjct: 221 --------------------------------RVEFTFPDFVT-------EGA--RDLIS 239
Query: 697 TLLEINPQRRPTAREALDHPWLQ 719
LL+ NP +RP RE L+HPW+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWIT 262
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 82/315 (26%), Positives = 143/315 (45%), Gaps = 42/315 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQS-LDEIKLLKLVNKND 471
+Y+ E +G + V++AQ+ + G LK I+ + + + + EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I++LYD + + L +V E L +L + + + Q
Sbjct: 59 ----HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQL 109
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L + Y H ++H DLKP+N+LI E+KI D G + + Y + + YR
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
AP+V++G Y ID+WS+GCI AE+ G LFP + L RI +LG +
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN------ 221
Query: 647 GQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
+ + T+ +YD + E E + ID + +L+++P
Sbjct: 222 -SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD--------ESG--IDLLSKMLKLDPN 270
Query: 705 RRPTAREALDHPWLQ 719
+R TA++AL+H + +
Sbjct: 271 QRITAKQALEHAYFK 285
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 58/330 (17%), Positives = 109/330 (33%), Gaps = 51/330 (15%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLV 467
+ + +++ LG A + VF+ + TG +K+ N D + E ++LK +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 468 NKNDPADEH-HILRLYDYFYHL--EHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 519
N H +I++L+ H ++ E L L E E
Sbjct: 65 N-------HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--- 114
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQTDNL 577
++ R + + +L GI+H ++KP NI+ + + K+ D G++ D+
Sbjct: 115 ----LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 578 CL--YVQSRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627
+ Y P++ Y +DLWS+G TG + F
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF------- 223
Query: 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 687
GP + +M K + +P SL LQ
Sbjct: 224 -----RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ-- 276
Query: 688 DAFFIDFVRTLLEINPQRRPTAREALDHPW 717
+ +LE + ++ +
Sbjct: 277 -VLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-42
Identities = 78/334 (23%), Positives = 135/334 (40%), Gaps = 87/334 (26%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--------------NDKDFFDQS 457
I Y+ LGS A+ +V ++ + + +K+IK N + F ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 458 LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE- 515
+EI LLK ++ H +I++L+D F ++ ++V E GGE
Sbjct: 94 YNEISLLKSLD-------HPNIIKLFDVFEDKKYFYLVTEFY-------------EGGEL 133
Query: 516 -------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567
F I +Q L + YLH I+H D+KPENIL+++ IKI+D
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 568 GSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625
G S F + + L + + Y APEV+ Y++K D+WS G I+ L G F
Sbjct: 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
Query: 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 685
I+ ++ G + + + I +E+
Sbjct: 253 QDIIKKV--EKGKYYFD--------FNDWKN-----------------ISDEA------- 278
Query: 686 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
+ ++ +L + +R TA EAL+ W++
Sbjct: 279 ------KELIKLMLTYDYNKRCTAEEALNSRWIK 306
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 62/319 (19%), Positives = 102/319 (31%), Gaps = 83/319 (26%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH-HI 478
+G +F +V + +D TG +K + ++E+ ++ I
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLS-------SPRI 112
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG------EAY--FTLGRLQVITRQC 530
+ LY + I ELL GG + R Q
Sbjct: 113 VPLYGAVREGPWVNIFMELL-------------EGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS---- 585
LE LEYLH+ I+H D+K +N+L+ S + D G + C Q D L + +
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
+ APEV++G P D K+D+WS C++ + G + + + I P E
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIRE 277
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
IP + ++ L
Sbjct: 278 -------------------------------IPPSCAPL---------TAQAIQEGLRKE 297
Query: 703 PQRRPTAREALDHPWLQHP 721
P R +A E
Sbjct: 298 PVHRASAMELRRKVGKALQ 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-42
Identities = 79/332 (23%), Positives = 112/332 (33%), Gaps = 84/332 (25%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EI 461
Y + LG F VF L + V +K+I ++ L E+
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 462 KLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYF 518
LL V H ++RL D+F E +V E + Y
Sbjct: 86 ALLWKVGA---GGGHPGVIRLLDWFETQEGFMLVLER------------PLPAQDLFDYI 130
Query: 519 TL-GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
T G L Q + A+++ HS G++H D+K ENILI +R K+ID GS
Sbjct: 131 TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCAKLIDFGSGAL 189
Query: 573 QTDNLCL-YVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630
D + +R Y PE I Y +WSLG +L ++ G++ F D
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------- 242
Query: 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 690
QEI + E P S D
Sbjct: 243 -----------------QEILEA-----------------ELHFPAHVS-------PDC- 260
Query: 691 FIDFVRTLLEINPQRRPTAREALDHPWLQHPY 722
+R L P RP+ E L PW+Q P
Sbjct: 261 -CALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 90/316 (28%), Positives = 145/316 (45%), Gaps = 42/316 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKND 471
+Y E +G + VF+A++ T V LK ++ +D + +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+RL+D + + L +V E +L ++ ++ Q
Sbjct: 60 ----HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-----LDPEIVKSFLFQL 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L+ L + HS ++H DLKP+N+LI E+K+ + G + + Y V + YR
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
P+V+ G Y ID+WS GCI AEL G LFP + V L RI +LG
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT----- 223
Query: 646 QGQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703
+E + TK +Y Y + T L ++P+ + + D ++ LL+ NP
Sbjct: 224 --EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN--------ATG--RDLLQNLLKCNP 271
Query: 704 QRRPTAREALDHPWLQ 719
+R +A EAL HP+
Sbjct: 272 VQRISAEEALQHPYFS 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 80/313 (25%), Positives = 143/313 (45%), Gaps = 37/313 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKND 471
+Y E +G + V++A+D G V LK I+ + + ++ EI LLK ++
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--- 77
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+ L D + L +V E + +L + N+ ++++ Q
Sbjct: 78 ----HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG-----LQDSQIKIYLYQL 128
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L + + H I+H DLKP+N+LI S +K+ D G + + Y V + YR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINS--DGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
AP+V++G Y +D+WS+GCI AE+ TG+ LFP L +I +LG +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN------ 240
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+ + L+ Q + + E+ + ID + +L +P +R
Sbjct: 241 -PREWPQVQE-LPLW------KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292
Query: 707 PTAREALDHPWLQ 719
+AR+A++HP+ +
Sbjct: 293 ISARDAMNHPYFK 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 69/332 (20%), Positives = 123/332 (37%), Gaps = 85/332 (25%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
R V L F+ V++AQD+ +G + LK + N+++ + E+ +K ++ +
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP-- 86
Query: 474 DEHHILRLYDYFYHLEH--------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+I++ + ++ EL + L EF K + G + +
Sbjct: 87 ---NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLK 140
Query: 526 ITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
I Q A++++H IIH DLK EN+L+ + IK+ D GS+ + +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 584 R---------------SYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625
+ YR PE+I P +K D+W+LGCIL L + F + A
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
Query: 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 685
+ I+ +Y IP H
Sbjct: 259 LRIV---------------------------------------NGKYSIPP------HDT 273
Query: 686 FSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717
F +R +L++NP+ R + E +
Sbjct: 274 QYTV-FHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-41
Identities = 89/344 (25%), Positives = 139/344 (40%), Gaps = 80/344 (23%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--- 447
H + + EN + A RY + LG +F +V + +D T + +K+I
Sbjct: 3 HHHHHSSGREN----LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQ 506
L E++LLK ++ H +I++L++ +IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-------HPNIMKLFEILEDSSSFYIVGELY-------- 103
Query: 507 KFNQESGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-Y 557
+GGE F+ I +Q + Y+H I+H DLKPENIL++S
Sbjct: 104 -----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 558 QRCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ C+IKIID G S N + + + Y APEV+ G YD+K D+WS G IL L +
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
Query: 616 GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIP 675
G F IL R+ G + + I
Sbjct: 218 GTPPFYGKNEYDILKRV--ETGKYAFD--------LPQWRT-----------------IS 250
Query: 676 EESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
+++ D +R +L +P R TA + L+HPW+Q
Sbjct: 251 DDA-------------KDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 60/333 (18%), Positives = 111/333 (33%), Gaps = 84/333 (25%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
++ + E +GS F +VF+A+ G +K +K + + ++ E+K L
Sbjct: 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAK 60
Query: 467 VNKNDPADEH-HILRLYDYFYHLEH----------------LFIVCELL-RANLYEFQKF 508
++ H +I+ + ++ LFI E + L ++ +
Sbjct: 61 LD-------HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + Q + ++Y+HS +I+ DLKP NI + + ++KI D G
Sbjct: 114 RRGE----KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFG 167
Query: 569 SSCF--QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626
+ Y +PE I Y +++DL++LG ILAEL +
Sbjct: 168 LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 227
Query: 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQF 686
R + II + F
Sbjct: 228 FTDLR---------------------------------------DGIISD--------IF 240
Query: 687 SDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
++ LL P+ RP E L +
Sbjct: 241 DKK-EKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 72/317 (22%), Positives = 125/317 (39%), Gaps = 65/317 (20%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ V LG +F+ V++A+ +HTG++V +K+I + +E+K+ +
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK- 69
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H IL LY+YF ++++V E+ E ++ + F+ +
Sbjct: 70 ------HPSILELYNYFEDSNYVYLVLEMCHNG--EMNRYLKNRVK--PFSENEARHFMH 119
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQ--SRS 585
Q + + YLHS GI+H DL N+L+ IKI D G ++ + + Y + +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
Y +PE+ + + D+WSLGC+ L G F D V L ++
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------------- 224
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
+Y +P S +A D + LL NP
Sbjct: 225 ----------------------VLADYEMPSFLS-------IEA--KDLIHQLLRRNPAD 253
Query: 706 RPTAREALDHPWLQHPY 722
R + LDHP++
Sbjct: 254 RLSLSSVLDHPFMSRNS 270
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-41
Identities = 63/322 (19%), Positives = 116/322 (36%), Gaps = 41/322 (12%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
T G + + E LG+ F V + TG V +K + + ++ EI+++K +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 468 NKNDPADEH-HILRLYDYFYHLEHL------FIVCELLRANLYEFQKFNQESGGEAYFTL 520
N H +++ + L+ L + E + +K+ +
Sbjct: 70 N-------HPNVVSAREVPDGLQKLAPNDLPLLAMEY--CEGGDLRKYLNQFENCCGLKE 120
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCL 579
G ++ + AL YLH IIH DLKPENI+++ QR KIIDLG +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 580 --YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+V + Y APE++ Y +D WS G + E TG F + + +
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---- 236
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
+ E + + ++ + ++
Sbjct: 237 ------REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERW----------LQC 280
Query: 698 LLEINPQRRPTAREALDHPWLQ 719
+L + ++R T + + Q
Sbjct: 281 MLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 81/325 (24%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ LG +FS + + +KII K + EI LKL +
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLC------EG 64
Query: 476 H-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVI 526
H +I++L++ F+ H F+V ELL GGE +F+ I
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLN-------------GGELFERIKKKKHFSETEASYI 111
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNLCLY--VQ 582
R+ + A+ ++H +G++H DLKPEN+L EIKIID G + DN L
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAEL-------WTGEVLFPNDAVVMILARIIGM 635
+ Y APE++ YD+ DLWSLG IL + + + + V I+ +I
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI--K 229
Query: 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 695
G E + + +++E L +
Sbjct: 230 KGDFSFE------------GEAWK--NVSQEAKDL------------------------I 251
Query: 696 RTLLEINPQRRPTAREALDHPWLQH 720
+ LL ++P +R + WLQ
Sbjct: 252 QGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-41
Identities = 85/370 (22%), Positives = 141/370 (38%), Gaps = 81/370 (21%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I RY + +G+ ++ V +A D V +K I F+ +D EI +L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---FEDLIDCKRILREIAILN 107
Query: 466 LVNKNDPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N H H++++ D + L++V E+ ++ + + Y T
Sbjct: 108 RLN-------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV------YLT 154
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
++ + L ++Y+HS GI+H DLKP N L+ C +K+ D G
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVKVCDFGLARTVDYPENG 212
Query: 569 -------------------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGC 608
+ L +V +R YRAPE+I+ Y + ID+WS+GC
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 609 ILAEL-----------WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ--EIYKYFT 655
I AEL LFP + + + Q I+
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG 332
Query: 656 K--EYDLYYINEETNQLEYI----IPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
E D+ + +E + YI E + L S A I ++ +L NP +R T
Sbjct: 333 TPSEEDIEALEKE-DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391
Query: 710 REALDHPWLQ 719
E L HP+ +
Sbjct: 392 NECLAHPFFK 401
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 5e-41
Identities = 81/317 (25%), Positives = 141/317 (44%), Gaps = 39/317 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDL-HTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKN 470
+Y +G A+ KVF+A+DL + G V LK ++ ++ ++ E+ +L+ +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 471 DPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+ H +++RL+D L +V E + +L + + E ++
Sbjct: 72 E----HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIK 123
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQ 582
+ Q L L++LHS ++H DLKP+NIL+ S +IK+ D G + + + L V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
+ YRAPEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G E
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG-E 240
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
+ +E + D D + L N
Sbjct: 241 EDWPRDVALPRQA----------------FHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284
Query: 703 PQRRPTAREALDHPWLQ 719
P +R +A AL HP+ Q
Sbjct: 285 PAKRISAYSALSHPYFQ 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 77/328 (23%), Positives = 124/328 (37%), Gaps = 84/328 (25%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EI 461
+ +Y V LGS F V+ + + V +K ++ D+ L E+
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 462 KLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYFT 519
LLK V+ ++RL D+F + ++ E E + + T
Sbjct: 98 VLLKKVSSGFS----GVIRLLDWFERPDSFVLILERP------------EPVQDLFDFIT 141
Query: 520 L-GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
G LQ Q LEA+ + H+ G++H D+K ENILI R E+K+ID GS
Sbjct: 142 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALL 200
Query: 574 TDNLCL-YVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631
D + + +R Y PE I Y + +WSLG +L ++ G++ F +D
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------- 252
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF 691
+EI + + + S S+
Sbjct: 253 ----------------EEIIRG-----------------QVFFRQRVS-------SEC-- 270
Query: 692 IDFVRTLLEINPQRRPTAREALDHPWLQ 719
+R L + P RPT E +HPW+Q
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 87/323 (26%), Positives = 135/323 (41%), Gaps = 59/323 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ------SLDEIKLLKLVN 468
RY ++LG F+ V++A+D +T V +K IK + +L EIKLL+ ++
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D F H ++ +V + + +L K N T ++
Sbjct: 71 -------HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYM 118
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSR 584
L+ LEYLH I+H DLKP N+L+ +K+ D G + Y V +R
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTR 176
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PIDLE 642
YRAPE++ G Y +D+W++GCILAEL P D+ + L RI LG P
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP---- 232
Query: 643 MLMQGQEIYKYFTKEYDLYYINEET--------NQLEYIIPEESSLEHHLQFSDAFFIDF 694
EE + + + L H + +D
Sbjct: 233 ---------------------TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 271
Query: 695 VRTLLEINPQRRPTAREALDHPW 717
++ L NP R TA +AL +
Sbjct: 272 IQGLFLFNPCARITATQALKMKY 294
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 75/320 (23%), Positives = 123/320 (38%), Gaps = 64/320 (20%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNK 469
+ + + +G FS+V++A L GV V LK ++ D + EI LLK +N
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H ++++ Y F L IV EL A +L K ++ +
Sbjct: 91 ------HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR--LIPERTVWKYF 142
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSR 584
Q ALE++HS ++H D+KP N+ I + +K+ DLG F + V +
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPIDLEM 643
Y +PE I Y+ K D+WSLGC+L E+ + F D + + L + I
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---------- 250
Query: 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYI-IPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
Q +Y +P + +S+ V + +
Sbjct: 251 ------------------------EQCDYPPLPSD-------HYSEE-LRQLVNMCINPD 278
Query: 703 PQRRPTAREALDHPWLQHPY 722
P++RP D H
Sbjct: 279 PEKRPDVTYVYDVAKRMHAC 298
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 61/327 (18%), Positives = 111/327 (33%), Gaps = 76/327 (23%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
++ E +GS F VF+ G +K K +L E+ ++ ++
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H++R + + +H+ I E +L + N YF L+ + Q
Sbjct: 72 -----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS--YFKEAELKDLLLQV 124
Query: 531 LEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCEIKIIDLGSSCFQ 573
L Y+HS+ ++H D+KP NI I + + KI DLG +
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-R 183
Query: 574 TDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
+ + + A EV+ + K D+++L + E L N + +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ- 242
Query: 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692
G L IP+ S E F
Sbjct: 243 -GRLPR-----------------------------------IPQVLSQE---------FT 257
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
+ ++ ++ +P+RRP+A + H L
Sbjct: 258 ELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 80/327 (24%), Positives = 132/327 (40%), Gaps = 81/327 (24%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
Y V E +G ++S + T ++ +KII K +EI++L +
Sbjct: 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQ-- 74
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
H +I+ L D + +++++V EL++ GGE +F+
Sbjct: 75 ----HPNIITLKDVYDDGKYVYVVTELMK-------------GGELLDKILRQKFFSERE 117
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLG-SSCFQTDNLCL 579
+ + +EYLH+ G++H DLKP NIL +S I+I D G + + +N L
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 580 Y--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF---PNDAVVMILARIIG 634
+ ++ APEV+ YD D+WSLG +L + TG F P+D ILARI
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-- 235
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEY-DLYYINEETNQLEYIIPEESSLEHHLQFSDAFFID 693
G + Y + +++ L
Sbjct: 236 GSGKFS-------------LSGGYWN--SVSDTAKDL----------------------- 257
Query: 694 FVRTLLEINPQRRPTAREALDHPWLQH 720
V +L ++P +R TA L HPW+ H
Sbjct: 258 -VSKMLHVDPHQRLTAALVLRHPWIVH 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 72/342 (21%), Positives = 127/342 (37%), Gaps = 66/342 (19%)
Query: 386 HLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK 445
H H R I + LGS AF V ++ +G++ +K
Sbjct: 2 HHHHHHSSGRENLYFQGT--------IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK 53
Query: 446 IIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANL 502
I D+ EI++LK ++ H +I+++++ F +++IV E
Sbjct: 54 TINKDRSQVPMEQIEAEIEVLKSLD-------HPNIIKIFEVFEDYHNMYIVMETCEGG- 105
Query: 503 YE-FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRC 560
E ++ + G + + +Q + AL Y HS ++H DLKPENIL +
Sbjct: 106 -ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 561 EIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
IKIID G + + + Y APEV K D+WS G ++ L TG +
Sbjct: 165 PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCL 223
Query: 619 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 678
F ++ + + + + E + +
Sbjct: 224 PFTGTSLEEVQQKA--TYKEPN-------------YAVECR--PLTPQA----------- 255
Query: 679 SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
+D ++ +L +P+RRP+A + L H W +
Sbjct: 256 -------------VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 69/323 (21%), Positives = 119/323 (36%), Gaps = 86/323 (26%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ + LG F V+ A++ + LK++ + Q EI++ +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H +ILR+Y+YF+ + ++++ E GE Y L GR
Sbjct: 73 ------HPNILRMYNYFHDRKRIYLMLEFA-------------PRGELYKELQKHGRFDE 113
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 576
+ +AL Y H +IH D+KPEN+L+ + E+KI D G S
Sbjct: 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIADFGWSVHAPSLRRRT 171
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
+C + Y PE+I G +D+K+DLW G + E G F + + RI+
Sbjct: 172 MC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--- 225
Query: 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696
++ P S + D +
Sbjct: 226 --------------------------------NVDLKFPPFLS-------DGS--KDLIS 244
Query: 697 TLLEINPQRRPTAREALDHPWLQ 719
LL +P +R + ++HPW++
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVK 267
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 77/353 (21%), Positives = 122/353 (34%), Gaps = 85/353 (24%)
Query: 390 IHRKNRTGFEENKDLPIILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIK 448
H + +G E P + Y ++ + LG KV + TG LK++
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY 63
Query: 449 NDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLY 503
+ E+ + HI+ + D + + L I+ E +
Sbjct: 64 DSPKARQ----EVDHHWQASG------GPHIVCILDVYENMHHGKRCLLIIMECME---- 109
Query: 504 EFQKFNQESGGE----------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553
GGE FT I R A+++LHS I H D+KPEN+L
Sbjct: 110 ---------GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 554 IKS-YQRCEIKIIDLG-SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILA 611
S + +K+ D G + + L + Y APEV+ YD+ D+WSLG I+
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
Query: 612 ELWTGEVLF----PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEET 667
L G F + RI LG E+ ++E+
Sbjct: 221 ILLCGFPPFYSNTGQAISPGMKRRI--RLGQYGFP------------NPEWS--EVSEDA 264
Query: 668 NQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
QL +R LL+ +P R T + ++HPW+
Sbjct: 265 KQL------------------------IRLLLKTDPTERLTITQFMNHPWINQ 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 62/315 (19%), Positives = 121/315 (38%), Gaps = 68/315 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+Y + +G +F K + G +K I + K+ ++S E+ +L +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMK-- 81
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ + F L+IV + +L F++ N + G F ++
Sbjct: 82 -----HPNIVQYRESFEENGSLYIVMDYCEGGDL--FKRINAQKGV--LFQEDQILDWFV 132
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRS 585
Q AL+++H I+H D+K +NI + +++ D G + + + +
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPY 190
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPIDLEML 644
Y +PE+ PY+ K D+W+LGC+L EL T + F ++ ++ +II G P
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP------ 244
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
+ +S V L + NP+
Sbjct: 245 -----------------------------VSL--------HYSYD-LRSLVSQLFKRNPR 266
Query: 705 RRPTAREALDHPWLQ 719
RP+ L+ ++
Sbjct: 267 DRPSVNSILEKGFIA 281
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-40
Identities = 88/332 (26%), Positives = 139/332 (41%), Gaps = 84/332 (25%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---------EIK 462
+ Y +++ LGS A +V A + T V ++II K + + EI+
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 463 LLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------ 515
+LK +N H I+++ + F+ E +IV EL+ GGE
Sbjct: 193 ILKKLN-------HPCIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVV 231
Query: 516 --AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCF 572
++ Q L A++YLH GIIH DLKPEN+L+ S + C IKI D G S
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627
+ + + +Y APEV++ + Y++ +D WSLG IL +G F +
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351
Query: 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 687
L I G+ Y + + + ++E+
Sbjct: 352 SLKDQI-----------TSGK--YNFIPEVWA--EVSEKA-------------------- 376
Query: 688 DAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
+D V+ LL ++P+ R T EAL HPWLQ
Sbjct: 377 ----LDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-40
Identities = 74/331 (22%), Positives = 137/331 (41%), Gaps = 44/331 (13%)
Query: 417 YVTEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPA 473
Y +G + V++A+ D LK I+ + EI LL+ L + N
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPN--- 79
Query: 474 DEHHILRLYDYFYH--LEHLFIVCELLRANLY---EFQKFNQESGGEAYFTLGRLQVITR 528
++ L F ++++ + +L+ +F + ++ + G ++ +
Sbjct: 80 ----VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q L+ + YLH+ ++H DLKP NIL+ +R +KI D+G + L
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 586 -----YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMI---------LA 630
YRAPE+++G Y + ID+W++GCI AEL T E +F + L
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 631 RIIGMLGPIDLEMLMQGQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSD 688
RI ++G + ++ K E+ + N +E H D
Sbjct: 256 RIFNVMGFPA-------DKDWEDIKKMPEHSTLMKDFRRNTYTN-CSLIKYMEKHKVKPD 307
Query: 689 AFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
+ ++ LL ++P +R T+ +A+ P+
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-40
Identities = 61/322 (18%), Positives = 112/322 (34%), Gaps = 73/322 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
Y V +G+ ++ + + + G + K + + + + E+ LL+ +
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK-- 63
Query: 471 DPADEH-HILRLYDYFYHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
H +I+R YD L+IV E +L + Y + +
Sbjct: 64 -----HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRV 116
Query: 527 TRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
Q AL+ H ++H DLKP N+ + Q +K+ D G + +
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAK 174
Query: 580 -YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLG 637
+V + Y +PE + + Y++K D+WSLGC+L EL F + + +I G
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
IP S E + +
Sbjct: 235 R-----------------------------------IPYRYSDE---------LNEIITR 250
Query: 698 LLEINPQRRPTAREALDHPWLQ 719
+L + RP+ E L++P +
Sbjct: 251 MLNLKDYHRPSVEEILENPLIL 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 83/325 (25%), Positives = 145/325 (44%), Gaps = 50/325 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ-SLDEIKLLKLVNKND 471
+Y +G F +VF+A+ TG V LK + N+K+ F +L EIK+L+L+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--- 74
Query: 472 PADEH-HILRLYD--------YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
H +++ L + Y +++V + +L + FTL
Sbjct: 75 ----HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL----SNVLVK-FTLSE 125
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLC 578
++ + + L L Y+H I+H D+K N+LI +K+ D G S +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARAFSLAKNSQPN 183
Query: 579 LY---VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
Y V + YR PE+++G Y IDLW GCI+AE+WT + + LA I
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ--FSDAFFI 692
+ G I E++ Y+LY +LE + ++ ++ L+ D + +
Sbjct: 244 LCGSIT-------PEVWPNVDN-YELY------EKLELVKGQKRKVKDRLKAYVRDPYAL 289
Query: 693 DFVRTLLEINPQRRPTAREALDHPW 717
D + LL ++P +R + +AL+H +
Sbjct: 290 DLIDKLLVLDPAQRIDSDDALNHDF 314
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 71/374 (18%), Positives = 120/374 (32%), Gaps = 84/374 (22%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND 450
H + + EN + +Y++ +G ++ V A + T +KI+ +
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 451 KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL------------ 498
K D ++ V +I RLY+ + +++ +V EL
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 499 -----------------------RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ + I RQ AL
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-------QTDNLCLYVQSRSYRA 588
YLH+ GI H D+KPEN L + + EIK++D G S + + + + A
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 589 PEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
PEV+ Y K D WS G +L L G V FP ++++ +
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV------------LN 290
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+ + Y++ + + D + LL N R
Sbjct: 291 KK--LCFENPNYNV-------------LSPLA-------------RDLLSNLLNRNVDER 322
Query: 707 PTAREALDHPWLQH 720
A AL HPW+
Sbjct: 323 FDAMRALQHPWISQ 336
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 80/326 (24%), Positives = 139/326 (42%), Gaps = 85/326 (26%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-----EIKLLKLVN 468
G Y + + +G F+KV A+ + TG +V +KII DK + + E++++K++N
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILN 72
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ 524
H +I++L++ + L+++ E SGGE + L GR++
Sbjct: 73 -------HPNIVKLFEVIETEKTLYLIMEYA-------------SGGEVFDYLVAHGRMK 112
Query: 525 -----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--L 577
RQ + A++Y H I+H DLK EN+L+ + IKI D G S T L
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKL 170
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
+ + Y APE+ G YD ++D+WSLG IL L +G + F + + R+
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV---- 226
Query: 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696
++G +Y IP S + + ++
Sbjct: 227 --------LRG-----------------------KYRIPFYMSTDC---------ENLLK 246
Query: 697 TLLEINPQRRPTAREALDHPWLQHPY 722
L +NP +R T + + W+ +
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGH 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-39
Identities = 82/335 (24%), Positives = 123/335 (36%), Gaps = 86/335 (25%)
Query: 409 NTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLV 467
I Y VT + LG KV Q + T LK++++ E++L
Sbjct: 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRA 111
Query: 468 NKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
++ HI+R+ D + + L IV E L GGE
Sbjct: 112 SQ------CPHIVRIVDVYENLYAGRKCLLIVMECLD-------------GGELFSRIQD 152
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSC 571
FT I + EA++YLHS+ I H D+KPEN+L S +K+ D G +
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 572 FQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF----PNDAV 625
T + L + Y APEV+ YD+ D+WSLG I+ L G F
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272
Query: 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 685
+ RI +G + E+ ++EE L
Sbjct: 273 PGMKTRI--RMGQYEFP------------NPEWS--EVSEEVKML--------------- 301
Query: 686 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
+R LL+ P +R T E ++HPW+
Sbjct: 302 ---------IRNLLKTEPTQRMTITEFMNHPWIMQ 327
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 75/339 (22%), Positives = 128/339 (37%), Gaps = 68/339 (20%)
Query: 395 RTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDF 453
R+ E + + ++ LG + V+ +DL V + +K I D +
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62
Query: 454 FDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLR----ANLYEFQKF 508
+EI L K + H +I++ F + I E + + L K+
Sbjct: 63 SQPLHEEIALHKHLK-------HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-SKW 114
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
E + T+Q LE L+YLH I+H D+K +N+LI +Y +KI D G
Sbjct: 115 GPLKDNEQT-----IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV-LKISDFG 168
Query: 569 SSCFQTDNLCLYVQSRS----YRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPN 622
+S + + ++ + Y APE+I P Y + D+WSLGC + E+ TG+ F
Sbjct: 169 TSK-RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227
Query: 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682
L + Q ++ + ++ IPE S E
Sbjct: 228 ---------------------LGEPQAA---------MFKV--GMFKVHPEIPESMSAE- 254
Query: 683 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721
F+ E +P +R A + L +L+
Sbjct: 255 --------AKAFILKCFEPDPDKRACANDLLVDEFLKVS 285
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 82/330 (24%), Positives = 122/330 (36%), Gaps = 92/330 (27%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---------EIKLL 464
+Y LGS AF V+ A D +V +K IK +K D ++ EI +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 465 KLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYFTL- 520
V H +I+++ D F + +V E SG + A+
Sbjct: 84 SRVE-------HANIIKVLDIFENQGFFQLVMEK------------HGSGLDLFAFIDRH 124
Query: 521 GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
RL I RQ + A+ YL IIH D+K ENI+I IK+ID GS+ +
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLER 182
Query: 576 NLCLYVQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
Y + Y APEV++G PY ++++WSLG L L E F
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC----------- 231
Query: 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692
+LE ++ P S + +
Sbjct: 232 -------ELEETVEA-----------------------AIHPPYLVS-------KEL--M 252
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQHPY 722
V LL+ P+RR T + + PW+ P
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 46/356 (12%), Positives = 96/356 (26%), Gaps = 88/356 (24%)
Query: 403 DLPIILNTVIAGRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD 459
P + + + R LG +A D TG + + + ++
Sbjct: 64 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 460 EIK--------LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRAN---------L 502
++K L + N+ + +D + ++ L L
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 503 YEFQKFNQESGGEAYFTLGRLQV---------ITRQCLEALEYLHSLGIIHCDLKPENIL 553
Y + N ++ GE + +T Q + L LH G++H L+P +I+
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243
Query: 554 IKSYQRCEIKIIDLGSSCFQTDNLC----LYVQSRSYRAPEVIIGLP-----YDQKIDLW 604
+ QR + + + A ++ D W
Sbjct: 244 LD--QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 605 SLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYIN 664
+LG + +W ++ +DA + I F +
Sbjct: 302 TLGLAIYWIWCADLPNTDDAALGGSEWI---------------------FRSCKN----- 335
Query: 665 EETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
IP+ + L + R +A++ P +
Sbjct: 336 ---------IPQPVR-------------ALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 69/347 (19%), Positives = 126/347 (36%), Gaps = 77/347 (22%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKII-- 447
+N+ + + + GR+ +G +F V++ D T V+V +
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 448 -KNDKDFFDQSLDEIKLLK-LVNKNDPADEHHILRLYDYFYHL----EHLFIVCEL---- 497
K K + +E ++LK L + N I+R YD + + + +V EL
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPN-------IVRFYDSWESTVKGKKCIVLVTELMTSG 114
Query: 498 -LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILI 554
L+ L F+ + L+ RQ L+ L++LH+ IIH DLK +NI I
Sbjct: 115 TLKTYLKRFKVMK----------IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 555 KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY-RAPEVIIGLPYDQKIDLWSLGCILAEL 613
+KI DLG + + + V APE+ YD+ +D+++ G + E+
Sbjct: 165 TGPT-GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222
Query: 614 WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI 673
T E + + + Q IY+ T
Sbjct: 223 ATSEYPYS------------------ECQNAAQ---IYRRVTSG-----------VKPAS 250
Query: 674 IPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
+ + E + + + N R + ++ L+H + Q
Sbjct: 251 FDKVAIPE---------VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 74/309 (23%), Positives = 121/309 (39%), Gaps = 31/309 (10%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG+ VF+ +G+ + K+I +Q + E+++L + +I+
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH------ECNSPYIV 94
Query: 480 RLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
Y FY + I E + + + E L ++ ++ L
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ---------ILGKVSIAVIKGLT 145
Query: 536 YLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVII 593
YL I+H D+KP NIL+ S R EIK+ D G S D++ +V +RSY +PE +
Sbjct: 146 YLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 203
Query: 594 GLPYDQKIDLWSLGCILAELWTGEVLFP---NDAVVMILARIIGMLGPIDLEMLMQGQEI 650
G Y + D+WS+G L E+ G +P DA + L + G
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710
D L+YI+ E FS F DFV L NP R +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE-FQDFVNKCLIKNPAERADLK 320
Query: 711 EALDHPWLQ 719
+ + H +++
Sbjct: 321 QLMVHAFIK 329
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 83/325 (25%), Positives = 130/325 (40%), Gaps = 82/325 (25%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
G Y + + LG F KV + TG V +KI+ K D + EI+ LKL
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR- 69
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H HI++LY F+V E + SGGE + + GR++
Sbjct: 70 ------HPHIIKLYQVISTPTDFFMVMEYV-------------SGGELFDYICKHGRVEE 110
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +Q L A++Y H ++H DLKPEN+L+ ++ KI D G S +D L
Sbjct: 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 168
Query: 581 VQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
S +Y APEVI G Y ++D+WS G IL L G + F ++ V + +I
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----- 223
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
G + IPE + +
Sbjct: 224 -------RGG-----------------------VFYIPEYLN-------RSV--ATLLMH 244
Query: 698 LLEINPQRRPTAREALDHPWLQHPY 722
+L+++P +R T ++ +H W +
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDL 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 69/336 (20%), Positives = 117/336 (34%), Gaps = 88/336 (26%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDP 472
+ + LG F VF+A++ + +K I+ N + ++ + E+K L +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 61
Query: 473 ADEH-HILRLYDYF------------YHLEHLFIVCELL-RANLYEFQKFNQESGGEAYF 518
H I+R ++ + +L+I +L + NL ++
Sbjct: 62 ---HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN---GRCTIEER 115
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF------ 572
I Q EA+E+LHS G++H DLKP NI +K+ D G
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEE 173
Query: 573 ---------QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
V ++ Y +PE I G Y K+D++SLG IL EL L+P
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL-----LYPFS 228
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 683
M L + + F + Y P E +
Sbjct: 229 T---------QMERVRTLTDVRNLK-----FPPLFTQKY------------PCEYVM--- 259
Query: 684 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
V+ +L +P RP A +++ +
Sbjct: 260 -----------VQDMLSPSPMERPEAINIIENAVFE 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 70/211 (33%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKN 470
I + E LGS AFS+VF + TG LK IK F D SL +EI +LK +
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-- 64
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLG 521
H +I+ L D + H ++V +L+ SGGE +T
Sbjct: 65 -----HENIVTLEDIYESTTHYYLVMQLV-------------SGGELFDRILERGVYTEK 106
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNLCL 579
++ +Q L A++YLH GI+H DLKPEN+L + + +I I D G S Q +
Sbjct: 107 DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APEV+ PY + +D WS+G I
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 13/27 (48%), Positives = 17/27 (62%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
DF+ LLE +P R T +AL HPW+
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWID 266
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 77/329 (23%), Positives = 130/329 (39%), Gaps = 82/329 (24%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-----EIKLLKLVN 468
G+Y + + LG ++ KV + D T +KI+K K + + EI+LL+ +
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 469 KNDPADEH-HILRLYDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
H ++++L D Y+ E +++V E + E + R V
Sbjct: 65 -------HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM--LD-------SVPEKRFPV 108
Query: 526 IT-----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS----CFQTDN 576
Q ++ LEYLHS GI+H D+KP N+L+ + +KI LG + F D+
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADD 166
Query: 577 LCLYVQ-SRSYRAPEVIIGL-PYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
C Q S +++ PE+ GL + K+D+WS G L + TG F D + + I
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI- 225
Query: 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFID 693
+G Y IP + D
Sbjct: 226 -----------GKG-----------------------SYAIPGDCG-------PPL--SD 242
Query: 694 FVRTLLEINPQRRPTAREALDHPWLQHPY 722
++ +LE P +R + R+ H W + +
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 76/330 (23%), Positives = 126/330 (38%), Gaps = 76/330 (23%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
+ LG A ++V +L T + +KII K + E+++L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ------GHRN 72
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVITRQ 529
+L L ++F + ++V E +R GG +F V+ +
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMR-------------GGSILSHIHKRRHFNELEASVVVQD 119
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-- 585
AL++LH+ GI H DLKPENIL + Q +KI D S + + C + +
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 586 -------YRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y APEV+ YD++ DLWSLG IL L +G F
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239
Query: 634 GMLGPIDLEML---MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 690
+ +G+ Y++ K++ +I+ L
Sbjct: 240 EACPACQNMLFESIQEGK--YEFPDKDWA--HISCAAKDL-------------------- 275
Query: 691 FIDFVRTLLEINPQRRPTAREALDHPWLQH 720
+ LL + ++R +A + L HPW+Q
Sbjct: 276 ----ISKLLVRDAKQRLSAAQVLQHPWVQG 301
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 69/321 (21%), Positives = 107/321 (33%), Gaps = 70/321 (21%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
RY + +GS F +D T V +K I+ + EI + +
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR----- 74
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT-- 527
H +I+R + HL I+ E SGGE Y + GR
Sbjct: 75 --HPNIVRFKEVILTPTHLAIIMEYA-------------SGGELYERICNAGRFSEDEAR 119
Query: 528 ---RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQ 582
+Q L + Y HS+ I H DLK EN L+ +KI D G S + V
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 583 SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+ +Y APEV++ YD + D+WS G L + G F D R +
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKT-------I 231
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
+ ++ + Y IP++ + + +
Sbjct: 232 QRILSVK-----------------------YSIPDDIRISPECC-------HLISRIFVA 261
Query: 702 NPQRRPTAREALDHPWLQHPY 722
+P R + E H W
Sbjct: 262 DPATRISIPEIKTHSWFLKNL 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 84/329 (25%), Positives = 123/329 (37%), Gaps = 70/329 (21%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKN 470
Y + E +GS A + V A V +K I +K D+ L EI+ + +
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-- 71
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ--VI 526
H +I+ Y F + L++V +LL ++ + K G L I
Sbjct: 72 -----HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
R+ LE LEYLH G IH D+K NIL+ ++I D G S F +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQIADFGVSAFLATGGDITRNKV-- 182
Query: 587 R----------APEVII-GLPYDQKIDLWSLGCILAELWTGE----VLFPNDAVVMILAR 631
R APEV+ YD K D+WS G EL TG P +++ L
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF 691
P LE +Q +E+ K + K F
Sbjct: 243 -----DPPSLETGVQDKEMLKKYGKS---------------------------------F 264
Query: 692 IDFVRTLLEINPQRRPTAREALDHPWLQH 720
+ L+ +P++RPTA E L H + Q
Sbjct: 265 RKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 81/327 (24%), Positives = 123/327 (37%), Gaps = 87/327 (26%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLV 467
G Y + E LG +F KV A T V LK I + +S EI LKL+
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFI--SRQLLKKSDMHMRVEREISYLKLL 66
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL 523
H HI++LYD + +V E +GGE + + R+
Sbjct: 67 R-------HPHIIKLYDVITTPTDIVMVIEY--------------AGGELFDYIVEKKRM 105
Query: 524 Q-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+Q + A+EY H I+H DLKPEN+L+ +KI D G S TD
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNF 163
Query: 579 LYVQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
L S +Y APEVI G Y ++D+WS G +L + G + F ++ + + ++
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--- 220
Query: 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 695
Y++P+ S A +
Sbjct: 221 ---------NSC-----------------------VYVMPDFLS-------PGA--QSLI 239
Query: 696 RTLLEINPQRRPTAREALDHPWLQHPY 722
R ++ +P +R T +E PW
Sbjct: 240 RRMIVADPMQRITIQEIRRDPWFNVNL 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 61/335 (18%), Positives = 116/335 (34%), Gaps = 67/335 (20%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK------------------NDKDFFD 455
Y + L F+K+ + LK + + K +D
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 456 QSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEF--QKFNQE 511
+E++++ + + + L + + ++I+ E + ++ +F F +
Sbjct: 89 DFKNELQIITDIK-------NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 512 SGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+ + ++ I + L + Y+H+ I H D+KP NIL+ +K+ D G S
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGES 199
Query: 571 CFQTDNL----CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDA 624
+ D + + PE K+D+WSLG L ++ V F
Sbjct: 200 EYMVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 625 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL 684
++ L I + N Y + + S +
Sbjct: 257 SLVELFNNI-----------RTKN------------IEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 685 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
S+ IDF++ L NP R T+ +AL H WL
Sbjct: 294 FLSNE-DIDFLKLFLRKNPAERITSEDALKHEWLA 327
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 48/253 (18%), Positives = 93/253 (36%), Gaps = 36/253 (14%)
Query: 398 FEENKDLPIILN----TVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIK 448
FE LP I + + YV LG AF++V++A D LK+ K
Sbjct: 45 FEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 449 NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA----NLYE 504
+ + +L+ + P+ +H ++ Y +V EL N
Sbjct: 105 PANPW-----EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAIN 159
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--- 561
K E G + + L +E +H IIH D+KP+N ++ + +
Sbjct: 160 LYKNTPEKV----MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 562 ------IKIIDLGSSCF-----QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ +IDLG S + ++ ++ E++ P++ +ID + + +
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
Query: 611 AELWTGEVLFPND 623
+ G + +
Sbjct: 276 YCMLFGTYMKVKN 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 74/316 (23%), Positives = 125/316 (39%), Gaps = 64/316 (20%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
+GS +V++ + TG + +K ++ +K+ + L ++ ++ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH----- 81
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
D +I++ + F +FI EL+ + +K Q E L +T ++A
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI-----LGKMTVAIVKA 136
Query: 534 LEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPE 590
L YL G+IH D+KP NIL+ R +IK+ D G S D+ +Y APE
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 591 VI-----IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
I YD + D+WSLG L EL TG+ FP +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FPYK----------NCKTDFE----- 237
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEES-SLEHHLQFSDAFFIDFVRTLLEINPQ 704
L ++ EE L H+ FS F FV+ L + +
Sbjct: 238 -----------------------VLTKVLQEEPPLLPGHMGFSGD-FQSFVKDCLTKDHR 273
Query: 705 RRPTAREALDHPWLQH 720
+RP + L+H +++
Sbjct: 274 KRPKYNKLLEHSFIKR 289
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 83/325 (25%), Positives = 130/325 (40%), Gaps = 82/325 (25%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
G Y + + LG F KV + TG V +KI+ K D + EI+ LKL
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR- 74
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H HI++LY +F+V E + SGGE + + GRL
Sbjct: 75 ------HPHIIKLYQVISTPSDIFMVMEYV-------------SGGELFDYICKNGRLDE 115
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +Q L ++Y H ++H DLKPEN+L+ ++ KI D G S +D L
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 173
Query: 581 VQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
S +Y APEVI G Y ++D+WS G IL L G + F +D V + +I G
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--G 231
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
+ P+ + I ++
Sbjct: 232 ---------------------------------IFYTPQYLN-------PSV--ISLLKH 249
Query: 698 LLEINPQRRPTAREALDHPWLQHPY 722
+L+++P +R T ++ +H W +
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDL 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 60/328 (18%), Positives = 111/328 (33%), Gaps = 84/328 (25%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ + D + EI + K++N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 63
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT 527
H ++++ Y + ++ E SGGE + + +
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPD 106
Query: 528 -----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----L 577
Q + + YLH +GI H D+KPEN+L+ +KI D G + N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLF--PNDAVVMILARIIG 634
+ Y APE++ + + +D+WS G +L + GE+ + P+D+
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 694
+ + ++
Sbjct: 225 ------------------------------------KTYLNPWKKIDSAPL-------AL 241
Query: 695 VRTLLEINPQRRPTAREALDHPWLQHPY 722
+ +L NP R T + W P
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPL 269
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKN 470
I Y + +G ++ +V A T + K I + D+ EI+++K +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL--- 63
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
D +I+RLY+ F +++V EL +GGE F
Sbjct: 64 ---DHPNIIRLYETFEDNTDIYLVMELC-------------TGGELFERVVHKRVFRESD 107
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCFQTDNLCLY- 580
I + L A+ Y H L + H DLKPEN L + +K+ID G + +
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 581 -VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
V + Y +P+V+ G Y + D WS G ++
Sbjct: 168 KVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
+R LL +P++R T+ +AL+H W +
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFE 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVN 468
+ Y V E LG AFS V + TG++ KII K E ++ + +
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D ++V +L+ +GGE +++
Sbjct: 64 -------HPNIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYS 103
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLC 578
+Q LE++ Y HS GI+H +LKPEN+L+ S + +K+ D G + D+
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 579 LY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +D+W+ G IL
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
+ ++L +NP++R TA +AL PW+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWIC 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 74/312 (23%), Positives = 122/312 (39%), Gaps = 65/312 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG A+ V + + + +G + +K I+ + + L ++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP-----F 67
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG---EAYFTLGRLQVITRQCLEAL 534
+ Y + ++I EL+ +L +F K + G E L I ++AL
Sbjct: 68 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI-----LGKIAVSIVKAL 122
Query: 535 EYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEV 591
E+LHS L +IH D+KP N+LI + ++K+ D G S + D++ + + Y APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 592 IIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
I Y K D+WSLG + EL FP D+ P
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR--FPYDS----------WGTPFQ------- 221
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
QL+ ++ E S +FS F+DF L+ N + RP
Sbjct: 222 ---------------------QLKQVVEEPSPQLPADKFSAE-FVDFTSQCLKKNSKERP 259
Query: 708 TAREALDHPWLQ 719
T E + HP+
Sbjct: 260 TYPELMQHPFFT 271
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
++ + V LG A S V++ + T LK++K D EI +L +
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRL---- 105
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRL 523
+I++L + F + +V EL+ +GGE Y++
Sbjct: 106 --SHPNIIKLKEIFETPTEISLVLELV-------------TGGELFDRIVEKGYYSERDA 150
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLCLY-- 580
+Q LEA+ YLH GI+H DLKPEN+L + +KI D G S + +
Sbjct: 151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APE++ G Y ++D+WS+G I
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 12/27 (44%), Positives = 19/27 (70%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
D VR L+ ++P++R T +AL HPW+
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---------NDKDFFDQSLDEIK 462
+ Y +++ LGS A +V A + T V +KII + D EI+
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 463 LLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------ 515
+LK +N H I+++ + F+ E +IV EL+ GGE
Sbjct: 68 ILKKLN-------HPCIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVV 106
Query: 516 --AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCF 572
++ Q L A++YLH GIIH DLKPEN+L+ S + C IKI D G S
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL---PYDQKIDLWSLGCIL 610
+ + + +Y APEV++ + Y++ +D WSLG IL
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 15/27 (55%), Positives = 19/27 (70%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
D V+ LL ++P+ R T EAL HPWLQ
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 79/328 (24%), Positives = 135/328 (41%), Gaps = 95/328 (28%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y E +G A V+ A D+ TG +V ++ + + + ++EI +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR-------- 72
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQ 524
+ + I+ D + + L++V E L +GG E G++
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIA 119
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ R+CL+ALE+LHS +IH D+K +NIL+ +K+ D G C Q +
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFG-FCAQITP------EQ 170
Query: 585 SYR----------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
S R APEV+ Y K+D+WSLG + E+ GE P
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---P------------- 214
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFI 692
P Y+NE + Y+I L++ + S F
Sbjct: 215 ---P-----------------------YLNENPLRALYLIATNGTPELQNPEKLSAI-FR 247
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQH 720
DF+ LE++ ++R +A+E L H +L+
Sbjct: 248 DFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 70/328 (21%), Positives = 123/328 (37%), Gaps = 95/328 (28%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
+G + V A++ H+G V +K++ + + +E+ +++
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR-------- 97
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQ 524
D H ++ +Y + E L+++ E L GG + ++
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFL-------------QGGALTDIVSQVRLNEEQIA 144
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ L+AL YLH+ G+IH D+K ++IL+ +K+ D G C Q
Sbjct: 145 TVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFG-FCAQISK------DV 195
Query: 585 SYR----------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
R APEVI Y ++D+WSLG ++ E+ GE P
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE---P------------- 239
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFI 692
P Y ++ Q + + L++ + S
Sbjct: 240 ---P-----------------------YFSDSPVQAMKRLRDSPPPKLKNSHKVSPV-LR 272
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQH 720
DF+ +L +PQ R TA+E LDHP+L
Sbjct: 273 DFLERMLVRDPQERATAQELLDHPFLLQ 300
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 79/329 (24%), Positives = 121/329 (36%), Gaps = 95/329 (28%)
Query: 409 NTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLV 467
I Y VT + LG KV Q + T LK++++ E++L
Sbjct: 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRA 67
Query: 468 NKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
++ HI+R+ D + + L IV E L GGE
Sbjct: 68 SQ------CPHIVRIVDVYENLYAGRKCLLIVMECL-------------DGGELFSRIQD 108
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSC 571
FT I + EA++YLHS+ I H D+KPEN+L S + +K+ D G
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--- 165
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631
A E G YD+ D+WSLG I+ L G F ++ + I
Sbjct: 166 ---------------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 209
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF 691
+ + GQ Y++ E+ ++EE L
Sbjct: 210 M--------KTRIRMGQ--YEFPNPEWS--EVSEEVKML--------------------- 236
Query: 692 IDFVRTLLEINPQRRPTAREALDHPWLQH 720
+R LL+ P +R T E ++HPW+
Sbjct: 237 ---IRNLLKTEPTQRMTITEFMNHPWIMQ 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 66/374 (17%), Positives = 117/374 (31%), Gaps = 119/374 (31%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
+ + +G F VF+A++ + +K I+ N + ++ + E+K L +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 474 DEHH---------------------------------------------------ILRLY 482
+ +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 483 DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+L+I +L + NL ++ G I Q EA+E+LHS G
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMN---RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLG---------------SSCFQTDNLCLYVQSRSY 586
++H DLKP NI +K+ D G + V ++ Y
Sbjct: 185 LMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
+PE I G Y K+D++SLG IL EL F M RI + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQ---MERVRI--------ITDVRN 288
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+ F + Y P+E + V+ +L +P R
Sbjct: 289 LK-----FPLLFTQKY------------PQEHMM--------------VQDMLSPSPTER 317
Query: 707 PTAREALDHPWLQH 720
P A + +++ ++
Sbjct: 318 PEATDIIENAIFEN 331
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--- 447
H R A RY + LG +F +V + +D T + +K+I
Sbjct: 7 HSSGRENLYFQGT--------FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQ 506
L E++LLK ++ H +I++L++ +IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-------HPNIMKLFEILEDSSSFYIVGELY-------- 103
Query: 507 KFNQESGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
+GGE F+ I +Q + Y+H I+H DLKPENIL++S +
Sbjct: 104 -----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 559 R-CEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ C+IKIID G S N + + + Y APEV+ G YD+K D+WS G IL
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 7e-07
Identities = 12/28 (42%), Positives = 18/28 (64%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQH 720
D +R +L +P R TA + L+HPW+Q
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 63/319 (19%), Positives = 111/319 (34%), Gaps = 36/319 (11%)
Query: 423 GSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HI 478
G V A+ TG V ++ I + E+ + KL N H +I
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-------HPNI 88
Query: 479 LRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
+ F L++V + + + + G + I + L+AL+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---------- 587
H +G +H +K +ILI ++ + L S+ + +
Sbjct: 145 HHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 588 APEVI--IGLPYDQKIDLWSLGCILAELWTGEV----LFPNDAVVMILARIIGMLGPIDL 641
+PEV+ YD K D++S+G EL G V + ++ L + L
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
+ L + T+ + S +H FS F FV L+
Sbjct: 263 IPAEELTMSPSRSVANSGLSD-SLTTSTPRPSNGDSPSHPYHRTFSPH-FHHFVEQCLQR 320
Query: 702 NPQRRPTAREALDHPWLQH 720
NP RP+A L+H + +
Sbjct: 321 NPDARPSASTLLNHSFFKQ 339
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVN 468
+ Y V E LG AFS V + TG++ KII K F + E ++ + +
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D ++V +L+ +GGE +++
Sbjct: 87 -------HPNIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYS 126
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLC 578
+Q LE++ Y HS GI+H +LKPEN+L+ S + +K+ D G + D+
Sbjct: 127 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
Query: 579 LY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +D+W+ G IL
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
+ ++L +NP++R TA +AL PW+
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWIC 289
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 60/328 (18%), Positives = 111/328 (33%), Gaps = 84/328 (25%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ + D + EI + K++N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 63
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT 527
H ++++ Y + ++ E SGGE + + +
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPD 106
Query: 528 -----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----L 577
Q + + YLH +GI H D+KPEN+L+ +KI D G + N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLF--PNDAVVMILARIIG 634
+ Y APE++ + + +D+WS G +L + GE+ + P+D+
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 694
+ + ++
Sbjct: 225 ------------------------------------KTYLNPWKKIDSAPL-------AL 241
Query: 695 VRTLLEINPQRRPTAREALDHPWLQHPY 722
+ +L NP R T + W P
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPL 269
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 62/349 (17%), Positives = 122/349 (34%), Gaps = 107/349 (30%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-------------------------- 447
+Y + + +G ++ V A + + +K++
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 448 -KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLE--HLFIVCELLRANLY 503
+ +Q EI +LK ++ H ++++L + HL++V EL+
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLD-------HPNVVKLVEVLDDPNEDHLYMVFELV----- 120
Query: 504 EFQKFNQESGGE--AYFTLGRLQVIT-----RQCLEALEYLHSLGIIHCDLKPENILIKS 556
+ G TL L + ++ +EYLH IIH D+KP N+L+
Sbjct: 121 --------NQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172
Query: 557 YQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVIIGL--PYD-QKIDLWSLGCIL 610
IKI D G S + L V + ++ APE + + + +D+W++G L
Sbjct: 173 DGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 611 AELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQL 670
G+ F ++ ++ + ++I
Sbjct: 231 YCFVFGQCPFMDERIMCLHSKI------------KSQ----------------------- 255
Query: 671 EYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719
P++ + L+ D + +L+ NP+ R E HPW+
Sbjct: 256 ALEFPDQPDIAEDLK-------DLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 63/313 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIK-LLKLVNKNDPADEH 476
+G A+ V + +G + +K I+ D+ Q L ++ +++ D
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS------DCP 81
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I++ Y + +I EL+ + +F K+ + L IT ++AL +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV-IPEEILGKITLATVKALNH 140
Query: 537 LHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVI- 592
L L IIH D+KP NIL+ IK+ D G S D++ R Y APE I
Sbjct: 141 LKENLKIIHRDIKPSNILLDR--SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 593 ---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
YD + D+WSLG L EL TG FP D
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR--FPYPK----------WNSVFD--------- 237
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEES---SLEHHLQFSDAFFIDFVRTLLEINPQRR 706
QL ++ + S +FS + FI+FV L + +R
Sbjct: 238 -------------------QLTQVVKGDPPQLSNSEEREFSPS-FINFVNLCLTKDESKR 277
Query: 707 PTAREALDHPWLQ 719
P +E L HP++
Sbjct: 278 PKYKELLKHPFIL 290
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 59/226 (26%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----------NDKDFFDQSLDEI 461
Y E LG S V + T + +KII ++ + +L E+
Sbjct: 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 462 KLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE----- 515
+L+ V H +I++L D + F+V +L+ GE
Sbjct: 75 DILRKV------SGHPNIIQLKDTYETNTFFFLVFDLM-------------KKGELFDYL 115
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
+ + I R LE + LH L I+H DLKPENIL+ IK+ D G SC
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQ 173
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL------PYDQKIDLWSLGCIL 610
L + SY APE+I Y +++D+WS G I+
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 14/28 (50%), Positives = 17/28 (60%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQH 720
D V L + PQ+R TA EAL HP+ Q
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 41/224 (18%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIK 462
+ + Y + E +G FS V + + TG +KI+ K L E
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 463 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
+ ++ HI+ L + + L++V E + G +
Sbjct: 79 ICHML------KHPHIVELLETYSSDGMLYMVFEFM-------------DGADLCFEIVK 119
Query: 516 -----AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGS 569
++ RQ LEAL Y H IIH D+KP +L+ S + +K+ G
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 570 SCFQTDNLCLY---VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ ++ + V + + APEV+ PY + +D+W G IL
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 14/27 (51%), Positives = 19/27 (70%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
D VR +L ++P R T EAL+HPWL+
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ +Y + E LG F V + + + K +K EI +L +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--- 59
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLG 521
H +IL L++ F +E L ++ E + SG +
Sbjct: 60 ----HRNILHLHESFESMEELVMIFEFI-------------SGLDIFERINTSAFELNER 102
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
+ Q EAL++LHS I H D++PENI+ ++ + IKII+ G + +
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 582 Q--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APEV D+WSLG ++
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 15/29 (51%), Positives = 17/29 (58%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQHP 721
DFV LL + R TA EAL HPWL+
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 73/313 (23%), Positives = 130/313 (41%), Gaps = 63/313 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ V E LG ++ V++A TG V +K + + D + + EI +++ D
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQ------QCD 82
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H+++ Y ++ L+IV E A ++ + + ++ E + I + L+
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKG 137
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAPE 590
LEYLH + IH D+K NIL+ + K+ D G + TD + + + + APE
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
VI + Y+ D+WSLG E+ G+ P P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK---P----------------P------------ 224
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
Y + + ++IP + +SD F DFV+ L +P++R T
Sbjct: 225 -----------YADIHPMRAIFMIPTNPPPTFRKPELWSDN-FTDFVKQCLVKSPEQRAT 272
Query: 709 AREALDHPWLQHP 721
A + L HP+++
Sbjct: 273 ATQLLQHPFVRSA 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVN 468
Y + E LG AFS V + + G + II K E ++ +L+
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D H +++ +L+ +GGE Y++
Sbjct: 69 -------HPNIVRLHDSISEEGHHYLIFDLV-------------TGGELFEDIVAREYYS 108
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNL 577
+Q LEA+ + H +G++H +LKPEN+L+ S + +K+ D G + + +
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 578 CLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +DLW+ G IL
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 15/28 (53%), Positives = 19/28 (67%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQH 720
D + +L INP +R TA EAL HPW+ H
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISH 273
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLLKLV 467
Y + E LGS F+ V + ++ TG++ K IK + + E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +++ L+D + + + ++ EL+ SGGE
Sbjct: 73 L-------HHNVITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESL 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
+ +Q L+ + YLH+ I H DLKPENI++ K+ IK+ID G + D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + + APE++ P + D+WS+G I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 13/27 (48%), Positives = 18/27 (66%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
DF+R LL ++R T +EAL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWIT 277
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLLKLV 467
Y + E LGS F+ V + + TG + K IK + + E+ +L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +I+ L+D F + + ++ EL+ SGGE
Sbjct: 66 R-------HPNIITLHDIFENKTDVVLILELV-------------SGGELFDFLAEKESL 105
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
T +Q L+ + YLHS I H DLKPENI++ K+ IK+ID G +
Sbjct: 106 TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P + D+WS+G I
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 7e-07
Identities = 12/27 (44%), Positives = 20/27 (74%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
DF+R LL +P+RR T ++L+H W++
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-31
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 39/215 (18%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ Y + E LG+ AF V + + TG + K + +DK+ + EI+ + ++
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVL 211
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AY 517
H ++ L+D F + ++ E + SGGE
Sbjct: 212 R-------HPTLVNLHDAFEDDNEMVMIYEFM-------------SGGELFEKVADEHNK 251
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTD 575
+ RQ + L ++H +H DLKPENI+ + + E+K+ID G +
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 576 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
++ + + + APEV G P D+WS+G +
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 16/47 (34%), Positives = 21/47 (44%), Gaps = 7/47 (14%)
Query: 680 LEHHLQFSDAFF-------IDFVRTLLEINPQRRPTAREALDHPWLQ 719
D+ F DF+R LL +P R T +AL+HPWL
Sbjct: 369 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 45/224 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIK 462
+Y + +G S V + TG + +KI++ + + + E
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 463 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
+L+ V A HI+ L D + +F+V +L+ GE
Sbjct: 152 ILRQV-----AGHPHIITLIDSYESSSFMFLVFDLM-------------RKGELFDYLTE 193
Query: 516 -AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
+ + I R LEA+ +LH+ I+H DLKPENIL+ +I++ D G SC
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--NMQIRLSDFGFSCHLE 251
Query: 575 DNLCLY--VQSRSYRAPEVIIGL------PYDQKIDLWSLGCIL 610
L + Y APE++ Y +++DLW+ G IL
Sbjct: 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 11/27 (40%), Positives = 19/27 (70%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
D + LL+++P+ R TA +AL HP+ +
Sbjct: 338 DLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLL 464
+ Y E LGS F+ V + ++ TG+ K IK + + E+ +L
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------A 516
K + +++ L++ + + + ++ EL+ +GGE
Sbjct: 69 KEI------QHPNVITLHEVYENKTDVILILELV-------------AGGELFDFLAEKE 109
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQT 574
T +Q L + YLHSL I H DLKPENI++ ++ + IKIID G +
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 575 DNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P + D+WS+G I
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 12/27 (44%), Positives = 21/27 (77%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
DF+R LL +P++R T +++L HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKNDPA 473
Y + E LGS AF V + + TG K I ++ +EI ++ ++
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH----- 106
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLGRL 523
H ++ L+D F + ++ E L SGGE + +
Sbjct: 107 --HPKLINLHDAFEDKYEMVLILEFL-------------SGGELFDRIAAEDYKMSEAEV 151
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ- 582
RQ E L+++H I+H D+KPENI+ ++ + +KIID G + + + V
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 583 -SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P D+W++G +
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 13/28 (46%), Positives = 21/28 (75%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQH 720
DF++ LL+ P++R T +AL+HPWL+
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKG 310
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-------NDKDFFDQSLDEIKLLKLV 467
Y + E LGS F+ V + ++ TG++ K IK ++ E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +I+ L+D + + + ++ EL+ SGGE
Sbjct: 73 L-------HPNIITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESL 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
+ +Q L+ + YLH+ I H DLKPENI++ K+ IK+ID G + D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + + APE++ P + D+WS+G I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 13/27 (48%), Positives = 18/27 (66%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
DF+R LL ++R T +EAL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWIT 277
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 65/316 (20%), Positives = 120/316 (37%), Gaps = 67/316 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKN 470
+ +G +F V+ A+D+ V +K + K + + + E++ L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ----- 109
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ ++ + ++V E + + + +++ E + +T
Sbjct: 110 -KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGA 163
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 590
L+ L YLHS +IH D+K NIL+ + +K+ D GS+ +V + + APE
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSAS-IMAPANSFVGTPYWMAPE 220
Query: 591 VIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
VI+ + YD K+D+WSLG EL + P P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK---P----------------P--------- 252
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQR 705
N Y I + +L+ +S+ F +FV + L+ PQ
Sbjct: 253 --------------LFNMNAMSALYHIAQNESPALQSG-HWSEY-FRNFVDSCLQKIPQD 296
Query: 706 RPTAREALDHPWLQHP 721
RPT+ L H ++
Sbjct: 297 RPTSEVLLKHRFVLRE 312
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 41/241 (17%)
Query: 391 HRKNRTGFEENKDLPIILNTV--IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKII 447
H + + + + ++ Y +T + LG F+ V Q TG + K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 448 KNDKDFFDQSLD---EIKLLKLVNKNDPADEHH--ILRLYDYFYHLEHLFIVCELLRANL 502
K + D + EI +L+L ++ L++ + + + ++ E
Sbjct: 63 KKRRRGQDCRAEILHEIAVLELAK-------SCPRVINLHEVYENTSEIILILEYA---- 111
Query: 503 YEFQKFNQESGGE----------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552
+GGE + + + +Q LE + YLH I+H DLKP+NI
Sbjct: 112 ---------AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 553 LIKS-YQRCEIKIIDLGSSCFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCI 609
L+ S Y +IKI+D G S L + Y APE++ P D+W++G I
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 610 L 610
Sbjct: 223 A 223
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 15/27 (55%), Positives = 20/27 (74%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
DF+++LL NP++RPTA L H WLQ
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQ 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 39/208 (18%)
Query: 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPAD 474
TE LG F +V + ++ TG+ + KIIK DK+ +EI ++ ++
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV---KNEISVMNQLD------ 144
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLGRLQ 524
H ++++LYD F + +V E + GGE T
Sbjct: 145 -HANLIQLYDAFESKNDIVLVMEYV-------------DGGELFDRIIDESYNLTELDTI 190
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ-- 582
+ +Q E + ++H + I+H DLKPENIL + +IKIID G + L V
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APEV+ D+WS+G I
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 12/27 (44%), Positives = 15/27 (55%)
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQ 719
+F+ LL R +A EAL HPWL
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLS 347
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
V E +G AF V +A+ DV +K I+++ + + E++ L VN H
Sbjct: 12 VEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER-KAFIVELRQLSRVN-------HP 61
Query: 477 HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+I++LY L + +V E +LY + Y+T QC + +
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLY---NVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 536 YLHSL---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
YLHS+ +IH DLKP N+L+ + +KI D G++C ++ S ++ APEV
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV-LKICDFGTACDIQTHMTNNKGSAAWMAPEVF 175
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
G Y +K D++S G IL E+ T F
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 34/223 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
E LG F + + TG + +K + D++ L E+K+++ + H +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-------HPN 68
Query: 478 ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+L+ Y + L + E + L K ++ + + + + Y
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAY 123
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--------- 587
LHS+ IIH DL N L++ + + D G + D RS +
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNV--VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 588 --------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
APE+I G YD+K+D++S G +L E+ P+
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKN 470
+ E +G +F +VF+ D T V +KII + +D + EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC--- 77
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVI 526
D ++ + Y + L+I+ E L +L E + E + I
Sbjct: 78 ---DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-----ETQ-----IATI 124
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
R+ L+ L+YLHS IH D+K N+L+ E+K+ D G + TD
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQ-------IK 175
Query: 587 R----------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
R APEVI YD K D+WSLG EL GE
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 12/36 (33%), Positives = 17/36 (47%), Gaps = 1/36 (2%)
Query: 685 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
+S +FV L P RPTA+E L H ++
Sbjct: 242 NYSKPL-KEFVEACLNKEPSFRPTAKELLKHKFILR 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 52/237 (21%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKN--DKDFFDQSLDEIKLLKL 466
++AG+Y V + ++ A D + G V LK + + D + ++ E + L
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE 135
Query: 467 VNKNDPADEH-HILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTL 520
V H I++++++ H + +IV E + GG+ +L
Sbjct: 136 VV-------HPSIVQIFNFVEHTDRHGDPVGYIVMEYV--------------GGQ---SL 171
Query: 521 -----GRLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-- 568
+L V + L AL YLHS+G+++ DLKPENI++ Q +K+IDLG
Sbjct: 172 KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ---LKLIDLGAV 228
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625
S L + ++APE++ P D++++G LA L V
Sbjct: 229 SRINSFGYL---YGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRNGRYV 281
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 42/222 (18%), Positives = 78/222 (35%), Gaps = 31/222 (13%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD--------EIKLLKLVNK 469
+ +G F V + + + V +K + + + E+ ++ +N
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I++LY +V E + +LY +
Sbjct: 82 ------HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLRLM 128
Query: 528 RQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE---IKIIDLGSSCFQTDNLCLYVQ 582
+EY+ + I+H DL+ NI ++S K+ D G S ++ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 583 SRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPN 622
+ + APE I Y +K D +S IL + TGE F
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEH 476
E +G+ +F V +A+ G DV +KI+ + ++ L E+ ++K + H
Sbjct: 43 EKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-------H 93
Query: 477 -HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ +L IV E L R +LY + +SG R + + +
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLY---RLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 535 EYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR-SYR--AP 589
YLH+ I+H +LK N+L+ K+ D G S + + + AP
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTV--KVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
EV+ P ++K D++S G IL EL T + + N
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 56/243 (23%), Positives = 89/243 (36%), Gaps = 53/243 (21%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDF---FDQSLDEIKLLKL 466
G Y + +G V++A+D V LK++ +D F + L
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-- 91
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLG 521
E H++ ++D+ L++ L L A L G
Sbjct: 92 -------QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ---------------G 129
Query: 522 RLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------S 569
L I RQ AL+ H+ G H D+KPENIL+ + ++D G
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDE 187
Query: 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMIL 629
Q N V + Y APE + D+++L C+L E TG + D + ++
Sbjct: 188 KLTQLGNT---VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244
Query: 630 ARI 632
A I
Sbjct: 245 AHI 247
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ D ++ EI +LK
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK-----KY 77
Query: 473 ADEHHILRLYDYFYHL------EHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGR 522
+ +I Y F + L++V E A +L + K N E +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEW----- 130
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--- 579
+ I R+ L L +LH +IH D+K +N+L+ + E+K++D G S +
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 580 YVQSRSYRAPEVI-----IGLPYDQKIDLWSLGCILAELWTGE 617
++ + + APEVI YD K DLWSLG E+ G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 9/36 (25%), Positives = 19/36 (52%), Gaps = 1/36 (2%)
Query: 685 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
++S F F+ + L N +RP + + HP+++
Sbjct: 258 KWSKKF-QSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 59/223 (26%), Positives = 82/223 (36%), Gaps = 39/223 (17%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----FFDQSLDEIKLLKLVNKNDPAD 474
E +G F KV++A G +V +K ++D D + E KL ++
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK------ 64
Query: 475 EH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
H +I+ L +L +V E L + L Q
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-------IPPDILVNWAVQIAR 116
Query: 533 ALEYLHSLG---IIHCDLKPENILI------KSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
+ YLH IIH DLK NILI +KI D G + S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMS 173
Query: 584 R--SYR--APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
+Y APEVI + + D+WS G +L EL TGEV F
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 76/329 (23%), Positives = 131/329 (39%), Gaps = 84/329 (25%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKND 471
+ + LG AF KV++A++ TG K+I+ ++ + + EI++L +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--- 74
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H +I++L +YH L+I+ E + E +QV+ RQ
Sbjct: 75 ----HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQ 125
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
LEAL +LHS IIH DLK N+L+ +I++ D G S + R
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLADFGVSAKNLK-------TLQKRDS 176
Query: 588 --------APEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
APEV++ PYD K A++W+
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYK----------ADIWS------------------- 207
Query: 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFI 692
LG +EM + + + ++ I + +L ++S F
Sbjct: 208 -LGITLIEMA------------QIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF-R 253
Query: 693 DFVRTLLEINPQRRPTAREALDHPWLQHP 721
DF++ L+ NP+ RP+A + L+HP++
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 44/215 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +FS V A++L T + +KI++ ++ E ++ ++ H
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--------H 89
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC----- 530
++LY F E L+ GE + ++ C
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYA-------------KNGELLKYIRKIGSFDETCTRFYT 136
Query: 531 ---LEALEYLHSLGIIHCDLKPENILIKSYQRCEI------KIIDLGSSCFQTDNLCLYV 581
+ ALEYLH GIIH DLKPENIL+ +I K++ S + ++
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Q Y +PE++ + DLW+LGCI+ +L G
Sbjct: 197 Q---YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 55/236 (23%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL- 464
+I RY + + LG S V+ A+D + V +K I ++ + E+
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 519
+L + +I+ + D + ++V E L + +
Sbjct: 67 QL---SHQ----NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----------HGPLS 109
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------SSCF 572
+ T Q L+ +++ H + I+H D+KP+NILI S + +KI D G +S
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLT 167
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
QT+++ + + Y +PE G D+ D++S+G +L E+ GE F + V I
Sbjct: 168 QTNHV---LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 49/241 (20%), Positives = 91/241 (37%), Gaps = 46/241 (19%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVNKNDPADEH 476
E +G F +V+ + H +V +++I ++D DQ E+ +
Sbjct: 39 ELIGKGRFGQVYHGR-WHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT--------R 87
Query: 477 H--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H ++ HL I+ L LY + + + + + I ++ ++
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-----DAKIVLDVNKTRQIAQEIVKG 142
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR--------S 585
+ YLH+ GI+H DLK +N+ + + + I D G + +
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 586 YRAPEVI---------IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
+ APE+I LP+ + D+++LG I EL E F II +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT----QPAEAIIWQM 255
Query: 637 G 637
G
Sbjct: 256 G 256
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEH 476
+ +GS +F V++ H DV +K++ +E+ +L+
Sbjct: 30 QRIGSGSFGTVYKG-KWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT--------R 78
Query: 477 H--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H IL Y L IV + ++LY E F + +L I RQ
Sbjct: 79 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH-----ASETKFEMKKLIDIARQTARG 132
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRA 588
++YLH+ IIH DLK NI + KI D G + ++ + + + A
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 589 PEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPN 622
PEVI PY + D+++ G +L EL TG++ + N
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 72/261 (27%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDF---FDQ----- 456
+ ++ RY + E LG S+V A+DL DV +K+++ D F F +
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 457 -SLDEIKLLKLVNKNDPADEHHILRLYDY----FYHLEHLFIVCEL-----LRANLYEFQ 506
+L N P I+ +YD +IV E LR ++
Sbjct: 67 AAL-----------NHP----AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE- 110
Query: 507 KFNQESGGEAYFTLGRLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561
G + + +AL + H GIIH D+KP NI+I +
Sbjct: 111 --------------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-- 154
Query: 562 IKIIDLG---------SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAE 612
+K++D G +S QT + + + Y +PE G D + D++SLGC+L E
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAV---IGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 613 LWTGEVLFPND-AVVMILARI 632
+ TGE F D V + +
Sbjct: 212 VLTGEPPFTGDSPVSVAYQHV 232
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 28/223 (12%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
N V+ Y V +G +F +F+ +L V +K D Q DE + KL+
Sbjct: 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLA 63
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I +Y + H +V +LL +L + F++ + + +
Sbjct: 64 GC-----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAK 113
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q L ++ +H +++ D+KP+N LI S I ++D G F D + Q
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--KQHIP 171
Query: 586 YRAPEVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
YR + + G L +Q + DL +LG + G
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 2e-21
Identities = 46/220 (20%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ ++ + +GS +F +++ ++ T +V +K+ Q L E K+ +++
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQG- 61
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYE-FQKFNQESGGEAYFTLGRLQVITRQ 529
I + + ++ +V +LL +L + F +++ +L + ++ Q
Sbjct: 62 ----GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK------LSLKTVLMLADQ 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
+ +E++HS +H D+KP+N L+ +R ++ IID G + D Q YR
Sbjct: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYRE 169
Query: 589 PEVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
+ + G L +Q + DL SLG +L G
Sbjct: 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 47/234 (20%), Positives = 87/234 (37%), Gaps = 50/234 (21%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
++ + V + +G F ++ ++L+T V +K+ Q E + K +
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLG 62
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I ++Y + ++ +V ELL +L + + F+L + +I
Sbjct: 63 SG-----DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT-----FSLKTVLMIAI 112
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q + +EY+HS +I+ D+KPEN LI + + I IID ++
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL-------------AKE 159
Query: 586 YRAPEVIIGLPYDQKI-----------------------DLWSLGCILAELWTG 616
Y PE +PY + DL +LG + G
Sbjct: 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 57/236 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + +G +KI+ + +L+E ++L+ VN
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--------F 100
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
+++L F +L++V E + +GGE + L R+ +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYV-------------AGGEMFSHLRRIGRFSEPHARFYA 147
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q + EYLHSL +I+ DLKPEN+LI Y I++ D G V+ R+
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY----IQVTDFG--------FAKRVKGRT 195
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
APE+I+ Y++ +D W+LG ++ E+ G F D + I +I+
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 32/226 (14%), Positives = 62/226 (27%), Gaps = 45/226 (19%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLK 465
+ GRY + + G + +QA D V L + D ++L L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQ 524
++ P + R+ D + +V E +R +L E ++ +
Sbjct: 87 RID--KP----GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIR--- 133
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ A + H G+ P + + + +
Sbjct: 134 -AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA---------------- 174
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630
+ + D+ +G L L P V LA
Sbjct: 175 -TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 26/219 (11%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ RY + +GS +F ++ D+ G +V +K+ Q E K+ K++
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGG 64
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
I + ++ +V ELL +L + F F+L + ++ Q
Sbjct: 65 -----VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQM 114
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
+ +EY+HS IH D+KP+N L+ ++ + IID G + D Q YR
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIPYREN 172
Query: 590 EVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
+ + G L +Q + DL SLG +L G
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 38/219 (17%), Positives = 72/219 (32%), Gaps = 33/219 (15%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVNKNDPAD 474
L ++++ G D+ +K++K +S D E L++ +
Sbjct: 14 FLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS------ 65
Query: 475 EH-HILRLYDYFYH--LEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H ++L + H ++ + +LY G +
Sbjct: 66 -HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH----EGTNFVVDQSQAVKFALDM 120
Query: 531 LEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
+ +LH+L I L +++I +I +Y +
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA--RISMADVKFSFQSPGRMY----APAW 174
Query: 588 -APEVIIGLPYD---QKIDLWSLGCILAELWTGEVLFPN 622
APE + P D + D+WS +L EL T EV F +
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 42/310 (13%), Positives = 88/310 (28%), Gaps = 65/310 (20%)
Query: 392 RKNRTGFEENKDLP--IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN 449
+ ++ P +L+ + ++ + + +GS F ++ A + ++K
Sbjct: 13 LGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV 72
Query: 450 DKDFFDQSLDEIKLLKLVNKNDPADEHH---------ILRLYDYFYHL----EHLFIVCE 496
+ E+K + V K D + I Y + F+V E
Sbjct: 73 EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME 132
Query: 497 LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556
L +L + N F + + + L+ LEY+H +H D+K N+L+
Sbjct: 133 RLGIDLQKISGQNGT------FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186
Query: 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKI--------------- 601
++ + D G S Y + +
Sbjct: 187 KNPDQVYLADYGL-------------SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK 233
Query: 602 --------DLWSLGCILAEL------WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
D+ LG + W + P + + +
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGS 293
Query: 648 --QEIYKYFT 655
EI ++
Sbjct: 294 SCCEIAQFLV 303
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 57/219 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + H G +K++K + + + DE +L +V H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--------H 65
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV----ITR--- 528
I+R++ F + +F++ + + GGE + L + Q + +
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYI-------------EGGELFSLLRKSQRFPNPVAKFYA 112
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
+ ALEYLHS II+ DLKPENIL+ + IKI D G YV +
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGH----IKITDFG--------FAKYVPDVT 160
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y APEV+ PY++ ID WS G ++ E+ G
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 49/228 (21%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
E +G + +V++ G +V +KI ++K +F ++ E+ ++ H
Sbjct: 14 ECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRET--ELYNTVMLR-------HE 62
Query: 477 HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+IL + L+++ +LY++ + I
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIA 115
Query: 532 EALEYLHSL--------GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
L +LH I H DLK +NIL+K +C I DLG + + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC--CIADLGLAVMHSQSTNQLDVG 173
Query: 584 RS-------YRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEV 618
+ Y APEV+ +++D+W+ G +L E+ V
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 7e-19
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG K ++ + +L+E ++L+ VN
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--------S 243
Query: 478 --ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
++ L + + L +V L+ +L KF+ G+A F R + L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRA 588
E LH I++ DLKPENIL+ + I+I DLG + + + Y A
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEG----QTIKGRVGTVGYMA 353
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
PEV+ Y D W+LGC+L E+ G+ F
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-18
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G F +V+ + TG +K + K +L+E +L LV+ D
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-----C 251
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
I+ + F+ + L + +L+ +GG+ ++ L + V +
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLM-------------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQS 583
+ + LE++H+ +++ DLKP NIL+ + ++I DLG +C +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHG- 355
Query: 584 RSYRAPEVII-GLPYDQKIDLWSLGCILAELWTG 616
Y APEV+ G+ YD D +SLGC+L +L G
Sbjct: 356 --YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 62/321 (19%), Positives = 107/321 (33%), Gaps = 88/321 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F KV Q T +K + ++ E+++++ + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--------H 74
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
++ L+ F E +F+V +LL GG+ + L +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLL-------------LGGDLRYHLQQNVHFKEETVKLFI 121
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
+ + AL+YL + IIH D+KP+NIL+ + I D + + + +
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDE--HGHVHITDFNIAAMLPRETQIT--TMAGT 177
Query: 586 --YRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
Y APE+ G Y +D WSLG EL G P
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG-------------------RRPYH 218
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
+ +EI F P S E + ++ LLE
Sbjct: 219 IRSSTSSKEIVHTFETT-------------VVTYPSAWSQE---------MVSLLKKLLE 256
Query: 701 INPQRR-PTAREALDHPWLQH 720
NP +R + + P++
Sbjct: 257 PNPDQRFSQLSDVQNFPYMND 277
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 49/224 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +++KV + T +K++K + + D E + + + H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 69
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
++ L+ F LF V E + +GG+ + +
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYS 116
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLCLYVQSRS 585
+ AL YLH GII+ DLK +N+L+ S E IK+ D G + L + +
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDS----EGHIKLTDYGMC---KEGLRPGDTTST 169
Query: 586 ------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE++ G Y +D W+LG ++ E+ G F
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 49/245 (20%), Positives = 89/245 (36%), Gaps = 45/245 (18%)
Query: 403 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK 462
LP+++ IA + + + +G + +V+ + G V +K+ ++ EI
Sbjct: 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWFRETEIY 83
Query: 463 LLKLVNKNDPADEH-HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEA 516
L+ H +IL L+++ + +LY++ K
Sbjct: 84 QTVLMR-------HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT------ 130
Query: 517 YFTLGRLQVITRQCLEALEYLHSL--------GIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + + L +LH+ I H DLK +NIL+K C I DLG
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC--CIADLG 187
Query: 569 SSC-FQTDNLCLYVQSRS------YRAPEVIIG------LPYDQKIDLWSLGCILAELWT 615
+ F +D + + + Y PEV+ D++S G IL E+
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
Query: 616 GEVLF 620
V
Sbjct: 248 RCVSG 252
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 60/229 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI++ + KD ++ E ++L+ H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--------H 64
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
+ L F + L V E +GGE +F L R +V T
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFTEERARFYG 111
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC---LYVQ 582
+ + ALEYLHS +++ D+K EN+++ + IKI D G LC +
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDK----DGHIKITDFG--------LCKEGISDG 159
Query: 583 SRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 47/242 (19%), Positives = 91/242 (37%), Gaps = 49/242 (20%)
Query: 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEI 461
LP+++ IA + E +G F +V++ + G +V +KI ++ +F ++ EI
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREA--EI 87
Query: 462 KLLKLVNKNDPADEH-HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGE 515
++ H +IL L++V + +L+++
Sbjct: 88 YQTVMLR-------HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----- 135
Query: 516 AYFTLGRLQVITRQCLEALEYLHS--------LGIIHCDLKPENILIKSYQRCEIKIIDL 567
T+ + + L +LH I H DLK +NIL+K C I DL
Sbjct: 136 --VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC--CIADL 191
Query: 568 GSSCFQTDNLCLYVQSRS-------YRAPEVIIG------LPYDQKIDLWSLGCILAELW 614
G + + + Y APEV+ ++ D++++G + E+
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
Query: 615 TG 616
Sbjct: 252 RR 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 6e-18
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +VF Q TG K + + + ++ E K+L V+
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--------S 244
Query: 478 --ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ L F L +V ++ Y ++++ G F R T Q +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG---FQEPRAIFYTAQIVSG 301
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YR 587
LE+LH II+ DLKPEN+L+ ++I DLG + + +++ +
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAV---ELKAGQTKTKGYAGTPGFM 356
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
APE+++G YD +D ++LG L E+ F
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 55/227 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KVF A+ T +K +K D D + ++ E ++L L ++ P
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH-P----F 79
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR--------Q 529
+ ++ F E+LF V E L +GG+ + + +
Sbjct: 80 LTHMFCTFQTKENLFFVMEYL-------------NGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC---LYVQSR 584
+ L++LHS GI++ DLK +NIL+ + IKI D G +C + ++
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDK----DGHIKIADFG--------MCKENMLGDAK 174
Query: 585 --------SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE+++G Y+ +D WS G +L E+ G+ F
Sbjct: 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ TG +K++K D D + ++ E ++L L H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------H 83
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
+ +L+ F + LF V E + +GG+ F R +
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFV-------------NGGDLMFHIQKSRRFDEARARFYA 130
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
+ + AL +LH GII+ DLK +N+L+ K+ D G + +C V + +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMC---KEGICNGVTTATFC 185
Query: 586 ----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE++ + Y +D W++G +L E+ G F +
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 49/224 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +++KV + T ++++K ND + D E + + + H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 112
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
++ L+ F LF V E + +GG+ + +
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYS 159
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLCLYVQSRS 585
+ AL YLH GII+ DLK +N+L+ S E IK+ D G + L + +
Sbjct: 160 AEISLALNYLHERGIIYRDLKLDNVLLDS----EGHIKLTDYGMC---KEGLRPGDTTST 212
Query: 586 ------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE++ G Y +D W+LG ++ E+ G F
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 53/226 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV ++ T +KI+K D D + ++ E ++L L K
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------PP 81
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ +L+ F ++ L+ V E + +GG+ + + ++
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAA 128
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L +L S GII+ DLK +N+++ S IKI D G +C ++ +
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFG--------MCKENIWDGVTT 178
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE+I PY + +D W+ G +L E+ G+ F +
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 2e-17
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 43/221 (19%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV ++ T +KI+K D D + ++ E ++L L K
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------PP 402
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ +L+ F ++ L+ V E + +GG+ + + ++
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAA 449
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
+ L +L S GII+ DLK +N+++ S IKI D G +N+ V +++
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC---KENIWDGVTTKTFCG 504
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE+I PY + +D W+ G +L E+ G+ F +
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 66/326 (20%), Positives = 121/326 (37%), Gaps = 71/326 (21%)
Query: 345 DTRDGEVNGALHEGKADAEEHGVATPDLL-MFDNLEEECEIFHLRIIHRKNRTGFEENKD 403
+ R ++ + +G A + LL + L +EC LR KN + E
Sbjct: 3 EVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRRE--KNILEYLEWAK 60
Query: 404 LPIILNTVIAGRYYVTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
+ V R + ++ +G AF +V + + +KI+ K
Sbjct: 61 P--FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KW------ 110
Query: 459 DEIKLLKLVNKNDPA---DEHHILRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQ---- 510
+++ + + A +E +L + + +I L Y FQ N
Sbjct: 111 ------EMLKRAETACFREERDVLV------NGDSKWIT------TLHYAFQDDNNLYLV 152
Query: 511 ---ESGGEAYFTLGRLQVI---------TRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
GG+ L + + + + A++ +H L +H D+KP+NIL+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 559 RCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPEVIIGLP-----YDQKIDLWSLG 607
I++ D GS VQS Y +PE++ + Y + D WSLG
Sbjct: 213 --HIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 608 CILAELWTGEVLFPNDAVVMILARII 633
+ E+ GE F +++V +I+
Sbjct: 269 VCMYEMLYGETPFYAESLVETYGKIM 294
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 55/227 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-------HP 208
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ L F + L V E +GGE +F L R +V +
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYGA 255
Query: 529 QCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSR 584
+ + AL+YLHS +++ DLK EN+++ IKI D G LC + +
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFG--------LCKEGIKDGAT 305
Query: 585 S--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 70/236 (29%)
Query: 422 LGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478
LG + KVFQ + + +TG +K++K K ++ + K E +I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTK--------AERNI 74
Query: 479 LRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQE---------SGGEAYFTLGRLQVITR 528
L ++H FIV +L Y FQ SGGE + L R +
Sbjct: 75 LE------EVKHPFIV------DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 529 --------QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC 578
+ AL +LH GII+ DLKPENI++ + +K+ D G LC
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH----QGHVKLTDFG--------LC 168
Query: 579 ---LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
++ + + Y APE+++ +++ +D WSLG ++ ++ TG F +
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 50/240 (20%), Positives = 90/240 (37%), Gaps = 53/240 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G AFS+V + TG +KI+ + +E +L +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--------R 120
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI--------- 526
I +L+ F +L++V E GG+ L +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYY-------------VGGDLLTLLSKFGERIPAEMARFY 167
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
+ + A++ +H LG +H D+KP+NIL+ I++ D GS V+S
Sbjct: 168 LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSC--LKLRADGTVRSLVA 223
Query: 586 -----YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y +PE++ + Y + D W+LG E++ G+ F D+ +I+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 73/236 (30%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA---DEHHI 478
+G +F KV A+ V +K+++ K ++ K + E ++
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQ--KKA------------ILKKKEEKHIMSERNV 91
Query: 479 LRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQE---------SGGEAYFTLGRLQVITR 528
L +++H F+V L + FQ + +GGE ++ L R +
Sbjct: 92 LLK-----NVKHPFLV------GLHFSFQ--TADKLYFVLDYINGGELFYHLQRERCFLE 138
Query: 529 --------QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC 578
+ AL YLHSL I++ DLKPENIL+ S + I + D G LC
Sbjct: 139 PRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS----QGHIVLTDFG--------LC 186
Query: 579 ---LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ S + Y APEV+ PYD+ +D W LG +L E+ G F +
Sbjct: 187 KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 32/214 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEH- 476
LG + +V++ + V +K +K D ++F L E ++K + H
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIK-------HP 276
Query: 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
++++L +I+ E + NL ++ + + L + Q A+E
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAME 332
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------AP 589
YL IH +L N L+ K+ D G S T + Y + AP
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLV--KVADFGLSRLMTGD--TYTAHAGAKFPIKWTAP 388
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
E + + K D+W+ G +L E+ T G +P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 49/235 (20%), Positives = 96/235 (40%), Gaps = 48/235 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G AF +V + T +K++ + +E ++ N
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--------S 128
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV---ITR---- 528
+++L+ F +L++V E + GG+ + V R
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYM-------------PGGDLVNLMSNYDVPEKWARFYTA 175
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
+ + AL+ +HS+G IH D+KP+N+L+ + +K+ D G+ V+ +
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKE--GMVRCDTAVG 231
Query: 586 ---YRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 60/233 (25%), Positives = 93/233 (39%), Gaps = 66/233 (28%)
Query: 422 LGSAAFSKVFQAQ---DLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLKLVNKNDPA 473
LG +F KVF + +K++K K + E +L VN
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLK--KATLKVRDRVRTKMERDILVEVN----- 84
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRL 523
H I++L+ F L+++ + L GG+ FT +
Sbjct: 85 ---HPFIVKLHYAFQTEGKLYLILDFL-------------RGGDLFTRLSKEVMFTEEDV 128
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC--- 578
+ + AL++LHSLGII+ DLKPENIL+ E IK+ D G L
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDE----EGHIKLTDFG--------LSKES 176
Query: 579 LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ + ++ Y APEV+ + Q D WS G ++ E+ TG + F
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 32/215 (14%), Positives = 76/215 (35%), Gaps = 39/215 (18%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQSLDEI 461
I+ + A + V +G F ++ A + + + +K+ +D E+
Sbjct: 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTEL 84
Query: 462 KLLKLVNKNDPADEHH---------ILRLYDYFYH----LEHLFIVCELLRANLYEFQKF 508
K + K + + + + + H + F++ + ++L + +
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
N + F+ + ++ + L+ LEY+H +H D+K N+L+ ++ ++D G
Sbjct: 145 NAKR-----FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDL 603
+ Y V D K
Sbjct: 200 L-------------AYRYCPEGVHKAYAADPKRCH 221
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 55/250 (22%), Positives = 98/250 (39%), Gaps = 41/250 (16%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQ---- 69
Query: 473 ADEH-HILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ Y +L ++ E L +L ++ + ++E +L T
Sbjct: 70 ---HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTS 121
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q + +EYL + IH DL NIL+++ R KI D G + + +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRV--KIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARI--IGMLGP 638
APE + + D+WS G +L EL+T + P + ++ M+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 639 IDLEMLMQGQ 648
+E+L
Sbjct: 240 HLIELLKNNG 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F +V+ + V +K +K + L E +++K + ++
Sbjct: 273 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLV 325
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY E ++IV E + +L +F K Y L +L + Q + Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVI 592
+ +H DL+ NIL+ C K+ D G + DN Y + + APE
Sbjct: 381 RMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAA 436
Query: 593 IGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ + K D+WS G +L EL T G V +P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 48/224 (21%), Positives = 78/224 (34%), Gaps = 46/224 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
E F V++AQ V +KI DK + E+ L + +H +
Sbjct: 30 EVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEY-EVYSLPGM-------KHEN 79
Query: 478 ILRLYDY----FYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
IL+ L+++ + +L +F K N + L I
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-------VSWNELCHIAETMAR 132
Query: 533 ALEYLHS----------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L YLH I H D+K +N+L+K+ I D G +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDT 190
Query: 583 SRS-----YRAPEVIIG-----LPYDQKIDLWSLGCILAELWTG 616
Y APEV+ G +ID++++G +L EL +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F +V+ + V +K +K + L E +++K + ++
Sbjct: 190 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLV 242
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY E ++IV E + +L +F K Y L +L + Q + Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVI 592
+ +H DL+ NIL+ C K+ D G + DN Y + + APE
Sbjct: 298 RMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAA 353
Query: 593 IGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ + K D+WS G +L EL T G V +P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 39/249 (15%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSL----- 99
Query: 473 ADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+I++ Y +L ++ E L +L ++ + ++E +L T Q
Sbjct: 100 -QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQ 153
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL + IH DL NIL+++ R KI D G + + Y
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRV--KIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARI--IGMLGPI 639
APE + + D+WS G +L EL+T + P + ++ M+
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 640 DLEMLMQGQ 648
+E+L
Sbjct: 272 LIELLKNNG 280
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ A + V +K +K + L E ++K + +++L
Sbjct: 196 LGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL------QHDKLVKL 248
Query: 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
+ E ++I+ E + +L +F K S + L +L + Q E + ++
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLK----SDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVIIG 594
IH DL+ NIL+ + C KI D G + DN Y + APE I
Sbjct: 304 NYIHRDLRAANILVSASLVC--KIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINF 359
Query: 595 LPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ K D+WS G +L E+ T G + +P
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+ +G+ F +V + + V +K +K +DF L E ++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQF--- 103
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
D +I+RL + + IV E + F ++ + FT+ +L + R
Sbjct: 104 ---DHPNIIRLEGVVTKSKPVMIVTEYME--NGSLDSFLRKHDAQ--FTVIQLVGMLRGI 156
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--- 587
++YL +G +H DL NILI S C K+ D G D+ +R +
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVC--KVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 588 ---APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+PE I + D+WS G +L E+ + GE +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 38/248 (15%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF----QREIQILKAL----- 81
Query: 473 ADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
I++ Y + L +V E L + L +F + ++ RL + + Q
Sbjct: 82 -HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQ 135
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL S +H DL NIL++S KI D G + + YV +
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHV--KIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT-GEV--LFPNDAVVMILARIIGMLGPID 640
APE + + ++ D+WS G +L EL+T + + + M+
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 641 LEMLMQGQ 648
LE+L +GQ
Sbjct: 254 LELLEEGQ 261
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 32/215 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADE 475
+ LGS F V + DV +K+IK +F E + + +
Sbjct: 14 KELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEF----FQEAQTMMKL------SH 62
Query: 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++ Y ++IV E + L + + + + +L + E +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-----LEPSQLLEMCYDVCEGM 117
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------A 588
+L S IH DL N L+ K+ D G + + D+ YV S + A
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCV--KVSDFGMTRYVLDD--QYVSSVGTKFPVKWSA 173
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
PEV Y K D+W+ G ++ E+++ G++ +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 49/221 (22%), Positives = 87/221 (39%), Gaps = 35/221 (15%)
Query: 420 EYLGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNK 469
+ +G+ F +V++ V V +K +K DF L E ++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGIMGQF-- 103
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H+I+RL + + I+ E + L +F + F++ +L + R
Sbjct: 104 ----SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLR 154
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
++YL ++ +H DL NIL+ S C K+ D G S D+ + +
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVC--KVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE I + D+WS G ++ E+ T GE +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 34/220 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+ +GS +V + G V V +K +K +DF L E ++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQF--- 107
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
D +I+RL IV E + +L F + + FT+ +L + R
Sbjct: 108 ---DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRG 159
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ YL LG +H DL N+L+ S C K+ D G S D+ + +
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVC--KVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE I + D+WS G ++ E+ GE + N
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 57/243 (23%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
E +G + V++ V +K+ N ++F ++ I + L+ EH
Sbjct: 19 ELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEK--NIYRVPLM-------EHD 67
Query: 477 HILRLY-----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+I R +V E +L ++ + +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSV 120
Query: 531 LEALEYLHS---------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
L YLH+ I H DL N+L+K+ C I D G S T N +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC--VISDFGLSMRLTGNRLVRP 178
Query: 582 QSRS-----------YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTG-EVLFPN 622
Y APEV+ G +++D+++LG I E++ LFP
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 623 DAV 625
++V
Sbjct: 239 ESV 241
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 30/213 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG + +V++ + V +K +K D ++F L E ++K + +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEI------KHPN 70
Query: 478 ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++L +I+ E + NL ++ + + L + Q A+EY
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEY 126
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L IH DL N L+ K+ D G S T + Y + APE
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLV--KVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPE 182
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ + K D+W+ G +L E+ T G +P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 34/216 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADE 475
+G F +VF + V +K + F L E ++LK
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQY------SH 171
Query: 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+RL + ++IV EL++ + F + + L + +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGM 226
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------- 587
EYL S IH DL N L+ KI D G S + D +Y S R
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVL--KISDFGMSREEADG--VYAASGGLRQVPVKWT 282
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE + Y + D+WS G +L E ++ G +PN
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 68/230 (29%)
Query: 422 LGSAAFSKVFQAQDL---HTGVDVCLKIIK------NDKDFFDQSLDEIKLLKLVNKNDP 472
LG+ A+ KVF + + TG +K++K K + + E ++L+ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIR---- 116
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
++ L+ F L ++ + + +GGE FT
Sbjct: 117 ---QSPFLVTLHYAFQTETKLHLILDYI-------------NGGELFTHLSQRERFTEHE 160
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC-L 579
+Q+ + + ALE+LH LGII+ D+K ENIL+ S + + D G L
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS----NGHVVLTDFG--------LSKE 208
Query: 580 YVQSRS-----------YRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 616
+V + Y AP+++ G +D+ +D WSLG ++ EL TG
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 46/218 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH-H 477
+G F V + G V +K IKND + F L E ++ + H +
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQLR-------HSN 247
Query: 478 ILRLY-----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+++L + L+IV E + +L ++ + S G + L +
Sbjct: 248 LVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVC 299
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---- 587
EA+EYL +H DL N+L+ K+ D G + + +
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVA--KVSDFGLTKE------ASSTQDTGKLPVK 351
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE + + K D+WS G +L E+++ G V +P
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 25/179 (13%), Positives = 59/179 (32%), Gaps = 24/179 (13%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV--------DVCLKIIKNDKDFFDQSL 458
+L ++ + + +++A T LK+ D F++
Sbjct: 35 VLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQN 94
Query: 459 --------DEIKLLKLVNKNDPADEHHILRLYDYFYHL-EHLFIVCELLRANLYEFQKFN 509
++ K + I + H ++ F+V L +L +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTP---LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA--LD 149
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + + + L+ALE+LH +H ++ ENI + + ++ + G
Sbjct: 150 VSPKHV--LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 34/214 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEH- 476
+GS F V V +K I+ +DF ++E +++ ++ H
Sbjct: 16 IGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDF----IEEAEVMMKLS-------HP 63
Query: 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+++LY + +V E + L ++ + + F L + E +
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMA 118
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------AP 589
YL +IH DL N L+ Q K+ D G + F D+ Y S + +P
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVI--KVSDFGMTRFVLDD--QYTSSTGTKFPVKWASP 174
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
EV Y K D+WS G ++ E+++ G++ + N
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 52/250 (20%), Positives = 93/250 (37%), Gaps = 41/250 (16%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG F KV + +TG V +K +K + D EI++L+ +
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KKEIEILRNLY--- 81
Query: 472 PADEH-HILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I++ + ++ E L + +L E+ N+ L +
Sbjct: 82 ----HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYA 132
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
Q + ++YL S +H DL N+L++S + KI D G + + Y
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQV--KIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI--IGMLGP 638
APE ++ + D+WS G L EL T + A+ + + M
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 639 IDLEMLMQGQ 648
+ L +G+
Sbjct: 251 RLVNTLKEGK 260
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 32/213 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V+ + V +K +K F L E L+K +
Sbjct: 21 LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAF----LAEANLMKQL------QHQR 69
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++RLY E ++I+ E + +L +F K + T+ +L + Q E + +
Sbjct: 70 LVRLYAVVTQ-EPIYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
+ IH DL+ NIL+ C KI D G + DN Y + APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDN--EYTAREGAKFPIKWTAPE 180
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
I + K D+WS G +L E+ T G + +P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F V + DV +K+IK +F ++E K++ +
Sbjct: 32 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEF----IEEAKVMMNL------SHEK 80
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++LY +FI+ E + L + + + F +L + + EA+EY
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEY 135
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L S +H DL N L+ K+ D G S + D+ Y S + PE
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVV--KVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPE 191
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
V++ + K D+W+ G ++ E+++ G++ +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 36/213 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHI 478
+G F V + G V +K IKND + F L E ++ + ++
Sbjct: 29 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQL------RHSNL 76
Query: 479 LRLYDY-FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++L L+IV E + +L ++ + S G + L + EA+EY
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L +H DL N+L+ K+ D G + + + + APE
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVA--KVSDFGLT---KE---ASSTQDTGKLPVKWTAPE 184
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ + K D+WS G +L E+++ G V +P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 55/249 (22%), Positives = 89/249 (35%), Gaps = 41/249 (16%)
Query: 422 LGSAAFSKVFQAQ----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG F KV + TG V +K +K D + EI +L+ +
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDILRTL---- 90
Query: 472 PADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
HI++ L +V E + +L ++ + L +L + +
Sbjct: 91 --YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQ 141
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q E + YLH+ IH DL N+L+ + + KI D G + + Y
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLV--KIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI--IGMLGPI 639
APE + + D+WS G L EL T + + L I M
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 640 DLEMLMQGQ 648
E+L +G+
Sbjct: 260 LTELLERGE 268
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 47/225 (20%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND--------KDFFDQSLDEIKLLKLVNKN 470
LG +F V + V V +K +K D DF + E+ + ++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF----IREVNAMHSLD-- 79
Query: 471 DPADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
H +++RLY + +V EL +L + + +Q F LG L
Sbjct: 80 -----HRNLIRLYGVVLT-----PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLS 124
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
Q E + YL S IH DL N+L+ + KI D G N YV
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV--KIGDFGLMRALPQNDDHYVMQE 182
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ APE + + D W G L E++T G+ +
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 36/218 (16%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476
LGS F V + Q V +KI+KN+ D+ L E +++ + D
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL------DNP 78
Query: 477 HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+R+ E +V E+ L ++ + N+ + + Q
Sbjct: 79 YIVRMIGICEA-----ESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVS 127
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---- 587
++YL +H DL N+L+ + KI D G S + Y +
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE I + K D+WS G ++ E ++ G+ +
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 52/259 (20%), Positives = 95/259 (36%), Gaps = 62/259 (23%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS F V + + + VC+K+I++ + D + + +
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV----TDHMLAIGSL---- 72
Query: 472 PADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
D HI+RL L +V + L +L + + ++ + L
Sbjct: 73 --DHAHIVRLLGLCPG-----SSLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNW 120
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS 585
Q + + YL G++H +L N+L+KS + ++ D G + D+ +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQV--QVADFGVADLLPPDD--KQLLYSE 176
Query: 586 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG- 637
+ A E I Y + D+WS G + EL T G + + LA + +L
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG----LRLAEVPDLLEK 232
Query: 638 ----------PIDLEMLMQ 646
ID+ M+M
Sbjct: 233 GERLAQPQICTIDVYMVMV 251
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 52/260 (20%), Positives = 99/260 (38%), Gaps = 64/260 (24%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS AF V++ + + V +K ++ K+ LDE ++ V+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVD--- 75
Query: 472 PADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+ H+ RL + ++ +L+ L ++ + ++++ L
Sbjct: 76 ----NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR 584
Q + + YL ++H DL N+L+K+ Q KI D G + + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV--KITDFGLAKLLGAEE--KEYHAE 177
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML- 636
+ A E I+ Y + D+WS G + EL T G + + + I +L
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----IPASEISSILE 233
Query: 637 -G---------PIDLEMLMQ 646
G ID+ M+M+
Sbjct: 234 KGERLPQPPICTIDVYMIMR 253
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 46/213 (21%), Positives = 80/213 (37%), Gaps = 26/213 (12%)
Query: 422 LGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH 476
LG F V Q +DV +K++K + D + E +++ + D
Sbjct: 344 LGCGNFGSVRQGV-YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNP 396
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I+RL E L +V E+ A KF E + + + Q ++Y
Sbjct: 397 YIVRLIGVCQA-EALMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKY 451
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L +H +L N+L+ + KI D G S + Y + + APE
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
I + + D+WS G + E + G+ +
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 41/231 (17%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 420 EYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKND-----KDFFDQSLDEIKLLKLV 467
E LG F+K+F+ G +V LK++ + F + ++ +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF----FEAASMMSKL 69
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
H++ Y + +V E ++ +L + K N+ + +
Sbjct: 70 ------SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEV 118
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE------IKIIDLGSSCFQTDNLCLY 580
+Q A+ +L +IH ++ +NIL+ + + IK+ D G + +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG--------ISIT 170
Query: 581 VQSRSYR-------APEVII-GLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
V + PE I + D WS G L E+ + G+
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 42/221 (19%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPA 473
LG F V Q +DV +K++K ++ + E +++ ++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLD----- 68
Query: 474 DEH-HILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ +I+RL E L +V E+ A KF E + + +
Sbjct: 69 --NPYIVRLIGVCQA-----EALMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLH 117
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q ++YL +H DL N+L+ + KI D G S + Y + +
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKW 175
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE I + + D+WS G + E + G+ +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 40/223 (17%)
Query: 422 LGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG+ AF KV +A + V +K++K ++ + E+K+L +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 85
Query: 475 EH-HILRLYDYFYHLEHLFIVCEL---------LRAN----LYEFQKFNQESGGEAYFTL 520
H +I+ L ++ E LR + E L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLC 578
L + Q + + +L S IH DL NIL+ + KI D G + N
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSN-- 200
Query: 579 LYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
YV + R APE I Y + D+WS G L EL++
Sbjct: 201 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG+ AF KV +A G + V +K++K+ ++ + E+K++ + +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ----- 108
Query: 475 EH-HILRLYDYFYHLEHLFIVCEL---------LRANLYEFQKFNQESGGEAYFTLGRLQ 524
H +I+ L H + ++ E LR + + + + L
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQ 582
+ Q + + +L S IH D+ N+L+ + KI D G + N Y+
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA--KIGDFGLARDIMNDSN---YIV 222
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ R APE I Y + D+WS G +L E+++
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 50/223 (22%), Positives = 79/223 (35%), Gaps = 43/223 (19%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+G F V Q + + V +K KN + F L E ++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTMRQF--- 448
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
D HI++L + ++I+ EL E + F Q L L +
Sbjct: 449 ---DHPHIVKLIGVITE-----NPVWIIMELCTLG--ELRSFLQVRKFS--LDLASLILY 496
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
Q AL YL S +H D+ N+L+ S K+ D G S + D+ Y ++
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASKG 552
Query: 587 R------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ APE I + D+W G + E+ G F
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 64/260 (24%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS AF V++ + + V +K ++ K+ LDE ++ V+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVD--- 75
Query: 472 PADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+ H+ RL + ++ +L+ L ++ + ++++ L
Sbjct: 76 ----NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR 584
Q + + YL ++H DL N+L+K+ Q KI D G + + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV--KITDFGLAKLLGAEE--KEYHAE 177
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML- 636
+ A E I+ Y + D+WS G + EL T G + + + I +L
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----IPASEISSILE 233
Query: 637 -G---------PIDLEMLMQ 646
G ID+ M+M
Sbjct: 234 KGERLPQPPICTIDVYMIMV 253
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 1e-08
Identities = 44/251 (17%), Positives = 74/251 (29%), Gaps = 59/251 (23%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLK 465
+ E +G F +VFQ HT V +KII + F++ L EI + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIV-----CELLRANLYEFQKFNQESGGEAYF-- 518
++ + + F L + V LL+A + + +F
Sbjct: 79 ELSLLSGEVCNRT----EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 519 ------------------------TLGRLQVITRQCLEALEYLH-SLGIIHCDLKPENIL 553
+L + I Q +L SL H DL N+L
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 554 IKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+K ++ G S + S + + Y + ++
Sbjct: 195 LKKTSLKKLHYTLNGKS--------STIPSCGLQVSII----DYTLSRLERDGIVVFCDV 242
Query: 614 WTGEVLFPNDA 624
E LF D
Sbjct: 243 SMDEDLFTGDG 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 43/218 (19%), Positives = 80/218 (36%), Gaps = 39/218 (17%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND-------KDFFDQSLDEIKLLKLVNKND 471
LG F V + Q+ T + V +K +K D ++F L E +K
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF----LSEAACMKDF---- 93
Query: 472 PADEHHILRLY-----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+++RL + ++ ++ +L+ + +++ G + L L
Sbjct: 94 --SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQS 583
+EYL + +H DL N +++ + D G S + D Y Q
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV--CVADFGLSKKIYSGD---YYRQG 206
Query: 584 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
R + A E + Y K D+W+ G + E+ T
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 50/224 (22%), Positives = 80/224 (35%), Gaps = 45/224 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+G F V Q + + V +K KN + F L E ++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTMRQF--- 73
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
D HI++L + ++I+ EL L F + + S L L +
Sbjct: 74 ---DHPHIVKLIGVITE-----NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 120
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q AL YL S +H D+ N+L+ S K+ D G S + D+ Y ++
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASK 176
Query: 586 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ APE I + D+W G + E+ G F
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 48/227 (21%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V A + V +K++K+D D + E++++K++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISEMEMMKMIG 132
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEA 516
K H +I+ L L+++ E L+A +N E
Sbjct: 133 K------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQT 574
+ L Q +EYL S IH DL N+L+ KI D G +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIHHI 244
Query: 575 DNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
D Y ++ + R APE + Y + D+WS G +L E++T
Sbjct: 245 DY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 40/219 (18%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND-------KDFFDQSLDEIKLLKLVNKND 471
LG F V +A Q+ + V V +K++K D ++F L E +K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF----LREAACMKEF---- 82
Query: 472 PADEHHILRLY------DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
D H+ +L L ++ ++ +L+ F ++ L L
Sbjct: 83 --DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQ 582
+EYL S IH DL N ++ + + + D G S + D Y Q
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCML-AEDMT-VCVADFGLSRKIYSGD---YYRQ 195
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + A E + Y D+W+ G + E+ T
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 6e-08
Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 45/224 (20%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG F +V++ ++V +K K D + F + E ++K +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIMKNL--- 70
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
D HI++L + E +I+ EL L + + N+ S + L +
Sbjct: 71 ---DHPHIVKLIGIIEE-----EPTWIIMELYPYGELGHYLERNKNS-----LKVLTLVL 117
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
+ Q +A+ YL S+ +H D+ NIL+ S + K+ D G S + D Y ++
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECV--KLGDFGLSRYIEDE--DYYKASV 173
Query: 586 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
R +PE I + D+W + E+ + G+ F
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 40/223 (17%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
LG AF +V A V V +K++K +KD D + E++++K++ K+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 101
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTL 520
+I+ L L+++ E LRA ++ E T
Sbjct: 102 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLC 578
L T Q +EYL S IH DL N+L+ KI D G + D
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDINNIDY-- 212
Query: 579 LYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y ++ + R APE + Y + D+WS G ++ E++T
Sbjct: 213 -YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 47/219 (21%), Positives = 80/219 (36%), Gaps = 40/219 (18%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPA 473
+G F +V +A+ +D +K +K +DF E+++L + +
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGELEVLCKLGHHP-- 86
Query: 474 DEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTLGR 522
+I+ L H +L++ E LR + L F + + + +
Sbjct: 87 ---NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L ++YL IH DL NIL+ KI D G S + YV+
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLS-RGQEV---YVK 197
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
R A E + Y D+WS G +L E+ +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG F +V A V V +K++K+D D + E++++K++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIG 144
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAY 517
K+ +I+ L L+++ E LRA ++ E
Sbjct: 145 KHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
T L T Q +EYL S IH DL N+L+ KI D G + D
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDINNID 257
Query: 576 NLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y ++ + R APE + Y + D+WS G ++ E++T
Sbjct: 258 Y---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 51/231 (22%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LGS AF KV A + V +K++K + + E+K++ + +
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELKMMTQLGSH 108
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN---------LYEFQKFNQES 512
+ +I+ L ++++ E LR+ YE QK +E
Sbjct: 109 E-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-- 570
T L Q + +E+L +H DL N+L+ + KI D G +
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV--KICDFGLARD 221
Query: 571 CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
N YV + R APE + Y K D+WS G +L E+++
Sbjct: 222 IMSDSN---YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 54/228 (23%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKND 471
LG AF KVF A+ + V +K +K+ KDF E +LL +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QREAELLTNL---- 74
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTL 520
HI++ Y + L +V E LRA+ Q + L
Sbjct: 75 --QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
++ I Q + YL S +H DL N L+ + +KI D G +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA--NLLVKIGDFG--------MSRD 182
Query: 581 VQSRSY-----------R--APEVIIGLPYDQKIDLWSLGCILAELWT 615
V S Y R PE I+ + + D+WS G IL E++T
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 45/225 (20%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG AF +V +A T V +K++K + + E+K+L + +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELKILIHIGHH 90
Query: 471 DPADEHHILRLYDY-FYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYF 518
+++ L L ++ E LR+ + K E + +
Sbjct: 91 L-----NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDN 576
TL L + Q + +E+L S IH DL NIL+ KI D G + ++ +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDIYKDPD 203
Query: 577 LCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
YV+ R APE I Y + D+WS G +L E+++
Sbjct: 204 ---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 39/210 (18%), Positives = 71/210 (33%), Gaps = 27/210 (12%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
E +G F V+ + + +K + D + S L E ++K
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------S 148
Query: 475 EHHILRLYDYFYHLEH-LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
++L L E +V ++ +L F + + T+ L Q +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 203
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRSYR---- 587
+++L S +H DL N ++ K+ D G + +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 42/214 (19%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG +F V++ V +K + ++ L+E ++K N
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 87
Query: 475 EHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
HH++RL + ++ EL L++ L + + A +L ++ + +
Sbjct: 88 -HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR 587
+ + YL++ +H DL N ++ KI D G + ++TD Y +
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTV--KIGDFGMTRDIYETDY---YRKGGKGL 201
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+PE + + D+WS G +L E+ T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 62/448 (13%), Positives = 125/448 (27%), Gaps = 132/448 (29%)
Query: 323 GSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAE-EHGVATPD-----LLMFD 376
G +K A +DN D +D V + E +H + + D L +F
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKD--VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 377 NLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDL 436
L K ++ + V+ Y ++L S + +
Sbjct: 70 TLL------------SKQEEMVQK------FVEEVLRINY---KFLMSP-----IKTEQR 103
Query: 437 HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496
+ + + D +L N N ++++ R ++
Sbjct: 104 QPSMM---------TRMYIEQRD-----RLYNDNQVFAKYNVSR--------LQPYLK-- 139
Query: 497 LLRANLYEFQKFNQESGGEAYFTL------GRLQVITRQCLEALEYLHSLGII------- 543
LR L E + + G + + AL+ S +
Sbjct: 140 -LRQALLELRP-------AKNVLIDGVLGSG------KTWV-ALDVCLSYKVQCKMDFKI 184
Query: 544 ------HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
+C+ PE +L + + S + N+ L + S ++ PY
Sbjct: 185 FWLNLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 598 DQKIDLWSLGCILAELWTGEVL--FPNDAVVMILAR---IIGMLGP-----IDLEMLMQG 647
+ L +L + + F +++ R + L I L+
Sbjct: 244 EN-----CL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 648 QEIYKYFTKEY--DLY--YINEETNQLEYIIPEESSLEHHLQFS--DAFFIDFVRT---L 698
T + L Y++ L P E + + S D + T
Sbjct: 298 ------LTPDEVKSLLLKYLDCRPQDL----PREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 699 LEINPQRRPTAREA----LDHPWLQHPY 722
+N + T E+ L+ + +
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMF 375
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 93/627 (14%), Positives = 164/627 (26%), Gaps = 206/627 (32%)
Query: 114 HGNSEASSESLSQFDTARDY--DLQNDFYWHDEKDE--GYFMTPSYGGSDFFGCPSEDKF 169
H + E D + ++F D +D
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI--DHIIMSKDAV-- 61
Query: 170 IMTSEADRLFE--------------------------NPLAVYDQSEGLHSEASTDYLDK 203
S RLF +P+ + + + + D+
Sbjct: 62 ---SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 204 PCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEKL------------------KDC- 244
L++ + V R + + +++ L K
Sbjct: 119 --LYNDNQVFAKYNV-----SRLQPYLK-----LRQALLELRPAKNVLIDGVLGSGKTWV 166
Query: 245 AAYGCSEPLCKCCAGEGK--INNDYGYLSSKEADLIDLQ---HNVVGDSSTDCD------ 293
A C +C +N +S E L LQ + + + ++ D
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 294 LAPHPGTEKSSSYSSSKRGSS----ID--W----IEGFKGSSDLHFKGAEKDLMPAEIDN 343
L H + SK + + F S K L+
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC--------KILLT----- 271
Query: 344 SDTRDGEVN---GALHEGKADAEEHGVA-TPD----LLM------FDNL-EEECEI--FH 386
TR +V A + H + TPD LL+ +L E
Sbjct: 272 --TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 387 LRIIHRKNRTGFEENKDLPII----LNTVIAGRYYVTEYLGSAAFSKVFQA-----QDLH 437
L II R G + + L T+I L A + K+F H
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSVFPPSAH 386
Query: 438 TGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKN-------------------DPADEH 476
+ L +I D D ++++ LV K +
Sbjct: 387 IPTIL-LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 477 H--------ILRLYD-----------YFY-HLE-HLFIV-----CELLRANLY---EF-- 505
H I + +D YFY H+ HL + L R ++ F
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR-MVFLDFRFLE 504
Query: 506 QK-----FNQESGGEAYFTLGRLQV----ITRQCLEALEYLHSLGIIHCDLKPENILIKS 556
QK + G TL +L+ I + +++ I+ K E LI S
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA--ILDFLPKIEENLICS 562
Query: 557 YQRCEIKIIDLGSSCFQTDNLCLYVQS 583
++I ++ ++ ++
Sbjct: 563 KYTDLLRIA------LMAEDEAIFEEA 583
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 55/233 (23%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG F KV +A V +K++K + +D L E +LK VN
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFNVLKQVN-- 84
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCEL---------LRAN----------LYEFQKFNQ 510
H H+++LY L ++ E LR + +
Sbjct: 85 -----HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 511 ESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+ E T+G L Q + ++YL + ++H DL NIL+ ++ KI D G S
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM--KISDFGLS 197
Query: 571 --CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ D+ YV+ R A E + Y + D+WS G +L E+ T
Sbjct: 198 RDVYEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 55/228 (24%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKND 471
LG AF KVF A+ + V +K +K +DF E +LL ++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF----QREAELLTML---- 100
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN-LYEFQKFNQESGGEAYFTLG 521
HI+R + L +V E LR++ E LG
Sbjct: 101 --QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCL 579
+L + Q + YL L +H DL N L+ +KI D G S + TD
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ--GLVVKIGDFGMSRDIYSTD---- 212
Query: 580 YVQSRSYR------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y YR PE I+ + + D+WS G +L E++T
Sbjct: 213 Y-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 43/231 (18%), Positives = 77/231 (33%), Gaps = 55/231 (23%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
E LG F KV++ V +K +K+ ++F E L +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----RHEAMLRARL- 69
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAY 517
+++ L + L ++ L + + + ++
Sbjct: 70 -----QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 577
+ Q +EYL S ++H DL N+L+ KI DLG L
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV--KISDLG--------L 174
Query: 578 CLYVQSRS-YR------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
V + Y+ APE I+ + D+WS G +L E+++
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 44/223 (19%), Positives = 75/223 (33%), Gaps = 45/223 (20%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V++ Q + + + V +K + DF L E ++ N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKFN 132
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQVI 526
+I+R FI+ EL+ +L F ++ + + L +
Sbjct: 133 ------HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
R +YL IH D+ N L+ KI D G + +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG--------MARDIYRAG 238
Query: 586 YR-------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y PE + + K D WS G +L E+++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 33/213 (15%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
E +G F V+ + + +K + D + S L E ++K
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------S 84
Query: 475 EHHILRLYDYFYHLEH-LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
++L L E +V ++ +L F + + T+ L Q +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 139
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR--- 587
++YL S +H DL N ++ K+ D G + + + Y
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKE---YYSVHNKTGAKL 194
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 44/223 (19%), Positives = 76/223 (34%), Gaps = 45/223 (20%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V++ Q + + + V +K + DF L E ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKF- 90
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQVI 526
+ +I+R FI+ EL+ +L F ++ + + L +
Sbjct: 91 -----NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
R +YL IH D+ N L+ KI D G + + S
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG--------MARDIYRAS 197
Query: 586 YR-------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y PE + + K D WS G +L E+++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 39/212 (18%), Positives = 74/212 (34%), Gaps = 35/212 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH 476
+G F V+ + + + +K + + L E L++ + +
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL------NHP 82
Query: 477 HILRLYDYFYHLE-HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
++L L E ++ + +L +F + Q + T+ L Q +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVARGM 137
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR----- 587
EYL +H DL N ++ K+ D G + + Y + +R
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTV--KVADFGLARDILDRE----YYSVQQHRHARLP 191
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
TL L + Q + +E+L S IH DL NIL+ KI D G + ++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDIYKDP 247
Query: 576 NLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ YV+ R APE I Y + D+WS G +L E+++
Sbjct: 248 D---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 48/234 (20%), Positives = 78/234 (33%), Gaps = 53/234 (22%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
+G AF +VFQA+ V +K++K + DF E L+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAALMAEF- 107
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN----------LYEFQKFN 509
D +I++L + + ++ E LR+ +
Sbjct: 108 -----DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
S G + I RQ + YL +H DL N L+ KI D G
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV--KIADFGL 220
Query: 570 S--CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
S + D Y + PE I Y + D+W+ G +L E+++
Sbjct: 221 SRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 722 | |||
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 2z0u_A | 155 | WW domain-containing protein 1; C2 domain, alterna | 99.71 | |
| 3fbk_A | 153 | RGS3, RGP3, regulator of G-protein signaling 3; al | 99.67 | |
| 3rdl_A | 137 | Protein kinase C alpha type; protein kinase PKC, t | 99.65 | |
| 1v27_A | 141 | Regulating synaptic membrane exocytosis protein 2; | 99.65 | |
| 1a25_A | 149 | CALB, protein kinase C (beta); calcium++/phospholi | 99.64 | |
| 1w15_A | 153 | Synaptotagmin IV; metal binding protein, endocytos | 99.63 | |
| 2bwq_A | 129 | Regulating synaptic membrane exocytosis protein 2; | 99.62 | |
| 2dmg_A | 142 | KIAA1228 protein; beta-sandwich, structural genomi | 99.62 | |
| 2b3r_A | 134 | Phosphatidylinositol-4-phosphate 3-kinase C2 DOMA | 99.62 | |
| 3fdw_A | 148 | Synaptotagmin-like protein 4; structural genomics, | 99.62 | |
| 3n5a_A | 138 | Synaptotagmin-7; calcium/phospholipid binding prot | 99.61 | |
| 1wfm_A | 138 | Synaptotagmin XIII; C2 domain, exocytosis, neurotr | 99.61 | |
| 1ugk_A | 138 | Synaptotagmin IV, KIAA1342; beta sandwich, structu | 99.59 | |
| 2cm5_A | 166 | Rabphilin-3A; protein transport, zinc-finger, Ca2+ | 99.58 | |
| 2enp_A | 147 | B/K protein; C2 type 1,beta sandwich, structural g | 99.58 | |
| 1rsy_A | 152 | Synaptotagmin I; calcium/phospholipid binding prot | 99.58 | |
| 1tjx_A | 159 | Similar to synaptotagmini/P65; C2B domain, calcium | 99.58 | |
| 3f04_A | 143 | Synaptotagmin-1; C2A, calcium, cell junction, cyto | 99.57 | |
| 2q3x_A | 171 | Regulating synaptic membrane exocytosis protein 1; | 99.57 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 2chd_A | 142 | Rabphilin-3A, exophilin-1; C2 domain, C2A, calcium | 99.57 | |
| 1dqv_A | 296 | Synaptotagmin III; beta sandwich, calcium ION, C2 | 99.56 | |
| 2d8k_A | 141 | Synaptotagmin VII; exocytosis, calcium binding, ly | 99.56 | |
| 1rh8_A | 142 | Piccolo protein; beta-sandwich, metal binding prot | 99.54 | |
| 2fk9_A | 157 | Protein kinase C, ETA type; ATP-binding, metal-bin | 99.49 | |
| 1rlw_A | 126 | Phospholipase A2, CALB domain; hydrolase, C2 domai | 99.49 | |
| 3pyc_A | 132 | E3 ubiquitin-protein ligase smurf1; phospholipid b | 99.48 | |
| 2dmh_A | 140 | Myoferlin; beta-sandwich, FER-1-like protein 3, mu | 99.47 | |
| 3b7y_A | 153 | E3 ubiquitin-protein ligase NEDD4; C2 domain, UBL- | 99.46 | |
| 2r83_A | 284 | Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cel | 99.46 | |
| 1gmi_A | 136 | Protein kinase C, epsilon type; PKC, C2 domain, X- | 99.46 | |
| 3m7f_B | 176 | E3 ubiquitin-protein ligase NEDD4; C2 domain, GRB1 | 99.46 | |
| 2ep6_A | 133 | MCTP2 protein; beta sandwich, Ca2+ binding, membra | 99.46 | |
| 1dqv_A | 296 | Synaptotagmin III; beta sandwich, calcium ION, C2 | 99.45 | |
| 1wfj_A | 136 | Putative elicitor-responsive gene; C2 domain, rike | 99.43 | |
| 3nsj_A | 540 | Perforin-1; pore forming protein, immune system; H | 99.42 | |
| 2r83_A | 284 | Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cel | 99.41 | |
| 3kwu_A | 148 | MUNC13-1; calcium binding protein, phospholipid bi | 99.4 | |
| 2nq3_A | 173 | Itchy homolog E3 ubiquitin protein ligase; C2 doma | 99.36 | |
| 2cjt_A | 131 | UNC-13 homolog A, MUNC13-1; phorbol-ester binding, | 99.33 | |
| 2cjs_A | 167 | UNC-13 homolog A, MUNC13-1; neurotransmitter trans | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 99.15 | |
| 1cjy_A | 749 | CPLA2, protein (cytosolic phospholipase A2); lipid | 99.14 | |
| 3jzy_A | 510 | Intersectin 2; C2 domain, structural genomics cons | 99.12 | |
| 3l9b_A | 144 | Otoferlin; C2-domain, beta-sheets, cell membrane, | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3bxj_A | 483 | RAS GTPase-activating protein syngap; GTPase activ | 98.84 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 98.47 | |
| 3qr0_A | 816 | Phospholipase C-beta (PLC-beta); PH domain, EF han | 98.36 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 3ohm_B | 885 | 1-phosphatidylinositol-4,5-bisphosphate phosphodi | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.97 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.74 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.69 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.38 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.22 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.76 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.68 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.62 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.49 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.08 | |
| 2enj_A | 138 | NPKC-theta, protein kinase C theta type; beta-sand | 95.95 | |
| 1yrk_A | 126 | NPKC-delta, protein kinase C, delta type; C2 domai | 95.6 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.18 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.15 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.82 | |
| 3hhm_A | 1091 | Phosphatidylinositol-4,5-bisphosphate 3-kinase cat | 80.87 |
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=570.06 Aligned_cols=489 Identities=20% Similarity=0.288 Sum_probs=328.2
Q ss_pred CCCccCCCCCCCCCCCCCCCCeeeec--ccccccccCceeecccccccccccccccCCCccccccccCCCCCccccc---
Q 004954 147 EGYFMTPSYGGSDFFGCPSEDKFIMT--SEADRLFENPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVT--- 221 (722)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~--- 221 (722)
.|.|+...|..+- -|.-|..||.| .....|..|.+..| |.|.-+++..|-+.....+
T Consensus 37 ~H~f~~~~~~~p~--~C~~C~~~i~g~~~qg~~C~~C~~~~H----------------~~C~~~v~~~c~~~~~~~~~~~ 98 (674)
T 3pfq_A 37 NHKFTARFFKQPT--FCSHCTDFIWGFGKQGFQCQVCSFVVH----------------KRCHEFVTFSCPGADKGPASDD 98 (674)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CceEEeeeCCCCC--ccccccccccccCCceeECCCCCCCcC----------------hhhcCcCcccCCCccccccccc
Confidence 3666666665555 48889999976 67788888888888 9999999888866544332
Q ss_pred --ceeeccccCCCccCCcccccccc-----------------cc---ccCC---CCCccccCCCCc--------ccccee
Q 004954 222 --DYYRFEKTNQPEAGGIKEKLKDC-----------------AA---YGCS---EPLCKCCAGEGK--------INNDYG 268 (722)
Q Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~-----------------~~---~~~~---~~~~~~~~~~~~--------~s~~~l 268 (722)
--|++..|+ .....-|+.| .+ --|. +..|+..+.+.+ ...+.|
T Consensus 99 ~~~~h~~~~~~----~~~~~~C~~C~~~l~g~~~qg~~C~~C~~~~H~~C~~~v~~~C~~d~~~~~g~i~~~~~~~~~~L 174 (674)
T 3pfq_A 99 PRSKHKFKIHT----YSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVL 174 (674)
T ss_dssp ---CCCCCEEC----CSSCCCCSSSCSCCBBSSSCEECCSSSCCCBCSSTTSSSCCCSSSCSSCCSCEEEEEEEECSSEE
T ss_pred ccCCcceeecC----CCCCCCCCccccccchhhcCccccccCCcchhhhhhhccCcccccccccccccccccceecccee
Confidence 124444444 2234445544 31 1354 345655444333 145678
Q ss_pred EEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCCCC
Q 004954 269 YLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTR 347 (722)
Q Consensus 269 ~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~~~ 347 (722)
+|.|.+| +|.+||.+|.+|||||+.++|+++...++||+++++|+||+|||+|.|. +.....++.|.++|||+|.++
T Consensus 175 ~V~v~~a~~L~~~d~~g~sDPyvkv~l~p~~~~~~k~kT~v~~~tlnP~wne~f~f~--~~~~~~~~~L~v~v~d~d~~~ 252 (674)
T 3pfq_A 175 IVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQ--LKESDKDRRLSVEIWDWDLTS 252 (674)
T ss_dssp EEEEEEEESCCCCSTTSSCCEEEEEEEESCSSCCSCEECCCCSSCSSCEEEEEEEEE--CCSTTTTCEEEEEEEECCSSS
T ss_pred eeeeecccccCCCCcccccCcccccccccCccccccccccccccccCCCccceeeee--cccCCccceeeeEEeeccccc
Confidence 8999999 9999999999999999999999888889999999999999999999999 777667777999999999999
Q ss_pred CCccccccccCccccccccCCCcchhhhhhhHhHhhhheeeeeecc--------------ccCCc--cC-----CCCcc-
Q 004954 348 DGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIFHLRIIHRK--------------NRTGF--EE-----NKDLP- 405 (722)
Q Consensus 348 ~~d~iG~v~~~~~~~~~e~~~~~~~l~f~~L~ee~~~~~lr~i~~~--------------~~~~~--~~-----~~~~p- 405 (722)
+++++|.+.++..++......+ |+..+..+...+........ ...+. .. .....
T Consensus 253 ~dd~iG~~~i~l~~l~~~~~~~----w~~Lls~~~g~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (674)
T 3pfq_A 253 RNDFMGSLSFGISELQKAGVDG----WFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328 (674)
T ss_dssp CCEECCBCCCBTTHHHHCCEEE----EEECBCTTGGGTCCEECCC-----------------------------------
T ss_pred ccccccccccchhhhccCCccc----ceeecccccceecccCCCCccccccHHHHHHHhhccccCCCCCccccccccccc
Confidence 9999999999988777666555 44444333332211111000 00000 00 00000
Q ss_pred ----eeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCc
Q 004954 406 ----IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHH 477 (722)
Q Consensus 406 ----i~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpn 477 (722)
.....+..++|+++++||+|+||+||+|+++.+++.||||++++.. ........|..++..+. .||+
T Consensus 329 ~~~~~~~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~ 403 (674)
T 3pfq_A 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPF 403 (674)
T ss_dssp -----------CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT-----CCTT
T ss_pred ccccCccccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc-----CCCe
Confidence 0011233578999999999999999999999999999999998642 23345666777766554 4789
Q ss_pred eeEEEEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 478 Iv~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
|++++++|...+.+||||||+.| +|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 404 i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~ 477 (674)
T 3pfq_A 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 477 (674)
T ss_dssp BCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECS
T ss_pred EEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcC
Confidence 99999999999999999999975 6766665432 2899999999999999999999999999999999999996
Q ss_pred cCCCeEEEEecCCccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 557 YQRCEIKIIDLGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
++.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||+||||++|++||.+.+..+++..|.
T Consensus 478 --~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 555 (674)
T 3pfq_A 478 --EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555 (674)
T ss_dssp --SSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred --CCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 7899999999997532 23445789999999999999999999999999999999999999999988888887775
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH----
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA---- 709 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa---- 709 (722)
..... +|. ..+..+.+||++||+.||.+||++
T Consensus 556 ~~~~~-----------------------------------~p~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~ 591 (674)
T 3pfq_A 556 EHNVA-----------------------------------YPK---------SMSKEAVAICKGLMTKHPGKRLGCGPEG 591 (674)
T ss_dssp SSCCC-----------------------------------CCT---------TSCHHHHHHHHHHSCSSSTTCTTCSTTH
T ss_pred hCCCC-----------------------------------CCc---------cCCHHHHHHHHHHccCCHHHCCCCCCCc
Confidence 32111 111 234678999999999999999997
Q ss_pred -HHHHhCCCCCC
Q 004954 710 -REALDHPWLQH 720 (722)
Q Consensus 710 -~ElL~HPwf~~ 720 (722)
+||++||||+.
T Consensus 592 ~~ei~~h~ff~~ 603 (674)
T 3pfq_A 592 ERDIKEHAFFRY 603 (674)
T ss_dssp HHHHHSSGGGSS
T ss_pred HHHHhcCccccC
Confidence 99999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=444.65 Aligned_cols=249 Identities=30% Similarity=0.509 Sum_probs=203.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....++.+|+.+++.++ ||||++++++|.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR------HPHIIKLYDVIKSKD 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC------CTTBCCEEEEEECSS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC------CCCCCeEEEEEEECC
Confidence 68999999999999999999999999999999997532 33456889999999885 789999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.+||||||++|+|++.+.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~--~~~vkl~DFGl 158 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE--HLNVKIADFGL 158 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TCCEEECCSSC
T ss_pred EEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC--CCCEEEeecCC
Confidence 999999999999999887543 2999999999999999999999999999999999999986 78999999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
|+..... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+..+++..+.....
T Consensus 159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--------- 229 (275)
T 3hyh_A 159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--------- 229 (275)
T ss_dssp C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------
T ss_pred CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 9765443 345789999999999999886 5799999999999999999999999887777766642211
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+|. ..++.+++||++||+.||++|||++|+|+||||+.
T Consensus 230 --------------------------~~p~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 --------------------------TLPK---------FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------------------------CCCT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------------------------CCCC---------CCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1111 23467899999999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=453.32 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=215.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
.+|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++ |||||+++++|.+.+++|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC------CTTBCCEEEEEEETTEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCEEE
Confidence 57999999999999999999999999999999997543 33456789999999885 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
||||||.| +|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+
T Consensus 148 ivmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGla~ 218 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCA 218 (346)
T ss_dssp EEECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCE
T ss_pred EEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC--CCCEEEecCcCce
Confidence 99999985 566665421 2899999999999999999999999999999999999986 7899999999998
Q ss_pred cccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.....+.
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------- 289 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR--------- 289 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC---------
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---------
Confidence 75433 445789999999999999999999999999999999999999999988877777664321110
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
++. ....++++++||.+||+.||++|||++|+|+||||++.
T Consensus 290 -------------------------~~~-------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 290 -------------------------LKN-------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp -------------------------CSC-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------------CCc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 000 11234678999999999999999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=456.80 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=212.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++++.||+|+||+||+|+++.+|+.||||++... ......+.+|+++++.|+ |||||+++++|.+.+.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~------HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK------HPNIVQYRESFEENGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC------CCCCCcEEEEEEECCE
Confidence 6899999999999999999999999999999999754 334567889999999885 7899999999999999
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+|||||||. |+|.+++..... ..+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGl 171 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTVQLGDFGI 171 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT--TCCEEECSTTE
T ss_pred EEEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCCEEEccccc
Confidence 999999997 578888864432 23789999999999999999999999999999999999986 78999999999
Q ss_pred cccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
|+..... ....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|....-+
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------- 243 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------- 243 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred ceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------
Confidence 9876543 23468999999999999999999999999999999999999999999888888777532110
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.++ ...++++.+||.+||+.||++|||++|+|+||||++
T Consensus 244 --------------------------~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 244 --------------------------PVS---------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------------------CCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------------------CCC---------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 000 123467899999999999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=446.09 Aligned_cols=249 Identities=28% Similarity=0.440 Sum_probs=215.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+++++.++ |||||+++++|++.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD------HPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC------CTTBCCEEEEEECSS
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEeCC
Confidence 67999999999999999999999999999999997532 33456788888888774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++||||||+.| +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~--~g~vKl~DFG 177 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFG 177 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC--CCCEEEEEcC
Confidence 99999999975 7888886543 2999999999999999999999999999999999999986 7899999999
Q ss_pred CcccccC-----CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~-----~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
+|+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|....
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------- 250 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------- 250 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------
Confidence 9986532 2345789999999999999999999999999999999999999999988888887775321
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHH------HHhCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE------ALDHPW 717 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~E------lL~HPw 717 (722)
..+|. ..++++++||++||+.||++|||++| +++|||
T Consensus 251 ----------------------------~~~p~---------~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 251 ----------------------------YDFPE---------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293 (311)
T ss_dssp ----------------------------CCCCT---------TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred ----------------------------CCCCc---------ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCC
Confidence 11121 12466899999999999999999987 589999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 294 F~~ 296 (311)
T 4aw0_A 294 FES 296 (311)
T ss_dssp GTT
T ss_pred cCC
Confidence 975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=456.32 Aligned_cols=281 Identities=31% Similarity=0.490 Sum_probs=229.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++++.||+|+||+||+|+++.+|+.||||+++... ....++.+|+++|+.++ |||||++++++...
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK------HDNIIAIKDILRPT 125 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCCS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC------CCCcceEeeeeecc
Confidence 4678999999999999999999999999999999997542 33456788999999885 78999999998643
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
+++|||||||+|+|.+++.... .+++..++.|++||+.||.|||++|||||||||+|||++. ++.+
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~--~~~~ 197 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE--NCEL 197 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCE
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC--CCCE
Confidence 6799999999999988886432 3999999999999999999999999999999999999996 8899
Q ss_pred EEEecCCcccccC-------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 004954 563 KIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (722)
Q Consensus 563 kL~DFGls~~~~~-------~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~ 634 (722)
||+|||+|+.... .....+||+.|+|||++.+. .++.++||||+|||+|||++|++||.+.+..+++..|..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999975432 23457899999999999876 468999999999999999999999999999999999999
Q ss_pred hcCCCcHHHHhhhhhh--hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 635 MLGPIDLEMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
..|.++...+...... ..++. .+... ....+.......++++++||++||++||.+||||.|+
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~-------------~~~~~--~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 342 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQ-------------SLPPR--QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHH-------------SSCCC--CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred hcCCCChHHhhhhhhhhhhhhhh-------------cCCCc--CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 9998887654332111 00000 00000 0112233334556789999999999999999999999
Q ss_pred HhCCCCCCC
Q 004954 713 LDHPWLQHP 721 (722)
Q Consensus 713 L~HPwf~~~ 721 (722)
|+||||++-
T Consensus 343 L~Hp~f~~~ 351 (398)
T 4b99_A 343 LRHPFLAKY 351 (398)
T ss_dssp TTSGGGTTT
T ss_pred hcCHhhCcC
Confidence 999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=454.94 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=216.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
.+|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++ |||||+++++|.+.+.+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC------CTTBCCEEEEEEETTEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC------CCCCCceEEEEEECCEEE
Confidence 57999999999999999999999999999999997543 33456889999999885 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
||||||.| +|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+
T Consensus 225 iVmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~--~g~vKl~DFGla~ 295 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCA 295 (423)
T ss_dssp EEEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT--TCCEEECCCTTCE
T ss_pred EEEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC--CCCEEEecCccce
Confidence 99999985 566665432 2899999999999999999999999999999999999986 7899999999998
Q ss_pred cccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
..... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.....+.
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------- 366 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR--------- 366 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---------
Confidence 65433 445789999999999999999999999999999999999999999988877776664321100
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
++ .....++.+++||.+||+.||.+|||+.|+|+||||++.
T Consensus 367 -------------------------~~-------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 367 -------------------------LK-------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -------------------------CS-------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------------Cc-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 00 011234678999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=430.84 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=204.9
Q ss_pred cCcE-EEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 004954 413 AGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (722)
Q Consensus 413 ~~rY-~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~- 487 (722)
.+|| ++.++||+|+||+||+|.++.+++.||+|++... ......+.+|+++++.++ |||||+++++|..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~------HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ------HPNIVRFYDSWEST 97 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEEEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEeec
Confidence 4566 7888999999999999999999999999998653 334466788999998875 7899999999975
Q ss_pred ---cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCCCe
Q 004954 488 ---LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 488 ---~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~~~ 561 (722)
...++||||||.| +|.+++.... .+++..++.|+.||+.||+|||++| ||||||||+||||+. .++.
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-~~g~ 170 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGS 170 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-TTSC
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-CCCC
Confidence 3568999999984 7777776433 2899999999999999999999998 999999999999974 3678
Q ss_pred EEEEecCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHHhhcCCC
Q 004954 562 IKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPI 639 (722)
Q Consensus 562 vkL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~-~e~l~~i~~~lg~~ 639 (722)
+||+|||+|+..... ....+||+.|+|||++.+ +|+.++|||||||++|||+||++||.+... ..++..+.....
T Consensus 171 vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-- 247 (290)
T 3fpq_A 171 VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-- 247 (290)
T ss_dssp EEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--
T ss_pred EEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--
Confidence 999999999865443 445789999999999875 699999999999999999999999976443 333333321100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
| . ......++++.+||.+||+.||++|||++|+|+||||+
T Consensus 248 ~-----------------------------------~-----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 248 P-----------------------------------A-----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp C-----------------------------------G-----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred C-----------------------------------C-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 0 0 00112346789999999999999999999999999998
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
+
T Consensus 288 ~ 288 (290)
T 3fpq_A 288 E 288 (290)
T ss_dssp -
T ss_pred C
Confidence 6
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=436.26 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=205.7
Q ss_pred CcEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
++|++++.||+|+||+||+|++. .+++.||||++++.. ....++.+|+.+++. +.|||||+++++|.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~------l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE------VNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCC------CCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHH------CCCCCCCeEEEEEEE
Confidence 68999999999999999999874 468899999997542 122345556655544 458999999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+||||||+. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~D 169 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTD 169 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TSCEEEES
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcC--CCCEEecc
Confidence 999999999998 57888876543 2999999999999999999999999999999999999986 78999999
Q ss_pred cCCcccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 567 LGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 567 FGls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
||+|+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|.....+
T Consensus 170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~----- 244 (304)
T 3ubd_A 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----- 244 (304)
T ss_dssp SEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----
T ss_pred cccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-----
Confidence 999976432 344578999999999999999999999999999999999999999999888888777532111
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWL 718 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf 718 (722)
+|. ..++++.+||++||+.||++||| ++|+++||||
T Consensus 245 ------------------------------~p~---------~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 245 ------------------------------MPQ---------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp ------------------------------CCT---------TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred ------------------------------CCC---------cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 111 23467899999999999999998 5899999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 286 ~~ 287 (304)
T 3ubd_A 286 ST 287 (304)
T ss_dssp TT
T ss_pred cC
Confidence 85
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=440.82 Aligned_cols=293 Identities=21% Similarity=0.339 Sum_probs=218.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++.++||+|+||+||+|+++ .+++.||||++..... ..+..+|+++|+.+. .||||++++++|...
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~-----~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAG-----GQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTC-----SBTTBCCCSEEEEET
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhc-----CCCCCceEEEEEEEC
Confidence 4678999999999999999999874 4688999999876543 356788999998875 378999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+++||||||++| +|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++. +.+.+||+||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~-~~~~~kl~DF 162 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR-RLKKYALVDF 162 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCC
T ss_pred CEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC-CCCeEEECcC
Confidence 999999999974 6777653 1899999999999999999999999999999999999985 3479999999
Q ss_pred CCcccccCC-------------------------------ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHh
Q 004954 568 GSSCFQTDN-------------------------------LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT 615 (722)
Q Consensus 568 Gls~~~~~~-------------------------------~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~ellt 615 (722)
|+|+..... ....+||+.|+|||++.+.+ |+.++||||+||++|+|++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 999654321 22357999999999998764 8999999999999999999
Q ss_pred CCCCC-CCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhh---ccccccccCCcc-------chhhhhc
Q 004954 616 GEVLF-PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE---ETNQLEYIIPEE-------SSLEHHL 684 (722)
Q Consensus 616 G~~PF-~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ip~~-------~~l~~~~ 684 (722)
|+.|| .+.+..+.+.+|...+|.++..................+...... .........|.. .......
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 99999 556778899999998886554433321110000000000000000 000001111110 0000112
Q ss_pred ccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 685 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 685 ~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...+++++|||++||++||++||||+|+|+||||++
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 234577899999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=435.08 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=204.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+++.+ .|||||+++++|.+.+.+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l------~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL------SSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC------CCTTBCCEEEEEEETTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC------CCCCCCcEEEEEEECCEEEE
Confidence 579999999999999999999999999999999986532 23577776655 48999999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC-eEEEEecCCcc
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSC 571 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~-~vkL~DFGls~ 571 (722)
|||||. |+|.++++... .+++..++.|+.||+.||+|||++|||||||||+||||+. ++ .+||+|||+|+
T Consensus 128 vmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHAL 199 (336)
T ss_dssp EECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT--TSCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC--CCCEEEEeeCCCCe
Confidence 999998 47888876443 2999999999999999999999999999999999999986 55 69999999997
Q ss_pred cccCC--------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 572 FQTDN--------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 572 ~~~~~--------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
..... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|.... ++
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~--- 274 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PP--- 274 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CG---
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CC---
Confidence 65432 123579999999999999999999999999999999999999998766555554443210 00
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH-----------
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA----------- 712 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El----------- 712 (722)
+...+...++.+.+||.+||+.||.+|||+.|+
T Consensus 275 ------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 275 ------------------------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ------------------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------------------------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 001112345778999999999999999999998
Q ss_pred --HhCCCCCC
Q 004954 713 --LDHPWLQH 720 (722)
Q Consensus 713 --L~HPwf~~ 720 (722)
|+|||++.
T Consensus 319 ~~l~hPw~~~ 328 (336)
T 4g3f_A 319 GGLKSPWKGE 328 (336)
T ss_dssp TSSCSCSSSS
T ss_pred hhccCCCcCC
Confidence 57999964
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=425.71 Aligned_cols=311 Identities=36% Similarity=0.598 Sum_probs=259.1
Q ss_pred eeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 407 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..++.+..+|+++++||+|+||+||+|.+..+++.||||+++..........+|+++++.+++.....|+||+++++++.
T Consensus 90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 44567889999999999999999999999999999999999988777788889999999999988889999999999999
Q ss_pred ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 487 ~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
...++++||||+.++|.+++...... .+++..++.|+.||+.||+|||+.||+||||||+||||+.+....+||+|
T Consensus 170 ~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 170 FRNHICMTFELLSMNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp ETTEEEEEECCCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred cCCeEEEEEeccCCCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 99999999999999999988765432 28999999999999999999999999999999999999974444499999
Q ss_pred cCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 567 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 567 FGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
||++..........++|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..++..++.++.+++..
T Consensus 246 FG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 246 FGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 99998877777778899999999999999999999999999999999999999999999999999999999999998887
Q ss_pred hhhhhhhhcccccchhhhhc--------------cccccccCCccchhhhh-cccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 647 GQEIYKYFTKEYDLYYINEE--------------TNQLEYIIPEESSLEHH-LQFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~ip~~~~l~~~-~~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
......++.......+.... ........+....+... ....++.+.+||++||++||++|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 76666665433221110000 00000011111112111 1234678999999999999999999999
Q ss_pred HHhCCCCCCC
Q 004954 712 ALDHPWLQHP 721 (722)
Q Consensus 712 lL~HPwf~~~ 721 (722)
||+||||++.
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=412.14 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=190.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (722)
++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+++++.++ |||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~------HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE------HPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEEEC--
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEecCcc
Confidence 46999999999999999999999999999999987533 33456778888887764 789999999998654
Q ss_pred ----------eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 490 ----------HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 490 ----------~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
++||||||+.| +|.+++...... .......++.|+.||+.||+|||++||+||||||+||||+.
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~-- 153 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-- 153 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC--
Confidence 47999999975 777777643221 12556678899999999999999999999999999999996
Q ss_pred CCeEEEEecCCcccccCC---------------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004954 559 RCEIKIIDLGSSCFQTDN---------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~---------------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~ 623 (722)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++ ||.+.
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 789999999999765432 123579999999999999999999999999999999996 88654
Q ss_pred hHH-HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 624 AVV-MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 624 ~~~-e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
... ..+..+.. +.+ |+. .....+.+.+||++||+.|
T Consensus 231 ~~~~~~~~~~~~--~~~-----------------------------------p~~------~~~~~~~~~~li~~~L~~d 267 (299)
T 4g31_A 231 MERVRTLTDVRN--LKF-----------------------------------PPL------FTQKYPCEYVMVQDMLSPS 267 (299)
T ss_dssp HHHHHHHHHHHT--TCC-----------------------------------CHH------HHHHCHHHHHHHHHHTCSS
T ss_pred cHHHHHHHHHhc--CCC-----------------------------------CCC------CcccCHHHHHHHHHHcCCC
Confidence 321 12222110 011 100 0011244679999999999
Q ss_pred CCCCcCHHHHHhCCCCCC
Q 004954 703 PQRRPTAREALDHPWLQH 720 (722)
Q Consensus 703 P~kRpTa~ElL~HPwf~~ 720 (722)
|.+|||+.|+|+||||+.
T Consensus 268 P~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 268 PMERPEAINIIENAVFED 285 (299)
T ss_dssp GGGSCCHHHHHTSGGGCC
T ss_pred hhHCcCHHHHhcCHhhCC
Confidence 999999999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=443.64 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=222.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+.++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++ ||||++++++|.+..+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------HPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC------CTTBCCEEEEEECSSE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC------CCCCCeEEEEEEECCE
Confidence 4578999999999999999999999999999999987643 34566788999999885 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++||||||.| +|.+++.... ..+++..++.+++||+.||.|||++||+||||||+|||++....+.+||+|||+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEEEEeecCCCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999975 7777765322 238999999999999999999999999999999999999875568999999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
++..... ....+||+.|+|||++.+.+|+.++|||||||++|+|++|++||.+.+..+.+..|......++...
T Consensus 304 a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---- 379 (573)
T 3uto_A 304 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---- 379 (573)
T ss_dssp CEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG----
T ss_pred eeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc----
Confidence 9876543 3456899999999999999999999999999999999999999999988888888764433222111
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
....++.+++||++||+.||.+|||+.|+|+||||+..
T Consensus 380 ------------------------------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 380 ------------------------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp ------------------------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ------------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 11234668899999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=411.46 Aligned_cols=302 Identities=30% Similarity=0.555 Sum_probs=249.6
Q ss_pred CCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 402 KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 402 ~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
..+....+.++.++|+++++||+|+||+||+|++..+++.||||+++...........|..+++.+.. ....||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~-~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN-DDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCC-CSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcc-cCCCCCCeecc
Confidence 34455667889999999999999999999999999999999999998776666778889999999985 34579999999
Q ss_pred EEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-----
Q 004954 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS----- 556 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~----- 556 (722)
++++...++.++||||++++|.+++...... .+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 9999999999999999988999888754432 2899999999999999999999999999999999999974
Q ss_pred ------------------cCCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 004954 557 ------------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618 (722)
Q Consensus 557 ------------------~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~ 618 (722)
..++.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 23678999999999887776677789999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh--hhhcccccchhhhhccccccccCCccch-----------hhhhcc
Q 004954 619 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY--KYFTKEYDLYYINEETNQLEYIIPEESS-----------LEHHLQ 685 (722)
Q Consensus 619 PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ip~~~~-----------l~~~~~ 685 (722)
||.+.+..+.+..+....++++..++....... .++.... .....|.... +.....
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDE-----------LKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTT-----------TEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCccc-----------ceecCcccccchhhhhhhhhccccccc
Confidence 999999999999999999999988765543211 1111100 0001111000 001112
Q ss_pred cCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 686 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 686 ~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
..++.+.+||++||+.||.+|||+.|||+||||+
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 2346789999999999999999999999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=411.81 Aligned_cols=315 Identities=36% Similarity=0.560 Sum_probs=256.5
Q ss_pred CcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 403 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 403 ~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
.+++..++.+.++|++.+.||+|+||+||+|++..+++.||||+++..........+|+++++.+++.....|++|++++
T Consensus 43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 45667788899999999999999999999999999999999999988776677888999999999877666777899999
Q ss_pred EEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH--HCCCccccCCCCceEEcccCCC
Q 004954 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLH--s~gIvHrDLKp~NILl~~~~~~ 560 (722)
+++...++.++||||+.++|.+++...... .+++..++.++.||+.||.||| +.||+||||||+|||++.+.++
T Consensus 123 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred eeeccCCceEEEEecCCCCHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 999999999999999999999988755322 2899999999999999999999 5799999999999999765678
Q ss_pred eEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 561 EIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++
T Consensus 199 ~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp CEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred cEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 89999999998887777778899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhcccccchhh-hh-ccccccccCCccchhhhhc------------------ccCcHHHHHHHHHhcc
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYI-NE-ETNQLEYIIPEESSLEHHL------------------QFSDAFFIDFVRTLLE 700 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~ip~~~~l~~~~------------------~~~~~~l~dLL~~mL~ 700 (722)
...+.......+++..-...... .. .........|....+.... ....+.+++||++||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 88877665555554432111000 00 0000001111111111100 0012478999999999
Q ss_pred cCCCCCcCHHHHHhCCCCCCC
Q 004954 701 INPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 701 ~dP~kRpTa~ElL~HPwf~~~ 721 (722)
+||++|||++|+|+||||++.
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC-
T ss_pred CChhhCCCHHHHhcCcccccC
Confidence 999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=401.65 Aligned_cols=313 Identities=31% Similarity=0.523 Sum_probs=251.3
Q ss_pred cceeeCceecCcEEEEEEeccCCCCceEEEEE-CCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQD-LHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 404 ~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d-~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
+++..++++.++|++.+.||+|+||+||+|.+ ..+++.||||+++..........+|+.+++.+++.....|++|++++
T Consensus 4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 45667889999999999999999999999998 56899999999987776677889999999999998888889999999
Q ss_pred EEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC----
Q 004954 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ---- 558 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~---- 558 (722)
+++...++.++||||++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++..+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHHGHICIVFELLGLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred cccccCCcEEEEEcCCCCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 99999999999999998899998875432 2388999999999999999999999999999999999998633
Q ss_pred -------------CCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH
Q 004954 559 -------------RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (722)
Q Consensus 559 -------------~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~ 625 (722)
++.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 5679999999998877666677899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
.+.+..+....+++|..++........+..................................++.+.+||++||+.||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 99999999999999988776543222111110000000000000000000000000011122467899999999999999
Q ss_pred CcCHHHHHhCCCCCC
Q 004954 706 RPTAREALDHPWLQH 720 (722)
Q Consensus 706 RpTa~ElL~HPwf~~ 720 (722)
|||+.|+|+||||+.
T Consensus 320 Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 320 RITLREALKHPFFDL 334 (339)
T ss_dssp SCCHHHHTTSGGGGG
T ss_pred ccCHHHHhcCHHHHH
Confidence 999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=413.81 Aligned_cols=315 Identities=33% Similarity=0.547 Sum_probs=252.3
Q ss_pred cCCccCCCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccC--C
Q 004954 395 RTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND--P 472 (722)
Q Consensus 395 ~~~~~~~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~--~ 472 (722)
...+.....+++..++.+.++|++.++||+|+||+||+|++..+++.||||+++........+.+|+.+++.+++.. .
T Consensus 18 ~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~ 97 (397)
T 1wak_A 18 PNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97 (397)
T ss_dssp ----CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTC
T ss_pred cccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCC
Confidence 34556667889999999999999999999999999999999999999999999887766778899999999998753 2
Q ss_pred CCCCceeEEEEEEE----ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccC
Q 004954 473 ADEHHILRLYDYFY----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDL 547 (722)
Q Consensus 473 ~~hpnIv~l~~~f~----~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDL 547 (722)
..|+||++++++|. ...++++||||+.+++++.+..... ..+++..++.|+.||+.||.|||++ ||+||||
T Consensus 98 ~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDi 173 (397)
T 1wak_A 98 PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDI 173 (397)
T ss_dssp GGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCC
T ss_pred CCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 24889999999998 4568999999999999888875432 2389999999999999999999998 9999999
Q ss_pred CCCceEEcccC-----------------------------------------------CCeEEEEecCCcccccCCcccc
Q 004954 548 KPENILIKSYQ-----------------------------------------------RCEIKIIDLGSSCFQTDNLCLY 580 (722)
Q Consensus 548 Kp~NILl~~~~-----------------------------------------------~~~vkL~DFGls~~~~~~~~~~ 580 (722)
||+||||+.++ ...+||+|||++..........
T Consensus 174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 253 (397)
T 1wak_A 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED 253 (397)
T ss_dssp SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSC
T ss_pred CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccC
Confidence 99999998521 1379999999998877666677
Q ss_pred ccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh------HHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 004954 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA------VVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (722)
Q Consensus 581 ~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~------~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~ 654 (722)
.+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ ..+.+..+...+|.++..++........++
T Consensus 254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 333 (397)
T 1wak_A 254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333 (397)
T ss_dssp CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence 89999999999999999999999999999999999999997643 667788889999999988877666555554
Q ss_pred cccccchhhhhccccccccCCcc--chhhhh---cccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 655 TKEYDLYYINEETNQLEYIIPEE--SSLEHH---LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~ip~~--~~l~~~---~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
........... ..+.. ..+... ....+..+.+||++||+.||++|||+.|||+||||++
T Consensus 334 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 334 TKKGDLKHITK-------LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CTTSSBSSCCC-------CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCccccccccc-------cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 43322211110 00000 000000 1112356899999999999999999999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=402.25 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=204.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
.++|.+.+.||+|+||+||+|++. .+++.||||+++... ...+.+.+|+++++.++ |||||++++++.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~------HpnIV~l~g~~~ 85 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ------HEHIVKFYGVCV 85 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC------CCCCccEEEEEe
Confidence 467999999999999999999874 468899999997643 34566788888887774 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhc-------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQE-------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~-------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
+.+.++||||||. |+|.+++..... ......+++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~-- 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-- 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC--
Confidence 9999999999997 578888865421 122345999999999999999999999999999999999999996
Q ss_pred CCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i 632 (722)
++.+||+|||+|+..... .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+++..+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 789999999999754332 122468999999999999999999999999999999999 99999998887777666
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
..... ...| ...++.+.+||.+||+.||++|||++|+
T Consensus 244 ~~~~~----------------------------------~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 244 TQGRV----------------------------------LQRP---------RTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp HHTCC----------------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HcCCC----------------------------------CCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 42110 0111 1234678999999999999999999999
Q ss_pred Hh
Q 004954 713 LD 714 (722)
Q Consensus 713 L~ 714 (722)
++
T Consensus 281 ~~ 282 (299)
T 4asz_A 281 HT 282 (299)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=400.69 Aligned_cols=317 Identities=29% Similarity=0.460 Sum_probs=254.2
Q ss_pred CCCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCC-cEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCce
Q 004954 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478 (722)
Q Consensus 400 ~~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg-~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnI 478 (722)
....+++..++.+.++|++.+.||+|+||+||+|.+..++ +.||+|+++..........+|+.+++.+++.....++++
T Consensus 5 ~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 84 (355)
T 2eu9_A 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84 (355)
T ss_dssp TTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCB
T ss_pred cCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeE
Confidence 3456778889999999999999999999999999998777 789999998776667788899999999998877777889
Q ss_pred eEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc--
Q 004954 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-- 556 (722)
Q Consensus 479 v~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-- 556 (722)
+.+++++...++.++||||+++++++.+..... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 85 VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160 (355)
T ss_dssp CCEEEEEEETTEEEEEEECCCCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCC
T ss_pred EEeeeeeeeCCeEEEEEeccCCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccc
Confidence 999999999999999999999999988775432 23899999999999999999999999999999999999943
Q ss_pred ---------------cCCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004954 557 ---------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (722)
Q Consensus 557 ---------------~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~ 621 (722)
..++.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 13688999999999887776677789999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhccc
Q 004954 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701 (722)
Q Consensus 622 ~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~ 701 (722)
.....+.+..+....+++|..++........++....................+............+..+.+||++||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 99999999999999999998887654433222111110000000000000000000000001111235789999999999
Q ss_pred CCCCCcCHHHHHhCCCCCC
Q 004954 702 NPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 702 dP~kRpTa~ElL~HPwf~~ 720 (722)
||.+|||+.|+|+||||+.
T Consensus 321 dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp STTTSCCHHHHTTSGGGGG
T ss_pred ChhhCcCHHHHhcChhhcC
Confidence 9999999999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=402.80 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=201.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+|.+.++||+|+||+||+|++. .+++.||||+++... ...+.+.+|+++++.++ |||||++++++.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~------HpnIV~l~g~~~ 113 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ------HQHIVRFFGVCT 113 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEC
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEE
Confidence 467899999999999999999864 468899999997543 34566788888888774 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhcc---------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQES---------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~---------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
+.+.++||||||. |+|.+++...... .....+++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999998 5788877654321 12345999999999999999999999999999999999999995
Q ss_pred cCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 004954 557 YQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~ 630 (722)
++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||+||||+| |+.||.+.+..+++.
T Consensus 194 --~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 --GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp --TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred --CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 889999999999764322 233578999999999999999999999999999999999 999999988777776
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+..... ..+| ...++.+.+||.+||+.||++|||+.
T Consensus 272 ~i~~g~~----------------------------------~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~ 308 (329)
T 4aoj_A 272 CITQGRE----------------------------------LERP---------RACPPEVYAIMRGCWQREPQQRHSIK 308 (329)
T ss_dssp HHHHTCC----------------------------------CCCC---------TTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred HHHcCCC----------------------------------CCCc---------ccccHHHHHHHHHHcCcChhHCcCHH
Confidence 6542110 1111 12346789999999999999999999
Q ss_pred HHHhC
Q 004954 711 EALDH 715 (722)
Q Consensus 711 ElL~H 715 (722)
||+++
T Consensus 309 ei~~~ 313 (329)
T 4aoj_A 309 DVHAR 313 (329)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=391.72 Aligned_cols=287 Identities=25% Similarity=0.417 Sum_probs=228.8
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
+++++.++|++.+.||+|+||+||+|++..+|+.||||++.... .......+|+.+++.++.. .||||+++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~niv~~ 79 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF---EHPNVVRL 79 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH---CCTTBCCE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc---CCCCeEEe
Confidence 35677899999999999999999999999999999999987432 1234667888888888743 48999999
Q ss_pred EEEEEecC-----eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 482 YDYFYHLE-----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 482 ~~~f~~~~-----~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
++++.... ..++||||+.++|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 155 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT
T ss_pred eeeeeccCCCCceeEEEEehhhhcCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 99998765 5899999999999888875432 23899999999999999999999999999999999999985
Q ss_pred cCCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 004954 557 YQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~ 634 (722)
++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.++..
T Consensus 156 --~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 156 --GGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp --TSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred --CCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 788999999999765433 3446789999999999999999999999999999999999999999999999999998
Q ss_pred hcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
..+.++...+......... ... ......+.......++.+.+||.+||+.||.+|||+.|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~---------------~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRG---------------AFP--PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGG---------------GSC--CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhcccc---------------ccC--CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 8887776554432111100 000 00111222333445678999999999999999999999999
Q ss_pred CCCCCC
Q 004954 715 HPWLQH 720 (722)
Q Consensus 715 HPwf~~ 720 (722)
||||++
T Consensus 297 h~~~~~ 302 (308)
T 3g33_A 297 HSYLHK 302 (308)
T ss_dssp STTC--
T ss_pred CccccC
Confidence 999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=397.85 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=196.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
++-.+++++.++||+|+||+||+|++. ..||||+++.. ....+.+.+|+.+++.++ |||||++++++.
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~------HpNIV~l~g~~~ 102 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR------HVNILLFMGYMT 102 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEE
Confidence 344577899999999999999999853 35999998743 334566788888887774 789999999875
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
.+.++||||||. |+|.+++.... ..+++.++..|+.||+.||+|||+++||||||||+||||+. ++.+||+
T Consensus 103 -~~~~~iVmEy~~gGsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~--~~~~Ki~ 174 (307)
T 3omv_A 103 -KDNLAIVTQWCEGSSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHE--GLTVKIG 174 (307)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEET--TEEEEEC
T ss_pred -CCeEEEEEEcCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECC--CCcEEEe
Confidence 567899999998 57777775432 23899999999999999999999999999999999999996 8899999
Q ss_pred ecCCcccccC-----CccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 566 DLGSSCFQTD-----NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 566 DFGls~~~~~-----~~~~~~gt~~y~APE~l~~---~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|||+|+.... .....+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.+....+..++....
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~ 254 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY 254 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 9999976542 2334689999999999974 3589999999999999999999999987655444433321100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH-----
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA----- 712 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El----- 712 (722)
..|. +.......++.+.+||.+||+.||++|||+.|+
T Consensus 255 -----------------------------------~~p~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 255 -----------------------------------ASPD---LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp -----------------------------------CCCC---STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred -----------------------------------CCCC---cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 0010 011112345679999999999999999999976
Q ss_pred -HhCCCC
Q 004954 713 -LDHPWL 718 (722)
Q Consensus 713 -L~HPwf 718 (722)
|+|++-
T Consensus 297 ~l~~~lp 303 (307)
T 3omv_A 297 LLQHSLP 303 (307)
T ss_dssp HHHTTCC
T ss_pred HHhccCC
Confidence 567664
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=431.66 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=208.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. .......+|..++..++. ..|||||+++++|++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~---~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTP 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS---SCCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh---CCCCCEeEEEEEEEEC
Confidence 467999999999999999999999999999999997542 223345566667776664 3699999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+++||||||+.| +|..++.... .+++..++.++.||+.||.|||++|||||||||+||||+. ++.+||+||
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~--~G~vKL~DF 336 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDL 336 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC--CCCEEeccc
Confidence 999999999985 6777776433 2999999999999999999999999999999999999996 889999999
Q ss_pred CCcccccC-CccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCChH---HHHHHHHHhhcCCCcHH
Q 004954 568 GSSCFQTD-NLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGMLGPIDLE 642 (722)
Q Consensus 568 Gls~~~~~-~~~~~~gt~~y~APE~l~-~~~~s~ksDIWSLGviL~elltG~~PF~~~~~---~e~l~~i~~~lg~~~~~ 642 (722)
|+|+.... .....+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+. .++...+...
T Consensus 337 GlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~------- 409 (689)
T 3v5w_A 337 GLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 409 (689)
T ss_dssp TTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-------
T ss_pred ceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-------
Confidence 99987544 345679999999999997 46799999999999999999999999976432 2222222110
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPW 717 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPw 717 (722)
...+|. ..++++++||.+||+.||.+|++ ++||++|||
T Consensus 410 ----------------------------~~~~p~---------~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 410 ----------------------------AVELPD---------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp ----------------------------CCCCCT---------TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred ----------------------------CCCCCc---------cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 111121 23467899999999999999998 899999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 453 F~~ 455 (689)
T 3v5w_A 453 FRS 455 (689)
T ss_dssp GTT
T ss_pred ccC
Confidence 985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=399.37 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=208.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
+-...++++++||+|+||+||+|+.. .+++.||||+++... ...+.+.+|+.+++.++ |||||++++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~------HpNIV~l~g 96 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ------HPNVVCLLG 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC------CCCCCCcce
Confidence 33467899999999999999999853 467899999997532 33467889999999885 789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 004954 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~----------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NI 552 (722)
++...+.++||||||. |+|.+++....... ....+++..+..|+.||+.||+|||+++||||||||+||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 9999999999999997 57888886443211 123489999999999999999999999999999999999
Q ss_pred EEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHH
Q 004954 553 LIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVV 626 (722)
Q Consensus 553 Ll~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~ 626 (722)
||+. ++.+||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||+||||+| |..||.+.+..
T Consensus 177 Ll~~--~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 177 LVYD--KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp EECG--GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred EECC--CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9996 789999999999754322 234578999999999999999999999999999999998 89999998887
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
+++..+..... ...| ...+..+.+||.+||+.||++|
T Consensus 255 ~~~~~i~~~~~----------------------------------~~~p---------~~~~~~~~~li~~C~~~dP~~R 291 (308)
T 4gt4_A 255 DVVEMIRNRQV----------------------------------LPCP---------DDCPAWVYALMIECWNEFPSRR 291 (308)
T ss_dssp HHHHHHHTTCC----------------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHcCCC----------------------------------CCCc---------ccchHHHHHHHHHHcCCChhHC
Confidence 77766542110 0011 1234678899999999999999
Q ss_pred cCHHHHHhC
Q 004954 707 PTAREALDH 715 (722)
Q Consensus 707 pTa~ElL~H 715 (722)
||+.||+++
T Consensus 292 Ps~~ei~~~ 300 (308)
T 4gt4_A 292 PRFKDIHSR 300 (308)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999976
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=394.74 Aligned_cols=286 Identities=28% Similarity=0.427 Sum_probs=232.5
Q ss_pred eeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 407 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
...+.+.++|+++++||+|+||+||+|++. +|+.||+|+++... .....+.+|+.+++.++ ||||+++++
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~ 86 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH------HPNIVSLID 86 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC------CCCEeeeee
Confidence 345677899999999999999999999985 58999999987543 22356778999998885 789999999
Q ss_pred EEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 484 YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
++....+.++||||+.+++.+.+..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~--~~~~k 159 (311)
T 3niz_A 87 VIHSERCLTLVFEFMEKDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS--DGALK 159 (311)
T ss_dssp EECCSSCEEEEEECCSEEHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEE
T ss_pred EEccCCEEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC--CCCEE
Confidence 9999999999999999998888765332 3899999999999999999999999999999999999986 78899
Q ss_pred EEecCCcccccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+...++.+
T Consensus 160 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 239 (311)
T 3niz_A 160 LADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP 239 (311)
T ss_dssp ECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC
T ss_pred EccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC
Confidence 9999999765432 334578999999999987 568999999999999999999999999988888888998888887
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+...+........+...... ......+.......+.++.+||++||++||.+|||++|+|+||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 240 NPREWPQVQELPLWKQRTFQ--------------VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp CTTTSGGGTTSHHHHSCCCC--------------CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred ChHHhhhhhccchhhhcccc--------------cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 77666655444333221111 1111122223334567899999999999999999999999999998
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
+
T Consensus 306 ~ 306 (311)
T 3niz_A 306 D 306 (311)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=387.12 Aligned_cols=279 Identities=30% Similarity=0.426 Sum_probs=228.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++++.||+|+||+||+|++..+|+.||||++.... .......+|+.+++.++ ||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC------CTTBCCEEEEEEETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC------CCCEeeEEeEEEeCCE
Confidence 58999999999999999999999999999999997543 23355667777777664 7899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+.+++++.+..... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTC
T ss_pred EEEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeecccc
Confidence 999999999998888765432 2899999999999999999999999999999999999996 788999999999
Q ss_pred ccccCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~P-F~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+....+.++.+.+.
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred eecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 765432 23457899999999998766 89999999999999999987666 67888888999999888887776655
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.......+.. ....+....+.......+..+.+||++||+.||++|||++|+|+||||++
T Consensus 229 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 229 SMTKLPDYKP---------------YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TGGGSTTCCC---------------CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhcccccccc---------------cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 4433222110 01111122222233345678999999999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=413.71 Aligned_cols=299 Identities=29% Similarity=0.501 Sum_probs=229.4
Q ss_pred CCcceeeCc---eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCC
Q 004954 402 KDLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADE 475 (722)
Q Consensus 402 ~~~pi~~~~---~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~h 475 (722)
..+++..++ .+.++|++++.||+|+||+||+|++..+|+.||||++... .....++.+|+.+++.++ |
T Consensus 47 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h 120 (464)
T 3ttj_A 47 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------H 120 (464)
T ss_dssp CEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC------C
T ss_pred cceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC------C
Confidence 344454444 4578999999999999999999999999999999999753 334566778888888885 7
Q ss_pred CceeEEEEEEEec------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 476 HHILRLYDYFYHL------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 476 pnIv~l~~~f~~~------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
|||+++++++... .++++||||+.+++...+.. .+++..++.++.||+.||+|||+.||+||||||
T Consensus 121 pnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp 192 (464)
T 3ttj_A 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192 (464)
T ss_dssp TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred CCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence 8999999999754 46899999999998877642 188999999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e 627 (722)
+|||++. ++.+||+|||++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+
T Consensus 193 ~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~ 270 (464)
T 3ttj_A 193 SNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270 (464)
T ss_dssp GGEEECT--TSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HhEEEeC--CCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999996 789999999999876543 344689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccc--hhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 628 ~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~--~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
.+..|+..+|.++.+.+.........+........ ...+...+|... .........++.+++||++||++||++
T Consensus 271 ~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA----GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCC----CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccC----CCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 99999999999888877655432221111110000 000011111100 000001111457899999999999999
Q ss_pred CcCHHHHHhCCCCCC
Q 004954 706 RPTAREALDHPWLQH 720 (722)
Q Consensus 706 RpTa~ElL~HPwf~~ 720 (722)
|||++|+|+||||+.
T Consensus 347 R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 347 RISVDDALQHPYINV 361 (464)
T ss_dssp SCCHHHHHTSTTTGG
T ss_pred CCCHHHHhcChhhhh
Confidence 999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=401.70 Aligned_cols=296 Identities=28% Similarity=0.470 Sum_probs=220.9
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
+..+.++|++++.||+|+||+||+|.+..+|+.||||++... ........+|+.+++.+. .||||+++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~~~~ 78 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-----GHENIVNLLNVL 78 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc-----CCCCCCeeeeEE
Confidence 455678999999999999999999999999999999998642 334566778888888886 378999999999
Q ss_pred EecC--eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 486 YHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 486 ~~~~--~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
...+ .+++||||+.++|..++... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+|
T Consensus 79 ~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~k 149 (388)
T 3oz6_A 79 RADNDRDVYLVFDYMETDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVK 149 (388)
T ss_dssp ECTTSSCEEEEEECCSEEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEE
T ss_pred ecCCCCEEEEEecccCcCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC--CCCEE
Confidence 8654 79999999999988887642 2889999999999999999999999999999999999986 78999
Q ss_pred EEecCCcccccC------------------------CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCC
Q 004954 564 IIDLGSSCFQTD------------------------NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEV 618 (722)
Q Consensus 564 L~DFGls~~~~~------------------------~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~ 618 (722)
|+|||+++.... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|++
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 999999975422 1233578999999999987 678999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh--hhhhcccccchhhhhccccccccCCccchh---hhhcccCcHHHHH
Q 004954 619 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSL---EHHLQFSDAFFID 693 (722)
Q Consensus 619 PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l---~~~~~~~~~~l~d 693 (722)
||.+.+..+.+..|...++.++.+.+...... ..++.. .... ............+..... .......++.+.+
T Consensus 230 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 307 (388)
T 3oz6_A 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES-LKEK-VEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307 (388)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHH-HHHH-CC-----CCCCHHHHHHHHHHHCTTCCCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh-Cccc-ccccCCCHHHhCcchhhhcccccccccCCHHHHH
Confidence 99999999999999999998887766432211 000000 0000 000000000000000000 0001134578999
Q ss_pred HHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 694 FVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 694 LL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
||++||+.||.+|||++|+|+||||+.
T Consensus 308 ll~~~L~~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 308 LLDKLLQFNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred HHHHhhccCcccCCCHHHHhCCHHHHH
Confidence 999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=381.20 Aligned_cols=278 Identities=30% Similarity=0.478 Sum_probs=221.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|++++.||+|+||+||+|++ .+|+.||+|++..... ....+.+|+.+++.++ ||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK------HSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC------CTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC------CCCEeeeeeEEccCCe
Confidence 5899999999999999999998 6799999999875432 2355667888777664 7899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+.++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 75 LVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (288)
T ss_dssp EEEEEECCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred EEEEEEecCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEeECccc
Confidence 999999999998888765432 2889999999999999999999999999999999999985 788999999998
Q ss_pred ccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++...++.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 765432 2345789999999999764 589999999999999999999999999988888888888887766554443
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....++-. ... ......+.......++.+.+||++||+.||++|||+.|+|+||||++
T Consensus 228 ~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 228 VTELPKYDP-------------NFT--VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp GGGSTTCCT-------------TCC--CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhccccccc-------------ccc--cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 322211100 000 00011122233445678999999999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=388.77 Aligned_cols=288 Identities=31% Similarity=0.501 Sum_probs=218.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.++|++++.||+|+||+||+|.+..+|+.||+|+++... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK------HENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC------BTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC------CCCcceEEEEEEECCe
Confidence 468999999999999999999999999999999997543 23356778888887764 7899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||||+.++|.+++...........+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCSSC
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC--CCCEEECcCccc
Confidence 999999999999998876654444445899999999999999999999999999999999999986 788999999999
Q ss_pred ccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...+..
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence 765432 3345789999999999874 689999999999999999999999999999999999998888777665554
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCcc--chh-hhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSL-EHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~--~~l-~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
.....++... .....+.. ..+ .......+..+.+||++||+.||++|||+.|+|+||||++-
T Consensus 236 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 236 VTKLPKYNPN-------------IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GGGCTTCCTT-------------CCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhhhcccc-------------cccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 4332221110 00000000 000 01112346789999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=396.98 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=205.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~t-----g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
-.++|++.+.||+|+||+||+|++..+ ++.||||+++... .....+.+|++++..+.+ |||||+++++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~h-----hpnIV~l~g~ 136 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLGA 136 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-----CTTBCCEEEE
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCC-----CCcEEEEEEE
Confidence 357899999999999999999987544 4689999997643 334668899999999975 5799999999
Q ss_pred EEec-CeEEEEEEccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 004954 485 FYHL-EHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (722)
Q Consensus 485 f~~~-~~l~iVmEy~~-gsLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NI 552 (722)
|... +.++||||||. |+|.++++..... .....+++..+..|+.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 8764 57999999997 5788888754321 1123489999999999999999999999999999999999
Q ss_pred EEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHH
Q 004954 553 LIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVV 626 (722)
Q Consensus 553 Ll~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~ 626 (722)
|++. ++.+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..
T Consensus 217 Ll~~--~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EECG--GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeCC--CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9996 7899999999998654321 23578999999999999999999999999999999998 99999876543
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
+.+.+++.. .....+| ...++++.+||.+||+.||++|
T Consensus 295 ~~~~~~i~~---------------------------------g~~~~~p---------~~~~~~~~~li~~c~~~dP~~R 332 (353)
T 4ase_A 295 EEFCRRLKE---------------------------------GTRMRAP---------DYTTPEMYQTMLDCWHGEPSQR 332 (353)
T ss_dssp HHHHHHHHH---------------------------------TCCCCCC---------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHc---------------------------------CCCCCCC---------ccCCHHHHHHHHHHcCcChhHC
Confidence 333222210 0011112 1234678999999999999999
Q ss_pred cCHHHHHhC
Q 004954 707 PTAREALDH 715 (722)
Q Consensus 707 pTa~ElL~H 715 (722)
||+.||++|
T Consensus 333 Pt~~eil~~ 341 (353)
T 4ase_A 333 PTFSELVEH 341 (353)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=393.59 Aligned_cols=315 Identities=33% Similarity=0.574 Sum_probs=246.2
Q ss_pred ccCCCCcceeeCcee-cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCC----
Q 004954 398 FEENKDLPIILNTVI-AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP---- 472 (722)
Q Consensus 398 ~~~~~~~pi~~~~~l-~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~---- 472 (722)
|.+...+|...++.+ .++|++.+.||+|+||+||+|++..+++.||||++...........+|+.+++.+.+...
T Consensus 2 y~~~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 81 (373)
T 1q8y_A 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81 (373)
T ss_dssp -----CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CCCCCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchh
Confidence 345567777777766 579999999999999999999999999999999998777667788899999999986532
Q ss_pred -CCCCceeEEEEEEEecC----eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCcccc
Q 004954 473 -ADEHHILRLYDYFYHLE----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCD 546 (722)
Q Consensus 473 -~~hpnIv~l~~~f~~~~----~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrD 546 (722)
..|+||+++++++...+ ++++||||++++|.+++...... .+++..++.++.||+.||+|||++ ||+|||
T Consensus 82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~D 157 (373)
T 1q8y_A 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 157 (373)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCEECSC
T ss_pred ccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 23789999999998764 89999999988999888754322 288999999999999999999998 999999
Q ss_pred CCCCceEEccc----CCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004954 547 LKPENILIKSY----QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (722)
Q Consensus 547 LKp~NILl~~~----~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~ 622 (722)
|||+|||++.. ..+.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999642 24589999999998877666667899999999999999999999999999999999999999986
Q ss_pred Ch------HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhh---cccCcHHHHH
Q 004954 623 DA------VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH---LQFSDAFFID 693 (722)
Q Consensus 623 ~~------~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~---~~~~~~~l~d 693 (722)
.+ ..+.+..+...+|.+|..++........++............ .. .+....+... ....+..+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~ 312 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL----KF-WPLEDVLTEKYKFSKDEAKEISD 312 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC----CB-CCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccc----cc-cchhhhhhhcccCCcchHHHHHH
Confidence 54 566788888999999988887766655555432221111000 00 0000000000 1122467899
Q ss_pred HHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 694 FVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 694 LL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
||++||+.||.+|||+.|||+||||+..
T Consensus 313 li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHhccCccccCCHHHHhhChhhhcc
Confidence 9999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=383.85 Aligned_cols=253 Identities=26% Similarity=0.475 Sum_probs=215.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
...++|++++.||+|+||.||+|++..+|+.||||++... .....++.+|+++++.++ ||||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN------HPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEE
Confidence 3457899999999999999999999999999999999753 234566778999998885 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+++||||+. ++|.+++..... +++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~--~~~~kl~D 157 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIAD 157 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECS
T ss_pred CCEEEEEEECCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC--CCCEEEee
Confidence 999999999996 577777765432 899999999999999999999999999999999999986 78899999
Q ss_pred cCCcccccC--CccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 567 LGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 567 FGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s-~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..++...+.....
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------ 231 (328)
T 3fe3_A 158 FGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY------ 231 (328)
T ss_dssp TTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------
T ss_pred ccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------
Confidence 999976543 34456899999999999988875 799999999999999999999999887777666542211
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
.+|. ..+..+.+||++||+.||.+|||++|+|+||||+..
T Consensus 232 -----------------------------~~p~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 232 -----------------------------RIPF---------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp -----------------------------CCCT---------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred -----------------------------CCCC---------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 1111 134668899999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=384.87 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=221.4
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+.++|++.+.||+|+||+||+|.+..+++.+|+|++.........+.+|+.+++.++ ||||+++++++...+.+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------HRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC------CTTBCCEEEEEEETTEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCC------CCCCCeEeEEEecCCEE
Confidence 468999999999999999999999999999999999876666667888999998875 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.| +|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++...++.+||+|||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 999999985 7777765322 2389999999999999999999999999999999999999655789999999999
Q ss_pred ccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 571 ~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++...+
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---- 227 (321)
T 1tki_A 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---- 227 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH----
T ss_pred eECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh----
Confidence 775433 33467899999999999988999999999999999999999999998888877777644333222111
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...+..+.+||++||+.||.+|||+.|+|+||||+.
T Consensus 228 ------------------------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 228 ------------------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 123466899999999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=388.47 Aligned_cols=280 Identities=27% Similarity=0.403 Sum_probs=222.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~--~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++|++++.||+|+||+||+|++..+++.||||+++..... .....+|+.+++.++ ||||+++++++...+..
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC------CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC------CCCCCeeeeEEeeCCEE
Confidence 5899999999999999999999999999999998754321 123446777776664 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++||||+.++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLAR 148 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT--TCCEEECSSSEEE
T ss_pred EEEecccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC--CCCEEEccCcccc
Confidence 99999999999988875432 3889999999999999999999999999999999999986 7889999999987
Q ss_pred cccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.++.+.+...
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 149 AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp CC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhh
Confidence 65432 233577999999999987 56899999999999999999999999999999999999999998877665543
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....+.... ........+.......++.+.+||++||+.||.+|||++|+|+||||++
T Consensus 229 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 229 LSNEEFKTYN--------------YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp GGCHHHHHTC--------------CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hcchhhcccc--------------cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 3222111100 0000111122233445678999999999999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=402.65 Aligned_cols=282 Identities=29% Similarity=0.469 Sum_probs=213.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.++|+++++||+|+||+||+|+++.+|+.||||++... .....++.+|+++++.++ ||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 123 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN------HDHVVKVLDIVIP 123 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC------CCCCCceEEEEec
Confidence 4568999999999999999999999999999999998653 334567788999999885 7899999999954
Q ss_pred c-----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 488 L-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 488 ~-----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
. ..+|+||||++++|..++.... .+++..++.++.||+.||+|||+.||+||||||+||||+. ++.+
T Consensus 124 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~--~~~~ 195 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIADSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSV 195 (458)
T ss_dssp SCTTTCCCEEEEECCCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCE
T ss_pred CCcccCceEEEEEeccccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC--CCCE
Confidence 3 5799999999999988876432 3899999999999999999999999999999999999996 7899
Q ss_pred EEEecCCcccccC------------------------------CccccccCCcccCchhhc-CCCCCchhhHHHHHHHHH
Q 004954 563 KIIDLGSSCFQTD------------------------------NLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILA 611 (722)
Q Consensus 563 kL~DFGls~~~~~------------------------------~~~~~~gt~~y~APE~l~-~~~~s~ksDIWSLGviL~ 611 (722)
||+|||+++.... .....+||+.|+|||++. +..++.++||||||||||
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 9999999976432 123457899999999874 567999999999999999
Q ss_pred HHHh-----------CCCCCCCCh--------------------HHHHHHHHHhhcCCCcHHHHhhhhhh--hhhhcccc
Q 004954 612 ELWT-----------GEVLFPNDA--------------------VVMILARIIGMLGPIDLEMLMQGQEI--YKYFTKEY 658 (722)
Q Consensus 612 ellt-----------G~~PF~~~~--------------------~~e~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~ 658 (722)
||++ |++||++.+ ..+.+..|...+|.++.+.+...... ..+...
T Consensus 276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-- 353 (458)
T 3rp9_A 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI-- 353 (458)
T ss_dssp HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTT--
T ss_pred HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHh--
Confidence 9999 788887654 35778888888998888776543221 111100
Q ss_pred cchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 659 DLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 659 ~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
+. ......+.......++.+++||++||++||.+|||++|+|+||||+..
T Consensus 354 -----------~~--~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 354 -----------FP--KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp -----------SC--CCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred -----------cC--CCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 00 001112222333456789999999999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=385.38 Aligned_cols=287 Identities=24% Similarity=0.397 Sum_probs=221.5
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.....++|+++++||+|+||+||+|++..+++.||||+++.... ....+.+|+.+++.++ ||||+++++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~ 102 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ------HRNIIELKSVI 102 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC------CTTBCCEEEEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC------CCCcceEEEEE
Confidence 34556899999999999999999999999999999999975432 2334567777777664 78999999999
Q ss_pred EecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc---CCCeE
Q 004954 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEI 562 (722)
Q Consensus 486 ~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~---~~~~v 562 (722)
...+..++||||+.++|.+++..... +++..++.|+.||+.||.|||++||+||||||+|||++.. ..+.+
T Consensus 103 ~~~~~~~lv~e~~~~~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 103 HHNHRLHLIFEYAENDLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEE
T ss_pred ecCCEEEEEEecCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceE
Confidence 99999999999999999888875432 8999999999999999999999999999999999999641 35579
Q ss_pred EEEecCCcccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 563 KIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 563 kL~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp EECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999998765432 3345679999999999875 4899999999999999999999999999999999999988887
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
++...+........+..... ...............+..+.+||++||+.||.+|||+.|+|+||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFP--------------KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCC--------------CCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred Cchhhhhhhhhhhhhhhhhh--------------hhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 77655544332222211000 0000000011112345789999999999999999999999999999
Q ss_pred CCC
Q 004954 719 QHP 721 (722)
Q Consensus 719 ~~~ 721 (722)
++.
T Consensus 323 ~~~ 325 (329)
T 3gbz_A 323 SHN 325 (329)
T ss_dssp SSS
T ss_pred CCC
Confidence 863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=388.80 Aligned_cols=279 Identities=31% Similarity=0.549 Sum_probs=226.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++++.||+|+||.||+|.+..+|+.||||++... .....++.+|+++++.++ ||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR------HENVIGLLDVFTPD 96 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------BTTBCCCSEEECSC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC------CcCCCCceeeEecC
Confidence 468999999999999999999999999999999998542 233466788999998885 68999999999866
Q ss_pred C------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ~------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
. .+++||||++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~ 167 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCEL 167 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred CccccCceEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC--CCCE
Confidence 3 46999999988888877642 2889999999999999999999999999999999999986 7899
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
||+|||++..........++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|....|.++.
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 168 KILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred EEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999999887776677789999999999987 67999999999999999999999999999999999999999999888
Q ss_pred HHHhhhhhh--hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+.+...... ..+... +.. . ....+.......++.+.+||++||+.||.+|||+.|+|+||||+
T Consensus 248 ~~~~~~~~~~~~~~~~~-------------~~~-~-~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKG-------------LPE-L-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HHHHTCSCHHHHHHHHH-------------SCC-C-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHhhhHHHHHHHHh-------------CCC-C-CCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 776543211 111110 000 0 01122223334567899999999999999999999999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 313 ~ 313 (367)
T 1cm8_A 313 S 313 (367)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=387.17 Aligned_cols=259 Identities=28% Similarity=0.445 Sum_probs=218.2
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
..+.++|++.+.||+|+||+||+|+++.+|+.||+|+++.... ....+.+|+.+++.++ ||||++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~ 81 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL------HPNIITLH 81 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC------CTTBCCEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC------CcCCCcEE
Confidence 4567899999999999999999999999999999999976432 2356778888887764 78999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC--C
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--R 559 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~--~ 559 (722)
++|.....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++... .
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCc
Confidence 99999999999999996 5777776532 2389999999999999999999999999999999999998522 1
Q ss_pred CeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 560 CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
..+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 156 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235 (361)
T ss_dssp CCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred cCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 27999999999765543 3456799999999999999999999999999999999999999999888888877764433
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.++.+.+ ...+..+++||++||+.||.+|||+.|+|+|||
T Consensus 236 ~~~~~~~----------------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 236 DFDEEFF----------------------------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp CCCHHHH----------------------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCchhc----------------------------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 3332211 123466889999999999999999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 276 ~~~ 278 (361)
T 2yab_A 276 ITP 278 (361)
T ss_dssp TSC
T ss_pred cCC
Confidence 974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=388.91 Aligned_cols=300 Identities=30% Similarity=0.503 Sum_probs=224.7
Q ss_pred CCcceeeCc---eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCC
Q 004954 402 KDLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADE 475 (722)
Q Consensus 402 ~~~pi~~~~---~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~h 475 (722)
..+++.+++ .+.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ |
T Consensus 10 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h 83 (371)
T 2xrw_A 10 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------H 83 (371)
T ss_dssp GEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC------C
T ss_pred cceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC------C
Confidence 344555554 3578999999999999999999999999999999999753 233456778888888874 7
Q ss_pred CceeEEEEEEEecC------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 476 HHILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 476 pnIv~l~~~f~~~~------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
|||+++++++.... ..++||||+.++|.+.+.. .+++..++.++.||+.||.|||++||+||||||
T Consensus 84 pniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 155 (371)
T 2xrw_A 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 155 (371)
T ss_dssp TTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred CCccceEEeeccccccccccceEEEEEcCCCCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCH
Confidence 89999999998664 7899999999998887741 188999999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e 627 (722)
+|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 156 ~NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 233 (371)
T 2xrw_A 156 SNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 233 (371)
T ss_dssp GGEEECT--TSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHEEEcC--CCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999996 788999999999765543 334678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccc-cccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQL-EYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 628 ~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
.+..+...++.+..+.+.........+......+......... ....|.... .....+..+++||++||+.||.+|
T Consensus 234 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSE---HNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSH---HHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccc---ccccccHHHHHHHHHHCcCChhhC
Confidence 9999999999888776655433222111111000000000000 000111110 011124578999999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 004954 707 PTAREALDHPWLQH 720 (722)
Q Consensus 707 pTa~ElL~HPwf~~ 720 (722)
||++|+|+||||+.
T Consensus 311 ~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 311 ISVDEALQHPYINV 324 (371)
T ss_dssp CCHHHHHHSHHHHT
T ss_pred CCHHHHhCCcchhh
Confidence 99999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=371.32 Aligned_cols=281 Identities=26% Similarity=0.409 Sum_probs=220.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK------HPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC------CCCccchhheeecCC
Confidence 478999999999999999999999999999999986543 23455678888888885 789999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
..++||||+.++++..+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~ 148 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGF 148 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTT
T ss_pred eEEEEEEeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC--CCCEEEeeCCC
Confidence 999999999987655544322 22899999999999999999999999999999999999985 78999999999
Q ss_pred cccccCC---ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 570 SCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 570 s~~~~~~---~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
+...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+.+..+...++........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp CEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred chhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 9765432 234578999999999986 568999999999999999999999999999988888888888876654432
Q ss_pred hhhhhhhhhcccccchhhhhcccccccc-CCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYI-IPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..... .++. ..... ......+.......+..+.+||++||+.||.+|||++|+|+||||++
T Consensus 229 ~~~~~-~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 229 VFSTN-QYFS-------------GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp HHHTC-GGGT-------------TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccc-cccc-------------cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 21110 1110 00000 01111222233445678999999999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=384.79 Aligned_cols=291 Identities=30% Similarity=0.520 Sum_probs=233.1
Q ss_pred CcceeeCcee--cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCce
Q 004954 403 DLPIILNTVI--AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHI 478 (722)
Q Consensus 403 ~~pi~~~~~l--~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnI 478 (722)
...+..++++ .++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+++++.++ ||||
T Consensus 14 ~~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni 87 (364)
T 3qyz_A 14 GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR------HENI 87 (364)
T ss_dssp -CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC------CTTB
T ss_pred ceEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC------CCCC
Confidence 3344445554 48999999999999999999999999999999999743 333467788999998885 7899
Q ss_pred eEEEEEEEec-----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceE
Q 004954 479 LRLYDYFYHL-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (722)
Q Consensus 479 v~l~~~f~~~-----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NIL 553 (722)
+++++++... ...++||||+.++|.+++... .+++..++.++.||+.||+|||+.||+||||||+|||
T Consensus 88 v~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 160 (364)
T 3qyz_A 88 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 160 (364)
T ss_dssp CCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred ccceeEEecCCccccceEEEEEcccCcCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEE
Confidence 9999999765 478999999999998887642 2899999999999999999999999999999999999
Q ss_pred EcccCCCeEEEEecCCcccccCC------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHH
Q 004954 554 IKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (722)
Q Consensus 554 l~~~~~~~vkL~DFGls~~~~~~------~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~ 626 (722)
++. ++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 161 ~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 161 LNT--TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp ECT--TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred ECC--CCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 985 788999999999765432 234578999999998765 45899999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
+.+..+...++.++.+.+.......... . ......+....+.......+..+.+||++||++||.+|
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~------~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 305 (364)
T 3qyz_A 239 DQLNHILGILGSPSQEDLNCIINLKARN------Y-------LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305 (364)
T ss_dssp GHHHHHHHHHCSCCHHHHHTCCCHHHHH------H-------HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHH------H-------HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999999998887765432211100 0 00000011112233334456789999999999999999
Q ss_pred cCHHHHHhCCCCCCC
Q 004954 707 PTAREALDHPWLQHP 721 (722)
Q Consensus 707 pTa~ElL~HPwf~~~ 721 (722)
||+.|+|+||||+..
T Consensus 306 ~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 306 IEVEQALAHPYLEQY 320 (364)
T ss_dssp CCHHHHHTSGGGTTT
T ss_pred CCHHHHhcCcchhhc
Confidence 999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=394.24 Aligned_cols=281 Identities=30% Similarity=0.484 Sum_probs=224.3
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.++|++.+.||+|+||+||+|++..+|+.||||+++.. .....++.+|+++++.++ ||||+++++++..
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK------SDYIIRLYDLIIP 96 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC------CCCcceEEEEEec
Confidence 4578999999999999999999999999999999999753 234467788999999885 6899999999987
Q ss_pred c-----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 488 L-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 488 ~-----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
. ..+|+||||++++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||||+. ++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~~ 168 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIADSDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ--DCSV 168 (432)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred CCCCcCCeEEEEEecCCcCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC--CCCE
Confidence 6 5799999999999988886432 3899999999999999999999999999999999999986 7899
Q ss_pred EEEecCCcccccCC-------------------------ccccccCCcccCchhh-cCCCCCchhhHHHHHHHHHHHHh-
Q 004954 563 KIIDLGSSCFQTDN-------------------------LCLYVQSRSYRAPEVI-IGLPYDQKIDLWSLGCILAELWT- 615 (722)
Q Consensus 563 kL~DFGls~~~~~~-------------------------~~~~~gt~~y~APE~l-~~~~~s~ksDIWSLGviL~ellt- 615 (722)
||+|||+++..... ....++|+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999765432 2456889999999997 45669999999999999999998
Q ss_pred ----------CCCCCCCCh-----------------HHHHHHHHHhhcCCCcHHHHhhhhh--hhhhhcccccchhhhhc
Q 004954 616 ----------GEVLFPNDA-----------------VVMILARIIGMLGPIDLEMLMQGQE--IYKYFTKEYDLYYINEE 666 (722)
Q Consensus 616 ----------G~~PF~~~~-----------------~~e~l~~i~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 666 (722)
|.++|++.+ ..+.+..|...+|.++.+.+..... ..+++.
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~----------- 317 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK----------- 317 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH-----------
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH-----------
Confidence 455555532 4678888999999988877654321 111111
Q ss_pred cccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 667 TNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 667 ~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.... .....+.......++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus 318 --~~~~--~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 318 --LFPH--RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp --TSCC--CCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred --hCCC--CCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 0000 0111222333445678999999999999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=377.02 Aligned_cols=267 Identities=21% Similarity=0.226 Sum_probs=213.0
Q ss_pred CccCCCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCC
Q 004954 397 GFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPA 473 (722)
Q Consensus 397 ~~~~~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~ 473 (722)
.+......|...++.+.++|++.++||+|+||+||+|++..+|+.||||++.... ........|+..+..+.
T Consensus 40 ~~~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~----- 114 (311)
T 3p1a_A 40 TLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG----- 114 (311)
T ss_dssp SCCCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC-----
T ss_pred ccCCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc-----
Confidence 3445566778888899999999999999999999999999999999999986532 22233444444444442
Q ss_pred CCCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceE
Q 004954 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (722)
Q Consensus 474 ~hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NIL 553 (722)
.||||+++++++...+.+++||||++++|.+.+..... .+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 115 ~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 189 (311)
T 3p1a_A 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 48899999999999999999999999999888775432 3899999999999999999999999999999999999
Q ss_pred EcccCCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHH
Q 004954 554 IKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631 (722)
Q Consensus 554 l~~~~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~ 631 (722)
++. ++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .
T Consensus 190 l~~--~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~ 263 (311)
T 3p1a_A 190 LGP--RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---Q 263 (311)
T ss_dssp ECG--GGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---H
T ss_pred ECC--CCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---H
Confidence 986 788999999998765443 233568999999999887 78999999999999999999977765533211 1
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 632 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
+.. +..+. ......++.+.+||.+||+.||.+|||+.|
T Consensus 264 ~~~--~~~~~----------------------------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 301 (311)
T 3p1a_A 264 LRQ--GYLPP----------------------------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEA 301 (311)
T ss_dssp HTT--TCCCH----------------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred Hhc--cCCCc----------------------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 110 00000 001123567899999999999999999999
Q ss_pred HHhCCCCCCC
Q 004954 712 ALDHPWLQHP 721 (722)
Q Consensus 712 lL~HPwf~~~ 721 (722)
+|+||||++|
T Consensus 302 ll~hp~~~~p 311 (311)
T 3p1a_A 302 LLALPVLRQP 311 (311)
T ss_dssp HHTSGGGSCC
T ss_pred HHhCccccCC
Confidence 9999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=387.78 Aligned_cols=279 Identities=31% Similarity=0.567 Sum_probs=212.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+++++.++ ||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPA 100 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEecC
Confidence 468999999999999999999999999999999998653 234456778999988885 68999999999754
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
...++|||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~ 171 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 171 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCE
T ss_pred CccccCCeEEEEecccCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC--CCCE
Confidence 56899999998888877653 12899999999999999999999999999999999999986 7899
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|...+|.++.
T Consensus 172 kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 172 KILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp EECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999887766667789999999999987 67899999999999999999999999999999999999999998887
Q ss_pred HHHhhhhhh--hhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+.+...... ..++. .+. ..+ ...+.......++.+.+||++||+.||.+|||+.|+|+||||+
T Consensus 252 ~~~~~~~~~~~~~~~~-------------~~~-~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 252 ELLKKISSESARNYIQ-------------SLT-QMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HHHTTCCCHHHHHHHH-------------TSC-CCC-CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHhhhHHHHHHHh-------------ccC-CCC-CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 766543211 11110 000 001 1122233334567899999999999999999999999999998
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 317 ~ 317 (367)
T 2fst_X 317 Q 317 (367)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=381.09 Aligned_cols=281 Identities=27% Similarity=0.460 Sum_probs=225.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-- 487 (722)
.++|++++.||+|+||+||+|++..+|+.||||++.... .......+|+.+++.++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC------CTTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc------CCCcccHhheeeccc
Confidence 478999999999999999999999999999999986532 22346778999998885 6899999999987
Q ss_pred ------cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 488 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 488 ------~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
.+.+++||||+.+++.+.+..... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~--~~~ 162 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 162 (351)
T ss_dssp -------CEEEEEEECCSEEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSC
T ss_pred cccccCCceEEEEEeccCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCC
Confidence 457899999999998888764432 2899999999999999999999999999999999999986 789
Q ss_pred EEEEecCCcccccC-------CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 562 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 562 vkL~DFGls~~~~~-------~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999875432 1234577999999999986 458999999999999999999999999999999999999
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhc--ccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL--QFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~--~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
...+.++.+.+........+. ...........+.... ...++.+.+||.+||+.||.+|||++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYE--------------KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGT--------------SSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHhCCCChhhccccccchhhc--------------ccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 988888876655433221110 0000011111111111 123567899999999999999999999
Q ss_pred HHhCCCCCC
Q 004954 712 ALDHPWLQH 720 (722)
Q Consensus 712 lL~HPwf~~ 720 (722)
+|+||||+.
T Consensus 309 ~l~hp~f~~ 317 (351)
T 3mi9_A 309 ALNHDFFWS 317 (351)
T ss_dssp HHTSGGGGS
T ss_pred HhCCCCcCC
Confidence 999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=385.44 Aligned_cols=253 Identities=23% Similarity=0.404 Sum_probs=210.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+..++|+++++||+|+||+||+|+++.+|+.||||++++.. .......+|..+++.+. .||||++++++|.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLFCCFQ 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT-----TCTTBCCEEEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc-----CCCceeeEEEEEE
Confidence 34578999999999999999999999999999999997642 23455677888888774 4789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+.+++||||+.| +|..++.... .+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~g~ikL~ 166 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLA 166 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECC--CCCEEEc
Confidence 99999999999985 6766665432 2899999999999999999999999999999999999986 7899999
Q ss_pred ecCCccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 566 DLGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 566 DFGls~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|.....
T Consensus 167 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----- 241 (353)
T 3txo_A 167 DFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----- 241 (353)
T ss_dssp CCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred cccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 999987532 223456899999999999998999999999999999999999999999888887777653211
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH------HHHHhCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA------REALDHP 716 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa------~ElL~HP 716 (722)
.+|. ..+..+.+||++||+.||.+||++ .|+++||
T Consensus 242 ------------------------------~~p~---------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 242 ------------------------------VYPT---------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp ------------------------------CCCT---------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred ------------------------------CCCC---------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 1111 134668899999999999999998 9999999
Q ss_pred CCCC
Q 004954 717 WLQH 720 (722)
Q Consensus 717 wf~~ 720 (722)
||+.
T Consensus 283 ~f~~ 286 (353)
T 3txo_A 283 FFKE 286 (353)
T ss_dssp GGTT
T ss_pred cccC
Confidence 9975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=386.66 Aligned_cols=279 Identities=29% Similarity=0.533 Sum_probs=223.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~-- 488 (722)
...++|++.+.||+|+||+||+|++..+|+.||||++..+... ..+|+.+++.++ ||||++++++|...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~------hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLD------HVNIIKLVDYFYTTGD 74 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCC------CTTBCCEEEEEEEC--
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcC------CCCccchhheeeecCc
Confidence 3467899999999999999999999999999999999765432 346888887764 78999999999543
Q ss_pred ------------------------------------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHH
Q 004954 489 ------------------------------------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532 (722)
Q Consensus 489 ------------------------------------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~ 532 (722)
..+++||||+.++|.+.+....... ..+++..++.++.||+.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~--~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcC--CCCCHHHHHHHHHHHHH
Confidence 3489999999999888776533222 23899999999999999
Q ss_pred HHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC--CccccccCCcccCchhhcCCC-CCchhhHHHHHHH
Q 004954 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCI 609 (722)
Q Consensus 533 aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGvi 609 (722)
||+|||+.||+||||||+|||++. .++.+||+|||++..... ......+|+.|+|||++.+.. ++.++|||||||+
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEET-TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcC-CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999999974 367999999999976533 334467899999999998754 8999999999999
Q ss_pred HHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCc--cchhhh-hccc
Q 004954 610 LAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEH-HLQF 686 (722)
Q Consensus 610 L~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~--~~~l~~-~~~~ 686 (722)
+|+|++|++||.+.+..+.+.+++..+|.++.+.+......... ..+|. ...+.. ....
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~ 293 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE------------------VRFPTLKAKDWRKILPEG 293 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--------------------CCCCCCCCCCHHHHSCTT
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc------------------ccCCccCcccHHhhCCCC
Confidence 99999999999999999999999999998887766543211100 00010 001111 1223
Q ss_pred CcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 687 SDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 687 ~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.++.+.+||++||+.||.+|||+.|+|+||||+
T Consensus 294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCHHHH
Confidence 567799999999999999999999999999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=376.06 Aligned_cols=250 Identities=26% Similarity=0.480 Sum_probs=214.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++|++++.||+|+||+||+++++.+|+.||+|++++.. .......+|..+++.+ .||||+++++++.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV------THPFIIRMWGTFQDA 78 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CBTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC------CCCCCceEeEEEEeC
Confidence 468999999999999999999999999999999997642 2334566777777765 478999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
..+++||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~Df 150 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDF 150 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcC--CCCEEEeec
Confidence 999999999975 7777776432 2899999999999999999999999999999999999985 789999999
Q ss_pred CCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 568 Gls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
|++..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++.....
T Consensus 151 g~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------- 220 (318)
T 1fot_A 151 GFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------- 220 (318)
T ss_dssp SSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC----------
T ss_pred CcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 9998877766678899999999999999999999999999999999999999998877777666642111
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
.+| ...++.+.+||++||+.||++|| +++++++||||+.
T Consensus 221 -------------------------~~p---------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 221 -------------------------RFP---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp -------------------------CCC---------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred -------------------------CCC---------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 111 12346789999999999999999 9999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=374.62 Aligned_cols=259 Identities=28% Similarity=0.439 Sum_probs=216.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|+++.... ....+.+|+.+++.++ ||||++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 80 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ------HPNVITLH 80 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC------CCCCCcEE
Confidence 3466889999999999999999999999999999999875432 2456788999999885 78999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC--C
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--R 559 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~--~ 559 (722)
+++......++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++... .
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCC
Confidence 99999999999999997 5777776532 2389999999999999999999999999999999999998622 2
Q ss_pred CeEEEEecCCcccccC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 560 CEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
..+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234 (326)
T ss_dssp CCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred CCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence 3799999999976543 23446799999999999999999999999999999999999999998887777766653322
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.++... ....+..+.+||++||+.||.+|||+.|+|+|||
T Consensus 235 ~~~~~~----------------------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 235 EFEDEY----------------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp CCCHHH----------------------------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred CcCccc----------------------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 222111 1123466889999999999999999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 275 ~~~ 277 (326)
T 2y0a_A 275 IKP 277 (326)
T ss_dssp TSC
T ss_pred ccC
Confidence 975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=377.78 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=211.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+|..+++.+ .||||++++++|...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC------CCCcCcceEEEEEeC
Confidence 478999999999999999999999999999999997642 2345567777777755 478999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+++++||||+.| +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~DF 149 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDF 149 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECC--CCCEEEeec
Confidence 999999999986 6666665432 2899999999999999999999999999999999999986 789999999
Q ss_pred CCccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+....
T Consensus 150 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------- 221 (337)
T 1o6l_A 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-------- 221 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred cchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 9987532 23445689999999999999999999999999999999999999999887776666554210
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQ 719 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~ 719 (722)
..+| ...++.+.+||++||+.||.+|| +++|+++||||+
T Consensus 222 ---------------------------~~~p---------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 222 ---------------------------IRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp ---------------------------CCCC---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred ---------------------------CCCC---------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 0111 12346789999999999999999 999999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 266 ~ 266 (337)
T 1o6l_A 266 S 266 (337)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=382.88 Aligned_cols=278 Identities=29% Similarity=0.553 Sum_probs=225.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++|++.+.||+|+||+||+|.+..+|+.||||++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~ 113 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ------HENVIGLLDVFTPA 113 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC------CCCchhhhhheecc
Confidence 578999999999999999999999999999999999753 233466778888888885 68999999999877
Q ss_pred CeE------EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 EHL------FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ~~l------~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
+.. ++||||+.++|.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~ 183 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCEL 183 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCE
T ss_pred CCcccceeEEEEEccccccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC--CCCE
Confidence 654 99999999988776531 2899999999999999999999999999999999999996 7889
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.
T Consensus 184 kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 184 KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp EECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999999887777677789999999999987 67899999999999999999999999999999999999999998887
Q ss_pred HHHhhhhhhh--hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEIY--KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+.+....... .+.. ... ......+.......++.+.+||++||+.||.+|||+.|+|+||||+
T Consensus 264 ~~~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQ-------------SLP--QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp HHHTTCSCHHHHHHHH-------------HSC--CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHhhhhhhhhhhh-------------ccC--CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 7665432111 0000 000 0011112223334567899999999999999999999999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 329 ~ 329 (371)
T 4exu_A 329 P 329 (371)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=392.05 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=216.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+.++|++.+.||+|+||+||+|.+..+|+.+|+|++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~ 80 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK------HPNIVRLHDSIS 80 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC------BTTBCCEEEEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CcCCCeEEEEEE
Confidence 456789999999999999999999999999999999987543 33456778999998885 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-CCCeEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKI 564 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~~~~vkL 564 (722)
..+..++||||+.| +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.. .++.+||
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEE
Confidence 99999999999975 7777776432 28999999999999999999999999999999999999853 3578999
Q ss_pred EecCCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 565 IDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 565 ~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+++..+......++.
T Consensus 155 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp CCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc
Confidence 999999765543 23467999999999999999999999999999999999999999998887777776543222221
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.. ....++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 235 ~~----------------------------------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 235 PE----------------------------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp TT----------------------------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred cc----------------------------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 10 012346789999999999999999999999999995
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=379.28 Aligned_cols=287 Identities=28% Similarity=0.438 Sum_probs=217.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe--
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH-- 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~-- 490 (722)
.++|++.+.||+|+||+||+|++..+|+.||||++...........++++.+..++ ||||++++++|.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~------h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH------HPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHC------CTTBCCEEEEEEEECSSC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcC------CCCcccHHHhhhcccccc
Confidence 47899999999999999999999999999999999776655555666666666664 7899999999976543
Q ss_pred -----EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH--HCCCccccCCCCceEEcccCCCeEE
Q 004954 491 -----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 491 -----l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLH--s~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+++||||+.+++...+..... ....+++..++.++.||+.||.||| +.||+||||||+|||++. .++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE-ADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-TTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-CCCcEE
Confidence 899999999988776654322 2233889999999999999999999 999999999999999984 367999
Q ss_pred EEecCCcccccCC--ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+...++.++
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999999765443 33457899999999997654 89999999999999999999999999999999999999999988
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+.+........... ..... .++-...+.......+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~------~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 253 REVLRKLNPSHTDVD------LYNSK------GIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHHHHCTTCCCGG------GGCCC------CCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHHhcccchhhcc------ccccc------cCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 877655432111100 00000 001001111112224577999999999999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=379.83 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=213.7
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ........|..+++.+. .||||++++++|.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~-----~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-----EHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-----TCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC-----CCCCCCcEEEEEE
Confidence 44588999999999999999999999999999999997642 23455677888887763 4789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
+.+.+++||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~ 160 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIA 160 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC--CCCEEEe
Confidence 99999999999975 7777766432 2899999999999999999999999999999999999986 7899999
Q ss_pred ecCCccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 566 DLGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 566 DFGls~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+.....
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----- 235 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP----- 235 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 999987532 234456899999999999999999999999999999999999999998887777766642110
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH-HHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR-EALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~-ElL~HPwf~~ 720 (722)
.+| ...+..+.+||++||+.||++||++. ++++||||+.
T Consensus 236 ------------------------------~~p---------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 236 ------------------------------FYP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp ------------------------------CCC---------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ------------------------------CCC---------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 111 11346789999999999999999998 9999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.84 Aligned_cols=264 Identities=20% Similarity=0.223 Sum_probs=185.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (722)
++.+|.+.++||+|+||+||+|++ +|+.||||++..... .....|.+++. .....|||||++++++...+
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~----~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQ----TVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHT----STTCCCTTBCCEEEEEEEECSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHH----HhcCCCCCCCcEEEEEEecCCC
Confidence 356899999999999999999986 689999999976543 23333433332 22346999999999998664
Q ss_pred --eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC--------CCccccCCCCceEEcccC
Q 004954 490 --HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--------GIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 490 --~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~--------gIvHrDLKp~NILl~~~~ 558 (722)
.++|||||++ |+|.+++... .+++..+..|+.|++.||+|||+. +||||||||+||||+.
T Consensus 73 ~~~~~lV~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~-- 143 (303)
T 3hmm_A 73 WTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-- 143 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT--
T ss_pred ceEEEEEecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC--
Confidence 6899999998 5777777532 288999999999999999999987 9999999999999996
Q ss_pred CCeEEEEecCCcccccCCc-------cccccCCcccCchhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCChH
Q 004954 559 RCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGL------PYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~~-------~~~~gt~~y~APE~l~~~------~~s~ksDIWSLGviL~elltG~~PF~~~~~ 625 (722)
++.+||+|||+++...... ...+||+.|+|||++.+. .++.++|||||||+||||+||.+||.....
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~ 223 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc
Confidence 8899999999997654322 235799999999999765 366799999999999999999887743211
Q ss_pred HHH-HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCC
Q 004954 626 VMI-LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704 (722)
Q Consensus 626 ~e~-l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~ 704 (722)
... ...+ ....+..+. +.+.+ .....+..+|..... ......+.+||.+||+.||+
T Consensus 224 ~~~p~~~~--~~~~~~~~~------~~~~~-----------~~~~~rp~~p~~~~~----~~~~~~l~~li~~cl~~dP~ 280 (303)
T 3hmm_A 224 YQLPYYDL--VPSDPSVEE------MRKVV-----------CEQKLRPNIPNRWQS----CEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp CCCTTTTT--SCSSCCHHH------HHHHH-----------TTSCCCCCCCGGGGS----SHHHHHHHHHHHTTCCSSGG
T ss_pred ccccchhc--ccccchHHH------HHHHH-----------hcccCCCCCCccccc----hHHHHHHHHHHHHHcccCHh
Confidence 000 0000 000000000 00000 001111222221110 01124688999999999999
Q ss_pred CCcCHHHHHhC
Q 004954 705 RRPTAREALDH 715 (722)
Q Consensus 705 kRpTa~ElL~H 715 (722)
+|||+.||++.
T Consensus 281 ~RPt~~ei~~~ 291 (303)
T 3hmm_A 281 ARLTALRIKKT 291 (303)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=370.54 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=210.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
..++|++.+.||+|+||+||+|.+..+|+.||||++.... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCC------CCCCCeEeEEEEECCE
Confidence 3578999999999999999999999999999999987543 23456778888888874 7899999999999999
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+. ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~~kl~Dfg~ 162 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGF 162 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC--CCCEEEeeCCC
Confidence 999999996 4677666532 2889999999999999999999999999999999999986 78899999999
Q ss_pred cccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....+
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------- 234 (297)
T 3fxz_A 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-------- 234 (297)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC--------
T ss_pred ceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 8765433 33457899999999999999999999999999999999999999887766555444311100
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.... ....+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 ------------------------~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 235 ------------------------ELQN---------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp ------------------------CCSC---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------------------CCCC---------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 0000 1123466899999999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=381.48 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=217.6
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
....+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.++ ||||++++++
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~ 96 (362)
T 2bdw_A 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDS 96 (362)
T ss_dssp -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEE
Confidence 34556789999999999999999999999999999999997542 34456778999998885 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeE
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 562 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~v 562 (722)
+...+..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++... .+.+
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 97 IQEESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCE
Confidence 9999999999999985 676766532 2389999999999999999999999999999999999998632 3579
Q ss_pred EEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 563 kL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..++...+......++
T Consensus 171 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 250 (362)
T 2bdw_A 171 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 250 (362)
T ss_dssp EECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99999999766543 2346799999999999999999999999999999999999999998887777766653322111
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
... ....++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 251 ~~~----------------------------------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 251 SPE----------------------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp TTG----------------------------------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ccc----------------------------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 100 0122466899999999999999999999999999963
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=377.89 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=215.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..++|++++.||+|+||+||+++++.+|+.||||++.... .......+|+.+++.+ .||||+++++++..
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV------NFPFLVKLEFSFKD 112 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEEEC
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEc
Confidence 3578999999999999999999999999999999997543 2334566677777655 48899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
...+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~D 184 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTD 184 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECC--CCCEEEcc
Confidence 999999999997 57777776432 2899999999999999999999999999999999999985 78999999
Q ss_pred cCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 567 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 567 FGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+.....
T Consensus 185 Fg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------- 255 (350)
T 1rdq_E 185 FGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--------- 255 (350)
T ss_dssp CTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred cccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 99998877766677899999999999999999999999999999999999999998887777766652211
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
.+|. ..+..+.+||++||+.||.+||+ ++++++||||+.
T Consensus 256 --------------------------~~p~---------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 256 --------------------------RFPS---------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp --------------------------CCCT---------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred --------------------------CCCC---------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 1111 23467899999999999999998 999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=389.19 Aligned_cols=278 Identities=30% Similarity=0.496 Sum_probs=223.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec----
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~---- 488 (722)
..+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+++++.++ ||||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~------hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLD------HCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCC------CTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcC------CCCccceeeEEeccCCCC
Confidence 4579999999999999999999999999999999976543 2346888888774 78999999998643
Q ss_pred --CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 489 --~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
..+++||||+.+++...+...... ...+++..++.++.||+.||+|||+.||+||||||+||||+. +.+.+||+|
T Consensus 124 ~~~~~~lv~e~~~~~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~~kl~D 200 (420)
T 1j1b_A 124 DEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCD 200 (420)
T ss_dssp TEEEEEEEEECCCEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET-TTTEEEECC
T ss_pred cceeEEeehhcccccHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC-CCCeEEecc
Confidence 247899999999888777643322 223899999999999999999999999999999999999985 346799999
Q ss_pred cCCcccccC--CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 567 LGSSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 567 FGls~~~~~--~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
||+++.... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.++++.+|.++.+.
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999976432 23446789999999999875 789999999999999999999999999999999999999999888776
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCc--cchhhh-hcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEH-HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~--~~~l~~-~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+....... . ...+|. ...+.. .....++.+.+||++||+.||.+|||+.|+|+||||+.
T Consensus 281 ~~~~~~~~-------~-----------~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 281 IREMNPNY-------T-----------EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHCSCC-------C-----------CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHhhChhh-------h-----------hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 64421100 0 001111 001111 11234578999999999999999999999999999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=383.66 Aligned_cols=281 Identities=31% Similarity=0.526 Sum_probs=223.9
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
++....+|++.++||+|+||+||+|++..+++ +|+|.+...... ..+|+.+++.++ ||||++++++|...
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~------h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVK------HPNVVDLKAFFYSN 104 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCC------CTTBCCEEEEEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCC------CCCcceEEEEEEec
Confidence 34567789999999999999999999877666 888887654432 236888888774 78999999999765
Q ss_pred C------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 489 ~------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
. .+++||||+.++++..+....... ..+++..++.++.||+.||+|||+.||+||||||+|||++. .++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLK--QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEE
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC-CCCcE
Confidence 4 388999999998877665433222 23899999999999999999999999999999999999983 37899
Q ss_pred EEEecCCccccc--CCccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 563 KIIDLGSSCFQT--DNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 563 kL~DFGls~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||+|||++.... .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+++.+|.+
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999997653 233456789999999999775 58999999999999999999999999999999999999999988
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCc--cchhhh-hcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEH-HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~--~~~l~~-~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
+.+.+...... +. ...+|. ...+.. .....++.+.+||.+||+.||.+|||+.|+|+||
T Consensus 262 ~~~~~~~~~~~--~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 262 SREQIKTMNPN--YM----------------EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp CHHHHHHHCGG--GS----------------SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHhhChh--hh----------------hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 87766443211 00 001111 011111 1123567899999999999999999999999999
Q ss_pred CCCC
Q 004954 717 WLQH 720 (722)
Q Consensus 717 wf~~ 720 (722)
||+.
T Consensus 324 ~f~~ 327 (394)
T 4e7w_A 324 FFDE 327 (394)
T ss_dssp GGST
T ss_pred hhhh
Confidence 9975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=377.74 Aligned_cols=261 Identities=26% Similarity=0.381 Sum_probs=212.2
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
.+.++|++.+.||+|+||+||+|.++.+|+.||||++..... ..+.+.+|+.+++.++ ||||++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~ 94 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK------HPHIVELLET 94 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC------CCCCCcEEEE
Confidence 456789999999999999999999999999999999865321 2456788999998885 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeE
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 562 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~v 562 (722)
+...+.+++||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||++||+||||||+|||++... ...+
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcE
Confidence 9999999999999984 676666544322 22389999999999999999999999999999999999998632 3569
Q ss_pred EEEecCCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 563 KIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 563 kL~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... +.+..+......+
T Consensus 173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKM 251 (351)
T ss_dssp EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCC
T ss_pred EEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCC
Confidence 99999999776543 2345789999999999999999999999999999999999999987643 3333333211111
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+... ....+..+.+||++||+.||.+|||+.|+|+||||+
T Consensus 252 ~~~~----------------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 252 NPRQ----------------------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp CHHH----------------------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred Cccc----------------------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 1100 012346789999999999999999999999999996
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 292 ~ 292 (351)
T 3c0i_A 292 E 292 (351)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=378.81 Aligned_cols=280 Identities=31% Similarity=0.459 Sum_probs=222.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
..++|++.+.||+|+||+||+|++..+|+.||||+++.... ....+.+|+.+++.++ ||||+++++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~ 81 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS------HPNIIGLLDAF 81 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC------CCCCCeEEEEE
Confidence 35789999999999999999999999999999999875321 1245678999998885 78999999999
Q ss_pred EecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 486 ~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
......++||||+.++|...+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 82 ~~~~~~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~--~~~~kl~ 154 (346)
T 1ua2_A 82 GHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLA 154 (346)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEEC
T ss_pred eeCCceEEEEEcCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC--CCCEEEE
Confidence 9999999999999998888776432 23888999999999999999999999999999999999986 7899999
Q ss_pred ecCCcccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++....+.++.
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 155 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp CCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred ecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999765432 3345789999999999764 5899999999999999999999999999999999999888887766
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+.+.......+++.. ...| ...+.......+..+.+||++||+.||.+|||+.|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~---------------~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTF---------------KSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp TTSSSTTSSTTCCCC---------------CCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhhhccCcccccc---------------cccC-CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 555443222111110 0001 11122233445678999999999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=381.44 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=201.4
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..++|++++.||+|+||+||++++..+++.||||++...........+|+.+++.++ ||||+++++++......
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR------HPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCC------CTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCC------CCCCCcEEEEEeeCCEE
Confidence 458999999999999999999999999999999999876665677889999998885 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++....+.+||+|||++
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 999999964 7777765433 289999999999999999999999999999999999998755566999999998
Q ss_pred cccc--CCccccccCCcccCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQT--DNLCLYVQSRSYRAPEVIIGLPYDQK-IDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~--~~~~~~~gt~~y~APE~l~~~~~s~k-sDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+...+
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~----------- 234 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI----------- 234 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH-----------
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-----------
Confidence 7432 23345679999999999998887765 899999999999999999997654322221111000
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
......+|.. ...++.+.+||++||+.||.+|||+.|+|+||||++
T Consensus 235 --------------------~~~~~~~~~~-------~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 235 --------------------LSVKYSIPDD-------IRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp --------------------HTTCCCCCTT-------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred --------------------hcCCCCCCCc-------CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 0001111111 123467899999999999999999999999999954
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=371.95 Aligned_cols=283 Identities=25% Similarity=0.403 Sum_probs=223.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
..++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR------HENLVNLLEVCKKK 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEET
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC------CCCEeeEEEEeecC
Confidence 3578999999999999999999999999999999986532 23445678888888885 68999999999999
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 489 ~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
+..++||||+.++++..+..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg 169 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFG 169 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCT
T ss_pred CEEEEEEecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcC--CCcEEEEeCC
Confidence 99999999999877766543322 2899999999999999999999999999999999999985 7899999999
Q ss_pred CcccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 569 ls~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.......
T Consensus 170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp TC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred CceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 99764432 2345789999999999875 6899999999999999999999999999998988888888887765543
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
........+ . ......+.............++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 250 ~~~~~~~~~-~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 250 ELFNKNPVF-A------------GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHCGGG-T------------TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hHhhhcccc-c------------cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 222111100 0 00001111122223333445788999999999999999999999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=384.37 Aligned_cols=253 Identities=31% Similarity=0.502 Sum_probs=208.8
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
....++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~ 78 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR------HPHIIKLYDVI 78 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC------CTTBCCEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC------CCCCCeEEEEE
Confidence 445689999999999999999999999999999999997532 22345677888887664 78999999999
Q ss_pred EecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 486 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 486 ~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
......++||||++|+|++++..... +++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 79 ~~~~~~~lv~E~~~g~l~~~l~~~~~------l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~ 150 (336)
T 3h4j_B 79 TTPTDIVMVIEYAGGELFDYIVEKKR------MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD--NLNVKIA 150 (336)
T ss_dssp ECSSEEEEEECCCCEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT--TCCEEEC
T ss_pred EeCCEEEEEEECCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC--CCCEEEE
Confidence 99999999999999999998875432 899999999999999999999999999999999999995 7889999
Q ss_pred ecCCcccccCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........
T Consensus 151 DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------- 219 (336)
T 3h4j_B 151 DFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------- 219 (336)
T ss_dssp CSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------
T ss_pred EeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------
Confidence 99999765443 345679999999999998876 6899999999999999999999965421110000
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.......+| ...++.+.+||++||+.||.+|||++|+++||||+.
T Consensus 220 ------------------------i~~~~~~~p---------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 220 ------------------------VNSCVYVMP---------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp ------------------------CCSSCCCCC---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred ------------------------HHcCCCCCc---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 000011112 123567899999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=380.77 Aligned_cols=252 Identities=21% Similarity=0.351 Sum_probs=206.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
-.++|+++++||+|+||+||+|+++.+++.||||++++.. .......+|..+++.+. .||||++++++|..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT-----TCTTBCCEEEEEEC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC-----CCCCcCeeEEEEEE
Confidence 3478999999999999999999999999999999998642 23345778888888774 37899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+++||||+.| +|...+.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~--~g~ikL~D 196 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTD 196 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECC--CCCEEEee
Confidence 9999999999986 6666665432 2899999999999999999999999999999999999986 78999999
Q ss_pred cCCcccc---cCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH---------HHHHHHHHh
Q 004954 567 LGSSCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMILARIIG 634 (722)
Q Consensus 567 FGls~~~---~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~---------~e~l~~i~~ 634 (722)
||+++.. .......+||+.|+|||++.+..++.++|||||||++|+|++|++||..... ..+...+..
T Consensus 197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred cceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 9999752 2334557899999999999999999999999999999999999999964321 111111110
Q ss_pred hcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH-----
Q 004954 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----- 709 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa----- 709 (722)
....+|. ..+..+.+||++||+.||.+||++
T Consensus 277 -----------------------------------~~~~~p~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 312 (396)
T 4dc2_A 277 -----------------------------------KQIRIPR---------SLSVKAASVLKSFLNKDPKERLGCHPQTG 312 (396)
T ss_dssp -----------------------------------CCCCCCT---------TSCHHHHHHHHHHTCSCTTTSTTCSTTTH
T ss_pred -----------------------------------cccCCCC---------cCCHHHHHHHHHHhcCCHhHcCCCCCCCC
Confidence 0111221 234678999999999999999985
Q ss_pred -HHHHhCCCCCC
Q 004954 710 -REALDHPWLQH 720 (722)
Q Consensus 710 -~ElL~HPwf~~ 720 (722)
.|+++||||+.
T Consensus 313 ~~ei~~Hpff~~ 324 (396)
T 4dc2_A 313 FADIQGHPFFRN 324 (396)
T ss_dssp HHHHHHSTTTTT
T ss_pred HHHHhcCccccC
Confidence 89999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=365.21 Aligned_cols=283 Identities=28% Similarity=0.446 Sum_probs=227.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEEC-CCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDL-HTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY- 486 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~-~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~- 486 (722)
..++|++.+.||+|+||+||+|++. .+|+.||+|+++... .......+|+.+++.+... .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhcc---CCCCeEeeeeeeee
Confidence 4578999999999999999999995 678999999987532 2234677889998888643 5899999999997
Q ss_pred ----ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 487 ----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 487 ----~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
.....++||||+.++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~--~~~~ 159 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQI 159 (326)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCE
T ss_pred cccCCCceEEEEEecCCCCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC--CCCE
Confidence 4568999999999999888875432 23899999999999999999999999999999999999986 7889
Q ss_pred EEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 563 kL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+...++.++
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999998765432 2345789999999999999999999999999999999999999999988888888888877666
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...+......... .. .......+.......+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~---------------~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 240 EEDWPRDVALPRQ---------------AF--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp GGGSCTTCSSCGG---------------GS--CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccCccccccchh---------------hh--cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 5544322111000 00 000011122223345678999999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=372.84 Aligned_cols=286 Identities=30% Similarity=0.494 Sum_probs=224.1
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
....+.++|++.+.||+|+||+||+|.+..+|+.||||++... ......+.+|+.+++.++ ||||+++++++
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~ 78 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK------HENIITIFNIQ 78 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC------CTTBCCEEEEC
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc------CCCcCCeeeee
Confidence 4456788999999999999999999999999999999999643 233456778999988885 78999999988
Q ss_pred Eec-----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC
Q 004954 486 YHL-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 486 ~~~-----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~ 560 (722)
... ...++||||+.++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++
T Consensus 79 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~--~~ 149 (353)
T 2b9h_A 79 RPDSFENFNEVYIIQELMQTDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--NC 149 (353)
T ss_dssp CCSCSTTCCCEEEEECCCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TC
T ss_pred cccccCccceEEEEEeccCccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC--CC
Confidence 754 679999999999988877642 2899999999999999999999999999999999999986 78
Q ss_pred eEEEEecCCcccccCC-------------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHH
Q 004954 561 EIKIIDLGSSCFQTDN-------------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~-------------~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~ 626 (722)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 150 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 229 (353)
T 2b9h_A 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229 (353)
T ss_dssp CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 8999999998765422 122468999999999865 67899999999999999999999999999888
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
+.+..+....+.++............. ......+ ... ....+.......+..+.+||++||+.||++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (353)
T 2b9h_A 230 HQLLLIFGIIGTPHSDNDLRCIESPRA----------REYIKSL-PMY-PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297 (353)
T ss_dssp HHHHHHHHHHCCCCSTTTTTTCCCHHH----------HHHHHTS-CCC-CCCCHHHHSTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHhCCCchhccccccccchh----------hHHhhcc-cCC-CCcchhhhcccCCHHHHHHHHHhcCcCcccC
Confidence 888888877776553221111000000 0000000 000 1112223334456789999999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 004954 707 PTAREALDHPWLQH 720 (722)
Q Consensus 707 pTa~ElL~HPwf~~ 720 (722)
||+.|+|+||||+.
T Consensus 298 pt~~ell~hp~~~~ 311 (353)
T 2b9h_A 298 ITAKEALEHPYLQT 311 (353)
T ss_dssp CCHHHHHTSGGGTT
T ss_pred CCHHHHhcCccccc
Confidence 99999999999976
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=375.61 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=211.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. ........|..++..+. .||+|++++++|..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPFLTQLHSCFQT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT-----CCTTBCCEEEEEEC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC-----CCCEEeeEEEEEEc
Confidence 3578999999999999999999999999999999997643 22344566766665543 48899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+++||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL~D 164 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIAD 164 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC--CCcEEEEe
Confidence 9999999999975 7777765432 2899999999999999999999999999999999999986 78999999
Q ss_pred cCCccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 567 LGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 567 FGls~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|.....
T Consensus 165 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------ 238 (353)
T 2i0e_A 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------ 238 (353)
T ss_dssp CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------
T ss_pred CCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC------
Confidence 99997532 234456899999999999999999999999999999999999999999888777777653111
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWL 718 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf 718 (722)
.+| ...+..+.+||++||+.||.+|| +++++++||||
T Consensus 239 -----------------------------~~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 239 -----------------------------AYP---------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp -----------------------------CCC---------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred -----------------------------CCC---------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 111 12346789999999999999999 57999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 281 ~~ 282 (353)
T 2i0e_A 281 RY 282 (353)
T ss_dssp TT
T ss_pred cC
Confidence 74
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=365.72 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=202.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---------------------------hhHhHHHHHHH
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------------------------FFDQSLDEIKL 463 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---------------------------~~~~~~~E~~i 463 (722)
+..++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 345899999999999999999999999999999999875431 12456788888
Q ss_pred HHHhcccCCCCCCceeEEEEEEEe--cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC
Q 004954 464 LKLVNKNDPADEHHILRLYDYFYH--LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540 (722)
Q Consensus 464 l~~L~~~~~~~hpnIv~l~~~f~~--~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~ 540 (722)
++.++ ||||+++++++.. ..+.++||||+.+ +|.++.. ...+++..++.++.||+.||.|||+.
T Consensus 90 l~~l~------h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 90 LKKLD------HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp HHTCC------CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-------SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhCC------CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 88774 7899999999987 5789999999985 4443221 22489999999999999999999999
Q ss_pred CCccccCCCCceEEcccCCCeEEEEecCCcccccCC---ccccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHH
Q 004954 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELW 614 (722)
Q Consensus 541 gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~---~s~ksDIWSLGviL~ell 614 (722)
||+||||||+|||++. ++.+||+|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 157 ~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGE--DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp TEECCCCCGGGEEECT--TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECC--CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999986 788999999999765433 23457899999999998765 377899999999999999
Q ss_pred hCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHH
Q 004954 615 TGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 694 (722)
Q Consensus 615 tG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dL 694 (722)
+|+.||.+.........+..... ..|. ....++.+.+|
T Consensus 235 ~g~~pf~~~~~~~~~~~~~~~~~-----------------------------------~~~~-------~~~~~~~l~~l 272 (298)
T 2zv2_A 235 FGQCPFMDERIMCLHSKIKSQAL-----------------------------------EFPD-------QPDIAEDLKDL 272 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCC-----------------------------------CCCS-------SSCCCHHHHHH
T ss_pred HCCCCCCCccHHHHHHHHhcccC-----------------------------------CCCC-------ccccCHHHHHH
Confidence 99999988766555444321100 0111 01234678999
Q ss_pred HHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 695 VRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 695 L~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
|.+||+.||++|||+.|+|+||||++
T Consensus 273 i~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 273 ITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999999999999999999999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=386.28 Aligned_cols=297 Identities=25% Similarity=0.375 Sum_probs=213.4
Q ss_pred eecCcEEEE-EEeccCCCCceEEEEEC--CCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVT-EYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~-~~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.+.|++. ++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+++.++ ||||+++++++..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~------hpniv~~~~~~~~ 89 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELK------HPNVISLQKVFLS 89 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCC------CTTBCCCCEEEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcC------CCCeeeEeeEEec
Confidence 345678874 47999999999999965 5789999999975432 346778999999985 7899999999965
Q ss_pred --cCeEEEEEEccccchHHHHhhhhccC---CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc--cCCC
Q 004954 488 --LEHLFIVCELLRANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRC 560 (722)
Q Consensus 488 --~~~l~iVmEy~~gsLl~~l~~~~~~~---~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~--~~~~ 560 (722)
...+++||||+.++|.+++....... ....+++..++.|+.||+.||+|||+.||+||||||+||||.. ..++
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 90 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 67899999999999998887554321 2224899999999999999999999999999999999999943 2368
Q ss_pred eEEEEecCCcccccCC------ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH--------
Q 004954 561 EIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV-------- 625 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~------~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~-------- 625 (722)
.+||+|||++...... ....++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999999765432 2346789999999999875 489999999999999999999999976554
Q ss_pred -HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCC
Q 004954 626 -VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704 (722)
Q Consensus 626 -~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~ 704 (722)
.+.+.++...+|.++...|.....+..+...... ..............+.......+..+.+||++||++||.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~ 323 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD------FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHH------CCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhh------ccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence 4788888888888877666544332221110000 000000000000011111122345688999999999999
Q ss_pred CCcCHHHHHhCCCCCC
Q 004954 705 RRPTAREALDHPWLQH 720 (722)
Q Consensus 705 kRpTa~ElL~HPwf~~ 720 (722)
+|||++|||+||||+.
T Consensus 324 ~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 324 KRITSEQAMQDPYFLE 339 (405)
T ss_dssp GSCCHHHHHTSGGGTS
T ss_pred cCCCHHHHhcChhhcc
Confidence 9999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=380.12 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=214.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+.++|++++.||+|+||+||+|.+..+|+.+|+|++.... .....+.+|+.+++.+ .||||+++++++.....
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL------HHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC------CSTTBCCEEEEEECSSE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC------CCcCCCeEEEEEEeCCE
Confidence 4578999999999999999999999999999999997643 2334567788877766 47899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++....+.+||+|||+
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999975 6767665322 238999999999999999999999999999999999999865567899999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------- 270 (387)
T 1kob_A 198 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------- 270 (387)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-------
T ss_pred ceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 9876543 2345789999999999999999999999999999999999999998877776666542211111
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
. ......++.+.+||++||+.||.+|||+.|+|+||||+..
T Consensus 271 ----------------------------~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 271 ----------------------------E-----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ----------------------------S-----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------------------c-----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 0 0011235678999999999999999999999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=371.00 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=206.4
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..++|++++.||+|+||+||+|+++.+++.||||++++.. .......+|..+++.+. .||||++++++|..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQT 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEEC
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC-----CCCccCeEEEEEEe
Confidence 3578999999999999999999999999999999997542 33455677888887763 47899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
...+++||||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~D 153 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTD 153 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEEe
Confidence 9999999999975 6766665432 2899999999999999999999999999999999999986 78999999
Q ss_pred cCCccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH---------HHHHHHHHh
Q 004954 567 LGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMILARIIG 634 (722)
Q Consensus 567 FGls~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~---------~e~l~~i~~ 634 (722)
||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+...+..
T Consensus 154 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred ccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 99987532 234456899999999999999999999999999999999999999964211 111111110
Q ss_pred hcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH-----
Q 004954 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----- 709 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa----- 709 (722)
....+| ...+..+.+||++||+.||.+||++
T Consensus 234 -----------------------------------~~~~~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 269 (345)
T 3a8x_A 234 -----------------------------------KQIRIP---------RSLSVKAASVLKSFLNKDPKERLGCHPQTG 269 (345)
T ss_dssp -----------------------------------CCCCCC---------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTH
T ss_pred -----------------------------------CCCCCC---------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCC
Confidence 011112 1234678999999999999999995
Q ss_pred -HHHHhCCCCCC
Q 004954 710 -REALDHPWLQH 720 (722)
Q Consensus 710 -~ElL~HPwf~~ 720 (722)
.|+++||||+.
T Consensus 270 ~~~i~~hp~f~~ 281 (345)
T 3a8x_A 270 FADIQGHPFFRN 281 (345)
T ss_dssp HHHHHTSGGGTT
T ss_pred HHHHhcCCccCC
Confidence 89999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=372.97 Aligned_cols=279 Identities=29% Similarity=0.547 Sum_probs=223.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.++|.+.+.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.++ ||||+++++++..
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 94 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ------HENVIGLLDVFTP 94 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECS
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC------CCCcccHhheEec
Confidence 3568999999999999999999999999999999999653 233456778888888875 7899999999987
Q ss_pred cCe------EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 488 LEH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 488 ~~~------l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
... .++||||+.++|.+++.. .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~--~~~ 164 (353)
T 3coi_A 95 ASSLRNFYDFYLVMPFMQTDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCE 164 (353)
T ss_dssp CSSGGGCCCCEEEEECCSEEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TCC
T ss_pred ccccccceeEEEEeccccCCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC--CCc
Confidence 654 599999999887765531 2899999999999999999999999999999999999995 788
Q ss_pred EEEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 562 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 562 vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
+||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.++
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 165 LKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp EEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred EEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999999877666666788999999999987 6789999999999999999999999999999999999999999888
Q ss_pred HHHHhhhhhhh--hhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 641 LEMLMQGQEIY--KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 641 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.+++....... .++. .+... ....+.......++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~-------------~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQ-------------SLPQT--PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HHHHTTCSCHHHHHHHH-------------TSCBC--SSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHhhHHHHHHHH-------------hCcCC--CCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 77665432111 0000 00000 0111122223456789999999999999999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 310 ~~ 311 (353)
T 3coi_A 310 EP 311 (353)
T ss_dssp TT
T ss_pred hh
Confidence 74
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=363.42 Aligned_cols=284 Identities=25% Similarity=0.425 Sum_probs=219.1
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY- 486 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~- 486 (722)
+..+.++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+|+++++.++ ||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD------HDNIVKVFEILGP 79 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC------CTTBCCEEEEECT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC------CCCeeEEEEeccc
Confidence 4567899999999999999999999999999999999987543 34466778888888774 789999999874
Q ss_pred -------------ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceE
Q 004954 487 -------------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (722)
Q Consensus 487 -------------~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NIL 553 (722)
.....++||||+.++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 152 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred cccccccccccccccCceeEEeeccCCCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 3468999999999988887753 12889999999999999999999999999999999999
Q ss_pred EcccCCCeEEEEecCCcccccCC------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHH
Q 004954 554 IKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (722)
Q Consensus 554 l~~~~~~~vkL~DFGls~~~~~~------~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~ 626 (722)
++. .++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 153 ~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 153 INT-EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp EET-TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EcC-CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 974 3578999999998765322 233467899999999876 67899999999999999999999999999888
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
+.+..+....+....+............. .. .. ......+.......+..+.+||++||+.||.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~----~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYI-------RN----DM---TEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHH-------HH----HT---TSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccc-------cc----cc---cCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence 88888887777665554332211100000 00 00 001112223334456789999999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 004954 707 PTAREALDHPWLQH 720 (722)
Q Consensus 707 pTa~ElL~HPwf~~ 720 (722)
||+.|+|+||||+.
T Consensus 298 pt~~ell~hp~~~~ 311 (320)
T 2i6l_A 298 LTAEEALSHPYMSI 311 (320)
T ss_dssp CCHHHHHTSHHHHT
T ss_pred CCHHHHhCCccccc
Confidence 99999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=365.13 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=217.5
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
...+.++|++.+.||+|+||.||+|++..+|+.||+|+++.... ....+.+|+.+++.++ ||||+++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~ 80 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL------HHNVITL 80 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC------CTTBCCE
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC------CCCcceE
Confidence 34567899999999999999999999999999999999875432 2456788999998885 7899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC-
Q 004954 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR- 559 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~- 559 (722)
++++......++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+..
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 81 HDVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred EEEEecCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCC
Confidence 999999999999999996 57777775322 3889999999999999999999999999999999999986221
Q ss_pred -CeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 560 -CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 560 -~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
..+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234 (321)
T ss_dssp SCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred cCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 17999999999765543 234578999999999999999999999999999999999999999888777776665432
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
..++... ....++.+.+||++||+.||.+|||+.|+|+||
T Consensus 235 ~~~~~~~----------------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 235 YDFDEEF----------------------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp CCCCHHH----------------------------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred cccChhh----------------------------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 2222111 112346689999999999999999999999999
Q ss_pred CCCC
Q 004954 717 WLQH 720 (722)
Q Consensus 717 wf~~ 720 (722)
||+.
T Consensus 275 ~~~~ 278 (321)
T 2a2a_A 275 WITP 278 (321)
T ss_dssp TTSC
T ss_pred cccC
Confidence 9975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=373.09 Aligned_cols=284 Identities=28% Similarity=0.505 Sum_probs=221.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------------hhhHhHHHHHHHHHHhcccCCCCCCce
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------------DFFDQSLDEIKLLKLVNKNDPADEHHI 478 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~------------~~~~~~~~E~~il~~L~~~~~~~hpnI 478 (722)
.+.++|++.+.||+|+||.||+|.+.. |+.||||++.... .....+.+|+++++.++ ||||
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i 91 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH------HPNI 91 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC------CTTB
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC------CcCc
Confidence 456899999999999999999999754 9999999986422 12366788999999885 7899
Q ss_pred eEEEEEEEec-----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceE
Q 004954 479 LRLYDYFYHL-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (722)
Q Consensus 479 v~l~~~f~~~-----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NIL 553 (722)
+++++++... ..+++||||+.++|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence 9999999643 3689999999999998887432 23899999999999999999999999999999999999
Q ss_pred EcccCCCeEEEEecCCcccccCC--ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 004954 554 IKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (722)
Q Consensus 554 l~~~~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~ 630 (722)
++. ++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.
T Consensus 167 ~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LAD--NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECT--TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcC--CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 985 788999999999754332 334578999999999987 678999999999999999999999999999999999
Q ss_pred HHHhhcCCCcHHHHhhhhh--hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 631 RIIGMLGPIDLEMLMQGQE--IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
.+....+.++.+.+..... ...++.. .....+ ...+.......++.+.+||.+||+.||.+|||
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRN-------------SLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTT-------------CCCCCC-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHh-------------hcccCC-hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 9999999888765543211 1111100 000111 11222233445678999999999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 004954 709 AREALDHPWLQHPY 722 (722)
Q Consensus 709 a~ElL~HPwf~~~~ 722 (722)
+.|+|+||||+..+
T Consensus 311 ~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 311 TEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHTSGGGTTTC
T ss_pred HHHHHcCchhhhcc
Confidence 99999999998743
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=359.59 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=209.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..+.++|++.+.||+|+||+||++++..+++.+|+|++..... ....+.+|+++++.++ ||||+++++++..
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~ 91 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD------HPNIIKIFEVFED 91 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC------CTTBCCEEEEEEC
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC------CchHHhHHHheec
Confidence 3567899999999999999999999999999999999976532 3466788999888774 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-CCCeEEEE
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKII 565 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~~~~vkL~ 565 (722)
....++||||+.+ +|.+.+....... ..+++..++.++.||+.||.|||+.||+||||||+|||++.. .++.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARG--KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 9999999999975 7877776543222 238999999999999999999999999999999999999642 35789999
Q ss_pred ecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
|||++...... .....+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 170 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 245 (285)
T 3is5_A 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA--- 245 (285)
T ss_dssp CCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred eeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc---
Confidence 99999764432 33467899999999986 4689999999999999999999999998776665544431111000
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
......++.+.+||++||+.||++|||+.|+|+||||+++
T Consensus 246 --------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 246 --------------------------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp --------------------------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred --------------------------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 0001134678899999999999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=357.69 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=215.3
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDSIQE 76 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC------CCCcCeEEEEEEc
Confidence 46789999999999999999999999999999999987543 33456778899988885 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeEEEE
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKII 565 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~vkL~ 565 (722)
....++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+||+++.+. .+.+||+
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 9999999999975 6767665432 289999999999999999999999999999999999998632 3569999
Q ss_pred ecCCcccccCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 566 DLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 566 DFGls~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+.......+.
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 228 (284)
T 3kk8_A 151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-- 228 (284)
T ss_dssp CCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred eceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc--
Confidence 999997655432 3357899999999999999999999999999999999999999988777766665432221111
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+. ....++.+.+||++||+.||++|||+.|+|+||||++
T Consensus 229 -------------------------------~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 229 -------------------------------PE-------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp -------------------------------TT-------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred -------------------------------hh-------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 00 1123467899999999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=378.32 Aligned_cols=289 Identities=22% Similarity=0.291 Sum_probs=207.6
Q ss_pred cCcEEEEEEeccC--CCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTEYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G--~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.++|+++++||+| +||+||+|++..+|+.||||+++... .....+.+|+.+++.++ ||||+++++++..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~ 97 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN------HPNIVPYRATFIA 97 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC------CCCCCcEeEEEEE
Confidence 5789999999999 99999999999999999999997543 33456777999998885 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+++||||+. ++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~--~~~~kl~d 171 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSG 171 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcc
Confidence 999999999998 467777664322 22899999999999999999999999999999999999985 78999999
Q ss_pred cCCccccc----------CCccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 004954 567 LGSSCFQT----------DNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (722)
Q Consensus 567 FGls~~~~----------~~~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~ 634 (722)
||.+.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99875321 11223478999999999988 5789999999999999999999999987655444433322
Q ss_pred hcCCC-------cHHHHhhhhhhhhhhcccccchhhhhccccccccCCc--cchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 635 MLGPI-------DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 635 ~lg~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~--~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
...+. +.+.+..... ..... ...... .......+. ...........++.+.+||++||+.||++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 324 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPS--RSVAN----SGLSDS-LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324 (389)
T ss_dssp -------------------------------------------------------------CCHHHHHHHHHHTCSCTTT
T ss_pred CCCCcccccccccccccccccc--ccccc----cccccc-cccCccccccCCCCCCccccccCHHHHHHHHHHhhcCccc
Confidence 11100 0000000000 00000 000000 000000000 00011122345678999999999999999
Q ss_pred CcCHHHHHhCCCCCC
Q 004954 706 RPTAREALDHPWLQH 720 (722)
Q Consensus 706 RpTa~ElL~HPwf~~ 720 (722)
|||+.|+|+||||+.
T Consensus 325 Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 325 RPSASTLLNHSFFKQ 339 (389)
T ss_dssp SCCHHHHTTSGGGGG
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=370.99 Aligned_cols=264 Identities=26% Similarity=0.394 Sum_probs=211.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~------~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+++++.++ ||||++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~ 96 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH------HPNIARLYEV 96 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC------CCCcceeehh
Confidence 3568999999999999999999999999999999998753 234467888999999885 7899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhcc----------------------------------CCCcccCHHHHHHHHHH
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQES----------------------------------GGEAYFTLGRLQVITRQ 529 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~----------------------------------~~~~~ls~~~i~~i~~q 529 (722)
+...+..++||||+. ++|.+++...... .....+++..++.++.|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 999999999999996 5677766421110 00122567788899999
Q ss_pred HHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccC-------CccccccCCcccCchhhcC--CCCCch
Q 004954 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIG--LPYDQK 600 (722)
Q Consensus 530 Il~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~-------~~~~~~gt~~y~APE~l~~--~~~s~k 600 (722)
|+.||+|||+.||+||||||+|||++.++...+||+|||++..... ......+|+.|+|||++.+ ..++.+
T Consensus 177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999999999999999999999875555899999999975432 1234578999999999975 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchh
Q 004954 601 IDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSL 680 (722)
Q Consensus 601 sDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l 680 (722)
+|||||||++|+|++|+.||.+.+..+....+......++. +
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------------~----- 298 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------------------------P----- 298 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------------------------G-----
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------------------------c-----
Confidence 99999999999999999999988877776666532211110 0
Q ss_pred hhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 681 EHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 681 ~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 299 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 299 --NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp --GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 01123467899999999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=382.08 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=213.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..++|+++++||+|+||+||+|+++.+++.||+|++++.. .....+.+|..+++.++ ||||++++++|.+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------SPWVVQLFYAFQD 140 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEE
Confidence 3578999999999999999999999999999999997532 22345778888888774 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
..++++||||+. |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~--~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECC--CCCEEEec
Confidence 999999999996 4677766432 2899999999999999999999999999999999999986 78999999
Q ss_pred cCCcccccCC----ccccccCCcccCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 567 FGls~~~~~~----~~~~~gt~~y~APE~l~~~~----~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+.+|.....
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~- 290 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN- 290 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-
Confidence 9999765543 23568999999999998766 78999999999999999999999999888888777753110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC--CcCHHHHHhCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHP 716 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k--RpTa~ElL~HP 716 (722)
....|.. ...+..+++||++||+.+|.+ |++++|+++||
T Consensus 291 --------------------------------~~~~p~~-------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 291 --------------------------------SLTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp --------------------------------HCCCCTT-------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred --------------------------------cccCCCc-------ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0111111 123467899999999999998 99999999999
Q ss_pred CCCC
Q 004954 717 WLQH 720 (722)
Q Consensus 717 wf~~ 720 (722)
||+.
T Consensus 332 ~f~~ 335 (410)
T 3v8s_A 332 FFKN 335 (410)
T ss_dssp GGCC
T ss_pred cccC
Confidence 9986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=369.10 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=204.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+.++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC------CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC------CCCCCeEEEEEecCC
Confidence 4579999999999999999999999999999999986543 23356788999998885 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~Dfg 150 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFG 150 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeC--CCCEEEEEee
Confidence 99999999975 676665432 23899999999999999999999999999999999999985 7889999999
Q ss_pred CcccccC-----CccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHH-HHHHHhhcCCCcH
Q 004954 569 SSCFQTD-----NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMI-LARIIGMLGPIDL 641 (722)
Q Consensus 569 ls~~~~~-----~~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~-l~~i~~~lg~~~~ 641 (722)
++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+...
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------ 224 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------ 224 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT------
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc------
Confidence 9975432 1234678999999999988775 7789999999999999999999976432211 1111100
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
....+. ....+..+.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 225 -----------------------------~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 225 -----------------------------KTYLNP-------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -----------------------------CTTSTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------------------------cccCCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 000000 11234678899999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.30 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=204.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
+..++|++.+.||+|+||+||++++. .+|+.||+|+++... .......+|+.+++.++ ||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 87 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK------HPFIVDLI 87 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC------CTTBCCEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC------CCCcccee
Confidence 44678999999999999999999985 689999999997642 23345677888888875 78999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
+++...+++++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~--~~~ 159 (327)
T 3a62_A 88 YAFQTGGKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH--QGH 159 (327)
T ss_dssp EEEECSSCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TSC
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECC--CCc
Confidence 99999999999999997 57777765432 2889999999999999999999999999999999999985 789
Q ss_pred EEEEecCCcccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 562 IKIIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 562 vkL~DFGls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 239 (327)
T 3a62_A 160 VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239 (327)
T ss_dssp EEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred EEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999999875332 233467899999999999999999999999999999999999999988777776665432111
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHH
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREAL 713 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL 713 (722)
+| ...+..+.+||.+||+.||.+|| ++.|++
T Consensus 240 -----------------------------------~p---------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 240 -----------------------------------LP---------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp -----------------------------------CC---------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred -----------------------------------CC---------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence 11 11346688999999999999999 899999
Q ss_pred hCCCCCC
Q 004954 714 DHPWLQH 720 (722)
Q Consensus 714 ~HPwf~~ 720 (722)
+||||+.
T Consensus 276 ~hp~f~~ 282 (327)
T 3a62_A 276 AHPFFRH 282 (327)
T ss_dssp HSGGGSS
T ss_pred cCCcccC
Confidence 9999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=375.83 Aligned_cols=257 Identities=29% Similarity=0.389 Sum_probs=208.4
Q ss_pred cCcEEE--EEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 413 AGRYYV--TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 413 ~~rY~i--~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
...|++ .+.||+|+||.||+|++..+|+.||+|+++... .....+.+|+.+++.+ .||||+++++++...+
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL------DHANLIQLYDAFESKN 159 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEECSS
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC------CCCCCCeEEEEEEECC
Confidence 345665 678999999999999999999999999998643 3445677888888776 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+.+..... .+++..++.++.||+.||.|||+.||+||||||+|||+....++.+||+|||
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG 234 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG 234 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred EEEEEEeCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCC
Confidence 99999999974 77777754322 2889999999999999999999999999999999999965457899999999
Q ss_pred CcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 569 SSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 569 ls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++..
T Consensus 235 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~---- 310 (373)
T 2x4f_A 235 LARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE---- 310 (373)
T ss_dssp SCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG----
T ss_pred CceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh----
Confidence 99865443 334578999999999999999999999999999999999999999988877777765432221110
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 311 ------------------------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 311 ------------------------------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp ------------------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ------------------------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 01123467899999999999999999999999999964
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=371.85 Aligned_cols=259 Identities=28% Similarity=0.406 Sum_probs=198.4
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+.+.++|++.+.||+|+||+||+|++..+++.||||+++... ..+.+.+|+.+++.++ ||||+++++++....
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLS------HPNIIKLKEIFETPT 121 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCC------CTTBCCEEEEEECSS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCC------CCCCcceeeeEecCC
Confidence 456788999999999999999999999999999999998654 2356778999998885 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEEEec
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL~DF 567 (722)
..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ..++.+||+||
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEK------GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTC------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEEeCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 99999999974 777776532 23899999999999999999999999999999999999974 34788999999
Q ss_pred CCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH-HHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e-~l~~i~~~lg~~~~~~~ 644 (722)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+..+.......+.
T Consensus 196 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~--- 272 (349)
T 2w4o_A 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS--- 272 (349)
T ss_dssp C----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT---
T ss_pred ccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC---
Confidence 998765443 234678999999999999999999999999999999999999997654433 33333321110000
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
+ .....+..+.+||++||+.||++|||+.|+|+||||+..
T Consensus 273 ------------------------------~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 273 ------------------------------P-------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp ------------------------------T-------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred ------------------------------c-------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0 011234678999999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=362.73 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=202.6
Q ss_pred ceecCcEEEE-EEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~-~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..+.++|++. +.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+. .||||+++++++..
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-----~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-----GHRNVLELIEFFEE 82 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc-----CCCCeeeEEEEEee
Confidence 3456889996 78999999999999999999999999997643 33467788999888763 47899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC-CeEEEE
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKII 565 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~-~~vkL~ 565 (722)
.+..++||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEE
Confidence 999999999997 57877776542 2889999999999999999999999999999999999986322 349999
Q ss_pred ecCCcccccC----------CccccccCCcccCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHH----
Q 004954 566 DLGSSCFQTD----------NLCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVV---- 626 (722)
Q Consensus 566 DFGls~~~~~----------~~~~~~gt~~y~APE~l~~-----~~~s~ksDIWSLGviL~elltG~~PF~~~~~~---- 626 (722)
|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 9999865431 1223468999999999975 45789999999999999999999999764311
Q ss_pred -----------HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHH
Q 004954 627 -----------MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 695 (722)
Q Consensus 627 -----------e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL 695 (722)
.+...+... ...+|. ......+..+.+||
T Consensus 237 ~~~~~~~~~~~~~~~~i~~~-----------------------------------~~~~~~-----~~~~~~~~~~~~li 276 (316)
T 2ac3_A 237 DRGEACPACQNMLFESIQEG-----------------------------------KYEFPD-----KDWAHISCAAKDLI 276 (316)
T ss_dssp ----CCHHHHHHHHHHHHHC-----------------------------------CCCCCH-----HHHTTSCHHHHHHH
T ss_pred cccccchhHHHHHHHHHhcc-----------------------------------CcccCc-----hhcccCCHHHHHHH
Confidence 111111110 001111 01112356789999
Q ss_pred HHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 696 RTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 696 ~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
++||+.||.+|||+.|+|+||||+.
T Consensus 277 ~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 277 SKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHhhCChhhCCCHHHHhcChhhcC
Confidence 9999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=361.46 Aligned_cols=286 Identities=27% Similarity=0.439 Sum_probs=216.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--cC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--~~ 489 (722)
..++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+|+.+++.++ .||||+++++++.. ..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcC-----CCCCEEEeeeeeccCCCC
Confidence 3578999999999999999999999999999999997543 357889999999997 37899999999997 67
Q ss_pred eEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.++ |.+++. .+++..++.++.||+.||+|||+.||+||||||+|||++. ....+||+|||
T Consensus 107 ~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-~~~~~kl~Dfg 176 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWG 176 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCCT
T ss_pred ceEEEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC-CCCEEEEEeCC
Confidence 899999999864 444432 1889999999999999999999999999999999999985 23489999999
Q ss_pred CcccccC--CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCChHHHHHHHHHhhcCCCcHHHH
Q 004954 569 SSCFQTD--NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 569 ls~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF-~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+...++..+...+
T Consensus 177 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp TCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 9976543 2344678999999999987 67899999999999999999999999 455666777777766664333221
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
...... .+...............+....+ .......++.+.+||++||++||.+|||++|+|+||||+..
T Consensus 257 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 257 IDKYNI--ELDPRFNDILGRHSRKRWERFVH-----SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHTTC--CCCTHHHHHHCCCCCCCGGGGCC-----TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHhcc--ccccchhhhhhhccccchhhhcc-----ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 111000 00000000000000000000000 01112246789999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=375.65 Aligned_cols=295 Identities=24% Similarity=0.311 Sum_probs=211.3
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.+++..++|++.+.||+|+||+||++.+..+++.||+|++... ......+.+|+.+++.+ .||||+++++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~ 100 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGAF 100 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC------CCTTBCCEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC------CCCCEEEEeEEE
Confidence 3566778999999999999999999999999999999999764 23345566777766665 478999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEE
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vk 563 (722)
...+..++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+|||++. ++.+|
T Consensus 101 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~k 172 (360)
T 3eqc_A 101 YSDGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIK 172 (360)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEE
T ss_pred EECCEEEEEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC--CCCEE
Confidence 999999999999975 7777776443 288999999999999999999996 9999999999999996 78899
Q ss_pred EEecCCcccccC-CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 564 IIDLGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 564 L~DFGls~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..........
T Consensus 173 l~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 173 LCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp ECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred EEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 999999865432 2334578999999999999999999999999999999999999998877665544332111111111
Q ss_pred HH----hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 643 ML----MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 643 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.. ........+.....................+.. ......+..+.+||++||+.||.+|||+.|+|+||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK----LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCC----CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCC----CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 00 000000000000000000000000000000000 0011235679999999999999999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 329 ~~ 330 (360)
T 3eqc_A 329 KR 330 (360)
T ss_dssp HH
T ss_pred hc
Confidence 64
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=367.95 Aligned_cols=271 Identities=27% Similarity=0.383 Sum_probs=219.5
Q ss_pred CCCcceeeCceecCcEEEE-EEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCC
Q 004954 401 NKDLPIILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEH 476 (722)
Q Consensus 401 ~~~~pi~~~~~l~~rY~i~-~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hp 476 (722)
.+++.....+.+.++|.+. +.||+|+||+||+|++..+|+.||+|+++... .....+.+|+.+++.+.+ ||
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~ 89 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS-----CP 89 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT-----CT
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC-----CC
Confidence 3445555667788999998 89999999999999999999999999987543 234577889999988863 68
Q ss_pred ceeEEEEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEc
Q 004954 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (722)
Q Consensus 477 nIv~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~ 555 (722)
||+++++++......++||||+.+ +|.+++... ....+++..++.++.||+.||+|||+.||+||||||+|||++
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPE----LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC----C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEe
Confidence 999999999999999999999975 666655322 123489999999999999999999999999999999999998
Q ss_pred cc-CCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHH
Q 004954 556 SY-QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632 (722)
Q Consensus 556 ~~-~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i 632 (722)
.. .++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 245 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 52 2578999999999765543 23457899999999999999999999999999999999999999988877776665
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
.......+.+ .....+..+.+||.+||+.||.+|||++++
T Consensus 246 ~~~~~~~~~~----------------------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l 285 (327)
T 3lm5_A 246 SQVNVDYSEE----------------------------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285 (327)
T ss_dssp HHTCCCCCTT----------------------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HhcccccCch----------------------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 5332221110 011234668999999999999999999999
Q ss_pred HhCCCCCC
Q 004954 713 LDHPWLQH 720 (722)
Q Consensus 713 L~HPwf~~ 720 (722)
|+||||+.
T Consensus 286 l~h~~~~~ 293 (327)
T 3lm5_A 286 LSHSWLQQ 293 (327)
T ss_dssp TTCGGGCC
T ss_pred hCCHhhcc
Confidence 99999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.85 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=214.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+.++|++.+.||+|+||+||+|.+..+++.+|+|++... ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD------HPNIIRLYETFEDNT 79 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCC------CTTBCCEEEEEECSS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCC------CCCEeeEEEEEecCC
Confidence 3567899999999999999999999999999999998754 233467788999888774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEEEec
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL~DF 567 (722)
..++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||+.. ..++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999975 6777665432 2899999999999999999999999999999999999932 13778999999
Q ss_pred CCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 568 Gls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
|++...... .....+|+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+......++...+
T Consensus 154 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (277)
T 3f3z_A 154 GLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW- 231 (277)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-
T ss_pred ccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh-
Confidence 998765433 3346789999999998765 899999999999999999999999988877777666544333332211
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...++.+.+||++||+.||.+|||+.++|+||||++
T Consensus 232 ---------------------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 ---------------------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ---------------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ---------------------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 123466889999999999999999999999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=384.10 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=213.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..++|+++++||+|+||+||+|+++.+++.||||++++.. .....+.+|..++..++ ||||++++++|..
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~------hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD------SKWITTLHYAFQD 145 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC------TTTBCCEEEEEEC
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEee
Confidence 4578999999999999999999999999999999997532 22334778888888764 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~--~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcC--CCCEEEcc
Confidence 999999999996 57777776422 23899999999999999999999999999999999999986 78999999
Q ss_pred cCCcccccCCc----cccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 567 LGSSCFQTDNL----CLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 567 FGls~~~~~~~----~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
||++....... ...+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+.+.+|+....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 99997654332 2358999999999997 55689999999999999999999999999888888777752110
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC--CcCHHHHHhC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k--RpTa~ElL~H 715 (722)
...+|.. ....++.+++||++||+.+|.+ |++++|+++|
T Consensus 299 ---------------------------------~~~~p~~------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 ---------------------------------RFQFPTQ------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---------------------------------HCCCCSS------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---------------------------------cccCCcc------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0111111 1123567899999999998888 9999999999
Q ss_pred CCCCC
Q 004954 716 PWLQH 720 (722)
Q Consensus 716 Pwf~~ 720 (722)
|||+.
T Consensus 340 pff~~ 344 (437)
T 4aw2_A 340 PFFSG 344 (437)
T ss_dssp GGGTT
T ss_pred CccCC
Confidence 99975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=385.23 Aligned_cols=264 Identities=28% Similarity=0.439 Sum_probs=217.0
Q ss_pred cceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--------------hhhHhHHHHHHHHHHhcc
Q 004954 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--------------DFFDQSLDEIKLLKLVNK 469 (722)
Q Consensus 404 ~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--------------~~~~~~~~E~~il~~L~~ 469 (722)
+.......+.++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+++.++
T Consensus 26 ~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 104 (504)
T 3q5i_A 26 YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD- 104 (504)
T ss_dssp GCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-
T ss_pred eeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-
Confidence 334445567899999999999999999999999999999999987543 23456778888888774
Q ss_pred cCCCCCCceeEEEEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 004954 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (722)
Q Consensus 470 ~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLK 548 (722)
||||+++++++......++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+|||||
T Consensus 105 -----hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 173 (504)
T 3q5i_A 105 -----HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKHNIVHRDIK 173 (504)
T ss_dssp -----CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred -----CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCc
Confidence 78999999999999999999999975 7777776432 28999999999999999999999999999999
Q ss_pred CCceEEcccCC-CeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH
Q 004954 549 PENILIKSYQR-CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (722)
Q Consensus 549 p~NILl~~~~~-~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~ 625 (722)
|+|||++..+. ..+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.
T Consensus 174 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp GGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999986322 37999999999765543 344679999999999874 689999999999999999999999999888
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
.+++..+......++...+ ...+..+++||++||+.||.+
T Consensus 253 ~~~~~~i~~~~~~~~~~~~----------------------------------------~~~s~~~~~li~~~L~~dp~~ 292 (504)
T 3q5i_A 253 QDIIKKVEKGKYYFDFNDW----------------------------------------KNISDEAKELIKLMLTYDYNK 292 (504)
T ss_dssp HHHHHHHHHCCCCCCHHHH----------------------------------------TTSCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHcCCCCCCcccc----------------------------------------CCCCHHHHHHHHHHcCCChhH
Confidence 8888777643332222111 123466899999999999999
Q ss_pred CcCHHHHHhCCCCCC
Q 004954 706 RPTAREALDHPWLQH 720 (722)
Q Consensus 706 RpTa~ElL~HPwf~~ 720 (722)
|||+.|+|+||||++
T Consensus 293 R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 293 RCTAEEALNSRWIKK 307 (504)
T ss_dssp SCCHHHHHTSHHHHH
T ss_pred CCCHHHHhcCHhhhh
Confidence 999999999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=373.81 Aligned_cols=256 Identities=29% Similarity=0.429 Sum_probs=208.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.+.++|++.+.||+|+||+||+|.++.+|+.||||++..... ...+|+.++.++. .||||+++++++.....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG-----QHPNIITLKDVYDDGKY 90 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT-----TSTTBCCEEEEEECSSE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc-----CCCCcCeEEEEEEcCCE
Confidence 356889999999999999999999999999999999976543 3456888887774 47899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC--CCeEEEEec
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDL 567 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~--~~~vkL~DF 567 (722)
+++||||+.| +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||+.... .+.+||+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 9999999975 7777765432 389999999999999999999999999999999999986422 246999999
Q ss_pred CCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---ChHHHHHHHHHhhcCCCcH
Q 004954 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN---DAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~---~~~~e~l~~i~~~lg~~~~ 641 (722)
|++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|..||.+ ....+++..+....-.
T Consensus 165 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~--- 241 (342)
T 2qr7_A 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS--- 241 (342)
T ss_dssp TTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC---
T ss_pred CCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc---
Confidence 999765432 3346789999999999988889999999999999999999999975 3344444444311100
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
++. ......+..+.+||++||+.||++|||+.++|+||||.+
T Consensus 242 --------------------------------~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 242 --------------------------------LSG-----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp --------------------------------CCS-----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred --------------------------------cCc-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 000 001123567899999999999999999999999999953
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=357.55 Aligned_cols=261 Identities=26% Similarity=0.365 Sum_probs=192.6
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++..++|++.+.||+|+||+||+|++..+|+.||+|+++.............+....+ ....||||+++++++...+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~---~~~~h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM---RTVDCPFTVTFYGALFREG 79 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHH---TTCCCTTBCCEEEEEECSS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHH---HhCCCCeEEEEeeeeeccC
Confidence 3456899999999999999999999999999999999976432221111111111112 2346899999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||++++|.+++....... ..+++..++.++.||+.||.|||++ ||+||||||+||+++. ++.+||+|||
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKG--QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT--TCCEEBCCC-
T ss_pred CEEEEEehhccchHHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecC
Confidence 999999999999888776533222 2389999999999999999999998 9999999999999985 7899999999
Q ss_pred CcccccCCc--cccccCCcccCchhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCcH
Q 004954 569 SSCFQTDNL--CLYVQSRSYRAPEVI----IGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 569 ls~~~~~~~--~~~~gt~~y~APE~l----~~~~~s~ksDIWSLGviL~elltG~~PF~~-~~~~e~l~~i~~~lg~~~~ 641 (722)
++....... ....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||.. ......+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 231 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS---- 231 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC----
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC----
Confidence 987654432 234789999999996 456789999999999999999999999975 222222222221000
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
...+ ....+..+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 232 ------------------------------~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 232 ------------------------------PQLP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp ------------------------------CCCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred ------------------------------CCcc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 0000 012346789999999999999999999999999996
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=385.71 Aligned_cols=258 Identities=32% Similarity=0.516 Sum_probs=215.4
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+.++|++.++||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~ 91 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD------HPNIMKLFEILE 91 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC------CTTBCCEEEEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC------CCCcCeEEEEEE
Confidence 456789999999999999999999999999999999986532 23467788999999884 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-CCCeEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKI 564 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~~~~vkL 564 (722)
....+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.. .++.+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEE
Confidence 99999999999975 6777765443 28999999999999999999999999999999999999752 3568999
Q ss_pred EecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+......++.+
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (486)
T ss_dssp CSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG
T ss_pred EECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 999999765433 334679999999999986 58999999999999999999999999988888777765332221111
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
. ....++.+.+||++||+.||.+|||+.|+|+||||++
T Consensus 245 ---------------------------------~-------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 245 ---------------------------------Q-------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp ---------------------------------G-------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred ---------------------------------c-------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0 0123466899999999999999999999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=366.29 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=202.7
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+..++|++++.||+|+||+||++.+ .+++.||||++... ....+.+.+|+.+++.+++. |+||+++++++..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~----~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEIT 80 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT----CTTBCCEEEEEEC
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhc----CCceEEEeeeEee
Confidence 4467899999999999999999997 56899999998753 23346678899999999753 4799999999999
Q ss_pred cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 488 ~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
...+++|||+..++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---~~~~kl~DF 151 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDF 151 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEECCC
T ss_pred CCEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---CCcEEEeec
Confidence 99999999988889999887532 288999999999999999999999999999999999997 678999999
Q ss_pred CCcccccCCc-----cccccCCcccCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHH
Q 004954 568 GSSCFQTDNL-----CLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILA 630 (722)
Q Consensus 568 Gls~~~~~~~-----~~~~gt~~y~APE~l~~-----------~~~s~ksDIWSLGviL~elltG~~PF~~~~~-~e~l~ 630 (722)
|++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+.
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 231 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH
Confidence 9997654332 24578999999999865 6788999999999999999999999975321 11221
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+... ......| ...+..+.+||.+||+.||.+|||+.
T Consensus 232 ~~~~~---------------------------------~~~~~~~---------~~~~~~l~~li~~~L~~dp~~Rpt~~ 269 (343)
T 3dbq_A 232 AIIDP---------------------------------NHEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIP 269 (343)
T ss_dssp HHHCT---------------------------------TSCCCCC---------CCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHhcC---------------------------------CcccCCc---------ccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 11100 0001111 12245688999999999999999999
Q ss_pred HHHhCCCCCC
Q 004954 711 EALDHPWLQH 720 (722)
Q Consensus 711 ElL~HPwf~~ 720 (722)
|+|+||||+.
T Consensus 270 e~l~hp~~~~ 279 (343)
T 3dbq_A 270 ELLAHPYVQI 279 (343)
T ss_dssp HHHTSHHHHS
T ss_pred HHHhCccccc
Confidence 9999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=387.77 Aligned_cols=259 Identities=32% Similarity=0.510 Sum_probs=216.0
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
...+.++|++.+.||+|+||+||+|++..+|+.||||++... ......+.+|+.+++.++ ||||++++++
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~ 94 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD------HPNIMKLYEF 94 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC------CTTBCCEEEE
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC------CCCCCcEEEE
Confidence 456788999999999999999999999999999999998653 233466778888887774 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeE
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEI 562 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~v 562 (722)
+......++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ..++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcE
Confidence 9999999999999974 6777665432 2899999999999999999999999999999999999964 246789
Q ss_pred EEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 563 kL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+......++
T Consensus 169 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 169 RIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247 (484)
T ss_dssp EECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999998765443 334679999999999987 689999999999999999999999999888887777653322211
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
. |. ....++.+.+||++||+.||.+|||+.|+|+||||+.
T Consensus 248 ~---------------------------------~~-------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 248 L---------------------------------PQ-------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp S---------------------------------GG-------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred C---------------------------------cc-------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 1 10 0123467899999999999999999999999999963
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=367.33 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=189.3
Q ss_pred cCcEEEE---EEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 413 AGRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 413 ~~rY~i~---~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.++|.+. +.||+|+||+||+|.+..+|+.||||++.... .....+|+.+++.+. .||||+++++++....
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCE-----GHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--HHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSS
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh--hhhHHHHHHHHHHhc-----CCCCeeEEEEEEEcCC
Confidence 4567776 78999999999999999999999999997543 356778999998886 3789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-CCCeEEEEec
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDL 567 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~~~~vkL~DF 567 (722)
+.++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.. ....+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCC
T ss_pred EEEEEEEccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecc
Confidence 99999999975 7777776432 38999999999999999999999999999999999999852 2338999999
Q ss_pred CCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH-------HHHHHHHHhhcC
Q 004954 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-------VMILARIIGMLG 637 (722)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~-------~e~l~~i~~~lg 637 (722)
|++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .+++..+.....
T Consensus 154 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 154 GFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp TTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred ccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 999765432 2345789999999999999999999999999999999999999976432 222222221111
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.++.+ .....++.+.+||++||+.||.+|||+.|+|+|||
T Consensus 234 ~~~~~----------------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 234 SFEGE----------------------------------------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp CCCSH----------------------------------------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred CCCcc----------------------------------------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 11000 01123567899999999999999999999999999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 274 ~~~ 276 (325)
T 3kn6_A 274 LQD 276 (325)
T ss_dssp GCT
T ss_pred hcc
Confidence 975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=377.60 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=211.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..++|+++++||+|+||+||+++++.+|+.||||++++.. .....+.+|..++..++ ||||++++++|.+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~------hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD------RRWITQLHFAFQD 132 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC------TTTBCCEEEEEEC
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC------CCCeeeEEEEEee
Confidence 4578999999999999999999999999999999997532 23345778888887764 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+++++||||+. |+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~--~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR--CGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecC--CCCEEEee
Confidence 999999999996 577777764321 2899999999999999999999999999999999999986 78999999
Q ss_pred cCCcccccCCc----cccccCCcccCchhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 004954 567 LGSSCFQTDNL----CLYVQSRSYRAPEVII-------GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 567 FGls~~~~~~~----~~~~gt~~y~APE~l~-------~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~ 635 (722)
||++....... ...+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+.+.+|...
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99997654432 2358999999999997 356899999999999999999999999998888877776521
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC---cCHHHH
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR---PTAREA 712 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR---pTa~El 712 (722)
.. ...+|. .....++.+++||++||+ +|.+| ++++|+
T Consensus 286 ~~---------------------------------~~~~p~------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei 325 (412)
T 2vd5_A 286 KE---------------------------------HLSLPL------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325 (412)
T ss_dssp HH---------------------------------HCCCC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred cc---------------------------------CcCCCc------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 00 000110 011235678999999999 99998 599999
Q ss_pred HhCCCCCC
Q 004954 713 LDHPWLQH 720 (722)
Q Consensus 713 L~HPwf~~ 720 (722)
++||||+.
T Consensus 326 ~~Hpff~~ 333 (412)
T 2vd5_A 326 RTHPFFFG 333 (412)
T ss_dssp HTSGGGTT
T ss_pred hcCCCcCC
Confidence 99999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=369.24 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=205.7
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcc-cCCCCCCceeEEEEEEEecC
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK-NDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~-~~~~~hpnIv~l~~~f~~~~ 489 (722)
...++|++++.||+|+||+||+|+++.+++.||||++++....... .+..++++... .....||||++++++|...+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~--~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH--HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 3457899999999999999999999999999999999765321111 11222222221 23467999999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++++||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~ikL~DFG 184 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFG 184 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEeeCc
Confidence 99999999985 6766665432 2889999999999999999999999999999999999986 7899999999
Q ss_pred Cccccc---CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
+++... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..|....-
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------- 256 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-------- 256 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--------
T ss_pred cccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------
Confidence 997532 234457899999999999999999999999999999999999999999888777766652100
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH----HHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa----~ElL~HPwf~~ 720 (722)
.+| ...+..+.+||++||+.||.+||++ .++++||||+.
T Consensus 257 ---------------------------~~~---------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 257 ---------------------------QLK---------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp ---------------------------CCC---------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred ---------------------------CCC---------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 011 1234668899999999999999986 79999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=378.60 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=204.6
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.+..++|+++++||+|+||.||+|++..+|+.||||+++.... ......+|+.+ .....||||+++++++
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~------l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV------LQNSRHPFLTALKYSF 217 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------C------CCCCSCTTSCCEEEEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHH------HHhCCCCeEeeEEEEE
Confidence 3456789999999999999999999999999999999975421 12223334333 3345689999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEE
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
...+.+++||||+.+ +|...+.... .+++..++.++.||+.||+|||+ .||+||||||+||||+. ++.+|
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~--~~~~k 289 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIK 289 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS--SSCEE
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC--CCCEE
Confidence 999999999999986 6666665432 28999999999999999999998 99999999999999986 78999
Q ss_pred EEecCCcccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 290 l~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--- 366 (446)
T 4ejn_A 290 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--- 366 (446)
T ss_dssp ECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred EccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC---
Confidence 999999875332 23456899999999999999999999999999999999999999998877776666542111
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDH 715 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~H 715 (722)
.+| ...++.+.+||.+||+.||.+|| |++|+|+|
T Consensus 367 --------------------------------~~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 --------------------------------RFP---------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --------------------------------CCC---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------------------------------CCC---------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111 12346789999999999999999 99999999
Q ss_pred CCCCC
Q 004954 716 PWLQH 720 (722)
Q Consensus 716 Pwf~~ 720 (722)
|||+.
T Consensus 406 p~f~~ 410 (446)
T 4ejn_A 406 RFFAG 410 (446)
T ss_dssp GGGTT
T ss_pred ccccC
Confidence 99985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.21 Aligned_cols=251 Identities=29% Similarity=0.456 Sum_probs=206.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..++|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+|+.+++.+ .||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL------RHPNILRLYGYFHD 80 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC------CCTTBCCEEEEEEC
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC------CCCCCcchhheEec
Confidence 45789999999999999999999999999999999865421 234456677776665 47899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
....++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~~l~D 152 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIAD 152 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECT--TSCEEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcC--CCCEEEEe
Confidence 9999999999984 6777665432 2899999999999999999999999999999999999985 78899999
Q ss_pred cCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 567 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 567 FGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 225 (279)
T 3fdn_A 153 FGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------- 225 (279)
T ss_dssp CCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred ccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC-------
Confidence 9988654433 34467899999999999999999999999999999999999999988777766655422111
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.| ...+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 226 ----------------------------~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 226 ----------------------------FP---------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp ----------------------------CC---------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred ----------------------------CC---------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 11 113466889999999999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=370.50 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=207.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.+..++|++++.||+|+||+||++++..+++.||+|++.... .....+.+|+.+++.++ ||||++++++|
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~~ 84 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE------HPFLVNLWYSF 84 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC------CCCCCcEEEEE
Confidence 345689999999999999999999999999999999997543 23456778888887774 78999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
.....+++||||+.| +|..++... ..+++..++.++.||+.||.|||+.||+||||||+||||+. ++.+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL 156 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQN------VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE--HGHVHI 156 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEE
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECC--CCCEEE
Confidence 999999999999975 666665532 22899999999999999999999999999999999999986 789999
Q ss_pred EecCCcccccC--CccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCh---HHHHHHHHHhhc
Q 004954 565 IDLGSSCFQTD--NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGML 636 (722)
Q Consensus 565 ~DFGls~~~~~--~~~~~~gt~~y~APE~l~~---~~~s~ksDIWSLGviL~elltG~~PF~~~~---~~e~l~~i~~~l 636 (722)
+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..++...+....
T Consensus 157 ~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 236 (384)
T 4fr4_A 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236 (384)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC
T ss_pred eccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc
Confidence 99999986543 3445789999999999974 458999999999999999999999997432 222222221110
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-HHHHHhC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-AREALDH 715 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-a~ElL~H 715 (722)
...| ...+..+.+||++||+.||.+||+ ++++++|
T Consensus 237 -----------------------------------~~~p---------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 237 -----------------------------------VTYP---------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -----------------------------------CCCC---------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -----------------------------------cCCC---------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 0111 123467899999999999999998 9999999
Q ss_pred CCCCC
Q 004954 716 PWLQH 720 (722)
Q Consensus 716 Pwf~~ 720 (722)
|||+.
T Consensus 273 p~f~~ 277 (384)
T 4fr4_A 273 PYMND 277 (384)
T ss_dssp GGGTT
T ss_pred hhhhc
Confidence 99975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=367.08 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=211.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
..+|++++.||+|+||+||+|++..+|+.||||++.... .....+.+|+++++.++ ||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLRE 126 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEET
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEEC
Confidence 467999999999999999999999999999999987532 23456778999998885 78999999999999
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 489 ~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
+..++||||+.|++.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG 199 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFG 199 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTEEEECCCT
T ss_pred CeEEEEEecCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEEeecc
Confidence 99999999999999888764432 3899999999999999999999999999999999999995 7899999999
Q ss_pred CcccccCCccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
++...... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+....+..+.....+
T Consensus 200 ~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~------- 271 (348)
T 1u5q_A 200 SASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP------- 271 (348)
T ss_dssp TCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------
T ss_pred CceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------
Confidence 99765533 3467999999999985 567899999999999999999999999887665555444321000
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
... ....+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 272 ---------------------------~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 272 ---------------------------ALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---------------------------CCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------------------------CCC--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 000 0123467899999999999999999999999999964
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=385.03 Aligned_cols=257 Identities=32% Similarity=0.505 Sum_probs=210.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+.++|++++.||+|+||+||+|+++.+++.||||+++... .....+.+|+.+++.+ .||||+++++++..
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 107 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL------DHPNIMKLYDFFED 107 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC------CCTTBCCEEEEEEC
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC------CCCCCCeEEEEEEe
Confidence 45678999999999999999999999999999999997542 2345677888888766 47899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-CCCeEEEE
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKII 565 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~~~~vkL~ 565 (722)
....++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEE
Confidence 9999999999975 6777665442 28999999999999999999999999999999999999853 24679999
Q ss_pred ecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
|||++...... ....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+++..+......++...
T Consensus 182 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (494)
T 3lij_A 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE 260 (494)
T ss_dssp CCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG
T ss_pred ECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence 99999765543 33467999999999986 4689999999999999999999999999888887777654322222111
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
....++.+.+||++||+.||.+|||+.|+|+||||+.
T Consensus 261 ----------------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 ----------------------------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp ----------------------------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred ----------------------------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 0123466889999999999999999999999999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=352.22 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=212.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
++.++|++.+.||+|+||+||++++..+|+.||+|+++.... ..+.+.+|+.+++.++ ||||+++++
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~ 75 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR------HPNIITLHD 75 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC------CCCeeehhh
Confidence 456789999999999999999999999999999999875421 2466788999998885 689999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC--CC
Q 004954 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RC 560 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~--~~ 560 (722)
++......++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++... ..
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence 9999999999999996 57777775432 289999999999999999999999999999999999998632 23
Q ss_pred eEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+....+.+..+......
T Consensus 150 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229 (283)
T ss_dssp CEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred ceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence 7999999998765432 23456899999999999999999999999999999999999999988777766665432222
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.+.+ .....+..+.+||++||+.||.+|||+.++|+||||
T Consensus 230 ~~~~----------------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 230 FDEE----------------------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp CCHH----------------------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred Ccch----------------------------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 1111 011234668899999999999999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 270 ~~ 271 (283)
T 3bhy_A 270 KA 271 (283)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=383.90 Aligned_cols=254 Identities=17% Similarity=0.231 Sum_probs=202.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE------
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY------ 482 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~------ 482 (722)
.++|++.+.||+|+||+||+|++..+|+.||||++... ....+.+.+|+.+++.+.. ..||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG---IKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT---CCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc---cCCHHHHHHHhhhhhh
Confidence 57899999999999999999999999999999998642 2344667788877766653 4699999998
Q ss_pred -EEEEecC-----------------eEEEEEEccccchHHHHhhhhccCC-CcccCHHHHHHHHHHHHHHHHHHHHCCCc
Q 004954 483 -DYFYHLE-----------------HLFIVCELLRANLYEFQKFNQESGG-EAYFTLGRLQVITRQCLEALEYLHSLGII 543 (722)
Q Consensus 483 -~~f~~~~-----------------~l~iVmEy~~gsLl~~l~~~~~~~~-~~~ls~~~i~~i~~qIl~aL~yLHs~gIv 543 (722)
+++...+ ..++||||++|+|.+++........ ...+++..++.|+.||+.||+|||+.||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 7666553 3899999999999999876543211 23355688889999999999999999999
Q ss_pred cccCCCCceEEcccCCCeEEEEecCCcccccCCccccccCCcccCchhhcCC-----------CCCchhhHHHHHHHHHH
Q 004954 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-----------PYDQKIDLWSLGCILAE 612 (722)
Q Consensus 544 HrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~-----------~~s~ksDIWSLGviL~e 612 (722)
||||||+||||+. ++.+||+|||++...........| +.|+|||++.+. .++.++|||||||++|+
T Consensus 229 HrDikp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQ--RGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECT--TCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcC--CCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999996 789999999999876666666678 999999999887 89999999999999999
Q ss_pred HHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHH
Q 004954 613 LWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692 (722)
Q Consensus 613 lltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~ 692 (722)
|++|+.||.+.........+ .. .....++.+.
T Consensus 306 lltg~~Pf~~~~~~~~~~~~-----------------------------------------~~-------~~~~~~~~~~ 337 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWI-----------------------------------------FR-------SCKNIPQPVR 337 (377)
T ss_dssp HHHSSCCC------CCSGGG-----------------------------------------GS-------SCCCCCHHHH
T ss_pred HHHCCCCCcccccccchhhh-----------------------------------------hh-------hccCCCHHHH
Confidence 99999999654321111000 00 0012356789
Q ss_pred HHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 693 DFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 693 dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+||.+||+.||.+|||+.|+|+||||+.
T Consensus 338 ~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999999999999999999963
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=372.94 Aligned_cols=261 Identities=14% Similarity=0.141 Sum_probs=195.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEE-------
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLY------- 482 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~------- 482 (722)
..|++.+.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.++. .||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~----~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG----ESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC--------------CBCCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc----cChhhhhhceeEEeee
Confidence 45999999999999999999999999999999998743 345567788888888875 489988765
Q ss_pred EEEEec-----------------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHH------HHHHHHHHHHHHHHHH
Q 004954 483 DYFYHL-----------------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL------QVITRQCLEALEYLHS 539 (722)
Q Consensus 483 ~~f~~~-----------------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i------~~i~~qIl~aL~yLHs 539 (722)
+++... .+++|||||+.++|.+++...... +....+ ..++.||+.||+|||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-----~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV-----YVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc-----cchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 455433 348999999999999998865432 344444 6777999999999999
Q ss_pred CCCccccCCCCceEEcccCCCeEEEEecCCcccccCCccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCC
Q 004954 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGE 617 (722)
Q Consensus 540 ~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~ 617 (722)
+||+||||||+||||+. ++.+||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 213 ~~ivHrDikp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMP--DGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TTEEETTCSGGGEEECT--TSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCcCCHHHEEECC--CCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999996 788999999999877665545677899999999987 67999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHH
Q 004954 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697 (722)
Q Consensus 618 ~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~ 697 (722)
.||.+...... . . + . ... ...........+ .....++.+.+||.+
T Consensus 291 ~Pf~~~~~~~~-------------~---~------~-~----~~~-~~~~~~~~~~~~-------~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 291 LPFGLVTPGIK-------------G---S------W-K----RPS-LRVPGTDSLAFG-------SCTPLPDFVKTLIGR 335 (371)
T ss_dssp CSTTBCCTTCT-------------T---C------C-C----BCC-TTSCCCCSCCCT-------TSSCCCHHHHHHHHH
T ss_pred CCCCCcCcccc-------------c---c------h-h----hhh-hhhccccccchh-------hccCCCHHHHHHHHH
Confidence 99976421100 0 0 0 0 000 000000011111 112346789999999
Q ss_pred hcccCCCCCcCHHHHHhCCCCCC
Q 004954 698 LLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 698 mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
||+.||++|||+.++|+||||++
T Consensus 336 ~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 336 FLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HcCCChhhCCCHHHHhcCHHHHH
Confidence 99999999999999999999963
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=351.03 Aligned_cols=259 Identities=23% Similarity=0.287 Sum_probs=205.3
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
...+.++|++.+.||+|+||+||+|++..+++.||||+++.. ........+|+.++..+. .||||+++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-----~h~~iv~~~~~~ 80 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-----QHSHVVRYFSAW 80 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC-----SCTTBCCEEEEE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeee
Confidence 345668999999999999999999999999999999999753 233456667777777763 478999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-------
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY------- 557 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~------- 557 (722)
...+..++||||+.+ +|.+++....... ..+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIM--SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccc
Confidence 999999999999975 8888877553321 238999999999999999999999999999999999999842
Q ss_pred ----------CCCeEEEEecCCcccccCCccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHH
Q 004954 558 ----------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (722)
Q Consensus 558 ----------~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~ 626 (722)
....+||+|||.+....... ...+|+.|+|||++.+. .++.++|||||||++|+|++|.+|+......
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred cccccccccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 24579999999997765443 34689999999999876 5668999999999999999999887654321
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
. .+... ....+| ...+..+.+||.+||+.||.+|
T Consensus 238 ~---~~~~~----------------------------------~~~~~~---------~~~~~~~~~li~~~l~~dp~~R 271 (289)
T 1x8b_A 238 H---EIRQG----------------------------------RLPRIP---------QVLSQEFTELLKVMIHPDPERR 271 (289)
T ss_dssp H---HHHTT----------------------------------CCCCCS---------SCCCHHHHHHHHHHTCSSGGGS
T ss_pred H---HHHcC----------------------------------CCCCCC---------cccCHHHHHHHHHHhCCCcccC
Confidence 1 11100 000111 1235678999999999999999
Q ss_pred cCHHHHHhCCCCCCC
Q 004954 707 PTAREALDHPWLQHP 721 (722)
Q Consensus 707 pTa~ElL~HPwf~~~ 721 (722)
||+.|+|+||||++.
T Consensus 272 ps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 272 PSAMALVKHSVLLSA 286 (289)
T ss_dssp CCHHHHHTCTTC---
T ss_pred CCHHHHhhChHhhhh
Confidence 999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=382.57 Aligned_cols=254 Identities=31% Similarity=0.538 Sum_probs=212.8
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+.+..++|++.+.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.+ .||||++++++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~~~ 84 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF------RHPHIIKLYQV 84 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC------CCTTBCCEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC------CCCCCCcEEEE
Confidence 4556789999999999999999999999999999999997543 2234567788877666 47899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+.....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~--~~~vk 156 (476)
T 2y94_A 85 ISTPSDIFMVMEYVSGGELFDYICKN------GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA--HMNAK 156 (476)
T ss_dssp EECSSEEEEEEECCSSEEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECT--TCCEE
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEec--CCCeE
Confidence 999999999999996 5777776532 23899999999999999999999999999999999999986 78899
Q ss_pred EEecCCcccccCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 157 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--- 233 (476)
T 2y94_A 157 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--- 233 (476)
T ss_dssp ECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---
T ss_pred EEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---
Confidence 9999999765443 345689999999999998775 6899999999999999999999988776666655542111
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..| ...++.+.+||++||+.||.+|||+.|+++||||+.
T Consensus 234 --------------------------------~~p---------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 234 --------------------------------YTP---------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp --------------------------------CCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred --------------------------------CCC---------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 011 123466889999999999999999999999999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=359.12 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=197.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+.++|++++.||+|+||.||+|++..+|+.||||+++... ...+.+.+|+++++.++ ||||++++++|....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE------HPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC------CTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC------CCCEeeEEEEEEEec
Confidence 4578999999999999999999999999999999997532 34466778888887774 789999999986543
Q ss_pred ---------------------------------------------------------eEEEEEEcccc-chHHHHhhhhc
Q 004954 490 ---------------------------------------------------------HLFIVCELLRA-NLYEFQKFNQE 511 (722)
Q Consensus 490 ---------------------------------------------------------~l~iVmEy~~g-sLl~~l~~~~~ 511 (722)
..++||||+.+ +|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999986 67777664332
Q ss_pred cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC---------------
Q 004954 512 SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--------------- 576 (722)
Q Consensus 512 ~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~--------------- 576 (722)
....++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 158 ---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 158 ---LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp ---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECSCC--------------C
T ss_pred ---ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeC--CCCEEEeecCcccccccchhhcccccccccccc
Confidence 223566778999999999999999999999999999999986 789999999998765443
Q ss_pred ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcc
Q 004954 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK 656 (722)
Q Consensus 577 ~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~ 656 (722)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+... ..
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~----------------- 291 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KF----------------- 291 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CC-----------------
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CC-----------------
Confidence 1234689999999999999999999999999999999998776421 11111111100 00
Q ss_pred cccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 657 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 657 ~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
|. ......+.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 292 ------------------~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 292 ------------------PL------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp ------------------CH------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ------------------Cc------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 00 00011245789999999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.06 Aligned_cols=259 Identities=30% Similarity=0.445 Sum_probs=213.3
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----------hhhHhHHHHHHHHHHhcccCCCCCCcee
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----------DFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----------~~~~~~~~E~~il~~L~~~~~~~hpnIv 479 (722)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+. .||||+
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~ 87 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNII 87 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBC
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEe
Confidence 345689999999999999999999999999999999997542 23456778899998885 378999
Q ss_pred EEEEEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 480 RLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 480 ~l~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
++++++......++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+||+++.
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-- 159 (298)
T 1phk_A 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD-- 159 (298)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--
T ss_pred eeeeeeccCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC--
Confidence 99999999999999999997 57877776432 2899999999999999999999999999999999999985
Q ss_pred CCeEEEEecCCcccccCC--ccccccCCcccCchhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~------~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~ 630 (722)
++.+||+|||++...... .....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 239 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239 (298)
T ss_dssp TCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH
Confidence 788999999998765432 33457899999999985 4568899999999999999999999998877666665
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+......++ .+. ....+..+.+||.+||+.||.+|||+.
T Consensus 240 ~~~~~~~~~~---------------------------------~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (298)
T 1phk_A 240 MIMSGNYQFG---------------------------------SPE-------WDDYSDTVKDLVSRFLVVQPQKRYTAE 279 (298)
T ss_dssp HHHHTCCCCC---------------------------------TTT-------GGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHhcCCcccC---------------------------------ccc-------ccccCHHHHHHHHHHccCCcccCCCHH
Confidence 5542211111 000 012346789999999999999999999
Q ss_pred HHHhCCCCCCC
Q 004954 711 EALDHPWLQHP 721 (722)
Q Consensus 711 ElL~HPwf~~~ 721 (722)
|+|+||||++.
T Consensus 280 ~ll~h~~~~~~ 290 (298)
T 1phk_A 280 EALAHPFFQQY 290 (298)
T ss_dssp HHTTSGGGCTT
T ss_pred HHHhChHhhhc
Confidence 99999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=370.32 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=202.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
..+|++++.||+|+||+||++.+.. ++.||||++... ......+.+|+.+++.+++. ||||+++++++...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~----~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEITDQ 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT----CTTBCCEEEEEECSS
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccC----CCeEEEEEEEEecCC
Confidence 4579999999999999999999764 999999999753 33456788999999999752 689999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+..++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~kl~DFG~ 200 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGI 200 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES---SSCEEECCCSS
T ss_pred EEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE---CCeEEEEecCc
Confidence 999999987788988887543 288899999999999999999999999999999999996 57899999999
Q ss_pred cccccCC-----ccccccCCcccCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHH
Q 004954 570 SCFQTDN-----LCLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARI 632 (722)
Q Consensus 570 s~~~~~~-----~~~~~gt~~y~APE~l~~-----------~~~s~ksDIWSLGviL~elltG~~PF~~~~-~~e~l~~i 632 (722)
+...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 9765432 234579999999999975 368899999999999999999999997642 22222222
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
... ......| ...+..+.+||++||+.||.+|||+.|+
T Consensus 281 ~~~---------------------------------~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~el 318 (390)
T 2zmd_A 281 IDP---------------------------------NHEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIPEL 318 (390)
T ss_dssp HCT---------------------------------TSCCCCC---------CCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hCc---------------------------------cccCCCC---------ccchHHHHHHHHHHcccChhhCCCHHHH
Confidence 110 0000111 1124668999999999999999999999
Q ss_pred HhCCCCCC
Q 004954 713 LDHPWLQH 720 (722)
Q Consensus 713 L~HPwf~~ 720 (722)
|+||||+.
T Consensus 319 l~hp~~~~ 326 (390)
T 2zmd_A 319 LAHPYVQI 326 (390)
T ss_dssp HTSHHHHS
T ss_pred hhCcCccc
Confidence 99999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.53 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=212.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
.+.++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|+.+++.+. .||||+++
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~ 165 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA-----GHPHIITL 165 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCCE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEeEE
Confidence 34578999999999999999999999999999999987542 12355678889998884 37899999
Q ss_pred EEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC
Q 004954 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~ 560 (722)
++++......++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++. ++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~--~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--NM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CC
Confidence 9999999999999999986 7777765432 2899999999999999999999999999999999999985 78
Q ss_pred eEEEEecCCcccccCC--ccccccCCcccCchhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHH
Q 004954 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~------~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i 632 (722)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+
T Consensus 238 ~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999998765432 344678999999999863 35888999999999999999999999887766666555
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
......++... ....+..+.+||++||+.||.+|||+.|+
T Consensus 318 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~el 357 (365)
T 2y7j_A 318 MEGQYQFSSPE----------------------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQA 357 (365)
T ss_dssp HHTCCCCCHHH----------------------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HhCCCCCCCcc----------------------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 43222111110 01234668899999999999999999999
Q ss_pred HhCCCCCC
Q 004954 713 LDHPWLQH 720 (722)
Q Consensus 713 L~HPwf~~ 720 (722)
|+||||++
T Consensus 358 l~hp~f~r 365 (365)
T 2y7j_A 358 LQHPFFER 365 (365)
T ss_dssp HHSGGGCC
T ss_pred hcCcccCC
Confidence 99999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=358.13 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=206.7
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
.|...+.||+|+||.||+|++..+|+.||||++..... ....+.+|+.+++.++ ||||+++++++...+..++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ------HFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC------CTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC------CCCcceEEEEEEECCEEEE
Confidence 58888999999999999999999999999999975432 3355677888877664 7899999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+.+ +|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..
T Consensus 120 v~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQ 190 (321)
T ss_dssp EECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCcEEEeeeeeeee
Confidence 9999976 55555432 12899999999999999999999999999999999999986 78899999999876
Q ss_pred ccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 573 ~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+.....+.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 260 (321)
T 2c30_A 191 ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK---------- 260 (321)
T ss_dssp CCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC----------
T ss_pred cccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----------
Confidence 5432 234578999999999999999999999999999999999999998877666555443211000
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.. .....++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 261 ------------------------~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 261 ------------------------LK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp ------------------------CT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred ------------------------cC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 00 01123466899999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.81 Aligned_cols=259 Identities=31% Similarity=0.466 Sum_probs=212.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
..+.++|++.+.||+|+||+||++++..+|+.||+|+++.... ....+.+|+.+++.++ ||||+++++++...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK------HENIVTLEDIYEST 78 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC------CTTBCCEEEEEECS
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC------CCCeeehhhhcccC
Confidence 3456899999999999999999999999999999999986532 2345678899988885 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEEEe
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIID 566 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL~D 566 (722)
...++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+||++.. +.++.+||+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITD 152 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred CEEEEEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEcc
Confidence 999999999974 7777775432 2889999999999999999999999999999999999942 2478899999
Q ss_pred cCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 567 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 567 FGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||........+..+......++.
T Consensus 153 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 228 (304)
T 2jam_A 153 FGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES---- 228 (304)
T ss_dssp CSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT----
T ss_pred CCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc----
Confidence 9998765443 23456899999999999999999999999999999999999999888777666665432111110
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+ .....+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 229 -----------------------------~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 229 -----------------------------P-------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp -----------------------------T-------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred -----------------------------c-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 0 01123467899999999999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=347.79 Aligned_cols=255 Identities=30% Similarity=0.522 Sum_probs=204.2
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+.+..++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|+.+++.++ ||||++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 79 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR------HPHIIKLYQV 79 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC------CCCEeEEEEE
Confidence 4566789999999999999999999999999999999997542 22346677888877664 7899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+...+..++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.+|
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~ 151 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA--HMNAK 151 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT--TSCEE
T ss_pred EecCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC--CCCEE
Confidence 999999999999997 47877776442 2889999999999999999999999999999999999985 78899
Q ss_pred EEecCCcccccCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++...... .....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+.....
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 228 (276)
T 2h6d_A 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF--- 228 (276)
T ss_dssp ECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred EeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---
Confidence 9999998765443 234568999999999988765 5899999999999999999999988776665554432110
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+| ...+..+.+||.+||+.||.+|||+.++|+||||++
T Consensus 229 --------------------------------~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 229 --------------------------------YIP---------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp --------------------------------CCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred --------------------------------cCc---------hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 011 112466889999999999999999999999999975
Q ss_pred C
Q 004954 721 P 721 (722)
Q Consensus 721 ~ 721 (722)
.
T Consensus 268 ~ 268 (276)
T 2h6d_A 268 D 268 (276)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=352.00 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=213.1
Q ss_pred eeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 407 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
.......++|++.+.||+|+||+||++++..+++.+|+|++.... ...+.+.+|+.+++.++ ||||++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~ 81 (294)
T 2rku_A 8 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA------HQHVVGFH 81 (294)
T ss_dssp EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC------CTTBCCEE
T ss_pred eeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC------CCCEeeee
Confidence 334456789999999999999999999999999999999987542 33456677888887664 78999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
+++...+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~ 153 (294)
T 2rku_A 82 GFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLE 153 (294)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCC
T ss_pred eeeccCCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC--CCC
Confidence 999999999999999985 6666655432 2899999999999999999999999999999999999985 788
Q ss_pred EEEEecCCcccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 562 IKIIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 562 vkL~DFGls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+||+|||++..... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+....
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-- 231 (294)
T 2rku_A 154 VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-- 231 (294)
T ss_dssp EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--
T ss_pred EEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--
Confidence 99999999876432 2334578999999999999999999999999999999999999998876655554433110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
..+| ...+..+.+||++||+.||++|||+.|+|+||||
T Consensus 232 ---------------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 232 ---------------------------------YSIP---------KHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp ---------------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ---------------------------------CCCc---------cccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 0111 1234668899999999999999999999999999
Q ss_pred CCC
Q 004954 719 QHP 721 (722)
Q Consensus 719 ~~~ 721 (722)
++.
T Consensus 270 ~~~ 272 (294)
T 2rku_A 270 TSG 272 (294)
T ss_dssp HTS
T ss_pred ecC
Confidence 764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=371.88 Aligned_cols=256 Identities=30% Similarity=0.418 Sum_probs=197.9
Q ss_pred ecCcEEEE-EEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe---
Q 004954 412 IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (722)
Q Consensus 412 l~~rY~i~-~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--- 487 (722)
+.++|++. ++||+|+||+||++.++.+|+.||||++... ....+|+.++.++. .||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~-----~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhc-----CCCCcceEeEEEeeccc
Confidence 34567776 7899999999999999999999999999754 34667888776553 47899999999886
Q ss_pred -cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeEEE
Q 004954 488 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKI 564 (722)
Q Consensus 488 -~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~vkL 564 (722)
..+++|||||+.| +|.+++.... ...+++..++.|+.||+.||.|||+.||+||||||+|||++... ++.+||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEE
Confidence 5689999999974 7888776432 22389999999999999999999999999999999999998532 678999
Q ss_pred EecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH----HHHHHHhhcCC
Q 004954 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM----ILARIIGMLGP 638 (722)
Q Consensus 565 ~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e----~l~~i~~~lg~ 638 (722)
+|||++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+..
T Consensus 206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---- 281 (400)
T 1nxk_A 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---- 281 (400)
T ss_dssp CCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----
T ss_pred EecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----
Confidence 999999765432 345678999999999999999999999999999999999999997653211 1111110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
.....|.. .....+..+.+||++||+.||.+|||+.|+|+||||
T Consensus 282 -------------------------------~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 282 -------------------------------GQYEFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp -------------------------------TCCCCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -------------------------------CcccCCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 00011100 011235678999999999999999999999999999
Q ss_pred CC
Q 004954 719 QH 720 (722)
Q Consensus 719 ~~ 720 (722)
+.
T Consensus 326 ~~ 327 (400)
T 1nxk_A 326 MQ 327 (400)
T ss_dssp HT
T ss_pred cC
Confidence 64
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=363.01 Aligned_cols=247 Identities=30% Similarity=0.463 Sum_probs=205.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---------hhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~---------~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
.+.++|++.+.||+|+||+||+|++..+++.||||+++.... ....+.+|+.+++.++ ||||+++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~Iv~~ 94 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE------HANIIKV 94 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC------CTTBCCE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC------CCCEeeE
Confidence 346789999999999999999999999999999999976431 2345667888888774 7899999
Q ss_pred EEEEEecCeEEEEEEccc-c-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC
Q 004954 482 YDYFYHLEHLFIVCELLR-A-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~-g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~ 559 (722)
++++...+..++||||+. | +|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++. +
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~ 166 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--D 166 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--T
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC--C
Confidence 999999999999999986 4 6666665332 2899999999999999999999999999999999999986 7
Q ss_pred CeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 560 CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
+.+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~--- 237 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV--- 237 (335)
T ss_dssp SCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT---
T ss_pred CcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH---
Confidence 89999999999765443 334678999999999998876 7899999999999999999999964210 00
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
......| ...+..+.+||++||+.||.+|||+.++|+||
T Consensus 238 --------------------------------~~~~~~~---------~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 238 --------------------------------EAAIHPP---------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp --------------------------------TTCCCCS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred --------------------------------hhccCCC---------cccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0000011 12356789999999999999999999999999
Q ss_pred CCCCC
Q 004954 717 WLQHP 721 (722)
Q Consensus 717 wf~~~ 721 (722)
||+.+
T Consensus 277 ~~~~~ 281 (335)
T 3dls_A 277 WVTQP 281 (335)
T ss_dssp TTTCC
T ss_pred cccCC
Confidence 99864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.05 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=207.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe---
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--- 487 (722)
...++|++.+.||+|+||.||+|++..+|+.||||++.........+.+|+.+++.+. .||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC-----CSTTBCCEEEEEEECC-
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc-----CCCCeeeeeeEEeeccC
Confidence 3568999999999999999999999999999999999876666678889999999885 37899999999987
Q ss_pred ---cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 488 ---LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 488 ---~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
....++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~--~~~~k 169 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVK 169 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC--CCCEE
Confidence 4689999999975 78887765432 23889999999999999999999999999999999999985 78899
Q ss_pred EEecCCcccccCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 004954 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~ 635 (722)
|+|||++...... .....+|+.|+|||++. +..++.++|||||||++|+|++|..||........+..+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 9999998765432 23457899999999997 566889999999999999999999999877655544333211
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.. +.. .....+..+.+||++||+.||.+|||+.++|+|
T Consensus 250 ~~-------------------------------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 250 PA-------------------------------------PRL-----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CC-------------------------------------CCC-----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cc-------------------------------------ccC-----CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000 011234678999999999999999999999999
Q ss_pred CCCCCC
Q 004954 716 PWLQHP 721 (722)
Q Consensus 716 Pwf~~~ 721 (722)
|||+..
T Consensus 288 p~~~~~ 293 (326)
T 2x7f_A 288 PFIRDQ 293 (326)
T ss_dssp HHHHCC
T ss_pred hHHhhC
Confidence 999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.68 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=211.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
...++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 84 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR------HPNILRMYNYFH 84 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC------CCCEeeEEEEEE
Confidence 34578999999999999999999999999999999987532 22356777888887774 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~ 156 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIA 156 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TCCEEEC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC--CCCEEEe
Confidence 99999999999974 7877776543 2889999999999999999999999999999999999985 7889999
Q ss_pred ecCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 566 DLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 566 DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 229 (284)
T 2vgo_A 157 DFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL------- 229 (284)
T ss_dssp CCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------
T ss_pred cccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-------
Confidence 99998665432 3346789999999999999999999999999999999999999988776665555432110
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+| ...+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 230 ----------------------------~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 230 ----------------------------KFP---------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp ----------------------------CCC---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ----------------------------CCC---------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 111 123466889999999999999999999999999963
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.48 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=205.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC------CTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC------CCCceeeeeEEEcCC
Confidence 4578999999999999999999999999999999987543 33456778888887764 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.+||+|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg 150 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFG 150 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCT
T ss_pred EEEEEEEecCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc--CCCEEEeeCC
Confidence 99999999975 776665432 23899999999999999999999999999999999999985 7889999999
Q ss_pred CcccccC-----CccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHH-HHHHHHHhhcCCCcH
Q 004954 569 SSCFQTD-----NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGPIDL 641 (722)
Q Consensus 569 ls~~~~~-----~~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~-e~l~~i~~~lg~~~~ 641 (722)
++..... ......+++.|+|||++.+..+ +.++||||||+++|+|++|+.||...... ..+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 225 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----- 225 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-----
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-----
Confidence 9875432 1234578999999999988765 67899999999999999999999764321 1111111000
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
...+. ....+..+.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 226 ------------------------------~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 226 ------------------------------TYLNP-------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ------------------------------TTSTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------------------------------cccCc-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 00000 11234678899999999999999999999999999876
Q ss_pred C
Q 004954 722 Y 722 (722)
Q Consensus 722 ~ 722 (722)
.
T Consensus 269 ~ 269 (276)
T 2yex_A 269 L 269 (276)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=350.29 Aligned_cols=251 Identities=27% Similarity=0.498 Sum_probs=182.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+|+.+++.++ ||||+++++++...+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK------HPSILELYNYFEDSN 84 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC------CTTBCCEEEEEECSS
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC------CCCeEeEEEEEccCC
Confidence 679999999999999999999999999999999975432 2345667777776664 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg 157 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFG 157 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT--TCCEEECCCT
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEEeec
Confidence 99999999975 6766665321 23899999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||........+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------ 225 (278)
T 3cok_A 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------ 225 (278)
T ss_dssp TCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC------------
T ss_pred ceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh------------
Confidence 98765432 234578999999999999899999999999999999999999997653222221110
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
......| ...+..+.+||.+||+.||++|||+.++|+||||+..
T Consensus 226 -----------------------~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 226 -----------------------LADYEMP---------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -----------------------SSCCCCC---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -----------------------hcccCCc---------cccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0000111 1234678999999999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=359.44 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=213.5
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
......++|++.+.||+|+||.||++++..+++.+|+|++.... .....+.+|+.+++.++ ||||+++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 108 (335)
T 2owb_A 35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA------HQHVVGFHG 108 (335)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC------CTTBCCEEE
T ss_pred cCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC------CCCCCeEEE
Confidence 34455678999999999999999999999999999999987542 34456677888887764 789999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
++...+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~~ 180 (335)
T 2owb_A 109 FFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEV 180 (335)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCE
T ss_pred EEecCCeEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC--CCCE
Confidence 99999999999999985 6766665432 2899999999999999999999999999999999999986 7889
Q ss_pred EEEecCCcccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 563 KIIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 563 kL~DFGls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||+|||++..... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+.+..+....
T Consensus 181 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--- 257 (335)
T 2owb_A 181 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--- 257 (335)
T ss_dssp EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---
T ss_pred EEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---
Confidence 9999999876532 2334578999999999999999999999999999999999999998876655554443110
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
..+| ...+..+.+||++||+.||.+|||+.|+|+||||+
T Consensus 258 --------------------------------~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 258 --------------------------------YSIP---------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp --------------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred --------------------------------CCCC---------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 0111 12346688999999999999999999999999998
Q ss_pred CCC
Q 004954 720 HPY 722 (722)
Q Consensus 720 ~~~ 722 (722)
..|
T Consensus 297 ~~~ 299 (335)
T 2owb_A 297 SGY 299 (335)
T ss_dssp TSC
T ss_pred CCC
Confidence 654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=353.94 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=205.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+.++|++.+.||+|+||.||++.+..+++.+|+|+++... .....+.+|+.+++.++ ||||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~ 76 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR------HKNVIQLVDVLY 76 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC------CTTBCCEEEEEE
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC------CCCeeEEEEEEE
Confidence 4578999999999999999999999999999999997542 23456677777776664 789999999985
Q ss_pred --ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 487 --HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 487 --~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
.....++||||+.+++.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~--~~~~kl 150 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCGMQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT--GGTLKI 150 (305)
T ss_dssp CC---CEEEEEECCSEEHHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEE
T ss_pred cCCCCeEEEEehhccCCHHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcC--CCcEEe
Confidence 4468999999999988887765432 23899999999999999999999999999999999999985 788999
Q ss_pred EecCCcccccCC-----ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 565 IDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 565 ~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~--~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
+|||++...... .....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+....+....
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~- 229 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS- 229 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-
Confidence 999998765321 23356899999999998754 3779999999999999999999999877666655543110
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
..+| ...+..+.+||++||+.||.+|||+.|+|+|||
T Consensus 230 ----------------------------------~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 230 ----------------------------------YAIP---------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp ----------------------------------CCCC---------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred ----------------------------------CCCC---------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 0111 123467889999999999999999999999999
Q ss_pred CCCC
Q 004954 718 LQHP 721 (722)
Q Consensus 718 f~~~ 721 (722)
|++.
T Consensus 267 ~~~~ 270 (305)
T 2wtk_C 267 FRKK 270 (305)
T ss_dssp HHSC
T ss_pred cccC
Confidence 9753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.46 Aligned_cols=279 Identities=19% Similarity=0.280 Sum_probs=209.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..+.++|++.++||+|+||+||+|++..+|+.||||+++... ...+...+|+++++.++ ||||+++++++..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 78 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN------HKNIVKLFAIEEE 78 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCCcceEEEEeec
Confidence 456789999999999999999999999999999999997543 23456778999998885 7899999999987
Q ss_pred cC--eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc--cCCCeE
Q 004954 488 LE--HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEI 562 (722)
Q Consensus 488 ~~--~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~--~~~~~v 562 (722)
.. +.++||||+. ++|.+++...... ..+++..++.++.||+.||+|||+.||+||||||+|||+.. +..+.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceE
Confidence 65 8899999997 5777777654322 22899999999999999999999999999999999999821 136789
Q ss_pred EEEecCCcccccCC--ccccccCCcccCchhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC----ChHHHH
Q 004954 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVII--------GLPYDQKIDLWSLGCILAELWTGEVLFPN----DAVVMI 628 (722)
Q Consensus 563 kL~DFGls~~~~~~--~~~~~gt~~y~APE~l~--------~~~~s~ksDIWSLGviL~elltG~~PF~~----~~~~e~ 628 (722)
||+|||++...... .....+|+.|+|||++. +..++.++|||||||++|+|++|+.||.. ....+.
T Consensus 156 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred EEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 99999999765443 23457899999999986 56789999999999999999999999964 223344
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
+..+..... ...+...... ......+....|....+. ...+..+.+||++||+.||++|||
T Consensus 236 ~~~~~~~~p---~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~---~~~~~~l~~ll~~~L~~dP~~R~s 296 (319)
T 4euu_A 236 MYKIITGKP---SGAISGVQKA-------------ENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWG 296 (319)
T ss_dssp HHHHHHHCC---TTCCEEEECS-------------TTCCEEEESSCCTTCSSC---HHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HHHHhcCCC---cccchhhhcc-------------cCCccccCccCCcccccc---hhHHHHhHHHHHHhccCChhhhcc
Confidence 444433211 1111110000 000111111222222211 122467899999999999999999
Q ss_pred HHHHHhCC
Q 004954 709 AREALDHP 716 (722)
Q Consensus 709 a~ElL~HP 716 (722)
++|+|+||
T Consensus 297 ~~ell~h~ 304 (319)
T 4euu_A 297 FDQFFAET 304 (319)
T ss_dssp HHHHHHHH
T ss_pred HHHhhhcc
Confidence 99999996
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.48 Aligned_cols=257 Identities=30% Similarity=0.447 Sum_probs=204.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
-...++|++++.||+|+||.||+|++..+++.+|+|++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD------HPYIVKLLGAYYHD 88 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCC------CTTBCCEEEEEECC
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCC------CCCEeeeeeeeeeC
Confidence 345689999999999999999999999999999999986542 33467778899888774 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Df 161 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLADF 161 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TSCEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC--CCCEEEEEC
Confidence 999999999986 55555543221 2899999999999999999999999999999999999985 788999999
Q ss_pred CCcccccC---CccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 568 GSSCFQTD---NLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 568 Gls~~~~~---~~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|++..... ......+|+.|+|||++. +..++.++||||||+++|+|++|..||...+....+..+.....+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 162 GVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT 241 (302)
T ss_dssp HHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc
Confidence 98753221 223357899999999984 6678999999999999999999999998877665554443211000
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
.. .....+..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 242 ----------------------------------~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 280 (302)
T 2j7t_A 242 ----------------------------------LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280 (302)
T ss_dssp ----------------------------------CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred ----------------------------------cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence 00 0112346689999999999999999999999999998
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 281 ~ 281 (302)
T 2j7t_A 281 S 281 (302)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.18 Aligned_cols=261 Identities=25% Similarity=0.321 Sum_probs=202.4
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
...+.++|++.+.||+|+||+||+|++..+++.||||+++........ ....+.+.+.......||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHH--HHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHH--HHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 456789999999999999999999999999999999999764321111 112233444444455689999999998865
Q ss_pred C----eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 489 E----HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 489 ~----~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
. ..++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~k 156 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TNAVK 156 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TSCEE
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcC--CCCEE
Confidence 4 3599999997 57777776432 2899999999999999999999999999999999999986 78899
Q ss_pred EEecCCcccccCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 564 IIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 564 L~DFGls~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 236 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence 9999998764432 2235689999999999999999999999999999999999999998877666555432211
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.++ .......+..+.+||.+||+.||.+||++.++|.|+|
T Consensus 237 ~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 237 IPP----------------------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp CCH----------------------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCc----------------------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 111 0111223567899999999999999999999999999
Q ss_pred CC
Q 004954 718 LQ 719 (722)
Q Consensus 718 f~ 719 (722)
++
T Consensus 277 ~~ 278 (311)
T 3ork_A 277 VR 278 (311)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=345.32 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=201.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-- 487 (722)
...|++.+.||+|+||+||+|.+..++..||+|++... ......+.+|+.+++.++ ||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ------HPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC------CCCeeeeeeeecccc
Confidence 45689999999999999999999999999999998753 233455667777777664 7899999999876
Q ss_pred --cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCCCeE
Q 004954 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 488 --~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~~~v 562 (722)
...+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++. .++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~ 171 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSV 171 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCE
T ss_pred CCCceEEEEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-CCCCE
Confidence 3568999999975 7777776432 2889999999999999999999999 999999999999973 36789
Q ss_pred EEEecCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHHhhcCCCc
Q 004954 563 KIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPID 640 (722)
Q Consensus 563 kL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~-~e~l~~i~~~lg~~~ 640 (722)
||+|||++...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ......+.....+
T Consensus 172 kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 248 (290)
T 1t4h_A 172 KIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-- 248 (290)
T ss_dssp EECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--
T ss_pred EEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--
Confidence 99999999765544 334678999999998875 589999999999999999999999977433 2332222111000
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.......++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 249 ----------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 ----------------------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0001123466899999999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=370.92 Aligned_cols=258 Identities=32% Similarity=0.474 Sum_probs=197.6
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---------~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
..+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~ 204 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN------HPCIIK 204 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC------CTTBCC
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC------CCCEee
Confidence 345789999999999999999999999999999999987542 12235678999999884 789999
Q ss_pred EEEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-C
Q 004954 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-Q 558 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~ 558 (722)
+++++. .+..++||||+.+ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.. .
T Consensus 205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 205 IKNFFD-AEDYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCEEEE-SSEEEEEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSS
T ss_pred EEEEEe-cCceEEEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCC
Confidence 999975 4568999999975 666655422 238999999999999999999999999999999999999753 2
Q ss_pred CCeEEEEecCCcccccCC--ccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH-HHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARI 632 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~---~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e-~l~~i 632 (722)
+..+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ....+
T Consensus 278 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i 357 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357 (419)
T ss_dssp SCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH
T ss_pred cceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH
Confidence 457999999999876543 234678999999999864 567889999999999999999999997643221 11111
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
........ .......++.+.+||++||+.||.+|||+.|+
T Consensus 358 ~~~~~~~~----------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 397 (419)
T 3i6u_A 358 TSGKYNFI----------------------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397 (419)
T ss_dssp HTTCCCCC----------------------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred hcCCCCCC----------------------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 11100000 01111235678999999999999999999999
Q ss_pred HhCCCCCC
Q 004954 713 LDHPWLQH 720 (722)
Q Consensus 713 L~HPwf~~ 720 (722)
|+||||+.
T Consensus 398 l~hp~~~~ 405 (419)
T 3i6u_A 398 LRHPWLQD 405 (419)
T ss_dssp HHSGGGCC
T ss_pred hCCcccCC
Confidence 99999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=350.06 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=204.9
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.....++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.++ ||||+++++++...
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 96 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCD------SPHVVKYYGSYFKN 96 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCC------CTTBCCEEEEEEET
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCC------CCCCccEEEEEEeC
Confidence 3455688999999999999999999999999999999997654 3356778888888774 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
...++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.+||+||
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~df 169 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT--EGHAKLADF 169 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCC
T ss_pred CEEEEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC--CCCEEEeec
Confidence 999999999986 77777653322 2899999999999999999999999999999999999986 788999999
Q ss_pred CCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 170 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 242 (314)
T 3com_A 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP------- 242 (314)
T ss_dssp TTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-------
T ss_pred ccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------
Confidence 999765443 2345789999999999999999999999999999999999999987655444333221100
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
.... .....+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 243 ---------------------------~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 243 ---------------------------PTFR-------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ---------------------------CCCS-------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ---------------------------cccC-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0000 011234678999999999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=350.92 Aligned_cols=251 Identities=20% Similarity=0.216 Sum_probs=205.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.+. .||||+++++++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~-----~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLG-----SGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHC-----SCTTSCCEEEEEEETTE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhh-----CCCCCCEEEEEEecCCc
Confidence 467899999999999999999999999999999999876432 356889999999995 37899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe-----EEEE
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE-----IKII 565 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~-----vkL~ 565 (722)
.++||||++++|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++. +||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~--~~~~~~~~~kl~ 152 (330)
T 2izr_A 80 NAMVLELLGPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR--PGNKTQQVIHII 152 (330)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC--GGGTCTTSEEEC
T ss_pred cEEEEEeCCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecc--CCCCCCceEEEE
Confidence 999999998889888875422 3899999999999999999999999999999999999986 444 9999
Q ss_pred ecCCcccccCCc----------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHH
Q 004954 566 DLGSSCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARI 632 (722)
Q Consensus 566 DFGls~~~~~~~----------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~---~~~e~l~~i 632 (722)
|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. ...+.+..+
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 999997654321 3467899999999999999999999999999999999999999873 333333333
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
.....+.+.+ ......+ .+.+||.+||+.||.+||+++++
T Consensus 233 ~~~~~~~~~~---------------------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 233 GDTKRATPIE---------------------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp HHHHHHSCHH---------------------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HhhhccCCHH---------------------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence 2111111100 0011122 68999999999999999999998
Q ss_pred Hh
Q 004954 713 LD 714 (722)
Q Consensus 713 L~ 714 (722)
++
T Consensus 273 ~~ 274 (330)
T 2izr_A 273 RK 274 (330)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.59 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=203.1
Q ss_pred eeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 407 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
.++.++.++|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.+++.+ .||||++++
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~ 77 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL------SHQNIVSMI 77 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC------CBTTBCCEE
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC------CCCCCceEE
Confidence 45788899999999999999999999999999999999998643 23335566677776665 478999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
+++...+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.
T Consensus 78 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~ 149 (294)
T 4eqm_A 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS--NKT 149 (294)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSC
T ss_pred EeeeeCCeEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCC
Confidence 999999999999999975 7777776443 2899999999999999999999999999999999999986 788
Q ss_pred EEEEecCCcccccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 562 IKIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 562 vkL~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+......+......
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 229 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229 (294)
T ss_dssp EEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred EEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence 999999999765433 2235689999999999999999999999999999999999999988776555444331110
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
+.. ........+..+.++|.+||+.||.+||+..+.+.+.|
T Consensus 230 ~~~---------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 230 PNV---------------------------------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CCH---------------------------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred CCc---------------------------------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 000 00011223467899999999999999995555554433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=376.50 Aligned_cols=256 Identities=25% Similarity=0.331 Sum_probs=209.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+..++|++.+.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|..+++.++ ||||++++++|.
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH------SRFIVSLAYAFE 255 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------CTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC------CCCEeeEEEEEe
Confidence 34578999999999999999999999999999999997543 23356778999998874 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
....+++||||+.| +|...+..... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~--~g~vkL~ 331 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD--DGNVRIS 331 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC--CCCEEEe
Confidence 99999999999985 66666553321 1234999999999999999999999999999999999999986 7899999
Q ss_pred ecCCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh----HHHHHHHHHhhcCC
Q 004954 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA----VVMILARIIGMLGP 638 (722)
Q Consensus 566 DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~----~~e~l~~i~~~lg~ 638 (722)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..++...+....
T Consensus 332 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-- 409 (543)
T 3c4z_A 332 DLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-- 409 (543)
T ss_dssp CCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--
T ss_pred ecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--
Confidence 99999765433 233589999999999999999999999999999999999999997642 233333332110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHH
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREAL 713 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL 713 (722)
..+| ...+..+.+||++||+.||.+||+ +++++
T Consensus 410 ---------------------------------~~~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 410 ---------------------------------VTYP---------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp ---------------------------------CCCC---------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred ---------------------------------cCCC---------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 0111 123467899999999999999995 59999
Q ss_pred hCCCCCC
Q 004954 714 DHPWLQH 720 (722)
Q Consensus 714 ~HPwf~~ 720 (722)
+||||+.
T Consensus 448 ~Hpff~~ 454 (543)
T 3c4z_A 448 THPLFRD 454 (543)
T ss_dssp TSGGGTT
T ss_pred cCccccC
Confidence 9999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=344.68 Aligned_cols=254 Identities=30% Similarity=0.437 Sum_probs=198.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~---- 487 (722)
+.++|++.+.||+|+||.||+|++..+|+.||||++.........+.+|+.+++.++ ||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN------HQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEECCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcC------chHHHHHHHHHHhhcch
Confidence 457899999999999999999999999999999999876666677788888887764 7899999999865
Q ss_pred ---------cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc
Q 004954 488 ---------LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (722)
Q Consensus 488 ---------~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~ 557 (722)
....++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~- 151 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE- 151 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC-
Confidence 4578999999975 8888776432 23788999999999999999999999999999999999985
Q ss_pred CCCeEEEEecCCcccccC-----------------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Q 004954 558 QRCEIKIIDLGSSCFQTD-----------------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVL 619 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~-----------------~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~P 619 (722)
++.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |
T Consensus 152 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 152 -SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp -TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred -CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 78899999999876432 12335689999999999865 68999999999999999998 6
Q ss_pred CCCC-hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHh
Q 004954 620 FPND-AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 698 (722)
Q Consensus 620 F~~~-~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~m 698 (722)
|... .....+..+..... .+|.. .....+..+.+||++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~-----~~~~~~~~~~~li~~~ 267 (303)
T 1zy4_A 228 FSTGMERVNILKKLRSVSI-----------------------------------EFPPD-----FDDNKMKVEKKIIRLL 267 (303)
T ss_dssp CSSHHHHHHHHHHHHSTTC-----------------------------------CCCTT-----CCTTTSHHHHHHHHHH
T ss_pred cCCchhHHHHHHhcccccc-----------------------------------ccCcc-----ccccchHHHHHHHHHH
Confidence 6543 22233322221100 11110 0112345688999999
Q ss_pred cccCCCCCcCHHHHHhCCCCCCC
Q 004954 699 LEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 699 L~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
|+.||.+|||+.++|+||||+..
T Consensus 268 l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 268 IDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp TCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HhcCcccCcCHHHHhCCCCcCCC
Confidence 99999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=379.60 Aligned_cols=254 Identities=26% Similarity=0.322 Sum_probs=209.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
+..++|++.++||+|+||+||+|+++.+|+.||||++.+.. .......+|+.+++.++ ||||++++++|.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~~~~~ 254 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN------SRFVVSLAYAYE 254 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------CTTBCCEEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC------CCCEeeEEEEEe
Confidence 44678999999999999999999999999999999997532 23345678899988875 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+.+++||||+.| +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~--~g~vKL~ 328 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD--HGHIRIS 328 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeC--CCCeEEE
Confidence 99999999999975 6666665332 223899999999999999999999999999999999999985 7899999
Q ss_pred ecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh----HHHHHHHHHhhcCCC
Q 004954 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA----VVMILARIIGMLGPI 639 (722)
Q Consensus 566 DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~----~~e~l~~i~~~lg~~ 639 (722)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ...+...+...
T Consensus 329 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---- 404 (576)
T 2acx_A 329 DLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---- 404 (576)
T ss_dssp CCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----
T ss_pred ecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----
Confidence 99999775433 344689999999999999999999999999999999999999997643 22222222100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~ 714 (722)
...+| ...++.+.+||++||+.||.+|| +++|+++
T Consensus 405 -------------------------------~~~~p---------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -------------------------------PEEYS---------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------------------------------CCCCC---------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------------------------------cccCC---------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00111 12346789999999999999999 8999999
Q ss_pred CCCCCC
Q 004954 715 HPWLQH 720 (722)
Q Consensus 715 HPwf~~ 720 (722)
||||+.
T Consensus 445 HpfF~~ 450 (576)
T 2acx_A 445 HPLFKK 450 (576)
T ss_dssp SGGGTT
T ss_pred Chhhcc
Confidence 999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.81 Aligned_cols=256 Identities=19% Similarity=0.229 Sum_probs=207.8
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+.++.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.+.+ |+|++++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAG-----CTGIPNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTT-----CTTCCCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhc-----CCCCCeEEeecCCC
Confidence 4678899999999999999999999999999999999987543 33567889999998853 67999999999999
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc---CCCeEEEE
Q 004954 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKII 565 (722)
Q Consensus 489 ~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~---~~~~vkL~ 565 (722)
...++||||+.++|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++.+ ....+||+
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred ceeEEEEEecCCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999998889888875432 28999999999999999999999999999999999999852 12349999
Q ss_pred ecCCcccccCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHH
Q 004954 566 DLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARI 632 (722)
Q Consensus 566 DFGls~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~---~~~e~l~~i 632 (722)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. .....+..+
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 99999765432 23457899999999999999999999999999999999999999773 333333333
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
.......+ ........++.+.+||.+||+.||.+|||++++
T Consensus 234 ~~~~~~~~---------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l 274 (298)
T 1csn_A 234 GEKKQSTP---------------------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 274 (298)
T ss_dssp HHHHHHSC---------------------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HhhccCcc---------------------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHH
Confidence 21111000 011112235678999999999999999999999
Q ss_pred Hh
Q 004954 713 LD 714 (722)
Q Consensus 713 L~ 714 (722)
++
T Consensus 275 ~~ 276 (298)
T 1csn_A 275 QG 276 (298)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=341.76 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=209.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-- 487 (722)
.++|++.+.||+|+||+||++++..+|+.||+|++... ....+.+.+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK------HPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC------CCCCCeEEEEEecCC
Confidence 47899999999999999999999999999999999753 234456778899888885 7899999998864
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC-----CccccCCCCceEEcccCCCe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g-----IvHrDLKp~NILl~~~~~~~ 561 (722)
....++||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+.| |+||||||+||+++. ++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~--~~~ 154 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQN 154 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS--SSC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC--CCC
Confidence 5789999999975 888887654432 233899999999999999999999999 999999999999985 788
Q ss_pred EEEEecCCcccccCCc---cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 562 IKIIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 562 vkL~DFGls~~~~~~~---~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+..++...+.....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~- 233 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 233 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-
Confidence 9999999987655432 235789999999999999999999999999999999999999988776665555432100
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
..+| ...+..+.+||.+||+.||.+|||+.|+|+|||+
T Consensus 234 ---------------------------------~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ---------------------------------RRIP---------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---------------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------------------------ccCC---------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0011 1234678999999999999999999999999999
Q ss_pred CCC
Q 004954 719 QHP 721 (722)
Q Consensus 719 ~~~ 721 (722)
..+
T Consensus 272 ~~~ 274 (279)
T 2w5a_A 272 LEH 274 (279)
T ss_dssp CGG
T ss_pred hhh
Confidence 754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.19 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=209.1
Q ss_pred CCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------hhHhHHHHHHHHHHhcccCCC
Q 004954 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPA 473 (722)
Q Consensus 401 ~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------~~~~~~~E~~il~~L~~~~~~ 473 (722)
.+..|....+.+.++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.+++.+++
T Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---- 105 (320)
T 3a99_A 30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---- 105 (320)
T ss_dssp ----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----
T ss_pred hccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc----
Confidence 3445666677889999999999999999999999999999999999976431 22456789999999975
Q ss_pred CCCceeEEEEEEEecCeEEEEEEccc--cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 004954 474 DEHHILRLYDYFYHLEHLFIVCELLR--ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (722)
Q Consensus 474 ~hpnIv~l~~~f~~~~~l~iVmEy~~--gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~N 551 (722)
.|+||+++++++...+..++|||++. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 179 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHH
Confidence 47899999999999999999999996 67888776532 28899999999999999999999999999999999
Q ss_pred eEEcccCCCeEEEEecCCcccccCC-ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHHH
Q 004954 552 ILIKSYQRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMIL 629 (722)
Q Consensus 552 ILl~~~~~~~vkL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~l 629 (722)
||++. .++.+||+|||++...... .....+|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 180 Ill~~-~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---- 254 (320)
T 3a99_A 180 ILIDL-NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---- 254 (320)
T ss_dssp EEEET-TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred EEEeC-CCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----
Confidence 99983 3678999999998766543 334578999999999987765 6889999999999999999999965421
Q ss_pred HHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH
Q 004954 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709 (722)
Q Consensus 630 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa 709 (722)
+... ....+ ...++.+.+||++||+.||.+|||+
T Consensus 255 --~~~~-----------------------------------~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~ 288 (320)
T 3a99_A 255 --IIRG-----------------------------------QVFFR---------QRVSSECQHLIRWCLALRPSDRPTF 288 (320)
T ss_dssp --HHHC-----------------------------------CCCCS---------SCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred --hhcc-----------------------------------ccccc---------ccCCHHHHHHHHHHccCChhhCcCH
Confidence 1000 00001 1234678999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 004954 710 REALDHPWLQHP 721 (722)
Q Consensus 710 ~ElL~HPwf~~~ 721 (722)
.|+|+||||++.
T Consensus 289 ~~ll~hp~~~~~ 300 (320)
T 3a99_A 289 EEIQNHPWMQDV 300 (320)
T ss_dssp HHHHTSGGGSSC
T ss_pred HHHhcCHhhcCc
Confidence 999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.59 Aligned_cols=259 Identities=32% Similarity=0.522 Sum_probs=212.2
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
...+.++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~ 90 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD------HPNIMKLFEIL 90 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc------CCCccEEEEEE
Confidence 4556789999999999999999999999999999999987532 23456778888888774 78999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeEE
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIK 563 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~vk 563 (722)
......++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+||+++... ++.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEE
Confidence 999999999999974 7777765432 289999999999999999999999999999999999997632 45799
Q ss_pred EEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 564 L~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
|+|||++...... .....+++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+.+..+......++
T Consensus 165 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 242 (287)
T 2wei_A 165 IIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD- 242 (287)
T ss_dssp ECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-
T ss_pred EeccCcceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 9999998765433 2334678999999998764 89999999999999999999999998877766655542211111
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+. ....+..+.+||++||+.||.+|||+.|+|+||||++
T Consensus 243 --------------------------------~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 243 --------------------------------LPQ-------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp --------------------------------SGG-------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred --------------------------------chh-------hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 000 0123467899999999999999999999999999964
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=352.06 Aligned_cols=258 Identities=33% Similarity=0.472 Sum_probs=202.2
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---------~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
..+.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++ ||||++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~ 79 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN------HPCIIK 79 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC------CTTBCC
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC------CCCCce
Confidence 456789999999999999999999999999999999986532 12345678899998884 789999
Q ss_pred EEEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-
Q 004954 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ- 558 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~- 558 (722)
+++++.... .++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 80 IKNFFDAED-YYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp EEEEEESSS-EEEEEECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS
T ss_pred EeeEEcCCc-eEEEEecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC
Confidence 999987654 8999999975 777766532 2389999999999999999999999999999999999998632
Q ss_pred CCeEEEEecCCcccccCCc--cccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH-HHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARI 632 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~~--~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e-~l~~i 632 (722)
+..+||+|||++....... ....+|+.|+|||++. ...++.++|||||||++|+|++|..||....... +...+
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 232 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232 (322)
T ss_dssp SCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH
T ss_pred CCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH
Confidence 3469999999998765442 2357899999999974 4668899999999999999999999997643221 11111
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
....... . .......+..+.+||.+||+.||.+|||+.++
T Consensus 233 ~~~~~~~----------------------------------~------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~ 272 (322)
T 2ycf_A 233 TSGKYNF----------------------------------I------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272 (322)
T ss_dssp HHTCCCC----------------------------------C------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HhCcccc----------------------------------C------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 1100000 0 00112235678999999999999999999999
Q ss_pred HhCCCCCC
Q 004954 713 LDHPWLQH 720 (722)
Q Consensus 713 L~HPwf~~ 720 (722)
|+||||+.
T Consensus 273 l~h~~~~~ 280 (322)
T 2ycf_A 273 LRHPWLQD 280 (322)
T ss_dssp HTSGGGCC
T ss_pred hhCcCcCC
Confidence 99999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=351.73 Aligned_cols=269 Identities=28% Similarity=0.391 Sum_probs=189.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+..++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+. ......||||+++++++..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~------~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ------AMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------CCCCCCCTTBCCEEEEEES
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHH------HHhhcCCCCEeeEEEEEee
Confidence 4556899999999999999999999988999999999865421 2233334443 3344568999999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhcc--CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQES--GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~--~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
.+..++||||+. ++|.+++...... .....+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl 162 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQI 162 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC--CCCEEE
Confidence 999999999996 5777777643221 12334899999999999999999999999999999999999985 788999
Q ss_pred EecCCcccccCC--------ccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 004954 565 IDLGSSCFQTDN--------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 565 ~DFGls~~~~~~--------~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~ 635 (722)
+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+......
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 999988654321 223578999999999876 56899999999999999999999999875543333222211
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+. .+............+..+.+||.+||+.||.+|||+.++|+|
T Consensus 243 ~~~~----------------------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPS----------------------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCC----------------------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCc----------------------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000 000000011122345679999999999999999999999999
Q ss_pred CCCCC
Q 004954 716 PWLQH 720 (722)
Q Consensus 716 Pwf~~ 720 (722)
|||++
T Consensus 289 ~~~~~ 293 (303)
T 2vwi_A 289 KFFQK 293 (303)
T ss_dssp TTC--
T ss_pred hhhhc
Confidence 99975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.22 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=208.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
..++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.+. ||||+++++++....
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD------SPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC------CTTBCCEEEEEEETT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC------CCCEeEEEEEEecCC
Confidence 3467999999999999999999999999999999997542 34567788888888774 689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+.+ +|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.+||+|||
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~Dfg 164 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFG 164 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCT
T ss_pred eEEEEEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC--CCCEEEeecc
Confidence 99999999985 66666542 23899999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 235 (303)
T 3a7i_A 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--------- 235 (303)
T ss_dssp TCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---------
T ss_pred cceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC---------
Confidence 99765443 234578999999999999999999999999999999999999998776555443332100
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
...+ ....+..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 236 -------------------------~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 236 -------------------------PPTL---------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp -------------------------CCCC---------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred -------------------------CCCC---------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 0000 112346789999999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.14 Aligned_cols=262 Identities=28% Similarity=0.387 Sum_probs=205.3
Q ss_pred cceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 404 ~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
+......+..++|++++.||+|+||.||++.+. +++.||||++... ......+.+|+.+++.+++. |+||++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~----~~~iv~ 92 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIR 92 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG----CTTBCC
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc----CCceEE
Confidence 333444556788999999999999999999974 5899999998653 33456788999999999863 579999
Q ss_pred EEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC
Q 004954 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~ 560 (722)
+++++......++|||+..++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++ ++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~ 163 (313)
T 3cek_A 93 LYDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DG 163 (313)
T ss_dssp EEEEEECSSEEEEEECCCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TT
T ss_pred EEEEeecCCEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE---CC
Confidence 999999999999999988889998887533 288999999999999999999999999999999999997 57
Q ss_pred eEEEEecCCcccccCCc-----cccccCCcccCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCh
Q 004954 561 EIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~-----------~~~s~ksDIWSLGviL~elltG~~PF~~~~ 624 (722)
.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 89999999987654322 23468999999999976 468889999999999999999999997542
Q ss_pred H-HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 625 V-VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 625 ~-~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
. ...+..+... ......| ...+..+.+||++||+.||
T Consensus 244 ~~~~~~~~~~~~---------------------------------~~~~~~~---------~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 244 NQISKLHAIIDP---------------------------------NHEIEFP---------DIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp SHHHHHHHHHCT---------------------------------TSCCCCC---------CCSCHHHHHHHHHHTCSST
T ss_pred HHHHHHHHHHhc---------------------------------ccccCCc---------ccchHHHHHHHHHHccCCc
Confidence 1 1112111100 0000111 1224678999999999999
Q ss_pred CCCcCHHHHHhCCCCCCC
Q 004954 704 QRRPTAREALDHPWLQHP 721 (722)
Q Consensus 704 ~kRpTa~ElL~HPwf~~~ 721 (722)
.+|||+.|+|+||||+..
T Consensus 282 ~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 282 KQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp TTSCCHHHHHTSHHHHCC
T ss_pred ccCcCHHHHhcCccccCC
Confidence 999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=353.52 Aligned_cols=278 Identities=21% Similarity=0.349 Sum_probs=212.6
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhh------------------HhHHHHHHHHHHhccc
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF------------------DQSLDEIKLLKLVNKN 470 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~------------------~~~~~E~~il~~L~~~ 470 (722)
++...++|++.+.||+|+||.||+|++ +|+.||||++....... ..+.+|+.+++.++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 101 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-- 101 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC--
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC--
Confidence 456678999999999999999999998 89999999987543211 66778888887774
Q ss_pred CCCCCCceeEEEEEEEecCeEEEEEEcccc-chHHHHhhhhcc--CCCcccCHHHHHHHHHHHHHHHHHHHH-CCCcccc
Q 004954 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES--GGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCD 546 (722)
Q Consensus 471 ~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~--~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrD 546 (722)
||||+++++++...+..++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||+ .||+|||
T Consensus 102 ----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 177 (348)
T 2pml_X 102 ----NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177 (348)
T ss_dssp ----CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred ----CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence 78999999999999999999999986 776662211101 113449999999999999999999999 9999999
Q ss_pred CCCCceEEcccCCCeEEEEecCCcccccCC-ccccccCCcccCchhhcCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCC
Q 004954 547 LKPENILIKSYQRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGL-PYDQ-KIDLWSLGCILAELWTGEVLFPND 623 (722)
Q Consensus 547 LKp~NILl~~~~~~~vkL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~-~~s~-ksDIWSLGviL~elltG~~PF~~~ 623 (722)
|||+||+++. ++.+||+|||++...... .....+++.|+|||++.+. .++. ++|||||||++|+|++|..||...
T Consensus 178 l~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 178 VKPSNILMDK--NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp CCGGGEEECT--TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CChHhEEEcC--CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999985 789999999999765433 3446789999999999887 5666 999999999999999999999876
Q ss_pred hH-HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 624 AV-VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 624 ~~-~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
.. .+....+.......+.... .+ .....+ ..........+..+.+||++||+.|
T Consensus 256 ~~~~~~~~~i~~~~~~~~~~~~-------~~----------------~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~d 310 (348)
T 2pml_X 256 ISLVELFNNIRTKNIEYPLDRN-------HF----------------LYPLTN--KKSTCSNNFLSNEDIDFLKLFLRKN 310 (348)
T ss_dssp SCSHHHHHHHTSCCCCCCCSSS-------SS----------------TTTTCC----------CCCHHHHHHHHHHCCSS
T ss_pred CcHHHHHHHHhccCcCCccchh-------hh----------------hccccc--cccccchhhcCHHHHHHHHHHccCC
Confidence 55 5555555432222221000 00 000000 0001112345678999999999999
Q ss_pred CCCCcCHHHHHhCCCCCCC
Q 004954 703 PQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 703 P~kRpTa~ElL~HPwf~~~ 721 (722)
|.+|||+.|+|+||||+..
T Consensus 311 P~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 311 PAERITSEDALKHEWLADT 329 (348)
T ss_dssp GGGSCCHHHHHTSGGGTTC
T ss_pred hhhCCCHHHHhcCccccCC
Confidence 9999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=355.09 Aligned_cols=252 Identities=28% Similarity=0.419 Sum_probs=202.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
..++|++++.||+|+||+||++++. .+++.||||+++... .....+.+|+.+++.+++ ||||+++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~iv~~~~ 126 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHY 126 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-----CTTBCCEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccC-----CCceeEEEE
Confidence 3478999999999999999999984 589999999986432 234556789999999863 689999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
++......++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 198 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHV 198 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCE
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCcE
Confidence 99999999999999975 7777776432 2899999999999999999999999999999999999985 7899
Q ss_pred EEEecCCcccccCC----ccccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCh----HHHHHHHH
Q 004954 563 KIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDA----VVMILARI 632 (722)
Q Consensus 563 kL~DFGls~~~~~~----~~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF~~~~----~~e~l~~i 632 (722)
||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...+...+
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 99999998754322 234578999999999986 347899999999999999999999996532 12222221
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP----- 707 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp----- 707 (722)
... ....| ...+..+.+||++||+.||.+||
T Consensus 279 ~~~-----------------------------------~~~~~---------~~~~~~~~~li~~~L~~dP~~R~~~~~~ 314 (355)
T 1vzo_A 279 LKS-----------------------------------EPPYP---------QEMSALAKDLIQRLLMKDPKKRLGCGPR 314 (355)
T ss_dssp HHC-----------------------------------CCCCC---------TTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred hcc-----------------------------------CCCCC---------cccCHHHHHHHHHHhhhCHHHhcCCCCC
Confidence 110 00011 12346688999999999999999
Q ss_pred CHHHHHhCCCCCC
Q 004954 708 TAREALDHPWLQH 720 (722)
Q Consensus 708 Ta~ElL~HPwf~~ 720 (722)
|++|+++||||++
T Consensus 315 s~~ell~h~~f~~ 327 (355)
T 1vzo_A 315 DADEIKEHLFFQK 327 (355)
T ss_dssp THHHHHTSGGGTT
T ss_pred CHHHHHcCcchhc
Confidence 9999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.44 Aligned_cols=267 Identities=26% Similarity=0.372 Sum_probs=182.8
Q ss_pred ceeeCceecCcEEEEE-EeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 405 PIILNTVIAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 405 pi~~~~~l~~rY~i~~-~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
|......+.++|++.+ .||+|+||+||+|++..+|+.||||++..... ..+|+..+..+ ..||||+++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~-----~~h~~i~~~~~ 89 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQA-----SGGPHIVCILD 89 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHH-----TTSTTBCCEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHh-----cCCCChHHHHH
Confidence 3334456789999966 69999999999999999999999999976543 22333333222 25889999999
Q ss_pred EEEe----cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-
Q 004954 484 YFYH----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY- 557 (722)
Q Consensus 484 ~f~~----~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~- 557 (722)
++.. ...+++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++..
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~ 165 (336)
T 3fhr_A 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165 (336)
T ss_dssp EEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred HHhhccCCCceEEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC
Confidence 9986 4568999999975 78887764322 248999999999999999999999999999999999999853
Q ss_pred CCCeEEEEecCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 558 QRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 166 ~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (336)
T 3fhr_A 166 KDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245 (336)
T ss_dssp TTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred CCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh
Confidence 2567999999999765443 334578999999999988889999999999999999999999997654433221111000
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
.......+. ......+..+.+||++||+.||.+|||+.|+|+||
T Consensus 246 -------------------------------~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 246 -------------------------------RLGQYGFPN-----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ------------------------------------CCCT-----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred -------------------------------hccccccCc-----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000000010 00122456799999999999999999999999999
Q ss_pred CCCC
Q 004954 717 WLQH 720 (722)
Q Consensus 717 wf~~ 720 (722)
||+.
T Consensus 290 ~~~~ 293 (336)
T 3fhr_A 290 WINQ 293 (336)
T ss_dssp HHHT
T ss_pred cccc
Confidence 9965
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.06 Aligned_cols=247 Identities=20% Similarity=0.324 Sum_probs=206.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
..++|++.+.||+|+||+||++.+. +++.||+|++.......+.+.+|+.+++.++ ||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSSSE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC------CCCEeeEEEEEecCCce
Confidence 3578999999999999999999986 5788999999876655677889999998885 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMT 153 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG--GGCEEECCTTGG
T ss_pred EEEEEeCCCCcHHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC--CCCEEecccccc
Confidence 999999975 6777665432 23899999999999999999999999999999999999986 788999999999
Q ss_pred ccccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------- 226 (269)
T 4hcu_A 154 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------- 226 (269)
T ss_dssp GGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------
T ss_pred ccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-------
Confidence 765432 223456778999999999999999999999999999999 99999988777766665422110
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..| ...+..+.+||.+||+.||.+|||+.++++|
T Consensus 227 ---------------------------~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ---------------------------YKP---------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ---------------------------CCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCC---------CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 011 1124668899999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=353.06 Aligned_cols=263 Identities=15% Similarity=0.204 Sum_probs=200.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecchhhhHhHHHHHHHHHHhcc---------cCCCCCC
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK---------NDPADEH 476 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~t-----g~~vAvKil~~~~~~~~~~~~E~~il~~L~~---------~~~~~hp 476 (722)
...++|++.+.||+|+||+||+|.+..+ ++.||||++.... ....+|+++++.+.+ .....||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 3446999999999999999999998664 5889999997654 345667777766654 3466899
Q ss_pred ceeEEEEEEEec----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 004954 477 HILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (722)
Q Consensus 477 nIv~l~~~f~~~----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NI 552 (722)
||+++++++... .+.+|||||++++|.+++.... ..+++..++.|+.||+.||+|||+.||+||||||+||
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence 999999999875 5689999999778888876532 2389999999999999999999999999999999999
Q ss_pred EEcccCCCeEEEEecCCcccccCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004954 553 LIKSYQRCEIKIIDLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (722)
Q Consensus 553 Ll~~~~~~~vkL~DFGls~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~ 622 (722)
|++...++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998545789999999999654322 1234589999999999999999999999999999999999999975
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 623 ~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
................ ........ ..++ ....+..+.+||..||+.|
T Consensus 264 ~~~~~~~~~~~~~~~~---------~~~~~~~~----------------~~~~--------~~~~~~~~~~li~~cl~~~ 310 (364)
T 3op5_A 264 NLKDPKYVRDSKIRYR---------ENIASLMD----------------KCFP--------AANAPGEIAKYMETVKLLD 310 (364)
T ss_dssp GTTCHHHHHHHHHHHH---------HCHHHHHH----------------HHSC--------TTCCCHHHHHHHHHHHTCC
T ss_pred cccCHHHHHHHHHHhh---------hhHHHHHH----------------Hhcc--------cccCHHHHHHHHHHHhcCC
Confidence 3222111111100000 00000000 0000 0233567999999999999
Q ss_pred CCCCcCHHHHHh
Q 004954 703 PQRRPTAREALD 714 (722)
Q Consensus 703 P~kRpTa~ElL~ 714 (722)
|.+||++.++++
T Consensus 311 p~~RP~~~~l~~ 322 (364)
T 3op5_A 311 YTEKPLYENLRD 322 (364)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.50 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=189.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~---~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+..++|++.+.||+|+||+||+|++..++. .||||+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD------HPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC------CTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC------CCceehhhce
Confidence 445789999999999999999999877765 8999998753 234456777888777664 7899999999
Q ss_pred EEecCeE------EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc
Q 004954 485 FYHLEHL------FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (722)
Q Consensus 485 f~~~~~l------~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~ 557 (722)
+...... ++||||+.+ +|.+++...........+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~- 172 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE- 172 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC-
Confidence 9877654 999999985 78777765554333345899999999999999999999999999999999999986
Q ss_pred CCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHH
Q 004954 558 QRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 631 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~ 631 (722)
++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....
T Consensus 173 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 173 -DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp -TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred -CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 7899999999997654321 22455778999999999999999999999999999999 9999987665555444
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC---
Q 004954 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT--- 708 (722)
Q Consensus 632 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT--- 708 (722)
+..... ...+ ...+..+.+||.+||+.||.+|||
T Consensus 252 ~~~~~~----------------------------------~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ 288 (323)
T 3qup_A 252 LIGGNR----------------------------------LKQP---------PECMEEVYDLMYQCWSADPKQRPSFTC 288 (323)
T ss_dssp HHTTCC----------------------------------CCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HhcCCC----------------------------------CCCC---------CccCHHHHHHHHHHccCChhhCcCHHH
Confidence 431110 0001 123467899999999999999999
Q ss_pred ----HHHHHhCCCCCC
Q 004954 709 ----AREALDHPWLQH 720 (722)
Q Consensus 709 ----a~ElL~HPwf~~ 720 (722)
++++++|||+..
T Consensus 289 l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 289 LRMELENILGHLSVLS 304 (323)
T ss_dssp HHHHHHHHHHC-----
T ss_pred HHHHHHHHHHHhhhcC
Confidence 889999999965
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.18 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=206.7
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+..++|++.+.||+|+||.||++.+. ++..||+|+++......+.+.+|+.+++.++ ||||+++++++.....
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS------HPKLVKFYGVCSKEYP 77 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSS
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCC------CCCEeeEEEEEccCCc
Confidence 45678999999999999999999875 5778999999877656677889999999885 6899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Dfg~ 150 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR--DLCVKVSDFGM 150 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT--TCCEEECCTTC
T ss_pred eEEEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC--CCCEEEccCcc
Confidence 9999999974 67777765432 2899999999999999999999999999999999999985 78899999999
Q ss_pred cccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
+........ ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------ 224 (268)
T 3sxs_A 151 TRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL------ 224 (268)
T ss_dssp EEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------
T ss_pred ceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC------
Confidence 976544322 2345677999999999889999999999999999999 99999887766665554321110
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..| ...+..+.+||.+||+.||.+|||+.++++|
T Consensus 225 ----------------------------~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ----------------------------YRP---------HLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------------------CCC---------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCC---------CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001 1124568899999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=352.96 Aligned_cols=260 Identities=19% Similarity=0.218 Sum_probs=209.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEE-----ECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~-----d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
++..++|++.+.||+|+||+||+|+ +..+++.||||+++.. ......+.+|+.+++.++ ||||++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~ 140 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN------HQNIVRCI 140 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC------CCCCCeEE
Confidence 4456789999999999999999999 4567889999998653 334456778888888884 78999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhcc-CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-C
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQES-GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-R 559 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~-~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~ 559 (722)
+++......++||||+. ++|.+++...... .....+++..++.++.||+.||+|||++||+||||||+|||++..+ +
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 99999999999999996 5888887765432 1223489999999999999999999999999999999999998532 4
Q ss_pred CeEEEEecCCccccc-----CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHH
Q 004954 560 CEIKIIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 633 (722)
Q Consensus 560 ~~vkL~DFGls~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~ 633 (722)
..+||+|||+++... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+++..+.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 469999999986432 12233567899999999999999999999999999999998 999999888777666654
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
..... ..+ ...+..+.+||.+||+.||.+|||+.+++
T Consensus 301 ~~~~~----------------------------------~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~eil 337 (367)
T 3l9p_A 301 SGGRM----------------------------------DPP---------KNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337 (367)
T ss_dssp TTCCC----------------------------------CCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCC----------------------------------CCC---------ccCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 22110 001 12345688999999999999999999999
Q ss_pred hCCCC
Q 004954 714 DHPWL 718 (722)
Q Consensus 714 ~HPwf 718 (722)
+|.|+
T Consensus 338 ~~l~~ 342 (367)
T 3l9p_A 338 ERIEY 342 (367)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=340.26 Aligned_cols=253 Identities=27% Similarity=0.373 Sum_probs=183.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhh--hHhHHHHHH-HHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~--~~~~~~E~~-il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+...|.. +++. ..||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~------~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS------HDCPYIVQCFGTFITNT 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHT------TTCTTBCCEEEEEECSS
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHh------cCCCceeeEEEEEecCC
Confidence 47899999999999999999999999999999999764322 122222332 2222 35899999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+++.+..+..... ..+++..++.++.||+.||.|||+. ||+||||||+||+++. ++.+||+|||
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg 170 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFG 170 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT--TSCEEECCCT
T ss_pred cEEEEEeccCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC--CCCEEEEECC
Confidence 999999999655544443322 1289999999999999999999995 9999999999999985 7889999999
Q ss_pred CcccccCC--ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCc
Q 004954 569 SSCFQTDN--LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPID 640 (722)
Q Consensus 569 ls~~~~~~--~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~-~~~~e~l~~i~~~lg~~~ 640 (722)
++...... .....+|+.|+|||++. ...++.++|||||||++|+|++|+.||.. ....+.+..+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 247 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP--- 247 (318)
T ss_dssp TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC---
T ss_pred CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC---
Confidence 98654432 23357899999999994 45688999999999999999999999976 333344433321100
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
..+|. ....+..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 248 -------------------------------~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 248 -------------------------------PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp -------------------------------CCCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred -------------------------------CCCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 00111 012356789999999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=342.25 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=197.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
++..++|++.+.||+|+||+||+|++ +|+.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~ 104 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR------HPNIVLFMGAVT 104 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEE
Confidence 34567999999999999999999986 68899999987542 33456778999998885 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCCCeEE
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~~~vk 563 (722)
.....++||||+.+ +|.+++..... ...+++..++.++.||+.||+|||+.| |+||||||+|||++. ++.+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~--~~~~k 179 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK--KYTVK 179 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT--TCCEE
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC--CCcEE
Confidence 99999999999975 77777764321 123889999999999999999999999 999999999999985 78999
Q ss_pred EEecCCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--- 256 (309)
T 3p86_A 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK--- 256 (309)
T ss_dssp ECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC---
T ss_pred ECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---
Confidence 9999998765433 2346789999999999999999999999999999999999999988776665554421110
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...+| ...++.+.+||++||+.||.+|||+.++++
T Consensus 257 ------------------------------~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 257 ------------------------------RLEIP---------RNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp ------------------------------CCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00111 123467899999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=335.00 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=205.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+..++|++++.||+|+||+||++.+. ++..||+|+++......+.+.+|+++++.++ ||||+++++++....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------HEKLVQLYGVCTKQR 92 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC------CCCEeeEEEEEecCC
Confidence 455679999999999999999999875 6788999999876655677888999988875 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~--~~~~kl~Dfg 165 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFG 165 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TSCEEECSTT
T ss_pred CeEEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC--CCCEEEcccc
Confidence 9999999996 577777764322 2899999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
++...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----- 240 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----- 240 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-----
Confidence 99765432 222355778999999999899999999999999999998 99999887776666655422111
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..| ...++.+.+||.+||+.||.+|||+.++|+|
T Consensus 241 -----------------------------~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 -----------------------------YRP---------HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -----------------------------CCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCC---------CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 011 1224668899999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=344.89 Aligned_cols=250 Identities=21% Similarity=0.267 Sum_probs=203.2
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~---~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
.++..++|++.+.||+|+||+||+|++..+++ .||||+++.. ......+.+|+.+++.++ ||||+++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 117 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD------HPNIIRLEG 117 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC------CTTBCCEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 45567899999999999999999999976555 5999999763 333456777888887764 789999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
++...+..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~ 190 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS--NLVC 190 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCE
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC--CCCE
Confidence 99999999999999975 7777765332 23899999999999999999999999999999999999985 7899
Q ss_pred EEEecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 004954 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 563 kL~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~ 635 (722)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 999999997654432 12345678999999999899999999999999999999 99999888777766665422
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
... ..+ ...+..+.+||.+||+.||.+|||+.++++
T Consensus 271 ~~~----------------------------------~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 271 YRL----------------------------------PAP---------MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCC----------------------------------CCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC----------------------------------CCC---------CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 110 001 123467899999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=334.72 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=210.1
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++..++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.++ ||||+++++++...
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTRE 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCC------CTTBCCEEEEECSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEccC
Confidence 345678999999999999999999999999999999999887777778889999999985 68999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
...++||||+. ++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Df 155 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADF 155 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECG--GGCEEECCC
T ss_pred CCEEEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcC--CCCEEEccC
Confidence 99999999998 578887764322 23899999999999999999999999999999999999985 778999999
Q ss_pred CCcccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 568 GSSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 568 Gls~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|++........ ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~------ 229 (288)
T 3kfa_A 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------ 229 (288)
T ss_dssp CGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------
T ss_pred ccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC------
Confidence 99976554322 2345778999999999999999999999999999999 999998765444443332110
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...++.+.+||++||+.||.+|||+.++++
T Consensus 230 ----------------------------~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 ----------------------------RMERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ----------------------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCC---------CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 00011 123467899999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.78 Aligned_cols=254 Identities=21% Similarity=0.268 Sum_probs=196.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.+.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+++. ++|..+..++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~-----~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGG-----VGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTS-----TTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCC-----CCCCeeeeecCCCCc
Confidence 457899999999999999999999999999999998765432 35678899999999854 356666666678889
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEEEecCC
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL~DFGl 569 (722)
.++||||++++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ..++.+||+|||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 80 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEccCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 999999998888888764332 2899999999999999999999999999999999999931 1378899999999
Q ss_pred cccccCCc----------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH---HHHHHHHhhc
Q 004954 570 SCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV---MILARIIGML 636 (722)
Q Consensus 570 s~~~~~~~----------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~---e~l~~i~~~l 636 (722)
+....... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..+..+....
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 97654332 2457899999999999999999999999999999999999999763211 1111111000
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.. .| ........++.+.+||.+||+.||++|||+.++++
T Consensus 235 ~~-----------------------------------~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 MS-----------------------------------TP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HH-----------------------------------SC----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cc-----------------------------------ch----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00 00 01111223567999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=350.21 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=205.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEEC-------CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~-------~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
+..++|++.+.||+|+||+||+|++. .++..||||+++... .....+.+|+.+++.+. .||||+++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~ 152 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINL 152 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC-----CCTTBCCE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc-----CCCCEeeE
Confidence 34578999999999999999999874 355689999997642 34467888999999884 37899999
Q ss_pred EEEEEecCeEEEEEEcccc-chHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 004954 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~ 550 (722)
++++...+.+++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 9999999999999999975 788887754321 12234889999999999999999999999999999999
Q ss_pred ceEEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCh
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDA 624 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~ 624 (722)
|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 233 NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTE--NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECT--TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECC--CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999985 789999999999765432 222456788999999999999999999999999999999 999998765
Q ss_pred HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCC
Q 004954 625 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704 (722)
Q Consensus 625 ~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~ 704 (722)
..++...+.... ....| ...+..+.+||.+||+.||.
T Consensus 311 ~~~~~~~~~~~~----------------------------------~~~~~---------~~~~~~l~~li~~~l~~dP~ 347 (370)
T 2psq_A 311 VEELFKLLKEGH----------------------------------RMDKP---------ANCTNELYMMMRDCWHAVPS 347 (370)
T ss_dssp GGGHHHHHHTTC----------------------------------CCCCC---------TTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHhcCC----------------------------------CCCCC---------CCCCHHHHHHHHHHcCCChh
Confidence 544443332110 00111 12346789999999999999
Q ss_pred CCcCHHHHHhC
Q 004954 705 RRPTAREALDH 715 (722)
Q Consensus 705 kRpTa~ElL~H 715 (722)
+|||+.|++++
T Consensus 348 ~Rpt~~ell~~ 358 (370)
T 2psq_A 348 QRPTFKQLVED 358 (370)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.70 Aligned_cols=248 Identities=21% Similarity=0.359 Sum_probs=198.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec-chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~-~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.++|++.++||+|+||+||+|.+..+++.||+|++.. .......+.+|+.+++.++ ||||+++++++...+..
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE------HPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEETTEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CcCcccEEEEEecCCee
Confidence 5789999999999999999999999999999998765 3445567778888887774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
++||||+.+ +|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~ 155 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE--NKNVVVADFGLA 155 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT--TSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC--CCCEEEeecccc
Confidence 999999975 77777764322 2899999999999999999999999999999999999985 788999999998
Q ss_pred ccccCCcc-----------------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 571 CFQTDNLC-----------------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 571 ~~~~~~~~-----------------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
........ ...||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---- 231 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---- 231 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT----
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH----
Confidence 76433211 357899999999999999999999999999999999999998653110000
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
....... ......| ...++.+.+||.+||+.||++|||+.+++
T Consensus 232 ------------~~~~~~~----------------~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~l~ 274 (310)
T 3s95_A 232 ------------FGLNVRG----------------FLDRYCP---------PNCPPSFFPITVRCCDLDPEKRPSFVKLE 274 (310)
T ss_dssp ------------SSBCHHH----------------HHHHTCC---------TTCCTTHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------Hhhhhhc----------------cccccCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 0000000 0000011 12335688999999999999999999998
Q ss_pred h
Q 004954 714 D 714 (722)
Q Consensus 714 ~ 714 (722)
+
T Consensus 275 ~ 275 (310)
T 3s95_A 275 H 275 (310)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=345.51 Aligned_cols=263 Identities=17% Similarity=0.214 Sum_probs=193.9
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECC---CCcEEEEEEeecchhhhHhHHHHHHHHHHhc---------ccCCCCCC
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN---------KNDPADEH 476 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~---tg~~vAvKil~~~~~~~~~~~~E~~il~~L~---------~~~~~~hp 476 (722)
.+...++|++.+.||+|+||+||+|.+.. ++..+|||++..... ...+|..+++.+. ......||
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKWIERKQLDYL 108 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C---HHHHHHHHHHHHCCHHHHHHHHHHHTCSCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc---chHHHHHHHHHHhhhHHHHHHHhhcccccc
Confidence 44456899999999999999999999987 888999999876532 2333444433332 22345689
Q ss_pred ceeEEEEEEEe----cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 004954 477 HILRLYDYFYH----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (722)
Q Consensus 477 nIv~l~~~f~~----~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NI 552 (722)
||+++++++.. ....++||||++++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||
T Consensus 109 ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 109 GIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182 (345)
T ss_dssp CCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHE
Confidence 99999999998 68899999999778888776443 389999999999999999999999999999999999
Q ss_pred EEcccCCCeEEEEecCCcccccCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004954 553 LIKSYQRCEIKIIDLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (722)
Q Consensus 553 Ll~~~~~~~vkL~DFGls~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~ 622 (722)
|++.+..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999744459999999999654321 1345789999999999999999999999999999999999999964
Q ss_pred C--hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcc
Q 004954 623 D--AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700 (722)
Q Consensus 623 ~--~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~ 700 (722)
. ...............++.... ...+ ....+..+.+||.+||+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~--------~~~~~~~l~~li~~~l~ 307 (345)
T 2v62_A 263 NLKDPVAVQTAKTNLLDELPQSVL---------------------------KWAP--------SGSSCCEIAQFLVCAHS 307 (345)
T ss_dssp GTTCHHHHHHHHHHHHHTTTHHHH---------------------------HHSC--------TTSCCHHHHHHHHHHHT
T ss_pred cccccHHHHHHHHhhcccccHHHH---------------------------hhcc--------ccccHHHHHHHHHHHhh
Confidence 2 222222211111111111000 0000 01345679999999999
Q ss_pred cCCCCCcCHHHHHhC
Q 004954 701 INPQRRPTAREALDH 715 (722)
Q Consensus 701 ~dP~kRpTa~ElL~H 715 (722)
.||.+|||+.++++.
T Consensus 308 ~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 308 LAYDEKPNYQALKKI 322 (345)
T ss_dssp CCTTCCCCHHHHHHH
T ss_pred cCcccCCCHHHHHHH
Confidence 999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=357.56 Aligned_cols=264 Identities=27% Similarity=0.318 Sum_probs=196.4
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+...+|+.+++.+. .||||+++++++....
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESD-----DHPNVIRYYCSETTDR 82 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECSS
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCC
Confidence 4456778889999999999998764 5689999999987643 356778999988774 4789999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCC-cccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-----------
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGE-AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY----------- 557 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~-~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~----------- 557 (722)
.++|||||++++|.+++......... ...++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 99999999999999988754432211 112344567899999999999999999999999999999752
Q ss_pred CCCeEEEEecCCcccccCCc-------cccccCCcccCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 004954 558 QRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVLFPN 622 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~~-------~~~~gt~~y~APE~l~~-------~~~s~ksDIWSLGviL~ellt-G~~PF~~ 622 (722)
.+..+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 34689999999997654421 23578999999999976 568999999999999999999 9999976
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 623 ~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
....+ ..+...... .+....+ .....+..+.+||.+||+.|
T Consensus 243 ~~~~~--~~i~~~~~~-----------------------------------~~~~~~~--~~~~~~~~~~~li~~~L~~d 283 (434)
T 2rio_A 243 KYSRE--SNIIRGIFS-----------------------------------LDEMKCL--HDRSLIAEATDLISQMIDHD 283 (434)
T ss_dssp TTTHH--HHHHHTCCC-----------------------------------CCCCTTC--CCHHHHHHHHHHHHHHTCSS
T ss_pred chhhH--HHHhcCCCC-----------------------------------ccccccc--ccccchHHHHHHHHHHhhCC
Confidence 43222 111111000 0000000 00012356889999999999
Q ss_pred CCCCcCHHHHHhCCCCCC
Q 004954 703 PQRRPTAREALDHPWLQH 720 (722)
Q Consensus 703 P~kRpTa~ElL~HPwf~~ 720 (722)
|.+|||+.++|+||||..
T Consensus 284 P~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 284 PLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp GGGSCCHHHHHTSGGGSC
T ss_pred hhhCCCHHHHHhCCccCC
Confidence 999999999999999964
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.60 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=201.3
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.+.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.+++. +++..+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~-----~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGG-----VGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTS-----TTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcC-----CCCCccccccCCCCc
Confidence 467899999999999999999999999999999999876543 35678999999999854 355566666677889
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEEEecCC
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL~DFGl 569 (722)
.++||||++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++. ..++.+||+|||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 80 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEecCCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 999999998889888864332 2899999999999999999999999999999999999941 1367899999999
Q ss_pred cccccCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH---HHHHHHHHhhc
Q 004954 570 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGML 636 (722)
Q Consensus 570 s~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~---~e~l~~i~~~l 636 (722)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ...+..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 8765433 2345789999999999999999999999999999999999999976321 11222221100
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
... | ........++.+.+||++||+.||.+|||+.++++
T Consensus 235 ~~~-----------------------------------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 235 MST-----------------------------------P----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHS-----------------------------------C----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cCC-----------------------------------c----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 000 0 00111223567899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=342.54 Aligned_cols=264 Identities=27% Similarity=0.363 Sum_probs=185.3
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
..+..++|++.+.||+|+||.||+|.+..+|+.||||+++.... ...+...|+..+ ++ ...||||+++++++.
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~--~~---~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV--MR---SSDCPYIVQFYGALF 91 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHH--HS---SCCCTTBCCEEEEEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHH--HH---cCCCCcEeeeeeEEE
Confidence 34556899999999999999999999999999999999976432 222333333322 22 346899999999999
Q ss_pred ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+..++||||+.++|.+++...... ....+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||+
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~--~~~~kl~ 168 (327)
T 3aln_A 92 REGDCWICMELMSTSFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR--SGNIKLC 168 (327)
T ss_dssp CSSEEEEEECCCSEEHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEET--TTEEEEC
T ss_pred eCCceEEEEeecCCChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcC--CCCEEEc
Confidence 99999999999999988887653321 123489999999999999999999999 9999999999999985 7899999
Q ss_pred ecCCcccccCCc--cccccCCcccCchhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH-HHHHHHHhhcCC
Q 004954 566 DLGSSCFQTDNL--CLYVQSRSYRAPEVI----IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGP 638 (722)
Q Consensus 566 DFGls~~~~~~~--~~~~gt~~y~APE~l----~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~-e~l~~i~~~lg~ 638 (722)
|||++....... ....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||...... +.+..+.
T Consensus 169 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----- 243 (327)
T 3aln_A 169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV----- 243 (327)
T ss_dssp CCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-----
T ss_pred cCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-----
Confidence 999997654432 234789999999998 4567899999999999999999999999764321 1110000
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
......++. ......+..+.+||++||+.||.+|||+.++|+||||
T Consensus 244 -----------------------------~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 244 -----------------------------KGDPPQLSN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp -----------------------------CSCCCCCCC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred -----------------------------cCCCCCCCC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 000000000 0112345779999999999999999999999999998
Q ss_pred C
Q 004954 719 Q 719 (722)
Q Consensus 719 ~ 719 (722)
+
T Consensus 290 ~ 290 (327)
T 3aln_A 290 L 290 (327)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=335.67 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=197.4
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
|.....||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK------HKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCC------CTTBCCEEEEEEETTEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCC------CCCEeeEeeEEEeCCcEEEE
Confidence 333448999999999999999999999999987643 33456778888888774 78999999999999999999
Q ss_pred EEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+. ++|.+++..... ...+++..++.++.||+.||.|||+.||+|+||||+||+++. .++.+||+|||++...
T Consensus 98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRL 173 (295)
T ss_dssp EECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTCCEEECCTTTCEES
T ss_pred EEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC-CCCCEEEeeccccccc
Confidence 99996 577777654321 223678899999999999999999999999999999999984 3678999999998765
Q ss_pred cCC---ccccccCCcccCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCChHHH-HHHHHHhhcCCCcHHHHhhh
Q 004954 574 TDN---LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 574 ~~~---~~~~~gt~~y~APE~l~~~~--~s~ksDIWSLGviL~elltG~~PF~~~~~~e-~l~~i~~~lg~~~~~~~~~~ 647 (722)
... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...... .
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~------------ 240 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-M------------ 240 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-H------------
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-c------------
Confidence 432 23457899999999997654 7899999999999999999999996532111 111100 0
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
......+| ...+..+.+||.+||+.||++|||+.++|+||||+.
T Consensus 241 --------------------~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 241 --------------------FKVHPEIP---------ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp --------------------HCCCCCCC---------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred --------------------cccccccc---------ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 00001111 123467899999999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=340.30 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=197.1
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
.+.+.++|++.+.||+|+||.||+|++..+++.||||++..... ......+|+.+++.+... ..|+||+++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~~h~~i~~~ 103 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG--GGHPGVIRL 103 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS--CCCSSBCCE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc--CCCCCeeeE
Confidence 45678899999999999999999999999999999999975432 223455788999888542 358999999
Q ss_pred EEEEEecCeEEEEEEc-cc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC
Q 004954 482 YDYFYHLEHLFIVCEL-LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy-~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~ 559 (722)
++++...+..++|||+ +. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++. .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-TT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-CC
Confidence 9999999999999998 54 67888776533 2899999999999999999999999999999999999983 37
Q ss_pred CeEEEEecCCcccccCC-ccccccCCcccCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 560 CEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s-~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
+.+||+|||++...... .....+++.|+|||++.+..+. .++|||||||++|+|++|+.||..... +...
T Consensus 177 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~-- 248 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA-- 248 (312)
T ss_dssp TEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--
T ss_pred CeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--
Confidence 78999999998765443 3445789999999999876664 589999999999999999999975321 1100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
...++ ...+..+.+||.+||+.||++|||+.|+|+|||
T Consensus 249 ---------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 249 ---------------------------------ELHFP---------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp ---------------------------------CCCCC---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred ---------------------------------ccCCc---------ccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00011 123466889999999999999999999999999
Q ss_pred CCCC
Q 004954 718 LQHP 721 (722)
Q Consensus 718 f~~~ 721 (722)
|+.+
T Consensus 287 ~~~~ 290 (312)
T 2iwi_A 287 MQTP 290 (312)
T ss_dssp TCC-
T ss_pred hcCc
Confidence 9874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=357.99 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=193.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
.+|++.++||+|+||+|+.. ...+|+.||||++.... .....+|+.+++.+. .||||+++++++......+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC--FSFADREVQLLRESD-----EHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT--EEECHHHHHHHHHSC-----CCTTBCCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCCEEEE
Confidence 46999999999999997643 35789999999986543 234668999998874 48899999999999999999
Q ss_pred EEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc---cCCCeEEEEecCCc
Q 004954 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSS 570 (722)
Q Consensus 494 VmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~---~~~~~vkL~DFGls 570 (722)
||||+.++|.+++...... +....++.++.||+.||.|||+.||+||||||+|||++. .....+||+|||++
T Consensus 96 v~E~~~g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCSEEHHHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCCCCHHHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999999988754322 445567789999999999999999999999999999953 23457889999998
Q ss_pred ccccCC------ccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 571 CFQTDN------LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 571 ~~~~~~------~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
...... .....||+.|+|||++. ...++.++|||||||++|+|++ |..||......... .+. +...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~---~~~~ 246 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL---GACS 246 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT---TCCC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh---ccCC
Confidence 765432 23457899999999997 4567889999999999999999 99999654322211 110 0000
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....+. ...+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 247 -----------------------------~~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 247 -----------------------------LDCLHPE--------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp -----------------------------CTTSCTT--------CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred -----------------------------ccccCcc--------ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0000000 111345789999999999999999999999999974
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.15 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=204.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEEE-----ECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~-----d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
++..++|++.+.||+|+||.||+|+ +..+++.||||+++... .....+.+|+++++.+. .||||++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpniv~~~ 92 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLL 92 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc-----CCcceeeee
Confidence 3456899999999999999999998 56677999999997643 33456889999999995 378999999
Q ss_pred EEEEecC-eEEEEEEcccc-chHHHHhhhhccC-----------------------------------------------
Q 004954 483 DYFYHLE-HLFIVCELLRA-NLYEFQKFNQESG----------------------------------------------- 513 (722)
Q Consensus 483 ~~f~~~~-~l~iVmEy~~g-sLl~~l~~~~~~~----------------------------------------------- 513 (722)
+++...+ ..++||||+.+ +|.+++.......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998765 49999999975 7888776543210
Q ss_pred -------------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccccCC----
Q 004954 514 -------------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 576 (722)
Q Consensus 514 -------------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~---- 576 (722)
....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCGGGSCTTSCTTCE
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCcEEEEeccceeeecccccch
Confidence 0122889999999999999999999999999999999999985 788999999999754332
Q ss_pred -ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 004954 577 -LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (722)
Q Consensus 577 -~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~ 654 (722)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+....
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------- 313 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT----------------- 313 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-----------------
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC-----------------
Confidence 223467889999999999999999999999999999998 9999987553333322221100
Q ss_pred cccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 655 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...++.+.+||.+||+.||.+|||+.|+++|
T Consensus 314 ----------------~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 314 ----------------RMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00011 1234678999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=351.01 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=204.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+-.++|++.+.||+|+||.||+|++..+++.||||+++.. ......+.+|+++++.++ ||||+++++++..
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~ 183 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS------HPNIVRLIGVCTQ 183 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC------CTTBCCEEEEECS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEec
Confidence 34467899999999999999999999999999999998754 233456778888887664 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+++||||+. ++|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~--~~~~kl~D 256 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE--KNVLKISD 256 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC--CCcEEECc
Confidence 999999999997 578888765432 2889999999999999999999999999999999999985 78999999
Q ss_pred cCCcccccCCccc-----cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 567 LGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 567 FGls~~~~~~~~~-----~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||++......... ..+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+....
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---- 332 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---- 332 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC----
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----
Confidence 9998765443221 234677999999998889999999999999999998 999998877655544432110
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...+..+.+||.+||+.||.+|||+.++++
T Consensus 333 ------------------------------~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 333 ------------------------------RLPCP---------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ------------------------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00111 123467899999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=345.41 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=209.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECC-------CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~-------tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
++..++|++.+.||+|+||+||+|++.. .+..||||+++... .....+.+|+++++.+. .||||++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~ 139 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 139 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCC
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc-----CCchhhh
Confidence 4556899999999999999999999754 33679999997643 33467889999999984 3789999
Q ss_pred EEEEEEecCeEEEEEEcccc-chHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
+++++...+..++||||+.+ +|.+++...... .....+++..++.|+.||+.||+|||+.||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 99999999999999999975 888887754421 1123489999999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~ 623 (722)
+||||+. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECT--TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcC--CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999986 788999999999765432 223456788999999999999999999999999999999 99999988
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 624 ~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
+..++...+..... ...| ...+..+.+||++||+.||
T Consensus 298 ~~~~~~~~~~~~~~----------------------------------~~~~---------~~~~~~l~~li~~~l~~dP 334 (382)
T 3tt0_A 298 PVEELFKLLKEGHR----------------------------------MDKP---------SNCTNELYMMMRDCWHAVP 334 (382)
T ss_dssp CHHHHHHHHHTTCC----------------------------------CCCC---------SSCCHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHcCCC----------------------------------CCCC---------ccCCHHHHHHHHHHcCCCh
Confidence 77666655432110 0011 1234678999999999999
Q ss_pred CCCcCHHHHHhC
Q 004954 704 QRRPTAREALDH 715 (722)
Q Consensus 704 ~kRpTa~ElL~H 715 (722)
++|||+.|++++
T Consensus 335 ~~Rps~~ell~~ 346 (382)
T 3tt0_A 335 SQRPTFKQLVED 346 (382)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.25 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=185.2
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE---
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY--- 486 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~--- 486 (722)
+...+|++.++||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+. .||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-----GHPNIVQFCSAASIGK 99 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT-----TSTTBCCEEEEEEECT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc-----cCCChhhccccccccc
Confidence 3456899999999999999999999999999999988654 334566788999999886 3789999999995
Q ss_pred -----ecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCC
Q 004954 487 -----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQR 559 (722)
Q Consensus 487 -----~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~ 559 (722)
.....++||||+.|+|.+++...... ..+++..++.++.||+.||.|||+.| |+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~--~ 174 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCKGQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN--Q 174 (337)
T ss_dssp TTSTTSSEEEEEEEECCSEEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT--T
T ss_pred cccccCCceEEEEEEecCCCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC--C
Confidence 33468999999999999988754322 23899999999999999999999999 999999999999996 7
Q ss_pred CeEEEEecCCcccccCCcc---------------ccccCCcccCchhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004954 560 CEIKIIDLGSSCFQTDNLC---------------LYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~~~---------------~~~gt~~y~APE~l---~~~~~s~ksDIWSLGviL~elltG~~PF~ 621 (722)
+.+||+|||++........ ...+|+.|+|||++ .+..++.++|||||||++|+|++|+.||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 7899999999976543221 34589999999998 56678999999999999999999999997
Q ss_pred CChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhccc
Q 004954 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701 (722)
Q Consensus 622 ~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~ 701 (722)
......++.... ..+.. ...+..+.+||++||+.
T Consensus 255 ~~~~~~~~~~~~---------------------------------------~~~~~-------~~~~~~~~~li~~~l~~ 288 (337)
T 3ll6_A 255 DGAKLRIVNGKY---------------------------------------SIPPH-------DTQYTVFHSLIRAMLQV 288 (337)
T ss_dssp -----------C---------------------------------------CCCTT-------CCSSGGGHHHHHHHSCS
T ss_pred chhHHHhhcCcc---------------------------------------cCCcc-------cccchHHHHHHHHHccC
Confidence 543322211100 00000 11123477999999999
Q ss_pred CCCCCcCHHHHHhCC
Q 004954 702 NPQRRPTAREALDHP 716 (722)
Q Consensus 702 dP~kRpTa~ElL~HP 716 (722)
||.+|||+.|+++|.
T Consensus 289 ~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 289 NPEERLSIAEVVHQL 303 (337)
T ss_dssp SGGGSCCHHHHHHHH
T ss_pred ChhhCcCHHHHHHHH
Confidence 999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.82 Aligned_cols=264 Identities=21% Similarity=0.190 Sum_probs=191.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~--- 489 (722)
.++|++.++||+|+||+||+|++. ++.||||+++..........+|+.+++.+ .||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM------KHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC------CCTTBCCEEEEEEEECSSS
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC------CCCCchhhcceeccCCCCC
Confidence 478999999999999999999874 79999999987654444444555555444 5899999999998754
Q ss_pred -eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC----------CCccccCCCCceEEccc
Q 004954 490 -HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL----------GIIHCDLKPENILIKSY 557 (722)
Q Consensus 490 -~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~----------gIvHrDLKp~NILl~~~ 557 (722)
.+++||||+.+ +|.+++... .+++..++.++.||+.||+|||+. ||+||||||+|||++.
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~- 166 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN- 166 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT-
T ss_pred ceEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC-
Confidence 47999999975 788777532 289999999999999999999999 9999999999999985
Q ss_pred CCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCChHHH
Q 004954 558 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~-----~~s~ksDIWSLGviL~elltG~~PF~~~~~~e 627 (722)
++.+||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.....
T Consensus 167 -~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 167 -NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp -TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred -CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 789999999999764432 2235789999999999873 45668899999999999999999997643211
Q ss_pred HHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc
Q 004954 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707 (722)
Q Consensus 628 ~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp 707 (722)
...........+....+.. .. ........++.... ....+..+.+||++||+.||++||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~------~~-----------~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rp 304 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQE------VV-----------VHKKKRPVLRDYWQ----KHAGMAMLCETIEECWDHDAEARL 304 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHH------HH-----------TTSCCCCCCCGGGG----SSHHHHHHHHHHHHHTCSSGGGSC
T ss_pred ccchhhhhccCCchhhhhh------hh-----------hcccCCCCcccccc----ccchHHHHHHHHHHHccCChhhCc
Confidence 1100000011111111100 00 00000111111000 011135689999999999999999
Q ss_pred CHHHHHh
Q 004954 708 TAREALD 714 (722)
Q Consensus 708 Ta~ElL~ 714 (722)
|+.|+++
T Consensus 305 s~~ell~ 311 (322)
T 3soc_A 305 SAGCVGE 311 (322)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.55 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=197.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhh--------hHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF--------FDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~--------~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
.+..++|++.+.||+|+||+||+|++..+++.||+|++...... ...+.+|+.+++.++ ||||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~ 88 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN------HPNIVKL 88 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC------CTTBCCE
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC------CCCchhh
Confidence 45568999999999999999999999999999999998653221 145667888777764 7899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccC
Q 004954 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQ 558 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~ 558 (722)
++++.... ++||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+.| |+||||||+|||++...
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCC
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccC
Confidence 99987655 69999998 57777765432 23899999999999999999999999 99999999999998522
Q ss_pred ---CCeEEEEecCCcccccCCccccccCCcccCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH--HHH
Q 004954 559 ---RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI--LAR 631 (722)
Q Consensus 559 ---~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~--~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~--l~~ 631 (722)
...+||+|||++...........+|+.|+|||++. ...++.++|||||||++|+|++|+.||........ ...
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 22499999999987777666678999999999984 45578999999999999999999999976432221 111
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 632 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
+... .....++ ...++.+.+||.+||+.||.+|||+.+
T Consensus 242 ~~~~---------------------------------~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ 279 (287)
T 4f0f_A 242 IREE---------------------------------GLRPTIP---------EDCPPRLRNVIELCWSGDPKKRPHFSY 279 (287)
T ss_dssp HHHS---------------------------------CCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred Hhcc---------------------------------CCCCCCC---------cccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 1100 0001111 123467899999999999999999999
Q ss_pred HHh
Q 004954 712 ALD 714 (722)
Q Consensus 712 lL~ 714 (722)
+++
T Consensus 280 ll~ 282 (287)
T 4f0f_A 280 IVK 282 (287)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.16 Aligned_cols=247 Identities=26% Similarity=0.335 Sum_probs=190.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
-.++|++.+.||+|+||.||+|.+ +|+.+|||+++... .....+.+|+++++.++ ||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 76 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK------HPNIIALRGVCL 76 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCC------CTTBCCEEEEEC
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC------CCCEeeEEEEEe
Confidence 357899999999999999999997 48899999987542 22356778888888885 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC---CccccCCCCceEEccc-----
Q 004954 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG---IIHCDLKPENILIKSY----- 557 (722)
Q Consensus 487 ~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g---IvHrDLKp~NILl~~~----- 557 (722)
..+..++||||+.+ +|.+++. . ..+++..++.++.||+.||.|||+.| |+||||||+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~-~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLS-G------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHT-S------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred cCCceEEEEEcCCCCCHHHHhh-c------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 99999999999975 5555543 1 23899999999999999999999999 8999999999999842
Q ss_pred -CCCeEEEEecCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 004954 558 -QRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 558 -~~~~vkL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~ 635 (722)
.++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp CSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred ccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 2578999999999765433 23457899999999999999999999999999999999999999887665554443211
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
. ....++ ...++.+.+||.+||+.||.+|||+.|+++|
T Consensus 230 ~---------------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 K---------------------------------LALPIP---------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp C---------------------------------CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---------------------------------CCCCCC---------cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0 000111 1234678999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=339.95 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=206.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
.+..++|++.+.||+|+||.||+|++. .+++.||||+++... .....+.+|+.+++.++ ||||++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 116 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------NPNIVKLL 116 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCEEEEE
Confidence 455689999999999999999999986 456899999997642 33456778888888774 78999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHhhhhccC------------------CCcccCHHHHHHHHHHHHHHHHHHHHCCCc
Q 004954 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESG------------------GEAYFTLGRLQVITRQCLEALEYLHSLGII 543 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~------------------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIv 543 (722)
+++...+..++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||+.||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 999999999999999975 8888876532110 114589999999999999999999999999
Q ss_pred cccCCCCceEEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CC
Q 004954 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617 (722)
Q Consensus 544 HrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~ 617 (722)
||||||+|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 197 H~Dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 197 HRDLATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSCCSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCcceEEECC--CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999986 789999999998654322 223467889999999999999999999999999999999 99
Q ss_pred CCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHH
Q 004954 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697 (722)
Q Consensus 618 ~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~ 697 (722)
.||.+....+....+..... ...| ...+..+.+||++
T Consensus 275 ~p~~~~~~~~~~~~~~~~~~----------------------------------~~~~---------~~~~~~l~~li~~ 311 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRDGNI----------------------------------LACP---------ENCPLELYNLMRL 311 (343)
T ss_dssp CTTTTSCHHHHHHHHHTTCC----------------------------------CCCC---------TTCCHHHHHHHHH
T ss_pred CcCCCCChHHHHHHHhCCCc----------------------------------CCCC---------CCCCHHHHHHHHH
Confidence 99988777666555432100 0011 1234678999999
Q ss_pred hcccCCCCCcCHHHHHhC
Q 004954 698 LLEINPQRRPTAREALDH 715 (722)
Q Consensus 698 mL~~dP~kRpTa~ElL~H 715 (722)
||+.||.+|||+.+++++
T Consensus 312 ~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 312 CWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcccCcccCCCHHHHHHH
Confidence 999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=325.13 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=205.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
.++|++.+.||+|+||.||++.+. +++.||+|++.......+.+.+|+.+++.++ ||||+++++++...+..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEccCCCeE
Confidence 478999999999999999999985 6788999999876655567888999888774 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++.
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTR 152 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG--GGCEEECCTTGGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC--CCCEEEccccccc
Confidence 99999974 77777764322 3889999999999999999999999999999999999985 7889999999987
Q ss_pred cccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 572 FQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 572 ~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
..... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~--------- 223 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------- 223 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---------
T ss_pred ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc---------
Confidence 65432 223456778999999998899999999999999999999 9999988776666655432110
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...| ...+..+.+||.+||+.||.+|||+.+++++
T Consensus 224 -------------------------~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 -------------------------LYKP---------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCC---------ccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011 1234668999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.46 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=190.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
++..++|++.+.||+|+||+||+|.+..+ +..||+|+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 84 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD------HPHIVKLIGV 84 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCccceEEEE
Confidence 45678999999999999999999998654 557999998753 233456777888887764 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+ ..+..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 85 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~k 156 (281)
T 1mp8_A 85 I-TENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVK 156 (281)
T ss_dssp E-CSSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEE
T ss_pred E-ccCccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC--CCCEE
Confidence 7 45678999999985 77777764321 2889999999999999999999999999999999999996 78999
Q ss_pred EEecCCcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 564 IIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 564 L~DFGls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+....
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-- 234 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-- 234 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC--
Confidence 99999987654332 22356788999999999999999999999999999997 999998765554444432110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...++ ...++.+.+||.+||+.||.+|||+.+++++
T Consensus 235 --------------------------------~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 235 --------------------------------RLPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --------------------------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------------CCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00011 1235678999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=337.69 Aligned_cols=261 Identities=19% Similarity=0.219 Sum_probs=206.0
Q ss_pred CceecCcEEEEEEeccCCCCceEEEE-----ECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~-----d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
.++..++|++.+.||+|+||.||+|+ +..+++.||||++... ......+.+|+.+++.++ ||||+++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~ 98 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN------HQNIVRC 98 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC------CTTBCCE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC------CCCCCeE
Confidence 34667899999999999999999999 5678889999999643 334456778888888874 7899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHhhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-C
Q 004954 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-Q 558 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~-~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~ 558 (722)
++++......++||||+. ++|.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|||++.. .
T Consensus 99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence 999999999999999995 68888887553221 12348899999999999999999999999999999999999853 2
Q ss_pred CCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHH
Q 004954 559 RCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i 632 (722)
...+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 457999999998643322 223467889999999999999999999999999999998 99999887766665554
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH
Q 004954 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 712 (722)
Q Consensus 633 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El 712 (722)
..... ...+ ...+..+.+||.+||+.||.+|||+.++
T Consensus 259 ~~~~~----------------------------------~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l 295 (327)
T 2yfx_A 259 TSGGR----------------------------------MDPP---------KNCPGPVYRIMTQCWQHQPEDRPNFAII 295 (327)
T ss_dssp HTTCC----------------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCC----------------------------------CCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 32110 0001 1234678999999999999999999999
Q ss_pred HhCCCC
Q 004954 713 LDHPWL 718 (722)
Q Consensus 713 L~HPwf 718 (722)
++|.|+
T Consensus 296 l~~l~~ 301 (327)
T 2yfx_A 296 LERIEY 301 (327)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999774
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.59 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=203.6
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
++..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.+ .||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 92 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV------NHPHVIKLY 92 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC------CCTTBCCEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC------CCCceeeEE
Confidence 34568899999999999999999997 3456899999997542 3345667788877766 378999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhccC------------------CCcccCHHHHHHHHHHHHHHHHHHHHCCCc
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESG------------------GEAYFTLGRLQVITRQCLEALEYLHSLGII 543 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~------------------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIv 543 (722)
+++...+..++||||+. ++|.+++....... ....+++..++.++.||+.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 99999999999999997 57888876543211 123489999999999999999999999999
Q ss_pred cccCCCCceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CC
Q 004954 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617 (722)
Q Consensus 544 HrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~ 617 (722)
||||||+|||++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 173 H~dikp~NIli~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 173 HRDLAARNILVAE--GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CCCCSGGGEEEET--TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccchheEEEcC--CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999995 7889999999997654322 22456788999999999899999999999999999999 99
Q ss_pred CCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHH
Q 004954 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697 (722)
Q Consensus 618 ~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~ 697 (722)
.||.+.........+.... ....+ ...++.+.+||.+
T Consensus 251 ~p~~~~~~~~~~~~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~ 287 (314)
T 2ivs_A 251 NPYPGIPPERLFNLLKTGH----------------------------------RMERP---------DNCSEEMYRLMLQ 287 (314)
T ss_dssp CSSTTCCGGGHHHHHHTTC----------------------------------CCCCC---------TTCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHhhcCC----------------------------------cCCCC---------ccCCHHHHHHHHH
Confidence 9998765444433322100 00011 1235678999999
Q ss_pred hcccCCCCCcCHHHHHhC
Q 004954 698 LLEINPQRRPTAREALDH 715 (722)
Q Consensus 698 mL~~dP~kRpTa~ElL~H 715 (722)
||+.||.+|||+.+++++
T Consensus 288 ~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 288 CWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.47 Aligned_cols=250 Identities=19% Similarity=0.295 Sum_probs=198.3
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCC-------cEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg-------~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
.++..++|++.+.||+|+||+||+|++..++ +.||+|++.... ...+.+.+|+.+++.++ ||||++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~ 76 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS------HKHLVL 76 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC------CTTBCC
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC------CCCEeE
Confidence 3456789999999999999999999988777 479999986543 34566778888888775 789999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC
Q 004954 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~ 559 (722)
+++++...+..++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.+..
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 151 (289)
T 4fvq_A 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREED 151 (289)
T ss_dssp EEEEECCTTCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCB
T ss_pred EEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCc
Confidence 9999999999999999998 578887765432 2889999999999999999999999999999999999986222
Q ss_pred ------CeEEEEecCCcccccCCccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHH
Q 004954 560 ------CEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILAR 631 (722)
Q Consensus 560 ------~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~ 631 (722)
+.+||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++| .+||...........
T Consensus 152 ~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 152 RKTGNPPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp GGGTBCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred ccccccceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 12999999998655433 33467899999999987 6789999999999999999995 555555443332222
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 632 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
.. .. ..+|. ..+..+.+||++||+.||.+|||+.+
T Consensus 231 ~~-~~-----------------------------------~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ 265 (289)
T 4fvq_A 231 YE-DR-----------------------------------HQLPA---------PKAAELANLINNCMDYEPDHRPSFRA 265 (289)
T ss_dssp HH-TT-----------------------------------CCCCC---------CSSCTTHHHHHHHSCSSGGGSCCHHH
T ss_pred hh-cc-----------------------------------CCCCC---------CCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 11 00 00111 11234779999999999999999999
Q ss_pred HHhC
Q 004954 712 ALDH 715 (722)
Q Consensus 712 lL~H 715 (722)
+++|
T Consensus 266 ll~~ 269 (289)
T 4fvq_A 266 IIRD 269 (289)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=330.58 Aligned_cols=265 Identities=21% Similarity=0.254 Sum_probs=199.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~----d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
.+..++|++++.||+|+||+||+|+ +..+++.||||++.... .....+.+|+.+++.++ ||||++++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 79 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ------HDNIVKYKGV 79 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEE
Confidence 4567899999999999999999998 66789999999987643 33466778898888875 7899999999
Q ss_pred EEec--CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 485 FYHL--EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 485 f~~~--~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
+... .++++||||+. ++|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~ 152 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--ENR 152 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTE
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC--CCe
Confidence 8654 56899999996 588888765432 2889999999999999999999999999999999999996 789
Q ss_pred EEEEecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 004954 562 IKIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 562 vkL~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~ 635 (722)
+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|..||....... . . .
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~-~---~ 227 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-M-R---M 227 (295)
T ss_dssp EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH-H-H---H
T ss_pred EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH-H-h---h
Confidence 9999999997654321 22346677999999999999999999999999999999999997643221 1 1 1
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.+..+........ ....+. ....... +...++.+.+||++||+.||.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~------------~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 228 IGNDKQGQMIVFH-LIELLK------------NNGRLPR---------PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HCTTCCTHHHHHH-HHHHHH------------TTCCCCC---------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcCccccchhHHH-HHHHHh------------ccCcCCC---------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111111000000 000000 0001111 1234577999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.06 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=202.9
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
++..+.++|++.+.||+|+||.||+|++..+|+.||+|+++... ....+|+++++.++ ||||+++++++..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 75 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLD------HVNIVHYNGCWDG 75 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCC------CTTBCCEEEEEEE
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCC------CCCEEEEeeeEec
Confidence 35567889999999999999999999999999999999998654 35678999998885 7899999999865
Q ss_pred ----------------cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 004954 488 ----------------LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (722)
Q Consensus 488 ----------------~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~ 550 (722)
...+++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 151 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPS 151 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHH
Confidence 4568999999986 88888765432 23889999999999999999999999999999999
Q ss_pred ceEEcccCCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~ 628 (722)
|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.... ..
T Consensus 152 Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~ 227 (284)
T 2a19_B 152 NIFLVD--TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KF 227 (284)
T ss_dssp GEEEEE--TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HH
T ss_pred HEEEcC--CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HH
Confidence 999996 789999999998765443 334578999999999999999999999999999999999998873211 11
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
...+. ...++ ...+..+.+||.+||+.||.+|||
T Consensus 228 ~~~~~-------------------------------------~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps 261 (284)
T 2a19_B 228 FTDLR-------------------------------------DGIIS---------DIFDKKEKTLLQKLLSKKPEDRPN 261 (284)
T ss_dssp HHHHH-------------------------------------TTCCC---------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHhh-------------------------------------ccccc---------ccCCHHHHHHHHHHccCChhhCcC
Confidence 11110 00011 123466889999999999999999
Q ss_pred HHHHHhCCCC
Q 004954 709 AREALDHPWL 718 (722)
Q Consensus 709 a~ElL~HPwf 718 (722)
+.|+++|+|.
T Consensus 262 ~~e~l~~l~~ 271 (284)
T 2a19_B 262 TSEILRTLTV 271 (284)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.53 Aligned_cols=259 Identities=13% Similarity=0.150 Sum_probs=196.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC--------CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccC---------CCCC
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLH--------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND---------PADE 475 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~--------tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~---------~~~h 475 (722)
.++|++.+.||+|+||.||+|++.. .++.||||++... ..+.+|+.+++.+++.+ ...+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5799999999999999999999987 4889999999765 36778999999886421 1123
Q ss_pred CceeEEEEEEEe-cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEE
Q 004954 476 HHILRLYDYFYH-LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (722)
Q Consensus 476 pnIv~l~~~f~~-~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl 554 (722)
.+++++++++.. ....++||||+.++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 344558888887 688999999997789988875421 239999999999999999999999999999999999999
Q ss_pred cccCCCeEEEEecCCcccccCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh
Q 004954 555 KSYQRCEIKIIDLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (722)
Q Consensus 555 ~~~~~~~vkL~DFGls~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~ 624 (722)
+.+....+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9622238999999999654322 123478999999999999999999999999999999999999997643
Q ss_pred --HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccC
Q 004954 625 --VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702 (722)
Q Consensus 625 --~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~d 702 (722)
...+...+...... .+............+..+.+||.+||+.|
T Consensus 273 ~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDK-----------------------------------PGPFVGPCGHWIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp TCHHHHHHHHHHHHHS-----------------------------------CCCEECTTSCEECCCHHHHHHHHHHHTCC
T ss_pred cCHHHHHHHHHhccCC-----------------------------------hhhhhhhccccCCCcHHHHHHHHHHHhCC
Confidence 22222221100000 00000000001123577999999999999
Q ss_pred CCCCcCHHHHHh
Q 004954 703 PQRRPTAREALD 714 (722)
Q Consensus 703 P~kRpTa~ElL~ 714 (722)
|.+|||+.++++
T Consensus 318 p~~Rps~~~l~~ 329 (352)
T 2jii_A 318 YEEKPPYAMLRN 329 (352)
T ss_dssp TTCCCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=333.65 Aligned_cols=257 Identities=18% Similarity=0.242 Sum_probs=206.1
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
..++..++|++.+.||+|+||.||+|++. .+++.||||++.... .....+.+|+.+++.+ .||||++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~ 92 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVR 92 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC------CCTTBCC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc------CCCCEee
Confidence 34566789999999999999999999876 467899999997543 2334566777777666 4789999
Q ss_pred EEEEEEecCeEEEEEEcccc-chHHHHhhhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEc
Q 004954 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~----~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~ 555 (722)
+++++...+..++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 99999999999999999974 888877654321 1122378999999999999999999999999999999999999
Q ss_pred ccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHH
Q 004954 556 SYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 629 (722)
Q Consensus 556 ~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l 629 (722)
. ++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 173 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 173 E--DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp T--TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred C--CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 5 7899999999987543321 22356888999999999999999999999999999999 89999887766665
Q ss_pred HHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCH
Q 004954 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709 (722)
Q Consensus 630 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa 709 (722)
..+..... ... ....+..+.+||.+||+.||.+|||+
T Consensus 251 ~~~~~~~~----------------------------------~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~ 287 (322)
T 1p4o_A 251 RFVMEGGL----------------------------------LDK---------PDNCPDMLFELMRMCWQYNPKMRPSF 287 (322)
T ss_dssp HHHHTTCC----------------------------------CCC---------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHcCCc----------------------------------CCC---------CCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 55431100 000 11234678999999999999999999
Q ss_pred HHHHhC
Q 004954 710 REALDH 715 (722)
Q Consensus 710 ~ElL~H 715 (722)
.|+++|
T Consensus 288 ~e~l~~ 293 (322)
T 1p4o_A 288 LEIISS 293 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=331.45 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=205.3
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
++..++|++.+.||+|+||+||+|.+ ..+++.||||+++... ...+.+.+|+.+++.+. .||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~ 93 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNLL 93 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc-----cCCCeeeEE
Confidence 34567999999999999999999985 4678899999997643 33467788999999984 378999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHhhhhcc------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQES------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
+++...+..++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||+.||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999975 888887754321 1123489999999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCcc-----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~~-----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~ 623 (722)
+|||++. ++.+||+|||++........ ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 174 ~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 174 RNILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GGEEEET--TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceEEEcC--CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999985 78999999999876544322 2346788999999999999999999999999999999 99999775
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 624 ~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
.....+..+.... .....+ ...+..+.+||.+||+.||
T Consensus 252 ~~~~~~~~~~~~~---------------------------------~~~~~~---------~~~~~~l~~li~~~l~~dp 289 (313)
T 1t46_A 252 PVDSKFYKMIKEG---------------------------------FRMLSP---------EHAPAEMYDIMKTCWDADP 289 (313)
T ss_dssp CSSHHHHHHHHHT---------------------------------CCCCCC---------TTSCHHHHHHHHHHTCSSG
T ss_pred cchhHHHHHhccC---------------------------------CCCCCc---------ccCCHHHHHHHHHHcCCCc
Confidence 4333332222100 000001 1234678999999999999
Q ss_pred CCCcCHHHHHhC
Q 004954 704 QRRPTAREALDH 715 (722)
Q Consensus 704 ~kRpTa~ElL~H 715 (722)
.+|||+.|++++
T Consensus 290 ~~Rps~~ell~~ 301 (313)
T 1t46_A 290 LKRPTFKQIVQL 301 (313)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=330.18 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=192.7
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
...+.++|++.+.||+|+||+||+|++ +|+.||||++.... ......|.+++.... ..||||+++++++...
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~----l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVM----LRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTC----CCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhh----ccCcCeeeEEEeeccc
Confidence 456789999999999999999999986 68999999997643 345566777777653 4589999999997653
Q ss_pred ----CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH--------HCCCccccCCCCceEEc
Q 004954 489 ----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--------SLGIIHCDLKPENILIK 555 (722)
Q Consensus 489 ----~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLH--------s~gIvHrDLKp~NILl~ 555 (722)
...++||||+.+ +|.+++... .+++..++.++.||+.||+||| +.||+||||||+|||++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred cCCCceeEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence 568999999985 787777421 2899999999999999999999 99999999999999999
Q ss_pred ccCCCeEEEEecCCcccccCCc-------cccccCCcccCchhhcCC------CCCchhhHHHHHHHHHHHHhC------
Q 004954 556 SYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGL------PYDQKIDLWSLGCILAELWTG------ 616 (722)
Q Consensus 556 ~~~~~~vkL~DFGls~~~~~~~-------~~~~gt~~y~APE~l~~~------~~s~ksDIWSLGviL~elltG------ 616 (722)
. ++.+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 148 ~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 148 K--NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp T--TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred C--CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 5 7899999999987654332 224789999999999876 445799999999999999999
Q ss_pred ----CCCCCCCh----HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCc
Q 004954 617 ----EVLFPNDA----VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 688 (722)
Q Consensus 617 ----~~PF~~~~----~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~ 688 (722)
..||.... ....+..+.... .....+|... .....+
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~----~~~~~~ 269 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVD--------------------------------QQRPNIPNRW----FSDPTL 269 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTS--------------------------------CCCCCCCGGG----GGSHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhcc--------------------------------CCCCCCChhh----ccCccH
Confidence 78875421 111111111000 0011111100 001123
Q ss_pred HHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 689 AFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 689 ~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
..+.+||.+||+.||.+|||+.++++
T Consensus 270 ~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 270 TSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 56899999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.62 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=194.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcE----EEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~----vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+..++|++++.||+|+||+||+|++..+++. ||+|++.... .....+.+|+.+++.++ ||||++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 83 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD------HAHIVRLLGL 83 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC------CTTBCCEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC------CCCcCeEEEE
Confidence 3457899999999999999999999888876 6777664332 22345667788877664 7899999998
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+. ....++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 84 ~~-~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~k 155 (325)
T 3kex_A 84 CP-GSSLQLVTQYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS--PSQVQ 155 (325)
T ss_dssp EC-BSSEEEEEECCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS--SSCEE
T ss_pred Ec-CCccEEEEEeCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECC--CCeEE
Confidence 86 567899999997 57888776432 23889999999999999999999999999999999999985 78899
Q ss_pred EEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 004954 564 IIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 564 L~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg 637 (722)
|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 234 (325)
T 3kex_A 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE- 234 (325)
T ss_dssp ECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-
T ss_pred ECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-
Confidence 9999999865432 223456789999999999999999999999999999999 999998765544443332110
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....|. ..+..+.+||.+||+.||.+|||+.++++|
T Consensus 235 ---------------------------------~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 ---------------------------------RLAQPQ---------ICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------------------BCCCCT---------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------------------CCCCCC---------cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000111 112346799999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=356.69 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=208.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++-..+|++.++||+|+||.||+|.+..+++.||||+++......+.+.+|+.+++.++ ||||+++++++....
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREP 289 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSS
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcC------CCCEeeEEEEEecCC
Confidence 34457899999999999999999999999999999999877666678899999999985 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.++|||||+. ++|.+++..... ..+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG 363 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE--NHLVKVADFG 363 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--GGCEEECCTT
T ss_pred cEEEEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECC--CCcEEEeecc
Confidence 9999999998 588888765322 23889999999999999999999999999999999999986 7889999999
Q ss_pred CcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+....
T Consensus 364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------- 436 (495)
T 1opk_A 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------- 436 (495)
T ss_dssp CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------
T ss_pred cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 998654332 12345678999999999899999999999999999999 999998765544443332110
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...+..+.+||.+||+.||.+|||+.+|++
T Consensus 437 ---------------------------~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 ---------------------------RMERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCC---------CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 00111 123467899999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.67 Aligned_cols=278 Identities=19% Similarity=0.282 Sum_probs=206.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
..+.++|++.++||+|+||+||+|++..+|+.||||+++... ...+...+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~ 78 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN------HKNIVKLFAIEEE 78 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCCCCeEEEeecc
Confidence 456789999999999999999999999999999999997543 23456778999998885 7899999999987
Q ss_pred cC--eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc--cCCCeE
Q 004954 488 LE--HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEI 562 (722)
Q Consensus 488 ~~--~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~--~~~~~v 562 (722)
.. +.++||||+. ++|.+++...... ..+++..++.++.||+.||+|||+.||+||||||+|||+.. +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeE
Confidence 65 7899999997 5777776643322 22899999999999999999999999999999999999821 236779
Q ss_pred EEEecCCcccccCC--ccccccCCcccCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC----ChHHHH
Q 004954 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG--------LPYDQKIDLWSLGCILAELWTGEVLFPN----DAVVMI 628 (722)
Q Consensus 563 kL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~--------~~~s~ksDIWSLGviL~elltG~~PF~~----~~~~e~ 628 (722)
||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+.
T Consensus 156 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp EECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred EEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 99999999765443 234578999999999875 4577899999999999999999999964 223344
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
+.++... .|...+...+.. ......+...+|....+. ...+..+.+||++||++||++|||
T Consensus 236 ~~~~~~~---~p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~l~---~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 236 MYKIITG---KPSGAISGVQKA-------------ENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp HHHHHHS---CCTTCCEEEECS-------------TTCCEEEESSCCTTCSSC---HHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HHHHhcC---CCcccchhheec-------------cCCCcccCccCCcccccc---hHHHhhchHHHHHhhccChhhhcc
Confidence 4444322 121111111000 000111112222222221 122457899999999999999999
Q ss_pred HHHHHhC
Q 004954 709 AREALDH 715 (722)
Q Consensus 709 a~ElL~H 715 (722)
+.+++++
T Consensus 297 ~~e~l~~ 303 (396)
T 4eut_A 297 FDQFFAE 303 (396)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.12 Aligned_cols=247 Identities=24% Similarity=0.304 Sum_probs=191.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.+++.+ .||||+++++++...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL------QEPHVVPIHDFGEID 106 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEET
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc------CCCCeeEEEEEEeeC
Confidence 4789999999999999999999999999999999875432 235566777777665 478999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~--~~~~kl~Df 178 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA--DDFAYLVDF 178 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSC
T ss_pred CeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC--CCCEEEecC
Confidence 999999999985 7777776432 2899999999999999999999999999999999999986 788999999
Q ss_pred CCcccccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 568 Gls~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
|++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.... +.
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~---- 253 (309)
T 2h34_A 179 GIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-PR---- 253 (309)
T ss_dssp CC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC-CC----
T ss_pred ccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC-CC----
Confidence 998765432 223578999999999999999999999999999999999999998876553333222100 00
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-CHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-TAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-Ta~ElL~ 714 (722)
........+..+.+||.+||+.||.+|| |++++++
T Consensus 254 ------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ------------------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ------------------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------------------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0001122345688999999999999999 8888875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.71 Aligned_cols=246 Identities=21% Similarity=0.320 Sum_probs=200.6
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC-
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 489 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~- 489 (722)
+..++|++.+.||+|+||.||+|.+. |+.||||+++... ....+.+|+.+++.++ ||||+++++++....
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLR------HSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCC------CTTBCCEEEEEECTTS
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhcc------CCCEEEEEEEEEcCCC
Confidence 34578999999999999999999874 7899999998754 4467889999998874 789999999987665
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.++|||||+.+ +|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG 334 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 334 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TSCEEECCCT
T ss_pred ceEEEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC--CCCEEEeeCC
Confidence 79999999974 88888875432 23789999999999999999999999999999999999986 7899999999
Q ss_pred CcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 569 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
++...........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 335 ~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----------- 403 (450)
T 1k9a_A 335 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------- 403 (450)
T ss_dssp TCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-----------
T ss_pred CcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 99865554444567889999999999999999999999999999998 999998765554444432110
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...++.+.+||.+||+.||.+|||+.++++
T Consensus 404 -----------------------~~~~p---------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 -----------------------KMDAP---------DGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCC---------CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01111 123567899999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=337.46 Aligned_cols=257 Identities=19% Similarity=0.291 Sum_probs=202.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
+..++|++.+.||+|+||+||+|++ ..+++.||||+++.. ......+.+|+.+++.+. .||||+++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~ 116 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLG 116 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 3457899999999999999999997 346778999999753 234467889999999994 3789999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHhhhhcc-----------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 004954 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQES-----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHC 545 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~-----------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHr 545 (722)
++...+..++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||+.||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999974 888887654321 011237899999999999999999999999999
Q ss_pred cCCCCceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 004954 546 DLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVL 619 (722)
Q Consensus 546 DLKp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~P 619 (722)
||||+|||++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 Dikp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVTH--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEET--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEcC--CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999985 7899999999987554322 22456788999999999999999999999999999998 9999
Q ss_pred CCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhc
Q 004954 620 FPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699 (722)
Q Consensus 620 F~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL 699 (722)
|.+......+..++.. ......| ...++.+.+||.+||
T Consensus 275 ~~~~~~~~~~~~~~~~---------------------------------~~~~~~~---------~~~~~~l~~li~~~l 312 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQN---------------------------------GFKMDQP---------FYATEEIYIIMQSCW 312 (344)
T ss_dssp STTCCCSHHHHHHHHT---------------------------------TCCCCCC---------TTCCHHHHHHHHHHT
T ss_pred cccCCcHHHHHHHHhc---------------------------------CCCCCCC---------CCCCHHHHHHHHHHc
Confidence 9775433333222210 0000011 123467899999999
Q ss_pred ccCCCCCcCHHHHHhCC
Q 004954 700 EINPQRRPTAREALDHP 716 (722)
Q Consensus 700 ~~dP~kRpTa~ElL~HP 716 (722)
+.||.+|||+.++++|.
T Consensus 313 ~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 313 AFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CSSGGGSCCHHHHHHHH
T ss_pred CCCchhCcCHHHHHHHH
Confidence 99999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=332.93 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=205.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEEC-------CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~-------~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
.+..++|++.+.||+|+||+||+|++. .+++.||||+++... .....+.+|+.+++.+. .||||++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~ 105 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIIN 105 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCC
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh-----cCCCEee
Confidence 345689999999999999999999975 467889999997643 34566788999999984 3789999
Q ss_pred EEEEEEecCeEEEEEEcccc-chHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 481 l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~----------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
+++++...+..++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||+.||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 99999999999999999975 8888876543211 123488999999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~ 623 (722)
+|||++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 186 ~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 186 RNVLVTE--NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGEEECT--TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcC--CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999985 7889999999997654432 22356788999999998889999999999999999999 99999887
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 624 ~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
+..++...+..... ...+ ...+..+.+||.+||+.||
T Consensus 264 ~~~~~~~~~~~~~~----------------------------------~~~~---------~~~~~~l~~li~~~l~~dp 300 (334)
T 2pvf_A 264 PVEELFKLLKEGHR----------------------------------MDKP---------ANCTNELYMMMRDCWHAVP 300 (334)
T ss_dssp CHHHHHHHHHHTCC----------------------------------CCCC---------TTCCHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHhcCCC----------------------------------CCCC---------ccCCHHHHHHHHHHccCCh
Confidence 76665544431100 0011 1234678999999999999
Q ss_pred CCCcCHHHHHhC
Q 004954 704 QRRPTAREALDH 715 (722)
Q Consensus 704 ~kRpTa~ElL~H 715 (722)
.+|||+.|++++
T Consensus 301 ~~Rps~~ell~~ 312 (334)
T 2pvf_A 301 SQRPTFKQLVED 312 (334)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=350.11 Aligned_cols=255 Identities=18% Similarity=0.270 Sum_probs=205.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
..+.++|++.++||+|+||.||+|++..+++.||||++..... ..++.+|+++++.+++. ++|+.+..++...+
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~-----~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGG-----TGIPNVRWFGVEGD 76 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTS-----TTCCCEEEEEEETT
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCC-----CCCCeEEEEEeeCC
Confidence 4678999999999999999999999999999999999875443 35678999999999863 47777778888889
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEEEecC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL~DFG 568 (722)
..+|||||+.++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+||||+. ...+.+||+|||
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEEEECCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 9999999998899988875432 2899999999999999999999999999999999999942 137889999999
Q ss_pred CcccccCCcc----------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh---HHHHHHHHHhh
Q 004954 569 SSCFQTDNLC----------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGM 635 (722)
Q Consensus 569 ls~~~~~~~~----------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~---~~e~l~~i~~~ 635 (722)
++........ ...||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.. ..+.+..+...
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 9976554321 4678999999999999999999999999999999999999997643 22333222210
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.-. ..........+..+.+||.+||+.||.+||++.+|++
T Consensus 232 ~~~---------------------------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 232 KVA---------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHH---------------------------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccc---------------------------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 0001111233567999999999999999999998875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.94 Aligned_cols=255 Identities=27% Similarity=0.366 Sum_probs=192.4
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 409 ~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+....++|++.+.||+|+||.||+|.+..+|+.||||+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~ 100 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN------HPNVIKYYAS 100 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC------CCCEeeEEEE
Confidence 334557899999999999999999999999999999998752 334456778888887774 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+...+..++||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+|
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~--~~~~k 176 (310)
T 2wqm_A 101 FIEDNELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVK 176 (310)
T ss_dssp EEETTEEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEE
T ss_pred EEcCCcEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcC--CCCEE
Confidence 9999999999999986 777777643322 223899999999999999999999999999999999999985 78899
Q ss_pred EEecCCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh--HHHHHHHHHhhcCC
Q 004954 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--VVMILARIIGMLGP 638 (722)
Q Consensus 564 L~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~--~~e~l~~i~~~lg~ 638 (722)
|+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+...
T Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 253 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--- 253 (310)
T ss_dssp ECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---
T ss_pred EEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---
Confidence 9999998765433 223568999999999999999999999999999999999999996542 11222221100
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+... ....+..+.+||.+||+.||.+|||+.+++++
T Consensus 254 ----------------------------------~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 254 ----------------------------------DYPPLP-----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ----------------------------------CSCCCC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------------cCCCCc-----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000000 01234678999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.97 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=203.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+..++|++.+.||+|+||.||+|.+. +++.||+|+++......+.+.+|+++++.++ ||||+++++++. .+
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------HQRLVRLYAVVT-QE 80 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEEC-SS
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCC------CcCcceEEEEEc-CC
Confidence 455689999999999999999999974 5778999999876655677889999999885 689999999876 45
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+. ++|.+++...... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg 154 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFG 154 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred CcEEEEecCCCCCHHHHHhcCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC--CCCEEECCCc
Confidence 6899999996 5787777643321 2889999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 228 (279)
T 1qpc_A 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------ 228 (279)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------
T ss_pred ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC------
Confidence 997655432 22345778999999998889999999999999999999 9999988776666555432100
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...+ ...+..+.+||.+||+.||++|||+.++++
T Consensus 229 ----------------------------~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ----------------------------MVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCc---------ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0001 123467899999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=348.88 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=204.8
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+..++|++.+.||+|+||+||+|.+. .+..||||+++......+.+.+|+.+++.++ ||||+++++++. .+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ------HDKLVKLHAVVT-KE 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCC------CTTBCCEEEEEC-SS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCC------CCCEeeEEEEEe-CC
Confidence 445678999999999999999999975 5788999999876656677888999888774 789999999986 67
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+++||||+. |+|.+++...... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DFG 329 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFG 329 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TCCEEECSTT
T ss_pred ccEEEEeecCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC--CCcEEEeeCC
Confidence 8999999997 5888888754322 2788999999999999999999999999999999999996 7899999999
Q ss_pred CcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
+++...... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+++..+.....
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------ 403 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------ 403 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC------
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 997654321 22345778999999998899999999999999999999 9999998877666655432110
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...| ...++.+.+||.+||+.||.+|||+.+|++
T Consensus 404 ----------------------------~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 404 ----------------------------MPRP---------ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCC---------CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 0011 123467899999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.34 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=192.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEE----EEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDV----CLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~v----AvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+..++|++.++||+|+||+||+|++..+++.+ |+|.++... .....+.+|+.+++.++ ||||++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 85 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGI 85 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC------BTTBCCEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC------CCCEeEEEEE
Confidence 34578999999999999999999998887765 777665322 33467788999998885 6899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+.... .++|++|+. ++|.+++..... .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~--~~~~k 157 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVK 157 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEE
T ss_pred EecCC-eEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC--CCCEE
Confidence 98755 678888886 578777765332 2899999999999999999999999999999999999986 78999
Q ss_pred EEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 004954 564 IIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 564 L~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg 637 (722)
|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+.....
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 237 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC
Confidence 99999987654332 22345778999999999999999999999999999999 9999987655444333321100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...+ ...+..+.+||.+||+.||.+|||+.+++++
T Consensus 238 ----------------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 ----------------------------------LPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------------------------------CCCC---------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ----------------------------------CCCC---------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0001 1124568899999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.54 Aligned_cols=241 Identities=29% Similarity=0.420 Sum_probs=185.4
Q ss_pred ecCcEEEE-EEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe---
Q 004954 412 IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (722)
Q Consensus 412 l~~rY~i~-~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--- 487 (722)
+.++|++. +.||+|+||.||++.+..+++.||||+++.. ....+|+.++.++. .||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~-----~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhc-----cCCCchhHHhhhhhhcC
Confidence 44667777 7899999999999999999999999999754 35567888775553 47899999999987
Q ss_pred -cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeEEE
Q 004954 488 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKI 564 (722)
Q Consensus 488 -~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~vkL 564 (722)
....++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++... ++.+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred CCceEEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence 6789999999975 88888775332 2389999999999999999999999999999999999998633 578999
Q ss_pred EecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 565 ~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
+|||++.... +..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 162 ~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~--------- 213 (299)
T 3m2w_A 162 TDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR--------- 213 (299)
T ss_dssp CCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS---------
T ss_pred eccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH---------
Confidence 9999986433 234678999999999999999999999765432221110000
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
........|. ......+..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 214 ----------------------~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 214 ----------------------IRMGQYEFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp ----------------------SCTTCCSSCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ----------------------HhhccccCCc-----hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 0000000110 011234577999999999999999999999999999965
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.77 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=188.1
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 408 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
.+++..++|++.++||+|+||+||++++. ..+|+|+++... .....+.+|+.+++.++ ||||++++++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 88 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR------HVNILLFMGY 88 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCC------CCcEEEEEee
Confidence 35677899999999999999999999853 359999987542 33455677887777664 7899999995
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
......++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 89 -~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~--~~~~k 160 (289)
T 3og7_A 89 -STAPQLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE--DNTVK 160 (289)
T ss_dssp -ECSSSCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TTEEE
T ss_pred -ccCCccEEEEEecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC--CCCEE
Confidence 456678999999974 6766664332 23899999999999999999999999999999999999996 78999
Q ss_pred EEecCCcccccC-----CccccccCCcccCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 004954 564 IIDLGSSCFQTD-----NLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 564 L~DFGls~~~~~-----~~~~~~gt~~y~APE~l~---~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~ 635 (722)
|+|||++..... ......+|+.|+|||++. +..++.++||||||+++|+|++|+.||.+....+.+..++..
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 999999875432 123357899999999997 667889999999999999999999999875444433333211
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.... + .+.......+..+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~-----------------------------------~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 GSLS-----------------------------------P---DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSCC-----------------------------------C---CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccC-----------------------------------c---chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000 0 000111223567999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.01 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=200.5
Q ss_pred cCcEEEEE-EeccCCCCceEEEEEC--CCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTE-YLGSAAFSKVFQAQDL--HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~-~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.++|.+.+ .||+|+||.||+|.+. .+++.||||+++.. ......+.+|+.+++.++ ||||+++++++ .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~-~ 80 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVC-Q 80 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEE-E
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC------CCCEeEEEEEe-c
Confidence 56788887 9999999999999863 57889999999863 344567888999999884 78999999999 5
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~D 153 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISD 153 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC--CCCEEECc
Confidence 6679999999985 6777665321 23899999999999999999999999999999999999986 78999999
Q ss_pred cCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 567 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 567 FGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--- 230 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--- 230 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC---
Confidence 99997654322 22345788999999998889999999999999999998 999998776655554443110
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
...+| ...++.+.+||.+||+.||.+|||+.++++|.
T Consensus 231 -------------------------------~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 -------------------------------RMECP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp -------------------------------CCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -------------------------------cCCCC---------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00111 12356799999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.45 Aligned_cols=247 Identities=20% Similarity=0.315 Sum_probs=192.4
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~- 488 (722)
.+..++|++.+.||+|+||+||++.+ +|+.||||+++... ..+.+.+|+.+++.++ ||||+++++++...
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLR------HSNLVQLLGVIVEEK 87 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCC------CTTBCCEEEEECCC-
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhCC------CCCEeeEEEEEEcCC
Confidence 34468899999999999999999986 48899999997654 3456778888887764 78999999997654
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+..++||||+.+ +|.+++...... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Df 161 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDF 161 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHH----HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCC
T ss_pred CceEEEEecCCCCCHHHHHHhcccc----cCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC--CCcEEEeec
Confidence 578999999975 888887654321 2788999999999999999999999999999999999985 788999999
Q ss_pred CCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 568 Gls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
|++...........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+...
T Consensus 162 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 230 (278)
T 1byg_A 162 GLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------- 230 (278)
T ss_dssp CC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------
T ss_pred cccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------
Confidence 999876665555677899999999999999999999999999999998 99999876544443332210
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.....+ ...++.+.+||++||+.||.+|||+.++++
T Consensus 231 -----------------------~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 -----------------------YKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -----------------------CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCc---------ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 000111 123567899999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.33 Aligned_cols=253 Identities=17% Similarity=0.242 Sum_probs=194.1
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECC---CCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~---tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
..++|++.+.||+|+||+||+|.+.. +++.||+|+++.. ......+.+|+.+++.++ ||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~ 105 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS------HPNVIRLLGVC 105 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC------CTTBCCCCEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC------CCCeeeeeEEE
Confidence 35789999999999999999998754 5668999998753 233456777888887774 78999999999
Q ss_pred EecC-----eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC
Q 004954 486 YHLE-----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (722)
Q Consensus 486 ~~~~-----~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~ 559 (722)
.... ..++||||+.+ +|.+++...........+++..++.++.||+.||.|||+.||+||||||+|||++. +
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD--D 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT--T
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--C
Confidence 8764 45999999985 78777765544344456999999999999999999999999999999999999986 7
Q ss_pred CeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHH
Q 004954 560 CEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 633 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~ 633 (722)
+.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 88999999998765432 223456788999999999999999999999999999999 999998765544443332
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
.... ...+ ...+..+.+||.+||+.||.+|||+.+++
T Consensus 264 ~~~~----------------------------------~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 300 (313)
T 3brb_A 264 HGHR----------------------------------LKQP---------EDCLDELYEIMYSCWRTDPLDRPTFSVLR 300 (313)
T ss_dssp TTCC----------------------------------CCCB---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred cCCC----------------------------------CCCC---------ccccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 1100 0011 12346789999999999999999999998
Q ss_pred hC
Q 004954 714 DH 715 (722)
Q Consensus 714 ~H 715 (722)
++
T Consensus 301 ~~ 302 (313)
T 3brb_A 301 LQ 302 (313)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.12 Aligned_cols=268 Identities=20% Similarity=0.249 Sum_probs=201.8
Q ss_pred eeeCceecCcEEEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCcee
Q 004954 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (722)
Q Consensus 406 i~~~~~l~~rY~i~~~LG~G~fG~Vy~a~----d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv 479 (722)
+........+|++++.||+|+||.||+|+ +..+++.||+|+++... .....+.+|+.+++.++ ||||+
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~ 86 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY------HENIV 86 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC------CTTBC
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC------CCCee
Confidence 34445567889999999999999999998 67789999999997543 23456778888888875 78999
Q ss_pred EEEEEEEec--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 480 RLYDYFYHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 480 ~l~~~f~~~--~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
++++++... ..+++||||+.+ +|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~ 161 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 161 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC
Confidence 999999877 679999999975 78777754432 2899999999999999999999999999999999999986
Q ss_pred cCCCeEEEEecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 004954 557 YQRCEIKIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~ 630 (722)
++.+||+|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++|..|+..... .
T Consensus 162 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~-- 235 (302)
T 4e5w_A 162 --EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--L-- 235 (302)
T ss_dssp --TTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--H--
T ss_pred --CCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--H--
Confidence 7899999999997654332 234577889999999999999999999999999999999998754321 1
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
+....++........ ....... ....... ....++.+.+||++||+.||.+|||+.
T Consensus 236 -~~~~~~~~~~~~~~~--~~~~~~~------------~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ 291 (302)
T 4e5w_A 236 -FLKMIGPTHGQMTVT--RLVNTLK------------EGKRLPC---------PPNCPDEVYQLMRKCWEFQPSNRTSFQ 291 (302)
T ss_dssp -HHHHHCSCCGGGHHH--HHHHHHH------------TTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred -HhhccCCcccccCHH--HHHHHHh------------ccCCCCC---------CCCCCHHHHHHHHHHcCCCCCCCCCHH
Confidence 111122221111000 0000000 0000111 123457799999999999999999999
Q ss_pred HHHh
Q 004954 711 EALD 714 (722)
Q Consensus 711 ElL~ 714 (722)
++++
T Consensus 292 ~ll~ 295 (302)
T 4e5w_A 292 NLIE 295 (302)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=328.97 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=196.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCC----cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg----~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
++...+|++.+.||+|+||+||+|.+..++ ..||||+++... .....+.+|+.+++.++ ||||+++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 113 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS------HHNIIRLEG 113 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 445678999999999999999999876543 469999997542 23445677888887774 789999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
++...+..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~ 186 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVC 186 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCE
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC--CCcE
Confidence 99999999999999985 7777765432 23899999999999999999999999999999999999985 7899
Q ss_pred EEEecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 004954 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 563 kL~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~ 635 (722)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......++...+...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 999999987654321 12345778999999999999999999999999999999 99999887766665554321
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.. .+. ....+..+.+||.+||+.||.+||++.+++++
T Consensus 267 ~~------------------------------------~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 FR------------------------------------LPT-------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CC------------------------------------CCC-------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred Cc------------------------------------CCC-------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 000 01234678999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=320.99 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=197.4
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECC---CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~---tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
.+..++|++.+.||+|+||+||+|++.. ++..||+|++... ......+.+|+.+++.++ ||||++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~ 81 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD------HPHIVKLIGI 81 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC------CTTBCCEEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC------CCCcceEEEE
Confidence 3456889999999999999999998643 3456999998764 334567888999999985 7899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+.. +..++||||+. ++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+|
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~k 153 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS--PECVK 153 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE--TTEEE
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC--CCcEE
Confidence 764 45689999998 477777764332 2889999999999999999999999999999999999986 78999
Q ss_pred EEecCCcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 564 IIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 564 L~DFGls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....
T Consensus 154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-- 231 (281)
T 3cc6_A 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-- 231 (281)
T ss_dssp ECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC--
T ss_pred eCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC--
Confidence 99999987654332 23456788999999999999999999999999999998 999997654444333322110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...++.+.+||.+||+.||.+|||+.|++++
T Consensus 232 --------------------------------~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 232 --------------------------------RLPKP---------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp --------------------------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------------CCCCC---------CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 00001 1234678999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.86 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=201.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEE--EEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDV--CLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~v--AvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.++|++.+.||+|+||.||+|++..++..+ |+|+++.. ......+.+|+.+++.+. .||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHR 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEET
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc-----CCCchhhhceeeeeC
Confidence 478999999999999999999998888865 99988753 233456778888887773 478999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~----------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~ 557 (722)
+..++||||+.+ +|.+++..... ......+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~- 177 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE- 177 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG-
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC-
Confidence 999999999964 88888765431 011234899999999999999999999999999999999999986
Q ss_pred CCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHh
Q 004954 558 QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG 634 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~ 634 (722)
++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 178 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 178 -NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp -GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred -CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 778999999998643322 233456889999999998889999999999999999998 9999988776655544321
Q ss_pred hcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.. ....| ...+..+.+||.+||+.||.+|||+.++++
T Consensus 257 ~~----------------------------------~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 257 GY----------------------------------RLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILV 293 (327)
T ss_dssp TC----------------------------------CCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC----------------------------------CCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 10 00011 123467899999999999999999999997
Q ss_pred C
Q 004954 715 H 715 (722)
Q Consensus 715 H 715 (722)
+
T Consensus 294 ~ 294 (327)
T 1fvr_A 294 S 294 (327)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.31 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=204.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCc-----EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV-----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~-----~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
++..++|++.+.||+|+||+||+|.+..+++ .||+|+++... .....+.+|+.+++.+. .||||++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 116 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-----QHENIVNLL 116 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc-----CCCCeeeEE
Confidence 3446789999999999999999999877664 79999997643 34566789999999984 378999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHhhhhccC--------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceE
Q 004954 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESG--------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~--------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NIL 553 (722)
+++...+..++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 999999999999999975 8888876543210 1223789999999999999999999999999999999999
Q ss_pred EcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHH
Q 004954 554 IKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVM 627 (722)
Q Consensus 554 l~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e 627 (722)
++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 197 ~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 197 LTN--GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EEG--GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred ECC--CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 986 7899999999987543321 22345778999999999999999999999999999999 999998754333
Q ss_pred HHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc
Q 004954 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707 (722)
Q Consensus 628 ~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp 707 (722)
.+..+.... .....| ...+..+.+||.+||+.||.+||
T Consensus 275 ~~~~~~~~~---------------------------------~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rp 312 (333)
T 2i1m_A 275 KFYKLVKDG---------------------------------YQMAQP---------AFAPKNIYSIMQACWALEPTHRP 312 (333)
T ss_dssp HHHHHHHHT---------------------------------CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHhcC---------------------------------CCCCCC---------CCCCHHHHHHHHHHhccChhhCc
Confidence 332222100 000001 12346789999999999999999
Q ss_pred CHHHHHhC
Q 004954 708 TAREALDH 715 (722)
Q Consensus 708 Ta~ElL~H 715 (722)
|+.+++++
T Consensus 313 s~~~l~~~ 320 (333)
T 2i1m_A 313 TFQQICSF 320 (333)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=315.93 Aligned_cols=246 Identities=16% Similarity=0.180 Sum_probs=194.6
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+..++|++.+.||+|+||+||+|++ .++.+|||+++... .....+.+|+.+++ ...||||+++++++..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~------~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR------IFSHPNVLPVLGACQS 78 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGC------CCSCTTEECEEEEECT
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHH------hcCCCchhheEEEEcc
Confidence 3457899999999999999999997 48899999997643 22233444444444 4468999999999988
Q ss_pred c--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCCCeE
Q 004954 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 488 ~--~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~~~v 562 (722)
. ...++||||+.+ +|.+++.... ...+++..++.++.||+.||+|||+.| |+||||||+|||++. ++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~ 152 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE--DMTA 152 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT--TSCE
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcC--Ccce
Confidence 7 789999999985 8888876432 224899999999999999999999999 999999999999995 7788
Q ss_pred EEEecCCcccccCCccccccCCcccCchhhcCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQ---KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 563 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~---ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
+|+|||++..... ....+|+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 153 ~l~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-- 228 (271)
T 3kmu_A 153 RISMADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-- 228 (271)
T ss_dssp EEEGGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC--
T ss_pred eEEeccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC--
Confidence 9988887654332 2346899999999998766554 79999999999999999999988776665544431100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...+| ...+..+.+||.+||+.||.+|||+.++++
T Consensus 229 -------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 229 -------------------------------RPTIP---------PGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -------------------------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------------CCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00111 123567899999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=345.22 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=201.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+..++|++.+.||+|+||+||+|.+.. +..||||+++......+.+.+|+.+++.++ ||||+++++++.. +
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVSE-E 251 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-S
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEcC-C
Confidence 4456789999999999999999999864 567999999876555567889999999885 7899999999865 7
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
..++||||+. |+|.+++...... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG 325 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFG 325 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC--CCCEEECCCc
Confidence 7899999997 5888887643322 2889999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+.....
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------ 399 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------ 399 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 997654321 22345778999999999999999999999999999999 9999998877666655532110
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...| ...++.+.+||.+||+.||.+|||++++++.
T Consensus 400 ----------------------------~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 400 ----------------------------MPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp ----------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011 1234678999999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.81 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=201.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
...++|++.+.||+|+||+||+|++ ..+++.||||+++... .....+.+|+.+++.+.+ ||||+++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-----hp~iv~~~~ 98 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLG 98 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhccc-----CCCeeeEEE
Confidence 4468999999999999999999985 4577899999997643 234567889999999853 789999999
Q ss_pred EEEecC-eEEEEEEcccc-chHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 004954 484 YFYHLE-HLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (722)
Q Consensus 484 ~f~~~~-~l~iVmEy~~g-sLl~~l~~~~~~~----------~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~N 551 (722)
++...+ .+++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988754 59999999984 7888776543210 01237899999999999999999999999999999999
Q ss_pred eEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChH
Q 004954 552 ILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAV 625 (722)
Q Consensus 552 ILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~ 625 (722)
|+++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 179 il~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 179 ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EEECG--GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EEECC--CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99985 7889999999987654322 22456889999999999999999999999999999998 9999976543
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
...+...+... .....| ...++.+.++|.+||+.||.+
T Consensus 257 ~~~~~~~~~~~---------------------------------~~~~~~---------~~~~~~l~~li~~~l~~dp~~ 294 (316)
T 2xir_A 257 DEEFCRRLKEG---------------------------------TRMRAP---------DYTTPEMYQTMLDCWHGEPSQ 294 (316)
T ss_dssp SHHHHHHHHHT---------------------------------CCCCCC---------TTCCHHHHHHHHHHTCSSGGG
T ss_pred hHHHHHHhccC---------------------------------ccCCCC---------CCCCHHHHHHHHHHcCCChhh
Confidence 22222211000 000011 123467899999999999999
Q ss_pred CcCHHHHHhC
Q 004954 706 RPTAREALDH 715 (722)
Q Consensus 706 RpTa~ElL~H 715 (722)
|||+.|+++|
T Consensus 295 Rps~~ell~~ 304 (316)
T 2xir_A 295 RPTFSELVEH 304 (316)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.99 Aligned_cols=244 Identities=20% Similarity=0.241 Sum_probs=197.2
Q ss_pred cCcEEEEE-EeccCCCCceEEEE--ECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTE-YLGSAAFSKVFQAQ--DLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~-~LG~G~fG~Vy~a~--d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
.++|++.+ .||+|+||+||+|. +..+++.||||+++... .....+.+|+.+++.++ ||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~- 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD------NPYIVRMIGIC- 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC------CTTBCCEEEEE-
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC------CCCEEEEEEEE-
Confidence 47899998 99999999999995 46678999999997542 23456778888888774 78999999998
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+..++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~--~~~~kl~ 159 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKIS 159 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC--CCcEEEc
Confidence 6678899999997 57777776432 2889999999999999999999999999999999999996 7899999
Q ss_pred ecCCcccccCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 566 DLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 566 DFGls~~~~~~~~------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|||++........ ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+....
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-- 237 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-- 237 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--
Confidence 9999876543321 2345688999999998889999999999999999999 999998877666554443110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...+..+.+||.+||+.||.+|||+.++++
T Consensus 238 --------------------------------~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 --------------------------------RMGCP---------AGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --------------------------------CCCCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------------CCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011 123567899999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.05 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=191.3
Q ss_pred eecCcEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~---~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
+...+|++.+.||+|+||.||+|++. .++..||||+++.. ......+.+|+.+++.+ .||||+++++++
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~ 115 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF------DHPNIIRLEGVV 115 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEE
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEE
Confidence 44578999999999999999999876 46778999999754 23345677788887766 478999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 486 ~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
......++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kl 188 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS--NLVCKV 188 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEE
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC--CCCEEE
Confidence 99999999999996 57877776432 23899999999999999999999999999999999999985 789999
Q ss_pred EecCCcccccCCcc------ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 004954 565 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 565 ~DFGls~~~~~~~~------~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg 637 (722)
+|||++........ ...+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.....
T Consensus 189 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~ 268 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268 (373)
T ss_dssp CCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred CcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999976543321 1234678999999999999999999999999999998 9999988776665544431100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
.+. ....+..+.+||.+||+.||.+||++.++++
T Consensus 269 ------------------------------------~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 269 ------------------------------------LPP-------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------------------------CCC-------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------------CCC-------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 000 0123467899999999999999999999886
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.32 Aligned_cols=248 Identities=21% Similarity=0.273 Sum_probs=191.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEE----EEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDV----CLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~v----AvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+..++|+++++||+|+||+||+|++..+++.+ |+|.+... ......+.+|+.+++.++ ||||++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~ 85 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGI 85 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC------BTTBCCCCEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC------CCCeeEEEEE
Confidence 34588999999999999999999998888765 55655432 234456778888887764 7899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+.... .++||+|+. ++|.+++..... .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~k 157 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVK 157 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEE
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC--CCCEE
Confidence 98765 778888886 578877765432 2899999999999999999999999999999999999986 78899
Q ss_pred EEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 004954 564 IIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 564 L~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg 637 (722)
|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+.....
T Consensus 158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 237 (327)
T 3lzb_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237 (327)
T ss_dssp ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999997654321 22345778999999999999999999999999999999 9999987655444433321100
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...+ ...+..+.+||++||+.||.+|||+.|+++.
T Consensus 238 ----------------------------------~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 238 ----------------------------------LPQP---------PICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------------------------------CCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------------CCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0001 1234568899999999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.28 Aligned_cols=262 Identities=20% Similarity=0.269 Sum_probs=197.1
Q ss_pred CCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 401 ~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
....|......+.++|++.+.||+|+||.||+|++. ++.||||++..... .....|.+++..+ ...||||++
T Consensus 24 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~----~~~h~~i~~ 95 (337)
T 3mdy_A 24 GSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTV----LMRHENILG 95 (337)
T ss_dssp CSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTST----TCCCTTBCC
T ss_pred CCCCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHH----hhcCCCeee
Confidence 445666777788899999999999999999999874 89999999975543 3444555555443 246999999
Q ss_pred EEEEEEec----CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC--------CCccccC
Q 004954 481 LYDYFYHL----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--------GIIHCDL 547 (722)
Q Consensus 481 l~~~f~~~----~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~--------gIvHrDL 547 (722)
+++++... ...++||||+.+ +|.+++... .+++..++.++.|++.||.|||+. ||+||||
T Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Di 168 (337)
T 3mdy_A 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168 (337)
T ss_dssp EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCC
T ss_pred EEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEeccc
Confidence 99999987 789999999975 788877532 289999999999999999999998 9999999
Q ss_pred CCCceEEcccCCCeEEEEecCCcccccCCc-------cccccCCcccCchhhcCCCCCch------hhHHHHHHHHHHHH
Q 004954 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLPYDQK------IDLWSLGCILAELW 614 (722)
Q Consensus 548 Kp~NILl~~~~~~~vkL~DFGls~~~~~~~-------~~~~gt~~y~APE~l~~~~~s~k------sDIWSLGviL~ell 614 (722)
||+|||++. ++.+||+|||++....... ....||+.|+|||++.+..+... +|||||||++|+|+
T Consensus 169 kp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 246 (337)
T 3mdy_A 169 KSKNILVKK--NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246 (337)
T ss_dssp CGGGEEECT--TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH
T ss_pred chHHEEECC--CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH
Confidence 999999985 7899999999986543322 23578999999999988776654 99999999999999
Q ss_pred hC----------CCCCCCCh----HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchh
Q 004954 615 TG----------EVLFPNDA----VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSL 680 (722)
Q Consensus 615 tG----------~~PF~~~~----~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l 680 (722)
+| +.||.... ....+..+.. .......+|....
T Consensus 247 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~- 293 (337)
T 3mdy_A 247 RRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC--------------------------------IKKLRPSFPNRWS- 293 (337)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT--------------------------------TSCCCCCCCGGGG-
T ss_pred hccCcccccccccccHhhhcCCCCchhhhHHHHh--------------------------------hhccCccccccch-
Confidence 99 55554321 0011111100 0011111111100
Q ss_pred hhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 681 EHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 681 ~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....+..+.+||.+||+.||.+|||+.++++|
T Consensus 294 ---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 294 ---SDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp ---GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 01123568999999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.24 Aligned_cols=268 Identities=21% Similarity=0.233 Sum_probs=199.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
....++|++.+.||+|+||+||+|++ .+|+.||||++.... .....+.+|+.+++.+ .||||+++++++...
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC------RHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC------CCTTBCCEEEECCCT
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC------CCCCEeeEEEEEcCC
Confidence 34568899999999999999999996 578999999887543 3345566777776655 488999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+..++||||+.+ +|.+++.... .....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Df 183 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSD--LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE--NFVPKITDF 183 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSC--CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT--TCCEEECCC
T ss_pred CeEEEEEEcCCCCcHHHHHhccC--CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC--CCCEEEeec
Confidence 999999999975 7766654322 12234899999999999999999999999999999999999985 789999999
Q ss_pred CCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 568 GSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 568 Gls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~---------- 253 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA---------- 253 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH----------
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH----------
Confidence 998754322 22346899999999999889999999999999999999999999764321111000
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.+.... . ....+...+.... ........+..+.+||.+||+.||++|||+.|+++|
T Consensus 254 ~~~~~~-----~-----------~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 254 EWAVES-----H-----------NNGQLEQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HHTHHH-----H-----------TTTCCCSSSSSSC-TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhhc-----c-----------ccccHHHhcChhh-ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000000 0 0000000000000 000011123568999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.75 Aligned_cols=262 Identities=21% Similarity=0.251 Sum_probs=199.9
Q ss_pred cCcEEEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY- 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~----d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~- 486 (722)
.++|++.+.||+|+||.||+++ +..+++.||||++.... .....+.+|+++++.++ ||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH------SDFIVKYRGVSYG 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEEEC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC------CCceeEEEEEEec
Confidence 4789999999999999999998 57789999999997643 33456788999888874 789999999987
Q ss_pred -ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 487 -HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 487 -~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
.....++||||+. ++|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~--~~~~kl 168 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES--EAHVKI 168 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEE
T ss_pred CCCceEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC--CCCEEE
Confidence 4567999999996 578777765432 2899999999999999999999999999999999999986 788999
Q ss_pred EecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 565 ~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||........... .....
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~ 246 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERD 246 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccc
Confidence 9999997654322 224567889999999998899999999999999999999999976543221110 00000
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.+. .....+... ....... ....++.+.+||++||+.||.+|||+.|++++
T Consensus 247 ~~~-----~~~~~~~~~------------~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 247 VPA-----LSRLLELLE------------EGQRLPA---------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCH-----HHHHHHHHH------------TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccc-----HHHHHHHhh------------cccCCCC---------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 000000000 0000001 12345779999999999999999999999754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.40 Aligned_cols=255 Identities=16% Similarity=0.204 Sum_probs=192.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccC----------CC------
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKND----------PA------ 473 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~----------~~------ 473 (722)
..|++.+.||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.+++.. ..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35889999999999999999999999999999987322 22456778888888776421 00
Q ss_pred CCCceeEEEEEEEe-----cCeEEEEEEccccchHHHHhhhhc-cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 004954 474 DEHHILRLYDYFYH-----LEHLFIVCELLRANLYEFQKFNQE-SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547 (722)
Q Consensus 474 ~hpnIv~l~~~f~~-----~~~l~iVmEy~~gsLl~~l~~~~~-~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDL 547 (722)
..++...+..++.. ....+++|+++.++|.+++..... ......+++..++.|+.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 00111112222222 235789999999999988864322 122344788899999999999999999999999999
Q ss_pred CCCceEEcccCCCeEEEEecCCcccccCCccccccCCcccCchhh----------cCCCCCchhhHHHHHHHHHHHHhCC
Q 004954 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI----------IGLPYDQKIDLWSLGCILAELWTGE 617 (722)
Q Consensus 548 Kp~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l----------~~~~~s~ksDIWSLGviL~elltG~ 617 (722)
||+||||+. ++.+||+|||+++.........+| +.|+|||++ .+..++.++|||||||++|+|++|+
T Consensus 238 Kp~NILl~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLDQ--RGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEECT--TCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEec--CCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 999999996 778999999999877666666778 999999999 5556888999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHH
Q 004954 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697 (722)
Q Consensus 618 ~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~ 697 (722)
.||...+..+... ..++. ....++.+.+||.+
T Consensus 315 ~Pf~~~~~~~~~~-----------------------------------------~~~~~-------~~~~~~~~~~li~~ 346 (413)
T 3dzo_A 315 LPNTDDAALGGSE-----------------------------------------WIFRS-------CKNIPQPVRALLEG 346 (413)
T ss_dssp CCCCTTGGGSCSG-----------------------------------------GGGSS-------CCCCCHHHHHHHHH
T ss_pred CCCCCcchhhhHH-----------------------------------------HHHhh-------cccCCHHHHHHHHH
Confidence 9997653211000 00000 01234678999999
Q ss_pred hcccCCCCCcCHHHHHhCCCCC
Q 004954 698 LLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 698 mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
||+.||.+|||+.++|+||||+
T Consensus 347 ~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 347 FLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HTCSSGGGSCCHHHHTTSHHHH
T ss_pred HccCChhhCcCHHHHHhCHHHH
Confidence 9999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.33 Aligned_cols=207 Identities=20% Similarity=0.311 Sum_probs=173.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEE-----EECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a-----~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
.+..++|++.++||+|+||+||+| .+..+++.||||+++... ...+..|..+++.++.. .|+||++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~---~~~~iv~~~~~ 135 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPS---MQHMFMKFYSA 135 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGG---GGGGBCCEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhh---hhhhhhhhhee
Confidence 344688999999999999999999 467889999999997654 35677888888888643 58999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-------
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS------- 556 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~------- 556 (722)
+...+..++||||+. |+|.+++..... .....+++..++.|+.||+.||+|||++||+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999997 578888765432 12334999999999999999999999999999999999999974
Q ss_pred --cCCCeEEEEecCCccccc-----CCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004954 557 --YQRCEIKIIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (722)
Q Consensus 557 --~~~~~vkL~DFGls~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~ 622 (722)
..++.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 125789999999996532 123346789999999999999999999999999999999999999854
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=324.03 Aligned_cols=244 Identities=27% Similarity=0.369 Sum_probs=187.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
.++|++.+.||+|+||+||++++ .++.||||++.... ....+.+|+++++.++ ||||+++++++. +..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------hp~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-ERKAFIVELRQLSRVN------HPNIVKLYGACL--NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-HHHHHHHHHHHHHHCC------CTTBCCEEEBCT--TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-HHHHHHHHHHHHhcCC------CCCcCeEEEEEc--CCcE
Confidence 47899999999999999999986 47899999997543 3467788999998885 789999999876 4589
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH---CCCccccCCCCceEEcccCCC-eEEEEec
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS---LGIIHCDLKPENILIKSYQRC-EIKIIDL 567 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs---~gIvHrDLKp~NILl~~~~~~-~vkL~DF 567 (722)
+||||+.+ +|.+++..... ...++...++.++.||+.||.|||+ .||+||||||+|||++. ++ .+||+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~~kl~Df 150 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDF 150 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET--TTTEEEECCC
T ss_pred EEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC--CCCEEEEccc
Confidence 99999975 77777764321 1237889999999999999999999 89999999999999985 44 4899999
Q ss_pred CCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh--HHHHHHHHHhhcCCCcHHHHh
Q 004954 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--VVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 568 Gls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~--~~e~l~~i~~~lg~~~~~~~~ 645 (722)
|++...........+|+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+...
T Consensus 151 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 220 (307)
T 2eva_A 151 GTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG---------- 220 (307)
T ss_dssp CC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT----------
T ss_pred ccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC----------
Confidence 999876665556679999999999999999999999999999999999999997532 11111111100
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+. .....+..+.+||.+||+.||.+|||+.+++++
T Consensus 221 ---------------------------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 221 ---------------------------TRPP------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ---------------------------CCCC------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCC------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0000 011234678999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.92 Aligned_cols=248 Identities=24% Similarity=0.295 Sum_probs=192.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECC-CCc--EEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLH-TGV--DVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~-tg~--~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
..++|++.+.||+|+||+||+|++.. +++ .||||+++.. ....+.+.+|+++++.++ ||||++++++
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 89 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD------HRNLIRLYGV 89 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC------CCCcccEEEE
Confidence 45789999999999999999998643 333 6899998753 234567778899888884 7899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+.... .++||||+. ++|.+++..... .+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.+|
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~--~~~~k 161 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVK 161 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEE
T ss_pred EccCC-ceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC--CCCEE
Confidence 88755 889999997 578887765432 2889999999999999999999999999999999999986 78899
Q ss_pred EEecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 004954 564 IIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 564 L~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~l 636 (722)
|+|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+.+..+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 99999987654332 22456778999999998889999999999999999999 999998887766665553211
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+ +. ....+..+.+||.+||+.||.+|||+.+++++
T Consensus 242 ~~~-----------------------------------~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 242 ERL-----------------------------------PR-------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CCC-----------------------------------CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-----------------------------------CC-------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 100 00 11234678999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=335.45 Aligned_cols=271 Identities=20% Similarity=0.247 Sum_probs=197.8
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
....++|++.+.||+|+||+||+|.+ .+|+.||||++..... ....+.+|+.+++.+ .||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA------VHRNLLRLRGFCMT 98 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC------CCTTBCCCCEEECC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc------cCCCccceEEEEec
Confidence 45578899999999999999999984 5789999999876432 223456777766555 47899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC---CCccccCCCCceEEcccCCCeEE
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---GIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~---gIvHrDLKp~NILl~~~~~~~vk 563 (722)
....++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~--~~~~k 174 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAV 174 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT--TCCEE
T ss_pred CCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC--CCCEE
Confidence 9999999999975 77777764332 233489999999999999999999999 9999999999999995 78999
Q ss_pred EEecCCcccccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 564 IIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 564 L~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .....
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~ 247 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN-------DDDVM 247 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT-------TSCSB
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc-------ccchh
Confidence 9999999765432 223458999999999998889999999999999999999999995321000 00000
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 716 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HP 716 (722)
..+++.. .... .......... ............+.+||.+||+.||.+|||+.|+|+|-
T Consensus 248 ~~~~~~~------~~~~-----------~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 248 LLDWVKG------LLKE-----------KKLEALVDVD-LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp HHHHHTT------TTSS-----------CCSTTSSCTT-CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHHHHHH------Hhhc-----------hhhhhhcChh-hccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 0000000 0000 0000000000 00000111235689999999999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=324.66 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=194.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe---
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--- 487 (722)
..++|++.+.||+|+||.||++++..+|+.||||++... ......+.+|+.+++.++ ||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN------HPNILRLVAYCLRERG 100 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC------CTTBCCCCEEEEEEET
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC------CCCeeeEEEEEEeccC
Confidence 357899999999999999999999999999999988653 344566778888888774 7899999999973
Q ss_pred -cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 488 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 488 -~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
....++||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~--~~~~kl~ 176 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD--EGQPVLM 176 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEEC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCCEEEE
Confidence 3578999999986 787777654322 234899999999999999999999999999999999999985 7889999
Q ss_pred ecCCcccccCCc------------cccccCCcccCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCChHH--HH
Q 004954 566 DLGSSCFQTDNL------------CLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPNDAVV--MI 628 (722)
Q Consensus 566 DFGls~~~~~~~------------~~~~gt~~y~APE~l~~~~---~s~ksDIWSLGviL~elltG~~PF~~~~~~--e~ 628 (722)
|||++....... ....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... ..
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 999886543211 1235699999999997654 688999999999999999999999431100 00
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC
Q 004954 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708 (722)
Q Consensus 629 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT 708 (722)
...+. . ....|. ....+..+.+||.+||+.||.+|||
T Consensus 257 ~~~~~----------------------------------~--~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps 293 (317)
T 2buj_A 257 ALAVQ----------------------------------N--QLSIPQ-------SPRHSSALWQLLNSMMTVDPHQRPH 293 (317)
T ss_dssp HHHHH----------------------------------C--C--CCC-------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hHHhh----------------------------------c--cCCCCc-------cccCCHHHHHHHHHHhhcChhhCCC
Confidence 00000 0 000111 0123467999999999999999999
Q ss_pred HHHHHhC
Q 004954 709 AREALDH 715 (722)
Q Consensus 709 a~ElL~H 715 (722)
+.+++++
T Consensus 294 ~~~ll~~ 300 (317)
T 2buj_A 294 IPLLLSQ 300 (317)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.23 Aligned_cols=244 Identities=19% Similarity=0.236 Sum_probs=192.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~---~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
+|++.++||+|+||+||+|.+..+++ .+|+|++.... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN------HPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC------CTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC------CCCeeeEEEEEecCC
Confidence 57888999999999999999755444 79999987533 33456778888888774 789999999998776
Q ss_pred eE-EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 490 HL-FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 490 ~l-~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
.. ++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+||
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~--~~~~kl~Df 168 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE--SFTVKVADF 168 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECCT
T ss_pred CCcEEEEecccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCcEEeCcC
Confidence 55 99999996 57877775422 23889999999999999999999999999999999999985 789999999
Q ss_pred CCcccccCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhhcCCC
Q 004954 568 GSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 568 Gls~~~~~~-------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|++...... .....+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+.....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-- 246 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-- 246 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC--
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC--
Confidence 998754322 2234668899999999999999999999999999999995 555555444333333321100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
... ....+..+.+||.+||+.||.+|||+.++++
T Consensus 247 --------------------------------~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 --------------------------------LPQ---------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------------------------CCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------------CCC---------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 1123467899999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.70 Aligned_cols=245 Identities=19% Similarity=0.249 Sum_probs=192.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-e
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-H 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~-~ 487 (722)
.+|++.+.||+|+||+||+|++..+ +..+|+|++.... .....+.+|+.+++.++ ||||+++++++. .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS------HPNVLSLLGICLRS 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC------CTTBCCCCEEECCS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC------CCCEeeeeeEEEcC
Confidence 5799999999999999999997543 3468999987532 34456778888888774 789999999865 4
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~D 171 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE--KFTVKVAD 171 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECS
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC--CCCEEECc
Confidence 5688999999986 7777775322 23889999999999999999999999999999999999985 78999999
Q ss_pred cCCcccccCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 567 LGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 567 FGls~~~~~~-------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 9998754432 223456788999999999999999999999999999999 67777765544444333211100
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
..| ...+..+.+||.+||+.||.+|||+.|+++
T Consensus 252 ----------------------------------~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 ----------------------------------LQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ----------------------------------CCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------------CCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001 123466899999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=328.14 Aligned_cols=261 Identities=21% Similarity=0.263 Sum_probs=202.9
Q ss_pred CCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 004954 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (722)
Q Consensus 401 ~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~ 480 (722)
....|+..+..+.++|++.+.||+|+||+||+|++ +|+.||||++.... .....+|.++++.+. ..||||++
T Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~----l~h~ni~~ 100 (342)
T 1b6c_B 29 GSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVM----LRHENILG 100 (342)
T ss_dssp CSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSC----CCCTTBCC
T ss_pred CCCCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhh----cCCCcEEE
Confidence 44677778888899999999999999999999997 58999999997543 356678888887753 35899999
Q ss_pred EEEEEEecC----eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH--------HCCCccccC
Q 004954 481 LYDYFYHLE----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--------SLGIIHCDL 547 (722)
Q Consensus 481 l~~~f~~~~----~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLH--------s~gIvHrDL 547 (722)
+++++.... ..++||||+.+ +|.+++... .+++..++.++.||+.||.||| +.||+||||
T Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred EEeeecccCCccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 999999876 89999999985 788877532 2889999999999999999999 899999999
Q ss_pred CCCceEEcccCCCeEEEEecCCcccccCCc-------cccccCCcccCchhhcCCC------CCchhhHHHHHHHHHHHH
Q 004954 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAELW 614 (722)
Q Consensus 548 Kp~NILl~~~~~~~vkL~DFGls~~~~~~~-------~~~~gt~~y~APE~l~~~~------~s~ksDIWSLGviL~ell 614 (722)
||+|||++. ++.+||+|||++....... ....+|+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 174 kp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 174 KSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp SGGGEEECT--TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEECC--CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 999999986 7789999999997654432 3357899999999998763 336899999999999999
Q ss_pred hC----------CCCCCCCh-----HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccch
Q 004954 615 TG----------EVLFPNDA-----VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS 679 (722)
Q Consensus 615 tG----------~~PF~~~~-----~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~ 679 (722)
+| ..||.... .......+.. ......+|....
T Consensus 252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~ 298 (342)
T 1b6c_B 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE---------------------------------QKLRPNIPNRWQ 298 (342)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT---------------------------------SCCCCCCCGGGG
T ss_pred hccCcCCcccccccCccccCcCcccHHHHHHHHHH---------------------------------HHhCCCCccccc
Confidence 99 77885431 1111111110 001111111100
Q ss_pred hhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 680 LEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 680 l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.......+.+||.+||+.||.+|||+.++++|
T Consensus 299 ----~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 299 ----SCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp ----TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ----chhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 01112468899999999999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=347.49 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=205.7
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++..++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+++++.++ |+||+++++++.. +
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVSE-E 334 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-S
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEee-c
Confidence 4556789999999999999999999864 567999999876555577889999999985 7899999999865 7
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.++|||||+. ++|.+++...... .+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG 408 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFG 408 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC--CCcEEEcccc
Confidence 7899999997 5888888643322 2889999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
++....... ....++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+++..+.....
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------ 482 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------ 482 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC------
T ss_pred cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 997654321 22345778999999999999999999999999999999 9999998877666655532110
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...| ...+..+.+||.+||+.||++|||+.+|++.
T Consensus 483 ----------------------------~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 483 ----------------------------MPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp ----------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCC---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0011 1234678999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=329.02 Aligned_cols=273 Identities=19% Similarity=0.232 Sum_probs=189.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~-- 488 (722)
+..++|++.+.||+|+||+||+|++ +++.||||++..... .....|..++. .....||||+++++.+...
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~----~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYR----VPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHT----STTCCCTTBCCEEEEEEEECT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHH----HHhccCcchhhheeccccccc
Confidence 3457899999999999999999975 789999999975443 33334433332 2235699999999866532
Q ss_pred ---CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC---------CCccccCCCCceEEc
Q 004954 489 ---EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---------GIIHCDLKPENILIK 555 (722)
Q Consensus 489 ---~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~---------gIvHrDLKp~NILl~ 555 (722)
..+++||||+. ++|.+++.... .++..++.++.||+.||.|||+. ||+||||||+|||++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 36799999996 57877775332 57889999999999999999999 999999999999999
Q ss_pred ccCCCeEEEEecCCcccccCC-----------ccccccCCcccCchhhcC-------CCCCchhhHHHHHHHHHHHHhCC
Q 004954 556 SYQRCEIKIIDLGSSCFQTDN-----------LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWTGE 617 (722)
Q Consensus 556 ~~~~~~vkL~DFGls~~~~~~-----------~~~~~gt~~y~APE~l~~-------~~~s~ksDIWSLGviL~elltG~ 617 (722)
. ++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 155 ~--~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 155 N--DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp T--TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred C--CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 5 789999999999765422 123468999999999987 34667899999999999999997
Q ss_pred CCCC-CChHHHHHHHHHhhcCCCc-HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHH
Q 004954 618 VLFP-NDAVVMILARIIGMLGPID-LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 695 (722)
Q Consensus 618 ~PF~-~~~~~e~l~~i~~~lg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL 695 (722)
.||. +....+....+....+..+ .+.+.. .. ........+|.... .....+..+.+||
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-----------~~~~~~~~~~~~~~---~~~~~~~~l~~li 292 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQV------LV-----------SREKQRPKFPEAWK---ENSLAVRSLKETI 292 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHH------HH-----------TTSCCCCCCCTTCC---CCSHHHHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHh------hh-----------cccccCCCCCcccc---cccchHHHHHHHH
Confidence 6663 2221111000000011111 000000 00 00111111221111 0111235689999
Q ss_pred HHhcccCCCCCcCHHHH------HhCCCCCC
Q 004954 696 RTLLEINPQRRPTAREA------LDHPWLQH 720 (722)
Q Consensus 696 ~~mL~~dP~kRpTa~El------L~HPwf~~ 720 (722)
.+||+.||++|||+.|+ |-++|-++
T Consensus 293 ~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 293 EDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 99999999999999999 55677754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.69 Aligned_cols=262 Identities=23% Similarity=0.252 Sum_probs=197.0
Q ss_pred ceecCcE-EEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRY-YVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY-~i~~~LG~G~fG~Vy~a~----d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
.++.++| ++++.||+|+||+||++. +..+++.||||+++... .....+.+|+++++.++ ||||++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~ 99 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY------HEHIIKYK 99 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC------CcchhhEE
Confidence 3455666 999999999999998875 34588999999998643 33566788999999885 68999999
Q ss_pred EEEEec--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC
Q 004954 483 DYFYHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (722)
Q Consensus 483 ~~f~~~--~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~ 559 (722)
+++... ..+++||||+.+ +|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~--~ 170 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN--D 170 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--T
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC--C
Confidence 999974 689999999975 777766532 1889999999999999999999999999999999999985 7
Q ss_pred CeEEEEecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 560 CEIKIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
+.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||......... ..
T Consensus 171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~ 248 (318)
T 3lxp_A 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE--LI 248 (318)
T ss_dssp CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HH
T ss_pred CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh--hh
Confidence 889999999997655432 2345678899999999989999999999999999999999999764322111 10
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
+... ..... ........ ....... ....+..+.+||++||+.||.+|||+.|++
T Consensus 249 ---~~~~-~~~~~-~~~~~~~~------------~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell 302 (318)
T 3lxp_A 249 ---GIAQ-GQMTV-LRLTELLE------------RGERLPR---------PDKCPAEVYHLMKNCWETEASFRPTFENLI 302 (318)
T ss_dssp ---CSCC-HHHHH-HHHHHHHH------------TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---cccc-cchhH-HHHHHHHh------------cccCCCC---------CccccHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 0000 00000 00000000 0000011 123457799999999999999999999998
Q ss_pred h
Q 004954 714 D 714 (722)
Q Consensus 714 ~ 714 (722)
+
T Consensus 303 ~ 303 (318)
T 3lxp_A 303 P 303 (318)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=337.05 Aligned_cols=254 Identities=21% Similarity=0.248 Sum_probs=189.4
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---------hhhHhHHHHHHHHHHhcccCC---CCCCcee
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDP---ADEHHIL 479 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---------~~~~~~~~E~~il~~L~~~~~---~~hpnIv 479 (722)
..++|++.+.||+|+||+||+|++ +|+.||||+++... .....+.+|+.+++.++.... ..||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999997 78999999997542 123678899999998874321 2466666
Q ss_pred EEEEEEE-----------------e-------------cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHH
Q 004954 480 RLYDYFY-----------------H-------------LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528 (722)
Q Consensus 480 ~l~~~f~-----------------~-------------~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~ 528 (722)
++.+++. . ...++|||||+.+ ++++.+.. ..+++..++.|+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILH 168 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHH
Confidence 6666543 2 6789999999975 46665532 2389999999999
Q ss_pred HHHHHHHHHH-HCCCccccCCCCceEEcccC------------------CCeEEEEecCCcccccCCccccccCCcccCc
Q 004954 529 QCLEALEYLH-SLGIIHCDLKPENILIKSYQ------------------RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589 (722)
Q Consensus 529 qIl~aL~yLH-s~gIvHrDLKp~NILl~~~~------------------~~~vkL~DFGls~~~~~~~~~~~gt~~y~AP 589 (722)
||+.||+||| +.||+||||||+||||+..+ ...+||+|||+++..... ..+||+.|+||
T Consensus 169 qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aP 246 (336)
T 2vuw_A 169 QLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCS
T ss_pred HHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccCh
Confidence 9999999999 99999999999999999632 128999999999876654 34799999999
Q ss_pred hhhcCCCCCchhhHHHHHHH-HHHHHhCCCCCCCChH-HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhcc
Q 004954 590 EVIIGLPYDQKIDLWSLGCI-LAELWTGEVLFPNDAV-VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEET 667 (722)
Q Consensus 590 E~l~~~~~s~ksDIWSLGvi-L~elltG~~PF~~~~~-~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (722)
|++.+.. +.++|||||+++ .+++++|..||.+... ......+.....
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------ 295 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT------------------------------ 295 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC------------------------------
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc------------------------------
Confidence 9999877 899999998777 7778889999854211 111112110000
Q ss_pred ccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH-hCCCCC
Q 004954 668 NQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL-DHPWLQ 719 (722)
Q Consensus 668 ~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL-~HPwf~ 719 (722)
....... ......++.+.+||++||+.| ||+|+| +||||+
T Consensus 296 ----~~~~~~~---~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 296 ----FKTKCNT---PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ----CSSCCCS---HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ----cCcccch---hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0000000 001123467899999999977 999999 999996
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=331.81 Aligned_cols=246 Identities=19% Similarity=0.251 Sum_probs=183.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~- 487 (722)
.+|++.+.||+|+||+||+|++..+ +..+|+|+++... .....+.+|+.+++.+ .||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------SHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC------CCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEEcC
Confidence 3589999999999999999987543 3468999886532 2334556666665555 48899999998754
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~D 235 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVAD 235 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred CCCeEEEEECCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC--CCCEEEee
Confidence 5688999999985 7887775432 22788999999999999999999999999999999999985 78999999
Q ss_pred cCCcccccCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 567 LGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 567 FGls~~~~~~-------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-- 313 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-- 313 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--
Confidence 9999754322 122456788999999999999999999999999999999 788887654433333322110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...+..+.+||.+||+.||.+|||+.|++++
T Consensus 314 --------------------------------~~~~p---------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 314 --------------------------------RLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------------------CCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------------CCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011 1234678999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=360.98 Aligned_cols=280 Identities=21% Similarity=0.260 Sum_probs=201.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~- 487 (722)
...++|++.+.||+|+||+||+|.+..+|+.||||+++.. ......+.+|+.+++.++ ||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~------HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN------HPNVVSAREVPDGL 84 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC------BTTBCCEEECCTTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC------CCCCCceeeeeccc
Confidence 3448999999999999999999999999999999998753 334566788999999885 7899999998765
Q ss_pred -----cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CC
Q 004954 488 -----LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RC 560 (722)
Q Consensus 488 -----~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~ 560 (722)
.+..++||||+. ++|.+++..... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ ..
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCce
Confidence 677899999996 577777764322 22388999999999999999999999999999999999998632 33
Q ss_pred eEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 561 ~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+........... ..
T Consensus 162 ~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~ 238 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---RE 238 (676)
T ss_dssp EEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C-
T ss_pred eEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hc
Confidence 5999999999775443 334678999999999999999999999999999999999999997653322110000 00
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
...... .... ............|.... .....+..+.+||++||++||.+|||+.++|+||||
T Consensus 239 ~~~~~~--------~~~~------~l~g~~~~~~~lp~p~~---l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F 301 (676)
T 3qa8_A 239 KSNEHI--------VVYD------DLTGAVKFSSVLPTPNH---LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301 (676)
T ss_dssp -----C--------CSCC------CCSSSCCCCSSSCCSCC---CCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred ccchhh--------hhhh------hhccccccccccCCchh---hchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence 000000 0000 00000001111111111 112235779999999999999999999999999998
Q ss_pred C
Q 004954 719 Q 719 (722)
Q Consensus 719 ~ 719 (722)
+
T Consensus 302 ~ 302 (676)
T 3qa8_A 302 Q 302 (676)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.42 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=198.2
Q ss_pred eecCcEEEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~----d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
+..++|++++.||+|+||.||+++ +..+|+.||||++.... .....+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~ 111 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ------HDNIVKYKGVC 111 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCCeeeEEEEE
Confidence 446789999999999999999998 46789999999997643 34456778888888774 78999999998
Q ss_pred EecC--eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 486 YHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 486 ~~~~--~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
...+ ..++||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~~~~ 184 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--ENRV 184 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEE
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC--CCcE
Confidence 7654 78999999975 88887765422 2889999999999999999999999999999999999986 7899
Q ss_pred EEEecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 004954 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (722)
Q Consensus 563 kL~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~l 636 (722)
||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|..||...... .. +. .
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-~~-~~---~ 259 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FM-RM---I 259 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-HH-HH---H
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-HH-Hh---h
Confidence 999999997654432 2234677899999999888999999999999999999999998653211 11 11 1
Q ss_pred CCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 637 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
+......... ..+...+. ....... ....+..+.+||++||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~-~~~~~~~~------------~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 260 GNDKQGQMIV-FHLIELLK------------NNGRLPR---------PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CTTCCTHHHH-HHHHHHHH------------TTCCCCC---------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccchhhhH-HHHHHHhh------------cCCCCCC---------CCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111100000 00000000 0000011 1224577999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=317.80 Aligned_cols=255 Identities=19% Similarity=0.249 Sum_probs=192.8
Q ss_pred EEEEeccCCCCceEEEEECCCCcEEEEEEeecc-----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 418 i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
..+.||+|+||+||+|.+ +++.||+|++... ......+.+|+.+++.++ ||||+++++++...+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ------HENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSSCE
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC------CCCeEEEEEEEecCCceE
Confidence 346799999999999985 6889999998653 233466788999998885 789999999999999999
Q ss_pred EEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+||||+. ++|.+++..... ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE--AFTAKISDFGLAR 181 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC--CCcEEEeeccccc
Confidence 9999996 578777764332 223899999999999999999999999999999999999985 7899999999987
Q ss_pred cccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 572 FQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 572 ~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
..... .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||........+..+.......
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 253 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE------- 253 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT-------
T ss_pred ccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh-------
Confidence 65432 223468999999999876 47899999999999999999999997644322222221100000
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...+..++. ..++. .....+..+.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~----------------~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 254 EKTIEDYID----------------KKMND------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCHHHHSC----------------SSCSC------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhhhhhhcc----------------ccccc------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000000000 00000 111123568899999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=343.87 Aligned_cols=245 Identities=19% Similarity=0.234 Sum_probs=194.8
Q ss_pred cCcEEEEE-EeccCCCCceEEEEEC--CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTE-YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~-~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+++.+.+ .||+|+||+||+|.+. .++..||||+++... .....+.+|+++++.++ ||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~------hpniv~l~~~~~~ 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVCQA 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC------CTTBCCEEEEEES
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC------CCCEeeEEEEecc
Confidence 45677777 8999999999999875 456789999997642 34567888888887764 7899999999876
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
+.+++||||+.+ +|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~vkL~D 479 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN--RHYAKISD 479 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC--CCcEEEee
Confidence 679999999985 6766665322 23899999999999999999999999999999999999996 78999999
Q ss_pred cCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 567 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 567 FGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
||++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+....
T Consensus 480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--- 556 (613)
T 2ozo_A 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--- 556 (613)
T ss_dssp CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC---
T ss_pred ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---
Confidence 99997654321 12234688999999999999999999999999999998 999998877666655543210
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...+..+.+||.+||+.||.+|||+.++++
T Consensus 557 -------------------------------~~~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 557 -------------------------------RMECP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -------------------------------CCCCC---------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -------------------------------CCCCC---------CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00111 123567899999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=344.20 Aligned_cols=242 Identities=20% Similarity=0.239 Sum_probs=194.6
Q ss_pred cEEEE-EEeccCCCCceEEEEE--CCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 415 RYYVT-EYLGSAAFSKVFQAQD--LHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 415 rY~i~-~~LG~G~fG~Vy~a~d--~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
.+.+. +.||+|+||+||+|.+ ..+++.||||+++... ...+.+.+|+++++.++ ||||+++++++. .
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~-~ 441 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD------NPYIVRMIGICE-A 441 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC------CTTBCCEEEEEE-S
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEe-c
Confidence 34444 4799999999999954 5677899999997643 23467889999999885 789999999986 4
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+..++||||+. ++|.+++.... .+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+||
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~--~~~~kL~DF 513 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDF 513 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECCT
T ss_pred CCEEEEEEccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC--CCCEEEEEc
Confidence 56899999997 46777775332 2889999999999999999999999999999999999996 789999999
Q ss_pred CCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 568 GSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 568 Gls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....++...+.....
T Consensus 514 Gla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--- 590 (635)
T 4fl3_A 514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--- 590 (635)
T ss_dssp THHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---
T ss_pred CCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 9987654321 22345788999999999999999999999999999998 9999998877776665542110
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...| ...+..+.+||.+||+.||.+|||+.+|++
T Consensus 591 -------------------------------~~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 -------------------------------MGCP---------AGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------------------------------CCCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------------------CCCC---------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0011 123467899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=318.45 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=193.4
Q ss_pred eeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 407 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
...++..++|++.+.||+|+||.||+|.+.. .+|+|+++... .....+.+|+.+++.+ .||||+++++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~ 96 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT------RHENVVLFMG 96 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC------CCTTBCCCCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC------CCCCEeEEEE
Confidence 3445567899999999999999999999753 49999987532 2223455666666555 4889999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 484 ~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
++......++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++ ++.+
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~---~~~~ 168 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD---NGKV 168 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CC
T ss_pred EEecCCceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe---CCCE
Confidence 9999999999999997 56777665322 2388999999999999999999999999999999999998 5689
Q ss_pred EEEecCCccccc--------CCccccccCCcccCchhhcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCChH
Q 004954 563 KIIDLGSSCFQT--------DNLCLYVQSRSYRAPEVIIG---------LPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (722)
Q Consensus 563 kL~DFGls~~~~--------~~~~~~~gt~~y~APE~l~~---------~~~s~ksDIWSLGviL~elltG~~PF~~~~~ 625 (722)
||+|||++.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999876532 12233468899999999975 3578999999999999999999999988777
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
......+.....+ ..+. ...+..+.+||.+||+.||.+
T Consensus 249 ~~~~~~~~~~~~~----------------------------------~~~~--------~~~~~~l~~li~~~l~~~p~~ 286 (319)
T 2y4i_B 249 EAIIWQMGTGMKP----------------------------------NLSQ--------IGMGKEISDILLFCWAFEQEE 286 (319)
T ss_dssp HHHHHHHHTTCCC----------------------------------CCCC--------SSCCTTHHHHHHHHHCSSTTT
T ss_pred HHHHHHhccCCCC----------------------------------CCCc--------CCCCHHHHHHHHHHhcCChhh
Confidence 6665554321110 0000 012345889999999999999
Q ss_pred CcCHHHHHhC
Q 004954 706 RPTAREALDH 715 (722)
Q Consensus 706 RpTa~ElL~H 715 (722)
|||+.++++.
T Consensus 287 Rpt~~~l~~~ 296 (319)
T 2y4i_B 287 RPTFTKLMDM 296 (319)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=341.51 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=200.2
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
.+..++|++.+.||+|+||+||+|.+..+ +..||||+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~ 459 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD------HPHIVKLIGV 459 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEE
Confidence 44568899999999999999999998643 567999998753 233466778888888874 7899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 485 f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
+. .+..++||||+. ++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+|
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~--~~~vk 531 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVK 531 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEE
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC--CCCEE
Confidence 84 567899999998 577777764321 2889999999999999999999999999999999999996 78999
Q ss_pred EEecCCcccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 564 IIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 564 L~DFGls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+.....
T Consensus 532 L~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~- 610 (656)
T 2j0j_A 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER- 610 (656)
T ss_dssp ECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-
T ss_pred EEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99999997654432 22456788999999999999999999999999999997 9999998877766655532110
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+| ...++.+.+||.+||+.||.+|||+.++++.
T Consensus 611 ---------------------------------~~~~---------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 611 ---------------------------------LPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp ---------------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------------CCCC---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0011 1234678999999999999999999999863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=304.22 Aligned_cols=234 Identities=15% Similarity=0.126 Sum_probs=179.9
Q ss_pred cceeeCc-eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCce
Q 004954 404 LPIILNT-VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHI 478 (722)
Q Consensus 404 ~pi~~~~-~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnI 478 (722)
-++..+. ++.++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|+.++..+ .||||
T Consensus 20 ~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~i 93 (286)
T 3uqc_A 20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI------DKPGV 93 (286)
T ss_dssp CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC------CCTTB
T ss_pred CcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC------CCCCc
Confidence 3455677 78899999999999999999999999999999999997642 2335667777777655 47899
Q ss_pred eEEEEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc
Q 004954 479 LRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (722)
Q Consensus 479 v~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~ 557 (722)
+++++++...+..++||||+.| +|.+++.. . ....++..|+.||+.||+|||++||+||||||+|||++.
T Consensus 94 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~- 164 (286)
T 3uqc_A 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI- 164 (286)
T ss_dssp CCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET-
T ss_pred ceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC-
Confidence 9999999999999999999975 67776632 1 345678889999999999999999999999999999996
Q ss_pred CCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 558 QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
++.+||++++ |++ +++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 165 -~g~~kl~~~~-----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------ 213 (286)
T 3uqc_A 165 -DGDVVLAYPA-----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------ 213 (286)
T ss_dssp -TSCEEECSCC-----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------
T ss_pred -CCCEEEEecc-----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------
Confidence 7888888543 333 368899999999999999999999976432110000
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
. ........+ .........++.+.+||.+||+.||.+| |+.|+++.
T Consensus 214 ------------~----------------~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 214 ------------A----------------ERDTAGQPI---EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp ------------C----------------CBCTTSCBC---CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ------------H----------------HHHhccCCC---ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0 000000000 1112223345779999999999999999 99999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=346.35 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=193.6
Q ss_pred eeCceecCcEEEEEEeccCCCCceEEEEECC-CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 004954 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (722)
Q Consensus 407 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~d~~-tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~ 483 (722)
..++++.++|++.+.||+|+||+||++.+.. +|+.||||++.... .....+.+|+.+++.+ .||||+++++
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~ 146 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV------VHPSIVQIFN 146 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC------CCTTBCCEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc------CCCCcCeEee
Confidence 4567888999999999999999999999976 79999999986532 3334566777776665 4889999999
Q ss_pred EEEecCe-----EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc
Q 004954 484 YFYHLEH-----LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (722)
Q Consensus 484 ~f~~~~~-----l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~ 557 (722)
++...+. .||||||+.| +|.+.+.. .+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~- 217 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE- 217 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-
Confidence 9997765 7999999985 55443321 3899999999999999999999999999999999999984
Q ss_pred CCCeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 558 QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
+.+||+|||++...... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+... .
T Consensus 218 --~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-----------~ 282 (681)
T 2pzi_A 218 --EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-----------D 282 (681)
T ss_dssp --SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------S
T ss_pred --CcEEEEecccchhcccC-CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------c
Confidence 48999999999876554 4567999999999998754 8999999999999999999988854210 0
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.++...... ..++.+.+||.+||+.||.+||++.++|.|+|
T Consensus 283 -----------------------------------~~~~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 283 -----------------------------------GLPEDDPVL----KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp -----------------------------------SCCTTCHHH----HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred -----------------------------------ccccccccc----ccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 000000000 01256889999999999999999999888877
Q ss_pred C
Q 004954 718 L 718 (722)
Q Consensus 718 f 718 (722)
+
T Consensus 324 ~ 324 (681)
T 2pzi_A 324 T 324 (681)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-28 Score=279.82 Aligned_cols=182 Identities=19% Similarity=0.065 Sum_probs=127.4
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecc-----------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKND-----------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-----------~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.++.|++|.+..++....|+.+|+|++.+. .....++.+|+++|+++. .|+||+++++++++.+
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP-----AGFDAPAVLAHGENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC-----TTCCCCCEEEEEECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEEEECC
Confidence 467788888888887889999999999754 123456788999998885 3789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+||||||++| +|.+.+..... ++.. .|+.||+.||+|||++|||||||||+||||+. ++.+||+|||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~------l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~--dg~vKL~DFG 384 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEE------IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA--RQHARLIDFG 384 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCC------CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHhCCC------CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECC--CCCEEEeecc
Confidence 99999999986 67777764322 5543 58899999999999999999999999999986 7899999999
Q ss_pred CcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004954 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619 (722)
Q Consensus 569 ls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~P 619 (722)
+++..... ....+||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus 385 lAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 385 SIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 99765433 3456899999999999874 57789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.8e-23 Score=234.54 Aligned_cols=178 Identities=17% Similarity=0.159 Sum_probs=138.2
Q ss_pred EEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 417 ~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
...+.||+|+||+||++. ..++.+++|...... ...+++.+|+++++.++ ||||+++..++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~------h~nIv~~~~~~~~ 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK------DFGIPAPYIFDVD 410 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG------GGTCCCCCEEEEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC------CCCcCceEEEEEe
Confidence 345689999999999995 567889999864321 11344688999999996 6799966556567
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+..+|||||++ ++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~D 472 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIID 472 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECC
T ss_pred CCccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEE
Confidence 778899999997 577776653 4579999999999999999999999999999993 899999
Q ss_pred cCCcccccCCc----------cccccCCcccCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 004954 567 LGSSCFQTDNL----------CLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLF 620 (722)
Q Consensus 567 FGls~~~~~~~----------~~~~gt~~y~APE~l~~--~~~s~ksDIWSLGviL~elltG~~PF 620 (722)
||+++...... ....||+.|+|||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99998776531 34688999999999987 56788899999998888888777766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=198.93 Aligned_cols=143 Identities=21% Similarity=0.263 Sum_probs=112.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------------------hhHhHHHHHHHHHHhcccCCCC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------------------FFDQSLDEIKLLKLVNKNDPAD 474 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------------------~~~~~~~E~~il~~L~~~~~~~ 474 (722)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++.... ....+.+|+.+++.++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------ 162 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------ 162 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc------
Confidence 3466779999999999999999 8899999999964321 2345788999999996
Q ss_pred CCceeEEEEEEEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceE
Q 004954 475 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (722)
Q Consensus 475 hpnIv~l~~~f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NIL 553 (722)
|.+++.+++ . +..++||||+.| +|.+ +. ......++.||+.||.|||+.||+||||||+|||
T Consensus 163 ~~~v~~~~~---~-~~~~lvmE~~~g~~L~~-l~------------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NIL 225 (282)
T 1zar_A 163 GLAVPKVYA---W-EGNAVLMELIDAKELYR-VR------------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 225 (282)
T ss_dssp TSSSCCEEE---E-ETTEEEEECCCCEEGGG-CC------------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred CCCcCeEEe---c-cceEEEEEecCCCcHHH-cc------------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEE
Confidence 124444332 2 556999999976 6655 31 1234579999999999999999999999999999
Q ss_pred EcccCCCeEEEEecCCcccccCCccccccCCcccCchhhc
Q 004954 554 IKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVII 593 (722)
Q Consensus 554 l~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~ 593 (722)
++ ++.+||+|||++. .+..+.|||.+.
T Consensus 226 l~---~~~vkl~DFG~a~----------~~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS---EEGIWIIDFPQSV----------EVGEEGWREILE 252 (282)
T ss_dssp EE---TTEEEECCCTTCE----------ETTSTTHHHHHH
T ss_pred EE---CCcEEEEECCCCe----------ECCCCCHHHHHH
Confidence 99 7889999999985 345678899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.3e-18 Score=177.48 Aligned_cols=137 Identities=18% Similarity=0.266 Sum_probs=104.9
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcE--EEEEEeecchhh-------------------------hHhHHHHHHHHHHhc
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKNDKDF-------------------------FDQSLDEIKLLKLVN 468 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~--vAvKil~~~~~~-------------------------~~~~~~E~~il~~L~ 468 (722)
|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ...+.+|..+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998788999 999997643211 125678999999998
Q ss_pred ccCCCCCCceeEEEEEEEecCeEEEEEEcccc------chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH-HCC
Q 004954 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA------NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-SLG 541 (722)
Q Consensus 469 ~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g------sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLH-s~g 541 (722)
+.. ..+|. +++. ...+|||||+++ .|.+.... .++..+..++.||+.||.||| +.|
T Consensus 129 ~~~-i~~p~---~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 129 EAG-VSVPQ---PYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HTT-CCCCC---EEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred hCC-CCCCe---EEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 653 22333 3332 356899999953 34333211 234567889999999999999 999
Q ss_pred CccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 542 IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 542 IvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|+||||||+|||++. .++|+|||++...
T Consensus 192 ivHrDlkp~NILl~~----~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID----KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS----SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC----cEEEEECcccccC
Confidence 999999999999983 8999999999654
|
| >2z0u_A WW domain-containing protein 1; C2 domain, alternative splicing, coiled coil, cytoplasm, phosphorylation, polymorphism, lipid binding protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=8.3e-19 Score=168.47 Aligned_cols=98 Identities=13% Similarity=0.038 Sum_probs=86.6
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCC-CcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~-~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
..+.|+|.|++| ||+++|.+|.+|||||++|++... +..++||+++++|+||+|||+|.|. ++.+.+ +++|.++|
T Consensus 41 ~~~~L~V~Vi~a~~L~~~d~~g~sDPyVkv~l~~~~~~~~~~~kT~v~~~tlnP~wnE~F~f~--v~~~~l~~~~L~~~V 118 (155)
T 2z0u_A 41 KNKQFAILIIQLSNLSALLQQQDQKVNIRVAVLPCSESTTCLFRTRPLDASDTLVFNEVFWVS--MSYPALHQKTLRVDV 118 (155)
T ss_dssp TTTEEEEEEEEEECGGGTCCSCCSEEEEEEEEESCSCHHHHEEECCCEECCSSEEEEEEEEEE--CCHHHHHHCEEEEEE
T ss_pred CCCEEEEEEEEccCcCCcccCCCCCEEEEEEEecCCCCCccceeCCcCCCCCCCccccEEEEE--cCHHHhCcCEEEEEE
Confidence 567999999999 999999999999999999998432 2347899999999999999999999 887666 66799999
Q ss_pred cccCCCCCCccccccccCccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
||+|++++++++|++.++..+..
T Consensus 119 ~d~d~~~~~d~iG~~~i~l~~l~ 141 (155)
T 2z0u_A 119 CTTDRSHLEECLGGAQISLAEVC 141 (155)
T ss_dssp EEECTTSCEEEEEEEEEECTTSC
T ss_pred EECCCCCCCcEEEEEEEEHHHcc
Confidence 99999999999999998877663
|
| >3fbk_A RGS3, RGP3, regulator of G-protein signaling 3; all beta-sheet fold, structural genomics, PSI-2, protein structure initiative; 2.00A {Homo sapiens} SCOP: b.7.1.0 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.4e-17 Score=157.48 Aligned_cols=98 Identities=14% Similarity=0.102 Sum_probs=88.5
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
..+.|+|.|.+| ||+++| +|.+||||++.+.++.....++||+++++|+||+|||+|.|. ++.....+.|.++|||
T Consensus 25 ~~~~L~V~v~~a~~L~~~d-~g~~Dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d 101 (153)
T 3fbk_A 25 QDRVLLLHIIEGKGLISKQ-PGTCDPYVKISLIPEDSRLRHQKTQTVPDCRDPAFHEHFFFP--VQEEDDQKRLLVTVWN 101 (153)
T ss_dssp SSSEEEEEEEEEESCCCCS-SSCCCEEEEEEEESCSCCTTCEECCCCTTCSSCEEEEEEEEE--CCGGGTTSEEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCC-CCCCCEEEEEEEEcCCCCccEEeccccCCCCCCccccEEEEe--cccHHhCCEEEEEEEe
Confidence 568899999999 999999 799999999999998877789999999999999999999999 8777776669999999
Q ss_pred cCCCCC-CccccccccCcccccc
Q 004954 343 NSDTRD-GEVNGALHEGKADAEE 364 (722)
Q Consensus 343 ~D~~~~-~d~iG~v~~~~~~~~~ 364 (722)
+|.+++ ++++|.+.+...++..
T Consensus 102 ~d~~~~~d~~lG~~~i~l~~l~~ 124 (153)
T 3fbk_A 102 RASQSRQSGLIGCMSFGVKSLLT 124 (153)
T ss_dssp CCSSGGGCEEEEEEEEEHHHHTC
T ss_pred CCCCCCCCcEEEEEEEEHHHhcC
Confidence 999987 9999999988776653
|
| >1v27_A Regulating synaptic membrane exocytosis protein 2; RAB3-interacting molecule, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.65 E-value=9.1e-17 Score=150.67 Aligned_cols=101 Identities=16% Similarity=0.114 Sum_probs=87.7
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++++.+++....++||+++++|+||+|||+|.|.. ++.+.. ...|.++||
T Consensus 19 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~~~~~t~nP~wne~f~f~~-~~~~~~~~~~l~i~V~ 97 (141)
T 1v27_A 19 VGHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSP-VHRREFRERMLEITLW 97 (141)
T ss_dssp TTTEEEEEEEEEESCCCCSSSCCCCEEEECCCSSCCSSSSCCBCCCCSSCSSCCCCCCCEECS-CCTTGGGTCEEEEEEE
T ss_pred CCCEEEEEEEEccCCCCcCCCCCCCCEEEEEEecCCCCCcceeCccccCCCCCccccEEEEcc-CCHHHhcCCEEEEEEE
Confidence 467899999999 99999999999999999999988777899999999999999999999982 344444 566999999
Q ss_pred ccCCCCC--CccccccccCccccccc
Q 004954 342 DNSDTRD--GEVNGALHEGKADAEEH 365 (722)
Q Consensus 342 D~D~~~~--~d~iG~v~~~~~~~~~e 365 (722)
|+|.+++ ++++|.+.+...++..+
T Consensus 98 d~d~~~~~~~~~lG~~~i~l~~l~~~ 123 (141)
T 1v27_A 98 DQARVREEESEFLGEILIELETALLD 123 (141)
T ss_dssp EBCSSSSCCBCCCEEEEEEGGGCCCS
T ss_pred ECCCCcCCCCceEEEEEEEccccCCC
Confidence 9999997 99999998877665443
|
| >1a25_A CALB, protein kinase C (beta); calcium++/phospholipid binding protein, calcium-binding protein; HET: PSE; 2.70A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.64 E-value=7.3e-17 Score=153.31 Aligned_cols=101 Identities=20% Similarity=0.296 Sum_probs=89.8
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
+.+.|+|.|.+| ||+++|.+|.+||||++++.++.+...++||+++++|+||+|||+|.|. +.....+..|.++|||
T Consensus 29 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d 106 (149)
T 1a25_A 29 DREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQ--LKESDKDRRLSVEIWD 106 (149)
T ss_dssp SSSEEEEEEEEEESCCCCSTTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEE--CCSGGGGCEEEEEEEE
T ss_pred cCCEEEEEEEEeeCCCCCCCCCCcCeEEEEEEECCCCCcceEecceeCCCCCCcCCcEEEEE--eccccCCCEEEEEEEE
Confidence 456899999999 9999999999999999999998777789999999999999999999999 7765556679999999
Q ss_pred cCCCCCCccccccccCcccccccc
Q 004954 343 NSDTRDGEVNGALHEGKADAEEHG 366 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~~~~~~e~ 366 (722)
+|.+++++++|.+.+...+.....
T Consensus 107 ~d~~~~~~~iG~~~i~l~~l~~~~ 130 (149)
T 1a25_A 107 WDLTSRNDFMGSLSFGISELQKAG 130 (149)
T ss_dssp CCSSSCCEEEEEEEEEHHHHTTCC
T ss_pred CCCCCCCCEEEEEEEEHHHhCcCc
Confidence 999999999999988876665543
|
| >1w15_A Synaptotagmin IV; metal binding protein, endocytosis/exocytosis neurotransmitter release, transmembrane; 1.93A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 1w16_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-17 Score=154.77 Aligned_cols=96 Identities=15% Similarity=0.041 Sum_probs=81.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~-~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++++.+++++..++||+++++|+||+|||+|.|. ++...++ ..|.++||
T Consensus 28 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~v~V~ 105 (153)
T 1w15_A 28 TTNTLTVVVLKARHLPKSDVSGLSDPYVKVNLYHAKKRISKKKTHVKKCTPNAVFNELFVFD--IPCESLEEISVEFLVL 105 (153)
T ss_dssp TTTEEEEEEEEEESCC------CCCEEEEEEEEETTEEEEEEECCCCCSCSSEEEEEEEEEE--CCSSSSTTEEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCcCCCCCCCeEEEEEEEeCCeEeceEecCcccCCCCCeecceEEEE--CCHHHhCceEEEEEEE
Confidence 457899999999 9999999999999999999998776678899999999999999999999 8777764 56999999
Q ss_pred ccCCCCCCccccccccCccc
Q 004954 342 DNSDTRDGEVNGALHEGKAD 361 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~ 361 (722)
|+|++++++++|.+.+...+
T Consensus 106 d~d~~~~~~~lG~~~i~l~~ 125 (153)
T 1w15_A 106 DSERGSRNEVIGRLVLGATA 125 (153)
T ss_dssp ECCTTSCCEEEEEEEESTTC
T ss_pred eCCCCCCCcEEEEEEECCCC
Confidence 99999999999999888755
|
| >2bwq_A Regulating synaptic membrane exocytosis protein 2; C2 domain, neurotransmitter release, transport protein; 1.41A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-16 Score=146.69 Aligned_cols=102 Identities=16% Similarity=0.113 Sum_probs=84.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++.+.+++....++||+++++|+||+|||+|.|.. ++.+.. ...|.++||
T Consensus 16 ~~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~~~~l~~~V~ 94 (129)
T 2bwq_A 16 VGHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSP-VHRREFRERMLEITLW 94 (129)
T ss_dssp TTTEEEEEEEEEESCCCCTTSCCBCEEEEEEEESSCSGGGEEECCCCSSBSSCEEEEEEEECS-CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCCEEEEEEecCCCCCcceecccccCCCCCccccEEEEcc-CCHHHhcCCeEEEEEE
Confidence 457899999999 99999999999999999999988777899999999999999999999982 344444 566999999
Q ss_pred ccCCCCC--CccccccccCcccccccc
Q 004954 342 DNSDTRD--GEVNGALHEGKADAEEHG 366 (722)
Q Consensus 342 D~D~~~~--~d~iG~v~~~~~~~~~e~ 366 (722)
|+|.+++ ++++|.+.+...+...++
T Consensus 95 d~d~~~~~~~~~lG~~~i~l~~l~~~~ 121 (129)
T 2bwq_A 95 DQARVREEESEFLGEILIELETALLDD 121 (129)
T ss_dssp EC-------CEEEEEEEEEGGGCCCSS
T ss_pred ECCcCcCcCCceeEEEEEEccccCCCc
Confidence 9999997 999999988877665544
|
| >2dmg_A KIAA1228 protein; beta-sandwich, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.5e-16 Score=148.22 Aligned_cols=97 Identities=14% Similarity=0.098 Sum_probs=85.4
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+| +||||++++.++.+...+++|+++++|+||+|||+|.|. ++.+.+ .+.|.++||
T Consensus 22 ~~~~L~v~v~~a~~L~~~d~~g-~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 98 (142)
T 2dmg_A 22 QRNKLIVVVHACRNLIAFSEDG-SDPYVRMYLLPDKRRSGRRKTHVSKKTLNPVFDQSFDFS--VSLPEVQRRTLDVAVK 98 (142)
T ss_dssp TTTEEEEEEEEEECCCCSSTTC-CCEEEEEEEESCCCSSSCEECCCCCSCSSCEEEEEEEEC--CCHHHHHHCEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCCCCCC-CCeeEEEEEEcCCCCCCcccCCccCCCCCCCcCceEEEE--ecHHHhCcCEEEEEEE
Confidence 457899999999 999999999 999999999998887789999999999999999999999 876665 456999999
Q ss_pred ccCCCCC--CccccccccCccccc
Q 004954 342 DNSDTRD--GEVNGALHEGKADAE 363 (722)
Q Consensus 342 D~D~~~~--~d~iG~v~~~~~~~~ 363 (722)
|+|.++. ++++|.+.+......
T Consensus 99 d~d~~~~~~~~~iG~~~i~l~~~~ 122 (142)
T 2dmg_A 99 NSGGFLSKDKGLLGKVLVALASEE 122 (142)
T ss_dssp ECCCSSCCSCCCCEEEEEECCCST
T ss_pred ECCCccccCCcEEEEEEEeccccc
Confidence 9999874 579999988765543
|
| >2b3r_A Phosphatidylinositol-4-phosphate 3-kinase C2 DOMA containing alpha polypeptide; C2 domain, lipid binding, PI3-kinase, transferase; 2.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-16 Score=148.45 Aligned_cols=99 Identities=12% Similarity=0.099 Sum_probs=86.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||++ |.+|.+||||+++++++.....++||+++++|+||+|||+|.|.. ++.+.+ +..|.++||
T Consensus 18 ~~~~L~V~V~~a~~L~~-~~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wnE~f~f~~-v~~~~l~~~~L~~~V~ 95 (134)
T 2b3r_A 18 RNGTLFIMVMHIKDLVT-EDGADPNPYVKTYLLPDTHKTSKRKTKISRKTRNPTFNEMLVYSG-YSKETLRQRELQLSVL 95 (134)
T ss_dssp ETTEEEEEEEEEECCCC-TTSCCCCEEEEEEEESCSSSCCCEECCCCCSCSSCEEEEEEEEES-CCHHHHTTCEEEEEEE
T ss_pred cCCEEEEEEEEeeCCCC-CCCCCCCeEEEEEEEcCCCCCceecCCcCcCCCCCCCccEEEECC-cCHHHhCcCEEEEEEE
Confidence 568999999999 9997 999999999999999987777899999999999999999999972 444443 566999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|++++++++|.+.+...+...
T Consensus 96 d~d~~~~~~~lG~~~i~l~~l~~ 118 (134)
T 2b3r_A 96 SAESLRENFFLGGITLPLKDFNL 118 (134)
T ss_dssp ECCSSSCCEEEEEEEEEGGGSCT
T ss_pred ECCCCCCCcEEEEEEEEhhhccC
Confidence 99999999999999887766544
|
| >3fdw_A Synaptotagmin-like protein 4; structural genomics, phospholipid binding, alternative splicing, cell membrane, cytoplasmic vesicle, membrane; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-16 Score=151.02 Aligned_cols=99 Identities=9% Similarity=-0.029 Sum_probs=88.8
Q ss_pred ccceeEEEEeec-CCcccc-CCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d-~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
..+.|+|.|.+| ||+++| .+|.+||||++++.++++...++||+++++|+||+|||+|.|. ++.+.+ .+.|.++|
T Consensus 21 ~~~~L~V~v~~a~~L~~~d~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~~L~~~V 98 (148)
T 3fdw_A 21 QTQSLVVHVKECHQLAYADEAKKRSNPYVKTYLLPDKSRQGKRKTSIKRDTVNPLYDETLRYE--IPESLLAQRTLQFSV 98 (148)
T ss_dssp TTTEEEEEEEEEESCCCSBTTTTBCCEEEEEEEETCCSGGGEEECCCCSSCSSCEEEEEEEEE--CCSTTGGGCEEEEEE
T ss_pred CCCEEEEEEEEecCCCCcccCCCCCCeEEEEEEEcCCcccCccccccCCCCCCCcEeeEEEEE--eChhHhCceEEEEEE
Confidence 457899999999 999999 6899999999999999887789999999999999999999999 887776 56699999
Q ss_pred cccCCCCCCccccccccCcccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
||+|++++++++|.+.+...+...
T Consensus 99 ~d~d~~~~~~~iG~~~i~l~~l~~ 122 (148)
T 3fdw_A 99 WHHGRFGRNTFLGEAEIQMDSWKL 122 (148)
T ss_dssp EEECGGGCEEEEEEEEEEHHHHHH
T ss_pred EECCCCcCCcEEEEEEEEcccccc
Confidence 999999999999999887655543
|
| >3n5a_A Synaptotagmin-7; calcium/phospholipid binding protein, protein transport; 1.44A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-16 Score=148.83 Aligned_cols=96 Identities=13% Similarity=0.069 Sum_probs=87.1
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|.+|.+||||++++.++.++..++||+++++|+||+|||+|.|. ++.+.+ +..|.++||
T Consensus 14 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~~~~~t~nP~wne~f~f~--v~~~~l~~~~l~~~V~ 91 (138)
T 3n5a_A 14 SANSIIVNIIKARNLKAMDIGGTSDPYVKVWLMYKDKRVEKKKTVTKKRNLNPIFNESFAFD--IPTEKLRETTIIITVM 91 (138)
T ss_dssp TTTEEEEEEEEEESCCCCBTTTBCCEEEEEEEEETTEEEEEEECCCCSSCSSCEEEEEEEEE--CCGGGGGGEEEEEEEE
T ss_pred CCCeEEEEEEEeeCCCCcCCCCCcCeEEEEEEEeCCCccceEeCccccCCCCCcCcceEEEE--CChhhcCceEEEEEEE
Confidence 457899999999 9999999999999999999988777778999999999999999999999 877776 456999999
Q ss_pred ccCCCCCCccccccccCccc
Q 004954 342 DNSDTRDGEVNGALHEGKAD 361 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~ 361 (722)
|+|.+++++++|.+.++..+
T Consensus 92 d~~~~~~~~~lG~~~i~l~~ 111 (138)
T 3n5a_A 92 DKDKLSRNDVIGKIYLSWKS 111 (138)
T ss_dssp ECCSSSCCEEEEEEEESSSS
T ss_pred ECCCCCCCcEEEEEEEcccc
Confidence 99999999999999988754
|
| >1wfm_A Synaptotagmin XIII; C2 domain, exocytosis, neurotransmitter release, riken structural genomics/proteomics initiative, RSGI, structural genomics; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-16 Score=147.72 Aligned_cols=95 Identities=18% Similarity=0.140 Sum_probs=82.7
Q ss_pred ccceeEEEEeecCCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccccc
Q 004954 264 NNDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~D 342 (722)
....|+|.|.+|. ++|.+|.+||||++++.|+.+ ..++||+++++|+||+|||+|.|. ++.+.+ ...|.++|||
T Consensus 24 ~~~~L~V~v~~a~--~~d~~g~sDPyv~v~l~~~~~-~~~~kT~v~~~tlnP~wnE~f~f~--v~~~~l~~~~L~~~V~d 98 (138)
T 1wfm_A 24 QKAELFVTRLEAV--TSNHDGGCDCYVQGSVANRTG-SVEAQTALKKRQLHTTWEEGLVLP--LAEEELPTATLTLTLRT 98 (138)
T ss_dssp TTTEEEEEEEEEE--CCCCSSCCCEEEEEEEEETTE-EEEEECCCCCCCSSEECSSCEEEE--CCTTSSTTCEEEEEEEE
T ss_pred CCCEEEEEEEEEE--cCCCCCCcceEEEEEEEcCCC-cccEecccCcCCCCCcCCceEEEE--ecHHHcCCCEEEEEEEE
Confidence 4578999999995 489999999999999998644 357889999999999999999999 887776 5669999999
Q ss_pred cCCCCCCccccccccCccccc
Q 004954 343 NSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~~~~~ 363 (722)
+|++++++++|.+.+...+..
T Consensus 99 ~d~~~~dd~lG~~~i~l~~l~ 119 (138)
T 1wfm_A 99 CDRFSRHSVAGELRLGLDGTS 119 (138)
T ss_dssp CCSSCTTSCSEEEEEESSSSS
T ss_pred CCCCCCCcEEEEEEEEccccc
Confidence 999999999999988776664
|
| >1ugk_A Synaptotagmin IV, KIAA1342; beta sandwich, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.59 E-value=9e-16 Score=143.73 Aligned_cols=98 Identities=12% Similarity=0.083 Sum_probs=84.6
Q ss_pred ccceeEEEEeec-CCccccCC-CCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~-g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
....|+|.|.+| ||+++|.+ |.+||||++++.++++ .++||+++++|+||+|||+|.|.. ++.+.+ ...|.++|
T Consensus 20 ~~~~L~v~v~~a~~L~~~d~~~~~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~~-v~~~~~~~~~l~i~V 96 (138)
T 1ugk_A 20 ERKAFVVNIKEARGLPAMDEQSMTSDPYIKMTILPEKK--HKVKTRVLRKTLDPAFDETFTFYG-IPYTQIQELALHFTI 96 (138)
T ss_dssp GGTEEEEEEEEEESCCCCBTTTTBCEEEEEEEEETTTC--SEEECCCCSSCSSCEEEEEEEEEC-CCSTTGGGCEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCCCEEEEEEecCCC--ceEecCcCcCCCCCcEeeEEEEcC-cCHHHhccCEEEEEE
Confidence 456799999999 99999995 9999999999998755 588999999999999999999941 666665 45699999
Q ss_pred cccCCCCCCccccccccCcccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
||+|.+++++++|.+.+...+...
T Consensus 97 ~d~d~~~~~~~lG~~~i~l~~l~~ 120 (138)
T 1ugk_A 97 LSFDRFSRDDIIGEVLIPLSGIEL 120 (138)
T ss_dssp EEECSSCCCCCCEEEEEECTTCCC
T ss_pred EECCCCCCCcEEEEEEEehhHccC
Confidence 999999999999999887765544
|
| >2cm5_A Rabphilin-3A; protein transport, zinc-finger, Ca2+ binding, metal-binding, synaptic exocytosis, C2A-C2B linker fragment, C2B, zinc, synapse; 1.28A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 2cm6_A 3rpb_A | Back alignment and structure |
|---|
Probab=99.58 E-value=7.9e-16 Score=148.92 Aligned_cols=97 Identities=14% Similarity=0.097 Sum_probs=85.4
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++++.++..+..++||+++++|+||+|||+|.|. ++.+.+ ...|.++||
T Consensus 35 ~~~~L~V~v~~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 112 (166)
T 2cm5_A 35 QQGGLIVGIIRCVHLAAMDANGYSDPFVKLWLKPDMGKKAKHKTQIKKKTLNPEFNEEFFYD--IKHSDLAKKSLDISVW 112 (166)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETC---CCEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCccCCCCCCcEEEEEEECCCCccceEeCCcccCCCCCcccceEEEE--cchHhcCCCEEEEEEE
Confidence 457899999999 9999999999999999999998776789999999999999999999999 776665 566999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|.+++++++|.+.++..+.
T Consensus 113 d~d~~~~~~~iG~~~i~l~~~ 133 (166)
T 2cm5_A 113 DYDIGKSNDYIGGCQLGISAK 133 (166)
T ss_dssp ECCSSSCCEEEEEEEEETTCC
T ss_pred ECCCCCCCcEEEeEEEecccC
Confidence 999999999999998877654
|
| >2enp_A B/K protein; C2 type 1,beta sandwich, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.6e-16 Score=145.83 Aligned_cols=97 Identities=15% Similarity=0.130 Sum_probs=83.8
Q ss_pred ccceeEEEEeec-CCcc-ccCCC------CCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cc
Q 004954 264 NNDYGYLSSKEA-DLID-LQHNV------VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EK 334 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~-~d~~g------~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~ 334 (722)
....|+|.|.+| ||++ ||.+| .+||||++++.++++ .++||+++++|+||+|||+|.|. ++.+.+ ++
T Consensus 24 ~~~~L~V~v~~a~~L~~~~d~~g~~~~~~~~dpyv~v~l~~~~~--~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~ 99 (147)
T 2enp_A 24 LHNHLTVRVIEARDLPPPISHDGSRQDMAHSNPYVKICLLPDQK--NSKQTGVKRKTQKPVFEERYTFE--IPFLEAQRR 99 (147)
T ss_dssp TTTEEEEEEEEEECCCCSCSSCCSSCTTCCCCCEEEEEEETCCS--SCEECCCCCSCSSCCCCBCCEEC--CCHHHHHHS
T ss_pred CCCEEEEEEEEEeCCCCccccccccccCCCCCcEEEEEEEeCCC--cceEeecccCCCCCeEeeeEEEE--eChHHhccC
Confidence 457899999999 9999 67764 799999999998765 37899999999999999999999 876665 46
Q ss_pred cccccccccCCCCCCccccccccCcccccc
Q 004954 335 DLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 335 ~L~~~V~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
.|.++|||+|++++++++|.+.+...+...
T Consensus 100 ~L~~~V~d~d~~~~~~~iG~~~i~l~~l~~ 129 (147)
T 2enp_A 100 TLLLTVVDFDKFSRHCVIGKVSVPLCEVDL 129 (147)
T ss_dssp EEEEEEECCSTTCCSCCCEEEEEETTTSCT
T ss_pred EEEEEEEECCCCcCCcEEEEEEEechhcCC
Confidence 699999999999999999999887765543
|
| >1rsy_A Synaptotagmin I; calcium/phospholipid binding protein; 1.90A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.58 E-value=6.9e-16 Score=147.14 Aligned_cols=96 Identities=16% Similarity=0.122 Sum_probs=85.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++++.++++ .++||+++++|+||+|||+|.|. ++.+.+ ...|.++||
T Consensus 40 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 115 (152)
T 1rsy_A 40 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKK--KKFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVY 115 (152)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETTCC--SCEECCCCTTCSSCEEEEEEEEC--CCHHHHTTCEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCccCCCCcCeEEEEEEEcCCC--ceEeccccCCCCCCcCcccEEEe--ecHHHcCCCEEEEEEE
Confidence 457899999999 999999999999999999998765 47889999999999999999998 776655 566999999
Q ss_pred ccCCCCCCccccccccCccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|+|.+++++++|.+.+...+..
T Consensus 116 d~d~~~~~~~iG~~~i~l~~l~ 137 (152)
T 1rsy_A 116 DFDRFSKHDIIGEFKVPMNTVD 137 (152)
T ss_dssp ECCSSSCCEEEEEEEEEGGGCC
T ss_pred ECCCCCCCcEEEEEEEEchhcc
Confidence 9999999999999988776553
|
| >1tjx_A Similar to synaptotagmini/P65; C2B domain, calcium binding, endocytosis-EX complex; HET: GOL; 1.04A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 1tjm_A* 1uov_A 1uow_A 1k5w_A 2lha_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=7.2e-16 Score=148.05 Aligned_cols=97 Identities=13% Similarity=0.113 Sum_probs=86.9
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|.+|.+||||++++.++++...++||+++++|+||+|||+|.|. ++.+.+ ...|.++||
T Consensus 23 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~i~V~ 100 (159)
T 1tjx_A 23 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVL 100 (159)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCeEEEEEEEeCCceeceeeCceecCCCCCcccceEEEE--cCHHHhCCcEEEEEEE
Confidence 457899999999 9999999999999999999987766678999999999999999999999 877666 456999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|.+++++++|.+.++....
T Consensus 101 d~d~~~~~~~iG~~~i~l~~~ 121 (159)
T 1tjx_A 101 DYDKIGKNDAIGKVFVGYNST 121 (159)
T ss_dssp ECCSSSCCEEEEEEEEETTCC
T ss_pred ECCCCCCCceEEEEEECCCCC
Confidence 999999999999998876543
|
| >3f04_A Synaptotagmin-1; C2A, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal- binding, palmitate, phosphoprotein; 1.35A {Homo sapiens} SCOP: b.7.1.2 PDB: 3f01_A 3f05_A 3f00_A 1byn_A 2k45_A 2k4a_A 2k8m_A 2ki6_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=9.8e-16 Score=144.30 Aligned_cols=97 Identities=15% Similarity=0.107 Sum_probs=85.8
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| +|+++|.+|.+||||++++.++++ +++||+++++|+||+|||+|.|. ++...+ +..|.++||
T Consensus 32 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~--~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 107 (143)
T 3f04_A 32 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKK--KKFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVY 107 (143)
T ss_dssp TTTEEEEEEEEEECCCCBGGGBCCCEEEEEEEESCCS--CCEECCCCCSCSSCEEEEEEEEC--CCHHHHTTCEEEEEEE
T ss_pred CCCEEEEEEEEecCCCCCCCCCCcCcEEEEEEECCCC--ccEECccCcCCCCCcCcCeEEEe--ecHhhcCCCEEEEEEE
Confidence 557899999999 999999999999999999998866 48899999999999999999999 776665 466999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|.+++++++|.+.+...+...
T Consensus 108 d~d~~~~~~~iG~~~i~l~~l~~ 130 (143)
T 3f04_A 108 DFDRFSKHDIIGEFKVPMNTVDF 130 (143)
T ss_dssp ECCSSSCCEEEEEEEEEGGGCCT
T ss_pred eCCCCCCCceEEEEEEEHHHccC
Confidence 99999999999999887665543
|
| >2q3x_A Regulating synaptic membrane exocytosis protein 1; C2 domain dimer, neurotransmitter release, transport protein; HET: MSE; 1.73A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.2e-16 Score=150.66 Aligned_cols=96 Identities=7% Similarity=-0.096 Sum_probs=83.8
Q ss_pred ccceeEEEEeec-CCccccC-CCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~-~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|. +|.+||||++++.++++...++||+++++|+||+|||+|.|. ++.. +..|.++||
T Consensus 28 ~~~~L~V~v~~a~~L~~~d~~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~--~~~L~~~V~ 103 (171)
T 2q3x_A 28 KKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFD--ESPQ--GKVLQVIVW 103 (171)
T ss_dssp ETTEEEEEEEEEESCCCCC---CCCEEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEECS--SCCT--TEEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCCcCCCCCCceEEEEEECCCccccceeCccCCCCCCCCCCcEEEEE--ecCC--CCEEEEEEE
Confidence 467899999999 9999996 799999999999998776678999999999999999999999 6543 466999999
Q ss_pred -ccCCCCCCccccccccCccccc
Q 004954 342 -DNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 342 -D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|+|++++++++|.+.+...+..
T Consensus 104 ~d~d~~~~d~~iG~~~i~l~~l~ 126 (171)
T 2q3x_A 104 GDYGRMDHKCFMGVAQILLEELD 126 (171)
T ss_dssp EECSTTCSSEEEEEEEECGGGSC
T ss_pred EcCCCCCCCCEEEEEEEEHHHcc
Confidence 9999999999999988876664
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.6e-15 Score=164.19 Aligned_cols=138 Identities=19% Similarity=0.196 Sum_probs=97.6
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------------------hh----HhHHHHHHHHHHhcccCC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------------------FF----DQSLDEIKLLKLVNKNDP 472 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------------------~~----~~~~~E~~il~~L~~~~~ 472 (722)
|+|.+.||.|++|.||+|.+ .+|+.||||+++.... +. -...+|...|.++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g- 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG- 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC-
Confidence 99999999999999999997 5799999999753210 00 01234667777775432
Q ss_pred CCCCceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 004954 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (722)
Q Consensus 473 ~~hpnIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NI 552 (722)
-.++..++. .. .+|||||++|..+..+ ........++.||+.+|.+||+.|||||||||.||
T Consensus 175 ---v~vp~p~~~---~~-~~LVME~i~G~~L~~l-----------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 175 ---FPVPEPIAQ---SR-HTIVMSLVDALPMRQV-----------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNI 236 (397)
T ss_dssp ---CSCCCEEEE---ET-TEEEEECCSCEEGGGC-----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred ---CCCCeeeec---cC-ceEEEEecCCccHhhh-----------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence 122333332 12 3799999987533211 11234567889999999999999999999999999
Q ss_pred EEcccCCC--------eEEEEecCCcccc
Q 004954 553 LIKSYQRC--------EIKIIDLGSSCFQ 573 (722)
Q Consensus 553 Ll~~~~~~--------~vkL~DFGls~~~ 573 (722)
|++.+++. .+.||||+.+...
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEeCCCCcccccccccceEEEEeCCcccC
Confidence 99864322 4899999987543
|
| >2chd_A Rabphilin-3A, exophilin-1; C2 domain, C2A, calcium binding, synaptic EXOC metal-binding, protein transport, synapse, transport, zinc-; 1.92A {Rattus norvegicus} PDB: 2k3h_A | Back alignment and structure |
|---|
Probab=99.57 E-value=6.3e-16 Score=145.43 Aligned_cols=102 Identities=14% Similarity=0.105 Sum_probs=88.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++++.++..+..++||+++++|+||+|||+|.|.. ++.+.. ...|.++||
T Consensus 27 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~~~~l~i~V~ 105 (142)
T 2chd_A 27 DNSNLQCTIIRAKGLKPMDSNGLADPYVKLHLLPGASKSNKLRTKTLRNTRNPVWNETLQYHG-ITEEDMQRKTLRISVC 105 (142)
T ss_dssp GGTEEEEEEEEEESCCCCCTTSCCCEEEEEEEESCCSGGGEEECCCCCSCSSCEEEEEEEEES-CCHHHHHHCEEEEEEE
T ss_pred CCCEEEEEEEEecCCCCCCCCCCCCCEEEEEEEcCCCCcceeeCCcCCCCCCCcCcCEEEEcc-cCHHHccCCEEEEEEE
Confidence 557899999999 99999999999999999999987777899999999999999999999972 444444 456999999
Q ss_pred ccCCCCCCccccccccCcccccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~ 366 (722)
|+|.+++++++|.+.+...+.....
T Consensus 106 d~d~~~~d~~iG~~~i~l~~l~~~~ 130 (142)
T 2chd_A 106 DEDKFGHNEFIGETRFSLKKLKANQ 130 (142)
T ss_dssp EECTTSCEEEEEEEEEEGGGCCTTC
T ss_pred ECCCCCCCcEEEEEEEEHHHcCCCC
Confidence 9999999999999988776655433
|
| >1dqv_A Synaptotagmin III; beta sandwich, calcium ION, C2 domain, endocytosis/exocytosis complex; 3.20A {Rattus rattus} SCOP: b.7.1.2 b.7.1.2 PDB: 3hn8_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-15 Score=161.42 Aligned_cols=99 Identities=16% Similarity=0.086 Sum_probs=89.4
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
+.+.|+|.|.+| ||+++|.+|.+|||||+++.+++++.+++||+++++|+||+|||+|.|. ++.+.+ +..|.++||
T Consensus 150 ~~~~l~v~v~~a~~L~~~d~~g~~Dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 227 (296)
T 1dqv_A 150 TAGLLTVTIIKASNLKAMDLTGFSDPYVKASLISEGRRLKKRKTSIKKNTLNPTYNEALVFD--VAPESVENVGLSIAVV 227 (296)
T ss_dssp TTTEEEEEEEEEESCCCCSSSSCCCEEEEECCCTTCCTTSCEECCCCCSCSSCEEEECCCCC--CCSGGGGSCCCCCEEE
T ss_pred ccceeEEEEEEeecCCccCCCCCCCcEEEEEEEeCCcCccceecceecCCCCCeECceEEEE--cCHHHccCcEEEEEEE
Confidence 457899999999 9999999999999999999998877789999999999999999999999 887776 456999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|.+++++++|.+.++..+...
T Consensus 228 d~d~~~~~~~iG~~~i~l~~~~~ 250 (296)
T 1dqv_A 228 DYDCIGHNEVIGVCRVGPEAADP 250 (296)
T ss_dssp ECCSSSCCEEEEECCCSSCTTCH
T ss_pred eCCCCCCCceEEEEEECCccCCc
Confidence 99999999999999988765544
|
| >2d8k_A Synaptotagmin VII; exocytosis, calcium binding, lysosome, C2 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2e-15 Score=141.91 Aligned_cols=98 Identities=11% Similarity=0.097 Sum_probs=84.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++++.++++ .++||+++++|+||+|||+|.|.. ++.+.+ +..|.++||
T Consensus 24 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~~~~l~i~V~ 100 (141)
T 2d8k_A 24 QESTLTVKIMKAQELPAKDFSGTSDPFVKIYLLPDKK--HKLETKVKRKNLNPHWNETFLFEG-FPYEKVVQRILYLQVL 100 (141)
T ss_dssp SSCCEEEEEEEEESCCCCSSSSCCCEEEEEEEESCCS--SEEECCCCTTCSSCCCCEEEEECS-CCHHHHTTSEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCCCCCCCCCcEEEEEEECCCC--ccEeCceEcCCCCCccccEEEECc-cCHHHcccCEEEEEEE
Confidence 457899999999 999999999999999999998765 378899999999999999999982 344443 566999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+|++++++++|.+.+...+...
T Consensus 101 d~d~~~~~~~iG~~~i~l~~l~~ 123 (141)
T 2d8k_A 101 DYDRFSRNDPIGEVSIPLNKVDL 123 (141)
T ss_dssp ECCSSSSCEEEEEEEEETTTSCT
T ss_pred ECCCCCCCcEEEEEEEEhhhhcC
Confidence 99999999999999887665543
|
| >1rh8_A Piccolo protein; beta-sandwich, metal binding protein; NMR {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-15 Score=143.40 Aligned_cols=99 Identities=14% Similarity=0.123 Sum_probs=84.2
Q ss_pred cceeEEEEeec-CCccccCCCCCCcceEEEecCCCCC---------cccceeeecccCCCcceeeeeecccccccCcc-c
Q 004954 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT---------EKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-E 333 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~---------~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~ 333 (722)
.+.|+|.|.+| ||+++|.+|.+||||++++.++.+. ..++||+++++|+||+|||+|.|.. ++.+.+ .
T Consensus 17 ~~~L~V~v~~a~~L~~~d~~g~~Dpyv~v~~~~~~~~~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-v~~~~l~~ 95 (142)
T 1rh8_A 17 LGNLIIHILQARNLVPRDNNGYSDPFVKVYLLPGRGQVMVVQNASAEYKRRTKYVQKSLNPEWNQTVIYKS-ISMEQLMK 95 (142)
T ss_dssp TTEEEEEEEEEESCCCCSSSSCSCCEEEEEETTSSCCCEECCCCCHHHHTTTTTTHHHHSCEEEEEEEECS-CCHHHHTT
T ss_pred CCEEEEEEEEecCCCCCCCCCCCCceEEEEEecCCCcccccccccccceeeccccCCCCCCCCCCEEEECC-cCHHHccC
Confidence 56899999999 9999999999999999999987543 2578999999999999999999962 454444 5
Q ss_pred ccccccccccCCCCCCccccccccCcccccc
Q 004954 334 KDLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 334 ~~L~~~V~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
..|.++|||+|.+++++++|.+.+...+...
T Consensus 96 ~~l~i~V~d~d~~~~~~~lG~~~i~l~~l~~ 126 (142)
T 1rh8_A 96 KTLEVTVWDYDRFSSNDFLGEVLIDLSSTSH 126 (142)
T ss_dssp CEEEEEEEEECSSSCEEEEEEEEEETTSCGG
T ss_pred CEEEEEEEECCCCCCCceEEEEEEecccccc
Confidence 5699999999999999999999887765543
|
| >2fk9_A Protein kinase C, ETA type; ATP-binding, metal-binding, nucleotide-binding, diacylglycerol binding, serine/threonine-protein kinase, transferase; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.6e-15 Score=142.45 Aligned_cols=92 Identities=12% Similarity=0.009 Sum_probs=77.4
Q ss_pred cccceeEEEEeec-CCccccCC----------CCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCc
Q 004954 263 INNDYGYLSSKEA-DLIDLQHN----------VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG 331 (722)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~----------g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~ 331 (722)
...++|+|.|.+| ||+++|.+ |.+||||++++-. ++..||+++++|+||+|||+|.|. ++.
T Consensus 26 ~~~g~L~V~VieA~~L~~~D~~~~~~~f~~~~g~sDPYv~v~l~~----~~~~kT~v~~ktlnP~WNE~F~f~--v~~-- 97 (157)
T 2fk9_A 26 KFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQ----VRVGQTSTKQKTNKPTYNEEFCAN--VTD-- 97 (157)
T ss_dssp CEEEEEEEEEEEEECCCCCHHHHHTTTSSSSCCCCCEEEEEEETT----EEEEECCCCSSCSSCEEEEEEEEE--EEE--
T ss_pred cCccEEEEEEEEEECCCCccccccccccccCCCCCCeEEEEEECC----EeeEEeeecCCCCCCccCcEEEEE--cCC--
Confidence 4668999999999 99999943 7899999999942 235688999999999999999998 653
Q ss_pred ccccccccccccCCCCCCccccccccCccccc
Q 004954 332 AEKDLMPAEIDNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 332 ~~~~L~~~V~D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
...|.++|||+|++++++++|.+.+...+..
T Consensus 98 -~~~L~~~V~D~d~~~~dd~iG~~~i~l~~l~ 128 (157)
T 2fk9_A 98 -GGHLELAVFHETPLGYDHFVANCTLQFQELL 128 (157)
T ss_dssp -ECEEEEEEEECCSSSSCEEEEEEEEEHHHHH
T ss_pred -CCEEEEEEEECCCCCCCCEEEEEEEEHHHhh
Confidence 2469999999999999999999988765443
|
| >1rlw_A Phospholipase A2, CALB domain; hydrolase, C2 domain; 2.40A {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-14 Score=133.46 Aligned_cols=94 Identities=13% Similarity=0.015 Sum_probs=79.5
Q ss_pred ccceeEEEEeec-CCccc---cCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDL---QHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~---d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~ 339 (722)
|.+.|+|.|.+| ||++| |.+|.+||||++++.++++ .++||+++++|+||+|||+|.|. +.... ...|.++
T Consensus 1 S~~~L~v~v~~a~~L~~~~~~d~~g~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~--v~~~~-~~~l~i~ 75 (126)
T 1rlw_A 1 SSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPD--SRKRTRHFNNDINPVWNETFEFI--LDPNQ-ENVLEIT 75 (126)
T ss_dssp CCEEEEEEEEEEESCCSCHHHHHHCCCCEEEEEECTTSTT--CCEECCCCTTCSSCEEEEEEEEE--ECTTS-CCEEEEE
T ss_pred CCcEEEEEEEeeeCCCCCCccccCCCCCCEEEEEEccCCC--ceEEccccCCCCCCcccceEEEE--ecCCC-CCEEEEE
Confidence 457899999999 99995 7889999999999987653 58899999999999999999999 64333 3459999
Q ss_pred ccccCCCCCCccccccccCccccc
Q 004954 340 EIDNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 340 V~D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|||+|.++ ++++|.+.+...+..
T Consensus 76 V~d~d~~~-~~~iG~~~i~l~~l~ 98 (126)
T 1rlw_A 76 LMDANYVM-DETLGTATFTVSSMK 98 (126)
T ss_dssp EEECCSSC-CEEEEEEEEEGGGSC
T ss_pred EEECCCCC-CceeEEEEEEHHHcc
Confidence 99999985 899999988765543
|
| >3pyc_A E3 ubiquitin-protein ligase smurf1; phospholipid binding, membrane associate, lipid binding PROT; 1.96A {Homo sapiens} PDB: 2jqz_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-14 Score=134.38 Aligned_cols=90 Identities=9% Similarity=-0.021 Sum_probs=77.1
Q ss_pred cceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccccc
Q 004954 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (722)
..+|+|.|.+| +|+++|.+|.+||||++++.+.. .+++|+++++|+||+|||+|.|. +... ..|.++|||+
T Consensus 4 ~~~L~V~v~~a~~L~~~d~~g~sDpyv~v~~~~~~---~~~kT~v~~~t~nP~wne~f~f~--v~~~---~~l~~~v~d~ 75 (132)
T 3pyc_A 4 FIKIRLTVLCAKNLAKKDFFRLPDPFAKIVVDGSG---QCHSTDTVKNTLDPKWNQHYDLY--VGKT---DSITISVWNH 75 (132)
T ss_dssp EEEEEEEEEEEESCCCCSTTCCCCEEEEEEETTTC---CEEECCCCSSCSSCEEEEEEEEE--EETT---CCEEEEEEEG
T ss_pred eEEEEEEEEEeECCCCCCCCCCcCeEEEEEECCCC---ceEECCccCCCCCCCccCEEEEE--eCCC---CEEEEEEEEC
Confidence 36789999999 99999999999999999997642 57899999999999999999998 5432 2399999999
Q ss_pred CCCCC---CccccccccCcccc
Q 004954 344 SDTRD---GEVNGALHEGKADA 362 (722)
Q Consensus 344 D~~~~---~d~iG~v~~~~~~~ 362 (722)
|.+++ ++++|.+.+....+
T Consensus 76 d~~~~~~~d~~lG~~~i~l~~l 97 (132)
T 3pyc_A 76 KKIHKKQGAGFLGCVRLLSNAI 97 (132)
T ss_dssp GGTTSSTTTTEEEEEEECHHHH
T ss_pred CCCCCCCCCCceEEEEEeHHHh
Confidence 99987 69999998865444
|
| >2dmh_A Myoferlin; beta-sandwich, FER-1-like protein 3, muscular dystrophy, cardiomyopathy, membrane fusion, dystrophin, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=4.3e-14 Score=132.38 Aligned_cols=91 Identities=10% Similarity=-0.026 Sum_probs=79.1
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc--cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA--EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~--~~~L~~~V 340 (722)
..+.|+|.|.+| ||+++|. |.+||||++++.. .++||+++++++||+|||+|.|. +..... ...|.++|
T Consensus 5 ~~g~L~v~v~~a~~L~~~~~-g~~dpyv~v~~~~-----~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~~~l~i~V 76 (140)
T 2dmh_A 5 SSGMLRVIVESASNIPKTKF-GKPDPIVSVIFKD-----EKKKTKKVDNELNPVWNEILEFD--LRGIPLDFSSSLGIIV 76 (140)
T ss_dssp BCCEEEEEEEEEESCCCCSS-SCCCEEEEEECSS-----CEEECCCCCSCSSCEEEEEEEEE--CSSCCCCTTCEEEEEE
T ss_pred CCcEEEEEEEEeeCCCCCCC-CCCCeEEEEEECC-----EeEEeeeecCCCCCccCcEEEEE--ecccccCCCCEEEEEE
Confidence 346899999999 9999999 9999999999973 36899999999999999999999 665433 45599999
Q ss_pred cccCCCCCCccccccccCcccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~ 362 (722)
||+|.+++++++|.+.+...+.
T Consensus 77 ~d~d~~~~~~~lG~~~i~l~~l 98 (140)
T 2dmh_A 77 KDFETIGQNKLIGTATVALKDL 98 (140)
T ss_dssp EETTCSSSCCCCEEEEEEGGGT
T ss_pred EECCCCCCCceEEEEEEEHHHh
Confidence 9999999999999998876554
|
| >3b7y_A E3 ubiquitin-protein ligase NEDD4; C2 domain, UBL-conjugation pathway, structural genomics consortium, SGC, cytoplasm; 1.80A {Homo sapiens} PDB: 2nsq_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.2e-14 Score=136.63 Aligned_cols=98 Identities=12% Similarity=0.047 Sum_probs=76.6
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCC-CcccceeeecccCCCcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~-~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++.+.+... ...+++|+++++|+||+|||+|.|. +... +..|.++||
T Consensus 18 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~--~~~l~~~V~ 93 (153)
T 3b7y_A 18 NSRIVRVRVIAGIGLAKKDILGASDPYVRVTLYDPMNGVLTSVQTKTIKKSLNPKWNEEILFR--VHPQ--QHRLLFEVF 93 (153)
T ss_dssp TCEEEEEEEEEEESCC-------CCEEEEEEEEETTTEEEEEEECCCCSSCSSCCCCEEEEEE--ECTT--TCEEEEEEE
T ss_pred CccEEEEEEEEeeCCCCCCCCCCCCcEEEEEEECCCCccceeeeCccccCCCCCCCCCEEEEE--ecCC--CCEEEEEEE
Confidence 557899999999 999999999999999999986433 2357899999999999999999998 6543 456999999
Q ss_pred ccCCCCCCccccccccCccccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEH 365 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e 365 (722)
|+|.+++++++|.+.+...+....
T Consensus 94 d~d~~~~d~~iG~~~i~l~~l~~~ 117 (153)
T 3b7y_A 94 DENRLTRDDFLGQVDVPLYPLPTE 117 (153)
T ss_dssp ECCSSSCCEEEEEEEEECCSCCBC
T ss_pred ECCCCcCCCeeEEEEEEHHHcccC
Confidence 999999999999998877655443
|
| >2r83_A Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal-binding palmitate; 2.70A {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.46 E-value=2.1e-14 Score=150.63 Aligned_cols=97 Identities=13% Similarity=0.113 Sum_probs=87.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+|||||+++.+++++..++||+++++|+||+|||+|.|. ++.+.+ +..|.++||
T Consensus 148 ~~~~l~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~i~V~ 225 (284)
T 2r83_A 148 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVL 225 (284)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCTTTGGGEEEEEEEE
T ss_pred cCCceEEEEEEeECCCCcCCCCCcCeEEEEEEEeCCcEeeeeccceecCCCCCEEceeEEEe--CCHHHhCceEEEEEEE
Confidence 356899999999 9999999999999999999988776678999999999999999999999 887776 456999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|++++++++|.+.++....
T Consensus 226 d~d~~~~~~~iG~~~i~l~~~ 246 (284)
T 2r83_A 226 DYDKIGKNDAIGKVFVGYNST 246 (284)
T ss_dssp ECCSSSCCCEEEEEEEETTCC
T ss_pred eCCCCCCCcEEEEEEECCCCC
Confidence 999999999999998876543
|
| >1gmi_A Protein kinase C, epsilon type; PKC, C2 domain, X-RAY, phospholipids, PKC epsilon.; 1.7A {Rattus rattus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-14 Score=136.28 Aligned_cols=91 Identities=10% Similarity=0.062 Sum_probs=76.2
Q ss_pred cceeEEEEeec-CCccccCCCC-----------CCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc
Q 004954 265 NDYGYLSSKEA-DLIDLQHNVV-----------GDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 332 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~-----------sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~ 332 (722)
.+.|+|.|.+| ||+++|.+|. +||||++.+-. +...+|+++++|+||+|||+|.|. ++..
T Consensus 5 ~g~L~v~v~~a~~L~~~d~~~~~~~g~~~~~~~~DPyv~v~l~~----~~~~~T~~~~~t~nP~WnE~f~f~--v~~~-- 76 (136)
T 1gmi_A 5 NGLLKIKICEAVSLKPTAWSLRDAVGPRPQTFLLDPYIALNVDD----SRIGQTATKQKTNSPAWHDEFVTD--VCNG-- 76 (136)
T ss_dssp EEEEEEEEEEEESCCCCHHHHCC-CCSSCCCCCCCEEEEEEETT----EEEEECCCCSSCSSCEEEEEEEEE--EEEE--
T ss_pred ceEEEEEEEeCcCCCCcccccccccccccCCcCcCcEEEEEECC----eEeeeeeEECCCcCCccCCEEEEE--ecCC--
Confidence 46899999999 9999997665 99999999832 235688889999999999999998 6543
Q ss_pred cccccccccccCCCCCCccccccccCcccccc
Q 004954 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 333 ~~~L~~~V~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
..|.++|||+|++++++++|.+.+...+...
T Consensus 77 -~~L~~~V~d~d~~~~dd~iG~~~i~l~~l~~ 107 (136)
T 1gmi_A 77 -RKIELAVFHDAPIGYDDFVANCTIQFEELLQ 107 (136)
T ss_dssp -CEEEEEEEECCSSSSCEEEEEEEEEHHHHTS
T ss_pred -CEEEEEEEeCCCCCCCCEEEEEEEEHHHhcc
Confidence 5699999999999999999999887654443
|
| >3m7f_B E3 ubiquitin-protein ligase NEDD4; C2 domain, GRB10, SH2 domain, phosphoprotein, conjugation pathway, signaling protein-ligase complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.46 E-value=3e-14 Score=139.13 Aligned_cols=99 Identities=9% Similarity=-0.012 Sum_probs=77.1
Q ss_pred cccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCC-cccceeeecccCCCcceeeeeecccccccCcccccccccc
Q 004954 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT-EKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (722)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~-~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V 340 (722)
+..+.|+|.|.+| +|+++|.+|.+||||++++.....+ ..+++|+++++++||+|||+|.|. +... ...|.++|
T Consensus 5 ~~~g~L~V~v~~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~~kT~v~~~t~nP~Wne~f~f~--v~~~--~~~L~~~V 80 (176)
T 3m7f_B 5 DDTRVVRVKVIAGIGLAKKDILGASDPYVRVTLYDPMSGILTSVQTKTIKKSLNPKWNEEILFR--VLPQ--RHRILFEV 80 (176)
T ss_dssp TTCEEEEEEEEEEESCC---CCCCCCEEEEEEEEETTTEEEEEEECCCCSSCSSCEEEEEEEEE--ECTT--TCEEEEEE
T ss_pred CCcEEEEEEEEEeeCCCCcCCCCCcCcEEEEEEECCCCCcccceeCceECCCCCCcccceEEEE--EcCC--CCEEEEEE
Confidence 3567899999999 9999999999999999999864332 257899999999999999999998 6532 35599999
Q ss_pred cccCCCCCCccccccccCccccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~e 365 (722)
||+|++++++++|.+.+....+...
T Consensus 81 ~d~d~~~~d~~lG~~~i~l~~l~~~ 105 (176)
T 3m7f_B 81 FDENRLTRDDFLGQVDVPLYPLPTE 105 (176)
T ss_dssp EECC----CEEEEEEEEESCSCCBC
T ss_pred EECCCCCCCcEEEEEEEEHHHcccc
Confidence 9999999999999998876655443
|
| >2ep6_A MCTP2 protein; beta sandwich, Ca2+ binding, membrane binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.46 E-value=2.7e-14 Score=132.72 Aligned_cols=91 Identities=11% Similarity=0.051 Sum_probs=80.1
Q ss_pred cccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccc
Q 004954 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
...+.|+|.|.+| ||+++|.+|.+||||++.+.+ .+++|+++++|+||+|||+|.|. +.. ....|.++||
T Consensus 10 ~~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~-----~~~kT~~~~~t~nP~wne~f~f~--~~~--~~~~l~i~V~ 80 (133)
T 2ep6_A 10 KDVGILQVKVLKAADLLAADFSGKSDPFCLLELGN-----DRLQTHTVYKNLNPEWNKVFTFP--IKD--IHDVLEVTVF 80 (133)
T ss_dssp CCSEEEEEEEEEEESCCCSSSSSCCCEEEEEEETT-----EEEECCCCSSCSSCCCCEEEEEE--ESC--TTCEEEEEEE
T ss_pred CCceEEEEEEEeeECCCCCCCCCCcCeEEEEEECC-----EEEEeeeecCCCCCccccEEEEE--ecC--CCCEEEEEEE
Confidence 4678999999999 999999999999999999965 36789999999999999999998 653 3456999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|.+++++++|.+.+...+.
T Consensus 81 d~d~~~~~~~lG~~~i~l~~l 101 (133)
T 2ep6_A 81 DEDGDKPPDFLGKVAIPLLSI 101 (133)
T ss_dssp EEETTEEEEECCBCEEEGGGC
T ss_pred ECCCCCCCCeeEEEEEEHHHc
Confidence 999999999999998876554
|
| >1dqv_A Synaptotagmin III; beta sandwich, calcium ION, C2 domain, endocytosis/exocytosis complex; 3.20A {Rattus rattus} SCOP: b.7.1.2 b.7.1.2 PDB: 3hn8_A | Back alignment and structure |
|---|
Probab=99.45 E-value=5.2e-14 Score=148.94 Aligned_cols=91 Identities=16% Similarity=0.088 Sum_probs=82.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||+++++|+++ .+++|+++++|+||+|||+|.|. ++.+.+ .+.|.++||
T Consensus 18 ~~~~L~v~v~~a~~L~~~d~~g~~dPyv~v~l~~~~~--~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~~~V~ 93 (296)
T 1dqv_A 18 GSDQLVVRILQALDLPAKDSNGFSDPYVKIYLLPDRK--KKFQTKVHRKTLNPIFNETFQFS--VPLAELAQRKLHFSVY 93 (296)
T ss_dssp SSCEEEEEEEEEECCCCCSTTSCCCEEEEEECTTSTT--SCEECCCCCSCSSCEEEEEEEEE--CCGGGGSSCCCEEEEE
T ss_pred CCCEEEEEEEEeECCCCcCCCCCcCeEEEEEEEcCCC--eeEeCCccCCCCCCcEeeEEEEE--ecHHHhcCCEEEEEEE
Confidence 457899999999 999999999999999999998765 47789999999999999999999 777666 456999999
Q ss_pred ccCCCCCCccccccccC
Q 004954 342 DNSDTRDGEVNGALHEG 358 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~ 358 (722)
|+|++++++++|++.+.
T Consensus 94 d~d~~~~~~~iG~~~i~ 110 (296)
T 1dqv_A 94 DFDRFSRHDLIGQVVLD 110 (296)
T ss_dssp ECCSSSCCCEEEEEECC
T ss_pred EcCCCCCCceEEEEEec
Confidence 99999999999999874
|
| >1wfj_A Putative elicitor-responsive gene; C2 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, plant protein; NMR {Arabidopsis thaliana} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.43 E-value=6.8e-14 Score=130.36 Aligned_cols=91 Identities=12% Similarity=0.047 Sum_probs=79.1
Q ss_pred cccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecc-cCCCcceeeeeecccccccCcccccccccc
Q 004954 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSK-RGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (722)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k-~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V 340 (722)
...+.|+|.|.+| +|+++|..|.+||||++.+.+. +++|++++ +++||+|||+|.|. +.. ....|.++|
T Consensus 7 ~~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~-----~~kT~~~~~~~~nP~Wne~f~f~--v~~--~~~~l~~~V 77 (136)
T 1wfj_A 7 GPHGTLEVVLVSAKGLEDADFLNNMDPYVQLTCRTQ-----DQKSNVAEGMGTTPEWNETFIFT--VSE--GTTELKAKI 77 (136)
T ss_dssp CCEEEEEEEEEEEEECSSCCSSCSSCCCEEEESSSC-----EEECCCCTTCCSSCEEEEEEEEE--EES--SCCEEEEEE
T ss_pred CCcEEEEEEEEeccCCCCcccCCCcCceEEEEECCc-----cceeEeccCCCCCCccCcEEEEE--ECC--CCCEEEEEE
Confidence 3567899999999 9999999999999999999753 56888887 99999999999998 664 445699999
Q ss_pred cccCCCCCCccccccccCcccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~ 362 (722)
||+|.+++++++|.+.+...+.
T Consensus 78 ~d~~~~~~d~~lG~~~i~l~~l 99 (136)
T 1wfj_A 78 FDKDVGTEDDAVGEATIPLEPV 99 (136)
T ss_dssp CCSSSCTTTCCSEEEEEESHHH
T ss_pred EECCCCCCCceEEEEEEEHHHh
Confidence 9999999999999998876544
|
| >3nsj_A Perforin-1; pore forming protein, immune system; HET: NAG; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.42 E-value=7.9e-14 Score=158.48 Aligned_cols=102 Identities=12% Similarity=0.089 Sum_probs=83.4
Q ss_pred CCCccc-cCCCCc---c------ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceee
Q 004954 251 EPLCKC-CAGEGK---I------NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIE 319 (722)
Q Consensus 251 ~~~~~~-~~~~~~---~------s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE 319 (722)
--.|.| |+..-- + ...+|+|.|.+| ||++ |.+|.+|||||+++.. .+.||+++++++||+|||
T Consensus 369 g~~C~C~C~~~~~t~~~~C~~~~~~~~L~V~V~~A~~L~~-D~~g~sDPYV~v~l~~-----~~~kTkvik~tlNP~Wne 442 (540)
T 3nsj_A 369 HDSCQCECQDSKVTNQDCCPRQRGLAHLVVSNFRAEHLWG-DYTTATDAYLKVFFGG-----QEFRTGVVWNNNNPRWTD 442 (540)
T ss_dssp SCTTCEEESCTTTBCGGGCBSSTTEEEEEEEEEEEESCCC-SSCSCCCEEEEEEETT-----EEEECCCBCSCSSCBCCC
T ss_pred CCceEeeCCCCCCcccccccccCcccEEEEEEEEccCCCc-ccCCCcCeEEEEEECC-----EeeeeeeecCCCCCCCCe
Confidence 345788 776411 1 246899999999 9999 9999999999999952 359999999999999999
Q ss_pred eeecccccccCcccccccccccccCCCCCCccccccccCcc
Q 004954 320 GFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKA 360 (722)
Q Consensus 320 ~f~f~~~v~~~~~~~~L~~~V~D~D~~~~~d~iG~v~~~~~ 360 (722)
+|.|. +........|.++|||+|.++++|++|.+.+...
T Consensus 443 ~f~f~--~~~~~~~~~L~~~V~D~D~~~~dD~LG~~~~~L~ 481 (540)
T 3nsj_A 443 KMDFE--NVLLSTGGPLRVQVWDADYGWDDDLLGSCDRSPH 481 (540)
T ss_dssp CEEEE--EEETTTCCCEEEEEEECCSSSCCEEEEEEEECCC
T ss_pred EEEEE--EecCCCCCEEEEEEEECCCCCCCCEEEEEEEEee
Confidence 99997 4322245569999999999999999999987664
|
| >2r83_A Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal-binding palmitate; 2.70A {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.41 E-value=1.4e-13 Score=144.32 Aligned_cols=96 Identities=15% Similarity=0.111 Sum_probs=85.1
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+||||++++.++++. +++|+++++|+||+|||+|.|. ++.+.. ...|.++||
T Consensus 17 ~~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~--~~~T~~~~~~~nP~wne~f~f~--v~~~~~~~~~l~~~V~ 92 (284)
T 2r83_A 17 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELAGKTLVMAVY 92 (284)
T ss_dssp TTTEEEEEEEEEECCCCCSSSSSCCEEEEEEEETCTTS--CEECCCCCSCSSCEEEEEEEEC--CCGGGCTTCEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCeEEEEEEEcCCCc--eEeCCcccCCCCCeeCceEEEE--echHHhCcCEEEEEEE
Confidence 457899999999 9999999999999999999987653 7789999999999999999999 887766 566999999
Q ss_pred ccCCCCCCccccccccCccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|+|++++++++|.+.+......
T Consensus 93 d~d~~~~~~~lG~~~i~l~~l~ 114 (284)
T 2r83_A 93 DFDRFSKHDIIGEFKVPMNTVD 114 (284)
T ss_dssp ECCSSSCCCEEEEEEEEGGGCC
T ss_pred ECCCCCCCceeEEEEEcchhcc
Confidence 9999999999999988765543
|
| >3kwu_A MUNC13-1; calcium binding protein, phospholipid binding protein, metal binding protein; HET: GOL; 1.37A {Rattus norvegicus} SCOP: b.7.1.0 PDB: 3kwt_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.7e-13 Score=129.60 Aligned_cols=90 Identities=11% Similarity=0.043 Sum_probs=77.8
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
..+.|+|.|.+| ||+++|.+|.+||||++.+- ..+++|+++++|+||+|||+|.|. +... ...|.++|||
T Consensus 15 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~-----~~~~kT~~~~~t~nP~Wne~f~f~--v~~~--~~~l~~~v~d 85 (148)
T 3kwu_A 15 WSAKISITVVCAQGLQAKDKTGSSDPYVTVQVG-----KTKKRTKTIYGNLNPVWEENFHFE--CHNS--SDRIKVRVLD 85 (148)
T ss_dssp CCEEEEEEEEEEESCCCCSTTSCCCEEEEEEET-----TEEEECCCCCSCSSCEEEEEEEEE--ECST--TCEEEEEEEE
T ss_pred cccEEEEEEEeeeCCCCCCCCCCcCeEEEEEEC-----CEEEECCccCCCCCCCcccEEEEE--ecCC--CCEEEEEEEE
Confidence 357899999999 99999999999999999992 257799999999999999999998 5433 2459999999
Q ss_pred cCCC-----------CCCccccccccCcccc
Q 004954 343 NSDT-----------RDGEVNGALHEGKADA 362 (722)
Q Consensus 343 ~D~~-----------~~~d~iG~v~~~~~~~ 362 (722)
+|.+ ++++++|.+.+.....
T Consensus 86 ~d~~~~~~~~~~~~~~~~~~lG~~~i~l~~l 116 (148)
T 3kwu_A 86 EDDDIKSRVKQRFKRESDDFLGQTIIEVRTL 116 (148)
T ss_dssp CCCSHHHHHHTTTSSCSSEEEEEEEEEGGGC
T ss_pred CCCCccccccccccCCCCccEEEEEEEHHHC
Confidence 9987 7899999998876555
|
| >2nq3_A Itchy homolog E3 ubiquitin protein ligase; C2 domain, UBL conjugation pathway, structural genomics consortium, SGC; 1.80A {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.36 E-value=2.1e-13 Score=133.12 Aligned_cols=88 Identities=7% Similarity=-0.057 Sum_probs=73.6
Q ss_pred ccceeEEEEeec-CCc-cccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLI-DLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~-~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
....|+|.|.+| +|+ ++|..+ +||||++++.. .++||+++++|+||+|||+|.|. +.. ...|.++||
T Consensus 34 ~~~~L~V~V~~A~~L~~~~~~~~-sDPYv~v~~~~-----~~~kT~v~~~tlnP~Wne~f~f~--v~~---~~~L~~~V~ 102 (173)
T 2nq3_A 34 MKSQLQITVISAKLKENKKNWFG-PSPYVEVTVDG-----QSKKTEKCNNTNSPKWKQPLTVI--VTP---VSKLHFRVW 102 (173)
T ss_dssp CCEEEEEEEEEEEECCCC--CCC-CCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--ECT---TCEEEEEEE
T ss_pred CceEEEEEEEEeECCCCcccCCC-CCeEEEEEECC-----EEeEccccCCCCCCeECCEEEEE--eCC---CCEEEEEEE
Confidence 456799999999 999 666555 99999999953 58899999999999999999998 642 556999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|.+++++++|.+.+...++
T Consensus 103 D~d~~~~dd~lG~~~i~l~~l 123 (173)
T 2nq3_A 103 SHQTLKSDVLLGTAALDIYET 123 (173)
T ss_dssp ECCSSSCCEEEEEEEEEHHHH
T ss_pred ECCCCCCCceEEEEEEEHHHh
Confidence 999999999999998866544
|
| >2cjt_A UNC-13 homolog A, MUNC13-1; phorbol-ester binding, neurotransmitter release, RIM, MUNC13 domains, exocytosis, metal-binding; 1.44A {Rattus norvegicus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.33 E-value=4.7e-13 Score=124.55 Aligned_cols=88 Identities=10% Similarity=-0.001 Sum_probs=69.6
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeee-cccCCCcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSS-SKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~-~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
+...|+|+|++| +|++ +|.+||||++. . .+.||++ +++|+||+|||+|.|. +.. .+..|.++||
T Consensus 3 ~~~~L~V~V~~A~~l~~---~g~~DPYv~v~--~-----~~~kt~~~~~~t~nP~WnE~f~f~--v~~--~~~~L~~~V~ 68 (131)
T 2cjt_A 3 VMSLLCVGVKKAKFDGA---QEKFNTYVTLK--V-----QNVKSTTIAVRGSQPSWEQDFMFE--INR--LDLGLTVEVW 68 (131)
T ss_dssp CCEEEEEEEEEEECSSC---GGGCEEEEEEE--E-----TTEEEECCCEESSSCEEEEEEEEE--ECC--CSSEEEEEEE
T ss_pred cceEEEEEEEEeECCCC---CCCcCeEEEEE--e-----cCEEEeEecCCCCCceECCEEEEE--EeC--CCCeEEEEEE
Confidence 457899999999 8753 78999999999 1 1334444 4589999999999998 653 3445999999
Q ss_pred ccCCCCCCccccccccCcccccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~ 366 (722)
|+| +++++++|.+.+...+....+
T Consensus 69 D~d-~~~dd~iG~~~i~l~~l~~~~ 92 (131)
T 2cjt_A 69 NKG-LIWDTMVGTVWIPLRTIRQSN 92 (131)
T ss_dssp ECC-SSCEEEEEEEEEEGGGSCBCS
T ss_pred ECC-CCCCCeEEEEEEEHHHhhhcC
Confidence 999 889999999988876665444
|
| >2cjs_A UNC-13 homolog A, MUNC13-1; neurotransmitter transport, zinc finger, synapto phorbol-ester binding; 1.78A {Rattus norvegicus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.24 E-value=4.8e-12 Score=122.72 Aligned_cols=86 Identities=10% Similarity=-0.020 Sum_probs=68.3
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeec-ccCCCcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~-k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
....|+|.|++| +|+ .+|.+||||++. . .+.||+++ ++++||+|||+|.|. +.. .+..|.++||
T Consensus 12 ~~~~L~V~V~~A~~l~---~~g~~DPYV~v~--~-----~~~kt~~~~~~t~nP~WnE~f~f~--v~~--~~~~L~~~V~ 77 (167)
T 2cjs_A 12 ILSLLCVGVKKAKFDG---AQEKFNTYVTLK--V-----QNVESTTIAVRGSQPSWEQDFMFE--INR--LDLGLTVEVW 77 (167)
T ss_dssp CCCEEEEEEEEEECSS---CGGGCEEEEEEE--E-----TTEEEECCCEESSSCEEEEEEEEE--CCC--TTSEEEEEEE
T ss_pred ceEEEEEEEEEEECCC---CCCCCCeEEEEE--e-----cceEEEEecCCCCCCCCCCEEEEE--eeC--CCCEEEEEEE
Confidence 467999999999 774 378999999999 1 23455554 479999999999999 653 3445999999
Q ss_pred ccCCCCCCccccccccCcccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
|+| +++++++|.+.+...+...
T Consensus 78 D~d-~~~dd~iG~~~i~L~~l~~ 99 (167)
T 2cjs_A 78 NKG-LIWDTMVGTVWIPLRTIRQ 99 (167)
T ss_dssp ECC-SSCCEEEEEEEEEGGGSCB
T ss_pred ECC-CCCCceEEEEEEEHHHhcc
Confidence 999 8899999999887655443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=1.4e-10 Score=119.21 Aligned_cols=139 Identities=17% Similarity=0.150 Sum_probs=107.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+.|++...++.|+.+.||++.. .++.+++|+..... .....+.+|..+++.+.. +..++++++++...+..+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-----KLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-----TSCCCCEEEEEEETTEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-----CCCCCeEEEEEecCCceE
Confidence 4688999999999999999974 46889999987532 223468899999999964 246888899888889999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH---------------------------------
Q 004954 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--------------------------------- 539 (722)
Q Consensus 493 iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs--------------------------------- 539 (722)
+||||++|..+.... .+......++.+++.+|+.||+
T Consensus 87 lv~e~i~G~~l~~~~----------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEY----------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHC----------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhcc----------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999985433221 1122345788899999999998
Q ss_pred --------------------------CCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 540 --------------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 540 --------------------------~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
..++|+|++|.|||++. ...+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~--~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD--GKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET--TEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC--CcEEEEEEchhcc
Confidence 45899999999999973 4456799999763
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.7e-11 Score=142.04 Aligned_cols=96 Identities=8% Similarity=-0.021 Sum_probs=81.0
Q ss_pred ccceeEEEEeec-CCccccC--CCCCCcceEEEecCCCCCcccceeeecccC-CCcceeeeeecccccccCccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQH--NVVGDSSTDCDLAPHPGTEKSSSYSSSKRG-SSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~--~g~sDpyvk~~l~~d~~~~~k~kt~~~k~t-lnP~~nE~f~f~~~v~~~~~~~~L~~~ 339 (722)
....|+|.|.+| +|+++|. +|.+||||++.+...+....++||++++++ +||+|||+|.|. +....+ ..|.++
T Consensus 495 ~~~~L~V~Vi~A~~L~~~d~~~~~~~DPYV~V~l~g~~~d~~~~kTkvi~~ng~NP~WnE~f~F~--v~~~el-~~L~~~ 571 (624)
T 1djx_A 495 RPERLRVRIISGQQLPKVNKNKNSIVDPKVIVEIHGVGRDTGSRQTAVITNNGFNPRWDMEFEFE--VTVPDL-ALVRFM 571 (624)
T ss_dssp CCEEEEEEEEEEESCCCCSSCSSSCCCEEEEEEEESSGGGCEEEECCCCTTCSSSCEEEEEEEEE--ESCGGG-CEEEEE
T ss_pred cceEEEEEEEEcCCCCcccccccCCCCcEEEEEEecCCCCcceeecccccCCCCCCccCceEEEE--EecCCC-CEEEEE
Confidence 457899999999 9999994 789999999999765444568899998887 999999999998 664443 349999
Q ss_pred ccccCCCCCCccccccccCcccc
Q 004954 340 EIDNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 340 V~D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|||+|++++++++|.+.+....+
T Consensus 572 V~D~D~~~~dd~iG~~~ipl~~L 594 (624)
T 1djx_A 572 VEDYDSSSKNDFIGQSTIPWNSL 594 (624)
T ss_dssp EEECCSSSCCEEEEEEEEEGGGB
T ss_pred EEEcCCCCCCceeEEEEEEHHHc
Confidence 99999999999999998766543
|
| >1cjy_A CPLA2, protein (cytosolic phospholipase A2); lipid-binding, hydrolase; HET: MES; 2.50A {Homo sapiens} SCOP: b.7.1.1 c.19.1.2 PDB: 1bci_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.8e-11 Score=143.35 Aligned_cols=94 Identities=13% Similarity=0.010 Sum_probs=81.8
Q ss_pred ccceeEEEEeec-CCcc---ccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccc
Q 004954 264 NNDYGYLSSKEA-DLID---LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~---~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~ 339 (722)
....|+|.|.+| +|++ +|.+|.+||||++++.+++. .++||+++++|+||+|||+|.|. +... ....|.++
T Consensus 16 ~~g~L~V~Vi~A~nL~~~~~~D~~g~sDPYV~V~l~~~~~--~k~kTkvik~tlNPvWNEtF~F~--v~~~-~~~~L~~~ 90 (749)
T 1cjy_A 16 YSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPD--SRKRTRHFNNDINPVWNETFEFI--LDPN-QENVLEIT 90 (749)
T ss_dssp CCEEEEEEEEEEECCCSCHHHHHHCCCCEEEEEECTTSTT--CCEECCCCTTCSSCEEEEEEEEE--ECTT-SCCBCEEE
T ss_pred CccEEEEEEEEEECCCCccccCCCCCcCeEEEEEEecCCC--CeEecceEcCCCCCeeeeEEEEE--ecCC-CCCEEEEE
Confidence 357899999999 9999 99999999999999987644 58899999999999999999999 6643 23459999
Q ss_pred ccccCCCCCCccccccccCccccc
Q 004954 340 EIDNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 340 V~D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|||+|+++ ++++|.+.+...+..
T Consensus 91 V~D~D~~~-ddfIG~v~I~L~~L~ 113 (749)
T 1cjy_A 91 LMDANYVM-DETLGTATFTVSSMK 113 (749)
T ss_dssp EEECCSSS-CEEEEEECCBSTTSC
T ss_pred EEECCCCC-CceeEEEEEEHHHcC
Confidence 99999999 999999988876553
|
| >3jzy_A Intersectin 2; C2 domain, structural genomics consortium (SGC), endocytosis; 1.56A {Homo sapiens} PDB: 3qbv_B* 1ki1_B | Back alignment and structure |
|---|
Probab=99.12 E-value=2.3e-11 Score=137.93 Aligned_cols=90 Identities=11% Similarity=0.014 Sum_probs=77.1
Q ss_pred ceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccC
Q 004954 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D 344 (722)
+.|+|.|.+| ||+++|.+|.+||||++.+.. .+++|+++++|+||+|||+|.|. +... ....|.++|||+|
T Consensus 387 ~~l~v~v~~a~~L~~~d~~~~sdpyv~v~~~~-----~~~~T~~~~~t~nP~w~e~f~f~--~~~~-~~~~l~~~v~d~d 458 (510)
T 3jzy_A 387 GRLMVHVIEATELKACKPNGKSNPYCEISMGS-----QSYTTRTIQDTLNPKWNFNCQFF--IKDL-YQDVLCLTLFDRD 458 (510)
T ss_dssp EEEEEEEEEEESCCCCSTTSCCCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--ESCT-TTCEEEEEEEECC
T ss_pred ceEEEEeceeecCCCCCCCCCCCeEEEEEECC-----eeccCCccCCCCCCccCceEEEE--ecCC-CCCEEEEEEEeCC
Confidence 5788999999 999999999999999999932 47899999999999999999998 5422 2345999999999
Q ss_pred CCCCCccccccccCccccc
Q 004954 345 DTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 345 ~~~~~d~iG~v~~~~~~~~ 363 (722)
.+++++++|.+.+...++.
T Consensus 459 ~~~~~d~lG~~~~~l~~l~ 477 (510)
T 3jzy_A 459 QFSPDDFLGRTEIPVAKIR 477 (510)
T ss_dssp SSSSCCEEEEEEEEHHHHH
T ss_pred CCCCCCceEEEEEEHHHhc
Confidence 9999999999988765443
|
| >3l9b_A Otoferlin; C2-domain, beta-sheets, cell membrane, synaptic V hearing, membrane, synapse, transmembrane, membrane protein; 1.95A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.4e-11 Score=112.04 Aligned_cols=91 Identities=12% Similarity=0.001 Sum_probs=77.5
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecc-cCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSK-RGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k-~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
+.+.|+|.|+.| ||+ |.+|||+|+.+ +..|+||++++ +++||+|||.|.|. +.-... +.+|.+.|
T Consensus 19 ~~msL~V~l~~a~~Lp-----g~~Dp~akv~F-----Rg~k~kTkvi~~~~~npvfnE~F~wp--l~~~ld~~e~L~v~V 86 (144)
T 3l9b_A 19 SHMALIVHLKTVSELR-----GRADRIAKVTF-----RGQSFYSRVLENCEDVADFDETFRWP--VASSIDRNEVLEIQI 86 (144)
T ss_dssp CCEEEEEEEEEEESCC-----SCEEEEEEEEE-----TTEEEECCCEEEECSCEEEEEEEEEE--ESSCCCTTCEEEEEE
T ss_pred CcEEEEEEEEEecCCC-----CCCCCeEEEEE-----eccceeeEEeccCCCCceEcceEEec--CCCCCCCCCEEEEEE
Confidence 778999999999 999 68999999999 35689999987 79999999999998 665333 55599999
Q ss_pred cccCCCCCCccccccccCcccccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAEEHG 366 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~~e~ 366 (722)
.|+++++++.++|++.+.......++
T Consensus 87 ~d~~~v~~nrlIG~~~i~Lq~lv~~~ 112 (144)
T 3l9b_A 87 FNYSKVFSNKLIGTFRMVLQKVVEEN 112 (144)
T ss_dssp EEECTTSCCEEEEEEEEESHHHHHHS
T ss_pred EECccccCCCEEEEEEEEhHHhccCC
Confidence 99999999999999988765554444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=1.7e-09 Score=110.04 Aligned_cols=136 Identities=14% Similarity=0.079 Sum_probs=97.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
..|.+....+.|..+.||++. ..+|+.+++|+.... ....+.+|..+++.+.... -.+++++++....+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~----~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTG----VPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTT----CCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCC----CCCCeEEEeccCCCCCEE
Confidence 346665544566679999996 456788999997654 2356788999999997531 136778888888788999
Q ss_pred EEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 004954 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-------------------------------- 541 (722)
Q Consensus 494 VmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g-------------------------------- 541 (722)
||||++|..+. .. . .. ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~-~~--~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 93 LLGEVPGQDLL-SS--H-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp EEECCSSEETT-TS--C-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred EEEecCCcccC-cC--c-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 99999875433 11 0 11 1245667777777777643
Q ss_pred --------------------------CccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 542 --------------------------IIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 542 --------------------------IvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
++|+|++|.|||++. +..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~--~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN--GRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET--TEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC--CcEEEEEcchhcc
Confidence 999999999999974 4456699999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=5e-09 Score=112.99 Aligned_cols=141 Identities=12% Similarity=0.187 Sum_probs=103.0
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEee--cch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---CeE
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---EHL 491 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~--~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~---~~l 491 (722)
++.|+.|.++.||++.. .+..+++|+.. ... .....+.+|..+++.+... +..+++++.++... +..
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~----~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGT----DVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTS----SSCCCCEEEEECCTTTTSSC
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcC----CCCCCcEEEECCCCCccCCe
Confidence 56789999999999974 34678899876 332 2235778899999999863 23578888887766 458
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH--------------------------------
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-------------------------------- 539 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-------------------------------- 539 (722)
++||||++|..+... ....++......++.+++.+|+.||+
T Consensus 117 ~~vme~v~G~~l~~~-------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ-------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp EEEEECCCCBCCCCT-------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCeecCCC-------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 999999997532110 01126778888899999999999997
Q ss_pred --------------------------CCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 540 --------------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 540 --------------------------~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
..++|+|+++.|||++.++...+.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 358999999999999863334479999998754
|
| >3bxj_A RAS GTPase-activating protein syngap; GTPase activation, membrane, phosphoprotein, SH3-binding, signaling protein; 3.00A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.84 E-value=3.6e-10 Score=127.50 Aligned_cols=88 Identities=15% Similarity=0.009 Sum_probs=9.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccC---CCcceeeeeecccccccCccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRG---SSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~t---lnP~~nE~f~f~~~v~~~~~~~~L~~~ 339 (722)
..+.|+|.|.+| +|+++| ||||++++-. +.+.||+++++| +||+|||+|.|. +... ...|.++
T Consensus 9 ~~~~L~V~VieAk~L~~~d-----dpYv~v~l~~----~~~~kT~v~~kt~~glnP~WnE~F~f~--~~~~--~~~L~v~ 75 (483)
T 3bxj_A 9 VDNVLKLWIIEARELPPKK-----RYYCELCLDD----MLYARTTSKPRSASGDTVFWGEHFEFN--NLPA--VRALRLH 75 (483)
T ss_dssp EEECC------------------------------------------------------CCEECC---------------
T ss_pred eccEEEEEEEEcCCcCCCC-----CCeEEEEECC----eEEeeeeEEeCCCCCCCCccccEEEEe--cCCC--ccEEEEE
Confidence 456899999999 999998 9999999942 235689999999 999999999998 3322 2569999
Q ss_pred ccc-cC---CCCCCccccccccCcccccc
Q 004954 340 EID-NS---DTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 340 V~D-~D---~~~~~d~iG~v~~~~~~~~~ 364 (722)
||| +| ++++++++|.+.++......
T Consensus 76 V~d~~d~~~~~~~d~~lG~v~i~l~~l~~ 104 (483)
T 3bxj_A 76 LYRDSDKKRKKDKAGYVGLVTVPVATLAG 104 (483)
T ss_dssp -----------------------------
T ss_pred EEecCCccccCCCCceEEEEEEEHHHhcC
Confidence 999 56 47889999999988766554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=3.5e-09 Score=111.62 Aligned_cols=183 Identities=17% Similarity=0.157 Sum_probs=118.1
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---eEEEEEEc
Q 004954 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---HLFIVCEL 497 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~---~l~iVmEy 497 (722)
.++.|....||++. ..+++|+.... .....+.+|..+++.+....... +++++....... ..|+||++
T Consensus 27 ~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~---vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLP---IPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp EEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSC---CCCEEEECCCCSSCSCSCEEEEC
T ss_pred ecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCC---CCceEeecCCCCCCCcceEEEcc
Confidence 48899999999863 46889987543 33467889999999986433222 444444433332 35889999
Q ss_pred cccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 004954 498 LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-------------------------------------- 539 (722)
Q Consensus 498 ~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-------------------------------------- 539 (722)
++|..+...... .++..+...++.|++..|+.||+
T Consensus 98 i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 98 IKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 998533221111 16677777888888888888885
Q ss_pred --------------------CCCccccCCCCceEEcccCCCeEEEEecCCcccccCCccccccCCcc---cCchhhc---
Q 004954 540 --------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY---RAPEVII--- 593 (722)
Q Consensus 540 --------------------~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~y---~APE~l~--- 593 (722)
..++|+|++|.||+++.+....+.|+||+.+.... ........... ..|+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hHHHHHHHHhhccccCHHHHHHHH
Confidence 13699999999999985324567899999876532 21111111111 2232211
Q ss_pred -C-CC---------CCchhhHHHHHHHHHHHHhCCCCC
Q 004954 594 -G-LP---------YDQKIDLWSLGCILAELWTGEVLF 620 (722)
Q Consensus 594 -~-~~---------~s~ksDIWSLGviL~elltG~~PF 620 (722)
. .. .....+.|+++.++|.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00 112368999999999999998776
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=98.47 E-value=7.1e-08 Score=114.56 Aligned_cols=86 Identities=13% Similarity=0.060 Sum_probs=66.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCC-Ccccceee-ecc-cCCCcceee-eeec-ccccccCccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYS-SSK-RGSSIDWIE-GFKG-SSDLHFKGAEKDLM 337 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~-~~~k~kt~-~~k-~tlnP~~nE-~f~f-~~~v~~~~~~~~L~ 337 (722)
....|+|.|.+| +|+. +.+|||||+.|...+. ..+|+||+ +++ +++||+||| +|.| . |....+. .|.
T Consensus 676 ~~~~L~V~Visa~~L~~----~~~DPYV~V~l~g~p~d~~~k~kTk~vv~~n~~NPvWnEe~f~F~~--v~~~el~-~Lr 748 (799)
T 2zkm_X 676 VATTLSITVISGQFLSE----RSVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEK--ILMPELA-SLR 748 (799)
T ss_dssp TCEEEEEEEEEEESCCS----SCCCEEEEEEEECCTTSCCCCEECCCCSSSCCSSCBCCCCCEEEEE--ESSGGGC-EEE
T ss_pred eeeeEEEEEEeccccCc----cCCCcEEEEEEEecCCCcccceeecccccCCCCCCeeecceEEEEE--EccCCcc-EEE
Confidence 346899999999 9985 5799999999975322 12367888 655 679999999 7999 6 5544443 489
Q ss_pred ccccccCCCCCCccccccccCcc
Q 004954 338 PAEIDNSDTRDGEVNGALHEGKA 360 (722)
Q Consensus 338 ~~V~D~D~~~~~d~iG~v~~~~~ 360 (722)
+.|||+| ++++|.+.+...
T Consensus 749 ~~V~D~d----~d~iG~~~ipl~ 767 (799)
T 2zkm_X 749 VAVMEEG----NKFLGHRIIPIN 767 (799)
T ss_dssp EEEEETT----TEEEEEEEEEGG
T ss_pred EEEEEeC----CCccceEeeehh
Confidence 9999997 799999877554
|
| >3qr0_A Phospholipase C-beta (PLC-beta); PH domain, EF hand, C2 domain, TIM barrel domain, hydrolase, calcium binding, phospholipid binding; 2.00A {Sepia officinalis} PDB: 3qr1_A | Back alignment and structure |
|---|
Probab=98.36 E-value=1.5e-07 Score=111.48 Aligned_cols=85 Identities=13% Similarity=-0.028 Sum_probs=64.1
Q ss_pred cceeEEEEeec-CCccccCCCCCCcceEEEecCCCCC--cccceeeeccc-CCCcceeee-eecccccccCccccccccc
Q 004954 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT--EKSSSYSSSKR-GSSIDWIEG-FKGSSDLHFKGAEKDLMPA 339 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~--~~k~kt~~~k~-tlnP~~nE~-f~f~~~v~~~~~~~~L~~~ 339 (722)
...|+|.|+.| +|+.+ .+||||++.|...+.. .+|+||+++++ ++||+|||+ |.|.. |....+ ..|.++
T Consensus 649 ~~~L~V~Visaq~L~~~----~~DPYV~V~l~g~p~d~~~~k~kTkvv~~nglNPvWNE~~F~F~~-v~~pel-a~Lrf~ 722 (816)
T 3qr0_A 649 AGTIEIKIISAQFLSDK----QISSYVEVEMYGLPTDTVRKKFKTKIIENNGMDPYYDEKVFVFKK-VVLPDL-AVVRII 722 (816)
T ss_dssp CEEEEEEEEEEECCCSS----CCCEEEEEEEESSGGGCEEEEEECCCBCSCSSCCBCCCCCEEEEE-ESCGGG-CEEEEE
T ss_pred ceEEEEEEEEcccCCCC----CCCCeEEEEEeCCCcccccceeeeEEecCCCCCCeEcCceeEEcc-ccCCCc-cEEEEE
Confidence 46799999999 99853 6899999999854332 25788998765 699999998 99972 222222 248999
Q ss_pred ccccCCCCCCccccccccCc
Q 004954 340 EIDNSDTRDGEVNGALHEGK 359 (722)
Q Consensus 340 V~D~D~~~~~d~iG~v~~~~ 359 (722)
|||++ ++++|...+..
T Consensus 723 V~D~d----ddfiG~~~ipL 738 (816)
T 3qr0_A 723 VSEEN----GKFIGHRVMPL 738 (816)
T ss_dssp EEETT----SCEEEEEEEES
T ss_pred EEecC----CCeeeEEEEEH
Confidence 99985 78999876543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=5.4e-06 Score=87.50 Aligned_cols=137 Identities=19% Similarity=0.190 Sum_probs=88.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-ecCeEEEEEEcc
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLFIVCELL 498 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~-~~~~l~iVmEy~ 498 (722)
+.++.|....||+. |..+++|+... ......+.+|..+++.+...... .+++++.+.. ..+..++|||++
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v---~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKV---NIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSS---BCCCEEEEEECTTSCEEEEEECC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCC---CCCCeEeecccCCCceEEEEecc
Confidence 44788888899988 56788998543 33456788999999999864222 3556666654 345678999999
Q ss_pred ccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q 004954 499 RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-------------------------------------- 540 (722)
Q Consensus 499 ~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~-------------------------------------- 540 (722)
+|..+....... ++......++.++...|+.||+.
T Consensus 96 ~G~~l~~~~~~~-------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGMAV-------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHHTT-------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhhhh-------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 985332211100 33344444444444444444432
Q ss_pred ----------------------CCccccCCCCceEEccc-CCCe-EEEEecCCccc
Q 004954 541 ----------------------GIIHCDLKPENILIKSY-QRCE-IKIIDLGSSCF 572 (722)
Q Consensus 541 ----------------------gIvHrDLKp~NILl~~~-~~~~-vkL~DFGls~~ 572 (722)
.++|+|++|.|||++.. .++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 35899999999999841 1244 58999998754
|
| >3ohm_B 1-phosphatidylinositol-4,5-bisphosphate phosphodi beta-3; PH domain, EF hand, TIM barrel, C2 domain, GTPase, lipase, C binding, GTP binding; HET: GDP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.31 E-value=2.7e-07 Score=109.92 Aligned_cols=84 Identities=15% Similarity=0.067 Sum_probs=62.6
Q ss_pred cceeEEEEeec-CCccccCCCCCCcceEEEecCCCC-Ccccceeeeccc-CCCcceee-eeecccccccCcccccccccc
Q 004954 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKR-GSSIDWIE-GFKGSSDLHFKGAEKDLMPAE 340 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~-~~~k~kt~~~k~-tlnP~~nE-~f~f~~~v~~~~~~~~L~~~V 340 (722)
...|+|.|+.| +|+.+ .+|||||+.+...+. ..+|+||+++++ ++||+||| +|.|.. |....+. .|.++|
T Consensus 724 ~~~L~V~Visaq~L~~~----~~DPYV~V~l~g~p~D~~~k~kTkvi~~NglNPvWnEe~F~F~~-V~~pela-~Lrf~V 797 (885)
T 3ohm_B 724 ANALRVKVISGQFLSDR----KVGIYVEVDMFGLPVDTRRKYRTRTSQGNSFNPVWDEEPFDFPK-VVLPTLA-SLRIAA 797 (885)
T ss_dssp CEEEEEEEEEEESCCSS----CCCEEEEEEEESSTTTCBCCCCCCCCSSCSSSCBCCCCCEEEEE-ESCGGGC-EEEEEE
T ss_pred ceEEEEEEEEeccCccc----CCCcEEEEEEeCCCcccccceeeEEeeCCCcCCeeccceeEEee-EEcCCcC-EEEEEE
Confidence 35799999999 99853 689999999975322 124678988765 69999999 699972 2222222 489999
Q ss_pred cccCCCCCCccccccccC
Q 004954 341 IDNSDTRDGEVNGALHEG 358 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~ 358 (722)
||+| ++++|.+.+.
T Consensus 798 ~D~d----ddfiG~~~lp 811 (885)
T 3ohm_B 798 FEEG----GKFVGHRILP 811 (885)
T ss_dssp EETT----TEEEEEEEEE
T ss_pred EcCC----ccEEeeEEEE
Confidence 9997 7899988553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=1.2e-05 Score=82.35 Aligned_cols=131 Identities=15% Similarity=0.159 Sum_probs=89.6
Q ss_pred eccCCCC-ceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc
Q 004954 422 LGSAAFS-KVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA 500 (722)
Q Consensus 422 LG~G~fG-~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g 500 (722)
+..|..+ .||+......+..+++|+-.... ...+.+|..+|+.+... --+++++.++...+..++|||+++|
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~-----vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAF-----MPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTT-----SCCCCEEEEEEETTEEEEEEECCCS
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccC-----CCcCeEEEEEEECCeEEEEEEeeCC
Confidence 3445444 69998877778889999876543 35677899999988642 1377888888889999999999987
Q ss_pred ch-HHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 004954 501 NL-YEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS---------------------------------------- 539 (722)
Q Consensus 501 sL-l~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs---------------------------------------- 539 (722)
.. .+.... .......+..++...|+-||.
T Consensus 105 ~~~~~~~~~----------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 105 KTAFQVLEE----------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp EEHHHHHHH----------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred ccccccccC----------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 43 222211 111222344444444544442
Q ss_pred -----------C-------CCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 540 -----------L-------GIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 540 -----------~-------gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
. .++|+|+.+.|||++. .+.+-|+||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~--~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE--GKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEET--TEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEEC--CeEEEEEECcccc
Confidence 1 2789999999999984 5556799999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.7e-05 Score=84.87 Aligned_cols=77 Identities=18% Similarity=0.126 Sum_probs=51.7
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecch--------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.+.||.|..+.||++.+...++.++||...... ...++...|.++++.+.... ...+++++.+ +.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~---~~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV---PHLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC---GGGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC---CCCcCeEEEE--cCCc
Confidence 457999999999999765667889999865321 12345678999999886532 1245566654 4455
Q ss_pred EEEEEEcccc
Q 004954 491 LFIVCELLRA 500 (722)
Q Consensus 491 l~iVmEy~~g 500 (722)
.++|||++.+
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 6899999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00038 Score=73.26 Aligned_cols=76 Identities=21% Similarity=0.305 Sum_probs=44.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE-E--EEEecCeEEEEEE
Q 004954 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY-D--YFYHLEHLFIVCE 496 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~-~--~f~~~~~l~iVmE 496 (722)
+.|+.|..+.||++.. .+..+++|+..... .....|..+++.|.... ...|.++... + +....+..++||+
T Consensus 38 ~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g-~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT--DSGAVCLKRIHRPE---KKALFSIFAQDYLAKKG-MNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEE--TTEEEEEEEECSCH---HHHHHHHHHHHHHHHHT-CSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEe--CCCCEEEEecCCCH---HHHHHHHHHHHHHHHcC-CCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566677889999874 33458999987643 34456777777776542 2233333310 0 1234677899999
Q ss_pred ccccc
Q 004954 497 LLRAN 501 (722)
Q Consensus 497 y~~gs 501 (722)
|++|.
T Consensus 112 ~i~G~ 116 (346)
T 2q83_A 112 WIEGR 116 (346)
T ss_dssp CCCCB
T ss_pred eecCc
Confidence 99873
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=5.8e-05 Score=80.73 Aligned_cols=82 Identities=9% Similarity=0.020 Sum_probs=56.2
Q ss_pred EEEEEe-ccCCCCceEEEEEC--C----CCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 417 YVTEYL-GSAAFSKVFQAQDL--H----TGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 417 ~i~~~L-G~G~fG~Vy~a~d~--~----tg~~vAvKil~~~~~----~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
...+.| +.|....+|+.... . +++.+++|+...... ......+|..+++.+..... -.+++++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~---vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTD---VPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCC---SCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCC---CCCCcEEEEc
Confidence 445678 88889999988642 0 267889998765331 12567889999999876411 2366777776
Q ss_pred Eec---CeEEEEEEccccc
Q 004954 486 YHL---EHLFIVCELLRAN 501 (722)
Q Consensus 486 ~~~---~~l~iVmEy~~gs 501 (722)
... +..++|||+++|.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGV 118 (357)
T ss_dssp CSSTTTSSCEEEEECCCCB
T ss_pred cCCCccCCceEEEEecCCC
Confidence 554 3568999999873
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00061 Score=71.15 Aligned_cols=69 Identities=16% Similarity=0.126 Sum_probs=45.7
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~ 498 (722)
++.|+.|....+|++ ..+++|+........-...+|..+++.+..... . ++++.. ..+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~-~----P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGV-S----PEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTS-S----CCEEEE--CTTTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCC-C----CceEEE--ECCCCEEEEeec
Confidence 567888999999998 558899886543322334678999998886531 1 344443 344457899999
Q ss_pred -cc
Q 004954 499 -RA 500 (722)
Q Consensus 499 -~g 500 (722)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00086 Score=73.66 Aligned_cols=75 Identities=13% Similarity=0.138 Sum_probs=47.4
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecc-----hh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-----KD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-----~~---~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++.||.|..+.||++.. +++.++||..... .. ...+...|.+++..+.... ...+++++.+. .+.
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~---~~~vP~v~~~~--~~~ 111 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS---PDHVPEVYHFD--RTM 111 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS---GGGSCCEEEEE--TTT
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC---CCCCCeEEEEC--CCc
Confidence 45689999999999963 5678999943211 11 1123344555555543221 23567777765 567
Q ss_pred EEEEEEcc-cc
Q 004954 491 LFIVCELL-RA 500 (722)
Q Consensus 491 l~iVmEy~-~g 500 (722)
.++||||+ +|
T Consensus 112 ~~lv~e~l~~g 122 (420)
T 2pyw_A 112 ALIGMRYLEPP 122 (420)
T ss_dssp TEEEECCCCTT
T ss_pred cEEEEeecCCc
Confidence 78999999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0053 Score=64.91 Aligned_cols=76 Identities=21% Similarity=0.244 Sum_probs=59.4
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~ 498 (722)
.+.|+.|....+|+... .+..+++|+.... ....+..|...|+.|.... ...+++++.+....+..++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~---~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTN---SINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTT---SSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhC---CCCcceEEEEeecCCceEEEEEec
Confidence 45689999999999974 5678899987654 2456788999999987542 235778888877778899999999
Q ss_pred ccc
Q 004954 499 RAN 501 (722)
Q Consensus 499 ~gs 501 (722)
+|.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.003 Score=67.84 Aligned_cols=73 Identities=16% Similarity=0.129 Sum_probs=45.4
Q ss_pred EEEeccCCCCceEEEEECC--------CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 419 TEYLGSAAFSKVFQAQDLH--------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~--------tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.+.|+.|..-.+|++.... .++.+++|+.............|..+++.+.... -++++++.+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g-----~~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYK-----IAPQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTT-----SSCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcC-----CCCceEEec--C--
Confidence 3457788888999987532 1368899987654333223467899999987653 134555544 2
Q ss_pred EEEEEEcccc
Q 004954 491 LFIVCELLRA 500 (722)
Q Consensus 491 l~iVmEy~~g 500 (722)
-++||+|++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 2689999986
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0096 Score=62.45 Aligned_cols=74 Identities=18% Similarity=0.216 Sum_probs=48.4
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE-----EEecCeEEEEE
Q 004954 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY-----FYHLEHLFIVC 495 (722)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~-----f~~~~~l~iVm 495 (722)
.|+ |....||++.. .+|+.+++|+..........+..|..+++.+.... .. +++++.. ....+..++||
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g-~~---vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VP---VAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CS---BCCCCCBTTBSCEEETTEEEEEE
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcC-Ce---ecceeecCCcEEEEECCEEEEEE
Confidence 355 77888998763 45667999998743223356677899999887642 11 3333322 22345678999
Q ss_pred Ecccc
Q 004954 496 ELLRA 500 (722)
Q Consensus 496 Ey~~g 500 (722)
++++|
T Consensus 107 ~~i~G 111 (328)
T 1zyl_A 107 PSVGG 111 (328)
T ss_dssp ECCCC
T ss_pred EecCC
Confidence 99987
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0081 Score=62.07 Aligned_cols=80 Identities=10% Similarity=0.115 Sum_probs=56.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+....-++.+|.|..+.||+.. ..+|+.+++|+...... ....+..|...|+.|....... +++++.. +.-
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vp---vP~v~~~----~~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSP---VPQVAGW----DDR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCC---SCCEEEE----ETT
T ss_pred CCCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCC---cceEEec----cCc
Confidence 4456677889999999999998 46789999998764332 2345678999999997653333 4444443 224
Q ss_pred EEEEEcccc
Q 004954 492 FIVCELLRA 500 (722)
Q Consensus 492 ~iVmEy~~g 500 (722)
++||||+.+
T Consensus 86 ~lv~e~l~~ 94 (288)
T 3f7w_A 86 TLAMEWVDE 94 (288)
T ss_dssp EEEEECCCC
T ss_pred eEEEEeecc
Confidence 689999864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0058 Score=66.42 Aligned_cols=143 Identities=15% Similarity=0.131 Sum_probs=79.8
Q ss_pred EEeccCCCCceEEEEECC-------CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 420 EYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~-------tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+.|..|-...+|++.... +++.+++|+............+|.++++.|..... .+++++.+.. .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv-----~P~ll~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSL-----GPQLYGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTS-----SCCEEEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCC-----CCeEEEEcCC----c
Confidence 346667778888887532 35789999864432234556689999999987642 2556666543 2
Q ss_pred EEEEccccchHH---------------HHh-hhhc--cCCCccc-CHHHHHHHHHHHHH-------------------HH
Q 004954 493 IVCELLRANLYE---------------FQK-FNQE--SGGEAYF-TLGRLQVITRQCLE-------------------AL 534 (722)
Q Consensus 493 iVmEy~~gsLl~---------------~l~-~~~~--~~~~~~l-s~~~i~~i~~qIl~-------------------aL 534 (722)
+||||++|..+. .+. .... ....... -..++..+..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 999999863211 111 1111 0011111 12444545444321 23
Q ss_pred HHHH----H----CCCccccCCCCceEEccc--CCCeEEEEecCCcc
Q 004954 535 EYLH----S----LGIIHCDLKPENILIKSY--QRCEIKIIDLGSSC 571 (722)
Q Consensus 535 ~yLH----s----~gIvHrDLKp~NILl~~~--~~~~vkL~DFGls~ 571 (722)
..|. . ..++|+|+.+.|||++.. ..+.+.|+||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3333 2 249999999999999863 13689999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.016 Score=60.49 Aligned_cols=148 Identities=11% Similarity=0.088 Sum_probs=79.8
Q ss_pred EEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE-E--EEEecCeEEEE
Q 004954 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY-D--YFYHLEHLFIV 494 (722)
Q Consensus 418 i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~-~--~f~~~~~l~iV 494 (722)
-++.|+.|....+|+... ..| .+++|+..... ....+..|..+++.+.... ..-|.++... + +....+..++|
T Consensus 26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g-~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKG-LSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC----CCHHHHHHHHHHHHHHTT-CCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCC-CCCCcccCCCCCCEEEEECCEEEEE
Confidence 455678888899999874 233 68899887531 2245667888998887653 2223333211 0 11234667899
Q ss_pred EEccccchHH---------------HHhhh-hccCCCc--ccCHHHHHH---------------HHHHHHHHHHHHHH--
Q 004954 495 CELLRANLYE---------------FQKFN-QESGGEA--YFTLGRLQV---------------ITRQCLEALEYLHS-- 539 (722)
Q Consensus 495 mEy~~gsLl~---------------~l~~~-~~~~~~~--~ls~~~i~~---------------i~~qIl~aL~yLHs-- 539 (722)
|+|++|.... .++.. ....... ......... +...+...+..++.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 9999873210 01111 0000000 011110000 01113445555653
Q ss_pred -----CCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 540 -----LGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 540 -----~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
.+++|+|+++.|||++. +..+.|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~--~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLG--DELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEET--TEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeC--CceEEEecchhcc
Confidence 36999999999999984 4445799999774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0054 Score=67.72 Aligned_cols=72 Identities=14% Similarity=0.115 Sum_probs=49.2
Q ss_pred EEEeccCCCCceEEEEECC-------CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 419 TEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~-------tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
++.|+.|....||++.... .++.+++|+..... ....+.+|..+++.|.... -.+++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g-----~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERH-----LGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTT-----SSSCEEEEET--T--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCC-----CCCcEEEEeC--C--
Confidence 4568888889999997542 35789999884421 1145568999999998653 1355666553 2
Q ss_pred EEEEEcccc
Q 004954 492 FIVCELLRA 500 (722)
Q Consensus 492 ~iVmEy~~g 500 (722)
.+||||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 289999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.25 E-value=0.049 Score=54.39 Aligned_cols=99 Identities=12% Similarity=0.013 Sum_probs=61.7
Q ss_pred chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEecCCcccccCCccc
Q 004954 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579 (722)
Q Consensus 501 sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~ 579 (722)
+|.+.+..... ++++.++|.++.|.+.+|.-+-. ..-..+=+.|..|++.. +|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~--dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWR--DGAVTLAP-AADD-------- 97 (229)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEET--TSCEEECC-C-----------
T ss_pred cHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEec--CCceeccc-cccc--------
Confidence 57777776543 39999999999999999877632 12224445568888875 66665553 1110
Q ss_pred cccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCC
Q 004954 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617 (722)
Q Consensus 580 ~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~ 617 (722)
.....+.|||... ...+.+.=|||||+++|..+--.
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1233456787753 34567888999999999998633
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.016 Score=61.00 Aligned_cols=70 Identities=16% Similarity=0.115 Sum_probs=37.3
Q ss_pred eccCCCCc-eEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc
Q 004954 422 LGSAAFSK-VFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA 500 (722)
Q Consensus 422 LG~G~fG~-Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g 500 (722)
|+.|+... +|+... .+|..+++|....... .....|..+++.+.... . .+++++.+.... -++|||++++
T Consensus 26 l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g-~---~vP~v~~~d~~~--g~ll~e~l~~ 96 (333)
T 3csv_A 26 LAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLD-I---SAPEIYAEEHAR--GLLLIEDLGD 96 (333)
T ss_dssp --------CCEEEEC-TTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTT-C---BCCCEEEEETTT--TEEEECCCCS
T ss_pred CCCCCCCceEEEEEc-CCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCC-C---CCCceeeecCCC--CEEEEeeCCC
Confidence 54444443 667652 2366777776544321 34567888888887542 1 355666653222 2789999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.043 Score=61.02 Aligned_cols=73 Identities=10% Similarity=0.174 Sum_probs=47.9
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~ 498 (722)
++.|+.|-...+|++.....+..+++|+........-...+|..+++.|.... -.+++++.+. + .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g-----l~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN-----IAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS-----SBCCEEEEET--T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC-----CCCCEEEEeC--C--eEEEEee
Confidence 45688888899999986444578999987543222222358999999997643 2356777663 2 2599999
Q ss_pred cc
Q 004954 499 RA 500 (722)
Q Consensus 499 ~g 500 (722)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 76
|
| >2enj_A NPKC-theta, protein kinase C theta type; beta-sandwich, phosphotyrosine binding, TCR, T-cell, diacylglycerol, phorbol ester, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.95 E-value=0.0027 Score=58.16 Aligned_cols=90 Identities=6% Similarity=-0.039 Sum_probs=60.7
Q ss_pred ccceeEEEEeecCCcccc--CCCCCCcceEEEecCCCCCccccee-eecccCCCcceeeeeecccccccCcccccccccc
Q 004954 264 NNDYGYLSSKEADLIDLQ--HNVVGDSSTDCDLAPHPGTEKSSSY-SSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~~L~~~d--~~g~sDpyvk~~l~~d~~~~~k~kt-~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V 340 (722)
....|||.+...++.+.. ..-..|||+.+++--.... .+-+| .++++|..|+|||+|.-+ |. ..+.|.+.|
T Consensus 8 m~~flRi~l~~~~~~~~~~~~~~~lDPY~aV~VdE~~~t-e~gqtl~~KkkT~~P~Wne~Fd~~--V~---~Gr~l~i~V 81 (138)
T 2enj_A 8 MSPFLRIGLSNFDCGSCQSCQGEAVNPYCAVLVKEYVES-ENGQMYIQKKPTMYPPWDSTFDAH--IN---KGRVMQIIV 81 (138)
T ss_dssp CCCCEEEEEEEEECCCCCCSCCCCCCCEEEEEEEEEEEE-TTEEEEEEEEEEECCCSSSEEEEC--CC---SSCEEEEEE
T ss_pred cCcceEEEeeccccCCCCCcccccCCceEEEEeeeeeec-cCceeecccCCCCCccccceEeee--EE---CCeEEEEEE
Confidence 556899999888554433 2335799999888432111 13455 668899999999999966 32 245588888
Q ss_pred cccCCCCCCccccccccCccccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
++-.. +|+..+.+...++.
T Consensus 82 fh~a~----~fVAn~tV~~edL~ 100 (138)
T 2enj_A 82 KGKNV----DLISETTVELYSLA 100 (138)
T ss_dssp ECSSC----SCCEEEEEESHHHH
T ss_pred EcCCC----CeeeEEEEEHHHHH
Confidence 85444 78888777655444
|
| >1yrk_A NPKC-delta, protein kinase C, delta type; C2 domain, protein binding; HET: PTR; 1.70A {Homo sapiens} PDB: 1bdy_A | Back alignment and structure |
|---|
Probab=95.60 E-value=0.005 Score=55.67 Aligned_cols=90 Identities=10% Similarity=0.096 Sum_probs=58.2
Q ss_pred ccceeEEEEeecCCcccc-CCCCCCcceEEEecCCCCCccccee-eecccCCCcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEADLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSY-SSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~~L~~~d-~~g~sDpyvk~~l~~d~~~~~k~kt-~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
....|||.+...++.++. ..-..|||+.+++--.... .+-+| .++++|..|+|||+|.-+ |. ..+.|.+.|+
T Consensus 4 m~~flRi~~~~~~~~~~~~~~~~lDPy~aV~vdE~~~~-e~g~t~~~K~kT~~P~Wne~Fd~~--V~---~Gr~l~i~Vf 77 (126)
T 1yrk_A 4 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALST-ERGKTLVQKKPTMYPEWKSTFDAH--IY---EGRVIQIVLM 77 (126)
T ss_dssp CCCEEEEEEEEEECSSCCCSSSSCCCEEEEEEEEEEEE-TTEEEEECCSCCBCCCTTCEEEEE--CC---TTCEEEEEEE
T ss_pred cCccEEeeeccccccccCCccccCCceEEEEeeeeEEc-ccceeecccCCCCCcCccceEEee--ee---CCEEEEEEEE
Confidence 346889988777543322 2336799999888422111 12244 668999999999999966 32 2455888888
Q ss_pred ccCCCCCCccccccccCccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
+-.. +|+..+.++..++.
T Consensus 78 h~a~----~fvAn~tV~~edL~ 95 (126)
T 1yrk_A 78 RAAE----EPVSEVTVGVSVLA 95 (126)
T ss_dssp EETT----EEEEEEEEEHHHHH
T ss_pred cCCC----CeeeEEEEEHHHHH
Confidence 5444 77777766544333
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.18 E-value=0.09 Score=55.77 Aligned_cols=69 Identities=12% Similarity=0.153 Sum_probs=43.9
Q ss_pred ccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE------EEecCeEEEEEE
Q 004954 423 GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY------FYHLEHLFIVCE 496 (722)
Q Consensus 423 G~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~------f~~~~~l~iVmE 496 (722)
|.|....||+... .+| .+++|+..... ...|..+++.|.... . +++++++.. ....+..++||+
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g-~--~~vp~pi~~~~G~~~~~~~g~~~~l~~ 101 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH-----DEINLSIIRLLHDSG-I--KEIIFPIHTLEAKLFQQLKHFKIIAYP 101 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS-----CCHHHHHHHHHHHTT-C--CSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc-----chHHHHHHHHHHhcC-C--cccccceecCCCCEEEEECCEEEEEEe
Confidence 3444678999973 445 89999876543 146778888887642 1 223333322 233577899999
Q ss_pred ccccc
Q 004954 497 LLRAN 501 (722)
Q Consensus 497 y~~gs 501 (722)
|++|.
T Consensus 102 ~i~G~ 106 (339)
T 3i1a_A 102 FIHAP 106 (339)
T ss_dssp CCCCC
T ss_pred ccCCC
Confidence 99874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.15 E-value=0.046 Score=60.20 Aligned_cols=73 Identities=11% Similarity=0.106 Sum_probs=47.3
Q ss_pred EEeccCCCCceEEEEECC-------CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 420 EYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~-------tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+.|..|-...+|++.... .++.+++|+........-...+|.++++.+.... -.+++++.+. -+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~g-----i~P~l~~~~~----~~ 146 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNIN-----IAPNIIADFP----EG 146 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTT-----SSCCEEEEET----TE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcC-----CCCCEEEEcC----CC
Confidence 346667777888887532 1578999987554333334468999999998653 2345555432 26
Q ss_pred EEEEccccc
Q 004954 493 IVCELLRAN 501 (722)
Q Consensus 493 iVmEy~~gs 501 (722)
+||+|++|.
T Consensus 147 ~I~efI~G~ 155 (424)
T 3mes_A 147 RIEEFIDGE 155 (424)
T ss_dssp EEEECCCSE
T ss_pred EEEEEeCCc
Confidence 899999873
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.82 E-value=0.54 Score=50.96 Aligned_cols=31 Identities=26% Similarity=0.443 Sum_probs=25.3
Q ss_pred CccccCCCCceEEcc----cCCCeEEEEecCCccc
Q 004954 542 IIHCDLKPENILIKS----YQRCEIKIIDLGSSCF 572 (722)
Q Consensus 542 IvHrDLKp~NILl~~----~~~~~vkL~DFGls~~ 572 (722)
++|+|+.+.|||+.. ..+..+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999953 2356799999998753
|
| >3hhm_A Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_A 2rd0_A 4a55_A* 2enq_A | Back alignment and structure |
|---|
Probab=80.87 E-value=2 Score=52.21 Aligned_cols=79 Identities=8% Similarity=-0.092 Sum_probs=58.3
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-c-ccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-E-KDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~-~~L~~~V 340 (722)
-...++|.|..+ ++. .+.+...+.||++.|..+.+.-.+..+...+...||.|||..+|+ +...++ . ..|-++|
T Consensus 353 ~~~~f~v~i~~~~~~n-~~~~~~~~~~V~~~l~hG~~~L~~~~~T~~~~~~~~~Wne~l~f~--i~i~dLPr~arL~~tl 429 (1091)
T 3hhm_A 353 INSALRIKILCATYVN-VNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYD--IYIPDLPRAARLCLSI 429 (1091)
T ss_dssp CCSEEEEEEEEESCCC-CCCSSCCCCCEEEEEESSSCSSCCEECCCCCCTTSCEEEEEEEEE--EEGGGCCTTCEEEEEE
T ss_pred CCCCEEEEEEEecCCC-CCccccceEEEEEEEEECCEEccCceeccccCCCCCCCCeeEEec--CccccCChhcEEEEEE
Confidence 446888999888 544 444556789999999999877544433334556788999999998 777777 2 3399999
Q ss_pred cccCC
Q 004954 341 IDNSD 345 (722)
Q Consensus 341 ~D~D~ 345 (722)
|+...
T Consensus 430 ~~~~~ 434 (1091)
T 3hhm_A 430 CSVKG 434 (1091)
T ss_dssp CCCCC
T ss_pred EEecC
Confidence 98765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 722 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-57 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-55 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-53 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-53 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-52 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-51 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-51 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-48 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-46 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-18 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-59
Identities = 74/311 (23%), Positives = 120/311 (38%), Gaps = 21/311 (6%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDP 472
+ LG+ VF+ +G+ + K+I +Q + E+++L N
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN---- 62
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+ Y FY + I E + + L ++ +
Sbjct: 63 ---SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVI 114
Query: 532 EALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQSRSYRAP 589
+ L YL I+H D+KP NIL+ S R EIK+ D G S D++ +V +RSY +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPIDLEMLMQGQ 648
E + G Y + D+WS+G L E+ G P DA + L + G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
+ D L+YI+ E FS F DFV L NP R
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE-FQDFVNKCLIKNPAERAD 291
Query: 709 AREALDHPWLQ 719
++ + H +++
Sbjct: 292 LKQLMVHAFIK 302
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 197 bits (501), Expect = 2e-57
Identities = 102/335 (30%), Positives = 166/335 (49%), Gaps = 25/335 (7%)
Query: 405 PIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 463
P RY + LG FS V+ A+D+ V +KI++ DK + + + DEIKL
Sbjct: 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL 62
Query: 464 LKLVN-----KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
L+ VN K D +HIL+L D+F H + ++ L E +
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122
Query: 519 TLGRLQVITRQCLEALEYL-HSLGIIHCDLKPENILIKS----YQRCEIKIIDLGSSCFQ 573
L ++ I++Q L L+Y+ GIIH D+KPEN+L++ +IKI DLG++C+
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 574 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV------VM 627
++ +Q+R YR+PEV++G P+ D+WS C++ EL TG+ LF D
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 687
+A+II +LG + +L G+ +F L I++ P E L +FS
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK-----FWPLEDVLTEKYKFS 297
Query: 688 DAF---FIDFVRTLLEINPQRRPTAREALDHPWLQ 719
DF+ +L+++P++R A ++HPWL+
Sbjct: 298 KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-56
Identities = 79/311 (25%), Positives = 138/311 (44%), Gaps = 27/311 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y +G A+ KVF+A+DL G V LK ++ L I+ + ++ +
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 474 DEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ +++RL+D L +V E + +L + E G ++ +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMF 123
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L L++LHS ++H DLKP+NIL+ S + ++ L L V + YRA
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G + G+
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-------LPGE 236
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
E + + ++ +E + + L D + L NP +R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL----------GKDLLLKCLTFNPAKRIS 286
Query: 709 AREALDHPWLQ 719
A AL HP+ Q
Sbjct: 287 AYSALSHPYFQ 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 191 bits (487), Expect = 1e-55
Identities = 69/317 (21%), Positives = 120/317 (37%), Gaps = 55/317 (17%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLK 465
I + + Y + E LG+ AF V + + TG + K + + +++ EI+ +
Sbjct: 19 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78
Query: 466 LVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
++ H ++ L+D F + ++ E + F+K E +
Sbjct: 79 VLR-------HPTLVNLHDAFEDDNEMVMIYEFMSGGEL-FEKVADEHNK---MSEDEAV 127
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQ 582
RQ + L ++H +H DLKPENI+ + + E+K+ID G + + +
Sbjct: 128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
+ + APEV G P D+WS+G + L +G F + L + +D
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
I E+ DF+R LL +
Sbjct: 248 AFSG---------------------------ISED-------------GKDFIRKLLLAD 267
Query: 703 PQRRPTAREALDHPWLQ 719
P R T +AL+HPWL
Sbjct: 268 PNTRMTIHQALEHPWLT 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 72/310 (23%), Positives = 117/310 (37%), Gaps = 62/310 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ + LG F V+ A++ + + LK++ Q E+++ +
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ILRLY YF+ ++++ E + F R +
Sbjct: 66 -----PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITEL 115
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-QTDNLCLYVQSRSYRAP 589
AL Y HS +IH D+KPEN+L+ S E+KI D G S + + Y P
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 173
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
E+I G +D+K+DLWSLG + E G+ F + RI
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------------- 217
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
++E+ P+ + D + LL+ NP +RP
Sbjct: 218 -------------------RVEFTFPDFVTEG---------ARDLISRLLKHNPSQRPML 249
Query: 710 REALDHPWLQ 719
RE L+HPW+
Sbjct: 250 REVLEHPWIT 259
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-53
Identities = 84/314 (26%), Positives = 138/314 (43%), Gaps = 36/314 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y T+ +G+ +F V+QA+ +G V +K + DK F ++ E+++++ ++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLD------ 71
Query: 475 EHHILRLYDYFYH------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+I+RL +FY +L +V + + +Y + + + +++
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMY 129
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSY 586
Q +L Y+HS GI H D+KP+N+L+ +K+ D GS+ Y+ SR Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
RAPE+I G Y ID+WS GC+LAEL G+ +FP D+ V L II +LG E +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
+ Y F I + + I LLE P
Sbjct: 249 EMNPNYTEFKFPQ---------------IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 706 RPTAREALDHPWLQ 719
R T EA H +
Sbjct: 294 RLTPLEACAHSFFD 307
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 6e-53
Identities = 75/311 (24%), Positives = 120/311 (38%), Gaps = 54/311 (17%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ +Y + E LG F V + + + K +K EI +L +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+IL L++ F +E L ++ E + +++E + + Q
Sbjct: 60 ---HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQV 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYVQSRSYRA 588
EAL++LHS I H D++PENI+ ++ + IKII+ G + DN L + Y A
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEV D+WSLG ++ L +G F + I+ I+ D +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------E 224
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
E +K + E +DFV LL + R T
Sbjct: 225 EAFKEISIE---------------------------------AMDFVDRLLVKERKSRMT 251
Query: 709 AREALDHPWLQ 719
A EAL HPWL+
Sbjct: 252 ASEALQHPWLK 262
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 184 bits (468), Expect = 7e-53
Identities = 65/313 (20%), Positives = 122/313 (38%), Gaps = 57/313 (18%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKN 470
+ Y + E LGS AF V + + TG K I ++ +EI ++ ++
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-- 84
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H ++ L+D F + ++ E L L++ + + R
Sbjct: 85 -----HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMR 134
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSY 586
Q E L+++H I+H D+KPENI+ ++ + +KIID G + + + + + +
Sbjct: 135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 194
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
APE++ P D+W++G + L +G F + + L + D +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
+ E DF++ LL+ P++R
Sbjct: 255 ---------------------------VSPE-------------AKDFIKNLLQKEPRKR 274
Query: 707 PTAREALDHPWLQ 719
T +AL+HPWL+
Sbjct: 275 LTVHDALEHPWLK 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-53
Identities = 83/312 (26%), Positives = 137/312 (43%), Gaps = 34/312 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+ E +G + V++A++ TG V LK I+ + ++ EI LLK +N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I++L D + L++V E L +L +F + +G L ++ Q L
Sbjct: 61 ----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ L + HS ++H DLKP+N+LI + IK+ D G + V + YRA
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 589 PEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
PE+++G Y +D+WSLGCI AE+ T LFP D+ + L RI LG D +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
+ Y + + + D + +L +P +R
Sbjct: 231 TSMPDY---------------KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
Query: 708 TAREALDHPWLQ 719
+A+ AL HP+ Q
Sbjct: 276 SAKAALAHPFFQ 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 42/325 (12%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNK 469
+ RY Y+G A+ V A D V V +K I + + ++L EIK+L
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 64
Query: 470 NDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+I+ + D ++ +++V L+ A+LY+ K + +
Sbjct: 65 -----HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-------LSNDHIC 112
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LC 578
Q L L+Y+HS ++H DLKP N+L+ + C++KI D G + + L
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHTGFLT 170
Query: 579 LYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ Y + ID+WS+GCILAE+ + +FP + L I+G+LG
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
E L I + Y L ++ + P S +D +
Sbjct: 231 SPSQEDL---NCIINLKARNYLLSLPHKNKVPWNRLFPNADSK----------ALDLLDK 277
Query: 698 LLEINPQRRPTAREALDHPWLQHPY 722
+L NP +R +AL HP+L+ Y
Sbjct: 278 MLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-52
Identities = 71/311 (22%), Positives = 127/311 (40%), Gaps = 61/311 (19%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDP 472
+Y E +G A V+ A D+ TG +V ++ + + + ++EI +++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK---- 75
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ +I+ D + + L++V E L G++ + R+CL
Sbjct: 76 ---NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECL 126
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ALE+LHS +IH D+K +NIL+ +K+ D G + V + + A
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEV+ Y K+D+WSLG + E+ GE + N+ + L I P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---------- 234
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
E PE+ S F DF+ L+++ ++R +
Sbjct: 235 ----------------------ELQNPEKLSAI---------FRDFLNRCLDMDVEKRGS 263
Query: 709 AREALDHPWLQ 719
A+E L H +L+
Sbjct: 264 AKELLQHQFLK 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 6e-52
Identities = 80/314 (25%), Positives = 126/314 (40%), Gaps = 62/314 (19%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
+ + LG AF KV++AQ+ T V K+I ++ + + EI +L +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH---- 68
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++L D FY+ +L+I+ E + E T ++QV+ +Q L+A
Sbjct: 69 --PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDA 122
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPE 590
L YLH IIH DLK NIL +IK+ D G S T + ++ + + APE
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 591 VIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
V++ PYD K D+WSLG L E+ E + +L +I
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------------ 228
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
++ P S F DF++ LE N
Sbjct: 229 --------------------KSEPPTLAQPSRWSSN---------FKDFLKKCLEKNVDA 259
Query: 706 RPTAREALDHPWLQ 719
R T + L HP++
Sbjct: 260 RWTTSQLLQHPFVT 273
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 7e-52
Identities = 82/311 (26%), Positives = 130/311 (41%), Gaps = 39/311 (12%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK------NDKDFFDQSLDEIKLLKLVNKNDPA 473
++LG F+ V++A+D +T V +K IK +L EIKLL+ ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I+ L D F H ++ +V + + +L K N + ++ L+
Sbjct: 60 --PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS-----HIKAYMLMTLQG 112
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPE 590
LEYLH I+H DLKP N+L+ +K+ D G + V +R YRAPE
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 591 VIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
++ G Y +D+W++GCILAEL P D+ + L RI LG E
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
+ Y T + L H + +D ++ L NP R TA
Sbjct: 231 LPDYVTFKS----------------FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
Query: 710 REALDHPWLQH 720
+AL + +
Sbjct: 275 TQALKMKYFSN 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 1e-51
Identities = 77/320 (24%), Positives = 135/320 (42%), Gaps = 32/320 (10%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKN 470
+Y +G F +VF+A+ TG V LK + + + F +L EIK+L+L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 471 DPADEHHILRLYDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ + I R Y+ +++V + +L FTL ++ + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQ 124
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-------CFQTDNLCLYV 581
L L Y+H I+H D+K N+LI + +K+ D G + Q + V
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+ YR PE+++G Y IDLW GCI+AE+WT + + LA I + G I
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
E+ Y E + ++L+ + D + +D + LL
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV------------RDPYALDLIDKLLV 290
Query: 701 INPQRRPTAREALDHPWLQH 720
++P +R + +AL+H +
Sbjct: 291 LDPAQRIDSDDALNHDFFWS 310
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-51
Identities = 83/314 (26%), Positives = 146/314 (46%), Gaps = 13/314 (4%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVN 468
+ RY + +GS A V A D +V +K + ++ ++ E+ L+K VN
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ ++ + +++V EL+ ANL + + R+ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLY 126
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L +++LHS GIIH DLKP NI++KS +I L + + + YV +R YRA
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG E + + Q
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
+ + + Y + S + L+ S A D + +L I+P +R +
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA--RDLLSKMLVIDPAKRIS 304
Query: 709 AREALDHPWLQHPY 722
+AL HP++ Y
Sbjct: 305 VDDALQHPYINVWY 318
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 175 bits (443), Expect = 4e-50
Identities = 84/312 (26%), Positives = 141/312 (45%), Gaps = 36/312 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
+Y+ E +G + V++AQ+ + G LK I K D+ ++ EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I++LYD + + L +V E L +L + + + Q L
Sbjct: 59 ---HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRA 588
+ Y H ++H DLKP+N+LI E+KI D G + + + YRA
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 589 PEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
P+V++G Y ID+WS+GCI AE+ G LFP + L RI +LG + +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
E+ KY + + E E L+ D ID + +L+++P +R
Sbjct: 229 TELPKY---------------DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
Query: 708 TAREALDHPWLQ 719
TA++AL+H + +
Sbjct: 274 TAKQALEHAYFK 285
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-50
Identities = 81/318 (25%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 411 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK 469
I Y VT + LG KV Q + T LK++++ E++L ++
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQ 63
Query: 470 NDPADEHHILRLYDYFYHL----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
HI+R+ D + +L + L IV E L L+ + G+ FT
Sbjct: 64 CP-----HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREAS 114
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDN--LCLYV 581
I + EA++YLHS+ I H D+KPEN+L S +K+ D G + T + L
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+ Y APEV+ YD+ D+WSLG I+ L G F ++ + I +
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------- 225
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
Q E+ PE S + ++ +R LL+
Sbjct: 226 --------------------KTRIRMGQYEFPNPEWSEVSEEVK-------MLIRNLLKT 258
Query: 702 NPQRRPTAREALDHPWLQ 719
P +R T E ++HPW+
Sbjct: 259 EPTQRMTITEFMNHPWIM 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 9e-49
Identities = 62/313 (19%), Positives = 115/313 (36%), Gaps = 65/313 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ +G +F V+ A+D+ V +K + + + + E++ L+ +
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-- 73
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H + ++ + ++V E + + + +++ + +T
Sbjct: 74 -----HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHG 123
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
L+ L YLHS +IH D+K NIL+ +K+ D GS+ +V + + AP
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAPA-NSFVGTPYWMAP 180
Query: 590 EVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
EVI+ + YD K+D+WSLG EL + N + L I
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------------- 227
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
N+ + S F +FV + L+ PQ R
Sbjct: 228 --------------------QNESPALQSGHWSEY---------FRNFVDSCLQKIPQDR 258
Query: 707 PTAREALDHPWLQ 719
PT+ L H ++
Sbjct: 259 PTSEVLLKHRFVL 271
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 89/318 (27%), Positives = 147/318 (46%), Gaps = 38/318 (11%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVN 468
+ Y + +GS A+ V A D TG V +K + + F ++ E++LLK +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 469 KNDPADEHHILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
+++ L D F E ++V + +L + K + R
Sbjct: 76 ------HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------LGEDR 122
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
+Q + Q L+ L Y+H+ GIIH DLKP N+ + + CE+KI+D G + + YV
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQADSEMTGYVV 180
Query: 583 SRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+R YRAPEVI+ + Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
E + Q + K Y E I+ S L ++ + +L +
Sbjct: 241 EFV---QRLQSDEAKNYMKGLPELEKKDFASILTNASPL----------AVNLLEKMLVL 287
Query: 702 NPQRRPTAREALDHPWLQ 719
+ ++R TA EAL HP+ +
Sbjct: 288 DAEQRVTAGEALAHPYFE 305
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 60/317 (18%), Positives = 112/317 (35%), Gaps = 62/317 (19%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ K D + EI + K++N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 61
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
++++ Y + ++ E F + + G Q Q +
Sbjct: 62 ---HENVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG----MPEPDAQRFFHQLM 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSRSY 586
+ YLH +GI H D+KPEN+L+ R +KI D G + + L + Y
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 587 RAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
APE++ + + +D+WS G +L + GE+ +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP---------------------- 209
Query: 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705
++ Q E+ + + + D+ + + +L NP
Sbjct: 210 -------------------SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSA 250
Query: 706 RPTAREALDHPWLQHPY 722
R T + W P
Sbjct: 251 RITIPDIKKDRWYNKPL 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 72/317 (22%), Positives = 118/317 (37%), Gaps = 68/317 (21%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLL 464
+ +Y V LGS F V+ + + V +K ++ D+ + E+ LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
K V+ ++RL D+F + ++ E F + +
Sbjct: 62 KKVSSGFS----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELAR 113
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQS 583
Q LEA+ + H+ G++H D+K ENILI R E+K+ID GS D + + +
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDFDGT 172
Query: 584 RSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
R Y PE I Y + +WSLG +L ++ G++ F +D
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------------------- 213
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
EE + + + S E +R L +
Sbjct: 214 ----------------------EEIIRGQVFFRQRVSSE---------CQHLIRWCLALR 242
Query: 703 PQRRPTAREALDHPWLQ 719
P RPT E +HPW+Q
Sbjct: 243 PSDRPTFEEIQNHPWMQ 259
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-48
Identities = 82/312 (26%), Positives = 138/312 (44%), Gaps = 26/312 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVN 468
+ RY +GS A+ V A D TG+ V +K + ++ E++LLK +
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ + +++V L+ A+L K + T +Q +
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIY 128
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L L+Y+HS IIH DLKP N+ + KI+D G + D + YV +R YRA
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEMTGYVATRWYRA 186
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
PE+++ + Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G E+L
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL--- 243
Query: 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 707
++I + Y + + L +D + +L ++ +R
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPL----------AVDLLEKMLVLDSDKRI 293
Query: 708 TAREALDHPWLQ 719
TA +AL H +
Sbjct: 294 TAAQALAHAYFA 305
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 9e-48
Identities = 84/313 (26%), Positives = 135/313 (43%), Gaps = 36/313 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+Y E +G + VF+A++ T V LK ++ +D+ +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+RL+D + + L +V E +L ++ ++ Q L
Sbjct: 60 ---HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-----IVKSFLFQLL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ L + HS ++H DLKP+N+LI K+ + G + V + YR
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEV-LFPNDAVVMILARIIGMLGPIDLEMLMQ 646
P+V+ G Y ID+WS GCI AEL LFP + V L RI +LG E
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
++ Y + P +SL + + +A D ++ LL+ NP +R
Sbjct: 230 MTKLPDYKPYP---------------MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274
Query: 707 PTAREALDHPWLQ 719
+A EAL HP+
Sbjct: 275 ISAEEALQHPYFS 287
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-47
Identities = 72/319 (22%), Positives = 118/319 (36%), Gaps = 69/319 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ + LG +FS V A++L T + +KI++ ++ E ++ ++
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-- 66
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H ++LY F E L+ + S F + T +
Sbjct: 67 -----HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAE 116
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSR 584
+ ALEYLH GIIH DLKPENIL+ I+I D G++ + +V +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
Y +PE++ + DLW+LGCI+ +L G F +I +II
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------- 223
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
+LEY PE+ + D V LL ++
Sbjct: 224 ------------------------KLEYDFPEKFFPK---------ARDLVEKLLVLDAT 250
Query: 705 RRPTAREALDHPW-LQHPY 722
+R E + HP+
Sbjct: 251 KRLGCEEMEGYGPLKAHPF 269
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (423), Expect = 2e-47
Identities = 78/324 (24%), Positives = 127/324 (39%), Gaps = 72/324 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----------NDKDFFDQSLDEIKLL 464
Y E LG S V + T + +KII ++ + +L E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRL 523
+ V+ +I++L D + F+V +L++ L+++ +
Sbjct: 64 RKVS-----GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKET 112
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYV 581
+ I R LE + LH L I+H DLKPENIL+ IK+ D G SC + L
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 582 QSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
+ SY APE+I Y +++D+WS G I+ L G F + +++L I+
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-- 228
Query: 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 695
+ ++ PE ++ D V
Sbjct: 229 -------------------------------SGNYQFGSPEWDDYSDTVK-------DLV 250
Query: 696 RTLLEINPQRRPTAREALDHPWLQ 719
L + PQ+R TA EAL HP+ Q
Sbjct: 251 SRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 4e-47
Identities = 81/315 (25%), Positives = 129/315 (40%), Gaps = 60/315 (19%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNK 469
I Y + LG+ AFS+V A+D T V +K I + +EI +L +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D + HL+++ +L+ L++ ++T +
Sbjct: 66 ------HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLI 113
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCFQTDN--LCLYVQSR 584
Q L+A++YLH LGI+H DLKPEN+L S + +I I D G S + L +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 173
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
Y APEV+ PY + +D WS+G I L G F ++ + +I+ D
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
I + DF+R L+E +P+
Sbjct: 234 DD---------------------------ISDS-------------AKDFIRHLMEKDPE 253
Query: 705 RRPTAREALDHPWLQ 719
+R T +AL HPW+
Sbjct: 254 KRFTCEQALQHPWIA 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 9e-47
Identities = 58/321 (18%), Positives = 118/321 (36%), Gaps = 65/321 (20%)
Query: 410 TVIAGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLK 465
GR+ +G +F V++ D T V+V +++ K + +E ++LK
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 466 LVNKNDPADEHHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+ +I+R YD + + + +V EL+ + + + +
Sbjct: 64 GLQ------HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIK 112
Query: 522 RLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
L+ RQ L+ L++LH+ IIH DLK +NI I +KI DLG + + +
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRASFAK 171
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
+ + + APE+ YD+ +D+++ G + E+ T E + + R +
Sbjct: 172 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----- 225
Query: 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 698
+ + + E + +
Sbjct: 226 ---------------------------TSGVKPASFDKVAIPE---------VKEIIEGC 249
Query: 699 LEINPQRRPTAREALDHPWLQ 719
+ N R + ++ L+H + Q
Sbjct: 250 IRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 6e-46
Identities = 56/317 (17%), Positives = 111/317 (35%), Gaps = 67/317 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDP 472
Y V +G+ ++ + + + G + K + + + E+ LL+ +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK---- 61
Query: 473 ADEHHILRLYDYFYHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+I+R YD L+IV E +L + Y + + Q
Sbjct: 62 --HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRVMTQ 117
Query: 530 CLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YV 581
AL+ H ++H DLKP N+ + + +K+ D G + + +V
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARILNHDTSFAKAFV 175
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+ Y +PE + + Y++K D+WSLGC+L EL F + + +I
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------- 226
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701
+ ++ Y +E + + +L +
Sbjct: 227 ---------------------REGKFRRIPYRYSDE-------------LNEIITRMLNL 252
Query: 702 NPQRRPTAREALDHPWL 718
RP+ E L++P +
Sbjct: 253 KDYHRPSVEEILENPLI 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 164 bits (415), Expect = 9e-46
Identities = 82/309 (26%), Positives = 137/309 (44%), Gaps = 25/309 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + LG +S+VF+A ++ V +KI+K K + EIK+L+ +
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGP--- 90
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ L D N +F++ Q T ++ + L+AL
Sbjct: 91 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKAL 142
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVI 592
+Y HS+GI+H D+KP N++I + ++++ID G + F + V SR ++ PE++
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 593 IGLP-YDQKIDLWSLGCILAELWTGEV-LFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
+ YD +D+WSLGC+LA + + F L RI +LG DL + I
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710
E D + + E+ S +DF+ LL + Q R TAR
Sbjct: 262 ------ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA-LDFLDKLLRYDHQSRLTAR 314
Query: 711 EALDHPWLQ 719
EA++HP+
Sbjct: 315 EAMEHPYFY 323
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-44
Identities = 72/320 (22%), Positives = 124/320 (38%), Gaps = 64/320 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-------LDEIKLL 464
+ Y E LGS F+ V + ++ TG+ K IK + + E+ +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 465 KLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
K + H +++ L++ + + + ++ EL+ +ES E
Sbjct: 68 KEIQ-------HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-----A 115
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCF--QTDNLCL 579
+Q L + YLHSL I H DLKPENI++ ++ + IKIID G + +
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
+ + APE++ P + D+WS+G I L +G F D LA + +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699
+ E DF+R LL
Sbjct: 236 EDEYFSN---------------------------TSAL-------------AKDFIRRLL 255
Query: 700 EINPQRRPTAREALDHPWLQ 719
+P++R T +++L HPW++
Sbjct: 256 VKDPKKRMTIQDSLQHPWIK 275
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 4e-43
Identities = 54/325 (16%), Positives = 108/325 (33%), Gaps = 61/325 (18%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ RY + +GS +F ++ D+ G +V +K+ Q E K+ K++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQ--- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I + ++ +V ELL +L + F F+L + ++ Q +
Sbjct: 61 --GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMI 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDN----------LCLY 580
+EY+HS IH D+KP+N L+ + + IID G + D
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+ Y + +G+ ++ DL SLG +L G + + +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------- 225
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
+ ++ L P E F ++
Sbjct: 226 ---------------ERISEKKMSTPIEVLCKGYPSE-------------FATYLNFCRS 257
Query: 701 INPQRRPTA---REALDHPWLQHPY 722
+ +P R+ + + + +
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFHRQGF 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (391), Expect = 1e-42
Identities = 65/314 (20%), Positives = 114/314 (36%), Gaps = 68/314 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + LG+ +F +V + H G +K++K + + DE +L +V
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--- 62
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H I+R++ F + +F++ + + + F + +
Sbjct: 63 ----HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEV 113
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 590
ALEYLHS II+ DLKPENIL+ IKI D G + + D + Y APE
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTLCGTPDYIAPE 171
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
V+ PY++ ID WS G ++ E+ G F + + +I+
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----------------- 214
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR---- 706
E P + + D + L+ + +R
Sbjct: 215 ------------------NAELRFPPFFNED---------VKDLLSRLITRDLSQRLGNL 247
Query: 707 -PTAREALDHPWLQ 719
+ +HPW +
Sbjct: 248 QNGTEDVKNHPWFK 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 154 bits (389), Expect = 7e-42
Identities = 68/316 (21%), Positives = 120/316 (37%), Gaps = 62/316 (19%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ V +G F +V+ + TG +K + K +L+E +L LV+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
D I+ + F+ + L + +L+ + EA ++ +
Sbjct: 65 D---CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEI 116
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRAP 589
+ LE++H+ +++ DLKP NIL+ + ++I DLG +C F V + Y AP
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASVGTHGYMAP 174
Query: 590 EVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
EV+ G+ YD D +SLGC+L +L G F
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH------------------------- 209
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
K D + I+ T + +P+ S E + LL+ + RR
Sbjct: 210 -------KTKDKHEIDRMTLTMAVELPDSFSPE---------LRSLLEGLLQRDVNRRLG 253
Query: 709 -----AREALDHPWLQ 719
A+E + P+ +
Sbjct: 254 CLGRGAQEVKESPFFR 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 2e-41
Identities = 66/322 (20%), Positives = 114/322 (35%), Gaps = 63/322 (19%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLK 465
+ ++ RY + E LG S+V A+DL DV +K+++ D F+ + E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 466 LVNKNDPADEHHILRLYDYFYHLEH----LFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+N I+ +YD +IV E + + T
Sbjct: 63 ALN------HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPK 111
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----L 577
R + +AL + H GIIH D+KP NI+I + ++ + + + N
Sbjct: 112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+ + Y +PE G D + D++SLGC+L E+ TGE F D+ V + + +
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---- 227
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 697
+ + I P H S V
Sbjct: 228 -------------------------------REDPIPPS----ARHEGLSAD-LDAVVLK 251
Query: 698 LLEINPQRRPTAREALDHPWLQ 719
L NP+ R + ++
Sbjct: 252 ALAKNPENRYQTAAEMRADLVR 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 5e-41
Identities = 53/264 (20%), Positives = 94/264 (35%), Gaps = 29/264 (10%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
V+ Y V +G +F +F+ +L V +K D Q DE + KL+
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGC 60
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
I +Y + H +V +LL +L + F++ + + +Q
Sbjct: 61 -----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQM 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCE---IKIIDLGSSCFQTDNLC--------- 578
L ++ +H +++ D+KP+N LI I ++D G F D +
Sbjct: 111 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 579 -LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP---NDAVVMILARIIG 634
+ Y + +G ++ DL +LG + G + + RI
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
Query: 635 MLGPIDLEMLMQG--QEIYKYFTK 656
L L G +E YKY
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHY 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 66/314 (21%), Positives = 111/314 (35%), Gaps = 66/314 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKN 470
+ + + LG +F KVF A+ T +K +K D D + ++ E ++L L ++
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ F E+LF V E L +L + + F L R +
Sbjct: 63 P-----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAE 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSY 586
+ L++LHS GI++ DLK +NIL+ KI D G + + Y
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLDKDGHI--KIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
APE+++G Y+ +D WS G +L E+ G+ F + I
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------------- 216
Query: 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706
P E D + L P++R
Sbjct: 217 ----------------------MDNPFYPRWLEKE---------AKDLLVKLFVREPEKR 245
Query: 707 PTAR-EALDHPWLQ 719
R + HP +
Sbjct: 246 LGVRGDIRQHPLFR 259
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 64/316 (20%), Positives = 111/316 (35%), Gaps = 69/316 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKND 471
+ + LG F KV ++ TG +KI++ + KD ++ E ++L+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--- 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ L F + L V E F + FT R + + +
Sbjct: 64 ---HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIV 115
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQSRSYRA 588
ALEYLHS +++ D+K EN+++ IKI D G + + + Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEV+ Y + +D W LG ++ E+ G + F N + I+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--------------- 218
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP- 707
E P S E + LL+ +P++R
Sbjct: 219 --------------------MEEIRFPRTLSPE---------AKSLLAGLLKKDPKQRLG 249
Query: 708 ----TAREALDHPWLQ 719
A+E ++H +
Sbjct: 250 GGPSDAKEVMEHRFFL 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 54/310 (17%), Positives = 107/310 (34%), Gaps = 65/310 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ + +G F V + G V +K IKND L E ++ +
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATA-QAFLAEASVMTQLR------ 58
Query: 475 EH-HILRLYDYFYHLE-HLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++L + L+IV E + + +L ++ + S G + L +
Sbjct: 59 -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVC 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
EA+EYL +H DL N+L+ K+ D G + + + APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA 171
Query: 592 IIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
+ + K D+WS G +L E+++ G V +P + ++ R+
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------------------ 213
Query: 651 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710
+ P+ + ++ ++ RP+
Sbjct: 214 ----------------EKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAMRPSFL 248
Query: 711 EALDHPWLQH 720
+ + L+H
Sbjct: 249 QLREQ--LEH 256
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 4e-37
Identities = 68/336 (20%), Positives = 125/336 (37%), Gaps = 67/336 (19%)
Query: 393 KNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK- 451
K + F + + P NT ++ + LG+ +F +V + +G +KI+ K
Sbjct: 21 KAKEDFLKKWETPS-QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 452 ---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKF 508
+ +L+E ++L+ VN +++L F +L++V E +
Sbjct: 80 VKLKQIEHTLNEKRILQAVNF------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
F+ + Q + EYLHSL +I+ DLKPEN+LI Q+ I++ D G
Sbjct: 134 RIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFG 186
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
+ + APE+I+ Y++ +D W+LG ++ E+ G F D + I
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 688
+I + P S +
Sbjct: 247 YEKI-----------------------------------VSGKVRFPSHFSSD------- 264
Query: 689 AFFIDFVRTLLEINPQRR-----PTAREALDHPWLQ 719
D +R LL+++ +R + +H W
Sbjct: 265 --LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-37
Identities = 65/313 (20%), Positives = 111/313 (35%), Gaps = 65/313 (20%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDV-CLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
G+ V + +GS +F V++ + H V V L + +E+ +L+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR---- 62
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +IL Y L IV + ++LY + F + +L I RQ
Sbjct: 63 ---HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQT 113
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSRS 585
+ ++YLH+ IIH DLK NI + +KI D G + + S
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 586 YRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
+ APEVI PY + D+++ G +L EL TG++ + N + ++G
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------- 224
Query: 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 702
Y+ P+ S + + + L+
Sbjct: 225 ----------------------------GYLSPDLSKVRSNC---PKAMKRLMAECLKKK 253
Query: 703 PQRRPTAREALDH 715
RP + L
Sbjct: 254 RDERPLFPQILAS 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 56/314 (17%), Positives = 95/314 (30%), Gaps = 63/314 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ LG F +V+ T V +K +K + L E +++K +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLR------ 70
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++LY E ++IV E + + Y L +L + Q +
Sbjct: 71 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGM 126
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPE 590
Y+ + +H DL+ NIL+ K+ D G + DN + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
+ + K D+WS G +L EL T G V +P +L ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---------------- 228
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
P E D + P+ RPT
Sbjct: 229 ------------------RGYRMPCPPECPES---------LHDLMCQCWRKEPEERPTF 261
Query: 710 REALD--HPWLQHP 721
+
Sbjct: 262 EYLQAFLEDYFTST 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 59/313 (18%), Positives = 101/313 (32%), Gaps = 63/313 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ E LG+ F +V+ + V +K +K D L E L+K +
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------ 66
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
++RLY E ++I+ E + T+ +L + Q E +
Sbjct: 67 HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGM 122
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS----YRAPE 590
++ IH DL+ NIL+ C KI D G + DN + + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
I + K D+WS G +L E+ T G + +P ++ +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------------- 223
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
+ P+ E +R + P+ RPT
Sbjct: 224 -----------------ERGYRMVRPDNCPEE---------LYQLMRLCWKERPEDRPTF 257
Query: 710 REALDHPWLQHPY 722
L+ +
Sbjct: 258 DYLRS--VLEDFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-34
Identities = 54/307 (17%), Positives = 106/307 (34%), Gaps = 65/307 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ LG+ F V + DV +K+IK D+ ++E K++ ++
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------- 57
Query: 476 H-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H +++LY +FI+ E + L + + + F +L + + EA
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEA 112
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAP 589
+EYL S +H DL N L+ + +K+ D G S + D+ + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
EV++ + K D+W+ G ++ E+++ G++ + I
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA--------------- 215
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
L P +S + + + RPT
Sbjct: 216 -------------------QGLRLYRPHLASEK---------VYTIMYSCWHEKADERPT 247
Query: 709 AREALDH 715
+ L +
Sbjct: 248 FKILLSN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 5e-34
Identities = 53/314 (16%), Positives = 99/314 (31%), Gaps = 61/314 (19%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ LG + +V++ + V +K +K D ++ L E ++K +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------ 71
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H ++++L +I+ E + + L + Q A
Sbjct: 72 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSA 127
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAP 589
+EYL IH DL N L+ +K+ D G S T + + AP
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
E + + K D+W+ G +L E+ T + + +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---------------------IDLSQ 224
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
+Y+ K+Y + PE + + +R + NP RP+
Sbjct: 225 VYELLEKDYRMER------------PEGCPEK---------VYELMRACWQWNPSDRPSF 263
Query: 710 REALD--HPWLQHP 721
E Q
Sbjct: 264 AEIHQAFETMFQES 277
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 7e-34
Identities = 70/324 (21%), Positives = 125/324 (38%), Gaps = 71/324 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIK-----NDKDFFDQSLDEIKLLKL 466
+ + + LG+ A+ KVF + + TG +K++K + + E ++L+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ ++ L+ F L ++ + + +E FT +Q+
Sbjct: 85 IR-----QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY 134
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQ 582
+ + ALE+LH LGII+ D+K ENIL+ S + + D G S +T+ +
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 583 SRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+ Y AP+++ G +D+ +D WSLG ++ EL TG F D A I
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------- 245
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
+ E P+E S D ++ LL
Sbjct: 246 ------------------------RRILKSEPPYPQEMSAL---------AKDLIQRLLM 272
Query: 701 INPQRRP-----TAREALDHPWLQ 719
+P++R A E +H + Q
Sbjct: 273 KDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 9e-34
Identities = 50/307 (16%), Positives = 98/307 (31%), Gaps = 63/307 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ +GS F V L V +K I+ + ++E +++ ++
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------ 58
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
H +++LY + +V E + L ++ + + L + E
Sbjct: 59 -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE-----TLLGMCLDVCE 112
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRA 588
+ YL +IH DL N L+ + IK+ D G + F D+ + +
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVG--ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEV Y K D+WS G ++ E+++ + +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---------------------RSNS 209
Query: 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 708
E+ + + + LY P +S + + P+ RP
Sbjct: 210 EVVEDISTGFRLY------------KPRLASTH---------VYQIMNHCWKERPEDRPA 248
Query: 709 AREALDH 715
L
Sbjct: 249 FSRLLRQ 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 56/332 (16%), Positives = 105/332 (31%), Gaps = 80/332 (24%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKD--FFDQSLDEIKLLKLV 467
+ LGS AF KV A + V +K++K D + + E+K++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL------------------RANLYEFQKFN 509
++ +I+ L ++++ E YE QK
Sbjct: 98 GSHE-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
+E T L Q + +E+L +H DL N+L+ +KI D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH--GKVVKICDFGL 210
Query: 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623
+ + + APE + Y K D+WS G +L E+++ G +P
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 683
V ++I N + P ++ E
Sbjct: 271 PVDANFYKLI---------------------------------QNGFKMDQPFYATEE-- 295
Query: 684 LQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715
+++ + ++RP+
Sbjct: 296 -------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-32
Identities = 60/316 (18%), Positives = 98/316 (31%), Gaps = 71/316 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQ---DLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ E LG +F V + + V V +K +K + + D + E+ + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ H +++RLY + +L + + +Q F LG L
Sbjct: 69 D-------HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRY 116
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q E + YL S IH DL N+L+ R +KI D G N YV
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639
+ APE + + D W G L E++T G+ + IL +I
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------ 228
Query: 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 699
PE+ + + +
Sbjct: 229 ---------------------------KEGERLPRPEDCPQD---------IYNVMVQCW 252
Query: 700 EINPQRRPTAREALDH 715
P+ RPT D
Sbjct: 253 AHKPEDRPTFVALRDF 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 4e-31
Identities = 56/313 (17%), Positives = 98/313 (31%), Gaps = 71/313 (22%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH 476
LGS F V + Q V +KI+K ND D+ L E +++ ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN------P 68
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I+R+ E +V E+ + + + Q ++Y
Sbjct: 69 YIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKY 122
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPE 590
L +H DL N+L+ + + KI D G S + Y + APE
Sbjct: 123 LEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
I + K D+WS G ++ E ++ G+ + M+G E
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG----------------------MKGSE 218
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
+ K + P E D + + + RP
Sbjct: 219 VTAMLEKGERMG------------CPAGCPRE---------MYDLMNLCWTYDVENRPGF 257
Query: 710 REALDHPWLQHPY 722
L++ Y
Sbjct: 258 AAVELR--LRNYY 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 6e-31
Identities = 50/323 (15%), Positives = 106/323 (32%), Gaps = 71/323 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND--KDFFDQSLDEIKLLKLVNK 469
+ + +G+ F +V G + V +K +K+ + L E ++ +
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD- 85
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+++ L + I+ E + + + FT+ +L + R
Sbjct: 86 -----HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRG 136
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS---- 585
++YL + +H DL NIL+ S K+ D G S F D+ + +
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 586 ----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640
+ APE I + D+WS G ++ E+ + GE + +
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------------------ 236
Query: 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700
M Q++ ++Y L P + + +
Sbjct: 237 ----MTNQDVINAIEQDYRLP------------PPMDCPSA---------LHQLMLDCWQ 271
Query: 701 INPQRRPTAREALDH--PWLQHP 721
+ RP + ++ +++P
Sbjct: 272 KDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 6e-31
Identities = 55/311 (17%), Positives = 101/311 (32%), Gaps = 66/311 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIK--NDKDFFDQSLDEIKLLKLVNK 469
+ + LGS AF V++ + G + V +K ++ + LDE ++ V+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H+ RL I + L ++ + ++++ G Y L Q
Sbjct: 71 ------PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----LLNWCVQ 119
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSR 584
+ + YL ++H DL N+L+K+ +KI D G + + +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
+ A E I+ Y + D+WS G + EL T +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------------- 216
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
+ EI K L P +++ + I+
Sbjct: 217 IPASEISSILEKGERL------------PQPPICTID---------VYMIMVKCWMIDAD 255
Query: 705 RRPTAREALDH 715
RP RE +
Sbjct: 256 SRPKFRELIIE 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 55/322 (17%), Positives = 102/322 (31%), Gaps = 51/322 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
IA + E +G F +V++ + G +V +KI + ++ E ++ + V
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE--RSWFREAEIYQTVMLRH 56
Query: 472 PADEHHILRLYDYFYH----LEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQV 525
+IL L++V + +L+++ ++ G L
Sbjct: 57 E----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 112
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY----- 580
+ +E + I H DLK +NIL+K I DLG +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 581 --VQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
V ++ Y APEV+ ++ D++++G + E+ + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 692
+ P EM E +L IP L+
Sbjct: 231 LVPSDPSVEEMRKVVCE------------------QKLRPNIPNRWQSCEALR----VMA 268
Query: 693 DFVRTLLEINPQRRPTAREALD 714
+R N R TA
Sbjct: 269 KIMRECWYANGAARLTALRIKK 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 56/313 (17%), Positives = 102/313 (32%), Gaps = 71/313 (22%)
Query: 422 LGSAAFSKVFQAQDLHT--GVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F V Q +DV +K++K +K ++ + E +++ + D +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNPY 70
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL E L +V E+ L++F G + + + Q ++Y
Sbjct: 71 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLV-----GKREEIPVSNVAELLHQVSMGMKY 124
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPE 590
L +H DL N+L+ + R KI D G S + Y + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
I + + D+WS G + E + G+ + M+G E
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK----------------------MKGPE 220
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
+ + + + P E E + + RP
Sbjct: 221 VMAFIEQGKRME------------CPPECPPE---------LYALMSDCWIYKWEDRPDF 259
Query: 710 REALDHPWLQHPY 722
++ Y
Sbjct: 260 LTVEQR--MRACY 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 51/311 (16%), Positives = 90/311 (28%), Gaps = 62/311 (19%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ +G F +V +A+ G+ + I + KD E+++L + +
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP---- 71
Query: 476 HHILRLYDYFYHLEHLFIVCELL-----------RANLYEFQKFNQESGGEAYFTLGRLQ 524
+I+ L H +L++ E L F + + + +L
Sbjct: 72 -NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
++YL IH DL NIL+ +I L +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
+ A E + Y D+WS G +L E+ +
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------------------- 229
Query: 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704
M E+Y+ + Y L P E D +R P
Sbjct: 230 MTCAELYEKLPQGYRLE------------KPLNCDDE---------VYDLMRQCWREKPY 268
Query: 705 RRPTAREALDH 715
RP+ + L
Sbjct: 269 ERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 60/325 (18%), Positives = 108/325 (33%), Gaps = 75/325 (23%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
R + LG+ AF KV +A + V +K++K ++ + E+K+L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL-------------RANLYEFQKFNQESGG 514
+ +I+ L ++ E + +
Sbjct: 84 -----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E L L + Q + + +L S IH DL NIL+ KI D G +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIK 196
Query: 575 DNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMI 628
++ V+ + + APE I Y + D+WS G L EL++ G +P V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 688
++I + PE + E
Sbjct: 257 FYKMI---------------------------------KEGFRMLSPEHAPAE------- 276
Query: 689 AFFIDFVRTLLEINPQRRPTAREAL 713
D ++T + +P +RPT ++ +
Sbjct: 277 --MYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-29
Identities = 59/324 (18%), Positives = 107/324 (33%), Gaps = 70/324 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVD-------VCLKIIKND--KDFFDQSLDEIKLLK 465
R + + LG AF +V A+ + D V +K++K+D + + E++++K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEF----------QKFNQESGG 514
++ K+ +I+ L L+++ E + NL E+ +N
Sbjct: 74 MIGKH-----KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E + L Q +EYL S IH DL N+L+ +I L
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631
D + APE + Y + D+WS G +L E++T V L +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF 691
++ P + E
Sbjct: 249 LL---------------------------------KEGHRMDKPSNCTNE---------L 266
Query: 692 IDFVRTLLEINPQRRPTAREALDH 715
+R P +RPT ++ ++
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-29
Identities = 54/333 (16%), Positives = 100/333 (30%), Gaps = 73/333 (21%)
Query: 401 NKDLPIILNTVIAGRYYVT----EYLGSAAFSKVFQAQDLH---TGVDVCLKIIK--NDK 451
N +L + V+ G + E +G F V+ L + +K + D
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 452 DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-HLFIVCELLRA-NLYEFQKFN 509
Q L E ++K + ++L L E +V ++ +L F +
Sbjct: 70 GEVSQFLTEGIIMKDFSH------PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
+ T+ L Q + +++L S +H DL N ++ + +K+ D G
Sbjct: 124 THN-----PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGL 176
Query: 570 SCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
+ D + A E + + K D+WS G +L EL T
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682
D + +I Y + L + PE
Sbjct: 237 D---------------------VNTFDITVYLLQGRRL------------LQPEYCPDP- 262
Query: 683 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715
+ + + RP+ E +
Sbjct: 263 --------LYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 48/314 (15%), Positives = 98/314 (31%), Gaps = 68/314 (21%)
Query: 422 LGSAAFSKVFQAQDLHTG----VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADE 475
+G+ F +V++ + V V +K +K + L E ++ +
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH------ 68
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
H+I+RL + + I+ E + + ++ F++ +L + R ++
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMK 124
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAP 589
YL ++ +H DL NIL+ S K+ D G S D+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
E I + D+WS G ++ E+ T + + + I
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------------- 226
Query: 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 709
+ P + + + RRP
Sbjct: 227 -----------------NDGFRLPTPMDCPSA---------IYQLMMQCWQQERARRPKF 260
Query: 710 REALD--HPWLQHP 721
+ + ++ P
Sbjct: 261 ADIVSILDKLIRAP 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 2e-28
Identities = 56/338 (16%), Positives = 97/338 (28%), Gaps = 85/338 (25%)
Query: 415 RYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLV 467
+G AF +VFQA+ V +K++K + D E L+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEF------------------QKF 508
+ +I++L + + ++ E + +L EF +
Sbjct: 74 DN------PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
S G + I RQ + YL +H DL N L+ +KI D G
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE--NMVVKIADFG 185
Query: 569 SSCFQTDNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPN 622
S + PE I Y + D+W+ G +L E+++ + +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 682
A ++ + + PE LE
Sbjct: 246 MAHEEVIYYVR----------------------------------DGNILACPENCPLE- 270
Query: 683 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720
+ +R P RP+ LQ
Sbjct: 271 --------LYNLMRLCWSKLPADRPSFCSIHR--ILQR 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 57/312 (18%), Positives = 90/312 (28%), Gaps = 68/312 (21%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKN--DKDFFDQSLDEIKLLKLVNK 469
R + +G F V Q + + V +K KN ++ L E ++ +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H HI++L I+ L F + + S L L +
Sbjct: 67 ------HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAY 115
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
Q AL YL S +H D+ N+L+ S +K+ D G S + D+
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 586 -YRAPEVIIGLPYDQKIDLWSLGCILAE-LWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643
+ APE I + D+W G + E L G F ++ RI
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---------- 223
Query: 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703
N +P + +P
Sbjct: 224 ------------------------NGERLPMPPNCPPT---------LYSLMTKCWAYDP 250
Query: 704 QRRPTAREALDH 715
RRP E
Sbjct: 251 SRRPRFTELKAQ 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 59/326 (18%), Positives = 107/326 (32%), Gaps = 74/326 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLV 467
R + + LG AF +V +A T V +K++K + E+K+L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 468 NKNDPADEHHILRLYDYFYHL-EHLFIVCELL-----------RANLYEFQKFNQESGGE 515
+++ L L ++ E + N + K E +
Sbjct: 74 G-----HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
+ TL L + Q + +E+L S IH DL NIL+ + +KI D G +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYK 186
Query: 576 NLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPNDAVVMIL 629
+ + + + APE I Y + D+WS G +L E+++ +P +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDA 689
R + P+ ++ E
Sbjct: 247 CRRL---------------------------------KEGTRMRAPDYTTPE-------- 265
Query: 690 FFIDFVRTLLEINPQRRPTAREALDH 715
+ P +RPT E ++H
Sbjct: 266 -MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 4e-26
Identities = 51/331 (15%), Positives = 110/331 (33%), Gaps = 75/331 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
+ ++ LG +F V++ V +K + ++ L+E ++K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGR 522
N HH++RL + ++ EL L++ L + + A +L +
Sbjct: 81 N------CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
+ + + + + YL++ +H DL N ++ +KI D G + +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGMTRDIYETDYYRKG 192
Query: 583 SRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGML 636
+ + +PE + + D+WS G +L E+ T E + + +L ++
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--- 249
Query: 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 696
E L+ P+ + +R
Sbjct: 250 -----------------------------EGGLLD--KPDNCPDM---------LFELMR 269
Query: 697 TLLEINPQRRPTAREALD------HPWLQHP 721
+ NP+ RP+ E + P +
Sbjct: 270 MCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.0 bits (199), Expect = 4e-18
Identities = 30/191 (15%), Positives = 53/191 (27%), Gaps = 7/191 (3%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G S VF + +K K F + ++ L
Sbjct: 8 MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV--LAIRSARNE 64
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+ L+ L + + +V+ LE + + G
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVL-DMILEEVAKFYHRG 123
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKI 601
I+H DL N+L+ I IID S + + R R Y +
Sbjct: 124 IVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEK 180
Query: 602 DLWSLGCILAE 612
D+ S + +
Sbjct: 181 DINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 722 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1a25a_ | 132 | C2 domain from protein kinase c (beta) {Rat (Rattu | 99.74 | |
| d1dqva1 | 130 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 99.64 | |
| d2bwqa1 | 125 | Regulating synaptic membrane exocytosis protein, r | 99.63 | |
| d1dqva2 | 145 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 99.62 | |
| d1w15a_ | 138 | Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: | 99.61 | |
| d1uowa_ | 157 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 99.61 | |
| d2cm5a1 | 137 | C2b-domain of rabphilin {Rat (Rattus norvegicus) [ | 99.59 | |
| d1rsya_ | 143 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 99.58 | |
| d1rh8a_ | 142 | Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | 99.57 | |
| d1ugka_ | 138 | Synaptotagmin IV {Human (Homo sapiens) [TaxId: 960 | 99.55 | |
| d1wfma_ | 138 | Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9 | 99.52 | |
| d2ep6a1 | 126 | Multiple C2 and transmembrane domain-containing pr | 99.52 | |
| d1qasa2 | 131 | PI-specific phospholipase C isozyme D1 (PLC-D1), C | 99.42 | |
| d1rlwa_ | 126 | Domain from cytosolic phospholipase A2 {Human (Hom | 99.37 | |
| d1wfja_ | 136 | C2 domain protein At1g63220 {Thale cress (Arabidop | 99.35 | |
| d1gmia_ | 136 | Domain from protein kinase C epsilon {Rat (Rattus | 99.28 | |
| d2nq3a1 | 133 | E3 ubiquitin-protein ligase Itchy {Human (Homo sap | 99.22 | |
| d1bdya_ | 123 | Domain from protein kinase C delta {Rat (Rattus no | 99.12 | |
| d2cjta1 | 128 | Unc-13 homolog A {Rat (Rattus norvegicus) [TaxId: | 99.0 | |
| d2zkmx2 | 122 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 98.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.48 | |
| d1e7ua2 | 174 | Phoshoinositide 3-kinase (PI3K) {Pig (Sus scrofa) | 82.07 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=427.57 Aligned_cols=249 Identities=29% Similarity=0.474 Sum_probs=214.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.. .....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR------HPNILRLYGYFHDAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC------CCCCCeEEEEEEECC
Confidence 67999999999999999999999999999999987532 23456778888888775 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.++|||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~~kl~DFG 151 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFG 151 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC--CCCEeecccc
Confidence 99999999985 7777766433 2899999999999999999999999999999999999996 7889999999
Q ss_pred CcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 569 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 569 ls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.++.....
T Consensus 152 ~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------- 221 (263)
T d2j4za1 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------- 221 (263)
T ss_dssp SCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------
T ss_pred eeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 99776543 4456899999999999999999999999999999999999999999888777776642211
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.+|. ..++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 222 -------------------------~~p~---------~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 -------------------------TFPD---------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------------------CCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------------------CCCc---------cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1111 23467899999999999999999999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=427.53 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=205.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.++|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC------CTTBCCEEEEEEETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC------CCCEeeEeeeeccCce
Confidence 468999999999999999999999999999999987543 23456788999988875 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++|||||+.+ +|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~--~~~~KL~DFG~ 149 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGL 149 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC--CCCEEEccchh
Confidence 9999999985 777766432 23999999999999999999999999999999999999986 77899999999
Q ss_pred cccccC-----CccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 570 SCFQTD-----NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 570 s~~~~~-----~~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
|..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||..................
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~----- 224 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----- 224 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-----
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Confidence 976432 2344689999999999998876 57899999999999999999999764322211111100000
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
..+ .....++.+.+||++||+.||++|||++|+|+||||+++
T Consensus 225 -----------------------------~~~-------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 225 -----------------------------YLN-------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp -----------------------------TST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------------------------CCC-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 000 011234678899999999999999999999999999876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=428.51 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=212.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++ ||||++++++|...+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC------CCCEeeEeEEEEECCEE
Confidence 357999999999999999999999999999999987543 33466889999999885 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+|||||+.| +|.+++.. . .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 93 ~ivmEy~~gg~L~~~~~~-~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~vkl~DFG~a 163 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE-T------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (293)
T ss_dssp EEEEECCTTCBHHHHHHH-S------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHhhc-c------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC--CCcEeeccchhh
Confidence 999999986 55554432 1 2899999999999999999999999999999999999986 788999999999
Q ss_pred ccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 571 CFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 571 ~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....+
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~--------- 234 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------- 234 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---------
T ss_pred eeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 86543 234567999999999999999999999999999999999999999988776666555421100
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
....| ...++.+++||++||+.||.+|||++|+|+||||+.
T Consensus 235 -----------------------~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 -----------------------ELQNP---------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -----------------------CCSSG---------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------------------CCCCc---------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 00001 123467899999999999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=441.41 Aligned_cols=292 Identities=25% Similarity=0.328 Sum_probs=208.2
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
+..++|+++++||+|+||+||+|+++.+|+.||+|+++.. .....++.+|+.+|+.++ ||||++++++|.+.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSD 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC------CTTBCCEEEEEECS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEEEC
Confidence 4467899999999999999999999999999999999754 233456777888777664 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceEEcccCCCeEEEEe
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
++++|||||+.| +|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+||||+. ++.+||+|
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~--~~~vkl~D 148 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCD 148 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC--CCCEEEee
Confidence 999999999985 6777665432 28999999999999999999997 59999999999999986 78999999
Q ss_pred cCCcccccC-CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH-HHHHHhhcCCCcHHH-
Q 004954 567 LGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI-LARIIGMLGPIDLEM- 643 (722)
Q Consensus 567 FGls~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~-l~~i~~~lg~~~~~~- 643 (722)
||+|..... .....+||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+..+. ...+....+......
T Consensus 149 FGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 149 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp CCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred CCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 999986543 34457899999999999999999999999999999999999999977543322 211222222111000
Q ss_pred --HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 644 --LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 644 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.........+.....................|.. + .....+.++++||.+||+.||.+||||+|+|+||||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK--L--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCC--C--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCcc--C--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0000000000000000000000000000000100 0 00123567999999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.1e-50 Score=433.68 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=220.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+.++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++ ||||++++++|.+.++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------HPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC------CTTBCCEEEEEEETTE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCE
Confidence 4578999999999999999999999999999999987643 33456778999998885 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++|||||+.| +|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+.++.+||+|||+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999985 7777764322 239999999999999999999999999999999999999865678999999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|......++..
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 247 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS----- 247 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG-----
T ss_pred heecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-----
Confidence 9876543 334689999999999999999999999999999999999999999988888887776433222211
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....++.+++||++||+.||++|||++|+|+||||+.
T Consensus 248 -----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 248 -----------------------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp -----------------------------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred -----------------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 01123467899999999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-50 Score=428.85 Aligned_cols=258 Identities=31% Similarity=0.471 Sum_probs=203.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
-+.++|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.+++.++ ||||++++++|.+.
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK------HPNIVALDDIYESG 79 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCC------CTTBCCEEEEEECS
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC------CCCCCcEEEEEEEC
Confidence 35678999999999999999999999999999999997543 22345668888888774 78999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc-cCCCeEEEEe
Q 004954 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIID 566 (722)
Q Consensus 489 ~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~-~~~~~vkL~D 566 (722)
+.+||||||+. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+.. ..++.+||+|
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CEEEEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEec
Confidence 99999999998 57888776432 3999999999999999999999999999999999999974 3468899999
Q ss_pred cCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 567 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 567 FGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+....++...+......++.
T Consensus 154 FG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~--- 230 (307)
T d1a06a_ 154 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS--- 230 (307)
T ss_dssp C------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT---
T ss_pred cceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC---
Confidence 9999865433 34568999999999999999999999999999999999999999998887777776532211110
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
+ .....++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus 231 ------------------------------~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 231 ------------------------------P-------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------------------------------T-------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------------------------------c-------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 0 01123467899999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=422.95 Aligned_cols=280 Identities=30% Similarity=0.449 Sum_probs=226.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
++|+++++||+|+||+||+|+++.+|+.||||+++... ....++.+|+++++.++ ||||++++++|.+.++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN------HPNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC------CTTBCCEEEEEEETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC------CCcEEEeccccccccc
Confidence 58999999999999999999999999999999996543 23456778888888774 7899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+++||||+.++++.++...... .+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||.+
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~--~~~~kl~DFG~a 149 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLA 149 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSTTHH
T ss_pred eeEEEeecCCchhhhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc--cCcceeccCCcc
Confidence 9999999999888777644332 3999999999999999999999999999999999999985 778999999999
Q ss_pred ccccCC---ccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
...... .....+|+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+.++....+.++...+..
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred eeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc
Confidence 765433 33458899999999987766 57899999999999999999999999999999999988888776554443
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....++.. .. ...............+..+++||++||+.||.+|||++|+|+||||++
T Consensus 230 ~~~~~~~~~-------------~~--~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 230 VTSMPDYKP-------------SF--PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp GGGSTTCCT-------------TS--CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccc-------------cc--ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 222211100 00 000011112223345678999999999999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=422.84 Aligned_cols=254 Identities=31% Similarity=0.439 Sum_probs=211.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~-~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+.|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+++++.++ ||||+++++++.+.+.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD------HPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC------CTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEeeCCeEE
Confidence 4699999999999999999999999999999999753 344577889999999885 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 493 iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
|||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|.
T Consensus 86 lvmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~--~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSA 158 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC--CCCEEEEechhhh
Confidence 99999986 55555443322 3899999999999999999999999999999999999996 7889999999987
Q ss_pred cccCC---ccccccCCcccCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~-----~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
..... ....+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+..+.+.++.....+
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~----- 233 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP----- 233 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-----
T ss_pred ccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 54432 33468999999999984 456889999999999999999999999887766666555421100
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
.++ .+...++++.+||++||+.||.+|||++|+|+||||+..
T Consensus 234 -----------------------------~~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 234 -----------------------------TLA-------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp -----------------------------CCS-------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred -----------------------------CCC-------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 000 011235678999999999999999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=421.60 Aligned_cols=282 Identities=28% Similarity=0.438 Sum_probs=227.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCC-CcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~t-g~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~- 487 (722)
.++|++++.||+|+||+||+|++..+ ++.||||+++... .......+|+.+++.+... .||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~---~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc---CCCCcceeeeeeccc
Confidence 57899999999999999999999765 6789999986532 2334677899999988753 48999999999864
Q ss_pred ----cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 488 ----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 488 ----~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
..+++++|||+.++++.+...... ..+++..++.++.||+.||+|||++||+||||||+|||++. .+.+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~--~~~~k 156 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIK 156 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccccCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC--CCCee
Confidence 357899999999887766554332 23899999999999999999999999999999999999995 78999
Q ss_pred EEecCCcccccC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 004954 564 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (722)
Q Consensus 564 L~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~ 641 (722)
|+|||++..... ......||+.|+|||++.+.+|+.++|||||||++|||++|++||.+.+..+.+.++....+.++.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 157 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 999999875433 334578999999999999999999999999999999999999999999999999999998888776
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
..+........... ...............++.+++||++||++||++||||+|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 237 EDWPRDVALPRQAF-----------------HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp GGSCTTCSSCGGGS-----------------CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hcccccccchhhhh-----------------ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 55443221111000 000011122223345678999999999999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=424.99 Aligned_cols=274 Identities=31% Similarity=0.458 Sum_probs=221.9
Q ss_pred EEEEeccCCCCceEEEEECCCCcEEEEEEeecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 418 i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
.+++||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+++.++ ||||++++++|...+++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~~~~~~~~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS------HPNIIGLLDAFGHKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC------CTTBCCEEEEECCTTCC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC------CCCEeEEEeeeccCCce
Confidence 46899999999999999999999999999865322 2345788999999885 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcc
Q 004954 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (722)
Q Consensus 492 ~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 571 (722)
+|||||+.++++..+.... ..+++..++.+++||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~ivmE~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~--~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAK 148 (299)
T ss_dssp EEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECCCGGGS
T ss_pred eehhhhhcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC--CCccccccCcccc
Confidence 9999999988766655322 23889999999999999999999999999999999999996 7899999999997
Q ss_pred cccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 572 ~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... ....++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+++.+|.+.+|.++.+.+...
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 65443 3346789999999998754 5799999999999999999999999999999999999999888776554433
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....+.. ....+ ...+.......++.+++||++||+.||++||||+|+|+||||++
T Consensus 229 ~~~~~~~~---------------~~~~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 229 CSLPDYVT---------------FKSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TSSTTCCC---------------CCCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hccchhhh---------------hccCC-CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 22211110 00011 11223333455688999999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.6e-50 Score=432.61 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=218.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+++.++ ||||++++++|.+.++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH------HPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC------STTBCCEEEEEECSSE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCE
Confidence 3468999999999999999999999999999999987643 23445667888887664 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++|||||+.| +|.+.+.... ..+++.+++.|+.||+.||+|||++||+||||||+||||+...++.+||+|||+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence 9999999985 6666554322 239999999999999999999999999999999999999865678999999999
Q ss_pred cccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 570 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++..
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 250 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED----- 250 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS-----
T ss_pred ceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-----
Confidence 9876543 334689999999999999999999999999999999999999999988888887776433222210
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCCC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
.....++.+.+||++||+.||.+|||++|+|+||||+..
T Consensus 251 -----------------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 -----------------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 011234678999999999999999999999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=417.97 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=218.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.++ ||||++++++
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~ 81 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ------HPNVITLHEV 81 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC------CCCCCcEEEE
Confidence 5678999999999999999999999999999999986532 12456889999999985 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCC--Ce
Q 004954 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--CE 561 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~--~~ 561 (722)
|.+.++++|||||+.| +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++..+. ..
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCC
T ss_pred EEECCEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccc
Confidence 9999999999999985 7777776443 2999999999999999999999999999999999999986332 36
Q ss_pred EEEEecCCcccccC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 562 IKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 562 vkL~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 156 vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp EEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred eEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999999976543 3445688999999999999999999999999999999999999999988888887776433222
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 719 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~ 719 (722)
+... ....+..+++||++||+.||.+|||++|+|+||||+
T Consensus 236 ~~~~----------------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 275 (293)
T d1jksa_ 236 EDEY----------------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275 (293)
T ss_dssp CHHH----------------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred Cchh----------------------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 2111 112346688999999999999999999999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 276 ~ 276 (293)
T d1jksa_ 276 P 276 (293)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=418.39 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=199.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-- 487 (722)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+|+++++.+ .||||+++++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL------KHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC------CCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC------CCCCEeeEEEEEEeCC
Confidence 367999999999999999999999999999999987542 2334556677766555 48999999999965
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC-----CccccCCCCceEEcccCCCe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g-----IvHrDLKp~NILl~~~~~~~ 561 (722)
.+.++|||||++ |+|.+++....... ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~--~~~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQN 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT--TSC
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC--CCc
Confidence 467899999997 57888776543322 23999999999999999999999976 999999999999996 789
Q ss_pred EEEEecCCcccccCC---ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 562 IKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 562 vkL~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++..++....-
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~- 231 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 231 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-
T ss_pred EEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-
Confidence 999999999765433 3346899999999999999999999999999999999999999999888777766542100
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 718 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf 718 (722)
..+| ...++++.+||++||+.||.+|||++|+|+|||+
T Consensus 232 ---------------------------------~~~~---------~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 ---------------------------------RRIP---------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------------------------CCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0011 1234678999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-49 Score=423.61 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=215.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT------HPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC------BTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc------CcChhheeeeEeeCC
Confidence 57999999999999999999999999999999997532 23456778888888775 789999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.+++||||+.|+.+..+..... .+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||+
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~--~g~vkL~DFG~ 150 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGF 150 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCCSS
T ss_pred eeeeEeeecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC--CCCEEEecCcc
Confidence 9999999998754444333322 2788999999999999999999999999999999999986 78999999999
Q ss_pred cccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~~ 649 (722)
++.........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+++.++.....
T Consensus 151 a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------ 218 (316)
T d1fota_ 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------ 218 (316)
T ss_dssp CEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------
T ss_pred ceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 99888877788999999999999999999999999999999999999999999888887777653211
Q ss_pred hhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 650 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
.+| ...++.+.+||++||+.||.+|+ |++++|+||||+.
T Consensus 219 -----------------------~~p---------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 219 -----------------------RFP---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp -----------------------CCC---------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred -----------------------CCC---------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 111 12346689999999999999996 9999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=413.06 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=203.8
Q ss_pred eecCcE-EEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 411 VIAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 411 ~l~~rY-~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
...+|| ++.++||+|+||+||+|++..+++.||+|++... ......+.+|+++++.++ ||||++++++|.
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~ 78 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ------HPNIVRFYDSWE 78 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEE
T ss_pred CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC------CCCeeeEEEEEe
Confidence 344566 6778999999999999999999999999998753 233456678888887664 789999999997
Q ss_pred e----cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCceEEcccCC
Q 004954 487 H----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQR 559 (722)
Q Consensus 487 ~----~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~g--IvHrDLKp~NILl~~~~~ 559 (722)
. ...++|||||+++ +|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++. .+
T Consensus 79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~-~~ 151 (270)
T d1t4ha_ 79 STVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PT 151 (270)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TT
T ss_pred eccccCCEEEEEEeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC-CC
Confidence 5 3568999999985 6777776443 2899999999999999999999998 999999999999973 36
Q ss_pred CeEEEEecCCcccccCC-ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHHHhhcC
Q 004954 560 CEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLG 637 (722)
Q Consensus 560 ~~vkL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~-~~e~l~~i~~~lg 637 (722)
+.+||+|||++...... ....+||+.|+|||++.+ +++.++|||||||++|+|++|+.||.+.. ..++...+.....
T Consensus 152 ~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 152 GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp SCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC
Confidence 78999999999865543 445789999999999876 59999999999999999999999997643 3334444321110
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
+. ......++++.+||.+||+.||++|||++|+|+|||
T Consensus 231 ~~------------------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 231 PA------------------------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp CG------------------------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred Cc------------------------------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 00 001123466899999999999999999999999999
Q ss_pred CC
Q 004954 718 LQ 719 (722)
Q Consensus 718 f~ 719 (722)
||
T Consensus 269 fk 270 (270)
T d1t4ha_ 269 FQ 270 (270)
T ss_dssp GC
T ss_pred cC
Confidence 97
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=419.50 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=212.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+++++.++ ||||++++++|.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD------HPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------STTBCCEEEEEECSS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC------CCCeeEEEEEEEECC
Confidence 67999999999999999999999999999999997532 23456788999998885 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+||||||+.| +|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~--~~~vkl~DFG 153 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFG 153 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEEccCCCCHHHhhhccCC------CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC--CceEEecccc
Confidence 99999999985 67777664432 899999999999999999999999999999999999996 7889999999
Q ss_pred CcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|.....
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------ 227 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY------ 227 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC------
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC------
Confidence 99765422 2346799999999999999999999999999999999999999999888887777652211
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHH------HHhCCC
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE------ALDHPW 717 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~E------lL~HPw 717 (722)
.+|. ..++.+++||++||+.||++|||++| +++|||
T Consensus 228 -----------------------------~~p~---------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpf 269 (288)
T d1uu3a_ 228 -----------------------------DFPE---------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269 (288)
T ss_dssp -----------------------------CCCT---------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred -----------------------------CCCc---------cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCc
Confidence 1121 13466899999999999999999987 589999
Q ss_pred CCC
Q 004954 718 LQH 720 (722)
Q Consensus 718 f~~ 720 (722)
|+.
T Consensus 270 f~~ 272 (288)
T d1uu3a_ 270 FES 272 (288)
T ss_dssp GTT
T ss_pred cCC
Confidence 975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-49 Score=422.28 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=210.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
.+|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+++++.++ ||||+++++++.+.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLREH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC------CCCEeeEEEEEEECC
Confidence 46999999999999999999999999999999987542 23355778888887764 789999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
+++|||||+.++++..+..... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGS 161 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTEEEECCCTT
T ss_pred EEEEEEEecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC--CCCEEEeeccc
Confidence 9999999999877765544332 3899999999999999999999999999999999999995 88999999999
Q ss_pred cccccCCccccccCCcccCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 570 SCFQTDNLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 570 s~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+...... ....||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+.++.....+.
T Consensus 162 a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~------- 233 (309)
T d1u5ra_ 162 ASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------- 233 (309)
T ss_dssp CBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred ccccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 9865543 44689999999999964 458899999999999999999999998887777666654211100
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
++ ....++.+.+||++||+.||.+|||++|+|+||||++
T Consensus 234 ---------------------------~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 ---------------------------LQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ---------------------------CS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------------------------CC--------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 00 0123467999999999999999999999999999964
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=423.49 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=223.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (722)
+-++|++++.||+|+||+||+|+++.+|+.||||+++........+.+|+++|+.++ ||||++++++|.+.+++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------HRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC------CTTBCCEEEEEEETTEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCC------CCCCCeEEEEEEECCEE
Confidence 457899999999999999999999999999999999887666667889999998885 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 492 ~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
||||||+.| +|.+++.... ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+....+||+|||++
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchh
Confidence 999999985 7877775432 1389999999999999999999999999999999999998766779999999999
Q ss_pred ccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 571 ~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
...... .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+.+.+|......++...+
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---- 227 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---- 227 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH----
T ss_pred hccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc----
Confidence 775443 34467899999999999999999999999999999999999999999888888887644333332211
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...++.+++||++||+.||.+|||++|+|+||||++
T Consensus 228 ------------------------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 228 ------------------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------------------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 112456889999999999999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=423.40 Aligned_cols=289 Identities=30% Similarity=0.505 Sum_probs=231.2
Q ss_pred cceeeCce---ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCc
Q 004954 404 LPIILNTV---IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHH 477 (722)
Q Consensus 404 ~pi~~~~~---l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpn 477 (722)
++..++.. +.++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+++|+.++ |||
T Consensus 5 ~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------hpn 78 (346)
T d1cm8a_ 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR------HEN 78 (346)
T ss_dssp CCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------BTT
T ss_pred EEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC------CCC
Confidence 44445544 688999999999999999999999999999999999753 334567788999999885 689
Q ss_pred eeEEEEEEEecC------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 004954 478 ILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (722)
Q Consensus 478 Iv~l~~~f~~~~------~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~N 551 (722)
|++++++|...+ ++++||||++.++..+.+.. .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 79 iv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~N 151 (346)
T d1cm8a_ 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 151 (346)
T ss_dssp BCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred eeEEEEEeccCccccccceEEEEEecccccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcch
Confidence 999999998664 57999999977776665432 29999999999999999999999999999999999
Q ss_pred eEEcccCCCeEEEEecCCcccccCCccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 004954 552 ILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (722)
Q Consensus 552 ILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~ 630 (722)
||++. ++.+||+|||++.......+...+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.
T Consensus 152 IL~~~--~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~ 229 (346)
T d1cm8a_ 152 LAVNE--DCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229 (346)
T ss_dssp EEECT--TCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred hhccc--ccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH
Confidence 99996 8899999999999888888888999999999999874 56899999999999999999999999999999999
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH
Q 004954 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 710 (722)
Q Consensus 631 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ 710 (722)
.+....+.++.+.+........... . ..+. .. ....+.......++.+++||++||+.||++||||+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~----~~~~-~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (346)
T d1cm8a_ 230 EIMKVTGTPPAEFVQRLQSDEAKNY-------M----KGLP-EL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296 (346)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHH-------H----HHSC-CC-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHhccCCCcHHHHhhhcchhhhhh-------h----ccCC-cc-cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 9999999988877654332111100 0 0000 00 11122233344567899999999999999999999
Q ss_pred HHHhCCCCCC
Q 004954 711 EALDHPWLQH 720 (722)
Q Consensus 711 ElL~HPwf~~ 720 (722)
|||+||||+.
T Consensus 297 eiL~Hp~f~~ 306 (346)
T d1cm8a_ 297 EALAHPYFES 306 (346)
T ss_dssp HHHHSGGGTT
T ss_pred HHhcChhhCc
Confidence 9999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-49 Score=412.22 Aligned_cols=278 Identities=30% Similarity=0.474 Sum_probs=224.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+||+++++||+|+||+||+|+++ +|+.||||+++... ....++.+|+.+++.++ ||||++++++|...++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK------HSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC------CTTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC------CCcEEeeeeecccCCc
Confidence 68999999999999999999985 78999999997643 22456778888887774 7899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.+++|||+.++++..+.... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||.+
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~--~~~~kl~DfG~a 147 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (286)
T ss_dssp EEEEEECCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred eeEEEEeehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC--CCCEEecccccc
Confidence 99999999998877776433 23999999999999999999999999999999999999986 789999999998
Q ss_pred ccccCC---ccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
...... .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++...++.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 765443 3335689999999999765 568999999999999999999999999999999999998888877665544
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.....++... ................++.+.+||++||+.||++||||+|+|+||||++
T Consensus 228 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 228 VTELPKYDPN---------------FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp GGGSTTCCTT---------------CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhhhhcccc---------------cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 3322221110 0000111122233445678999999999999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-49 Score=423.98 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=215.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+++++.+ .||||++++++|....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV------NFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEEECSS
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc------CCCcEeeccccccccc
Confidence 68999999999999999999999999999999997532 2345677888888766 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+++||||+.+ ++...+.... .+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~--~g~ikL~DFG 186 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTDFG 186 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCT
T ss_pred ccccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC--CCCEEeeece
Confidence 99999999985 5666655432 2899999999999999999999999999999999999986 7899999999
Q ss_pred CcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 004954 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (722)
Q Consensus 569 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~~ 648 (722)
+++..........||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+...++.++......+
T Consensus 187 ~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------- 257 (350)
T d1rdqe_ 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--------- 257 (350)
T ss_dssp TCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred eeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC---------
Confidence 99988877777899999999999999999999999999999999999999999988887777765321111
Q ss_pred hhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCCC
Q 004954 649 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 720 (722)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~~ 720 (722)
| ...++.+.+||++||+.||.+|+ |+++||+||||+.
T Consensus 258 --------------------------p---------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 258 --------------------------P---------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp --------------------------C---------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred --------------------------C---------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 1 12346789999999999999995 9999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=419.82 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=213.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
-++|++++.||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+|+.++ ||||++++++|.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR------HPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC------CTTBCCEEEEEECS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC------CCCEEEEEeeeccc
Confidence 36799999999999999999999999999999999754 233466788888888774 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+++|+||||+.| +|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~--~g~vkl~DF 149 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDF 149 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred cccccceeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecC--CCCEEEeec
Confidence 999999999985 5666655433 2899999999999999999999999999999999999986 789999999
Q ss_pred CCcccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 568 GSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 568 Gls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|+|+.... .....+||+.|+|||++.+.+|+.++|||||||++|+|++|++||.+.+..+++..+.....
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~------- 222 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------- 222 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred ccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-------
Confidence 99986433 33457899999999999999999999999999999999999999999888777766542211
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHHhCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQ 719 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL~HPwf~ 719 (722)
.+|. ..++++++||++||+.||.+|+ +++|+++||||+
T Consensus 223 ----------------------------~~p~---------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 223 ----------------------------RFPR---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp ----------------------------CCCT---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred ----------------------------CCCc---------cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 1121 2346789999999999999999 499999999997
Q ss_pred C
Q 004954 720 H 720 (722)
Q Consensus 720 ~ 720 (722)
.
T Consensus 266 ~ 266 (337)
T d1o6la_ 266 S 266 (337)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-48 Score=405.50 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=214.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----------hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----------DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----------~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
.++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.++. ||||++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG-----HPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT-----CTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEEE
Confidence 578999999999999999999999999999999987542 123457789999999963 68999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
++|.+.+++||||||+. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~ 148 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMN 148 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCC
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC--CCC
Confidence 99999999999999997 58888876433 2899999999999999999999999999999999999985 889
Q ss_pred EEEEecCCcccccC--CccccccCCcccCchhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 562 IKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 562 vkL~DFGls~~~~~--~~~~~~gt~~y~APE~l~~------~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
+||+|||++..... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+.
T Consensus 149 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence 99999999987654 3445679999999999863 347889999999999999999999999988877776665
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
...-.++ .+ .....++++++||.+||+.||++|||++|||
T Consensus 229 ~~~~~~~---------------------------------~~-------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 229 SGNYQFG---------------------------------SP-------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HTCCCCC---------------------------------TT-------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred hCCCCCC---------------------------------Cc-------ccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 3211110 00 0112346799999999999999999999999
Q ss_pred hCCCCCC
Q 004954 714 DHPWLQH 720 (722)
Q Consensus 714 ~HPwf~~ 720 (722)
+||||+.
T Consensus 269 ~h~~~~~ 275 (277)
T d1phka_ 269 AHPFFQQ 275 (277)
T ss_dssp TSGGGCT
T ss_pred cCHHHHH
Confidence 9999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=418.97 Aligned_cols=300 Identities=29% Similarity=0.502 Sum_probs=227.9
Q ss_pred CCcceeeCce---ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCC
Q 004954 402 KDLPIILNTV---IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADE 475 (722)
Q Consensus 402 ~~~pi~~~~~---l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~h 475 (722)
..+|+.+++. +.++|+++++||+|+||+||+|+++.+|+.||||+++.. .....++.+|+.+++.++ |
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------h 75 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------H 75 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC------C
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC------C
Confidence 3578888883 458999999999999999999999999999999999754 334456788999998875 6
Q ss_pred CceeEEEEEEEec------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 476 HHILRLYDYFYHL------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 476 pnIv~l~~~f~~~------~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
|||++++++|... .++|+||||+.++++..+.. .+++..++.+++||+.||.|||++||+||||||
T Consensus 76 pnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP 147 (355)
T d2b1pa1 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147 (355)
T ss_dssp TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred CCeeEEEEEEecccccccCceeEEEEeccchHHHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCc
Confidence 8999999999743 68999999999998876631 289999999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCC--ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e 627 (722)
+|||++. ++.+||+|||++...... ....++|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+...
T Consensus 148 ~Nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 148 SNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp GGEEECT--TCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccccccc--ccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence 9999996 788999999987655433 344678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchh-hhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYY-INEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 628 ~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
.+.+++..++.+..+.+.........+........ ............+... ......++.+.+||++||+.||++|
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dll~~mL~~dP~~R 302 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS---EHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSS---HHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccc---cccccCCHHHHHHHHHHCcCChhHC
Confidence 99999988888887777654433322211111000 0000000000011110 1111124678999999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 004954 707 PTAREALDHPWLQH 720 (722)
Q Consensus 707 pTa~ElL~HPwf~~ 720 (722)
|||+|||+||||+.
T Consensus 303 ~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 303 ISVDDALQHPYINV 316 (355)
T ss_dssp CCHHHHHTSTTTGG
T ss_pred cCHHHHhcCcccCC
Confidence 99999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=416.09 Aligned_cols=279 Identities=29% Similarity=0.471 Sum_probs=223.9
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec------
Q 004954 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL------ 488 (722)
Q Consensus 415 rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~------ 488 (722)
+|+++++||+|+||+||+|+++.+|+.||||+++.+.. ...+|+.+++.++ ||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~------h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLD------HCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCC------CTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcC------CCCCCcEEEEEEecCccCCc
Confidence 79999999999999999999999999999999987653 2347999998885 78999999999643
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 489 ~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+++|||||+++++...+...... ...+++..++.|+.||+.||+|||++||+||||||+|||++. +...+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~-~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec-CCCceeEeccc
Confidence 368999999998877766543322 223999999999999999999999999999999999999985 23579999999
Q ss_pred CcccccC--CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQTD--NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
++..... .....++|+.|+|||++.+ ..++.++|||||||++|||++|++||...+..+.+.++.+.+|.++.+.+.
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 9976543 3445689999999999876 468999999999999999999999999999999999999999998887765
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
....... .. .. ................++.+.+||++||+.||.+||||.|+|+||||+.
T Consensus 249 ~~~~~~~--~~------------~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 249 EMNPNYT--EF------------KF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHCC-----CC------------CC-CCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhccchh--hc------------cc-cccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 4321110 00 00 0000001111112234678999999999999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=404.39 Aligned_cols=249 Identities=29% Similarity=0.468 Sum_probs=206.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
+.++|++.+.||+|+||+||+|+++.+|+.||||++++... ...++.+|+.+++.+++ .||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~----~h~nIv~~~~~ 77 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----GFSGVIRLLDW 77 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----SSCSBCCEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc----CCCCccEEEEE
Confidence 46899999999999999999999999999999999875321 12346689999999974 38999999999
Q ss_pred EEecCeEEEEEEcccc--chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeE
Q 004954 485 FYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (722)
Q Consensus 485 f~~~~~l~iVmEy~~g--sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~v 562 (722)
|.+.+..++||||+.+ .+.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. +++.+
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-~~~~v 150 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGEL 150 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEE
T ss_pred EeeCCeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec-CCCeE
Confidence 9999999999999964 4555555432 2899999999999999999999999999999999999985 35789
Q ss_pred EEEecCCcccccCC-ccccccCCcccCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 563 KIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 563 kL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~-s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ++...
T Consensus 151 kl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~----- 219 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG----- 219 (273)
T ss_dssp EECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----
T ss_pred EECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-----
Confidence 99999999865543 345789999999999987765 577999999999999999999997642 11100
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...++ ...++++.+||++||+.||++|||++|+|+||||++
T Consensus 220 ------------------------------~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 220 ------------------------------QVFFR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp ------------------------------CCCCS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred ------------------------------ccCCC---------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 00111 123467899999999999999999999999999986
Q ss_pred C
Q 004954 721 P 721 (722)
Q Consensus 721 ~ 721 (722)
.
T Consensus 261 ~ 261 (273)
T d1xwsa_ 261 V 261 (273)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=409.95 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=210.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|+++++||+|+||+||+|+++.+|+.||||+++++. ........|..++... ..||||+++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~-----~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-----TTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh-----CCCCcEEEEEEEEccCC
Confidence 57999999999999999999999999999999997542 2334556666665543 24889999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
++||||||+.+ +|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~--~~~~kl~DFG 148 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIADFG 148 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC--CCceeccccc
Confidence 99999999985 67777664432 889999999999999999999999999999999999996 7899999999
Q ss_pred CcccccC---CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 569 SSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 569 ls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.++.....
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------- 220 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-------- 220 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred hhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 9975433 23346899999999999999999999999999999999999999999888887776642111
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH-HHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR-EALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~-ElL~HPwf~~ 720 (722)
.+| ...++.+.+||++||+.||.+|||+. |+++||||++
T Consensus 221 ---------------------------~~p---------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 221 ---------------------------FYP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp ---------------------------CCC---------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ---------------------------CCC---------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 111 12346789999999999999999995 8999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=407.10 Aligned_cols=281 Identities=26% Similarity=0.454 Sum_probs=220.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-- 487 (722)
.+||+++++||+|+||+||+|+++.+|+.||||++.... ....++.+|+++|+.++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC------CTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc------CCCccceEeeeeccc
Confidence 489999999999999999999999999999999986432 23456789999999885 6799999999865
Q ss_pred ------cCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCe
Q 004954 488 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (722)
Q Consensus 488 ------~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~ 561 (722)
.+++++||||+.++++....... ..+++..++.+++||+.||.|||++||+||||||+|||++. ++.
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~--~~~ 155 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 155 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSC
T ss_pred ccccccCceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC--CCc
Confidence 35689999999988877655332 23899999999999999999999999999999999999996 789
Q ss_pred EEEEecCCcccccC-------CccccccCCcccCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 004954 562 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (722)
Q Consensus 562 vkL~DFGls~~~~~-------~~~~~~gt~~y~APE~l~~~-~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~ 633 (722)
+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+.
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 99999999865432 22335789999999999865 68999999999999999999999999999999999999
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhh--cccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH--LQFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~--~~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
...+.++.+.+........+.. .............. ....++.+++||.+||++||++||||+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEK--------------LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp HHHCCCCTTTSTTCCCC---------------------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HhcCCCChhhccccchhhhhhh--------------hcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 8888877655433221111000 00000000011111 1123567899999999999999999999
Q ss_pred HHhCCCCCC
Q 004954 712 ALDHPWLQH 720 (722)
Q Consensus 712 lL~HPwf~~ 720 (722)
+|+||||+.
T Consensus 302 lL~Hpff~~ 310 (318)
T d3blha1 302 ALNHDFFWS 310 (318)
T ss_dssp HHHSGGGSS
T ss_pred HHcChhhcc
Confidence 999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-47 Score=415.46 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=206.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|+++++||+|+||+||+|+++.+|+.||||++.+.. .......+|..+++.++.. .||||++++++|...+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~---~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG---DCPFIVCMSYAFHTPD 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS---CCTTBCCEEEEEECSS
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC---CCCcEEEEEEEEEECC
Confidence 67999999999999999999999999999999987532 2223456677777777643 5999999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+||||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~--~g~iKl~DFG 152 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLG 152 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS--SSCEEECCCT
T ss_pred EEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcC--CCcEEEeeec
Confidence 9999999998 56777766433 2889999999999999999999999999999999999985 7899999999
Q ss_pred CcccccC-CccccccCCcccCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 569 SSCFQTD-NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 569 ls~~~~~-~~~~~~gt~~y~APE~l~~-~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
+|+.... .....+||+.|+|||++.. ..|+.++|||||||++|+|+||+.||.+.+..+.........
T Consensus 153 la~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~---------- 222 (364)
T d1omwa3 153 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------- 222 (364)
T ss_dssp TCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS----------
T ss_pred eeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Confidence 9986554 3445789999999999974 568999999999999999999999997653222111110000
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpT-----a~ElL~HPwf~~ 720 (722)
.....+| ...++.+++||.+||+.||.+||| |+|+++||||+.
T Consensus 223 ----------------------~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 223 ----------------------TMAVELP---------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp ----------------------SCCCCCC---------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred ----------------------cCCCCCC---------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 0011111 123567899999999999999999 899999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=398.43 Aligned_cols=279 Identities=30% Similarity=0.424 Sum_probs=223.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~---~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+||+++++||+|+||+||+|+++.+|+.||||+++... ....++.+|+.+++.++ ||||+++++++....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC------CTTBCCEEEEEECSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC------cCCEEeeccccccccc
Confidence 58999999999999999999999999999999997543 33466778888887664 7899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
.++||+++.++.+..+.... ..+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||.+
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~--~~~~kl~DFG~a 148 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred eeEEeeeccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc--CCceeeeecchh
Confidence 99999999987666655432 23889999999999999999999999999999999999996 778999999999
Q ss_pred ccccCCc---cccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC-CCChHHHHHHHHHhhcCCCcHHHHh
Q 004954 571 CFQTDNL---CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPIDLEMLM 645 (722)
Q Consensus 571 ~~~~~~~---~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF-~~~~~~e~l~~i~~~lg~~~~~~~~ 645 (722)
....... ....+++.|+|||++.+.. ++.++|||||||++|+|++|+.|| .+.+..+.+..+....++++...+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred hcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 8755432 2345688899999998765 689999999999999999998885 6677788888888888877765544
Q ss_pred hhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 646 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
.......+.. ....+............++.+.+||++||++||.+||||+|+|+||||++
T Consensus 229 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 229 SMTKLPDYKP---------------YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TGGGSTTCCC---------------CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred hhhhcccccc---------------cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 4322221111 00111111222233345678999999999999999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=412.57 Aligned_cols=260 Identities=29% Similarity=0.406 Sum_probs=205.6
Q ss_pred ecCcEEEEE-EeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe---
Q 004954 412 IAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (722)
Q Consensus 412 l~~rY~i~~-~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~--- 487 (722)
+.++|+|++ .||+|+||+||+|+++.+|+.||||+++.. ....+|+.++.++. .||||++++++|.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~-----~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhc-----CCCCCCeEEEEEeeccc
Confidence 457899986 599999999999999999999999999754 35667888876663 48899999999976
Q ss_pred -cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC-CCeEEE
Q 004954 488 -LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKI 564 (722)
Q Consensus 488 -~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~-~~~vkL 564 (722)
..++|||||||+ |+|.+++.... ...+++..++.|+.||+.||+|||++||+||||||+|||++... .+.+||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccc
Confidence 467999999997 58888876432 23499999999999999999999999999999999999998633 568999
Q ss_pred EecCCcccccC--CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 565 IDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 565 ~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
+|||+++.... .....+||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+.......+....
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i------ 229 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------ 229 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC------
T ss_pred cccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH------
Confidence 99999976543 3445689999999999999999999999999999999999999997654433332221110
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
......+|.. .....++++.+||++||+.||++|||+.|+|+||||++
T Consensus 230 -------------------------~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 230 -------------------------RMGQYEFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp -------------------------CSCSSSCCTT-----HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred -------------------------hcCCCCCCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 0001111110 00123567999999999999999999999999999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=403.23 Aligned_cols=285 Identities=27% Similarity=0.433 Sum_probs=214.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--Ce
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EH 490 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~--~~ 490 (722)
.++|+++++||+|+||+||+|+++.+|+.||||+++... ..++.+|+.+|+.++ .||||++++++|... .+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~-----~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTCS
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCCcEEEEEEEecCCCc
Confidence 368999999999999999999999999999999997654 357889999999986 378999999999854 57
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCc
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 570 (722)
+++||||+.++.+..+. ..+++..++.+++||+.||.|||++||+||||||+||||+. .+..+||+|||++
T Consensus 107 ~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~-~~~~vkl~DFG~a 177 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLA 177 (328)
T ss_dssp EEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCGGGC
T ss_pred eeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC-CCCeeeecccccc
Confidence 99999999875433221 12899999999999999999999999999999999999985 3457999999999
Q ss_pred ccccC--CccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 571 CFQTD--NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 571 ~~~~~--~~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF~~-~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.. .+..+....+...+|.+....+..
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 76543 345567899999999988754 79999999999999999999999965 445566666777666543332221
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
...... .................... ........++++++||++||++||++||||+|||+||||+.
T Consensus 258 ~~~~~~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 258 KYNIEL--DPRFNDILGRHSRKRWERFV-----HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp HTTCCC--CGGGGGTCCCCCCCCGGGGC-----CTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hccccc--Ccccchhcccccccchhhcc-----cccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 110000 00000000000000000000 01111234578999999999999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=403.20 Aligned_cols=282 Identities=30% Similarity=0.526 Sum_probs=221.1
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~- 488 (722)
++.||+++++||+|+||+||+|+++.+|+.||||++... .....++.+|+.+|+.++ ||||+++++++...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~------hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR------HENIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC------CTTBCCCCEEECCSS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC------CCCCCcEEEEEeecc
Confidence 457899999999999999999999999999999999753 334567889999999986 67999999998764
Q ss_pred ----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 489 ----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 489 ----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
.+.+++|++++++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~--~~~~kl 150 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKI 150 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEE
T ss_pred ccccceEEEEEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC--CCCEEE
Confidence 357788877778999888642 2899999999999999999999999999999999999985 789999
Q ss_pred EecCCcccccCC------ccccccCCcccCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 004954 565 IDLGSSCFQTDN------LCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 565 ~DFGls~~~~~~------~~~~~gt~~y~APE~l~-~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg 637 (722)
+|||++...... ....++|+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..+....+...++
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 999998654322 34467899999999985 45678999999999999999999999999988888888888877
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 717 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPw 717 (722)
.++............. . ............+.......+..+++||.+||+.||.+||||+|+|+|||
T Consensus 231 ~~~~~~~~~~~~~~~~-----------~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 231 SPSQEDLNCIINLKAR-----------N--YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp SCCHHHHHTCCCHHHH-----------H--HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCChhhhhhhhhhhhh-----------c--ccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 7776554322111100 0 00000000111222333345677999999999999999999999999999
Q ss_pred CCCC
Q 004954 718 LQHP 721 (722)
Q Consensus 718 f~~~ 721 (722)
|+.-
T Consensus 298 ~~~~ 301 (345)
T d1pmea_ 298 LEQY 301 (345)
T ss_dssp GTTT
T ss_pred hccC
Confidence 9853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=403.69 Aligned_cols=280 Identities=31% Similarity=0.526 Sum_probs=223.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~- 488 (722)
.+||+++++||+|+||+||+|+++.+|+.||||+++.. .....++.+|+.+|+.++ ||||++++++|...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC------CCCeeeEEEEEeecc
Confidence 68999999999999999999999999999999999754 234456788999999885 68999999999743
Q ss_pred -----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEE
Q 004954 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (722)
Q Consensus 489 -----~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vk 563 (722)
...++++++.+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~--~~~~k 161 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELK 161 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccccCceEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc--ccccc
Confidence 345666655567787776422 2999999999999999999999999999999999999996 78999
Q ss_pred EEecCCcccccCCccccccCCcccCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 004954 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (722)
Q Consensus 564 L~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~~~~ 642 (722)
|+|||++...........||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+....+.++.+
T Consensus 162 l~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 162 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp ECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 999999988877777788999999999987764 6889999999999999999999999999999999999888888776
Q ss_pred HHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 004954 643 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 720 (722)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~HPwf~~ 720 (722)
............. . ......+ ...+.......++.+++||++||+.||.+||||+|||+||||++
T Consensus 242 ~~~~~~~~~~~~~-----------~-~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 242 LLKKISSESARNY-----------I-QSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHTTCCCHHHHHH-----------H-TTSCCCC-CCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred Hhhhccchhhhhh-----------h-hhcccCC-CcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 6543321111000 0 0000011 11222333445678999999999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-46 Score=389.30 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=206.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++-.++|++.+.||+|+||+||+|+++.+|+.||||+++.+....+++.+|+.+++.++ ||||+++++++...+
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREP 86 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSS
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCC------CCCEecCCccEeeCC
Confidence 34457899999999999999999999999999999999877766778899999999885 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.++|||||+. |+|.+++..... ..+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~DFG 160 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFG 160 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCC
T ss_pred eeEEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECC--CCcEEEcccc
Confidence 9999999998 567777654322 23899999999999999999999999999999999999986 7899999999
Q ss_pred CcccccCCcc----ccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCCChHHHHHHHHHhhcCCCcHHH
Q 004954 569 SSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEM 643 (722)
Q Consensus 569 ls~~~~~~~~----~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~P-F~~~~~~e~l~~i~~~lg~~~~~~ 643 (722)
+++....... ...+++.|+|||++.+..++.++|||||||++|||++|..| |.+.+...+...+...
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-------- 232 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------- 232 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------
Confidence 9987654322 23578899999999999999999999999999999996555 5555554444333211
Q ss_pred HhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 644 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....+| ...++.+.+||.+||+.||.+|||++|+++
T Consensus 233 --------------------------~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 233 --------------------------YRMERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --------------------------CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCC---------ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 001111 123467999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-46 Score=400.68 Aligned_cols=310 Identities=33% Similarity=0.555 Sum_probs=239.6
Q ss_pred CcceeeCceec-CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCC-----CCC
Q 004954 403 DLPIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA-----DEH 476 (722)
Q Consensus 403 ~~pi~~~~~l~-~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~-----~hp 476 (722)
++|+.+|+.+. +||+++++||+|+||+||+|+++.+|+.||||+++++....+...+|+++++.+++.... .|+
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 47889999886 579999999999999999999999999999999998876677888999999999876543 578
Q ss_pred ceeEEEEEEEec--CeEEEEEEccc--cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCc
Q 004954 477 HILRLYDYFYHL--EHLFIVCELLR--ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPEN 551 (722)
Q Consensus 477 nIv~l~~~f~~~--~~l~iVmEy~~--gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs-~gIvHrDLKp~N 551 (722)
||+++++++... ...+++|.++. ++......... ...+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred ceEEEEEEeeeccccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 999999998754 45666666664 33333333222 2338999999999999999999998 899999999999
Q ss_pred eEEcccCC----CeEEEEecCCcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh---
Q 004954 552 ILIKSYQR----CEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--- 624 (722)
Q Consensus 552 ILl~~~~~----~~vkL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~--- 624 (722)
|||+..+. ..++|+|||.+..........++|+.|+|||++.+..++.++||||+||++++|++|+.||....
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred eeeeccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 99986332 35999999999887777777889999999999999999999999999999999999999996532
Q ss_pred ---HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhc---ccCcHHHHHHHHHh
Q 004954 625 ---VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL---QFSDAFFIDFVRTL 698 (722)
Q Consensus 625 ---~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~---~~~~~~l~dLL~~m 698 (722)
..+.+..++..+|.++.+++........++.............. .+......... ...++.+.+||.+|
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF-----WPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB-----CCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccC-----CchhhhcccccccCcccCHHHHHHHHHH
Confidence 34677788889999998888776665555543222211111100 00000011111 12246789999999
Q ss_pred cccCCCCCcCHHHHHhCCCCCCC
Q 004954 699 LEINPQRRPTAREALDHPWLQHP 721 (722)
Q Consensus 699 L~~dP~kRpTa~ElL~HPwf~~~ 721 (722)
|++||.+||||+|||+||||++.
T Consensus 312 L~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp GCSSTTTCBCHHHHHTCGGGTTC
T ss_pred CCCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999853
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=382.72 Aligned_cols=245 Identities=20% Similarity=0.338 Sum_probs=198.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
++|++++.||+|+||+||+|++. +++.||||+++......+.+.+|+++++.++ ||||+++++++...+..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcC------CCCcccccceeccCCceEE
Confidence 67999999999999999999975 5788999999877666678899999999885 7899999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+. |+|.+++.... ..+++..+..|+.||+.||.|||+++|+||||||+|||++. ++.+||+|||+++.
T Consensus 78 v~E~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~--~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRF 150 (263)
T ss_dssp EEECCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG--GGCEEECSCC----
T ss_pred EEEecCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC--CCCeEecccchhee
Confidence 999997 46777665432 23889999999999999999999999999999999999996 78999999999976
Q ss_pred ccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 573 QTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 573 ~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
..... ....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+++..+.....
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---------- 220 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 220 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC----------
T ss_pred ccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC----------
Confidence 54332 23567899999999999999999999999999999999 5777777777666665542111
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
...| ...++.+.+||.+||+.||++|||++|+|+|
T Consensus 221 ------------------------~~~p---------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 ------------------------LYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCc---------cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0111 1234678999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-45 Score=385.40 Aligned_cols=255 Identities=26% Similarity=0.346 Sum_probs=200.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~----~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
..+.++|++.+.||+|+||+||+|+++.+|+.||||+++... .....+.+|+++++.++ ||||+++++++
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~------hpniv~~~~~~ 76 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN------HPAIVAVYDTG 76 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC------CCCCCccccee
Confidence 356889999999999999999999999999999999997532 33456778888887764 78999999999
Q ss_pred EecC----eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCC
Q 004954 486 YHLE----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (722)
Q Consensus 486 ~~~~----~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~ 560 (722)
...+ .+||||||+.| +|...+.... .+++.+++.|+.||+.||+|||++||+||||||+|||++. ++
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~--~~ 148 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TN 148 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TS
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc--cc
Confidence 8764 48999999986 5555554332 2899999999999999999999999999999999999996 78
Q ss_pred eEEEEecCCcccccC------CccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 004954 561 EIKIIDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (722)
Q Consensus 561 ~vkL~DFGls~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~ 634 (722)
.++|+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+..+.+.+++.
T Consensus 149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 899999998764332 23346799999999999999999999999999999999999999999887777666543
Q ss_pred hcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 635 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....++. ......++.+.+||++||+.||.+||+..+.|.
T Consensus 229 ~~~~~~~----------------------------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 229 EDPIPPS----------------------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp CCCCCGG----------------------------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred cCCCCCc----------------------------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 2111110 011223567899999999999999995444445
Q ss_pred CCCC
Q 004954 715 HPWL 718 (722)
Q Consensus 715 HPwf 718 (722)
|+|+
T Consensus 269 ~~l~ 272 (277)
T d1o6ya_ 269 ADLV 272 (277)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=387.25 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=207.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+-.++|++.+.||+|+||+||+|+++ +++.||||+++......+.+.+|+.+++.++ ||||+++++++. .+.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~-~~~ 81 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------HQRLVRLYAVVT-QEP 81 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEEC-SSS
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCC------CCCEeEEEeeec-cCC
Confidence 34578999999999999999999974 6788999999877666678899999999986 689999999874 467
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
++|||||+.+ +|.+++...... .+++..+..|+.||+.||.|||+++|+||||||+||||+. ++.+||+|||+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~----~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~--~~~~Kl~DFGl 155 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFGL 155 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec--ccceeeccccc
Confidence 7999999985 566655443322 2899999999999999999999999999999999999996 88999999999
Q ss_pred cccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
|+...... ....+|+.|+|||++.+..++.++|||||||++|||+|| .+||...+..+++..+.....
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~------- 228 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------- 228 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-------
Confidence 98765432 235678999999999999999999999999999999995 666676666666655532111
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh--CCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD--HPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~--HPwf~~ 720 (722)
..+| ...++.+.+||++||+.||++|||++|+++ |+||++
T Consensus 229 ---------------------------~~~p---------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 ---------------------------MVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------------CCCc---------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1111 123467899999999999999999999998 788753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-45 Score=387.80 Aligned_cols=247 Identities=20% Similarity=0.272 Sum_probs=192.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~---~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.++|++.++||+|+||+||+|+++.+++ .||||.+... ....+.+.+|+++++.++ |||||++++++..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD------HPNVIHLEGVVTK 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEECS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC------CCCCccEEEEEee
Confidence 4679999999999999999999877665 5888987653 334456788888887774 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.+++||||+.+ +|.+++.... ..+++.++..|+.||+.||+|||++||+||||||+||||+. ++.+||+|
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~D 171 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSD 171 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEecCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC--CCcEEECC
Confidence 9999999999985 5655555322 23899999999999999999999999999999999999996 88999999
Q ss_pred cCCcccccCCc--------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 004954 567 LGSSCFQTDNL--------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (722)
Q Consensus 567 FGls~~~~~~~--------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg 637 (722)
||+++...... ....+|+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+++..+.....
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99997654321 11356889999999999999999999999999999998 8999998887777666542111
Q ss_pred CCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
+ ..| ...+..+.+||.+||+.||++|||+.|++++
T Consensus 252 ~----------------------------------~~~---------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 L----------------------------------PPP---------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp C----------------------------------CCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred C----------------------------------CCC---------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 011 1234678999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=379.96 Aligned_cols=245 Identities=21% Similarity=0.335 Sum_probs=207.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~i 493 (722)
++|++.++||+|+||+||+|++ .+++.||||+++......+.+.+|+.+++.++ ||||+++++++...+.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~------HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------HEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCC------CTTBCCEEEEECCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcC------CCceeeEEEEEeeCCceEE
Confidence 5788999999999999999997 47889999999887666678889999998885 7899999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCccc
Q 004954 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (722)
Q Consensus 494 VmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 572 (722)
||||+. |++..++..... .+++..++.|+.||++||+|||+.||+||||||+|||++. ++.+||+|||+++.
T Consensus 77 v~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~--~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRY 149 (258)
T ss_dssp EEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT--TCCEEECCCSSCCB
T ss_pred EEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC--CCcEEECcchhhee
Confidence 999997 456665544332 2889999999999999999999999999999999999996 78999999999975
Q ss_pred ccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 573 QTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 573 ~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
.... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+......
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------- 220 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------- 220 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred ccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 4432 223567899999999999999999999999999999998 89999998888777666532111
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..| ...++.+.+||++||+.||++|||++++|+|
T Consensus 221 -------------------------~~p---------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 -------------------------YRP---------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------------------CCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCc---------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 111 1234678999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=389.43 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=203.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc-----EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV-----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg~-----~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.++|++.++||+|+||+||+|++..+++ .||+|++... ......+.+|+.++..+. .|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~l~~~~ 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLGAC 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc-----CCCcEeEEEEEE
Confidence 4689999999999999999999866543 6999998653 334456788999998884 378999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHhhhhcc-----------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 004954 486 YHLEHLFIVCELLR-ANLYEFQKFNQES-----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547 (722)
Q Consensus 486 ~~~~~l~iVmEy~~-gsLl~~l~~~~~~-----------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDL 547 (722)
...+.++|||||+. |+|.+++...... .....+++..++.|+.||+.||+|||++||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999997 5788887654321 11234899999999999999999999999999999
Q ss_pred CCCceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 004954 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFP 621 (722)
Q Consensus 548 Kp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~ 621 (722)
||+|||++. ++.+||+|||+|+...... ....+|+.|+|||++.+..++.++|||||||++|||+| |++||.
T Consensus 191 Kp~Nill~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTH--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEET--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhcccccc--CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999986 7899999999997654332 23467999999999999999999999999999999998 899998
Q ss_pred CChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhccc
Q 004954 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 701 (722)
Q Consensus 622 ~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~ 701 (722)
+.+..+.+.+++.... ....| ...++.+.+||.+||+.
T Consensus 269 ~~~~~~~~~~~~~~~~---------------------------------~~~~p---------~~~~~~l~~li~~cl~~ 306 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGF---------------------------------KMDQP---------FYATEEIYIIMQSCWAF 306 (325)
T ss_dssp TCCCSHHHHHHHHTTC---------------------------------CCCCC---------TTCCHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHhcCC---------------------------------CCCCC---------CcCCHHHHHHHHHHcCC
Confidence 8665555544432100 00111 12356799999999999
Q ss_pred CCCCCcCHHHHHhC
Q 004954 702 NPQRRPTAREALDH 715 (722)
Q Consensus 702 dP~kRpTa~ElL~H 715 (722)
||++|||++||++|
T Consensus 307 dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 307 DSRKRPSFPNLTSF 320 (325)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=380.96 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=194.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
+-.++|++.+.||+|+||+||+|+. +..||||+++.. ......+.+|+.+++.++ ||||+++++++.
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~~~~~- 74 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR------HVNILLFMGYST- 74 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC------CTTBCCEEEEEC-
T ss_pred cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCEeeeeEEEe-
Confidence 3357899999999999999999974 346999998643 334466778888887764 789999999864
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.+.++|||||+. |+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+. ++.+||+|
T Consensus 75 ~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~--~~~~Kl~D 147 (276)
T d1uwha_ 75 APQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGD 147 (276)
T ss_dssp SSSCEEEEECCCEEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TSSEEECC
T ss_pred ccEEEEEEecCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC--CCCEEEcc
Confidence 567899999998 57877775432 23899999999999999999999999999999999999985 78999999
Q ss_pred cCCcccccCC-----ccccccCCcccCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 567 LGSSCFQTDN-----LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 567 FGls~~~~~~-----~~~~~gt~~y~APE~l~~~---~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
||+|+..... .....||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+....+..++.....
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 9999765432 2345789999999999753 5889999999999999999999999876544444333211000
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.|. +.......++.+.+||.+||+.||.+|||++|+++|
T Consensus 228 -----------------------------------~p~---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 228 -----------------------------------SPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -----------------------------------CCC---GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------------CCc---chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 000 011112345679999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=378.95 Aligned_cols=248 Identities=20% Similarity=0.249 Sum_probs=201.1
Q ss_pred CcEEEEEE-eccCCCCceEEEEECC--CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 004954 414 GRYYVTEY-LGSAAFSKVFQAQDLH--TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (722)
Q Consensus 414 ~rY~i~~~-LG~G~fG~Vy~a~d~~--tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~ 488 (722)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ....+.+.+|+++++.++ ||||+++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVCQA- 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEES-
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC------CCCEeeEeeeecc-
Confidence 57888885 9999999999998753 4568999999753 344567889999999885 7899999999864
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEec
Q 004954 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (722)
Q Consensus 489 ~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DF 567 (722)
+.++|||||+++ +|.+++.... ..+++..+..|+.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~--~~~~Kl~DF 153 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISDF 153 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc--CCceeeccc
Confidence 568999999985 6666654322 23899999999999999999999999999999999999996 789999999
Q ss_pred CCcccccCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 568 GSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 568 Gls~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
|+++..... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+++..+....
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~---- 229 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---- 229 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----
Confidence 999765432 223467899999999999999999999999999999998 999998877666665553211
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH---HhCCC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA---LDHPW 717 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El---L~HPw 717 (722)
...+| ...++++.+||.+||+.||++|||+.++ |+|+|
T Consensus 230 ------------------------------~~~~p---------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 ------------------------------RMECP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ------------------------------CCCCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------------------------CCCCC---------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01111 1234678999999999999999999888 56776
Q ss_pred C
Q 004954 718 L 718 (722)
Q Consensus 718 f 718 (722)
+
T Consensus 271 ~ 271 (285)
T d1u59a_ 271 Y 271 (285)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=377.37 Aligned_cols=241 Identities=21% Similarity=0.261 Sum_probs=193.9
Q ss_pred EEeccCCCCceEEEEEC--CCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 004954 420 EYLGSAAFSKVFQAQDL--HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~--~tg~~vAvKil~~~---~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iV 494 (722)
++||+|+||+||+|.+. .+++.||||+++.. ....+.+.+|+++++.++ ||||+++++++.. +..+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD------NPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC------CTTBCCEEEEEES-SSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC------CCCCceEEEEecc-CCEEEE
Confidence 46999999999999753 45688999999653 233466888999988774 7899999999864 567899
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCCcccc
Q 004954 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (722)
Q Consensus 495 mEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 573 (722)
|||+.+ +|.+++.... .+++..+..|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 86 mE~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~--~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKAL 157 (277)
T ss_dssp EECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc--cCcccccchhhhhhc
Confidence 999985 6777665432 2899999999999999999999999999999999999996 889999999999765
Q ss_pred cCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 004954 574 TDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (722)
Q Consensus 574 ~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~ 646 (722)
.... ....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...+....
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~---------- 227 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---------- 227 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 4332 22468899999999999999999999999999999998 899999887776665553210
Q ss_pred hhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHH---HhCCCC
Q 004954 647 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA---LDHPWL 718 (722)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~El---L~HPwf 718 (722)
...+| ...++.+.+||.+||+.||.+|||++++ |+|+|+
T Consensus 228 ------------------------~~~~p---------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 228 ------------------------RMGCP---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ------------------------CCCCC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------------------------CCCCC---------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 01111 1234678999999999999999999998 567664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=375.37 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=202.2
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
+-.++|++.+.||+|+||+||+|++..+ +.||||+++......+.+.+|+.+++.++ |||||++++++. .+.
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~g~~~-~~~ 85 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVS-EEP 85 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEEC-SSS
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcc------cCCEeEEEEEEe-cCC
Confidence 3357899999999999999999998654 67999999877666678899999999886 679999999985 456
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+.+ ++..++...... .+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||+
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~--~~~~kl~DfGl 159 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGL 159 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCT
T ss_pred eEEEEEecCCCchhhhhhhcccc----cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECC--CCcEEEcccch
Confidence 7899999985 556555543322 2899999999999999999999999999999999999986 78999999999
Q ss_pred cccccCCc----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 004954 570 SCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLEML 644 (722)
Q Consensus 570 s~~~~~~~----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~i~~~lg~~~~~~~ 644 (722)
++...... ....+|+.|+|||++.+..++.++|||||||++|||++| .+||.+....+++..+.....
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~------- 232 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------- 232 (285)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred hhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-------
Confidence 97654322 235689999999999999999999999999999999995 555666666666655532110
Q ss_pred hhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh--CCCCCC
Q 004954 645 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD--HPWLQH 720 (722)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~--HPwf~~ 720 (722)
..++ ...++.+.+||.+||+.||++|||+++|++ |+||++
T Consensus 233 ---------------------------~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 233 ---------------------------MPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ---------------------------CCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---------------------------CCCC---------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 0111 123467899999999999999999999998 899965
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=368.14 Aligned_cols=246 Identities=20% Similarity=0.278 Sum_probs=190.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCC----cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~~tg----~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
...|++.++||+|+||+||+|.+..++ ..||||+++... .....+.+|+.+++.++ |||||++++++.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~------H~nIv~~~g~~~ 79 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS------HHNIIRLEGVIS 79 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEEC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC------CCCEeeeeEEEe
Confidence 467999999999999999999876554 479999987532 33446778888888874 789999999999
Q ss_pred ecCeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~gs-Ll~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
..+..++||||+.++ +.+.+.... ..+++..+..++.||+.||+|||+++|+||||||+||||+. ++.+||+
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~--~~~~Kl~ 152 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVCKVS 152 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEEC
T ss_pred cCCceEEEEEecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC--CCeEEEc
Confidence 999999999999865 444443322 23899999999999999999999999999999999999996 8899999
Q ss_pred ecCCcccccCC------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhhcCC
Q 004954 566 DLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 566 DFGls~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++| .+||...+..+++..+....
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-- 230 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-- 230 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC--
Confidence 99999765432 1224678999999999999999999999999999999995 55555555555554443111
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
....| ...+..+.+||.+||+.||++|||+.|+++
T Consensus 231 --------------------------------~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 231 --------------------------------RLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------------------CCCCC---------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------------CCCCc---------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01111 123466899999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=370.25 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=191.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~t---g~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
+-.++|++.+.||+|+||+||+|++..+ +..||||+++.. ......+.+|+.+++.++ ||||+++++++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~~ 77 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD------HPHIVKLIGVI 77 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEE
Confidence 3357899999999999999999998654 356889988643 333456778888888774 78999999998
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
. .+.+++||||+.+ ++.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~--~~~~Kl 149 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKL 149 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEE
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC--CCcEEE
Confidence 5 5788999999985 5555544332 23899999999999999999999999999999999999996 789999
Q ss_pred EecCCcccccCC----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 004954 565 IDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 565 ~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+++..+.....
T Consensus 150 ~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-- 227 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-- 227 (273)
T ss_dssp CC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred ccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--
Confidence 999999765432 233567899999999999999999999999999999998 8999988776666655542100
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
..+| ...++.+.+||.+||+.||.+|||+.||++|
T Consensus 228 --------------------------------~~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 --------------------------------LPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --------------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------------CCCC---------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0111 1234679999999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=380.90 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=204.9
Q ss_pred CcEEEEEEeccCCCCceEEEEE---CCCCcEEEEEEeecc-----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQD---LHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d---~~tg~~vAvKil~~~-----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
++|++++.||+|+||+||+|++ ..+|+.||||+++.. ....+.+.+|+++++++++ ||||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h-----~pnIv~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-----CTTBCCEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC-----CCeEEEeeeee
Confidence 7899999999999999999987 447899999998643 2334667899999999985 46999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEE
Q 004954 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (722)
Q Consensus 486 ~~~~~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL 564 (722)
.+....++||||+.+ +|.+.+..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~vkL 170 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVL 170 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecC--CCCEEE
Confidence 999999999999985 67777665443 788999999999999999999999999999999999996 789999
Q ss_pred EecCCcccccCC----ccccccCCcccCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 004954 565 IDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 565 ~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~--~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
+|||++...... .....+++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.+..+....+.....
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~- 249 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL- 249 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-
Confidence 999998764332 2346789999999999765 467899999999999999999999977644333333221000
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCc-----CHHHHH
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREAL 713 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRp-----Ta~ElL 713 (722)
.....+| ...++.+.+||++||+.||.+|| ||+|+|
T Consensus 250 ------------------------------~~~~~~~---------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 250 ------------------------------KSEPPYP---------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp ------------------------------HCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred ------------------------------cCCCCCc---------ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 0000111 12357799999999999999999 599999
Q ss_pred hCCCCCC
Q 004954 714 DHPWLQH 720 (722)
Q Consensus 714 ~HPwf~~ 720 (722)
+||||+.
T Consensus 291 ~Hpff~~ 297 (322)
T d1vzoa_ 291 EHLFFQK 297 (322)
T ss_dssp TSGGGTT
T ss_pred cCHhhcC
Confidence 9999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-43 Score=372.67 Aligned_cols=262 Identities=19% Similarity=0.250 Sum_probs=205.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.++++|++.+.||+|+||+||+|++..+|+.||||++..... ..++.+|+++++.+++ |++|+.+.+++...+.
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~-----~~~i~~~~~~~~~~~~ 77 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQG-----GVGIPTIRWCGAEGDY 77 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTT-----STTCCCEEEEEEETTE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccC-----CCcccEEEEEEecCCE
Confidence 456899999999999999999999999999999999876543 3567889999999875 3477788888888899
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc-CCCeEEEEecCC
Q 004954 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~-~~~~vkL~DFGl 569 (722)
.++||||+++++...+..... .+++..+..++.|++.||+|||++||+||||||+|||++.. .+..+||+|||+
T Consensus 78 ~~ivme~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred EEEEEEEcCCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCc
Confidence 999999999988877664432 28999999999999999999999999999999999998642 356799999999
Q ss_pred cccccCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 004954 570 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (722)
Q Consensus 570 s~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~~~e~l~~i~~~lg~~ 639 (722)
|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~-- 230 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-- 230 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH--
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc--
Confidence 9865432 2335799999999999999999999999999999999999999987655443333221000
Q ss_pred cHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHH---HHHhCC
Q 004954 640 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR---EALDHP 716 (722)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~---ElL~HP 716 (722)
..... ..+......++++.+||.+||+.||++||+++ ++|+|+
T Consensus 231 ------------------------------~~~~~----~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 231 ------------------------------KKMST----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ------------------------------HHHHS----CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ------------------------------ccCCC----ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00000 01111223457799999999999999999987 557777
Q ss_pred CCC
Q 004954 717 WLQ 719 (722)
Q Consensus 717 wf~ 719 (722)
|.+
T Consensus 277 ~~~ 279 (299)
T d1ckia_ 277 FHR 279 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=374.42 Aligned_cols=245 Identities=21% Similarity=0.270 Sum_probs=193.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~----~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~ 487 (722)
.+|+++++||+|+||+||+|++..+|+ +||+|.++.. ....+.+.+|+++++.++ ||||+++++++..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGICLT 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC------CTTBCCEEEEEES
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEec
Confidence 469999999999999999999988876 5788877643 234567889999999885 7899999999987
Q ss_pred cCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEe
Q 004954 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (722)
Q Consensus 488 ~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~D 566 (722)
.. .+++|||+. ++|++.+..... .+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~--~~~~kl~D 154 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITD 154 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEECC
T ss_pred CC-eeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC--CCCeEeec
Confidence 54 556666665 678777664332 3899999999999999999999999999999999999996 78999999
Q ss_pred cCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 004954 567 LGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (722)
Q Consensus 567 FGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~ 640 (722)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+....
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~---- 230 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---- 230 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC----
T ss_pred cccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----
Confidence 9999765432 222467999999999999999999999999999999998 899998776555544432110
Q ss_pred HHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 641 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....| ...++.+.+||.+||+.||.+|||+.|+++|
T Consensus 231 ------------------------------~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 231 ------------------------------RLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------------------CCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCCCC---------cccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 00111 1234678999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=365.43 Aligned_cols=247 Identities=20% Similarity=0.320 Sum_probs=194.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-cC
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LE 489 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-~~ 489 (722)
+-.++|+++++||+|+||.||+|++ .|+.||||+++.+. ..+.+.+|++++++++ ||||+++++++.. .+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLR------HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCC------CTTBCCEEEEECCC--
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-HHHHHHHHHHHHHhCC------CCCEeeEEEEEEecCC
Confidence 3346899999999999999999997 57899999997654 3466788998887764 7899999999864 46
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFG 568 (722)
.+++||||+. |+|.+++...... .+++..++.|+.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~----~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~--~~~~kl~dfg 148 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 148 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHH----HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCC
T ss_pred cEEEEEeccCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC--CCCEeecccc
Confidence 7899999997 5788877654322 2889999999999999999999999999999999999996 8889999999
Q ss_pred CcccccCCccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 004954 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (722)
Q Consensus 569 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~~~~~~~~~~ 647 (722)
+++..........+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..++...+...
T Consensus 149 ~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~------------ 216 (262)
T d1byga_ 149 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------ 216 (262)
T ss_dssp C------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT------------
T ss_pred cceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------
Confidence 99887776666788999999999999999999999999999999998 79999876665555444210
Q ss_pred hhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 648 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
....+|. ..++.+.+||++||+.||.+|||+.+++++
T Consensus 217 ----------------------~~~~~~~---------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 ----------------------YKMDAPD---------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----------------------CCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCc---------cCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111121 234678999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=366.44 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=192.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~-----tg~~vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~ 484 (722)
-.++|++.++||+|+||+||+|++.. +++.||||+++.. ......+.+|..++.++.+ |+||++++++
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~-----h~~iv~~~~~ 85 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLGA 85 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCC-----CTTBCCEEEE
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcC-----CCeEEEeeee
Confidence 34789999999999999999999744 4578999998753 2334567778888877764 6799999998
Q ss_pred EEec-CeEEEEEEccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 004954 485 FYHL-EHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (722)
Q Consensus 485 f~~~-~~l~iVmEy~~-gsLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NI 552 (722)
+... ..+++||||+. |+|.+++...... .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 8765 56899999998 5788877654321 1123489999999999999999999999999999999999
Q ss_pred EEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHH
Q 004954 553 LIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVV 626 (722)
Q Consensus 553 Ll~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~ 626 (722)
||+. ++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+....
T Consensus 166 Ll~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 166 LLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp EECG--GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eECC--CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9986 789999999999754332 2235789999999999999999999999999999999996 5688765443
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCC
Q 004954 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 706 (722)
Q Consensus 627 e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kR 706 (722)
+.+..++.. .....+| ...++.+.+||.+||+.||++|
T Consensus 244 ~~~~~~~~~---------------------------------~~~~~~~---------~~~~~~l~~li~~cl~~dP~~R 281 (299)
T d1ywna1 244 EEFCRRLKE---------------------------------GTRMRAP---------DYTTPEMYQTMLDCWHGEPSQR 281 (299)
T ss_dssp HHHHHHHHH---------------------------------TCCCCCC---------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHhc---------------------------------CCCCCCC---------ccCCHHHHHHHHHHcCCChhHC
Confidence 333332210 0001111 1234678999999999999999
Q ss_pred cCHHHHHhC
Q 004954 707 PTAREALDH 715 (722)
Q Consensus 707 pTa~ElL~H 715 (722)
||++|+++|
T Consensus 282 pt~~eil~~ 290 (299)
T d1ywna1 282 PTFSELVEH 290 (299)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-41 Score=359.04 Aligned_cols=255 Identities=19% Similarity=0.237 Sum_probs=205.6
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++++++|+|.+.||+|+||+||+|+++.+|+.||||++..... ...+.+|+++++.+++ |+|++.+++++....
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAG-----CTGIPNVYYFGQEGL 74 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTT-----CTTCCCEEEEEEETT
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcC-----CCCCCEEEEEeecCC
Confidence 4678999999999999999999999999999999999876432 3567889999999875 469999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc---CCCeEEEEe
Q 004954 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKIID 566 (722)
Q Consensus 490 ~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~---~~~~vkL~D 566 (722)
+.++||||++++|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||++.. ..+.+||+|
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred ccEEEEEecCCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence 9999999999999888765432 28999999999999999999999999999999999999742 356899999
Q ss_pred cCCcccccCC----------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh---HHHHHHHHH
Q 004954 567 LGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARII 633 (722)
Q Consensus 567 FGls~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~~---~~e~l~~i~ 633 (722)
||+|+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ......++.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 9999765432 223579999999999999999999999999999999999999997542 222222221
Q ss_pred hhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 004954 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 713 (722)
Q Consensus 634 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL 713 (722)
...-.+ ......+..++++.++|..|+..+|++||+.+.+.
T Consensus 230 ~~~~~~---------------------------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 230 EKKQST---------------------------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHS---------------------------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hccCCC---------------------------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 100000 01111123356799999999999999999876654
Q ss_pred h
Q 004954 714 D 714 (722)
Q Consensus 714 ~ 714 (722)
+
T Consensus 271 ~ 271 (293)
T d1csna_ 271 G 271 (293)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=359.97 Aligned_cols=245 Identities=25% Similarity=0.308 Sum_probs=191.8
Q ss_pred CcEEEEEEeccCCCCceEEEEEC-CCC--cEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDL-HTG--VDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~-~tg--~~vAvKil~~~----~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~ 486 (722)
++|++++.||+|+||+||+|++. .++ ..||||+++.. ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD------HRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC------CTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEe
Confidence 57999999999999999999864 333 46899998653 234467789999999885 789999999996
Q ss_pred ecCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEE
Q 004954 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (722)
Q Consensus 487 ~~~~l~iVmEy~~-gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~ 565 (722)
+ ...++||||+. +++.+.+...... +++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~-----l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~--~~~vkl~ 153 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVKIG 153 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHGGG-----SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEEEC
T ss_pred e-cchheeeeeecCcchhhhhhcccCC-----CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc--ccceeec
Confidence 5 56789999997 4666666544322 899999999999999999999999999999999999996 7899999
Q ss_pred ecCCcccccCCc------cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 004954 566 DLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (722)
Q Consensus 566 DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~~~e~l~~i~~~lg~ 638 (722)
|||+++...... ....+|+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+.+.++....-.
T Consensus 154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233 (273)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence 999998754432 22456789999999999999999999999999999998 89999998888887776521100
Q ss_pred CcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHh
Q 004954 639 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 714 (722)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~ 714 (722)
...| ...+..+.+||.+||+.||.+|||+.||++
T Consensus 234 ---------------------------------~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 ---------------------------------LPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ---------------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------------CCCc---------ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0011 123467899999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-42 Score=363.58 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=203.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 004954 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (722)
Q Consensus 413 ~~rY~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f 485 (722)
.++|++++.||+|+||+||+|+++ .+++.||||+++... ....++.+|+.+++.++ ||||+++++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~------h~niv~~~~~~ 85 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------NPNIVKLLGVC 85 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC------CCCcccceeee
Confidence 467999999999999999999864 356889999987543 33466888999888775 78999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHhhhhc------------------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 004954 486 YHLEHLFIVCELLR-ANLYEFQKFNQE------------------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCD 546 (722)
Q Consensus 486 ~~~~~l~iVmEy~~-gsLl~~l~~~~~------------------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrD 546 (722)
......++||||+. |+|.+++..... ......+++..+..|+.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999997 578877754321 11223488999999999999999999999999999
Q ss_pred CCCCceEEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCC
Q 004954 547 LKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLF 620 (722)
Q Consensus 547 LKp~NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF 620 (722)
|||+||||+. ++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||++| .+||
T Consensus 166 lKp~NILld~--~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC--CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999996 788999999998754322 2235678999999999999999999999999999999998 4789
Q ss_pred CCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcc
Q 004954 621 PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 700 (722)
Q Consensus 621 ~~~~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~ 700 (722)
.+.+..+++..+..... ..+| ...++.+.+||.+||+
T Consensus 244 ~~~~~~e~~~~v~~~~~----------------------------------~~~p---------~~~~~~~~~li~~cl~ 280 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNI----------------------------------LACP---------ENCPLELYNLMRLCWS 280 (301)
T ss_dssp TTSCHHHHHHHHHTTCC----------------------------------CCCC---------TTCCHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHcCCC----------------------------------CCCC---------ccchHHHHHHHHHHcC
Confidence 88888877766542110 0111 1234678999999999
Q ss_pred cCCCCCcCHHHHHh
Q 004954 701 INPQRRPTAREALD 714 (722)
Q Consensus 701 ~dP~kRpTa~ElL~ 714 (722)
.||++|||+.||++
T Consensus 281 ~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 281 KLPADRPSFCSIHR 294 (301)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=360.01 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=201.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCC-------cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 004954 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (722)
Q Consensus 411 ~l~~rY~i~~~LG~G~fG~Vy~a~d~~tg-------~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l 481 (722)
+-.++|++.+.||+|+||.||+|++..++ ..||||+++.+. .....+.+|..++.++. .||||+++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-----~HpnIv~~ 84 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINL 84 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc-----CCCeEEec
Confidence 44679999999999999999999876554 479999997643 34466777888888774 37899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 004954 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (722)
Q Consensus 482 ~~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~----------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~ 550 (722)
++++...+.+++||||+. |+|.+++...... .....+++..++.++.||+.||+|||+.+||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999997 5777777644321 12345899999999999999999999999999999999
Q ss_pred ceEEcccCCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCh
Q 004954 551 NILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDA 624 (722)
Q Consensus 551 NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~~ 624 (722)
|||++. ++.+||+|||++...... .....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 165 NiLl~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 165 NVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GEEECT--TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeecC--CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999996 788999999998765432 233578899999999999999999999999999999998 799998887
Q ss_pred HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCC
Q 004954 625 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 704 (722)
Q Consensus 625 ~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~ 704 (722)
..++...+.... ....| ...++.+.+||.+||+.||+
T Consensus 243 ~~~~~~~i~~~~----------------------------------~~~~p---------~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1fgka_ 243 VEELFKLLKEGH----------------------------------RMDKP---------SNCTNELYMMMRDCWHAVPS 279 (299)
T ss_dssp HHHHHHHHHTTC----------------------------------CCCCC---------SSCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHcCC----------------------------------CCCCC---------ccchHHHHHHHHHHccCCHh
Confidence 766655443111 00111 12346789999999999999
Q ss_pred CCcCHHHHHh
Q 004954 705 RRPTAREALD 714 (722)
Q Consensus 705 kRpTa~ElL~ 714 (722)
+|||+.|||+
T Consensus 280 ~Rps~~eil~ 289 (299)
T d1fgka_ 280 QRPTFKQLVE 289 (299)
T ss_dssp GSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=363.89 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=201.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcE--EEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~--vAvKil~~~--~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (722)
++|++.++||+|+||+||+|+++.+|.. ||||.++.. ....+.+.+|++++.++. .||||+++++++...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc-----CCCCEeeEEEEEecCC
Confidence 6899999999999999999999888875 667776532 234456788998888774 3789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccC
Q 004954 490 HLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 490 ~l~iVmEy~~-gsLl~~l~~~~~----------~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~ 558 (722)
.++|||||+. |+|.+++..... ......+++..++.++.||+.||.|||+.+|+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~-- 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC--
Confidence 9999999998 578887754311 122344899999999999999999999999999999999999996
Q ss_pred CCeEEEEecCCcccccCCc--cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhh
Q 004954 559 RCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGM 635 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~i~~~ 635 (722)
++.+||+|||+++...... ....+|+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+++..+...
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 7899999999987644332 235689999999999999999999999999999999996 5678888777766554321
Q ss_pred cCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 636 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
. ...+| ...++.+.+||.+||+.||++|||+.|||+|
T Consensus 243 ~----------------------------------~~~~~---------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 Y----------------------------------RLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C----------------------------------CCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C----------------------------------CCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 01111 1234679999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=357.03 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=204.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAvKil~~~~--~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
++-.++|++.++||+|+||.||+|++ ..+++.||||+++... .....+.+|+.+++.+. .||||++++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-----~HpnIv~~~ 93 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNLL 93 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc-----CCCCEEEEE
Confidence 44468999999999999999999985 3567899999997643 33456778999999884 388999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhcc------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQES------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~~------------~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp 549 (722)
+++...+.+++||||+. |+|.+++...... .....+++..+..|+.||+.||+|||+++|+||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999997 4677776543321 1223489999999999999999999999999999999
Q ss_pred CceEEcccCCCeEEEEecCCcccccCCc-----cccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 004954 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (722)
Q Consensus 550 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~ellt-G~~PF~~~ 623 (722)
+|||++. ++.+||+|||.++...... ....+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.
T Consensus 174 ~NIl~~~--~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 174 RNILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GGEEEET--TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccc--cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999986 7899999999997654332 23577999999999999999999999999999999999 67777666
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCC
Q 004954 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 703 (722)
Q Consensus 624 ~~~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP 703 (722)
+..+.+.+++.. ......|. ..+..+.+||.+||+.||
T Consensus 252 ~~~~~~~~~i~~---------------------------------~~~~~~~~---------~~~~~l~~Li~~cl~~dP 289 (311)
T d1t46a_ 252 PVDSKFYKMIKE---------------------------------GFRMLSPE---------HAPAEMYDIMKTCWDADP 289 (311)
T ss_dssp CSSHHHHHHHHH---------------------------------TCCCCCCT---------TSCHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHhc---------------------------------CCCCCCcc---------cccHHHHHHHHHHcCCCh
Confidence 554544444311 01111111 234678999999999999
Q ss_pred CCCcCHHHHHh
Q 004954 704 QRRPTAREALD 714 (722)
Q Consensus 704 ~kRpTa~ElL~ 714 (722)
.+|||+.|||+
T Consensus 290 ~~RPs~~~il~ 300 (311)
T d1t46a_ 290 LKRPTFKQIVQ 300 (311)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=358.82 Aligned_cols=259 Identities=19% Similarity=0.264 Sum_probs=207.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 004954 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (722)
Q Consensus 410 ~~l~~rY~i~~~LG~G~fG~Vy~a~d~~-----tg~~vAvKil~~~~~--~~~~~~~E~~il~~L~~~~~~~hpnIv~l~ 482 (722)
++-.++|++.+.||+|+||+||+|.+.. +++.||||+++.... ....+.+|+.+++.+ .||||++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~~~ 89 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRLL 89 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC------CCTTBCCEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc------CCCCEeeee
Confidence 4445899999999999999999998742 467899999975432 233456777777666 478999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHhhhhc----cCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEccc
Q 004954 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQE----SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (722)
Q Consensus 483 ~~f~~~~~l~iVmEy~~-gsLl~~l~~~~~----~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~ 557 (722)
+++...+..++||||+. |+|.+++..... ......+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~- 168 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 168 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT-
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC-
Confidence 99999999999999997 567777654321 122234788999999999999999999999999999999999995
Q ss_pred CCCeEEEEecCCcccccCC-----ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHH
Q 004954 558 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILAR 631 (722)
Q Consensus 558 ~~~~vkL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG-~~PF~~~~~~e~l~~ 631 (722)
++.+||+|||+++..... .....+|+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..
T Consensus 169 -~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 169 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp -TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred -CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 889999999999765433 2234678999999999999999999999999999999998 688988888777766
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHH
Q 004954 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 711 (722)
Q Consensus 632 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~E 711 (722)
+..... ..+| ...++.+.+||.+||+.||++|||+.+
T Consensus 248 i~~~~~----------------------------------~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~ 284 (308)
T d1p4oa_ 248 VMEGGL----------------------------------LDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLE 284 (308)
T ss_dssp HHTTCC----------------------------------CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHhCCC----------------------------------CCCc---------ccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 642110 0011 123467999999999999999999999
Q ss_pred HHh------CCCCC
Q 004954 712 ALD------HPWLQ 719 (722)
Q Consensus 712 lL~------HPwf~ 719 (722)
||+ +|+|+
T Consensus 285 il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 285 IISSIKEEMEPGFR 298 (308)
T ss_dssp HHHHHGGGSCTTHH
T ss_pred HHHHHHHhcCCCCc
Confidence 998 77764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-40 Score=349.29 Aligned_cols=243 Identities=19% Similarity=0.248 Sum_probs=188.2
Q ss_pred EEEEEeccCCCCceEEEEECCCC---cEEEEEEeec--chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-cCe
Q 004954 417 YVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LEH 490 (722)
Q Consensus 417 ~i~~~LG~G~fG~Vy~a~d~~tg---~~vAvKil~~--~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~-~~~ 490 (722)
.+.++||+|+||+||+|++..++ ..||||+++. +.....++.+|++++++++ ||||+++++++.. ...
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~~ 103 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS------HPNVLSLLGICLRSEGS 103 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC------CTTBCCCCEEEEETTTE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC------CCCEeEEeEEEEecCCc
Confidence 34678999999999999986543 3689999864 3444567889999998875 7899999999876 468
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcccCCCeEEEEecCC
Q 004954 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (722)
Q Consensus 491 l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 569 (722)
.++||||+++ +|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+||||+. ++.+||+|||+
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~--~~~~kL~DFG~ 176 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGL 176 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECSSGG
T ss_pred eEEEEEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC--CCCEEEecccc
Confidence 9999999985 55555543222 2778889999999999999999999999999999999985 78999999999
Q ss_pred cccccCC-------ccccccCCcccCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcH
Q 004954 570 SCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDL 641 (722)
Q Consensus 570 s~~~~~~-------~~~~~gt~~y~APE~l~~~~~s~ksDIWSLGviL~elltG~~PF~~~-~~~e~l~~i~~~lg~~~~ 641 (722)
++..... .....+|+.|+|||.+.+..++.++||||||+++|||+||..||... +..++...+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g------ 250 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------ 250 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT------
T ss_pred hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------
Confidence 9764432 12246789999999999999999999999999999999987777543 222333222211
Q ss_pred HHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 004954 642 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 715 (722)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~kRpTa~ElL~H 715 (722)
.....| ...+..+.+||.+||+.||++|||+.|+++|
T Consensus 251 ----------------------------~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 251 ----------------------------RRLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------------------------CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCc---------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011111 1234678999999999999999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=350.00 Aligned_cols=265 Identities=20% Similarity=0.197 Sum_probs=186.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 004954 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (722)
Q Consensus 412 l~~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (722)
++.+|.+.+.||+|+||+||+|++ +|+.||||+++.+.. ....+|.+++ ......||||+++++++...+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~----~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIY----QTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHH----TSTTCCCTTBCCEEEEEEEECSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHH----HHhhCCCCcCcceEEEEEeCCCc
Confidence 356799999999999999999985 689999999975543 3344444333 222346999999999998654
Q ss_pred --eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH--------CCCccccCCCCceEEcccC
Q 004954 490 --HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--------LGIIHCDLKPENILIKSYQ 558 (722)
Q Consensus 490 --~l~iVmEy~~g-sLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs--------~gIvHrDLKp~NILl~~~~ 558 (722)
.+++||||+.+ +|.+++... .+++..+..++.|++.||+|||+ +||+||||||+||||+.
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-- 143 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-- 143 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT--
T ss_pred ceEEEEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC--
Confidence 68999999974 777777532 28899999999999999999996 59999999999999985
Q ss_pred CCeEEEEecCCcccccCC-------ccccccCCcccCchhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCCChH
Q 004954 559 RCEIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (722)
Q Consensus 559 ~~~vkL~DFGls~~~~~~-------~~~~~gt~~y~APE~l~~~~------~s~ksDIWSLGviL~elltG~~PF~~~~~ 625 (722)
++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||+||||+||..||.....
T Consensus 144 ~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc
Confidence 889999999998765432 22357899999999987653 56789999999999999999988743211
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhcccccchhhhhccccccccCCccchhhhhcccCcHHHHHHHHHhcccCCCC
Q 004954 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 705 (722)
Q Consensus 626 ~e~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~~~l~~~~~~~~~~l~dLL~~mL~~dP~k 705 (722)
....... ........... .+. .........+|.... .......+.+||.+||+.||++
T Consensus 224 ~~~~~~~-~~~~~~~~~~~------~~~-----------~~~~~~~p~~~~~~~----~~~~~~~l~~li~~cl~~dp~~ 281 (303)
T d1vjya_ 224 YQLPYYD-LVPSDPSVEEM------RKV-----------VCEQKLRPNIPNRWQ----SCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp CCCTTTT-TSCSSCCHHHH------HHH-----------HTTSCCCCCCCGGGG----GCHHHHHHHHHHHTTCCSSGGG
T ss_pred cccchhh-cccccchHHHH------HHH-----------HhccccCCCCCcccC----ChHHHHHHHHHHHHHcccCHhH
Confidence 0000000 00000000000 000 000111111111110 0111245889999999999999
Q ss_pred CcCHHHHHhC
Q 004954 706 RPTAREALDH 715 (722)
Q Consensus 706 RpTa~ElL~H 715 (722)
|||+.||+++
T Consensus 282 Rps~~ei~~~ 291 (303)
T d1vjya_ 282 RLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=4.6e-22 Score=194.73 Aligned_cols=164 Identities=18% Similarity=0.173 Sum_probs=115.3
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-------------------hhHhHHHHHHHHHHhcccCCCCCC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------------------FFDQSLDEIKLLKLVNKNDPADEH 476 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~-------------------~~~~~~~E~~il~~L~~~~~~~hp 476 (722)
+.+.++||+|+||+||+|++ .+|+.||||+++.... ......+|...+..+. |.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~ 74 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------GL 74 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------TS
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc------CC
Confidence 45789999999999999997 4789999998753211 0112234555666554 45
Q ss_pred ceeEEEEEEEecCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceEEcc
Q 004954 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (722)
Q Consensus 477 nIv~l~~~f~~~~~l~iVmEy~~gsLl~~l~~~~~~~~~~~ls~~~i~~i~~qIl~aL~yLHs~gIvHrDLKp~NILl~~ 556 (722)
+++..+++. ..++||||+++.... .++...+..++.||+.+|.|||++||+||||||+|||++.
T Consensus 75 ~v~~~~~~~----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~ 138 (191)
T d1zara2 75 AVPKVYAWE----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138 (191)
T ss_dssp SSCCEEEEE----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred CcceEEEec----CCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence 787777652 237999999875321 1455567789999999999999999999999999999983
Q ss_pred cCCCeEEEEecCCcccccCCccccccCCcccCch-----hhcCCCCCchhhHHHHHHHH
Q 004954 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE-----VIIGLPYDQKIDLWSLGCIL 610 (722)
Q Consensus 557 ~~~~~vkL~DFGls~~~~~~~~~~~gt~~y~APE-----~l~~~~~s~ksDIWSLGviL 610 (722)
..++|+|||.|.....+... .|.... .+..+.|+.++|+||+.--+
T Consensus 139 ---~~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 139 ---EGIWIIDFPQSVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ---TEEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ---CCEEEEECCCcccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 45999999998765533221 111110 11235678899999975443
|
| >d1a25a_ b.7.1.2 (A:) C2 domain from protein kinase c (beta) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain from protein kinase c (beta) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.74 E-value=4.7e-19 Score=163.11 Aligned_cols=111 Identities=21% Similarity=0.304 Sum_probs=95.9
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
..+.|+|.|.+| ||+++|.+|.+|||||++|.++.....++||+++++|+||+|||+|.|. ++....+..|.++|||
T Consensus 13 ~~~~L~V~V~~a~~L~~~d~~g~~DpYv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d 90 (132)
T d1a25a_ 13 DREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQ--LKESDKDRRLSVEIWD 90 (132)
T ss_dssp SSSEEEEEEEEEESCCCCSTTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEE--CCSGGGGCEEEEEEEE
T ss_pred cCCEEEEEEEeeeCCCCCCCCCCcCeEEEEEEccCCCCccccEEeeecCCCCCccceEEEEE--eEccccCCEEeEEEEe
Confidence 557899999999 9999999999999999999999888889999999999999999999998 7665556679999999
Q ss_pred cCCCCCCccccccccCccccccccCCCcchhhhhhhHh
Q 004954 343 NSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEE 380 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~~~~~~e~~~~~~~l~f~~L~e 380 (722)
+|.+++++++|.+.++..++...+... |+..+.+
T Consensus 91 ~d~~~~d~~iG~~~i~l~~l~~~~~~~----W~~L~~~ 124 (132)
T d1a25a_ 91 WDLTSRNDFMGSLSFGISELQKAGVDG----WFKLLSQ 124 (132)
T ss_dssp CCSSSCCEEEEEEEEEHHHHTTCCEEE----EEECBCH
T ss_pred cCCCCCCcEeEEEEEeHHHcCCCCCCe----EEECCCC
Confidence 999999999999999887766555444 5544443
|
| >d1dqva1 b.7.1.2 (A:295-424) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.64 E-value=1e-16 Score=146.99 Aligned_cols=92 Identities=15% Similarity=0.078 Sum_probs=82.9
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|.+|.+|||||+.|++++++ ++||+++++|+||+|||+|.|. ++.... +..|.++||
T Consensus 16 ~~~~L~V~V~~a~~L~~~~~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~~P~wne~f~f~--v~~~~~~~~~L~v~V~ 91 (130)
T d1dqva1 16 GSDQLVVRILQALDLPAKDSNGFSDPYVKIYLLPDRKK--KFQTKVHRKTLNPIFNETFQFS--VPLAELAQRKLHFSVY 91 (130)
T ss_dssp SSCEEEEEEEEEECCCCCSTTSCCCEEEEEECTTSTTS--CEECCCCCSCSSCEEEEEEEEE--CCGGGGSSCCCEEEEE
T ss_pred CCCEEEEEEEeeeCCccccCCCCcceEEEEEEccCCCc--eEeceeEcCCCCeeeeeEEEEE--EchHHcCCCeEEEEEE
Confidence 557899999999 9999999999999999999997654 7889999999999999999999 877666 455999999
Q ss_pred ccCCCCCCccccccccCc
Q 004954 342 DNSDTRDGEVNGALHEGK 359 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~ 359 (722)
|+|.+++++++|++.+..
T Consensus 92 d~~~~~~d~~iG~~~i~~ 109 (130)
T d1dqva1 92 DFDRFSRHDLIGQVVLDN 109 (130)
T ss_dssp ECCSSSCCCEEEEEECCC
T ss_pred EcCCCCCCceEEEEEECc
Confidence 999999999999998864
|
| >d2bwqa1 b.7.1.2 (A:729-853) Regulating synaptic membrane exocytosis protein, rim2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Regulating synaptic membrane exocytosis protein, rim2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=5.3e-17 Score=147.73 Aligned_cols=105 Identities=15% Similarity=0.104 Sum_probs=86.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
...+|+|.|.+| ||+++|.+|.+|||||+.|+|+.....++||+++++|+||.|||+|.|.. ++.+.+ +++|.++||
T Consensus 12 ~~~~L~V~V~~a~~L~~~~~~~~~dpyVkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~f~~-~~~~~l~~~~L~i~v~ 90 (125)
T d2bwqa1 12 VGHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSP-VHRREFRERMLEITLW 90 (125)
T ss_dssp TTTEEEEEEEEEESCCCCTTSCCBCEEEEEEEESSCSGGGEEECCCCSSBSSCEEEEEEEECS-CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCcCCCCCCCEEEEEEEeCCCCCccccccCEEcCCCCCEEccEEEEee-eChhhcCCCEEEEEEE
Confidence 457899999999 99999999999999999999998888889999999999999999999974 444444 667999999
Q ss_pred ccCCCC--CCccccccccCccccccccCCC
Q 004954 342 DNSDTR--DGEVNGALHEGKADAEEHGVAT 369 (722)
Q Consensus 342 D~D~~~--~~d~iG~v~~~~~~~~~e~~~~ 369 (722)
|.++++ +++++|++.++..+...+....
T Consensus 91 d~~~~~~~~~~~iG~~~i~l~~~~~~~~~~ 120 (125)
T d2bwqa1 91 DQARVREEESEFLGEILIELETALLDDEPH 120 (125)
T ss_dssp EC-------CEEEEEEEEEGGGCCCSSCEE
T ss_pred ECCCCCCCCCeeEEEEEEEchhcCCCCCCE
Confidence 999875 3679999999877666555433
|
| >d1dqva2 b.7.1.2 (A:425-569) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.62 E-value=7.7e-17 Score=150.46 Aligned_cols=104 Identities=17% Similarity=0.115 Sum_probs=92.2
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
.++.|+|.|++| ||+++|.+|.+||||++.|.++.++..++||+++++|+||.|||+|.|. ++.+.. ..+|.++||
T Consensus 18 ~~~~L~V~V~~a~nL~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~--v~~~~~~~~~l~v~v~ 95 (145)
T d1dqva2 18 TAGLLTVTIIKASNLKAMDLTGFSDPYVKASLISEGRRLKKRKTSIKKNTLNPTYNEALVFD--VAPESVENVGLSIAVV 95 (145)
T ss_dssp TTTEEEEEEEEEESCCCCSSSSCCCEEEEECCCTTCCTTSCEECCCCCSCSSCEEEECCCCC--CCSGGGGSCCCCCEEE
T ss_pred CCCEEEEEEEEEeCCCCcCCCCCcCceEEEEEccCCccceeecCEEEeCCCCceecceEEEE--EehhhcCCCEEEEEEE
Confidence 567899999999 9999999999999999999999888889999999999999999999998 887776 455999999
Q ss_pred ccCCCCCCccccccccCccccccccCCC
Q 004954 342 DNSDTRDGEVNGALHEGKADAEEHGVAT 369 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~~e~~~~ 369 (722)
|++.+++++++|.+.++......++...
T Consensus 96 d~~~~~~~~~iG~~~i~l~~~~~~~~~~ 123 (145)
T d1dqva2 96 DYDCIGHNEVIGVCRVGPEAADPHGREH 123 (145)
T ss_dssp ECCSSSCCEEEEECCCSSCTTCHHHHHH
T ss_pred ecCCCCCCcEEEEEEECchHcCchhhHH
Confidence 9999999999999999876655444333
|
| >d1w15a_ b.7.1.2 (A:) Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=9.7e-17 Score=148.57 Aligned_cols=97 Identities=14% Similarity=0.041 Sum_probs=82.5
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~-~~L~~~V~ 341 (722)
.++.|+|.|.+| ||+++|.+|.+|||||++|.++++...++||+++++|.||.|||+|.|. ++.+..+ .+|.++||
T Consensus 13 ~~~~L~V~v~~a~~L~~~~~~~~~dpyvkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~--v~~~~~~~~~l~i~v~ 90 (138)
T d1w15a_ 13 TTNTLTVVVLKARHLPKSDVSGLSDPYVKVNLYHAKKRISKKKTHVKKCTPNAVFNELFVFD--IPCESLEEISVEFLVL 90 (138)
T ss_dssp TTTEEEEEEEEEESCC------CCCEEEEEEEEETTEEEEEEECCCCCSCSSEEEEEEEEEE--CCSSSSTTEEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCCCCCCCcCEEEEEEEeCCcccCccccceeECCCCCCeECcEEEEE--ecHHHhCccEEEEEEE
Confidence 457899999999 9999999999999999999999888888999999999999999999998 8877774 45999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|.+++++++|++.++..+.
T Consensus 91 d~~~~~~~~~iG~~~i~l~~~ 111 (138)
T d1w15a_ 91 DSERGSRNEVIGRLVLGATAE 111 (138)
T ss_dssp ECCTTSCCEEEEEEEESTTCC
T ss_pred eCCCCCCCCEEEEEEEcchhC
Confidence 999999999999999987543
|
| >d1uowa_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=1.6e-16 Score=150.40 Aligned_cols=98 Identities=13% Similarity=0.110 Sum_probs=88.9
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~-~~L~~~V~ 341 (722)
.++.|+|.|++| ||++++.+|.+|||||++|.+++++..++||+++++++||+|||+|.|. ++.+.++ ..|.++||
T Consensus 23 ~~~~L~V~V~~a~~L~~~~~~~~~dpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~F~--v~~~~l~~~~l~i~v~ 100 (157)
T d1uowa_ 23 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVL 100 (157)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEEEEcccccCCCCCCeeEEEEEecCCccccceecccccCCCCcccCCeEEEE--ecHHHcCccEEEEEEc
Confidence 457999999999 9999999999999999999999888888899999999999999999999 8887774 45999999
Q ss_pred ccCCCCCCccccccccCccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|++++++++++|++.++..+..
T Consensus 101 d~~~~~~~~~iG~~~i~l~~~~ 122 (157)
T d1uowa_ 101 DYDKIGKNDAIGKVFVGYNSTG 122 (157)
T ss_dssp ECCSSSCCCEEEEEEEETTCCH
T ss_pred ccCCCCCCceeEEEEEecccCC
Confidence 9999999999999999875443
|
| >d2cm5a1 b.7.1.2 (A:541-677) C2b-domain of rabphilin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2b-domain of rabphilin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=3.8e-16 Score=143.95 Aligned_cols=97 Identities=14% Similarity=0.097 Sum_probs=86.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
..+.|+|.|.+| ||+++|.+|.+|||||++|.++.+...++||+++++|+||.|||+|.|. ++.+.+ ..+|.++||
T Consensus 13 ~~~~L~V~v~~a~nL~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~--v~~~~l~~~~l~v~v~ 90 (137)
T d2cm5a1 13 QQGGLIVGIIRCVHLAAMDANGYSDPFVKLWLKPDMGKKAKHKTQIKKKTLNPEFNEEFFYD--IKHSDLAKKSLDISVW 90 (137)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETC---CCEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCCCCCCCCcCeEEEEEEEcCCccceeecCEeEcCCCCCccceEEEEE--eEHHHccccEEEEEee
Confidence 557899999999 9999999999999999999999888889999999999999999999999 887777 455999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|++.+++++++|++.++..+.
T Consensus 91 ~~~~~~~~~~iG~~~i~l~~~ 111 (137)
T d2cm5a1 91 DYDIGKSNDYIGGCQLGISAK 111 (137)
T ss_dssp ECCSSSCCEEEEEEEEETTCC
T ss_pred eCCCCCCCCEEEEEEeCcccc
Confidence 999999999999999987543
|
| >d1rsya_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=2.7e-16 Score=146.37 Aligned_cols=96 Identities=15% Similarity=0.111 Sum_probs=85.0
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|+|.|.+| ||+++|.+|.+|||||+.|++++++ +++|+++++|+||+|||+|.|. ++...+ +.+|.++||
T Consensus 32 ~~~~L~V~V~~a~~L~~~~~~g~~dpyV~v~l~~~~~~--~~kT~~~~~t~~P~wne~f~f~--i~~~~l~~~~L~i~V~ 107 (143)
T d1rsya_ 32 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVY 107 (143)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETTCCS--CEECCCCTTCSSCEEEEEEEEC--CCHHHHTTCEEEEEEE
T ss_pred CCCEEEEEEEEccCCCCCCCCCCCCeEEEEEEcCCCCe--eEEEEEeccccCcceeeeeEEE--EEeeccCCceEEEEEE
Confidence 457899999999 9999999999999999999998664 6789999999999999999998 776655 556999999
Q ss_pred ccCCCCCCccccccccCccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|++++++++++|.+.+...+..
T Consensus 108 d~d~~~~~~~iG~~~i~L~~~~ 129 (143)
T d1rsya_ 108 DFDRFSKHDIIGEFKVPMNTVD 129 (143)
T ss_dssp ECCSSSCCEEEEEEEEEGGGCC
T ss_pred EcCCCCCCcEEEEEEEEchhcc
Confidence 9999999999999998766553
|
| >d1rh8a_ b.7.1.2 (A:) Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Piccolo species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=2e-16 Score=146.72 Aligned_cols=100 Identities=13% Similarity=0.111 Sum_probs=84.7
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCc---------ccceeeecccCCCcceeeeeecccccccCcc-
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE---------KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA- 332 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~---------~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~- 332 (722)
..+.|+|.|.+| ||+++|..|.+|||||+.|+++.... .++||+++++|+||.|||+|.|.. ++.+.+
T Consensus 16 ~~~~L~V~V~~A~~L~~~d~~g~~DpyV~v~l~~~~~~~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~ 94 (142)
T d1rh8a_ 16 DLGNLIIHILQARNLVPRDNNGYSDPFVKVYLLPGRGQVMVVQNASAEYKRRTKYVQKSLNPEWNQTVIYKS-ISMEQLM 94 (142)
T ss_dssp ETTEEEEEEEEEESCCCCSSSSCSCCEEEEEETTSSCCCEECCCCCHHHHTTTTTTHHHHSCEEEEEEEECS-CCHHHHT
T ss_pred eCCEEEEEEEEeECCCCcCCCCCCCcCEEEEEecCcccccccccCCCceeeeccCCcCCCCceeEEEEEEee-ecccccC
Confidence 346899999999 99999999999999999999876543 357899999999999999999974 444444
Q ss_pred cccccccccccCCCCCCccccccccCcccccc
Q 004954 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 333 ~~~L~~~V~D~D~~~~~d~iG~v~~~~~~~~~ 364 (722)
...|.++|||+|.+++++++|++.+...+...
T Consensus 95 ~~~L~i~V~d~d~~~~~~~lG~~~i~L~~l~~ 126 (142)
T d1rh8a_ 95 KKTLEVTVWDYDRFSSNDFLGEVLIDLSSTSH 126 (142)
T ss_dssp TCEEEEEEEEECSSSCEEEEEEEEEETTSCGG
T ss_pred CCEEEEEEEEecCCCCCeeeEEEEEEhHHcCC
Confidence 55699999999999999999999987765544
|
| >d1ugka_ b.7.1.2 (A:) Synaptotagmin IV {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.7e-15 Score=140.03 Aligned_cols=96 Identities=11% Similarity=0.075 Sum_probs=82.9
Q ss_pred ccceeEEEEeec-CCccccCCCC-CCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-cccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVV-GDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~-sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V 340 (722)
....|+|.|.+| ||+++|..|. +|||||+.|+|+++. ++||+++++++||.|||+|.|.. ++.+.+ +.+|.++|
T Consensus 20 ~~~~L~V~V~~a~~L~~~d~~~~~~dpyV~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~~-~~~~~l~~~~L~~~V 96 (138)
T d1ugka_ 20 ERKAFVVNIKEARGLPAMDEQSMTSDPYIKMTILPEKKH--KVKTRVLRKTLDPAFDETFTFYG-IPYTQIQELALHFTI 96 (138)
T ss_dssp GGTEEEEEEEEEESCCCCBTTTTBCEEEEEEEEETTTCS--EEECCCCSSCSSCEEEEEEEEEC-CCSTTGGGCEEEEEE
T ss_pred CCCEEEEEEEEecCCCCCCCCCCccceEEEEEEcCCCCE--eEeCeeEeCCCCCceeeEEEEee-eCHHHcccceEEEEE
Confidence 557899999999 9999998874 799999999997654 77899999999999999999962 566665 55699999
Q ss_pred cccCCCCCCccccccccCcccc
Q 004954 341 IDNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 341 ~D~D~~~~~d~iG~v~~~~~~~ 362 (722)
||.|++++++++|++.+...+.
T Consensus 97 ~d~d~~~~~~~iG~~~i~L~~~ 118 (138)
T d1ugka_ 97 LSFDRFSRDDIIGEVLIPLSGI 118 (138)
T ss_dssp EEECSSCCCCCCEEEEEECTTC
T ss_pred EECCCCCCCcEEEEEEEEcccc
Confidence 9999999999999998876554
|
| >d1wfma_ b.7.1.2 (A:) Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin XIII species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=2.9e-15 Score=138.49 Aligned_cols=94 Identities=18% Similarity=0.151 Sum_probs=81.9
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc-ccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~-~~~L~~~V~ 341 (722)
....|.|.|++| || +.+|.+|||||++|+|+.+ ..+++|+++++++||+|||+|.|. ++.+.+ ..+|.++||
T Consensus 24 ~~~~L~V~v~~a~~L---~~~g~~dpyVkv~l~~~~~-~~~~kT~v~~~~~~P~wne~f~f~--v~~~~l~~~~L~~~V~ 97 (138)
T d1wfma_ 24 QKAELFVTRLEAVTS---NHDGGCDCYVQGSVANRTG-SVEAQTALKKRQLHTTWEEGLVLP--LAEEELPTATLTLTLR 97 (138)
T ss_dssp TTTEEEEEEEEEECC---CCSSCCCEEEEEEEEETTE-EEEEECCCCCCCSSEECSSCEEEE--CCTTSSTTCEEEEEEE
T ss_pred CCCEEEEEEEEcCCC---CCCCCcCcEEEEEECCCCC-ccceeeeEECCCCCceEeeeEEEE--eeehhccceEEEEEEe
Confidence 457899999999 98 4678999999999999855 357789999999999999999999 877766 566999999
Q ss_pred ccCCCCCCccccccccCccccc
Q 004954 342 DNSDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~~ 363 (722)
|++++++++++|++.++..+..
T Consensus 98 d~~~~~~~~~iG~~~i~L~~l~ 119 (138)
T d1wfma_ 98 TCDRFSRHSVAGELRLGLDGTS 119 (138)
T ss_dssp ECCSSCTTSCSEEEEEESSSSS
T ss_pred eecccccceeeeEEEEEhHHcc
Confidence 9999999999999998876654
|
| >d2ep6a1 b.7.1.1 (A:92-217) Multiple C2 and transmembrane domain-containing protein 2, MCTP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Multiple C2 and transmembrane domain-containing protein 2, MCTP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.9e-15 Score=137.48 Aligned_cols=90 Identities=11% Similarity=0.053 Sum_probs=78.2
Q ss_pred cceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccccccc
Q 004954 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (722)
.++|+|.|.+| ||+++|.+|.+||||++.+.. .+++|+++++|+||.|||+|.|. ++. ....|.++|||+
T Consensus 5 ~G~L~V~v~~A~~L~~~d~~g~~Dpyv~v~~~~-----~~~~T~~~~~t~nP~wne~f~f~--v~~--~~~~L~i~V~d~ 75 (126)
T d2ep6a1 5 VGILQVKVLKAADLLAADFSGKSDPFCLLELGN-----DRLQTHTVYKNLNPEWNKVFTFP--IKD--IHDVLEVTVFDE 75 (126)
T ss_dssp SEEEEEEEEEEESCCCSSSSSCCCEEEEEEETT-----EEEECCCCSSCSSCCCCEEEEEE--ESC--TTCEEEEEEEEE
T ss_pred cEEEEEEEEEeECCCCCCCCCCcCeEEEEEcCC-----eEEEEEeeCCceeEEEEEEEEEE--Eec--cCceeEEEEEEc
Confidence 46899999999 999999999999999999943 46789999999999999999998 553 234699999999
Q ss_pred CCCCCCccccccccCccccc
Q 004954 344 SDTRDGEVNGALHEGKADAE 363 (722)
Q Consensus 344 D~~~~~d~iG~v~~~~~~~~ 363 (722)
+.+++++++|.+.+...+..
T Consensus 76 ~~~~~d~~lG~~~i~l~~l~ 95 (126)
T d2ep6a1 76 DGDKPPDFLGKVAIPLLSIR 95 (126)
T ss_dssp ETTEEEEECCBCEEEGGGCC
T ss_pred cCCcCcceEEEEEEEHHHCC
Confidence 99999999999988765543
|
| >d1qasa2 b.7.1.1 (A:626-756) PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=4.2e-14 Score=129.41 Aligned_cols=94 Identities=10% Similarity=-0.008 Sum_probs=72.8
Q ss_pred ceeEEEEeec-CCcc--ccCCCCCCcceEEEecCCCCCcccceeeec-ccCCCcceeeeeecccccccCccccccccccc
Q 004954 266 DYGYLSSKEA-DLID--LQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~--~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~-k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
..|+|.|++| +|+. +|.+|.+||||++.|...+....+++|++. ++++||.|||+|.|. +..... ..|.++||
T Consensus 4 ~~l~V~Vi~a~~L~~~~~~~~~~~DPyV~v~l~g~~~~~~~~~T~~v~~~~~nP~wne~f~f~--~~~~~~-~~L~~~V~ 80 (131)
T d1qasa2 4 ERLRVRIISGQQLPKVNKNKNSIVDPKVIVEIHGVGRDTGSRQTAVITNNGFNPRWDMEFEFE--VTVPDL-ALVRFMVE 80 (131)
T ss_dssp EEEEEEEEEEESCCCCC-----CCCEEEEEEEESSTTTCEEEECCCCSSCSSSCEEEEEEEEE--ESCGGG-CEEEEEEE
T ss_pred EEEEEEEEEeeCCCCCCCCCCCCcCeEEEEEEccCCCCcEEEEEEEEecccCCceEEEEEEEE--EEcchh-ceEEEEEE
Confidence 5799999999 9964 567888999999999877666677888875 466899999999997 544333 24899999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|.+++++++|++.+.....
T Consensus 81 D~d~~~~d~~iG~~~i~l~~l 101 (131)
T d1qasa2 81 DYDSSSKNDFIGQSTIPWNSL 101 (131)
T ss_dssp ECCTTTCCEEEEEEEEEGGGB
T ss_pred EecCCCCCcEEEEEEEEEecc
Confidence 999999999999998865433
|
| >d1rlwa_ b.7.1.1 (A:) Domain from cytosolic phospholipase A2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from cytosolic phospholipase A2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.1e-13 Score=125.37 Aligned_cols=93 Identities=13% Similarity=0.014 Sum_probs=76.5
Q ss_pred ccceeEEEEeec-CCcc---ccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCccccccccc
Q 004954 264 NNDYGYLSSKEA-DLID---LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~---~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~ 339 (722)
|..+|+|.|.+| ||+. .|..|.+||||++++.+++. .+++|+++++++||.|||+|.|. +... ....|.++
T Consensus 1 ss~~l~V~v~~a~~L~~~~~~d~~~~~Dpyv~v~l~~~~~--~~~~T~~~~~t~nP~wne~f~f~--i~~~-~~~~L~v~ 75 (126)
T d1rlwa_ 1 SSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPD--SRKRTRHFNNDINPVWNETFEFI--LDPN-QENVLEIT 75 (126)
T ss_dssp CCEEEEEEEEEEESCCSCHHHHHHCCCCEEEEEECTTSTT--CCEECCCCTTCSSCEEEEEEEEE--ECTT-SCCEEEEE
T ss_pred CCcEEEEEEEEccCCCCccccccCCCCCcEEEEEECCccc--ceeEeeecCCCccceeceeeeec--ccCc-ccCcEEEE
Confidence 457899999999 9986 56788999999999977654 47889999999999999999998 5422 23459999
Q ss_pred ccccCCCCCCccccccccCcccc
Q 004954 340 EIDNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 340 V~D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|||+|.++ ++++|.+.+...+.
T Consensus 76 V~d~d~~~-d~~lG~~~i~L~~l 97 (126)
T d1rlwa_ 76 LMDANYVM-DETLGTATFTVSSM 97 (126)
T ss_dssp EEECCSSC-CEEEEEEEEEGGGS
T ss_pred EEECCCCC-CCeEEEEEEEHHHc
Confidence 99999765 68999998876555
|
| >d1wfja_ b.7.1.2 (A:) C2 domain protein At1g63220 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain protein At1g63220 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.35 E-value=1.8e-13 Score=125.66 Aligned_cols=90 Identities=12% Similarity=0.066 Sum_probs=74.7
Q ss_pred ccceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecc-cCCCcceeeeeecccccccCccccccccccc
Q 004954 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSK-RGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (722)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k-~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~ 341 (722)
+.+.|+|.|++| +|+++|..|.+||||++.+-. .+++|++++ +++||+|||+|.|. +.. ....|.++||
T Consensus 8 p~G~L~V~v~~a~~L~~~d~~g~~Dpyv~v~~~~-----~~~~t~~~~~~~~nP~Wne~f~f~--v~~--~~~~L~v~V~ 78 (136)
T d1wfja_ 8 PHGTLEVVLVSAKGLEDADFLNNMDPYVQLTCRT-----QDQKSNVAEGMGTTPEWNETFIFT--VSE--GTTELKAKIF 78 (136)
T ss_dssp CEEEEEEEEEEEEECSSCCSSCSSCCCEEEESSS-----CEEECCCCTTCCSSCEEEEEEEEE--EES--SCCEEEEEEC
T ss_pred CcEEEEEEEEEeeCCCCCCCCCCCCccEEEEEee-----eeEEEEEEecCCCcEEEeeEEEEE--EcC--ccceEEEEEE
Confidence 446899999999 999999999999999999853 245666654 79999999999998 653 2334999999
Q ss_pred ccCCCCCCccccccccCcccc
Q 004954 342 DNSDTRDGEVNGALHEGKADA 362 (722)
Q Consensus 342 D~D~~~~~d~iG~v~~~~~~~ 362 (722)
|+|.+++++++|.+.+...++
T Consensus 79 d~d~~~~d~~iG~~~i~L~~l 99 (136)
T d1wfja_ 79 DKDVGTEDDAVGEATIPLEPV 99 (136)
T ss_dssp CSSSCTTTCCSEEEEEESHHH
T ss_pred EecCCCCCCEEEEEEEEhHHh
Confidence 999999999999998765443
|
| >d1gmia_ b.7.1.1 (A:) Domain from protein kinase C epsilon {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C epsilon species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.28 E-value=4.4e-13 Score=123.30 Aligned_cols=93 Identities=11% Similarity=0.105 Sum_probs=77.2
Q ss_pred cceeEEEEeec-CCcccc-----------CCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcc
Q 004954 265 NDYGYLSSKEA-DLIDLQ-----------HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 332 (722)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d-----------~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~ 332 (722)
++.|+|.|.+| +|+++| .+|.+||||++.+- .+...+|++++++.||+|||+|.|. ++.
T Consensus 5 ~G~L~v~I~~A~~L~~~~~~~~~~~~~~~~~~~~DPYv~v~l~----~~~~~~T~~~~~t~~P~Wne~f~f~--v~~--- 75 (136)
T d1gmia_ 5 NGLLKIKICEAVSLKPTAWSLRDAVGPRPQTFLLDPYIALNVD----DSRIGQTATKQKTNSPAWHDEFVTD--VCN--- 75 (136)
T ss_dssp EEEEEEEEEEEESCCCCHHHHCC-CCSSCCCCCCCEEEEEEET----TEEEEECCCCSSCSSCEEEEEEEEE--EEE---
T ss_pred EEEEEEEEEEeECCCcccccccccccccCCCCCcCcEEEEEeC----CCcCcEeeEEcCCCCccCccEEEEE--Eec---
Confidence 46899999999 999987 57788999999992 2345678889999999999999998 653
Q ss_pred cccccccccccCCCCCCccccccccCcccccccc
Q 004954 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHG 366 (722)
Q Consensus 333 ~~~L~~~V~D~D~~~~~d~iG~v~~~~~~~~~e~ 366 (722)
.+.|.++|||++.+++++++|.+.+...++...+
T Consensus 76 ~~~l~i~V~d~~~~~~d~~iG~~~i~l~~l~~~~ 109 (136)
T d1gmia_ 76 GRKIELAVFHDAPIGYDDFVANCTIQFEELLQNG 109 (136)
T ss_dssp ECEEEEEEEECCSSSSCEEEEEEEEEHHHHTSTT
T ss_pred CCceEEEEEEecCCCCceeEEEEEEEHHHhhhcC
Confidence 3559999999999999999999988776654443
|
| >d2nq3a1 b.7.1.1 (A:13-145) E3 ubiquitin-protein ligase Itchy {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: E3 ubiquitin-protein ligase Itchy species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=1.9e-12 Score=118.54 Aligned_cols=87 Identities=7% Similarity=-0.036 Sum_probs=72.6
Q ss_pred ceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccC
Q 004954 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D 344 (722)
..|.|+|.+| +|+..+..+..||||++.+-. ++++|+++++|+||.|||.|.|. +... ..|.++|||+|
T Consensus 6 ~~L~v~v~~A~~~~~~~~~~~~dpyv~v~~~~-----~~~kT~v~~~t~nP~wne~f~f~--~~~~---~~l~~~V~d~d 75 (133)
T d2nq3a1 6 SQLQITVISAKLKENKKNWFGPSPYVEVTVDG-----QSKKTEKCNNTNSPKWKQPLTVI--VTPV---SKLHFRVWSHQ 75 (133)
T ss_dssp EEEEEEEEEEEECCCC--CCCCCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--ECTT---CEEEEEEEECC
T ss_pred eEEEEEEEEeECCCcCCCCCCcCeEEEEEECC-----eEEeeEEEEecccEEEcceEEEE--EEec---ceeEEEEEEcc
Confidence 5789999999 899989888999999999853 36789999999999999999998 5432 35999999999
Q ss_pred CCCCCccccccccCcccc
Q 004954 345 DTRDGEVNGALHEGKADA 362 (722)
Q Consensus 345 ~~~~~d~iG~v~~~~~~~ 362 (722)
.+++++++|++.+...++
T Consensus 76 ~~~~d~~iG~~~i~L~~l 93 (133)
T d2nq3a1 76 TLKSDVLLGTAALDIYET 93 (133)
T ss_dssp SSSCCEEEEEEEEEHHHH
T ss_pred CCCCCceEEEEEEEHHHh
Confidence 999999999998865433
|
| >d1bdya_ b.7.1.1 (A:) Domain from protein kinase C delta {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C delta species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.12 E-value=9.1e-12 Score=112.39 Aligned_cols=84 Identities=10% Similarity=0.076 Sum_probs=64.7
Q ss_pred eEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccCCC
Q 004954 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (722)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D~~ 346 (722)
++|.+.++ .++. ..|.+||||+++|....+..++++|+++|+|+||+|||+|.|. +.. ...|.+.|||+|
T Consensus 7 ~~~~~~~~~~~~~--~~~~~dPY~~v~l~~~~~~~~~~~t~~~kkT~nP~WnE~F~~~--v~~---~~~l~i~V~d~d-- 77 (123)
T d1bdya_ 7 ISFNSYELGSLQA--EDDASQPFCAVKMKEALTTDRGKTLVQKKPTMYPEWKSTFDAH--IYE---GRVIQIVLMRAA-- 77 (123)
T ss_dssp EEEEEEECCTTCC--CCCSCCCEEEEEEEEECCGGGTTBEEECSCCBCCCTTCEEEEE--CCT---TCEEEEEEEEET--
T ss_pred EEEEEeecccCCC--CCCCCCCEEEEEEcCccccccceEEEEeCCCCCcccceEEEEE--Ecc---ccEEEEEEEEcc--
Confidence 34555555 5554 5889999999999887666667789999999999999999998 653 245999999986
Q ss_pred CCCccccccccCcccc
Q 004954 347 RDGEVNGALHEGKADA 362 (722)
Q Consensus 347 ~~~d~iG~v~~~~~~~ 362 (722)
++++|...++...+
T Consensus 78 --d~~~g~~~i~l~~l 91 (123)
T d1bdya_ 78 --EDPMSEVTVGVSVL 91 (123)
T ss_dssp --TEEEEEEEEEHHHH
T ss_pred --ccccCccEEehhhe
Confidence 67888877665433
|
| >d2cjta1 b.7.1.1 (A:1-128) Unc-13 homolog A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Unc-13 homolog A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.00 E-value=7.7e-11 Score=106.90 Aligned_cols=85 Identities=11% Similarity=0.026 Sum_probs=69.0
Q ss_pred ceeEEEEeec-CCccccCCCCCCcceEEEecCCCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccccC
Q 004954 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (722)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D~D 344 (722)
..|+|.|.+| +|.++| ..||||++.+- ..|.+|.+.| +.||+|||+|.|. +.. .+..|.++|||++
T Consensus 2 ~~L~V~v~~a~~l~~~~---~~dpYv~l~~~-----~~k~~T~~~k-~~nP~Wne~f~f~--v~~--~~~~L~v~V~d~~ 68 (128)
T d2cjta1 2 SLLCVGVKKAKFDGAQE---KFNTYVTLKVQ-----NVKSTTIAVR-GSQPSWEQDFMFE--INR--LDLGLTVEVWNKG 68 (128)
T ss_dssp EEEEEEEEEEECSSCGG---GCEEEEEEEET-----TEEEECCCEE-SSSCEEEEEEEEE--ECC--CSSEEEEEEEECC
T ss_pred eEEEEEEEEEECCCCCC---CcCeEEEEEeC-----CEEEEEEEec-CCCCeEEEEEEEe--ecc--ccceEEEEEEeCC
Confidence 4689999999 999987 57999999993 2467777664 6799999999998 543 3455999999999
Q ss_pred CCCCCccccccccCcccccc
Q 004954 345 DTRDGEVNGALHEGKADAEE 364 (722)
Q Consensus 345 ~~~~~d~iG~v~~~~~~~~~ 364 (722)
..+ ++++|.+.+...++..
T Consensus 69 ~~~-d~~lG~~~I~L~~l~~ 87 (128)
T d2cjta1 69 LIW-DTMVGTVWIPLRTIRQ 87 (128)
T ss_dssp SSC-EEEEEEEEEEGGGSCB
T ss_pred CcC-CcceEEEEEEehhhcc
Confidence 875 7899999998877643
|
| >d2zkmx2 b.7.1.1 (X:678-799) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=6.1e-10 Score=100.01 Aligned_cols=84 Identities=12% Similarity=0.009 Sum_probs=58.4
Q ss_pred eeEEEEeec-CCccccCCCCCCcceEEEecC---CCCCcccceeeecccCCCcceeeeeecccccccCcccccccccccc
Q 004954 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAP---HPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (722)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyvk~~l~~---d~~~~~k~kt~~~k~tlnP~~nE~f~f~~~v~~~~~~~~L~~~V~D 342 (722)
.|+|.|+.| +|+.. ..|||||+.|.. |.+++.++++.++++++||.|||++.|...+...++ ..|.++|||
T Consensus 2 tl~V~Visaq~L~~~----~~dPyV~V~l~g~~~D~~~~~~t~~~~~~n~~nP~wne~~~~~~~~~~~~l-~~L~f~V~D 76 (122)
T d2zkmx2 2 TLSITVISGQFLSER----SVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEKILMPEL-ASLRVAVME 76 (122)
T ss_dssp EEEEEEEEEESCCSS----CCCEEEEEEEECCTTSCCCCEECCCCSSSCCSSCBCCCCCEEEEEESSGGG-CEEEEEEEE
T ss_pred EEEEEEEEeeCCCCC----CCCcEEEEEEECcCCCCCccEEEEEEEeCCeecceEcccEeEEEecCCCcc-cEEEEEEEC
Confidence 478999999 99865 479999999963 334434444445788999999987333211222222 248999999
Q ss_pred cCCCCCCccccccccCc
Q 004954 343 NSDTRDGEVNGALHEGK 359 (722)
Q Consensus 343 ~D~~~~~d~iG~v~~~~ 359 (722)
+| ++++|.+.+..
T Consensus 77 ~d----~~~lG~~~ipl 89 (122)
T d2zkmx2 77 EG----NKFLGHRIIPI 89 (122)
T ss_dssp TT----TEEEEEEEEEG
T ss_pred CC----CCEEEEEEEEc
Confidence 85 78999887754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.23 E-value=4.8e-06 Score=82.53 Aligned_cols=82 Identities=10% Similarity=0.065 Sum_probs=58.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 414 ~rY~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~-~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
..|++.+..+-++.+.||+.. ..++.+++|+..... .......+|..+++.+.... -+++++.+....+..+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~v-----pvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKL-----PVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTS-----CCCCEEEEEEETTEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccC-----CCCcEEEEEecCCceE
Confidence 456777665555567899986 466678888876543 23346778999998886421 3677788888889999
Q ss_pred EEEEccccch
Q 004954 493 IVCELLRANL 502 (722)
Q Consensus 493 iVmEy~~gsL 502 (722)
+||++++|..
T Consensus 87 lv~~~l~G~~ 96 (263)
T d1j7la_ 87 LLMSEADGVL 96 (263)
T ss_dssp EEEECCSSEE
T ss_pred EEEEeccccc
Confidence 9999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.59 E-value=0.00011 Score=72.07 Aligned_cols=72 Identities=10% Similarity=0.038 Sum_probs=52.8
Q ss_pred eccCC-CCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc
Q 004954 422 LGSAA-FSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA 500 (722)
Q Consensus 422 LG~G~-fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~iVmEy~~g 500 (722)
+..|. .+.||+... ..+..+++|+..... ...+..|..+++.+.... -.+++++.+..+.+..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~g----vpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTG----VPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTT----CCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcC----CCCCceeeecccccceEEEEEeeec
Confidence 44444 367899873 567778899876543 346778999999887642 2367788888888899999999976
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.57 E-value=0.00012 Score=77.44 Aligned_cols=77 Identities=18% Similarity=0.125 Sum_probs=51.5
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecc--------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 004954 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (722)
Q Consensus 419 ~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~--------~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (722)
.+.||.|....||++.+..+++.++||.-... ....++...|..+|+.+.... ...+++++.+ +.+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~---p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV---PHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTC---GGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhC---CCCcceEEEE--cCCC
Confidence 34589999999999988777889999975321 112345677999998886542 2356677654 4556
Q ss_pred EEEEEEcccc
Q 004954 491 LFIVCELLRA 500 (722)
Q Consensus 491 l~iVmEy~~g 500 (722)
.++|||++.+
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 6799999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.88 E-value=0.0009 Score=68.41 Aligned_cols=71 Identities=17% Similarity=0.204 Sum_probs=47.6
Q ss_pred CceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEE--EEEEEecCeEEEEEEcccc
Q 004954 428 SKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL--YDYFYHLEHLFIVCELLRA 500 (722)
Q Consensus 428 G~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l--~~~f~~~~~l~iVmEy~~g 500 (722)
-.||++.. .+|+.+++|+.+.......++..|..++..|...... .+..+.. -..+...+..+.|++++.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gip-v~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVP-VAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCS-BCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCC-CCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 57999974 6788999999877654556788899999998865311 1111111 1122345678889999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.55 E-value=0.0026 Score=66.60 Aligned_cols=72 Identities=14% Similarity=0.127 Sum_probs=49.3
Q ss_pred EEeccCCCCceEEEEECC-------CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 004954 420 EYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (722)
Q Consensus 420 ~~LG~G~fG~Vy~a~d~~-------tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (722)
+.|+-|-.=.+|++.... ..+.|.+++.-..... -...+|..+++.+.... -.+++++++.. .
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~g-----l~Pkll~~~~~----g 117 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERH-----LGPKLYGIFSG----G 117 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTT-----SSSCEEEEETT----E
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCC-----CCCeEEEEcCC----c
Confidence 467778888889887532 3466888887643333 34568999999988653 24577777642 6
Q ss_pred EEEEccccc
Q 004954 493 IVCELLRAN 501 (722)
Q Consensus 493 iVmEy~~gs 501 (722)
+||||+.|.
T Consensus 118 ~I~efi~g~ 126 (395)
T d1nw1a_ 118 RLEEYIPSR 126 (395)
T ss_dssp EEECCCCEE
T ss_pred eEEEEeccc
Confidence 899999863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.48 E-value=0.044 Score=54.61 Aligned_cols=53 Identities=6% Similarity=-0.022 Sum_probs=32.5
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccC
Q 004954 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471 (722)
Q Consensus 416 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAvKil~~~~~~~~~~~~E~~il~~L~~~~ 471 (722)
..-.+.|..|---+.|+.+. ..| .+++|+..... ..+.+..|+.++..|....
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC----CCHHHHHHHHHHHHHHTT
T ss_pred ceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhcc
Confidence 34445677777788899873 334 58999986532 2345667888888887754
|